PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jung, J; Byeon, IJL; DeLucia, M; Koharudin, LMI; Ahn, J; Gronenborn, AM				Jung, Jinwon; Byeon, In-Ja L.; DeLucia, Maria; Koharudin, Leonardus M. I.; Ahn, Jinwoo; Gronenborn, Angela M.			Binding of HIV-1 Vpr Protein to the Human Homolog of the Yeast DNA Repair Protein RAD23 (hHR23A) Requires Its Xeroderma Pigmentosum Complementation Group C Binding (XPCB) Domain as Well as the Ubiquitin-associated 2 (UBA2) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Base Excision Repair; HIV-1; NMR; Protein-Protein Interactions; Ubiquitination; Binding; UBA2; Vpr; XPCB; hHR23A	IMMUNODEFICIENCY-VIRUS TYPE-1; NUCLEOTIDE EXCISION-REPAIR; CELL-CYCLE ARREST; RECRUITING DCAF1/VPRBP; MUTATIONAL ANALYSIS; R VPR; G(2); COMPLEX; INTERACTS; GENE	Background: The HIV-1 accessory protein Vpr interacts with the human nucleotide excision repair protein hHR23A. Results: NMR and other biophysical/biochemical techniques were used to identify Vpr binding sites on hHR23A. Conclusion: hHR23A interacts with Vpr via two domains, XPCB and UBA2. Significance: The involvement of the hHR23A XPCB and UBA2 domains in Vpr binding suggests that cellular effects can be modulated by diverse mechanisms. The human homolog of the yeast DNA repair protein RAD23, hHR23A, has been found previously to interact with the human immunodeficiency virus, type 1 accessory protein Vpr. hHR23A is a modular protein containing an N-terminal ubiquitin-like (UBL) domain and two ubiquitin-associated domains (UBA1 and UBA2) separated by a xeroderma pigmentosum complementation group C binding (XPCB) domain. All domains are connected by flexible linkers. hHR23A binds ubiquitinated proteins and acts as a shuttling factor to the proteasome. Here, we show that hHR23A utilizes both the UBA2 and XPCB domains to form a stable complex with Vpr, linking Vpr directly to cellular DNA repair pathways and their probable exploitation by the virus. Detailed structural mapping of the Vpr contacts on hHR23A, by NMR, revealed substantial contact surfaces on the UBA2 and XPCB domains. In addition, Vpr binding disrupts an intramolecular UBL-UBA2 interaction. We also show that Lys-48-linked di-ubiquitin, when binding to UBA1, does not release the bound Vpr from the hHR23A-Vpr complex. Instead, a ternary hHR23AVprdi-Ub(K48) complex is formed, indicating that Vpr does not necessarily abolish hHR23A-mediated shuttling to the proteasome.	[Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Host Prot Interact, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gronenborn, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15261 USA.	amg100@pitt.edu		Jung, Jinwon/0000-0002-7981-3316; Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health [P50GM82251]; University of Pittsburgh Center For AIDS Research Pilot grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh Center For AIDS Research Pilot grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P50GM82251 (to A. M. G.). This work was also supported by a University of Pittsburgh Center For AIDS Research Pilot grant (to J. A.).	Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; BALLIET JW, 1994, VIROLOGY, V200, P623, DOI 10.1006/viro.1994.1225; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, J VIROL, V84, P3320, DOI 10.1128/JVI.02590-09; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desrosiers RC, 1998, J VIROL, V72, P1431, DOI 10.1128/JVI.72.2.1431-1437.1998; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; GIBBS JS, 1995, J VIROL, V69, P2378, DOI 10.1128/JVI.69.4.2378-2383.1995; Gragerov A, 1998, VIROLOGY, V245, P323, DOI 10.1006/viro.1998.9138; GUZDER SN, 1995, J BIOL CHEM, V270, P12973, DOI 10.1074/jbc.270.22.12973; Hartmann-Petersen R, 2004, CURR BIOL, V14, pR754, DOI 10.1016/j.cub.2004.09.012; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Kamionka M, 2004, PROTEIN SCI, V13, P2370, DOI 10.1110/ps.04824304; Keller R.L.J., 2005, OPTIMIZING PROCESS N; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; LANG SM, 1993, J VIROL, V67, P902, DOI 10.1128/JVI.67.2.902-912.1993; Le Rouzic E, 2008, J BIOL CHEM, V283, P21686, DOI 10.1074/jbc.M710298200; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lee JH, 2005, P NATL ACAD SCI USA, V102, P9144, DOI 10.1073/pnas.0502082102; Li G., 2010, PLOS ONE, V5; Li G, 2009, CURR HIV RES, V7, P178, DOI 10.2174/157016209787581436; Li L, 1997, MUTAT RES-DNA REPAIR, V383, P197, DOI 10.1016/S0921-8777(97)00002-5; Maciejewski MW, 2012, TOP CURR CHEM, V316, P49, DOI 10.1007/128_2011_185; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mansky LM, 2001, VIROLOGY, V282, P176, DOI 10.1006/viro.2000.0791; Masutani C, 1997, MOL CELL BIOL, V17, P6915, DOI 10.1128/MCB.17.12.6915; MASUTANI C, 1994, EMBO J, V13, P1831, DOI 10.1002/j.1460-2075.1994.tb06452.x; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Mobli M, 2007, J BIOMOL NMR, V39, P133, DOI 10.1007/s10858-007-9180-8; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Mueller TD, 2004, J BIOL CHEM, V279, P11926, DOI 10.1074/jbc.M312865200; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Planelles V, 1996, J VIROL, V70, P2516, DOI 10.1128/JVI.70.4.2516-2524.1996; RE F, 1995, J VIROL, V69, P6859, DOI 10.1128/JVI.69.11.6859-6864.1995; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Simon JHM, 1998, EMBO J, V17, P1259, DOI 10.1093/emboj/17.5.1259; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 1997, MOL CELL BIOL, V17, P6924, DOI 10.1128/MCB.17.12.6924; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Transy C, 2009, CELL CYCLE, V8, P2489, DOI 10.4161/cc.8.16.9129; vanderSpek PJ, 1996, NUCLEIC ACIDS RES, V24, P2551, DOI 10.1093/nar/24.13.2551; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Varthakavi V, 2003, P NATL ACAD SCI USA, V100, P15154, DOI 10.1073/pnas.2433165100; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walters KJ, 2003, P NATL ACAD SCI USA, V100, P12694, DOI 10.1073/pnas.1634989100; Ward J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000613; WATKINS JF, 1993, MOL CELL BIOL, V13, P7757, DOI 10.1128/MCB.13.12.7757; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Withers-Ward ES, 2000, BIOCHEMISTRY-US, V39, P14103, DOI 10.1021/bi0017071; WithersWard ES, 1997, J VIROL, V71, P9732, DOI 10.1128/JVI.71.12.9732-9742.1997; Zhao RY, 2011, J NEUROIMMUNE PHARM, V6, P216, DOI 10.1007/s11481-011-9261-z	64	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2577	2588		10.1074/jbc.M113.534453	http://dx.doi.org/10.1074/jbc.M113.534453			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24318982	Green Published, hybrid			2022-12-25	WOS:000333403000009
J	Lipscomb, GL; Schut, GJ; Thorgersen, MP; Nixon, WJ; Kelly, RM; Adams, MWW				Lipscomb, Gina L.; Schut, Gerrit J.; Thorgersen, Michael P.; Nixon, William J.; Kelly, Robert M.; Adams, Michael W. W.			Engineering Hydrogen Gas Production from Formate in a Hyperthermophile by Heterologous Production of an 18-Subunit Membrane-bound Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Archaea; Enzymes; Genetics; Metabolic Engineering; Microbiology; Hydrogen; Hyperthermophiles	ARCHAEON PYROCOCCUS-FURIOSUS; SULFUR METABOLISM; SYSTEM; GENOME; FUELS; SURR	Background: Biohydrogen production from formate may aid in efficient chemical and fuel production using H-2 as the energy carrier. Results: The hyperthermophile Pyrococcus furiosus was engineered to convert formate to H-2. Conclusion: An 18-gene cluster can be inserted into the P. furiosus chromosome for active production of a membrane-bound system. Significance: This work demonstrates the versatility of this model organism for metabolic engineering purposes. Biohydrogen gas has enormous potential as a source of reductant for the microbial production of biofuels, but its low solubility and poor gas mass transfer rates are limiting factors. These limitations could be circumvented by engineering biofuel production in microorganisms that are also capable of generating H-2 from highly soluble chemicals such as formate, which can function as an electron donor. Herein, the model hyperthermophile, Pyrococcus furiosus, which grows optimally near 100 degrees C by fermenting sugars to produce H-2, has been engineered to also efficiently convert formate to H-2. Using a bacterial artificial chromosome vector, the 16.9-kb 18-gene cluster encoding the membrane-bound, respiratory formate hydrogen lyase complex of Thermococcus onnurineus was inserted into the P. furiosus chromosome and expressed as a functional unit. This enabled P. furiosus to utilize formate as well as sugars as an H-2 source and to do so at both 80 degrees and 95 degrees C, near the optimum growth temperature of the donor (T. onnurineus) and engineered host (P. furiosus), respectively. This accomplishment also demonstrates the versatility of P. furiosus for metabolic engineering applications.	[Lipscomb, Gina L.; Schut, Gerrit J.; Thorgersen, Michael P.; Nixon, William J.; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Kelly, Robert M.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA	University System of Georgia; University of Georgia; University of North Carolina; North Carolina State University	Adams, MWW (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	adams@bmb.uga.edu		Thorgersen, Michael/0000-0001-9552-762X; Kelly, Robert/0000-0002-0639-3592; Adams, Michael/0000-0002-9796-5014	United States Department of Energy as part of the Electrofuels Project of ARPA-E [DE-AR0000081]; Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences [DE-FG05-95ER20175]	United States Department of Energy as part of the Electrofuels Project of ARPA-E(United States Department of Energy (DOE)); Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy as part of the Electrofuels Project of ARPA-E (DE-AR0000081) for strain construction and analysis and by the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences (DE-FG05-95ER20175) for strain characterization.	Adams MWW, 2001, J BACTERIOL, V183, P716, DOI 10.1128/JB.183.2.716-724.2001; Armaroli N, 2011, CHEMSUSCHEM, V4, P21, DOI 10.1002/cssc.201000182; Bae SS, 2012, BIOTECHNOL LETT, V34, P75, DOI 10.1007/s10529-011-0732-3; Basen M, 2012, MBIO, V3, DOI 10.1128/mBio.00053-12; Bridger SL, 2012, J BACTERIOL, V194, P4097, DOI 10.1128/JB.00439-12; Bridger SL, 2011, J BACTERIOL, V193, P6498, DOI 10.1128/JB.05445-11; Chandrayan SK, 2012, J BIOL CHEM, V287, P3257, DOI 10.1074/jbc.M111.290916; Crable Bryan R, 2011, Enzyme Res, V2011, P532536, DOI 10.4061/2011/532536; DURST HD, 1975, ANAL CHEM, V47, P1797, DOI 10.1021/ac60361a025; Farkas J, 2011, APPL ENVIRON MICROB, V77, P6343, DOI 10.1128/AEM.05057-11; Farkas JZ, 2012, J BIOL DYNAM, V6, P1, DOI 10.1080/17513758.2011.615464; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; Hawkins AS, 2013, CURR OPIN BIOTECH, V24, P376, DOI 10.1016/j.copbio.2013.02.017; Hopkins RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026569; Kanjee U, 2013, ANNU REV MICROBIOL, V67, P65, DOI 10.1146/annurev-micro-092412-155708; Keller MW, 2013, P NATL ACAD SCI USA, V110, P5840, DOI 10.1073/pnas.1222607110; Kim YJ, 2010, NATURE, V467, P352, DOI 10.1038/nature09375; Lipscomb GL, 2011, APPL ENVIRON MICROB, V77, P2232, DOI 10.1128/AEM.02624-10; Lipscomb GL, 2009, MOL MICROBIOL, V71, P332, DOI 10.1111/j.1365-2958.2008.06525.x; Lu W, 2011, SCIENCE, V332, P352, DOI 10.1126/science.1199098; Maeda T, 2012, MICROB BIOTECHNOL, V5, P214, DOI 10.1111/j.1751-7915.2011.00282.x; Merryman C, 2012, METAB ENG, V14, P196, DOI 10.1016/j.ymben.2012.02.005; Miyazaki R, 2013, APPL ENVIRON MICROB, V79, P4440, DOI 10.1128/AEM.00711-13; Moon YJ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015420; Navarro RM, 2007, CHEM REV, V107, P3952, DOI 10.1021/cr0501994; Sabri S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-60; Sapra R, 2000, J BACTERIOL, V182, P3423, DOI 10.1128/JB.182.12.3423-3428.2000; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; Schut GJ, 2013, FEMS MICROBIOL REV, V37, P182, DOI 10.1111/j.1574-6976.2012.00346.x; Schut GJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00163; Schut GJ, 2001, J BACTERIOL, V183, P7027, DOI 10.1128/JB.183.24.7027-7036.2001; Thorgersen MP, 2012, P NATL ACAD SCI USA, V109, P18547, DOI 10.1073/pnas.1208605109; Yang H, 2010, MOL MICROBIOL, V77, P1111, DOI 10.1111/j.1365-2958.2010.07275.x; Yoon SH, 2011, GENOME RES, V21, P1892, DOI 10.1101/gr.122218.111	34	33	34	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2873	2879		10.1074/jbc.M113.530725	http://dx.doi.org/10.1074/jbc.M113.530725			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24318960	Green Published, hybrid			2022-12-25	WOS:000333403000035
J	Huse, HK; Kwon, T; Zlosnik, JEA; Speert, DP; Marcotte, EM; Whiteley, M				Huse, Holly K.; Kwon, Taejoon; Zlosnik, James E. A.; Speert, David P.; Marcotte, Edward M.; Whiteley, Marvin			Pseudomonas aeruginosa Enhances Production of a Non-Alginate Exopolysaccharide during Long-Term Colonization of the Cystic Fibrosis Lung	PLOS ONE			English	Article							MATRIX POLYSACCHARIDE PSL; PLANKTONIC CULTURES; BIOFILM STRUCTURE; EXPRESSION; ROLES; EVOLUTION; ADAPTATION; RESISTANCE; ADHESION; SYSTEM	The gram-negative opportunistic pathogen Pseudomonas aeruginosa is the primary cause of chronic respiratory infections in individuals with the heritable disease cystic fibrosis (CF). These infections can last for decades, during which time P. aeruginosa has been proposed to acquire beneficial traits via adaptive evolution. Because CF lacks an animal model that can acquire chronic P. aeruginosa infections, identifying genes important for long-term in vivo fitness remains difficult. However, since clonal, chronological samples can be obtained from chronically infected individuals, traits undergoing adaptive evolution can be identified. Recently we identified 24 P. aeruginosa gene expression traits undergoing parallel evolution in vivo in multiple individuals, suggesting they are beneficial to the bacterium. The goal of this study was to determine if these genes impact P. aeruginosa phenotypes important for survival in the CF lung. By using a gain-of-function genetic screen, we found that 4 genes and 2 operons undergoing parallel evolution in vivo promote P. aeruginosa biofilm formation. These genes/operons promote biofilm formation by increasing levels of the non-alginate exopolysaccharide Psl. One of these genes, phaF, enhances Psl production via a post-transcriptional mechanism, while the other 5 genes/operons do not act on either psl transcription or translation. Together, these data demonstrate that P. aeruginosa has evolved at least two pathways to over-produce a non-alginate exopolysaccharide during long-term colonization of the CF lung. More broadly, this approach allowed us to attribute a biological significance to genes with unknown function, demonstrating the power of using evolution as a guide for targeted genetic studies.	[Huse, Holly K.; Whiteley, Marvin] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Huse, Holly K.; Kwon, Taejoon; Marcotte, Edward M.; Whiteley, Marvin] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Huse, Holly K.; Kwon, Taejoon; Marcotte, Edward M.; Whiteley, Marvin] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Zlosnik, James E. A.; Speert, David P.] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; [Zlosnik, James E. A.; Speert, David P.] Univ British Columbia, Ctr Understanding & Preventing Infect Children, Vancouver, BC V5Z 1M9, Canada	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of British Columbia; University of British Columbia	Whiteley, M (corresponding author), Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA.	mwhiteley@mail.utexas.edu	Kwon, Taejoon/AAR-9814-2020; Kwon, Taejoon/S-3835-2016	Kwon, Taejoon/0000-0002-9794-6112; Marcotte, Edward/0000-0001-8808-180X; Zlosnik, James/0000-0002-9708-9034	NIH [5R01AI075068]; NSF; ARO [W911NF-12-1-0390]; Welch Foundation [F1515]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076536] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); ARO; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the NIH, 5R01AI075068 to Marvin Whiteley http://www.nih.gov. MW is a Burroughs Wellcome Investigator in the Pathogenesis of Infectious Disease. EMM acknowledges support from the NIH, NSF, ARO award W911NF-12-1-0390, and the Welch Foundation (F1515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Byrd MS, 2009, MOL MICROBIOL, V73, P622, DOI 10.1111/j.1365-2958.2009.06795.x; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Damron FH, 2009, MICROBIOL-SGM, V155, P1028, DOI 10.1099/mic.0.025833-0; DOGGETT RG, 1969, APPL MICROBIOL, V18, P936, DOI 10.1128/AEM.18.5.936-937.1969; Galan B, 2011, MOL MICROBIOL, V79, P402, DOI 10.1111/j.1365-2958.2010.07450.x; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOIBY N, 1975, ACTA PATH MICRO IM B, V83, P549; Huse HK, 2010, MBIO, V1, DOI 10.1128/mBio.00199-10; Irie Y, 2010, MOL MICROBIOL, V78, P158, DOI 10.1111/j.1365-2958.2010.07320.x; Jorth P, 2010, J BACTERIOL, V192, P6240, DOI 10.1128/JB.00935-10; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Ma L, 2006, J BACTERIOL, V188, P8213, DOI 10.1128/JB.01202-06; Ma LY, 2012, FEMS IMMUNOL MED MIC, V65, P377, DOI 10.1111/j.1574-695X.2012.00934.x; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Mahenthiralingam E, 1996, J CLIN MICROBIOL, V34, P1129, DOI 10.1128/JCM.34.5.1129-1135.1996; Malone JG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002760; Mishra M, 2012, CELL MICROBIOL, V14, P95, DOI 10.1111/j.1462-5822.2011.01704.x; Musken M, 2010, MICROBIOL-SGM, V156, P431, DOI 10.1099/mic.0.033290-0; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; Notley-McRobb L, 1999, ENVIRON MICROBIOL, V1, P45, DOI 10.1046/j.1462-2920.1999.00003.x; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Ramsey MM, 2004, MOL MICROBIOL, V53, P1075, DOI 10.1111/j.1365-2958.2004.04181.x; Roy AB, 2012, J BACTERIOL, V194, P2904, DOI 10.1128/JB.05346-11; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Waite RD, 2005, J BACTERIOL, V187, P6571, DOI 10.1128/JB.187.18.6571-6576.2005; Waite RD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-162; Wilder CN, 2009, INFECT IMMUN, V77, P5631, DOI 10.1128/IAI.00755-09; Wong A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002928; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108; Yang L, 2011, ENVIRON MICROBIOL, V13, P1705, DOI 10.1111/j.1462-2920.2011.02503.x	35	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82621	10.1371/journal.pone.0082621	http://dx.doi.org/10.1371/journal.pone.0082621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324811	Green Submitted, gold, Green Published			2022-12-25	WOS:000328566700091
J	Sun, XM; Zhang, XK; Zhang, SX; Dai, GH; Han, SJ; Liang, WJ				Sun, Xiaoming; Zhang, Xiaoke; Zhang, Shixiu; Dai, Guanhua; Han, Shijie; Liang, Wenju			Soil Nematode Responses to Increases in Nitrogen Deposition and Precipitation in a Temperate Forest	PLOS ONE			English	Article							CLIMATE-CHANGE; MICROBIAL BIOMASS; CHANGBAI MOUNTAIN; EXTRACTION METHOD; FEEDING-HABITS; ELEVATED CO2; DIVERSITY; CARBON; ECOSYSTEM; BIODIVERSITY	The environmental changes arising from nitrogen (N) deposition and precipitation influence soil ecological processes in forest ecosystems. However, the corresponding effects of environmental changes on soil biota are poorly known. Soil nematodes are the important bioindicator of soil environmental change, and their responses play a key role in the feedbacks of terrestrial ecosystems to climate change. Therefore, to explore the responsive mechanisms of soil biota to N deposition and precipitation, soil nematode communities were studied after 3 years of environmental changes by water and/or N addition in a temperate forest of Changbai Mountain, Northeast China. The results showed that water combined with N addition treatment decreased the total nematode abundance in the organic horizon (O), while the opposite trend was found in the mineral horizon (A). Significant reductions in the abundances of fungivores, plant-parasites and omnivores-predators were also found in the water combined with N addition treatment. The significant effect of water interacted with N on the total nematode abundance and trophic groups indicated that the impacts of N on soil nematode communities were mediated by water availability. The synergistic effect of precipitation and N deposition on soil nematode communities was stronger than each effect alone. Structural equation modeling suggested water and N additions had direct effects on soil nematode communities. The feedback of soil nematodes to water and nitrogen addition was highly sensitive and our results indicate that minimal variations in soil properties such as those caused by climate changes can lead to severe changes in soil nematode communities.	[Sun, Xiaoming; Zhang, Xiaoke; Dai, Guanhua; Han, Shijie; Liang, Wenju] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Zhang, Shixiu] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China; [Dai, Guanhua; Han, Shijie] Chinese Acad Sci, Res Stn Changbai Mt Forest Ecosyst, Erdaobaihe, Peoples R China; [Sun, Xiaoming] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, XK (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	zxk@iae.ac.cn; liangwj@iae.ac.cn			National Natural Science Foundation of China [31170484, 31170577]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was financially supported by the National Natural Science Foundation of China (31170484 and 31170577). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg MP, 1998, BIOL FERT SOILS, V26, P258, DOI 10.1007/s003740050377; Bongers T, 1999, TRENDS ECOL EVOL, V14, P224, DOI 10.1016/S0169-5347(98)01583-3; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Britton AJ, 2001, J VEG SCI, V12, P797, DOI 10.2307/3236867; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; [蔡玉婷 Cai Yuting], 2013, [生态环境学报, Ecology and Environmental Sciences], V22, P755; Deng HongBing, 2001, Journal of Forestry Research, V12, P89, DOI 10.1007/BF02867202; DISE NB, 1995, FOREST ECOL MANAG, V71, P153, DOI 10.1016/0378-1127(94)06092-W; Ekschmitt K, 1999, PLANT SOIL, V212, P45, DOI 10.1023/A:1004682620283; Ferris H, 2001, APPL SOIL ECOL, V18, P13, DOI 10.1016/S0929-1393(01)00152-4; Ferris H, 2006, J NEMATOL, V38, P3; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; Gaudnik C, 2011, GLOBAL CHANGE BIOL, V17, P3351, DOI 10.1111/j.1365-2486.2011.02463.x; Gleixner G, 2005, ECOL STUD-ANAL SYNTH, V176, P165; Grace JB, 2007, ECOL LETT, V10, P680, DOI 10.1111/j.1461-0248.2007.01058.x; GRIFFITHS BS, 1993, BIOL FERT SOILS, V15, P201, DOI 10.1007/BF00361612; Hagvar S, 2009, GLOBAL CHANGE BIOL, V15, P2972, DOI 10.1111/j.1365-2486.2009.01926.x; Heisler JL, 2006, NEW PHYTOL, V172, P189, DOI 10.1111/j.1469-8137.2006.01876.x; Hogberg MN, 2010, NEW PHYTOL, V187, P485, DOI 10.1111/j.1469-8137.2010.03274.x; Kardol P, 2011, APPL SOIL ECOL, V47, P37, DOI 10.1016/j.apsoil.2010.11.001; Kardol P, 2010, ECOLOGY, V91, P767, DOI 10.1890/09-0135.1; Landesman WJ, 2011, PEDOBIOLOGIA, V54, P87, DOI 10.1016/j.pedobi.2010.10.002; Landesman WJ, 2010, SOIL BIOL BIOCHEM, V42, P1751, DOI 10.1016/j.soilbio.2010.06.012; Lensing JR, 2006, P NATL ACAD SCI USA, V103, P15502, DOI 10.1073/pnas.0607064103; Li Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060441; Li Q, 2010, APPL SOIL ECOL, V46, P111, DOI 10.1016/j.apsoil.2010.06.016; Li Q, 2009, SOIL BIOL BIOCHEM, V41, P1497, DOI 10.1016/j.soilbio.2009.04.006; Li XF, 2010, CAN J FOREST RES, V40, P2256, DOI 10.1139/X10-167; Liang WJ, 2009, SOIL BIOL BIOCHEM, V41, P883, DOI 10.1016/j.soilbio.2008.06.018; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Lue C., 2007, J GEOPHYS RES, V112, DOI [DOI 10.1029/2006JD007990, 10. 1029/2006JD007990]; Luo YQ, 2008, GLOBAL CHANGE BIOL, V14, P1986, DOI 10.1111/j.1365-2486.2008.01629.x; Matson P, 2002, AMBIO, V31, P113, DOI 10.1639/0044-7447(2002)031[0113:TGONDC]2.0.CO;2; Minami K, 2005, PEDOSPHERE, V15, P164; Neher DA, 2001, J NEMATOL, V33, P161; Neher DA, 2005, APPL SOIL ECOL, V30, P47, DOI 10.1016/j.apsoil.2005.01.002; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; Okada H, 2005, SOIL BIOL BIOCHEM, V37, P1113, DOI 10.1016/j.soilbio.2004.11.010; Providoli I, 2006, SOIL BIOL BIOCHEM, V38, P1645, DOI 10.1016/j.soilbio.2005.11.019; [齐莎 Qi Sha], 2010, [生态学报, Acta Ecologica Sinica], V30, P5518; Ruess L, 1999, PLANT SOIL, V212, P63, DOI 10.1023/A:1004567816355; Saul-Tcherkas V, 2013, MICROB ECOL, V65, P689, DOI 10.1007/s00248-012-0141-8; Schimel DS, 1997, P NATL ACAD SCI USA, V94, P8280, DOI 10.1073/pnas.94.16.8280; Schleppi P, 1999, WATER AIR SOIL POLL, V116, P129, DOI 10.1023/A:1005206927764; Shen CC, 2013, SOIL BIOL BIOCHEM, V57, P204, DOI 10.1016/j.soilbio.2012.07.013; Sherman C, 2012, EUR J SOIL BIOL, V52, P48, DOI 10.1016/j.ejsobi.2012.06.001; SOHLENIUS B, 1984, J APPL ECOL, V21, P327, DOI 10.2307/2403057; St Clair SB, 2009, J VEG SCI, V20, P860, DOI 10.1111/j.1654-1103.2009.01089.x; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; Van Dommelen A, 2009, BIOL FERT SOILS, V45, P549, DOI 10.1007/s00374-009-0357-z; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wall DH, 2010, NAT GEOSCI, V3, P297, DOI 10.1038/ngeo860; Wan S, 2007, GLOBAL CHANGE BIOL, V13, P2411, DOI 10.1111/j.1365-2486.2007.01433.x; Wang CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031042; Wang XG, 2010, J ECOL, V98, P674, DOI 10.1111/j.1365-2745.2010.01644.x; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wei CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043384; Wu Ting-juan, 2013, Yingyong Shengtai Xuebao, V24, P581; Xu GL, 2007, J ENVIRON SCI-CHINA, V19, P603, DOI 10.1016/S1001-0742(07)60100-4; Xu GL, 2009, ENVIRON POLLUT, V157, P2030, DOI 10.1016/j.envpol.2009.02.026; Xu XK, 2009, GEODERMA, V151, P370, DOI 10.1016/j.geoderma.2009.05.008; Yeates GW, 2007, CAN J FOREST RES, V37, P216, DOI 10.1139/X06-172; Yeates GW, 2003, BIOL FERT SOILS, V37, P199, DOI 10.1007/s00374-003-0586-5; YEATES GW, 1993, J NEMATOL, V25, P315; Yeates GW, 1999, AGR ECOSYST ENVIRON, V74, P113, DOI 10.1016/S0167-8809(99)00033-X; Zhang M, 2012, ZOOL STUD, V51, P619; Zhang M, 2011, PEDOSPHERE, V21, P615, DOI 10.1016/S1002-0160(11)60163-X; Zhang Nai-Li, 2007, Zhiwu Shengtai Xuebao, V31, P252; Zhang XK, 2012, ECOL INDIC, V13, P75, DOI 10.1016/j.ecolind.2011.05.009	69	37	46	10	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82468	10.1371/journal.pone.0082468	http://dx.doi.org/10.1371/journal.pone.0082468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324794	gold, Green Published			2022-12-25	WOS:000328566700082
J	Mork, LM; Rehnmark, S; Davoodpour, P; Norata, GD; Larsson, L; Witt, MR; Malm, J; Parini, P				Mork, Lisa-Mari; Rehnmark, Stefan; Davoodpour, Padideh; Norata, Giuseppe Danilo; Larsson, Lilian; Witt, Michael-Robin; Malm, Johan; Parini, Paolo			The Thyroid Receptor Modulator KB3495 Reduces Atherosclerosis Independently of Total Cholesterol in the Circulation in ApoE Deficient Mice	PLOS ONE			English	Article							BILIARY STEROL SECRETION; MESSENGER-RNA LEVELS; HORMONE RECEPTOR; LDL RECEPTOR; INTESTINAL-ABSORPTION; APOLIPOPROTEIN; LIVER; LIPOPROTEIN; BETA; 7-ALPHA-HYDROXYLASE	Background: Thyroid hormones (TH) regulate cholesterol metabolism but their use as lipid-lowering drugs is restricted due to negative cardiac effects. TH mimetic compounds modulating TH receptor beta (THR beta) have been designed as potential drugs, reducing serum cholesterol levels while avoiding apparent deleterious cardiac effects. Objective: Using ApoE deficient mice, we examined whether KB3495, a TH mimetic compound, reduces atherosclerosis and if there is a synergistic effect with atorvastatin. The effect of KB3495 was investigated after 10 and 25 weeks. Results: KB3495 treatment reduced atherosclerotic plaque formation in aorta and decreased the cholesteryl ester (CE) content by 57%. Treatment with KB3495 was also associated with a reduction of macrophage content in the atherosclerotic plaques and reduced serum levels of IL-1 beta, TNFalpha, IL-6, Interferon gamma, MCP-1 and M-CSF. Serum lipoprotein analysis showed no change in total cholesterol levels in ApoB-containing lipoproteins. KB3495 alone increased fecal BA excretion by 90%. The excretion of neutral sterols increased in all groups, with the largest increase in the combination group (350%). After 25 weeks, the animals treated with KB3495 showed 50% lower CE levels in the skin and even further reductions were observed in the combination group where the CE levels were reduced by almost 95% as compared to controls. Conclusion: KB3495 treatment reduced atherosclerosis independently of total cholesterol levels in ApoB-containing lipoproteins likely by stimulation of sterol excretion from the body and by inhibition of the inflammatory response.	[Mork, Lisa-Mari; Davoodpour, Padideh; Larsson, Lilian; Parini, Paolo] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Rehnmark, Stefan; Witt, Michael-Robin; Malm, Johan] KaroBio AB, Stockholm, Sweden; [Norata, Giuseppe Danilo] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Parini, Paolo] Karolinska Inst, Mol Nutr Unit, Dept Biosci, Stockholm, Sweden	Karolinska Institutet; University of Milan; Karolinska Institutet	Mork, LM (corresponding author), Karolinska Inst, Dept Lab Med, Stockholm, Sweden.	lisa-mari.mork@ki.se	Norata, Giuseppe Danilo/AAC-2863-2019	Norata, Giuseppe Danilo/0000-0002-6081-1257	Karolinska Institutet; KaroBio AB; Swedish Research Council; Swedish Heart-Lung Foundation	Karolinska Institutet(Karolinska Institutet); KaroBio AB; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	This work was supported by Karolinska Institutet, KaroBio AB, the Swedish Research Council and the Swedish Heart-Lung Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS JJ, 1981, J LIPID RES, V22, P323; Angeli V, 2004, IMMUNITY, V21, P561, DOI 10.1016/j.immuni.2004.09.003; [Anonymous], 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI DOI 10.1001/JAMA.285.19.2486.PUBMED:11368702; Bassett JHD, 2003, TRENDS ENDOCRIN MET, V14, P356, DOI 10.1016/S1043-2760(03)00144-90; Baxter JD, 2009, NAT REV DRUG DISCOV, V8, P308, DOI 10.1038/nrd2830; Berkenstam A, 2008, P NATL ACAD SCI USA, V105, P663, DOI 10.1073/pnas.0705286104; BJORKHEM I, 1974, CLIN CHIM ACTA, V54, P185, DOI 10.1016/0009-8981(74)90236-8; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Brown JM, 2008, J BIOL CHEM, V283, P10522, DOI 10.1074/jbc.M707659200; Chiellini G, 1998, CHEM BIOL, V5, P299, DOI 10.1016/S1074-5521(98)90168-5; Duntas LH, 2002, THYROID, V12, P287, DOI 10.1089/10507250252949405; Erion MD, 2007, P NATL ACAD SCI USA, V104, P15490, DOI 10.1073/pnas.0702759104; FEINGOLD KR, 1995, J INVEST DERMATOL, V104, P246, DOI 10.1111/1523-1747.ep12612790; FOLCH J, 1957, J BIOL CHEM, V226, P497; Galman C, 2008, GASTROENTEROLOGY, V134, P1127, DOI 10.1053/j.gastro.2008.01.032; GEBHARD RL, 1992, J LIPID RES, V33, P1459; George W, 1980, STAT METHODS; GLOMSET JA, 1968, J LIPID RES, V9, P155; Grover GJ, 2007, FUTURE LIPIDOL, V2, P641, DOI 10.2217/17460875.2.6.641; Grover GJ, 2003, P NATL ACAD SCI USA, V100, P10067, DOI 10.1073/pnas.1633737100; GRUNDY SM, 1965, J LIPID RES, V6, P397; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Johansson L, 2005, P NATL ACAD SCI USA, V102, P10297, DOI 10.1073/pnas.0504379102; Khera AV, 2010, CURR ATHEROSCLER REP, V12, P73, DOI 10.1007/s11883-009-0080-0; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Kruit JK, 2005, GASTROENTEROLOGY, V128, P147, DOI 10.1053/j.gastro.2004.10.006; Kuipers F, 1997, J CLIN INVEST, V100, P2915, DOI 10.1172/JCI119841; Ladenson PW, 2010, NEW ENGL J MED, V362, P906, DOI 10.1056/NEJMoa0905633; Lopez D, 2007, BBA-MOL CELL BIOL L, V1771, P1216, DOI 10.1016/j.bbalip.2007.05.001; LUND E, 1989, SCAND J CLIN LAB INV, V49, P165, DOI 10.3109/00365518909105417; MIETTINEN TA, 1982, CLIN CHIM ACTA, V124, P245, DOI 10.1016/0009-8981(82)90393-X; Murphy C, 2005, BBA-MOL CELL BIOL L, V1735, P167, DOI 10.1016/j.bbalip.2005.06.001; NESS GC, 1990, BIOCHEM BIOPH RES CO, V172, P1150, DOI 10.1016/0006-291X(90)91568-D; Ness GC, 2000, P SOC EXP BIOL MED, V224, P8, DOI 10.1046/j.1525-1373.2000.22359.x; Pandak WM, 1997, J LIPID RES, V38, P2483; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Rudel LL, 1998, ARTERIOSCL THROM VAS, V18, P1818, DOI 10.1161/01.ATV.18.11.1818; Shin DJ, 2006, NUCLEIC ACIDS RES, V34, P3853, DOI 10.1093/nar/gkl506; STAELS B, 1990, ENDOCRINOLOGY, V127, P1144, DOI 10.1210/endo-127-3-1144; Tancevski I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008722; Tancevski I, 2009, CURR OPIN INVEST DR, V10, P912; Van der Velde AE, 2007, GASTROENTEROLOGY, V133, P967, DOI 10.1053/j.gastro.2007.06.019; VANREE JH, 1995, ATHEROSCLEROSIS, V112, P237, DOI 10.1016/0021-9150(94)05419-J; Weiss RE, 2002, AM J PHYSIOL-ENDOC M, V283, pE428, DOI 10.1152/ajpendo.00019.2002; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]; Zabalawi M, 2007, J LIPID RES, V48, P52, DOI 10.1194/jlr.M600370-JLR200	48	7	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e78534	10.1371/journal.pone.0078534	http://dx.doi.org/10.1371/journal.pone.0078534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324578	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300006
J	Nowotny, T; Rospars, JP; Martinez, D; Elbanna, S; Anton, S				Nowotny, Thomas; Rospars, Jean-Pierre; Martinez, Dominique; Elbanna, Shereen; Anton, Sylvia			Machine Learning for Automatic Prediction of the Quality of Electrophysiological Recordings	PLOS ONE			English	Article							SPIKE DETECTION	The quality of electrophysiological recordings varies a lot due to technical and biological variability and neuroscientists inevitably have to select "good" recordings for further analyses. This procedure is time-consuming and prone to selection biases. Here, we investigate replacing human decisions by a machine learning approach. We define 16 features, such as spike height and width, select the most informative ones using a wrapper method and train a classifier to reproduce the judgement of one of our expert electrophysiologists. Generalisation performance is then assessed on unseen data, classified by the same or by another expert. We observe that the learning machine can be equally, if not more, consistent in its judgements as individual experts amongst each other. Best performance is achieved for a limited number of informative features; the optimal feature set being different from one data set to another. With 80-90% of correct judgements, the performance of the system is very promising within the data sets of each expert but judgments are less reliable when it is used across sets of recordings from different experts. We conclude that the proposed approach is relevant to the selection of electrophysiological recordings, provided parameters are adjusted to different types of experiments and to individual experimenters.	[Nowotny, Thomas] Univ Sussex, Sussex Neurosci, Brighton, E Sussex, England; [Nowotny, Thomas] Univ Sussex, Ctr Computat Neurosci & Robot, Brighton, E Sussex, England; [Rospars, Jean-Pierre; Elbanna, Shereen; Anton, Sylvia] INRA, Physiol Insecte Signalisat & Commun, F-78026 Versailles, France; [Rospars, Jean-Pierre; Elbanna, Shereen; Anton, Sylvia] Univ Paris 06, Versailles, France; [Martinez, Dominique] CNRS, Lab Lorrain Rech Informat & Applicat, Vandoeuvre Les Nancy, France	University of Sussex; University of Sussex; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Nowotny, T (corresponding author), Univ Sussex, Sussex Neurosci, Brighton, E Sussex, England.	t.nowotny@sussex.ac.uk	Elbanna, Shereen M./AAU-7319-2020	Nowotny, Thomas/0000-0002-4451-915X	EPSRC [EP/J019690/1]; BBSRC [BB/F005113/1]; state program "Investissements d'avenir" [ANR-10-BINF-05, ANR-12-ADAP-0012-01]; Biotechnology and Biological Sciences Research Council [BB/F005113/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J019690/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); state program "Investissements d'avenir"(French National Research Agency (ANR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the EPSRC (http://www.epsrc.ac.uk/), grant number EP/J019690/1 "Green Brain", and BBSRC (http://www.bbsrc.ac.uk/), grant number BB/F005113/1 "PheroSys", to TN, the state program "Investissements d'avenir" managed by the Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/), grant ANR-10-BINF-05 "Pherotaxis" to JPR, DM and SA and grant ANR-12-ADAP-0012-01 "Pherotox" in the programm Bioadapt to SA and JPR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmild M, 2003, RECEPTOR CHANNEL, V9, P49, DOI 10.1080/10606820308258; Breiman L, 1984, WADSWORTH STAT PROBA; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Franke F, 2010, J COMPUT NEUROSCI, V29, P127, DOI 10.1007/s10827-009-0163-5; Friedrich R, 2010, J NEUROSCI METH, V193, P271, DOI 10.1016/j.jneumeth.2010.09.004; Galizia CG, 2004, J COMP PHYSIOL A, V190, P21, DOI 10.1007/s00359-003-0469-0; Galizia CG., 2010, NEUROBIOLOGY OLFACTI, V35, P70, DOI [10.1201/9781420071993, DOI 10.1201/9781420071993-C2, 10.1201/9781420071993-c2, DOI 10.1201/9781420071993]; Ignell Rickard, 2005, P319; Jackson P., 1998, INTRO EXPERT SYSTEMS, V3rd ed.; Kohavi J., 1994, P 11 INT C MACH LEAR, P121, DOI [DOI 10.1016/B978-1-55860-335-6.50023-4, 10.1016/B978-1-55860-335-6.50023-4]; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Koolen Ninah, 2012, Proceedings of the International Conference on Bio-inspired Systems and Signal Processing (BIOSIGNALS 2012), P169; Lei H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023382; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Mathes C, 2006, EXPERT OPIN THER TAR, V10, P319, DOI 10.1517/14728222.10.2.319; Matic V, 2012, IEEE ENG MED BIO, P17, DOI 10.1109/EMBC.2012.6345860; Mohri M., 2018, FDN MACHINE LEARNING; Nowotny T, 2013, SENSOR ACTUAT B-CHEM, V187, P471, DOI 10.1016/j.snb.2013.01.088; Panzeri S, 2007, J NEUROPHYSIOL, V98, P1064, DOI 10.1152/jn.00559.2007; Priest BT, 2007, CURR PHARM DESIGN, V13, P2325; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Takahashi S, 2003, J NEUROPHYSIOL, V89, P2245, DOI 10.1152/jn.00827.2002; Weiss S. M., 1991, COMPUTER SYSTEMS LEA; Wilson SB, 2002, CLIN NEUROPHYSIOL, V113, P1873, DOI 10.1016/S1388-2457(02)00297-3; Wiltschko AB, 2008, J NEUROSCI METH, V173, P34, DOI 10.1016/j.jneumeth.2008.05.016	25	2	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80838	10.1371/journal.pone.0080838	http://dx.doi.org/10.1371/journal.pone.0080838			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324634	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000327949300048
J	Wang, L; Cossette, SM; Rarick, KR; Gershan, J; Dwinell, MB; Harder, DR; Ramchandran, R				Wang, Ling; Cossette, Stephanie M.; Rarick, Kevin R.; Gershan, Jill; Dwinell, Michael B.; Harder, David R.; Ramchandran, Ramani			Astrocytes Directly Influence Tumor Cell Invasion and Metastasis In Vivo	PLOS ONE			English	Article							BREAST-CANCER CELLS; BRAIN METASTASIS; HEMATOGENOUS METASTASES; ENERGY-METABOLISM; LUNG-CARCINOMA; EXPRESSION; RAT; MICROENVIRONMENT; COLONIZATION; PATHOGENESIS	Brain metastasis is a defining component of tumor pathophysiology, and the underlying mechanisms responsible for this phenomenon are not well understood. Current dogma is that tumor cells stimulate and activate astrocytes, and this mutual relationship is critical for tumor cell sustenance in the brain. Here, we provide evidence that primary rat neonatal and adult astrocytes secrete factors that proactively induced human lung and breast tumor cell invasion and metastasis capabilities. Among which, tumor invasion factors namely matrix metalloprotease-2 (MMP-2) and MMP-9 were partly responsible for the astrocyte media-induced tumor cell invasion. Inhibiting MMPs reduced the ability of tumor cell to migrate and invade in vitro. Further, injection of astrocyte media-conditioned breast cancer cells in mice showed increased invasive activity to the brain and other distant sites. More importantly, blocking the preconditioned tumor cells with broad spectrum MMP inhibitor decreased the invasion and metastasis of the tumor cells, in particular to the brain in vivo. Collectively, our data implicate astrocyte-derived MMP-2 and MMP-9 as critical players that facilitate tumor cell migration and invasion leading to brain metastasis.	[Wang, Ling; Cossette, Stephanie M.; Ramchandran, Ramani] Med Coll Wisconsin, Dept Pediat, Childrens Res Inst, Milwaukee, WI 53226 USA; [Rarick, Kevin R.; Harder, David R.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Gershan, Jill] Med Coll Wisconsin, Translat & Biomed Res Ctr, Div Hematol Oncol, Milwaukee, WI 53226 USA; [Dwinell, Michael B.] Med Coll Wisconsin, Dept Microbiol, Milwaukee, WI 53226 USA; [Ramchandran, Ramani] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Ramchandran, R (corresponding author), Med Coll Wisconsin, Dept Pediat, Childrens Res Inst, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	rramchan@mcw.edu			NHLBI; NIH [HL090712, HL102745, HL112639]; Children's Research Institute at the Medical College of Wisconsin;  [HL033833]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102745, R37HL033833, R01HL090712, R01HL112639, R01HL033833] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Research Institute at the Medical College of Wisconsin; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Ling Wang and Stephanie Cossette are supported by T32 fellowships from NHLBI. Ramani Ramchandran is partly supported by NIH grants HL090712, HL102745 and HL112639. David Harder is supported by HL033833. Wisconsin Breast Cancer Showhouse supports MBD. Supplies for this project were supported by seed funds from the Children's Research Institute at the Medical College of Wisconsin, Milwaukee to Ramani Ramchandran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; Brewer GJ, 1997, J NEUROSCI METH, V71, P143, DOI 10.1016/S0165-0270(96)00136-7; BROWN PD, 1993, J NATL CANCER I, V85, P574, DOI 10.1093/jnci/85.7.574; Cheng G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-285; Drury LJ, 2011, P NATL ACAD SCI USA, V108, P17655, DOI 10.1073/pnas.1101133108; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Feng SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020599; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FIDLER IJ, 1986, CANCER RES, V46, P5167; Fidler IJ, 2011, SEMIN CANCER BIOL, V21, P107, DOI 10.1016/j.semcancer.2010.12.009; Fidler IJ, 2010, MOL CELLS, V30, P93, DOI 10.1007/s10059-010-0133-9; Fitzgerald DP, 2008, CLIN EXP METASTAS, V25, P799, DOI 10.1007/s10585-008-9193-z; GAY PC, 1987, J NEURO-ONCOL, V5, P51, DOI 10.1007/BF00162765; GOTTSCHALL PE, 1995, J NEUROCHEM, V64, P1513; GROOTHUIS DR, 1982, J NEUROPATH EXP NEUR, V41, P164, DOI 10.1097/00005072-198203000-00006; HART IR, 1981, CANCER RES, V41, P1281; Hengel K, 2012, INT J CLIN ONCOL; Herbst RS, 2000, CLIN CANCER RES, V6, P790; Keene SD, 2009, PROTEOMICS, V9, P768, DOI 10.1002/pmic.200800385; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Langley RR, 2009, INT J ONCOL, V35, P665, DOI 10.3892/ijo_00000378; Lorger M, 2010, AM J PATHOL, V176, P2958, DOI 10.2353/ajpath.2010.090838; Munzenmaier DH, 2000, AM J PHYSIOL-HEART C, V278, pH1163, DOI 10.1152/ajpheart.2000.278.4.H1163; Neria F, 2013, GLIA, V61, P1052, DOI 10.1002/glia.22494; Nicolson GL, 1996, CURR TOP MICROBIOL, V213, P89; PAGET S, 1989, CANCER METAST REV, V8, P98; Peuchen S, 1996, NEUROSCIENCE, V71, P855, DOI 10.1016/0306-4522(95)00480-7; Sarkar P, 2011, NEUROSCIENCE, V194, P241, DOI 10.1016/j.neuroscience.2011.07.058; Sbai O, 2010, GLIA, V58, P344, DOI 10.1002/glia.20927; Seike T, 2011, CLIN EXP METASTAS, V28, P13, DOI 10.1007/s10585-010-9354-8; Sierra A, 1997, LAB INVEST, V77, P357; Skalnikova H, 2011, PROTEOMICS, V11, P691, DOI 10.1002/pmic.201000402; STEWART PA, 1987, DEV BRAIN RES, V32, P271, DOI 10.1016/0165-3806(87)90107-6; Vikis HG, 2010, CANCER RES, V70, P4859, DOI 10.1158/0008-5472.CAN-09-4177; WEISS L, 1985, P NATL ACAD SCI USA, V82, P5737, DOI 10.1073/pnas.82.17.5737; Wendt MK, 2006, ONCOGENE, V25, P4986, DOI 10.1038/sj.onc.1209505; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; ZHANG M, 1995, J NEUROL SCI, V134, P26, DOI 10.1016/0022-510X(95)00227-9; Zhang M, 1997, J NEURO-ONCOL, V35, P81, DOI 10.1023/A:1005799805335	41	60	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80933	10.1371/journal.pone.0080933	http://dx.doi.org/10.1371/journal.pone.0080933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324647	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300059
J	DeLong, JP; Hanley, TC				DeLong, John P.; Hanley, Torrance C.			The Rate-Size Trade-Off Structures Intraspecific Variation in Daphnia ambigua Life History Parameters	PLOS ONE			English	Article							BODY-SIZE; OXYGEN-CONSUMPTION; RESPIRATION RATES; SPACER-LENGTH; GROWTH-RATE; TEMPERATURE; EVOLUTION; MAGNA; STOICHIOMETRY; REPRODUCTION	The identification of trade-offs is necessary for understanding the evolution and maintenance of diversity. Here we employ the supply-demand (SD) body size optimization model to predict a trade-off between asymptotic body size and growth rate. We use the SD model to quantitatively predict the slope of the relationship between asymptotic body size and growth rate under high and low food regimes and then test the predictions against observations for Daphnia ambigua. Close quantitative agreement between observed and predicted slopes at both food levels lends support to the model and confirms that a 'rate-size' trade-off structures life history variation in this population. In contrast to classic life history expectations, growth and reproduction were positively correlated after controlling for the rate-size trade-off. We included 12 Daphnia clones in our study, but clone identity explained only some of the variation in life history traits. We also tested the hypothesis that growth rate would be positively related to intergenic spacer length (i.e. the growth rate hypothesis) across clones, but we found that clones with intermediate intergenic spacer lengths had larger asymptotic sizes and slower growth rates. Our results strongly support a resource-based optimization of body size following the SD model. Furthermore, because some resource allocation decisions necessarily precede others, understanding interdependent life history traits may require a more nested approach.	[DeLong, John P.; Hanley, Torrance C.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA	Yale University	DeLong, JP (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA.	jpdelong@unl.edu		DeLong, John/0000-0003-0558-8213	Yale University Brown Fellowship; Yale University; National Science Foundation (DEB) [0717265]	Yale University Brown Fellowship; Yale University; National Science Foundation (DEB)(National Science Foundation (NSF))	JPD was supported by a Yale University Brown Fellowship. TCH was supported by Yale University and the National Science Foundation (DEB #0717265). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Agrawal A.A., 2010, EVOLUTION DARWIN 1 1, P243; Angilletta MJ, 2003, TRENDS ECOL EVOL, V18, P234, DOI 10.1016/S0169-5347(03)00087-9; ARMITAGE KB, 1979, COMP BIOCHEM PHYS A, V62, P807, DOI 10.1016/0300-9629(79)90007-0; Arnott SA, 2006, EVOLUTION, V60, P1269; BERRIGAN D, 1994, OIKOS, V70, P474, DOI 10.2307/3545787; BIZER JR, 1978, OECOLOGIA, V34, P175, DOI 10.1007/BF00345165; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Brown JH, 2006, P NATL ACAD SCI USA, V103, P17595, DOI 10.1073/pnas.0608522103; BUTLER MI, 1995, HYDROBIOLOGIA, V308, P153, DOI 10.1007/BF00007401; Charnov Eric L., 1993, P1; CLUSTER PD, 1987, P NATL ACAD SCI USA, V84, P610, DOI 10.1073/pnas.84.2.610; Condit R, 2006, SCIENCE, V313, P98, DOI 10.1126/science.1124712; DeLong JP, 2008, OIKOS, V117, P1329, DOI 10.1111/j.0030-1299.2008.16832.x; DeLong JP, 2014, FUNCT ECOL, V28, P487, DOI 10.1111/1365-2435.12199; DeLong JP, 2012, EVOL ECOL RES, V14, P343; Dudycha JL, 2005, EVOLUTION, V59, P565; Elser JJ, 1996, BIOSCIENCE, V46, P674, DOI 10.2307/1312897; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Finkel ZV, 2004, MAR ECOL PROG SER, V273, P269, DOI 10.3354/meps273269; GLAZIER DS, 1991, LIMNOL OCEANOGR, V36, P354, DOI 10.4319/lo.1991.36.2.0354; GLAZIER DS, 1992, OECOLOGIA, V90, P540, DOI 10.1007/BF01875448; Gorokhova E, 2002, P ROY SOC B-BIOL SCI, V269, P2373, DOI 10.1098/rspb.2002.2145; HALL DJ, 1976, ANNU REV ECOL SYST, V7, P177, DOI 10.1146/annurev.es.07.110176.001141; HANLEY T, 2009, THESIS YALE U NEW HA; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Jensen AL, 1997, CAN J FISH AQUAT SCI, V54, P987, DOI 10.1139/cjfas-54-5-987; Jessop BM, 2010, CAN J FISH AQUAT SCI, V67, P326, DOI 10.1139/F09-189; Jeyasingh PD, 2005, ECOL LETT, V8, P1021, DOI 10.1111/j.1461-0248.2005.00803.x; Jeyasingh PD, 2007, ECOL LETT, V10, P282, DOI 10.1111/j.1461-0248.2007.01023.x; KERSTING K, 1976, HYDROBIOLOGIA, V49, P137, DOI 10.1007/BF00772684; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; Knops JMH, 2007, P NATL ACAD SCI USA, V104, P16982, DOI 10.1073/pnas.0704251104; KOBAYASHI M, 1982, COMP BIOCHEM PHYS A, V73, P239; Lotka AJ, 1922, P NATL ACAD SCI USA, V8, P147, DOI 10.1073/pnas.8.6.147; LYNCH M, 1977, ECOLOGY, V58, P763, DOI 10.2307/1936212; LYNCH M, 1986, LIMNOL OCEANOGR, V31, P17, DOI 10.4319/lo.1986.31.1.0017; McFeeters BJ, 2011, FRESHWATER BIOL, V56, P1447, DOI 10.1111/j.1365-2427.2011.02586.x; MOSS T, 1995, PROG NUCLEIC ACID RE, V50, P25, DOI 10.1016/S0079-6603(08)60810-7; REEDER RH, 1984, CELL, V38, P349, DOI 10.1016/0092-8674(84)90489-6; REZNICK D, 1983, ECOLOGY, V64, P862, DOI 10.2307/1937209; RICHMAN S, 1958, ECOL MONOGR, V28, P274; Riessen HP, 1999, CAN J FISH AQUAT SCI, V56, P2487, DOI 10.1139/cjfas-56-12-2487; ROFF DA, 1986, BIOSCIENCE, V36, P316, DOI 10.2307/1310236; ROGERS SO, 1987, PLANT MOL BIOL, V9, P509, DOI 10.1007/BF00015882; SCHINDLER DW, 1968, J ANIM ECOL, V37, P369, DOI 10.2307/2954; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stearns S.C., 1992, pi; Taylor RB, 1998, MAR FRESHWATER RES, V49, P255, DOI 10.1071/MF97016; von Bertalanffy L, 1960, PRINCIPLES THEORY GR, P137; Walsh MR, 2012, P ROY SOC B-BIOL SCI, V279, P3184, DOI 10.1098/rspb.2012.0496; Walsh MR, 2011, P ROY SOC B-BIOL SCI, V278, P2628, DOI 10.1098/rspb.2010.2634; Weider LJ, 2005, ANNU REV ECOL EVOL S, V36, P219, DOI 10.1146/annurev.ecolsys.36.102003.152620; Weider LJ, 2005, OECOLOGIA, V143, P537, DOI 10.1007/s00442-005-0003-x; Weider LJ, 2004, LIMNOL OCEANOGR, V49, P1417, DOI 10.4319/lo.2004.49.4_part_2.1417; Xiao X, 2011, ECOLOGY, V92, P1887, DOI 10.1890/11-0538.1; Yurista PM, 2001, J PLANKTON RES, V23, P733, DOI 10.1093/plankt/23.7.733	57	11	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81024	10.1371/journal.pone.0081024	http://dx.doi.org/10.1371/journal.pone.0081024			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312518	Green Published, gold, Green Submitted			2022-12-25	WOS:000327947800030
J	Liu, L; Xu, XL; Zhuang, DF; Chen, X; Li, S				Liu, Luo; Xu, Xinliang; Zhuang, Dafang; Chen, Xi; Li, Shuang			Changes in the Potential Multiple Cropping System in Response to Climate Change in China from 1960-2010	PLOS ONE			English	Article								The multiple cropping practice is essential to agriculture because it has been shown to significantly increase the grain yield and promote agricultural economic development. In this study, potential multiple cropping systems in China are calculated based on meteorological observation data by using the Agricultural Ecology Zone (AEZ) model. Following this, the changes in the potential cropping systems in response to climate change between the 1960s and the 2010s were subsequently analyzed. The results indicate that the changes of potential multiple cropping systems show tremendous heterogeneity in respect to the spatial pattern in China. A key finding is that the magnitude of change of the potential cropping systems showed a pattern of increase both from northern China to southern China and from western China to eastern China. Furthermore, the area found to be suitable only for single cropping decreased, while the area suitable for triple cropping increased significantly from the 1960s to the 2000s. During the studied period, the potential multiple cropping index (PMCI) gap between rain-fed and irrigated scenarios increased from 18% to 24%, which indicated noticeable growth of water supply limitations under the rain-fed scenario. The most significant finding of this research was that from the 1960s to the 2000s climate change had led to a significant increase of PMCI by 13% under irrigated scenario and 7% under rain-fed scenario across the whole of China. Furthermore, the growth of the annual mean temperature is identified as the main reason underlying the increase of PMCI. It has also been noticed that across China the changes of potential multiple cropping systems under climate change were different from region to region.	[Liu, Luo; Chen, Xi] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China; [Liu, Luo; Xu, Xinliang; Zhuang, Dafang; Li, Shuang] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China; [Liu, Luo; Li, Shuang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, XL (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.	xuxl@lreis.ac.cn			National Program on Key Basic Research Project (973 Program) [2010CB950901]; Project of Remote sensing investigation and assessment for Ecological environment changes in China [STSN-14-00]; CAS [KZCX2-XB3-08-01]	National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); Project of Remote sensing investigation and assessment for Ecological environment changes in China; CAS(Chinese Academy of Sciences)	This research was supported and funded by National Program on Key Basic Research Project (973 Program) (Grant No. 2010CB950901), Project of Remote sensing investigation and assessment for Ecological environment changes in China(No. STSN-14-00) and project of CAS action-plan for West Development (No. KZCX2-XB3-08-01) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingwei H, 1958, ACTA GEOGRAPHICA SIN, V4; [范锦龙 Fan Jinlong], 2004, [遥感学报, Journal of Remote Sensing], V8, P628; [范锦龙 Fan Jinlong], 2004, [遥感学报, Journal of Remote Sensing], V8, P637; FAO, 1985, GUIDELINE LAND EVALU, V55; FAO, 1984, FAO SOILS B, V52; FAO, 1992, 46 FAO LAND WAT DEV; FAO, 1998, 56 FAO; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Fischer G., 2002, RR0202 IIASA; Fisher G., 2002, CLIMATE CHANGE AGR V, P150; Fu Z.Q., 2001, J NAT RESOUR, V16, P313, DOI DOI 10.3321/J.ISSN:1000-3037.2001.04.003; Guo Bailin, 1997, ECON GEOGR, V17, P8; Hongping D, 2001, CROPPING PLANTING, V3, P1; Hoque M. Z., 1984, CROPPING SYSTEMS ASI; Hutchinson M.F., 1998, J GEOGR INF DECIS AN, V2, P153; Hutchinson MF, 1998, J GEOGRAPHIC INFORMA, V2, P168; Jin ShuLan, 2011, Guizhou Agricultural Sciences, P201; [金姝兰 Jin Shulan], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P208; Jinshen Y, 2000, ACTA AGR BOREALI SIN, V4, P126; Jiyuan L, 2005, GEOPHYS RES LETT, V32; Jiyuan L, 2005, REMOTE SENS ENVIRON, V98, P442; [李晶 LI Jing], 2011, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V25, P86; [李茂 Li Mao], 2002, [地理科学进展, Progress in geography], V21, P163; Li P, 2012, J GEOGR SCI, V22, P653, DOI 10.1007/s11442-012-0954-x; Liu JY, 2012, CHINESE GEOGR SCI, V22, P1, DOI 10.1007/s11769-012-0510-8; Liu JY, 2010, J GEOGR SCI, V20, P483, DOI 10.1007/s11442-010-0483-4; Liu JY, 2003, SCI CHINA SER D, V46, P373; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; MONTEITH JL, 1981, Q J ROY METEOR SOC, V107, P1, DOI 10.1256/smsqj.45101; Peng DaiLiang, 2007, Agricultural Sciences in China, V6, P208, DOI 10.1016/S1671-2927(07)60036-4; Shortridge A, 2011, REMOTE SENS ENVIRON, V115, P1576, DOI 10.1016/j.rse.2011.02.017; Shumin L, 2007, PROBLEMS AGR EC, V5, P85; Von B, 2007, INT J RURAL DEV RURA, V42, P19; Xin J., 2003, INT J APPL EARTH OBS, V4, P109, DOI [10.1016/S0303-2434(02)00007-7, DOI 10.1016/S0303-2434(02)00007-7]; Yan HM, 2009, AGR ECOSYST ENVIRON, V129, P391, DOI 10.1016/j.agee.2008.10.017; [闫慧敏 Yan Huimin], 2005, [地理学报, Acta Geographica Sinica], V60, P559; Yang H, 2000, LAND USE POLICY, V17, P73, DOI 10.1016/S0264-8377(00)00008-9; Yue TX, 2013, CLIMATIC CHANGE, V120, P137, DOI 10.1007/s10584-013-0785-5; Zandbergen P, 2008, GEOGR COMPASS, V2, P1404, DOI 10.1111/j.1749-8198.2008.00154.x; Zhang Z G, 2011, HUBEI AGR SCI, V50, P3653; Zhao DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060849; [朱孝林 ZHU Xiaolin], 2008, [自然资源学报, Journal of Natural Resources], V23, P534	42	43	48	10	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e80990	10.1371/journal.pone.0080990	http://dx.doi.org/10.1371/journal.pone.0080990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312511	Green Published, Green Submitted, gold			2022-12-25	WOS:000327947800026
J	Nakano, H; Shibata, Y; Inoue, S; Igarashi, A; Yamauchi, K; Abe, S; Sato, M; Aida, Y; Nunomiya, K; Kimura, T; Nemoto, T; Watanabe, T; Konta, T; Ueno, Y; Kato, T; Kayama, T; Kubota, I				Nakano, Hiroshi; Shibata, Yoko; Inoue, Sumito; Igarashi, Akira; Yamauchi, Keiko; Abe, Shuichi; Sato, Masamichi; Aida, Yasuko; Nunomiya, Keiko; Kimura, Tomomi; Nemoto, Takako; Watanabe, Tetsu; Konta, Tsuneo; Ueno, Yoshiyuki; Kato, Takeo; Kayama, Takamasa; Kubota, Isao			Relationships between Values of Antibodies to Several Connective Tissue Disease Autoantigens and Pulmonary Function in a Japanese General Population: The Takahata Study	PLOS ONE			English	Article							BODY-MASS INDEX; ANTINUCLEAR ANTIBODIES; CIGARETTE-SMOKING; HEALTH CHECK; MALE SMOKERS; COPD; CELL; AUTOANTIBODIES; PARTICIPANTS; OBSTRUCTION	Background: Accumulating evidence suggests the involvement of an autoimmune mechanism in the pathogenesis of respiratory dysfunction. The aim of this study was to investigate the relationship between pulmonary function and serum antibodies to several connective tissue disease autoantigens (ACTDA) levels, which has not been investigated in a general population. Methods: Blood sampling and spirometry were performed for subjects (n = 3,257) aged >= 40 years who participated in a community-based annual health check in Takahata, Japan, from 2004 to 2006. ACTDA was measured by enzyme immunoassay, and subjects with ACTDA values >= 20 were defined as positive. Results: In males, there were significant inverse relationships between logarithmically transformed ACTDA values and spirometric parameters, including % predicted values for forced expiratory volume in 1 s (FEV1) and maximal midexpiratory flow (MMF) as well as FEV1/forced vital capacity (FVC). Multiple linear regression analysis revealed that except for the relationship between ACTDA and FEV1/FVC, these relationships were still significant after adjustment for Brinkman index (a measure of inhaled cigarette consumption). The prevalence of positive ACTDA was greater in male never-smokers with mixed ventilation disorders and relatively severe airflow obstruction (% predicted FEV1 below the median value). Conclusions: Autoimmunity may be involved in the mechanism of impaired pulmonary function in the general population.	[Nakano, Hiroshi; Shibata, Yoko; Inoue, Sumito; Igarashi, Akira; Yamauchi, Keiko; Abe, Shuichi; Sato, Masamichi; Aida, Yasuko; Nunomiya, Keiko; Kimura, Tomomi; Nemoto, Takako; Watanabe, Tetsu; Konta, Tsuneo; Kubota, Isao] Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan; [Ueno, Yoshiyuki; Kato, Takeo; Kayama, Takamasa] Yamagata Univ, Sch Med, Global Ctr Excellence Program Study Grp, Yamagata 99023, Japan	Yamagata University; Yamagata University	Shibata, Y (corresponding author), Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan.	shibata@med.id.yamagata-u.ac.jp	Konta, Tsuneo/AAO-9286-2021; Ueno, Yoshiyuki/R-9242-2019	Ueno, Yoshiyuki/0000-0001-5623-4250	Global COE program of the Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [24700963] Funding Source: KAKEN	Global COE program of the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-aid from the Global COE program of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2003, THORAX, V58, P832, DOI 10.1136/thorax.58.10.832; Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Aida Y, 2011, INT J MED SCI, V8, P470, DOI 10.7150/ijms.8.470; Arao T, 2003, J NUCL MED, V44, P1747; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Bonarius HPJ, 2011, THORAX, V66, P101, DOI 10.1136/thx.2009.134171; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; *COMM PULM PHYS JA, 2004, GUID PULM FUNCT TEST, P56; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Deesomchok A, 2010, COPD, V7, P428, DOI 10.3109/15412555.2010.528087; Di Stefano A, 2004, CLIN EXP ALLERGY, V34, P1156, DOI 10.1111/j.1365-2222.2004.02030.x; Fabbri LM, 2007, LANCET, V370, P797, DOI 10.1016/S0140-6736(07)61383-X; Feghali-Bostwick CA, 2008, AM J RESP CRIT CARE, V177, P156, DOI 10.1164/rccm.200701-014OC; Fischer A, 2012, LANCET, V380, P689, DOI 10.1016/S0140-6736(12)61079-4; Fukuchi Y, 2004, RESPIROLOGY, V9, P458, DOI 10.1111/j.1440-1843.2004.00637.x; *GOLD GLOB IN CHRO, OBSTR LUNG DIS GLOB; Hayashi N, 2008, MOD RHEUMATOL, V18, P153, DOI 10.1007/s10165-008-0028-1; Ishikawa M, 2008, CLIN EXP NEPHROL, V12, P200, DOI 10.1007/s10157-008-0030-0; Karayama M, 2010, CHEST, V138, P1303, DOI 10.1378/chest.10-0863; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kirkham PA, 2011, AM J RESP CRIT CARE, V184, P796, DOI 10.1164/rccm.201010-1605OC; Kishi H, 2011, INTERNAL MED, V50, P87, DOI 10.2169/internalmedicine.50.4276; Klareskog L, 2007, CURR OPIN RHEUMATOL, V19, P49, DOI 10.1097/BOR.0b013e32801127c8; Leidinger P, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-20; Munakata M, 1994, Nihon Kyobu Shikkan Gakkai Zasshi, V32 Suppl, P187; Nemoto T, 2011, INTERNAL MED, V50, P2547, DOI 10.2169/internalmedicine.50.5948; Ntatsaki E, 2010, RHEUM DIS CLIN N AM, V36, P447, DOI 10.1016/j.rdc.2010.04.002; Nunez B, 2011, AM J RESP CRIT CARE, V183, P1025, DOI 10.1164/rccm.201001-0029OC; Nunomiya K, 2013, EUR RESPIR J, V42, P18, DOI 10.1183/09031936.00066212; Ohta Ken, 2011, Allergology International, V60, P115, DOI 10.2332/allergolint.11-RAI-0327; Osaka D, 2010, INTERNAL MED, V49, P1489, DOI 10.2169/internalmedicine.49.3364; Sato M, 2013, INT J MED SCI, V10, P1, DOI 10.7150/ijms.5003; Satoh M, 2012, ARTHRITIS RHEUM-US, V64, P2319, DOI 10.1002/art.34380; Shibata Y, 2011, INT J MED SCI, V8, P514, DOI 10.7150/ijms.8.514; SZCZEKLIK A, 1995, AM J RESP CRIT CARE, V152, P1753, DOI 10.1164/ajrccm.152.6.8520733; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81678	10.1371/journal.pone.0081678	http://dx.doi.org/10.1371/journal.pone.0081678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312572	Green Published, Green Submitted, gold			2022-12-25	WOS:000327947800053
J	Burbelo, PD; Ching, KH; Morse, CG; Alevizos, I; Bayat, A; Cohen, JI; Ali, MA; Kapoor, A; Browne, SK; Holland, SM; Kovacs, JA; Iadarola, MJ				Burbelo, Peter D.; Ching, Kathryn H.; Morse, Caryn G.; Alevizos, Ilias; Bayat, Ahmad; Cohen, Jeffrey I.; Ali, Mir A.; Kapoor, Amit; Browne, Sarah K.; Holland, Steven M.; Kovacs, Joseph A.; Iadarola, Michael J.			Altered Antibody Profiles against Common Infectious Agents in Chronic Disease	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; LUCIFERASE IMMUNOPRECIPITATION SYSTEMS; SALIVARY-GLAND BIOPSIES; SJOGRENS-SYNDROME; HUMORAL RESPONSES; HOMOSEXUAL MEN; GUT MICROBIOME; DNA; IMMUNODEFICIENCY; TYPE-2	Despite the important diagnostic value of evaluating antibody responses to individual human pathogens, antibody profiles against multiple infectious agents have not been used to explore health and disease mainly for technical reasons. We hypothesized that the interplay between infection and chronic disease might be revealed by profiling antibodies against multiple agents. Here, the levels of antibodies against a panel of 13 common infectious agents were evaluated with the quantitative Luciferase Immunoprecipitation Systems (LIPS) in patients from three disease cohorts including those with pathogenic anti-interferon-gamma autoantibodies (IFN-gamma AAB), HIV and Sjogren's syndrome (SjS) to determine if their antibody profiles differed from control subjects. The IFN-gamma AAB patients compared to controls demonstrated statistically higher levels of antibodies against VZV (p=0.0003), EBV (p=0.002), CMV (p=0.003), and C. albicans (p=0.03), but lower antibody levels against poliovirus (p=0.04). Comparison of HIV patients with blood donor controls revealed that the patients had higher levels of antibodies against CMV (p=0.0008), HSV-2 (p=0.0008), EBV (p=0.001), and C. albicans (p=0.01), but showed decreased levels of antibodies against coxsackievirus B4 (p=0.0008), poliovirus (p=0.0005), and HHV-6B (p=0.002). Lastly, SjS patients had higher levels of anti-EBV antibodies (p=0.03), but lower antibody levels against several enteroviruses including a newly identified picornavirus, HCoSV-A (p=0.004), coxsackievirus B4 (p=0.04), and poliovirus (p=0.02). For the IFN-gamma AAB and HIV cohorts, principal component analysis revealed unique antibody clusters that showed the potential to discriminate patients from controls. The results suggest that antibody profiles against these and likely other common infectious agents may yield insight into the interplay between exposure to infectious agents, dysbiosis, adaptive immunity and disease activity.	[Burbelo, Peter D.] Natl Inst Dent & Craniofacial Res, Clin Dent Res Core, NIH, Bethesda, MD USA; [Ching, Kathryn H.] USDA, Western Reg Res Ctr, Albany, CA 94710 USA; [Morse, Caryn G.; Kovacs, Joseph A.] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA; [Alevizos, Ilias] Natl Inst Dent & Craniofacial Res, Sjogren Syndrome Clin, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA; [Bayat, Ahmad; Iadarola, Michael J.] NIH, Dept Perioperat Med, Ctr Clin, Bethesda, MD 20892 USA; [Cohen, Jeffrey I.; Ali, Mir A.] NIAID, Med Virol Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Kapoor, Amit] Columbia Univ, Ctr Infect & Immun, New York, NY USA; [Browne, Sarah K.; Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Burbelo, PD (corresponding author), Natl Inst Dent & Craniofacial Res, Clin Dent Res Core, NIH, Bethesda, MD USA.	burbelop@nidcr.nih.gov	Kovacs, Joseph/AAU-6105-2021	Kovacs, Joseph/0000-0002-5191-9880; Morse, Caryn/0000-0002-1177-4365	Division of Intramural Research, National Institute of Dental and Craniofacial Research; National Institute of Allergy and Infectious Diseases; Clinical Center, NIH; Center for Neuroscience and Regenerative Medicine; NIH [AI090196, AI081132]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000646, ZIAAI000058, ZIAAI001069, ZIAAI000647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000704] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL008075, ZIACL090034] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Clinical Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Neuroscience and Regenerative Medicine(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); CLINICAL CENTER	This work was supported by the Division of Intramural Research, National Institute of Dental and Craniofacial Research, the National Institute of Allergy and Infectious Diseases, the Clinical Center, NIH, the Center for Neuroscience and Regenerative Medicine and from NIH grants AI090196 and AI081132. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Burbelo PD, 2007, BIOCHEM BIOPH RES CO, V352, P889, DOI 10.1016/j.bbrc.2006.11.140; Burbelo PD, 2012, AM J TRANSL RES, V4, P443; Burbelo PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022576; Burbelo PD, 2011, EXPERT REV PROTEOMIC, V8, P309, DOI [10.1586/EPR.11.23, 10.1586/epr.11.23]; Burbelo PD, 2011, MOL BIOSYST, V7, P1453, DOI 10.1039/c0mb00342e; Burbelo PD, 2010, EXPERT REV VACCINES, V9, P567, DOI [10.1586/erv.10.50, 10.1586/ERV.10.50]; Burbelo Peter D, 2009, J Vis Exp, DOI 10.3791/1549; Burbelo PD, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-45; Burbelo PD, 2009, CLIN VACCINE IMMUNOL, V16, P366, DOI 10.1128/CVI.00350-08; Chi CY, 2012, BLOOD; Cohen JI, 2011, BLOOD, V117, P5835, DOI 10.1182/blood-2010-11-316745; Doukas C, 2010, IEEE ENG MED BIO, P4108, DOI 10.1109/IEMBS.2010.5627332; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; FOX RI, 1986, J IMMUNOL, V137, P3162; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kapoor A, 2008, P NATL ACAD SCI USA, V105, P20482, DOI 10.1073/pnas.0807979105; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li LL, 2013, J VIROL, V87, P10912, DOI 10.1128/JVI.01839-13; Ling PD, 2003, CLIN INFECT DIS, V37, P1244, DOI 10.1086/378808; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Mendoza D, 2012, BLOOD, V119, P4645, DOI 10.1182/blood-2011-10-381996; Parks T, 2012, NEW ENGL J MED, V367, P90, DOI [10.1056/NEJMra1108296, 10.1056/NEJMc1202013, 10.1056/NEJMc1204960]; Perrot S, 2003, J CLIN VIROL, V28, P165, DOI 10.1016/S1386-6532(02)00277-9; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Posnett DN, 2008, CURR OPIN INVEST DR, V9, P505; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; RAHMAN MA, 1989, J INFECT DIS, V159, P472, DOI 10.1093/infdis/159.3.472; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Russell DB, 2001, J CLIN VIROL, V22, P305, DOI 10.1016/S1386-6532(01)00203-7; SAITO I, 1989, J EXP MED, V169, P2191, DOI 10.1084/jem.169.6.2191; Spector SA, 1998, J CLIN INVEST, V101, P497, DOI 10.1172/JCI1101; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; WRAY D, 1990, BRIT DENT J, V168, P326, DOI 10.1038/sj.bdj.4807186	40	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81635	10.1371/journal.pone.0081635	http://dx.doi.org/10.1371/journal.pone.0081635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312567	Green Submitted, gold, Green Published			2022-12-25	WOS:000327944500082
J	Chen, XY; Fan, ZY; Chen, YZ; Fang, XL; Sha, XY				Chen, Xinyi; Fan, Zhuoyang; Chen, Yanzuo; Fang, Xiaoling; Sha, Xianyi			Retro-Inverso Carbohydrate Mimetic Peptides with Annexin1-Binding Selectivity, Are Stable In Vivo, and Target Tumor Vasculature	PLOS ONE			English	Article							DRUG-DELIVERY; ANTIGENIC MIMICRY; NANOPARTICLES; PEPTIDOMIMETICS; CELLS; ANTAGONISTS; ANTIBODIES; ANALOGS; SURFACE; TISSUE	Previous research suggests that carbohydrate mimetic peptide IF7 (IFLLWQR) has an excellent targeting property to annexin1 (Anxa1), a specific marker on the tumor endothelium. However, IF7 is susceptible to proteolysis and has a poor stability in vivo. We prepared a D-amino acid, reverse sequence peptide of IF7, designated RIF7, to confer protease resistance while retaining bioactivity. Experimental results indicate that RIF7 had significantly increased stability and an increased receptor binding affinity than IF7, and this new moiety may represent a clinically relevant vehicle for anticancer drugs.	[Chen, Xinyi; Fan, Zhuoyang; Chen, Yanzuo; Fang, Xiaoling; Sha, Xianyi] Fudan Univ, Sch Pharm, Dept Pharmaceut, Key Lab Smart Drug Delivery,Minist Educ, Shanghai 200433, Peoples R China	Fudan University	Sha, XY (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmaceut, Key Lab Smart Drug Delivery,Minist Educ, Shanghai 200433, Peoples R China.	shaxy@fudan.edu.cn			National Nature Science Foundation of China [81273459]; Shanghai Rising-Star Program [10QA1400800]; National Basic Research Program of China [2013CB932500]; National Science and Technology Major Project [2012ZX09304004]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; National Basic Research Program of China(National Basic Research Program of China); National Science and Technology Major Project	The work was sponsored by National Nature Science Foundation of China (81273459), Shanghai Rising-Star Program (10QA1400800), National Basic Research Program of China (2013CB932500) and National Science and Technology Major Project (2012ZX09304004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino M, 2011, EXPERT OPIN BIOL TH, V11, P211, DOI 10.1517/14712598.2011.542140; Alessi P, 2004, BBA-REV CANCER, V1654, P39, DOI 10.1016/j.bbcan.2003.08.001; BRIAND JP, 1995, J BIOL CHEM, V270, P20686, DOI 10.1074/jbc.270.35.20686; CHOREV M, 1995, TRENDS BIOTECHNOL, V13, P438, DOI 10.1016/S0167-7799(00)88999-4; Dhar S, 2008, P NATL ACAD SCI USA, V105, P17356, DOI 10.1073/pnas.0809154105; Eck W, 2008, ACS NANO, V2, P2263, DOI 10.1021/nn800429d; Fukuda MN, 2012, BIOL PHARM BULL, V35, P1626, DOI 10.1248/bpb.b12-00395; Guichard G, 1996, TRENDS BIOTECHNOL, V14, P44, DOI 10.1016/0167-7799(96)80919-X; GUICHARD G, 1994, P NATL ACAD SCI USA, V91, P9765, DOI 10.1073/pnas.91.21.9765; Guptasarma P, 1996, TRENDS BIOTECHNOL, V14, P42, DOI 10.1016/0167-7799(96)80917-6; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hatakeyama S, 2011, P NATL ACAD SCI USA, V108, P19587, DOI 10.1073/pnas.1105057108; JAMESON BA, 1994, NATURE, V368, P744, DOI 10.1038/368744a0; KUCHARCZYK N, 1993, J MED CHEM, V36, P1654, DOI 10.1021/jm00063a015; Landon Linda A, 2004, Curr Drug Discov Technol, V1, P113, DOI 10.2174/1570163043335108; Langer R, 1998, NATURE, V392, P5; LEBAN JJ, 1993, P NATL ACAD SCI USA, V90, P1922, DOI 10.1073/pnas.90.5.1922; Leung D, 2000, J MED CHEM, V43, P305, DOI 10.1021/jm990412m; Loffet A, 2002, J PEPT SCI, V8, P1, DOI 10.1002/psc.366; Lu J, 2009, BIOCONJUGATE CHEM, V20, P87, DOI 10.1021/bc8003167; McCarron PA, 2008, BIOCONJUGATE CHEM, V19, P1561, DOI 10.1021/bc800057g; Oh P, 2004, NATURE, V429, P629, DOI 10.1038/nature02580; Otvos Laszlo Jr., 2008, V494, P1, DOI 10.1007/978-1-59745-419-3_1; Passarella RJ, 2010, CANCER RES, V70, P4550, DOI 10.1158/0008-5472.CAN-10-0339; Phan-Chan-Du A, 2001, BIOCHEMISTRY-US, V40, P5720, DOI 10.1021/bi001151h; Roy O, 2006, TETRAHEDRON LETT, V47, P5981, DOI 10.1016/j.tetlet.2006.06.027; Solito E, 1998, CELL GROWTH DIFFER, V9, P327; Van Regenmortel MHV, 1998, CURR OPIN BIOTECH, V9, P377, DOI 10.1016/S0958-1669(98)80011-6; Wu Z, 2011, ACS NANO, V5, P7696, DOI 10.1021/nn2037384; Zhang ZP, 2007, BIOMATERIALS, V28, P1889, DOI 10.1016/j.biomaterials.2006.12.018	31	7	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80390	10.1371/journal.pone.0080390	http://dx.doi.org/10.1371/journal.pone.0080390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312470	Green Published, gold, Green Submitted			2022-12-25	WOS:000327944500022
J	Delano, K; Gareri, J; Koren, G				Delano, Kaitlyn; Gareri, Joey; Koren, Gideon			Rates of Fetal Polydrug Exposures in Methadone-Maintained Pregnancies from a High-Risk Population	PLOS ONE			English	Article							NEONATAL OUTCOMES; DRUG; BUPRENORPHINE; MECONIUM; ABUSE; METABOLITES; CLEARANCE; WOMEN	Methadone maintenance treatment (MMT) is the standard of care during pregnancy for opioid-dependency, showing efficacy in improving prenatal care and reducing risk of relapse. By design, however, MMT is only intended to prevent withdrawal thus facilitating cognitive behavioural interventions. In order to maximize the benefits of MMT, it is essential that methadone is both properly prescribed and that additional addiction treatment is concurrently administered. This study aims to determine the effectiveness of MMT engagement in high-risk pregnant women in reducing polydrug use by objective laboratory examination of neonatal meconium. Patients and Methods: Over a 29-month period, the Motherisk Laboratory at the Hospital for Sick Children in Toronto analyzed meconium samples as per request by social services and hospitals for drugs of abuse. Results: Of the 904 meconium samples received, 273 were tested for methadone with 164 positive and 109 negative for methadone. Almost half of the methadone positive samples (46.34%) were also positive for at least one other opioid compound, which did not differ statistically from the methadone-negative control samples (46.79%; Chi square test, p=0.94). No differences were found between the methadone positive and negative groups in rates of concurrent amphetamines, cocaine, cannabis, and alcohol use indicating a similar risk of polydrug use between pregnant women taking or not taking methadone in this population. Discussion: The high rates of additional opioid and other drug use in the MMT group, suggest that MMT is failing this population of patients. It is possible that methadone doses during pregnancy are not appropriately adjusted for changes in pharmacokinetic parameters (e. g. blood volume, renal function) during the second and third trimesters. This may result in sub-therapeutic dosing creating withdrawal symptoms leading to additional substance use. Alternatively, these results may be demonstrating a substantial lack in delivery of addiction support services in this vulnerable population.	[Delano, Kaitlyn; Gareri, Joey; Koren, Gideon] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada; [Delano, Kaitlyn; Koren, Gideon] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Gareri, Joey] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON, Canada; [Koren, Gideon] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Western University (University of Western Ontario)	Koren, G (corresponding author), Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada.	gkoren@sickkids.ca	Koren, Gideon/AAG-7726-2019	Koren, Gideon/0000-0002-9234-0875	Research Leadership for Better Pharmacotherapy During Pregnancy and Lactation	Research Leadership for Better Pharmacotherapy During Pregnancy and Lactation	The source of funding for this study was the Research Leadership for Better Pharmacotherapy During Pregnancy and Lactation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksa K, 2012, FORENSIC SCI INT, V218, P31, DOI 10.1016/j.forsciint.2011.10.002; Bar-Oz B, 2003, ARCH DIS CHILD-FETAL, V88, pF98, DOI 10.1136/fn.88.2.F98; Bessa MA, 2010, ADDICT BEHAV, V35, P266, DOI 10.1016/j.addbeh.2009.10.007; Clancy Zoe, 2013, J Opioid Manag, V9, P121, DOI 10.5055/jom.2013.0153; Dickmann LJ, 2013, DRUG METAB DISPOS, V41, P270, DOI 10.1124/dmd.112.047118; Finnegan LP, 1971, CONTEMP DRUG PROBS, V1, P795; Gray TR, 2010, NICOTINE TOB RES, V12, P658, DOI 10.1093/ntr/ntq068; Hutson JR, 2011, ALCOHOL, V45, P193, DOI 10.1016/j.alcohol.2010.07.005; Jaffee WB, 2007, J SUBST ABUSE TREAT, V33, P33, DOI 10.1016/j.jsat.2006.11.008; Jarvis MAE, 1999, J ADDICT DIS, V18, P51, DOI 10.1300/J069v18n04_05; Kacinko SL, 2008, CLIN PHARMACOL THER, V84, P604, DOI 10.1038/clpt.2008.156; KANDALL SR, 1977, EARLY HUM DEV, V1, P159, DOI 10.1016/0378-3782(77)90017-2; Keegan J, 2010, J ADDICT DIS, V29, P175, DOI 10.1080/10550881003684723; Kelly L, 2011, CAN FAM PHYSICIAN, V57, pE441; Koren G, 2008, CLIN PHARMACOL THER, V83, P631, DOI 10.1038/sj.clpt.6100506; Kuczkowski KM, 2007, CURR OPIN OBSTET GYN, V19, P578, DOI 10.1097/GCO.0b013e3282f1bf17; Kwong TC, 1997, CLIN CHEM, V43, P235; Loudenburg R, 2003, NEUROTOXICOL TERATOL, V25, P737, DOI 10.1016/j.ntt.2003.07.009; McCarthy JJ, 2012, J MATERN-FETAL NEO M, V25, P109, DOI 10.3109/14767058.2011.600371; Miller V, 1974, GROWTH DEV ENDODERMA, P281; Moller Monique, 2010, Can J Clin Pharmacol, V17, pe177; Pepler D. J., 2002, BREAKING CYCLE EVALU; Poole N, 2000, EVALUATION REPORT SH; Welle-Strand GK, 2013, DRUG ALCOHOL DEPEN, V127, P200, DOI 10.1016/j.drugalcdep.2012.07.001; Wolff K, 2005, EUR J CLIN PHARMACOL, V61, P763, DOI 10.1007/s00228-005-0035-5	25	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82647	10.1371/journal.pone.0082647	http://dx.doi.org/10.1371/journal.pone.0082647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312668	gold, Green Submitted, Green Published			2022-12-25	WOS:000327944500142
J	Glockner, G; Heinze, I; Platzer, M; Held, C; Abele, D				Gloeckner, Gernot; Heinze, Ivonne; Platzer, Matthias; Held, Christoph; Abele, Doris			The Mitochondrial Genome of Arctica islandica; Phylogeny and Variation	PLOS ONE			English	Article							DOUBLY UNIPARENTAL INHERITANCE; MAXIMUM-LIKELIHOOD; DNA-SEQUENCE; EVOLUTION; POPULATION; LONGEVITY; MODEL; MTDNA	Arctica islandica is known as the longest-lived non-colonial metazoan species on earth and is therefore increasingly being investigated as a new model in aging research. As the mitochondrial genome is associated with the process of aging in many species and bivalves are known to possess a peculiar mechanism of mitochondrial genome inheritance including doubly uniparental inheritance (DUI), we aimed to assess the genomic variability of the A. islandica mitochondrial DNA (mtDNA). We sequenced the complete mitochondrial genomes of A. islandica specimens from three different sites in the Western Palaearctic (Iceland, North Sea, Baltic Sea). We found the A. islandica mtDNA to fall within the normal size range (18 kb) and exhibit similar coding capacity as other animal mtDNAs. The concatenated protein sequences of all currently known Veneroidea mtDNAs were used to robustly place A. islandica in a phylogenetic framework. Analysis of the observed single nucleotide polymorphism (SNP) patterns on further specimen revealed two prevailing haplotypes. Populations in the Baltic and the North Sea are very homogenous, whereas the Icelandic population, from which exceptionally old individuals have been collected, is the most diverse one. Homogeneity in Baltic and North Sea populations point to either stronger environmental constraints or more recent colonization of the habitat. Our analysis lays the foundation for further studies on A. islandica population structures, age research with this organism, and for phylogenetic studies. Accessions for the mitochondrial genome sequences: KC197241 Iceland; KF363951 Baltic Sea; KF363952 North Sea; KF465708 to KF465758 individual amplified regions from different speciemen	[Gloeckner, Gernot] Univ Cologne, Fac Med, Inst Biochem 1, D-50931 Cologne, Germany; [Gloeckner, Gernot] IGB, Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany; [Heinze, Ivonne; Platzer, Matthias] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Held, Christoph; Abele, Doris] AWI, Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany	University of Cologne; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Glockner, G (corresponding author), Univ Cologne, Fac Med, Inst Biochem 1, D-50931 Cologne, Germany.	gernot.gloeckner@uni-koeln.de	Glöckner, Gernot/A-7800-2010	Glöckner, Gernot/0000-0002-9061-1061; Abele, Doris/0000-0002-5766-5017	FLI (Fritz-Lipmann Institute)	FLI (Fritz-Lipmann Institute)	Internal project funding of the FLI (Fritz-Lipmann Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2004, COMP BIOCHEM PHYS A, V138, P405, DOI 10.1016/j.cbpb.2004.05.013; Abele D, 2013, GERONTOLOGY, V59, P261, DOI 10.1159/000345331; BARJA G, 1994, COMP BIOCHEM PHYS B, V108, P501, DOI 10.1016/0305-0491(94)90103-1; Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516; Basova L, 2012, AQUAT BIOL, V14, P141, DOI 10.3354/ab00387; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Breton S, 2006, GENETICS, V172, P1107, DOI 10.1534/genetics.105.047159; Breton S, 2007, TRENDS GENET, V23, P465, DOI 10.1016/j.tig.2007.05.011; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Butler P.G., 2012, PALAEOGEOGRAPHY PALA; Buttemer WA, 2010, FUNCT ECOL, V24, P971, DOI 10.1111/j.1365-2435.2010.01740.x; Dahlgren TG, 2000, MAR BIOL, V137, P487, DOI 10.1007/s002270000342; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Jha M, 2008, EVOLUTION, V62, P99, DOI 10.1111/j.1558-5646.2007.00262.x; Juhling F, 2012, NUCLEIC ACIDS RES, V40, P2833, DOI 10.1093/nar/gkr1131; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Papillon D, 2004, MOL BIOL EVOL, V21, P2122, DOI 10.1093/molbev/msh229; Philipp EER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044621; Plazzi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027147; Rokas A, 2003, TRENDS ECOL EVOL, V18, P411, DOI 10.1016/S0169-5347(03)00125-3; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roure B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schneider A, 2011, ANNU REV BIOCHEM, V80, P1033, DOI 10.1146/annurev-biochem-060109-092838; Serb JM, 2003, MOL BIOL EVOL, V20, P1854, DOI 10.1093/molbev/msg218; Smith DR, 2007, J MOL EVOL, V65, P380, DOI 10.1007/s00239-007-9016-x; Strahl J, 2007, AQUAT BIOL, V1, P77, DOI 10.3354/ab00008; Strahl J, 2010, MAR BIOL, V157, P1283, DOI 10.1007/s00227-010-1408-6; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; WANNAMAKER AD, 2008, PAGES NEWS, V16, P4; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Witbaard R, 2003, J SEA RES, V50, P11, DOI 10.1016/S1385-1101(03)00039-X; Yuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032353; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	40	15	15	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82857	10.1371/journal.pone.0082857	http://dx.doi.org/10.1371/journal.pone.0082857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312674	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500147
J	Heather, NL; Derraik, JGB; Beca, J; Hofman, PL; Dansey, R; Hamill, J; Cutfield, WS				Heather, Natasha L.; Derraik, Jose G. B.; Beca, John; Hofman, Paul L.; Dansey, Rangi; Hamill, James; Cutfield, Wayne S.			Glasgow Coma Scale and Outcomes after Structural Traumatic Head Injury in Early Childhood	PLOS ONE			English	Article							BRAIN-INJURY; CHILDREN; MORTALITY; SCORE; RELIABILITY; SEVERITY	Objective: To assess the association of the Glasgow Coma Scale (GCS) with radiological evidence of head injury (the Abbreviated Injury Scale for the head region, AIS-HR) in young children hospitalized with traumatic head injury (THI), and the predictive value of GCS and AIS-HR scores for long-term impairment. Methods: Our study involved a 10-year retrospective review of a database encompassing all patients admitted to Starship Children's Hospital (Auckland, New Zealand, 2000-2010) with THI. Results: We studied 619 children aged <5 years at the time of THI, with long-term outcome data available for 161 subjects. Both GCS and AIS-HR scores were predictive of length of intensive care unit and hospital stay (all p<0.001). GCS was correlated with AIS-HR (rho=-0.46; p<0.001), although mild GCS scores (13-15) commonly undere-stimated the severity of radiological injury: 42% of children with mild GCS scores had serious-critical THI (AIS-HR 3-5). Increasingly severe GCS or AIS-HR scores were both associated with a greater likelihood of long-term impairment (neurological disability, residual problems, and educational support). However, long-term impairment was also relatively common in children with mild GCS scores paired with structural THI more severe than a simple linear skull fracture. Conclusion: Severe GCS scores will identify most cases of severe radiological injury in early childhood, and are good predictors of poor long-term outcome. However, young children admitted to hospital with structural THI and mild GCS scores have an appreciable risk of long-term disability, and also warrant long-term follow-up.	[Heather, Natasha L.; Derraik, Jose G. B.; Hofman, Paul L.; Cutfield, Wayne S.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Hofman, Paul L.; Cutfield, Wayne S.] Univ Auckland, Natl Res Ctr Growth & Dev, Auckland 1, New Zealand; [Beca, John] Starship Childrens Hosp, Auckland Dist Hlth Board, Paediat Intens Care Unit, Auckland, New Zealand; [Dansey, Rangi; Hamill, James] Starship Childrens Hosp, Auckland Dist Hlth Board, Trauma Serv, Auckland, New Zealand	University of Auckland; University of Auckland; Auckland District Health Board; Starship Children's Hospital; Auckland District Health Board; Starship Children's Hospital	Cutfield, WS (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	w.cutfield@auckland.ac.nz	Heather, Natasha/AAV-8425-2020; Derraik, José Guilherme Behrensdorf/A-1925-2008	Derraik, José Guilherme Behrensdorf/0000-0003-1226-1956	Health Research Council of New Zealand; Australasian Paediatric Endocrine Group; Starship Foundation Fellowship	Health Research Council of New Zealand(Health Research Council of New Zealand); Australasian Paediatric Endocrine Group; Starship Foundation Fellowship	This study was supported by grants from the Health Research Council of New Zealand and the Australasian Paediatric Endocrine Group. NLH was supported by a Starship Foundation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; *ASS ADV AUT MED, 2001, ABBR INJ SCAL; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chung CY, 2006, PEDIATR NEUROL, V34, P379, DOI 10.1016/j.pediatrneurol.2005.10.012; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Douglas NM, 2007, J PAEDIATR CHILD H, V43, P173, DOI 10.1111/j.1440-1754.2007.01038.x; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Fortune PM, 2010, PEDIATR CRIT CARE ME, V11, P339, DOI 10.1097/PCC.0b013e3181c014ab; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Holdgate Anna, 2006, Emerg Med Australas, V18, P379, DOI 10.1111/j.1742-6723.2006.00867.x; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lam WH, 1999, PAEDIATR ANAESTH, V9, P377; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; Salmond C., 2007, NZDEP2006 INDEX DEPR; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; TEASDALE G, 1974, LANCET, V2, P81; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5	28	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82245	10.1371/journal.pone.0082245	http://dx.doi.org/10.1371/journal.pone.0082245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312648	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500131
J	Kudva, AK; Kaushal, N; Mohinta, S; Kennett, MJ; August, A; Paulson, RF; Prabhu, KS				Kudva, Avinash K.; Kaushal, Naveen; Mohinta, Sonia; Kennett, Mary J.; August, Avery; Paulson, Robert F.; Prabhu, K. Sandeep			Evaluation of the Stability, Bioavailability, and Hypersensitivity of the Omega-3 Derived Anti-Leukemic Prostaglandin: Delta(12)-Prostaglandin J(3)	PLOS ONE			English	Article							CYCLOPENTENONE PROSTAGLANDIN; RECEPTOR AGONISTS; D-2; 15-DEOXY-DELTA(12,14)-PGJ(2); IDENTIFICATION; CELLS; DP1	Previous studies have demonstrated the ability of an eicosapentaenoic acid (EPA)-derived endogenous cyclopentenone prostaglandin (CyPG) metabolite, Delta(12)-PGJ(3), to selectively target leukemic stem cells, but not the normal hematopoietic stems cells, in in vitro and in vivo models of chronic myelogenous leukemia (CML). Here we evaluated the stability, bioavailability, and hypersensitivity of Delta(12)-PGJ(3). The stability of Delta(12)-PGJ(3) was evaluated under simulated conditions using artificial gastric and intestinal juice. The bioavailability of Delta(12)-PGJ(3) in systemic circulation was demonstrated upon intraperitoneal injection into mice by LC-MS/MS. Delta(12)-PGJ(3) being a downstream metabolite of PGD(3) was tested in vitro using primary mouse bone marrow-derived mast cells (BMMCs) and in vivo mouse models for airway hypersensitivity. ZK118182, a synthetic PG analog with potent PGD(2) receptor (DP)-agonist activity and a drug candidate in current clinical trials, was used for toxicological comparison. Delta(12)-PGJ(3) was relatively more stable in simulated gastric juice than in simulated intestinal juice that followed first-order kinetics of degradation. Intraperitoneal injection into mice revealed that Delta(12)-PGJ(3) was bioavailable and well absorbed into systemic circulation with a C-max of 263 mg/L at 12 h. Treatment of BMMCs with ZK118182 for 12 h resulted in increased production of histamine, while Delta(12)-PGJ(3) did not induce degranulation in BMMCs nor increase histamine. In addition, in vivo testing for hypersensitivity in mice showed that ZK118182 induces higher airways hyperresponsiveness when compared Delta(12)-PGJ(3) and/or PBS control. Based on the stability studies, our data indicates that intraperitoneal route of administration of Delta(12)-PGJ(3) was favorable than oral administration to achieve effective pharmacological levels in the plasma against leukemia. Delta(12)-PGJ(3) failed to increase histamine and IL-4 in BMMCs, which is in agreement with reduced airway hyperresponsiveness in mice. In summary, our studies suggest Delta(12)-PGJ(3) to be a promising bioactive metabolite for further evaluation as a potential drug candidate for treating CML.	[Kudva, Avinash K.; Kaushal, Naveen; Kennett, Mary J.; Paulson, Robert F.; Prabhu, K. Sandeep] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Mohinta, Sonia; August, Avery] Cornell Univ, Dept Microbiol & Immunol, Ithaca, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Cornell University	Prabhu, KS (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	ksp4@psu.edu	Kudva, Avinash Kundadka/J-4678-2017	Kudva, Avinash Kundadka/0000-0003-3619-4292; Kaushal, Naveen/0000-0001-9979-5664	Public Health Service grant from the National Institute of Health [CA175576-01]; NATIONAL CANCER INSTITUTE [R01CA175576] Funding Source: NIH RePORTER	Public Health Service grant from the National Institute of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The studies were funded by a Public Health Service grant from the National Institute of Health CA175576-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almishri W, 2005, J PHARMACOL EXP THER, V313, P64, DOI 10.1124/jpet.104.079079; Arima Masafumi, 2011, Korean Journal of Internal Medicine, V26, P8, DOI 10.3904/kjim.2011.26.1.8; BEDRICK AD, 1989, BIOL NEONATE, V56, P192, DOI 10.1159/000243122; Brunoldi EA, 2007, CHEM RES TOXICOL, V20, P1528, DOI 10.1021/tx700231a; EWART S, 1995, J APPL PHYSIOL, V79, P560, DOI 10.1152/jappl.1995.79.2.560; FITZPATRICK FA, 1983, J BIOL CHEM, V258, P1713; Hegde S, 2011, BLOOD, V118, P6909, DOI 10.1182/blood-2010-11-317750; Hellberg MR, 2002, BIOORGAN MED CHEM, V10, P2031, DOI 10.1016/S0968-0896(02)00016-0; Hoff J, 2000, LAB ANIMAL, V29, P47; Jensen Bettina M, 2006, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0323s74; Bargut TCL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075059; Luster AD, 2004, NAT REV IMMUNOL, V4, P711, DOI 10.1038/nri1438; O'Brien JJ, 2008, BLOOD, V112, P4051, DOI 10.1182/blood-2008-05-158535; Pettipher R, 2008, BRIT J PHARMACOL, V153, pS191, DOI 10.1038/sj.bjp.0707488; PIFER DD, 1981, PROSTAG OTH LIPID M, V21, P165, DOI 10.1016/0090-6980(81)90135-0; Ravindra KC, 2012, CHEM RES TOXICOL, V25, P337, DOI 10.1021/tx200383c; Sahu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011348; Sawyer N, 2002, BRIT J PHARMACOL, V137, P1163, DOI 10.1038/sj.bjp.0704973; SCHULZ BG, 1991, ADV PROSTAG THROMB L, V21, P591; Smith WL, 2005, CURR OPIN CELL BIOL, V17, P174, DOI 10.1016/j.ceb.2005.02.005; Straus DS, 2001, MED RES REV, V21, P185, DOI 10.1002/med.1006.abs; YOUNGER EW, 1986, PROSTAGLANDINS, V31, P923, DOI 10.1016/0090-6980(86)90024-9; Yu M, 2011, J CLIN INVEST, V121, P3133, DOI 10.1172/JCI43598	23	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80622	10.1371/journal.pone.0080622	http://dx.doi.org/10.1371/journal.pone.0080622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312486	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500033
J	Plouviez, S; Faure, B; Le Guen, D; Lallier, FH; Bierne, N; Jollivet, D				Plouviez, Sophie; Faure, Baptiste; Le Guen, Dominique; Lallier, Francois H.; Bierne, Nicolas; Jollivet, Didier			A New Barrier to Dispersal Trapped Old Genetic Clines That Escaped the Easter Microplate Tension Zone of the Pacific Vent Mussels	PLOS ONE			English	Article							HYDROTHERMAL-VENT; HYBRID ZONE; COMPARATIVE PHYLOGEOGRAPHY; POPULATION-STRUCTURE; ALLOZYME LOCI; SEA; FLOW; SELECTION; RISE; BATHYMODIOLUS	Comparative phylogeography of deep-sea hydrothermal vent species has uncovered several genetic breaks between populations inhabiting northern and southern latitudes of the East Pacific Rise. However, the geographic width and position of genetic clines are variable among species. In this report, we further characterize the position and strength of barriers to gene flow between populations of the deep-sea vent mussel Bathymodiolus thermophilus. Eight allozyme loci and DNA sequences of four nuclear genes were added to previously published sequences of the cytochrome c oxidase subunit I gene. Our data confirm the presence of two barriers to gene flow, one located at the Easter Microplate (between 21 degrees 33'S and 31 degrees S) recently described as a hybrid zone, and the second positioned between 7 degrees 25'S and 14 degrees S with each affecting different loci. Coalescence analysis indicates a single vicariant event at the origin of divergence between clades for all nuclear loci, although the clines are now spatially discordant. We thus hypothesize that the Easter Microplate barrier has recently been relaxed after a long period of isolation and that some genetic clines have escaped the barrier and moved northward where they have subsequently been trapped by a reinforcing barrier to gene flow between 7 degrees 25'S and 14 degrees S.	[Plouviez, Sophie; Faure, Baptiste; Le Guen, Dominique; Lallier, Francois H.; Jollivet, Didier] Univ Paris 06, Lab Adaptat & Diversite Milieu Marin, Stn Biol Roscoff, Roscoff, France; [Plouviez, Sophie; Faure, Baptiste; Le Guen, Dominique; Lallier, Francois H.; Jollivet, Didier] CNRS, UMR 7144, Stn Biol Roscoff, Roscoff, France; [Plouviez, Sophie] Duke Univ, Div Marine Sci & Conservat, Nicholas Sch Environm, Beaufort, NC USA; [Faure, Baptiste; Bierne, Nicolas] Univ Montpellier 2, Montpellier, France; [Faure, Baptiste; Bierne, Nicolas] Inst Sci Evolut, CNRS UMR 5554, Stn Mediterraneenne Environm Littoral, Sete, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Duke University; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Plouviez, S (corresponding author), Univ Paris 06, Lab Adaptat & Diversite Milieu Marin, Stn Biol Roscoff, Roscoff, France.	sophie.plouviez@duke.edu		Bierne, Nicolas/0000-0003-1856-3197	GDR Ecchis; Universite Pierre et Marie Curie; National Science Foundation [OCE-1031050]; NoE "Marine Genomics Europe" (Fish & Shellfish node);  [ANR-06-BDV-005]	GDR Ecchis; Universite Pierre et Marie Curie; National Science Foundation(National Science Foundation (NSF)); NoE "Marine Genomics Europe" (Fish & Shellfish node); 	This work was supported by the GDR Ecchis and the ANR-06-BDV-005 (Deep Oases: coord. D. Desbruyes). The 'Bivalvomix'GIS programme (coord. N. Bierne) partly supported the sequencing costs of the B. azoricus cDNA library construction together with the NoE "Marine Genomics Europe". S. Plouviez was supported by a PhD grant from the Universite Pierre et Marie Curie and the National Science Foundation under Grant Number OCE-1031050 (coord. C. Van Dover). B. Faure was supported by the NoE "Marine Genomics Europe" (Fish & Shellfish node). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arellano SM, 2009, BIOL BULL-US, V216, P149, DOI 10.1086/BBLv216n2p149; Audzijonyte A, 2010, EVOLUTION, V64, P2369, DOI 10.1111/j.1558-5646.2010.00987.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barton NH, 2011, AM NAT, V178, pE48, DOI 10.1086/661246; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BARTON NH, 1979, HEREDITY, V43, P341, DOI 10.1038/hdy.1979.87; Belkhir K, 2004, GENETIX 4 05 LOGICIE, V2; Bierne N, 2007, MOL ECOL NOTES, V7, P562, DOI 10.1111/j.1471-8286.2007.01685.x; Bierne N, 2003, MOL ECOL, V12, P447, DOI 10.1046/j.1365-294X.2003.01730.x; Bierne N, 2003, MOL ECOL, V12, P2505, DOI 10.1046/j.1365-294X.2003.01936.x; Bierne N, 2011, MOL ECOL, V20, P2044, DOI 10.1111/j.1365-294X.2011.05080.x; Boutet I, 2009, P ROY SOC B-BIOL SCI, V276, P3071, DOI 10.1098/rspb.2009.0503; Buggs RJA, 2007, HEREDITY, V99, P301, DOI 10.1038/sj.hdy.6800997; Burton KW, 1997, NATURE, V386, P382, DOI 10.1038/386382a0; Carney SL, 2006, DEEP-SEA RES PT I, V53, P1061, DOI 10.1016/j.dsr.2006.03.002; Castric V, 2003, GENETICS, V163, P983; CRADDOCK C, 1995, MAR BIOL, V124, P137, DOI 10.1007/BF00349155; Dasmahapatra KK, 2002, EVOLUTION, V56, P741, DOI 10.1111/j.0014-3820.2002.tb01385.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Faure B, 2007, GENE, V406, P99, DOI 10.1016/j.gene.2007.06.025; Faure B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006485; Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30; FRANCHETEAU J, 1990, EARTH PLANET SC LETT, V101, P281, DOI 10.1016/0012-821X(90)90160-Y; FUJIO SZ, 1991, J GEOPHYS RES-OCEANS, V96, P759, DOI 10.1029/90JC02130; Gay L, 2008, EVOLUTION, V62, P2789, DOI 10.1111/j.1558-5646.2008.00491.x; GRASSLE JP, 1985, B BIOL SOC WASH, V6, P429; HEWITT GM, 1988, TRENDS ECOL EVOL, V3, P158, DOI 10.1016/0169-5347(88)90033-X; HEWITT GM, 1975, HEREDITY, V35, P375, DOI 10.1038/hdy.1975.108; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1992, GENETICS, V132, P583; Hurtado LA, 2004, MOL ECOL, V13, P2603, DOI 10.1111/j.1365-294X.2004.02287.x; Johnson SB, 2006, BIOL BULL-US, V210, P140, DOI 10.2307/4134603; Johnson SB, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-21; Jollivet D, 1999, EVOLUTION, V53, P1128, DOI 10.1111/j.1558-5646.1999.tb04527.x; Jolly MT, 2006, MOL ECOL, V15, P1841, DOI 10.1111/j.1365-294X.2006.02910.x; KARL SA, 1992, SCIENCE, V256, P100, DOI 10.1126/science.1348870; KIMURA M, 1964, GENETICS, V49, P561; Kumar S, 1996, GENETICS, V142, P965; KURETH CL, 1981, MAR GEOPHYS RES, V5, P119; LARSON RL, 1992, NATURE, V356, P571, DOI 10.1038/356571a0; Lemaire C, 2000, MOL ECOL, V9, P457, DOI 10.1046/j.1365-294x.2000.00884.x; LEWONTIN RC, 1973, GENETICS, V74, P175; Lupton J, 1998, J GEOPHYS RES-OCEANS, V103, P15853, DOI 10.1029/98JC00146; LUPTON JE, 1981, SCIENCE, V214, P13, DOI 10.1126/science.214.4516.13; LUTZ RA, 1984, SCIENCE, V226, P1451, DOI 10.1126/science.226.4681.1451; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Matabos M, 2011, J BIOGEOGR, V38, P575, DOI 10.1111/j.1365-2699.2010.02418.x; McDonald JH, 1996, MOL BIOL EVOL, V13, P1114, DOI 10.1093/oxfordjournals.molbev.a025673; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mullineaux LS, 2010, P NATL ACAD SCI USA, V107, P7829, DOI 10.1073/pnas.0913187107; Naar DF, 2004, GEOPH MONOG SERIES, V148, P305, DOI 10.1029/148GM13; NAAR DF, 1989, GEOLOGY, V17, P420, DOI 10.1130/0091-7613(1989)017<0420:SLFOTF>2.3.CO;2; Olson MS, 2012, MOL ECOL, V21, P2315, DOI 10.1111/j.1365-294X.2012.05503.x; Olu-Le Roy K, 2007, DEEP-SEA RES PT I, V54, P1890, DOI 10.1016/j.dsr.2007.07.004; Plouviez S, 2009, MOL ECOL, V18, P3903, DOI 10.1111/j.1365-294X.2009.04325.x; Plouviez S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-220; POGSON GH, 1995, GENETICS, V139, P375; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; REMINGTON C L, 1968, Evolutionary Biology (New York), P321; Riginos C, 2002, MOL BIOL EVOL, V19, P347, DOI 10.1093/oxfordjournals.molbev.a004088; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SLATKIN M, 1973, GENETICS, V75, P733; Stiller J, 2013, SYST BIODIVERS, V11, P35, DOI 10.1080/14772000.2013.772925; Tebbens SF, 1997, J GEOPHYS RES SOLID, V102, P12601; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vrijenhoek RC, 1997, J HERED, V88, P285, DOI 10.1093/oxfordjournals.jhered.a023106; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Won Y, 2003, MOL ECOL, V12, P3185, DOI 10.1046/j.1365-294X.2003.01974.x; Won Y, 2003, MOL ECOL, V12, P169, DOI 10.1046/j.1365-294X.2003.01726.x; Young CR, 2008, MOL ECOL, V17, P1718, DOI 10.1111/j.1365-294X.2008.03609.x	71	19	19	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81555	10.1371/journal.pone.0081555	http://dx.doi.org/10.1371/journal.pone.0081555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312557	Green Published, gold			2022-12-25	WOS:000327944500075
J	Derscheid, RJ; Gallup, JM; Knudson, CJ; Varga, SM; Grosz, DD; van Geelen, A; Hostetter, SJ; Ackermann, MR				Derscheid, Rachel J.; Gallup, Jack M.; Knudson, Cory J.; Varga, Steven M.; Grosz, Drew D.; van Geelen, Albert; Hostetter, Shannon J.; Ackermann, Mark R.			Effects of Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) in the Perinatal Lamb Model of RSV	PLOS ONE			English	Article							PULMONARY HISTOPATHOLOGY; COTTON RATS; BALB/C MICE; GLYCOPROTEIN; IMMUNIZATION; ENHANCEMENT; EXPRESSION; INFECTION; DISEASE	Respiratory syncytial virus (RSV) is the most frequent cause of bronchiolitis in infants and children worldwide. There are currently no licensed vaccines or effective antivirals. The lack of a vaccine is partly due to increased caution following the aftermath of a failed clinical trial of a formalin-inactivated RSV vaccine (FI-RSV) conducted in the 1960's that led to enhanced disease, necessitating hospitalization of 80% of vaccine recipients and resulting in two fatalities. Perinatal lamb lungs are similar in size, structure and physiology to those of human infants and are susceptible to human strains of RSV that induce similar lesions as those observed in infected human infants. We sought to determine if perinatal lambs immunized with FI-RSV would develop key features of vaccine-enhanced disease. This was tested in colostrum-deprived lambs immunized at 3-5 days of age with FI-RSV followed two weeks later by RSV infection. The FI-RSV-vaccinated lambs exhibited several key features of RSV vaccine-enhanced disease, including reduced RSV titers in bronchoalveolar lavage fluid and lung, and increased infiltration of peribronchiolar and perivascular lymphocytes compared to lambs either undergoing an acute RSV infection or naive controls; all features of RSV vaccine-enhanced disease. These results represent a first step proof-of-principle demonstration that the lamb can develop altered responses to RSV following FI-RSV vaccination. The lamb model may be useful for future mechanistic studies as well as the assessment of RSV vaccines designed for infants.	[Derscheid, Rachel J.; Gallup, Jack M.; Grosz, Drew D.; van Geelen, Albert; Hostetter, Shannon J.; Ackermann, Mark R.] Iowa State Univ, Coll Vet Med, Dept Vet Pathol, Ames, IA 50011 USA; [Knudson, Cory J.; Varga, Steven M.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA USA; [Varga, Steven M.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Varga, Steven M.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA	Iowa State University; University of Iowa; University of Iowa; University of Iowa	Ackermann, MR (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Pathol, Ames, IA 50011 USA.	mackerma@iastate.edu	Hostetter, Shannon J/T-5724-2017; Varga, Steven/C-2009-2009; Derscheid, Rachel/AAV-9043-2021	Varga, Steven/0000-0001-7332-4290; 	NIH NIAID [R56AI09100]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007485, R01AI009100] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The studies were supported by NIH NIAID R56AI09100. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bem RA, 2011, AM J PHYSIOL-LUNG C, V301, pL148, DOI 10.1152/ajplung.00065.2011; Castilow EM, 2008, FUTURE VIROL, V3, P445, DOI 10.2217/17460794.3.5.445; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; CONNORS M, 1992, J VIROL, V66, P7444, DOI 10.1128/JVI.66.12.7444-7451.1992; de Swart RL, 2002, J VIROL, V76, P11561, DOI 10.1128/JVI.76.22.11561-11569.2002; Derscheid RJ, 2012, VIRUSES-BASEL, V4, P2359, DOI 10.3390/v4102359; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; GALLUP JM, 2008, INT J BIOMED SCI, V4, P100; Gershwin LJ, 1998, VACCINE, V16, P1225, DOI 10.1016/S0264-410X(98)80123-0; GRAHAM BS, 1993, J IMMUNOL, V151, P2032; Johnson JE, 2007, MODERN PATHOL, V20, P108, DOI 10.1038/modpathol.3800725; Johnson TR, 1999, J VIROL, V73, P8485, DOI 10.1128/JVI.73.10.8485-8495.1999; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kpaikian AZ, 1969, AM J EPIDEMIOL, V89, P405; Lazic T, 2007, ALCOHOL, V41, P347, DOI 10.1016/j.alcohol.2007.07.006; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; Meyerholz DK, 2004, MICROBES INFECT, V6, P1312, DOI 10.1016/j.micinf.2004.08.006; MURPHY BR, 1990, VACCINE, V8, P497, DOI 10.1016/0264-410X(90)90253-I; Olivier A, 2009, INT J EXP PATHOL, V90, P431, DOI 10.1111/j.1365-2613.2009.00643.x; Olivier AK, 2011, EXP LUNG RES, V37, P131, DOI 10.3109/01902148.2010.484518; Olson MR, 2007, J IMMUNOL, V179, P5415, DOI 10.4049/jimmunol.179.8.5415; Polack FP, 2002, J EXP MED, V196, P859, DOI 10.1084/jem.20020781; Ponnuraj EM, 2003, J INFECT DIS, V187, P1257, DOI 10.1086/374604; PRINCE GA, 1986, J VIROL, V57, P721, DOI 10.1128/JVI.57.3.721-728.1986; Shaw CA, 2013, VACCINE, V31, P306, DOI 10.1016/j.vaccine.2012.11.006; Sow Fatoumata B, 2009, Int J Biomed Sci, V5, P105; Waris ME, 1996, J VIROL, V70, P2852, DOI 10.1128/JVI.70.5.2852-2860.1996; Welliver RC, 2010, CURR MED RES OPIN, V26, P2175, DOI 10.1185/03007995.2010.505126	28	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81472	10.1371/journal.pone.0081472	http://dx.doi.org/10.1371/journal.pone.0081472			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324695	Green Published, gold, Green Submitted			2022-12-25	WOS:000328566700039
J	Bosman, DS; Vercruijsse, HJP; Stienen, EWM; Vincx, M; Lens, L				Bosman, Davy S.; Vercruijsse, Harry J. P.; Stienen, Eric W. M.; Vincx, Magda; Lens, Luc			Age of First Breeding Interacts with Pre- and Post-Recruitment Experience in Shaping Breeding Phenology in a Long-Lived Gull	PLOS ONE			English	Article							REPRODUCTIVE-PERFORMANCE; PUBLIC INFORMATION; HABITAT SELECTION; EARLY ARRIVAL; SUCCESS; IMPROVEMENT; SEX; CONSEQUENCES; MIGRATION; SURVIVAL	Individual variation in timing of breeding is a key factor affecting adaptation to environmental change, yet our basic understanding of the causes of such individual variation is incomplete. This study tests several hypotheses for age-related variation in the breeding timing of Lesser Black-backed Gulls, based on a 13 year longitudinal data set that allows to decouple effects of age, previous prospecting behavior, and years of breeding experience on arrival timing at the colony. At the population level, age of first breeding was significantly associated with timing of arrival and survival, i.e. individuals tended to arrive later if they postponed their recruitment, and individuals recruiting at the age of 4 years survived best. However, up to 81% of the temporal variation in arrival dates was explained by within-individual effects. When excluding the pre-recruitment period, the effect of increasing age on advanced arrival was estimated at 11 days, with prior breeding experience accounting for a 7 days advance and postponed breeding for a 4 days delay. Overall, results of this study show that delayed age of first breeding can serve to advance arrival date (days after December 1st) in successive breeding seasons throughout an individual's lifetime, in large part due to the benefits of learning or experience gained during prospecting. However, prospecting and the associated delay in breeding also bear a survival cost, possibly because prospectors have been forced to delay through competition with breeders. More generally, results of this study set the stage for exploring integrated temporal shifts in phenology, resource allocation and reproductive strategies during individual lifecycles of long-lived migratory species.	[Bosman, Davy S.; Lens, Luc] Univ Ghent, Dept Biol, Terr Ecol Unit, B-9000 Ghent, Belgium; [Vercruijsse, Harry J. P.; Stienen, Eric W. M.] Res Inst Nat & Forest, Brussels, Belgium; [Vincx, Magda] Univ Ghent, Dept Biol, Marine Biol Sect, B-9000 Ghent, Belgium	Ghent University; Research Institute for Nature & Forest; Ghent University	Bosman, DS (corresponding author), Univ Ghent, Dept Biol, Terr Ecol Unit, B-9000 Ghent, Belgium.	Davy.Bosman@ugent.be	Stienen, Eric/ABC-1652-2020	Stienen, Eric/0000-0002-4315-0936; Lens, Luc/0000-0002-0241-2215	Research Foundation Flanders [FWO 1-1-819-12-N]	Research Foundation Flanders(FWO)	This study was funded by a doctoral grant from the Research Foundation Flanders to D. S. B, Grant number: FWO 1-1-819-12-N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 1998, J APPL STAT, V25, P263, DOI 10.1080/02664769823250; Aubry LM, 2011, J ANIM ECOL, V80, P375, DOI 10.1111/j.1365-2656.2010.01784.x; Aubry LM, 2009, ECOLOGY, V90, P2491, DOI 10.1890/08-1475.1; Becker PH, 2008, P NATL ACAD SCI USA, V105, P12349, DOI 10.1073/pnas.0804179105; Bety J, 2004, BEHAV ECOL SOCIOBIOL, V57, P1, DOI 10.1007/s00265-004-0840-3; Blas J, 2009, ECOGRAPHY, V32, P647, DOI 10.1111/j.1600-0587.2008.05700.x; Bosman DS, 2012, IBIS, V154, P52, DOI 10.1111/j.1474-919X.2011.01182.x; Brodersen J, 2012, BIOL LETTERS, V8, P21, DOI 10.1098/rsbl.2011.0634; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Camphuysen CJ, 2012, ARDEA, V100, P113, DOI 10.5253/078.100.0202; Cooper NW, 2009, OIKOS, V118, P413, DOI 10.1111/j.1600-0706.2008.16997.x; Cooper NW, 2009, J FIELD ORNITHOL, V80, P35, DOI 10.1111/j.1557-9263.2009.00203.x; Coulson T, 2006, P ROY SOC B-BIOL SCI, V273, P547, DOI 10.1098/rspb.2005.3357; CURIO E, 1983, IBIS, V125, P400, DOI 10.1111/j.1474-919X.1983.tb03130.x; Dittmann T, 2003, ANIM BEHAV, V65, P981, DOI 10.1006/anbe.2003.2128; Dittmann T, 2007, BEHAV PROCESS, V76, P198, DOI 10.1016/j.beproc.2007.05.002; Doligez B, 2004, ANIM BEHAV, V67, P457, DOI 10.1016/j.anbehav.2003.03.010; Drent RH, 2006, ARDEA, V94, P305; Dugdale HL, 2011, MOL ECOL, V20, P3261, DOI 10.1111/j.1365-294X.2011.05167.x; FORSLUND P, 1992, J ANIM ECOL, V61, P195, DOI 10.2307/5522; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Forstmeier W, 2002, J ANIM ECOL, V71, P1, DOI 10.1046/j.0021-8790.2001.00569.x; Froy H, 2013, ECOL LETT, V16, P642, DOI 10.1111/ele.12092; Gauthier G, 2003, ECOLOGY, V84, P3250, DOI 10.1890/02-0613; Hammers M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040413; Hotker H, 2002, ARDEA, V90, P379; Jenouvrier S, 2008, OIKOS, V117, P620, DOI 10.1111/j.0030-1299.2008.16394.x; Jorge PE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022433; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; Lescroel A, 2009, J ANIM ECOL, V78, P798, DOI 10.1111/j.1365-2656.2009.01542.x; Limmer B, 2010, OIKOS, V119, P500, DOI 10.1111/j.1600-0706.2009.16673.x; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Low M, 2007, J ANIM ECOL, V76, P459, DOI 10.1111/j.1365-2656.2007.01234.x; Martin JGA, 2011, ECOL LETT, V14, P576, DOI 10.1111/j.1461-0248.2011.01621.x; Mauck RA, 2012, OIKOS, V121, P1379, DOI 10.1111/j.1600-0706.2012.20271.x; Morbey YE, 2001, ECOL LETT, V4, P663, DOI 10.1046/j.1461-0248.2001.00265.x; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nussey DH, 2006, ECOL LETT, V9, P1342, DOI 10.1111/j.1461-0248.2006.00989.x; PART T, 1995, P ROY SOC B-BIOL SCI, V260, P113, DOI 10.1098/rspb.1995.0067; Part T, 2011, J ANIM ECOL, V80, P1227, DOI 10.1111/j.1365-2656.2011.01854.x; PIANKA ER, 1975, AM NAT, V109, P453, DOI 10.1086/283013; Ponchon A, 2013, METHODS ECOL EVOL, V4, P143, DOI 10.1111/j.2041-210x.2012.00259.x; Pradel R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051016; Pyle P, 1997, BEHAV ECOL, V8, P140, DOI 10.1093/beheco/8.2.140; Rebke M, 2010, P NATL ACAD SCI USA, V107, P7841, DOI 10.1073/pnas.1002645107; Reid JM, 2003, J ANIM ECOL, V72, P765, DOI 10.1046/j.1365-2656.2003.00750.x; Rock R, 2002, MIGRATION ATLAS MOVE, P365; Saino N, 2004, ECOL LETT, V7, P21, DOI 10.1046/j.1461-0248.2003.00553.x; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Schjorring S, 1999, ANIM BEHAV, V57, P647, DOI 10.1006/anbe.1998.0993; Schroeder J, 2012, J ORNITHOL, V153, P327, DOI 10.1007/s10336-011-0747-5; Smith RJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P231, DOI 10.1007/s00265-004-0855-9; Stearns S.C., 1992, pi; van de Pol M, 2006, AM NAT, V167, P766, DOI 10.1086/503331; Van Waeyenberge Jeroen, 2002, Natuur.oriolus, V68, P146; Vardanis Y, 2011, BIOL LETTERS, V7, P502, DOI 10.1098/rsbl.2010.1180; Veiga JP, 2012, ETHOLOGY, V118, P917, DOI 10.1111/j.1439-0310.2012.02083.x; Wiebe KL, 1998, IBIS, V140, P14, DOI 10.1111/j.1474-919X.1998.tb04536.x	58	13	13	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82093	10.1371/journal.pone.0082093	http://dx.doi.org/10.1371/journal.pone.0082093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324750	gold, Green Submitted, Green Published			2022-12-25	WOS:000327949300130
J	Hagglund, AC; Berghard, A; Carlsson, L				Hagglund, Anna-Carin; Berghard, Anna; Carlsson, Leif			Canonical Wnt/beta-Catenin Signalling Is Essential for Optic Cup Formation	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; EARLY EYE DEVELOPMENT; BETA-CATENIN; NEURAL RETINA; MOUSE RETINA; GENE-EXPRESSION; HOMEOBOX GENE; CHICK EYE; CELL FATE; DIFFERENTIATION	A multitude of signalling pathways are involved in the process of forming an eye. Here we demonstrate that beta-catenin is essential for eye development as inactivation of beta-catenin prior to cellular specification in the optic vesicle caused anophthalmia in mice. By achieving this early and tissue-specific beta-catenin inactivation we find that retinal pigment epithelium (RPE) commitment was blocked and eye development was arrested prior to optic cup formation due to a loss of canonical Wnt signalling in the dorsal optic vesicle. Thus, these results show that Wnt/beta-catenin signalling is required earlier and play a more central role in eye development than previous studies have indicated. In our genetic model system a few RPE cells could escape beta-catenin inactivation leading to the formation of a small optic rudiment. The optic rudiment contained several neural retinal cell classes surrounded by an RPE. Unlike the RPE cells, the neural retinal cells could be beta-catenin- negative revealing that differentiation of the neural retinal cell classes is beta-catenin-independent. Moreover, although dorsoventral patterning is initiated in the mutant optic vesicle, the neural retinal cells in the optic rudiment displayed almost exclusively ventral identity. Thus, beta-catenin is required for optic cup formation, commitment to RPE cells and maintenance of dorsal identity of the retina.	[Hagglund, Anna-Carin; Carlsson, Leif] Umea Univ, Umea Ctr Mol Med, Umea, Sweden; [Berghard, Anna] Umea Univ, Dept Mol Biol, Umea, Sweden	Umea University; Umea University	Carlsson, L (corresponding author), Umea Univ, Umea Ctr Mol Med, Umea, Sweden.	leif.carlsson@umu.se			Swedish Research Council; Swedish Cancer Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation	This work has been supported by the Swedish Research Council and the Swedish Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Behesti H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-62; Bovolenta P, 1997, J NEUROSCI, V17, P4243; Brault V, 2001, DEVELOPMENT, V128, P1253; Bumsted KM, 2000, INVEST OPHTH VIS SCI, V41, P903; Burns CJ, 2008, DEV DYNAM, V237, P1614, DOI 10.1002/dvdy.21565; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Cho SH, 2006, DEVELOPMENT, V133, P3167, DOI 10.1242/dev.02474; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Eiraku M, 2012, BIOESSAYS, V34, P17, DOI 10.1002/bies.201100070; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Fu XY, 2006, DEV BIOL, V299, P424, DOI 10.1016/j.ydbio.2006.08.015; Fuhrmann S, 2000, DEVELOPMENT, V127, P4599; Fuhrmann S, 2009, INVEST OPHTH VIS SCI, V50, P432, DOI 10.1167/iovs.08-2270; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; Fujitani Y, 2006, DEVELOPMENT, V133, P4439, DOI 10.1242/dev.02598; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Hagglund AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023387; Harlow E., 1999, USING ANTIBODIES LAB; Horsford DJ, 2005, DEVELOPMENT, V132, P177, DOI 10.1242/dev.01571; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kaufman MH, 1994, ATLAS MOUSE DEV; Koshiba-Takeuchi K, 2000, SCIENCE, V287, P134, DOI 10.1126/science.287.5450.134; LAVAIL MM, 1991, J COMP NEUROL, V309, P86, DOI 10.1002/cne.903090107; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Liu CQ, 2012, HUM MOL GENET, V21, P1848, DOI 10.1093/hmg/ddr616; Liu H, 2006, INVEST OPHTH VIS SCI, V47, P5088, DOI 10.1167/iovs.06-0403; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Martinez-Morales JR, 2001, DEVELOPMENT, V128, P2019; Matsunami H, 1995, DEV BIOL, V172, P466, DOI 10.1006/dbio.1995.8029; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Muller F, 2007, DEVELOPMENT, V134, P3483, DOI 10.1242/dev.02884; Nakhai H, 2007, DEVELOPMENT, V134, P1151, DOI 10.1242/dev.02781; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Nguyen MTT, 2000, DEVELOPMENT, V127, P3581; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; NORNES HO, 1990, DEVELOPMENT, V109, P797; Ouyang MX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2560; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; RAYMOND SM, 1995, CURR BIOL, V5, P1286, DOI 10.1016/S0960-9822(95)00255-7; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Satoh S, 2009, J NEUROSCI, V29, P12401, DOI 10.1523/JNEUROSCI.0951-09.2009; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schepsky A, 2006, MOL CELL BIOL, V26, P8914, DOI 10.1128/MCB.02299-05; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STIEMKE MM, 1995, DIFFERENTIATION, V58, P189, DOI 10.1046/j.1432-0436.1995.5830189.x; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tang K, 2010, DEVELOPMENT, V137, P725, DOI 10.1242/dev.040568; Torres MA, 1996, DEVELOPMENT, V122, P3381; Tsukiyama T, 2012, NEUROSCI LETT, V512, P48, DOI 10.1016/j.neulet.2012.01.062; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Van Raay TJ, 2004, DEV NEUROSCI-BASEL, V26, P352, DOI 10.1159/000082277; Van Raay TJ, 2005, NEURON, V46, P23, DOI 10.1016/j.neuron.2005.02.023; Veien ES, 2008, DEVELOPMENT, V135, P4101, DOI 10.1242/dev.027367; Wawersik S, 1999, DEV BIOL, V207, P176, DOI 10.1006/dbio.1998.9153; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Yasumoto K, 2002, EMBO J, V21, P2703, DOI 10.1093/emboj/21.11.2703; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zakin LDJ, 1998, MECH DEVELOP, V73, P107, DOI 10.1016/S0925-4773(98)00040-9; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang XM, 2001, DEV BIOL, V233, P271, DOI 10.1006/dbio.2000.0195; Zhou CJ, 2008, DEV DYNAM, V237, P3681, DOI 10.1002/dvdy.21770; Zhou CJ, 2010, DEV DYNAM, V239, P318, DOI 10.1002/dvdy.22054	76	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81158	10.1371/journal.pone.0081158	http://dx.doi.org/10.1371/journal.pone.0081158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324671	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300074
J	Hagino, K; Onuma, R; Kawachi, M; Horiguchi, T				Hagino, Kyoko; Onuma, Ryo; Kawachi, Masanobu; Horiguchi, Takeo			Discovery of an Endosymbiotic Nitrogen-Fixing Cyanobacterium UCYN-A in Braarudosphaera bigelowii (Prymnesiophyceae)	PLOS ONE			English	Article							SP-NOV; EMILIANIA-HUXLEYI; ULTRASTRUCTURE; NANNOPLANKTON; COCCOSPHERES; MORPHOTYPES; EXTINCTIONS; PHYLOGENIES; TAXONOMY; N-2	Braarudosphaera bigelowii (Prymnesiophyceae) is a coastal coccolithophore with a long fossil record, extending back to the late Cretaceous (ca. 100 Ma). A recent study revealed close phylogenetic relationships between B. bigelowii, Chrysochromulina parkeae (Prymnesiophyceae), and a prymnesiophyte that forms a symbiotic association with the nitrogen-fixing cyanobacterium UCYN-A. In order to further examine these relationships, we conducted transmission electron microscopic and molecular phylogenetic studies of B. bigelowii. TEM studies showed that, in addition to organelles, such as the nucleus, chloroplasts and mitochondria, B. bigelowii contains one or two spheroid bodies with internal lamellae. In the 18S rDNA tree of the Prymnesiophyceae, C. parkeae fell within the B. bigelowii clade, and was close to B. bigelowii Genotype III (99.89% similarity). Plastid 16S rDNA sequences obtained from B. bigelowii were close to the unidentified sequences from the oligotrophic SE Pacific Ocean (e. g. HM133411) (99.86% similarity). Bacterial16S rDNA sequences obtained from B. bigelowii were identical to the UCYN-A sequence AY621693 from Arabian Sea, and fell in the UCYN-A clade. From these results, we suggest that; 1) C. parkeae is the alternate life cycle stage of B. bigelowii sensu stricto or that of a sibling species of B. bigelowii, and 2) the spheroid body of B. bigelowii originated from endosymbiosis of the nitrogen-fixing cyanobacterium UCYN-A.	[Hagino, Kyoko] Okayama Univ, Inst Study Earths Interior, Misasa, Tottori 68202, Japan; [Onuma, Ryo] Hokkaido Univ, Dept Nat Hist Sci, Grad Sch Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Kawachi, Masanobu] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan; [Horiguchi, Takeo] Hokkaido Univ, Fac Sci, Dept Nat Hist Sci, Kita Ku, Sapporo, Hokkaido 060, Japan	Okayama University; Hokkaido University; National Institute for Environmental Studies - Japan; Hokkaido University	Hagino, K (corresponding author), Okayama Univ, Inst Study Earths Interior, Misasa, Tottori 68202, Japan.	kyokohagino@frontier.hokudai.ac.jp	Onuma, Ryo/AAZ-4295-2020; Horiguchi, Takeo/D-7612-2012; Onuma, Ryo/AAI-2075-2020; Hagino, Kyoko/T-6060-2019	Onuma, Ryo/0000-0003-1592-0814; Horiguchi, Takeo/0000-0002-6118-8460; 	Japan Society for the Promotion of Sciences [20740296]; Tottori Prefecture, Japan; National Institute for Environmental Studies [1115AA051]; Grants-in-Aid for Scientific Research [23540550] Funding Source: KAKEN	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tottori Prefecture, Japan; National Institute for Environmental Studies; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grant-in Aid for Scientific Research from the Japan Society for the Promotion of Sciences (No. 20740296), Grant-in Aid for Environmental Studies from Tottori Prefecture, Japan, and by Grand-in Aid for Biodiversity Research Program (No. 1115AA051) from the National Institute for Environmental Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bown P, 2005, GEOLOGY, V33, P653, DOI 10.1130/G21566.1; Bown P., 1998, CALCAREOUS NANNOFOSS; Bown PR, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P481; Cros L, 2000, MAR MICROPALEONTOL, V39, P1, DOI 10.1016/S0377-8398(00)00010-4; DEFLANDRE G, 1947, CR HEBD ACAD SCI, V225, P439; DRUM RW, 1965, PROTOPLASMA, V60, P141, DOI 10.1007/BF01248136; Edvardsen B, 2011, EUR J PHYCOL, V46, P202, DOI 10.1080/09670262.2011.594095; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Foster RA, 2006, J PHYCOL, V42, P453, DOI 10.1111/j.1529-8817.2006.00206.x; Green JC, 1996, J MARINE SYST, V9, P33, DOI 10.1016/0924-7963(96)00014-0; GREEN JC, 1972, J MAR BIOL ASSOC UK, V52, P469, DOI 10.1017/S002531540001883X; GREEN JC, 1982, BRIT PHYCOL J, V17, P363, DOI 10.1080/00071618200650381; Hagino K, 2005, MAR MICROPALEONTOL, V55, P19, DOI 10.1016/j.marmicro.2005.02.002; Hagino K, 2009, MAR MICROPALEONTOL, V72, P210, DOI 10.1016/j.marmicro.2009.06.001; INOUYE I, 1984, BRIT PHYCOL J, V19, P357, DOI 10.1080/00071618400650401; JABLONSKI D, 1994, PHILOS T R SOC B, V344, P11, DOI 10.1098/rstb.1994.0045; Klaveness D., 1972, British phycol J, V7, P309; KLAVENESS D, 1973, Norwegian Journal of Botany, V20, P151; Konno Susumu, 2007, Journal of Nannoplankton Research, V29, P78; Krupke A, 2013, SYST APPL MICROBIOL, V36, P259, DOI 10.1016/j.syapm.2013.02.002; Lambert B., 1986, Revue de Micropaleontologie, V28, P255; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lefort F, 1972, BOTANISTE, V20, P13; Mai H, 1997, MICROPALEONTOLOGY, V43, P281, DOI 10.2307/1485829; Martini E., 1967, NEUES JB GEOLOGIE PA, V10, P597; Mazard SL, 2004, APPL ENVIRON MICROB, V70, P7355, DOI 10.1128/AEM.70.12.7355-7364.2004; Medlin LK, 2008, MAR MICROPALEONTOL, V67, P69, DOI 10.1016/j.marmicro.2007.08.007; Nakayama Takeshi, 1996, Phycological Research, V44, P47, DOI 10.1111/j.1440-1835.1996.tb00037.x; Nubel U, 1999, APPL ENVIRON MICROB, V65, P422; NYLANDER J.A.A., 2004, MRMODELTEST 2 2 PROG; PARKE M, 1960, J MAR BIOL ASSOC UK, V39, P263, DOI 10.1017/S002531540001331X; Peleo-Alampay Alyssa M., 1999, Journal of Nannoplankton Research, V21, P17; Perch-Nielsen K., 1985, P427; Perch-Nielsen K., 1985, P329; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prechtl J, 2004, MOL BIOL EVOL, V21, P1477, DOI 10.1093/molbev/msh086; Probert I, 2007, J PHYCOL, V43, P319, DOI 10.1111/j.1529-8817.2007.00324.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Seoane S, 2009, PHYCOLOGIA, V48, P165, DOI 10.2216/08-63.1; Shi XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018979; Shi Xiaolin, 2009, PLOS ONE, V4, p1 6; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Takano Y, 2004, PHYCOL RES, V52, P107, DOI 10.1111/j.1440-183.2004.00332.x; Takano Y, 2006, MAR MICROPALEONTOL, V60, P145, DOI 10.1016/j.marmicro.2006.04.002; Takayama T, 1972, T P PALAEONTOLOGICAL, V87, P429; Tanaka Y, 1991, CALCAREOUS NANNOPLAN; Taniuchi Y, 2012, ENVIRON MICROBIOL, V14, P641, DOI 10.1111/j.1462-2920.2011.02606.x; Thompson AW, 2012, SCIENCE, V337, P1546, DOI 10.1126/science.1222700; Young J.R., 2003, J NANNOPLANKTON RES, V1, P1; Young JR, 1999, J STRUCT BIOL, V126, P195, DOI 10.1006/jsbi.1999.4132; Yuasa T, 2012, SYMBIOSIS, V57, P51, DOI 10.1007/s13199-012-0174-2; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	53	64	68	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81749	10.1371/journal.pone.0081749	http://dx.doi.org/10.1371/journal.pone.0081749			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324722	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300108
J	Li, W; Yi, LN; Su, J; Lu, J; Ke, C; Zeng, HW; Guan, DW; Ma, C; Zhang, WL; Xiao, H; Li, H; Lin, JY; Zhang, YH				Li, Wei; Yi, Lina; Su, Juan; Lu, Jing; Ke, Changwen; Zeng, Hanri; Guan, Dawei; Ma, Cong; Zhang, Wanly; Xiao, Hong; Li, Hui; Lin, Jinyan; Zhang, Yonghui			Seroprevalence of Human Enterovirus 71 and Coxsackievirus A16 in Guangdong, China, in Pre- and Post-2010 HFMD Epidemic Period	PLOS ONE			English	Article							MOUTH-DISEASE; CHILDREN; SEROEPIDEMIOLOGY; INFECTION; SINGAPORE; PROVINCE; VACCINE; TRIAL; FOOT; CITY	Background: Human Enterovirus 71 and Coxsackie A16 have caused many outbreaks in the last decade in mainland China, resulting in thousands of fatal cases. Seroepidemiology which provides important information to document population immunity is rare in China. Methodology/Principal Findings: A cross sectional study of Enterovirus 71 (EV71) and Coxsackie A16 (CA16) seroprevalence was carried out in Guangdong, China, pre- and post-the 2010 hand, foot and mouth disease (HFMD) epidemic period. The levels of EV71 and CA16 specific antibodies were evaluated by a microneutralization test and the geometric mean titer (GMT) was calculated and compared. Our results indicated frequent infection by EV71 and CA16 in Guangdong before the 2010 epidemic. Only EV71 neutralizing antibody but not CA16 seroprevalence was significantly increased after the 2010 HFMD epidemic. Children less than 3 years old especially those aged 2 years showed the lowest positive rates for EV71 and CA16 NA before epidemic and the most significantly increased EV71 seroprevalence after epidemic. CA16 GMT values declined after the 2010 epidemic. Conclusions: These results indicate EV71 was the major pathogen of HFMD in Guangdong during the 2010 epidemic. The infection occurs largely in children less than 3 years, who should have first priority to receive an EV71 vaccine.	[Li, Wei; Yi, Lina; Su, Juan; Lu, Jing; Ke, Changwen; Zeng, Hanri; Guan, Dawei; Ma, Cong; Zhang, Wanly; Xiao, Hong; Li, Hui; Lin, Jinyan; Zhang, Yonghui] Guangdong Prov Ctr Dis Control & Prevent, Ctr Pathogen Detect Res Emerging Infect Dis, Guangzhou, Guangdong, Peoples R China; [Li, Wei; Su, Juan; Ke, Changwen; Zeng, Hanri; Guan, Dawei; Ma, Cong; Zhang, Wanly; Xiao, Hong; Li, Hui; Lin, Jinyan; Zhang, Yonghui] Guangdong Prov Ctr Dis Control & Prevent, Key Lab Pathogen Detect Emergency Response, Guangzhou, Guangdong, Peoples R China; [Li, Wei; Su, Juan; Ke, Changwen; Zeng, Hanri; Guan, Dawei; Ma, Cong; Zhang, Wanly; Xiao, Hong; Li, Hui; Lin, Jinyan; Zhang, Yonghui] Guangdong Prov Ctr Dis Control & Prevent, Key Lab Depository & Applicat Pathogen Microbiol, Guangzhou, Guangdong, Peoples R China; [Yi, Lina; Lu, Jing] Guangdong Prov Inst Publ Hlth, Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China	Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention	Zhang, YH (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Ctr Pathogen Detect Res Emerging Infect Dis, Guangzhou, Guangdong, Peoples R China.	zyh@cdcp.org.cn			National Major Projects of Major Infectious Disease Control and Prevention, the Ministry of Science and Technology of the People's Republic of China [2012ZX10004213-004]; Medical Scientific Research Foundation of Guangdong Province [C2010016]; Guangdong Provincial Scientific Plan Program [2012B031500007]	National Major Projects of Major Infectious Disease Control and Prevention, the Ministry of Science and Technology of the People's Republic of China; Medical Scientific Research Foundation of Guangdong Province; Guangdong Provincial Scientific Plan Program	This work was supported by National Major Projects of Major Infectious Disease Control and Prevention, the Ministry of Science and Technology of the People's Republic of China (2012ZX10004213-004), Medical Scientific Research Foundation of Guangdong Province (C2010016) and Guangdong Provincial Scientific Plan Program (2012B031500007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-270; Bland JM, 1996, BMJ-BRIT MED J, V312, P1153; Deng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056943; Denizot M, 2012, J INFECTION, V65, P1, DOI 10.1016/j.jinf.2012.03.019; Diedrich S, 2009, ARCH VIROL, V154, P1139, DOI 10.1007/s00705-009-0413-x; Dudareva S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021340; Fan X, 2012, VIRUS GENES; Guan DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044386; Huang WC, 2012, J MICROBIOL IMMUNOL, V45, P96, DOI 10.1016/j.jmii.2011.09.025; Ji H, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-248; Koroleva G. A., 2010, Voprosy Virusologii, V55, P4; Lee MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001476; Lee MS, 2010, PEDIATR INFECT DIS J, V29, P1030, DOI 10.1097/INF.0b013e3181e52945; Li YP, 2013, J INFECT DIS; Liang ZL, 2013, HUM VACCIN IMMUNOTHE, V9; Mao QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046043; Mao QY, 2012, ARCH VIROL, V157, P37, DOI 10.1007/s00705-011-1136-3; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; McMinn PC, 2012, CURR OPIN VIROL, V2, P199, DOI 10.1016/j.coviro.2012.02.009; Meng FY, 2012, HUM VACC IMMUNOTHER, V8, P669, DOI 10.4161/hv.19521; Ooi EE, 2002, EMERG INFECT DIS, V8, P995, DOI 10.3201/eid0809.010397; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Sun LM, 2011, JPN J INFECT DIS, V64, P13; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Tarr AW, 2012, VIRUSES-BASEL, V4, P1, DOI 10.3390/v4010001; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Yan XF, 2012, SCAND J INFECT DIS, V44, P297, DOI 10.3109/00365548.2011.634433; Yang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038768; Yi LN, 2011, CRIT REV MICROBIOL, V37, P313, DOI 10.3109/1040841X.2011.580723; Yu HY, 2011, JPN J INFECT DIS, V64, P528; Zeng M, 2012, J CLIN VIROL, V53, P285, DOI 10.1016/j.jcv.2011.12.025; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1; Zhu FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037206; Zhu Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-300; Zou XN, 2012, BRAZ J INFECT DIS, V16, P457, DOI 10.1016/j.bjid.2012.08.001	37	24	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80515	10.1371/journal.pone.0080515	http://dx.doi.org/10.1371/journal.pone.0080515			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324604	Green Submitted, Green Published, gold			2022-12-25	WOS:000327949300024
J	Schnabel, RB; Michal, M; Wilde, S; Wiltink, J; Wild, PS; Sinning, CR; Lubos, E; Ojeda, FM; Zeller, T; Munzel, T; Blankenberg, S; Beutel, ME				Schnabel, Renate B.; Michal, Matthias; Wilde, Sandra; Wiltink, Joerg; Wild, Philipp S.; Sinning, Christoph R.; Lubos, Edith; Ojeda, Francisco M.; Zeller, Tanja; Munzel, Thomas; Blankenberg, Stefan; Beutel, Manfred E.			Depression in Atrial Fibrillation in the General Population	PLOS ONE			English	Article							QUALITY-OF-LIFE; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; HEART-FAILURE; SYMPTOMS; HEALTH; ASSOCIATION; MORTALITY; ANXIETY; EVENTS	Background: Initial evidence suggests that depressive symptoms are more frequent in patients with atrial fibrillation. Data from the general population are limited. Methods and Results: In 10,000 individuals (mean age 56 +/- 11 years, 49.4% women) of the population-based Gutenberg Health Study we assessed depression by the Patient Health Questionnaire (PHQ-9) and a history of depression in relation to manifest atrial fibrillation (n = 309 cases). The median (25th/75th percentile) PHQ-9 score of depressive symptoms was 4 (2/6) in atrial fibrillation individuals versus 3 (2/6) individuals without atrial fibrillation, PX2-Test = 0.32. Multivariable regression analyses of the severity of depressive symptoms in relation to atrial fibrillation in cardiovascular risk factor adjusted models revealed a relation of PHQ-9 values and atrial fibrillation (odds ratio (OR) 1.04, 95% confidence interval (CI) 1.01-1.08; P = 0.023). The association was stronger for the somatic symptom dimension of depression (OR 1.08, 95% CI 1.02-1.15; P = 0.0085) than for cognitive symptoms (OR 1.05, 95% CI 0.98-1.11; P = 0.15). Results did not change markedly after additional adjustment for heart failure, partnership status or the inflammatory biomarker C-reactive protein. Both, self-reported physical health status, very good/good versus fair/bad, (OR 0.54, 95% CI 0.41-0.70; P < 0.001) and mental health status (OR 0.61 (0.46-0.82); P = 0.0012) were associated with atrial fibrillation in multivariable-adjusted models. Conclusions: In a population-based sample we observed a higher burden of depressive symptoms driven by somatic symptom dimensions in individuals with atrial fibrillation. Depression was associated with a worse perception of physical or mental health status. Whether screening and treatment of depressive symptoms modulates disease progression and outcome needs to be shown.	[Schnabel, Renate B.; Wilde, Sandra; Sinning, Christoph R.; Lubos, Edith; Ojeda, Francisco M.; Zeller, Tanja; Blankenberg, Stefan] Univ Heart Ctr, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Michal, Matthias; Wiltink, Joerg; Beutel, Manfred E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, D-55122 Mainz, Germany; [Wild, Philipp S.; Munzel, Thomas] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 2, D-55122 Mainz, Germany; [Wild, Philipp S.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Thrombosis & Hemostasis, D-55122 Mainz, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Schnabel, RB (corresponding author), Univ Heart Ctr, Dept Gen & Intervent Cardiol, Hamburg, Germany.	schnabelr@gmx.de	Schnabel, Renate B/ABE-6668-2021; Munzel, Thomas/A-2912-2014	Schnabel, Renate B/0000-0001-7170-9509; Munzel, Thomas/0000-0001-5503-4150; Zeller, Tanja/0000-0003-3379-2641; Ojeda, Francisco/0000-0003-4037-144X; Wild, Philipp/0000-0003-4413-9752	government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation") [AZ 961-386261/733]; Johannes Gutenberg-University of Mainz; Boehringer Ingelheim; PHILIPS Medical Systems; Deutsche Forschungsgemeinschaft (German Research Foundation) [SCHN 1149/3-1]	government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation"); Johannes Gutenberg-University of Mainz; Boehringer Ingelheim(Boehringer Ingelheim); PHILIPS Medical Systems; Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	The Gutenberg Health Study is funded through the government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation", contract number AZ 961-386261/733), the research programs "Wissen schafft Zukunft" and "Schwerpunkt Vaskulare Pravention" of the Johannes Gutenberg-University of Mainz and its contract with Boehringer Ingelheim and PHILIPS Medical Systems including an unrestricted grant for the Gutenberg Health Study. Dr. Schnabel is supported by Deutsche Forschungsgemeinschaft (German Research Foundation) Emmy Noether Program SCHN 1149/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariansen I, 2011, CLIN CARDIOL, V34, P327, DOI 10.1002/clc.20883; Blumenthal JA, 2012, JAMA-J AM MED ASSOC, V308, P465, DOI 10.1001/jama.2012.8720; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Carney RM, 1999, BIOL PSYCHIAT, V45, P458, DOI 10.1016/S0006-3223(98)00049-3; De Jonge P, 2007, PSYCHOSOM MED, V69, P735, DOI 10.1097/PSY.0b013e31815743ca; Dorian P, 2000, J AM COLL CARDIOL, V36, P1303, DOI 10.1016/S0735-1097(00)00886-X; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Frasure-Smith N, 2007, BIOL PSYCHIAT, V62, P302, DOI 10.1016/j.biopsych.2006.09.029; Frasure-Smith N, 2009, CIRCULATION, V120, P134, DOI 10.1161/CIRCULATIONAHA.109.851675; Gehi AK, 2012, J CARDIOVASC ELECTR, V23, P473, DOI 10.1111/j.1540-8167.2011.02264.x; Hoen PW, 2010, J AM COLL CARDIOL, V56, P838, DOI 10.1016/j.jacc.2010.03.080; Holstenson E, 2011, EUROPACE, V13, P23, DOI 10.1093/europace/euq325; Jiang W, 2001, ARCH INTERN MED, V161, P1849, DOI 10.1001/archinte.161.15.1849; Jones A, 2011, J MAGN RESON IMAGING, V33, P448, DOI 10.1002/jmri.22438; Katon W, 2012, AM J PREV MED, V42, P550, DOI 10.1016/j.amepre.2012.01.017; Lange HW, 2007, J PSYCHOSOM RES, V63, P509, DOI 10.1016/j.jpsychores.2007.07.010; Lowe B, 2004, PSYCHOTHER PSYCHOSOM, V73, P386, DOI 10.1159/000080393; Martens EJ, 2010, PSYCHOL MED, V40, P807, DOI 10.1017/S0033291709990997; McCabe PJ, 2010, J CARDIOVASC NURS, V25, P40, DOI 10.1097/JCN.0b013e3181b7be36; Michal M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072014; Michal M, 2013, J HYPERTENS, V31, P893, DOI 10.1097/HJH.0b013e32835f5768; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Ormel J, 2011, PSYCHOTHER PSYCHOSOM, V80, P264, DOI 10.1159/000323165; Sang CH, 2013, CLIN CARDIOL, V36, P40, DOI 10.1002/clc.22039; Schnabel RB, 2009, AM J CARDIOL, V104, P92, DOI 10.1016/j.amjcard.2009.02.053; Sears SF, 2005, PACE, V28, P801, DOI 10.1111/j.1540-8159.2005.00171.x; Smolderen KG, 2009, CIRC-CARDIOVASC QUAL, V2, P328, DOI 10.1161/CIRCOUTCOMES.109.868588; Son YJ, 2012, EUR J CARDIOVASC NUR, V11, P304, DOI 10.1016/j.ejcnurse.2011.04.004; Thrall G, 2007, CHEST, V132, P1259, DOI 10.1378/chest.07-0036; Vaccarino V, 2007, J AM COLL CARDIOL, V50, P2044, DOI 10.1016/j.jacc.2007.07.069; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711	32	27	27	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e79109	10.1371/journal.pone.0079109	http://dx.doi.org/10.1371/journal.pone.0079109			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324579	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300007
J	Zhang, Y; Wang, CP; Zhang, Y; Zhang, L; Yu, T				Zhang, Yu; Wang, Chaoping; Zhang, Yi; Zhang, Lin; Yu, Tian			GABA(A) Receptor in the Thalamic Specific Relay System Contributes to the Propofol-Induced Somatosensory Cortical Suppression in Rat	PLOS ONE			English	Article							MEDIATED INHIBITION; CONSCIOUSNESS; CONNECTIVITY; ANESTHESIA; INFORMATION; FLOW; VPM	Interaction with the gamma-aminobutyric-acid-type-A (GABA(A)) receptors is recognized as an important component of the mechanism of propofol, a sedative-hypnotic drug commonly used as anesthetic. However the contribution of GABA(A) receptors to the central nervous system suppression is still not well understood, especially in the thalamocortical network. In the present study, we investigated if intracerebral injection of bicuculline (a GABA(A) receptor antagonist) into the thalamus ventral posteromedial nucleus (VPM, a thalamus specific relay nuclei that innervated S1 mostly) could reverse propofol-induced cortical suppression, through recording the changes of both spontaneous and somatosensory neural activities in rat's somatosensory cortex (S1). We found that after injection of bicuculline into VPM, significant increase of neural activities were observed in all bands of local field potentials (total band, 182 +/- 6%), while the amplitude of all components in somatosensory evoked potentials were also increased (negative, 121 +/- 9% and positive, 124 +/- 6%). These data support that the potentiation of GABA(A) receptor-mediated synaptic inhibition in a thalamic specific relay system seems to play a crucial role in propofol-induced cortical suppression in the somatosensory cortex of rats.	[Zhang, Yu; Wang, Chaoping; Zhang, Yi; Zhang, Lin; Yu, Tian] Zunyi Med Coll, Affiliated Hosp, Dept Anesthesiol, Zunyi, Guizhou, Peoples R China	Zunyi Medical University	Yu, T (corresponding author), Zunyi Med Coll, Affiliated Hosp, Dept Anesthesiol, Zunyi, Guizhou, Peoples R China.	dllyutian@163.com	Zhang, Yi/AAQ-6320-2021		National Natural Science Foundation of China [81060266]; Shanghai Institutes for Biological Sciences [skln-2008a09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences)	This work was supported by The National Natural Science Foundation of China (81060266) and the open project of Shanghai Institutes for Biological Sciences (skln-2008a09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Alkire MT, 2007, ANESTHESIOLOGY, V107, P264, DOI 10.1097/01.anes.0000270741.33766.24; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Campagna-Slater V, 2007, NEUROSCI LETT, V418, P28, DOI 10.1016/j.neulet.2007.02.091; Chen XD, 2005, J NEUROPHYSIOL, V94, P3872, DOI 10.1152/jn.00389.2005; DI S, 1991, BRAIN RES, V546, P106, DOI 10.1016/0006-8993(91)91164-V; Edelman GM, 2003, P NATL ACAD SCI USA, V100, P5520, DOI 10.1073/pnas.0931349100; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Grasshoff C, 2006, BRIT J ANAESTH, V97, P687, DOI 10.1093/bja/ael239; HEINRICHER MM, 1991, PAIN, V47, P105, DOI 10.1016/0304-3959(91)90017-R; Higuchi H, 2003, NEUROSCI RES, V45, P459, DOI 10.1016/S0168-0102(03)00003-8; Huguenard JR, 2007, TRENDS NEUROSCI, V30, P350, DOI 10.1016/j.tins.2007.05.007; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Imas OA, 2005, NEUROSCI LETT, V387, P145, DOI 10.1016/j.neulet.2005.06.018; John ER, 2002, BRAIN RES REV, V39, P1, DOI 10.1016/S0165-0173(02)00142-X; Landisman CE, 2007, CEREB CORTEX, V17, P2853, DOI 10.1093/cercor/bhm025; LEE SM, 1994, J NEUROPHYSIOL, V71, P1716, DOI 10.1152/jn.1994.71.5.1716; Liu XL, 2012, HUM BRAIN MAPP, V33, P2487, DOI 10.1002/hbm.21385; Llinas R, 2001, ANN NY ACAD SCI, V929, P166; Llinas R, 1998, PHILOS T ROY SOC B, V353, P1841, DOI 10.1098/rstb.1998.0336; Mashour GA, 2006, ANESTH ANALG, V103, P975, DOI 10.1213/01.ane.0000232442.69757.4a; Ohmori H, 2004, ANESTH ANALG, V99, P1095, DOI 10.1213/01.ane.0000130356.22414.2b; Ozgoren Murat, 2010, Open Neuroimag J, V4, P121, DOI 10.2174/1874440001004010121; Paz JT, 2010, J NEUROSCI, V30, P5465, DOI 10.1523/JNEUROSCI.5083-09.2010; Plourde G, 2006, ANESTHESIOLOGY, V104, P448, DOI 10.1097/00000542-200603000-00011; Schlunzen L, 2012, ACTA ANAESTH SCAND, V56, P248, DOI 10.1111/j.1399-6576.2011.02561.x; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Tononi G, 2008, ANN NY ACAD SCI, V1124, P239, DOI 10.1196/annals.1440.004; Tu Y, 2011, PHARMACOLOGY, V88, P322, DOI 10.1159/000334168; White NS, 2003, NEUROIMAGE, V19, P402, DOI 10.1016/S1053-8119(03)00103-4; Willis CKR, 2001, CAN J VET RES, V65, P188	31	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82377	10.1371/journal.pone.0082377	http://dx.doi.org/10.1371/journal.pone.0082377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324778	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300143
J	Bonderman, D; Graf, A; Kammerlander, AA; Kocher, A; Laufer, G; Lang, IM; Mascherbauer, J				Bonderman, Diana; Graf, Alexandra; Kammerlander, Andreas A.; Kocher, Alfred; Laufer, Guenter; Lang, Irene M.; Mascherbauer, Julia			Factors Determining Patient-Prosthesis Mismatch after Aortic Valve Replacement - A Prospective Cohort Study	PLOS ONE			English	Article							HEART-VALVE; CLINICAL IMPACT; ENLARGEMENT; STENOSIS; POSITION; BIOPROSTHESIS; IMPLANTATION; PREVENTION; MORTALITY; SURVIVAL	Objective: "Patient-prosthesis mismatch'' (PPM) after aortic valve replacement (AVR) has been reported to increase morbidity and mortality. Although algorithms have been developed to avoid PPM, factors favouring its occurrence have not been well defined. Design and Setting: This was a prospective cohort study performed at the Medical University of Vienna. Patients: 361 consecutive patients who underwent aortic valve replacement for isolated severe aortic stenosis were enrolled. Main Outcome Measures: Patient-as well as prosthesis-related factors determining the occurrence of moderate and severe PPM (defined as effective orifice area indexed to body surface area <= 0.8 cm(2)/m(2)) were studied. Results: Postoperatively, 172 patients (48%) were diagnosed with PPM. The fact that predominantly female patients were affected (58% with PPM diagnosis in women versus 36% in men, p<0.001) was explained by the finding that they had smaller aortic root diameters (30.5 +/- 4.7 mm versus 35.3 +/- 4.2 mm, p<0.0001) and a higher proportion of bioprosthetic valves (82% versus 62%, p<0.0001), both independent predictors of PPM (aortic root diameter: OR 0.009 [95% CI, 0.004;0.013]; p = 0.0003, presence of bioprosthetic valve: OR 0.126 [95% CI, 0.078;0.175]; p<0.0001). Conclusions: The occurrence of PPM is determined by aortic root diameter and prosthesis type. Novel sutureless bioprostheses with optimized hemodynamic performance or transcatheter aortic valves may become a promising alternative to conventional bioprosthetic valves in the future.	[Bonderman, Diana; Kammerlander, Andreas A.; Lang, Irene M.; Mascherbauer, Julia] Med Univ Vienna, Vienna Gen Hosp, Dept Cardiol, Vienna, Austria; [Graf, Alexandra] Med Univ Vienna, Vienna Gen Hosp, Dept Med Stat, Vienna, Austria; [Kocher, Alfred; Laufer, Guenter] Med Univ Vienna, Vienna Gen Hosp, Dept Cardiothorac Surg, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Mascherbauer, J (corresponding author), Med Univ Vienna, Vienna Gen Hosp, Dept Cardiol, Vienna, Austria.	julia.mascherbauer@meduniwien.ac.at	Kammerlander, Andreas/F-7391-2018	Kammerlander, Andreas/0000-0002-7632-9879; Mascherbauer, Julia/0000-0001-7478-1450; Graf, Alexandra/0000-0003-0035-2658; Lang, Irene/0000-0003-0485-2692	Austrian Society of Cardiology; Osterreichischer Herzfonds; Austrian fellowship [KLI 246, KLI 245]	Austrian Society of Cardiology; Osterreichischer Herzfonds; Austrian fellowship	This study received financial support from the Austrian Society of Cardiology (to JM), the Osterreichischer Herzfonds (to JM) and the Austrian fellowship grants KLI 246 (to DB), and KLI 245 (to JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonow Robert O, 2008, Circulation, V118, pe523, DOI 10.1161/CIRCULATIONAHA.108.190748; Castro LJ, 2002, ANN THORAC SURG, V74, P31, DOI 10.1016/S0003-4975(02)03680-9; CHAMBERS J, 1993, J AM COLL CARDIOL, V21, P398, DOI 10.1016/0735-1097(93)90681-P; Dalmau Maria Jose, 2007, Interact Cardiovasc Thorac Surg, V6, P345, DOI 10.1510/icvts.2006.144196; Driever R, 2004, J CARDIAC SURG, V19, P226, DOI 10.1111/j.0886-0440.2004.04060.x; Eichinger WB, 2005, J HEART VALVE DIS, V14, P822; Ewe SH, 2011, J AM COLL CARDIOL, V58, P1910, DOI 10.1016/j.jacc.2011.08.027; Flameng W, 2010, CIRCULATION, V121, P2123, DOI 10.1161/CIRCULATIONAHA.109.901272; Fuchs C, 2010, HEART, V96, P539, DOI 10.1136/hrt.2009.186650; Head SJ, 2012, EUR HEART J, V33, P1518, DOI 10.1093/eurheartj/ehs003; Koertke H, 2003, J HEART VALVE DIS, V12, P348; Kukucka M, 2013, J THORAC CARDIOV SUR, V145, P391, DOI 10.1016/j.jtcvs.2012.01.043; Kulik A, 2010, ANN THORAC SURG, V90, P703, DOI 10.1016/j.athoracsur.2010.05.012; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Lawrie Gerald M, 2012, Methodist Debakey Cardiovasc J, V8, P4; Mannacio VA, 2009, J THORAC CARDIOV SUR, V138, P632, DOI 10.1016/j.jtcvs.2009.01.009; Mascherbauer J, 2008, HEART, V94, P1639, DOI 10.1136/hrt.2008.142596; Monin JL, 2009, HEART, V95, P948, DOI 10.1136/hrt.2008.151928; Nashef SAM, 2002, EUR J CARDIO-THORAC, V22, P101, DOI 10.1016/S1010-7940(02)00208-7; Pibarot P, 2000, J AM COLL CARDIOL, V36, P1131, DOI 10.1016/S0735-1097(00)00859-7; Pibarot P, 2006, HEART, V92, P1022, DOI 10.1136/hrt.2005.067363; Rosenhek R, 2003, J AM SOC ECHOCARDIOG, V16, P1116, DOI 10.1067/S0894-7317(03)00638-2; SALOMON NW, 1991, CIRCULATION, V84, P140; Shrestha M, 2013, INTERACT CARDIOVASC; Sommers KE, 1997, ANN THORAC SURG, V63, P1608, DOI 10.1016/S0003-4975(97)00127-6; Tasca G, 2006, CIRCULATION, V113, P570, DOI 10.1161/CIRCULATIONAHA.105.587022; Vahanian A, 2007, EUR HEART J, V28, P230, DOI 10.1093/eurheartj/ehl428	27	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81940	10.1371/journal.pone.0081940	http://dx.doi.org/10.1371/journal.pone.0081940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312608	Green Published, gold, Green Submitted			2022-12-25	WOS:000327947800071
J	Nakamura, Y; Feary, DA; Kanda, M; Yamaoka, K				Nakamura, Yohei; Feary, David A.; Kanda, Masaru; Yamaoka, Kosaku			Tropical Fishes Dominate Temperate Reef Fish Communities within Western Japan	PLOS ONE			English	Article							CLIMATE-CHANGE; INTERSPECIFIC COMPETITION; HABITAT SPECIALIZATION; RANGE SHIFTS; ASSEMBLAGES; AUSTRALIA; IMPACTS; OVERLAP; GUILD	Climate change is resulting in rapid poleward shifts in the geographical distribution of tropical and subtropical fish species. We can expect that such range shifts are likely to be limited by species-specific resource requirements, with temperate rocky reefs potentially lacking a range of settlement substrates or specific dietary components important in structuring the settlement and success of tropical and subtropical fish species. We examined the importance of resource use in structuring the distribution patterns of range shifting tropical and subtropical fishes, comparing this with resident temperate fish species within western Japan (Tosa Bay); the abundance, diversity, size class, functional structure and latitudinal range of reef fishes utilizing both coral reef and adjacent rocky reef habitat were quantified over a 2 year period (2008-2010). This region has undergone rapid poleward expansion of reef-building corals in response to increasing coastal water temperatures, and forms one of the global hotspots for rapid coastal changes. Despite the temperate latitude surveyed (33 degrees N, 133 degrees E) the fish assemblage was both numerically, and in terms of richness, dominated by tropical fishes. Such tropical faunal dominance was apparent within both coral, and rocky reef habitats. The size structure of the assemblage suggested that a relatively large number of tropical species are overwintering within both coral and rocky habitats, with a subset of these species being potentially reproductively active. The relatively high abundance and richness of tropical species with obligate associations with live coral resources (i.e., obligate corallivores) shows that this region holds the most well developed temperate-located tropical fish fauna globally. We argue that future tropicalisation of the fish fauna in western Japan, associated with increasing coral habitat development and reported increasing shifts in coastal water temperatures, may have considerable positive economic impacts to the local tourism industry and bring qualitative changes to both local and regional fisheries resources.	[Nakamura, Yohei; Kanda, Masaru; Yamaoka, Kosaku] Kochi Univ, Grad Sch Kuroshio Sci, Nankoku, Kochi, Japan; [Feary, David A.] Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia; [Kanda, Masaru] Kuroshio Zikkan Ctr, Kochi, Japan	Kochi University; University of Technology Sydney	Nakamura, Y (corresponding author), Kochi Univ, Grad Sch Kuroshio Sci, Nankoku, Kochi, Japan.	ynakamura@kochi-u.ac.jp		Nakamura, Yohei/0000-0002-2412-2139	Ministry of Education, Culture, Sports, Science, and Technology of Japan; University of Technology, Sydney	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Technology, Sydney	This research was funded by the Ministry of Education, Culture, Sports, Science, and Technology of Japan. DA Feary was supported by the University of Technology, Sydney under the Chancellors Postdoctoral Research Fellowship scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird AH, 2012, CORAL REEFS, V31, P1063, DOI 10.1007/s00338-012-0928-6; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Bonin MC, 2009, CORAL REEFS, V28, P265, DOI 10.1007/s00338-008-0451-y; Booth DJ, 2007, ESTUAR COAST SHELF S, V72, P102, DOI 10.1016/j.ecss.2006.10.003; Booth DJ, 2011, MAR FRESHWATER RES, V62, P1027, DOI 10.1071/MF10270; Briggs J, 1974, MARINE ZOOGEOGRAPHY, DOI 10.2307/1442613; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; CONOVER DO, 1992, J FISH BIOL, V41, P161, DOI 10.1111/j.1095-8649.1992.tb03876.x; Eme J, 2008, J THERM BIOL, V33, P62, DOI 10.1016/j.jtherbio.2007.10.003; Emslie MJ, 2010, CORAL REEFS, V29, P705, DOI 10.1007/s00338-010-0619-0; Feary DA, 2007, OECOLOGIA, V153, P727, DOI 10.1007/s00442-007-0773-4; Feary DA, 2014, FISH FISH, V15, P593, DOI 10.1111/faf.12036; Figueira WF, 2010, GLOBAL CHANGE BIOL, V16, P506, DOI 10.1111/j.1365-2486.2009.01934.x; Figueira WF, 2009, MAR ECOL PROG SER, V384, P231, DOI 10.3354/meps08057; Froese R, 2012, FISHBASE WORLD WIDE; Gardiner NM, 2005, MAR ECOL PROG SER, V305, P163, DOI 10.3354/meps305163; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harriott VJ, 2002, CORAL REEFS, V21, P83, DOI 10.1007/s00338-001-0201-x; Hirata Tomonori, 2011, Japanese Journal of Ichthyology, V58, P49; HIXON MA, 1989, B MAR SCI, V44, P666; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Iwase F., 2004, CORAL REEFS OF JAPAN, P260; Japan Metrological Agency, 2013, WEATH STAT INF GLOB; Kamohara, 1964, REP USA MAR BIOL STN, V11, P1; Kamohara T, 1950, DESCR FISH PROV TOS; Kobayashi Koji, 2007, Japanese Journal of Ichthyology, V54, P21; Kokita T, 2004, ENVIRON BIOL FISH, V71, P213, DOI 10.1007/s10641-003-0304-z; Kuwahara Hisami, 2006, Global Environmental Research, V10, P189; Madin EMP, 2012, GLOBAL ENVIRON CHANG, V22, P137, DOI 10.1016/j.gloenvcha.2011.10.008; Mezaki T, 2012, AQUABIOLOGY, V201, P332; Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x; Munday PL, 1997, MAR ECOL PROG SER, V152, P227, DOI 10.3354/meps152227; Munday PL, 2001, ECOLOGY, V82, P2177, DOI 10.1890/0012-9658(2001)082[2177:ICACIA]2.0.CO;2; Nakabo T., 2002, FISHES JAPAN PICTORI; Nakazono A, 2002, FISHERIES SCI, V68, P127, DOI 10.2331/fishsci.68.sup1_127; Niwa S, 1735, FLORA FAUNA CROPS JA; OCHI H, 1989, ENVIRON BIOL FISH, V26, P257, DOI 10.1007/BF00002463; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Pratchett MS, 2005, MAR BIOL, V148, P373, DOI 10.1007/s00227-005-0084-4; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Shinbo T, 2008, KUROSHIO SCI, V2, P77; Soeparno, 2013, ENVIRON BIOL FISH, V96, P1101, DOI 10.1007/s10641-012-0106-2; Soeparno, 2012, J FISH BIOL, V80, P346, DOI 10.1111/j.1095-8649.2011.03175.x; Tanaka K, 2012, ECOL EVOL, V2, P2854, DOI 10.1002/ece3.391; Terazono Y, 2012, MAR ECOL PROG SER, V464, P209, DOI 10.3354/meps09873; Wu LX, 2012, NAT CLIM CHANGE, V2, P161, DOI 10.1038/NCLIMATE1353; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474	49	56	60	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81107	10.1371/journal.pone.0081107	http://dx.doi.org/10.1371/journal.pone.0081107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312528	Green Published, Green Submitted, gold			2022-12-25	WOS:000327947800036
J	Voss, U; Sand, E; Olde, B; Ekblad, E				Voss, Ulrikke; Sand, Elin; Olde, Bjorn; Ekblad, Eva			Enteric Neuropathy Can Be Induced by High Fat Diet In Vivo and Palmitic Acid Exposure In Vitro	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ENDOPLASMIC-RETICULUM; INSULIN-RESISTANCE; LIPOIC ACID; NEURONS; RAT; CARNITINE; LIPOTOXICITY; APOPTOSIS; GLUCOSE	Objective: Obese and/or diabetic patients have elevated levels of free fatty acids and increased susceptibility to gastrointestinal symptoms. Since the enteric nervous system is pivotal in regulating gastrointestinal functions alterations or neuropathy in the enteric neurons are suspected to occur in these conditions. Lipid induced intestinal changes, in particular on enteric neurons, were investigated in vitro and in vivo using primary cell culture and a high fat diet (HFD) mouse model. Design: Mice were fed normal or HFD for 6 months. Intestines were analyzed for neuronal numbers, remodeling and lipid accumulation. Co-cultures of myenteric neurons, glia and muscle cells from rat small intestine, were treated with palmitic acid (PA) (0 - 10(23) M) and / or oleic acid (OA) (0 - 10(23) M), with or without modulators of intracellular lipid metabolism. Analyses were by immunocyto- and histochemistry. Results: HFD caused substantial loss of myenteric neurons, leaving submucous neurons unaffected, and intramuscular lipid accumulation in ileum and colon. PA exposure in vitro resulted in neuronal shrinkage, chromatin condensation and a significant and concentration-dependent decrease in neuronal survival; OA exposure was neuroprotective. Carnitine palmitoyltransferase 1 inhibition, L-carnitine-or alpha lipoic acid supplementation all counteracted PA-induced neuronal loss. PA or OA alone both caused a significant and concentration-dependent loss of muscle cells in vitro. Simultaneous exposure of PA and OA promoted survival of muscle cells and increased intramuscular lipid droplet accumulation. PA exposure transformed glia from a stellate to a rounded phenotype but had no effect on their survival. Conclusions: HFD and PA exposure are detrimental to myenteric neurons. Present results indicate excessive palmitoylcarnitine formation and exhausted L-carnitine stores leading to energy depletion, attenuated acetylcholine synthesis and oxidative stress to be main mechanisms behind PA-induced neuronal loss. High PA exposure is suggested to be a factor in causing diabetic neuropathy and gastrointestinal dysregulation.	[Voss, Ulrikke; Ekblad, Eva] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Sand, Elin] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden; [Olde, Bjorn] Lund Univ, Dept Clin Sci Lund, Lund, Sweden	Lund University; Lund University; Lund University	Voss, U (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	Ulrikke.voss@med.lu.se			Ihre foundation; Pahlsson foundation; Royal Physiographic Society; Faculty of Medicine, Lund University	Ihre foundation; Pahlsson foundation; Royal Physiographic Society; Faculty of Medicine, Lund University	This study was supported by Ihre and Pahlsson foundations, Royal Physiographic Society and Faculty of Medicine, Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaguel FG, 2009, J NEUROSCI RES, V87, P1207, DOI 10.1002/jnr.21918; Artwohl M, 2009, ATHEROSCLEROSIS, V202, P351, DOI 10.1016/j.atherosclerosis.2008.05.030; Baille V, 2005, TOXICOLOGY, V215, P1, DOI 10.1016/j.tox.2005.05.028; Bento-Abreu A, 2007, J NEUROCHEM, V103, P871, DOI 10.1111/j.1471-4159.2007.04807.x; BRODERICK TL, 1992, J BIOL CHEM, V267, P3758; Brommage R, 2003, AM J PHYSIOL-ENDOC M, V285, pE454, DOI 10.1152/ajpendo.00470.2002; Bytzer P, 2001, ARCH INTERN MED, V161, P1989, DOI 10.1001/archinte.161.16.1989; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chandrasekharan B, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01611.x; Cheng C, 2003, DIABETES, V52, P2363, DOI 10.2337/diabetes.52.9.2363; Choi SJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE1122, DOI 10.1152/ajpendo.00006.2010; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; El-Salhy M, 1998, ACTA DIABETOL, V35, P194, DOI 10.1007/s005920050130; Farag YMK, 2011, NEPHROL DIAL TRANSPL, V26, P28, DOI 10.1093/ndt/gfq576; Fick LJ, 2011, BIOCHEM BIOPH RES CO, V413, P414, DOI 10.1016/j.bbrc.2011.08.103; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Goni FM, 1996, FEBS LETT, V390, P1, DOI 10.1016/0014-5793(96)00603-5; Goraca A, 2011, PHARMACOL REP, V63, P849; Lascola CD, 1996, J NEUROSCI, V16, P2532; Lelliott C, 2004, INT J OBESITY, V28, pS22, DOI 10.1038/sj.ijo.0802854; Lin Z, 2003, AUTON NEUROSCI-BASIC, V107, P9, DOI 10.1016/S1566-0702(03)00077-8; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu YM, 2011, ACTA PHARMACOL SIN, V32, P1475, DOI 10.1038/aps.2011.120; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Mattern HM, 2007, PHYSIOL RES, V56, P149, DOI 10.33549/physiolres.930899; Mutomba MC, 2000, FEBS LETT, V478, P19, DOI 10.1016/S0014-5793(00)01817-2; Nezami B, 2012, NEUROGASTROENT MOTIL, V24, P118; Orchard GE, 2000, HISTOCHEM J, V32, P475, DOI 10.1023/A:1004192232357; PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R; Peng G, 2011, ENDOCRINOLOGY, V152, P2206, DOI 10.1210/en.2010-1369; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; RICNY J, 1992, BRAIN RES, V576, P215, DOI 10.1016/0006-8993(92)90683-Z; Sand E, 2012, CELL TISSUE RES; Sand E, 2011, REGUL PEPTIDES, V166, P68, DOI 10.1016/j.regpep.2010.08.011; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; Sorensen Annette, 2002, Brain Res Gene Expr Patterns, V1, P167; Szczepankowska D, 2003, NEUROCHEM RES, V28, P645, DOI 10.1023/A:1022802229921; Tan SL, 1998, J NEUROCHEM, V71, P95; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; Virmani Ashraf, 2004, Molecular Aspects of Medicine, V25, P533, DOI 10.1016/j.mam.2004.06.003; Voss U, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-30; Wanic K, 2010, DIABETOLOGIA, V53; Yamada K, 2007, DIABETES RES CLIN PR, V75, P127, DOI 10.1016/j.diabres.2006.06.034	45	42	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81413	10.1371/journal.pone.0081413	http://dx.doi.org/10.1371/journal.pone.0081413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312551	Green Submitted, gold, Green Published			2022-12-25	WOS:000327947800046
J	Tamaru, T; Hattori, M; Ninomiya, Y; Kawamura, G; Vares, G; Honda, K; Mishra, DP; Wang, B; Benjamin, I; Sassone-Corsi, P; Ozawa, T; Takamatsu, K				Tamaru, Teruya; Hattori, Mitsuru; Ninomiya, Yasuharu; Kawamura, Genki; Vares, Guillaume; Honda, Kousuke; Mishra, Durga Prasad; Wang, Bing; Benjamin, Ivor; Sassone-Corsi, Paolo; Ozawa, Takeaki; Takamatsu, Ken			ROS Stress Resets Circadian Clocks to Coordinate Pro-Survival Signals	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVITY; HYDROGEN-PEROXIDE; REACTIVE OXYGEN; CELL-SURVIVAL; PROTEIN; PHOSPHORYLATION; BMAL1	Dysfunction of circadian clocks exacerbates various diseases, in part likely due to impaired stress resistance. It is unclear how circadian clock system responds toward critical stresses, to evoke life-protective adaptation. We identified a reactive oxygen species (ROS), H2O2 -responsive circadian pathway in mammals. Near-lethal doses of ROS-induced critical oxidative stress (cOS) at the branch point of life and death resets circadian clocks, synergistically evoking protective responses for cell survival. The cOS-triggered clock resetting and pro-survival responses are mediated by transcription factor, central clock-regulatory BMAL1 and heat shock stress-responsive (HSR) HSF1. Casein kinase II (CK2) -mediated phosphorylation regulates dimerization and function of BMAL1 and HSF1 to control the cOS-evoked responses. The core cOS-responsive transcriptome includes CK2-regulated crosstalk between the circadian, HSR, NF-kappa-B-mediated anti-apoptotic, and Nrf2-mediated anti-oxidant pathways. This novel circadian-adaptive signaling system likely plays fundamental protective roles in various ROS-inducible disorders, diseases, and death.	[Tamaru, Teruya; Takamatsu, Ken] Toho Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Tamaru, Teruya; Takamatsu, Ken] Toho Univ, Sch Med, Adv Res Ctr Med Sci, Tokyo, Japan; [Hattori, Mitsuru; Kawamura, Genki; Honda, Kousuke; Ozawa, Takeaki] Univ Tokyo, Sch Sci, Dept Chem, Tokyo, Japan; [Ninomiya, Yasuharu; Vares, Guillaume; Wang, Bing] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Chiba 260, Japan; [Mishra, Durga Prasad] CSIR, Cent Drug Res Inst, Div Endocrinol, Cell Death Res Lab, Lucknow, Uttar Pradesh, India; [Benjamin, Ivor] Univ Utah, Sch Med, Div Cardiol, Salt Lake City, UT USA; [Sassone-Corsi, Paolo] Univ Calif Irvine, Sch Med, Ctr Epigenet & Metab, Irvine, CA 92717 USA	Toho University; Toho University; University of Tokyo; National Institutes for Quantum Science & Technology; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Utah System of Higher Education; University of Utah; University of California System; University of California Irvine	Tamaru, T (corresponding author), Toho Univ, Sch Med, Dept Physiol, Tokyo, Japan.	tetamaru@med.toho-u.ac.jp; ozawa@chem.s.u-tokyo.ac.jp	Vares, Guillaume/S-6530-2019; Vares, Guillaume/A-9257-2011	Vares, Guillaume/0000-0002-6191-9032; Vares, Guillaume/0000-0002-6191-9032; Kawamura, Genki/0000-0002-5098-0911	Ministry of Education, Culture, Sports, Science and Technology (MEXT) (KAKENHI); Japan Society for the promotion of Science (JSPS); Grants-in-Aid for Scientific Research [21675001, 23590283, 24710259] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology (MEXT) (KAKENHI, T. Tamaru & T. Ozawa) and Japan Society for the promotion of Science (JSPS) (T. Tamaru & K. Takamatsu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Apopa PL, 2008, J BIOCHEM MOL TOXIC, V22, P63, DOI 10.1002/jbt.20212; Armogida M, 2012, BRIT J PHARMACOL, V166, P1211, DOI 10.1111/j.1476-5381.2012.01912.x; Arya R, 2007, J BIOSCIENCES, V32, P595, DOI 10.1007/s12038-007-0059-3; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bellet MM, 2010, J CELL SCI, V123, P3837, DOI 10.1242/jcs.051649; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chakraborty A, 2011, P NATL ACAD SCI USA, V108, P2205, DOI 10.1073/pnas.1019381108; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Doherty CJ, 2010, ANNU REV GENET, V44, P419, DOI 10.1146/annurev-genet-102209-163432; Duncan JS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001682; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gervais JLM, 1998, J BIOL CHEM, V273, P19207, DOI 10.1074/jbc.273.30.19207; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hirotsu Y, 2012, NUCLEIC ACIDS RES, V40, P10228, DOI 10.1093/nar/gks827; Insel PA, 2012, ACTA PHYSIOL, V204, P277, DOI 10.1111/j.1748-1716.2011.02273.x; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Khapre RV, 2011, CELL CYCLE, V10, P4162, DOI 10.4161/cc.10.23.18381; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kondratov RV, 2009, AGING-US, V1, P979, DOI 10.18632/aging.100113; Lee J, 2013, MOL CELL BIOL, V33, P2327, DOI 10.1128/MCB.01421-12; Liu GG, 2008, BIOCHEM BIOPH RES CO, V370, P651, DOI 10.1016/j.bbrc.2008.04.031; Liu T, 2012, PHARMACOL THERAPEUT, V136, P354, DOI 10.1016/j.pharmthera.2012.08.014; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; MARINA P, 2010, RESPONSE CIRC RES, V106, P68, DOI DOI 10.1161/CIRCRESAHA.109.207076; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Misawa N, 2010, ANAL CHEM, V82, P2552, DOI 10.1021/ac100104q; Mrad MF, 2012, J CELL BIOCHEM, V113, P3466, DOI 10.1002/jcb.24223; Murley JS, 2004, RADIAT RES, V162, P536, DOI 10.1667/RR3256; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; NAKAYAMA K, 2012, NUCLEIC ACIDS RES, V40, P10228, DOI DOI 10.1093/NAR/GKS827.PUBMED:22965115; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Nistico R, 2008, BRIT J PHARMACOL, V153, P1022, DOI 10.1038/sj.bjp.0707587; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; Reischl S, 2011, FEBS LETT, V585, P1393, DOI 10.1016/j.febslet.2011.02.038; Sai X, 2002, J BIOL CHEM, V277, P12915, DOI 10.1074/jbc.M112372200; Sant'Angelo DB, 2002, P NATL ACAD SCI USA, V99, P6931, DOI 10.1073/pnas.102182499; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Satyal SH, 1998, GENE DEV, V12, P1962, DOI 10.1101/gad.12.13.1962; Schibler Ueli, 2007, Dialogues Clin Neurosci, V9, P257; Schreck R, 1991, Trends Cell Biol, V1, P39, DOI 10.1016/0962-8924(91)90072-H; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Singh R, 2010, CURR PHARM DESIGN, V16, P796, DOI 10.2174/138161210790883499; Soncin F, 2003, BIOCHEM BIOPH RES CO, V303, P700, DOI 10.1016/S0006-291X(03)00398-X; Spengler ML, 2012, P NATL ACAD SCI USA, V109, pE2457, DOI 10.1073/pnas.1206274109; Stratmann M, 2012, MOL CELL, V48, P277, DOI 10.1016/j.molcel.2012.08.012; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tamaru T, 2003, GENES CELLS, V8, P973, DOI 10.1046/j.1365-2443.2003.00686.x; Tamaru T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024521; Tamaru T, 2009, NAT STRUCT MOL BIOL, V16, P446, DOI 10.1038/nsmb.1578; Uchida Y, 2010, BIOL PHARM BULL, V33, P535, DOI 10.1248/bpb.33.535; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Wang TA, 2012, SCIENCE, V337, P839, DOI 10.1126/science.1222826; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Zhang L, 2011, MOL CELL BIOCHEM, V347, P21, DOI 10.1007/s11010-010-0608-1	66	68	70	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82006	10.1371/journal.pone.0082006	http://dx.doi.org/10.1371/journal.pone.0082006			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312621	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500111
J	Bruce, DG; Davis, WA; Cetrullo, V; Starkstein, SE; Davis, TME				Bruce, David G.; Davis, Wendy A.; Cetrullo, Violetta; Starkstein, Sergio E.; Davis, Timothy M. E.			Clinical Impact of the Temporal Relationship between Depression and Type 2 Diabetes: The Fremantle Diabetes Study Phase II	PLOS ONE			English	Article							MAJOR DEPRESSION; LIFETIME PREVALENCE; RISK-FACTOR; ASSOCIATION; DISORDERS; ADULTS; CARE; COMMUNITY; SYMPTOMS; SMOKING	Background: The clinical features of type 2 diabetes may differ depending on whether first depression episode precedes or follows the diagnosis of diabetes. Methods: Type 2 patients from the observational community-based Fremantle Diabetes Study Phase II underwent assessment of lifetime depression using the Brief Lifetime Depression Scale (developed and validated for this study) supplemented by information on current depression symptoms (Patient Health Questionnaire, 9-item version) and use of antidepressants. Patients were categorized as never depressed (Group 1), having had depression before diabetes diagnosis (Group 2), diagnosed with depression and diabetes within 2 years of each other (Group 3) and having depression after diabetes diagnosis (Group 4). Results: Of 1391 patients, 20.8% were assigned to Group 2, 6.0% to Group 3 and 14.5% to Group 4. In Group 2, depression occurred a median 15.6 years before diabetes onset at age 37.2+/-14.7 years. These patients had similar clinical characteristics to never depressed patients except for reduced self-care behaviours and having more symptomatic peripheral arterial disease. In Group 4, depression occurred a median 9.9 years after diabetes onset at age 59.8+/-13.0 years. These patients had long duration diabetes, poor glycaemic control, more intensive management and more diabetic complications. Group 4 patients had more current depression than Group 2 but were less likely to be receiving antidepressants. Conclusions/Interpretation: The clinical features of depression and type 2 diabetes are heterogeneous depending on their temporal relationship. There may be corresponding differences in the pathogenesis of depression in diabetes that have implications for diagnosis and management.	[Bruce, David G.; Davis, Wendy A.; Cetrullo, Violetta; Davis, Timothy M. E.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Starkstein, Sergio E.] Univ Western Australia, Sch Psychiat & Neurosci, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Bruce, DG (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia.	David.Bruce@uwa.edu.au	Davis, Timothy ME/M-5144-2014; Bruce, David G/H-8900-2014	Bruce, David/0000-0002-9979-6867; Davis, Wendy/0000-0002-5709-8235; Davis, Timothy/0000-0003-0749-7411	National Health and Medical Research Council of Australia [513781]; National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The study was funded by the National Health and Medical Research Council of Australia (project grant 513781). TMED has a National Health and Medical Research Council of Australia Practitioner Fellowship. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andersohn F, 2009, AM J PSYCHIAT, V166, P591, DOI 10.1176/appi.ajp.2008.08071065; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Baumeister H, 2012, CURR OPIN PSYCHIATR, V25, P405, DOI 10.1097/YCO.0b013e3283556c63; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P161, DOI 10.1001/archpsyc.55.2.161; Browne MAO, 2006, AUST NZ J PSYCHIAT, V40, P865, DOI 10.1111/j.1440-1614.2006.01905.x; Bruce DG, 2005, DIABETOLOGIA, V48, P2532, DOI 10.1007/s00125-005-0024-3; Campayo A, 2010, AM J PSYCHIAT, V167, P580, DOI 10.1176/appi.ajp.2009.09010038; Cuijpers P, 2012, JAMA-J AM MED ASSOC, V307, P1033, DOI 10.1001/jama.2012.271; Davis TM, 2012, INT J EPIDEMIOL; Davis TME, 2000, DIABETIC MED, V17, P667, DOI 10.1046/j.1464-5491.2000.00359.x; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; FELDMAN EL, 1994, DIABETES CARE, V17, P1281, DOI 10.2337/diacare.17.11.1281; Golden SH, 2007, CURR DIABETES REV, V3, P252, DOI 10.2174/157339907782330021; Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751; Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158; Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Huang CJ, 2011, DIABETES RES CLIN PR, V93, P106, DOI 10.1016/j.diabres.2011.03.032; Katon W, 2012, AM J PREV MED, V42, P550, DOI 10.1016/j.amepre.2012.01.017; Katon W, 2009, PSYCHOSOMATICS, V50, P570, DOI 10.1176/appi.psy.50.6.570; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Khaled SM, 2012, J PSYCHIATR RES, V46, P436, DOI 10.1016/j.jpsychires.2011.11.011; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li CY, 2008, DIABETES CARE, V31, P105, DOI 10.2337/dc07-1154; Lustman PJ, 1997, GEN HOSP PSYCHIAT, V19, P138, DOI 10.1016/S0163-8343(96)00170-3; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Moffitt TE, 2010, PSYCHOL MED, V40, P899, DOI 10.1017/S0033291709991036; Naranjo DM, 2011, ANN FAM MED, V9, P115, DOI 10.1370/afm.1212; Norman PE, 2006, DIABETES CARE, V29, P575, DOI 10.2337/diacare.29.03.06.dc05-1567; Roy T, 2012, DIABETIC MED, V29, P164, DOI 10.1111/j.1464-5491.2011.03401.x; Schmitz N, 2012, J PSYCHOSOMATIC RES; Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828; Steffens DC, 2002, STROKE, V33, P1636, DOI 10.1161/01.STR.0000018405.59799.D5; Strine TW, 2008, GEN HOSP PSYCHIAT, V30, P127, DOI 10.1016/j.genhosppsych.2007.12.008; Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556; Wagner JA, 2010, DIABETIC MED, V27, P713, DOI 10.1111/j.1464-5491.2010.02996.x	38	20	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81254	10.1371/journal.pone.0081254	http://dx.doi.org/10.1371/journal.pone.0081254			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	265KD	24324682	Green Submitted, gold, Green Published			2022-12-25	WOS:000327949300084
J	Li, NF; Gemenetzidis, E; Marshall, FJ; Davies, D; Yu, YW; Frese, K; Froeling, FEM; Woolf, AK; Feakins, RM; Naito, Y; Iacobuzio-Donahue, C; Tuveson, DA; Hart, IR; Kocher, HM				Li, Ningfeng Fiona; Gemenetzidis, Emilios; Marshall, Francis J.; Davies, Derek; Yu, Yongwei; Frese, Kristopher; Froeling, Fieke E. M.; Woolf, Adam K.; Feakins, Roger M.; Naito, Yoshiki; Iacobuzio-Donahue, Christine; Tuveson, David A.; Hart, Ian R.; Kocher, Hemant M.			RhoC Interacts with Integrin alpha 5 beta 1 and Enhances Its Trafficking in Migrating Pancreatic Carcinoma Cells	PLOS ONE			English	Article							CANCER CELLS; ENDOCYTIC TRANSPORT; SIGNALING PROMOTES; FOCAL ADHESIONS; BETA-CATENIN; METASTASIS; INVASION; MOTILITY; GTPASE; ACTIVATION	Human pancreatic ductal adenocarcinoma (PDAC) is characterized by early systemic dissemination. Although RhoC has been implicated in cancer cell migration, the relevant underlying molecular mechanisms remain unknown. RhoC has been implicated in the enhancement of cancer cell migration and invasion, with actions which are distinct from RhoA (84% homology), and are possibly attributed to the divergent C-terminus domain. Here, we confirm that RhoC significantly enhances the migratory and invasive properties of pancreatic carcinoma cells. In addition, we show that RhoC over-expression decreases cancer cell adhesion and, in turn, accelerates cellular body movement and focal adhesion turnover, especially, on fibronectin-coated surfaces. Whilst RhoC over-expression did not alter integrin expression patterns, we show that it enhanced integrin alpha 5 beta 1 internalization and re-cycling (trafficking), an effect that was dependent specifically on the C-terminus (180-193 amino acids) of RhoC protein. We also report that RhoC and integrin alpha 5 beta 1 co-localize within the peri-nuclear region of pancreatic tumor cells, and by masking the CAAX motif at the C-terminal of RhoC protein, we were able to abolish this interaction in vitro and in vivo. Co-localization of integrin alpha 5 beta 1 and RhoC was demonstrable in invading cancer cells in 3D-organotypic cultures, and further mimicked in vivo analyses of, spontaneous human, (two distinct sources: operated patients and rapid autopsy programme) and transgenic murine (LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre), pancreatic cancers. In both cases, co-localization of integrin alpha 5 beta 1 and RhoC correlated with poor differentiation status and metastatic potential. We propose that RhoC facilitates tumor cell invasion and promotes subsequent metastasis, in part, by enhancing integrin alpha 5 beta 1 trafficking. Thus, RhoC may serve as a biomarker and a therapeutic target.	[Li, Ningfeng Fiona; Gemenetzidis, Emilios; Marshall, Francis J.; Froeling, Fieke E. M.; Woolf, Adam K.; Hart, Ian R.; Kocher, Hemant M.] Queen Mary Univ London, Ctr Tumour Biol, Barts Canc Inst, CR United Kingdom Ctr Excellence, London, England; [Davies, Derek] Canc Res UK London Res Inst, London WC2A 3PX, England; [Yu, Yongwei] Shanghai Second Mil Med Univ, Dept Pathol, Changhai Hosp, Shanghai, Peoples R China; [Frese, Kristopher; Tuveson, David A.] Canc Res United Kingdom Cambridge Res Inst, Cambridge, England; [Feakins, Roger M.; Kocher, Hemant M.] Royal London Hosp, Barts & London HPB Ctr, London E1 1BB, England; [Naito, Yoshiki; Iacobuzio-Donahue, Christine] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	University of London; Queen Mary University London; Cancer Research UK; Naval Medical University; Cancer Research UK; CRUK Cambridge Institute; Barts Health NHS Trust; Royal London Hospital; Johns Hopkins University	Kocher, HM (corresponding author), Queen Mary Univ London, Ctr Tumour Biol, Barts Canc Inst, CR United Kingdom Ctr Excellence, London, England.	h.kocher@qmul.ac.uk	Feakins, Roger/J-6782-2019; Iacobuzio-Donahue, Christine/ABF-1295-2020; Feakins, Roger/AAO-5570-2020	Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Kocher, Hemant M/0000-0001-6771-1905; Davies, Derek/0000-0002-6977-4181; LI, Ningfeng/0000-0001-5908-9976	NIHR Clinician Scientist Award; University of Cambridge; Cancer Research UK; Hutchinson Whampoa Limited; National Institute for Health Research [CL-2013-21-009] Funding Source: researchfish	NIHR Clinician Scientist Award; University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); Hutchinson Whampoa Limited; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by an NIHR Clinician Scientist Award to HMK. DAT acknowledges the support of the University of Cambridge, Cancer Research UK and Hutchinson Whampoa Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Arpaia E, 2012, ONCOGENE, V31, P884, DOI 10.1038/onc.2011.288; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Critchley DR, 1999, BIOCHEM SOC SYMP, V65, P79; Embuscado EE, 2005, CANCER BIOL THER, V4, P548, DOI 10.4161/cbt.4.5.1663; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Froeling FEM, 2011, GASTROENTEROLOGY, V141, P1486, DOI 10.1053/j.gastro.2011.06.047; Froeling FEM, 2010, J BIOTECHNOL, V148, P16, DOI 10.1016/j.jbiotec.2010.01.008; Froeling FEM, 2009, AM J PATHOL, V175, P636, DOI 10.2353/ajpath.2009.090131; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hall CL, 2008, NEOPLASIA, V10, P797, DOI 10.1593/neo.08380; Hall CL, 2006, CANCER RES, V66, P8648, DOI 10.1158/0008-5472.CAN-06-1544; Helm J, 2009, CANCER, V115, P4080, DOI 10.1002/cncr.24503; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Ho TTG, 2011, MOL BIOL CELL, V22, P3263, DOI 10.1091/mbc.E11-01-0020; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ikoma T, 2004, CLIN CANCER RES, V10, P1192, DOI 10.1158/1078-0432.CCR-03-0275; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; Kadaba R, 2013, J PATHOL, V230, P107, DOI 10.1002/path.4172; Kanai M, 2010, ONCOGENE, V29, P6040, DOI 10.1038/onc.2010.328; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Kocher HM, 2009, GUT, V58, P271, DOI 10.1136/gut.2008.159871; Li NF, 2009, ONCOGENE, V28, P773, DOI 10.1038/onc.2008.412; Lin M, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-21; Michaelson D, 2005, MOL BIOL CELL, V16, P1606, DOI 10.1091/mbc.e04-11-0960; Nicolas A, 2008, BIOPHYS J, V95, P527, DOI 10.1529/biophysj.107.127399; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Rosenthal DT, 2011, CANCER RES, V71, P6338, DOI 10.1158/0008-5472.CAN-11-1291; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; Sriuranpong V, 2003, CANCER RES, V63, P2948; Srivastava S, 2010, BRIT J CANCER, V102, P196, DOI 10.1038/sj.bjc.6605451; Thomson S, 2011, CLIN EXP METASTAS, V28, P137, DOI 10.1007/s10585-010-9367-3; Trerotola M, 2013, CANC RES; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Winterwood NE, 2006, MOL BIOL CELL, V17, P2707, DOI 10.1091/mbc.E05-11-1042	47	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81575	10.1371/journal.pone.0081575	http://dx.doi.org/10.1371/journal.pone.0081575			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312560	Green Submitted, Green Published, gold			2022-12-25	WOS:000327947800049
J	Lemgruber, RDP; Marshall, NAD; Ghelfi, A; Fagundes, DB; Val, AL				Pinto Lemgruber, Renato de Souza; dos Anjos Marshall, Nislanha Ana; Ghelfi, Andrea; Fagundes, Daniel Barros; Val, Adalberto Luis			Functional Categorization of Transcriptome in the Species Symphysodon aequifasciatus Pellegrin 1904 (Perciformes: Cichlidae) Exposed to Benzo[a]pyrene and Phenanthrene	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; CRUDE-OIL; HUMIC SUBSTANCES; ION REGULATION; GENE ONTOLOGY; PARENTAL CARE; FISH; STRESS; LIVER; RIVER	This study aims to evaluate the transcriptome alterations, through cDNA libraries, associated with the combined effects of two PAHs, benzo[a]pyrene (0.5 mu g/L) and phenanthrene (50 mu g/L), present in crude oil, on specimens of Symphysodon aequifasciatus (discus fish) after 48 h of exposure. The cDNA libraries were constructed according to the SOLiD (TM) SAGE (TM) protocol for sequencing in the SOLiD v.3 Plus sequencer. The results were analyzed by bioinformatics and differentially expressed genes were categorized using the gene ontology program. The functional categories (terms) found in the gene ontology and the gene network generated using STRING software were used to predict the adverse effects of benzo[a]pyrene and phenanthrene in the liver. In the present study, 27,127 genes (compared to Danio rerio database) were identified. Considering only those genes with a p-value less than or equal to 0.05 and greater than or equal to two-fold change in expression across libraries, we found 804 genes, 438 down-regulated (54%) and 366 up-regulated (46%), in the experimental group compared to the control. Out of this total, 327 genes were successfully categorized, 174 down-regulated and 153 up-regulated, using gene ontology. Using String, the gene network was composed by 199 nodes, 124 of them resulting in 274 interactions. The results showed that even an acute exposure of 48 h caused metabolic change in response to environmental contaminants, resulting in changes of cell integrity, in oxidation-reduction processes, in the immune response and disturbances of intracellular signaling of discus fish. Also the gene network has showed no central interplay cluster, exhibiting instead interconnected clusters interactions and connected sub-networks. These findings highlight that even an acute sublethal exposure of PAHs can cause metabolism changes that may affect survival of discus. Our findings using SOLiD coupled with SAGE-method resulted in a powerful and reliable means for gene expression analysis in discus, a non-model Amazonian fish.	[Pinto Lemgruber, Renato de Souza; dos Anjos Marshall, Nislanha Ana; Fagundes, Daniel Barros; Val, Adalberto Luis] Brazilian Natl Inst Res Amazon INPA, Lab Ecophysiol & Mol Evolut LEEM, Manaus, Amazonas, Brazil; [Ghelfi, Andrea] Fed Univ Amazon UFAM, Lab Bioinformat & Modelling Middle Solimoes LBMS, Coari, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Universidade Federal de Amazonas	Lemgruber, RDP (corresponding author), Brazilian Natl Inst Res Amazon INPA, Lab Ecophysiol & Mol Evolut LEEM, Manaus, Amazonas, Brazil.	renatospl@hotmail.com	Val, Adalberto Luis/I-3377-2014; Val, Adalberto/AAE-3983-2020	Val, Adalberto/0000-0002-3823-3868	Brazilian National Research Council (CNPq); Amazonas State Research Foundation (FAPEAM); CNPq; CAPES (Brazilian Federal Agency for Support and Evaluation of Graduate Education)	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Amazonas State Research Foundation (FAPEAM)(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Brazilian Federal Agency for Support and Evaluation of Graduate Education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	A joint grant from the Brazilian National Research Council (CNPq) and Amazonas State Research Foundation (FAPEAM) to INCT ADAPTA supported this work. Thanks are due to CNPq for MSc scholarship to RSPL and to CAPES (Brazilian Federal Agency for Support and Evaluation of Graduate Education) for MSc scholarship to DBF. ALV is a recipient of a research fellowship from CNPq. CNPq (www.cnpq.br); FAPEAM (www.fapeam.am.gov.br); CAPES (www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS SM, 1989, MAR ENVIRON RES, V28, P459, DOI 10.1016/0141-1136(89)90284-5; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Amat A, 2006, ENVIRON CHEM LETT, V4, P93, DOI 10.1007/s10311-006-0040-7; Anjos NA, 2011, AQUAT TOXICOL, V103, P46; Ankoma-Sey V, 1999, NEWS PHYSIOL SCI, V14, P149; [Anonymous], NUCLEIC ACIDS RES; Applied Biosystems, 2009, SOLID 3 SYST SOLID S; Applied Biosystems, 2009, SOLID SYST INSTR OP; Applied Biosystems, 2009, SOLID 3 SYST TEMPL B; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; BLACK JJ, 1991, ENVIRON HEALTH PERSP, V90, P27, DOI 10.2307/3430842; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Bleher H, 2006, BLEHERS DISCUS; Braunbeck T, 1999, DIS AQUAT ORGAN, V36, P183, DOI 10.3354/dao036183; Brauner CJ, 1999, COMP BIOCHEM PHYS C, V123, P127, DOI 10.1016/S0742-8413(99)00018-3; Buckley J, 2010, J EXP BIOL, V213, P3787, DOI 10.1242/jeb.042929; Carlson EA, 2002, AQUAT TOXICOL, V56, P289, DOI 10.1016/S0166-445X(01)00223-5; Cunha R, 2002, MIL UMA UTILIDADES L; Ding WX, 2000, ENVIRON HEALTH PERSP, V108, P605, DOI 10.2307/3434879; Duarte RM, 2010, AQUAT TOXICOL, V97, P134, DOI 10.1016/j.aquatox.2009.12.020; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; ERTEL JR, 1986, LIMNOL OCEANOGR, V31, P739, DOI 10.4319/lo.1986.31.4.0739; Fenzl N., 2004, ISSUES LOCAL GLOBAL, P57; Finer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002932; Fiol DF, 2006, COMP BIOCHEM PHYS D, V1, P344, DOI 10.1016/j.cbd.2006.08.002; Ghelfi A, 2012, 20 ANN INT C INT SYS; GOKSOYR A, 1992, AQUAT TOXICOL, V22, P287, DOI 10.1016/0166-445X(92)90046-P; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Hylland K, 2006, J TOXICOL ENV HEAL A, V69, P109, DOI 10.1080/15287390500259327; Junk WJ, 2005, ESTUD AV, V4, P126; Junk WJ, 2007, AQUAT ECOSYST HEALTH, V10, P153, DOI 10.1080/14634980701351023; Kassahn KS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-358; Lam SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028273; Lopes A, 2009, HYDROBIOLOGIA, V636, P295, DOI 10.1007/s10750-009-9959-6; Matsuo AYO, 2006, ENVIRON SCI TECHNOL, V40, P2851, DOI 10.1021/es052437i; Maunder RJ, 2013, J EXP BIOL, V216, P3587, DOI 10.1242/jeb.089102; Meire R.O., 2007, OECOLOGIA BRAS, V11, P188, DOI [10.4257/oeco.2007.1102.03, DOI 10.4257/OECO.2007.1102.03, DOI 10.4257/oeco.2007.1102.03]; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Moran PW, 2007, ENVIRON SCI TECHNOL, V41, P6591, DOI 10.1021/es070550y; Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006; Ribeiro CAO, 2007, SCI TOTAL ENVIRON, V372, P549, DOI 10.1016/j.scitotenv.2006.10.005; Park MT, 2003, J BIOCHEM MOL BIOL, V36, P60; Petrobras, 2008, PROV PETR UR 20 AN; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ready JS, 2006, J FISH BIOL, V69, P200, DOI 10.1111/j.1095-8649.2006.01232.x; Reynaud S, 2006, AQUAT TOXICOL, V77, P229, DOI 10.1016/j.aquatox.2005.10.018; Rossoni F, 2010, NEOTROP ICHTHYOL, V8, P379, DOI 10.1590/S1679-62252010000200018; Santos Geraldo Mendes dos, 2005, Estud. av., V19, P165; Schirmer K, 2010, ANAL BIOANAL CHEM, V397, P917, DOI 10.1007/s00216-010-3662-3; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; TUVIKENE A, 1995, ANN ZOOL FENN, V32, P295; Ung CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-212; Val AL, 1999, BIOL TROPICAL FISHES, P277; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; Wickstead B, 2011, J CELL BIOL, V194, P513, DOI 10.1083/jcb.201102065; Yuen BBH, 2007, AQUAT TOXICOL, V82, P181, DOI 10.1016/j.aquatox.2007.02.010	59	8	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81083	10.1371/journal.pone.0081083	http://dx.doi.org/10.1371/journal.pone.0081083			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312524	Green Published, Green Submitted, gold			2022-12-25	WOS:000327947800032
J	Wen, QW; Liang, T; Qin, FZ; Wei, JB; He, QL; Luo, X; Chen, XY; Zheng, N; Huang, RB				Wen, Qingwei; Liang, Tao; Qin, Feizhang; Wei, Jinbin; He, Qiaoling; Luo, Xiu; Chen, Xiaoyu; Zheng, Ni; Huang, Renbin			Lyoniresinol 3 alpha-O-beta-D-Glucopyranoside-Mediated Hypoglycaemia and Its Influence on Apoptosis-Regulatory Protein Expression in the Injured Kidneys of Streptozotocin-Induced Mice	PLOS ONE			English	Article							BETA-CELL APOPTOSIS; KAPPA-B ACTIVATION; DIABETIC-NEPHROPATHY; INSULIN-RESISTANCE; PATHWAYS; OBESITY; RECEPTOR; HYPERGLYCEMIA; INFLAMMATION; MECHANISM	Averrhoa carambola L. (Oxalidaceae) root (ACLR) has a long history of use in traditional Chinese medicine for treating diabetes and diabetic nephropathy (DN). (+/-)-Lyoniresinol 3 alpha-O-beta-D-glucopyranoside (LGP1, LGP2) were two chiral lignan glucosides that were isolated from the ACLR. The purpose of this study was to investigate the effect of LGP1 and LGP2-mediated hypoglycaemia on renal injury in streptozotocin (STZ)-induced diabetic mice. STZ-induced diabetic mice were administrated LGP1 and LGP2 orally (20, 40, 80 mg/kg body weight/d) for 14 days. Hyperglycaemia and the expression of related proteins such as nuclear factor-kappa B (NF-kappa B), caspase-3, -8, -9, and Bcl-associated X protein (Bax) were markedly decreased by LGP1 treatment. However, LGP2 treatment had no hypoglycaemic activity. Diabetes-dependent alterations in the kidney such as glomerular hypertrophy, excessive extracellular matrix amassing, and glomerular and tubular basement membrane thickening were improved after 14 days of LGP1 treatment. B cell lymphoma Leukaemia-2 (Bcl-2) expression was reduced in the STZ-induced diabetic mouse kidneys but was enhanced by LGP1 treatment. These findings suggest that LGP1 treatment may inhibit diabetic nephropathy progression and may regulate several pharmacological targets for treating or preventing diabetic nephropathy.	[Wen, Qingwei; Liang, Tao; Qin, Feizhang; Wei, Jinbin; He, Qiaoling; Luo, Xiu; Chen, Xiaoyu; Zheng, Ni; Huang, Renbin] Guangxi Med Univ, Pharmaceut Coll, Nanning, Guangxi, Peoples R China	Guangxi Medical University	Huang, RB (corresponding author), Guangxi Med Univ, Pharmaceut Coll, Nanning, Guangxi, Peoples R China.	huangrenbin518@163.com			National Natural Science Foundation of China [81160533, 81360129]; Guangxi Natural Science Foundation [2012GX NSFAA053106]; Education Innovation Plan Program for Postgraduates in the Guangxi Zhuang Autonomous Region [2011105981002D27]; Guangxi Key Laboratory of Metabolic Diseases Research [181H2012-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Education Innovation Plan Program for Postgraduates in the Guangxi Zhuang Autonomous Region; Guangxi Key Laboratory of Metabolic Diseases Research	We gratefully acknowledge financial support by the National Natural Science Foundation of China (No. 81160533, 81360129), the Guangxi Natural Science Foundation (No. 2012GX NSFAA053106), the Education Innovation Plan Program for Postgraduates in the Guangxi Zhuang Autonomous Region (No. 2011105981002D27), and the project (No. 181H2012-02) of Guangxi Key Laboratory of Metabolic Diseases Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rasheed NM, 2006, J AM SOC NEPHROL, V17, P986, DOI 10.1681/ASN.2005080797; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Candido R, 2002, CIRCULATION, V106, P246, DOI 10.1161/01.CIR.0000021122.63813.32; Cazarolli LH, 2009, EUR J MED CHEM, V44, P4668, DOI 10.1016/j.ejmech.2009.07.001; Cazarolli LH, 2009, CHEM-BIOL INTERACT, V179, P407, DOI 10.1016/j.cbi.2008.11.012; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Donath MY, 1999, DIABETES, V48, P738, DOI 10.2337/diabetes.48.4.738; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Gupta S, 2001, LIFE SCI, V69, P2957, DOI 10.1016/S0024-3205(01)01404-7; He ZH, 2006, ARTERIOSCL THROM VAS, V26, P787, DOI 10.1161/01.ATV.0000209500.15801.4e; Hirasawa Y, 2008, EXP ANIM TOKYO, V57, P423, DOI 10.1538/expanim.57.423; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; KARIN M, 2000, IMMUNOLOGY, V12, P85; Lehmann R, 2000, CLIN CHIM ACTA, V297, P135, DOI 10.1016/S0009-8981(00)00240-0; Liadis N, 2005, MOL CELL BIOL, V25, P3620, DOI 10.1128/MCB.25.9.3620-3629.2005; Maedler K, 2008, FASEB J, V22, P1905, DOI 10.1096/fj.07-101824; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; Marette A, 2003, INT J OBESITY, V27, pS46, DOI 10.1038/sj.ijo.0802500; Mezzano S, 2004, NEPHROL DIAL TRANSPL, V19, P2505, DOI 10.1093/ndt/gfh207; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Ranganayaki S., 1980, P NATL ACAD SCI IN A, V50, P61; Rudofsky G, 2004, HORM METAB RES, V36, P630, DOI 10.1005/s-2004-825904; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Su HC, 2006, AM J PHYSIOL-ENDOC M, V290, pE1339, DOI 10.1152/ajpendo.00487.2005; Talanian RV, 1997, J EXP MED, V186, P1323, DOI 10.1084/jem.186.8.1323; Verzola D, 2007, KIDNEY INT, V72, P1262, DOI 10.1038/sj.ki.5002531; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Wen QW, 2012, MOLECULES, V17, P12330, DOI 10.3390/molecules171012330; Yamashita H, 2002, METABOLISM, V51, P403, DOI 10.1053/meta.2002.30953; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zhang M., 2009, EXPT DIABETES RES, V2008; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	37	14	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81772	10.1371/journal.pone.0081772	http://dx.doi.org/10.1371/journal.pone.0081772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312585	Green Published, gold, Green Submitted			2022-12-25	WOS:000327947800056
J	Gong, PY; Shen, GM; Li, S; Zhang, GP; Fang, HC; Lei, L; Zhang, PZ; Zhang, FC				Gong, Pingyuan; Shen, Guomin; Li, She; Zhang, Guoping; Fang, Hongchao; Lei, Lin; Zhang, Peizhe; Zhang, Fuchang			Genetic Variations in COMT and DRD2 Modulate Attentional Bias for Affective Facial Expressions	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; DOPAMINE-RECEPTOR GENE; SELECTIVE ATTENTION; INDIVIDUAL-DIFFERENCES; ANXIETY; POLYMORPHISM; DEPRESSION; GENOTYPE; REWARD; THREAT	Studies have revealed that catechol-O-methyltransferase (COMT) and dopaminegic receptor2 (DRD2) modulate human attention bias for palatable food or tobacco. However, the existing evidence about the modulations of COMT and DRD2 on attentional bias for facial expressions was still limited. In the study, 650 college students were genotyped with regard to COMT Val158Met and DRD2 TaqI A polymorphisms, and the attentional bias for facial expressions was assessed using the spatial cueing task. The results indicated that COMT Val158Met underpinned the individual difference in attentional bias for negative emotional expressions (P = 0.03) and the Met carriers showed more engagement bias for negative expressions than the Val/Val homozygote. On the contrary, DRD2 TaqIA underpinned the individual difference in attentional bias for positive expressions (P = 0.003) and individuals with TT genotype showed much more engagement bias for positive expressions than the individuals with CC genotype. Moreover, the two genes exerted significant interactions on the engagements for negative and positive expressions (P = 0.046, P = 0.005). These findings suggest that the individual differences in the attentional bias for emotional expressions are partially underpinned by the genetic polymorphisms in COMT and DRD2.	[Gong, Pingyuan; Zhang, Guoping] Peking Univ, Ctr Brain & Cognit Sci, Beijing 100871, Peoples R China; [Gong, Pingyuan; Zhang, Guoping] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Gong, Pingyuan; Shen, Guomin; Li, She; Fang, Hongchao; Lei, Lin; Zhang, Peizhe] Henan Univ Sci & Technol, Lab Med Mol Biol, Luoyang, Peoples R China; [Zhang, Guoping] China Acad Corp Governance, Nankai Univ, Sch Business, Tianjin, Peoples R China; [Gong, Pingyuan; Zhang, Fuchang] NW Univ Xian, Coll Life Sci, Inst Populat & Hlth, Xian 710069, Peoples R China	Peking University; Peking University; Henan University of Science & Technology; Nankai University; Northwest University Xi'an	Gong, PY (corresponding author), Peking Univ, Ctr Brain & Cognit Sci, Beijing 100871, Peoples R China.	gpy1026@163.com; wzgp@163.com	Shen, Guomin/AAX-3150-2021; Shen, Guomin/G-8407-2018	Shen, Guomin/0000-0002-5006-2790; Shen, Guomin/0000-0002-5006-2790; Pingyuan, Gong/0000-0002-3915-2584	Visiting Scholar Program for Harvard University and NBER [CSC 201208120037]	Visiting Scholar Program for Harvard University and NBER	This study was provided by China Postdoctoral Science Foundation (2013M530002,2012T50023, 20100470156), Henan University of Science and Technology, Scientific Research Foundation for Ph.D (09001498), and National Natural Science Foundation of China (71172216, 71132001), and Visiting Scholar Program for Harvard University and NBER (CSC 201208120037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokhin AP, 2010, BEHAV GENET, V40, P178, DOI 10.1007/s10519-010-9337-1; [白露 BAI Lu], 2005, [中国心理卫生杂志, Chinese Mental Health Journal], V19, P719; Berman SM, 2003, ALCOHOL, V30, P201, DOI 10.1016/j.alcohol.2003.06.002; Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; Bowirrat A, 2005, AM J MED GENET B, V132B, P29, DOI 10.1002/ajmg.b.30080; Chao HF, 2010, EMOTION, V10, P272, DOI 10.1037/a0017400; Chen P, 2012, J APPL PSYCHOL, V97, P479, DOI 10.1037/a0026308; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Cisler JM, 2009, COGNITIVE THER RES, V33, P221, DOI 10.1007/s10608-007-9161-y; Csukly G, 2009, J NERV MENT DIS, V197, P98, DOI 10.1097/NMD.0b013e3181923f82; Davis C, 2008, PROG NEURO-PSYCHOPH, V32, P620, DOI 10.1016/j.pnpbp.2007.09.024; DELAMBALLERIE X, 1994, J CLIN PATHOL, V47, P466, DOI 10.1136/jcp.47.5.466; Fani N, 2013, JAMA PSYCHIAT, V70, P392, DOI 10.1001/2013.jamapsychiatry.210; Farrell SM, 2012, BIOL PSYCHIAT, V71, P538, DOI 10.1016/j.biopsych.2011.12.023; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Filopanti M, 2010, EXPERT OPIN DRUG MET, V6, P43, DOI 10.1517/17425250903352501; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Franken IHA, 2004, EUR NEUROPSYCHOPHARM, V14, P503, DOI 10.1016/j.euroneuro.2004.02.004; Frankort A, 2012, INT J OBESITY, V36, P627, DOI 10.1038/ijo.2011.213; Gibbs AA, 2007, AM J PSYCHIAT, V164, P1603, DOI 10.1176/appi.ajp.2007.06081241; Gibson BS, 2000, PERCEPT PSYCHOPHYS, V62, P496, DOI 10.3758/BF03212101; Gong PY, 2013, ACTA NEUROBIOL EXP, V73, P280; Gong PY, 2013, J MOL NEUROSCI, V49, P606, DOI 10.1007/s12031-012-9894-2; Gong PY, 2012, CELL MOL NEUROBIOL, V32, P1011, DOI 10.1007/s10571-012-9817-3; Hankin BL, 2010, J ABNORM PSYCHOL, V119, P491, DOI 10.1037/a0019609; Hannus A, 2005, ACTA PSYCHOL, V118, P171, DOI 10.1016/j.actpsy.2004.10.010; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Heinzel S, 2013, CEREB CORTEX, V23, P1453, DOI 10.1093/cercor/bhs132; Herrmann MJ, 2009, COGN AFFECT BEHAV NE, V9, P168, DOI 10.3758/CABN.9.2.168; Hirvonen MM, 2009, SYNAPSE, V63, P907, DOI 10.1002/syn.20672; Hogarth L, 2008, PSYCHOPHARMACOLOGY, V201, P29, DOI 10.1007/s00213-008-1244-2; Hunt C, 2007, BEHAV RES THER, V45, P497, DOI 10.1016/j.brat.2006.04.001; Jaber M, 1996, NEUROPHARMACOLOGY, V35, P1503, DOI 10.1016/S0028-3908(96)00100-1; Jongen EMM, 2007, PSYCHOL RES-PSYCH FO, V71, P516, DOI 10.1007/s00426-006-0065-3; Justinova Z, 2009, CURR TOP BEHAV NEURO, V1, P309, DOI 10.1007/978-3-540-88955-7_13; Kennedy DP, 2012, NEUROPSYCHOLOGIA, V50, P3313, DOI 10.1016/j.neuropsychologia.2012.09.038; Keogh E, 2001, J ANXIETY DISORD, V15, P299, DOI 10.1016/S0887-6185(01)00065-2; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Koster EHW, 2006, BEHAV RES THER, V44, P1757, DOI 10.1016/j.brat.2005.12.011; Kukreti R, 2006, NEUROSCI LETT, V392, P68, DOI 10.1016/j.neulet.2005.08.059; Kulas JF, 2003, J ANXIETY DISORD, V17, P103, DOI 10.1016/S0887-6185(02)00177-9; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lawrence AD, 2002, NEUROREPORT, V13, P881, DOI 10.1097/00001756-200205070-00029; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Luijten M, 2012, NEUROPSYCHOPHARMACOL, V37, P2772, DOI 10.1038/npp.2012.143; Najafabadi MS, 2005, AM J MED GENET B, V134B, P39, DOI 10.1002/ajmg.b.30117; Nathan PJ, 2012, INT J NEUROPSYCHOPH, V15, P149, DOI 10.1017/S1461145711001052; Naudts KH, 2012, INT J NEUROPSYCHOPH, V15, P1027, DOI 10.1017/S1461145711001295; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Nummenmaa L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019215; Olsson CA, 2005, PSYCHIAT GENET, V15, P109, DOI 10.1097/00041444-200506000-00007; Paclt I, 2010, NEUROENDOCRINOL LETT, V31, P131; Pecina M, 2012, CORTEX; Perkins KA, 2008, BEHAV PHARMACOL, V19, P641, DOI 10.1097/FBP.0b013e32830c367c; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Raymond JE, 2003, PSYCHOL SCI, V14, P537, DOI 10.1046/j.0956-7976.2003.psci_1462.x; Rijsdijk FV, 2009, PSYCHOL MED, V39, P45, DOI 10.1017/S0033291708003231; Rodriguez-Jimenez R, 2006, EUR PSYCHIAT, V21, P66, DOI 10.1016/j.eurpsy.2005.05.010; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; Shechner T, 2012, DEPRESS ANXIETY, V29, P282, DOI 10.1002/da.20914; Stevens S, 2009, BRIT J CLIN PSYCHOL, V48, P125, DOI 10.1348/014466508X368856; Stollstorff M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00327; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; Veenstra EM, 2012, APPETITE, V58, P133, DOI 10.1016/j.appet.2011.09.014; Waters FAV, 2006, PSYCHOL MED, V36, P455, DOI 10.1017/S0033291705007026; Yamamoto Kyoko, 2008, Shinrigaku Kenkyu, V78, P567; Zhu BT, 2002, CURR DRUG METAB, V3, P321, DOI 10.2174/1389200023337586; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008; ZUNG WWK, 1967, ARCH GEN PSYCHIAT, V16, P543	70	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81446	10.1371/journal.pone.0081446	http://dx.doi.org/10.1371/journal.pone.0081446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312552	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500070
J	Guo, Z; Johnston, W; Kovtun, O; Mureev, S; Brocker, C; Ungermann, C; Alexandrov, K				Guo, Zhong; Johnston, Wayne; Kovtun, Oleksiy; Mureev, Sergey; Broecker, Cornelia; Ungermann, Christian; Alexandrov, Kirill			Subunit Organisation of In Vitro Reconstituted HOPS and CORVET Multisubunit Membrane Tethering Complexes	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE; FUSION; PURIFICATION; ARCHITECTURE; EXPRESSION; INTERACTS; SYSTEM; YPT1P	Biochemical and structural analysis of macromolecular protein assemblies remains challenging due to technical difficulties in recombinant expression, engineering and reconstitution of multisubunit complexes. Here we use a recently developed cell-free protein expression system based on the protozoan Leishmania tarentolae to produce in vitro all six subunits of the 600 kDa HOPS and CORVET membrane tethering complexes. We demonstrate that both subcomplexes and the entire HOPS complex can be reconstituted in vitro resulting in a comprehensive subunit interaction map. To our knowledge this is the largest eukaryotic protein complex in vitro reconstituted to date. Using the truncation and interaction analysis, we demonstrate that the complex is assembled through short hydrophobic sequences located in the C-terminus of the individual Vps subunits. Based on this data we propose a model of the HOPS and CORVET complex assembly that reconciles the available biochemical and structural data.	[Guo, Zhong; Johnston, Wayne; Kovtun, Oleksiy; Mureev, Sergey; Alexandrov, Kirill] Univ Queensland, Inst Mol Biosci, Dept Cell & Mol Biol, Brisbane, Qld, Australia; [Broecker, Cornelia; Ungermann, Christian] Univ Osnabruck, Dept Biol Chem, Osnabruck, Germany	University of Queensland; University Osnabruck	Alexandrov, K (corresponding author), Univ Queensland, Inst Mol Biosci, Dept Cell & Mol Biol, Brisbane, Qld, Australia.	k.alexandrov@uq.edu.au	Kovtun, Oleksiy/AAE-5397-2019; GUO, Zhong/J-8723-2014; Mureev, Sergey/ABB-4757-2020; mureev, sergey/K-3521-2014; Alexandrov, Kirill/A-5830-2013; Kovtun, Oleksiy/F-7443-2015; Johnston, Wayne/D-2095-2017; GUO, Zhong/J-8723-2014	Kovtun, Oleksiy/0000-0001-6374-7863; GUO, Zhong/0000-0003-0285-5021; mureev, sergey/0000-0001-9999-3150; Alexandrov, Kirill/0000-0002-0957-6511; Kovtun, Oleksiy/0000-0001-6374-7863; Johnston, Wayne/0000-0002-7485-8363; GUO, Zhong/0000-0002-2277-0087	Australian Research Council [DP1094080, FT0991611]; National Health Medical Research Council [569652]	Australian Research Council(Australian Research Council); National Health Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by Australian Research Council grant DP1094080, Australian Research Council Future Fellowship FT0991611, and National Health Medical Research Council project grant 569652. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balderhaar HJK, 2013, J CELL SCI, V126, P1307, DOI 10.1242/jcs.107805; Brocker C, 2012, P NATL ACAD SCI USA; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; Brocker C, 2010, CURR BIOL, V20, pR943, DOI 10.1016/j.cub.2010.09.015; Cabrera M, 2008, METHOD ENZYMOL, V451, P177, DOI 10.1016/S0076-6879(08)03213-8; Epp N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067307; Graham SC, 2013, P NATL ACAD SCI USA, V110, P13345, DOI 10.1073/pnas.1307074110; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; Hirano N, 2006, PROTEINS, V64, P343, DOI 10.1002/prot.21008; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Kovtun O, 2011, METHODS, V55, P58, DOI 10.1016/j.ymeth.2011.06.006; Kovtun O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014388; Kubala MH, 2010, PROTEIN SCI, V19, P2389, DOI 10.1002/pro.519; Lees JA, 2010, NAT STRUCT MOL BIOL, V17, P1292, DOI 10.1038/nsmb.1917; Mureev S, 2009, NAT BIOTECHNOL, V27, P747, DOI 10.1038/nbt.1556; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; Ostrowicz CW, 2010, TRAFFIC, V11, P1334, DOI 10.1111/j.1600-0854.2010.01097.x; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Perrakis A, 2011, J STRUCT BIOL, V175, P106, DOI 10.1016/j.jsb.2011.05.014; Peterson MR, 2001, TRAFFIC, V2, P476, DOI 10.1034/j.1600-0854.2001.20705.x; Plemel RL, 2011, MOL BIOL CELL, V22, P1353, DOI 10.1091/mbc.E10-03-0260; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; Suvorova ES, 2002, J CELL BIOL, V157, P631, DOI 10.1083/jcb.200111081; Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Yip CK, 2010, NAT STRUCT MOL BIOL, V17, P1298, DOI 10.1038/nsmb.1914	29	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81534	10.1371/journal.pone.0081534	http://dx.doi.org/10.1371/journal.pone.0081534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312556	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500073
J	Medeiros, BNS; Copelli, M				Medeiros, Bruno N. S.; Copelli, Mauro			Synaptic Symmetry Increases Coherence in a Pair of Excitable Electronic Neurons	PLOS ONE			English	Article							RESONANCE; NOISE; SYNCHRONIZATION	We study how the synaptic connections in a pair of excitable electronic neurons affect the coherence of their spike trains when the neurons are submitted to noise from independent sources. The coupling is provided by electronic circuits which mimic the dynamics of chemical AMPA synapses. In particular, we show that increasing the strength of an unidirectional synapse leads to a decrease of coherence in the post-synaptic neuron. More interestingly, we show that the decrease of coherence can be reverted if we add a synapse of sufficient strength in the reverse direction. Synaptic symmetry plays an important role in this process and, under the right choice of parameters, increases the network coherence beyond the value achieved at the resonance due to noise alone in uncoupled neurons. We also show that synapses with a longer time scale sharpen the dependency of the coherence on the synaptic symmetry. The results were reproduced by numerical simulations of a pair of synaptically coupled FitzHugh-Nagumo models.	[Medeiros, Bruno N. S.; Copelli, Mauro] Univ Fed Pernambuco, Dept Fis, BR-50739 Recife, PE, Brazil	Universidade Federal de Pernambuco	Medeiros, BNS (corresponding author), Univ Fed Pernambuco, Dept Fis, BR-50739 Recife, PE, Brazil.	br.medeiros@gmail.com	Copelli, Mauro/AAG-8110-2020; Copelli, Mauro/C-6336-2009	Copelli, Mauro/0000-0001-7441-2858	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE); Programa de Apoio a Nucleos Emergentes (PRONEM); Programa de Apoio a Nucleos de Excelencia (PRONEX)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Programa de Apoio a Nucleos Emergentes (PRONEM); Programa de Apoio a Nucleos de Excelencia (PRONEX)	Financial support by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE) and special programs Programa de Apoio a Nucleos Emergentes (PRONEM) and Programa de Apoio a Nucleos de Excelencia (PRONEX) are acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Balenzuela P, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021901; Bing J, 2011, CHINESE PHYS LETT, V28; Dayan P., 2001, THEORETICAL NEUROSCI; Donges JF, 2011, EUR PHYS J B, V84, P635, DOI 10.1140/epjb/e2011-10795-8; Giacomelli G, 2000, PHYS REV LETT, V84, P3298, DOI 10.1103/PhysRevLett.84.3298; Gutkin BS, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/20005; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Koch C., 1998, METHODS NEURONAL MOD, DOI 10.1016/s0898-1221(98)91179-8; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Lee CY, 2010, SCIENCE, V329, P1320, DOI 10.1126/science.1193383; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Medeiros BNS, 2012, INT J BIFURCAT CHAOS, V22, DOI 10.1142/S0218127412502446; Miyakawa K, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.046204; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nordenfelt A, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.052903; Oh E, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011104; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Pikovsky AS, 1997, PHYS REV LETT, V78, P775, DOI 10.1103/PhysRevLett.78.775; Rinzel J., 1998, METHODS NEURONAL MOD, V2, P251; Senturia SD, 1981, ELECT CIRCUITS APPL; Toral R, 2003, EUROPHYS LETT, V61, P162, DOI 10.1209/epl/i2003-00207-5; Wang YQ, 2000, PHYS REV E, V61, P740, DOI 10.1103/PhysRevE.61.740; Wilson HR, 1999, SPIKES DECISION ACTI	24	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82051	10.1371/journal.pone.0082051	http://dx.doi.org/10.1371/journal.pone.0082051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312626	Green Published, gold, Green Submitted			2022-12-25	WOS:000327944500116
J	Silva, EJR; Hamil, KG; O'Rand, MG				Silva, Erick J. R.; Hamil, Katherine G.; O'Rand, Michael G.			Interacting Proteins on Human Spermatozoa: Adaptive Evolution of the Binding of Semenogelin I to EPPIN	PLOS ONE			English	Article							EPIDIDYMAL PROTEASE INHIBITOR; HUMAN SEMINAL PLASMA; MAMMALIAN SPERM PROTEINS; WHEY ACIDIC PROTEIN; MOTILITY INHIBITOR; MAXIMUM-LIKELIHOOD; POSITIVE SELECTION; HUMAN SEMEN; WFDC LOCUS; GENES	Semenogelin I (SEMG1) is found in human semen coagulum and on the surface of spermatozoa bound to EPPIN. The physiological significance of the SEMG1/EPPIN interaction on the surface of spermatozoa is its capacity to modulate sperm progressive motility. The present study investigates the hypothesis that the interacting surface of SEMG1 and EPPIN co-evolved within the Hominoidea time scale, as a result of adaptive pressures applied by their roles in sperm protection and reproductive fitness. Our results indicate that some amino acid residues of SEMG1 and EPPIN possess a remarkable deficiency of variation among hominoid primates. We observe a distinct residue change unique to humans within the EPPIN sequence containing a SEMG1 interacting surface, namely His92. In addition, Bayes Empirical Bayes analysis for positive selection indicates that the SEMG1 Cys239 residue underwent positive selection in humans, probably as a consequence of its role in increasing the binding affinity of these interacting proteins. We confirm the critical role of Cys239 residue for SEMG1 binding to EPPIN and inhibition of sperm motility by showing that recombinant SEMG1 mutants in which Cys239 residue was changed to glycine, aspartic acid, histidine, serine or arginine have reduced capacity to interact to EPPIN and to inhibit human sperm motility in vitro. In conclusion, our results indicate that EPPIN and SEMG1 rapidly co-evolved in primates due to their critical role in the modulation of sperm motility in the semen coagulum, providing unique insights into the molecular co-evolution of sperm surface interacting proteins.	[Silva, Erick J. R.; Hamil, Katherine G.; O'Rand, Michael G.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Silva, EJR (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA.	ejrsilva81@gmail.com	Hamil, Katherine G/D-5964-2015; Silva, Erick J R/D-2976-2009	Hamil, Katherine G/0000-0001-7430-8313; Silva, Erick J R/0000-0002-9330-8658	Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD048843, HD060494]; Fogarty International Center Program for Training and Research in Population and Health [D43TW-HD00627]	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Fogarty International Center Program for Training and Research in Population and Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Funding provided by grants HD048843 and HD060494 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and by grant D43TW-HD00627 from Fogarty International Center Program for Training and Research in Population and Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourgeon F, 2004, BIOL REPROD, V70, P768, DOI 10.1095/biolreprod.103.022533; Carnahan SJ, 2008, AM J PRIMATOL, V70, P939, DOI 10.1002/ajp.20585; Clauss A, 2005, BIOCHEM BIOPH RES CO, V333, P383, DOI 10.1016/j.bbrc.2005.05.125; Clauss A, 2002, BIOCHEM J, V368, P233, DOI 10.1042/BJ20020869; Dorus S, 2004, NAT GENET, V36, P1326, DOI 10.1038/ng1471; Edstrom AML, 2008, J IMMUNOL, V181, P3413, DOI 10.4049/jimmunol.181.5.3413; Ferreira Z, 2013, MOL BIOL EVOL, V30, P938, DOI 10.1093/molbev/mss329; Hirano Y, 2001, J ASSIST REPROD GEN, V18, P213; Hurle B, 2007, GENOME RES, V17, P276, DOI 10.1101/gr.6004607; Jensen-Seaman MI, 2003, J MOL EVOL, V57, P261, DOI 10.1007/s00239-003-2474-x; Juyena NS, 2012, J ANDROL, V33, P536, DOI 10.2164/jandrol.110.012583; Malm J, 1996, EUR J BIOCHEM, V238, P48, DOI 10.1111/j.1432-1033.1996.0048q.x; McCrudden MTC, 2008, FEBS J, V275, P1742, DOI 10.1111/j.1742-4658.2008.06333.x; Mitra A, 2010, BIOL REPROD, V82, P489, DOI 10.1095/biolreprod.109.081331; O'Rand MG, 2006, MOL CELL ENDOCRINOL, V250, P157, DOI 10.1016/j.mce.2005.12.039; O'Rand MG, 2004, SCIENCE, V306, P1189, DOI 10.1126/science.1099743; O'Rand MG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094227; O'Rand MG, 2011, J ANDROL, V32, P698, DOI 10.2164/jandrol.110.012781; O'Rand MG, 2009, BIOL REPROD, V80, P279, DOI 10.1095/biolreprod.108.072942; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Quinn AM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp899; Richardson RT, 2001, GENE, V270, P93, DOI 10.1016/S0378-1119(01)00462-0; Robert M, 1997, BIOCHEMISTRY-US, V36, P3811, DOI 10.1021/bi9626158; Robert M, 1999, CELL MOL LIFE SCI, V55, P944, DOI 10.1007/s000180050346; ROBERT M, 1995, HUM REPROD, V10, P2192, DOI 10.1093/oxfordjournals.humrep.a136267; Silva EJR, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101832; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Torgerson DG, 2003, MOL BIOL EVOL, V20, P1705, DOI 10.1093/molbev/msg193; Torgerson DG, 2002, MOL BIOL EVOL, V19, P1973, DOI 10.1093/oxfordjournals.molbev.a004021; Wang ZJ, 2008, ASIAN J ANDROL, V10, P770, DOI 10.1111/j.1745-7262.2008.00393.x; Wang ZJ, 2005, BIOL REPROD, V72, P1064, DOI 10.1095/biolreprod.104.036483; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yenugu S, 2004, BIOL REPROD, V71, P1484, DOI 10.1095/biolreprod.104.031567; Yoshida K, 2008, MOL HUM REPROD, V14, P151, DOI 10.1093/molehr/gan003	38	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82014	10.1371/journal.pone.0082014	http://dx.doi.org/10.1371/journal.pone.0082014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312623	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500113
J	Strenziok, M; Greenwood, PM; Cruz, SAS; Thompson, JC; Parasuraman, R				Strenziok, Maren; Greenwood, Pamela M.; Cruz, Sophia A. Santa; Thompson, James C.; Parasuraman, Raja			Differential Contributions of Dorso-Ventral and Rostro-Caudal Prefrontal White Matter Tracts to Cognitive Control in Healthy Older Adults	PLOS ONE			English	Article							COMPARATIVE CYTOARCHITECTONIC ANALYSIS; WORKING-MEMORY; EPISODIC MEMORY; INTERHEMISPHERIC INTERACTION; ORBITOFRONTAL CORTEX; EXECUTIVE FUNCTION; NEURAL SYSTEMS; BASAL GANGLIA; DIFFUSION; BRAIN	Prefrontal cortex mediates cognitive control by means of circuitry organized along dorso-ventral and rostro-caudal axes. Along the dorso-ventral axis, ventrolateral PFC controls semantic information, whereas dorsolateral PFC encodes task rules. Along the rostro-caudal axis, anterior prefrontal cortex encodes complex rules and relationships between stimuli, whereas posterior prefrontal cortex encodes simple relationships between stimuli and behavior. Evidence of these gradients of prefrontal cortex organization has been well documented in fMRI studies, but their functional correlates have not been examined with regard to integrity of underlying white matter tracts. We hypothesized that (a) the integrity of specific white matter tracts is related to cognitive functioning in a manner consistent with the dorso-ventral and rostro-caudal organization of the prefrontal cortex, and (b) this would be particularly evident in healthy older adults. We assessed three cognitive processes that recruit the prefrontal cortex and can distinguish white matter tracts along the dorso-ventral and rostro-caudal dimensions - episodic memory, working memory, and reasoning. Correlations between cognition and fractional anisotropy as well as fiber tractography revealed: (a) Episodic memory was related to ventral prefrontal cortex-thalamo-hippocampal fiber integrity; (b) Working memory was related to integrity of corpus callosum body fibers subserving dorsolateral prefrontal cortex; and (c) Reasoning was related to integrity of corpus callosum body fibers subserving rostral and caudal dorsolateral prefrontal cortex. These findings confirm the ventrolateral prefrontal cortex's role in semantic control and the dorsolateral prefrontal cortex's role in rule-based processing, in accordance with the dorsoventral prefrontal cortex gradient. Reasoning-related rostral and caudal superior frontal white matter may facilitate different levels of task rule complexity. This study is the first to demonstrate dorso-ventral and rostro-caudal prefrontal cortex processing gradients in white matter integrity.	[Strenziok, Maren; Greenwood, Pamela M.; Cruz, Sophia A. Santa; Thompson, James C.; Parasuraman, Raja] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA	George Mason University	Strenziok, M (corresponding author), George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA.	mstrenzi@gmu.edu			National Institutes of Health (NIH) [AG019653]; Air Force Office of Scientific Research [FA9550-10-1-0385]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by National Institutes of Health (NIH) grant AG019653 (to R. P.) and Air Force Office of Scientific Research grant FA9550-10-1-0385 (to R. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 2010, EUR J NEUROSCI, V31, P2292, DOI 10.1111/j.1460-9568.2010.07251.x; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Badre D, 2007, J COGNITIVE NEUROSCI, V19, P2082, DOI 10.1162/jocn.2007.19.12.2082; Badre D, 2009, NAT NEUROSCI, V12, P515, DOI 10.1038/nn.2277; Banich MT, 1998, BRAIN COGNITION, V36, P128, DOI 10.1006/brcg.1997.0950; BARBAS H, 1991, J COMP NEUROL, V313, P65, DOI 10.1002/cne.903130106; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Blumenfeld RS, 2006, J NEUROSCI, V26, P916, DOI 10.1523/JNEUROSCI.2353-05.2006; Bor D, 2004, EUR J NEUROSCI, V19, P3365, DOI 10.1111/j.1460-9568.2004.03438.x; Buchel C, 2004, CEREB CORTEX, V14, P945, DOI 10.1093/cercor/bhh055; Buckner RL, 2003, J NEUROSCI, V23, P3999; Burzynska AZ, 2011, CEREB CORTEX, V21, P2261, DOI 10.1093/cercor/bhq293; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; Catani M, 2012, CORTEX, V48, P1, DOI 10.1016/j.cortex.2011.11.001; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; Charlton RA, 2010, CORTEX, V46, P474, DOI 10.1016/j.cortex.2009.07.005; Christoff K, 2009, BRAIN RES, V1286, P94, DOI 10.1016/j.brainres.2009.05.096; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; D'Esposito M, 1999, P NATL ACAD SCI USA, V96, P7514, DOI 10.1073/pnas.96.13.7514; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; de Zubicaray GI, 2005, COGNITIVE BRAIN RES, V22, P439, DOI 10.1016/j.cogbrainres.2004.10.002; Desrochers TM, 2012, TRENDS COGN SCI, V16, P407, DOI 10.1016/j.tics.2012.06.009; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Doron KW, 2008, CORTEX, V44, P1023, DOI 10.1016/j.cortex.2008.03.007; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Edin F, 2009, P NATL ACAD SCI USA, V106, P6802, DOI 10.1073/pnas.0901894106; Emery L, 2008, NEUROIMAGE, V42, P1577, DOI 10.1016/j.neuroimage.2008.06.021; Engvig A, 2012, HUM BRAIN MAPP, V33, P2390, DOI 10.1002/hbm.21370; Ferry AT, 2000, J COMP NEUROL, V425, P447, DOI 10.1002/1096-9861(20000925)425:3<447::AID-CNE9>3.0.CO;2-V; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fuster JM, 2004, TRENDS COGN SCI, V8, P143, DOI 10.1016/j.tics.2004.02.004; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; GAZZANIGA MS, 1962, P NATL ACAD SCI USA, V48, P1765, DOI 10.1073/pnas.48.10.1765; Gerstorf D, 2011, DEV PSYCHOL, V47, P1026, DOI 10.1037/a0023426; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Glickstein M, 2008, CORTEX, V44, P914, DOI 10.1016/j.cortex.2008.04.001; GOLDMANRAKIC PS, 1985, J COMP NEUROL, V242, P535, DOI 10.1002/cne.902420406; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Greenwood PM, 2007, NEUROPSYCHOLOGY, V21, P657, DOI 10.1037/0894-4105.21.6.657; Grieve SM, 2007, AM J NEURORADIOL, V28, P226; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Haut M W, 2000, Appl Neuropsychol, V7, P237, DOI 10.1207/S15324826AN0704_5; Jancke Lutz, 2009, F1000 Biol Rep, V1, P78, DOI 10.3410/B1-78; Jonides J, 2006, NEUROSCIENCE, V139, P181, DOI 10.1016/j.neuroscience.2005.06.042; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; Kanaan RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038272; Karlsgodt KH, 2008, BIOL PSYCHIAT, V63, P512, DOI 10.1016/j.biopsych.2007.06.017; Kennedy KM, 2009, NEUROPSYCHOLOGIA, V47, P916, DOI 10.1016/j.neuropsychologia.2009.01.001; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Kohannim O, 2012, NEUROPSYCHOPHARMACOL, V37, P2012, DOI 10.1038/npp.2012.49; Kohler S, 2004, J COGNITIVE NEUROSCI, V16, P178, DOI 10.1162/089892904322984490; Kroger JK, 2002, CEREB CORTEX, V12, P477, DOI 10.1093/cercor/12.5.477; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; Lovden M, 2010, NEUROPSYCHOLOGIA, V48, P3878, DOI 10.1016/j.neuropsychologia.2010.08.026; Madden DJ, 2009, NEUROPSYCHOL REV, V19, P415, DOI 10.1007/s11065-009-9113-2; Maril A, 2003, NEUROIMAGE, V18, P827, DOI 10.1016/S1053-8119(03)00014-4; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Menon V, 2002, COGNITIVE BRAIN RES, V13, P261, DOI 10.1016/S0926-6410(01)00120-3; Mestres-Misse A, 2012, NEUROIMAGE, V62, P41, DOI 10.1016/j.neuroimage.2012.05.021; Middleton FA, 2000, BRAIN COGNITION, V42, P183, DOI 10.1006/brcg.1999.1099; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Morcom AM, 2003, BRAIN, V126, P213, DOI 10.1093/brain/awg020; MORECRAFT RJ, 1992, J COMP NEUROL, V323, P341, DOI 10.1002/cne.903230304; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Reilly RC, 2010, TRENDS NEUROSCI, V33, P355, DOI 10.1016/j.tins.2010.05.002; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Penke L, 2012, MOL PSYCHIATR, V17, P1026, DOI 10.1038/mp.2012.66; Perfetti B, 2009, HUM BRAIN MAPP, V30, P497, DOI 10.1002/hbm.20519; Persson J, 2006, CEREB CORTEX, V16, P907, DOI 10.1093/cercor/bhj036; Petrides M, 1999, EUR J NEUROSCI, V11, P1011, DOI 10.1046/j.1460-9568.1999.00518.x; Petrides M, 2006, J COMP NEUROL, V498, P227, DOI 10.1002/cne.21048; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Prabhakaran V, 1997, COGNITIVE PSYCHOL, V33, P43, DOI 10.1006/cogp.1997.0659; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; Rajah MN, 2005, J COGNITIVE NEUROSCI, V17, P470, DOI 10.1162/0898929053279478; Ranganath C, 2003, NEUROPSYCHOLOGIA, V41, P378, DOI 10.1016/S0028-3932(02)00169-0; RATCLIFF R, 1986, J EXP PSYCHOL LEARN, V12, P312; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Saalmann YB, 2011, NEURON, V71, P209, DOI 10.1016/j.neuron.2011.06.027; Sala S, 2012, NEUROBIOL AGING, V33, P488, DOI 10.1016/j.neurobiolaging.2010.04.027; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Salthouse TA, 2004, CURR DIR PSYCHOL SCI, V13, P140, DOI 10.1111/j.0963-7214.2004.00293.x; Sen PN, 2005, BIOPHYS J, V89, P2927, DOI 10.1529/biophysj.105.063016; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; Smith EE, 2011, NEUROLOGY, V76, P1492, DOI 10.1212/WNL.0b013e318217e7c8; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; van der Knaap LJ, 2011, BEHAV BRAIN RES, V223, P211, DOI 10.1016/j.bbr.2011.04.018; Van Der Werf YD, 2003, CORTEX, V39, P1047, DOI 10.1016/S0010-9452(08)70877-3; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D., 1997, WECHSLER ADULT INTEL; Welcome SE, 2008, BRAIN COGNITION, V67, P69, DOI 10.1016/j.bandc.2007.11.005; Whitney C, 2011, CEREB CORTEX, V21, P1066, DOI 10.1093/cercor/bhq180; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Ye Z, 2009, NEUROIMAGE, V48, P280, DOI 10.1016/j.neuroimage.2009.06.032; Ystad M, 2011, NEUROIMAGE, V55, P24, DOI 10.1016/j.neuroimage.2010.11.016; Zahr NM, 2009, NEUROIMAGE, V44, P1050, DOI 10.1016/j.neuroimage.2008.09.046	118	11	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81410	10.1371/journal.pone.0081410	http://dx.doi.org/10.1371/journal.pone.0081410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312550	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500069
J	Jeong, JJ; Park, N; Kwon, YJ; Ye, DJ; Moon, A; Chun, YJ				Jeong, Jin-Joo; Park, Nahee; Kwon, Yeo-Jung; Ye, Dong-Jin; Moon, Aree; Chun, Young-Jin			Role of Annexin A5 in Cisplatin-induced Toxicity in Renal Cells MOLECULAR MECHANISM OF APOPTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Annexin; Kidney; Mitochondrial Apoptosis; Protein Translocation; siRNA; VDAC; Annexin A5; Cisplatin; Nephrotoxicity; Renal Epithelial Cell	CYTOCHROME-C RELEASE; DEPENDENT ANION CHANNEL; INDUCED NEPHROTOXICITY; VDAC; MITOCHONDRIA; BIOMARKERS; DEATH; DELTA; AIF; TRANSLOCATION	Annexin A5 belongs to a large family of calcium-binding and phospholipid-binding proteins and may act as an endogenous regulator of various pathophysiological processes. There is increasing evidence that annexin A5 is related to cytotoxicity, but the precise function of this protein has yet to be elucidated. In this study, we aimed to verify the function of annexin A5 in the apoptosis of renal epithelial cells. Real-time PCR and Western blot analysis, together with immunofluorescence analysis, showed that the expression of annexin A5 significantly increased in the presence of cisplatin in both human and rat renal epithelial cells. With regard to the mechanism of cisplatin-induced apoptosis, apoptosis-inducing factor (AIF) release into the cytosol was observed, and the underlying mechanism was identified as voltage-dependent anion channel (VDAC) oligomerization. Mitochondrial membrane potential ((m)) was found to be greatly disrupted in cisplatin-treated cells. Moreover, cisplatin strongly induced translocation of annexin A5 into mitochondria. To understand the functional significance of annexin A5 in renal cell death, we used a siRNA-mediated approach to knock down annexin A5. Annexin A5 depletion by siRNA led to decreased annexin A5 translocation into mitochondria and significantly reduced VDAC oligomerization and AIF release. Annexin A5 siRNA also increased cell viability compared with the control. Moreover, expression of annexin A5 was induced by other nephrotoxicants such as CdCl2 and bacitracin. Taken together, our data suggest that annexin A5 may play a crucial role in cisplatin-induced toxicity by mediating the mitochondrial apoptotic pathway via the induction and oligomerization of VDAC.	[Jeong, Jin-Joo; Park, Nahee; Kwon, Yeo-Jung; Ye, Dong-Jin; Chun, Young-Jin] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea; [Moon, Aree] Duksung Womens Univ, Coll Pharm, Seoul 132714, South Korea	Chung Ang University; Duksung Women's University	Chun, YJ (corresponding author), Chung Ang Univ, Coll Pharm, 221 Heukseok Dong, Seoul 156756, South Korea.	yjchun@cau.ac.kr			Korea Food and Drug Administration (KFDA) [10182KFDA992-3202]	Korea Food and Drug Administration (KFDA)	This work was supported by Grant 10182KFDA992-3202 from the Korea Food and Drug Administration (KFDA).	Bogdanova N, 2007, HUM MOL GENET, V16, P573, DOI 10.1093/hmg/ddm017; Cande C, 2002, J CELL SCI, V115, P4727, DOI 10.1242/jcs.00210; Chirino YI, 2009, EXP TOXICOL PATHOL, V61, P223, DOI 10.1016/j.etp.2008.09.003; Desoize B, 2002, CRIT REV ONCOL HEMAT, V42, P317, DOI 10.1016/S1040-8428(01)00219-0; Ea HK, 2008, ANN RHEUM DIS, V67, P1617, DOI 10.1136/ard.2008.087718; Fella K, 2005, PROTEOMICS, V5, P1914, DOI 10.1002/pmic.200401067; Floryk D, 1999, BIOSCIENCE REP, V19, P27, DOI 10.1023/A:1020193906974; Giedroc DP, 2001, ANTIOXID REDOX SIGN, V3, P577, DOI 10.1089/15230860152542943; Hanigan Marie H, 2003, Cancer Ther, V1, P47; Hofstra L, 2007, EUR HEART J, V28, P2695, DOI 10.1093/eurheartj/ehm452; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; Kheifets V, 2006, J BIOL CHEM, V281, P23218, DOI 10.1074/jbc.M602075200; Kim SY, 2012, BIOMOL THER, V20, P268, DOI 10.4062/biomolther.2012.20.3.268; Lee WK, 2004, TOXICOL MECH METHOD, V14, P67, DOI 10.1080/15376520490257509; Majumder PK, 2000, J BIOL CHEM, V275, P21793, DOI 10.1074/jbc.C000048200; Markoff A, 2005, AM J PHYSIOL-RENAL, V289, pF949, DOI 10.1152/ajprenal.00089.2005; Matsuda R, 2000, CLIN CHIM ACTA, V298, P29, DOI 10.1016/S0009-8981(00)00218-7; Pabla N, 2011, J CLIN INVEST, V121, P2709, DOI 10.1172/JCI45586; Park MS, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134858; Ravassa S, 2007, EUR HEART J, V28, P2785, DOI 10.1093/eurheartj/ehm370; Ravassa S, 2010, CARDIOVASC RES, V88, P304, DOI 10.1093/cvr/cvq183; ROTHHUT B, 1995, EUR J BIOCHEM, V232, P865; Scharstuhl A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006688; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwacha MG, 2003, SHOCK, V20, P529, DOI 10.1097/01.shk.0000095059.62263.56; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; Shoshan-Barmatz V, 2010, BBA-BIOENERGETICS, V1797, P1281, DOI 10.1016/j.bbabio.2010.03.003; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Simsek B, 2008, PEDIATR NEPHROL, V23, P79, DOI 10.1007/s00467-007-0606-z; Tajeddine N, 2008, ONCOGENE, V27, P4221, DOI 10.1038/onc.2008.63; Toescu EC, 2000, PFLUG ARCH EUR J PHY, V440, P941, DOI 10.1007/s004240000390; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Wang EJ, 2008, TOXICOLOGY, V246, P91, DOI 10.1016/j.tox.2007.12.031; Wong A, 2002, BIOCHEM BIOPH RES CO, V298, P750, DOI 10.1016/S0006-291X(02)02546-9; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356; Zheng YH, 2004, ONCOGENE, V23, P1239, DOI 10.1038/sj.onc.1207205	36	33	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2469	2481		10.1074/jbc.M113.450163	http://dx.doi.org/10.1074/jbc.M113.450163			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24318879	Green Published, hybrid			2022-12-25	WOS:000331130200050
J	Wydeven, N; Posokhova, E; Xia, ZL; Martemyanov, KA; Wickman, K				Wydeven, Nicole; Posokhova, Ekaterina; Xia, Zhilian; Martemyanov, Kirill A.; Wickman, Kevin			RGS6, but Not RGS4, Is the Dominant Regulator of G Protein Signaling (RGS) Modulator of the Parasympathetic Regulation of Mouse Heart Rate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Proteins; Gene Knockout; Heart; Patch Clamp Electrophysiology; Potassium Channels; RGS Proteins; GIRK; Kir3; Muscarinic; Sinoatrial Node	GTPASE-ACTIVATING PROTEINS; SICK SINUS SYNDROME; END RULE PATHWAY; I-KACH; PACEMAKER ACTIVITY; GIRK CHANNELS; K+-CHANNEL; EXPRESSION; ASSOCIATION; RECEPTORS	Parasympathetic activity decreases heart rate (HR) by inhibiting pacemaker cells in the sinoatrial node (SAN). Dysregulation of parasympathetic influence has been linked to sinus node dysfunction and arrhythmia. RGS (regulator of G protein signaling) proteins are negative modulators of the parasympathetic regulation of HR and the prototypical M-2 muscarinic receptor (M2R)-dependent signaling pathway in the SAN that involves the muscarinic-gated atrial K+ channel I-KACh. Both RGS4 and RGS6-G5 have been implicated in these processes. Here, we used Rgs4(-/-), Rgs6(-/-), and Rgs4(-/-):Rgs6(-/-) mice to compare the relative influence of RGS4 and RGS6 on parasympathetic regulation of HR and M2R-I-KACh-dependent signaling in the SAN. In retrogradely perfused hearts, ablation of RGS6, but not RGS4, correlated with decreased resting HR, increased heart rate variability, and enhanced sensitivity to the negative chronotropic effects of the muscarinic agonist carbachol. Similarly, loss of RGS6, but not RGS4, correlated with enhanced sensitivity of the M2R-I-KACh signaling pathway in SAN cells to carbachol and a significant slowing of M2R-I-KACh deactivation rate. Surprisingly, concurrent genetic ablation of RGS4 partially rescued some deficits observed in Rgs6(-/-) mice. These findings, together with those from an acute pharmacologic approach in SAN cells from Rgs6(-/-) and G5(-/-) mice, suggest that the partial rescue of phenotypes in Rgs4(-/-):Rgs6(-/-) mice is attributable to another R7 RGS protein whose influence on M2R-I-KACh signaling is masked by RGS4. Thus, RGS6-G5, but not RGS4, is the primary RGS modulator of parasympathetic HR regulation and SAN M2R-I-KACh signaling in mice.	[Wydeven, Nicole; Xia, Zhilian; Wickman, Kevin] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Posokhova, Ekaterina; Martemyanov, Kirill A.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA	University of Minnesota System; University of Minnesota Twin Cities; Scripps Research Institute	Martemyanov, KA (corresponding author), Scripps Res Inst, Dept Neurosci, 130 Scripps Way,3C2, Jupiter, FL 33458 USA.	kirill@scripps.edu; wickm002@umn.edu		Wickman, Kevin/0000-0002-5179-9540	National Institutes of Health [HL105550, MH061933, DA007234]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants HL105550 (to K. W. and K. A. M.), MH061933 (to K. W.), and DA007234 (to N. W.).	Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Bettahi H, 2002, J BIOL CHEM, V277, P48282, DOI 10.1074/jbc.M209599200; Blazer LL, 2010, MOL PHARMACOL, V78, P524, DOI 10.1124/mol.110.065128; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Cifelli C, 2008, CIRC RES, V103, P527, DOI 10.1161/CIRCRESAHA.108.180984; Davydov IV, 2000, J BIOL CHEM, V275, P22931, DOI 10.1074/jbc.M001605200; DiFrancesco D, 2010, CIRC RES, V106, P434, DOI 10.1161/CIRCRESAHA.109.208041; Dobrzynski H, 2007, CIRCULATION, V115, P1921, DOI 10.1161/CIRCULATIONAHA.106.616011; Fowler CE, 2007, J PHYSIOL-LONDON, V580, P51, DOI 10.1113/jphysiol.2006.123216; Fu Y, 2006, CIRC RES, V98, P659, DOI 10.1161/01.RES.0000207497.50477.60; Fu Y, 2007, AM J PHYSIOL-HEART C, V292, pH2532, DOI 10.1152/ajpheart.01391.2006; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Huang CF, 1997, P NATL ACAD SCI USA, V94, P6159, DOI 10.1073/pnas.94.12.6159; Jaen C, 2006, J BIOL CHEM, V281, P34549, DOI 10.1074/jbc.M603177200; Kardestuncer T, 1998, FEBS LETT, V438, P285, DOI 10.1016/S0014-5793(98)01319-2; Kovoor P, 2001, J AM COLL CARDIOL, V37, P2136, DOI 10.1016/S0735-1097(01)01304-3; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Mesirca P, 2013, J GEN PHYSIOL, V142, P113, DOI 10.1085/jgp.201310996; Mighiu AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00204; Mittmann C, 2002, CARDIOVASC RES, V55, P778, DOI 10.1016/S0008-6363(02)00459-5; Neubig RR, 2008, CIRC RES, V103, P444, DOI 10.1161/CIRCRESAHA.108.183384; Posokhova E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076973; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Stewart A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00095; Vasan RS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S2; Vaseghi M, 2008, PROG CARDIOVASC DIS, V50, P404, DOI 10.1016/j.pcad.2008.01.003; Vashisth H., 2013, ACS CHEM BIOL, DOI 10.1021/cb400568g; Wang F, 2013, HEART RHYTHM, V10, P1500, DOI 10.1016/j.hrthm.2013.07.022; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; Wydeven N, 2012, P NATL ACAD SCI USA, V109, P21492, DOI 10.1073/pnas.1212019110; Xie KQ, 2010, NAT NEUROSCI, V13, P661, DOI 10.1038/nn.2549; Yan YB, 1997, J BIOL CHEM, V272, P11924, DOI 10.1074/jbc.272.18.11924; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Yang YZ, 2010, AM J HUM GENET, V86, P872, DOI 10.1016/j.ajhg.2010.04.017; Zhang QL, 2002, J PHYSIOL-LONDON, V545, P355, DOI 10.1113/jphysiol.2002.032151	43	25	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2440	2449		10.1074/jbc.M113.520742	http://dx.doi.org/10.1074/jbc.M113.520742			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24318880	hybrid, Green Published			2022-12-25	WOS:000331130200047
J	Birkhamshaw, E; Waitt, CJ; Innes, M; Waitt, PI				Birkhamshaw, Edmund; Waitt, Catriona J.; Innes, Michael; Waitt, Peter I.			Severity Assessment of Lower Respiratory Tract Infection in Malawi: Derivation of a Novel Index (SWAT-Bp) Which Outperforms CRB-65	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; PREDICTING MORTALITY; SEVERE SEPSIS; SEPTIC SHOCK; ADULTS; METAANALYSIS; ETIOLOGY; MANAGEMENT; PROGNOSIS; ADMISSION	Objective: To assess the validity of CRB-65 (Confusion, Respiratory rate > 30 breaths/min, BP < 90/60 mmHg, age > 65 years) as a pneumonia severity index in a Malawian hospital population, and determine whether an alternative score has greater accuracy in this setting. Design: Forty three variables were prospectively recorded during the first 48 hours of admission in all patients admitted to Queen Elizabeth Central Hospital, Malawi, for management of lower respiratory tract infection over a two month period (N = 240). Calculation of sensitivity and specificity for CRB-65 in predicting mortality was followed by multivariate modeling to create a score with superior performance in this population. Results: Median age 37, HIV prevalence 79.9%, overall mortality 18.3%. CRB-65 predicted mortality poorly, indicated by the area under the ROC curve of 0.649. Independent predictors of death were: Male sex, "S'' (AOR 2.6); Wasting, "W'' (AOR 6.6); non-ambulatory, "A'' (AOR 2.5); Temp > 38 degrees C or < 35 degrees C, "T'' (AOR 3.2); BP < 100/60, "Bp'' (AOR 3.7). Combining these factors to form a severity index (SWAT-Bp) predicted mortality with high sensitivity and specificity (AUC: 0.867). Mortality for scores 0-5 was 0%, 3.3%, 7.4%, 29.2%, 61.5% and 87.5% respectively. A score >= 3 was 84% sensitive and 77% specific for mortality prediction, with a negative predictive value of 95.8%. Conclusion: CRB-65 performs poorly in this population. The SWAT-Bp score can accurately stratify patients; <= 2 indicates non-severe infection (mortality 4.4%) and >= 3 severe illness (mortality 45%).	[Birkhamshaw, Edmund] Univ Birmingham, Birmingham Coll Med, Birmingham, W Midlands, England; [Waitt, Catriona J.] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England; [Innes, Michael] Univ Birmingham, Dept Primary Care, Birmingham, W Midlands, England; [Waitt, Peter I.] Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi	University of Birmingham; University of Liverpool; University of Birmingham; University of Malawi	Birkhamshaw, E (corresponding author), Univ Birmingham, Birmingham Coll Med, Birmingham, W Midlands, England.	Edbirkhamshaw@gmail.com; C.Waitt@liverpool.ac.uk		Waitt, Peter/0000-0002-7635-4038; Waitt, Catriona/0000-0003-0134-5855	Royal college of physicians: Wolfson Foundation intercalation research award; University of Birmingham: Population Sciences intercalation grant; National Institute for Health Research [CL-2010-07-004] Funding Source: researchfish	Royal college of physicians: Wolfson Foundation intercalation research award; University of Birmingham: Population Sciences intercalation grant; National Institute for Health Research(National Institute for Health Research (NIHR))	1.) Royal college of physicians: Wolfson Foundation intercalation research award. (http://www. wolfson. org. uk/funding/education/inter/) 2.) University of Birmingham: Population Sciences intercalat ion grant. (http://www.birmingham.ac.uk/students/courses/undergraduate/med/ PublicHealthPopulationScienceBMedSc-IntercalatedDegree.aspx#CourseDetailsTab). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN SC, 1984, THORAX, V39, P612, DOI 10.1136/thx.39.8.612; Angus DC, 2002, AM J RESP CRIT CARE, V166, P717, DOI 10.1164/rccm.2102084; [Anonymous], 2010, MAL DEM HLTH SURV KE; Aujesky D, 2005, AM J MED, V118, P384, DOI 10.1016/j.amjmed.2005.01.006; Bauer TT, 2006, J INTERN MED, V260, P93, DOI 10.1111/j.1365-2796.2006.01657.x; Chalmers JD, 2010, THORAX, V65, P878, DOI 10.1136/thx.2009.133280; Chen JH, 2010, THORAX, V65, P971, DOI 10.1136/thx.2009.129627; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Everett DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017765; Feldman C, 2007, J INFECTION, V55, P125, DOI 10.1016/j.jinf.2007.04.001; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Hartung TK, 2011, AM J TROP MED HYG, V85, P105, DOI 10.4269/ajtmh.2011.10-0640; Janssens JP, 2004, LANCET INFECT DIS, V4, P112, DOI 10.1016/S1473-3099(04)00931-4; Laterre PF, 2005, CRIT CARE MED, V33, P952, DOI 10.1097/01.CCM.0000162381.24074.D7; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Loke YK, 2010, THORAX, V65, P884, DOI 10.1136/thx.2009.134072; Macfarlane J., 1996, OXFORD TXB MED, V2; Madeddu G, 2010, CURR OPIN PULM MED, V16, P201, DOI 10.1097/MCP.0b013e3283375825; Muller MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009563; Neill AM, 1996, THORAX, V51, P1010, DOI 10.1136/thx.51.10.1010; Onyedum CC, 2011, RESP MED, V105, P298, DOI 10.1016/j.rmed.2010.11.003; Peters RPH, 2004, TROP MED INT HEALTH, V9, P928, DOI 10.1111/j.1365-3156.2004.01288.x; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rylance J, 2009, T ROY SOC TROP MED H, V103, P790, DOI 10.1016/j.trstmh.2009.05.004; Schuetz P, 2008, EPIDEMIOL INFECT, V136, P1628, DOI 10.1017/S0950268808000435; Scott JAG, 2000, LANCET, V355, P1225, DOI 10.1016/S0140-6736(00)02089-4; Ssekitoleko R, 2011, AM J TROP MED HYG, V85, P697, DOI 10.4269/ajtmh.2011.10-0692; Waitt CJ, 2011, J INFECT DIS, V204, P358, DOI 10.1093/infdis/jir265; Waitt CJ, 2013, EUROPEAN RA IN PRESS; World Health Organization, 2020, IMAI DISTR CLIN MAN	32	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82178	10.1371/journal.pone.0082178	http://dx.doi.org/10.1371/journal.pone.0082178			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324763	Green Submitted, gold, Green Published			2022-12-25	WOS:000328566700063
J	Borrell, A; Vacca, AV; Pinela, AM; Kinze, C; Lockyer, CH; Vighi, M; Aguilar, A				Borrell, Asuncion; Velasquez Vacca, Adriana; Pinela, Ana M.; Kinze, Carl; Lockyer, Christina H.; Vighi, Morgana; Aguilar, Alex			Stable Isotopes Provide Insight into Population Structure and Segregation in Eastern North Atlantic Sperm Whales	PLOS ONE			English	Article							PHYSETER-MACROCEPHALUS; TROPHIC RELATIONSHIPS; GENETIC-STRUCTURE; NITROGEN; CARBON; TEETH; MOVEMENTS; RATIOS; FOOD; MITOCHONDRIAL	In pelagic species inhabiting large oceans, genetic differentiation tends to be mild and populations devoid of structure. However, large cetaceans have provided many examples of structuring. Here we investigate whether the sperm whale, a pelagic species with large population sizes and reputedly highly mobile, shows indication of structuring in the eastern North Atlantic, an ocean basin in which a single population is believed to occur. To do so, we examined stable isotope values in sequential growth layer groups of teeth from individuals sampled in Denmark and NW Spain. In each layer we measured oxygen-isotope ratios (delta O-18) in the inorganic component (hydroxyapatite), and nitrogen and carbon isotope ratios (delta N-15: delta C-13) in the organic component (primarily collagenous). We found significant differences between Denmark and NW Spain in delta N-15 and delta O-18 values in the layer deposited at age 3, considered to be the one best representing the baseline of the breeding ground, in delta N-15, delta C-13 and delta O-18 values in the period up to age 20, and in the ontogenetic variation of delta N-15 and delta O-18 values. These differences evidence that diet composition, use of habitat and/or migratory destinations are dissimilar between whales from the two regions and suggest that the North Atlantic population of sperm whales is more structured than traditionally accepted.	[Borrell, Asuncion; Velasquez Vacca, Adriana; Pinela, Ana M.; Vighi, Morgana; Aguilar, Alex] Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain; [Borrell, Asuncion; Velasquez Vacca, Adriana; Pinela, Ana M.; Vighi, Morgana; Aguilar, Alex] Univ Barcelona, Biodivers Res Inst IRBio, Barcelona, Spain; [Kinze, Carl] Univ Copenhagen, Zool Museum, DK-2100 Copenhagen, Denmark; [Lockyer, Christina H.] Age Dynam, Konhgens Lyngby, Denmark	University of Barcelona; University of Barcelona; University of Copenhagen	Borrell, A (corresponding author), Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain.	xonborrell@ub.edu	Aguilar, Alex/L-1283-2014; Vighi, Morgana/B-7982-2015; Vacca, Adriana Velásquez/L-6787-2013; Borrell, Asunción/B-8257-2009	Aguilar, Alex/0000-0002-5751-2512; Vacca, Adriana Velásquez/0000-0002-4867-6371; Borrell, Asunción/0000-0002-6714-0724	University of Barcelona	University of Barcelona	The economic costs of publication of this article have been funded by the University of Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILAR A, 1985, MAMMALIA, V49, P421; Aguilar A, 2007, MAR MAMMAL SCI, V23, P322, DOI 10.1111/j.1748-7692.2007.00111.x; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; [Anonymous], 1989, CARNEGIE I WASH YR B; BADA JL, 1990, OECOLOGIA, V82, P102, DOI 10.1007/BF00318540; Best P.B., 1979, Behavior of Marine Animals, V3, P227; Best P.B., 1984, Reports of the International Whaling Commission Special Issue, P51; Best PB, 1999, S AFR J MARINE SCI, V21, P393; Borrell A, 2006, ENVIRON INT, V32, P516, DOI 10.1016/j.envint.2005.12.001; Bowen GJ, 2010, ANNU REV EARTH PL SC, V38, P161, DOI 10.1146/annurev-earth-040809-152429; Boyle WA, 2011, BIOL LETTERS, V7, P661, DOI 10.1098/rsbl.2011.0115; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Christal J, 1998, CAN J ZOOL, V76, P1431, DOI 10.1139/cjz-76-8-1431; Clapham PJ, 2008, MAR MAMMAL SCI, V24, P183, DOI 10.1111/j.1748-7692.2007.00175.x; CLARKE MR, 1974, J MAR BIOL ASSOC UK, V54, P959, DOI 10.1017/S0025315400057684; CLARKE MR, 1993, PHILOS T ROY SOC B, V339, P67, DOI 10.1098/rstb.1993.0005; Clementz MT, 2001, OECOLOGIA, V129, P461, DOI 10.1007/s004420100745; Coplen TB, 2011, RAPID COMMUN MASS SP, V25, P2538, DOI 10.1002/rcm.5129; Crawford K, 2008, MAMMAL REV, V38, P87, DOI 10.1111/j.1365-2907.2008.00120.x; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Drouot Violaine, 2004, Journal of Cetacean Research and Management, V6, P29; Dufault S., 1999, Journal of Cetacean Research and Management, V1, P1; Friedman I, 1977, DATA GEOCHEMISTRY 44; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Hobson KA, 2000, CAN J ZOOL, V78, P1332, DOI 10.1139/cjz-78-8-1332; Hobson KA, 1998, MAR MAMMAL SCI, V14, P116, DOI 10.1111/j.1748-7692.1998.tb00694.x; Hobson KA, 1997, MAR MAMMAL SCI, V13, P114, DOI 10.1111/j.1748-7692.1997.tb00615.x; Hobson KA, 1998, CAN J FISH AQUAT SCI, V55, P2601, DOI 10.1139/cjfas-55-12-2601; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hoelzel AR, 2007, MOL BIOL EVOL, V24, P1407, DOI 10.1093/molbev/msm063; Hoelzel AR, 1998, J HERED, V89, P451, DOI 10.1093/jhered/89.5.451; IWC, 1981, REPORT INT WHALING C, V31, P78; Jacob U, 2005, MAR ECOL PROG SER, V287, P251, DOI 10.3354/meps287251; Jenkins SG, 2001, OECOLOGIA, V129, P336, DOI 10.1007/s004420100755; Jennings S, 2002, MAR ECOL PROG SER, V226, P77, DOI 10.3354/meps226077; Kinze Carl Chr., 1998, Flora og Fauna, V104, P41; Kohn MJ, 2002, REV MINERAL GEOCHEM, V48, P455, DOI 10.2138/rmg.2002.48.12; Lettevall E, 2002, CAN J ZOOL, V80, P1189, DOI 10.1139/Z02-102; Lockyer C, 1977, VOYAGE DISCOVERY, P591; LUZ B, 1985, EARTH PLANET SC LETT, V75, P29, DOI 10.1016/0012-821X(85)90047-0; Lyrholm T, 1999, P ROY SOC B-BIOL SCI, V266, P347, DOI 10.1098/rspb.1999.0644; Lyrholm T, 1998, P ROY SOC B-BIOL SCI, V265, P1679, DOI 10.1098/rspb.1998.0488; MARTIN AR, 1982, MAMMALIA, V46, P259; Mendes S, 2007, J MAR BIOL ASSOC UK, V87, P621, DOI 10.1017/S0025315407056019; Mendes S, 2007, OECOLOGIA, V151, P605, DOI 10.1007/s00442-006-0612-z; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Mitchell E, 1975, REPORTS INT WHALING, V25, P270; Mizroch SA, 2013, MAR MAMMAL SCI, V29, pE136, DOI 10.1111/j.1748-7692.2012.00601.x; Mizue K, 1951, SCI REP WHALES RES, P81; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; PALSBOLL PJ, 1995, MAR ECOL PROG SER, V116, P1, DOI 10.3354/meps116001; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Pastene LA, 2007, MOL ECOL, V16, P1481, DOI 10.1111/j.1365-294X.2007.03244.x; Perrin WF, 1980, REP INT WHAL COMM; Pinela AM, 2009, CAN J ZOOL, V87, P802, DOI 10.1139/Z09-066; RAU GH, 1982, DEEP-SEA RES, V29, P1035, DOI 10.1016/0198-0149(82)90026-7; Rice D.W., 1989, P177; SIGURJONSSON J, 1985, Natturufraedingurinn, V54, P9; TOWNSEND CHARLES HASKINS, 1935, ZOOLOGICA [NEW YORK], V19, P1; Walker JL, 1999, MAR MAMMAL SCI, V15, P314, DOI 10.1111/j.1748-7692.1999.tb00804.x; Whitehead H., 2003, SPERM WHALES SOCIAL; YOSHIDA N, 1991, J GEOPHYS RES-OCEANS, V96, P815, DOI 10.1029/90JC01580	62	25	25	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82398	10.1371/journal.pone.0082398	http://dx.doi.org/10.1371/journal.pone.0082398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324782	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700076
J	Gangadharan, A; Sreerekha, MV; Whitehill, J; Ham, JH; Mackey, D				Gangadharan, Anju; Sreerekha, Mysore-Venkatarau; Whitehill, Justin; Ham, Jong Hyun; Mackey, David			The Pseudomonas syringae pv. tomato Type III Effector HopM1 Suppresses Arabidopsis Defenses Independent of Suppressing Salicylic Acid Signaling and of Targeting AtMIN7	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; TGA TRANSCRIPTION FACTORS; PLANT IMMUNE-RESPONSE; DISEASE RESISTANCE; LESION FORMATION; GENE-EXPRESSION; INNATE IMMUNITY; CELL-WALL; PROTEIN; NPR1	Pseudomonas syringae pv tomato strain DC3000 (Pto) delivers several effector proteins promoting virulence, including HopM1, into plant cells via type III secretion. HopM1 contributes to full virulence of Pto by inducing degradation of Arabidopsis proteins, including AtMIN7, an ADP ribosylation factor-guanine nucleotide exchange factor. Pseudomonas syringae pv phaseolicola strain NPS3121 (Pph) lacks a functional HopM1 and elicits robust defenses in Arabidopsis thaliana, including accumulation of pathogenesis related 1 (PR-1) protein and deposition of callose-containing cell wall fortifications. We have examined the effects of heterologously expressed HopM1(Pto) on Pph-induced defenses. HopM1 suppresses Pph-induced PR-1 expression, a widely used marker for salicylic acid (SA) signaling and systemic acquired resistance. Surprisingly, HopM1 reduces PR-1 expression without affecting SA accumulation and also suppresses the low levels of PR-1 expression apparent in SA-signaling deficient plants. Further, HopM1 enhances the growth of Pto in SA-signaling deficient plants. AtMIN7 contributes to Pph-induced PR-1 expression. However, HopM1 fails to degrade AtMIN7 during Pph infection and suppresses Pph-induced PR-1 expression and callose deposition in wild-type and atmin7 plants. We also show that the HopM1-mediated suppression of PR-1 expression is not observed in plants lacking the TGA transcription factor, TGA3. Our data indicate that HopM1 promotes bacterial virulence independent of suppressing SA-signaling and links TGA3, AtMIN7, and other HopM1 targets to pathways distinct from the canonical SA-signaling pathway contributing to PR-1 expression and callose deposition. Thus, efforts to understand this key effector must consider multiple targets and unexpected outputs of its action.	[Sreerekha, Mysore-Venkatarau; Ham, Jong Hyun; Mackey, David] Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA; [Gangadharan, Anju; Mackey, David] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Whitehill, Justin] Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Mackey, D (corresponding author), Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA.	mackey.86@osu.edu	Whitehill, Justin/AAE-2451-2019	Whitehill, Justin/0000-0003-2578-9522	National Science Foundation [MCB-0718882]; USDA [NIFA 2008-35319-04506]; Korean RDA Next-Generation BioGreen Program (SSAC); Korean RDA Next-Generation BioGreen Program [PJ009088]; Ohio Agricultural Research and Development Center of The Ohio State University	National Science Foundation(National Science Foundation (NSF)); USDA(United States Department of Agriculture (USDA)); Korean RDA Next-Generation BioGreen Program (SSAC); Korean RDA Next-Generation BioGreen Program; Ohio Agricultural Research and Development Center of The Ohio State University	This work was funded by the National Science Foundation (MCB-0718882), the USDA (NIFA 2008-35319-04506), the Korean RDA Next-Generation BioGreen Program (SSAC and PJ009088), and the Ohio Agricultural Research and Development Center of The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Assaad FF, 2004, MOL BIOL CELL, V15, P5118, DOI 10.1091/mbc.E04-02-0140; Badel JL, 2006, MOL PLANT MICROBE IN, V19, P99, DOI 10.1094/MPMI-19-0099; Badel JL, 2003, MOL MICROBIOL, V49, P1239, DOI 10.1046/j.1365-2958.2003.03647.x; Bednarek P, 2010, CURR OPIN PLANT BIOL, V13, P378, DOI 10.1016/j.pbi.2010.05.002; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Choi J, 2010, DEV CELL, V19, P284, DOI 10.1016/j.devcel.2010.07.011; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; Fan WH, 2002, PLANT CELL, V14, P1377, DOI 10.1105/tpc.001628; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; Gatz C, 2013, MOL PLANT MICROBE IN, V26, P151, DOI 10.1094/MPMI-04-12-0078-IA; Geng XQ, 2012, PLANT CELL, V24, P4763, DOI 10.1105/tpc.112.105312; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Ham JH, 2007, PLANT J, V51, P604, DOI 10.1111/j.1365-313X.2007.03165.x; Ham JH, 2009, MOL PLANT MICROBE IN, V22, P703, DOI 10.1094/MPMI-22-6-0703; Hann DR, 2010, CURR OPIN PLANT BIOL, V13, P388, DOI 10.1016/j.pbi.2010.04.003; Hass C, 2004, EMBO J, V23, P3290, DOI 10.1038/sj.emboj.7600337; Huang ZW, 2009, NAT STRUCT MOL BIOL, V16, P853, DOI 10.1038/nsmb.1647; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kalde M, 2007, P NATL ACAD SCI USA, V104, P11850, DOI 10.1073/pnas.0701083104; Kesarwani M, 2007, PLANT PHYSIOL, V144, P336, DOI 10.1104/pp.106.095299; Kim K, 2012, PLANT J, V69, P934, DOI 10.1111/j.1365-313X.2011.04843.x; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kim Min Gab, 2008, V415, P443, DOI 10.1007/978-1-59745-570-1_26; Kliebenstein DJ, 1999, MOL PLANT MICROBE IN, V12, P1022, DOI 10.1094/MPMI.1999.12.11.1022; LAWTON KA, 1994, PLANT CELL, V6, P581, DOI 10.1105/tpc.6.5.581; Lebel E, 1998, PLANT J, V16, P223, DOI 10.1046/j.1365-313x.1998.00288.x; Li X, 1999, CELL, V98, P329, DOI 10.1016/S0092-8674(00)81962-5; Mackey D, 2006, MOL MICROBIOL, V61, P1365, DOI 10.1111/j.1365-2958.2006.05311.x; Mosher RA, 2006, PLANT CELL, V18, P1750, DOI 10.1105/tpc.105.039677; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Nomura K, 2006, SCIENCE, V313, P220, DOI 10.1126/science.1129523; Nomura K, 2011, P NATL ACAD SCI USA, V108, P10774, DOI 10.1073/pnas.1103338108; Pape S, 2010, PLANT PHYSIOL, V154, P1805, DOI 10.1104/pp.110.165563; Shah J, 2003, CURR OPIN PLANT BIOL, V6, P365, DOI 10.1016/S1369-5266(03)00058-X; Song JQ, 2011, CELL HOST MICROBE, V9, P115, DOI 10.1016/j.chom.2011.01.011; Tanaka H, 2009, CURR BIOL, V19, P391, DOI 10.1016/j.cub.2009.01.057; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Zhang YL, 2003, PLANT CELL, V15, P2647, DOI 10.1105/tpc.014894	46	25	25	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82032	10.1371/journal.pone.0082032	http://dx.doi.org/10.1371/journal.pone.0082032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324742	gold, Green Submitted, Green Published			2022-12-25	WOS:000328566700057
J	Wang, J; Zhang, CY; Zhao, XH; Gadow, KV				Wang, Juan; Zhang, Chunyu; Zhao, Xiuhai; Gadow, Klaus V.			Limitations to Reproductive Success in the Dioecious Tree Rhamnus davurica	PLOS ONE			English	Article							POLLEN LIMITATION; PLANT REPRODUCTION; WIND POLLINATION; CLOUD FOREST; SEED; DENSITY; FEMALE; FRUIT; DISTANCE; FAILURE	The reproductive success of a female plant in a dioecious species may be affected by pollen limitation and resource limitation. This study presents evidence that the reproductive success of the dioecious understorey tree species, Rhamnus davurica, is affected by the distance to the nearest male. The sex ratios were female-biased, although showing fluctuations in the three years of conducting the study. The mortality rate of females was higher than that of males indicating a trade-off between reproduction and survival. Altogether 49 females, designated as "focal females'', were randomly selected for monitoring their reproductive status between April and October in 2010. But successful reproduction (meaning that the flowering female trees had fruit in the fruiting season) was observed only in 28 females in 2011 and 16 females in 2012. The method of path analysis was applied to determine the effect of topography, local competition and proximity to the nearest male on the fruit set of the females. In the three years of the study, elevation, competition and female size had no significant effect on the fruit set. The distance to the nearest male, however, had a significant effect on fruit set. Number of fruits and fruit set were decreased with increasing distance to the nearest male. It was possible to estimate maximum fruit set, based on the comparatively large dataset. The number of fruits and the fruit set are exponentially related to the distance to the nearest male and the relationships are described by an exponential model. The results of this study support the importance of pollen limitation on the reproductive success in Rhamnus davurica.	[Wang, Juan; Zhang, Chunyu; Zhao, Xiuhai] Beijing Forestry Univ, Key Lab Forest Resources & Ecosyst Proc Beijing, Beijing, Peoples R China; [Gadow, Klaus V.] Univ Gottingen, Fac Forestry & Forest Ecol, D-37073 Gottingen, Germany	Beijing Forestry University; University of Gottingen	Zhao, XH (corresponding author), Beijing Forestry Univ, Key Lab Forest Resources & Ecosyst Proc Beijing, Beijing, Peoples R China.	zhaoxh@bjfu.edu.cn	Zhang, Chunyu/GYA-2925-2022; von Gadow, Klaus/N-6368-2015; Zhang, Chun-yu/HDP-5776-2022	Zhang, Chunyu/0000-0003-3091-5060; 	National Science Foundation of China [31200315]; Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-12-0781]; 12th five-year National Science and Technology plan of China [2012BAC01B03]; Beijing Municipal Government of China	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); 12th five-year National Science and Technology plan of China(Chinese Academy of Sciences); Beijing Municipal Government of China	This research is supported by the National Science Foundation of China (31200315), the Program for New Century Excellent Talents in University of Ministry of Education of China (NCET-12-0781), the 12th five-year National Science and Technology plan of China (2012BAC01B03), and the Program of the Co-Construction with Beijing Municipal Government of China (2012).	ALLISON TD, 1990, ECOLOGY, V71, P516, DOI 10.2307/1940305; Benzioni A, 1998, IND CROP PROD, V8, P145, DOI 10.1016/S0926-6690(97)10019-X; Berry EJ, 2004, J TROP ECOL, V20, P369, DOI 10.1017/S0266467404001397; BURD M, 1994, BOT REV, V60, P83, DOI 10.1007/BF02856594; BURD M, 1995, EVOLUTION, V49, P100, DOI 10.1111/j.1558-5646.1995.tb05962.x; CHARLESWORTH D, 1989, TRENDS ECOL EVOL, V4, P289, DOI 10.1016/0169-5347(89)90023-2; Crone EE, 2004, ECOLOGY, V85, P1944, DOI 10.1890/03-0256; DAWSON TE, 1993, ECOLOGY, V74, P798, DOI 10.2307/1940807; de Jong TJ, 2005, ACTA OECOL, V28, P331, DOI 10.1016/j.actao.2005.07.001; Field DL, 2012, INT J PLANT SCI, V173, P184, DOI 10.1086/663164; FREEMAN DC, 1976, SCIENCE, V193, P597, DOI 10.1126/science.193.4253.597; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Griffin SR, 2002, INT J PLANT SCI, V163, P581, DOI 10.1086/340814; Gulias J, 2012, J PLANT ECOL, V5, P330, DOI 10.1093/jpe/rtr047; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Hesse E, 2011, J ECOL, V99, P1531, DOI 10.1111/j.1365-2745.2011.01880.x; HOUSE SM, 1992, J ECOL, V80, P57, DOI 10.2307/2261063; Knapp EE, 2001, OECOLOGIA, V128, P48, DOI 10.1007/s004420000623; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; Lee WK, 2004, ECOL MODEL, V176, P187, DOI 10.1016/j.ecolmodel.2003.11.012; LLOYD DG, 1977, BOT REV, V43, P177, DOI 10.1007/BF02860717; Merrett MF, 2012, NEW ZEAL J BOT, V50, P37, DOI 10.1080/0028825X.2011.640337; Nottebrock H, 2013, PERSPECT PLANT ECOL, V15, P150, DOI 10.1016/j.ppees.2013.03.003; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Osunkoya OO, 1999, BIOL CONSERV, V88, P347, DOI 10.1016/S0006-3207(98)00115-3; *R DEV COR TEAM, 2013, R LANG ENV STAT COMP; Rapp JM, 2013, J ECOL, V101, P1345, DOI 10.1111/1365-2745.12115; Shelton AO, 2008, ECOLOGY, V89, P3020, DOI 10.1890/07-1835.1; Somanathan H, 2000, BIOL CONSERV, V94, P243, DOI 10.1016/S0006-3207(99)00170-6; Steven JC, 2007, PLANT ECOL, V190, P131, DOI 10.1007/s11258-006-9196-2; Wilcock C, 2002, TRENDS PLANT SCI, V7, P270, DOI 10.1016/S1360-1385(02)02258-6; WILSON P, 1994, AM NAT, V143, P283, DOI 10.1086/285604; Wright S, 1934, ANN MATH STAT, V5, P161, DOI 10.1214/aoms/1177732676; Wright S, 1920, P NATL ACAD SCI USA, V6, P320, DOI 10.1073/pnas.6.6.320; Yamakura T., 1995, TROPICS, V5, P41, DOI [10.3759/tropics.5.41, DOI 10.3759/tropics.5.41, DOI 10.3759/TROPICS.5.41]; Yu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022903; Zhang CY, 2012, EUR J FOREST RES, V131, P1287, DOI 10.1007/s10342-012-0598-5	37	3	3	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81140	10.1371/journal.pone.0081140	http://dx.doi.org/10.1371/journal.pone.0081140			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324665	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700029
J	Yoshihara, D; Kugita, M; Sasaki, M; Horie, S; Nakanishi, K; Abe, T; Aukema, HM; Yamaguchi, T; Nagao, S				Yoshihara, Daisuke; Kugita, Masanori; Sasaki, Mai; Horie, Shigeo; Nakanishi, Koichi; Abe, Takaaki; Aukema, Harold M.; Yamaguchi, Tamio; Nagao, Shizuko			Telmisartan Ameliorates Fibrocystic Liver Disease in an Orthologous Rat Model of Human Autosomal Recessive Polycystic Kidney Disease	PLOS ONE			English	Article							CONGENITAL HEPATIC-FIBROSIS; PPAR-GAMMA; THERAPEUTIC TARGET; RECEPTOR; GENE	Human autosomal recessive polycystic kidney disease (ARPKD) produces kidneys which are massively enlarged due to multiple cysts, hypertension, and congenital hepatic fibrosis characterized by dilated bile ducts and portal hypertension. The PCK rat is an orthologous model of human ARPKD with numerous fluid-filled cysts caused by stimulated cellular proliferation in the renal tubules and hepatic bile duct epithelia, with interstitial fibrosis developed in the liver. We previously reported that a peroxisome proliferator activated receptor (PPAR)-gamma full agonist ameliorated kidney and liver disease in PCK rats. Telmisartan is an angiotensin receptor blocker (ARB) used widely as an antihypertensive drug and shows partial PPAR-gamma agonist activity. It also has nephroprotective activity in diabetes and renal injury and prevents the effects of drug-induced hepatotoxicity and hepatic fibrosis. In the present study, we determined whether telmisartan ameliorates progression of polycystic kidney and fibrocystic liver disease in PCK rats. Five male and 5 female PCK and normal control (+/+) rats were orally administered 3 mg/kg telmisartan or vehicle every day from 4 to 20 weeks of age. Treatment with telmisartan decreased blood pressure in both PCK and +/+ rats. Blood levels of aspartate amino transferase, alanine amino transferase and urea nitrogen were unaffected by telmisartan treatment. There was no effect on kidney disease progression, but liver weight relative to body weight, liver cystic area, hepatic fibrosis index, expression levels of Ki67 and TGF-beta, and the number of Ki67- and TGF-beta-positive interstitial cells in the liver were significantly decreased in telmisartan-treated PCK rats. Therefore, telmisartan ameliorates congenital hepatic fibrosis in ARPKD, possibly through the inhibition of signaling cascades responsible for cellular proliferation and interstitial fibrosis in PCK rats. The present results support the potential therapeutic use of ARBs for the treatment of fibrocystic liver disease in ARPKD patients.	[Yoshihara, Daisuke; Kugita, Masanori; Sasaki, Mai; Nagao, Shizuko] Fujita Hlth Univ, Educ & Res Ctr Anim Models Human Dis, Toyoake, Aichi, Japan; [Horie, Shigeo] Juntendo Univ, Dept Urol, Grad Sch Med, Tokyo, Japan; [Nakanishi, Koichi] Wakayama Med Univ, Dept Pediat, Wakayama, Japan; [Abe, Takaaki] Tohoku Univ, Grad Sch Biomed Engn, Div Med Sci, Sendai, Miyagi 980, Japan; [Aukema, Harold M.; Yamaguchi, Tamio] Univ Manitoba, Dept Human Nutr Sci, Winnipeg, MB, Canada	Fujita Health University; Juntendo University; Wakayama Medical University; Tohoku University; University of Manitoba	Nagao, S (corresponding author), Fujita Hlth Univ, Educ & Res Ctr Anim Models Human Dis, Toyoake, Aichi, Japan.	shizun@fujita-hu.ac.jp	Nakanishi, Koichi/AAF-6381-2020	Nakanishi, Koichi/0000-0001-8681-9129; Nagao, Shizuko/0000-0003-2014-9411; Aukema, Harold/0000-0002-6982-7239	Ministry of Education, Culture, Sports, Science and Technology of Japan [22590351]; Canadian Institutes of Health Research [MOP230564]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant-in-Aid for Scientific Research (http://www.jsps.go.jp/english/e-grants/, #22590351 to Shizuko Nagao) from Ministry of Education, Culture, Sports, Science and Technology of Japan and Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/37788.html, MOP230564 to Harold M. Aukema). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghamdi H, 2011, SAUDI J GASTROENTERO, V17, P155, DOI 10.4103/1319-3767.77251; Azoulay L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3645; Bataller R, 2005, HEPATOLOGY, V41, P1046, DOI 10.1002/hep.20665; Bright JJ, 2008, PPAR RES, V2008, DOI 10.1155/2008/658520; Dai B, 2010, CLIN SCI, V119, P323, DOI 10.1042/CS20100113; Dekkers JF, 2012, TRENDS MOL MED, V18, P283, DOI 10.1016/j.molmed.2012.03.004; Dias Natasha Favoretto, 2010, J Bras Nefrol, V32, P263; Doggrell SA, 2004, EXPERT OPIN PHARMACO, V5, P2397, DOI 10.1517/14656566.5.11.2397; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Ferwana M, 2013, DIABET MED IN PRESS; Fouad AA, 2012, TOXICOLOGY, V300, P149, DOI 10.1016/j.tox.2012.06.015; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Goto M, 2010, PEDIATR NEPHROL, V25, P2449, DOI 10.1007/s00467-010-1621-z; Goyal BR, 2011, PHARMACOL REP, V63, P956, DOI 10.1016/S1734-1140(11)70611-9; Grantham JJ, 2011, NAT REV NEPHROL, V7, P556, DOI 10.1038/nrneph.2011.109; Gunay-Aygun M, 2006, J PEDIATR-US, V149, P159, DOI 10.1016/j.jpeds.2006.03.014; Gunay-Aygun M, 2013, GASTROENTEROLOGY, V144, P112, DOI 10.1053/j.gastro.2012.09.056; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hsiao FY, 2013, DRUG SAF IN PRESS; Ishizaka N, 2005, AM J PHYSIOL-REG I, V288, pR1063, DOI 10.1152/ajpregu.00281.2004; Jin H, 2007, BIOCHEM BIOPH RES CO, V364, P801, DOI 10.1016/j.bbrc.2007.10.083; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; Kurtz TW, 2005, ACTA DIABETOL, V42, pS9, DOI 10.1007/s00592-005-0176-0; Liu C, 2013, MOL MED REP IN PRESS; Liu YW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028915; Nagao S, 2006, J AM SOC NEPHROL, V17, P2220, DOI 10.1681/ASN.2006030251; Nagao Shizuko, 2012, Curr Mol Pharmacol, V5, P292; Ohmura T, 2012, ACTA DIABETOL, V49, pS15, DOI 10.1007/s00592-007-0016-5; Sato Y, 2007, AM J PATHOL, V171, P1859, DOI 10.2353/ajpath.2007.070337; Schmidt MV, 2010, THESCIENTIFICWORLDJO, V10, P2181, DOI 10.1100/tsw.2010.213; Sipal S, 2012, J MOL HISTOL, V43, P723, DOI 10.1007/s10735-012-9441-z; Siragy H, 1999, AM J CARDIOL, V84, p3S; Sukumaran V, 2010, HYPERTENS RES, V33, P695, DOI 10.1038/hr.2010.67; Sweeney WE, 2011, PEDIATR NEPHROL, V26, P675, DOI 10.1007/s00467-010-1656-1; Tsunenari I, 2007, J RENIN-ANGIO-ALDO S, V8, P93, DOI 10.3317/jraas.2007.017; Turkbey B, 2009, PEDIATR RADIOL, V39, P100, DOI 10.1007/s00247-008-1064-x; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278; Xue ZF, 2013, WORLD J GASTROENTERO, V19, P1380, DOI 10.3748/wjg.v19.i9.1380; Yoshihara D, 2012, PPAR RES, V2012, DOI 10.1155/2012/695898; Yoshihara D, 2011, AM J PHYSIOL-RENAL, V300, pF465, DOI 10.1152/ajprenal.00460.2010; Zhao CY, 2006, BIOCHEM BIOPH RES CO, V350, P385, DOI 10.1016/j.bbrc.2006.09.069; Zong WN, 2011, ACTA PHARMACOL SIN, V32, P1345, DOI 10.1038/aps.2011.96	43	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81480	10.1371/journal.pone.0081480	http://dx.doi.org/10.1371/journal.pone.0081480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324698	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700041
J	Castanhinha, R; Araujo, R; Junior, LC; Angielczyk, KD; Martins, GG; Martins, RMS; Chaouiya, C; Beckmann, F; Wilde, F				Castanhinha, Rui; Araujo, Ricardo; Junior, Luis C.; Angielczyk, Kenneth D.; Martins, Gabriel G.; Martins, Rui M. S.; Chaouiya, Claudine; Beckmann, Felix; Wilde, Fabian			Bringing Dicynodonts Back to Life: Paleobiology and Anatomy of a New Emydopoid Genus from the Upper Permian of Mozambique	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; THERAPSIDA ANOMODONTIA; TRIASSIC DICYNODONTS; POSTCRANIAL SKELETON; STRATIGRAPHIC RANGE; TAXONOMIC REVISION; SUBARCUATE FOSSA; CRANIAL ANATOMY; BONE-HISTOLOGY; KAROO BASIN	Dicynodontia represent the most diverse tetrapod group during the Late Permian. They survived the Permo-Triassic extinction and are central to understanding Permo-Triassic terrestrial ecosystems. Although extensively studied, several aspects of dicynodont paleobiology such as, neuroanatomy, inner ear morphology and internal cranial anatomy remain obscure. Here we describe a new dicynodont (Therapsida, Anomodontia) from northern Mozambique: Niassodon mfumukasi gen. et sp. nov. The holotype ML1620 was collected from the Late Permian K5 formation, Metangula Graben, Niassa Province northern Mozambique, an almost completely unexplored basin and country for vertebrate paleontology. Synchrotron radiation based micro-computed tomography (SR mu CT), combined with a phylogenetic analysis, demonstrates a set of characters shared with Emydopoidea. All individual bones were digitally segmented allowing a 3D visualization of each element. In addition, we reconstructed the osseous labyrinth, endocast, cranial nerves and vasculature. The brain is narrow and the cerebellum is broader than the forebrain, resembling the conservative, "reptilian-grade'' morphology of other non-mammalian therapsids, but the enlarged paraflocculi occupy the same relative volume as in birds. The orientation of the horizontal semicircular canals indicates a slightly more dorsally tilted head posture than previously assumed in other dicynodonts. In addition, synchrotron data shows a secondary center of ossification in the femur. Thus ML1620 represents, to our knowledge, the oldest fossil evidence of a secondary center of ossification, pushing back the evolutionary origins of this feature. The fact that the specimen represents a new species indicates that the Late Permian tetrapod fauna of east Africa is still incompletely known.	[Castanhinha, Rui; Chaouiya, Claudine] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Castanhinha, Rui; Araujo, Ricardo; Martins, Rui M. S.] Museu Lourinha, Lourinha, Portugal; [Araujo, Ricardo] So Methodist Univ, Huffington Dept Earth Sci, Dallas, TX 75275 USA; [Junior, Luis C.] Museu Nacl Geol, Maputo, Mocambique, Mozambique; [Angielczyk, Kenneth D.] Field Museum Nat Hist, Integrat Res Ctr, Chicago, IL 60605 USA; [Martins, Rui M. S.] Univ Lisbon, Ctr Biol Ambiental, Fac Ciencias, P-1699 Lisbon, Portugal; [Martins, Rui M. S.] Inst Super Tecn, Bobadela, Portugal; [Martins, Rui M. S.] Univ Nova Lisboa, Ctr Invest Mat, Fac Ciencias Tecnol, Caparica, Portugal; [Martins, Rui M. S.] Univ Lisbon, Ctr Fis Nucl, P-1699 Lisbon, Portugal; [Beckmann, Felix; Wilde, Fabian] Helmholtz Zentrum Geesthacht, Geesthacht, Germany	Instituto Gulbenkian de Ciencia; Southern Methodist University; Field Museum of Natural History (Chicago); Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico; Universidade Nova de Lisboa; Universidade de Lisboa; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung	Castanhinha, R (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	rcastanhinha@gmail.com	Martins, Gabriel G/A-1538-2012; Martins, Rui/D-2143-2012; Araujo, R/AAL-4784-2020; Beckmann, Felix/E-1940-2016; Chaouiya, Claudine/F-8560-2012; Martins, Gabriel G/AAG-4074-2020; Castanhinha, Rui/F-4997-2017	Martins, Gabriel G/0000-0002-6506-9776; Martins, Rui/0000-0003-1912-150X; Beckmann, Felix/0000-0002-2266-9173; Chaouiya, Claudine/0000-0003-2350-0756; Martins, Gabriel G/0000-0002-6506-9776; Araujo, Ricardo/0000-0001-5058-2983; Castanhinha, Rui/0000-0002-3191-7482	Mozambique (Ministerio dos Recursos Minerais); National Geographic Society; DESY; European Community [312284]	Mozambique (Ministerio dos Recursos Minerais); National Geographic Society(National Geographic Society); DESY; European Community(European Commission)	The results here presented were primarily financed by Mozambique (Ministerio dos Recursos Minerais). Other partial funds were granted by National Geographic Society, TAP airlines and other anonymous patrons. The authors also would like to acknowledge the financial support from DESY through the I-20110184 EC project and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 312284. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboitiz F, 2002, BRAIN RES REV, V39, P141, DOI 10.1016/S0165-0173(02)00180-7; Agnew JD, 1958, PALEONTOL AFR, P77; Angielczyk KD, 2004, PALEOBIOLOGY, V30, P268, DOI 10.1666/0094-8373(2004)030<0268:PEFAIO>2.0.CO;2; Angielczyk KD, 2003, ZOOL J LINN SOC-LOND, V139, P157, DOI 10.1046/j.1096-3642.2003.00081.x; Angielczyk KD, 2002, J PALEONTOL, V76, P1047, DOI 10.1666/0022-3360(2002)076<1047:RPPASS>2.0.CO;2; Angielczyk KD, 2013, EARLY EVOLUTIONARY H, P305; Angielczyk KD, 2008, J PALEONTOL, V82, P528, DOI 10.1666/07-051.1; Angielczyk Kenneth D., 2005, Palaeontologia Africana, V41, P23; Angielczyk KD, 2007, J VERTEBR PALEONTOL, V27, P116, DOI 10.1671/0272-4634(2007)27[116:NSOTTD]2.0.CO;2; Angielczyk KD, 2013, J SYST PALAEONTOL, V11, P191, DOI 10.1080/14772019.2011.623723; Angielczyk KD, 2010, J VERTEBR PALEONTOL, V30, P1396, DOI 10.1080/02724634.2010.501447; Angielczyk KD, 2009, J VERTEBR PALEONTOL, V29, P1174, DOI 10.1671/039.029.0427; [Anonymous], AM MUS NOV; Antunes M.T., 1975, Colloques Internationaux du Centre National de la Recherche Scientifique, P371; Araujo R, 2012, CONHECER TERRA MEMOR, VI, P143; BANDYOPADHYAY S, 1988, PHILOS T ROY SOC B, V320, P185, DOI 10.1098/rstb.1988.0072; Barry T. H., 1974, ANN S AFR MUS, V64, P7; Barry TH, 1967, ANN S AFR MUS, V50, P7; Beckmann F, 2004, AIP CONF PROC, V705, P392, DOI 10.1063/1.1757816; Beckmann F, 2007, HARWI 2 NEW HIGH EN, P746; BLANKS RHI, 1972, AM J PHYSIOL, V223, P55, DOI 10.1152/ajplegacy.1972.223.1.55; Blob RW, 2001, PALEOBIOLOGY, V27, P14, DOI 10.1666/0094-8373(2001)027<0014:EOHPIN>2.0.CO;2; Boonstra L. D., 1968, Annals of the South African Museum, V50, P195; Borges A, 1953, PROVINCIA MOCAMBIQUE, V12, P1; Botha J, 2007, PALAEONTOLOGY, V50, P1175, DOI 10.1111/j.1475-4983.2007.00697.x; Botha Jennifer, 2003, Palaeontologia Africana, V39, P37; Botha-Brink J, 2010, ZOOL J LINN SOC-LOND, V160, P341, DOI 10.1111/j.1096-3642.2009.00601.x; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Brink A, 1983, GEOLOGICAL SURVEY S, V10; BRINK A. S., 1955, PALAEONTOL AFRICANA, V3, P3; Broom, 1932, MAMMAL LIKE REPTILES; Broom R., 1905, Transactions S African Soc, Vxv, P259; Broom R, 1912, P ZOOL SOC LOND, V1912, P419; Brown D.S., 1981, Bulletin of the British Museum (Natural History) Geology, V35, P253; Butler RJ, 2009, J VERTEBR PALEONTOL, V29, P1022, DOI 10.1671/039.029.0404; Camp C.L., 1956, MEM U CALIF, V13, P255; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Catuneanu O, 2005, J AFR EARTH SCI, V43, P211, DOI 10.1016/j.jafrearsci.2005.07.007; CLUVER M A, 1971, Annals of the South African Museum, V56, P155; CLUVER M A, 1978, Annals of the South African Museum, V76, P213; Cox C. B., 1959, Proceedings of the Zoological Society of London, V132, P321; Cox C.B., 1972, P173; COX C. BARRY, 1964, AMER MUS NOVITATES, V2171, P1; COX CB, 1965, PHILOS T ROY SOC B, V248, P457, DOI 10.1098/rstb.1965.0005; Crompton A. W., 1967, POSTILLA, V109, P1; de Beer G. R., 1947, Proceedings of the Linnean Society of London, V159, P125; DeFauw SL, 1986, APPENDICULAR SKELETO; DOYLE P, 1987, PALAEONTOLOGY, V30, P311; EDINGER TILLY, 1955, BULL MUS COMP ZOOL HARVARD UNIV, V114, P1; Eisenberg J. F., 1981, MAMMALIAN RADIATIONS; Ewer R. F., 1961, Proceedings of the Zoological Society of London, V186, P375; Forster R, 1975, GEOLOGISCHE ENTWICKL; Fourie H., 1993, Palaeontologia Africana, V30, P103; Franzosa J, 2004, EVOLUTION BRAIN THER; Frobisch J, 2007, ZOOL J LINN SOC-LOND, V150, P117, DOI 10.1111/j.1096-3642.2007.00285.x; Frobisch J, 2008, J VERTEBR PALEONTOL, V28, P770, DOI 10.1671/0272-4634(2008)28[770:ANSOES]2.0.CO;2; Frobisch J, 2010, NATURWISSENSCHAFTEN, V97, P187, DOI 10.1007/s00114-009-0626-6; Frobisch J, 2009, EARTH-SCI REV, V95, P119, DOI 10.1016/j.earscirev.2009.04.001; Fv Huene, 1935, ORDNUNG ANOMODONTIA, V1, P92; Galatius A, 2003, CAN J ZOOL, V81, P1851, DOI 10.1139/Z03-181; GANNON PJ, 1988, AM J PHYS ANTHROPOL, V77, P143, DOI 10.1002/ajpa.1330770202; Goloboff PA, 2003, CLADISTICS, V19, P324, DOI 10.1016/S0748-3007(03)00060-4; Goloboff P, 2008, CLADISTICS, V24, P91; Goloboff PA, 2006, CLADISTICS, V22, P589, DOI 10.1111/j.1096-0031.2006.00122.x; Goncalves, 1959, GARCIA ORTA, V7, P785; Green JL, 2010, PALAEONTOLOGY, V53, P347, DOI 10.1111/j.1475-4983.2010.00944.x; Haight J.R., 1987, P331; HAINES RW, 1975, J ANAT, V120, P1; Haines RW, 1938, J ANAT, V72, P323; Haughton S. H., 1963, Palaeontologia Africana, V8, P1; Herzen J, 2010, THESIS HAMBURG U; Hetherwick A, 1889, INTRO HDB YAO LANGUA; Hopson J.A., 1979, P39; Hotton N. III, 1986, P71; Huesman R., 1977, RECLBL LIB USERS MAN; Hurlburt G, 1999, J VERTEBR PALEONTOL, V19, P338, DOI 10.1080/02724634.1999.10011145; Ivakhnenko M, 2008, PALEONTOL J+, V42, P859, DOI 10.1134/S0031030108090013; Iwaniuk AN, 2002, CAN J ZOOL, V80, P16, DOI 10.1139/Z01-204; Jacobs LL, 2005, PALAEONTOL ELECTRON, V8; Jasinoski SC, 2010, J VERTEBR PALEONTOL, V30, P1283, DOI 10.1080/02724634.2010.483556; Jasinoski SC, 2010, J MORPHOL, V271, P705, DOI 10.1002/jmor.10828; Jasinoski SC, 2009, ANAT REC, V292, P862, DOI 10.1002/ar.20906; Jasinoski SC, 2012, FORERUNNERS MAMMALS, P149; Jenkins F.A., 1971, B PEABODY MUS NAT HI, V36, P1, DOI DOI 10.1671/0272-4634(2008)28[445:NMOMBC]2.0CO;2; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Jinnah ZA, 2007, S AFR J SCI, V103, P51; Jones MEH, 2011, PALAEONTOL ELECTRON, V14; Kammerer CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064203; Kammerer CF, 2011, J VERTEBR PALEONTOL, V31, P1, DOI 10.1080/02724634.2011.627074; Kammerer CF, 2009, ZOOTAXA, P1; Keyser A.W., 1973, GEOL SURV S AFR MEM, V61, P1; Keyser A.W., 1975, MEMOIRS GEOLOGICAL S, V67, P1; Keyser AW., 1993, GEOL SURV S AFR MEM, V82, P1; Kielan-Jaworowska Z, 2004, ACTA PALAEONTOL POL, V49, P177; KING GM, 1981, PHILOS T R SOC B, V291, P244; KING GM, 1993, ZOOL J LINN SOC-LOND, V107, P131, DOI 10.1111/j.1096-3642.1993.tb00218.x; King GM, 1988, ANOMODONTIA HDB PALA, V17C; Koyabu D, 2012, P NATL ACAD SCI USA, V109, P14075, DOI 10.1073/pnas.1208693109; Koyama E, 2010, DEVELOPMENT, V137, P3795, DOI 10.1242/dev.053447; Laass M, 2011, ACTA ZOOL-STOCKHOLM, V92, P363, DOI 10.1111/j.1463-6395.2010.00467.x; Latimer E. M., 1995, Palaeontologia Africana, V32, P75; Macrini TE, 2007, ANAT REC, V290, P875, DOI 10.1002/ar.20551; Mercader J, 2010, J ARCHAEOL SCI, V37, P1953, DOI 10.1016/j.jas.2010.03.001; Nasterlack T, 2012, J VERTEBR PALEONTOL, V32, P1396, DOI 10.1080/02724634.2012.697410; Nesbitt SJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0949; Nesbitt SJ, 2010, NATURE, V464, P95, DOI 10.1038/nature08718; Olson Everett C., 1944, GEOL SOC AMER SPEC PAPERS, V55, P1; Parsons FG, 1908, J ANAT PHYSIOL, V42, P388; Parsons FG, 1904, J ANAT PHYSIOL, V38, P248; Pearson HS, 1924, P ZOOL SOC LOND, V1924, P793; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Ray S, 2000, PALAEONTOLOGY, V43, P375, DOI 10.1111/1475-4983.00132; Ray S, 2004, J VERTEBR PALEONTOL, V24, P180, DOI 10.1671/1914-14; Ray Sanghamitra, 2010, P73; Reimers W, 2008, NEUTRONS SYNCHROTRON, P42, DOI DOI 10.1002/9783527621927.FMATTER/SUMMARY.ACCESSED; Resende MGC, 2010, COMPUT OPER RES, V37, P498, DOI 10.1016/j.cor.2008.05.011; Romer A. S., 1940, GEOLOGICAL SOC AM SP, V28, P1, DOI DOI 10.1130/SPE28-P1; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; Rubidge B.S., 1995, GEOLOGICAL SURVEY S, V1, P1; Rubidge BS, 2013, GEOLOGY, V41, P363, DOI 10.1130/G33622.1; Rubidge BS, 2005, S AFR J GEOL, V108, P135, DOI 10.2113/108.1.135; Ryan TM, 2006, J HUM EVOL, V51, P591, DOI 10.1016/j.jhevol.2006.06.004; Sanchez S, 2012, MICROSC MICROANAL, V18, P1095, DOI 10.1017/S1431927612001079; Sanchez-Villagra MR, 2002, ACTA THERIOL, V47, P1, DOI 10.1007/BF03193561; Schepers G. W. H., 1937, South African Journal of Science, V33, P731; Schepers GWH, 1939, J ANAT, V73, P451; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sidor CA, 2013, P NATL ACAD SCI USA, V110, P8129, DOI 10.1073/pnas.1302323110; Sidor CA, 2010, J VERTEBR PALEONTOL, V30, P696, DOI 10.1080/02724631003758086; Sigurdsen T, 2012, J VERTEBR PALEONTOL, V32, P1113, DOI 10.1080/02724634.2012.688693; Smith RS, 2011, THERAPSID BIODIVERSI, P352; Sokal R. R., 2012, BIOMETRY; Sollas IBJ, 1914, PHILOS T R SOC LON B, V204, P201, DOI 10.1098/rstb.1914.0006; Sookias RB, 2012, P ROY SOC B-BIOL SCI, V279, P2180, DOI 10.1098/rspb.2011.2441; Strong EE, 1999, CLADISTICS, V15, P363, DOI 10.1111/j.1096-0031.1999.tb00272.x; Sullivan C, 2005, ANN CARNEGIE MUS, V74, P45, DOI 10.2992/0097-4463(2005)74[45:CAATOT]2.0.CO;2; Sullivan C, 2003, P ROY SOC B-BIOL SCI, V270, P173, DOI 10.1098/rspb.2002.2189; Sun A. L., 1963, Paleont Sinica NS, VC17, P1; Surkov MV, 2005, J VERTEBR PALEONTOL, V25, P402, DOI 10.1671/0272-4634(2005)025[0402:LGADFT]2.0.CO;2; Surkov MV, 2004, PALAEONTOLOGY, V47, P619, DOI 10.1111/j.0031-0239.2004.00382.x; Vega-Dias Cristina, 2004, Paleobios, V24, P7; VERNIERS J, 1989, J AFR EARTH SCI, V9, P137, DOI 10.1016/0899-5362(89)90016-X; WALTER LR, 1985, J PALEONTOL, V59, P1486; WATSON D, 1960, TRANS ZOOL SOC LONDON, V29, P131; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048	146	72	75	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80974	10.1371/journal.pone.0080974	http://dx.doi.org/10.1371/journal.pone.0080974			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324653	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300064
J	Gage, BK; Webber, TD; Kieffer, TJ				Gage, Blair K.; Webber, Travis D.; Kieffer, Timothy J.			Initial Cell Seeding Density Influences Pancreatic Endocrine Development During in vitro Differentiation of Human Embryonic Stem Cells	PLOS ONE			English	Article							RETINOBLASTOMA PROTEIN; ISLET TRANSPLANTATION; DEFINITIVE ENDODERM; BETA-CELLS; PHASE; ARCHITECTURE; PROGENITORS; GENERATION; GENES; MAFA	Human embryonic stem cells (hESCs) have the ability to form cells derived from all three germ layers, and as such have received significant attention as a possible source for insulin-secreting pancreatic beta-cells for diabetes treatment. While considerable advances have been made in generating hESC-derived insulin-producing cells, to date in vitro-derived glucose-responsive beta-cells have remained an elusive goal. With the objective of increasing the in vitro formation of pancreatic endocrine cells, we examined the effect of varying initial cell seeding density from 1.3 x 10(4) cells/cm(2) to 5.3 x 10(4) cells/cm(2) followed by a 21-day pancreatic endocrine differentiation protocol. Low density-seeded cells were found to be biased toward the G2/M phases of the cell cycle and failed to efficiently differentiate into SOX17-CXCR4 co-positive definitive endoderm cells leaving increased numbers of OCT4 positive cells in day 4 cultures. Moderate density cultures effectively formed definitive endoderm and progressed to express PDX1 in approximately 20% of the culture. High density cultures contained approximately double the numbers of PDX1 positive pancreatic progenitor cells and also showed increased expression of MNX1, PTF1a, NGN3, ARX, and PAX4 compared to cultures seeded at moderate density. The cultures seeded at high density displayed increased formation of polyhormonal pancreatic endocrine cell populations co-expressing insulin, glucagon and somatostatin. The maturation process giving rise to these endocrine cell populations followed the expected cascade of pancreatic progenitor marker (PDX1 and MNX1) expression, followed by pancreatic endocrine specification marker expression (BRN4, PAX4, ARX, NEUROD1, NKX6.1 and NKX2.2) and then pancreatic hormone expression (insulin, glucagon and somatostatin). Taken together these data suggest that initial cell seeding density plays an important role in both germ layer specification and pancreatic progenitor commitment, which precedes pancreatic endocrine cell formation. This work highlights the need to examine standard culture variables such as seeding density when optimizing hESC differentiation protocols.	[Gage, Blair K.; Webber, Travis D.; Kieffer, Timothy J.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Kieffer, Timothy J.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada	University of British Columbia; University of British Columbia	Kieffer, TJ (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	tim.kieffer@ubc.ca			Stem Cell Network (SCN); STEMCELL Technologies; Juvenile Diabetes Research Foundation (JDRF); Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council; Michael Smith Foundation for Health Research; University of British Columbia	Stem Cell Network (SCN); STEMCELL Technologies; Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); University of British Columbia	This work was funded by the Stem Cell Network (SCN), STEMCELL Technologies, Juvenile Diabetes Research Foundation (JDRF) and Canadian Institutes of Health Research (CIHR). BKG has received PhD funding from the Natural Sciences and Engineering Research Council, the Michael Smith Foundation for Health Research, and the University of British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Becker KA, 2010, J CELL PHYSIOL, V222, P456, DOI 10.1002/jcp.21967; Becker KA, 2010, J CELL PHYSIOL, V222, P103, DOI 10.1002/jcp.21925; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Becker KA, 2007, J CELL PHYSIOL, V210, P517, DOI 10.1002/jcp.20903; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cai J, 2010, J MOL CELL BIOL, V2, P50, DOI 10.1093/jmcb/mjp037; Calder A, 2013, STEM CELLS DEV, V22, P279, DOI 10.1089/scd.2012.0168; Caron NJ, 2013, BIOTECHNOL BIOENG; Chen YL, 2004, DEV BIOL, V271, P144, DOI 10.1016/j.ydbio.2004.03.030; Chetty S, 2013, NAT METHODS; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Fujita Y, 2010, AM J PHYSIOL-GASTR L, V298, pG608, DOI 10.1152/ajpgi.00024.2010; Ghosh S, 2010, EXP CELL RES, V316, P2087, DOI 10.1016/j.yexcr.2010.04.015; Guo TX, 2009, ENDOCR REV, V30, P214, DOI 10.1210/er.2009-0004; Heller RS, 2010, ADV EXP MED BIOL, V654, P21, DOI 10.1007/978-90-481-3271-3_2; Jeon J, 2009, J HISTOCHEM CYTOCHEM, V57, P811, DOI 10.1369/jhc.2009.953307; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Kelly OG, 2011, NAT BIOTECHNOL, V29, P750, DOI 10.1038/nbt.1931; Kim A, 2009, ISLETS, V1, P129, DOI 10.4161/isl.1.2.9480; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; McKnight KD, 2010, CELL STEM CELL, V6, P300, DOI 10.1016/j.stem.2010.03.003; Mfopou JK, 2010, GASTROENTEROLOGY, V138, P2233, DOI 10.1053/j.gastro.2010.02.056; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polak M, 2000, DIABETES, V49, P225, DOI 10.2337/diabetes.49.2.225; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Riedel MJ, 2012, DIABETOLOGIA, V55, P372, DOI 10.1007/s00125-011-2344-9; Sarkar SA, 2008, DIABETOLOGIA, V51, P285, DOI 10.1007/s00125-007-0880-0; Sela Y, 2012, STEM CELLS, V30, P1097, DOI 10.1002/stem.1078; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Van Hoof D, 2009, STEM CELL RES, V3, P73, DOI 10.1016/j.scr.2009.08.003; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005	43	47	49	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82076	10.1371/journal.pone.0082076	http://dx.doi.org/10.1371/journal.pone.0082076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324748	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300128
J	Towers, RE; Murgiano, L; Millar, DS; Glen, E; Topf, A; Jagannathan, V; Drogemuller, C; Goodship, JA; Clarke, AJ; Leeb, T				Towers, Rachel E.; Murgiano, Leonardo; Millar, David S.; Glen, Elise; Topf, Ana; Jagannathan, Vidhya; Droegemueller, Cord; Goodship, Judith A.; Clarke, Angus J.; Leeb, Tosso			A Nonsense Mutation in the IKBKG Gene in Mares with Incontinentia Pigmenti	PLOS ONE			English	Article							ANHIDROTIC ECTODERMAL DYSPLASIA; X-LINKED DISORDER; NEMO; IDENTIFICATION; DEFICIENCY; ACTIVATION; DELETION; UPDATE; GENOME; CATTLE	Ectodermal dysplasias (EDs) are a large and heterogeneous group of hereditary disorders characterized by abnormalities in structures of ectodermal origin. Incontinentia pigmenti (IP) is an ED characterized by skin lesions evolving over time, as well as dental, nail, and ocular abnormalities. Due to X-linked dominant inheritance IP symptoms can only be seen in female individuals while affected males die during development in utero. We observed a family of horses, in which several mares developed signs of a skin disorder reminiscent of human IP. Cutaneous manifestations in affected horses included the development of pruritic, exudative lesions soon after birth. These developed into wart-like lesions and areas of alopecia with occasional wooly hair re-growth. Affected horses also had streaks of darker and lighter coat coloration from birth. The observation that only females were affected together with a high number of spontaneous abortions suggested an X-linked dominant mechanism of transmission. Using next generation sequencing we sequenced the whole genome of one affected mare. We analyzed the sequence data for non-synonymous variants in candidate genes and found a heterozygous nonsense variant in the X-chromosomal IKBKG gene (c.184C>T; p.Arg62*). Mutations in IKBKG were previously reported to cause IP in humans and the homologous p.Arg62* variant has already been observed in a human IP patient. The comparative data thus strongly suggest that this is also the causative variant for the observed IP in horses. To our knowledge this is the first large animal model for IP.	[Towers, Rachel E.; Millar, David S.; Clarke, Angus J.] Cardiff Univ, Inst Med Genet, Cardiff CF10 3AX, S Glam, Wales; [Towers, Rachel E.; Glen, Elise; Topf, Ana; Goodship, Judith A.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Murgiano, Leonardo; Jagannathan, Vidhya; Droegemueller, Cord; Leeb, Tosso] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland; [Murgiano, Leonardo; Jagannathan, Vidhya; Droegemueller, Cord; Leeb, Tosso] Univ Bern, Vetsuisse Fac, DermFocus, Bern, Switzerland	Cardiff University; Newcastle University - UK; University of Bern; University of Bern	Leeb, T (corresponding author), Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland.	tosso.leeb@vetsuisse.unibe.ch	Jagannathan, Vidhya/P-1055-2019; Leeb, Tosso/G-3187-2014	Jagannathan, Vidhya/0000-0002-8155-0041; Leeb, Tosso/0000-0003-0553-4880; Drogemuller, Cord/0000-0001-9773-522X	UK Ectodermal Dysplasia Society	UK Ectodermal Dysplasia Society	This study was funded in part by the UK Ectodermal Dysplasia Society. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aradhya S, 2001, HUM MOL GENET, V10, P2171, DOI 10.1093/hmg/10.19.2171; Berlin AL, 2002, J AM ACAD DERMATOL, V47, P169, DOI 10.1067/mjd.2002.125949; Casal ML, 2005, MAMM GENOME, V16, P524, DOI 10.1007/s00335-004-2463-4; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cluzeau C, 2011, HUM MUTAT, V32, P70, DOI 10.1002/humu.21384; DiGiovanna JJ, 2009, AM J MED GENET A, V149A, P2068, DOI [10.1002/ajmg.a.32961, 10.1002/ajmg.a.32804]; Drogemuller C, 2008, SCIENCE, V321, P1462, DOI 10.1126/science.1162525; Drogemuller C, 2001, GENOME RES, V11, P1699, DOI 10.1101/gr.182501; Drogemuller C, 2002, VET DERMATOL, V13, P307, DOI 10.1046/j.1365-3164.2002.00313.x; Drogemuller C, 2002, J MOL MED-JMM, V80, P319, DOI 10.1007/s00109-002-0320-z; Ehrenreich M, 2007, CUTIS, V79, P355; Fryssira H, 2011, ACTA PAEDIATR, V100, P128, DOI 10.1111/j.1651-2227.2010.01921.x; Fusco F, 2004, HUM MOL GENET, V13, P1763, DOI 10.1093/hmg/ddh192; Fusco F, 2008, HUM MUTAT, V29, P595, DOI 10.1002/humu.20739; Fusco F, 2012, HUM MOL GENET, V21, P1260, DOI 10.1093/hmg/ddr556; Garcia-Martin P, 2013, ACTAS DERMO-SIFILOGR, V104, P451, DOI 10.1016/j.ad.2012.07.012; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Krawczak M, 1998, AM J HUM GENET, V63, P474, DOI 10.1086/301965; Lee NC, 2009, CLIN GENET, V76, P417, DOI 10.1111/j.1399-0004.2009.01232.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mikkola ML, 2009, AM J MED GENET A, V149A, P2031, DOI 10.1002/ajmg.a.32855; Niehues T, 2004, J ALLERGY CLIN IMMUN, V114, P1456, DOI 10.1016/j.jaci.2004.08.047; Olivry T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032072; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Seeliger F, 2005, J COMP PATHOL, V132, P346, DOI 10.1016/j.jcpa.2004.11.001; Smahi A, 2000, NATURE, V405, P466; Wright J Timothy, 2009, Am J Med Genet A, V149A, P2062, DOI 10.1002/ajmg.a.32869; Zonana J, 2000, AM J HUM GENET, V67, P1555, DOI 10.1086/316914	30	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81625	10.1371/journal.pone.0081625	http://dx.doi.org/10.1371/journal.pone.0081625			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324710	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000327949300100
J	Okwera, A; Bwanga, F; Najjingo, I; Mulumba, Y; Mafigiri, DK; Whalen, CC; Joloba, ML				Okwera, Alphonse; Bwanga, Freddie; Najjingo, Irene; Mulumba, Yusuf; Mafigiri, David K.; Whalen, Christopher C.; Joloba, Moses L.			Aetiology of Pulmonary Symptoms in HIV-Infected Smear Negative Recurrent PTB Suspects in Kampala, Uganda: A Cross-Sectional Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PNEUMOCYSTIS-CARINII-PNEUMONIA; ACTIVE ANTIRETROVIRAL THERAPY; BACTERIAL PNEUMONIA; DNA AMPLIFICATION; TUBERCULOSIS; MORTALITY; DIAGNOSIS; ADULTS; IDENTIFICATION	Introduction: Previously treated TB patients with pulmonary symptoms are often considered recurrent TB suspects in the resource-limited settings, where investigations are limited to microscopy and chest x-ray. Category II anti-TB drugs may be inappropriate and may expose patients to pill burden, drug toxicities and drug-drug interactions. Objective: To determine the causes of pulmonary symptoms in HIV-infected smear negative recurrent pulmonary tuberculosis suspects at Mulago Hospital, Kampala. Methods: Between March 2008 and December 2011, induced sputum samples of 178 consented HIV-infected smear negative recurrent TB suspects in Kampala were subjected to MGIT and LJ cultures for mycobacteria at TB Reference Laboratory, Kampala. Processed sputum samples were also tested by PCR to detect 18S rRNA gene of P. jirovecii and cultured for other bacteria. Results: Bacteria, M. tuberculosis and Pneumocystis jirovecii were detected in 27%, 18% and 6.7% of patients respectively and 53.4% of the specimens had no microorganisms. S. pneumoniae, M. catarrhalis and H. influenzae were 100% susceptible to chloramphenicol and erythromycin but co-trimoxazole resistant. Conclusion: At least 81.5% of participants had no microbiologically-confirmed TB. However our findings call for thorough investigation of HIV-infected smear negative recurrent TB suspects to guide cost effective treatment.	[Okwera, Alphonse] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Internal Med, Kampala, Uganda; [Bwanga, Freddie; Najjingo, Irene; Joloba, Moses L.] Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Med Microbiol, Kampala, Uganda; [Mulumba, Yusuf] Uganda Case Res Collaborat Kampala, Kampala, Uganda; [Mafigiri, David K.] Makerere Univ, Coll Humanities & Social Sci, Sch Social Sci, Kampala, Uganda; [Whalen, Christopher C.] Univ Georgia Atlanta, Sch Publ Hlth, Dept Epidemiol & Biostat, Atlanta, GA USA	Makerere University; Makerere University; Makerere University	Okwera, A (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Med, Dept Internal Med, Kampala, Uganda.	A_okwera@mucwru.or.ug		Mafigiri, David/0000-0002-2699-4248; Joloba, Moses/0000-0002-0334-9983	Clinical Operational and Health Services Research at Joint Clinical Research Centre-Kampala; AIDS International Training and Research Programme at Case Western Reserve University [TW000011]; Fogarty International Centre of the National Institutes of Health, United States of America	Clinical Operational and Health Services Research at Joint Clinical Research Centre-Kampala; AIDS International Training and Research Programme at Case Western Reserve University; Fogarty International Centre of the National Institutes of Health, United States of America	Funding provided by Clinical Operational and Health Services Research at Joint Clinical Research Centre-Kampala and the AIDS International Training and Research Programme at Case Western Reserve University, Grant No: TW000011, funded by the Fogarty International Centre of the National Institutes of Health, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afessa B, 2000, CHEST, V117, P1017, DOI 10.1378/chest.117.4.1017; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Bakeera-Kitaka S, 2004, ANN TROP PAEDIATR, V24, P227, DOI 10.1179/027249304225019046; BATUNGWANAYO J, 1992, AM REV RESPIR DIS, V146, P53, DOI 10.1164/ajrccm/146.1.53; Becton Dickinson Co, 2004, BACTEC MGIT 960 SYST; Burman WJ, 2001, AM J RESP CRIT CARE, V164, P7, DOI 10.1164/ajrccm.164.1.2101133; CARTWRIGHT CP, 1994, J CLIN MICROBIOL, V32, P1634, DOI 10.1128/JCM.32.7.1634-1638.1994; U.S. Public Health Service, 2001, MMWR Recomm Rep, V50, P1; Centers for Disease Control and Prevention, 1979, LAB MAN AC FAST MICR; Chakaya J M, 2003, East Afr Med J, V80, P30; COMBALBERT J, 1989, DRUG METAB DISPOS, V17, P197; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; Davis JL, 2007, GLOBAL HIV AIDS MED, p309 ; de Olalla PG, 2002, INT J TUBERC LUNG D, V6, P1051; Dean GL, 2002, AIDS, V16, P75, DOI 10.1097/00002030-200201040-00010; DELUCA A, 1995, MOL CELL PROBE, V9, P333, DOI 10.1016/S0890-8508(95)91636-9; *DHHS, 2004, GUID US ANT AG HIV 1; Elvin K, 1996, AIDS, V10, P1296, DOI 10.1097/00002030-199609000-00021; EPSTEIN LJ, 1994, AM J RESP CRIT CARE, V150, P1456, DOI 10.1164/ajrccm.150.5.7952576; Everett DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017765; Fisk DT, 2003, CLIN INFECT DIS, V36, P70, DOI 10.1086/344951; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gwanzura L, 2003, INT J ANTIMICROB AG, V21, P557, DOI 10.1016/S0924-8579(03)00052-9; Harries AD, 1999, INT J TUBERC LUNG D, V3, P851; Harries AD, 2004, TB HIV CLIN MANUAL; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; Hurtado RM, 2002, J RESP DIS, V23, P591; Jones J L, 1999, MMWR CDC Surveill Summ, V48, P1; Kafuko JM, 2008, RATIONAL DRUG USE RU; Kamulegeya Adriane, 2011, J Dent Res Dent Clin Dent Prospects, V5, P61; Kariuki S, 2003, East Afr Med J, V80, P213; Kibiki G S, 2007, East Afr Med J, V84, P420; KOLARS JC, 1992, J CLIN INVEST, V90, P1871, DOI 10.1172/JCI116064; Kwara A, 2005, INT J TUBERC LUNG D, V9, P248; Kyeyune R, 2010, JAIDS-J ACQ IMM DEF, V55, P446, DOI 10.1097/QAI.0b013e3181eb611a; LEIGH TR, 1993, J CLIN PATHOL, V46, P140, DOI 10.1136/jcp.46.2.140; LU JJ, 1995, J CLIN MICROBIOL, V33, P2785, DOI 10.1128/JCM.33.10.2785-2788.1995; Mahomed AG, 1999, E AFR MED J, V76, P80; Ministry of Health, 2009, NAT ANT TREATM GUID; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Ole-Nguyaine S, 2004, ANN TROP MED PARASIT, V98, P171, DOI 10.1179/000349804225003163; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; POLSKY B, 1986, ANN INTERN MED, V104, P38, DOI 10.7326/0003-4819-104-1-38; Rabodonirina M, 1997, J CLIN MICROBIOL, V35, P2748, DOI 10.1128/JCM.35.11.2748-2751.1997; Santoro-Lopes G, 2002, CLIN INFECT DIS, V34, P543, DOI 10.1086/338641; Siddiqi SH, 2005, MGIT PROCEDURE MANUA; Temple B, 2008, CLIN INFECT DIS, V47, P1126, DOI 10.1086/592252; WAKEFIELD AE, 1991, LANCET, V337, P1378, DOI 10.1016/0140-6736(91)93062-E; WAKEFIELD AE, 1990, LANCET, V336, P451, DOI 10.1016/0140-6736(90)92008-6; World Health Organization, 2004, SCAL ANT THER RES LT; World Health Organization (WHO), 2006, GUID COTR PROPH HIV; Worodria W, 2003, INT J TUBERC LUNG D, V7, P117; Worodria W, 2010, EUR RESPIR J, V36, P446, DOI 10.1183/09031936.00010210; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222; Yoo SD, 2010, AFR J HLTH SCI, V17; Yoshimine H, 2001, AM J TROP MED HYG, V64, P172; Zouiten Faycal, 2003, Tunis Med, V81, P113	58	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82257	10.1371/journal.pone.0082257	http://dx.doi.org/10.1371/journal.pone.0082257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312650	Green Published, gold, Green Submitted			2022-12-25	WOS:000327947800089
J	Pei, YJ; Chen, X; Xiong, DD; Liao, SJ; Wang, GJ				Pei, Yuanjun; Chen, Xiao; Xiong, Dandan; Liao, Shuijiao; Wang, Gejiao			Removal and Recovery of Toxic Silver Ion Using Deep-Sea Bacterial Generated Biogenic Manganese Oxides	PLOS ONE			English	Article							HEAVY-METALS; OXIDIZING BACTERIUM; AQUEOUS-SOLUTIONS; ADSORPTION; SORPTION; BIOSORPTION; MECHANISM; ADSORBENT; OXIDATION; SURFACES	Products containing silver ion (Ag+) are widely used, leading to a large amount of Ag+-containing waste. The deep-sea manganese-oxidizing bacterium Marinobacter sp. MnI7-9 efficiently oxidizes Mn2+ to generate biogenic Mn oxide (BMO). The potential of BMO for recovering metal ions by adsorption has been investigated for some ions but not for Ag+. The main aim of this study was to develop effective methods for adsorbing and recovering Ag using BMO produced by Marinobacter sp. MnI7-9. In addition, the adsorption mechanism was determined using X-ray photoelectron spectroscopy analysis, specific surface area analysis, adsorption kinetics and thermodynamics. The results showed that BMO had a higher adsorption capacity for Ag+ compared to the chemical synthesized MnO2 (CMO). The isothermal absorption curves of BMO and CMO both fit the Langmuir model well and the maximum adsorption capacities at 28 degrees C were 8.097 mmol/g and 0.787 mmol/g, for BMO and CMO, respectively. The change in enthalpy (Delta H-theta) for BMO was 59.69 kJ/mol indicating that it acts primarily by chemical adsorption. The change in free energy (Delta H-theta) for BMO was negative, which suggests that the adsorption occurs spontaneously. Ag+ adsorption by BMO was driven by entropy based on the positive Delta S-theta values. The Ag+ adsorption kinetics by BMO fit the pseudo-second order model and the apparent activation energy of E-a is 21.72 kJ/mol. X-ray photoelectron spectroscopy analysis showed that 15.29% Ag+ adsorbed by BMO was transferred to Ag(0) and meant that redox reaction had happened during the adsorption. Desorption using nitric acid and Na2S completely recovered the Ag. The results show that BMO produced by strain MnI7-9 has potential for bioremediation and reutilization of Ag+-containing waste.	[Pei, Yuanjun; Chen, Xiao; Xiong, Dandan; Liao, Shuijiao; Wang, Gejiao] Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Chen, Xiao; Liao, Shuijiao] Huazhong Agr Univ, Coll Basic Sci, State Key Lab Agr Microbiol, Wuhan, Peoples R China	Huazhong Agricultural University	Liao, SJ (corresponding author), Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	liaosj@mail.hzau.edu.cn; gejiao@mail.hzau.edu.cn			Major International Collaborative Project of the National Natural Science Foundation of China [31010103903]; Chinese 863 project [2012AA101402-3]	Major International Collaborative Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 863 project(National High Technology Research and Development Program of China)	This project was supported by a Major International Collaborative Project of the National Natural Science Foundation of China (31010103903) and the Chinese 863 project (2012AA101402-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abollino O, 2003, WATER RES, V37, P1619, DOI 10.1016/S0043-1354(02)00524-9; Ashgar M, 1980, TROP AGR, V57, P245; Azizian S, 2004, J COLLOID INTERF SCI, V276, P47, DOI 10.1016/j.jcis.2004.03.048; Chun Y, 2004, ENVIRON SCI TECHNOL, V38, P4649, DOI 10.1021/es035034w; Coruh S, 2010, J HAZARD MATER, V180, P486, DOI 10.1016/j.jhazmat.2010.04.056; DEKANY I, 1987, COLLOID SURFACE, V23, P41, DOI 10.1016/0166-6622(87)80248-2; Dong Y, 2004, PHYS CHEM, P222; Duckworth OW, 2008, GEOCHIM COSMOCHIM AC, V72, P3371, DOI 10.1016/j.gca.2008.04.026; El-Ghaffar MAA, 2009, CHEM ENG J, V151, P30, DOI 10.1016/j.cej.2009.01.039; Elwakeel KZ, 2013, INT J MINER PROCESS, V120, P26, DOI 10.1016/j.minpro.2013.02.007; Ghadikolaei N. J., 2013, Research Journal of Applied Sciences, Engineering and Technology, V6, P26; Ghassabzadeh H, 2010, J HAZARD MATER, V177, P950, DOI 10.1016/j.jhazmat.2010.01.010; Glasby Geoffrey P., 2000, SCI MAGAZINE, p[551, 551]; Gokmen V, 2002, J FOOD ENG, V53, P221, DOI 10.1016/S0260-8774(01)00160-1; He JZ, 2010, J SOIL SEDIMENT, V10, P767, DOI 10.1007/s11368-009-0139-0; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Huo HY, 2009, CHEM ENG J, V150, P139, DOI 10.1016/j.cej.2008.12.014; Jiang GH, 2011, POWDER TECHNOL, V212, P284, DOI 10.1016/j.powtec.2011.04.025; Juang RS, 1999, WATER RES, V33, P2403, DOI 10.1016/S0043-1354(98)00469-2; Katsoyiannis IA, 2004, IND ENG CHEM RES, V43, P486, DOI 10.1021/ie030525a; KAUSHIK VK, 1991, J ELECTRON SPECTROSC, V56, P273, DOI 10.1016/0368-2048(91)85008-H; KHARE SK, 1987, J CHEM TECHNOL BIOT, V38, P99; Kim SS, 2011, ASTROBIOLOGY, V11, P775, DOI 10.1089/ast.2011.0619; LEE JW, 1992, J ELECTROCHEM SOC, V139, P3507, DOI 10.1149/1.2069107; Liao SJ, 2013, GEOMICROBIOL J, V30, P150, DOI 10.1080/01490451.2011.654379; Lin ZY, 2005, SPECTROCHIM ACTA A, V61, P1195, DOI 10.1016/j.saa.2004.06.041; Liu Y, 2000, CHEM RES CHINESE U, V16, P1; Liu YY, 2001, CHINESE SCI BULL, V46, P1709; Meng YT, 2009, ENVIRON POLLUT, V157, P2577, DOI 10.1016/j.envpol.2009.02.035; Naik RR, 2002, NAT MATER, V1, P169, DOI 10.1038/nmat758; Nelson YM, 1999, APPL ENVIRON MICROB, V65, P175; Ouvrard S, 2002, IND ENG CHEM RES, V41, P2785, DOI 10.1021/ie0106534; SALIM R, 1994, J ENVIRON SCI HEAL A, V29, P2087, DOI 10.1080/10934529409376166; Saratovsky I, 2006, J AM CHEM SOC, V128, P11188, DOI 10.1021/ja062097g; Shakoori AR, 2002, FOLIA MICROBIOL, V47, P43, DOI 10.1007/BF02818564; SHALVOY RB, 1977, PHYS REV B, V15, P1680, DOI 10.1103/PhysRevB.15.1680; SINGH BK, 1994, J CHEM TECHNOL BIOT, V61, P57, DOI 10.1002/jctb.280610109; Sun DH, 2013, APPL MECH MATER, V295-298, P129, DOI 10.4028/www.scientific.net/AMM.295-298.129; Tang B, 2010, J HAZARD MATER, V177, P377, DOI 10.1016/j.jhazmat.2009.12.042; Tani Y, 2004, J ENVIRON SCI HEAL A, V39, P2641, DOI [10.1081/ESE-200027021, 10.1081/LESA-200027021]; Tani Y, 2003, APPL GEOCHEM, V18, P1541, DOI 10.1016/S0883-2927(03)00075-1; Vakula NI, 2013, CHEM PHYS LETT, V567, P27, DOI 10.1016/j.cplett.2013.02.067; Villalobos M, 2005, ELEMENTS, V1, P223, DOI 10.2113/gselements.1.4.223; Villalobos M, 2003, GEOCHIM COSMOCHIM AC, V67, P2649, DOI 10.1016/S0016-7037(03)00217-5; Wang HF, 2012, J BACTERIOL, V194, P899, DOI 10.1128/JB.06551-11; Wang WM, 2009, MICROBIOL-SGM, V155, P1989, DOI 10.1099/mic.0.024141-0; Webb SM, 2006, ENVIRON SCI TECHNOL, V40, P771, DOI 10.1021/es051679f; Yang JY, 2006, ENVIRON POLLUT, V143, P9, DOI 10.1016/j.envpol.2005.11.010; Yi XS, 2011, J HAZARD MATER, V189, P495, DOI 10.1016/j.jhazmat.2011.02.063; Yin H, 2011, J HAZARD MATER, V196, P318, DOI 10.1016/j.jhazmat.2011.09.027; Yu B, 2000, J HAZARD MATER, V80, P33, DOI 10.1016/S0304-3894(00)00278-8	51	16	16	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81627	10.1371/journal.pone.0081627	http://dx.doi.org/10.1371/journal.pone.0081627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312566	gold, Green Submitted, Green Published			2022-12-25	WOS:000327944500081
J	Wang, JX; Liang, YC; Wang, Y; Cui, J; Liu, M; Du, W; Xu, Y				Wang, Jiaxin; Liang, Yanchun; Wang, Yan; Cui, Juan; Liu, Ming; Du, Wei; Xu, Ying			Computational Prediction of Human Salivary Proteins from Blood Circulation and Application to Diagnostic Biomarker Identification	PLOS ONE			English	Article							ORAL-CANCER; SERUM; RANKING; ENDOTHELIN-1; PROTEOMICS; CARCINOMA; C-ERBB-2; REMOTE; TUMORS; WOMEN	Proteins can move from blood circulation into salivary glands through active transportation, passive diffusion or ultrafiltration, some of which are then released into saliva and hence can potentially serve as biomarkers for diseases if accurately identified. We present a novel computational method for predicting salivary proteins that come from circulation. The basis for the prediction is a set of physiochemical and sequence features we found to be discerning between human proteins known to be movable from circulation to saliva and proteins deemed to be not in saliva. A classifier was trained based on these features using a support-vector machine to predict protein secretion into saliva. The classifier achieved 88.56% average recall and 90.76% average precision in 10-fold cross-validation on the training data, indicating that the selected features are informative. Considering the possibility that our negative training data may not be highly reliable (i.e., proteins predicted to be not in saliva), we have also trained a ranking method, aiming to rank the known salivary proteins from circulation as the highest among the proteins in the general background, based on the same features. This prediction capability can be used to predict potential biomarker proteins for specific human diseases when coupled with the information of differentially expressed proteins in diseased versus healthy control tissues and a prediction capability for blood-secretory proteins. Using such integrated information, we predicted 31 candidate biomarker proteins in saliva for breast cancer.	[Wang, Jiaxin; Liang, Yanchun; Wang, Yan; Liu, Ming; Du, Wei; Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun 130023, Peoples R China; [Cui, Juan; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Cui, Juan; Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	Jilin University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Du, W (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun 130023, Peoples R China.	weidu@jlu.edu.cn; xyn@bmb.uga.edu			Natural Science Foundation of China [61272207]; Science-Technology Development Projects of Jilin Province of China [20120730, 20130522111JH, 20130522114JH]; Ph.D. Program Foundation of MOE of China [20120061110094, 20120061120106]; Postdoctoral Science Foundation [2012M520678]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science-Technology Development Projects of Jilin Province of China; Ph.D. Program Foundation of MOE of China; Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work is supported by the Natural Science Foundation of China (61272207), the Science-Technology Development Projects of Jilin Province of China (20120730, 20130522111JH, 20130522114JH), the Ph.D. Program Foundation of MOE of China (20120061110094, 20120061120106), and the Postdoctoral Science Foundation (2012M520678). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, MATH STAT METASTATIS; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Becker KG, 2000, BIOINFORMATICS, V16, P745, DOI 10.1093/bioinformatics/16.8.745; BENCHETRIT E, 1993, CLIN RHEUMATOL, V12, P471, DOI 10.1007/BF02231773; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler LR, 2009, CLIN LAB MED, V29, P71, DOI 10.1016/j.cll.2009.01.004; BRANDTZAEG P, 1971, CLIN EXP IMMUNOL, V8, P69; CHEN DX, 1990, OBSTET GYNECOL, V75, P701; Chen YJ, 2005, NUCLEIC ACIDS RES, V33, pD169; Cheng YSL, 2011, ORAL ONCOL, V47, P1122, DOI 10.1016/j.oraloncology.2011.07.032; Chiappin S, 2007, CLIN CHIM ACTA, V383, P30, DOI 10.1016/j.cca.2007.04.011; Christodoulides N, 2005, LAB CHIP, V5, P261, DOI 10.1039/b414194f; Cui J, 2008, BIOINFORMATICS, V24, P2370, DOI 10.1093/bioinformatics/btn418; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j; Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI [10.1093/nar/gkj040, 10.1007/978-1-60761-444-9_19]; Du W, 2013, INT J DATA MIN BIOIN, V7, P58, DOI 10.1504/IJDMB.2013.050977; Grant K, 2003, BRIT J CANCER, V88, P163, DOI 10.1038/sj.bjc.6700750; He JR, 2006, IEEE T IMAGE PROCESS, V15, P3170, DOI 10.1109/TIP.2006.877491; Herr AE, 2007, P NATL ACAD SCI USA, V104, P5268, DOI 10.1073/pnas.0607254104; Holten-Andersen L, 2008, SCAND J CLIN LAB INV, V68, P548, DOI 10.1080/00365510701883180; Hong CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016875; Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037; JENZANO JW, 1986, J DENT RES, V65, P67, DOI 10.1177/00220345860650011201; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Li SJ, 2009, NUCLEIC ACIDS RES, V37, pD907, DOI 10.1093/nar/gkn849; Liu Q, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-250; Nishimura D., 2001, J SCI, V2, P117; Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767; Rhodus N, 1998, Clin Oral Investig, V2, P191, DOI 10.1007/s007840050069; SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161, DOI 10.1177/10454411950060020501; Scholkopf B, 2001, NEURAL COMPUT, V13, P1443, DOI 10.1162/089976601750264965; Sprenger J, 2008, NUCLEIC ACIDS RES, V36, pD230, DOI 10.1093/nar/gkm950; St John MAR, 2004, ARCH OTOLARYNGOL, V130, P929, DOI 10.1001/archotol.130.8.929; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Streckfus C, 2005, Adv Dent Res, V18, P17; Streckfus C, 2000, CLIN CANCER RES, V6, P2363; Streckfus C, 2001, Clin Oral Investig, V5, P133, DOI 10.1007/s007840100104; Streckfus C, 2000, CANCER INVEST, V18, P101, DOI 10.3109/07357900009038240; Streckfus CF, 2008, CANCER INVEST, V26, P159, DOI 10.1080/07357900701783883; Turan T, 2000, EUR UROL, V38, P550, DOI 10.1159/000020354; Wong DT, 2006, J AM DENT ASSOC, V137, P313, DOI 10.14219/jada.archive.2006.0180; Zhang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015573; Zhou DY, 2004, ADV NEUR IN, V16, P169	46	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80211	10.1371/journal.pone.0080211	http://dx.doi.org/10.1371/journal.pone.0080211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24324552	Green Published, gold			2022-12-25	WOS:000327252100133
J	Adeosun, SO; Hou, X; Zheng, BY; Stockmeier, C; Ou, XM; Paul, I; Mosley, T; Weisgraber, K; Wang, JM				Adeosun, Samuel O.; Hou, Xu; Zheng, Baoying; Stockmeier, Craig; Ou, Xiaoming; Paul, Ian; Mosley, Thomas; Weisgraber, Karl; Wang, Jun Ming			Cognitive Deficits and Disruption of Neurogenesis in a Mouse Model of Apolipoprotein E4 Domain Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Alzheimer Disease; ApoE; Apoptosis; BDNF; Neurogenesis; Protein Domains; Antagonistic Pleiotropy; Doublecortin; Learning and Memory	ADULT HIPPOCAMPAL NEUROGENESIS; INCREASED TAU PHOSPHORYLATION; ALZHEIMERS-DISEASE; E GENOTYPE; DENTATE GYRUS; TRANSGENIC MICE; E EPSILON-4; MEMORY PERFORMANCE; RECOGNITION MEMORY; APOE POLYMORPHISM	Background: Domain interaction may be the principal pathogenic feature of apoE4 in Alzheimer disease. Results: Young and old mice with mutations causing apoE4 domain interaction showed impaired cognition and a disruption in neurogenesis. Conclusion: Domain interaction mediates apoE4 neuro-pathologies and cognitive phenotype. Significance: Domain interaction is a viable prophylactic target against apoE4 cognitive phenotype and increased susceptibility to Alzheimer disease. Apolipoprotein E4 (apoE4) allele is the major genetic risk factor for sporadic Alzheimer disease (AD) due to the higher prevalence and earlier onset of AD in apoE4 carriers. Accumulating data suggest that the interaction between the N- and the C-terminal domains in the protein may be the main pathologic feature of apoE4. To test this hypothesis, we used Arg-61 mice, a model of apoE4 domain interaction, by introducing the domain interaction feature of human apoE4 into native mouse apoE. We carried out hippocampus-dependent learning and memory tests and related cellular and molecular assays on 12- and 3-month-old Arg-61 and age-matched background C57BL/6J mice. Learning and memory task performance were impaired in Arg-61 mice at both old and young ages compared with C57BL/6J mice. Surprisingly, young Arg-61 mice had more mitotic doublecortin-positive cells in the subgranular zone; mRNA levels of brain-derived neurotrophic factor (BDNF) and TrkB were also higher in 3-month-old Arg-61 hippocampus compared with C57BL/6J mice. These early-age neurotrophic and neurogenic (proliferative) effects in the Arg-61 mouse may be an inadequate compensatory but eventually detrimental attempt by the system to repair itself. This is supported by the higher cleaved caspase-3 levels in the young animals that not only persisted, but increased in old age, and the lower levels of doublecortin at old age in the hippocampus of Arg-61 mice. These results are consistent with human apoE4-dependent cognitive and neuro-pathologic changes, supporting the principal role of domain interaction in the pathologic effect of apoE4. Domain interaction is, therefore, a viable therapeutic/prophylactic target for cognitive impairment and AD in apoE4 subjects.	[Zheng, Baoying; Wang, Jun Ming] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA; [Adeosun, Samuel O.; Hou, Xu; Wang, Jun Ming] Univ Mississippi, Med Ctr, Grad Program Neurosci, Jackson, MS 39216 USA; [Stockmeier, Craig; Ou, Xiaoming; Paul, Ian; Wang, Jun Ming] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Mosley, Thomas; Wang, Jun Ming] Univ Mississippi, Med Ctr, Memory Impairment & Neurodegenerat Dementia Ctr, Jackson, MS 39216 USA; [Weisgraber, Karl] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of California System; University of California San Francisco; The J David Gladstone Institutes	Wang, JM (corresponding author), Univ Mississippi, Med Ctr, Dept Pathol, 2500 N State St, Jackson, MS 39216 USA.	jwang@umc.edu		Adeosun, Samuel/0000-0002-2331-7911	National Institutes of Health Center [RR17701]; Alzheimer's Association Investigator Initiated Research Grant [133086]; Carraway foundation grant; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017701] Funding Source: NIH RePORTER	National Institutes of Health Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association Investigator Initiated Research Grant; Carraway foundation grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by a training grant in National Institutes of Health Center Grant RR17701 (to J. M. W.). This work was supported by Alzheimer's Association Investigator Initiated Research Grant133086 and a Carraway foundation grant (to J. M. W.).	Abbott AC, 2013, J ALZHEIMERS DIS, V34, P873, DOI 10.3233/JAD-121714; Acevedo SF, 2010, PEDIATR RES, V67, P293, DOI 10.1203/PDR.0b013e3181cb8e68; Adeosun SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050040; Akanmu MA, 2007, BEHAV BRAIN RES, V182, P88, DOI 10.1016/j.bbr.2007.05.006; Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; [Anonymous], [No title captured]; Beffert U, 1999, MOL BRAIN RES, V68, P181, DOI 10.1016/S0169-328X(99)00073-X; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Bour A, 2008, BEHAV BRAIN RES, V193, P174, DOI 10.1016/j.bbr.2008.05.008; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; Cedazo-Minguez A, 2003, J NEUROCHEM, V87, P1152, DOI 10.1046/j.1471-4159.2003.02088.x; Cerf E, 2011, FASEB J, V25, P1585, DOI 10.1096/fj.10-175976; Chen Q, 2008, NEUROBIOL DIS, V29, P316, DOI 10.1016/j.nbd.2007.09.005; Coras R, 2010, BRAIN, V133, P3359, DOI 10.1093/brain/awq215; Corder EH, 1996, ARCH NEUROL-CHICAGO, V53, P418, DOI 10.1001/archneur.1996.00550050048022; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; De Blasi S, 2009, EXP GERONTOL, V44, P224, DOI 10.1016/j.exger.2008.11.005; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dodart JC, 2005, P NATL ACAD SCI USA, V102, P1211, DOI 10.1073/pnas.0409072102; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fagan AM, 2002, NEUROBIOL DIS, V9, P305, DOI 10.1006/nbdi.2002.0483; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Gang BZ, 2011, BRAIN RES, V1389, P183, DOI 10.1016/j.brainres.2011.03.039; Gibb GM, 2000, FEBS LETT, V485, P99, DOI 10.1016/S0014-5793(00)02196-7; Greenwood PM, 2005, NEUROPSYCHOLOGY, V19, P199, DOI 10.1037/0894-4105.19.2.199; Grootendorst J, 2005, BEHAV BRAIN RES, V159, P1, DOI 10.1016/j.bbr.2004.09.019; Han SD, 2008, ALZHEIMERS DEMENT, V4, P251, DOI 10.1016/j.jalz.2008.02.006; Harris FM, 2004, J BIOL CHEM, V279, P44795, DOI 10.1074/jbc.M408127200; Hartman RE, 2001, EXP NEUROL, V170, P326, DOI 10.1006/exnr.2001.7715; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; Hashimoto Y, 2000, J NEUROSCI, V20, P8401, DOI 10.1523/JNEUROSCI.20-22-08401.2000; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; Hwang IK, 2007, NEUROCHEM RES, V32, P1604, DOI 10.1007/s11064-007-9366-1; Hyman BT, 2011, ARCH NEUROL-CHICAGO, V68, P1062, DOI 10.1001/archneurol.2011.70; Inbar D, 2010, NEURODEGENER DIS, V7, P16, DOI 10.1159/000283477; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Jinno S, 1998, BRAIN RES, V814, P55, DOI 10.1016/S0006-8993(98)01075-0; Leung L, 2012, PLOS ONE, V7; Li G, 2009, CELL STEM CELL, V5, P634, DOI 10.1016/j.stem.2009.10.015; Lind J, 2006, NEUROSCI LETT, V396, P23, DOI 10.1016/j.neulet.2005.11.070; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Toledano MA, 2010, J ALZHEIMERS DIS, V20, P395, DOI 10.3233/JAD-2010-1388; Lovestone S, 1996, NEUROSCIENCE, V73, P1145, DOI 10.1016/0306-4522(96)00126-1; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mayeux R, 2001, NEUROBIOL AGING, V22, P683, DOI 10.1016/S0197-4580(01)00223-8; Michikawa M, 1998, J NEUROSCI RES, V54, P58, DOI 10.1002/(SICI)1097-4547(19981001)54:1<58::AID-JNR7>3.0.CO;2-G; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Negash S, 2009, NEUROPSYCHOLOGY, V23, P81, DOI 10.1037/a0014014; Nilsson LG, 2002, NEUROSCI BIOBEHAV R, V26, P841, DOI 10.1016/S0149-7634(02)00070-2; Paus M, 2013, BRAIN RES, V1497, P85, DOI 10.1016/j.brainres.2012.12.024; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Pomara N, 2005, ARCH GEN PSYCHIAT, V62, P209, DOI 10.1001/archpsyc.62.2.209; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Ready RE, 2011, AM J ALZHEIMERS DIS, V26, P463, DOI 10.1177/1533317511421921; REBECK GW, 1994, NEUROLOGY, V44, P1513, DOI 10.1212/WNL.44.8.1513; REBECK GW, 1993, NEURON, V11, P575; REED T, 1994, ARCH NEUROL-CHICAGO, V51, P1189, DOI 10.1001/archneur.1994.00540240033012; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Rodriguez GA, 2013, LEARN MEMORY, V20, P256, DOI 10.1101/lm.030031.112; Rodriguez JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002935; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Tesseur I, 2000, AM J PATHOL, V156, P951, DOI 10.1016/S0002-9440(10)64963-2; Tupler LA, 2007, NEUROBIOL AGING, V28, P1644, DOI 10.1016/j.neurobiolaging.2006.07.001; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Volz F, 2011, EPILEPSIA, V52, P1579, DOI 10.1111/j.1528-1167.2011.03086.x; Vuillermot S, 2011, GENES BRAIN BEHAV, V10, P589, DOI 10.1111/j.1601-183X.2011.00698.x; Vukovic J, 2013, J NEUROSCI, V33, P6603, DOI 10.1523/JNEUROSCI.3064-12.2013; Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007; Wang JM, 2010, P NATL ACAD SCI USA, V107, P6498, DOI 10.1073/pnas.1001422107; Waterhouse EG, 2012, J NEUROSCI, V32, P14318, DOI 10.1523/JNEUROSCI.0709-12.2012; WEISGRABER KH, 1990, J LIPID RES, V31, P1503; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Wright RL, 2005, STRESS, V8, P151, DOI 10.1080/10253890500156663; Yu YX, 2009, HIPPOCAMPUS, V19, P1247, DOI 10.1002/hipo.20587; Zepa L., 2011, INT J ALZHEIMERS DIS, V2011; Zetterberg H, 2009, ALZHEIMERS DEMENT, V5, P75, DOI 10.1016/j.jalz.2008.10.005; Zhang C, 2007, EXP NEUROL, V204, P77, DOI 10.1016/j.expneurol.2006.09.018; Zhong N, 2008, ALZHEIMERS DEMENT, V4, P179, DOI 10.1016/j.jalz.2008.01.006; Zhong N, 2009, J BIOL CHEM, V284, P27273, DOI 10.1074/jbc.M109.014464; Zhu YG, 2012, GLIA, V60, P559, DOI 10.1002/glia.22289	102	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2946	2959		10.1074/jbc.M113.497909	http://dx.doi.org/10.1074/jbc.M113.497909			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24324264	Green Published, hybrid			2022-12-25	WOS:000333403000042
J	Isaksen, T; Westereng, B; Aachmann, FL; Agger, JW; Kracher, D; Kittl, R; Ludwig, R; Haltrich, D; Eijsink, VGH; Horn, SJ				Isaksen, Trine; Westereng, Bjorge; Aachmann, Finn L.; Agger, Jane W.; Kracher, Daniel; Kittl, Roman; Ludwig, Roland; Haltrich, Dietmar; Eijsink, Vincent G. H.; Horn, Svein J.			A C4-oxidizing Lytic Polysaccharide Monooxygenase Cleaving Both Cellulose and Cello-oligosaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biofuel; Cellulase; Mass Spectrometry (MS); Metalloenzymes; NMR; AA10; AA9; CBM33; GH61; Lytic Polysaccharide Monooxygenase (LPMO)	CRYSTAL-STRUCTURE; PICHIA-PASTORIS; DEGRADATION; DEHYDROGENASE; NOMENCLATURE; OXIDATION; CLEAVAGE; ENZYMES; BINDING	Background: Lytic polysaccharide monooxygenases (LPMOs) are recently discovered enzymes that cleave polysaccharides. Results: We describe a novel LPMO and use a range of analytical methods to characterize its activity. Conclusion: Cellulose and cello-oligosaccharides are cleaved by oxidizing the sugar at the nonreducing end in the C4 position. Significance: This study provides unequivocal evidence for C4 oxidation of the nonreducing end sugar and demonstrates a novel LPMO substrate specificity. Lignocellulosic biomass is a renewable resource that significantly can substitute fossil resources for the production of fuels, chemicals, and materials. Efficient saccharification of this biomass to fermentable sugars will be a key technology in future biorefineries. Traditionally, saccharification was thought to be accomplished by mixtures of hydrolytic enzymes. However, recently it has been shown that lytic polysaccharide monooxygenases (LPMOs) contribute to this process by catalyzing oxidative cleavage of insoluble polysaccharides utilizing a mechanism involving molecular oxygen and an electron donor. These enzymes thus represent novel tools for the saccharification of plant biomass. Most characterized LPMOs, including all reported bacterial LPMOs, form aldonic acids, i.e., products oxidized in the C1 position of the terminal sugar. Oxidation at other positions has been observed, and there has been some debate concerning the nature of this position (C4 or C6). In this study, we have characterized an LPMO from Neurospora crassa (NcLPMO9C; also known as NCU02916 and NcGH61-3). Remarkably, and in contrast to all previously characterized LPMOs, which are active only on polysaccharides, NcLPMO9C is able to cleave soluble cello-oligosaccharides as short as a tetramer, a property that allowed detailed product analysis. Using mass spectrometry and NMR, we show that the cello-oligosaccharide products released by this enzyme contain a C4 gemdiol/keto group at the nonreducing end.	[Isaksen, Trine; Westereng, Bjorge; Agger, Jane W.; Eijsink, Vincent G. H.; Horn, Svein J.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Westereng, Bjorge] Univ Copenhagen, DK-1958 Frederiksberg C, Denmark; [Aachmann, Finn L.] Norwegian Univ Sci & Technol, Dept Biotechnol, NOBIPOL, N-7491 Trondheim, Norway; [Kracher, Daniel; Kittl, Roman; Ludwig, Roland; Haltrich, Dietmar] Univ Nat Resources & Life Sci, Dept Food Sci & Technol, BOKU, A-1190 Vienna, Austria	Norwegian University of Life Sciences; University of Copenhagen; Norwegian University of Science & Technology (NTNU); University of Natural Resources & Life Sciences, Vienna	Eijsink, VGH (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway.	vincent.eijsink@nmbu.no	Agger, Jane Wittrup/AAF-8701-2020; Aachmann, Finn/G-4136-2015; Agger, Jane Wittrup/B-7326-2015; Kracher, Daniel/H-6667-2019; Horn, Svein Jarle/C-6258-2008; Haltrich, Dietmar/N-2624-2019; Westereng, Bjørge/A-1688-2013; Agger, Jane Wittrup/G-6783-2017	Agger, Jane Wittrup/0000-0002-7796-3089; Aachmann, Finn/0000-0003-1613-4663; Agger, Jane Wittrup/0000-0002-7796-3089; Kracher, Daniel/0000-0002-3856-3170; Horn, Svein Jarle/0000-0002-1590-9001; Haltrich, Dietmar/0000-0002-8722-8176; Westereng, Bjørge/0000-0002-5141-7231; Agger, Jane Wittrup/0000-0002-7796-3089; Kittl, Roman/0000-0002-8923-481X; Ludwig, Roland/0000-0002-5058-5874	Norwegian Research Council [193817, 203402, 214613, 216162, 217708]; European Commission [FP7-KBBE-2013-7-613549]	Norwegian Research Council(Research Council of NorwayEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Norwegian Research Council Projects 193817, 203402, 214613, 216162, and 217708 and by the European Commission through the FP7-KBBE-2013-7-613549 project INDOX.	Aachmann FL, 2012, P NATL ACAD SCI USA, V109, P18779, DOI 10.1073/pnas.1208822109; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Bey M, 2013, APPL ENVIRON MICROB, V79, P488, DOI 10.1128/AEM.02942-12; Cancilla MT, 1999, ANAL CHEM, V71, P3206, DOI 10.1021/ac9813484; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Flitsch A, 2013, ENZYME MICROB TECH, V52, P60, DOI 10.1016/j.enzmictec.2012.10.007; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Harreither W, 2011, APPL ENVIRON MICROB, V77, P1804, DOI 10.1128/AEM.02052-10; Hemsworth GR, 2013, J AM CHEM SOC, V135, P6069, DOI 10.1021/ja402106e; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Ifuku S, 2012, NANOSCALE, V4, P3308, DOI 10.1039/c2nr30383c; Kitago Y, 2007, J BIOL CHEM, V282, P35703, DOI 10.1074/jbc.M706835200; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; Kopper S, 2003, HELV CHIM ACTA, V86, P827, DOI 10.1002/hlca.200390083; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sygmund C, 2012, APPL ENVIRON MICROB, V78, P6161, DOI 10.1128/AEM.01503-12; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Westereng B, 2013, J CHROMATOGR A, V1271, P144, DOI 10.1016/j.chroma.2012.11.048; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; WOOD TM, 1988, METHOD ENZYMOL, V160, P19; Wu M, 2013, J BIOL CHEM, V288, P12828, DOI 10.1074/jbc.M113.459396; Xia YL, 2005, MAGN RESON CHEM, V43, P372, DOI 10.1002/mrc.1558; Zamocky M, 2008, PROTEIN EXPRES PURIF, V59, P258, DOI 10.1016/j.pep.2008.02.007	33	220	228	3	160	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2632	2642		10.1074/jbc.M113.530196	http://dx.doi.org/10.1074/jbc.M113.530196			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24324265	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000333403000014
J	Ghosh, A; Luis, AS; Bras, JLA; Pathaw, N; Chrungoo, NK; Fontes, CMGA; Goyal, A				Ghosh, Arabinda; Luis, Ana Sofia; Bras, Joana L. A.; Pathaw, Neeta; Chrungoo, Nikhil K.; Fontes, Carlos M. G. A.; Goyal, Arun			Deciphering Ligand Specificity of a Clostridium thermocellum Family 35 Carbohydrate Binding Module (CtCBM35) for Gluco- and Galacto-Substituted Mannans and Its Calcium Induced Stability	PLOS ONE			English	Article							BACTERIAL CELLULASE; LIGHT-SCATTERING; POLYDISPERSITY; PROTEINS; GROMACS	This study investigated the role of CBM35 from Clostridium thermocellum (CtCBM35) in polysaccharide recognition. CtCBM35 was cloned into pET28a (+) vector with an engineered His(6) tag and expressed in Escherichia coli BL21 (DE3) cells. A homogenous 15 kDa protein was purified by immobilized metal ion chromatography (IMAC). Ligand binding analysis of CtCBM35 was carried out by affinity electrophoresis using various soluble ligands. CtCBM35 showed a manno-configured ligand specific binding displaying significant association with konjac glucomannan (K-a = 14.3x10(4) M-1), carob galactomannan (K-a = 12.4x10(4) M-1) and negligible association (K-a = 12 mu M-1) with insoluble mannan. Binding of CtCBM35 with polysaccharides which was calcium dependent exhibited two fold higher association in presence of 10 mM Ca2+ ion with konjac glucomannan (K-a = 41x10(4) M-1) and carob galactomannan (K-a = 30x10(4) M-1). The polysaccharide binding was further investigated by fluorescence spectrophotometric studies. On binding with carob galactomannan and konjac glucomannan the conformation of CtCBM35 changed significantly with regular 21 nm peak shifts towards lower quantum yield. The degree of association (K-a) with konjac glucomannan and carob galactomannan, 14.3x10(4) M-1 and 11.4x10(4) M-1, respectively, corroborated the findings from affinity electrophoresis. The association of CtCBM35with konjac glucomannan led to higher free energy of binding (Delta G) -25 kJ mole(-1) as compared to carob galactomannan (Delta G) -22 kJ mole(-1). On binding CtCBM35 with konjac glucomannan and carob galactomannan the hydrodynamic radius (R-H) as analysed by dynamic light scattering (DLS) study, increased to 8 nm and 6 nm, respectively, from 4.25 nm in absence of ligand. The presence of 10 mM Ca2+ ions imparted stiffer orientation of CtCBM35 particles with increased R-H of 4.52 nm. Due to such stiffer orientation CtCBM35 became more thermostable and its melting temperature was shifted to 70 degrees C from initial 50 degrees C.	[Ghosh, Arabinda; Goyal, Arun] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India; [Luis, Ana Sofia; Bras, Joana L. A.; Fontes, Carlos M. G. A.] CIISA Fac Med Vet, Lisbon, Portugal; [Pathaw, Neeta; Chrungoo, Nikhil K.] North Eastern Hill Univ, Shillong, Meghalaya, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Universidade de Lisboa; North Eastern Hill University	Goyal, A (corresponding author), Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India.	arungoyl@iitg.ernet.in	Ghosh, Arabinda/AAS-3900-2020; Luis, Ana/ABE-5158-2020	Luis, Ana/0000-0002-5086-7353; Ghosh, Arabinda/0000-0002-3891-5949; Bras, Joana/0000-0002-1141-5530; Fontes, Carlos/0000-0002-1219-9753	University Grants Commission (UGC), New Delhi, India	University Grants Commission (UGC), New Delhi, India(University Grants Commission, India)	Mr. Arabinda Ghosh is supported by a scholarship from University Grants Commission (UGC), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Hachem M, 2002, BIOCHEMISTRY-US, V41, P5720, DOI 10.1021/bi012094a; Belatik A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036723; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bolam DN, 2004, J BIOL CHEM, V279, P22953, DOI 10.1074/jbc.M313317200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branden K, 1999, INTRO PROTEIN STRUCT; Cai SC, 2011, J BACTERIOL, V193, P5199, DOI 10.1128/JB.05227-11; Correia MAS, 2010, BIOCHEMISTRY-US, V49, P6193, DOI 10.1021/bi1006139; DIN N, 1994, P NATL ACAD SCI USA, V91, P11383, DOI 10.1073/pnas.91.24.11383; DIN N, 1991, BIO-TECHNOL, V9, P1096, DOI 10.1038/nbt1191-1096; DOBSON CM, 1994, TRENDS BIOCHEM SCI, V19, P31, DOI 10.1016/0968-0004(94)90171-6; Dvortsov IA, 2009, MICROBIOL-SGM, V155, P2442, DOI 10.1099/mic.0.026930-0; Finkelstein AV, 2004, PHYS LIFE REV, V1, P23, DOI 10.1016/j.plrev.2004.03.001; GILKES NR, 1992, J BIOL CHEM, V267, P6743; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Johansson R, 2006, J MOL RECOGNIT, V19, P275, DOI 10.1002/jmr.794; Jorgensen H, 2010, APPL BIOCHEM BIOTECH, V161, P318, DOI 10.1007/s12010-009-8814-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mizutani K, 2012, APPL ENVIRON MICROB, V78, P4781, DOI 10.1128/AEM.07457-11; MORRISON JD, 1992, J APPL CRYSTALLOGR, V25, P504, DOI 10.1107/S0021889892001729; Noorbatcha I. A., 2012, Australian Journal of Basic and Applied Sciences, V6, P109; Ofir K, 2005, PROTEOMICS, V5, P1806, DOI 10.1002/pmic.200401078; OSTROWSKY N, 1981, OPT ACTA, V28, P1059, DOI 10.1080/713820704; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; PROVENCHER SW, 1979, MAKROMOL CHEM, V180, P201; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Sambrook J, 1989, MOL CLONING LAB MANU, VIII, P1647; Saravanan P, 2012, J MOL GRAPH MODEL, V38, P235, DOI 10.1016/j.jmgm.2012.06.016; Shiba K, 2010, ANAL SCI, V26, P659, DOI 10.2116/analsci.26.659; Sunna A, 2010, APPL MICROBIOL BIOT, V86, P189, DOI 10.1007/s00253-009-2242-y; TAKEO K, 1984, ELECTROPHORESIS, V5, P187, DOI 10.1002/elps.1150050402; Taylor EJ, 2005, J BIOL CHEM, V280, P32761, DOI 10.1074/jbc.M506580200; Tunnicliffe RB, 2005, J MOL BIOL, V347, P287, DOI 10.1016/j.jmb.2005.01.038; Valenzuela SV, 2012, APPL ENVIRON MICROB, V78, P3923, DOI 10.1128/AEM.07932-11; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291	35	6	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e80415	10.1371/journal.pone.0080415	http://dx.doi.org/10.1371/journal.pone.0080415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324599	Green Published, gold, Green Submitted			2022-12-25	WOS:000328566700008
J	Mokhtari, Z; Mech, F; Zitzmann, C; Hasenberg, M; Gunzer, M; Figge, MT				Mokhtari, Zeinab; Mech, Franziska; Zitzmann, Carolin; Hasenberg, Mike; Gunzer, Matthias; Figge, Marc Thilo			Automated Characterization and Parameter-Free Classification of Cell Tracks Based on Local Migration Behavior	PLOS ONE			English	Article							MICROSCOPY; REVEALS	Cell migration is the driving force behind the dynamics of many diverse biological processes. Even though microscopy experiments are routinely performed today by which populations of cells are visualized in space and time, valuable information contained in image data is often disregarded because statistical analyses are performed at the level of cell populations rather than at the single-cell level. Image-based systems biology is a modern approach that aims at quantitatively analyzing and modeling biological processes by developing novel strategies and tools for the interpretation of image data. In this study, we take first steps towards a fully automated characterization and parameter-free classification of cell track data that can be generally applied to tracked objects as obtained from image data. The requirements to achieve this aim include: (i) combination of different measures for single cell tracks, such as the confinement ratio and the asphericity of the track volume, and (ii) computation of these measures in a staggered fashion to retrieve local information from all possible combinations of track segments. We demonstrate for a population of synthetic cell tracks as well as for in vitro neutrophil tracks obtained from microscopy experiment that the information contained in the track data is fully exploited in this way and does not require any prior knowledge, which keeps the analysis unbiased and general. The identification of cells that show the same type of migration behavior within the population of all cells is achieved via agglomerative hierarchical clustering of cell tracks in the parameter space of the staggered measures. The recognition of characteristic patterns is highly desired to advance our knowledge about the dynamics of biological processes.	[Mokhtari, Zeinab; Mech, Franziska; Zitzmann, Carolin; Figge, Marc Thilo] HKI, Ctr Syst Biol Infect, Leibniz Inst Nat Product Res & Infect Biol, Jena, Germany; [Mokhtari, Zeinab; Zitzmann, Carolin; Figge, Marc Thilo] Univ Jena, D-07745 Jena, Germany; [Mech, Franziska] German Rheumatism Res Ctr DRFZ, Berlin, Germany; [Hasenberg, Mike; Gunzer, Matthias] Univ Duisburg Essen, Ctr Med Biotechnol, Essen, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Deutsches Rheuma-Forschungszentrum (DRFZ); University of Duisburg Essen	Figge, MT (corresponding author), HKI, Ctr Syst Biol Infect, Leibniz Inst Nat Product Res & Infect Biol, Jena, Germany.	thilo.figge@hki-jena.de	Gunzer, Matthias/AAW-7026-2021; Figge, Marc Thilo/J-7547-2017	Gunzer, Matthias/0000-0002-5534-6055; Braun, Franziska/0000-0003-1027-8084; Figge, Marc Thilo/0000-0002-4044-9166	Deutsche Forschungsgemeinschaft (DFG) [SPP 1468, NI1167/3-1, CRC 124 FungiNet]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was financially supported by the Deutsche Forschungsgemeinschaft (DFG): SPP 1468 to MG, NI1167/3-1 (JIMI Project) to FM and CRC 124 FungiNet (Project B4) to MTF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Antony PMA, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-24; Beltman JB, 2011, P NATL ACAD SCI USA, V108, P8755, DOI 10.1073/pnas.1101554108; Beltman JB, 2009, NAT REV IMMUNOL, V9, P789, DOI 10.1038/nri2638; Blavatska V, 2011, CONDENS MATTER PHYS, V14, DOI 10.5488/CMP.14.33701; Coelho FM, 2013, BLOOD, V121, P4101, DOI 10.1182/blood-2012-10-465336; Figge MT, 2011, MATHEMATICAL MODELS AND IMMUNE CELL BIOLOGY, P121, DOI 10.1007/978-1-4419-7725-0_6; Figge MT, 2008, J EXP MED, V205, P3019, DOI 10.1084/jem.20081160; Hasenberg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017314; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Huet S, 2006, BIOPHYS J, V91, P3542, DOI 10.1529/biophysj.105.080622; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Meyer-Hermann M, 2009, TRENDS IMMUNOL, V30, P157, DOI 10.1016/j.it.2009.01.005; Sarris M, 2012, CURR BIOL, V22, P2375, DOI 10.1016/j.cub.2012.11.018; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Vedel S, 2013, P NATL ACAD SCI USA, V110, P129, DOI 10.1073/pnas.1204291110; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Zimmer C, 2012, CELL MICROBIOL, V14, P1828, DOI 10.1111/cmi.12032	20	26	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e80808	10.1371/journal.pone.0080808	http://dx.doi.org/10.1371/journal.pone.0080808			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324630	Green Published, gold, Green Submitted			2022-12-25	WOS:000328566700016
J	Stratford, JP; Woodley, MA; Park, S				Stratford, James P.; Woodley, Michael A.; Park, Simon			Variation in the Morphology of Bacillus mycoides Due to Applied Force and Substrate Structure	PLOS ONE			English	Article							GLIDING MOTILITY; MYXOBACTERIA; CELLS	Response to mechanical force is a well characterised phenomenon in eukaryotic organisms, helping to organise multicellular structures. Mechanotactic responses have only rarely been observed in prokaryotic taxa. This work reports on a morphological change due to variations in applied force and surface structure by Bacillus mycoides Flugge. B. mycoides is a ubiquitous soil organism well known among microbiologists for its characteristic spreading colony morphology. An apparent mechanotactic response is elicited by physical deformation of the gel media on which B. mycoides is growing, including applied forces of compression or tension. Variations in the surface such as curvature produced by casting the agar gel in the presence of curved objects also elicited the change. The morphological change in B. mycoides colonies associated with the application of force manifests as a pattern of parallel rhizoid filaments perpendicular to compressing force and parallel to stretching force in the agar medium. The phenomenon is most clearly demonstrated by reversible changes in the orientation of B. mycoides filaments during time-lapse microscopy.	[Stratford, James P.] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England; [Woodley, Michael A.] Vrije Univ Brussel, Ctr Leo Apostel Interdisciplinary Studies, Brussels, Belgium; [Park, Simon] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England	University of Nottingham; Vrije Universiteit Brussel; University of Surrey	Stratford, JP (corresponding author), Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England.	james.stratford@nottingham.ac.uk	Woodley of Menie, Michael/AAC-2250-2019					BUYER JS, 1995, APPL ENVIRON MICROB, V61, P1839, DOI 10.1128/AEM.61.5.1839-1842.1995; Flugge C, 1886, MIKROORGANISMEN; Fontes M, 1999, P NATL ACAD SCI USA, V96, P8052, DOI 10.1073/pnas.96.14.8052; Goriely Alain, 2008, Fungal Biology Reviews, V22, P77, DOI 10.1016/j.fbr.2008.05.001; Ko KS, 2004, INFECT IMMUN, V72, P5253, DOI 10.1128/IAI.72.9.5253-5261.2004; Nakamura L, 1995, INT J SYSTEMATIC BAC, V45, P4; Nan BY, 2011, P NATL ACAD SCI USA, V108, P2498, DOI 10.1073/pnas.1018556108; PATE JL, 1979, CURR MICROBIOL, V2, P59, DOI 10.1007/BF02601737; Spormann AM, 1999, MICROBIOL MOL BIOL R, V63, P621, DOI 10.1128/MMBR.63.3.621-641.1999; Stanier RY, 1942, J BACTERIOL, V44, P405, DOI 10.1128/JB.44.4.405-412.1942; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269	11	8	8	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81549	10.1371/journal.pone.0081549	http://dx.doi.org/10.1371/journal.pone.0081549			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324702	Green Submitted, gold, Green Published			2022-12-25	WOS:000328566700045
J	Ahmadzadeh, F; Flecks, M; Carretero, MA; Mozaffari, O; Bohme, W; Harris, J; Freitas, S; Rodder, D				Ahmadzadeh, Faraham; Flecks, Morris; Carretero, Miguel A.; Mozaffari, Omid; Boehme, Wolfgang; Harris, James; Freitas, Susana; Roedder, Dennis			Cryptic Speciation Patterns in Iranian Rock Lizards Uncovered by Integrative Taxonomy	PLOS ONE			English	Article							BAYESIAN SPECIES DELIMITATION; CYTOCHROME-B GENE; LACERTID LIZARDS; DNA-SEQUENCES; PHYLOGENETIC-RELATIONSHIPS; GEOGRAPHIC DISTRIBUTIONS; REPTILIA LACERTIDAE; SQUAMATA-LACERTIDAE; MITOCHONDRIAL; EVOLUTION	While traditionally species recognition has been based solely on morphological differences either typological or quantitative, several newly developed methods can be used for a more objective and integrative approach on species delimitation. This may be especially relevant when dealing with cryptic species or species complexes, where high overall resemblance between species is coupled with comparatively high morphological variation within populations. Rock lizards, genus Darevskia, are such an example, as many of its members offer few diagnostic morphological features. Herein, we use a combination of genetic, morphological and ecological criteria to delimit cryptic species within two species complexes, D. chlorogaster and D. defilippii, both distributed in northern Iran. Our analyses are based on molecular information from two nuclear and two mitochondrial genes, morphological data (15 morphometric, 16 meristic and four categorical characters) and eleven newly calculated spatial environmental predictors. The phylogeny inferred for Darevskia confirmed monophyly of each species complex, with each of them comprising several highly divergent clades, especially when compared to other congeners. We identified seven candidate species within each complex, of which three and four species were supported by Bayesian species delimitation within D. chlorogaster and D. defilippii, respectively. Trained with genetically determined clades, Ecological Niche Modeling provided additional support for these cryptic species. Especially those within the D. defilippii-complex exhibit well-differentiated niches. Due to overall morphological resemblance, in a first approach PCA with mixed variables only showed the separation between the two complexes. However, MANCOVA and subsequent Discriminant Analysis performed separately for both complexes allowed for distinction of the species when sample size was large enough, namely within the D. chlorogaster-complex. In conclusion, the results support four new species, which are described herein.	[Ahmadzadeh, Faraham] Shahid Beheshti Univ, Environm Sci Res Inst, Dept Biodivers & Ecosyst Management, Tehran, Iran; [Ahmadzadeh, Faraham; Flecks, Morris; Boehme, Wolfgang; Roedder, Dennis] Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Carretero, Miguel A.; Harris, James; Freitas, Susana] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, P-4100 Oporto, Portugal; [Mozaffari, Omid] Aria Herpetol Inst, Tehran, Iran	Shahid Beheshti University; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Universidade do Porto	Ahmadzadeh, F (corresponding author), Shahid Beheshti Univ, Environm Sci Res Inst, Dept Biodivers & Ecosyst Management, Tehran, Iran.	Fahmadza@uni-bonn.de	de Freitas, Susana Nunes/AAO-2478-2020; Carretero, Miguel A/A-1472-2013; Ahmadzadeh, Faraham/AAB-1283-2021; Nunes de Freitas, Susana/I-8842-2014; Rödder, Dennis/AAT-8644-2021	Carretero, Miguel A/0000-0002-2335-7198; Ahmadzadeh, Faraham/0000-0001-7152-8484; Rödder, Dennis/0000-0002-6108-1639; Harris, D. James/0000-0001-5144-2421; Mozaffari, Omid/0000-0003-0147-7196	Iranian Ministry of Sciences, Research and Technology; Fundacao para a Ciencia e a Tecnologia (Portugal); Preserving Armenian biodiversity: Joint Portuguese-Armenian program for training in modern conservation biology; Gulbenkian Foundation (Portugal); Alexander Koenig Gesellschaft (AKG);  [PTDC/BIA-BEC/101256/2008]	Iranian Ministry of Sciences, Research and Technology; Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Preserving Armenian biodiversity: Joint Portuguese-Armenian program for training in modern conservation biology; Gulbenkian Foundation (Portugal); Alexander Koenig Gesellschaft (AKG); 	Research of FA was supported by the Iranian Ministry of Sciences, Research and Technology. The study was supported of the projects PTDC/BIA-BEC/101256/2008 funded by Fundacao para a Ciencia e a Tecnologia (Portugal) and "Preserving Armenian biodiversity: Joint Portuguese-Armenian program for training in modern conservation biology" funded by the Gulbenkian Foundation (Portugal). The traveling costs were partly funded by Alexander Koenig Gesellschaft (AKG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2005, CONSERV BIOL SER, V8, P57; Ahmadzadeh F, 2013, J BIOGEOGR IN PRESS; Ahmadzadeh F, 2012, AMPHIBIA-REPTILIA, V33, P1, DOI 10.1163/156853811X619718; Anderson SC, 1999, LIZARDS IRAN; ANDERSSON L, 1990, TAXON, V39, P375, DOI 10.2307/1223084; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Arnold E.N., 1989, Bulletin of the British Museum (Natural History) Zoology, V55, P209; Arnold EN, 2007, ZOOTAXA, P1, DOI 10.11646/zootaxa.1430.1.1; Arnold EN, 2002, J MORPHOL, V252, P145, DOI 10.1002/jmor.1096; Arribas O, 2004, ZOOTAXA, P1; Arribas O, 2006, ZOOTAXA, P1; Bauer AM, 2011, P ROY SOC B-BIOL SCI, V278, P490, DOI 10.1098/rspb.2010.1330; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bowman AW, 1997, APPL SMOOTHING TECHN; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Bruschi S., 2006, Proceedings of the California Academy of Sciences, V57, P225; Carranza S, 2012, ZOOTAXA, P1; Carretero MA, 2005, ANIM BIOL, V55, P259, DOI 10.1163/1570756054472854; Coyne JA, 2004, SPECIATION, V37; Darevsky I., 1967, ROCK LIZARDS CAUCASU; de Queiroz K, 2005, P NATL ACAD SCI USA, V102, P6600, DOI 10.1073/pnas.0502030102; den Bosch H. A. J, 1999, ZOOLOGY MIDDLE E, V19, P13, DOI [10.1080/09397140.1999.10637790, DOI 10.1080/09397140.1999.10637790]; Drummond A. J., 2009, TRACER MCMC TRACE AN; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eiselt Josef, 1995, Herpetozoa, V8, P59; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fu JZ, 1997, ZOOL J LINN SOC-LOND, V120, P463; Fu JZ, 2000, COPEIA, P432, DOI 10.1643/0045-8511(2000)000[0432:DOTCBG]2.0.CO;2; Fu JZ, 1999, GENETICA, V105, P227, DOI 10.1023/A:1003865227108; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; Godinho R, 2005, AMPHIBIA-REPTILIA, V26, P271, DOI 10.1163/156853805774408667; Gomez A, 2002, EVOLUTION, V56, P1431; Grechko VV, 2007, MOL BIOL+, V41, P764, DOI 10.1134/S0026893307050093; Harris DJ, 2002, HERPETOL J, V12, P85; Harris DJ, 1998, P ROY SOC B-BIOL SCI, V265, P1939, DOI 10.1098/rspb.1998.0524; Hawlitschek O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016662; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hijmans R. J., 2012, DISMO SPECIES DISTRI; Hijmans RJ., 2012, RASTER GEOGRAPHIC AN; Hijmans RJ, 2005, DIVA GIS VERSION 5 2; HSU KJ, 1973, NATURE, V242, P240, DOI 10.1038/242240a0; Huete AR, 1997, REMOTE SENS ENVIRON, V59, P440, DOI 10.1016/S0034-4257(96)00112-5; Jensen JR, 2007, REMOTE SENSING ENV E; Kaliontzopoulou A, 2012, ZOOL J LINN SOC-LOND, V164, P173, DOI 10.1111/j.1096-3642.2011.00760.x; Kaliontzopoulou A, 2010, HERPETOL J, V20, P41; Kehl M, 2009, ERDKUNDE, V63, P1, DOI 10.3112/erdkunde.2009.01.01; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Lomolino MV, 2006, BIOGEOGRAPHY; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; Macey JR, 2000, SYST BIOL, V49, P233, DOI 10.1093/sysbio/49.2.233; Mayr E., 1942, SYSTEMATICS ORIGIN S; Mayr W., 1969, PRINCIPLES SYSTEMATI; Miralles A, 2011, ZOOL SCR, V40, P16, DOI 10.1111/j.1463-6409.2010.00453.x; Morando M, 2003, SYST BIOL, V52, P159, DOI 10.1080/10635150390192717; Mu Q, 2007, REMOTE SENS ENVIRON, V111, P519, DOI 10.1016/j.rse.2007.04.015; Murienne J, 2009, BIOL J LINN SOC, V97, P177, DOI 10.1111/j.1095-8312.2008.01184.x; Murphy RW, 2000, ZOOL J LINN SOC-LOND, V130, P527, DOI 10.1006/zjls.1999.0241; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Nylander J, 2004, MR MODELTEST V2 PROG; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pavlicev M, 2009, MOL PHYLOGENET EVOL, V52, P727, DOI 10.1016/j.ympev.2009.04.020; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pinho C, 2010, CONSERV GENET RESOUR, V2, P181, DOI 10.1007/s12686-009-9126-4; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Rodder D, 2011, GLOBAL ECOL BIOGEOGR, V20, P915, DOI 10.1111/j.1466-8238.2011.00659.x; Saez AG, 2005, NATURE, V433, P111, DOI 10.1038/433111a; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SBORSHCHIKOV IM, 1981, TECTONOPHYSICS, V79, P45, DOI 10.1016/0040-1951(81)90232-8; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tarkhnishvili D., 2012, ADV ZOOL RES, V2, P79; Templeton AR, 2001, MOL ECOL, V10, P779, DOI 10.1046/j.1365-294x.2001.01199.x; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Tuniyev Sako B., 2011, Russian Journal of Herpetology, V18, P295; VANVALEN L, 1976, TAXON, V25, P233, DOI 10.2307/1219444; Vasconcelos R, 2012, ZOOL J LINN SOC-LOND, V164, P328, DOI 10.1111/j.1096-3642.2011.00768.x; Veith M, 2003, MOL ECOL, V12, P185, DOI 10.1046/j.1365-294X.2003.01714.x; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Wielstra B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046671; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhdanova Nadezhda P., 2006, P209	100	70	74	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80563	10.1371/journal.pone.0080563	http://dx.doi.org/10.1371/journal.pone.0080563			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324611	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300031
J	Berns, GS; Brooks, A; Spivak, M				Berns, Gregory S.; Brooks, Andrew; Spivak, Mark			Replicability and Heterogeneity of Awake Unrestrained Canine fMRI Responses	PLOS ONE			English	Article							FUNCTIONAL MRI; MONKEYS	Previously, we demonstrated the possibility of fMRI in two awake and unrestrained dogs. Here, we determined the replicability and heterogeneity of these results in an additional 11 dogs for a total of 13 subjects. Based on an anatomically placed region-of-interest, we compared the caudate response to a hand signal indicating the imminent availability of a food reward to a hand signal indicating no reward. 8 of 13 dogs had a positive differential caudate response to the signal indicating reward. The mean differential caudate response was 0.09%, which was similar to a comparable human study. These results show that canine fMRI is reliable and can be done with minimal stress to the dogs.	[Berns, Gregory S.; Brooks, Andrew] Emory Univ, Ctr Neuropolicy, Atlanta, GA 30322 USA; [Spivak, Mark] Comprehens Pet Therapy, Sandy Springs, GA USA	Emory University	Berns, GS (corresponding author), Emory Univ, Ctr Neuropolicy, Atlanta, GA 30322 USA.	gberns@emory.edu			Office of Naval Research [N00014-13-1-0253]; Emory College of Arts and Sciences	Office of Naval Research(Office of Naval Research); Emory College of Arts and Sciences	This work was funded, in part, by a grant from the Office of Naval Research (N00014-13-1-0253). Additional support from the Emory College of Arts and Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 2007, PLOS MED, V4, P1117, DOI 10.1371/journal.pmed.0040230; Berns GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038027; Bradshaw John, 2011, DOG SENSE NEW SCI DO; Chen G, 2012, MAGN RESON IMAGING, V30, P36, DOI 10.1016/j.mri.2011.09.010; Gonzalez-Castillo J, 2011, NEUROIMAGE, V54, P2764, DOI 10.1016/j.neuroimage.2010.11.020; Keliris GA, 2007, NEUROIMAGE, V36, P550, DOI 10.1016/j.neuroimage.2007.02.057; Kulkarni P, 2012, BEHAV BRAIN RES, V230, P201, DOI 10.1016/j.bbr.2012.02.002; Leite FP, 2002, NEUROIMAGE, V16, P283, DOI 10.1006/nimg.2002.1110; Liu JJV, 2013, NEUROIMAGE, V78, P186, DOI 10.1016/j.neuroimage.2013.03.038; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Martin C, 2006, NEUROIMAGE, V32, P33, DOI 10.1016/j.neuroimage.2006.02.021; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shipman P., 2011, ANIMAL CONNECTION NE; Stefanacci L, 1998, NEURON, V20, P1051, DOI 10.1016/S0896-6273(00)80485-7; Willis CKR, 2001, VET OPHTHALMOL, V4, P243, DOI 10.1046/j.1463-5216.2001.00183.x; Zink CF, 2004, NEURON, V42, P509, DOI 10.1016/S0896-6273(04)00183-7	18	40	40	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81698	10.1371/journal.pone.0081698	http://dx.doi.org/10.1371/journal.pone.0081698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324719	gold, Green Published			2022-12-25	WOS:000327949300105
J	Cao, W; Zhao, CY; Shen, C; Wang, YD				Cao, Wei; Zhao, Caiyan; Shen, Chuan; Wang, Yadong			Cytokeratin 18, Alanine Aminotransferase, Platelets and Triglycerides Predict the Presence of Nonalcoholic Steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; CLINICAL SCORING SYSTEM; METABOLIC SYNDROME; HEPATOCYTE APOPTOSIS; FIBROSIS; OBESE; DIAGNOSIS; BIOMARKER; SEVERITY; MANAGEMENT	Background: Nonalcoholic fatty liver disease (NAFLD) is one of the critical public health problems in China. The full spectrum of the disease ranges from simple steatosis and nonalcoholic steatohepatitis (NASH) to cirrhosis and hepatocellular carcinoma(HCC). The infiltration of inflammatory cells characterizes NASH. This characteristic contributes to the progression of hepatitis, fibrosis, cirrhosis, and HCC. Therefore, distinguishing NASH from NAFLD is crucial. Objective and Methods: Ninety-five patients with NAFLD, 44 with NASH, and 51 with non-NASH were included in the study to develop a new scoring system for differentiating NASH from NAFLD. Data on clinical and biological characteristics, as well as blood information, were obtained. Cytokeratin-18 (CK-18) fragments levels were measured using an enzyme-linked immunosorbant assay. Results: Several indexes show significant differences between the two groups, which include body mass index (BMI), waist-on-hip ratio (WHR), aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP),gamma-glutamyl transpeptidase (gamma-GT), platelets, uric acid (UA), hs-C-reactive protein (hs-CRP), triglycerides (TG), albumin (ALB), and CK-18 fragments (all P < 0.05). The CK-18 fragment levels showed a significant positive correlation with steatosis severity, ballooning, lobular inflammation, and fibrosis stage (all P < 0.05). Therefore, a new model that combines ALT, platelets, CK-18 fragments, and TG was established by logistic regression among NAFLD patients. The AUROC curve in predicting NASH was 0.920 (95% Cl: 0.866 - 0.974, cutoff value = 0.361, sensitivity = 89%, specificity = 86%, positive predictive value = 89%, negative predictive value = 89%). Conclusion: The novel scoring system may be considered as a useful model in predicting the presence of NASH in NAFLD patients.	[Cao, Wei; Zhao, Caiyan; Shen, Chuan; Wang, Yadong] Hebei Med Univ, Hosp 3, Dept Infect Dis, Shijiazhuang, Peoples R China	Hebei Medical University	Zhao, CY (corresponding author), Hebei Med Univ, Hosp 3, Dept Infect Dis, Shijiazhuang, Peoples R China.	zhaocy2005@163.com						Afdhal NH, 2012, JAMA-J AM MED ASSOC, V308, P608, DOI 10.1001/jama.2012.8402; Alisi A, 2009, HEPATOLOGY, V50, P2048, DOI 10.1002/hep.23345; Anty R, 2010, ALIMENT PHARM THER, V32, P1315, DOI 10.1111/j.1365-2036.2010.04480.x; Brunt EM, 2004, SEMIN LIVER DIS, V24, P3; Campos GM, 2008, HEPATOLOGY, V47, P1916, DOI 10.1002/hep.22241; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Das K, 2005, J Assoc Physicians India, V53, P195; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Diab DL, 2008, CLIN GASTROENTEROL H, V6, P1249, DOI 10.1016/j.cgh.2008.07.016; Fan JG, 2011, J DIGEST DIS, V12, P38, DOI 10.1111/j.1751-2980.2010.00476.x; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; Fealy CE, 2012, J APPL PHYSIOL, V113, P1, DOI 10.1152/japplphysiol.00127.2012; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Feldstein AE, 2009, HEPATOLOGY, V50, P1072, DOI 10.1002/hep.23050; Fitzpatrick E, 2010, J PEDIATR GASTR NUTR, V51, P500, DOI 10.1097/MPG.0b013e3181e376be; Francque SMA, 2012, CLIN GASTROENTEROL H, V10, P1162, DOI 10.1016/j.cgh.2012.06.019; Gholam PM, 2007, AM J GASTROENTEROL, V102, P399, DOI 10.1111/j.1572-0241.2006.01041.x; Hashimoto E, 2005, HEPATOL RES, V33, P72, DOI 10.1016/j.hepres.2005.09.007; Hsiao TJ, 2004, INT J OBESITY, V28, P167, DOI 10.1038/sj.ijo.0802519; Jian-gao Fan, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P163; Kashyap SR, 2009, OBESITY, V17, P1696, DOI 10.1038/oby.2009.89; Kistler KD, 2011, AM J GASTROENTEROL, V106, P460, DOI 10.1038/ajg.2010.488; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kowdley KV, 2012, HEPATOLOGY, V55, P77, DOI 10.1002/hep.24706; Liu WS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024363, 10.1371/journal.pone.0024406]; Malik R, 2009, J GASTROEN HEPATOL, V24, P564, DOI 10.1111/j.1440-1746.2008.05731.x; Maliken BD, 2013, HEPATOLOGY, V57, P1806, DOI 10.1002/hep.26238; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; Miele L, 2009, TRANSL RES, V154, P194, DOI 10.1016/j.trsl.2009.06.007; Myers RP, 2012, J HEPATOL, V56, P564, DOI 10.1016/j.jhep.2011.10.007; Neuschwander-Tetri BA, 2005, AM J MED SCI, V330, P326, DOI 10.1097/00000441-200512000-00011; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Palekar NA, 2006, LIVER INT, V26, P151, DOI 10.1111/j.1478-3231.2005.01209.x; Poynard T, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-34; Shen JY, 2012, J HEPATOL, V56, P1363, DOI 10.1016/j.jhep.2011.12.025; Sirota JC, 2013, METABOLISM, V62, P392, DOI 10.1016/j.metabol.2012.08.013; Sumida Y, 2011, J GASTROENTEROL, V46, P257, DOI 10.1007/s00535-010-0305-6; Tabuchi M, 2010, J NUTR SCI VITAMINOL, V56, P271, DOI 10.3177/jnsv.56.271; Tamimi TIAR, 2011, J HEPATOL, V54, P1224, DOI 10.1016/j.jhep.2010.08.023; Tsutsui M, 2010, J CLIN GASTROENTEROL, V44, P440, DOI 10.1097/MCG.0b013e3181bdefe2; Vanni E, 2010, DIGEST LIVER DIS, V42, P320, DOI 10.1016/j.dld.2010.01.016; Vos MB, 2008, J PEDIATR GASTR NUTR, V47, P481, DOI 10.1097/MPG.0b013e31817e2bfb; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Wong VWS, 2010, GUT, V59, P969, DOI 10.1136/gut.2009.205088; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312; Yilmaz Y, 2009, ALIMENT PHARM THER, V30, P1103, DOI 10.1111/j.1365-2036.2009.04148.x; Younossi ZM, 2008, OBES SURG, V18, P1430, DOI 10.1007/s11695-008-9506-y; Zelber-Sagi S, 2012, EUR J GASTROEN HEPAT, V24, P262, DOI 10.1097/MEG.0b013e32834f15dd	48	35	36	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82092	10.1371/journal.pone.0082092	http://dx.doi.org/10.1371/journal.pone.0082092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324749	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300129
J	Coburger, I; Dahms, SO; Roeser, D; Guhrs, KH; Hortschansky, P; Than, ME				Coburger, Ina; Dahms, Sven O.; Roeser, Dirk; Guehrs, Karl-Heinz; Hortschansky, Peter; Than, Manuel E.			Analysis of the Overall Structure of the Multi-Domain Amyloid Precursor Protein (APP)	PLOS ONE			English	Article							COPPER-BINDING DOMAIN; ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; EXTRACELLULAR DOMAIN; NEURITE OUTGROWTH; INHIBITOR DOMAIN; E2 DOMAIN; HEPARIN; IDENTIFICATION; DIMERIZATION	The amyloid precursor protein (APP) and its processing by the alpha-, beta- and gamma-secretases is widely believed to play a central role during the development of Alzheimer's disease. The three-dimensional structure of the entire protein, its physiologic function and the regulation of its proteolytic processing remain, however, largely unclear to date. To gain a deeper understanding of the structure of APP that underlies all of its functions, we first cloned and recombinantly expressed different constructs in E. coli. Using limited proteolysis followed by mass spectrometry and Edman degradation as well as analytical gel permeation chromatography coupled static light scattering, we experimentally analyzed the structural domain boundaries and determined that the large ectodomain of APP consists of exactly two rigidly folded domains - the E1-domain (Leu18-Ala190) and the E2-domain (Ser295-Asp500). Both, the acidic domain (AcD) connecting E1 and E2 as well as the juxtamembrane region (JMR) connecting E2 to the single transmembrane helix are highly flexible and extended. We identified in-between the E1-domain and the AcD an additional domain of conservation and partial flexibility that we termed extension domain (ED, Glu191-Glu227). Using Bio-layer interferometry, pull-down assays and analytical gel filtration experiments we demonstrated that the E1-domain does not tightly interact with the E2-domain, both in the presence and in the absence of heparin. APP hence forms an extended molecule that is flexibly tethered to the membrane. Its multi-domain architecture enables together with the many known functionalities the concomitant performance of several, independent functions, which might be regulated by cellular, compartment specific pH-changes.	[Coburger, Ina; Dahms, Sven O.; Roeser, Dirk; Than, Manuel E.] Fritz Lipmann Inst FLI, Leibniz Inst Age Res, Prot Crystallog Grp, Jena, Germany; [Guehrs, Karl-Heinz] Fritz Lipmann Inst FLI, Leibniz Inst Age Res, Prot Lab, Jena, Germany; [Hortschansky, Peter] Hans Knoll Inst HKI, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Hans Knoll Institute (HKI)	Than, ME (corresponding author), Fritz Lipmann Inst FLI, Leibniz Inst Age Res, Prot Crystallog Grp, Jena, Germany.	than@fli-leibniz.de	Than, Manuel/F-7536-2015	Than, Manuel/0000-0002-4707-9225; Dahms, Sven/0000-0002-0915-7579; Guehrs, Karl-Heinz/0000-0001-8847-1365				Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Aydin D, 2012, EXP BRAIN RES, V217, P423, DOI 10.1007/s00221-011-2861-2; Barnham KJ, 2003, J BIOL CHEM, V278, P17401, DOI 10.1074/jbc.M300629200; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Cappai R, 2005, J BIOL CHEM, V280, P13913, DOI 10.1074/jbc.M409179200; Dahms SO, 2012, J MOL BIOL, V416, P438, DOI 10.1016/j.jmb.2011.12.057; Dahms SO, 2010, P NATL ACAD SCI USA, V107, P5381, DOI 10.1073/pnas.0911326107; DAIGLE I, 1993, P NATL ACAD SCI USA, V90, P12045, DOI 10.1073/pnas.90.24.12045; Dulubova I, 2004, BIOCHEMISTRY-US, V43, P9583, DOI 10.1021/bi049041o; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Gralle M, 2006, J MOL BIOL, V357, P493, DOI 10.1016/j.jmb.2005.12.053; Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001; HEALD SL, 1991, BIOCHEMISTRY-US, V30, P10467, DOI 10.1021/bi00107a015; Ho A, 2004, P NATL ACAD SCI USA, V101, P2548, DOI 10.1073/pnas.0308655100; HYNES TR, 1990, BIOCHEMISTRY-US, V29, P10018, DOI 10.1021/bi00495a002; Keil C, 2004, ACTA CRYSTALLOGR D, V60, P1614, DOI 10.1107/S0907444904015343; Keil C, 2006, THESIS; Kong GKW, 2007, J MOL BIOL, V367, P148, DOI 10.1016/j.jmb.2006.12.041; Kriventseva EV, 2003, TRENDS GENET, V19, P124, DOI 10.1016/S0168-9525(03)00023-4; Kroenke CD, 1997, BIOCHEMISTRY-US, V36, P8145, DOI 10.1021/bi9705669; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee S, 2011, BIOCHEMISTRY-US, V50, P5453, DOI 10.1021/bi101846x; Libeu CP, 2011, J ALZHEIMERS DIS, V25, P547, DOI 10.3233/JAD-2011-101938; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; MULTHAUP G, 1994, BIOCHIMIE, V76, P304, DOI 10.1016/0300-9084(94)90163-5; Radzimanowski J, 2008, EMBO REP, V9, P1134, DOI 10.1038/embor.2008.188; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; SMALL DH, 1994, J NEUROSCI, V14, P2117; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Vella LJ, 2012, FASEB J, V26, P2930, DOI 10.1096/fj.11-200295; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Walter J, 1997, J BIOL CHEM, V272, P1896, DOI 10.1074/jbc.272.3.1896; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; Williamson TG, 1996, J BIOL CHEM, V271, P31215, DOI 10.1074/jbc.271.49.31215; Xue Y, 2011, P NATL ACAD SCI USA, V108, P16229, DOI 10.1073/pnas.1103407108	42	26	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81926	10.1371/journal.pone.0081926	http://dx.doi.org/10.1371/journal.pone.0081926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324731	Green Submitted, Green Published, gold			2022-12-25	WOS:000327949300115
J	Downs, CA; McDougall, KE; Woodley, CM; Fauth, JE; Richmond, RH; Kushmaro, A; Gibb, SW; Loya, Y; Ostrander, GK; Kramarsky-Winter, E				Downs, C. A.; McDougall, Kathleen E.; Woodley, Cheryl M.; Fauth, John E.; Richmond, Robert H.; Kushmaro, Ariel; Gibb, Stuart W.; Loya, Yossi; Ostrander, Gary K.; Kramarsky-Winter, Esti			Heat-Stress and Light-Stress Induce Different Cellular Pathologies in the Symbiotic Dinoflagellate during Coral Bleaching	PLOS ONE			English	Article							II REACTION-CENTER; PHOTOSYSTEM-II; OXIDATIVE STRESS; EVOLUTIONARY DIFFERENTIATION; STRUCTURAL REORGANIZATION; THYLAKOID MEMBRANES; SHOCK-PROTEIN; TEMPERATURE; PHOTOSYNTHESIS; DAMAGE	Coral bleaching is a significant contributor to the worldwide degradation of coral reefs and is indicative of the termination of symbiosis between the coral host and its symbiotic algae (dinoflagellate; Symbiodinium sp. complex), usually by expulsion or xenophagy (symbiophagy) of its dinoflagellates. Herein, we provide evidence that during the earliest stages of environmentally induced bleaching, heat stress and light stress generate distinctly different pathomorphological changes in the chloroplasts, while a combined heat-and light-stress exposure induces both pathomorphologies; suggesting that these stressors act on the dinoflagellate by different mechanisms. Within the first 48 hours of a heat stress (32 degrees C) under low-light conditions, heat stress induced decomposition of thylakoid structures before observation of extensive oxidative damage; thus it is the disorganization of the thylakoids that creates the conditions allowing photo-oxidative-stress. Conversely, during the first 48 hours of a light stress (2007 mmoles m(-2) s(-1) PAR) at 25 degrees C, condensation or fusion of multiple thylakoid lamellae occurred coincidently with levels of oxidative damage products, implying that photo-oxidative stress causes the structural membrane damage within the chloroplasts. Exposure to combined heat-and light-stresses induced both pathomorphologies, confirming that these stressors acted on the dinoflagellate via different mechanisms. Within 72 hours of exposure to heat and/or light stresses, homeostatic processes (e. g., heat-shock protein and anti-oxidant enzyme response) were evident in the remaining intact dinoflagellates, regardless of the initiating stressor. Understanding the sequence of events during bleaching when triggered by different environmental stressors is important for predicting both severity and consequences of coral bleaching.	[Downs, C. A.] Univ Hawaii Manoa, John A Burns Sch Med, Off Publ Hlth Studies, Honolulu, HI 96822 USA; [Downs, C. A.; Ostrander, Gary K.; Kramarsky-Winter, Esti] Univ Hawaii Manoa, Univ Hawaii, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA; [Downs, C. A.] Haereticus Environm Lab, Clifford, VA USA; [McDougall, Kathleen E.; Gibb, Stuart W.] UHI Millennium Inst, North Highland Coll, Environm Res Inst, Thurso, Scotland; [Woodley, Cheryl M.] NOAA, Natl Ocean Serv, Ctr Coastal Environm Hlth & Biomol Res, Charleston, SC USA; [Fauth, John E.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [Richmond, Robert H.] Univ Hawaii, Pacific Biosci Res Ctr, Kewalo Marine Lab, Honolulu, HI 96822 USA; [Kushmaro, Ariel; Kramarsky-Winter, Esti] Ben Gurion Univ Negev, Natl Inst Biotechnol, IL-84105 Beer Sheva, Israel; [Kushmaro, Ariel; Kramarsky-Winter, Esti] Ben Gurion Univ Negev, Dept Biotechnol, IL-84105 Beer Sheva, Israel; [Loya, Yossi; Kramarsky-Winter, Esti] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel; [Ostrander, Gary K.] Florida State Univ, Off Vice President Res, Tallahassee, FL 32306 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; UHI Millennium Institute; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; State University System of Florida; University of Central Florida; University of Hawaii System; Ben Gurion University; Ben Gurion University; Tel Aviv University; State University System of Florida; Florida State University	Downs, CA (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Off Publ Hlth Studies, Honolulu, HI 96822 USA.	cadowns@gmail.com; esti.winter@gmail.com	Kushmaro, Ariel/AAJ-8565-2021; Richmond, Robert/G-1385-2014; Loya, Joseph/AAJ-9014-2020; Loya, Yossi/J-3039-2012	Kushmaro, Ariel/0000-0002-1970-9656; Loya, Yossi/0000-0001-6870-9444; Gibb, Stuart/0000-0003-3882-338X	ISF [511/02, 1169/07]	ISF(Israel Science Foundation)	This study was supported by ISF grants 511/02 and 1169/07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMOND PA, 1978, PLANT PHYSIOL, V61, P411, DOI 10.1104/pp.61.3.411; ARMOND PA, 1980, BIOCHIM BIOPHYS ACTA, V601, P433, DOI 10.1016/0005-2736(80)90547-7; Ben-Haim Y, 2003, APPL ENVIRON MICROB, V69, P4236, DOI 10.1128/AEM.69.7.4236-4242.2003; BLANK RJ, 1985, SCIENCE, V229, P656, DOI 10.1126/science.229.4714.656; BLANK RJ, 1987, ANN NY ACAD SCI, V503, P530, DOI 10.1111/j.1749-6632.1987.tb40635.x; BLANK RJ, 1986, PLANT SYST EVOL, V151, P271, DOI 10.1007/BF02430280; Boschma H, 1925, P NATL ACAD SCI USA, V11, P65, DOI 10.1073/pnas.11.1.65; BROWN BE, 1995, MAR BIOL, V122, P655, DOI 10.1007/BF00350687; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; BROWN BE, 1994, MAR ECOL PROG SER, V105, P219, DOI 10.3354/meps105219; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; Carson F. L., 1997, HISTOTECHNOLOGY SELF; CLARKE AK, 1993, P NATL ACAD SCI USA, V90, P9973, DOI 10.1073/pnas.90.21.9973; Douglas AE, 2003, MAR POLLUT BULL, V46, P385, DOI 10.1016/S0025-326X(03)00037-7; Downs CA, 2002, FREE RADICAL BIO MED, V33, P533, DOI 10.1016/S0891-5849(02)00907-3; Downs CA, 1999, J PLANT PHYSIOL, V155, P488, DOI 10.1016/S0176-1617(99)80043-1; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; Downs CA, 2005, TECHNIQUES AQUATIC T, V2, P301; Downs CA, 2009, SCI TOTAL ENVIRON, V407, P4838, DOI 10.1016/j.scitotenv.2009.05.015; Downs CA, 2009, AUTOPHAGY, V5, P211, DOI 10.4161/auto.5.2.7405; Dunlap WC, 1998, J PHYCOL, V34, P418, DOI 10.1046/j.1529-8817.1998.340418.x; Dunn SR, 2004, CELL DEATH DIFFER, V11, P1213, DOI 10.1038/sj.cdd.4401484; Fang Lee-Shing, 1998, Proceedings of the National Science Council Republic of China Part B Life Sciences, V22, P150; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; GOMBOS Z, 1994, PLANT PHYSIOL, V104, P563, DOI 10.1104/pp.104.2.563; GOUNARIS K, 1984, BIOCHIM BIOPHYS ACTA, V766, P198, DOI 10.1016/0005-2728(84)90232-9; GOUNARIS K, 1983, FEBS LETT, V153, P47, DOI 10.1016/0014-5793(83)80117-3; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Heckathorn SA, 1998, PLANT PHYSIOL, V116, P439, DOI 10.1104/pp.116.1.439; Hideg E, 2000, PHILOS T R SOC B, V355, P1511, DOI 10.1098/rstb.2000.0711; Hippler M, 2000, J BIOL CHEM, V275, P5852, DOI 10.1074/jbc.275.8.5852; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; LeTissier MDA, 1996, MAR ECOL PROG SER, V136, P235, DOI 10.3354/meps136235; Lohr J, 2007, APPL ENVIRON MICROB, V73, P2976, DOI 10.1128/AEM.02449-06; MARSH J A JR, 1970, Ecology (Washington D C), V51, P255, DOI 10.2307/1933661; Mayer AG, 1914, PUBLICATIONS CARNEGI, V183, P3; McDougall KE, 2006, MAR ECOL PROG SER, V325, P137, DOI 10.3354/meps325137; Moore MN, 2008, AUTOPHAGY, V4, P254, DOI 10.4161/auto.5528; MOORE MN, 1976, CELL TISSUE RES, V175, P279; Muller EM, 2008, CORAL REEFS, V27, P191, DOI 10.1007/s00338-007-0310-2; Murata N, 1997, PLANT PHYSIOL, V115, P875, DOI 10.1104/pp.115.3.875; Ort DR, 2001, PLANT PHYSIOL, V125, P29, DOI 10.1104/pp.125.1.29; Ostrander GK, 2000, P NATL ACAD SCI USA, V97, P5297, DOI 10.1073/pnas.090104897; QUINN PJ, 1983, BIOCHIM BIOPHYS ACTA, V737, P223, DOI 10.1016/0304-4157(83)90002-3; Richier S, 2005, J EXP BIOL, V208, P277, DOI 10.1242/jeb.01368; RICHTER M, 1990, PHOTOSYNTH RES, V24, P237, DOI 10.1007/BF00032311; Robinson CE, 1999, ANAL BIOCHEM, V266, P48, DOI 10.1006/abio.1998.2932; Sawyer SJ, 2001, J EXP BIOL, V204, P3443; Schlesinger M. J., 1982, HEAT SHOCK BACTERIA; SEMENOVA G, 1994, BIOPHYS CHEM, V49, P59, DOI 10.1016/0301-4622(93)E0082-G; Semenova GA, 2004, PHOTOSYNTHETICA, V42, P521, DOI 10.1007/S11099-005-0008-z; Smith DJ, 2005, GLOBAL CHANGE BIOL, V11, P1, DOI 10.1111/j.1529-8817.2003.00895.x; Smith HG, 1939, J EXP BIOL, V16, P334; Sokal RR., 2012, BIOMETRY PRINCIPLES; SPECTOR DL, 1984, DINOFLAGELLATES; STEELE RD, 1977, J ZOOL, V181, P421; STEEN RG, 1987, BIOL BULL, V172, P246, DOI 10.2307/1541797; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; THOMPSON LK, 1989, BIOCHEMISTRY-US, V28, P6686, DOI 10.1021/bi00442a023; Titlyanov EA, 1998, MAR BIOL, V130, P471, DOI 10.1007/s002270050267; Warner CH, 1914, P R SOC LOND B-CONTA, V87, P378, DOI 10.1098/rspb.1914.0025; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Yamane Y, 1997, PHOTOSYNTH RES, V52, P57, DOI 10.1023/A:1005884717655; Yonge C. M., 1931, Scientific Reports Great Barrier Reef Expedition 1928-29 London, V1, P177; Yonge O. M., 1931, Scientific Reports Great Barrier Reef Expedition 1928-29 London, V1, P83	69	63	63	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e77173	10.1371/journal.pone.0077173	http://dx.doi.org/10.1371/journal.pone.0077173			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324575	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300003
J	Estavillo, C; Pardini, R; da Rocha, PLB				Estavillo, Candelaria; Pardini, Renata; Bernardo da Rocha, Pedro Luis			Forest Loss and the Biodiversity Threshold: An Evaluation Considering Species Habitat Requirements and the Use of Matrix Habitats	PLOS ONE			English	Article							ATLANTIC FOREST; LANDSCAPE CONTEXT; EXTINCTION RISK; FRAGMENTATION; CONSERVATION; DIVERSITY; GENERALIST; SPECIALIST; RESPONSES; MAMMALS	Habitat loss is the main driver of the current biodiversity crisis, a landscape-scale process that affects the survival of spatially-structured populations. Although it is well-established that species responses to habitat loss can be abrupt, the existence of a biodiversity threshold is still the cause of much controversy in the literature and would require that most species respond similarly to the loss of native vegetation. Here we test the existence of a biodiversity threshold, i.e. an abrupt decline in species richness, with habitat loss. We draw on a spatially-replicated dataset on Atlantic forest small mammals, consisting of 16 sampling sites divided between forests and matrix habitats in each of five 3600-ha landscapes (varying from 5% to 45% forest cover), and on an a priori classification of species into habitat requirement categories (forest specialists, habitat generalists and open-area specialists). Forest specialists declined abruptly below 30% of forest cover, and spillover to the matrix occurred only in more forested landscapes. Generalists responded positively to landscape heterogeneity, peaking at intermediary levels of forest cover. Open area specialists dominated the matrix and did not spillover to forests. As a result of these distinct responses, we observed a biodiversity threshold for the small mammal community below 30% forest cover, and a peak in species richness just above this threshold. Our results highlight that cross habitat spillover may be asymmetrical and contingent on landscape context, occurring mainly from forests to the matrix and only in more forested landscapes. Moreover, they indicate the potential for biodiversity thresholds in human-modified landscapes, and the importance of landscape heterogeneity to biodiversity. Since forest loss affected not only the conservation value of forest patches, but also the potential for biodiversity-mediated services in anthropogenic habitats, our work indicates the importance of proactive measures to avoid human-modified landscapes to cross this threshold.	[Estavillo, Candelaria; Bernardo da Rocha, Pedro Luis] Univ Fed Bahia, Inst Biol, Salvador, BA, Brazil; [Pardini, Renata] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil	Universidade Federal da Bahia; Universidade de Sao Paulo	Estavillo, C (corresponding author), Univ Fed Bahia, Inst Biol, Salvador, BA, Brazil.	cande.estavillo@gmail.com	Pardini, Renata/C-4095-2012; Rocha, Pedro Luís B./A-3325-2008	Pardini, Renata/0000-0002-3769-8401; Rocha, Pedro Luís B./0000-0002-8330-483X	CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [APP0049/2009]; FAPESB -Fundacao de Amparo a Pesquisa do Estado da Bahia [PNX0016/2009]; CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [303657/2009-0, 306715/2011-2]	CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESB -Fundacao de Amparo a Pesquisa do Estado da Bahia; CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - http://www.cnpq.br/ (APP0049/2009); FAPESB -Fundacao de Amparo a Pesquisa do Estado da Bahia - www.fapesb.ba.gov.br(PNX0016/2009); CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - http://www.capes.gov.br (303657/2009-0 and 306715/2011-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren H, 1997, OIKOS, V80, P193, DOI 10.2307/3546534; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Devictor V, 2008, GLOBAL ECOL BIOGEOGR, V17, P252, DOI 10.1111/j.1466-8238.2007.00364.x; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Ferreira J, 2012, J APPL ECOL, V49, P535, DOI 10.1111/j.1365-2664.2012.02145.x; Fine PVA, 2002, J TROP ECOL, V18, P687, DOI [10.1017/S0266467402002456, 10.1017/S00266467402002456]; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; HANSKI I, 1995, NATURE, V377, P618, DOI 10.1038/377618a0; Hanski I, 2011, AMBIO, V40, P248, DOI 10.1007/s13280-011-0147-3; Jonsen ID, 1997, LANDSCAPE ECOL, V12, P185, DOI 10.1023/A:1007961006232; Krauss J, 2003, J BIOGEOGR, V30, P889, DOI 10.1046/j.1365-2699.2003.00878.x; Kupfer JA, 2006, GLOBAL ECOL BIOGEOGR, V15, P8, DOI 10.1111/j.1466-822x.2006.00204.x; Lee TM, 2011, P ROY SOC B-BIOL SCI, V278, P1329, DOI 10.1098/rspb.2010.1877; Lima MM, 2014, FOREST ECOL MANAG, V312, P260, DOI 10.1016/j.foreco.2013.09.003; Lindenmayer DB, 2005, BIOL CONSERV, V124, P351, DOI 10.1016/j.biocon.2005.01.041; Marvier M, 2004, RISK ANAL, V24, P869, DOI 10.1111/j.0272-4332.2004.00485.x; McGarigal K., 1995, General Technical Report - Pacific Northwest Research Station, USDA Forest Service; Metzger JP, 1997, ACTA OECOL, V18, P1, DOI 10.1016/S1146-609X(97)80075-6; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Paglia A.P., 2012, OCCASIONAL PAPERS CO, V2nd; Pardini R, 2005, BIOL CONSERV, V124, P253, DOI 10.1016/j.biocon.2005.01.033; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Pardini R, 2009, BIOL CONSERV, V142, P1178, DOI 10.1016/j.biocon.2009.02.010; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Puttker T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027963; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Saatchi S, 2001, CONSERV BIOL, V15, P867, DOI 10.1046/j.1523-1739.2001.015004867.x; Silva JMC, 2003, ATLANTIC FOREST S AM, P43; Stenseth NC, 2003, FRONT ECOL ENVIRON, V1, P367, DOI 10.2307/3868189; Suzan G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005461; Suzuki A, 2004, EMERG INFECT DIS, V10, P2127, DOI 10.3201/eid1012.040295; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Swihart RK, 2006, DIVERS DISTRIB, V12, P277, DOI 10.1111/j.1366-9516.2006.00242.x; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; TURNER MG, 1989, OIKOS, V55, P121, DOI 10.2307/3565881; Umetsu F, 2007, LANDSCAPE ECOL, V22, P517, DOI 10.1007/s10980-006-9041-y; Wiens John A., 2001, P96; With KA, 1999, LANDSCAPE ECOL, V14, P73, DOI 10.1023/A:1008030215600; WITH KA, 1995, ECOLOGY, V76, P2446, DOI 10.2307/2265819	49	101	103	0	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82369	10.1371/journal.pone.0082369	http://dx.doi.org/10.1371/journal.pone.0082369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324776	Green Submitted, Green Published, gold			2022-12-25	WOS:000327949300142
J	Kwan, JC; Schmidt, EW				Kwan, Jason C.; Schmidt, Eric W.			Bacterial Endosymbiosis in a Chordate Host: Long-Term Co-Evolution and Conservation of Secondary Metabolism	PLOS ONE			English	Article							SEQUENCE-ANALYSIS; GENOME; SYMBIONT; EVOLUTION; DNA; BIOSYNTHESIS; DIVERGENCE; MECHANISMS; SPECIATION; ALIGNMENTS	Intracellular symbiosis is known to be widespread in insects, but there are few described examples in other types of host. These symbionts carry out useful activities such as synthesizing nutrients and conferring resistance against adverse events such as parasitism. Such symbionts persist through host speciation events, being passed down through vertical transmission. Due to various evolutionary forces, symbionts go through a process of genome reduction, eventually resulting in tiny genomes where only those genes essential to immediate survival and those beneficial to the host remain. In the marine environment, invertebrates such as tunicates are known to harbor complex microbiomes implicated in the production of natural products that are toxic and probably serve a defensive function. Here, we show that the intracellular symbiont Candidatus Endolissoclinum faulkneri is a long-standing symbiont of the tunicate Lissoclinum patella, that has persisted through cryptic speciation of the host. In contrast to the known examples of insect symbionts, which tend to be either relatively recent or ancient relationships, the genome of Ca. E. faulkneri has a very low coding density but very few recognizable pseudogenes. The almost complete degradation of intergenic regions and stable gene inventory of extant strains of Ca. E. faulkneri show that further degradation and deletion is happening very slowly. This is a novel stage of genome reduction and provides insight into how tiny genomes are formed. The ptz pathway, which produces the defensive patellazoles, is shown to date to before the divergence of Ca. E. faulkneri strains, reinforcing its importance in this symbiotic relationship. Lastly, as in insects we show that stable symbionts can be lost, as we describe an L. patella animal where Ca. E. faulkneri is displaced by a likely intracellular pathogen. Our results suggest that intracellular symbionts may be an important source of ecologically significant natural products in animals.	[Kwan, Jason C.; Schmidt, Eric W.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Schmidt, EW (corresponding author), Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA.	ews1@utah.edu	Kwan, Jason/S-3497-2019; Kwan, Jason/F-9589-2010	Kwan, Jason/0000-0001-9933-1536; Kwan, Jason/0000-0001-9933-1536	National Institutes of Health [GM092009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health GM092009 (www.NIH.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; Behrendt L, 2012, ISME J, V6, P1222, DOI 10.1038/ismej.2011.181; Bignell C, 2001, J BIOTECHNOL, V91, P1, DOI 10.1016/S0168-1656(01)00293-0; Bock DG, 2012, P ROY SOC B-BIOL SCI, V279, P2377, DOI 10.1098/rspb.2011.2610; Burke GR, 2011, GENOME BIOL EVOL, V3, P195, DOI 10.1093/gbe/evr002; Caputi L, 2007, P NATL ACAD SCI USA, V104, P9364, DOI 10.1073/pnas.0610158104; Clayton AL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002990; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collins NE, 2005, P NATL ACAD SCI USA, V102, P838, DOI 10.1073/pnas.0406633102; CORLEY DG, 1988, J AM CHEM SOC, V110, P7920, DOI 10.1021/ja00231a078; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Donia MS, 2011, P NATL ACAD SCI USA, V108, pE1423, DOI 10.1073/pnas.1111712108; Douglas AE, 2011, CELL HOST MICROBE, V10, P359, DOI 10.1016/j.chom.2011.09.001; Draskovic I, 2005, ADV M C M, V8, P235, DOI 10.1017/CBO9780511541544.007; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Foster JT, 2009, J BACTERIOL, V191, P2864, DOI 10.1128/JB.01581-08; Friedman CS, 2000, INT J SYST EVOL MICR, V50, P847, DOI 10.1099/00207713-50-2-847; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Helfrich EJN, 2016, NAT PROD REP, V33, P231, DOI 10.1039/c5np00125k; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jensen K, 2012, CHEM BIOL, V19, P329, DOI 10.1016/j.chembiol.2012.01.005; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuo CH, 2009, GENOME RES, V19, P1450, DOI 10.1101/gr.091785.109; Kwan JC, 2012, P NATL ACAD SCI USA, V109, P20655, DOI 10.1073/pnas.1213820109; Kwan JC, 2010, CHEM-EUR J, V16, P13020, DOI 10.1002/chem.201001562; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lerat E, 2005, NUCLEIC ACIDS RES, V33, P3125, DOI 10.1093/nar/gki631; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Lin MQ, 2009, NUCLEIC ACIDS RES, V37, P6076, DOI 10.1093/nar/gkp642; McBride JW, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001730; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; McCutcheon JP, 2011, CURR BIOL, V21, P1366, DOI 10.1016/j.cub.2011.06.051; McCutcheon JP, 2009, P NATL ACAD SCI USA, V106, P15394, DOI 10.1073/pnas.0906424106; Monniot C, 1991, CORAL REEF ASCIDIANS; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Mungall CJ, 2007, BIOINFORMATICS, V23, pI337, DOI 10.1093/bioinformatics/btm189; Nakabachi A, 2013, CURR BIOL, V23, P1478, DOI 10.1016/j.cub.2013.06.027; Namiki Toshiaki, 2012, Nucleic Acids Res, V40, pe155, DOI 10.1093/nar/gks678; OLSON RR, 1987, J EXP MAR BIOL ECOL, V110, P245, DOI 10.1016/0022-0981(87)90004-9; Orvis J, 2010, BIOINFORMATICS, V26, P1488, DOI 10.1093/bioinformatics/btq167; Perez-Portela R, 2008, ZOOLOGY, V111, P163, DOI 10.1016/j.zool.2007.06.006; Piel J, 2004, NAT PROD REP, V21, P519, DOI 10.1039/b310175b; Piel J, 2004, CHEMBIOCHEM, V5, P93, DOI 10.1002/cbic.200300782; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Piel J, 2004, J BACTERIOL, V186, P1280, DOI 10.1128/JB.186.5.1280-1286.2004; Piel J, 2009, NAT PROD REP, V26, P338, DOI 10.1039/b703499g; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; PRUCKLER JM, 1995, INFECT IMMUN, V63, P4928, DOI 10.1128/IAI.63.12.4928-4932.1995; Pundhir S, 2011, BIOINFORMATION, V6, P380, DOI 10.6026/97320630006380; Rahman MA, 2012, J INFECT DIS, V206, P110, DOI 10.1093/infdis/jis313; Ran LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011486; Rath CM, 2011, ACS CHEM BIOL, V6, P1244, DOI 10.1021/cb200244t; Reyes-Lamothe R, 2012, ANNU REV GENET, V46, P121, DOI 10.1146/annurev-genet-110711-155421; REYSENBACH AL, 1992, APPL ENVIRON MICROB, V58, P3417, DOI 10.1128/AEM.58.10.3417-3418.1992; Rubinstein ND, 2013, GENOME BIOL EVOL, V5, P1185, DOI 10.1093/gbe/evt081; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Schmidt EW, 2009, METHOD ENZYMOL, V458, P575, DOI 10.1016/S0076-6879(09)04823-X; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; Tarjuelo I, 2004, MOL ECOL, V13, P3125, DOI 10.1111/j.1365-294X.2004.02306.x; Tarjuelo I, 2001, MAR BIOL, V139, P455; Toh H, 2006, GENOME RES, V16, P149, DOI 10.1101/gr.4106106; Trindade-Silva AE, 2010, CURR OPIN BIOTECH, V21, P834, DOI 10.1016/j.copbio.2010.09.018; Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; ZABRISKIE TM, 1988, J AM CHEM SOC, V110, P7919, DOI 10.1021/ja00231a077; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang GI, 2008, INT J SYST EVOL MICR, V58, P479, DOI 10.1099/ijs.0.65344-0	81	32	33	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80822	10.1371/journal.pone.0080822	http://dx.doi.org/10.1371/journal.pone.0080822			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324632	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300046
J	Marvasi, M; Hochmuth, GJ; Giurcanu, MC; George, AS; Noel, JT; Bartz, J; Teplitski, M				Marvasi, Massimiliano; Hochmuth, George J.; Giurcanu, Mihai C.; George, Andree S.; Noel, Jason T.; Bartz, Jerry; Teplitski, Max			Factors That Affect Proliferation of Salmonella in Tomatoes Post-Harvest: The Roles of Seasonal Effects, Irrigation Regime, Crop and Pathogen Genotype	PLOS ONE			English	Article							ESCHERICHIA-COLI O157H7; ENTERICA SEROVAR TYPHIMURIUM; PLANTS; LETTUCE; COLONIZATION; SPINACH; WATER; CONTAMINATION; SURVIVAL; O157/H7	Main Objectives: Fresh fruits and vegetables become increasingly recognized as vehicles of human salmonellosis. Physiological, ecological, and environmental factors are all thought to contribute to the ability of Salmonella to colonize fruits and vegetables pre- and post-harvest. The goal of this study was to test how irrigation levels, fruit water congestion, crop and pathogen genotypes affect the ability of Salmonella to multiply in tomatoes post-harvest. Experimental Design: Fruits from three tomato varieties, grown over three production seasons in two Florida locations, were infected with seven strains of Salmonella and their ability to multiply post-harvest in field-grown tomatoes was tested. The field experiments were set up as a two-factor factorial split plot experiment, with the whole-plot treatments arranged in a randomized complete-block design. The irrigation treatment (at three levels) was the whole-plot factor, and the split-plot factor was tomato variety, with three levels. The significance of the main, two-way, and three-way interaction effects was tested using the (type III) F-tests for fixed effects. Mean separation for each significant fixed effect in the model was performed using Tukey's multiple comparison testing procedure. Most Important Discoveries and Significance: The irrigation regime per se did not affect susceptibility of the crop to post-harvest proliferation of Salmonella. However, Salmonella grew significantly better in water-congested tissues of green tomatoes. Tomato maturity and genotype, Salmonella genotype, and inter-seasonal differences were the strongest factors affecting proliferation. Red ripe tomatoes were significantly and consistently more conducive to proliferation of Salmonella. Tomatoes harvested in the driest, sunniest season were the most conducive to post-harvest proliferation of the pathogen. Statistically significant interactions between production conditions affected post-harvest susceptibility of the crop to the pathogen. UV irradiation of tomatoes post-harvest promoted Salmonella growth.	[Marvasi, Massimiliano; Hochmuth, George J.; George, Andree S.; Noel, Jason T.; Teplitski, Max] Univ Florida, Dept Soil & Water Sci, Gainesville, FL 32610 USA; [Giurcanu, Mihai C.] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [Bartz, Jerry] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Teplitski, M (corresponding author), Univ Florida, Dept Soil & Water Sci, Gainesville, FL 32610 USA.	maxtep@ufl.edu		Giurcanu, Mihai/0000-0001-6058-3891	USDA NIFA-AFRI grant [2011-67017-30127]; Center for Produce Safety through UCANR/USDA NIFA grant [2010-34608-20768 (SA7660)]; Florida Specialty Crops Foundation; McKnight Fellowship Program	USDA NIFA-AFRI grant; Center for Produce Safety through UCANR/USDA NIFA grant; Florida Specialty Crops Foundation; McKnight Fellowship Program	This research was supported by USDA NIFA-AFRI grant # 2011-67017-30127 and by funding provided by the Center for Produce Safety through UCANR/USDA NIFA grant # 2010-34608-20768 (SA7660) and the Florida Specialty Crops Foundation. A. S. George acknowledges support from the McKnight Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, FDA PROGRAM INFORM M; Aruscavage D, 2008, J FOOD PROTECT, V71, P2384, DOI 10.4315/0362-028X-71.12.2384; Aruscavage D, 2010, J FOOD SCI, V75, pM187, DOI 10.1111/j.1750-3841.2010.01593.x; Barak JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001657; Barak JD, 2012, ANNU REV PHYTOPATHOL, V50, P241, DOI 10.1146/annurev-phyto-081211-172936; Barak JD, 2011, APPL ENVIRON MICROB, V77, P498, DOI 10.1128/AEM.01661-10; Batz M. B. S., 2011, FOOD SAFETY RES CONS; Benard C, 2009, J AGR FOOD CHEM, V57, P4112, DOI 10.1021/jf8036374; Blodgett R, 2010, MICROBIOLOGICAL METH; Brandi MT, 2013, PHYTOPATHOLOGY, V103, P316, DOI 10.1094/PHYTO-11-12-0295-RVW; Brandl MT, 2008, APPL ENVIRON MICROB, V74, P5285, DOI 10.1128/AEM.01073-08; Bumann D, 2009, CURR OPIN MICROBIOL, V12, P559, DOI 10.1016/j.mib.2009.08.004; Carter MQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044186; Carter MQ, 2011, APPL ENVIRON MICROB, V77, P3685, DOI 10.1128/AEM.02315-10; Centers for Disease Control and Prevention, 2013, REP SEL SALM OUTBR I; Dong YM, 2003, APPL ENVIRON MICROB, V69, P1783, DOI 10.1128/AEM.69.3.1783-1790.2003; Erickson MC, 2010, J FOOD PROTECT, V73, P1809, DOI 10.4315/0362-028X-73.10.1809; Erickson MC, 2010, J FOOD PROTECT, V73, P1023, DOI 10.4315/0362-028X-73.6.1023; Erickson MC, 2010, J FOOD PROTECT, V73, P500, DOI 10.4315/0362-028X-73.3.500; Gorski L, 2011, APPL ENVIRON MICROB, V77, P2734, DOI 10.1128/AEM.02321-10; Goudeau D.M., 2013, APPL ENV MICROBIOL, V79; Greene SK, 2008, EPIDEMIOL INFECT, V136, P157, DOI 10.1017/S095026880700859X; Gutierrez-Rodriguez E, 2012, J APPL MICROBIOL, V112, P109, DOI 10.1111/j.1365-2672.2011.05184.x; Harris LJ, 2012, J FOOD PROTECT, V75, P2251, DOI 10.4315/0362-028X.JFP-12-252; Iniguez AL, 2005, MOL PLANT MICROBE IN, V18, P169, DOI 10.1094/MPMI-18-0169; Islam M, 2004, APPL ENVIRON MICROB, V70, P2497, DOI 10.1128/AEM.70.4.2497-2502.2004; Islam Mahbub, 2004, Foodborne Pathog Dis, V1, P27, DOI 10.1089/153531404772914437; Kar RK, 2011, PLANT SIGNAL BEHAV, V6, P1741, DOI 10.4161/psb.6.11.17729; Klerks MM, 2007, ISME J, V1, P620, DOI 10.1038/ismej.2007.82; Lapidot A, 2009, J FOOD PROTECT, V72, P618, DOI 10.4315/0362-028X-72.3.618; Lopez-Velasco G, 2012, INT J FOOD MICROBIOL, V158, P65, DOI 10.1016/j.ijfoodmicro.2012.07.005; Mandrell R., 2009, MICROBIAL SAFETY FRE; Marvasi M., 2013, MOL PLANT MICROBE IN; Mehlich A., 1953, DETERMINATION P CA M, P1; Moyne AL, 2011, FOOD MICROBIOL, V28, P1417, DOI 10.1016/j.fm.2011.02.001; Munoz-Carpena R., 2012, U FLORIDA COOPERATIV, V343; Noel JT, 2010, MOL PLANT MICROBE IN, V23, P273, DOI 10.1094/MPMI-23-3-0273; Noel JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012406; Olson SM, 2012, HS739 EDIS U FLOR IF; Park S, 2013, APPL ENVIRON MICROB, V79, P4347, DOI 10.1128/AEM.00474-13; Parker CT, 2012, APPL ENVIRON MICROB, V78, P455, DOI 10.1128/AEM.06251-11; Poza-Carrion C, 2013, PHYTOPATHOL IN PRESS, V103; Rastogi G, 2012, ISME J, V6, P1812, DOI 10.1038/ismej.2012.32; Roy D, 2013, PHYTOPATHOLOGY, V103, P326, DOI 10.1094/PHYTO-09-12-0230-FI; Savoy H.J., 2009, SO REGION COOPERAT D, V190D, P1; Schikora A, 2012, TRENDS PLANT SCI, V17, P245, DOI 10.1016/j.tplants.2012.03.007; Semenov AM, 2010, MICROB ECOL, V60, P239, DOI 10.1007/s00248-010-9663-0; Semenov AV, 2007, FEMS MICROBIOL ECOL, V60, P419, DOI 10.1111/j.1574-6941.2007.00306.x; Shi X, 2007, J FOOD PROTECT, V70, P2725, DOI 10.4315/0362-028X-70.12.2725; Shi X, 2009, J APPL MICROBIOL, V107, P329, DOI 10.1111/j.1365-2672.2009.04211.x; Steeb B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003301; Thompson S, 2013, AM NAT, V181, pE1, DOI 10.1086/668572; Williams TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068642; Zaragoza WJ, 2012, ENV MICROBIOL REP, V4, P453, DOI 10.1111/j.1758-2229.2012.00364.x	54	30	30	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80871	10.1371/journal.pone.0080871	http://dx.doi.org/10.1371/journal.pone.0080871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324640	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000327949300051
J	Neave, HW; Daros, RR; Costa, JHC; von Keyserlingk, MAG; Weary, DM				Neave, Heather W.; Daros, Rolnei R.; Costa, Joao H. C.; von Keyserlingk, Marina A. G.; Weary, Daniel M.			Pain and Pessimism: Dairy Calves Exhibit Negative Judgement Bias following Hot-Iron Disbudding	PLOS ONE			English	Article							COGNITIVE BIAS; DEPRESSION; ANXIETY; ANIMALS; MODULATION; STARLINGS; MELOXICAM; EMOTION; MODEL; RATS	Pain is defined as an unpleasant sensory and emotional experience associated with actual or potential tissue damage, but emotional states are difficult to directly assess in animals. Researchers have assessed pain using behavioural and physiological measures, but these approaches are limited to understanding the arousal rather than valence of the emotional experience. Cognitive bias tasks show that depressed humans judge ambiguous events negatively and this technique has been applied to assess emotional states in animals. However, limited research has examined how pain states affect cognitive processes in animals. Here we present the first evidence of cognitive bias in response to pain in any non-human species. In two experiments, dairy calves (n = 17) were trained to respond differentially to red and white video screens and then tested with unreinforced ambiguous colours in two or three test sessions before and two sessions after the routine practice of hot-iron disbudding. After disbudding calves were more likely to judge ambiguous colours as negative. This 'pessimistic' bias indicates that post-operative pain following hot-iron disbudding results in a negative change in emotional state.	[Neave, Heather W.; Daros, Rolnei R.; Costa, Joao H. C.; von Keyserlingk, Marina A. G.; Weary, Daniel M.] Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Weary, DM (corresponding author), Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada.	danweary@mail.ubc.ca	Neave, Heather/AAA-3837-2020; Daros, Ruan R./L-6395-2019; Weary, Daniel M/A-8868-2010; Costa, Joao H. C./M-6660-2014; von Keyserlingk, Marina/AAB-6353-2019; Costa, Joao H. C./ABD-4749-2021	Neave, Heather/0000-0002-1818-8131; Daros, Ruan R./0000-0003-2331-1648; Weary, Daniel M/0000-0002-0917-3982; Costa, Joao H. C./0000-0001-9311-4741; von Keyserlingk, Marina/0000-0002-1427-3152; Costa, Joao H. C./0000-0001-9311-4741	Natural Sciences and Engineering Research Council of Canada (NSERC); Biotechnology and Biological Sciences Research Council [BB/J004197/1] Funding Source: researchfish; BBSRC [BB/J004197/1] Funding Source: UKRI	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adobe Systems Inc, 2010, AD PHOT EL 9 0; Bateson M, 2011, CAN J PSYCHIAT, V56, P707, DOI 10.1177/070674371105601202; Bateson M, 2011, CURR BIOL, V21, P1070, DOI 10.1016/j.cub.2011.05.017; Brilot BO, 2010, ANIM COGN, V13, P721, DOI 10.1007/s10071-010-0323-z; Burman OHP, 2008, ANIM BEHAV, V76, P801, DOI 10.1016/j.anbehav.2008.02.014; Douglas C, 2012, APPL ANIM BEHAV SCI, V139, P65, DOI 10.1016/j.applanim.2012.02.018; Duffield TF, 2010, CAN VET J, V51, P283; EYSENCK MW, 1991, J ABNORM PSYCHOL, V100, P144, DOI 10.1037/0021-843X.100.2.144; Faulkner PM, 2000, J DAIRY SCI, V83, P2037, DOI 10.3168/jds.S0022-0302(00)75084-3; Grondahl-Nielsen C, 1999, VET J, V158, P14, DOI 10.1053/tvjl.1998.0284; Heinrich A, 2009, J DAIRY SCI, V92, P540, DOI 10.3168/jds.2008-1424; Heinrich A, 2010, J DAIRY SCI, V93, P2450, DOI 10.3168/jds.2009-2813; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Low LA, 2012, NEUROSCI LETT, V529, P103, DOI 10.1016/j.neulet.2012.09.027; MacLeod AK, 1996, J ABNORM PSYCHOL, V105, P286, DOI 10.1037/0021-843X.105.2.286; MacLeod AK, 1997, COGNITION EMOTION, V11, P467, DOI 10.1080/026999397379881; MacLeod AK, 2001, COGNITION EMOTION, V15, P99, DOI 10.1080/0269993004200006; Matheson SM, 2008, APPL ANIM BEHAV SCI, V109, P374, DOI 10.1016/j.applanim.2007.03.007; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; McGreevy P, 2007, CARROTS STICKS PRINC, P58; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Merskey H., 1994, CLASSIFICATION CHRON, P207, DOI DOI 10.1002/ANA.20394; Neave HW, 2013, DRYAD DIGITAL REPOSI; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Pincus T, 1996, BRIT J MED PSYCHOL, V69, P259, DOI 10.1111/j.2044-8341.1996.tb01868.x; Pincus T, 2001, PSYCHOL BULL, V127, P599, DOI 10.1037//0033-2909.127.5.599; Pomerantz O, 2012, ANIM COGN, V15, P689, DOI 10.1007/s10071-012-0497-7; Richter SH, 2012, COGN AFFECT BEHAV NE, V12, P527, DOI 10.3758/s13415-012-0101-2; Rutherford KMD, 2002, ANIM WELFARE, V11, P31; Salmeto AL, 2011, BRAIN RES, V1373, P124, DOI 10.1016/j.brainres.2010.12.007; Sanger ME, 2011, APPL ANIM BEHAV SCI, V131, P94, DOI 10.1016/j.applanim.2011.02.001; *SAS I INC, 2007, SAS ONLINEDOC 9 1 3; Stafford KJ, 2011, APPL ANIM BEHAV SCI, V135, P226, DOI 10.1016/j.applanim.2011.10.018; Stock ML, 2013, VET CLIN N AM-FOOD A, V29, P103, DOI 10.1016/j.cvfa.2012.11.001; Villemure C, 2002, PAIN, V95, P195, DOI 10.1016/S0304-3959(02)00007-6; Zhang XJ, 2011, NEUROSCI BULL, V27, P61, DOI 10.1007/s12264-011-1035-3	36	83	83	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80556	10.1371/journal.pone.0080556	http://dx.doi.org/10.1371/journal.pone.0080556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324609	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300029
J	Norambuena, F; Lewis, M; Hamid, NKA; Hermon, K; Donald, JA; Turchini, GM				Norambuena, Fernando; Lewis, Michael; Hamid, Noor Khalidah Abdul; Hermon, Karen; Donald, John A.; Turchini, Giovanni M.			Fish Oil Replacement in Current Aquaculture Feed: Is Cholesterol a Hidden Treasure for Fish Nutrition?	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; MEAL-BASED DIETS; MACCULLOCHELLA-PEELII-PEELII; STEAROYL-COA DESATURASE; RAT-LIVER MICROSOMES; SALMON SALMO-SALAR; BETA-OXIDATION; RAINBOW-TROUT; ONCORHYNCHUS-MYKISS; GROWTH-PERFORMANCE	Teleost fish, as with all vertebrates, are capable of synthesizing cholesterol and as such have no dietary requirement for it. Thus, limited research has addressed the potential effects of dietary cholesterol in fish, even if fish meal and fish oil are increasingly replaced by vegetable alternatives in modern aquafeeds, resulting in progressively reduced dietary cholesterol content. The objective of this study was to determine if dietary cholesterol fortification in a vegetable oil-based diet can manifest any effects on growth and feed utilization performance in the salmonid fish, the rainbow trout. In addition, given a series of studies in mammals have shown that dietary cholesterol can directly affect the fatty acid metabolism, the apparent in vivo fatty acid metabolism of fish fed the experimental diets was assessed. Triplicate groups of juvenile fish were fed one of two identical vegetable oil-based diets, with additional cholesterol fortification (high cholesterol; H-Chol) or without (low cholesterol; L-Chol), for 12 weeks. No effects were observed on growth and feed efficiency, however, in fish fed H-Col no biosynthesis of cholesterol, and a remarkably decreased apparent in vivo fatty acid beta-oxidation were recorded, whilst in L-Chol fed fish, cholesterol was abundantly biosynthesised and an increased apparent in vivo fatty acid b-oxidation was observed. Only minor effects were observed on the activity of stearyl-CoA desaturase, but a significant increase was observed for both the transcription rate in liver and the apparent in vivo activity of the fatty acid Delta-6 desaturase and elongase, with increasing dietary cholesterol. This study showed that the possible effects of reduced dietary cholesterol in current aquafeeds can be significant and warrant future investigations.	[Norambuena, Fernando; Lewis, Michael; Hermon, Karen; Turchini, Giovanni M.] Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia; [Hamid, Noor Khalidah Abdul; Donald, John A.] Deakin Univ, Sch Life & Environm Sci, Geelong, Vic 3217, Australia	Deakin University; Deakin University	Turchini, GM (corresponding author), Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia.	giovanni.turchini@deakin.edu.au	Hamid, Noor/AAX-5652-2021; Hamid, Noor K. A/Q-9142-2018; Donald, John/B-4656-2012	Hamid, Noor/0000-0001-8833-3683; Turchini, Giovanni/0000-0003-0694-4283; Donald, John/0000-0001-5930-2642	Australian Research Council [DP1093570]	Australian Research Council(Australian Research Council)	This research was supported under the Australian Research Council's Discovery Projects funding scheme (Project DP1093570). The views expressed herein are those of the authors and are not necessarily those of the Australian Research Council. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackman RG, 2002, ANAL CHIM ACTA, V465, P175, DOI 10.1016/S0003-2670(02)00098-3; AOAC, 2006, OFFICIAL METHODS ANA; Aschoff L, 1932, BRIT MED J, V1932, P1131, DOI 10.1136/bmj.2.3755.1131; ATKINSON JL, 1984, CAN J FISH AQUAT SCI, V41, P1384, DOI 10.1139/f84-170; Beier K, 1997, CARCINOGENESIS, V18, P1491, DOI 10.1093/carcin/18.8.1491; Bell JG, 2008, FISH OIL REPLACEMNET, P61; Bjerkeng B, 1999, AQUACULT NUTR, V5, P181; BROWN MS, 1976, SCIENCE, V191, P150, DOI 10.1126/science.174194; Brown TD, 2010, AQUACULTURE, V300, P148, DOI 10.1016/j.aquaculture.2009.12.020; Childs CE, 2008, P NUTR SOC, V67, P19, DOI 10.1017/S0029665108005983; Christie W.W, 2003, LIPID ANAL ISOLATION, V3rd; Coutteau P, 1997, AQUACULTURE, V155, P149, DOI 10.1016/S0044-8486(97)00125-7; Deng J, 2010, AQUACULT NUTR, V16, P419, DOI 10.1111/j.1365-2095.2009.00681.x; Deng JM, 2013, BRIT J NUTR, V110, P29, DOI 10.1017/S0007114512004680; Deng JM, 2013, FISH SHELLFISH IMMUN, V34, P324, DOI 10.1016/j.fsi.2012.11.008; Emery JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057463; Extier A, 2010, J NUTR BIOCHEM, V21, P180, DOI 10.1016/j.jnutbio.2008.10.008; FARRELL AP, 1986, ARTERIOSCLEROSIS, V6, P453, DOI 10.1161/01.ATV.6.4.453; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis DS, 2007, J AGR FOOD CHEM, V55, P1582, DOI 10.1021/jf062153x; Francis DS, 2006, AQUACULTURE, V253, P547, DOI 10.1016/j.aquaculture.2005.08.008; FUNGWE TV, 1994, J LIPID RES, V35, P311; GARG ML, 1988, J NUTR, V118, P661, DOI 10.1093/jn/118.6.661; GARG ML, 1988, BIOCHEM J, V249, P351, DOI 10.1042/bj2490351; GARG ML, 1988, BIOCHIM BIOPHYS ACTA, V962, P330, DOI 10.1016/0005-2760(88)90262-7; HAYASHI H, 1989, ARCH BIOCHEM BIOPHYS, V274, P582, DOI 10.1016/0003-9861(89)90473-6; KAUSHIK SJ, 1995, AQUACULTURE, V133, P257, DOI 10.1016/0044-8486(94)00403-B; Kritchevsky D., 2008, FOOD LIPIDS CHEM NUT, P499; Leaver MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-299; Liland N.S., 2012, METABOLIC REGULATION, P29; Liland N.S., 2013, BR J NUTR, P1; Moffat C, 2009, FISH OILS, P51; MURIANA FJG, 1992, BIOCHIMIE, V74, P551, DOI 10.1016/0300-9084(92)90153-6; Norambuena F, 2013, AQUACULTURE, V372, P80, DOI 10.1016/j.aquaculture.2012.10.035; Ntambi JM, 1999, J LIPID RES, V40, P1549; Olsen Y, 2011, AQUACULT ENV INTERAC, V1, P187, DOI 10.3354/aei00019; OSMUNDSEN H, 1991, BIOCHIM BIOPHYS ACTA, V1085, P141, DOI 10.1016/0005-2760(91)90089-Z; Parish EJ., 2008, FOOD LIPIDS CHEM NUT, P99; Parish EJ, 2008, FOOD LIPIDS CHEM NUT; Sealey WM, 2001, AQUACULT NUTR, V7, P25, DOI 10.1046/j.1365-2095.2001.00159.x; Sheen SS, 2000, AQUACULTURE, V189, P277, DOI 10.1016/S0044-8486(00)00379-3; Tabor DE, 1998, J BIOL CHEM, V273, P22052, DOI 10.1074/jbc.273.34.22052; Tocher DR, 2008, AQUACULTURE, V280, P21, DOI 10.1016/j.aquaculture.2008.04.034; Torstensen B. E., 2011, FISH OIL REPLACEMENT, P405, DOI 10.1201/9781439808634-c13; Turchini GM, 2007, LIPIDS, V42, P1065, DOI 10.1007/s11745-007-3105-x; Turchini GM, 2009, REV AQUACULT, V1, P10, DOI 10.1111/j.1753-5131.2008.01001.x; Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874; Twibell RG, 2004, AQUACULTURE, V236, P539, DOI 10.1016/j.aquaculture.2003.10.028; Vagner M, 2011, AQUACULTURE, V315, P131, DOI 10.1016/j.aquaculture.2010.11.031; VANKEULEN J, 1977, J ANIM SCI, V44, P282; Vlahcevic Z. Reno, 1994, P379; Yun BA, 2011, AQUACULTURE, V319, P105, DOI 10.1016/j.aquaculture.2011.06.028; Zhang WB, 2009, AQUACULTURE, V295, P271, DOI 10.1016/j.aquaculture.2009.07.006	53	58	59	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81705	10.1371/journal.pone.0081705	http://dx.doi.org/10.1371/journal.pone.0081705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324720	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300106
J	Obreli-Neto, PR; Pereira, LRL; Guidoni, CM; Baldoni, AD; Marusic, S; de Lyra, DP; de Almeida, KL; Pazete, ACM; do Nascimento, JD; Kos, M; Girotto, E; Kenji, R; Cuman, N				Obreli-Neto, Paulo Roque; Leira Pereira, Leonardo Regis; Guidoni, Camilo Molino; Baldoni, Andre de Oliveira; Marusic, Srecko; de Lyra-Junior, Divaldo Pereira; de Almeida, Kelsen Luis; Montolezi Pazete, Ana Claudia; do Nascimento, Janaina Dutra; Kos, Mitja; Girotto, Edmarlon; Kenji, Roberto; Cuman, Nakamura			Use of Simulated Patients to Evaluate Combined Oral Contraceptive Dispensing Practices of Community Pharmacists	PLOS ONE			English	Article							ANTIEPILEPTIC DRUGS; WOMENS; KNOWLEDGE; PILLS; RISK; CONTRAINDICATIONS; PRESCRIPTION; CARBAMAZEPINE; ATTITUDES; PERSONNEL	Background: Combined oral contraceptive (COC) use is the most commonly used reversible method of birth control. The incorrect use of COCs is frequent and one of the most common causes of unintended pregnancies. Community pharmacists (CPs) are in a strategic position to improve COC use because they are the last health professional to interact with patients before drug use. Objective: To evaluate the COC dispensing practices of CPs in a developing country. Method: A cross-sectional study was conducted in community pharmacies of Assis and Ourinhos microregions, Brazil, between June 1, 2012, and October 30, 2012. Four simulated patients (SPs) (with counseled audio recording) visited community pharmacies with a prescription for Ciclo 21 (R) (a COC containing ethinyl estradiol 30 mcg + levonorgestrel 15 mcg). The audio recording of every SP visit was listened to independently by 3 researchers to evaluate the COC dispensing practice. The percentage of CPs who performed a screening for safe use of COCs (i.e., taking of patients' medical and family history, and measuring of blood pressure) and provided counseling, as well as the quality of the screening and counseling, were evaluated. Results: Of the 185 CPs contacted, 41 (22.2%) agreed to participate in the study and finished the study protocol. Only 3 CPs asked the SP a question (1 question asked by each professional), and all of the questions were closed-ended, viz., "do you smoke?" (n = 2) and "what is your age?" (n = 1). None of the CPs measured the patient's blood pressure. Six CPs provided counseling when dispensing COCs (drug dosing, 5 CPs; possible adverse effects, 2 CPs), and one CP provided counseling regarding both aspects. Conclusion: The CPs evaluated did not dispense COC appropriately and could influence in the occurrence of negatives therapeutic outcomes such as adverse effects and treatment failure.	[Obreli-Neto, Paulo Roque; Cuman, Nakamura] Univ Estadual Maringa, Dept Pharmacol & Therapeut, Maringa, Parana, Brazil; [Leira Pereira, Leonardo Regis; Baldoni, Andre de Oliveira] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Dept Pharmaceut Sci, BR-14049 Ribeirao Preto, SP, Brazil; [Guidoni, Camilo Molino; Girotto, Edmarlon] Univ Estadual Londrina, Dept Pharmaceut Sci, Londrina, Parana, Brazil; [Marusic, Srecko] Univ Hosp Dubrava, Dept Clin Pharmacol, Zagreb, Croatia; [de Lyra-Junior, Divaldo Pereira] Univ Fed Sergipe, Lab Teaching & Res Social Pharm, Sao Cristovao, Sergipe, Brazil; [de Almeida, Kelsen Luis; Montolezi Pazete, Ana Claudia; do Nascimento, Janaina Dutra] Fac Integradas Ourinhos, Dept Pharm, Sao Paulo, Brazil; [Kos, Mitja] Univ Ljubljana, Fac Pharm, Chair Social Pharm, Ljubljana, Slovenia	Universidade Estadual de Maringa; Universidade de Sao Paulo; Universidade Estadual de Londrina; Universidade Federal de Sergipe; University of Ljubljana	Obreli-Neto, PR (corresponding author), Univ Estadual Maringa, Dept Pharmacol & Therapeut, Maringa, Parana, Brazil.	paulorobreli@yahoo.com.br	Junior, Divaldo Lyra/AAU-9987-2020; AO BALDONI, AO BALDONI/B-3219-2016; Lyra, Divaldo P/G-4622-2012; Baldoni, André Oliveira/AAO-2675-2021; Kos, Mitja/C-7440-2019; Pereira, Leonardo R L/J-9322-2012	Junior, Divaldo Lyra/0000-0002-0266-0702; AO BALDONI, AO BALDONI/0000-0001-6379-0415; Lyra, Divaldo P/0000-0002-0266-0702; Kos, Mitja/0000-0002-6801-6450; Pereira, Leonardo R L/0000-0002-8609-1390				Adab N, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858]; Alihonou E, 1997, CONTRACEPTION, V55, P97, DOI 10.1016/S0010-7824(96)00279-X; American College of Obstetrics and Gynecology, 2006, OBSTET GYNECOL, V73, P1453, DOI DOI 10.1097/00006250-200606000-00055.PUBMED:16738183; *ASHP, 1993, AM J HOSP PHARM, V50, P505; Beardsley RS KC, 2012, COMMUNICATION SKILLS; Becker D, 2004, CONTRACEPTION, V69, P295, DOI 10.1016/j.contraception.2003.11.014; BERGER BA, 2009, COMMUNICATION SKILLS; Berger K, 2005, J CLIN PHARM THER, V30, P45, DOI 10.1111/j.1365-2710.2004.00611.x; Blanchard K, 2005, INT FAM PLAN PERSPEC, V31, P172, DOI 10.1363/3117205; *BRAZ MIN HLTH, 2006, PESQ NAC DEM SAUD CR; Caamano F, 2002, PHARM WORLD SCI, V24, P217, DOI 10.1023/A:1021808923928; Chandra Ashish, 2003, Health Promot Pract, V4, P64, DOI 10.1177/1524839902238293; Chin-Quee DS, 2006, STUD FAMILY PLANN, V37, P99, DOI 10.1111/j.1728-4465.2006.00089.x; CHIRDAN OO, 2010, J MED TROPICS, V12, P18; Committee on Gynecologic Practice American College of Obstetricians and Gynecologists, 2012, Obstet Gynecol, V120, P1527, DOI 10.1097/01.AOG.0000423818.85283.bd; Curtis KM, 2006, CONTRACEPTION, V73, P179, DOI 10.1016/j.contraception.2005.08.005; Curtis KM, 2002, OBSTET GYNECOL, V99, P1100, DOI 10.1016/S0029-7844(02)01984-1; Dayal M, 2001, SEMIN REPROD MED, V19, P295, DOI 10.1055/s-2001-18637; de Oliveira DR, 2010, J MANAGE CARE PHARM, V16, P185, DOI 10.18553/jmcp.2010.16.3.185; Doose DR, 2003, EPILEPSIA, V44, P540, DOI 10.1046/j.1528-1157.2003.55602.x; Ehrle N, 2011, INT PERSPECT SEX R H, V37, P67, DOI 10.1363/3706711; Etminan M, 2005, BMJ-BRIT MED J, V330, P63, DOI 10.1136/bmj.38302.504063.8F; Frost JJ, 2007, PERSPECT SEX REPRO H, V39, P48, DOI 10.1363/3904807; Gardner JS, 2008, J AM PHARM ASSOC, V48, P212, DOI 10.1331/JAPhA.2008.07138; Grossman D, 2006, AM J PUBLIC HEALTH, V96, P791, DOI 10.2105/AJPH.2004.040774; Grossman D, 2008, OBSTET GYNECOL, V112, P572, DOI 10.1097/AOG.0b013e31818345f0; Grossman D, 2011, OBSTET GYNECOL, V117, P558, DOI 10.1097/AOG.0b013e31820b0244; HATCHER RA, 2007, CONTRACEPTIVE TECHNO; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Jensen JT, 2000, OBSTET GYN CLIN N AM, V27, P705, DOI 10.1016/S0889-8545(05)70169-8; Khader YS, 2003, CONTRACEPTION, V68, P11, DOI 10.1016/S0010-7824(03)00073-8; Landau SC, 2006, CONTRACEPTION, V74, P463, DOI 10.1016/j.contraception.2006.07.006; Machado RB, 2012, CONTRACEPTION, V86, P698, DOI 10.1016/j.contraception.2012.05.016; Matlow J, 2012, CAN FAM PHYSICIAN, V58, P163; McIntosh J, 2011, PHARMACOTHERAPY, V31, P424, DOI 10.1592/phco.31.4.424; Obreli-Neto PR, 2011, INT J CLIN PHARM-NET, V33, P642, DOI 10.1007/s11096-011-9518-x; ORTIZ M, 1989, J SOC ADMIN PHARM, V6, P39; Pharmaceutical Society of Australia, 2006, AUSTR PHARM FORM HDB; Ratanajamit C, 2001, PHARMACOEPIDEM DR S, V10, P149, DOI 10.1002/pds.573; Reddy Doodipala Samba, 2010, Expert Rev Clin Pharmacol, V3, P183, DOI 10.1586/ecp.10.3; Schwingl PJ, 1999, AM J OBSTET GYNECOL, V180, P241, DOI 10.1016/S0002-9378(99)70182-1; Shah MA, 2001, INT J GYNECOL OBSTET, V73, P243, DOI 10.1016/S0020-7292(01)00375-7; Shortridge E, 2007, CONTRACEPTION, V75, P355, DOI 10.1016/j.contraception.2006.12.022; Shorvon SD, 2002, J NEUROL NEUROSUR PS, V72, P114, DOI 10.1136/jnnp.72.1.114; Shotorbani S, 2006, CONTRACEPTION, V73, P501, DOI 10.1016/j.contraception.2005.12.001; Sonfield A, 2011, PERSPECT SEX REPRO H, V43, P94, DOI 10.1363/4309411; Tully MP, 2011, PATIENT EDUC COUNS, V83, P3, DOI 10.1016/j.pec.2010.04.029; *US PHARM, 2012, USP MED COUNS BEH GU; Van Riper KK, 2005, PERSPECT SEX REPRO H, V37, P19, DOI 10.1363/371905; Wang H, 2012, CONTRACEPTION, V85, P28, DOI 10.1016/j.contraception.2011.04.017; Watson MC, 2009, FAM PRACT, V26, P532, DOI 10.1093/fampra/cmp061; Watson MC, 2004, PHARM WORLD SCI, V26, P32, DOI 10.1023/B:PHAR.0000013467.61875.ce; WATSON MC, 2006, INT J PHARM PRACT, V14, P83; Weiss MC, 2010, PHARM WORLD SCI, V32, P353, DOI 10.1007/s11096-010-9375-z; Werner JB, 2008, AM J PHARM EDUC, V72, DOI 10.5688/aj7206136; Westhoff CL, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.015; WHO, 2015, MED EL CRIT CONTR US, V5th	57	19	20	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e79875	10.1371/journal.pone.0079875	http://dx.doi.org/10.1371/journal.pone.0079875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	265KD	24324584	Green Submitted, gold, Green Published			2022-12-25	WOS:000327949300011
J	Patton, DF; Parfyonov, M; Gourmelen, S; Opiol, H; Pavlovski, I; Marchant, EG; Challet, E; Mistlberger, RE				Patton, Danica F.; Parfyonov, Maksim; Gourmelen, Sylviane; Opiol, Hanna; Pavlovski, Ilya; Marchant, Elliott G.; Challet, Etienne; Mistlberger, Ralph E.			Photic and Pineal Modulation of Food Anticipatory Circadian Activity Rhythms in Rodents	PLOS ONE			English	Article							NOCTURNAL RODENTS; LIGHT; MASKING; OSCILLATORS; MELATONIN; RAT; ENTRAINMENT; MAMMALS; GLAND; EXPRESSION	Restricted daily feeding schedules entrain circadian oscillators that generate food anticipatory activity (FAA) rhythms in nocturnal rodents. The location of food-entrainable oscillators (FEOs) necessary for FAA remains uncertain. The most common procedure for inducing circadian FAA is to limit food access to a few hours in the middle of the light period, when activity levels are normally low. Although light at night suppresses activity (negative masking) in nocturnal rodents, it does not prevent the expression of daytime FAA. Nonetheless, light could reduce the duration or magnitude of FAA. If so, then neural or genetic ablations designed to identify components of the food-entrainable circadian system could alter the expression of FAA by affecting behavioral responses to light. To assess the plausibility of light as a potential mediating variable in studies of FAA mechanisms, we quantified FAA in rats and mice alternately maintained in a standard full photoperiod (12h of light/day) and in a skeleton photoperiod (two 60 min light pulses simulating dawn and dusk). In both species, FAA was significantly and reversibly enhanced in the skeleton photoperiod compared to the full photoperiod. In a third experiment, FAA was found to be significantly attenuated in rats by pinealectomy, a procedure that has been reported to enhance some effects of light on behavioral circadian rhythms. These results indicate that procedures affecting behavioral responses to light can significantly alter the magnitude of food anticipatory rhythms in rodents.	[Patton, Danica F.; Parfyonov, Maksim; Opiol, Hanna; Pavlovski, Ilya; Mistlberger, Ralph E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Gourmelen, Sylviane; Challet, Etienne] Univ Strasbourg, CNRS, Inst Cellular & Integrat Neurosci, UPR3212, Strasbourg, France; [Marchant, Elliott G.] Vancouver Isl Univ, Dept Psychol, Nanaimo, BC, Canada	Simon Fraser University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Vancouver Island University	Mistlberger, RE (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada.	mistlber@sfu.ca	Challet, Etienne/ABF-7553-2020; Parfyonov, Maksim/AAP-7478-2020	Challet, Etienne/0000-0001-9416-9496; Parfyonov, Maksim/0000-0003-0582-0852	NSERC Canada [RGPIN155172]; Centre National de la Recherche Scientifique, University of Strasbourg; Fondation pour la Recherche Medicale	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre National de la Recherche Scientifique, University of Strasbourg; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	RM is supported by NSERC Canada (http://www.nserc-crsng.gc.ca/) operating grant RGPIN155172. EC is supported by Centre National de la Recherche Scientifique, University of Strasbourg and Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; BOULOS Z, 1980, NEUROSCI BIOBEHAV R, V4, P119, DOI 10.1016/0149-7634(80)90010-X; CASSONE VM, 1992, J BIOL RHYTHM, V7, P27, DOI 10.1177/074873049200700103; Challet E, 1997, J BIOL RHYTHM, V12, P65, DOI 10.1177/074873049701200108; Challet E, 2009, EUR J NEUROSCI, V30, P1676, DOI 10.1111/j.1460-9568.2009.06962.x; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; Doi M, 2006, NAT NEUROSCI, V9, P732, DOI 10.1038/nn1711; Feillet CA, 2008, MOL CELL NEUROSCI, V37, P209, DOI 10.1016/j.mcn.2007.09.010; Feillet CA, 2008, EUR J NEUROSCI, V28, P2451, DOI 10.1111/j.1460-9568.2008.06538.x; Guler AD, 2007, COLD SPRING HARB SYM, V72, P509, DOI 10.1101/sqb.2007.72.074; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; HO AK, 1985, ENDOCRINOLOGY, V116, P1858, DOI 10.1210/endo-116-5-1858; HOLLOWAY WR, 1979, LIFE SCI, V25, P1837, DOI 10.1016/0024-3205(79)90431-4; Landry GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024187; Marston OJ, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-19; Mendoza J, 2005, J NEUROSCI, V25, P1514, DOI 10.1523/JNEUROSCI.4397-04.2005; Minana-Solis MC, 2009, CHRONOBIOL INT, V26, P808, DOI 10.1080/07420520903044240; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mistlberger RE, 2005, BRAIN RES REV, V49, P429, DOI 10.1016/j.brainresrev.2005.01.005; Mistlberger RE, 1999, BRAIN RES, V842, P73, DOI 10.1016/S0006-8993(99)01836-3; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Morin LP, 2013, J BIOL RHYTHM, V28, P95, DOI 10.1177/0748730413481921; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; QUAY WB, 1970, PHYSIOL BEHAV, V5, P1281, DOI 10.1016/0031-9384(70)90041-7; Redlin U, 2001, CHRONOBIOL INT, V18, P737, DOI 10.1081/CBI-100107511; Ribeiro AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023364; ROSENWASSER AM, 1983, PHYSIOL BEHAV, V30, P353, DOI 10.1016/0031-9384(83)90138-5; Rusak B, 1982, PINEAL GLAND, P27; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; STEPHAN FK, 1983, PHYSIOL BEHAV, V30, P451, DOI 10.1016/0031-9384(83)90152-X; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P346, DOI 10.1016/S0163-1047(79)90415-1; Uz T, 2003, NEUROPSYCHOPHARMACOL, V28, P2117, DOI 10.1038/sj.npp.1300254; Verwey M, 2009, EUR J NEUROSCI, V30, P1650, DOI 10.1111/j.1460-9568.2009.06960.x; Wu T, 2008, J NEUROSCI RES, V86, P3246, DOI 10.1002/jnr.21769; YANOVSKI JA, 1990, BRAIN RES, V537, P216, DOI 10.1016/0006-8993(90)90361-E	38	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81588	10.1371/journal.pone.0081588	http://dx.doi.org/10.1371/journal.pone.0081588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324709	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300099
J	Sun, Q; Meng, QT; Jiang, Y; Liu, HM; Lei, SQ; Su, WT; Duan, WN; Wu, Y; Xia, ZY; Xia, ZY				Sun, Qian; Meng, Qing-tao; Jiang, Ying; Liu, Hui-min; Lei, Shao-qing; Su, Wa-ting; Duan, Wei-na; Wu, Yang; Xia, Zheng-yuan; Xia, Zhong-yuan			Protective Effect of Ginsenoside Rb1 against Intestinal Ischemia-Reperfusion Induced Acute Renal Injury in Mice	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; TRANSCRIPTION FACTOR NRF2; MOLECULAR-MECHANISMS; HEME OXYGENASE-1; UP-REGULATION; LIVER-INJURY; ACTIVATION; EXPRESSION; STRESS; KIDNEY	Ginsenoside Rb1 (RB1), the most clinically effective constituent of ginseng, possesses a variety of biological activities. The objectives of this study were to investigate the protective effects of RB1 and its underlying mechanism on renal injury induced by intestinal ischemia-reperfusion (IIR) in mice. RB1 was administered prior to inducing IIR achieved by occluding the superior mesenteric artery for 45 min followed by 120 min of reperfusion. All-trans-retinoic acid (ATRA) was used as an inhibitor of NF-E2-related factor-2 (Nrf2) signaling. Adult male C57BL/6J mice were randomly divided into six groups: (1) sham group, (2) IIR group, (3) RB1 group, (4) sham + ATRA group, (5) IIR + ATRA group, and (6) RB1 + ATRA group. Intestinal histology and pathological injury score were observed. Intestinal mucosal injury was also evaluated by measuring serum diamine oxidase (DAO). Renal injury induced by IIR was characterized by increased levels of histological severity score, blood urea nitrogen (BUN), serum creatinine (Scr) and neutrophil gelatinase-associated lipocalin (NGAL), which was accompanied with elevated renal TUNEL-positive cells and the Bcl-2/Bax expression ratio. RB1 significantly reduced renal injury and apoptosis as compared with IIR group, which was reversed by ATRA treatment. Immunohistochemistry and Western blot analysis demonstrated that RB1 significantly upregulated the protein expression of heme oxygenase-1 (HO-1) and Nrf2, which were attenuated by ATRA treatment. Taken together, these results suggest that the protective effects of RB1 pretreatment against renal injury induced by IIR are associated with activation of the Nrf2/anti-oxidant response element (ARE) pathway.	[Sun, Qian; Meng, Qing-tao; Jiang, Ying; Liu, Hui-min; Lei, Shao-qing; Su, Wa-ting; Duan, Wei-na; Wu, Yang; Xia, Zhong-yuan] Wuhan Univ, Renmin Hosp, Dept Anesthesiol, Wuhan 430072, Hubei, Peoples R China; [Xia, Zheng-yuan] Univ Hong Kong, Dept Anesthesiol, Hong Kong, Hong Kong, Peoples R China; [Xia, Zheng-yuan] Guangdong Med Coll, Dept Anesthesiol, Affiliated Hosp, Zhanjiang, Guangdong, Peoples R China	Wuhan University; University of Hong Kong; Guangdong Medical University	Xia, ZY (corresponding author), Wuhan Univ, Renmin Hosp, Dept Anesthesiol, Wuhan 430072, Hubei, Peoples R China.	xiazhongyuan2005@aliyun.com	Irwin, Michael Garnet/C-4286-2009; Irwin, Michael Garnet/GLR-9714-2022	Irwin, Michael Garnet/0000-0001-5801-274X; Irwin, Michael Garnet/0000-0001-5801-274X; xia, zhongyuan/0000-0002-5807-9554	National Natural Science Foundation of China [81000027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81000027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng Y, 2005, ACTA PHARMACOL SIN, V26, P143, DOI 10.1111/j.1745-7254.2005.00034.x; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Deng C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058371; Fedorova LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064436; Greca FH, 2008, ACTA CIR BRAS, V23, P149, DOI 10.1590/S0102-86502008000200007; Guo YJ, 2011, LIFE SCI, V88, P598, DOI 10.1016/j.lfs.2011.01.022; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; HAGLUND U, 1987, ACTA CHIR SCAND, V153, P321; Hjortrup PB, 2013, CRIT CARE, V17, DOI 10.1186/cc11855; Hseu YC, 2012, FOOD CHEM TOXICOL, V50, P1245, DOI 10.1016/j.fct.2012.02.020; Hwang YP, 2010, TOXICOL APPL PHARM, V242, P18, DOI 10.1016/j.taap.2009.09.009; Jia JM, 2008, ZHONGGUO ZHONG YAO Z, V33, P1371; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kazantzidou D, 2010, MINERVA CHIR, V65, P515; Kim YM, 2011, ANTIOXID REDOX SIGN, V14, P137, DOI 10.1089/ars.2010.3153; Leonard MO, 2006, FASEB J, V20, P2624, DOI 10.1096/fj.06-5097fje; Mao XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068949; MCWHINNIE DL, 1986, TRANSPLANTATION, V42, P352, DOI 10.1097/00007890-198610000-00004; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Mutlu G, 2002, PEDIATR SURG INT, V18, P337, DOI 10.1007/s00383-002-0834-z; Niture SK, 2011, CELL DEATH DIFFER, V18, P439, DOI 10.1038/cdd.2010.114; Schwarz B, 1999, WIEN KLIN WOCHENSCHR, V111, P539; Shah ZA, 2007, NEUROSCIENCE, V147, P53, DOI 10.1016/j.neuroscience.2007.02.066; Srisook K, 2005, ANTIOXID REDOX SIGN, V7, P1674, DOI 10.1089/ars.2005.7.1674; Surh YJ, 2009, ARCH PHARM RES, V32, P1163, DOI 10.1007/s12272-009-1807-8; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Tanaka Y, 2007, MOL PHARMACOL, V71, P817, DOI 10.1124/mol.106.029033; Tkachev VO, 2011, BIOCHEMISTRY-MOSCOW+, V76, P407, DOI 10.1134/S0006297911040031; Wang J, 2008, EXP MOL MED, V40, P686, DOI 10.3858/emm.2008.40.6.686; Wang XJ, 2007, P NATL ACAD SCI USA, V104, P19589, DOI 10.1073/pnas.0709483104; Wu Y, 2011, MOL BIOL REP, V38, P4327, DOI 10.1007/s11033-010-0558-4; Xia R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/767930; Xie XS, 2009, CHIN J INTEGR MED, V15, P133, DOI 10.1007/s11655-009-0133-9; Yurdakan G, 2012, KAOHSIUNG J MED SCI, V28, P16, DOI 10.1016/j.kjms.2011.06.030; Zhao HD, 2010, WORLD J GASTROENTERO, V16, P3002, DOI 10.3748/wjg.v16.i24.3002; Zhu Min-Xia, 2009, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V25, P496	36	45	50	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80859	10.1371/journal.pone.0080859	http://dx.doi.org/10.1371/journal.pone.0080859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324637	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300049
J	Yan, BF; Duan, W; Liu, GT; Xu, HG; Wang, LJ; Li, SH				Yan, Bo-Fang; Duan, Wei; Liu, Guo-Tian; Xu, Hong-Guo; Wang, Li-Jun; Li, Shao-Hua			Response of Bean (Vicia faba L.) Plants to Low Sink Demand by Measuring the Gas Exchange Rates and Chlorophyll a Fluorescence Kinetics	PLOS ONE			English	Article							PHOTOSYSTEM-II PERFORMANCE; STOMATAL CONDUCTANCE; LEAF PHOTOSYNTHESIS; ELECTRON-TRANSPORT; CO2 ASSIMILATION; END-PRODUCTS; DONOR SIDE; PEACH; LEAVES; TEMPERATURE	Background: The decline of photosynthesis in plants under low sink demand is well known. Previous studies focused on the relationship between stomatal conductance (g(s)) and net photosynthetic rate (P-n). These studies investigated the effect of changes in Photosystem II (PSII) function on the P-n decline under low sink demand. However, little is known about its effects on different limiting steps of electron transport chain in PSII under this condition. Methodology/Principal Finding: Two-month-old bean plants were processed by removing pods and flowers (low sink demand). On the 1st day after low sink demand treatment, a decline of P-n was accompanied by a decrease in g(s) and internal-to-ambient CO2 concentration ratio (C-i/C-a). From the 3rd to 9th day, P-n and g(s) declined continuously while C-i/C-a ratio remained stable in the treatment. Moreover, these values were lower than that of control. W-k (a parameter reflecting the damage to oxygen evolving complex of the donor side of PSII) values in the treatment were significantly higher than their corresponding control values. However, RCQA (a parameter reflecting the number of active RCs per excited cross-section of PSII) values in the treatment were significantly lower than control from the 5th day. From the 11th to 21st day, P-n and g(s) of the treatment continued to decline and were lower than control. This was accompanied by a decrease of RCQA, and an increase of W-k. Furthermore, the quantum yield parameters phi(Po), phi(Eo) and psi(Eo) in the treatment were lower than in control; however, C-i/C-a values in the treatment gradually increased and were significantly higher than control on the 21st day. Conclusions: Stomatal limitation during the early stage, whereas a combination of stomatal and non-stomatal limitation during the middle stage might be responsible for the reduction of P-n under low sink demand. Non-stomatal limitation during the late stages after the removal of the sink of roots and pods may also cause P-n reduction. The non-stomatal limitation was associated with the inhibition of PSII electron transport chain. Our data suggests that the donor side of PSII was the most sensitive to low sink demand followed by the reaction center of PSII. The acceptor side of PSII may be the least sensitive.	[Yan, Bo-Fang; Duan, Wei; Liu, Guo-Tian; Xu, Hong-Guo; Wang, Li-Jun; Li, Shao-Hua] Chinese Acad Sci, Inst Bot, Beijing Key Lab Grape Sci & Enol, Beijing, Peoples R China; [Yan, Bo-Fang; Duan, Wei; Liu, Guo-Tian; Xu, Hong-Guo; Wang, Li-Jun; Li, Shao-Hua] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China; [Yan, Bo-Fang; Liu, Guo-Tian] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Shao-Hua] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Wang, LJ (corresponding author), Chinese Acad Sci, Inst Bot, Beijing Key Lab Grape Sci & Enol, Beijing, Peoples R China.	ljwang@ibcas.ac.cn; shhli@ibcas.ac.cn	Yan, Bo-fang/A-1405-2014; Yan, Bo-Fang/J-1133-2019	Yan, Bo-fang/0000-0001-7663-522X; Yan, Bo-Fang/0000-0001-7663-522X	National Natural Science Foundation of China [31270718]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by grants from the National Natural Science Foundation of China (Grant number 31270718). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert KR, 2005, PHYSIOL PLANTARUM, V124, P208, DOI 10.1111/j.1399-3054.2005.00502.x; Boussingault JB, 1868, AGRONOMIE CHIMIE AGR, P236; Chen HX, 2007, PHYSIOL PLANTARUM, V129, P386, DOI 10.1111/j.1399-3054.2006.00830.x; Chen LS, 2010, ACTA PHYSIOL PLANT, V32, P253, DOI 10.1007/s11738-009-0402-4; Cheng JS, 2009, J AM SOC HORTIC SCI, V134, P667, DOI 10.21273/JASHS.134.6.667; Cheng YH, 2008, J JPN SOC HORTIC SCI, V77, P115, DOI 10.2503/jjshs1.77.115; DaMatta FM, 2008, NEW PHYTOL, V178, P348, DOI 10.1111/j.1469-8137.2008.02367.x; DOWNTON WJS, 1982, BIOCHIM BIOPHYS ACTA, V679, P474, DOI 10.1016/0005-2728(82)90169-4; Duan W, 2008, TREE PHYSIOL, V28, P123, DOI 10.1093/treephys/28.1.123; Fan PG, 2010, TREE PHYSIOL, V30, P313, DOI 10.1093/treephys/tpp114; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; GOVINDJEE, 1995, AUST J PLANT PHYSIOL, V22, P131, DOI 10.1071/PP9950131; Guha A, 2013, J PHOTOCH PHOTOBIO B, V119, P71, DOI 10.1016/j.jphotobiol.2012.12.006; Hastings J.W., 1986, LIGHT EMISSION PLANT, P363; Kyselakova H, 2011, PLANT PHYSIOL BIOCH, V49, P1279, DOI 10.1016/j.plaphy.2011.08.006; Li PM, 2009, J PLANT PHYSIOL, V166, P1607, DOI 10.1016/j.jplph.2009.04.013; Li SH, 2001, J HORTIC SCI BIOTECH, V76, P61, DOI 10.1080/14620316.2001.11511328; Li WD, 2005, J HORTIC SCI BIOTECH, V80, P481, DOI 10.1080/14620316.2005.11511964; Li WD, 2007, TREE PHYSIOL, V27, P1307, DOI 10.1093/treephys/27.9.1307; Lin ZH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-43; Long SP, 2003, J EXP BOT, V54, P2393, DOI 10.1093/jxb/erg262; Luo HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023033; Mason TG, 1928, ANN BOT-LONDON, V42, P189, DOI 10.1093/oxfordjournals.aob.a090110; NEALES TF, 1968, BOT REV, V34, P107, DOI 10.1007/BF02872604; Nebauer SG, 2011, TREE PHYSIOL, V31, P169, DOI 10.1093/treephys/tpq103; Ni LX, 2012, B ENVIRON CONTAM TOX, V89, P1165, DOI 10.1007/s00128-012-0843-0; NII N, 1995, J JPN SOC HORTIC SCI, V64, P267, DOI 10.2503/jjshs.64.267; Nii N, 1997, ANN BOT-LONDON, V79, P139, DOI 10.1006/anbo.1996.0324; Papageorgiou G.C., 2004, CHLOROPHYLL FLUORESC; Paul MJ, 2003, J EXP BOT, V54, P539, DOI 10.1093/jxb/erg052; Schansker G, 2005, BBA-BIOENERGETICS, V1706, P250, DOI 10.1016/j.bbabio.2004.11.006; Schansker G, 2006, BBA-BIOENERGETICS, V1757, P787, DOI 10.1016/j.bbabio.2006.04.019; SETTER TL, 1980, PLANT PHYSIOL, V65, P884, DOI 10.1104/pp.65.5.884; Srivastava A, 1997, BBA-BIOENERGETICS, V1320, P95, DOI 10.1016/S0005-2728(97)00017-0; Stirbet A, 2012, PHOTOSYNTH RES, V113, P15, DOI 10.1007/s11120-012-9754-5; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Strasser BJ, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL 5, P977; Strasser BJ, 1997, PHOTOSYNTH RES, V52, P147, DOI 10.1023/A:1005896029778; Strasser RJ, 2004, ADV PHOTO RESPIRAT, V19, P321; STRASSER RJ, 1995, PHOTOCHEM PHOTOBIOL, V61, P32, DOI 10.1111/j.1751-1097.1995.tb09240.x; STRASSER RJ, 1992, NATO ADV SCI I A-LIF, V226, P423; Strasser RJ., 1999, CROP IMPROVEMENT FOO, P72; TAN CS, 1986, HORTSCIENCE, V21, P1180; Urban L, 2007, TREE PHYSIOL, V27, P345, DOI 10.1093/treephys/27.3.345; Venkatesh J, 2012, HORTIC ENVIRON BIOTE, V53, P320, DOI 10.1007/s13580-012-0035-1; Wang SZ, 2012, ECOTOX ENVIRON SAFE, V84, P104, DOI 10.1016/j.ecoenv.2012.06.028; Wu BH, 2008, J AM SOC HORTIC SCI, V133, P278, DOI 10.21273/JASHS.133.2.278; Wunsche JN, 2005, TREE PHYSIOL, V25, P1253, DOI 10.1093/treephys/25.10.1253; Xiang MM, 2013, PLANT PHYSIOL BIOCH, V65, P81, DOI 10.1016/j.plaphy.2013.01.013; Yan K, 2012, J AGRON CROP SCI, V198, P218, DOI 10.1111/j.1439-037X.2011.00498.x; Yan K, 2011, J AGRON CROP SCI, V197, P400, DOI 10.1111/j.1439-037X.2011.00469.x; Yan ST, 2011, BIOL PLANTARUM, V55, P83, DOI 10.1007/s10535-011-0011-0; Zhang ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042936; [赵洪梅 ZHAO Hong-mei], 2009, [大豆科学, Soybean Science], V28, P736	54	7	7	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80770	10.1371/journal.pone.0080770	http://dx.doi.org/10.1371/journal.pone.0080770			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324626	Green Submitted, Green Published, gold			2022-12-25	WOS:000327949300043
J	Cheng, QS; Blais, MO; Harris, G; Jabbarzadeh, E				Cheng, Qingsu; Blais, Marc-Olivier; Harris, Greg; Jabbarzadeh, Ehsan			PLGA-Carbon Nanotube Conjugates for Intercellular Delivery of Caspase-3 into Osteosarcoma Cells	PLOS ONE			English	Article							GENE DELIVERY; SYSTEMIC DELIVERY; PLASMID DNA; NANOPARTICLES; DOXORUBICIN; TRACKING; CHITOSAN; GROWTH; SIRNA; PLA	Cancer has arisen to be of the most prominent health care issues across the world in recent years. Doctors have used physiological intervention as well as chemical and radioactive therapeutics to treat cancer thus far. As an alternative to current methods, gene delivery systems with high efficiency, specificity, and safety that can reduce side effects such as necrosis of tissue are under development. Although viral vectors are highly efficient, concerns have arisen from the fact that viral vectors are sourced from lethal diseases. With this in mind, rod shaped nano-materials such as carbon nanotubes (CNTs) have become an attractive option for drug delivery due to the enhanced permeability and retention effect in tumors as well as the ability to penetrate the cell membrane. Here, we successfully engineered poly (lactic-co-glycolic) (PLGA) functionalized CNTs to reduce toxicity concerns, provide attachment sites for pro-apoptotic protein caspase-3 (CP3), and tune the temporal release profile of CP3 within bone cancer cells. Our results showed that CP3 was able to attach to functionalized CNTs, forming CNT-PLGA-CP3 conjugates. We show this conjugate can efficiently transduce cells at dosages as low as 0.05 mu g/ml and suppress cell proliferation up to a week with no further treatments. These results are essential to showing the capabilities of PLGA functionalized CNTs as a non-viral vector gene delivery technique to tune cell fate.	[Cheng, Qingsu; Jabbarzadeh, Ehsan] Univ S Carolina, Dept Biomed Engn, Columbia, SC 29208 USA; [Blais, Marc-Olivier; Harris, Greg; Jabbarzadeh, Ehsan] Univ S Carolina, Dept Chem Engn, Columbia, SC 29208 USA; [Jabbarzadeh, Ehsan] Univ S Carolina, Dept Orthopaed Surg, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Jabbarzadeh, E (corresponding author), Univ S Carolina, Dept Biomed Engn, Columbia, SC 29208 USA.	ehsan@sc.edu	Harris, Greg M./R-3910-2017	Harris, Greg M./0000-0001-5594-9780	United States National Institutes of Health [NIH P20 GM103641]; National Science Foundation [EPS-0903795]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge support from the United States National Institutes of Health (Grant NIH P20 GM103641) and National Science Foundation (Grant EPS-0903795). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3; Anderson WF, 1998, NATURE, V392, P25; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; BLAESE RM, 1990, HUM GENE THER, V1, P327; Chen J, 2002, J AM CHEM SOC, V124, P9034, DOI 10.1021/ja026104m; Chen X, 2006, J AM CHEM SOC, V128, P6292, DOI 10.1021/ja060276s; Chen Z, 2008, NAT BIOTECHNOL, V26, P1285, DOI 10.1038/nbt.1501; Cheng FY, 2010, CHEM COMMUN, V46, P3167, DOI 10.1039/b919172k; Cheng Q, 2013, ANN BIOMEDICAL ENG; CHOPRA NG, 1995, SCIENCE, V269, P966, DOI 10.1126/science.269.5226.966; Diao XH, 2012, J NANOMATER, V2012, DOI 10.1155/2012/806019; Donaldson K, 2004, OCCUP ENVIRON MED, V61, P727, DOI 10.1136/oem.2004.013243; Ebbesen T. W., 1997, CARBON NANOTUBES PRE; Ge J, 2012, BIOTECHNOL BIOPROC E, V17, P160, DOI 10.1007/s12257-011-0423-x; Goldberger J, 2003, NATURE, V422, P599, DOI 10.1038/nature01551; Gul-Uludag H, 2012, STEM CELLS DEV, V21, P1587, DOI 10.1089/scd.2011.0297; Heller DA, 2005, ADV MATER, V17, P2793, DOI 10.1002/adma.200500477; Hilder TA, 2008, MICRO NANO LETT, V3, P41, DOI 10.1049/mnl:20080008; Hoffman RM, 2007, CANCER, V109, P1213, DOI 10.1002/cncr.22494; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; Jin H, 2008, NANO LETT, V8, P1577, DOI 10.1021/nl072969s; Karajanagi SS, 2006, LANGMUIR, V22, P1392, DOI 10.1021/la0528201; Kim SK, 2012, NANO LETT, V12, P4971, DOI 10.1021/nl302578z; Kim TH, 2006, MOL CANCER THER, V5, P1723, DOI 10.1158/1535-7163.MCT-05-0540; Lacerda L, 2007, NANO TODAY, V2, P38, DOI 10.1016/S1748-0132(07)70172-X; Lacerda L, 2006, ADV DRUG DELIVER REV, V58, P1460, DOI 10.1016/j.addr.2006.09.015; Ladeira MS, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/38/385101; Liu Y, 2008, J AM CHEM SOC, V130, P10431, DOI 10.1021/ja802465g; Liu Z, 2008, CANCER RES, V68, P6652, DOI 10.1158/0008-5472.CAN-08-1468; Liu Z, 2007, ANGEW CHEM INT EDIT, V46, P2023, DOI 10.1002/anie.200604295; Liu Z, 2009, ANGEW CHEM INT EDIT, V48, P7668, DOI 10.1002/anie.200902612; Liu Z, 2009, NAT PROTOC, V4, P1372, DOI 10.1038/nprot.2009.146; Liu Z, 2009, NANO RES, V2, P85, DOI 10.1007/s12274-009-9009-8; Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6; MATSUMURA Y, 1986, CANCER RES, V46, P6387; McCarron PA, 2008, J BIOMED MATER RES A, V87A, P873, DOI 10.1002/jbm.a.31835; Mikael PE, 2011, J BIOMATER TISS ENG, V1, P76, DOI 10.1166/jbt.2011.1011; Moon HK, 2008, NANO RES, V1, P351, DOI 10.1007/s12274-008-8038-z; Mor GK, 2006, SOL ENERG MAT SOL C, V90, P2011, DOI 10.1016/j.solmat.2006.04.007; Na K, 2006, EUR J PHARM SCI, V27, P115, DOI 10.1016/j.ejps.2005.08.012; Nicklas M, 2009, DRUG DEV IND PHARM, V35, P1035, DOI 10.1080/03639040902755213; Niyogi S, 2002, ACCOUNTS CHEM RES, V35, P1105, DOI 10.1021/ar010155r; O'Connell MJ, 2006, CARBON NANOTUBES PRO; Pantarotto D, 2004, ANGEW CHEM INT EDIT, V43, P5242, DOI 10.1002/anie.200460437; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Rosca ID, 2005, CARBON, V43, P3124, DOI 10.1016/j.carbon.2005.06.019; Sayes CM, 2006, TOXICOL SCI, V92, P174, DOI 10.1093/toxsci/kfj197; Singh R, 2005, J AM CHEM SOC, V127, P4388, DOI 10.1021/ja0441561; Singh R, 2006, P NATL ACAD SCI USA, V103, P3357, DOI 10.1073/pnas.0509009103; Stewart B.W., 2003, WORLD CANC REPORT; Sun YS, 2005, CANCER GENE THER, V12, P900, DOI 10.1038/sj.cgt.7700854; Wang MY, 2010, ACS NANO, V4, P6483, DOI 10.1021/nn101445y; Wang ZL, 2004, J PHYS-CONDENS MAT, V16, pR829, DOI 10.1088/0953-8984/16/25/R01; Weng XX, 2009, MOL BIOSYST, V5, P1224, DOI 10.1039/b906948h; Wu YR, 2008, ACS NANO, V2, P2023, DOI 10.1021/nn800325a; Xu JS, 2010, BIOMATERIALS, V31, P1716, DOI 10.1016/j.biomaterials.2009.11.052; Yang XZ, 2011, J CONTROL RELEASE, V156, P203, DOI 10.1016/j.jconrel.2011.07.035; Yoshimura SH, 2011, BIOMACROMOLECULES, V12, P1200, DOI 10.1021/bm101491s; Zhang ZH, 2006, CLIN CANCER RES, V12, P4933, DOI 10.1158/1078-0432.CCR-05-2831; Zhao B, 2005, J AM CHEM SOC, V127, P8197, DOI 10.1021/ja042924i; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877	61	33	33	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81947	10.1371/journal.pone.0081947	http://dx.doi.org/10.1371/journal.pone.0081947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312611	gold, Green Published, Green Submitted			2022-12-25	WOS:000327947800074
J	Kuzmina, NA; Lemey, P; Kuzmin, IV; Mayes, BC; Ellison, JA; Orciari, LA; Hightower, D; Taylor, ST; Rupprecht, CE				Kuzmina, Natalia A.; Lemey, Philippe; Kuzmin, Ivan V.; Mayes, Bonny C.; Ellison, James A.; Orciari, Lillian A.; Hightower, Dillon; Taylor, Steven T.; Rupprecht, Charles E.			The Phylogeography and Spatiotemporal Spread of South-Central Skunk Rabies Virus	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; STRIPED SKUNKS; POPULATION; EPIZOOTIOLOGY; MUTATIONS; EVOLUTION; INFERENCE; RANGE; MODEL; WAVE	The south-central skunk rabies virus (SCSK) is the most broadly distributed terrestrial viral lineage in North America. Skunk rabies has not been efficiently targeted by oral vaccination campaigns and represents a natural system of pathogen invasion, yielding insights to rabies emergence. In the present study we reconstructed spatiotemporal spread of SCSK in the whole territory of its circulation using a combination of Bayesian methods. The analysis based on 241 glycoprotein gene sequences demonstrated that SCSK is much more divergent phylogenetically than was appreciated previously. According to our analyses the SCSK originated in the territory of Texas similar to 170 years ago, and spread geographically during the following decades. The wavefront velocity in the northward direction was significantly greater than in the eastward and westward directions. Rivers (except the Mississippi River and Rio Grande River) did not constitute significant barriers for epizootic spread, in contrast to deserts and mountains. The mean dispersal rate of skunk rabies was lower than that of the raccoon and fox rabies. Viral lineages circulate in their areas with limited evidence of geographic spread during decades. However, spatiotemporal reconstruction shows that after a long period of stability the dispersal rate and wavefront velocity of SCSK are increasing. Our results indicate that there is a need to develop control measures for SCSK, and suggest how such measure can be implemented most efficiently. Our approach can be extrapolated to other rabies reservoirs and used as a tool for investigation of epizootic patterns and planning interventions towards disease elimination.	[Kuzmina, Natalia A.; Kuzmin, Ivan V.; Ellison, James A.; Orciari, Lillian A.; Hightower, Dillon; Taylor, Steven T.; Rupprecht, Charles E.] Ctr Dis Control & Prevent, Rabies Program, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA; [Lemey, Philippe] Katholieke Univ Leuven, Dept Microbiol & Immunol, Louvain, Belgium; [Mayes, Bonny C.] Texas Dept State Hlth Serv, Zoonosis Control Branch, Austin, TX USA; [Rupprecht, Charles E.] Ross Univ, Sch Vet Med, Dept Epidemiol & Publ Hlth, Basseterre, St Kitts, St Kitts & Nevi	Centers for Disease Control & Prevention - USA; KU Leuven; Texas Department of State Health Services	Kuzmina, NA (corresponding author), Ctr Dis Control & Prevent, Rabies Program, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA.	natakuzmina@yandex.ru	Lemey, Philippe/C-3755-2018; Rupprecht, Charles/AAI-1544-2020; Kuzmina, Natalia/AAY-8589-2020	Lemey, Philippe/0000-0003-2826-5353; Kuzmina, Natalia/0000-0001-6650-9369; Ellison, James/0000-0003-4492-4857	European Union [278433-PREDEMICS]; ERC [260864]	European Union(European Commission); ERC(European Research Council (ERC)European Commission)	PL acknowledges funding from the European Union Seventh Framework Programme [FP7/2007-2013] under Grant Agreement no. 278433-PREDEMICS and ERC Grant agreement no. 260864. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badrane H, 2001, J VIROL, V75, P8096, DOI 10.1128/JVI.75.17.8096-8104.2001; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Barton HD, 2010, MOL ECOL, V19, P2725, DOI 10.1111/j.1365-294X.2010.04668.x; Biek R, 2007, P NATL ACAD SCI USA, V104, P7993, DOI 10.1073/pnas.0700741104; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Blanton JD, 2012, JAVMA-J AM VET MED A, V241, P712, DOI 10.2460/javma.241.6.712; Bourhy H, 1999, J GEN VIROL, V80, P2545, DOI 10.1099/0022-1317-80-10-2545; Bourhy H, 2008, J GEN VIROL, V89, P2673, DOI 10.1099/vir.0.2008/003913-0; CHARLTON KM, 1988, REV INFECT DIS, V10, pS626; Davis R, 2013, VIRUS RES, V174, P27, DOI 10.1016/j.virusres.2013.02.008; Dragoo JW, 2004, J WILDLIFE DIS, V40, P371, DOI 10.7589/0090-3558-40.2.371; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edmonds CA, 2004, P NATL ACAD SCI USA, V101, P975, DOI 10.1073/pnas.0308064100; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Greenwood RJ, 1997, J WILDLIFE DIS, V33, P226, DOI 10.7589/0090-3558-33.2.226; GREMILLIONSMITH C, 1988, J WILDLIFE DIS, V24, P620, DOI 10.7589/0090-3558-24.4.620; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hass CC, 2006, J WILDLIFE DIS, V42, P825, DOI 10.7589/0090-3558-42.4.825; HEIDT GA, 1982, J WILDLIFE DIS, V18, P269, DOI 10.7589/0090-3558-18.3.269; Hovey HC, 1874, AM J SCI ARTS, V7, P477; Klopfstein S, 2006, MOL BIOL EVOL, V23, P482, DOI 10.1093/molbev/msj057; Kuzmin IV, 2003, VIRUS RES, V97, P65, DOI 10.1016/S0168-1702(03)00217-X; Kuzmin IV, 2004, J WILDLIFE DIS, V40, P617, DOI 10.7589/0090-3558-40.4.617; Kuzmin IV, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002786; Lembo T, 2007, P ROY SOC B-BIOL SCI, V274, P2123, DOI 10.1098/rspb.2007.0664; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nadin-Davis SA, 2013, RABIES: SCIENTIFIC BASIS OF THE DISEASE AND ITS MANAGEMENT, 3RD EDITION, P123, DOI 10.1016/B978-0-12-396547-9.00004-3; Oertli EH, 2009, JAVMA-J AM VET MED A, V234, P616, DOI 10.2460/javma.234.5.616; Parker R.L., 1975, P41; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Purdy MA, 2010, PLOS ONE, V17; Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109; Rupprecht C.E., 2012, RHABDOVIRUSES MOL TA, P215; Rupprecht CE, 2011, CURR OPIN VIROL, V1, P662, DOI 10.1016/j.coviro.2011.10.014; SACRAMENTO D, 1991, MOL CELL PROBE, V5, P229, DOI 10.1016/0890-8508(91)90045-L; SMITH JS, 1986, J CLIN MICROBIOL, V24, P573, DOI 10.1128/JCM.24.4.573-580.1986; Steck F, 1980, Epidemiol Rev, V2, P71; Streicker DG, 2012, P NATL ACAD SCI USA, V109, P19715, DOI 10.1073/pnas.1203456109; Suchard MA, 2003, SYST BIOL, V52, P649, DOI 10.1080/10635150390238879; Szanto AG, 2011, EPIDEMICS-NETH, V3, P76, DOI 10.1016/j.epidem.2011.02.002; Talbot B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049736; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toma B, 1977, Adv Virus Res, V21, P1, DOI 10.1016/S0065-3527(08)60760-5; Velasco-Villa A, 2005, VIRUS RES, V111, P13, DOI 10.1016/j.virusres.2005.03.007; Weissinger MD, 2009, J WILDLIFE DIS, V45, P388, DOI 10.7589/0090-3558-45.2.388; Wertheim JO, 2011, MOL BIOL EVOL, V28, P3355, DOI 10.1093/molbev/msr170; Wozencraft WC, 2005, MAMMAL SPECIES WORLD, P532; Wunner WH, 2013, RABIES: SCIENTIFIC BASIS OF THE DISEASE AND ITS MANAGEMENT, 3RD EDITION, P17, DOI 10.1016/B978-0-12-396547-9.00002-X; Yount CE, 1910, PRACTITIONER, V25, P105	52	17	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82348	10.1371/journal.pone.0082348	http://dx.doi.org/10.1371/journal.pone.0082348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312657	Green Submitted, Green Published, gold			2022-12-25	WOS:000327947800094
J	Smit, AJ; Roberts, M; Anderson, RJ; Dufois, F; Dudley, SFJ; Bornman, TG; Olbers, J; Bolton, JJ				Smit, Albertus J.; Roberts, Michael; Anderson, Robert J.; Dufois, Francois; Dudley, Sheldon F. J.; Bornman, Thomas G.; Olbers, Jennifer; Bolton, John J.			A Coastal Seawater Temperature Dataset for Biogeographical Studies: Large Biases between In Situ and Remotely-Sensed Data Sets around the Coast of South Africa	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; ROCKY INTERTIDAL COMMUNITIES; WEST-COAST; MARINE BIODIVERSITY; GLOBAL PATTERNS; SATELLITE; NEARSHORE; BENGUELA; CLIMATE; SHELF	Gridded SST products developed particularly for offshore regions are increasingly being applied close to the coast for biogeographical applications. The purpose of this paper is to demonstrate the dangers of doing so through a comparison of reprocessed MODIS Terra and Pathfinder v5.2 SSTs, both at 4 km resolution, with instrumental in situ temperatures taken within 400 m from the coast. We report large biases of up to +6 degrees C in places between satellite-derived and in situ climatological temperatures for 87 sites spanning the entire ca. 2 700 km of the South African coastline. Although biases are predominantly warm (i.e. the satellite SSTs being higher), smaller or even cold biases also appear in places, especially along the southern and western coasts of the country. We also demonstrate the presence of gradients in temperature biases along shore-normal transects - generally SSTs extracted close to the shore demonstrate a smaller bias with respect to the in situ temperatures. Contributing towards the magnitude of the biases are factors such as SST data source, proximity to the shore, the presence/absence of upwelling cells or coastal embayments. Despite the generally large biases, from a biogeographical perspective, species distribution retains a correlative relationship with underlying spatial patterns in SST, but in order to arrive at a causal understanding of the determinants of biogeographical patterns we suggest that in shallow, inshore marine habitats, temperature is best measured directly.	[Smit, Albertus J.] Univ KwaZulu Natal, Sch Life Sci, Westville, South Africa; [Roberts, Michael] Dept Environm Affairs, Cape Town, South Africa; [Roberts, Michael] Rhodes Univ, Dept Ichthyol & Fisheries Sci, ZA-6140 Grahamstown, South Africa; [Anderson, Robert J.; Bolton, John J.] Univ Cape Town, Dept Biol Sci, ZA-7700 Rondebosch, South Africa; [Anderson, Robert J.; Dudley, Sheldon F. J.; Bolton, John J.] Univ Cape Town, Marine Res Inst, ZA-7700 Rondebosch, South Africa; [Anderson, Robert J.] Dept Agr Forestry & Fisheries, Seaweed Unit, Fisheries Branch, Cape Town, South Africa; [Dufois, Francois] Univ Cape Town, Dept Oceanog, ZA-7700 Rondebosch, South Africa; [Dudley, Sheldon F. J.] KwaZulu Natal Sharks Board, Umhlanga Rocks, South Africa; [Bornman, Thomas G.] South African Environm Observat Network, Grahamstown, South Africa; [Bornman, Thomas G.] Nelson Mandela Metropolitan Univ, Dept Bot, Coastal & Marine Res Unit, Port Elizabeth, South Africa; Ezemvelo KZN Wildlife, Ecol Advice, Durban, South Africa	University of Kwazulu Natal; Department of Environment, Forestry & Fisheries; Rhodes University; University of Cape Town; University of Cape Town; University of Cape Town; National Research Foundation - South Africa; South African Environmental Observation Network (SAEON); Nelson Mandela University	Smit, AJ (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Westville Campus, Westville, South Africa.	albertus.smit@gmail.com	Dufois, Francois/B-5545-2012; Bornman, Thomas G/V-7794-2019; Olbers, Jennifer M/C-2438-2017	Dufois, Francois/0000-0002-7135-2893; Bornman, Thomas G/0000-0003-1868-479X; Olbers, Jennifer M/0000-0001-8357-5157; Bolton, John/0000-0003-0589-9564	ACCESS; SATREPS; MARE-BASICS program	ACCESS; SATREPS; MARE-BASICS program	Funding for the participation of Francois Dufois was provided by ACCESS, SATREPS and the MARE-BASICS program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna FH, 2004, AFR ZOOL, V39, P193; Anderson RJ, 2012, AFR J MAR SCI, V34, P1, DOI 10.2989/1814232X.2012.673267; Anderson RJ, 2009, DIVERS DISTRIB, V15, P1017, DOI 10.1111/j.1472-4642.2009.00614.x; Barton I, 2006, J OCEANOGR, V62, P303, DOI 10.1007/s10872-006-0055-5; Bartsch I, 2012, SEAWEED BIOL, P383, DOI DOI 10.1007/978-3-642-28451-9_18; Blanchette CA, 2008, J BIOGEOGR, V35, P1593, DOI 10.1111/j.1365-2699.2008.01913.x; Blythe JN, 2011, ICES J MAR SCI, V68, P1827, DOI 10.1093/icesjms/fsr109; Bolton J. J., 1997, P348; Bolton JJ, 2012, AFR J MAR SCI, V34, P147, DOI 10.2989/1814232X.2012.675125; Bolton JJ, 2004, MAR BIOL, V144, P51, DOI 10.1007/s00227-003-1182-9; BOLTON JJ, 1987, S AFR J MARINE SCI, V5, P319, DOI 10.2989/025776187784522810; BOLTON JJ, 1986, BOT MAR, V29, P251, DOI 10.1515/botm.1986.29.3.251; BREEMAN AM, 1988, HELGOLANDER MEERESUN, V42, P199, DOI 10.1007/BF02366043; Briggs J, 1974, MARINE ZOOGEOGRAPHY, DOI 10.2307/1442613; Broitman BR, 2008, ECOLOGY, V89, pS81, DOI 10.1890/08-0635.1; Brown A.C., 1978, Monographiae Biologicae, V31, P1239; Brown OB, 1999, MODIS INFRARED SEA S, P33149; Byrne M, 2009, P ROY SOC B-BIOL SCI, V276, P1883, DOI 10.1098/rspb.2008.1935; Casey KS, 1999, J CLIMATE, V12, P1848, DOI 10.1175/1520-0442(1999)012<1848:ACOSAI>2.0.CO;2; Castillo KD, 2010, LIMNOL OCEANOGR-METH, V8, P107, DOI 10.4319/lom.2010.8.0107; CLIFF G, 1988, S AFR J MARINE SCI, V7, P255, DOI 10.2989/025776188784379035; Colman B. R., 2003, HDB WEATHER CLIMATE, P885, DOI [10.1002/0471721603.ch47, DOI 10.1002/0471721603.CH47]; Couce E, 2012, J BIOGEOGR, V39, P1508, DOI 10.1111/j.1365-2699.2012.02706.x; Donlon C, 2007, B AM METEOROL SOC, V88, P1197, DOI 10.1175/BAMS-88-8-1197; Donlon CJ, 2002, J CLIMATE, V15, P353, DOI 10.1175/1520-0442(2002)015<0353:TIVOSS>2.0.CO;2; Dudley SFJ, 2010, AFR J MAR SCI, V32, P383, DOI 10.2989/1814232X.2010.502641; Dufois F, 2012, CONT SHELF RES, V43, P24, DOI 10.1016/j.csr.2012.04.009; Dufois F, 2012, OCEAN MODEL, V47, P113, DOI 10.1016/j.ocemod.2012.01.007; EMANUEL BP, 1992, S AFR J MARINE SCI, V12, P341; Fawcett AL, 2008, CONT SHELF RES, V28, P1026, DOI 10.1016/j.csr.2008.02.005; FIELD JG, 1980, T ROY SOC S AFR, V44, P145, DOI 10.1080/00359198009520561; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; Hilbish TJ, 2012, J BIOGEOGR, V39, P676, DOI 10.1111/j.1365-2699.2011.02633.x; Hutchings L., 2004, S AFRICAN NATL SPATI; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; Leichter JJ, 2006, J MAR RES, V64, P563, DOI 10.1357/002224006778715711; Luning K, 1990, SEAWEEDS THEIR ENV B; Lutjeharms JRE, 2000, CONT SHELF RES, V20, P737, DOI 10.1016/S0278-4343(99)00092-8; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; Minnett PJ, 2004, INT GEOSCI REMOTE SE, P4576; Minnett PJ, 2002, INT GEOSCI REMOTE SE, P1177, DOI 10.1109/IGARSS.2002.1025872; Muller R, 2009, BOT MAR, V52, P617, DOI 10.1515/BOT.2009.080; Narvaez DA, 2004, CONT SHELF RES, V24, P279, DOI 10.1016/j.csr.2003.09.008; Overpeck JT, 2011, SCIENCE, V331, P700, DOI 10.1126/science.1197869; Payne MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030105; Pearce A, 2006, INT J REMOTE SENS, V27, P2503, DOI 10.1080/01431160500472138; Proches S, 2002, J BIOGEOGR, V29, P1201, DOI 10.1046/j.1365-2699.2002.00772.x; R Core Team, 2021, R LANG ENV STAT COMP; Rouault M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037987; Selig ER, 2010, GLOBAL ECOL BIOGEOGR, V19, P397, DOI 10.1111/j.1466-8238.2009.00522.x; SHANNON LV, 1985, OCEANOGR MAR BIOL, V23, P105; Sink KJ, 2005, AFR J MAR SCI, V27, P81, DOI 10.2989/18142320509504070; Smale DA, 2009, MAR ECOL PROG SER, V387, P27, DOI 10.3354/meps08132; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stegenga H, 1997, CONTRIBUTIONS BOLUS; STEPHENSON T. A., 1948, ANN NATAL MUS, V11, P207; Stott PA, 2010, NATURE, V465, P158, DOI 10.1038/465158a; Tang DL, 2003, REMOTE SENS ENVIRON, V84, P506, DOI 10.1016/S0034-4257(02)00149-9; Thomas A, 2002, REMOTE SENS ENVIRON, V81, P262, DOI 10.1016/S0034-4257(02)00004-4; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Turpie JK, 2000, BIOL CONSERV, V92, P59, DOI 10.1016/S0006-3207(99)00063-4; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; VANDENHOEK C, 1982, BIOL J LINN SOC, V18, P81; Verbruggen H, 2009, GLOBAL ECOL BIOGEOGR, V18, P393, DOI 10.1111/j.1466-8238.2009.00463.x; WALDRON HN, 1992, S AFR J MARINE SCI, V12, P29; Wieters EA, 2009, J EXP MAR BIOL ECOL, V374, P37, DOI 10.1016/j.jembe.2009.04.006; Xie JP, 2008, CONT SHELF RES, V28, P1286, DOI 10.1016/j.csr.2008.02.020	68	72	72	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81944	10.1371/journal.pone.0081944	http://dx.doi.org/10.1371/journal.pone.0081944			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312609	gold, Green Published, Green Submitted			2022-12-25	WOS:000327947800072
J	Akasheh, RT; Pini, M; Pang, JB; Fantuzzi, G				Akasheh, Rand T.; Pini, Maria; Pang, Jingbo; Fantuzzi, Giamila			Increased Adiposity in Annexin A1-Deficient Mice	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; HIGH-FAT DIET; HUMAN OBESITY; IN-VITRO; GLUCOCORTICOIDS; TISSUE; RAT; A1; INFLAMMATION; SECRETION	Production of Annexin A1 (ANXA1), a protein that mediates the anti-inflammatory action of glucocorticoids, is altered in obesity, but its role in modulation of adiposity has not yet been investigated. The objective of this study was to investigate modulation of ANXA1 in adipose tissue in murine models of obesity and to study the involvement of ANXA1 in diet-induced obesity in mice. Significant induction of ANXA1 mRNA was observed in adipose tissue of both C57BL6 and Balb/c mice with high fat diet (HFD)-induced obesity versus mice on chow diet. Upregulation of ANXA1 mRNA was independent of leptin or IL-6, as demonstrated by use of leptin-deficient ob/ob mice and IL-6 KO mice. Compared to WT mice, female Balb/c ANXA1 KO mice on HFD had increased adiposity, as indicated by significantly elevated body weight, fat mass, leptin levels, and adipocyte size. Whereas Balb/c WT mice upregulated expression of enzymes involved in the lipolytic pathway in response to HFD, this response was absent in ANXA1 KO mice. A significant increase in fasting glucose and insulin levels as well as development of insulin resistance was observed in ANXA1 KO mice on HFD compared to WT mice. Elevated plasma corticosterone levels and blunted downregulation of 11-beta hydroxysteroid dehydrogenase type 1 in adipose tissue was observed in ANXA1 KO mice compared to diet-matched WT mice. However, no differences between WT and KO mice on either chow or HFD were observed in expression of markers of adipose tissue inflammation. These data indicate that ANXA1 is an important modulator of adiposity in mice, with female ANXA1 KO mice on Balb/c background being more susceptible to weight gain and diet-induced insulin resistance compared to WT mice, without significant changes in inflammation.	[Akasheh, Rand T.; Pini, Maria; Pang, Jingbo; Fantuzzi, Giamila] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Fantuzzi, G (corresponding author), Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60607 USA.	giamila@uic.edu	Fantuzzi, Giamila/A-1758-2009; Pini, Maria/O-8620-2019; Akasheh, Rand/AAY-2606-2020; Pini, Maria/AAC-2530-2021; Pang, Jingbo/AAQ-3660-2021; Pini, Maria/T-6292-2018	Fantuzzi, Giamila/0000-0001-5334-0082; Pini, Maria/0000-0002-9995-5370; Pang, Jingbo/0000-0001-8325-8434; Pini, Maria/0000-0002-9995-5370	NIH [DK083328]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083328] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partly funded by NIH grant DK083328 to GF. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, OBESITY, V18, P27, DOI 10.1038/oby.2009.208; BLACKWELL GJ, 1980, NATURE, V287, P147, DOI 10.1038/287147a0; Bujalska IJ, 2008, J ENDOCRINOL, V197, P297, DOI 10.1677/JOE-08-0050; CRUMPTON MJ, 1990, NATURE, V345, P212, DOI 10.1038/345212a0; Fujimoto S, 2010, LIFE SCI, V87, P679, DOI 10.1016/j.lfs.2010.10.001; GEISOW MJ, 1987, BIOSCIENCE REP, V7, P289, DOI 10.1007/BF01121450; GEISOW MJ, 1986, FEBS LETT, V203, P99, DOI 10.1016/0014-5793(86)81445-4; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; Haslam D, 2007, OBES REV, V8, P31, DOI 10.1111/j.1467-789X.2007.00314.x; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Kosicka A, 2013, FASEB J, V27, P368, DOI 10.1096/fj.12-213728; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; LOXLEY HD, 1993, J NEUROENDOCRINOL, V5, P51, DOI 10.1111/j.1365-2826.1993.tb00363.x; Marcelin G, 2012, J LIPID RES, V53, P964, DOI 10.1194/jlr.M022467; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Morton NM, 2004, ENDOCRINOLOGY, V145, P2707, DOI 10.1210/en.2003-1674; Ng FSP, 2011, CLIN EXP ALLERGY, V41, P1793, DOI 10.1111/j.1365-2222.2011.03855.x; Nishikawa S, 2007, EXP ANIM TOKYO, V56, P263, DOI 10.1538/expanim.56.263; Pang JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057915; Patel HB, 2012, ANN RHEUM DIS, V71, P1872, DOI 10.1136/annrheumdis-2011-201180; Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012; de Heredia FP, 2012, P NUTR SOC, V71, P332, DOI 10.1017/S0029665112000092; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Philip JG, 2001, BRIT J PHARMACOL, V134, P887, DOI 10.1038/sj.bjp.0704324; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rhodes DH, 2013, OBESITY, V21, P310, DOI 10.1002/oby.20016; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; TAYLOR AD, 1993, NEUROENDOCRINOLOGY, V58, P430, DOI 10.1159/000126572; Taylor AD, 1997, ENDOCRINOLOGY, V138, P2909, DOI 10.1210/en.138.7.2909; Vago JP, 2012, J LEUKOCYTE BIOL, V92, P249, DOI 10.1189/jlb.0112008; Warne JP, 2006, AM J PHYSIOL-ENDOC M, V291, pE1264, DOI 10.1152/ajpendo.00655.2005	31	25	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82608	10.1371/journal.pone.0082608	http://dx.doi.org/10.1371/journal.pone.0082608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312665	Green Submitted, gold, Green Published			2022-12-25	WOS:000327944500140
J	Chang, CC; Althaus, JC; Carruthers, CJL; Sutton, MA; Steel, DG; Gafni, A				Chang, Chun-Chieh; Althaus, John Christian; Carruthers, Cynthia J. L.; Sutton, Michael A.; Steel, Duncan G.; Gafni, Ari			Synergistic Interactions between Alzheimer's A beta 40 and A beta 42 on the Surface of Primary Neurons Revealed by Single Molecule Microscopy	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; CEREBROSPINAL-FLUID A-BETA(42); A-BETA; IN-VIVO; BIOMARKER SIGNATURE; MEMBRANE-BINDING; SENILE PLAQUES; DISEASE BRAIN; OLIGOMERS; TOXICITY	Two amyloid-beta peptides (A beta 40 and A beta 42) feature prominently in the extracellular brain deposits associated with Alzheimer's disease. While A beta 40 is the prevalent form in the cerebrospinal fluid, the fraction of A beta 42 increases in the amyloid deposits over the course of disease development. The low in vivo concentration (pM-nM) and metastable nature of A beta oligomers have made identification of their size, composition, cellular binding sites and mechanism of action challenging and elusive. Furthermore, recent studies have suggested that synergistic effects between A beta 40 and A beta 42 alter both the formation and stability of various peptide oligomers as well as their cytotoxicity. These studies often utilized A beta oligomers that were prepared in solution and at mu M peptide concentrations. The current work was performed using physiological A beta concentrations and single-molecule microscopy to follow peptide binding and association on primary cultured neurons. When the cells were exposed to a 1: 1 mixture of nM A beta 40:A beta 42, significantly larger membrane-bound oligomers developed compared to those formed from either peptide alone. Fluorescence resonance energy transfer experiments at the single molecule level reveal that these larger oligomers contained both A beta 40 and A beta 42, but that the growth of these oligomers was predominantly by addition of A beta 42. Both pure peptides form very few oligomers larger than dimers, but either membrane bound A beta 40/42 complex, or A beta 40, bind A beta 42 to form increasingly larger oligomers. These findings may explain how A beta 42-dominant oligomers, suspected of being more cytotoxic, develop on the neuronal membrane under physiological conditions.	[Chang, Chun-Chieh; Steel, Duncan G.; Gafni, Ari] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA; [Althaus, John Christian; Carruthers, Cynthia J. L.; Sutton, Michael A.] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Sutton, Michael A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Steel, Duncan G.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Steel, Duncan G.] Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA; [Gafni, Ari] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chang, CC (corresponding author), Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA.	andchang@umich.edu		Sutton, Michael/0000-0002-0692-6459	National Institutes of Health [1R01AG032276-01A1, 5R21AG03374902]; NATIONAL INSTITUTE ON AGING [R01AG032276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (http://www.nih.gov/) 1R01AG032276-01A1 and 5R21AG03374902. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Bateman DA, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-29; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Chafekar SM, 2008, BBA-MOL BASIS DIS, V1782, P523, DOI 10.1016/j.bbadis.2008.06.003; Davis CH, 2010, PROTEINS, V78, P2533, DOI 10.1002/prot.22763; Davis DG, 1999, J NEUROPATH EXP NEUR, V58, P376, DOI 10.1097/00005072-199904000-00008; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x; Ding H, 2012, BIOPHYS J, V103, P1500, DOI 10.1016/j.bpj.2012.08.051; Ding H, 2009, BIOPHYS J, V97, P912, DOI 10.1016/j.bpj.2009.05.035; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2009, ANN NEUROL, V65, P176, DOI 10.1002/ana.21559; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Golde TE, 2000, BBA-MOL BASIS DIS, V1502, P172, DOI 10.1016/S0925-4439(00)00043-0; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Hong SY, 2011, J NEUROSCI, V31, P15861, DOI 10.1523/JNEUROSCI.3272-11.2011; Ishii Y, 1999, CHEM PHYS, V247, P163, DOI 10.1016/S0301-0104(99)00174-3; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jakawich SK, 2010, NEURON, V68, P1143, DOI 10.1016/j.neuron.2010.11.034; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; Johnson RD, 2013, BIOPHYS J, V104, P894, DOI 10.1016/j.bpj.2012.12.051; Johnson RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023970; Kawahara M, 1997, BIOPHYS J, V73, P67, DOI 10.1016/S0006-3495(97)78048-2; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Viet MH, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4730410; Mc Donald JM, 2010, BRAIN, V133, P1328, DOI 10.1093/brain/awq065; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; MOTTER R, 1995, ANN NEUROL, V38, P643, DOI 10.1002/ana.410380413; Murray MM, 2009, J AM CHEM SOC, V131, P6316, DOI 10.1021/ja8092604; Nag S, 2010, BIOPHYS J, V99, P1969, DOI 10.1016/j.bpj.2010.07.020; Narayan P, 2013, J AM CHEM SOC, V135, P1491, DOI 10.1021/ja3103567; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; Omtri RS, 2012, MOL PHARMACEUT, V9, P1887, DOI 10.1021/mp200530q; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Pauwels K, 2012, J BIOL CHEM, V287, P5650, DOI 10.1074/jbc.M111.264473; Schauerte JA, 2010, BIOCHEMISTRY-US, V49, P3031, DOI 10.1021/bi901444w; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Shoji M, 1998, J NEUROL SCI, V158, P134, DOI 10.1016/S0022-510X(98)00122-1; Simakova O, 2007, J NEUROSCI, V27, P13719, DOI 10.1523/JNEUROSCI.3006-07.2007; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Ungureanu A.-A., 2012, NAN IEEE NANO 12 IEE; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; Wang RS, 2006, J BIOL CHEM, V281, P15330, DOI 10.1074/jbc.M512574200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wong PT, 2009, J MOL BIOL, V386, P81, DOI 10.1016/j.jmb.2008.11.060; Yan YL, 2007, J MOL BIOL, V369, P909, DOI 10.1016/j.jmb.2007.04.014	63	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82139	10.1371/journal.pone.0082139	http://dx.doi.org/10.1371/journal.pone.0082139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312636	Green Submitted, gold, Green Published			2022-12-25	WOS:000327944500120
J	Honarvar, B; Odoomi, N; Moghadami, M; Kazerooni, PA; Hassanabadi, A; Dolatabadi, PZ; Farzanfar, E; Lankarani, KB				Honarvar, Behnam; Odoomi, Neda; Moghadami, Mohsen; Kazerooni, Parvin Afsar; Hassanabadi, Alireza; Dolatabadi, Parvin Zare; Farzanfar, Ehsan; Lankarani, Kamran Bagheri			Blood-Borne Hepatitis in Opiate Users in Iran: A Poor Outlook and Urgent Need to Change Nationwide Screening Policy	PLOS ONE			English	Article							SOUTHERN IRAN; HIV-INFECTION; INJECT DRUGS; COHORT; SHIRAZ; PEOPLE	Objective: Iran has the highest rate of opiate use worldwide. However, most opiate users are not screened for hepatitis virus infections. This study aimed to provide accurate, detailed data on the size of the opiate user population at risk of developing these infections. Method: This seroprevalence study was conducted in the city of Shiraz, southern Iran. All participants were screened for HBV, HCV and HIV infection. The data were analyzed with SPSS. Result: Among 569 participants, 233 (40.9%) were injection drug users (IDU), 369 (64.8%) were heterosexual, 84 (14.7%) were bisexual and 15 (2.6%) were homosexual. One hundred nine (19.1%) were HCV antibody-positive, 18 (3.1%) were HBS antigen-positive, 72 (12.6%) were HBc antibody-positive and 23 (4%) were HIV-positive. Among IDU compared to non-IDU, positivity rates for HBS antigen (5.5 vs 1.4%), HBc antibody (22.7 vs 5.6%), HCV antibody (40.3 vs 4.4%) and HIV (7.7 vs 1.4%) were higher (P < 0.05). Most patients with HBV (80.7%) and HCV infection (83.4%) were HIV-negative. In the cumulative analysis, only history of imprisonment was a statistically significant determinant of infection by HCV or HBV in opiate users. Conclusion: The current policy of screening only HIV-positive drug users for HBV and HCV in Iran misses most cases of HBV and HCV infection. We therefore recommend urgent revision of the nationwide protocol by the Ministry of Health in Iran to implement routine screening of all opiate users and especially IDU for these viruses, regardless of their HIV status.	[Honarvar, Behnam; Lankarani, Kamran Bagheri] Shiraz Univ Med Sci, Ctr Hlth Policy Res, Shiraz, Iran; [Odoomi, Neda] Shiraz Univ Med Sci, Dept Hlth, Shiraz, Iran; [Moghadami, Mohsen; Kazerooni, Parvin Afsar] Shiraz Univ Med Sci, HIV AIDS Res Ctr, Shiraz, Iran; [Hassanabadi, Alireza] Shiraz Univ Med Sci, HIV AIDS Res Ctr, Behav Counseling Ctr, Shiraz, Iran; [Dolatabadi, Parvin Zare] Shiraz Univ Med Sci, Behav Counseling Ctr, Shiraz, Iran; [Farzanfar, Ehsan] Shiraz Univ Med Sci, Sch Paramed Sci, Diagnost Lab Sci, Shiraz, Iran; [Farzanfar, Ehsan] Shiraz Univ Med Sci, Sch Paramed Sci, Technol Res Ctr, Shiraz, Iran	Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science	Honarvar, B (corresponding author), Shiraz Univ Med Sci, Ctr Hlth Policy Res, Shiraz, Iran.	honarvarbh32@yahoo.com	Hassanabadi, Alireza/AAO-4797-2021; lankarani, kamran b/D-5901-2012; Lankarani, Kamran Bagheri/P-2066-2017; Lankarani, Kamran B/P-5336-2019; Honarvar, Behnam/K-1623-2013; moghadami, mohsen/T-6539-2018	Lankarani, Kamran Bagheri/0000-0002-7524-9017; Lankarani, Kamran B/0000-0002-7524-9017; Honarvar, Behnam/0000-0002-1081-5778; moghadami, mohsen/0000-0001-8015-0313	Department of Research affiliated; Fars Provincial Government; Shiraz University of Medical Sciences [19260]	Department of Research affiliated; Fars Provincial Government; Shiraz University of Medical Sciences	This study was supported by the Department of Research affiliated with Fars Provincial Government and Shiraz University of Medical Sciences through shared contract No. 19260. Neither of these institutions was involved in the collection of data or other steps of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davarpanah MA, 2007, IRAN RED CRESCENT ME, V9, P224; Davarpanah MA, 2009, HEPAT MON, V9, P122; Honarvar B, 2013, J ADDICT MED; Keramat F, 2011, IRAN RED CRESCENT ME, V13, P42; Khademi H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2502; Mehrabani D, 2008, CLIN INFECT DIS, V3, P209; Mir-Nasseri MM, 2011, HEPAT MON, V11, P19; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Rahimi-Movaghar A, 2010, INT J INFECT DIS, V14, pE28, DOI 10.1016/j.ijid.2009.03.002; Sofian M, 2012, J ADDICT MED, V6, P292, DOI 10.1097/ADM.0b013e3182659928; United Nations Office On Drugs and Crime, DRUG US NAT TYP; United Nations Office On Drugs and Crime, EXP PERC TREND CHANG; United Nations Office on Drugs and Crime, OP HER MARK; United Nations Office On Drugs and Crime, TRANSN DRUG MARK AN; United Nations Office On Drugs and Crime, DRUG REL MORT RANK D; United Nations Office on Drugs and Crime, PREV DRUG US GEN POP; United Nations Office On Drugs and Crime. PREFACE, PREFACE WORLD DRUG R; Winter RJ, 2013, J GASTROEN HEPATOL, V28, P314, DOI 10.1111/jgh.12063; World Health Organization, HEP BFACT SHEET 204; World Health Organization, VIRAL HEPATITIS; World Health Organization (WHO), HEP C FACT SHEET 164; Zamani S, 2010, INT J DRUG POLICY, V21, P493, DOI 10.1016/j.drugpo.2010.04.006; Zhou YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042937	23	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82230	10.1371/journal.pone.0082230	http://dx.doi.org/10.1371/journal.pone.0082230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312645	Green Published, gold, Green Submitted			2022-12-25	WOS:000327944500128
J	Kim, S; Park, YM				Kim, Sollip; Park, Young-Min			Serum Prolactin and Macroprolactin Levels among Outpatients with Major Depressive Disorder Following the Administration of Selective Serotonin-Reuptake Inhibitors: A Cross-Sectional Pilot Study	PLOS ONE			English	Article							CLINICAL-RELEVANCE; HYPERPROLACTINEMIA; ANTIDEPRESSANTS; RISPERIDONE; FLUOXETINE; CITALOPRAM; OLANZAPINE; PAROXETINE	Clinical trials evaluating the rate of short-term selective serotonin-reuptake inhibitor (SSRI)-induced hyperprolactinemia have produced conflicting results. Thus, the aim of this study was to clarify whether SSRI therapy can induce hyperprolactinemia and macroprolactinemia. Fifty-five patients with major depressive disorder (MDD) were enrolled in this study. Serum prolactin and macroprolactin levels were measured at a single time point (i.e., in a cross-sectional design). All patients had received SSRI monotherapy (escitalopram, paroxetine, or sertraline) for a mean of 14.75 months. Their mean prolactin level was 15.26 ng/ml. The prevalence of patients with hyperprolactinemia was 10.9% for 6/55, while that of patients with macroprolactinemia was 3.6% for 2/55. The mean prolactin levels were 51.36 and 10.84 ng/ml among those with hyperprolactinemia and a normal prolactin level, respectively. The prolactin level and prevalence of hyperprolactinemia did not differ significantly within each SSRI group. Correlation analysis revealed that there was no correlation between the dosage of each SSRI and prolactin level. These findings suggest that SSRI therapy can induce hyperprolactinemia in patients with MDD. Clinicians should measure and monitor serum prolactin levels, even when both SSRIs and antipsychotics are administered.	[Kim, Sollip] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Lab Med, Goyang, South Korea; [Park, Young-Min] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Psychiat, Goyang, South Korea	Inje University; Inje University	Park, YM (corresponding author), Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Psychiat, Goyang, South Korea.	medipark@hanmail.net	Kim, Sollip/AAB-5748-2022; Kim, Sollip/E-8546-2011	Kim, Sollip/0000-0003-0474-5897; Kim, Sollip/0000-0003-0474-5897	Inje University	Inje University	This work was supported by the 2012 Inje University research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam JD, 1997, J AFFECT DISORDERS, V46, P151, DOI 10.1016/S0165-0327(97)00086-4; BJORO T, 1995, SCAND J CLIN LAB INV, V55, P139, DOI 10.3109/00365519509089606; COHEN MA, 1998, ADVERSE DRUG REACT B, V190, P723; Coker F, 2010, CNS DRUGS, V24, P563, DOI 10.2165/11533140-000000000-00000; Emiliano ABF, 2004, NEUROPSYCHOPHARMACOL, V29, P833, DOI 10.1038/sj.npp.1300412; Gibney J, 2005, J CLIN ENDOCR METAB, V90, P3927, DOI 10.1210/jc.2004-2234; Gibney J, 2005, CLIN ENDOCRINOL, V62, P633, DOI 10.1111/j.1365-2265.2005.02243.x; Hattori N, 2012, EUR J ENDOCRINOL, V166, P625, DOI 10.1530/EJE-11-1007; Hattori N, 2010, CLIN ENDOCRINOL, V73, P792, DOI 10.1111/j.1365-2265.2010.03880.x; Hattori N, 2009, CLIN ENDOCRINOL, V71, P702, DOI 10.1111/j.1365-2265.2009.03570.x; Hauache OM, 2002, CLIN ENDOCRINOL, V57, P327, DOI 10.1046/j.1365-2265.2002.01586.x; Karagianis JL, 2003, J CLIN PSYCHIAT, V64, P1192, DOI 10.4088/JCP.v64n1008; Kitaichi Y, 2010, EUR J PHARMACOL, V647, P90, DOI 10.1016/j.ejphar.2010.08.026; Laine K, 1997, CLIN NEUROPHARMACOL, V20, P419, DOI 10.1097/00002826-199710000-00006; Lee BH, 2012, PSYCHIAT CLIN NEUROS, V66, P69, DOI 10.1111/j.1440-1819.2011.02296.x; Leslie H, 2001, J CLIN ENDOCR METAB, V86, P2743, DOI 10.1210/jc.86.6.2743; McKenna TJ, 2009, CLIN ENDOCRINOL, V71, P466, DOI 10.1111/j.1365-2265.2009.03577.x; Molitch ME, 2008, PITUITARY, V11, P209, DOI 10.1007/s11102-008-0106-6; Muck-Seler D, 2002, PROG NEURO-PSYCHOPH, V26, P1235, DOI 10.1016/S0278-5846(02)00259-2; Olukoga AO, 1999, CLIN ENDOCRINOL, V51, P119, DOI 10.1046/j.1365-2265.1999.00757.x; Papakostas GI, 2006, J CLIN PSYCHIAT, V67, P952, DOI 10.4088/JCP.v67n0612; Richelson E, 2003, J CLIN PSYCHIAT, V64, P5; Sagud M, 2002, NEUROPSYCHOBIOLOGY, V45, P139, DOI 10.1159/000054954; SALZMAN C, 1993, BIOL PSYCHIAT, V34, P569, DOI 10.1016/0006-3223(93)90202-O; Schlosser R, 2000, PSYCHONEUROENDOCRINO, V25, P377, DOI 10.1016/S0306-4530(99)00065-7; Shimatsu A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/167132; Shlik J, 1997, J PSYCHIATR NEUROSCI, V22, P332; Spigset O, 1997, J CLIN PSYCHOPHARM, V17, P292, DOI 10.1097/00004714-199708000-00009; Stevens JR, 2005, J CHILD ADOL PSYCHOP, V15, P893, DOI 10.1089/cap.2005.15.893; Torre Daria La, 2007, Ther Clin Risk Manag, V3, P929; URBAN RJ, 1991, AM J OBSTET GYNECOL, V164, P147, DOI 10.1016/0002-9378(91)90645-8; Vallette-Kasic S, 2002, J CLIN ENDOCR METAB, V87, P581, DOI 10.1210/jc.87.2.581; Volavka J, 2004, J CLIN PSYCHIAT, V65, P57	33	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82749	10.1371/journal.pone.0082749	http://dx.doi.org/10.1371/journal.pone.0082749			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312671	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500145
J	Signorelli, JR; Diaz, ES; Fara, K; Baron, L; Morales, P				Signorelli, Janetti R.; Diaz, Emilce S.; Fara, Karla; Baron, Lina; Morales, Patricio			Protein Phosphatases Decrease Their Activity during Capacitation: A New Requirement for This Event	PLOS ONE			English	Article							HUMAN SPERM CAPACITATION; TYROSINE PHOSPHORYLATION; ACROSOME REACTION; HUMAN-SPERMATOZOA; KINASE-A; PHOSPHOPROTEIN PHOSPHATASE; CALYCULIN-A; MOUSE SPERM; THREONINE PHOSPHORYLATION; EPIDIDYMAL SPERMATOZOA	There are few reports on the role of protein phosphatases during capacitation. Here, we report on the role of PP2B, PP1, and PP2A during human sperm capacitation. Motile sperm were resuspended in non-capacitating medium (NCM, Tyrode's medium, albumin-and bicarbonate-free) or in reconstituted medium (RCM, NCM plus 2.6% albumin/25 mM bicarbonate). The presence of the phosphatases was evaluated by western blotting and the subcellular localization by indirect immunofluorescence. The function of these phosphatases was analyzed by incubating the sperm with specific inhibitors: okadaic acid, I2, endothall, and deltamethrin. Different aliquots were incubated in the following media: 1) NCM; 2) NCM plus inhibitors; 3) RCM; and 4) RCM plus inhibitors. The percent capacitated sperm and phosphatase activities were evaluated using the chlortetracycline assay and a phosphatase assay kit, respectively. The results confirm the presence of PP2B and PP1 in human sperm. We also report the presence of PP2A, specifically, the catalytic subunit and the regulatory subunits PR65 and B. PP2B and PP2A were present in the tail, neck, and postacrosomal region, and PP1 was present in the postacrosomal region, neck, middle, and principal piece of human sperm. Treatment with phosphatase inhibitors rapidly (<= 1 min) increased the percent of sperm depicting the pattern B, reaching a maximum of similar to 40% that was maintained throughout incubation; after 3 h, the percent of capacitated sperm was similar to that of the control. The enzymatic activity of the phosphatases decreased during capacitation without changes in their expression. The pattern of phosphorylation on threonine residues showed a sharp increase upon treatment with the inhibitors. In conclusion, human sperm express PP1, PP2B, and PP2A, and the activity of these phosphatases decreases during capacitation. This decline in phosphatase activities and the subsequent increase in threonine phosphorylation may be an important requirement for the success of sperm capacitation.	[Signorelli, Janetti R.; Diaz, Emilce S.; Fara, Karla; Baron, Lina; Morales, Patricio] Univ Antofagasta, Fac Hlth Sci, Dept Biomed, Antofagasta, Chile; [Morales, Patricio] Univ Antofagasta, Antofagasta Inst, Antofagasta, Chile	Universidad de Antofagasta; Universidad de Antofagasta	Morales, P (corresponding author), Univ Antofagasta, Fac Hlth Sci, Dept Biomed, Antofagasta, Chile.	pmorales@uantof.cl	Morales, Patricio/ABC-4290-2021	Morales, Patricio/0000-0002-0379-7110; Signorelli, Janetti/0000-0001-9776-2690	Fondecyt [1080028, 1120056]; Antofagasta Institute Fellowship; Conicyt	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Antofagasta Institute Fellowship; Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	Fondecyt No1080028; Fondecyt No1120056. Antofagasta Institute Fellowship. Doctorate Fellowship from Conicyt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2008, J REPROD DEVELOP, V54, P171, DOI 10.1262/jrd.19172; AHMAD K, 1995, ARCH ANDROLOGY, V35, P187, DOI 10.3109/01485019508987871; Ashizawa K, 2004, REPRODUCTION, V128, P783, DOI 10.1530/rep.1.00327; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; BARUA M, 1985, BIOCHEM INT, V10, P733; Battistone MA, 2013, MOL HUM REPROD, V19, P570, DOI 10.1093/molehr/gat033; Bedu-Addo K, 2005, MOL HUM REPROD, V11, P683, DOI 10.1093/molehr/gah226; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Bennett JC, 2010, J BIOL CHEM, V285, P26269, DOI 10.1074/jbc.M109.095752; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chakrabarti R, 2007, BIOL REPROD, V76, P992, DOI 10.1095/biolreprod.106.058610; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Chernyavsky AI, 2008, J BIOL CHEM, V283, P3401, DOI 10.1074/jbc.M704956200; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; CROSS NL, 1986, CELL BIOL INT REP, V10, P545, DOI 10.1016/0309-1651(86)90029-9; Diaz ES, 2007, HUM REPROD, V22, P1420, DOI 10.1093/humrep/dem023; Fardilha M, 2011, MOL HUM REPROD, V17, P466, DOI 10.1093/molehr/gar004; FERNLEY HN, 1965, BIOCHEM J, V97, P95, DOI 10.1042/bj0970095; FURUYA S, 1993, FERTIL STERIL, V59, P216; FURUYA S, 1992, J ASSIST REPROD GEN, V9, P391, DOI 10.1007/BF01203965; Goto N, 2009, J REPROD DEVELOP, V55, P327, DOI 10.1262/jrd.20170; Harrison RAP, 2004, MOL REPROD DEV, V67, P337, DOI 10.1002/mrd.20028; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Huang ZH, 2005, BIOL REPROD, V72, P384, DOI 10.1095/biolreprod.104.034140; Huang ZH, 2004, BIOL REPROD, V70, P439, DOI 10.1095/biolreprod.103.020024; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Jha KN, 2002, MOL REPROD DEV, V63, P119, DOI 10.1002/mrd.10152; Kong M, 2009, BIOL REPROD, V80, P1026, DOI 10.1095/biolreprod.108.073924; Korrodi-Gregorio L, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-15; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leclerc P, 1996, BIOL REPROD, V55, P684, DOI 10.1095/biolreprod55.3.684; LEE MA, 1987, FERTIL STERIL, V48, P649; LI YM, 1992, P NATL ACAD SCI USA, V89, P11867, DOI 10.1073/pnas.89.24.11867; Morales P, 2003, HUM REPROD, V18, P1010, DOI 10.1093/humrep/deg111; MORALES P, 1994, ANDROLOGIA, V26, P131; Moseley FLC, 2005, MOL HUM REPROD, V11, P523, DOI 10.1093/molehr/gah188; Naz RK, 1999, BIOL REPROD, V60, P1402, DOI 10.1095/biolreprod60.6.1402; Osheroff JE, 1999, MOL HUM REPROD, V5, P1017, DOI 10.1093/molehr/5.11.1017; Pastula C, 2003, COMB CHEM HIGH T SCR, V6, P341; Peknicova J, 2007, FERTIL STERIL, V88, P1120, DOI 10.1016/j.fertnstert.2006.12.070; Salicioni Ana M, 2007, Soc Reprod Fertil Suppl, V65, P245; Shen Y, 2001, P NATL ACAD SCI USA, V98, P13613, DOI 10.1073/pnas.231499098; Si YM, 1999, BIOL REPROD, V61, P240, DOI 10.1095/biolreprod61.1.240; Smith GD, 1996, BIOL REPROD, V54, P719, DOI 10.1095/biolreprod54.3.719; Soler DC, 2009, BIOL REPROD, V81, P343, DOI 10.1095/biolreprod.109.076398; Suzuki T, 2010, REPRODUCTION, V139, P847, DOI 10.1530/REP-08-0366; SWARUP G, 1982, BIOL REPROD, V26, P953, DOI 10.1095/biolreprod26.5.953; TANG FY, 1975, BIOCHEM BIOPH RES CO, V62, P328, DOI 10.1016/S0006-291X(75)80142-2; TASH JS, 1988, J CELL BIOL, V106, P1625, DOI 10.1083/jcb.106.5.1625; TASH JS, 1994, J ANDROL, V15, P505; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vijayaraghavan S, 1996, BIOL REPROD, V54, P709, DOI 10.1095/biolreprod54.3.709; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Visconti PE, 2009, P NATL ACAD SCI USA, V106, P667, DOI 10.1073/pnas.0811895106; Visconti PE, 1999, BIOL REPROD, V61, P76, DOI 10.1095/biolreprod61.1.76; Visconti PE, 1999, DEV BIOL, V214, P429, DOI 10.1006/dbio.1999.9428; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Yanagimachi R., 1994, Zygote, V2, P371	61	14	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81286	10.1371/journal.pone.0081286	http://dx.doi.org/10.1371/journal.pone.0081286			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312544	gold, Green Published, Green Submitted			2022-12-25	WOS:000327944500065
J	Zhang, TX; Wang, HZ; Wu, LS; Lou, J; Wu, JJ; Brookes, PC; Xu, JM				Zhang, Taoxiang; Wang, Haizhen; Wu, Laosheng; Lou, Jun; Wu, Jianjun; Brookes, Philip C.; Xu, Jianming			Survival of Escherichia coli O157:H7 in Soils from Jiangsu Province, China	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; MANURE-AMENDED SOIL; MICROBIAL COMMUNITIES; O157-H7; PH; RHIZOSPHERE; O157/H7; CULTIVATION; DIVERSITY; FATE	Escherichia coli O157:H7 (E. coli O157: H7) is recognized as a hazardous microorganism in the environment and for public health. The E. coli O157: H7 survival dynamics were investigated in 12 representative soils from Jiangsu Province, where the largest E. coli O157: H7 infection in China occurred. It was observed that E. coli O157: H7 declined rapidly in acidic soils (pH, 4.57 - 5.14) but slowly in neutral soils (pH, 6.51 - 7.39). The survival dynamics were well described by the Weibull model, with the calculated t(d) value (survival time of the culturable E. coli O157: H7 needed to reach the detection limit of 100 CFU g(-1)) from 4.57 days in an acidic soil (pH, 4.57) to 34.34 days in a neutral soil (pH, 6.77). Stepwise multiple regression analysis indicated that soil pH and soil organic carbon favored E. coli O157: H7 survival, while a high initial ratio of Gram-negative bacteria phospholipid fatty acids (PLFAs) to Gram-positive bacteria PLFAs, and high content of exchangeable potassium inhibited E. coli O157: H7 survival. Principal component analysis clearly showed that the survival profiles in soils with high pH were different from those with low pH.	[Zhang, Taoxiang; Wang, Haizhen; Wu, Laosheng; Lou, Jun; Wu, Jianjun; Brookes, Philip C.; Xu, Jianming] Zhejiang Univ, Zhejiang Prov Key Lab Subtrop Soil & Plant Nutr, Coll Environm & Nat Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wang, HZ (corresponding author), Zhejiang Univ, Zhejiang Prov Key Lab Subtrop Soil & Plant Nutr, Coll Environm & Nat Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China.	mywhz@163.com; jmxu@zju.edu.cn	Lou, Jun/E-8203-2016; Xu, Jianming/C-8752-2016; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Lou, Jun/0000-0001-7872-8200; Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	National Natural Science Foundation of China [41130532, 40971255]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Major Program of National Natural Science Foundation of China (41130532) and the National Natural Science Foundation of China (40971255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agricultural Chemistry Committee of China, 1983, CONV METH SOIL AGR C; BENJAMIN MM, 1995, APPL ENVIRON MICROB, V61, P1669, DOI 10.1128/AEM.61.4.1669-1672.1995; Birk J. J., 2009, P309, DOI 10.1007/978-1-4020-9031-8_16; Cai P, 2013, ENVIRON SCI TECHNOL, V47, P1896, DOI 10.1021/es304686a; Curtin D, 1998, SOIL BIOL BIOCHEM, V30, P57, DOI 10.1016/S0038-0717(97)00094-1; Dangi SR, 2012, SOIL SCI SOC AM J, V76, P915, DOI 10.2136/sssaj2011.0288; Devau N, 2009, APPL GEOCHEM, V24, P2163, DOI 10.1016/j.apgeochem.2009.09.020; Ding N, 2009, FEMS MICROBIOL ECOL, V70, P305, DOI 10.1111/j.1574-6941.2009.00742.x; Doyle MP, 2008, J APPL MICROBIOL, V105, P317, DOI 10.1111/j.1365-2672.2008.03746.x; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Franz E, 2008, ENVIRON MICROBIOL, V10, P313, DOI 10.1111/j.1462-2920.2007.01453.x; Institute of Soil Science Academia Sinica, 1990, SOILS CHIN, P514; Jiang XP, 2002, APPL ENVIRON MICROB, V68, P2605, DOI 10.1128/AEM.68.5.2605-2609.2002; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Li Hongwei, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P119; Liu JB, 2007, CHIN J SCH DOCTO, V21, P720; Liu JB, 2007, DIS SURVEILL, V22, P516; Ma JC, 2013, FEMS MICROBIOL ECOL, V84, P542, DOI 10.1111/1574-6941.12083; Ma JC, 2012, ENVIRON SCI TECHNOL, V46, P12154, DOI 10.1021/es302738z; Majeed H, 2011, ISME J, V5, P71, DOI 10.1038/ismej.2010.90; [缪启龙 MIAO Qilong], 2008, [热带气象学报, Journal of Tropical Meteorology], V24, P737; Mubiru DN, 2000, J ENVIRON QUAL, V29, P1821, DOI 10.2134/jeq2000.00472425002900060012x; Mukherjee A, 2006, J APPL MICROBIOL, V101, P429, DOI 10.1111/j.1365-2672.2006.02913.x; Ogden ID, 2001, INT J FOOD MICROBIOL, V66, P111, DOI 10.1016/S0168-1605(00)00508-0; OKSANEN J, 2012, R PACKAGE VERSION, V2, P1, DOI DOI 10.3856/V0L41-ISSUEL-FULLTEXT-11; Ongeng D, 2011, J APPL MICROBIOL, V110, P1007, DOI 10.1111/j.1365-2672.2011.04956.x; Ongeng DC, 2011, INT J FOOD MICROBIOL, V149, P133, DOI 10.1016/j.ijfoodmicro.2011.06.009; Pietri JCA, 2008, SOIL BIOL BIOCHEM, V40, P1856, DOI [10.1016/j.soilbio.2008.03.020, 10.1016/i.soilbio.2008.03.020]; RICHARDS LA, 1949, SOIL SCI, V68, P95, DOI 10.1097/00010694-194907000-00008; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Semenov AV, 2011, J ENVIRON MANAGE, V92, P780, DOI 10.1016/j.jenvman.2010.10.031; Simonetti G, 2012, SOIL SCI SOC AM J, V76, P880, DOI 10.2136/sssaj2011.0243; Swallow M, 2013, APPL SOIL ECOL, V63, P120, DOI 10.1016/j.apsoil.2012.09.006; van Elsas JD, 2012, P NATL ACAD SCI USA, V109, P1159, DOI 10.1073/pnas.1109326109; van Elsas JD, 2011, ISME J, V5, P173, DOI 10.1038/ismej.2010.80; Vidovic S, 2007, CAN J MICROBIOL, V53, P822, DOI 10.1139/W07-041; Wang GD, 1998, J FOOD PROTECT, V61, P662, DOI 10.4315/0362-028X-61.6.662; Wang HZ, 2014, ENVIRON SCI POLLUT R, V21, P518, DOI 10.1007/s11356-013-1938-9; Westphal A, 2011, APPL ENVIRON MICROB, V77, P2113, DOI 10.1128/AEM.01655-10; Williams AP, 2007, J APPL MICROBIOL, V102, P319, DOI 10.1111/j.1365-2672.2006.03104.x; Wu EP, 2006, MOD PREV MED, V13, P2455; Wu YP, 2009, APPL SOIL ECOL, V43, P234, DOI 10.1016/j.apsoil.2009.08.002; XU JG, 1990, CURR MICROBIOL, V20, P299, DOI 10.1007/BF02091909; Yao ZY, 2013, APPL ENVIRON MICROB, V79, P1755, DOI 10.1128/AEM.03605-12; Yee N, 2000, GEOCHIM COSMOCHIM AC, V64, P609, DOI 10.1016/S0016-7037(99)00342-7; Ying JY, 2013, J SOIL SEDIMENT, V13, P1223, DOI 10.1007/s11368-013-0704-4; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533; Zhao WenQiang, 2013, Acta Pedologica Sinica, V50, P221; Zhu WenGuan, 2006, Chinese Journal of Zoonoses, V22, P428	49	19	21	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81178	10.1371/journal.pone.0081178	http://dx.doi.org/10.1371/journal.pone.0081178			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312534	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500056
J	Battaile, BC; Trites, AW				Battaile, Brian C.; Trites, Andrew W.			Linking Reproduction and Survival Can Improve Model Estimates of Vital Rates Derived from Limited Time-Series Counts of Pinnipeds and Other Species	PLOS ONE			English	Article							CALIFORNIA SEA LION; FUR SEALS; POPULATION-DYNAMICS; ZALOPHUS-CALIFORNIANUS; TUGIDAK ISLAND; SENESCENCE; GROWTH; GULF; PERFORMANCE; DEMOGRAPHY	We propose a method to model the physiological link between somatic survival and reproductive output that reduces the number of parameters that need to be estimated by models designed to determine combinations of birth and death rates that produce historic counts of animal populations. We applied our Reproduction and Somatic Survival Linked (RSSL) method to the population counts of three species of North Pacific pinnipeds (harbor seals, Phoca vitulina richardii (Gray, 1864); northern fur seals, Callorhinus ursinus (L., 1758); and Steller sea lions, Eumetopias jubatus (Schreber, 1776))-and found our model outperformed traditional models when fitting vital rates to common types of limited datasets, such as those from counts of pups and adults. However, our model did not perform as well when these basic counts of animals were augmented with additional observations of ratios of juveniles to total non-pups. In this case, the failure of the ratios to improve model performance may indicate that the relationship between survival and reproduction is redefined or disassociated as populations change over time or that the ratio of juveniles to total non-pups is not a meaningful index of vital rates. Overall, our RSSL models show advantages to linking survival and reproduction within models to estimate the vital rates of pinnipeds and other species that have limited time-series of counts.	[Battaile, Brian C.; Trites, Andrew W.] Univ British Columbia, Fisheries Ctr, Marine Mammal Res Unit, AERL, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Battaile, BC (corresponding author), Univ British Columbia, Fisheries Ctr, Marine Mammal Res Unit, AERL, Vancouver, BC V5Z 1M9, Canada.	b.battaile@fisheries.ubc.ca	Trites, Andrew/K-5648-2012	Trites, Andrew/0000-0003-0342-5322	National Oceanographic and Atmospheric Administration through the North Pacific Marine Science Foundation [NA16FX2629]; North Pacific Universities Marine Mammal Research Consortium	National Oceanographic and Atmospheric Administration through the North Pacific Marine Science Foundation; North Pacific Universities Marine Mammal Research Consortium	This research was funded by the National Oceanographic and Atmospheric Administration under award number NA16FX2629 through the North Pacific Marine Science Foundation and the North Pacific Universities Marine Mammal Research Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauplet G, 2006, OIKOS, V112, P430, DOI 10.1111/j.0030-1299.2006.14412.x; Berube CH, 1999, ECOLOGY, V80, P2555, DOI 10.1890/0012-9658(1999)080[2555:IDLARS]2.0.CO;2; Bouwhuis S, 2012, AM NAT, V179, pE15, DOI 10.1086/663194; Bowen WD, 2006, J ANIM ECOL, V75, P1340, DOI 10.1111/j.1365-2656.2006.01157.x; Boyd IL, 2010, BIOL CONSERV, V143, P1664, DOI 10.1016/j.biocon.2010.04.006; BOYD IL, 1995, J ANIM ECOL, V64, P505, DOI 10.2307/5653; Burnham K. P., 2002, MODEL SELECTION AND; Calkins D.G., 1982, ENV ASSESSMENT ALASK, V19, P445; Chapman DG, 1964, FISH B, V63, P657; Childerhouse SJ, 2010, J MAMMAL, V91, P165, DOI 10.1644/09-MAMM-A-110R.1; Chilvers BL, 2010, J AGR BIOL ENVIR ST, V15, P259, DOI 10.1007/s13253-009-0011-0; Cohen AA, 2004, BIOL REV, V79, P733, DOI 10.1017/S1464793103006432; EBERHARDT LL, 1985, J WILDLIFE MANAGE, V49, P997, DOI 10.2307/3801386; Fisher RA, 1930, THE GENETICAL THEORY; GAILLARD JM, 1994, EVOLUTION, V48, P509, DOI 10.1111/j.1558-5646.1994.tb01329.x; Gibbens J, 2009, CAN J ZOOL, V87, P902, DOI 10.1139/Z09-080; Gibbens J, 2010, J MAMMAL, V91, P510, DOI 10.1644/08-MAMM-A-377.1; Godinez CR, 1999, J WILDLIFE DIS, V35, P108, DOI 10.7589/0090-3558-35.1.108; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Hastings KK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00215.1; Hernandez-Camacho CJ, 2008, J MAMMAL, V89, P1059, DOI 10.1644/07-MAMM-A-404.1; Hernandez-Camacho CJ, 2008, MAR MAMMAL SCI, V24, P664, DOI 10.1111/j.1748-7692.2008.00199.x; Herrando-Perez S, 2012, ECOLOGY, V93, P1728, DOI 10.1890/11-1415.1; Holmes EE, 2007, ECOL APPL, V17, P2214, DOI 10.1890/07-0508.1; Holmes EE, 2003, CONSERV BIOL, V17, P1794, DOI 10.1111/j.1523-1739.2003.00191.x; Jemison LA, 2006, MAR MAMMAL SCI, V22, P339, DOI 10.1111/j.1748-7692.2006.00021.x; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kirkwood TBL, 2010, ANN NY ACAD SCI, V1204, P21, DOI 10.1111/j.1749-6632.2010.05520.x; LANDER RH, 1981, FISH RES, V1, P55, DOI 10.1016/0165-7836(81)90007-2; Lander RH, 1980, NOAA TECH MEM NMFS F, V1, P315; LIMA M, 1995, J MAMMAL, V76, P1249, DOI 10.2307/1382619; Lima M, 1997, J MAMMAL, V78, P914, DOI 10.2307/1382951; McKenzie J, 2006, POPULATION DEMOGRAPH; Monaghan P, 2008, FUNCT ECOL, V22, P371, DOI 10.1111/j.1365-2435.2008.01418.x; National Marine Fisheries Service, 2008, REC PLAN STELL SEA L, P325; Partridge L, 1996, P ROY SOC B-BIOL SCI, V263, P1365, DOI 10.1098/rspb.1996.0200; Pistorius PA, 2002, CAN J ZOOL, V80, P395, DOI 10.1139/Z02-017; PITCHER KW, 1990, MAR MAMMAL SCI, V6, P121, DOI 10.1111/j.1748-7692.1990.tb00234.x; Pitcher KW, 1998, CAN J ZOOL, V76, P2075, DOI 10.1139/cjz-76-11-2075; Pitcher KW, 1979, BIOLOGY OF THE HARBO, P231; Proffitt KM, 2007, OIKOS, V116, P1683, DOI 10.1111/j.2007.0030-1299.16139.x; R Core Team, 2021, R LANG ENV STAT COMP; Ricklefs RE, 2001, EXP GERONTOL, V36, P845, DOI 10.1016/S0531-5565(00)00245-X; Robinson MR, 2012, ECOLOGY LETTERS; SILER W, 1979, ECOLOGY, V60, P750, DOI 10.2307/1936612; TRITES AW, 1991, CAN J ZOOL, V69, P2608, DOI 10.1139/z91-367; Trites AW, 1992, THE STATUS OF STELLE; Weladji RB, 2006, P ROY SOC B-BIOL SCI, V273, P1239, DOI 10.1098/rspb.2005.3393; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Winship AJ, 2006, MAR MAMMAL SCI, V22, P124, DOI 10.1111/j.1748-7692.2006.00009.x; YORK AE, 1994, MAR MAMMAL SCI, V10, P38, DOI 10.1111/j.1748-7692.1994.tb00388.x	51	2	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e77389	10.1371/journal.pone.0077389	http://dx.doi.org/10.1371/journal.pone.0077389			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24324541	Green Published, gold			2022-12-25	WOS:000327252100008
J	Vassilopoulos, A; Chisholm, C; Lahusen, T; Zheng, H; Deng, CX				Vassilopoulos, A.; Chisholm, C.; Lahusen, T.; Zheng, H.; Deng, C-X			A critical role of CD29 and CD49f in mediating metastasis for cancer-initiating cells isolated from a Brca1-associated mouse model of breast cancer	ONCOGENE			English	Article						CD29; CD49f; CSCs; EMT; cancer metastasis	EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; BRCA1; IDENTIFICATION; SUSCEPTIBILITY; EXPRESSION; MECHANISMS; SIGNATURE; MARKERS; TUMORS	Cancer metastasis is a lethal problem that claims the lives of over 90% of cancer patients. In this study, we have investigated metastatic potential of cancer stem cells (CSCs) isolated from mammary tumors of a Brca1-mutant mouse model. Our data indicated that CSCs, which are enriched in CD24(+)CD29(+)/CD49f(+) cell population, displayed much higher migration ability than CD24(-)CD29(-)/CD49f (-) cells in tissue culture and enhanced metastatic potential in allograft-nude mice. CD24(+)CD29(+) cells maintained the ability to differentiate and reconstitute heterogeneity in the metastatic tumors whereas CD24(-)CD29(-) cells could not. Corresponding to their enhanced metastatic ability, CD24(+)CD29(+) cells exhibited features of the epithelial to mesenchymal transition. Finally, using short hairpin RNA to knock down CD29 and/or CD49f in metastatic cancer cells, we demonstrated that while acute knockdown of CD29 or CD49f alone slightly decreased cell migration ability, knockdown of both genes generated a profound effect to block their migration, revealing an overlapping, yet critical function of both genes in the migration of CSCs. Our findings indicate that in addition to serving as markers of CSCs, CD29 and CD49f may also serve as potential therapeutic targets for cancer metastasis.	[Vassilopoulos, A.; Chisholm, C.; Lahusen, T.; Zheng, H.; Deng, C-X] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Deng, CX (corresponding author), NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA.	chuxiad@bdg10.niddk.nih.gov	deng, chuxia/N-6713-2016		Intramural Research Program of the National Institute of Diabetes, Digestive and Kidney Diseases; National Institutes of Health, USA	Intramural Research Program of the National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Deng lab for critical reading of the manuscript. This work was supported by the Intramural Research Program of the National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, USA.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alberg Anthony J., 1997, Current Opinion in Oncology, V9, P505, DOI 10.1097/00001622-199711000-00003; Ali HR, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3061; Baccelli I, 2012, J CELL BIOL, V198, P281, DOI 10.1083/jcb.201202014; Brody LC, 1998, MEDICINE, V77, P208, DOI 10.1097/00005792-199805000-00006; Dave B, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr2938; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Deng CX, 2003, HUM MOL GENET, V12, pR113, DOI 10.1093/hmg/ddg082; Deng CX, 2000, BIOESSAYS, V22, P728; Deng CX, 2002, ENVIRON MOL MUTAGEN, V39, P171, DOI 10.1002/em.10069; Diaz-Cruz Edgar S, 2010, Breast Dis, V32, P85, DOI 10.3233/BD-2010-0308; Dine J, 2013, CANCER METAST REV, V32, P25, DOI 10.1007/s10555-012-9403-7; Drost RM, 2009, BRIT J CANCER, V101, P1651, DOI 10.1038/sj.bjc.6605350; Eccles DM, 2005, LANCET ONCOL, V6, P705, DOI 10.1016/S1470-2045(05)70318-1; Foroni C, 2012, CANCER TREAT REV, V38, P689, DOI 10.1016/j.ctrv.2011.11.001; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gritsenko PG, 2012, J PATHOL, V226, P185, DOI 10.1002/path.3031; Hale JS, 2012, CELL ADHES MIGR, V6, P346, DOI 10.4161/cam.21294; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hu YF, 2009, INT J BIOL SCI, V5, P20; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lahlou H, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2905; Lanza DG, 2012, TUMOR BIOL, V33, P1997, DOI 10.1007/s13277-012-0459-3; Lathia JD, 2011, CELL STEM CELL, V8, P482, DOI 10.1016/j.stem.2011.04.013; LEE EC, 1992, J CELL BIOL, V117, P671, DOI 10.1083/jcb.117.3.671; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NICOLSON GL, 1992, ONCOL RES, V4, P389; Nielsen PK, 2001, J BIOL CHEM, V276, P10906, DOI 10.1074/jbc.M008743200; NIESSEN CM, 1994, J CELL SCI, V107, P543; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Song LL, 2007, EXPERT OPIN BIOL TH, V7, P431, DOI 10.1517/14712598.7.4.431; SONNENBERG A, 1991, EXP CELL RES, V197, P234, DOI 10.1016/0014-4827(91)90428-W; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vassilopoulos A, 2008, INT J BIOL SCI, V4, P133, DOI 10.7150/ijbs.4.133; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Zhang JR, 2005, MOL CANCER RES, V3, P531, DOI 10.1158/1541-7786.MCR-05-0192; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	47	48	51	1	15	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 20	2014	33	47					5477	5482		10.1038/onc.2013.516	http://dx.doi.org/10.1038/onc.2013.516			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MG	24317509				2022-12-25	WOS:000345120700010
J	Mealer, RG; Murray, AJ; Shahani, N; Subramaniam, S; Snyder, SH				Mealer, Robert G.; Murray, Alexandra J.; Shahani, Neelam; Subramaniam, Srinivasa; Snyder, Solomon H.			Rhes, a Striatal-selective Protein Implicated in Huntington Disease, Binds Beclin-1 and Activates Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Bcl-2; Huntington Disease; mTOR; Neurodegenerative Diseases; Beclin-1; Rhes	MUTANT-HUNTINGTIN; MTOR; PHOSPHORYLATION; INHIBITION; CLEARANCE; MODEL	Background: The striatal-specific protein Rhes is implicated in the selective pathology of HD. Results: Rhes binds Beclin-1 and activates autophagy, a lysosomal degradation pathway critical in aging and neurodegeneration. Conclusion: Rhes-induced autophagy occurs independent of mTOR and JNK-1 signaling and is inhibited by huntingtin. Significance: The restricted expression of Rhes and its effect on autophagy may explain the selective striatal pathology and delayed onset of HD. The protein mutated in Huntington disease (HD), mutant huntingtin (mHtt), is expressed throughout the brain and body. However, the pathology of HD is characterized by early and dramatic destruction selectively of the striatum. We previously reported that the striatal-specific protein Rhes binds mHtt and enhances its cytotoxicity. Moreover, Rhes-deleted mice are dramatically protected from neurodegeneration and motor dysfunction in mouse models of HD. We now report a function of Rhes in autophagy, a lysosomal degradation pathway implicated in aging and HD neurodegeneration. In PC12 cells, deletion of endogenous Rhes decreases autophagy, whereas Rhes overexpression activates autophagy. These effects are independent of mTOR and opposite in the direction predicted by the known activation of mTOR by Rhes. Rhes robustly binds the autophagy regulator Beclin-1, decreasing its inhibitory interaction with Bcl-2 independent of JNK-1 signaling. Finally, co-expression of mHtt blocks Rhes-induced autophagy activation. Thus, the isolated pathology and delayed onset of HD may reflect the striatal-selective expression and changes in autophagic activity of Rhes.	[Mealer, Robert G.; Murray, Alexandra J.; Snyder, Solomon H.] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Shahani, Neelam; Subramaniam, Srinivasa] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Scripps Research Institute	Subramaniam, S (corresponding author), Scripps Res Inst, Dept Neurosci, 130 Scripps Way 3C1, Jupiter, FL 33458 USA.	ssubrama@scripps.edu; ssnyder@jhmi.edu		Bender, Alexandra/0000-0002-6980-3878	National Institutes of Health from USPHS [MH18501]; Cure Huntington's Disease Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH094612, R01MH018501, R37MH018501] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; Cure Huntington's Disease Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH18501 from USPHS (to S. H. S.) and a grant from the Cure Huntington's Disease Initiative (to S. H. S.).	Baiamonte BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053606; Banerjee R, 2010, TRENDS NEUROSCI, V33, P541, DOI 10.1016/j.tins.2010.09.001; Bang S, 2012, NEUROSCI LETT, V521, P142, DOI 10.1016/j.neulet.2012.05.073; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Choi BR, 2013, NEUROSCIENCE, V253, P214, DOI 10.1016/j.neuroscience.2013.08.043; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; Harrison LM, 2013, NEUROSCIENCE, V236, P21, DOI 10.1016/j.neuroscience.2012.12.062; Jimenez-Sanchez M, 2012, PROG NEUROBIOL, V97, P67, DOI 10.1016/j.pneurobio.2011.08.013; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; Li XJ, 2011, NEUROBIOL DIS, V43, P4, DOI 10.1016/j.nbd.2010.11.018; Lu BX, 2013, FASEB J, V27, P1820, DOI 10.1096/fj.12-219220; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Mealer RG, 2013, J NEUROSCI, V33, P4206, DOI 10.1523/JNEUROSCI.3730-12.2013; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nagata E, 2004, NEUROREPORT, V15, P1325, DOI 10.1097/01.wnr.0000127073.66692.8f; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Renna M, 2010, J BIOL CHEM, V285, P11061, DOI 10.1074/jbc.R109.072181; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Salminen A, 2009, TRENDS MOL MED, V15, P217, DOI 10.1016/j.molmed.2009.03.004; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Sarkar S, 2008, FEBS J, V275, P4263, DOI 10.1111/j.1742-4658.2008.06562.x; Sbodio JI, 2013, CELL REP, V4, P890, DOI 10.1016/j.celrep.2013.08.001; Seredenina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022231; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Snyder SH, 2012, EUR J NEURODEGEN DIS, V1, P89; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Subramaniam S, 2012, NAT NEUROSCI, V15, P191, DOI 10.1038/nn.2994; Subramaniam S, 2011, NEUROPHARMACOLOGY, V60, P1187, DOI 10.1016/j.neuropharm.2010.10.025; Subramaniam S, 2010, J BIOL CHEM, V285, P20428, DOI 10.1074/jbc.C110.127191; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Vargiu P, 2004, ONCOGENE, V23, P559, DOI 10.1038/sj.onc.1207161; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zheng S, 2010, PLOS GENET, V6; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	44	86	91	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3547	3554		10.1074/jbc.M113.536912	http://dx.doi.org/10.1074/jbc.M113.536912			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24324270	Green Published, hybrid			2022-12-25	WOS:000331368700039
J	Lou, JT; Ben, SQ; Yang, GH; Liang, XH; Wang, XQ; Ni, SS; Han, BH				Lou, Jiatao; Ben, Suqin; Yang, Guohua; Liang, Xiaohui; Wang, Xiaoqian; Ni, Songshi; Han, Baohui			Quantification of Rare Circulating Tumor Cells in Non-Small Cell Lung Cancer by Ligand-Targeted PCR	PLOS ONE			English	Article							FOLATE RECEPTOR-ALPHA; POLYMERASE CHAIN-REACTION; PERIPHERAL-BLOOD; BREAST-CANCER; MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; EXPRESSION; PROGNOSIS; MARKER; QUANTITATION	Background: Quantification of circulating tumor cells (CTC) is valuable for evaluation of non-small cell lung cancer (NSCLC). The sensitivity of current methods constrains their use to detect rare CTCs in early stage. Here we evaluate a novel method, ligand-targeted polymerase chain reaction (LT-PCR), that can detect rare CTCs in NSCLC patients. Methods: CTCs were enriched by immunomagnetic depletion of leukocytes and then labeled by a conjugate of a tumor-specific ligand and an oligonucleotide. After washing off free conjugates, the bound conjugates were stripped from CTCs and then analyzed by qPCR. To evaluate the clinical utility, blood samples were obtained from 72 NSCLC patients (33 initially diagnosed and 39 on chemotherapy), 20 benign patients, and 24 healthy donors. Results: Experiments with healthy blood spiked with tumor cells indicated the LT-PCR allows specific detection of CTC. The clinical study showed that the initially diagnosed patients have an average of 20.8 CTC units with metastatic diseases, 11.8 CTC units with localized diseases, and 6.0 CTC units with benign diseases. With the threshold of 8.5 CTC units, the assay can detect 80% of stage I/II, 67% of stage III, and 93% of stage IV cancer. With the benign patients and healthy donors as control group, the method can detect cancer with a sensitivity of 81.8% and a specificity of 93.2%. Conclusion: The LT-PCR would allow quantification of CTC in NSCLC patients at a more sensitive level, providing a potential tool for stratifying malignant lung diseases, especially at early stage.	[Lou, Jiatao; Liang, Xiaohui; Wang, Xiaoqian] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Clin Lab, Shanghai 200030, Peoples R China; [Han, Baohui] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm Med, Shanghai 200030, Peoples R China; [Ben, Suqin; Ni, Songshi] Nantong Univ, Affiliated Hosp, Dept Resp Med, Nantong, Jiangsu, Peoples R China; [Yang, Guohua] GenoSaber Biotech Co Ltd, Dept Res & Dev, Shanghai, Peoples R China; [Ben, Suqin] Shanghai Jiao Tong Univ, Peoples Hosp 1, Dept Resp Dis, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Nantong University; Shanghai Jiao Tong University	Han, BH (corresponding author), Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm Med, Shanghai 200030, Peoples R China.	schbhhan@gmail.com	Lou, Jiatao/AAY-9830-2020		Key Project of Shanghai Science and Technology Commission [10411950600]	Key Project of Shanghai Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Key Project of Shanghai Science and Technology Commission (Grand No: 10411950600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AL, 2005, CYTOM PART A, V65A, P4, DOI 10.1002/cyto.a.20132; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Audic Y, 2004, BIOL CELL, V96, P479, DOI 10.1016/j.biolcel.2004.05.002; Brechot JM, 1997, EUR J CANCER, V33, P385, DOI 10.1016/S0959-8049(97)89010-7; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; CROWE DL, 1993, J CELL SCI, V106, P183; Cruz I, 2005, AM J CLIN PATHOL, V123, P66, DOI 10.1309/WP3QWKVJFYDHHXQD; Devriese LA, 2012, LUNG CANCER, V75, P242, DOI 10.1016/j.lungcan.2011.07.003; Hayes DC, 2006, ANTICANCER RES, V26, P1567; He W, 2008, INT J CANCER, V123, P1968, DOI 10.1002/ijc.23717; He W, 2007, P NATL ACAD SCI USA, V104, P11760, DOI 10.1073/pnas.0703875104; Iwakiri S, 2008, ANN SURG ONCOL, V15, P889, DOI 10.1245/s10434-007-9755-3; Krebs MG, 2012, J THORAC ONCOL, V7, P306, DOI 10.1097/JTO.0b013e31823c5c16; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Krivacic RT, 2004, P NATL ACAD SCI USA, V101, P10501, DOI 10.1073/pnas.0404036101; Kurusu Y, 1999, SURGERY, V126, P820, DOI 10.1016/S0039-6060(99)70020-6; Lankiewicz S, 2006, MOL BIOTECHNOL, V34, P15, DOI 10.1385/MB:34:1:15; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Muller V, 2005, CLIN CANCER RES, V11, P3678, DOI 10.1158/1078-0432.CCR-04-2469; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Naume B, 2004, CYTOTHERAPY, V6, P244, DOI 10.1080/14653240410006086; Nieva J, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016004; Nunez MI, 2012, J THORAC ONCOL, V7, P833, DOI 10.1097/JTO.0b013e31824de09c; O'Shannessy DJ, 2012, ONCOTARGET, V3, P414; Oremek GM, 2007, ANTICANCER RES, V27, P1911; Pachmann K, 2005, CLIN CHEM LAB MED, V43, P617, DOI 10.1515/CCLM.2005.107; Parker N, 2005, ANAL BIOCHEM, V338, P284, DOI 10.1016/j.ab.2004.12.026; Puig-Kroger A, 2009, CANCER RES, V69, P9395, DOI 10.1158/0008-5472.CAN-09-2050; Pujol JL, 2001, LUNG CANCER, V31, P221, DOI 10.1016/S0169-5002(00)00186-0; Punnoose EA, 2012, CLIN CANCER RES, V18, P2391, DOI 10.1158/1078-0432.CCR-11-3148; Rao CG, 2005, INT J ONCOL, V27, P49; Reddy JA, 1999, BLOOD, V93, P3940, DOI 10.1182/blood.V93.11.3940.411k09_3940_3948; Stathopoulou A, 2002, J CLIN ONCOL, V20, P3404, DOI 10.1200/JCO.2002.08.135; Su L, 1996, HUM PATHOL, V27, P800, DOI 10.1016/S0046-8177(96)90452-9; Valcourt U, 2007, J BIOL CHEM, V282, P5691, DOI 10.1074/jbc.M610536200; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; WIESKOPF B, 1995, CHEST, V108, P163, DOI 10.1378/chest.108.1.163; Wu C, 2009, J THORAC ONCOL, V4, P30, DOI 10.1097/JTO.0b013e3181914125; YAKUBOV LA, 1989, P NATL ACAD SCI USA, V86, P6454, DOI 10.1073/pnas.86.17.6454; Yamashita J, 2002, J THORAC CARDIOV SUR, V124, P299, DOI 10.1067/mtc.2002.124370; Yoon SO, 2011, LUNG CANCER, V71, P209, DOI 10.1016/j.lungcan.2010.04.017	41	36	45	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e80458	10.1371/journal.pone.0080458	http://dx.doi.org/10.1371/journal.pone.0080458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324600	Green Published, gold, Green Submitted			2022-12-25	WOS:000328566700009
J	Orozco, CA; Acevedo, A; Cortina, L; Cuellar, GE; Duarte, M; Martin, L; Mesa, NM; Munoz, J; Portilla, CA; Quijano, SM; Quintero, G; Rodriguez, M; Saavedra, CE; Groot, H; Torres, MM; Lopez-Segura, V				Orozco, Carlos A.; Acevedo, Andres; Cortina, Lazaro; Cuellar, Gina E.; Duarte, Monica; Martin, Liliana; Mesa, Nestor M.; Munoz, Javier; Portilla, Carlos A.; Quijano, Sandra M.; Quintero, Guillermo; Rodriguez, Miriam; Saavedra, Carlos E.; Groot, Helena; Torres, Maria M.; Lopez-Segura, Valeriano			The Combined Expression Patterns of Ikaros Isoforms Characterize Different Hematological Tumor Subtypes	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; DNA-BINDING PROTEINS; LYMPHOCYTE DEVELOPMENT; TRANSCRIPTION FACTOR; MIQE GUIDELINES; GENE ENCODES; HELIOS; FAMILY; AIOLOS; OVEREXPRESSION	A variety of genetic alterations are considered hallmarks of cancer development and progression. The Ikaros gene family, encoding for key transcription factors in hematopoietic development, provides several examples as genetic defects in these genes are associated with the development of different types of leukemia. However, the complex patterns of expression of isoforms in Ikaros family genes has prevented their use as clinical markers. In this study, we propose the use of the expression profiles of the Ikaros isoforms to classify various hematological tumor diseases. We have standardized a quantitative PCR protocol to estimate the expression levels of the Ikaros gene exons. Our analysis reveals that these levels are associated with specific types of leukemia and we have found differences in the levels of expression relative to five interexonic Ikaros regions for all diseases studied. In conclusion, our method has allowed us to precisely discriminate between B-ALL, CLL and MM cases. Differences between the groups of lymphoid and myeloid pathologies were also identified in the same way.	[Orozco, Carlos A.; Groot, Helena; Torres, Maria M.; Lopez-Segura, Valeriano] Univ Los Andes, Lab Human Genet, Bogota, Colombia; [Acevedo, Andres; Cuellar, Gina E.; Duarte, Monica; Martin, Liliana; Mesa, Nestor M.; Munoz, Javier; Quijano, Sandra M.; Quintero, Guillermo; Rodriguez, Miriam; Saavedra, Carlos E.] Santa Fe Bogota Fdn, Bogota, Colombia; [Cortina, Lazaro; Portilla, Carlos A.] Univ Hosp Valle, Pediat Hematooncol Unit, Cali, Colombia	Universidad de los Andes (Colombia)	Lopez-Segura, V (corresponding author), Univ Los Andes, Lab Human Genet, Bogota, Colombia.	vlopezsegura@gmail.com	Acevedo-Melo, Andrés Mauricio/A-2309-2014; Orozco Castaño, Carlos Alberto/AAX-9828-2021; Quijano, Sandra/AAF-2945-2019	Acevedo-Melo, Andrés Mauricio/0000-0003-4878-9541; Orozco Castaño, Carlos Alberto/0000-0002-7256-0942; Torres, Maria/0000-0001-7033-0097; Groot, Helena/0000-0002-9152-2175; Quijano, Sandra/0000-0003-4452-9291; Quintero Vega, Guillermo Enrique/0000-0002-3671-6911	FPIT - Foundation for the promotion of the research and the technology; Republic Bank of Colombia	FPIT - Foundation for the promotion of the research and the technology; Republic Bank of Colombia	This work was supported by FPIT - Foundation for the promotion of the research and the technology, Republic Bank of Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antica M, 2008, BLOOD, V111, P3296, DOI 10.1182/blood-2007-12-125682; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caballero R, 2007, J CELL SCI, V120, P2619, DOI 10.1242/jcs.007344; Cobb BS, 2005, CURR TOP MICROBIOL, V290, P29; Cortes M, 1999, CURR OPIN IMMUNOL, V11, P167, DOI 10.1016/S0952-7915(99)80028-4; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Francis Olivia L, 2011, World J Biol Chem, V2, P119, DOI 10.4331/wjbc.v2.i6.119; Fujii K, 2003, BRIT J HAEMATOL, V120, P986, DOI 10.1046/j.1365-2141.2003.04216.x; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; Iacobucci I, 2008, HAEMATOL-HEMATOL J, V93, P1814, DOI 10.3324/haematol.13260; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; John LB, 2011, MOL IMMUNOL, V48, P1272, DOI 10.1016/j.molimm.2011.03.006; Kelley CM, 1998, CURR BIOL, V8, P508, DOI 10.1016/S0960-9822(98)70202-7; Kirstetter P, 2002, EUR J IMMUNOL, V32, P720, DOI 10.1002/1521-4141(200203)32:3<720::AID-IMMU720>3.0.CO;2-P; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Molnar A, 1996, J IMMUNOL, V156, P585; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Nakase K, 2002, EXP HEMATOL, V30, P313, DOI 10.1016/S0301-472X(01)00796-2; Nakase K, 2000, CANCER RES, V60, P4062; Nakayama H, 1999, CANCER RES, V59, P3931; Oberdoerffer S, 2012, TRANSCR-AUSTIN, V3, P106, DOI 10.4161/trns.19816; Olivero S, 2000, BRIT J HAEMATOL, V110, P826, DOI 10.1046/j.1365-2141.2000.02297.x; Payne KJ, 2003, J IMMUNOL, V170, P3091, DOI 10.4049/jimmunol.170.6.3091; Rebollo A, 2003, IMMUNOL CELL BIOL, V81, P171, DOI 10.1046/j.1440-1711.2003.01159.x; Ruiz A, 2004, BRIT J HAEMATOL, V125, P31, DOI 10.1111/j.1365-2141.2004.04854.x; Sun L, 1999, CLIN CANCER RES, V5, P2112; Sun L, 1999, P NATL ACAD SCI USA, V96, P680, DOI 10.1073/pnas.96.2.680; Sun L, 1999, J CLIN ONCOL, V17, P3753, DOI 10.1200/JCO.1999.17.12.3753; Sun L, 2002, LEUKEMIA LYMPHOMA, V43, P841, DOI 10.1080/10428190290016980; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Westman BJ, 2002, INT J BIOCHEM CELL B, V34, P1304, DOI 10.1016/S1357-2725(02)00070-5; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Yagi T, 2002, BLOOD, V99, P1350, DOI 10.1182/blood.V99.4.1350	39	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82411	10.1371/journal.pone.0082411	http://dx.doi.org/10.1371/journal.pone.0082411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324784	Green Submitted, Green Published, gold			2022-12-25	WOS:000328566700078
J	Tchioffo, MT; Boissiere, A; Churcher, TS; Abate, L; Gimonneau, G; Nsango, SE; Awono-Ambene, PH; Christen, R; Berry, A; Morlais, I				Tchioffo, Majoline T.; Boissiere, Anne; Churcher, Thomas S.; Abate, Luc; Gimonneau, Geoffrey; Nsango, Sandrine E.; Awono-Ambene, Parfait H.; Christen, Richard; Berry, Antoine; Morlais, Isabelle			Modulation of Malaria Infection in Anopheles gambiae Mosquitoes Exposed to Natural Midgut Bacteria	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; SPOROGONIC DEVELOPMENT; VERTICAL TRANSMISSION; INDEPENDENT METHODS; DIVERSITY; CULICIDAE; PARASITE; DIPTERA; MICROBIOTA; SYMBIONTS	The development of Plasmodium falciparum within the Anopheles gambiae mosquito relies on complex vector-parasite interactions, however the resident midgut microbiota also plays an important role in mediating parasite infection. In natural conditions, the mosquito microbial flora is diverse, composed of commensal and symbiotic bacteria. We report here the isolation of culturable midgut bacteria from mosquitoes collected in the field in Cameroon and their identification based on the 16S rRNA gene sequencing. We next measured the effect of selected natural bacterial isolates on Plasmodium falciparum infection prevalence and intensity over multiple infectious feedings and found that the bacteria significantly reduced the prevalence and intensity of infection. These results contrast with our previous study where the abundance of Enterobacteriaceae positively correlated with P. falciparum infection (Boissiere et al. 2012). The oral infection of bacteria probably led to the disruption of the gut homeostasis and activated immune responses, and this pinpoints the importance of studying microbe-parasite interactions in natural conditions. Our results indicate that the effect of bacterial exposure on P. falciparum infection varies with factors from the parasite and the human host and calls for deeper dissection of these parameters for accurate interpretation of bacterial exposure results in laboratory settings.	[Tchioffo, Majoline T.; Boissiere, Anne; Abate, Luc; Gimonneau, Geoffrey; Morlais, Isabelle] UMR MIVEGEC IRD 224 CNRS 5290 UM1 UM2, Inst Rech Dev, Montpellier, France; [Tchioffo, Majoline T.; Gimonneau, Geoffrey; Nsango, Sandrine E.; Awono-Ambene, Parfait H.; Morlais, Isabelle] Org Coordinat Lutte Endemies Afrique Cent, Lab Entomol Med, Yaounde, Cameroon; [Churcher, Thomas S.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Nsango, Sandrine E.] Univ Douala, Fac Med & Sci Pharmaceut, Douala, Cameroon; [Christen, Richard] Univ Nice, CNRS UMR 7138, Fac Sci, Nice, France; [Christen, Richard] Univ Nice, Fac Sci, Lab Biol Virtuelle, UMR 713, Nice, France; [Berry, Antoine] Hop Rangueil, Ctr Hosp Univ Toulouse, Serv Parasitol Mycol, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Imperial College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU de Toulouse	Morlais, I (corresponding author), UMR MIVEGEC IRD 224 CNRS 5290 UM1 UM2, Inst Rech Dev, Montpellier, France.	isabelle.morlais@ird.fr	Morlais, Isabelle/Q-2171-2019; Gimonneau, Geoffrey/C-1681-2013; Berry, Antoine/J-9352-2014; BOISSIERE, Anne/ABB-5669-2020; Morlais, Isabelle/F-5078-2014	Morlais, Isabelle/0000-0002-2962-7670; Morlais, Isabelle/0000-0002-2962-7670; BOISSIERE, Anne/0000-0003-3958-2602; Christen, Richard/0000-0002-3396-4362; abate, luc/0000-0003-3973-3036; Gimonneau, Geoffrey/0000-0002-0613-841X; Churcher, Thomas/0000-0002-8442-0525; Berry, Antoine/0000-0002-6626-7766	Institut de Recherche pour le Developpement (IRD); Agence Nationale de la Recherche [ANR-11-BSV7-009-01]; APEGE programme from the Institut Ecologie et Environnement; European Union [242095- EVIMalaR, 223601- MALVECBLOK]; Infectiopole Sud foundation; IRD; Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI	Institut de Recherche pour le Developpement (IRD); Agence Nationale de la Recherche(French National Research Agency (ANR)); APEGE programme from the Institut Ecologie et Environnement; European Union(European Commission); Infectiopole Sud foundation; IRD; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by funds from the Institut de Recherche pour le Developpement (IRD), the Agence Nationale de la Recherche (grant awarded to IM, ANR-11-BSV7-009-01), the APEGE programme from the Institut Ecologie et Environnement and the European Union Seventh Framework Programme (FP7) (grant agreements No 242095- EVIMalaR and No 223601- MALVECBLOK). MTT and SEN were supported by a fellowship from the Infectiopole Sud foundation and GG from the IRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrisano F, 2012, INT J PARASITOL, V42, P519, DOI 10.1016/j.ijpara.2012.02.004; Bando H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01641; BEIER MS, 1994, J MED ENTOMOL, V31, P561, DOI 10.1093/jmedent/31.4.561; Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241; Boissiere A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054820; Boissiere A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002742; Boudin C, 2005, AM J TROP MED HYG, V73, P1090, DOI 10.4269/ajtmh.2005.73.1090; Bousema T, 2013, TRENDS PARASITOL, V29, P53, DOI 10.1016/j.pt.2012.11.004; Bousema T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042821; Chavshin AR, 2012, ACTA TROP, V121, P129, DOI 10.1016/j.actatropica.2011.10.015; Churcher TS, 2012, INT J PARASITOL, V42, P1037, DOI 10.1016/j.ijpara.2012.09.002; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; da Mota FF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001631; DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Djadid ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028484; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Gaio Analiz de O, 2011, Parasit Vectors, V4, P105, DOI 10.1186/1756-3305-4-105; Geiger A, 2010, INT J SYST EVOL MICR, V60, P1261, DOI 10.1099/ijs.0.013441-0; Geiger A, 2011, MICROB ECOL, V62, P632, DOI 10.1007/s00248-011-9830-y; Geiger A, 2009, INFECT GENET EVOL, V9, P1364, DOI 10.1016/j.meegid.2009.09.013; Ghosh A, 2000, PARASITOL TODAY, V16, P196, DOI 10.1016/S0169-4758(99)01626-9; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371; Harris C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001112; Hosokawa T, 2007, MOL ECOL, V16, P5316, DOI 10.1111/j.1365-294X.2007.03592.x; Johnston GL, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003025; Kampfer P, 2011, INT J SYST EVOL MICR, V61, P2670, DOI 10.1099/ijs.0.026393-0; Kamdem C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039453; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Lindh JM, 2011, ANTON LEEUW INT J G, V99, P711, DOI 10.1007/s10482-010-9546-x; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Lowenberger CA, 1999, EXP PARASITOL, V91, P59, DOI 10.1006/expr.1999.4350; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Mendes AM, 2011, INFECT IMMUN, V79, P4708, DOI 10.1128/IAI.05647-11; Moll RM, 2001, J MED ENTOMOL, V38, P29, DOI 10.1603/0022-2585-38.1.29; Moro CV, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-70; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; MURRELL P, 2009, J STAT SOFTW, V30, P1; Nsango SE, 2012, INT J PARASITOL, V42, P589, DOI 10.1016/j.ijpara.2012.03.008; Oksanen J., 2013, R PACKAGE VERSION 23, V2; Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; PUMPUNI CB, 1993, EXP PARASITOL, V77, P195, DOI 10.1006/expr.1993.1076; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; ROBERT V, 1993, ANN SOC BELG MED TR, V73, P71; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; Sinden RE, 2007, PLOS PATHOG, V3, P2005, DOI 10.1371/journal.ppat.0030195; Skaug H, 2012, GLMMADMB GEN LINEAR; Straif SC, 1998, J MED ENTOMOL, V35, P222, DOI 10.1093/jmedent/35.3.222; Team RDC, 2012, R LANG ENV STAT COMP; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	57	49	49	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81663	10.1371/journal.pone.0081663	http://dx.doi.org/10.1371/journal.pone.0081663			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324714	gold, Green Submitted, Green Published			2022-12-25	WOS:000328566700049
J	Thamm, M; Rolke, D; Jordan, N; Balfanz, S; Schiffer, C; Baumann, A; Blenau, W				Thamm, Markus; Rolke, Daniel; Jordan, Nadine; Balfanz, Sabine; Schiffer, Christian; Baumann, Arnd; Blenau, Wolfgang			Function and Distribution of 5-HT2 Receptors in the Honeybee (Apis mellifera)	PLOS ONE			English	Article							D2-LIKE DOPAMINE-RECEPTOR; BIOGENIC-AMINE RECEPTORS; DIVISION-OF-LABOR; SEROTONIN RECEPTOR; DROSOPHILA-MELANOGASTER; HYPOPHARYNGEAL GLAND; DECAPOD CRUSTACEANS; MOLECULAR-BIOLOGY; EXPRESSION; VARIANT	Background: Serotonin plays a pivotal role in regulating and modulating physiological and behavioral processes in both vertebrates and invertebrates. In the honeybee (Apis mellifera), serotonin has been implicated in division of labor, visual processing, and learning processes. Here, we present the cloning, heterologous expression, and detailed functional and pharmacological characterization of two honeybee 5-HT2 receptors. Methods: Honeybee 5-HT2 receptor cDNAs were amplified from brain cDNA. Recombinant cell lines were established constitutively expressing receptor variants. Pharmacological properties of the receptors were investigated by Ca2+ imaging experiments. Quantitative PCR was applied to explore the expression patterns of receptor mRNAs. Results: The honeybee 5-HT2 receptor class consists of two subtypes, Am5-HT2 alpha and Am5-HT2 beta. Each receptor gene also gives rise to alternatively spliced mRNAs that possibly code for truncated receptors. Only activation of the full-length receptors with serotonin caused an increase in the intracellular Ca2+ concentration. The effect was mimicked by the agonists 5-methoxytryptamine and 8-OH-DPAT at low micromolar concentrations. Receptor activities were blocked by established 5-HT receptor antagonists such as clozapine, methiothepin, or mianserin. High transcript numbers were detected in exocrine glands suggesting that 5-HT2 receptors participate in secretory processes in the honeybee. Conclusions: This study marks the first molecular and pharmacological characterization of two 5-HT2 receptor subtypes in the same insect species. The results presented should facilitate further attempts to unravel central and peripheral effects of serotonin mediated by these receptors.	[Thamm, Markus; Rolke, Daniel; Blenau, Wolfgang] Univ Potsdam, Dept Biol & Biochem, Potsdam, Germany; [Jordan, Nadine; Balfanz, Sabine; Schiffer, Christian; Baumann, Arnd] Res Ctr Julich, Inst Complex Syst ICS 4, Julich, Germany; [Blenau, Wolfgang] Goethe Univ Frankfurt, Polytech Gesell, Inst Bienenkunde, Oberursel, Germany	University of Potsdam; Helmholtz Association; Research Center Julich; Goethe University Frankfurt	Blenau, W (corresponding author), Univ Potsdam, Dept Biol & Biochem, Potsdam, Germany.	Blenau@bio.uni-frankfurt.de	Thamm, Markus/AAO-1678-2021; Baumann, Arnd/I-7941-2013; Blenau, Wolfgang/A-4304-2010	Thamm, Markus/0000-0003-0480-2206; Baumann, Arnd/0000-0001-9456-7275; Blenau, Wolfgang/0000-0002-6874-4730; Balfanz, Sabine/0000-0002-7082-3999	German Science Foundation [BL 469/7-1]	German Science Foundation(German Research Foundation (DFG))	This work was supported by the German Science Foundation (Grant BL 469/7-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balfanz S, 2012, INSECT BIOCHEM MOLEC, V42, P435, DOI 10.1016/j.ibmb.2012.02.005; Beggs KT, 2005, INSECT BIOCHEM MOLEC, V35, P873, DOI 10.1016/j.ibmb.2005.03.005; Beggs KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026809; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Blenau W, 2001, ARCH INSECT BIOCHEM, V48, P13, DOI 10.1002/arch.1055; Blenau W, 2000, J NEUROCHEM, V74, P900, DOI 10.1046/j.1471-4159.2000.0740900.x; Blenau W, 1998, J NEUROCHEM, V70, P15; Blenau W., 2013, SEROTONIN INSECTS DI, P1; Blenau W, 2011, ARTHROPOD STRUCT DEV, V40, P381, DOI 10.1016/j.asd.2011.01.004; Canton H, 1996, MOL PHARMACOL, V50, P799; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Clark MC, 2004, J NEUROSCI, V24, P3421, DOI 10.1523/JNEUROSCI.0062-04.2004; COLAS JF, 1995, P NATL ACAD SCI USA, V92, P5441, DOI 10.1073/pnas.92.12.5441; Colas JF, 1999, MECH DEVELOP, V87, P77, DOI 10.1016/S0925-4773(99)00141-0; Deseyn J, 2005, APIDOLOGIE, V36, P49, DOI 10.1051/apido:2004068; Drapeau MD, 2006, GENOME RES, V16, P1385, DOI 10.1101/gr.5012006; Ellen CW, 2012, J MOL HISTOL, V43, P401, DOI 10.1007/s10735-012-9401-7; Goldman TD, 2007, PLOS GENET, V3, P2278, DOI 10.1371/journal.pgen.0030216; Grohmann L, 2003, J NEUROCHEM, V86, P725, DOI 10.1046/j.1471-4159.2003.01876.x; Guest PC, 2000, BRAIN RES, V876, P238, DOI 10.1016/S0006-8993(00)02664-0; Hannon J, 2008, BEHAV BRAIN RES, V195, P198, DOI 10.1016/j.bbr.2008.03.020; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Huang XY, 2002, J NEUROCHEM, V83, P249, DOI 10.1046/j.1471-4159.2002.01067.x; Humphries MA, 2003, J NEUROBIOL, V55, P315, DOI 10.1002/neu.10209; Jones BJ, 2002, PHARMACOL BIOCHEM BE, V71, P555, DOI 10.1016/S0091-3057(01)00745-6; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kilpatrick GJ, 2000, TRENDS PHARMACOL SCI, V20, P294; Komuniecki RW, 2004, MOL BIOCHEM PARASIT, V137, P1, DOI 10.1016/j.molbiopara.2004.05.010; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kristiansen K, 2000, J PHARMACOL EXP THER, V293, P735; Lee SP, 2000, MOL PHARMACOL, V58, P120, DOI 10.1124/mol.58.1.120; Maleszka R, 2008, EPIGENETICS-US, V3, P188, DOI 10.4161/epi.3.4.6697; MORO O, 1993, J BIOL CHEM, V268, P22273; Mustard JA, 2003, MOL BRAIN RES, V113, P67, DOI 10.1016/S0169-328X(03)00091-3; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; Ohashi K, 2000, ZOOL SCI, V17, P1089, DOI 10.2108/zsj.17.1089; Pytliak M, 2011, PHYSIOL RES, V60, P15, DOI 10.33549/physiolres.931903; Roser C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049459; SAUDOU F, 1992, EMBO J, V11, P7, DOI 10.1002/j.1460-2075.1992.tb05021.x; Schaerlinger B, 2007, DEV DYNAM, V236, P991, DOI 10.1002/dvdy.21110; Scheiner R, 2006, CURR NEUROPHARMACOL, V4, P259, DOI 10.2174/157015906778520791; Schlenstedt J, 2006, J NEUROCHEM, V98, P1985, DOI 10.1111/j.1471-4159.2006.04012.x; Schulz DJ, 1999, J COMP PHYSIOL A, V184, P481, DOI 10.1007/s003590050348; SCHURMANN FW, 1984, J COMP NEUROL, V225, P570, DOI 10.1002/cne.902250407; Seidel C, 1996, TISSUE CELL, V28, P663, DOI 10.1016/S0040-8166(96)80070-X; Spitzer N, 2008, J EXP BIOL, V211, P92, DOI 10.1242/jeb.012450; Sugiura M, 2005, J NEUROCHEM, V94, P1146, DOI 10.1111/j.1471-4159.2005.03268.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor DJ, 1996, J COMP PHYSIOL A, V170, P715; Thamm M, 2010, CELL MOL LIFE SCI, V67, P2467, DOI 10.1007/s00018-010-0350-6; Wagener-Hulme C, 1999, J COMP PHYSIOL A, V184, P471, DOI 10.1007/s003590050347; Wang J, 2003, NAT REV GENET, V4, P741, DOI 10.1038/nrg1160; Wang QD, 2000, J NEUROCHEM, V74, P1290; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WITZ P, 1990, P NATL ACAD SCI USA, V87, P8940, DOI 10.1073/pnas.87.22.8940; Wright GA, 2011, COMMUN INTEGR BIOL, V4, P18; Wright GA, 2010, CURR BIOL, V20, P2234, DOI 10.1016/j.cub.2010.11.040	57	29	31	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82407	10.1371/journal.pone.0082407	http://dx.doi.org/10.1371/journal.pone.0082407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324783	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700077
J	Tomar, N; De, RK				Tomar, Namrata; De, Rajat K.			A Model of an Integrated Immune System Pathway in Homo sapiens and Its Interaction with Superantigen Producing Expression Regulatory Pathway in Staphylococcus aureus: Comparing Behavior of Pathogen Perturbed and Unperturbed Pathway	PLOS ONE			English	Article							T-CELL-RECEPTOR; NF-KAPPA-B; PROTEIN-KINASE-C; TUMOR-NECROSIS-FACTOR; TOXIC-SHOCK-SYNDROME; MEDIATED SIGNAL-TRANSDUCTION; CLASS-II MOLECULES; ENTEROTOXIN-B; CBL-B; TYROSINE KINASE	Response of an immune system to a pathogen attack depends on the balance between the host immune defense and the virulence of the pathogen. Investigation of molecular interactions between the proteins of a host and a pathogen helps in identifying the pathogenic proteins. It is necessary to understand the dynamics of a normally behaved host system to evaluate the capacity of its immune system upon pathogen attack. In this study, we have compared the behavior of an unperturbed and pathogen perturbed host system. Moreover, we have developed a formalism under Flux Balance Analysis (FBA) for the optimization of conflicting objective functions. We have constructed an integrated pathway system, which includes Staphylococcal Superantigen (SAg) expression regulatory pathway and TCR signaling pathway of Homo sapiens. We have implemented the method on this pathway system and observed the behavior of host signaling molecules upon pathogen attack. The entire study has been divided into six different cases, based on the perturbed/unperturbed conditions. In other words, we have investigated unperturbed and pathogen perturbed human TCR signaling pathway, with different combinations of optimization of concentrations of regulatory and signaling molecules. One of these cases has aimed at finding out whether minimization of the toxin production in a pathogen leads to the change in the concentration levels of the proteins coded by TCR signaling pathway genes in the infected host. Based on the computed results, we have hypothesized that the balance between TCR signaling inhibitory and stimulatory molecules can keep TCR signaling system into resting/stimulating state, depending upon the perturbation. The proposed integrated host-pathogen interaction pathway model has accurately reflected the experimental evidences, which we have used for validation purpose. The significance of this kind of investigation lies in revealing the susceptible interaction points that can take back the Staphylococcal Enterotoxin (SE)-challenged system within the range of normal behavior.	[Tomar, Namrata; De, Rajat K.] Indian Stat Inst, Machine Intelligence Unit, Kolkata, India	Indian Statistical Institute; Indian Statistical Institute Kolkata	De, RK (corresponding author), Indian Stat Inst, Machine Intelligence Unit, Kolkata, India.	rajat@isical.ac.in			CSIR, India [9/93 (0145)/12, EMR-I]	CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	Ms. Namrata Tomar, one of the authors, gratefully acknowledges CSIR, India for providing her a Senior Research Fellowship (9/93 (0145)/12, EMR-I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann L, 1998, IMMUNOLOGY, V94, P247, DOI 10.1046/j.1365-2567.1998.00508.x; Aktories K, 1997, TRENDS MICROBIOL, V5, P282, DOI 10.1016/S0966-842X(97)01067-6; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Baker JE, 2001, MOL CELL BIOL, V21, P2393, DOI 10.1128/MCB.21.7.2393-2403.2001; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; BAYLES KW, 1989, J BACTERIOL, V171, P4799, DOI 10.1128/jb.171.9.4799-4806.1989; Below S, 2009, AM J PHYSIOL-LUNG C, V296, pL470, DOI 10.1152/ajplung.90498.2008; Boerth NJ, 2000, J EXP MED, V192, P1047, DOI 10.1084/jem.192.7.1047; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; BUDAY L, 1994, J BIOL CHEM, V269, P9019; CARLSSON R, 1988, J IMMUNOL, V140, P2484; CHATILA T, 1993, IMMUNOL REV, V131, P43, DOI 10.1111/j.1600-065X.1993.tb01529.x; Che TJ, 2004, J BIOL CHEM, V279, P15870, DOI 10.1074/jbc.M310599200; CHEUNG AL, 1992, P NATL ACAD SCI USA, V89, P6462, DOI 10.1073/pnas.89.14.6462; Cheung AL, 2008, INT J BIOCHEM CELL B, V40, P355, DOI 10.1016/j.biocel.2007.10.032; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Chien YT, 1998, MOL MICROBIOL, V30, P991, DOI 10.1046/j.1365-2958.1998.01126.x; Chu PC, 2004, J IMMUNOL, V172, P7324, DOI 10.4049/jimmunol.172.12.7324; CLIPSTONE NA, 1993, ANN NY ACAD SCI, V696, P20; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012475; Davis SJ, 2003, NAT IMMUNOL, V4, P217, DOI 10.1038/ni0303-217; De RK, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-65; Dong S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015114; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Fawcett VCJ, 2005, J IMMUNOL, V174, P2849, DOI 10.4049/jimmunol.174.5.2849; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Fischetti V., 2006, GRAM POSITIVE PATHOG, V2nd; FLEISCHER B, 1988, J EXP MED, V167, P1697, DOI 10.1084/jem.167.5.1697; FLORQUIN S, 1995, EUR J IMMUNOL, V25, P1148, DOI 10.1002/eji.1830250503; FULEIHAN R, 1991, J IMMUNOL, V146, P1661; Fumanelli L, 2011, J THEOR BIOL, V270, P19, DOI 10.1016/j.jtbi.2010.11.018; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Ganguly U, 2001, FEMS MICROBIOL LETT, V204, P65, DOI 10.1111/j.1574-6968.2001.tb10864.x; GAUR A, 1993, J IMMUNOL, V150, P3062; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; Gough SCL, 2005, IMMUNOL REV, V204, P102, DOI 10.1111/j.0105-2896.2005.00249.x; Gruber T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000046; Hanada T, 1997, J BIOL CHEM, V272, P26899, DOI 10.1074/jbc.272.43.26899; Hanlon A, 2005, IMMUNOLOGY, V116, P507, DOI 10.1111/j.1365-2567.2005.02252.x; Haykin S., 2001, NEURAL NETWORKS; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Hsieh HY, 2008, J BACTERIOL, V190, P546, DOI 10.1128/JB.00536-07; Hu D, 2007, HIROSAKI MED J, V59, pS219; IKEJIMA T, 1988, J INFECT DIS, V158, P1017, DOI 10.1093/infdis/158.5.1017; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Jacinto E, 1998, IMMUNITY, V8, P31, DOI 10.1016/S1074-7613(00)80456-2; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Jain R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-121; Janeway C., 2001, IMMUNOBIOLOGY, V5th; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Jelsbak L, 2010, INT J MED MICROBIOL, V300, P229, DOI 10.1016/j.ijmm.2009.07.003; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; JETT M, 1990, INFECT IMMUN, V58, P3494, DOI 10.1128/IAI.58.11.3494-3499.1990; Ji GY, 1995, P NATL ACAD SCI USA, V92, P12055, DOI 10.1073/pnas.92.26.12055; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; JOHNSON HM, 1991, FASEB J, V5, P2706, DOI 10.1096/fasebj.5.12.1916093; Jones R, 2000, J EXP MED, V191; JONSSON K, 1991, EUR J BIOCHEM, V202, P1041, DOI 10.1111/j.1432-1033.1991.tb16468.x; Junecko J.M., 2012, WORLD J CLIN INFECT, V2, P63, DOI [10.5495/wjcid.v2.i4.63, DOI 10.5495/WJCID.V2.I4.63]; Kane LP, 2002, TRENDS IMMUNOL, V23, P413, DOI 10.1016/S1471-4906(02)02264-0; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; KARNITZ L, 1992, MOL CELL BIOL, V12, P4521, DOI 10.1128/MCB.12.10.4521; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; Kimura M, 2000, INT IMMUNOL, V12, P817, DOI 10.1093/intimm/12.6.817; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Lemichez E, 2010, NAT REV MICROBIOL, V8, P93, DOI 10.1038/nrmicro2269; Li DM, 2008, INFECT IMMUN, V76, P1068, DOI 10.1128/IAI.01069-07; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; LIN YS, 1995, BIOCHEM BIOPH RES CO, V213, P1132, DOI 10.1006/bbrc.1995.2244; Llewelyn M, 2002, LANCET INFECT DIS, V2, P156, DOI 10.1016/S1473-3099(02)00222-0; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Makrogianneli K, 2009, MOL CELL BIOL, V29, P2997, DOI 10.1128/MCB.01008-08; MALCHIODI EL, 1995, J EXP MED, V182, P1833, DOI 10.1084/jem.182.6.1833; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; MATSUYAMA S, 1993, EUR J IMMUNOL, V23, P3194, DOI 10.1002/eji.1830231223; McNamara PJ, 2000, J BACTERIOL, V182, P3197, DOI 10.1128/JB.182.11.3197-3203.2000; Mele T, 2010, INT J BIOCHEM CELL B, V42, P1066, DOI 10.1016/j.biocel.2010.03.021; MIETHKE T, 1992, J EXP MED, V175, P91, DOI 10.1084/jem.175.1.91; MOLLICK JA, 1989, SCIENCE, V244, P817, DOI 10.1126/science.2658055; Mourad W, 1993, Semin Immunol, V5, P47, DOI 10.1006/smim.1993.1007; MURRAY JS, 1995, CELL IMMUNOL, V166, P9, DOI 10.1006/cimm.1995.0002; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Narayan P, 2006, MOL CELL BIOL, V26, P2327, DOI 10.1128/MCB.26.6.2327-2336.2006; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; NIELSEN M, 1995, P NATL ACAD SCI USA, V92, P10995, DOI 10.1073/pnas.92.24.10995; Novick RP, 2000, SCIENCE, V287, P391, DOI DOI 10.1126/SCIENCE.287.5452.391A; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; Otto M, 1998, FEBS LETT, V424, P89, DOI 10.1016/S0014-5793(98)00145-8; PALKAMA T, 1993, HUM IMMUNOL, V36, P259, DOI 10.1016/0198-8859(93)90133-L; Perez de Castro I, 2004, MOL CELL BIOL, V24, P3485, DOI 10.1128/MCB.24.8.3485-3496.2004; PONTZER CH, 1991, P NATL ACAD SCI USA, V88, P125, DOI 10.1073/pnas.88.1.125; Qi Q, 2007, SCI STKE, V396, P39; Rajagopalan G, 2006, SHOCK, V25, P647, DOI 10.1097/01.shk.0000209565.92445.7d; REGASSA LB, 1991, INFECT IMMUN, V59, P955, DOI 10.1128/IAI.59.3.955-962.1991; RELLAHAN BL, 1990, J EXP MED, V172, P1091, DOI 10.1084/jem.172.4.1091; Rink L, 1996, J INTERF CYTOK RES, V16, P41, DOI 10.1089/jir.1996.16.41; Said-Salim B, 2003, J BACTERIOL, V185, P610, DOI 10.1128/JB.185.2.610-619.2003; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Salojin KV, 1999, J IMMUNOL, V163, P844; Sankarshanan M, 2007, J IMMUNOL, V179, P483, DOI 10.4049/jimmunol.179.1.483; Schilling CH, 2000, J THEOR BIOL, V203, P229, DOI 10.1006/jtbi.2000.1073; Schultz H, 1996, IMMUNOLOGY, V87, P49; SETH A, 1994, NATURE, V369, P324, DOI 10.1038/369324a0; Shim EK, 2011, J IMMUNOL, V186, P2926, DOI 10.4049/jimmunol.1001785; SHIROO M, 1992, EMBO J, V11, P4887, DOI 10.1002/j.1460-2075.1992.tb05595.x; SPERTINI F, 1991, P NATL ACAD SCI USA, V88, P7533, DOI 10.1073/pnas.88.17.7533; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Sundstedt A, 1997, J IMMUNOL, V158, P180; Tanner MJ, 2007, J BIOL CHEM, V282, P17141, DOI 10.1074/jbc.M700169200; Thakar J, 2007, PLOS COMPUT BIOL, V3, P1022, DOI 10.1371/journal.pcbi.0030109; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; TOKURA Y, 1994, J INVEST DERMATOL, V102, P31, DOI 10.1111/1523-1747.ep12371727; Tseng CW, 2005, J BACTERIOL, V187, P5301, DOI 10.1128/JB.187.15.5301-5309.2005; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; WAKITA H, 1995, J INVEST DERMATOL, V105, P536, DOI 10.1111/1523-1747.ep12323426; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wang ZQ, 1998, IMMUNOLOGY, V94, P331, DOI 10.1046/j.1365-2567.1998.00519.x; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; Watson ARO, 2006, CELL IMMUNOL, V242, P80, DOI 10.1016/j.cellimm.2006.09.008; WEBB SR, 1994, CURR OPIN IMMUNOL, V6, P467, DOI 10.1016/0952-7915(94)90129-5; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; Wunderlich L, 1999, EUR J IMMUNOL, V29, P1068, DOI 10.1002/(SICI)1521-4141(199904)29:04<1068::AID-IMMU1068>3.0.CO;2-P; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044; Yablonski D, 1998, EMBO J, V17, P5647, DOI 10.1093/emboj/17.19.5647; Yan ZY, 1999, INFECT IMMUN, V67, P6611; Zhang SP, 2000, J BACTERIOL, V182, P2321, DOI 10.1128/JB.182.8.2321-2325.2000; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhao H, 1997, J BIOL CHEM, V272, P21625, DOI 10.1074/jbc.272.34.21625	140	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e80918	10.1371/journal.pone.0080918	http://dx.doi.org/10.1371/journal.pone.0080918			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324645	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700023
J	Wagatsuma, N; Potjans, TC; Diesmann, M; Sakai, K; Fukai, T				Wagatsuma, Nobuhiko; Potjans, Tobias C.; Diesmann, Markus; Sakai, Ko; Fukai, Tomoki			Spatial and Feature-Based Attention in a Layered Cortical Microcircuit Model	PLOS ONE			English	Article							VISUAL-CORTEX; RECEPTIVE-FIELDS; SELECTIVE ATTENTION; TARGET SELECTION; LOCAL CIRCUITS; NEURONS; CAT; SYNCHRONIZATION; ORIENTATION; CONNECTIONS	Directing attention to the spatial location or the distinguishing feature of a visual object modulates neuronal responses in the visual cortex and the stimulus discriminability of subjects. However, the spatial and feature-based modes of attention differently influence visual processing by changing the tuning properties of neurons. Intriguingly, neurons' tuning curves are modulated similarly across different visual areas under both these modes of attention. Here, we explored the mechanism underlying the effects of these two modes of visual attention on the orientation selectivity of visual cortical neurons. To do this, we developed a layered microcircuit model. This model describes multiple orientation-specific microcircuits sharing their receptive fields and consisting of layers 2/3, 4, 5, and 6. These microcircuits represent a functional grouping of cortical neurons and mutually interact via lateral inhibition and excitatory connections between groups with similar selectivity. The individual microcircuits receive bottom-up visual stimuli and top-down attention in different layers. A crucial assumption of the model is that feature-based attention activates orientation-specific microcircuits for the relevant feature selectively, whereas spatial attention activates all microcircuits homogeneously, irrespective of their orientation selectivity. Consequently, our model simultaneously accounts for the multiplicative scaling of neuronal responses in spatial attention and the additive modulations of orientation tuning curves in feature-based attention, which have been observed widely in various visual cortical areas. Simulations of the model predict contrasting differences between excitatory and inhibitory neurons in the two modes of attentional modulations. Furthermore, the model replicates the modulation of the psychophysical discriminability of visual stimuli in the presence of external noise. Our layered model with a biologically suggested laminar structure describes the basic circuit mechanism underlying the attention-mode specific modulations of neuronal responses and visual perception.	[Wagatsuma, Nobuhiko] Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA; [Wagatsuma, Nobuhiko] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD USA; [Wagatsuma, Nobuhiko; Diesmann, Markus; Fukai, Tomoki] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Potjans, Tobias C.] Res Ctr Juelich, Inst Neurosci & Med Computat & Syst Neurosci INM, Julich, Germany; [Wagatsuma, Nobuhiko; Potjans, Tobias C.; Fukai, Tomoki] RIKEN Computat Sci Res Program, Brain & Neural Syst Team, Wako, Saitama, Japan; [Potjans, Tobias C.] Univ Freiburg, Fac Biol 3, Freiburg, Germany; [Sakai, Ko] Univ Tsukuba, Dept Comp Sci, Tsukuba, Ibaraki, Japan; [Fukai, Tomoki] JST, CREST, Kawaguchi, Saitama, Japan	Johns Hopkins University; Johns Hopkins University; RIKEN; Helmholtz Association; Research Center Julich; RIKEN; University of Freiburg; University of Tsukuba; Japan Science & Technology Agency (JST)	Wagatsuma, N (corresponding author), Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA.	nwagatsuma@jhu.edu	Fukai, Tomoki/A-3936-2015; Diesmann, Markus/H-3722-2013	Fukai, Tomoki/0000-0001-6977-5638; Diesmann, Markus/0000-0002-2308-5727; Sakai, Ko/0000-0002-6960-1520	MEXT, Japan; EU (BrainScaleS) the Helmholtz Alliance on Systems Biology [269921];  [22115013]; Grants-in-Aid for Scientific Research [22300090] Funding Source: KAKEN	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); EU (BrainScaleS) the Helmholtz Alliance on Systems Biology; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grants-in-Aid for Scientific Research on Innovative Areas to TF (no. 22115013), the Next-Generation Supercomputer Project of MEXT, Japan, and EU Grant 269921 (BrainScaleS) the Helmholtz Alliance on Systems Biology to MD supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Ardid S, 2007, J NEUROSCI, V27, P8486, DOI 10.1523/JNEUROSCI.1145-07.2007; Ardid S, 2010, J NEUROSCI, V30, P2856, DOI 10.1523/JNEUROSCI.4222-09.2010; Armstrong KM, 2006, NEURON, V50, P791, DOI 10.1016/j.neuron.2006.05.010; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Boynton GM, 2005, CURR OPIN NEUROBIOL, V15, P465, DOI 10.1016/j.conb.2005.06.009; Buehlmann A, 2008, J NEUROSCI, V28, P7679, DOI 10.1523/JNEUROSCI.5640-07.2008; Buia C, 2006, J COMPUT NEUROSCI, V20, P247, DOI 10.1007/s10827-006-6358-0; Buia CI, 2008, J NEUROPHYSIOL, V99, P2158, DOI 10.1152/jn.01004.2007; CALLAWAY EM, 1991, P NATL ACAD SCI USA, V88, P745, DOI 10.1073/pnas.88.3.745; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Chalupa L.M., 2004, VISUAL NEUROSCIENCES; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Cohen MR, 2011, NEURON, V70, P1192, DOI 10.1016/j.neuron.2011.04.029; Compte A, 2006, CEREB CORTEX, V16, P761, DOI 10.1093/cercor/bhj021; Dakin SC, 2005, VISION RES, V45, P3027, DOI 10.1016/j.visres.2005.07.037; Deco G, 2004, EUR J NEUROSCI, V20, P1089, DOI 10.1111/j.1460-9568.2004.03528.x; Deco G, 2011, EUR J NEUROSCI, V34, P146, DOI 10.1111/j.1460-9568.2011.07749.x; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; Dosher BA, 1999, VISION RES, V39, P3197, DOI 10.1016/S0042-6989(99)00059-0; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fitzpatrick D, 1996, CEREB CORTEX, V6, P329, DOI 10.1093/cercor/6.3.329; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Gewaltig MO, 2007, SCHOLARPEDIA, V2, P1430, DOI [DOI 10.4249/SCH0LARPEDIA.1430, 10.4249/scholarpedia.1430, DOI 10.4249/SCHOLARPEDIA.1430]; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Green DM, 1966, SIGNAL DETECTION THE; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Holm L, 2008, J VISION, V8, DOI 10.1167/8.4.14; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Lee HL, 2013, PLOS COMPUT BIOL, V9, DOI [10.1371/journal.pcbi.1003164, DOI 10.1371/J0URNAL.PCBI.1003164]; Lewis TJ, 2003, J COMPUT NEUROSCI, V14, P283, DOI 10.1023/A:1023265027714; Ling S, 2009, VISION RES, V49, P1194, DOI 10.1016/j.visres.2008.05.025; Liu TS, 2007, VISION RES, V47, P108, DOI 10.1016/j.visres.2006.09.017; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mancilla JG, 2007, J NEUROSCI, V27, P2058, DOI 10.1523/JNEUROSCI.2715-06.2007; Mansouri B, 2006, VISION RES, V46, P4104, DOI 10.1016/j.visres.2006.07.017; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Mihalas S, 2011, P NATL ACAD SCI USA, V108, P7583, DOI 10.1073/pnas.1014655108; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Morgan M, 2008, J VISION, V8, DOI 10.1167/8.11.9; MORRONE MC, 1987, EXP BRAIN RES, V67, P635; Murphy BK, 2003, J NEUROSCI, V23, P10040; Nomura M, 2003, NEURAL COMPUT, V15, P2179, DOI 10.1162/089976603322297340; Noudoost B, 2010, CURR OPIN NEUROBIOL, V20, P183, DOI 10.1016/j.conb.2010.02.003; Ogawa T, 2004, J NEUROSCI, V24, P6371, DOI 10.1523/JNEUROSCI.0569-04.2004; Ogawa T, 2009, J NEUROPHYSIOL, V101, P721, DOI 10.1152/jn.90817.2008; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohtsuki G, 2012, NEURON, V75, P65, DOI 10.1016/j.neuron.2012.05.023; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Peters A, 1994, CEREBRAL CORTEX PRIM; Peters RJ, 2005, VISION RES, V45, P2397, DOI 10.1016/j.visres.2005.03.019; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Potjans TC, 2014, CEREB CORTEX, V24, P785, DOI 10.1093/cercor/bhs358; Reid AT, 2009, NEUROIMAGE, V47, P611, DOI 10.1016/j.neuroimage.2009.04.061; Reynolds JH, 2003, NEURON, V37, P853, DOI 10.1016/S0896-6273(03)00097-7; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2008, NAT NEUROSCI, V11, P861, DOI 10.1038/nn0808-861; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rolls ET, 2002, COMPUTATIONAL NEUROS; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; Smith MA, 2006, J NEUROSCI, V26, P4826, DOI 10.1523/JNEUROSCI.5542-06.2006; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Sommer MA, 2007, NEURON, V55, P6, DOI 10.1016/j.neuron.2007.06.022; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 2002, J NEUROCYTOL, V31, P239, DOI 10.1023/A:1024117908539; Tiesinga P, 2009, NEURON, V63, P727, DOI 10.1016/j.neuron.2009.09.009; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Tzvetanov T, 2006, VISION RES, V46, P3651, DOI 10.1016/j.visres.2006.05.018; Wagatsuma N, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00123; Wagatsuma Nobuhiko, 2011, Front Comput Neurosci, V5, P31, DOI 10.3389/fncom.2011.00031; Wagatsuma N, 2008, J VISION, V8, DOI 10.1167/8.7.22; Wang CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062379; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Yoshida M, 2012, CURR BIOL, V22, P1429, DOI 10.1016/j.cub.2012.05.046	86	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e80788	10.1371/journal.pone.0080788	http://dx.doi.org/10.1371/journal.pone.0080788			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324628	Green Published, gold, Green Submitted			2022-12-25	WOS:000328566700015
J	Ali, MM; Minor, T; Amialchuk, A				Ali, Mir M.; Minor, Travis; Amialchuk, Aliaksandr			Estimating the Biases Associated with Self-Perceived, Self-Reported, and Measured BMI on Mental Health	PLOS ONE			English	Article							BODY-MASS INDEX; OBESITY; ADOLESCENTS; WEIGHT; DEPRESSION; RISK	Purpose: The purpose of the study is to explore the relationship between individuals' perceptions of their weight-status, self-reported height and weight, and measured weight status. Methods: A national survey of 9,248 adolescents (47% male) between the ages of 11 and 27 is analyzed to determine whether inaccuracies in reporting are caused by misperception or conscious intent, and whether there tends to be a systematic bias in how individuals self-report. Self-esteem was used as an example of an important outcome variable in order to illustrate the magnitudes of the biases that may arise when using different measures of body size. Results: Our results indicate that measured obesity status is associated with the reduction in Rosenberg Self-Esteem (RSE) of 0.30 points (p-value 0.005) among adolescents and 0.20 points (p-value 0.002) among young adults; in addition, using self-reported height and weight as opposed to measured height and weight does not result in a statistically detectable difference in the estimates. Conclusions: Individuals' self-reports of height and weight are not as unreliable as we might have expected. Although estimates from measured height and weight are preferred, in the absence of such measures, self-reported measures would likely be a reliable alternative. The differences in self-perception of weight status, however, imply that it is not comparable to measured weight categories.	[Ali, Mir M.] Subst Abuse & Mental Hlth Serv Adm, Anal & Serv Res Branch, Rockville, MD USA; [Minor, Travis] US FDA, Off Regulat Policy & Social Sci, College Pk, MD USA; [Amialchuk, Aliaksandr] Univ Toledo, Dept Econ, Toledo, OH 43606 USA	US Food & Drug Administration (FDA); University of Toledo	Ali, MM (corresponding author), Subst Abuse & Mental Hlth Serv Adm, Anal & Serv Res Branch, Rockville, MD USA.	mir.ali@samhsa.hhs.gov		Minor, Travis/0000-0002-5297-7695	National Institute of Child Health and Human Development [P01-HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The views expressed here are those of the authors and do not necessarily reflect the views of the Substance Abuse & Mental Health Services Administration or the Food & Drug Administration. This research uses data from Add Health, a program project designed by J. Richard Udry Peter S. Bearman, and Kathleen Mullan Harris, and funded by a grant P01-HD31921 from the National Institute of Child Health and Human Development, with cooperative funding from 17 other agencies. Special acknowledgment is due Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design. Persons interested in obtaining data files from Add Health should contact Add Health, Carolina Population Center, 123 W. Franklin Street, Chapel Hill, NC 27516-2524 (addhealth@unc.edu).	Ali MM, 2011, SOUTH ECON J, V77, P827, DOI 10.4284/0038-4038-77.4.827; Ali MM, 2010, J MENT HEALTH POLICY, V13, P53; Burkhauser R, 2007, IMPORTANCE OBJECTIVE; Cawley J, 2010, HEALTH AFFAIR, V29, P364, DOI 10.1377/hlthaff.2009.0721; CHOW GC, 1960, ECONOMETRICA, V28, P591, DOI 10.2307/1910133; Gariepy G, 2010, INT J OBESITY, V34, P407, DOI 10.1038/ijo.2009.252; Goodman E, 2002, PEDIATRICS, V110, P497, DOI 10.1542/peds.110.3.497; Goodman E, 2000, PEDIATRICS, V106, P52, DOI 10.1542/peds.106.1.52; Han TS, 1998, AM J PUBLIC HEALTH, V88, P1814, DOI 10.2105/AJPH.88.12.1814; Liechty JM, 2010, J ADOLESCENT HEALTH, V47, P176, DOI 10.1016/j.jadohealth.2010.01.004; Merrill RM, 2009, PREV CHRONIC DIS, V6; Nelson MC, 2006, PEDIATRICS, V117, P1281, DOI 10.1542/peds.2005-1692; Odone A, 2014, EUR J CANCER PREV, V23, P141, DOI 10.1097/CEJ.0b013e32836014dd; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Shrier LA, 2001, PREV MED, V33, P179, DOI 10.1006/pmed.2001.0869	17	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81021	10.1371/journal.pone.0081021	http://dx.doi.org/10.1371/journal.pone.0081021			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	265KD	24324658	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300067
J	Eiriksdottir, VH; Asgeirsdottir, TL; Bjarnadottir, RI; Kaestner, R; Cnattingius, S; Valdimarsdottir, UA				Eiriksdottir, Vedis Helga; Asgeirsdottir, Tinna Laufey; Bjarnadottir, Ragnheiour Ingibjorg; Kaestner, Robert; Cnattingius, Sven; Valdimarsdottir, Unnur Anna			Low Birth Weight, Small for Gestational Age and Preterm Births before and after the Economic Collapse in Iceland: A Population Based Cohort Study	PLOS ONE			English	Article							MATERNAL EXPOSURE; LIFE EVENTS; PREGNANCY COMPLICATIONS; STRESS; OUTCOMES; UNEMPLOYMENT; EMPLOYMENT; INFANT; HEALTH; FETAL	Objective: Infants born small for gestational age (SGA) or preterm have increased rates of perinatal morbidity and mortality. Stressful events have been suggested as potential contributors to preterm birth (PB) and low birth weight (LBW). We studied the effect of the 2008 economic collapse in Iceland on the risks of adverse birth outcomes. Study design: The study population constituted all Icelandic women giving birth to live-born singletons from January 1st 2006 to December 31st 2009. LBW infants were defined as those weighing <2500 grams at birth, PB infants as those born before 37 weeks of gestation and SGA as those with a birth weight for gestational age more than 2 standard deviations (SD's) below the mean according to the Swedish fetal growth curve. We used logistic regression analysis to estimate odds ratios [OR] and corresponding 95 percent confidence intervals [95% CI] of adverse birth outcomes by exposure to calendar time of the economic collapse, i.e. after October 6th 2008. Results: Compared to the preceding period, we observed an increased adjusted odds in LBW-deliveries following the collapse (aOR = 1.24, 95% CI [1.02, 1.52]), particularly among infants born to mothers younger than 25 years (aOR = 1.85, 95% CI [1.25, 2.72]) and not working mothers (aOR = 1.61, 95% CI [1.10, 2.35]). Similarly, we found a tendency towards higher incidence of SGA-births (aOR = 1.14, 95% CI [0.86, 1.51]) particularly among children born to mothers younger than 25 years (aOR = 1.87, 95% CI [1.09, 3.23]) and not working mothers (aOR = 1.86, 95% CI [1.09, 3.17]). No change in risk of PB was observed. The increase of LBW was most distinct 6-9 months after the collapse. Conclusion: The results suggest an increase in risk of LBW shortly after the collapse of the Icelandic national economy. The increase in LBW seems to be driven by reduced fetal growth rate rather than shorter gestation.	[Eiriksdottir, Vedis Helga; Valdimarsdottir, Unnur Anna] Univ Iceland, Ctr Publ Hlth Sci, Reykjavik, Iceland; [Asgeirsdottir, Tinna Laufey] Univ Iceland, Dept Econ, Reykjavik, Iceland; [Bjarnadottir, Ragnheiour Ingibjorg] Landspitali Univ Hosp, Dept Obstet & Gynecol, Reykjavik, Iceland; [Kaestner, Robert] Univ Illinois, Dept Econ, Chicago, IL 60680 USA; [Kaestner, Robert] Univ Illinois, Inst Govt & Publ Affairs, Chicago, IL 60680 USA; [Cnattingius, Sven] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Valdimarsdottir, Unnur Anna] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	University of Iceland; University of Iceland; Landspitali National University Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Karolinska Institutet; Harvard University; Harvard T.H. Chan School of Public Health	Eiriksdottir, VH (corresponding author), Univ Iceland, Ctr Publ Hlth Sci, Reykjavik, Iceland.	vedis.helga@gmail.com	Eiriksdottir, Vedis/M-1964-2015	Valdimarsdottir, Unnur/0000-0001-5382-946X	RANNIS (The Icelandic Centre for Research)	RANNIS (The Icelandic Centre for Research)	Financial support from RANNIS (The Icelandic Centre for Research) is acknowledged, however, RANNIS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Adda J, 2009, J EUR ECON ASSOC, V7, P1361, DOI 10.1162/JEEA.2009.7.6.1361; Asgeirsdottir TL, 2013, EC HUM BIOL; Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; Bergmark A, 2003, INT J SOC WELF, V12, P108, DOI 10.1111/1468-2397.00249; BRENNER MH, 1973, INT J HEALTH SERV, V3, P145, DOI 10.2190/UM5L-TVN7-VDFR-UU0B; CATALANO R, 1992, J HEALTH SOC BEHAV, V33, P363, DOI 10.2307/2137314; Catalano R, 1999, J HEALTH SOC BEHAV, V40, P422, DOI 10.2307/2676334; Chang HL, 2002, PSYCHIAT CLIN NEUROS, V56, P139, DOI 10.1046/j.1440-1819.2002.00948.x; Cnattingius S, 2002, SEMIN PERINATOL, V26, P286, DOI 10.1053/sper.2002.34771; Cox SM, 2001, INT J GYNECOL OBSTET, V72, P85; Dancause KN, 2011, EARLY HUM DEV, V87, P813, DOI 10.1016/j.earlhumdev.2011.06.007; Dehejia R, 2004, Q J ECON, V119, P1091, DOI 10.1162/0033553041502216; Dooley D, 2005, J HEALTH SOC BEHAV, V46, P141, DOI 10.1177/002214650504600202; El-Sayed A, 2008, ETHNIC DIS, V18, P348; Endara SM, 2009, BMC PUBLIC HEALTH, V9, P9; Eskenazi B, 2007, HUM REPROD, V22, P3013, DOI 10.1093/humrep/dem301; Geirsson R, 1997, LAEKNABLADID, V83, P751; Glynn LM, 2001, AM J OBSTET GYNECOL, V184, P637, DOI 10.1067/mob.2001.111066; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hauksdottir A, 2013, AM J EPIDEMIOL; Hedegaard M, 1996, EPIDEMIOLOGY, V7, P339, DOI 10.1097/00001648-199607000-00001; Hobel CJ, 2008, CLIN OBSTET GYNECOL, V51, P333, DOI 10.1097/GRF.0b013e31816f2709; Jansen PW, 2010, OCCUP ENVIRON MED, V67, P387, DOI 10.1136/oem.2009.046300; Joyce T, 1989, J Health Econ, V8, P419; JOYCE T, 1993, J HUM RESOUR, V28, P185, DOI 10.2307/146093; Khashan AS, 2009, HUM REPROD, V24, P429, DOI 10.1093/humrep/den418; Khashan AS, 2008, PSYCHOSOM MED, V70, P688, DOI 10.1097/PSY.0b013e318177940d; Kim C, 2010, INT J WOMENS HEALTH, V2, P339, DOI 10.2147/IJWH.S13333; Kramer MS, 2003, J NUTR, V133, p1592S, DOI 10.1093/jn/133.5.1592S; Latendresse G, 2009, J MIDWIFERY WOM HEAL, V54, P8, DOI 10.1016/j.jmwh.2008.08.001; Lederman SA, 2004, ENVIRON HEALTH PERSP, V112, P1772, DOI 10.1289/ehp.7348; Lobel M, 2008, HEALTH PSYCHOL, V27, P604, DOI 10.1037/a0013242; LUBCHENCO LO, 1972, J PEDIATR-US, V81, P814, DOI 10.1016/S0022-3476(72)80114-8; Mansour H, 2012, J DEV ECON, V99, P190, DOI 10.1016/j.jdeveco.2011.12.005; Margerison-Zilko CE, 2011, EPIDEMIOLOGY, V22, P855, DOI 10.1097/EDE.0b013e318230a66e; Maric NP, 2010, ARCH WOMEN MENT HLTH, V13, P83, DOI 10.1007/s00737-009-0099-9; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; McClure CB, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001386; Pinto SM, 2010, EUR J OBSTET GYN R B, V150, P137, DOI 10.1016/j.ejogrb.2010.02.026; Resnik R, 2002, OBSTET GYNECOL, V99, P490, DOI 10.1016/S0029-7844(01)01780-X; Sjostrom K, 1999, J PSYCHOSOM OBST GYN, V20, P170, DOI 10.3109/01674829909075592; Statistic Iceland, 2011, ACT RAT UN LAB FORC; Tan CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008200; Thorsson B, 2009, LAEKNABLADID, V95, P259; Xiong X, 2008, AM J MED SCI, V336, P111, DOI 10.1097/MAJ.0b013e318180f21c	46	35	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80499	10.1371/journal.pone.0080499	http://dx.doi.org/10.1371/journal.pone.0080499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	265KD	24324602	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300023
J	Lafontaine, MP; Theoret, H; Gosselin, F; Lippe, S				Lafontaine, Marc Philippe; Theoret, Hugo; Gosselin, Frederic; Lippe, Sarah			Transcranial Direct Current Stimulation of the Dorsolateral Prefrontal Cortex Modulates Repetition Suppression to Unfamiliar Faces: An ERP Study	PLOS ONE			English	Article							NONINVASIVE BRAIN-STIMULATION; HUMAN MOTOR CORTEX; WORKING-MEMORY; INTEGRATIVE THEORY; NEURAL MECHANISMS; DECISION-MAKING; INVERTED FACES; VISUAL-CORTEX; N170; HUMANS	Repeated visual processing of an unfamiliar face suppresses neural activity in face-specific areas of the occipito-temporal cortex. This "repetition suppression" (RS) is a primitive mechanism involved in learning of unfamiliar faces, which can be detected through amplitude reduction of the N170 event-related potential (ERP). The dorsolateral prefrontal cortex (DLPFC) exerts top-down influence on early visual processing. However, its contribution to N170 RS and learning of unfamiliar faces remains unclear. Transcranial direct current stimulation (tDCS) transiently increases or decreases cortical excitability, as a function of polarity. We hypothesized that DLPFC excitability modulation by tDCS would cause polarity-dependent modulations of N170 RS during encoding of unfamiliar faces. tDCS-induced N170 RS enhancement would improve long-term recognition reaction time (RT) and/or accuracy rates, whereas N170 RS impairment would compromise recognition ability. Participants underwent three tDCS conditions in random order at,72 hour intervals: right anodal/left cathodal, right cathodal/left anodal and sham. Immediately following tDCS conditions, an EEG was recorded during encoding of unfamiliar faces for assessment of P100 and N170 visual ERPs. The P3a component was analyzed to detect prefrontal function modulation. Recognition tasks were administered similar to 72 hours following encoding. Results indicate the right anodal/left cathodal condition facilitated N170 RS and induced larger P3a amplitudes, leading to faster recognition RT. Conversely, the right cathodal/left anodal condition caused N170 amplitude and RTs to increase, and a delay in P3a latency. These data demonstrate that DLPFC excitability modulation can influence early visual encoding of unfamiliar faces, highlighting the importance of DLPFC in basic learning mechanisms.	[Lafontaine, Marc Philippe; Theoret, Hugo; Gosselin, Frederic; Lippe, Sarah] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Lafontaine, Marc Philippe; Theoret, Hugo; Lippe, Sarah] St Justine Univ Hosp, Res Ctr, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Lafontaine, MP (corresponding author), Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada.	marc.philippe.lafontaine@umontreal.ca		Theoret, Hugo/0000-0002-7458-8797	Natural Sciences and Engineering Research Council of Canada (NSERC); Sainte-Justine UHC Foundation; Foundation of Stars scholarship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Sainte-Justine UHC Foundation; Foundation of Stars scholarship	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) grant to SL; MPL is supported by a Sainte-Justine UHC Foundation and Foundation of Stars scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2004, NEUROREPORT, V15, P1307, DOI 10.1097/01.wnr.0000127460.08361.84; Backhaus J, 2006, BIOL PSYCHIAT, V60, P1324, DOI 10.1016/j.biopsych.2006.03.051; Barcelo F, 2000, NAT NEUROSCI, V3, P399, DOI 10.1038/73975; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Boggio PS, 2010, EUR J NEUROSCI, V31, P593, DOI 10.1111/j.1460-9568.2010.07080.x; Brunoni AR, 2011, INT J NEUROPSYCHOPH, V14, P1133, DOI 10.1017/S1461145710001690; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Caharel S, 2011, BRAIN RES, V1387, P85, DOI 10.1016/j.brainres.2011.02.070; Caharel S, 2009, NEUROPSYCHOLOGIA, V47, P639, DOI 10.1016/j.neuropsychologia.2008.11.016; Campanella S, 2000, PSYCHOPHYSIOLOGY, V37, P796, DOI 10.1017/S0048577200991728; Chadick JZ, 2011, NAT NEUROSCI, V14, P830, DOI 10.1038/nn.2823; Daffner KR, 2000, BRAIN, V123, P927, DOI 10.1093/brain/123.5.927; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Dering B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00093; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dockery CA, 2009, J NEUROSCI, V29, P7271, DOI 10.1523/JNEUROSCI.0065-09.2009; Elmer S, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-29; FABIANI M, 1990, ELECTROEN CLIN NEURO, V75, P22, DOI 10.1016/0013-4694(90)90149-E; FABIANI M, 1986, PSYCHOPHYSIOLOGY, V23, P298, DOI 10.1111/j.1469-8986.1986.tb00636.x; Faria P, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066017; Fecteau S, 2007, J NEUROSCI, V27, P12500, DOI 10.1523/JNEUROSCI.3283-07.2007; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; Fleuaris AV, 2008, BRAIN RES, V1194, P100, DOI 10.1016/j.brainres.2007.11.071; Floel A, 2008, J COGNITIVE NEUROSCI, V20, P1415, DOI 10.1162/jocn.2008.20098; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Friedman D, 2011, NEUROPSYCHOLOGIA, V49, P3474, DOI 10.1016/j.neuropsychologia.2011.08.023; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Gonsalves BD, 2005, NEURON, V47, P751, DOI 10.1016/j.neuron.2005.07.013; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Habib R, 2003, TRENDS COGN SCI, V7, P241, DOI 10.1016/S1364-6613(03)00110-4; Heisz JJ, 2006, VISION RES, V46, P4604, DOI 10.1016/j.visres.2006.09.026; Heisz JJ, 2009, J COGNITIVE NEUROSCI, V21, P1127, DOI 10.1162/jocn.2009.21104; Heisz JJ, 2006, VISION RES, V46, P47, DOI 10.1016/j.visres.2005.09.028; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hofer A, 2007, BRAIN COGNITION, V63, P174, DOI 10.1016/j.bandc.2006.11.005; Hsu TY, 2011, NEUROIMAGE, V56, P2249, DOI 10.1016/j.neuroimage.2011.03.059; Ishai A, 2008, NEUROIMAGE, V40, P415, DOI 10.1016/j.neuroimage.2007.10.040; Itier RJ, 2004, NEUROIMAGE, V21, P1518, DOI 10.1016/j.neuroimage.2003.12.016; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; Kadosh RC, 2010, CURR BIOL, V20, P2016, DOI 10.1016/j.cub.2010.10.007; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Kim KH, 2008, NEUROSCI LETT, V445, P179, DOI 10.1016/j.neulet.2008.09.004; Kovacs G, 2006, CEREB CORTEX, V16, P742, DOI 10.1093/cercor/bhj020; Kovacs G, 2013, J NEUROSCI, V33, P9805, DOI 10.1523/JNEUROSCI.3423-12.2013; Kovacs G, 2012, NEUROIMAGE, V60, P2128, DOI 10.1016/j.neuroimage.2012.02.038; Kuo BC, 2011, NEUROPSYCHOLOGIA, V49, P1589, DOI 10.1016/j.neuropsychologia.2010.12.043; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Massicotte-Marquez J, 2008, NEUROLOGY, V70, P1250, DOI 10.1212/01.wnl.0000286943.79593.a6; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Mercure E, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00006, 10.3389/fnhum.2011.00062]; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Morgan HM, 2008, J COGNITIVE NEUROSCI, V20, P989, DOI 10.1162/jocn.2008.20072; Mulquiney PG, 2011, CLIN NEUROPHYSIOL, V122, P2384, DOI 10.1016/j.clinph.2011.05.009; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; Pihlajamaki M, 2011, BRAIN IMAGING BEHAV, V5, P36, DOI 10.1007/s11682-010-9110-3; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pourtois G, 2005, HUM BRAIN MAPP, V26, P65, DOI 10.1002/hbm.20130; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Rossion B, 1999, BIOL PSYCHOL, V50, P173, DOI 10.1016/S0301-0511(99)00013-7; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Sadeh B, 2010, NEUROIMAGE, V53, P782, DOI 10.1016/j.neuroimage.2010.06.029; Sayres R, 2006, J NEUROPHYSIOL, V95, P995, DOI 10.1152/jn.00500.2005; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Schiltz C, 2006, CEREB CORTEX, V16, P574, DOI 10.1093/cercor/bhj005; Sergerie K, 2005, NEUROIMAGE, V24, P580, DOI 10.1016/j.neuroimage.2004.08.051; Sparing R, 2008, METHODS, V44, P329, DOI 10.1016/j.ymeth.2007.02.001; Summerfield C, 2008, NAT NEUROSCI, V11, P1004, DOI 10.1038/nn.2163; Taschereau-Dumouchel V, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00159; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Vizioli L, 2010, P NATL ACAD SCI USA, V107, P20081, DOI 10.1073/pnas.1005751107; Wassermann EM, 2005, TRENDS COGN SCI, V9, P503, DOI 10.1016/j.tics.2005.09.001; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Willenbockel V, 2010, BEHAV RES METHODS, V42, P671, DOI 10.3758/BRM.42.3.671; Williams MA, 2007, CURR BIOL, V17, P1259, DOI 10.1016/j.cub.2007.06.042; WOODS DL, 1986, NEUROLOGY, V36, P212, DOI 10.1212/WNL.36.2.212; Zago L, 2005, CEREB CORTEX, V15, P1655, DOI 10.1093/cercor/bhi060; Zanto TP, 2011, NAT NEUROSCI, V14, P656, DOI 10.1038/nn.2773	88	22	24	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81721	10.1371/journal.pone.0081721	http://dx.doi.org/10.1371/journal.pone.0081721			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324721	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300107
J	Rasmussen, C; Dupont, YL; Mosbacher, JB; Trojelsgaard, K; Olesen, JM				Rasmussen, Claus; Dupont, Yoko L.; Mosbacher, Jesper B.; Trojelsgaard, Kristian; Olesen, Jens M.			Strong Impact of Temporal Resolution on the Structure of an Ecological Network	PLOS ONE			English	Article							ANIMAL MUTUALISTIC NETWORKS; POLLINATION NETWORKS; COMPLEX NETWORKS; BIODIVERSITY; NESTEDNESS; CLIMATE; TIME; ARCHITECTURE; SPACE; ROBUSTNESS	Most ecological networks are analysed as static structures, where all observed species and links are present simultaneously. However, this is over-simplified, because networks are temporally dynamical. We resolved an arctic, entire-season plant-flower visitor network into a temporal series of 1-day networks and compared the properties with its static equivalent based on data pooled over the entire season. Several properties differed. The nested link pattern in the static network was blurred in the dynamical version, because the characteristic long nestedness tail of flower-visitor specialists got stunted in the dynamical networks. This tail comprised a small food web of pollinators, parasitoids and hyper-parasitoids. The dynamical network had strong time delays in the transmission of direct and indirect effects among species. Twenty percent of all indirect links were impossible in the dynamical network. Consequently, properties and thus also robustness of ecological networks cannot be deduced from the static topology alone.	[Rasmussen, Claus; Dupont, Yoko L.; Trojelsgaard, Kristian; Olesen, Jens M.] Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark; [Mosbacher, Jesper B.] Univ Copenhagen, Dept Biol, Sect Terr Ecol, Copenhagen K, Denmark	Aarhus University; University of Copenhagen	Rasmussen, C (corresponding author), Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark.	claus.rasmussen@biology.au.dk	Trøjelsgaard, Kristian/U-4442-2018; Olesen, Jens M/A-3011-2009; Rasmussen, Claus/J-6714-2012; Dupont, Yoko/GOE-4804-2022; Rasmussen, Claus/X-4760-2019	Trøjelsgaard, Kristian/0000-0001-6807-8363; Olesen, Jens M/0000-0003-1998-1083; Rasmussen, Claus/0000-0003-1529-6548; Olesen, Jes/0000-0002-6712-2702	Carlsberg Foundation; Danish Research Council; Faculty of Science & Technology, Aarhus University	Carlsberg Foundation(Carlsberg Foundation); Danish Research Council(Det Frie Forskningsrad (DFF)); Faculty of Science & Technology, Aarhus University	The authors acknowledge support from the Carlsberg Foundation (CR), the Danish Research Council (JMO), and the Faculty of Science & Technology, Aarhus University (KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Belgrano A, 2005, AQUATIC FOOD WEBS EC; Blonder B, 2012, METHODS ECOL EVOL, V3, P958, DOI 10.1111/j.2041-210X.2012.00236.x; Bocher J., 2001, INSEKTER ANDRE SMADY; Bosch J, 2009, ECOL LETT, V12, P409, DOI 10.1111/j.1461-0248.2009.01296.x; Burkle LA, 2011, AM J BOT, V98, P528, DOI 10.3732/ajb.1000391; Colwell R.K., 2006, RANGEMODEL MONTE CAR; COLWELL RK, 1994, AM NAT, V144, P570, DOI 10.1086/285695; Dupont YL, 2003, ECOGRAPHY, V26, P301, DOI 10.1034/j.1600-0587.2003.03443.x; Dupont YL, 2012, ECOL COMPLEX, V11, P84, DOI 10.1016/j.ecocom.2012.03.004; Elberling H, 1999, ECOGRAPHY, V22, P314, DOI 10.1111/j.1600-0587.1999.tb00507.x; Elmendorf SC, 2012, ECOL LETT, V15, P164, DOI 10.1111/j.1461-0248.2011.01716.x; Fang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032663; Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Hagen M, 2012, ADV ECOL RES, V46, P89, DOI 10.1016/B978-0-12-396992-7.00002-2; HAWKINS BA, 1990, J ANIM ECOL, V59, P57, DOI 10.2307/5158; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Hoye TT, 2008, ADV ECOL RES, V40, P299, DOI 10.1016/S0065-2504(07)00013-X; Hoye TT, 2007, CURR BIOL, V17, pR449, DOI 10.1016/j.cub.2007.04.047; James A, 2012, NATURE, V487, P227, DOI 10.1038/nature11214; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; Longstaff TG, 1932, J ANIM ECOL, V1, P119, DOI 10.2307/974; Lundgren R, 2005, ARCT ANTARCT ALP RES, V37, P514, DOI 10.1657/1523-0430(2005)037[0514:TDAHCW]2.0.CO;2; MCALPINE JF, 1965, ARCTIC, V18, P73, DOI 10.14430/arctic3455; Nielsen A, 2007, J ECOL, V95, P1134, DOI 10.1111/j.1365-2745.2007.01271.x; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Olesen JM, 2006, J THEOR BIOL, V240, P270, DOI 10.1016/j.jtbi.2005.09.014; Olesen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026455; Olesen JM, 2010, ADV ECOL RES, V42, P1, DOI 10.1016/S0065-2504(10)42001-2; Olesen JM, 2011, P ROY SOC B-BIOL SCI, V278, P725, DOI 10.1098/rspb.2010.1371; Olesen JM., 2012, EVOLUTION PLANT POLL, P375, DOI DOI 10.1016/J.ECOINF.2007.03.005; Olesen JM, 2000, EXACTLY GEN POLLINAT, P161; Ollerton J, 2003, ANN BOT-LONDON, V92, P807, DOI 10.1093/aob/mcg206; Perra N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00469; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Petanidou Theodora, 1996, Linnean Society Symposium Series, V18, P201; Tanaka G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00232; Tang J, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.055101; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Trojelsgaard K, 2013, GLOBAL ECOL BIOGEOGR, V22, P149, DOI 10.1111/j.1466-8238.2012.00777.x; Woodward G, 2010, ADV ECOL RES, V42, P71, DOI 10.1016/S0065-2504(10)42002-4; Zamora R, 2000, OIKOS, V88, P442, DOI 10.1034/j.1600-0706.2000.880222.x	49	47	47	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81694	10.1371/journal.pone.0081694	http://dx.doi.org/10.1371/journal.pone.0081694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324718	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300104
J	Sapsford, SJ; Alford, RA; Schwarzkopf, L				Sapsford, Sarah J.; Alford, Ross A.; Schwarzkopf, Lin			Elevation, Temperature, and Aquatic Connectivity All Influence the Infection Dynamics of the Amphibian Chytrid Fungus in Adult Frogs	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS INFECTION; NORTHERN QUEENSLAND; POPULATION DECLINES; DISEASE; CHYTRIDIOMYCOSIS; PATHOGEN; MORTALITY; SEASON; HOSTS; WATER	Infectious diseases can cause population declines and even extinctions. The amphibian chytrid fungus, Batrachochytrium dendrobatidis (Bd), has caused population declines and extinctions in amphibians on most continents. In the tropics, research on the dynamics of this disease has focused on amphibian populations in mountainous areas. In most of these areas, high and low elevation sites are connected by an assemblage of streams that may transport the infectious stage of the pathogen from high to low elevations, and, also, this pathogen, which grows well at cool temperatures, may persist better in cooler water flowing from high elevations. Thus, the dynamics of disease at low elevation sites without aquatic connections to higher elevation sites, i.e., non-contiguous low elevation sites, may differ from dynamics at contiguous low elevation sites. We sampled adult common mistfrogs (Litoria rheocola) at six sites of three types: two at high (> 400m) elevations, two at low elevations contiguous with high elevation streams, and two at low elevations non-contiguous with any high elevation site. Adults were swabbed for Bd diagnosis from June 2010 to June 2011 in each season, over a total of five sampling periods. The prevalence of Bd fluctuated seasonally and was highest in winter across all site types. Site type significantly affected seasonal patterns of prevalence of Bd. Prevalence remained well above zero throughout the year at the high elevation sites. Prevalence declined to lower levels in contiguous low sites, and reached near-zero at non-contiguous low sites. Patterns of air temperature fluctuation were very similar at both the low elevation site types, suggesting that differences in water connectivity to high sites may have affected the seasonal dynamics of Bd prevalence between contiguous and non-contiguous low elevation site types. Our results also suggest that reservoir hosts may be important in the persistence of disease at low elevations.	[Sapsford, Sarah J.; Alford, Ross A.; Schwarzkopf, Lin] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University	Sapsford, SJ (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	sarah.sapsford@gmail.com	Sapsford, Sarah/C-1885-2015; Schwarzkopf, Lin/C-1242-2012; Alford, Ross A/H-1577-2011	Sapsford, Sarah/0000-0001-6019-5063; Schwarzkopf, Lin/0000-0002-1009-670X; Alford, Ross A/0000-0002-3010-6768	Powerlink Queensland; Australian Research Council [DP0986537]; James Cook University	Powerlink Queensland; Australian Research Council(Australian Research Council); James Cook University	Funding was provided by Powerlink Queensland, the Australian Research Council (DP0986537) and the James Cook University Graduate Research Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AA, 2008, ANN NY ACAD SCI, V1149, P1, DOI 10.1196/annals.1428.052; Alford RA, 2010, ECOTOXICOLOGY OF AMPHIBIANS AND REPTILES, SECOND EDITION, P13, DOI 10.1201/EBK1420064162-c2; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brem FMR, 2008, DIS AQUAT ORGAN, V81, P189, DOI 10.3354/dao01960; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; BRITTAIN JE, 1988, HYDROBIOLOGIA, V166, P77, DOI 10.1007/BF00017485; Brunner JL, 2004, ECOLOGY, V85, P560, DOI 10.1890/02-0374; Curtis Lee K., 2012, P1; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; Di Rosa I, 2007, NATURE, V447, pE4, DOI 10.1038/nature05941; Garmyn A, 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0044821.PUBMED:22984569; HODGKISON S, 2002, FROGS COMMUNITY, P29; Hoskin C, 2008, RAINFOREST FROGS W T; IUCN, 2022, IUCN RED LIST THREAT; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Johnson ML, 2005, DIS AQUAT ORGAN, V65, P181, DOI 10.3354/dao065181; Kilburn VL, 2011, DIS AQUAT ORGAN, V97, P127, DOI 10.3354/dao02409; Kriger KM, 2008, AUSTRAL ECOL, V33, P1022, DOI 10.1111/j.1442-9993.2008.01872.x; La Marca E, 2005, BIOTROPICA, V37, P190, DOI 10.1111/j.1744-7429.2005.00026.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; McDonald K, 1999, DECLINES DISAPPEARAN, P14; McDonald K. R., 2005, PAC CONSERV BIOL, V11, P114, DOI DOI 10.1071/PC050114; McMahon TA, 2013, P NATL ACAD SCI USA, V110, P210, DOI 10.1073/pnas.1200592110; North S, 2008, DIS AQUAT ORGAN, V81, P177, DOI 10.3354/dao01958; Pearl CA, 2009, ECOHEALTH, V6, P209, DOI 10.1007/s10393-009-0237-x; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Pullen KD, 2010, DIS AQUAT ORGAN, V91, P9, DOI 10.3354/dao02249; R Core Team, 2012, R LANG ENV STAT COMP; RETALLICK R, 2002, USING EXPT TRANSLOCA; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Rowley JJL, 2006, THESIS J COOK U TOWN; Rowley JJL, 2007, ECOHEALTH, V4, P31, DOI 10.1007/s10393-006-0075-z; Rowley JJL, 2007, DIS AQUAT ORGAN, V74, P7, DOI 10.3354/dao074007; Roznik EA, 2012, J THERM BIOL, V37, P260, DOI 10.1016/j.jtherbio.2012.02.004; Russell DM, 2010, DIS AQUAT ORGAN, V92, P223, DOI 10.3354/dao02286; Sapsford S. J., 2012, THESIS J COOK U TOWN; Savage AE, 2011, BIOL CONSERV, V144, P1910, DOI 10.1016/j.biocon.2011.03.018; Skerratt LF, 2008, DIS AQUAT ORGAN, V80, P85, DOI 10.3354/dao01923; Stevenson LA, 2012, THESIS J COOK U TOWN; Stevenson LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073830; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x	48	49	50	2	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82425	10.1371/journal.pone.0082425	http://dx.doi.org/10.1371/journal.pone.0082425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324786	Green Published, gold, Green Accepted			2022-12-25	WOS:000327949300145
J	Velo-Suarez, L; Brosnahan, ML; Anderson, DM; McGillicuddy, DJ				Velo-Suarez, Lourdes; Brosnahan, Michael L.; Anderson, Donald M.; McGillicuddy, Dennis J., Jr.			A Quantitative Assessment of the Role of the Parasite Amoebophrya in the Termination of Alexandrium fundyense Blooms within a Small Coastal Embayment	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; DINOFLAGELLATE AMOEBOPHRYA; POPULATION-DYNAMICS; GENETIC DIVERSITY; CHESAPEAKE BAY; 2 STRAINS; CAPE-COD; INFECTION; ESCAPE; IDENTIFICATION	Parasitic dinoflagellates of the genus Amoebophrya infect free-living dinoflagellates, some of which can cause harmful algal blooms (HABs). High prevalence of Amoebophrya spp. has been linked to the decline of some HABs in marine systems. The objective of this study was to evaluate the impact of Amoebophrya spp. on the dynamics of dinoflagellate blooms in Salt Pond (MA, USA), particularly the harmful species Alexandrium fundyense. The abundance of Amoebophrya life stages was estimated 3-7 days per week through the full duration of an annual A. fundyense bloom using fluorescence in situ hybridization coupled with tyramide signal amplification (FISH-TSA). More than 20 potential hosts were recorded including Dinophysis spp., Protoperidinium spp. and Gonyaulax spp., but the only dinoflagellate cells infected by Amoebophrya spp. during the sampling period were A. fundyense. Maximum A. fundyense concentration co-occurred with an increase of infected hosts, followed by a massive release of Amoebophrya dinospores in the water column. On average, Amoebophrya spp. infected and killed similar to 30% of the A. fundyense population per day in the end phase of the bloom. The decline of the host A. fundyense population coincided with a dramatic life-cycle transition from vegetative division to sexual fusion. This transition occurred after maximum infected host concentrations and before peak infection percentages were observed, suggesting that most A. fundyense escaped parasite infection through sexual fusion. The results of this work highlight the importance of high frequency sampling of both parasite and host populations to accurately assess the impact of parasites on natural plankton assemblages.	[Velo-Suarez, Lourdes; McGillicuddy, Dennis J., Jr.] Woods Hole Oceanog Inst, Dept Appl Ocean Phys & Engn, Woods Hole, MA 02543 USA; [Velo-Suarez, Lourdes] IFREMER, Dept Dynam Environm Cotier, F-29280 Plouzane, France; [Brosnahan, Michael L.; Anderson, Donald M.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution; Ifremer; Woods Hole Oceanographic Institution	Velo-Suarez, L (corresponding author), Woods Hole Oceanog Inst, Dept Appl Ocean Phys & Engn, Woods Hole, MA 02543 USA.	lvelosuarez@whoi.edu	Velo-Suárez, Lourdes/C-2664-2009	Brosnahan, Michael/0000-0002-2620-7638; McGillicuddy, Dennis/0000-0002-1437-2425	Marie Curie International Outgoing Fellowship (IOF) [MOHAB PIOF-GA-252260]; NSF [OCE-0430724, OCE-0911031]; National Institute of Environmental Health Sciences [1P50-ES01274201, 1P01ES021923-01]; Woods Hole Center for Oceans and Human Health; National Park Service [H238015504]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES021923] Funding Source: NIH RePORTER	Marie Curie International Outgoing Fellowship (IOF); NSF(National Science Foundation (NSF)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Woods Hole Center for Oceans and Human Health; National Park Service; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	L. Velo-Suarez was supported by a Marie Curie International Outgoing Fellowship (IOF; grant agreement: MOHAB PIOF-GA-252260). This work was supported in part by NSF grants OCE-0430724 and OCE-0911031 and National Institute of Environmental Health Sciences grants 1P50-ES01274201 and 1P01ES021923-01 to D.M. Anderson and D.J. McGillicuddy through the Woods Hole Center for Oceans and Human Health, National Park Service Cooperative Agreement H238015504 to D. M. Anderson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-de-Souza C, 2011, INTERACTIONS PARASIT; Alves-de-Souza C, 2012, AQUAT MICROB ECOL, V66, P183, DOI 10.3354/ame01567; Anderson DM, 2005, DEEP-SEA RES PT II, V52, P2467, DOI 10.1016/j.dsr2.2005.06.015; ANDERSON DM, 1983, MAR BIOL, V76, P179, DOI 10.1007/BF00392734; ANDERSON DM, 1985, MAR ECOL PROG SER, V25, P39, DOI 10.3354/meps025039; Arancio M, ECOL MODEL IN PRESS; Brosnahan ML, 2014, DEEP-SEA RES PT II, V103, P185, DOI 10.1016/j.dsr2.2013.05.034; Brosnahan ML, 2012, 15 INT C HARMF ALG C; Cachon J., 1969, ANN SCI NAT ZOOL, V6, P1; Chambouvet A, 2008, SCIENCE, V322, P1254, DOI 10.1126/science.1164387; Chambouvet A, 2011, RES MICROBIOL, V162, P959, DOI 10.1016/j.resmic.2011.03.002; Chambouvet A, 2011, PROTIST, V162, P637, DOI 10.1016/j.protis.2010.12.001; Coats DW, 2002, J PHYCOL, V38, P520, DOI 10.1046/j.1529-8817.2002.t01-1-01200.x; COATS DW, 1994, J EUKARYOT MICROBIOL, V41, P586, DOI 10.1111/j.1550-7408.1994.tb01520.x; Coats DW, 1996, AQUAT MICROB ECOL, V11, P1, DOI 10.3354/ame011001; Crespo BG, 2011, HARMFUL ALGAE, V12, P26, DOI 10.1016/j.hal.2011.08.009; Frada M, 2008, P NATL ACAD SCI USA, V105, P15944, DOI 10.1073/pnas.0807707105; FRITZ L, 1992, J PHYCOL, V28, P312, DOI 10.1111/j.0022-3646.1992.00312.x; Goedknegt A., 2012, PARASITES PREY; Guillou L, 2008, ENVIRON MICROBIOL, V10, P3349, DOI 10.1111/j.1462-2920.2008.01731.x; HOWARD RS, 1994, NATURE, V368, P358, DOI 10.1038/368358a0; Hudson PJ, 2006, TRENDS ECOL EVOL, V21, P381, DOI 10.1016/j.tree.2006.04.007; Figueroa RI, 2010, HARMFUL ALGAE, V10, P56, DOI 10.1016/j.hal.2010.06.002; Jacobson DM, 1987, ECOLOGY FEEDING BIOL; Johansson M, 2002, AQUAT MICROB ECOL, V28, P69, DOI 10.3354/ame028069; Kim S, 2004, J PHYCOL, V40, P815, DOI 10.1111/j.1529-8817.2004.04002.x; Kremp A, 2009, LIMNOL OCEANOGR, V54, P1125, DOI 10.4319/lo.2009.54.4.1125; Lilly EL, 2007, J PHYCOL, V43, P1329, DOI 10.1111/j.1529-8817.2007.00420.x; Miller JJ, 2012, PROTIST, V163, P720, DOI 10.1016/j.protis.2011.11.007; Montagnes DJS, 2008, AQUAT MICROB ECOL, V53, P211, DOI 10.3354/ame01245; Not F, 2002, AQUAT MICROB ECOL, V28, P157, DOI 10.3354/ame028157; Olson RJ, 2007, LIMNOL OCEANOGR-METH, V5, P195, DOI 10.4319/lom.2007.5.195; Park MG, 2004, J EUKARYOT MICROBIOL, V51, P145, DOI 10.1111/j.1550-7408.2004.tb00539.x; Park MG, 2002, MAR ECOL PROG SER, V227, P281, DOI 10.3354/meps227281; Park MG, 2002, AQUAT MICROB ECOL, V29, P11, DOI 10.3354/ame029011; Pernthaler A., 2004, Molecular microbial ecology manual. Volumes 1 and 2, P711; Rengefors K, 1998, P ROY SOC B-BIOL SCI, V265, P1353, DOI 10.1098/rspb.1998.0441; Richlen ML, 2012, ECOL EVOL, V2, P2583, DOI 10.1002/ece3.373; Salomon PS, 2010, MAR ECOL PROG SER, V419, P1, DOI 10.3354/meps08839; Salomon PS, 2009, AQUAT MICROB ECOL, V55, P143, DOI 10.3354/ame01293; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; Sengco MR, 2003, BIOL PHYLOGENETIC CH; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Siano R, 2011, BIOGEOSCIENCES, V8, P267, DOI 10.5194/bg-8-267-2011; TOMAS RN, 1974, J PROTOZOOL, V21, P316, DOI 10.1111/j.1550-7408.1974.tb03661.x; Toth GB, 2004, P ROY SOC B-BIOL SCI, V271, P733, DOI 10.1098/rspb.2003.2654; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Velo-Suarez L, 2014, DEEP-SEA RES PT II, V101, P141, DOI 10.1016/j.dsr2.2013.03.033	48	36	36	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81150	10.1371/journal.pone.0081150	http://dx.doi.org/10.1371/journal.pone.0081150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324668	gold, Green Published			2022-12-25	WOS:000327949300072
J	Zaproudina, N; Teplov, V; Nippolainen, E; Lipponen, JA; Kamshilin, AA; Narhi, M; Karjalainen, PA; Giniatullin, R				Zaproudina, Nina; Teplov, Victor; Nippolainen, Ervin; Lipponen, Jukka A.; Kamshilin, Alexei A.; Narhi, Matti; Karjalainen, Pasi A.; Giniatullin, Rashid			Asynchronicity of Facial Blood Perfusion in Migraine	PLOS ONE			English	Article							VASCULAR THEORY; RESPONSES; HEADACHE; FLOW; HABITUATION; ACTIVATION	Asymmetrical changes in blood perfusion and asynchronous blood supply to head tissues likely contribute to migraine pathophysiology. Imaging was widely used in order to understand hemodynamic variations in migraine. However, mapping of blood pulsations in the face of migraineurs has not been performed so far. We used the Blood Pulsation Imaging (BPI) technique, which was recently developed in our group, to establish whether 2D-imaging of blood pulsations parameters can reveal new biomarkers of migraine. BPI characteristics were measured in migraineurs during the attack-free interval and compared to healthy subjects with and without a family history of migraine. We found a novel phenomenon of transverse waves of facial blood perfusion in migraineurs in contrast to healthy subjects who showed synchronous blood delivery to both sides of the face. Moreover, the amplitude of blood pulsations was symmetrically distributed over the face of healthy subjects, but asymmetrically in migraineurs and subjects with a family history of migraine. In the migraine patients we found a remarkable correlation between the side of unilateral headache and the direction of the blood perfusion wave. Our data suggest that migraine is associated with lateralization of blood perfusion and asynchronous blood pulsations in the facial area, which could be due to essential dysfunction of the autonomic vascular control in the face. These findings may further enhance our understanding of migraine pathophysiology and suggest new easily available biomarkers of this pathology.	[Zaproudina, Nina; Narhi, Matti] Univ Eastern Finland, Inst Biomed, Kuopio, Finland; [Zaproudina, Nina; Narhi, Matti] Univ Eastern Finland, Inst Dent, Kuopio, Finland; [Teplov, Victor; Nippolainen, Ervin; Lipponen, Jukka A.; Kamshilin, Alexei A.; Karjalainen, Pasi A.] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Giniatullin, Rashid] Univ Eastern Finland, AI Virtanen Inst, Dept Neurobiol, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland	Kamshilin, AA (corresponding author), Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland.	alexei.kamshilin@uef.fi	Kamshilin, Alexei A./Q-9775-2016; Karjalainen, Pasi A/G-4043-2016; Karjalainen, Pasi/AAC-5465-2019; Giniatullin, Rashid/Y-9687-2018; Nippolainen, Ervin/J-9123-2014	Kamshilin, Alexei A./0000-0003-2506-9736; Karjalainen, Pasi A/0000-0002-1267-493X; Karjalainen, Pasi/0000-0002-1267-493X; Lipponen, Jukka/0000-0002-4182-1994; Giniatullin, Rashid/0000-0002-1580-6280; Nippolainen, Ervin/0000-0002-1317-2683	Photonics Program of the Academy of Finland [135179, 136881]; Academy of Finland [252748]	Photonics Program of the Academy of Finland; Academy of Finland(Academy of Finland)	The authors are grateful to Prof. Riitta Hari from the Aalto University, Helsinki for comments on the manuscript. This work was partially supported by the Photonics Program of the Academy of Finland (projects No. 135179 and No. 136881) and by the project No. 252748 of the Academy of Finland, http://www.aka.fi/en-GB/A/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Afridi SK, 2005, BRAIN, V128, P932, DOI 10.1093/brain/awh416; Amin FM, 2013, LANCET NEUROL, V12, P454, DOI 10.1016/S1474-4422(13)70067-X; Antonova M, 2011, CEPHALALGIA, V31, P1532, DOI 10.1177/0333102411423314; Asghar MS, 2011, ANN NEUROL, V69, P635, DOI 10.1002/ana.22292; Avnon Y, 2004, BRAIN, V127, P2099, DOI 10.1093/brain/awh236; BERGERSEN TK, 1993, ACTA PHYSIOL SCAND, V147, P195, DOI 10.1111/j.1748-1716.1993.tb09489.x; Chernyshev OY, 2001, HEADACHE, V41, P704, DOI 10.1046/j.1526-4610.2001.041007704.x; Di Clemente L, 2007, BRAIN, V130, P765, DOI 10.1093/brain/awl351; Drummond P D, 1994, Clin Auton Res, V4, P273, DOI 10.1007/BF01827433; DRUMMOND PD, 1984, CEPHALALGIA, V4, P149, DOI 10.1046/j.1468-2982.1984.0403149.x; DRUMMOND PD, 1990, J NEUROL NEUROSUR PS, V53, P121, DOI 10.1136/jnnp.53.2.121; FOX RH, 1962, J PHYSIOL-LONDON, V161, P298, DOI 10.1113/jphysiol.1962.sp006887; Goadsby PJ, 2009, BRAIN, V132, P6, DOI 10.1093/brain/awn321; GRUZELIER JH, 1987, J NEUROL NEUROSUR PS, V50, P416, DOI 10.1136/jnnp.50.4.416; Guyton AC., 2010, GUYTON HALL TXB MED, V12th edn; Huber D, 2003, BEHAV MED, V29, P4, DOI 10.1080/08964280309596169; ISHIMARU A, 1989, APPL OPTICS, V28, P2210, DOI 10.1364/AO.28.002210; Kamshilin AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057117; Kamshilin AA, 2011, BIOMED OPT EXPRESS, V2, P996, DOI 10.1364/BOE.2.000996; Kashima H, 2013, EUR J APPL PHYSIOL, V113, P1035, DOI 10.1007/s00421-012-2522-6; O'Doherty J, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3149863; Papa M, 2009, AM J CARDIOL, V104, P434, DOI 10.1016/j.amjcard.2009.03.061; Peroutka SJ, 2004, HEADACHE, V44, P53, DOI 10.1111/j.1526-4610.2004.04011.x; Pietrobon D, 2003, NAT REV NEUROSCI, V4, P386, DOI 10.1038/nrn1102; Rahmann A, 2008, CEPHALALGIA, V28, P226, DOI 10.1111/j.1468-2982.2007.01497.x; Reisner A, 2008, ANESTHESIOLOGY, V108, P950, DOI 10.1097/ALN.0b013e31816c89e1; Schoonman GG, 2008, BRAIN, V131, P2192, DOI 10.1093/brain/awn094; Shechter A, 2002, NEUROLOGY, V58, P422, DOI 10.1212/WNL.58.3.422; Shevel E, 2011, HEADACHE, V51, P409, DOI 10.1111/j.1526-4610.2011.01844.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Siniatchkin M, 2000, CEPHALALGIA, V20, P881, DOI 10.1046/j.1468-2982.2000.00132.x; Tietjen GE, 2009, CEPHALALGIA, V29, P989, DOI 10.1111/j.1468-2982.2009.01937.x; Victor TW, 2010, CEPHALALGIA, V30, P1065, DOI 10.1177/0333102409355601; WEILLER C, 1995, NAT MED, V1, P658, DOI 10.1038/nm0795-658; Wolff H. G., 1963, HEADACHE OTHER HEAD; Yildiz SK, 2008, CEPHALALGIA, V28, P696, DOI 10.1111/j.1468-2982.2008.01574.x; Zaproudina N, 2013, CLIN PHYSIOL FUNCT I, V33, P409, DOI 10.1111/cpf.12042	37	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80189	10.1371/journal.pone.0080189	http://dx.doi.org/10.1371/journal.pone.0080189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324592	Green Submitted, Green Published, gold			2022-12-25	WOS:000327949300018
J	Gillett, A; Bergman, P; Parsa, R; Bremges, A; Giegerich, R; Jagodic, M				Gillett, Alan; Bergman, Petra; Parsa, Roham; Bremges, Andreas; Giegerich, Robert; Jagodic, Maja			A Silent Exonic SNP in Kdm3a Affects Nucleic Acids Structure but Does Not Regulate Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							RNA SECONDARY STRUCTURE; GENOME-WIDE ASSOCIATION; MESSENGER-RNA; GENE-EXPRESSION; TRANSLATION EFFICIENCY; HISTONE DEMETHYLATION; PROTEIN; POLYMORPHISM; ARTHRITIS; SEVERITY	Defining genetic variants that predispose for diseases is an important initiative that can improve biological understanding and focus therapeutic development. Genetic mapping in humans and animal models has defined genomic regions controlling a variety of phenotypes known as quantitative trait loci (QTL). Causative disease determinants, including single nucleotide polymorphisms (SNPs), lie within these regions and can often be identified through effects on gene expression. We previously identified a QTL on rat chromosome 4 regulating macrophage phenotypes and immune-mediated diseases including experimental autoimmune encephalomyelitis (EAE). Gene analysis and a literature search identified lysine-specific demethylase 3A (Kdm3a) as a potential regulator of these phenotypes. Genomic sequencing determined only two synonymous SNPs in Kdm3a. The silent synonymous SNP in exon 15 of Kdm3a caused problems with quantitative PCR detection in the susceptible strain through reduced amplification efficiency due to altered secondary cDNA structure. Shape Probability Shift analysis predicted that the SNP often affects RNA folding; thus, it may impact protein translation. Despite these differences in rats, genetic knockout of Kdm3a in mice resulted in no dramatic effect on immune system development and activation or EAE susceptibility and severity. These results provide support for tools that analyze causative SNPs that impact nucleic acid structures.	[Gillett, Alan; Bergman, Petra; Parsa, Roham; Jagodic, Maja] Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Stockholm, Sweden; [Bremges, Andreas; Giegerich, Robert] Univ Bielefeld, Ctr Biotechnol, D-33615 Bielefeld, Germany; [Bremges, Andreas; Giegerich, Robert] Univ Bielefeld, Fac Technol, D-33615 Bielefeld, Germany	Karolinska Institutet; University of Bielefeld; University of Bielefeld	Jagodic, M (corresponding author), Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Stockholm, Sweden.	maja.jagodic@ki.se	Parsa, Roham/AAV-4002-2021; Parsa, Roham/AHA-7145-2022	Parsa, Roham/0000-0002-0864-6098; Parsa, Roham/0000-0002-0864-6098	Swedish Research Council; Jeanssons Foundation; Swedish Association for Persons with Neurological Disabilities; Ake Wibergs Foundation; Swedish Brain Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Jeanssons Foundation; Swedish Association for Persons with Neurological Disabilities; Ake Wibergs Foundation; Swedish Brain Foundation	This work was supported by grants from The Swedish Research Council (www.vr.se), Jeanssons Foundation (www.jeanssonsstiftelser.se), The Swedish Association for Persons with Neurological Disabilities (www.nhr.se), Ake Wibergs Foundation (www.ake-wiberg.com), and the Swedish Brain Foundation (www.hjarnfonden.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; Dahlman I, 1998, EUR J IMMUNOL, V28, P2188, DOI 10.1002/(SICI)1521-4141(199807)28:07<2188::AID-IMMU2188>3.0.CO;2-B; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Giegerich R, 2004, NUCLEIC ACIDS RES, V32, P4843, DOI 10.1093/nar/gkh779; Gillett A, 2010, J IMMUNOL, V185, P442, DOI 10.4049/jimmunol.0904101; Gillett A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007773; Griseri P, 2011, HUM MOL GENET, V20, P4556, DOI 10.1093/hmg/ddr390; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Huberle A, 2009, J IMMUNOL, V182, P4432, DOI 10.4049/jimmunol.0803847; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Janssen S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-429; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Naslavsky MS, 2010, IMMUNOL LETT, V129, P53, DOI 10.1016/j.imlet.2009.12.024; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; PURVIS IJ, 1987, J MOL BIOL, V193, P413, DOI 10.1016/0022-2836(87)90230-0; Remmers EF, 1996, NAT GENET, V14, P82, DOI 10.1038/ng0996-82; Rosenfeld JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-143; Sabarinathan R, 2013, HUM MUTAT, V34, P546, DOI 10.1002/humu.22273; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Shen LX, 1999, P NATL ACAD SCI USA, V96, P7871, DOI 10.1073/pnas.96.14.7871; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Thomas LR, 2008, J IMMUNOL, V181, P485, DOI 10.4049/jimmunol.181.1.485; Vingsbo-Lundberg C, 1998, NAT GENET, V20, P401, DOI 10.1038/3887; Voss B, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-5; Wakabayashi Y, 2011, J BIOL CHEM, V286, P35456, DOI 10.1074/jbc.M111.236794; Waldman YY, 2011, GENOME BIOL EVOL, V3, P749, DOI 10.1093/gbe/evr076; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zhang KL, 2011, NUCLEIC ACIDS RES, V39, pW437, DOI 10.1093/nar/gkr391	49	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81912	10.1371/journal.pone.0081912	http://dx.doi.org/10.1371/journal.pone.0081912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312603	Green Published, Green Submitted, gold			2022-12-25	WOS:000327947800066
J	Bunse, S; Garg, S; Junek, S; Vogel, D; Ansari, N; Stelzer, EHK; Schuman, E				Bunse, Stefanie; Garg, Sakshi; Junek, Stephan; Vogel, Dirk; Ansari, Nariman; Stelzer, Ernst H. K.; Schuman, Erin			Role of N-Cadherin cis and trans Interfaces in the Dynamics of Adherens Junctions in Living Cells	PLOS ONE			English	Article							ADHESION; CALCIUM; CULTURE; MUTATIONS; MECHANISM; CATENINS; MATRIX	Cadherins, Ca2+-dependent adhesion molecules, are crucial for cell-cell junctions and remodeling. Cadherins form inter-junctional lattices by the formation of both cis and trans dimers. Here, we directly visualize and quantify the spatiotemporal dynamics of wild-type and dimer mutant N-cadherin interactions using time-lapse imaging of junction assembly, disassembly and a FRET reporter to assess Ca2+-dependent interactions. A trans dimer mutant (W2A) and a cis mutant (V81D/V174D) exhibited an increased Ca2+-sensitivity for the disassembly of trans dimers compared to the WT, while another mutant (R14E) was insensitive to Ca2+-chelation. Time-lapse imaging of junction assembly and disassembly, monitored in 2D and 3D (using cellular spheroids), revealed kinetic differences in the different mutants as well as different behaviors in the 2D and 3D environment. Taken together, these data provide new insights into the role that the cis and trans dimers play in the dynamic interactions of cadherins.	[Bunse, Stefanie; Garg, Sakshi; Vogel, Dirk; Schuman, Erin] Max Planck Inst Brain Res, Dept Synapt Plast, Frankfurt, Germany; [Junek, Stephan] Max Planck Inst Brain Res, Dept Neural Syst, Frankfurt, Germany; [Ansari, Nariman; Stelzer, Ernst H. K.] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci BMLS, D-60054 Frankfurt, Germany	Max Planck Society; Max Planck Society; Goethe University Frankfurt	Schuman, E (corresponding author), Max Planck Inst Brain Res, Dept Synapt Plast, Frankfurt, Germany.	Erin.Schuman@brain.mpg.de	Schuman, Erin M/D-6204-2011; Stelzer, Ernst H K/A-7648-2011	Stelzer, Ernst H K/0000-0003-1545-0736	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This study was supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELLO JC, 1982, BIOCHEM BIOPH RES CO, V107, P1130, DOI 10.1016/0006-291X(82)90639-8; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; CLEEMANN L, 1984, SCIENCE, V226, P174, DOI 10.1126/science.6091269; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dickinson ME, 2006, DEV DYNAM, V235, P2386, DOI 10.1002/dvdy.20889; Emond MR, 2011, J CELL BIOL, V195, P1115, DOI 10.1083/jcb.201108115; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Handschuh G, 1999, ONCOGENE, V18, P4301, DOI 10.1038/sj.onc.1202790; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; Harrison OJ, 2010, NAT STRUCT MOL BIOL, V17, P348, DOI 10.1038/nsmb.1784; Hirano S, 2012, PHYSIOL REV, V92, P597, DOI 10.1152/physrev.00014.2011; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Katsamba P, 2009, P NATL ACAD SCI USA, V106, P11594, DOI 10.1073/pnas.0905349106; Kim SA, 2011, P NATL ACAD SCI USA, V108, P9857, DOI 10.1073/pnas.1019003108; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Mariotti A, 2007, EXPERT OPIN INV DRUG, V16, P451, DOI 10.1517/13543784.16.4.451; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; NEDERMAN T, 1984, CANCER RES, V44, P3090; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pampaloni F, 2013, CELL TISSUE RES, V352, P161, DOI 10.1007/s00441-013-1589-7; Perez-Armendariz E, 1986, Adv Exp Med Biol, V211, P31; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; PUMAIN R, 1985, J NEUROPHYSIOL, V53, P1; Redies C, 2012, BRAIN RES, V1470, P130, DOI 10.1016/j.brainres.2012.06.020; ROSKELLEY CD, 1995, CURR OPIN CELL BIOL, V7, P736, DOI 10.1016/0955-0674(95)80117-0; Rothen-Rutishauser B, 2002, J MEMBRANE BIOL, V188, P151, DOI 10.1007/s00232-001-0182-2; Sivasankar S, 2009, STRUCTURE, V17, P1075, DOI 10.1016/j.str.2009.06.012; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; SUTHERLAND RM, 1980, CANCER CLIN TRIALS, V3, P73; Tai CY, 2007, NEURON, V54, P771, DOI 10.1016/j.neuron.2007.05.013; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Walpita D, 2002, NAT REV MOL CELL BIO, V3, P137, DOI 10.1038/nrm727; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wiest MC, 2000, J NEUROPHYSIOL, V83, P1329, DOI 10.1152/jn.2000.83.3.1329; YONEMURA S, 1995, J CELL SCI, V108, P127; YUHAS JM, 1977, CANCER RES, V37, P3639	42	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81517	10.1371/journal.pone.0081517	http://dx.doi.org/10.1371/journal.pone.0081517			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312555	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500072
J	Keitel, A; Ferrea, S; Sudmeyer, M; Schnitzler, A; Wojtecki, L				Keitel, Ariane; Ferrea, Stefano; Suedmeyer, Martin; Schnitzler, Alfons; Wojtecki, Lars			Expectation Modulates the Effect of Deep Brain Stimulation on Motor and Cognitive Function in Tremor-Dominant Parkinson's Disease	PLOS ONE			English	Article							SUBTHALAMIC NUCLEUS STIMULATION; PLACEBO-RESPONSE; DOPAMINE RELEASE; TRIALS; NOCEBO	Expectation contributes to placebo and nocebo responses in Parkinson's disease (PD). While there is evidence for expectation-induced modulations of bradykinesia, little is known about the impact of expectation on resting tremor. Subthalamic nucleus (STN) deep brain stimulation (DBS) improves cardinal PD motor symptoms including tremor whereas impairment of verbal fluency (VF) has been observed as a potential side-effect. Here we investigated how expectation modulates the effect of STN-DBS on resting tremor and its interaction with VF. In a within-subject- design, expectation of 24 tremor-dominant PD patients regarding the impact of STN-DBS on motor symptoms was manipulated by verbal suggestions (positive [placebo], negative [nocebo], neutral [control]). Patients participated with (MedON) and without (MedOFF) antiparkinsonian medication. Resting tremor was recorded by accelerometry and bradykinesia of finger tapping and diadochokinesia were assessed by a 3D ultrasound motion detection system. VF was quantified by lexical and semantic tests. In a subgroup of patients, the effect of STN-DBS on tremor was modulated by expectation, i.e. tremor decreased (placebo response) or increased (nocebo response) by at least 10% as compared to the control condition while no significant effect was observed for the overall group. Interestingly, nocebo responders in MedON were additionally characterized by significant impairment in semantic verbal fluency. In contrast, bradykinesia was not affected by expectation. These results indicate that the therapeutic effect of STN-DBS on tremor can be modulated by expectation in a subgroup of patients and suggests that tremor is also among the parkinsonian symptoms responsive to placebo and nocebo interventions. While positive expectations enhanced the effect of STN-DBS by further decreasing the magnitude of tremor, negative expectations counteracted the therapeutic effect and at the same time exacerbated a side-effect often associated with STN-DBS. The present findings underscore the potency of patients' expectation and its relevance for therapeutic outcomes.	[Keitel, Ariane; Ferrea, Stefano; Suedmeyer, Martin; Schnitzler, Alfons; Wojtecki, Lars] Heinrich Heine Univ, Fac Med, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany; [Ferrea, Stefano; Suedmeyer, Martin; Schnitzler, Alfons; Wojtecki, Lars] Heinrich Heine Univ, Univ Hosp, Fac Med, Dept Neurol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Schnitzler, A (corresponding author), Heinrich Heine Univ, Fac Med, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany.	schnitza@uni-duesseldorf.de; wojtecki@uni-duesseldorf.de	Wojtecki, Lars/AAT-6604-2021; Ferrea, Stefano/AAP-5169-2020; Schnitzler, Alfons/K-4625-2014; Schnitzler, Alfons/AAT-1054-2021; Schnitzler, Alfons/Q-5520-2019	Wojtecki, Lars/0000-0002-6205-4405; Schnitzler, Alfons/0000-0002-6414-7939; Schnitzler, Alfons/0000-0002-6414-7939	German Research Foundation (DFG) within the Research Unit 'Expectation and Conditioning as Basic Processes of the Placebo and Nocebo Response - from Neurobiology to Clinical Application' [FOR 1328]	German Research Foundation (DFG) within the Research Unit 'Expectation and Conditioning as Basic Processes of the Placebo and Nocebo Response - from Neurobiology to Clinical Application'(German Research Foundation (DFG))	This study was funded by the German Research Foundation (DFG) within the Research Unit 'Expectation and Conditioning as Basic Processes of the Placebo and Nocebo Response - from Neurobiology to Clinical Application' (FOR 1328), Subproject 7 (A. Schnitzler/L. Wojtecki). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck AT., 1996, BECK DEPRESSION INVE; Benedetti F, 2004, NAT NEUROSCI, V7, P587, DOI 10.1038/nn1250; Benedetti F, 2003, J NEUROSCI, V23, P4315; Benedetti F, 2011, PATIENT EDUC COUNS, V84, P413, DOI 10.1016/j.pec.2011.04.034; Brown P, 2007, CURR OPIN NEUROBIOL, V17, P656, DOI 10.1016/j.conb.2007.12.001; Colloca L, 2008, PAIN, V136, P211, DOI 10.1016/j.pain.2008.02.006; Colloca L, 2010, PAIN, V151, P430, DOI 10.1016/j.pain.2010.08.007; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Eggers C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046813; Enck P, 2013, NAT REV DRUG DISCOV, V12, P191, DOI 10.1038/nrd3923; Goetz CG, 2000, NEUROLOGY, V54, P710, DOI 10.1212/WNL.54.3.710; Goetz CG, 2008, MOVEMENT DISORD, V23, P690, DOI 10.1002/mds.21894; Groiss S J, 2009, Ther Adv Neurol Disord, V2, P20, DOI 10.1177/1756285609339382; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; Kaptchuk TJ, 2008, CONTEMP CLIN TRIALS, V29, P587, DOI 10.1016/j.cct.2008.02.002; Keitel A, 2013, BEHAV BRAIN RES, V250, P199, DOI 10.1016/j.bbr.2013.04.051; Kumar R, 2003, CUR CLIN NEUROL, P189; Laux L., 1981, STATE TRAIT ANGSTINV; Lidstone SC, 2010, ARCH GEN PSYCHIAT, V67, P857, DOI 10.1001/archgenpsychiatry.2010.88; Mattis S, 1988, DEMENTIA RATING SCAL; Mercado R, 2006, MOVEMENT DISORD, V21, P1457, DOI 10.1002/mds.20935; Parsons TD, 2006, LANCET NEUROL, V5, P578, DOI 10.1016/S1474-4422(06)70475-6; Pollo A, 2002, NEUROREPORT, V13, P1383, DOI 10.1097/00001756-200208070-00006; Saez-Zea C, 2012, EUR NEUROL, V68, P361, DOI 10.1159/000341380; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; Smeding HMM, 2006, NEUROLOGY, V66, P1830, DOI 10.1212/01.wnl.0000234881.77830.66; Stathis P, 2013, EUR J NEUROL, V20, P527, DOI 10.1111/ene.12014; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; van de Berg Wilma D J, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS28, DOI 10.1016/S1353-8020(11)70011-6; Volkmann J, 2003, HAND CLIN N, V1st, P377; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929; Witt K, 2008, LANCET NEUROL, V7, P605, DOI 10.1016/S1474-4422(08)70114-5; Wojtecki L, 2006, ARCH NEUROL-CHICAGO, V63, P1273, DOI 10.1001/archneur.63.9.1273	34	25	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81878	10.1371/journal.pone.0081878	http://dx.doi.org/10.1371/journal.pone.0081878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312596	Green Published, gold, Green Submitted			2022-12-25	WOS:000327944500101
J	Wang, Z; Hong, KX; Zhang, J; Zhang, L; Li, D; Ren, L; Liang, H; Shao, YM				Wang, Zheng; Hong, Kunxue; Zhang, Jing; Zhang, Lei; Li, Dan; Ren, Li; Liang, Hua; Shao, Yiming			Construction and Characterization of Highly Infectious Full-Length Molecular Clones of a HIV-1 CRF07_BC Isolate from Xinjiang, China	PLOS ONE			English	Article							SUBTYPE-C; TYPE-1; CRF01-AE; PROVINCE	Among the various subtypes of the M group of human immunodeficiency virus type 1 (HIV-1), clade CRF07_BC is the most prevalent in China. To date, no strong replicable CRF07_BC infectious clone has been constructed. Here we report on the construction and characterization of highly replicable infectious molecular clones from the isolate XJDC6291 of this HIV-1 subtype. Four full-length clones pXJDC2-7, pXJDC3-7, pXJDC2-6 and pXJDC3-6 were successfully produced, but only pXJDC2-7 presented detectable infectivity and replication capability. To improve the replication capability of pXJDC2-7, a 4.8 kb region spanning from the pol Integrase to nef gene of the clone was replaced by PCR products of the corresponding fragments from the original isolate XJDC6291, which produced two clones pXJDC13 and pXJDC17 that exhibited strong replication capability. The viral stocks obtained by pXJDC-13 and pXJDC-17 transfection into 293T cells replicated efficiently in human PBMCs, human primary CD4(+) T cells and displayed CCR5 tropism. Sequence alignment between pXJDC13, pXJDC17 and pXJDC2-7 suggested that polymorphisms in the V1V2 region may influence infectivity, and reverse genetic experiment showed that V1V2 polymorphisms may influence the infectivity of the clones but did not affect the replication capability at a significant level. pXJDC13 and pXJDC17 displayed strong replication capability and are the first full-length infectious clones of HIV-1 CRF07_BC clade in the world. The availability of CRF07_BC infectious clones provides a useful tool for a wide range of studies, including antiretroviral drug and vaccine research as related to this HIV subtype.	[Wang, Zheng; Hong, Kunxue; Zhang, Jing; Zhang, Lei; Li, Dan; Ren, Li; Liang, Hua; Shao, Yiming] China CDC, Natl Ctr AIDS STD Control & Prevent, Div Res Virol & Immunol, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Wang, Zheng; Hong, Kunxue; Zhang, Jing; Zhang, Lei; Li, Dan; Ren, Li; Liang, Hua; Shao, Yiming] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Shao, YM (corresponding author), China CDC, Natl Ctr AIDS STD Control & Prevent, Div Res Virol & Immunol, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	yshao08@gmail.com			National Natural Science Foundation of China [81101281, 31100126]; National Science and Technology Major Project [2012ZX10001-002]; Project Sponsored by the Yong Scientific Research Foundation of China CDC [2013A102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; Project Sponsored by the Yong Scientific Research Foundation of China CDC	This work is partly supported by the National Natural Science Foundation of China (grants 81101281 and 31100126), National Science and Technology Major Project (grant 2012ZX10001-002), and The Project Sponsored by the Yong Scientific Research Foundation of China CDC (grant 2013A102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Bharat TAM, 2012, NATURE, V487, P385, DOI 10.1038/nature11169; Chen MS, 2001, VIRUS RES, V79, P91, DOI 10.1016/S0168-1702(01)00322-7; Dash PK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-25; He X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047289; Kraus MH, 2010, VIROLOGY, V397, P346, DOI 10.1016/j.virol.2009.11.019; Kusagawa S, 2002, AIDS RES HUM RETROV, V18, P115, DOI 10.1089/08892220252779656; Ma LY, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-45; Meng ZF, 2008, AIDS RES HUM RETROV, V24, P259, DOI 10.1089/aid.2007.0128; Mochizuki N, 1999, AIDS RES HUM RETROV, V15, P1321, DOI 10.1089/088922299310223; Mukai T, 2002, AIDS RES HUM RETROV, V18, P585, DOI 10.1089/088922202753747932; Ndung'u T, 2000, VIROLOGY, V278, P390, DOI 10.1006/viro.2000.0583; Novelli P, 2002, AIDS RES HUM RETROV, V18, P85, DOI 10.1089/088922202753394754; Parrish NF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002686; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Wang Z, 2008, AIDS RES HUM RETROV, V24, P251, DOI 10.1089/aid.2007.0226; Wei M, 2004, J CLIN MICROBIOL, V42, P4261, DOI 10.1128/JCM.42.9.4261-4267.2004; Yang RG, 2003, J VIROL, V77, P685, DOI 10.1128/JVI.77.1.685-695.2003; Zhang QW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031233	20	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e79177	10.1371/journal.pone.0079177	http://dx.doi.org/10.1371/journal.pone.0079177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24324545	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500032
J	Alam, I; Antunes, A; Kamau, AA; Alawi, WB; Kalkatawi, M; Stingl, U; Bajic, VB				Alam, Intikhab; Antunes, Andre; Kamau, Allan Anthony; Alawi, Wail Ba; Kalkatawi, Manal; Stingl, Ulrich; Bajic, Vladimir B.			INDIGO - INtegrated Data Warehouse of MIcrobial GenOmes with Examples from the Red Sea Extremophiles	PLOS ONE			English	Article							BRINE-SEAWATER INTERFACE; DEEP-SEA; SALINISPHAERA-SHABANENSIS; HALORHABDUS-TIAMATEA; SP NOV.; SEQUENCE; GENERATION; ANNOTATION; PREDICTION; CONTRACTILE	Background: The next generation sequencing technologies substantially increased the throughput of microbial genome sequencing. To functionally annotate newly sequenced microbial genomes, a variety of experimental and computational methods are used. Integration of information from different sources is a powerful approach to enhance such annotation. Functional analysis of microbial genomes, necessary for downstream experiments, crucially depends on this annotation but it is hampered by the current lack of suitable information integration and exploration systems for microbial genomes. Results: We developed a data warehouse system (INDIGO) that enables the integration of annotations for exploration and analysis of newly sequenced microbial genomes. INDIGO offers an opportunity to construct complex queries and combine annotations from multiple sources starting from genomic sequence to protein domain, gene ontology and pathway levels. This data warehouse is aimed at being populated with information from genomes of pure cultures and uncultured single cells of Red Sea bacteria and Archaea. Currently, INDIGO contains information from Salinisphaera shabanensis, Haloplasma contractile, and Halorhabdus tiamatea-extremophiles isolated from deep-sea anoxic brine lakes of the Red Sea. We provide examples of utilizing the system to gain new insights into specific aspects on the unique lifestyle and adaptations of these organisms to extreme environments. Conclusions: We developed a data warehouse system, INDIGO, which enables comprehensive integration of information from various resources to be used for annotation, exploration and analysis of microbial genomes. It will be regularly updated and extended with new genomes. It is aimed to serve as a resource dedicated to the Red Sea microbes. In addition, through INDIGO, we provide our Automatic Annotation of Microbial Genomes (AAMG) pipeline. The INDIGO web server is freely available at http:// www.cbrc.kaust.edu.sa/indigo.	[Alam, Intikhab; Kamau, Allan Anthony; Alawi, Wail Ba; Kalkatawi, Manal; Bajic, Vladimir B.] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Thuwal, Saudi Arabia; [Antunes, Andre] Univ Minho, Micoteca Univ Minho, Ctr Biol Engn, IBB Inst Biotechnol & Bioengn, Braga, Portugal; [Stingl, Ulrich] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia	King Abdullah University of Science & Technology; Universidade do Minho; King Abdullah University of Science & Technology	Alam, I (corresponding author), King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Thuwal, Saudi Arabia.	intikhab.alam@kaust.edu.sa; vladimir.bajic@kaust.edu.sa	Kalkatawi, Manal/H-2887-2018; Kalkatawi, Manal/H-4433-2019; Stingl, Uli/H-1191-2014; Antunes, André/A-8711-2012; alawi, Wail Ba/E-6680-2016; Bajic, Vladimir/D-2810-2009; Ba Alawi, Wail/M-4890-2016	Kalkatawi, Manal/0000-0002-9820-4129; Stingl, Uli/0000-0002-0684-2597; Antunes, André/0000-0001-7668-9842; alawi, Wail Ba/0000-0002-5218-6113; Bajic, Vladimir/0000-0001-5435-4750; Ba Alawi, Wail/0000-0002-2747-4703; Kamau, Allan/0000-0002-6659-3713; Alam, Intikhab/0000-0001-5306-847X	KAUST CBRC Base Fund of VBB; KAUST Base Funds of VBB; KAUST Base Fund of US; Saudi Economic and Development Company (SEDCO) Research Excellence award	KAUST CBRC Base Fund of VBB; KAUST Base Funds of VBB(King Abdullah University of Science & Technology); KAUST Base Fund of US(King Abdullah University of Science & Technology); Saudi Economic and Development Company (SEDCO) Research Excellence award	IA and AAK were supported from the KAUST CBRC Base Fund of VBB. WBa and VBB were supported from the KAUST Base Funds of VBB. US was supported by the KAUST Base Fund of US. This study was partly supported by the Saudi Economic and Development Company (SEDCO) Research Excellence award to US and VBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Valderrama JA, 2012, J BIOL CHEM, V287, P10494, DOI 10.1074/jbc.M111.309005; Antunes A, 2003, EXTREMOPHILES, V7, P29, DOI 10.1007/s00792-002-0292-5; Antunes A, 2008, J BACTERIOL, V190, P3580, DOI 10.1128/JB.01860-07; Antunes A, 2008, INT J SYST EVOL MICR, V58, P215, DOI 10.1099/ijs.0.65316-0; Antunes A, 2011, ENV MICROBIOL REP, V3, P416, DOI 10.1111/j.1758-2229.2011.00264.x; Antunes A, 2011, J BACTERIOL, V193, P4553, DOI 10.1128/JB.05462-11; Antunes A, 2011, J BACTERIOL, V193, P4551, DOI 10.1128/JB.05461-11; Antunes A, 2011, J BACTERIOL, V193, P4555, DOI 10.1128/JB.05459-11; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Garcia Castro Alexander, 2005, Appl Bioinformatics, V4, P157; HUBER R, 1995, NATURE, V376, P57, DOI 10.1038/376057a0; Huber R, 2000, FEMS MICROBIOL REV, V24, P615, DOI 10.1111/j.1574-6976.2000.tb00562.x; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lin SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060843; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Markowitz VM, 2007, CURR OPIN BIOTECH, V18, P267, DOI 10.1016/j.copbio.2007.04.005; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Medigue C, 2007, RES MICROBIOL, V158, P724, DOI 10.1016/j.resmic.2007.09.009; MICHAELIS W, 1990, APPL GEOCHEM, V5, P103, DOI 10.1016/0883-2927(90)90041-3; Mingorance J, 2004, J MOL RECOGNIT, V17, P481, DOI 10.1002/jmr.718; Nakabachi A, 2013, CURR BIOL, V23, P1478, DOI 10.1016/j.cub.2013.06.027; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Ngugi DK, 2012, MOL ECOL, V21, P388, DOI 10.1111/j.1365-294X.2011.05378.x; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; O'Malley MA, 2012, STUD HIST PHI PART C, V43, P58, DOI 10.1016/j.shpsc.2011.10.006; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Pareja-Tobes P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049239; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Richardson EJ, 2013, BRIEF BIOINFORM, V14, P1, DOI 10.1093/bib/bbs007; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Siefert JL, 1998, MICROBIOL-UK, V144, P2803, DOI 10.1099/00221287-144-10-2803; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Smith RN, 2012, BIOINFORMATICS, V28, P3163, DOI 10.1093/bioinformatics/bts577; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Stein LD, 2003, NAT REV GENET, V4, P337, DOI 10.1038/nrg1065; Tamames J, 2001, TRENDS GENET, V17, P124, DOI 10.1016/S0168-9525(00)02212-5; Tragou E, 1997, DEEP-SEA RES PT I, V44, P1355, DOI 10.1016/S0967-0637(97)00026-5; Triplet T, 2013, BRIEF BIOINFORM MEDL; Triplet T, 2011, DBKDA 2011: THE THIRD INTERNATIONAL CONFERENCE ON ADVANCES IN DATABASES, KNOWLEDGE, AND DATA APPLICATIONS, P34; Vallenet D, 2013, NUCLEIC ACIDS RES, V41, pE636, DOI 10.1093/nar/gks1194; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang J, 2011, DATABASE-OXFORD	62	59	60	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82210	10.1371/journal.pone.0082210	http://dx.doi.org/10.1371/journal.pone.0082210			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324765	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700065
J	Jonas, JB; Nangia, V; Wang, NL; Bhate, K; Nangia, P; Nangia, P; Yang, DY; Xie, XB; Panda-Jonas, S				Jonas, Jost B.; Nangia, Vinay; Wang, Ningli; Bhate, Karishma; Nangia, Prabhat; Nangia, Purna; Yang, Diya; Xie, Xiaobin; Panda-Jonas, Songhomitra			Trans-Lamina Cribrosa Pressure Difference and Open-Angle Glaucoma. The Central India Eye and Medical Study	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PRESSURE; BODY-MASS INDEX; INTRAOCULAR SPACE; BEIJING EYE; PREVALENCE; ASSOCIATIONS; HYPERTENSION; POPULATION	Purpose: To assess associations of the trans-lamina cribrosa pressure difference (TLCPD) with glaucomatous optic neuropathy. Methods: The population-based Central India Eye and Medical Study included 4711 subjects. Based on a previous study with lumbar cerebrospinal fluid pressure (CSFP) measurements, CSFP was calculated as CSFP[mmHg]=0.44 Body Mass Index[kg/m2]+0.16 Diastolic Blood Pressure[mmHg]-0.18xAge[Years]-1.91. TLCPD was IOP-CSFP. Results: Mean TLCPD was 3.64 +/- 4.25 mm Hg in the non-glaucomatous population and 9.65 +/- 8.17 mmHg in the glaucomatous group. In multivariate analysis, TLCPD was associated with older age (P < 0.001; standardized coefficient beta: 0.53; regression coefficient B: 0.18; 95% confidence interval (CI): 0.17, 0.18), lower body mass index (P < 0.001; beta: -0.28; B: -0.36; 95% CI: -0.38, -0.31), lower diastolic blood pressure (P < 0.001; beta: -0.31; B: -0.12; 95% CI: -0.13, -0.11), higher pulse (P < 0.001; beta: 0.05; B: 0.02; 95% CI: 0.01,0.2), lower body height (P = 0.02; beta: -0.02; B: -0.01; 95% CI: -0.02,0.00), higher educational level (P < 0.001; beta: 0.04; B: 0.15; 95% CI: 0.09,0.22), higher cholesterol blood concentrations (P < 0.001; beta: 0.04; B: 0.01; 95% CI: 0.01,0.01), longer axial length (P=0.006; beta: 0.03; B: 0.14; 95% CI: 0.04,0.24), thicker central cornea (P < 0.001; beta: 0.15; B: 0.02; 95% CI: 0.02,0.02), higher corneal refractive power (P < 0.001; beta: 0.07; B: 0.18; 95% CI: 0.13,0.23) and presence of glaucomatous optic neuropathy (P < 0.001; beta: 0.11; B: 3.43; 95% CI: 2.96,3.99). Differences between glaucomatous subjects and non-glaucomatous subjects in CSFP were more pronounced for open-angle glaucoma (OAG) than for angle-closure glaucoma (ACG) (3.0 mmHg versus 1.8 mmHg), while differences between glaucomatous subjects and non-glaucomatous subjects in IOP were higher for ACG than for OAG (8.5 mmHg versus 3.0 mmHg). Presence of OAG was significantly associated with TLCPD (P < 0.001; OR: 1.24; 95% CI: 1.19,1.29) but not with IOP (P = 0.08; OR: 0.96; 95% CI: 0.91,1.00). Prevalence of ACG was significantly associated with IOP (P = 0.04; OR: 1.19; 95% CI: 1.01,1.40) but not with TLCPD (P = 0.92). Conclusions: In OAG, but not in ACG, calculated TLCPD versus IOP showed a better association with glaucoma presence and amount of glaucomatous optic neuropathy. It supports the notion of a potential role of low CSFP in the pathogenesis of open-angle glaucoma.	[Jonas, Jost B.; Bhate, Karishma; Nangia, Prabhat; Nangia, Purna; Panda-Jonas, Songhomitra] Suraj Eye Inst, Nagpur, Maharashtra, India; [Jonas, Jost B.; Nangia, Vinay] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany; [Wang, Ningli; Yang, Diya; Xie, Xiaobin] Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China	Suraj Eye Institute; Ruprecht Karls University Heidelberg; Capital Medical University	Jonas, JB (corresponding author), Suraj Eye Inst, Nagpur, Maharashtra, India.	jost.jonas@medma.uni-heidelberg.de; nagpursuraj@gmail.com	Bhate, Karishma/AAD-8609-2019		Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; Carl Zeiss Meditec Co., Jena, Germany	Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; Carl Zeiss Meditec Co., Jena, Germany	This study was supported by an unrestricted grant from Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; and Carl Zeiss Meditec Co., Jena, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2012, INVEST OPHTH VIS SCI, V53, P1422, DOI 10.1167/iovs.11-8220; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; GILLAND O, 1969, NEW ENGL J MED, V280, P904; Jonas JB, 2004, INVEST OPHTH VIS SCI, V45, P2660, DOI 10.1167/iovs.03-1363; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; Jonas JB, 1999, J GLAUCOMA, V8, P227; Jonas JB, 2010, AM J HYPERTENS, V23, P347, DOI 10.1038/ajh.2009.276; MORGAN WH, 1995, INVEST OPHTH VIS SCI, V36, P1163; Morgan WH, 2008, J GLAUCOMA, V17, P408, DOI 10.1097/IJG.0b013e31815c5f7c; Morgan WH, 2008, CLIN EXP OPHTHALMOL, V36, P802, DOI 10.1111/j.1442-9071.2008.01881.x; Nangia V, 2013, PLOS ONE, V30; Nangia V, 2010, OPHTHALMOLOGY, V117, P1360, DOI 10.1016/j.ophtha.2009.11.040; Ren RJ, 2012, GRAEF ARCH CLIN EXP, V250, P445, DOI 10.1007/s00417-011-1746-1; Ren RJ, 2011, GRAEF ARCH CLIN EXP, V249, P1057, DOI 10.1007/s00417-011-1657-1; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; STRAUME M, 1992, METHOD ENZYMOL, V210, P87; Wang NL, 2012, OPHTHALMOLOGY, V119, P2065, DOI 10.1016/j.ophtha.2012.03.054; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Xie XB, 2013, CRIT CARE, V17, DOI 10.1186/cc12841; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Yablonski M, 1979, INVEST OPHTHALMOL  S, V18, P165	23	45	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82284	10.1371/journal.pone.0082284	http://dx.doi.org/10.1371/journal.pone.0082284			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324767	Green Published, gold, Green Submitted			2022-12-25	WOS:000328566700066
J	Alves, LR; Guerra-Slompo, EP; de Oliveira, AV; Malgarin, JS; Goldenberg, S; Dallagiovanna, B				Alves, Lysangela R.; Guerra-Slompo, Eloise P.; de Oliveira, Arthur V.; Malgarin, Juliane S.; Goldenberg, Samuel; Dallagiovanna, Bruno			mRNA Localization Mechanisms in Trypanosoma cruzi	PLOS ONE			English	Article							BINDING PROTEIN; DIFFERENTIATION; PROTEOMICS	Asymmetric mRNA localization is a sophisticated tool for regulating and optimizing protein synthesis and maintaining cell polarity. Molecular mechanisms involved in the regulated localization of transcripts are widespread in higher eukaryotes and fungi, but not in protozoa. Trypanosomes are ancient eukaryotes that branched off early in eukaryote evolution. We hypothesized that these organisms would have basic mechanisms of mRNA localization. FISH assays with probes against transcripts coding for proteins with restricted distributions showed a discrete localization of the mRNAs in the cytoplasm. Moreover, cruzipain mRNA was found inside reservosomes suggesting new unexpected functions for this vacuolar organelle. Individual mRNAs were also mobilized to RNA granules in response to nutritional stress. The cytoplasmic distribution of these transcripts changed with cell differentiation, suggesting that localization mechanisms might be involved in the regulation of stage-specific protein expression. Transfection assays with reporter genes showed that, as in higher eukaryotes, 3'UTRs were responsible for guiding mRNAs to their final location. Our results strongly suggest that Trypanosoma cruzi have a core, basic mechanism of mRNA localization. This kind of controlled mRNA transport is ancient, dating back to early eukaryote evolution.	[Alves, Lysangela R.; Guerra-Slompo, Eloise P.; de Oliveira, Arthur V.; Malgarin, Juliane S.; Goldenberg, Samuel; Dallagiovanna, Bruno] Fiocruz Parana, Inst Carlos Chagas, Lab Regulacao Expressao Genica, Curitiba, Parana, Brazil	Fundacao Oswaldo Cruz	Dallagiovanna, B (corresponding author), Fiocruz Parana, Inst Carlos Chagas, Lab Regulacao Expressao Genica, Curitiba, Parana, Brazil.	brunod@tecpar.br	Alves, Lysangela Ronalte/H-5599-2012; Dallagiovanna, Bruno/G-2531-2013; Goldenberg, Samuel/ABD-8908-2022; Dallagiovanna, Bruno/AAA-3603-2019; GOLDENBERG, SAMUEL/B-4116-2009	Alves, Lysangela Ronalte/0000-0002-1972-2658; Dallagiovanna, Bruno/0000-0001-6992-7048; GOLDENBERG, SAMUEL/0000-0002-4892-163X; Pavao Guerra Slompo, Eloise/0000-0003-2379-5099	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Oswaldo Cruz; CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Oswaldo Cruz; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao Oswaldo Cruz. LRA, SG and BD received fellowships from CNPq. The funders had no role in study design, data collection and analysis, the decision to publish or preparation of the manuscript.	Aparicio IM, 2004, INFECT IMMUN, V72, P5892, DOI 10.1128/IAI.72.10.5892-5902.2004; Araujo PR, 2011, PARASITOL INT, V60, P161, DOI 10.1016/j.parint.2011.01.006; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Cassola Alejandro, 2011, Curr Chem Biol, V5, P108; Cassola A, 2009, J BIOL CHEM, V284, P35015, DOI 10.1074/jbc.M109.031633; Cazzulo JJ, 1997, BIOL CHEM, V378, P1; CONTRERAS V T, 1988, Memorias do Instituto Oswaldo Cruz, V83, P123, DOI 10.1590/S0074-02761988000100016; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Cunha-e-Silva NL, 2002, FEMS MICROBIOL LETT, V214, P7, DOI 10.1111/j.1574-6968.2002.tb11317.x; de Souza W, 1999, MEM I OSWALDO CRUZ, V94, P17, DOI 10.1590/S0074-02761999000700003; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Fernandez-Moya SM, 2010, WIRES RNA, V1, P34, DOI 10.1002/wrna.6; Figueiredo RCBQ, 2000, J PARASITOL, V86, P1213, DOI 10.1645/0022-3395(2000)086[1213:DOTCEM]2.0.CO;2; de Godoy LMF, 2012, PROTEOMICS, V12, P2694, DOI 10.1002/pmic.201200078; Garcia-Silva MR, 2010, MOL BIOCHEM PARASIT, V171, P64, DOI 10.1016/j.molbiopara.2010.02.003; Giorgi C, 2007, SEMIN CELL DEV BIOL, V18, P186, DOI 10.1016/j.semcdb.2007.01.002; Girard-Dias W, 2012, HISTOCHEM CELL BIOL, V138, P821, DOI 10.1007/s00418-012-1002-8; Guerra-Slompo EP, 2012, BIOCHEM BIOPH RES CO, V420, P302, DOI 10.1016/j.bbrc.2012.02.154; Holetz FB, 2010, FEBS J, V277, P3415, DOI 10.1111/j.1742-4658.2010.07747.x; Holetz FB, 2007, BIOCHEM BIOPH RES CO, V356, P1062, DOI 10.1016/j.bbrc.2007.03.104; Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488; Jambhekar A, 2007, RNA, V13, P625, DOI 10.1261/rna.262607; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Li CH, 2006, RNA, V12, P2171, DOI 10.1261/rna.291506; Long RM, 2000, EMBO J, V19, P6592, DOI 10.1093/emboj/19.23.6592; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mili S, 2009, TRENDS CELL BIOL, V19, P156, DOI 10.1016/j.tcb.2009.02.001; Nardelli SC, 2007, EUKARYOT CELL, V6, P337, DOI 10.1128/EC.00279-06; Paquin N, 2008, TRENDS CELL BIOL, V18, P105, DOI 10.1016/j.tcb.2007.12.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SABORIO JL, 1989, J BIOL CHEM, V264, P4071; Sant'Anna C, 2009, PROTEOMICS, V9, P1782, DOI 10.1002/pmic.200800730; Serpeloni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020730; Serpeloni M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-7; SOARES MJ, 1988, J SUBMICR CYTOL PATH, V20, P349; Torrecilhas AC, 2012, MICROBES INFECT, V14, P1465, DOI 10.1016/j.micinf.2012.07.008; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Zarnack K, 2010, EUKARYOT CELL, V9, P982, DOI 10.1128/EC.00030-10	38	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81375	10.1371/journal.pone.0081375	http://dx.doi.org/10.1371/journal.pone.0081375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324687	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300088
J	Chang, SP; Morrison, HD; Nilsson, F; Kenyon, CJ; West, JD; Morley, SD				Chang, Su-Ping; Morrison, Hamish D.; Nilsson, Frida; Kenyon, Christopher J.; West, John D.; Morley, Steven D.			Cell Proliferation, Movement and Differentiation during Maintenance of the Adult Mouse Adrenal Cortex	PLOS ONE			English	Article							IN-VIVO; ADRENOCORTICAL REGENERATION; CENTRIPETAL MIGRATION; ALDOSTERONE SYNTHASE; GENE-EXPRESSION; MOSAIC PATTERN; STEM; GLAND; ZONATION; FETAL	Appropriate maintenance and regeneration of adult endocrine organs is important in both normal physiology and disease. We investigated cell proliferation, movement and differentiation in the adult mouse adrenal cortex, using different 5-bromo-2'-deoxyuridine (BrdU) labelling regimens and immunostaining for phenotypic steroidogenic cell markers. Pulse-labelling showed that cell division was largely confined to the outer cortex, with most cells moving inwards towards the medulla at around 13-20 mu m per day, though a distinct labelled cell population remained in the outer 10% of the cortex. Pulse-chase-labelling coupled with phenotypic immunostaining showed that, unlike cells in the inner cortex, most BrdU-positive outer cortical cells did not express steroidogenic markers, while co-staining for BrdU and Ki67 revealed that some outer cortical BrdU-positive cells were induced to proliferate following acute adrenocorticotropic hormone (ACTH) treatment. Extended pulse-chase-labelling identified cells in the outer cortex which retained BrdU label for up to 18-23 weeks. Together, these observations are consistent with the location of both slow-cycling stem/progenitor and transiently amplifying cell populations in the outer cortex. Understanding the relationships between these distinct adrenocortical cell populations will be crucial to clarify mechanisms underpinning adrenocortical maintenance and long-term adaptation to pathophysiological states.	[Chang, Su-Ping; West, John D.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Morrison, Hamish D.; Nilsson, Frida; Morley, Steven D.] Univ Edinburgh, Div Hlth Sci, Edinburgh, Midlothian, Scotland; [Kenyon, Christopher J.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Morley, SD (corresponding author), Univ Edinburgh, Div Hlth Sci, Edinburgh, Midlothian, Scotland.	steve.morley@ed.ac.uk	Morley, Steve/AAY-9985-2020	Morrison, Hamish/0000-0001-9358-7936; West, John/0000-0002-5886-0359; Morley, Steven/0000-0002-7355-3349	Tenovus Scotland [E04/6]; Biochemical Society Guildford Bench Methodology Fund; Edinburgh Development Trust [GR000184]; Charlie Walters Bequest Fund; University of Edinburgh Common Bursaries Fund; Carnegie Trust; Biochemical Society; University of Edinburgh; British Heart Foundation Centre of Research Excellence award; Medical Research Council [G1002033] Funding Source: researchfish; MRC [G1002033] Funding Source: UKRI	Tenovus Scotland; Biochemical Society Guildford Bench Methodology Fund; Edinburgh Development Trust; Charlie Walters Bequest Fund; University of Edinburgh Common Bursaries Fund; Carnegie Trust(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Biochemical Society; University of Edinburgh; British Heart Foundation Centre of Research Excellence award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Tenovus Scotland (http://www.tenovus-scotland.org.uk/) grant award (E04/6) to JDW and SDM, and small project grant awards from the Biochemical Society Guildford Bench Methodology Fund (http://www.biochemistry.org/), the Edinburgh Development Trust (GR000184) (http://www.edinburghcampaign.com/) and the Charlie Walters Bequest Fund to SDM. S-PC is grateful for an award from the University of Edinburgh Common Bursaries Fund (http://www.ed.ac.uk/). HDM & FN received vacation studentships from the Carnegie Trust (http://www.carnegietrust.org/), the Biochemical Society (http://www.biochemistry.org/), and the University of Edinburgh Research Bursary Awards (http://www.ed.ac.uk/). CJK is funded from a British Heart Foundation Centre of Research Excellence award (http://www.bhf.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 2009, J PATHOL, V217, P144, DOI 10.1002/path.2498; BERTHOLET JY, 1980, J ENDOCRINOL, V87, P1, DOI 10.1677/joe.0.0870001; Bielohuby M, 2007, AM J PHYSIOL-ENDOC M, V293, pE139, DOI 10.1152/ajpendo.00705.2006; Breidert M, 1998, EXP CLIN ENDOCR DIAB, V106, P478, DOI 10.1055/s-0029-1212020; Carsia RV, 1996, CELL TISSUE RES, V283, P247, DOI 10.1007/s004410050535; Chang SP, 2011, ORGANOGENESIS, V7, P267, DOI 10.4161/org.7.4.18060; CHOU FP, 1989, J ENDOCRINOL, V122, P403, DOI 10.1677/joe.0.1220403; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Ennen WB, 2005, AM J PHYSIOL-ENDOC M, V289, pE883, DOI 10.1152/ajpendo.00031.2005; ESTIVARIZ FE, 1992, ADRENAL GLAND, P43; Iannaccone P, 2002, FASEB J, V16, P41, DOI 10.1096/fj.02-0451fje; IANNACCONE PM, 1987, CELL DIFFER DEV, V21, P79, DOI 10.1016/0045-6039(87)90415-5; IANNACCONE PM, 1987, J EXP ZOOL, V243, P217, DOI 10.1002/jez.1402430207; Kataoka Y, 1996, J ANAT, V188, P375; Kim AC, 2009, ENDOCR REV, V30, P241, DOI 10.1210/er.2008-0039; King P, 2009, P NATL ACAD SCI USA, V106, P21185, DOI 10.1073/pnas.0909471106; MCEWAN PE, 1995, ENDOCR RES, V21, P91, DOI 10.3109/07435809509030424; McEwan PE, 1999, AM J PHYSIOL-ENDOC M, V276, pE303, DOI 10.1152/ajpendo.1999.276.2.E303; MCNICOL AM, 1987, CELL TISSUE KINET, V20, P519, DOI 10.1111/j.1365-2184.1987.tb01361.x; Mitani F, 1999, ENDOCRINOLOGY, V140, P3342, DOI 10.1210/en.140.7.3342; Mitani F, 2003, BBA-GEN SUBJECTS, V1619, P317, DOI 10.1016/S0304-4165(02)00490-7; Miyamoto H, 1999, J BIOCHEM, V126, P1175, DOI 10.1093/oxfordjournals.jbchem.a022564; Morley SD, 2002, ENDOCR RES, V28, P657, DOI 10.1081/ERC-120016982; Morley SD, 1996, MOL ENDOCRINOL, V10, P585, DOI 10.1210/me.10.5.585; Nishimoto K, 2010, J CLIN ENDOCR METAB, V95, P2296, DOI 10.1210/jc.2009-2010; RASCHELLA G, 1989, J HISTOCHEM CYTOCHEM, V37, P751, DOI 10.1177/37.5.2784812; Snippert HJ, 2011, EMBO REP, V12, P113, DOI 10.1038/embor.2010.216; Toth ZE, 2007, J HISTOCHEM CYTOCHEM, V55, P545, DOI 10.1369/jhc.6A7134.2007; VECCHI A, 1994, EUR J CELL BIOL, V63, P247; Vinson GP, 2003, MICROSC RES TECHNIQ, V61, P227, DOI 10.1002/jemt.10331; WEST JD, 2001, ENCY GENETICS, P293; Wood MA, 2011, MOL CELL ENDOCRINOL, V336, P206, DOI 10.1016/j.mce.2010.11.012; Wotus C, 1998, ENDOCRINOLOGY, V139, P4397, DOI 10.1210/en.139.10.4397; Ye P, 2003, ENDOCRINOLOGY, V144, P3321, DOI 10.1210/en.2003-0109; ZAJICEK G, 1986, J ENDOCRINOL, V111, P477, DOI 10.1677/joe.0.1110477; Zhang H, 1999, ENDOCR RES, V25, P51, DOI 10.1080/07435809909066129; ZIMMERMAN M, 1985, ATHEROSCLEROSIS, V58, P39, DOI 10.1016/0021-9150(85)90054-1	37	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81865	10.1371/journal.pone.0081865	http://dx.doi.org/10.1371/journal.pone.0081865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324726	Green Submitted, Green Published, gold			2022-12-25	WOS:000327949300111
J	Gesualdo, F; Stilo, G; Agricola, E; Gonfiantini, MV; Pandolfi, E; Velardi, P; Tozzi, AE				Gesualdo, Francesco; Stilo, Giovanni; Agricola, Eleonora; Gonfiantini, Michaela V.; Pandolfi, Elisabetta; Velardi, Paola; Tozzi, Alberto E.			Influenza-Like Illness Surveillance on Twitter through Automated Learning of Naive Language	PLOS ONE			English	Article							COMMUNICATION; SEARCH	Twitter has the potential to be a timely and cost-effective source of data for syndromic surveillance. When speaking of an illness, Twitter users often report a combination of symptoms, rather than a suspected or final diagnosis, using naive, everyday language. We developed a minimally trained algorithm that exploits the abundance of health-related web pages to identify all jargon expressions related to a specific technical term. We then translated an influenza case definition into a Boolean query, each symptom being described by a technical term and all related jargon expressions, as identified by the algorithm. Subsequently, we monitored all tweets that reported a combination of symptoms satisfying the case definition query. In order to geolocalize messages, we defined 3 localization strategies based on codes associated with each tweet. We found a high correlation coefficient between the trend of our influenza-positive tweets and ILI trends identified by US traditional surveillance systems.	[Gesualdo, Francesco; Agricola, Eleonora; Gonfiantini, Michaela V.; Pandolfi, Elisabetta; Tozzi, Alberto E.] Bambino Gesu Childrens Hosp IRCCS, Multifactorial Dis & Complex Phenotypes Res Area, Rome, Italy; [Stilo, Giovanni; Velardi, Paola] Univ Roma La Sapienza, Dept Informat, I-00185 Rome, Italy	IRCCS Bambino Gesu; Sapienza University Rome	Gesualdo, F (corresponding author), Bambino Gesu Childrens Hosp IRCCS, Multifactorial Dis & Complex Phenotypes Res Area, Rome, Italy.	f.gesualdo@gmail.com	Stilo, Giovanni/AAE-5484-2020; Gonfiantini, Michaela Veronika/AAA-7363-2020; Tozzi, Alberto Eugenio/F-9494-2012; Gesualdo, Francesco/H-9221-2012; Pandolfi, Elisabetta/K-5173-2016	Tozzi, Alberto Eugenio/0000-0002-6884-984X; Gesualdo, Francesco/0000-0002-9087-4398; Velardi, Paola/0000-0003-0884-1499; Pandolfi, Elisabetta/0000-0003-2424-2736	Bambino Gesu Children's Hospital	Bambino Gesu Children's Hospital	The study has been funded by the Bambino Gesu Children's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althouse BM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001258; Batler D., 2013, GOOGLE GOT FLU WRONG; BERENDT B, 2010, ENCY MACHINE LEARNIN, P968, DOI DOI 10.1007/978-0-387-30164-8\827; Bodnar T, 2013, PROCEEDINGS OF THE 22ND INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'13 COMPANION), P699; Bosley JC, 2013, RESUSCITATION, V84, P206, DOI 10.1016/j.resuscitation.2012.10.017; Burton SH, 2012, J MED INTERNET RES, V14, P366, DOI 10.2196/jmir.2121; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P914; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; CLEVELAND WS, 1988, J ECONOMETRICS, V37, P87, DOI 10.1016/0304-4076(88)90077-2; Cohen AM, 2005, BRIEF BIOINFORM, V6, P57, DOI 10.1093/bib/6.1.57; Cook S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023610, 10.1371/journal.pone.0025407]; Cooper Crystale Purvis, 2005, J Med Internet Res, V7, pe36, DOI 10.2196/jmir.7.3.e36; *EUR CTR DIS PREV, 2013, INFL CAS DEF; Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Hay SI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001413; Heaivilin N, 2011, J DENT RES, V90, P1047, DOI 10.1177/0022034511415273; *INFL, 2013, ILI CAS DEF; *JOBSTOCK, 2013, SOC MED STAT; John CA, 2012, EPIDEMIOLOGY, V23, P764, DOI 10.1097/EDE.0b013e3182625e5d; Lamb A., 2013, P NAACL HLT, V2013, P789; Ortiz JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018687; Paul M. J., 2011, 5 INT AAAI C WEB SOC; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Smith A., 2012, PEW INTERNET AM LIFE; Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]	27	39	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82489	10.1371/journal.pone.0082489	http://dx.doi.org/10.1371/journal.pone.0082489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324799	Green Submitted, gold, Green Published			2022-12-25	WOS:000327949300155
J	Hoppner, H; McIntyre, J; van der Smagt, P				Hoeppner, Hannes; McIntyre, Joseph; van der Smagt, Patrick			Task Dependency of Grip Stiffness-A Study of Human Grip Force and Grip Stiffness Dependency during Two Different Tasks with Same Grip Forces	PLOS ONE			English	Article							PRECISION GRIP; FINGER FORCES; LOAD FORCE; POSTURE; STABILITY	It is widely known that the pinch-grip forces of the human hand are linearly related to the weight of the grasped object. Less is known about the relationship between grip force and grip stiffness. We set out to determine variations to these dependencies in different tasks with and without visual feedback. In two different settings, subjects were asked to (a) grasp and hold a stiffness-measuring manipulandum with a predefined grip force, differing from experiment to experiment, or (b) grasp and hold this manipulandum of which we varied the weight between trials in a more natural task. Both situations led to grip forces in comparable ranges. As the measured grip stiffness is the result of muscle and tendon properties, and since muscle/tendon stiffness increases more-or-less linearly as a function of muscle force, we found, as might be predicted, a linear relationship between grip force and grip stiffness. However, the measured stiffness ranges and the increase of stiffness with grip force varied significantly between the two tasks. Furthermore, we found a strong correlation between regression slope and mean stiffness for the force task which we ascribe to a force stiffness curve going through the origin. Based on a biomechanical model, we attributed the difference between both tasks to changes in wrist configuration, rather than to changes in cocontraction. In a new set of experiments where we prevent the wrist from moving by fixing it and resting it on a pedestal, we found subjects exhibiting similar stiffness/force characteristics in both tasks.	[Hoeppner, Hannes] German Aerosp Ctr, Inst Robot & Mechatron, Wessling, Germany; [McIntyre, Joseph] CNRS, Ctr Etud Sensorimotricite, Paris, France; [McIntyre, Joseph] Univ Paris 05, Paris, France; [van der Smagt, Patrick] Tech Univ Munich, Fac Informat, D-80290 Munich, Germany	Helmholtz Association; German Aerospace Centre (DLR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Technical University of Munich	Hoppner, H (corresponding author), German Aerosp Ctr, Inst Robot & Mechatron, Wessling, Germany.	hannes.hoeppner@dlr.de	McIntyre, Joseph/K-6395-2015	McIntyre, Joseph/0000-0003-4974-4257; Hoppner, Hannes/0000-0003-3184-7653; van der Smagt, Patrick/0000-0003-4418-4916	European Commission [FP7-ICT-231576]; Hand Embodied [FP7-ICT-248587]	European Commission(European CommissionEuropean Commission Joint Research Centre); Hand Embodied	This work has been partially funded by the European Commission's Seventh Framework Programme as part of the projects STIFF under grant no. (FP7-ICT-231576) and The Hand Embodied under grant no. (FP7-ICT-248587). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLUM JHJ, 1984, J NEUROPHYSIOL, V52, P797, DOI 10.1152/jn.1984.52.5.797; Brand P. W., 1999, CLIN MECH HAND; CARTER RR, 1993, J NEUROPHYSIOL, V69, P943, DOI 10.1152/jn.1993.69.3.943; CARTER RR, 1990, J NEUROPHYSIOL, V64, P105, DOI 10.1152/jn.1990.64.1.105; EDIN BB, 1992, J PHYSIOL-LONDON, V450, P547, DOI 10.1113/jphysiol.1992.sp019142; FLANAGAN JR, 1995, EXP BRAIN RES, V105, P455; FLANAGAN JR, 1994, J EXP PSYCHOL HUMAN, V20, P944, DOI 10.1037/0096-1523.20.5.944; FLANAGAN JR, 1993, EXP BRAIN RES, V95, P131; FORSSBERG H, 1991, EXP BRAIN RES, V85, P451; Hajian AZ, 1997, J BIOMECH ENG-T ASME, V119, P109, DOI 10.1115/1.2796052; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; HOGAN N, 1985, BIOL CYBERN, V52, P315, DOI 10.1007/BF00355754; Hoppner H., 2011, 2011 IEEE International Conference on Robotics and Automation (ICRA 2011), P3312, DOI 10.1109/ICRA.2011.5980217; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; Kinoshita H, 1996, ERGONOMICS, V39, P243, DOI 10.1080/00140139608964455; Mandel J, 1984, STAT ANAL EXPT DATA; Milner TE, 1998, IEEE T BIO-MED ENG, V45, P1363, DOI 10.1109/10.725333; MUSSAIVALDI FA, 1985, J NEUROSCI, V5, P2732; ODRISCOLL SW, 1992, J HAND SURG-AM, V17A, P169, DOI 10.1016/0363-5023(92)90136-D; Rancourt D, 2001, J MOTOR BEHAV, V33, P351, DOI 10.1080/00222890109601919; SHADMEHR R, 1992, BIOL CYBERN, V66, P463, DOI 10.1007/BF00204111; TARKKA IM, 1986, ACTA PHYSIOL SCAND, V128, P71, DOI 10.1111/j.1748-1716.1986.tb07951.x; Van Doren C L, 1998, Motor Control, V2, P352; Vaus D., 2002, ANAL SOCIAL SCI DATA; White O, 2011, J NEUROSCIENCE, P189; Zatsiorsky VM, 2006, J NEUROPHYSIOL, V95, P2513, DOI 10.1152/jn.00839.2005; Zatsiorsky VM, 2005, EXP BRAIN RES, V162, P300, DOI 10.1007/s00221-004-2152-2	27	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80889	10.1371/journal.pone.0080889	http://dx.doi.org/10.1371/journal.pone.0080889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324643	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000327949300054
J	Abe, Y; Ozaki, Y; Kasuya, J; Yamamoto, K; Ando, J; Sudo, R; Ikeda, M; Tanishita, K				Abe, Yoshinori; Ozaki, Yoshiyuki; Kasuya, Junichi; Yamamoto, Kimiko; Ando, Joji; Sudo, Ryo; Ikeda, Mariko; Tanishita, Kazuo			Endothelial Progenitor Cells Promote Directional Three-Dimensional Endothelial Network Formation by Secreting Vascular Endothelial Growth Factor	PLOS ONE			English	Article							IN-VITRO; POSTNATAL NEOVASCULARIZATION; THERAPEUTIC ANGIOGENESIS; MYOCARDIAL-ISCHEMIA; VEGF-A; TRANSPLANTATION; MORPHOGENESIS; DELIVERY	Endothelial progenitor cell (EPC) transplantation induces the formation of new blood-vessel networks to supply nutrients and oxygen, and is feasible for the treatment of ischemia and cardiovascular diseases. However, the role of EPCs as a source of proangiogenic cytokines and consequent generators of an extracellular growth factor microenvironment in three-dimensional (3D) microvessel formation is not fully understood. We focused on the contribution of EPCs as a source of proangiogenic cytokines on 3D microvessel formation using an in vitro 3D network model. To create a 3D network model, EPCs isolated from rat bone marrow were sandwiched with double layers of collagen gel. Endothelial cells (ECs) were then cultured on top of the upper collagen gel layer. Quantitative analyses of EC network formation revealed that the length, number, and depth of the EC networks were significantly enhanced in a 3D model with ECs and EPCs compared to an EC monoculture. In addition, conditioned medium (CM) from the 3D model with ECs and EPCs promoted network formation compared to CM from an EC monoculture. We also confirmed that EPCs secreted vascular endothelial growth factor (VEGF). However, networks cultured with the CM were shallow and did not penetrate the collagen gel in great depth. Therefore, we conclude that EPCs contribute to 3D network formation at least through indirect incorporation by generating a local VEGF gradient. These results suggest that the location of EPCs is important for controlling directional 3D network formation in the field of tissue engineering.	[Abe, Yoshinori; Kasuya, Junichi; Sudo, Ryo] Keio Univ, Grad Sch Sci & Technol, Sch Integrated Design Engn, Kohoku Ku, Yokohama, Kanagawa 223, Japan; [Ozaki, Yoshiyuki] Keio Univ, Grad Sch Sci & Technol, Sch Fundamental Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 223, Japan; [Kasuya, Junichi] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Yamamoto, Kimiko] Univ Tokyo, Grad Sch Med, Dept Biomed Engn, Lab Syst Physiol, Tokyo, Japan; [Ando, Joji] Dokkyo Med Univ, Sch Med, Biomed Engn Lab, Mibu, Tochigi, Japan; [Sudo, Ryo; Ikeda, Mariko; Tanishita, Kazuo] Keio Univ, Sch Sci & Technol, Dept Syst Design Engn, Kohoku Ku, Yokohama, Kanagawa 223, Japan; [Tanishita, Kazuo] Waseda Univ, Inst Nanosci & Nanotechnol, Shinjuku Ku, Tokyo, Japan	Keio University; Keio University; Massachusetts Institute of Technology (MIT); University of Tokyo; Dokkyo Medical University; Keio University; Waseda University	Tanishita, K (corresponding author), Keio Univ, Sch Sci & Technol, Dept Syst Design Engn, Kohoku Ku, Yokohama, Kanagawa 223, Japan.	tanishita@aoni.waseda.jp	Sudo, Ryo/D-2319-2010	Sudo, Ryo/0000-0002-1053-9662	Grants-in-Aid for Scientific Research [25249018, 24650250, 25560208] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Asahara T, 2007, YAKUGAKU ZASSHI, V127, P841, DOI 10.1248/yakushi.127.841; Blebea J, 2002, J VASC SURG, V35, P532, DOI 10.1067/mva.2002.120042; Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643; Finkenzeller G, 2007, TISSUE ENG, V13, P1413, DOI 10.1089/ten.2006.0369; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Helm CLE, 2005, P NATL ACAD SCI USA, V102, P15779, DOI 10.1073/pnas.0503681102; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Jeon O, 2006, J ENDOVASC THER, V13, P175, DOI 10.1583/05-1713MR.1; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kano MR, 2005, J CELL SCI, V118, P3759, DOI 10.1242/jcs.02483; Kawamoto A, 2001, CIRCULATION, V103, P634; Khademhosseini A, 2009, SCI AM, V300, P64, DOI 10.1038/scientificamerican0509-64; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Koga M, 2009, TISSUE ENG PT A, V15, P2727, DOI [10.1089/ten.tea.2008.0417, 10.1089/ten.TEA.2008.0417]; Laham RJ, 2000, J PHARMACOL EXP THER, V292, P795; Lederman RJ, 2002, LANCET, V359, P2053, DOI 10.1016/S0140-6736(02)08937-7; Masuda H, 2003, CARDIOVASC RES, V58, P390, DOI 10.1016/S0008-6363(02)00785-X; Mukai N, 2008, EXP CELL RES, V314, P430, DOI 10.1016/j.yexcr.2007.11.016; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Scheubel RJ, 2010, INT J CARDIOL, V139, P134, DOI 10.1016/j.ijcard.2008.10.009; Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Wang QR, 2008, J CELL BIOCHEM, V103, P21, DOI 10.1002/jcb.21377; Yamato M, 2009, TRENDS SCI, V14, P36, DOI [10.5363/tits.14.10_36, DOI 10.5363/TITS.14.10_]	32	24	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82085	10.1371/journal.pone.0082085	http://dx.doi.org/10.1371/journal.pone.0082085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312630	Green Published, gold, Green Submitted			2022-12-25	WOS:000327947800082
J	Dorries, K; Lalk, M				Doerries, Kirsten; Lalk, Michael			Metabolic Footprint Analysis Uncovers Strain Specific Overflow Metabolism and D-Isoleucine Production of Staphylococcus Aureus COL and HG001	PLOS ONE			English	Article							D-AMINO ACIDS; CHAIN FATTY-ACIDS; LACTOCOCCUS-LACTIS; ENDOTHELIAL-CELLS; STATIONARY-PHASE; EXPRESSION; ACETATE; VIRULENCE; ALCOHOL; GROWTH	During infection processes, Staphylococcus aureus is able to survive within the host and to invade tissues and cells. For studying the interaction between the pathogenic bacterium and the host cell, the bacterial growth behaviour and its metabolic adaptation to the host cell environment provides first basic information. In the present study, we therefore cultivated S. aureus COL and HG001 in the eukaryotic cell culture medium RPMI 1640 and analyzed the extracellular metabolic uptake and secretion patterns of both commonly used laboratory strains. Extracellular accumulation of D-isoleucine was detected starting during exponential growth of COL and HG001 in RPMI medium. This non-canonical D-amino acid is known to play a regulatory role in adaptation processes. Moreover, individual uptake of glucose, accumulation of acetate, further overflow metabolites, and intermediates of the branched-chain amino acid metabolism constitute unique metabolic footprints. Altogether these time-resolved footprint analyses give first metabolic insights into staphylococcal growth behaviour in a culture medium used for infection related studies.	[Doerries, Kirsten; Lalk, Michael] Ernst Moritz Arndt Univ Greifswald, Inst Biochem, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald	Lalk, M (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Biochem, Greifswald, Germany.	lalk@uni-greifswald.de	Lalk, Michael/C-1618-2010	Lalk, Michael/0000-0002-9230-0267	Deutsche Forschungsgemeinschaft (DFG) [SFB/TRR34]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by a grant of the Deutsche Forschungsgemeinschaft (DFG) within the SFB/TRR34. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse SL, 1999, CARCINOGENESIS, V20, P629, DOI 10.1093/carcin/20.4.629; Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; BLUMENTH.HJ, 1974, ANN NY ACAD SCI, V236, P105, DOI 10.1111/j.1749-6632.1974.tb41485.x; Burian M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010040; Cava F, 2011, EMBO J, V30, P3442, DOI 10.1038/emboj.2011.246; Chambellon E, 2003, APPL ENVIRON MICROB, V69, P3061, DOI 10.1128/AEM.69.6.3061-3068.2003; de Felipe FL, 1998, J BACTERIOL, V180, P3804; Dickinson JR, 1998, J BIOL CHEM, V273, P25751, DOI 10.1074/jbc.273.40.25751; Dickinson JR, 1997, J BIOL CHEM, V272, P26871, DOI 10.1074/jbc.272.43.26871; Dickinson JR, 2000, J BIOL CHEM, V275, P10937, DOI 10.1074/jbc.275.15.10937; Fuchs S, 2007, J BACTERIOL, V189, P4275, DOI 10.1128/JB.00081-07; GARDNER JF, 1962, J GEN MICROBIOL, V29, P157, DOI 10.1099/00221287-29-1-157; Garzoni C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-171; Gaupp R, 2010, J BACTERIOL, V192, P2385, DOI 10.1128/JB.01472-09; Gertz S, 1999, MOL GEN GENET, V261, P558, DOI 10.1007/s004380051001; Giese B, 2011, CELL MICROBIOL, V13, P316, DOI 10.1111/j.1462-5822.2010.01538.x; GOLDSCHMIDT MC, 1953, ARCH BIOCHEM BIOPHYS, V46, P154, DOI 10.1016/0003-9861(53)90178-7; HAMILL RJ, 1986, INFECT IMMUN, V54, P833, DOI 10.1128/IAI.54.3.833-836.1986; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Hochbaum AI, 2011, J BACTERIOL, V193, P5616, DOI 10.1128/JB.05534-11; Horcajo P, 2012, MICROB DRUG RESIST, V18, P306, DOI 10.1089/mdr.2012.0009; Hugenholtz J, 2000, APPL ENVIRON MICROB, V66, P4112, DOI 10.1128/AEM.66.9.4112-4114.2000; Jan G, 2002, CELL DEATH DIFFER, V9, P179, DOI 10.1038/sj.cdd.4400935; Klukas C, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-112; Kohler C, 2005, INT J MED MICROBIOL, V295, P547, DOI 10.1016/j.ijmm.2005.08.002; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Lavermicocca P, 2000, APPL ENVIRON MICROB, V66, P4084, DOI 10.1128/AEM.66.9.4084-4090.2000; Le Bars D, 2008, J APPL MICROBIOL, V104, P171, DOI 10.1111/j.1365-2672.2007.03539.x; Liebeke M, 2011, MOL BIOSYST, V7, P1241, DOI 10.1039/c0mb00315h; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lupoli TJ, 2011, J AM CHEM SOC, V133, P10748, DOI 10.1021/ja2040656; Majerczyk CD, 2010, J BACTERIOL, V192, P2861, DOI 10.1128/JB.00220-10; Patton TG, 2005, MOL MICROBIOL, V56, P1664, DOI 10.1111/j.1365-2958.2005.04653.x; Pfortner H, 2013, METHODS, V61, P244, DOI 10.1016/j.ymeth.2013.04.009; Pothera DC, 2013, INT J MED MICROBIOL, V303, P114, DOI 10.1016/j.ijmm.2013.01.003; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Sachse F, 2010, ALLERGY, V65, P1430, DOI 10.1111/j.1398-9995.2010.02381.x; Sadykov MR, 2011, MICROBIOL-SGM, V157, P3458, DOI 10.1099/mic.0.051243-0; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SCHABERG DR, 1991, AM J MED, V91, pS72, DOI 10.1016/0002-9343(91)90346-Y; Schmidt F, 2010, PROTEOMICS, V10, P2801, DOI 10.1002/pmic.201000045; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Seidl K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-95; SHAFER WM, 1979, INFECT IMMUN, V25, P902, DOI 10.1128/IAI.25.3.902-911.1979; Shi L, 2006, J BIOL CHEM, V281, P29131, DOI 10.1074/jbc.M604640200; Somerville GA, 2003, INFECT IMMUN, V71, P4724, DOI 10.1128/IAI.71.8.4724-4732.2003; Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002; Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001; STRASTERS KC, 1963, J GEN MICROBIOL, V33, P213, DOI 10.1099/00221287-33-2-213; Valerio F, 2004, FEMS MICROBIOL LETT, V233, P289, DOI [10.1111/j.1574-6968.2004.tb09494.x, 10.1016/j.femsle.2004.02.020]; VANN JM, 1987, INFECT IMMUN, V55, P2155, DOI 10.1128/IAI.55.9.2155-2163.1987; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Zhu YF, 2009, INFECT IMMUN, V77, P4256, DOI 10.1128/IAI.00195-09	55	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81500	10.1371/journal.pone.0081500	http://dx.doi.org/10.1371/journal.pone.0081500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312553	Green Published, Green Submitted, gold			2022-12-25	WOS:000327947800047
J	Murphy, MC; Huston, J; Jack, CR; Glaser, KJ; Senjem, ML; Chen, J; Manduca, A; Felmlee, JP; Ehman, RL				Murphy, Matthew C.; Huston, John, III; Jack, Clifford R., Jr.; Glaser, Kevin J.; Senjem, Matthew L.; Chen, Jun; Manduca, Armando; Felmlee, Joel P.; Ehman, Richard L.			Measuring the Characteristic Topography of Brain Stiffness with Magnetic Resonance Elastography	PLOS ONE			English	Article							ALZHEIMERS-DISEASE	Purpose: To develop a reliable magnetic resonance elastography (MRE)-based method for measuring regional brain stiffness. Methods: First, simulation studies were used to demonstrate how stiffness measurements can be biased by changes in brain morphometry, such as those due to atrophy. Adaptive postprocessing methods were created that significantly reduce the spatial extent of edge artifacts and eliminate atrophy-related bias. Second, a pipeline for regional brain stiffness measurement was developed and evaluated for test-retest reliability in 10 healthy control subjects. Results: This technique indicates high test-retest repeatability with a typical coefficient of variation of less than 1% for global brain stiffness and less than 2% for the lobes of the brain and the cerebellum. Furthermore, this study reveals that the brain possesses a characteristic topography of mechanical properties, and also that lobar stiffness measurements tend to correlate with one another within an individual. Conclusion: The methods presented in this work are resistant to noise-and edge-related biases that are common in the field of brain MRE, demonstrate high test-retest reliability, and provide independent regional stiffness measurements. This pipeline will allow future investigations to measure changes to the brain's mechanical properties and how they relate to the characteristic topographies that are typical of many neurologic diseases.	[Murphy, Matthew C.; Huston, John, III; Jack, Clifford R., Jr.; Glaser, Kevin J.; Senjem, Matthew L.; Chen, Jun; Felmlee, Joel P.; Ehman, Richard L.] Mayo Clin, Coll Med, Dept Radiol, Rochester, MN 55905 USA; [Manduca, Armando] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Huston, J (corresponding author), Mayo Clin, Coll Med, Dept Radiol, Rochester, MN 55905 USA.	jhuston@mayo.edu	Senjem, Matthew L/GRF-6799-2022; Jack, Clifford R/F-2508-2010; Chen, Jun/A-3426-2013	Senjem, Matthew L/0000-0001-9308-9275; Jack, Clifford R/0000-0001-7916-622X; Chen, Jun/0000-0003-0563-542X	NIH [EB001981, AG11378]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH (http://www.nih.gov/), R01 grants EB001981 and AG11378. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ehman, 2012, PHASE CORRECTION INT, P3426; Glaser K, 2009, P 17 ANN M ISMRM HON, P4669; Guo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071807; Jack CR, 2008, BRAIN, V131, P665, DOI 10.1093/brain/awm336; Johnson C.L., 2012, MAGN RESON MED; Johnson CL, 2013, NEUROIMAGE, V79, P145, DOI 10.1016/j.neuroimage.2013.04.089; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; Murphy MC, 2013, J NEUROSURG, V118, P643, DOI 10.3171/2012.9.JNS12519; Murphy MC, 2011, J MAGN RESON IMAGING, V34, P494, DOI 10.1002/jmri.22707; Murphy MC, 2013, P ISMRM 21, V21, P2878; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Papazoglou S, 2008, PHYS MED BIOL, V53, P3147, DOI 10.1088/0031-9155/53/12/005; Romano AJ, 2000, IEEE T ULTRASON FERR, V47, P1575, DOI 10.1109/58.883546; Romano A, 2012, MAGN RESON MED, V68, P1410, DOI 10.1002/mrm.24141; Sack I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023451; Streitberger KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029888; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Wuerfel J, 2010, NEUROIMAGE, V49, P2520, DOI 10.1016/j.neuroimage.2009.06.018; Xu L, 2007, ACTA RADIOL, V48, P327, DOI 10.1080/02841850701199967; Yin M, 2007, CLIN GASTROENTEROL H, V5, P1207, DOI 10.1016/j.cgh.2007.06.012; Zhang J, 2011, J BIOMECH, V44, P1909, DOI 10.1016/j.jbiomech.2011.04.034	22	111	111	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81668	10.1371/journal.pone.0081668	http://dx.doi.org/10.1371/journal.pone.0081668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312570	Green Published, gold, Green Submitted			2022-12-25	WOS:000327944500084
J	Shi, Y; Wang, JL; Li, JD; Ren, HG; Guan, WJ; He, M; Yan, WQ; Zhou, Y; Hu, ZM; Zhang, JG; Xiao, JJ; Su, Z; Dai, MZ; Wang, J; Jiang, H; Guo, JF; Zhou, YF; Zhang, FF; Li, N; Du, J; Xu, Q; Hu, YC; Pan, Q; Shen, L; Wang, GH; Xia, K; Zhang, ZH; Tang, BS				Shi, Yuting; Wang, Junling; Li, Jia-Da; Ren, Haigang; Guan, Wenjuan; He, Miao; Yan, Weiqian; Zhou, Ying; Hu, Zhengmao; Zhang, Jianguo; Xiao, Jingjing; Su, Zheng; Dai, Meizhi; Wang, Jun; Jiang, Hong; Guo, Jifeng; Zhou, Yafang; Zhang, Fufeng; Li, Nan; Du, Juan; Xu, Qian; Hu, Yacen; Pan, Qian; Shen, Lu; Wang, Guanghui; Xia, Kun; Zhang, Zhuohua; Tang, Beisha			Identification of CHIP as a Novel Causative Gene for Autosomal Recessive Cerebellar Ataxia	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; PROTEIN; MUTATIONS; DISEASE; DEGRADATION; DEFICIENCY; EXPRESSION; PHENOTYPES; ALIGNMENT; PROMOTES	Autosomal recessive cerebellar ataxias are a group of neurodegenerative disorders that are characterized by complex clinical and genetic heterogeneity. Although more than 20 disease-causing genes have been identified, many patients are still currently without a molecular diagnosis. In a two-generation autosomal recessive cerebellar ataxia family, we mapped a linkage to a minimal candidate region on chromosome 16p13.3 flanked by single-nucleotide polymorphism markers rs11248850 and rs1218762. By combining the defined linkage region with the whole-exome sequencing results, we identified a homozygous mutation (c. 493CT) in CHIP (NM_005861) in this family. Using Sanger sequencing, we also identified two compound heterozygous mutations (c. 389AT/c. 441GT; c. 621C>G/c. 707GC) in CHIP gene in two additional kindreds. These mutations co-segregated exactly with the disease in these families and were not observed in 500 control subjects with matched ancestry. CHIP colocalized with NR2A, a subunit of the N-methyl-D-aspartate receptor, in the cerebellum, pons, medulla oblongata, hippocampus and cerebral cortex. Wild-type, but not disease-associated mutant CHIPs promoted the degradation of NR2A, which may underlie the pathogenesis of ataxia. In conclusion, using a combination of whole-exome sequencing and linkage analysis, we identified CHIP, encoding a U-box containing ubiquitin E3 ligase, as a novel causative gene for autosomal recessive cerebellar ataxia.	[Shi, Yuting; Wang, Junling; Guan, Wenjuan; He, Miao; Yan, Weiqian; Zhou, Ying; Jiang, Hong; Guo, Jifeng; Zhou, Yafang; Zhang, Fufeng; Li, Nan; Du, Juan; Xu, Qian; Hu, Yacen; Shen, Lu; Tang, Beisha] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Wang, Junling; Li, Jia-Da; Hu, Zhengmao; Jiang, Hong; Guo, Jifeng; Pan, Qian; Shen, Lu; Xia, Kun; Zhang, Zhuohua; Tang, Beisha] State Key Lab Med Genet, Changsha, Peoples R China; [Zhang, Jianguo; Xiao, Jingjing; Su, Zheng; Dai, Meizhi; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Ren, Haigang] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Suzhou, Peoples R China; [Wang, Junling; Jiang, Hong; Guo, Jifeng; Shen, Lu; Tang, Beisha] Cent S Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha, Hunan, Peoples R China; [Zhang, Jianguo] Fudan Univ, T Life Res Ctr, Shanghai 200433, Peoples R China; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Wang, Jun] Aarhus Univ, Ctr iSequencing, Aarhus C, Denmark	Central South University; Beijing Genomics Institute (BGI); Soochow University - China; Central South University; Fudan University; University of Copenhagen; King Abdulaziz University; Novo Nordisk Foundation; University of Copenhagen; Aarhus University	Tang, BS (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China.	bstang7398@163.com	Wang, Guanghui/U-3979-2017; XIA, KUN/AAO-3525-2020; Ren, Haigang/U-6034-2017; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Wang, Guanghui/0000-0001-8551-6468; Ren, Haigang/0000-0001-8844-4754; Su, Zheng/0000-0002-1414-6970; Wang, Jun/0000-0002-2113-5874; Li, Jia-Da/0000-0002-4236-3518; Wang, Jun/0000-0002-8540-8931	Projects in the Major State Basic Research Development Program of China (973 Program) [2011CB510001]; State Key Program of the National Natural Science Foundation of China [81130021]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004562] Funding Source: NIH RePORTER	Projects in the Major State Basic Research Development Program of China (973 Program); State Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Projects in the Major State Basic Research Development Program of China (973 Program) (2011CB510001 to Bei-Sha Tang) and the State Key Program of the National Natural Science Foundation of China (81130021 to Bei-Sha Tang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; Altafaj X, 2008, NEUROBIOL DIS, V32, P377, DOI 10.1016/j.nbd.2008.07.024; Anheim M, 2012, NEW ENGL J MED, V366, P636, DOI 10.1056/NEJMra1006610; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Barski JJ, 2003, J NEUROSCI, V23, P3469; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Dickey CA, 2007, TRENDS MOL MED, V13, P32, DOI 10.1016/j.molmed.2006.11.003; Ding JQ, 2006, HUM MOL GENET, V15, P1451, DOI 10.1093/hmg/ddl069; Ding XD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005949; Dingledine R, 1999, PHARMACOL REV, V51, P7; Embirucu EK, 2009, ARQ NEURO-PSIQUIAT, V67, P1143, DOI 10.1590/S0004-282X2009000600036; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Fogel BL, 2007, LANCET NEUROL, V6, P245, DOI 10.1016/S1474-4422(07)70054-6; Gros-Louis F, 2007, NAT GENET, V39, P80, DOI 10.1038/ng1927; HARDING AE, 1983, LANCET, V1, P1151; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klucken J, 2004, BIOCHEM BIOPH RES CO, V325, P367, DOI 10.1016/j.bbrc.2004.10.037; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Margolin DH, 2013, NEW ENGL J MED, V368, P1992, DOI 10.1056/NEJMoa1215993; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Nelson RF, 2006, J BIOL CHEM, V281, P20242, DOI 10.1074/jbc.M602423200; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; Palau F, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-47; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Rao SNR, 2010, J BIOL CHEM, V285, P1404, DOI 10.1074/jbc.M109.006312; Sahara N, 2005, J NEUROCHEM, V94, P1254, DOI 10.1111/j.1471-4159.2005.03272.x; Sailer A, 2012, CURR NEUROL NEUROSCI, V12, P227, DOI 10.1007/s11910-012-0267-6; Sanchez-Perez A, 2005, CEREBELLUM, V4, P162, DOI 10.1080/14734220510008003; Vermeer S, 2011, J MED GENET, V48, P651, DOI 10.1136/jmedgenet-2011-100210; Vermeer S, 2010, AM J HUM GENET, V87, P813, DOI 10.1016/j.ajhg.2010.10.015; Vig PJS, 2012, CEREBELLUM, V11, P718, DOI 10.1007/s12311-011-0323-9; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Wang JL, 2011, BRAIN, V134, P3490, DOI 10.1093/brain/awr289	45	65	68	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81884	10.1371/journal.pone.0081884	http://dx.doi.org/10.1371/journal.pone.0081884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312598	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500102
J	Liu, YA; Pan, ST; Hou, YC; Shen, MY; Peng, SJ; Tang, SC; Chung, YC				Liu, Yuan-An; Pan, Shien-Tung; Hou, Yung-Chi; Shen, Ming-Yin; Peng, Shih-Jung; Tang, Shiue-Cheng; Chung, Yuan-Chiang			3-D Visualization and Quantitation of Microvessels in Transparent Human Colorectal Carcinoma	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; TUMOR ANGIOGENESIS; PROGNOSTIC-FACTORS; IMAGING DEPTH; HUMAN COLON; DENSITY; CANCER; ILLUSTRATION; BIOPSIES; METASTASIS	Microscopic analysis of tumor vasculature plays an important role in understanding the progression and malignancy of colorectal carcinoma. However, due to the geometry of blood vessels and their connections, standard microtome-based histology is limited in providing the spatial information of the vascular network with a 3-dimensional (3-D) continuum. To facilitate 3-D tissue analysis, we prepared transparent human colorectal biopsies by optical clearing for in-depth confocal microscopy with CD34 immunohistochemistry. Full-depth colons were obtained from colectomies performed for colorectal carcinoma. Specimens were prepared away from (control) and at the tumor site. Taking advantage of the transparent specimens, we acquired anatomic information up to 200 mu m in depth for qualitative and quantitative analyses of the vasculature. Examples are given to illustrate: (1) the association between the tumor microstructure and vasculature in space, including the perivascular cuffs of tumor outgrowth, and (2) the difference between the 2-D and 3-D quantitation of microvessels. We also demonstrate that the optically cleared mucosa can be retrieved after 3-D microscopy to perform the standard microtome-based histology (H&E staining and immunohistochemistry) for systematic integration of the two tissue imaging methods. Overall, we established a new tumor histological approach to integrate 3-D imaging, illustration, and quantitation of human colonic microvessels in normal and cancerous specimens. This approach has significant promise to work with the standard histology to better characterize the tumor microenvironment in colorectal carcinoma.	[Liu, Yuan-An; Tang, Shiue-Cheng] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu, Taiwan; [Pan, Shien-Tung] Miaoli Gen Hosp, Dept Pathol, Miaoli, Taiwan; [Hou, Yung-Chi; Shen, Ming-Yin; Chung, Yuan-Chiang] Natl Taiwan Univ Hosp Hsinchu, Dept Surg, Hsinchu, Taiwan; [Peng, Shih-Jung; Tang, Shiue-Cheng] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Tang, Shiue-Cheng] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Chung, Yuan-Chiang] Cheng Ching Gen Hosp, Chung Kang Branch, Dept Surg, Taichung, Taiwan	National Tsing Hua University; National Taiwan University; National Taiwan University Hospital; National Tsing Hua University; National Tsing Hua University	Tang, SC (corresponding author), Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu, Taiwan.	sctang@life.nthu.edu.tw; 11722@ccgh.com.tw			National Taiwan University Hospital - Hsinchu Branch; National Tsing Hua University [100N2775E1, 102N2734E1]; Taiwan National Health Research Institutes [NHRI-EX102-10044EI]; National Science Council [NSC 102-2628-B-007-002-MY2]	National Taiwan University Hospital - Hsinchu Branch; National Tsing Hua University; Taiwan National Health Research Institutes; National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants from the joint research program between National Taiwan University Hospital - Hsinchu Branch and National Tsing Hua University (100N2775E1 and 102N2734E1 to S. C. T. and Y.C.C.), the Taiwan National Health Research Institutes (NHRI-EX102-10044EI to S. C. T.), and National Science Council (NSC 102-2628-B-007-002-MY2 to S. C. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bui AK, 2009, LASER SURG MED, V41, P142, DOI 10.1002/lsm.20742; Calhoun BC, 2003, AM J SURG PATHOL, V27, P254, DOI 10.1097/00000478-200302000-00016; Carl Zeiss Microimaging GmbH, 2009, VIS ARCH CELLS TISS; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chiu YC, 2012, DIABETOLOGIA, V55, P3252, DOI 10.1007/s00125-012-2699-6; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; Denis B, 2009, EUR J GASTROEN HEPAT, V21, P1153, DOI 10.1097/MEG.0b013e3283221124; Des Guetz G, 2006, BRIT J CANCER, V94, P1823, DOI 10.1038/sj.bjc.6603176; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; FOX SB, 1995, J PATHOL, V177, P275, DOI 10.1002/path.1711770310; Fu YY, 2013, AM J PHYSIOL-GASTR L, V304, pG1, DOI 10.1152/ajpgi.00209.2012; Fu YY, 2010, MICROVASC RES, V80, P512, DOI 10.1016/j.mvr.2010.06.003; Fu YY, 2010, GASTROENTEROLOGY, V139, P1100, DOI 10.1053/j.gastro.2010.08.025; Fu YY, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3470241; Fu YY, 2009, GASTROENTEROLOGY, V137, P453, DOI 10.1053/j.gastro.2009.05.008; Hasan J, 2002, BRIT J CANCER, V86, P1566, DOI 10.1038/sj.bjc.6600315; Hlatky L, 2002, JNCI-J NATL CANCER I, V94, P883; Hua TE, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00036; Liu YA, 2013, NEUROGASTROENT MOTIL, V25, pe324, DOI 10.1111/nmo.12115; Liu YA, 2011, NEUROGASTROENT MOTIL, V23, pE446, DOI 10.1111/j.1365-2982.2011.01773.x; Liu YA, 2012, AM J PHYSIOL-GASTR L, V302, pG1099, DOI 10.1152/ajpgi.00432.2011; McNichols RJ, 2005, LASER SURG MED, V36, P289, DOI 10.1002/lsm.20152; Moy AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053753; Parameswaran L, 2008, HUM PATHOL, V39, P579, DOI 10.1016/j.humpath.2007.08.015; Polydorides AD, 2007, AM J CLIN PATHOL, V127, P409, DOI 10.1309/C8Y207EUPCUYR7HY; Rajaganeshan R, 2007, BRIT J CANCER, V96, P1112, DOI 10.1038/sj.bjc.6603677; Roberts N, 2012, AM J PATHOL, V180, P1835, DOI 10.1016/j.ajpath.2012.01.033; Secomb TW, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002983; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tang SC, 2013, DIABETOLOGIA, V56, P2424, DOI 10.1007/s00125-013-2977-y; TEARNEY GJ, 1995, OPT LETT, V20, P2258, DOI 10.1364/OL.20.002258; Tseng SJ, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3158998; Tuchin VV, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2903745; Wang RKK, 2001, J OPT SOC AM B, V18, P948, DOI 10.1364/JOSAB.18.000948; Wang X J, 1996, J Biomed Opt, V1, P212, DOI 10.1117/12.227699; WEIDNER N, 1995, AM J PATHOL, V147, P9; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; WEIDNER N, 1993, AM J PATHOL, V143, P401; Weinstein W M, 2000, Gastrointest Endosc Clin N Am, V10, P555; Wenner M, 2009, NAT MED, V15, P1106, DOI 10.1038/nm1009-1106; Wu MLC, 2005, ARCH PATHOL LAB MED, V129, P507; Wu MLC, 2002, AM J CLIN PATHOL, V117, P424, DOI 10.1309/VBYP-UT2E-V198-M1TQ; Zhu D, 2013, LASER PHOTONICS REV, V13	43	5	6	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81857	10.1371/journal.pone.0081857	http://dx.doi.org/10.1371/journal.pone.0081857			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24324559	gold, Green Published, Green Submitted			2022-12-25	WOS:000327670300055
J	Liu, MX; Seo, JM; Allegood, J; Bi, X; Zhu, XW; Boudyguina, E; Gebre, AK; Avni, D; Shah, D; Sorci-Thomas, MG; Thomas, MJ; Shelness, GS; Spiegel, S; Parks, JS				Liu, Mingxia; Seo, Jeongmin; Allegood, Jeremy; Bi, Xin; Zhu, Xuewei; Boudyguina, Elena; Gebre, Abraham K.; Avni, Dorit; Shah, Dharika; Sorci-Thomas, Mary G.; Thomas, Michael J.; Shelness, Gregory S.; Spiegel, Sarah; Parks, John S.			Hepatic Apolipoprotein M (ApoM) Overexpression Stimulates Formation of Larger ApoM/Sphingosine 1-Phosphateenriched Plasma High Density Lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apolipoproteins; Hepatocyte; High Density Lipoprotein (HDL); Liver; Sphingolipid; ApoM; Sphingosine 1-Phosphate	REVERSE CHOLESTEROL TRANSPORT; PRE-BETA-HDL; RECEPTOR-RELATED PROTEIN; SPHINGOSINE 1-PHOSPHATE; SELECTIVE UPTAKE; TRANSGENIC MICE; A-I; ACYLTRANSFERASE REACTION; SCAVENGER RECEPTOR; SR-BI	Background: ApoM overexpression in nonhepatic cells generates larger nascent HDLs. Results: Hepatocyte-specific apoM transgenic mice have larger plasma HDLs and hepatocytes that generate larger nascent HDLs and increased S1P secretion. Conclusion: Hepatocyte-specific apoM overexpression facilitates large apoM/S1P-enriched HDL formation by promoting large nascent HDL formation and stimulating sphingolipid synthesis and S1P secretion. Significance: Hepatic apoM regulates HDL and S1P production. Apolipoprotein M (apoM), a lipocalin family member, preferentially associates with plasma HDL and binds plasma sphingosine 1-phosphate (S1P), a signaling molecule active in immune homeostasis and endothelial barrier function. ApoM overexpression in ABCA1-expressing HEK293 cells stimulated larger nascent HDL formation, compared with cells that did not express apoM; however, the in vivo role of apoM in HDL metabolism remains poorly understood. To test whether hepatic apoM overexpression increases plasma HDL size, we generated hepatocyte-specific apoM transgenic (APOM Tg) mice, which had an approximate to 3-5-fold increase in plasma apoM levels compared with wild-type mice. Although HDL cholesterol concentrations were similar to wild-type mice, APOM Tg mice had larger plasma HDLs enriched in apoM, cholesteryl ester, lecithin:cholesterol acyltransferase, and S1P. Despite the presence of larger plasma HDLs in APOM Tg mice, in vivo macrophage reverse cholesterol transport capacity was similar to that in wild-type mice. APOM Tg mice had an approximate to 5-fold increase in plasma S1P, which was predominantly associated with larger plasma HDLs. Primary hepatocytes from APOM Tg mice generated larger nascent HDLs and displayed increased sphingolipid synthesis and S1P secretion. Inhibition of ceramide synthases in hepatocytes increased cellular S1P levels but not S1P secretion, suggesting that apoM is rate-limiting in the export of hepatocyte S1P. Our data indicate that hepatocyte-specific apoM overexpression generates larger nascent HDLs and larger plasma HDLs, which preferentially bind apoM and S1P, and stimulates S1P biosynthesis for secretion. The unique apoM/S1P-enriched plasma HDL may serve to deliver S1P to extrahepatic tissues for atheroprotection and may have other as yet unidentified functions.	[Liu, Mingxia; Seo, Jeongmin; Bi, Xin; Zhu, Xuewei; Boudyguina, Elena; Gebre, Abraham K.; Sorci-Thomas, Mary G.; Shelness, Gregory S.; Parks, John S.] Wake Forest Sch Med, Dept Pathol Lipid Sci, Winston Salem, NC 27157 USA; [Shah, Dharika; Thomas, Michael J.; Parks, John S.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Allegood, Jeremy; Avni, Dorit; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA	Wake Forest University; Wake Forest University; Virginia Commonwealth University	Parks, JS (corresponding author), Wake Forest Sch Med, Dept Pathol, Sect Lipid Sci, Med Ctr Blvd, Winston Salem, NC 27157 USA.	jparks@wakehealth.edu		Sorci-Thomas, Mary/0000-0002-6464-5006; Avni, Dorit/0000-0002-0444-881X	National Institutes of Health NCI Center [5P30CA12197]; North Carolina Biotechnology Center [2007-IDG-1021]; National Institutes of Health NCI Cancer Center [P30 CA016059]; NATIONAL CANCER INSTITUTE [P30CA012197, R01CA061774, P30CA016059] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119962, R01HL112270, P01HL049373, R01HL064163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880, R37GM043880] Funding Source: NIH RePORTER	National Institutes of Health NCI Center; North Carolina Biotechnology Center; National Institutes of Health NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge Karen Klein (Translational Science Institute, Wake Forest School of Medicine) for editing the manuscript. LDL receptor-related protein antibody was generously provided by Dr. Joachim Herz (University of Texas Southwestern Medical Center), and ldlA-SR-BI-expressing cells were generously provided by Dr. Monty Krieger (Massachusetts Institute of Technology). Mass spectrometry analyses in Fig. 6 were performed at the Mass Spectrometer Facility, Comprehensive Cancer Center, Wake Forest University, and were supported, in part, by National Institutes of Health NCI Center Grant 5P30CA12197. The TSQ Discovery Max LC-MS/MS was acquired through a North Carolina Biotechnology Center Grant 2007-IDG-1021 (to M. J. T.). Sphingolipid analyses were performed at the Lipidomics Facility, Department of Biochemistry and Molecular Biology, Virginia Commonwealth University School of Medicine, and were supported, in part, by funding to the Massey Cancer Center from National Institutes of Health NCI Cancer Center Support Grant P30 CA016059.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Ahnstrom J, 2007, J LIPID RES, V48, P1754, DOI 10.1194/jlr.M700103-JLR200; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; BARTER PJ, 1982, BIOCHEM J, V208, P1; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Berdyshev EV, 2005, ANAL BIOCHEM, V339, P129, DOI 10.1016/j.ab.2004.12.006; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Brown JM, 2008, J BIOL CHEM, V283, P10522, DOI 10.1074/jbc.M707659200; Brundert M, 2005, ARTERIOSCL THROM VAS, V25, P143, DOI 10.1161/01.ATV.0000149381.16166.c6; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; CARR TP, 1992, ARTERIOSCLER THROMB, V12, P1274, DOI 10.1161/01.ATV.12.11.1274; Christoffersen C, 2008, J BIOL CHEM, V283, P18765, DOI 10.1074/jbc.M800695200; Christoffersen C, 2008, J BIOL CHEM, V283, P1839, DOI 10.1074/jbc.M704576200; Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Christoffersen C, 2010, CIRC RES, V106, P1624, DOI 10.1161/CIRCRESAHA.109.211086; Chung Soonkyu, 2010, J Biol Chem, V285, P12197, DOI 10.1074/jbc.M109.096933; Dahlback B, 2009, CELL MOL LIFE SCI, V66, P559, DOI 10.1007/s00018-009-8764-8; Egom EE, 2013, CURR OPIN LIPIDOL, V24, P351, DOI 10.1097/MOL.0b013e328361f822; Elsoe S, 2013, BBA-MOL CELL BIOL L, V1831, P1287, DOI 10.1016/j.bbalip.2013.04.009; Elsoe S, 2012, ATHEROSCLEROSIS, V221, P91, DOI 10.1016/j.atherosclerosis.2011.11.031; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; English D, 2000, FASEB J, V14, P2255, DOI 10.1096/fj.00-0134com; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; Fiske CH, 1925, J BIOL CHEM, V66, P375; GLOMSET JA, 1968, J LIPID RES, V9, P155; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Jiang XC, 2003, J BIOL CHEM, V278, P49072, DOI 10.1074/jbc.M304274200; Karuna R, 2011, ATHEROSCLEROSIS, V219, P855, DOI 10.1016/j.atherosclerosis.2011.08.049; KORITNIK DL, 1983, J LIPID RES, V24, P1639; Kurano M, 2013, ATHEROSCLEROSIS, V229, P102, DOI 10.1016/j.atherosclerosis.2013.04.024; Lee MH, 2010, J LIPID RES, V51, P2619, DOI 10.1194/jlr.M003988; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Mineo C, 2012, CIRC RES, V111, P1079, DOI 10.1161/CIRCRESAHA.111.258673; Mitra P, 2007, METHOD ENZYMOL, V434, P257, DOI 10.1016/S0076-6879(07)34014-7; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Mulya A, 2007, ARTERIOSCL THROM VAS, V27, P1828, DOI 10.1161/ATVBAHA.107.142455; Mulya A, 2010, J LIPID RES, V51, P514, DOI 10.1194/jlr.M002162; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Nielsen LB, 2009, TRENDS ENDOCRIN MET, V20, P66, DOI 10.1016/j.tem.2008.11.003; Nofer JR, 2008, J CLIN LIPIDOL, V2, P4, DOI 10.1016/j.jacl.2007.11.002; Obinata H, 2012, SEMIN IMMUNOPATHOL, V34, P73, DOI 10.1007/s00281-011-0287-3; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Puri V, 2003, J BIOL CHEM, V278, P20961, DOI 10.1074/jbc.M300304200; RUBIN EM, 1991, P NATL ACAD SCI USA, V88, P434, DOI 10.1073/pnas.88.2.434; Santamarina-Fojo S, 2000, CURR OPIN LIPIDOL, V11, P267, DOI 10.1097/00041433-200006000-00007; Scheek S, 1997, P NATL ACAD SCI USA, V94, P11179, DOI 10.1073/pnas.94.21.11179; SIMONET WS, 1993, J BIOL CHEM, V268, P8221; SUBBAIAH PV, 1993, J BIOL CHEM, V268, P20156; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Temel RE, 2010, CELL METAB, V12, P96, DOI 10.1016/j.cmet.2010.05.011; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Vaisman BL, 2001, J CLIN INVEST, V108, P303; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; Vassiliou G, 2004, ARTERIOSCL THROM VAS, V24, P1669, DOI 10.1161/01.ATV.0000134295.09932.60; Vassiliou G, 2001, J BIOL CHEM, V276, P48823, DOI 10.1074/jbc.M103954200; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; WANG E, 1991, J BIOL CHEM, V266, P14486; Wilkerson BA, 2012, J BIOL CHEM, V287, P44645, DOI 10.1074/jbc.M112.423426; Witting SR, 2003, J BIOL CHEM, V278, P40121, DOI 10.1074/jbc.M305193200; Wolfrum C, 2005, NAT MED, V11, P418, DOI 10.1038/nm1211; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; Yatomi Y, 1997, J BIOCHEM, V121, P969; Yazdanyar A, 2011, CURR ATHEROSCLER REP, V13, P242, DOI 10.1007/s11883-011-0172-5	68	57	60	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2801	2814		10.1074/jbc.M113.499913	http://dx.doi.org/10.1074/jbc.M113.499913			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24318881	hybrid, Green Published			2022-12-25	WOS:000333403000029
J	Feng, YL; Wu, HX; Xu, YX; Zhang, ZM; Liu, T; Lin, X; Feng, XH				Feng, Yili; Wu, Hongxing; Xu, Yongxian; Zhang, Zhengmao; Liu, Ting; Lin, Xia; Feng, Xin-Hua			Zinc Finger Protein 451 Is a Novel Smad Corepressor in Transforming Growth Factor-beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Signal Transduction; SMAD Transcription Factor; Transcription Repressor; Transforming Growth Factor (TGF); Zinc Finger	TRANSCRIPTIONAL ACTIVATION; MEDIATED INDUCTION; C-MYC; COACTIVATORS; SMAD4/DPC4; REPRESSION; P15(INK4B); MECHANISM; CBP/P300; PROMOTER	ZNF451 is a transcriptional cofactor localized to promyelocytic leukemia bodies. Here, we present evidence demonstrating that ZNF451 physically interacts with Smad3/4 and functionally inhibits TGF- signaling. Increased expression of ZNF451 attenuates TGF--induced growth inhibitory and gene transcriptional responses, whereas depletion of ZNF451 enhances TGF- responses. Mechanistically, ZNF451 blocks the ability of Smad3/4 to recruit p300 in response to TGF-, which causes reduction of histone H3K9 acetylation on the promoters of TGF- target genes. Taken together, ZNF451 acts as a transcriptional corepressor for Smad3/4 and negatively regulates TGF- signaling.	[Feng, Yili; Wu, Hongxing; Xu, Yongxian; Liu, Ting; Feng, Xin-Hua] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Zhengmao; Lin, Xia; Feng, Xin-Hua] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Zhang, Zhengmao; Lin, Xia; Feng, Xin-Hua] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA	Zhejiang University; Baylor College of Medicine; Baylor College of Medicine	Feng, XH (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	xfeng@bcm.edu	Zhang, Zhengmao/C-4566-2014; Huang, Xiaoyan/N-2561-2014	Zhang, Zhengmao/0000-0002-7968-9968; Feng, Yili/0000-0002-7143-9956; ZHANG, ZHENGMAO/0000-0003-4035-0331	NSFC [31090360]; MOST [2012CB966600, 2011CB910501]; NSFZ [Z2110591]; Project 985; Fundamental Research Funds for the Central Universities; National Institutes of Health [R01GM63773, R01AR053591, R01CA108454, R01DK073932]; NATIONAL CANCER INSTITUTE [R01CA108454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063773] Funding Source: NIH RePORTER	NSFC(National Natural Science Foundation of China (NSFC)); MOST; NSFZ; Project 985; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NSFC Grant 31090360, MOST Grants 2012CB966600 and 2011CB910501, NSFZ Grant Z2110591, Project 985, the Fundamental Research Funds for the Central Universities. National Institutes of Health Grants R01GM63773, R01AR053591, R01CA108454, and R01DK073932.	Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Alliston T, 2005, J BIOL CHEM, V280, P24227, DOI 10.1074/jbc.M414305200; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; Chan HM, 2001, J CELL SCI, V114, P2363; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Chen YG, 2004, CELL RES, V14, P441, DOI 10.1038/sj.cr.7290246; Dai FY, 2009, DEV CELL, V16, P345, DOI 10.1016/j.devcel.2009.01.022; Datta PK, 2000, J BIOL CHEM, V275, P40014, DOI 10.1074/jbc.C000508200; Datto MB, 1997, MOL CELL BIOL, V17, P2030, DOI 10.1128/MCB.17.4.2030; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Karvonen U, 2008, J MOL BIOL, V382, P585, DOI 10.1016/j.jmb.2008.07.016; Kundu TK, 2000, MOL CELL, V6, P551, DOI 10.1016/S1097-2765(00)00054-X; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Salovaara R, 2002, GUT, V51, P56, DOI 10.1136/gut.51.1.56; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Stroschein SL, 1999, J BIOL CHEM, V274, P9431, DOI 10.1074/jbc.274.14.9431; Tascilar M, 2001, CLIN CANCER RES, V7, P4115; Wang DG, 2008, CANCER RES, V68, P783, DOI 10.1158/0008-5472.CAN-07-0008; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323	30	22	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2072	2083		10.1074/jbc.M113.526905	http://dx.doi.org/10.1074/jbc.M113.526905			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24324267	Green Published, hybrid			2022-12-25	WOS:000331130200017
J	Graham, LA; Hobbs, RS; Fletcher, GL; Davies, PL				Graham, Laurie A.; Hobbs, Rod S.; Fletcher, Garth L.; Davies, Peter L.			Helical Antifreeze Proteins Have Independently Evolved in Fishes on Four Occasions	PLOS ONE			English	Article							WINTER FLOUNDER; SHORTHORN SCULPIN; MYOXOCEPHALUS-SCORPIUS; CONVERGENT EVOLUTION; FREEZING RESISTANCE; CRYSTAL-STRUCTURE; OCEAN POUT; SEA RAVEN; SKIN-TYPE; BINDING	Alanine-rich alpha-helical (type I) antifreeze proteins (AFPs) are produced by a variety of fish species from three different orders to protect against freezing in icy seawater. Interspersed amongst and within these orders are fishes making AFPs that are completely different in both sequence and structure. The origin of this variety of types I, II, III and antifreeze glycoproteins (AFGPs) has been attributed to adaptation following sea-level glaciations that occurred after the divergence of most of the extant families of fish. The presence of similar types of AFPs in distantly related fishes has been ascribed to lateral gene transfer in the case of the structurally complex globular type II lectin-like AFPs and to convergent evolution for the AFGPs, which consist of a well-conserved tripeptide repeat. In this paper, we examine the genesis of the type I AFPs, which are intermediate in complexity. These predominantly alpha-helical peptides share many features, such as putative capping structures, Ala-richness and amphipathic character. We have added to the type I repertoire by cloning additional sequences from sculpin and have found that the similarities between the type I AFPs of the four distinct groups of fishes are not borne out at the nucleotide level. Both the non-coding sequences and the codon usage patterns are strikingly different. We propose that these AFPs arose via convergence from different progenitor helices with a weak affinity for ice and that their similarity is dictated by the propensity of specific amino acids to form helices and to align water on one side of the helix into an ice-like pattern.	[Graham, Laurie A.; Davies, Peter L.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Hobbs, Rod S.; Fletcher, Garth L.] Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada	Queens University - Canada; Memorial University Newfoundland	Davies, PL (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	peter.davies@queensu.ca			Canadian Institutes of Health Research [106612]; Natural Sciences and Engineering Research Council of Canada [6836-06]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by grant # 106612 from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html), Dr. Peter L. Davies, who holds a Canada Research Chair in Protein Engineering and by grant # 6836-06 from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), Dr. Garth L. Fletcher. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Baardsnes J, 1999, FEBS LETT, V463, P87, DOI 10.1016/S0014-5793(99)01588-4; Baardsnes J, 2001, TRENDS BIOCHEM SCI, V26, P468, DOI 10.1016/S0968-0004(01)01879-5; Baardsnes J, 2001, PROTEIN SCI, V10, P2566, DOI 10.1110/ps.ps.26501; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; CHAKRABARTTY A, 1989, J BIOL CHEM, V264, P11307; Chao HM, 1997, BIOCHEMISTRY-US, V36, P14652, DOI 10.1021/bi970817d; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3811, DOI 10.1073/pnas.94.8.3811; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3817, DOI 10.1073/pnas.94.8.3817; Cheng CHC, 1998, CURR OPIN GENET DEV, V8, P715, DOI 10.1016/S0959-437X(98)80042-7; Cheng CHC, 2003, MOL BIOL EVOL, V20, P1897, DOI 10.1093/molbev/msg208; DeConto RM, 2008, NATURE, V455, P652, DOI 10.1038/nature07337; Deng C, 2010, P NATL ACAD SCI USA; DEVRIES AL, 1969, SCIENCE, V163, P1073, DOI 10.1126/science.163.3871.1073; DOOLITTLE RF, 1994, TRENDS BIOCHEM SCI, V19, P15, DOI 10.1016/0968-0004(94)90167-8; DUMAN JG, 1974, NATURE, V247, P237, DOI 10.1038/247237a0; DUMAN JG, 1976, COMP BIOCHEM PHYS B, V54, P375, DOI 10.1016/0305-0491(76)90260-1; Evans RP, 2005, J MOL EVOL, V61, P417, DOI 10.1007/s00239-004-0067-y; Evans RP, 2005, FEBS J, V272, P5327, DOI 10.1111/j.1742-4658.2005.04929.x; Evans RP, 2004, BBA-PROTEINS PROTEOM, V1700, P209, DOI 10.1016/j.bbapap.2004.05.006; Evans RP, 2001, BBA-PROTEIN STRUCT M, V1547, P235, DOI 10.1016/S0167-4838(01)00190-X; Ewart KV, 1999, CELL MOL LIFE SCI, V55, P271, DOI 10.1007/s000180050289; Eyles N, 2008, PALAEOGEOGR PALAEOCL, V258, P89, DOI 10.1016/j.palaeo.2007.09.021; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; Garnham CP, 2011, P NATL ACAD SCI USA, V108, P7363, DOI 10.1073/pnas.1100429108; Gong ZY, 1996, J BIOL CHEM, V271, P4106, DOI 10.1074/jbc.271.8.4106; GONG ZY, 1995, BIOCHEM BIOPH RES CO, V206, P387, DOI 10.1006/bbrc.1995.1053; GOURLIE B, 1984, J BIOL CHEM, V259, P4960; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; Graham LA, 1997, NATURE, V388, P727, DOI 10.1038/41908; Graham LA, 2008, BIOCHEMISTRY-US, V47, P2051, DOI 10.1021/bi7020316; Graham LA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-190; Graham LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002616; HEW CL, 1984, J COMP PHYSIOL B, V155, P81, DOI 10.1007/BF00688795; HEW CL, 1980, CAN J BIOCHEM CELL B, V58, P377, DOI 10.1139/o80-049; HEW CL, 1985, EUR J BIOCHEM, V151, P167, DOI 10.1111/j.1432-1033.1985.tb09081.x; Hobbs RS, 2013, COMP BIOCHEM PHYS A, V164, P111, DOI 10.1016/j.cbpa.2012.10.017; Hobbs RS, 2011, FEBS J, V278, P3699, DOI 10.1111/j.1742-4658.2011.08288.x; Kondo H, 2012, P NATL ACAD SCI USA, V109, P9360, DOI 10.1073/pnas.1121607109; Kwan AHY, 2005, BIOCHEMISTRY-US, V44, P1980, DOI 10.1021/bi047782j; Lavoue S, 2007, MOL PHYLOGENET EVOL, V43, P1096, DOI 10.1016/j.ympev.2006.09.018; Leinala EK, 2002, STRUCTURE, V10, P619, DOI 10.1016/S0969-2126(02)00745-1; LI XM, 1985, J BIOL CHEM, V260, P2904; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Liu Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000548; Loh YH, 2008, MOL BIOL EVOL, V25, P526, DOI 10.1093/molbev/msm278; Losos JB, 2011, EVOLUTION, V65, P1827, DOI 10.1111/j.1558-5646.2011.01289.x; Low WK, 1998, J BIOL CHEM, V273, P23098, DOI 10.1074/jbc.273.36.23098; Low WK, 2001, J BIOL CHEM, V276, P11582, DOI 10.1074/jbc.M009293200; Mabuchi K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-10; Maeso I, 2012, GENOME BIOL EVOL, V4, P486, DOI 10.1093/gbe/evs022; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; Marshall CB, 2005, J BIOL CHEM, V280, P17920, DOI 10.1074/jbc.M500622200; Marshall CB, 2004, NATURE, V429, P153, DOI 10.1038/429153a; Matschiner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018911; Middleton AJ, 2012, J MOL BIOL, V416, P713, DOI 10.1016/j.jmb.2012.01.032; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Mok YF, 2010, BIOCHEMISTRY-US, V49, P2593, DOI 10.1021/bi901929n; NG NF, 1986, J BIOL CHEM, V261, P5690; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Peng ZG, 2006, GENE, V370, P113, DOI 10.1016/j.gene.2005.11.024; Pentelute BL, 2008, J AM CHEM SOC, V130, P9695, DOI 10.1021/ja8013538; RAYMOND JA, 1977, P NATL ACAD SCI USA, V74, P2589, DOI 10.1073/pnas.74.6.2589; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SCOTT GK, 1985, P NATL ACAD SCI USA, V82, P2613, DOI 10.1073/pnas.82.9.2613; SICHERI F, 1995, NATURE, V375, P427, DOI 10.1038/375427a0; SLAUGHTER D, 1981, J BIOL CHEM, V256, P2022; Sorhannus U, 2012, EVOL BIOINFORM, V8, P535, DOI 10.4137/EBO.S9976; Steinke D, 2006, J MOL EVOL, V62, P772, DOI 10.1007/s00239-005-0170-8; YANG DSC, 1988, NATURE, V333, P232, DOI 10.1038/333232a0	71	36	37	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81285	10.1371/journal.pone.0081285	http://dx.doi.org/10.1371/journal.pone.0081285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324684	Green Submitted, Green Published, gold			2022-12-25	WOS:000328566700034
J	Griffin, AJ; Crane, DD; Wehrly, TD; Scott, DP; Bosio, CM				Griffin, Amanda J.; Crane, Deborah D.; Wehrly, Tara D.; Scott, Dana P.; Bosio, Catharine M.			Alternative Activation of Macrophages and Induction of Arginase Are Not Components of Pathogenesis Mediated by Francisella Species	PLOS ONE			English	Article							EARLY IL-4 PRODUCTION; TULARENSIS SCHU S4; SCHISTOSOMA-MANSONI; IMMUNE-RESPONSE; TULAREMIA; INFECTION; PULMONARY; VACCINE; CELLS; REPLICATION	Virulent Francisella tularensis ssp tularensis is an intracellular, Gram negative bacterium that causes acute lethal disease following inhalation of fewer than 15 organisms. Pathogenicity of Francisella infections is tied to its unique ability to evade and suppress inflammatory responses in host cells. It has been proposed that induction of alternative activation of infected macrophages is a mechanism by which attenuated Francisella species modulate host responses. In this report we reveal that neither attenuated F. tularensis Live Vaccine Strain (LVS) nor virulent F. tularensis strain SchuS4 induce alternative activation of macrophages in vitro or in vivo. LVS, but not SchuS4, provoked production of arginase1 independent of alternative activation in vitro and in vivo. However, absence of arginase1 did not significantly impact intracellular replication of LVS or SchuS4. Together our data establish that neither induction of alternative activation nor expression of arginase1 are critical features of disease mediated by attenuated or virulent Francisella species.	[Griffin, Amanda J.; Crane, Deborah D.; Wehrly, Tara D.; Bosio, Catharine M.] NIAID, Immun Pulm Pathogens Sect, Intracellular Parasites Lab, Rocky Mt Vet Branch,Rocky Mt Labs,NIH, Hamilton, MT USA; [Scott, Dana P.] NIAID, Vet Pathol Sect, Rocky Mt Vet Branch, Rocky Mt Labs,NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bosio, CM (corresponding author), NIAID, Immun Pulm Pathogens Sect, Intracellular Parasites Lab, Rocky Mt Vet Branch,Rocky Mt Labs,NIH, Hamilton, MT USA.	bosioc@niaid.nih.gov	Bosio, Catharine/D-7456-2015		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIGAI001048, ZIAAI001013] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson RV, 2010, VACCINE, V28, P6562, DOI 10.1016/j.vaccine.2010.07.072; Barron L, 2011, EUR J IMMUNOL, V41, P2509, DOI 10.1002/eji.201141869; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bosio CM, 2001, INFECT IMMUN, V69, P194, DOI 10.1128/IAI.69.1.194-203.2001; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Chase JC, 2009, INFECT IMMUN; Chase JC, 2010, INFECT IMMUN, V78, P154, DOI 10.1128/IAI.00750-09; Chase JC, 2009, INFECT IMMUN, V77, P180, DOI 10.1128/IAI.00879-08; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Conlan JW, 2008, MOL IMMUNOL, V45, P2962, DOI 10.1016/j.molimm.2008.01.022; Crane DD, 2013, CLIN VACCINE IMMUNOL; Crane DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033349; Crane DD, 2009, J IMMUNOL, V183, P4593, DOI 10.4049/jimmunol.0901655; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Elkins KL, 1996, INFECT IMMUN, V64, P3288, DOI 10.1128/IAI.64.8.3288-3293.1996; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Habibzay M, 2012, MUCOSAL IMMUNOL, V5, P524, DOI 10.1038/mi.2012.28; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Ireland R, 2013, J IMMUNOL; Jones CL, 2012, MICROBIOL MOL BIOL R, V76, P383, DOI 10.1128/MMBR.05027-11; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Ketavarapu JM, 2008, P NATL ACAD SCI USA, V105, P9313, DOI 10.1073/pnas.0707636105; PARKER RR, 1926, PUB HLTH REP, V41, P1341; Pearce EJ, 1998, ADV EXP MED BIOL, V452, P67; Qualls JE, 2012, CELL HOST MICROBE, V12, P313, DOI 10.1016/j.chom.2012.07.012; RISI GF, 1995, CLIN INFECT DIS, V20, P174, DOI 10.1093/clinids/20.1.174; SABIN EA, 1995, J IMMUNOL, V155, P4844; Sabin EA, 1996, J EXP MED, V184, P1871, DOI 10.1084/jem.184.5.1871; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; Shirey KA, 2008, J IMMUNOL, V181, P4159, DOI 10.4049/jimmunol.181.6.4159; Sjostedt A, 2005, FRANCISELLA, P200; Takatsu K, 2009, ADV IMMUNOL, V101, P191, DOI 10.1016/S0065-2776(08)01006-7	33	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82096	10.1371/journal.pone.0082096	http://dx.doi.org/10.1371/journal.pone.0082096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324751	gold, Green Published, Green Submitted			2022-12-25	WOS:000328566700058
J	Merker, M; Kohl, TA; Roetzer, A; Truebe, L; Richter, E; Rusch-Gerdes, S; Fattorini, L; Oggioni, MR; Cox, H; Varaine, F; Niemann, S				Merker, Matthias; Kohl, Thomas A.; Roetzer, Andreas; Truebe, Leona; Richter, Elvira; Ruesch-Gerdes, Sabine; Fattorini, Lanfranco; Oggioni, Marco R.; Cox, Helen; Varaine, Francis; Niemann, Stefan			Whole Genome Sequencing Reveals Complex Evolution Patterns of Multidrug-Resistant Mycobacterium tuberculosis Beijing Strains in Patients	PLOS ONE			English	Article							DRUG-RESISTANCE; CONFERS RESISTANCE; NUCLEOTIDE POLYMORPHISMS; AMINOSALICYLIC ACID; RPOB MUTATIONS; GENOTYPE; ETHIONAMIDE; INFECTION; OVEREXPRESSION; MECHANISMS	Multidrug-resistant (MDR) Mycobacterium tuberculosis complex (MTBC) strains represent a major threat for tuberculosis (TB) control. Treatment of MDR-TB patients is long and less effective, resulting in a significant number of treatment failures. The development of further resistances leads to extensively drug-resistant (XDR) variants. However, data on the individual reasons for treatment failure, e.g. an induced mutational burst, and on the evolution of bacteria in the patient are only sparsely available. To address this question, we investigated the intra-patient evolution of serial MTBC isolates obtained from three MDR-TB patients undergoing longitudinal treatment, finally leading to XDR-TB. Sequential isolates displayed identical IS6110 fingerprint patterns, suggesting the absence of exogenous re-infection. We utilized whole genome sequencing (WGS) to screen for variations in three isolates from Patient A and four isolates from Patient B and C, respectively. Acquired polymorphisms were subsequently validated in up to 15 serial isolates by Sanger sequencing. We determined eight (Patient A) and nine (Patient B) polymorphisms, which occurred in a stepwise manner during the course of the therapy and were linked to resistance or a potential compensatory mechanism. For both patients, our analysis revealed the long-term co-existence of clonal subpopulations that displayed different drug resistance allele combinations. Out of these, the most resistant clone was fixed in the population. In contrast, baseline and follow-up isolates of Patient C were distinguished each by eleven unique polymorphisms, indicating an exogenous re-infection with an XDR strain not detected by IS6110 RFLP typing. Our study demonstrates that intra-patient microevolution of MDR-MTBC strains under longitudinal treatment is more complex than previously anticipated. However, a mutator phenotype was not detected. The presence of different subpopulations might confound phenotypic and molecular drug resistance tests. Furthermore, high resolution WGS analysis is necessary to accurately detect exogenous re-infection as classical genotyping lacks discriminatory power in high incidence settings.	[Merker, Matthias; Kohl, Thomas A.; Roetzer, Andreas; Truebe, Leona; Niemann, Stefan] Res Ctr Borstel, Borstel, Germany; [Richter, Elvira; Ruesch-Gerdes, Sabine] Res Ctr Borstel, Natl Reference Ctr Mycobacteria, Borstel, Germany; [Fattorini, Lanfranco] Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, I-00161 Rome, Italy; [Oggioni, Marco R.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Cox, Helen] Medecins Sans Frontieres, Cape Town, South Africa; [Cox, Helen] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Varaine, Francis] Medecins Sans Frontieres, Dept Med, Paris, France; [Roetzer, Andreas] Biomed Forsch gmbH, Vienna, Austria; [Truebe, Leona] Univ Klinikum Eppendorf, Dept Med Microbiol Virol & Hyg, Hamburg, Germany	Forschungszentrum Borstel; Forschungszentrum Borstel; Istituto Superiore di Sanita (ISS); University of Leicester; University of Cape Town; Doctors Without Borders; Sanofi-Aventis; Sanofi France; University of Hamburg; University Medical Center Hamburg-Eppendorf	Niemann, S (corresponding author), Res Ctr Borstel, Borstel, Germany.	stniemann@yahoo.de	Merker, Matthias/P-7399-2015; Oggioni, Marco Rinaldo/K-3839-2016; Fattorini, Lanfranco/C-1032-2016; Niemann, Stefan/C-9327-2011; Kohl, Thomas Andreas/AAB-9782-2020	Merker, Matthias/0000-0003-1386-2331; Oggioni, Marco Rinaldo/0000-0003-4117-793X; Fattorini, Lanfranco/0000-0003-1673-1804; Kohl, Thomas Andreas/0000-0002-1126-6803; Niemann, Stefan/0000-0002-6604-0684; Cox, Helen/0000-0002-6538-7192	European Community [QLK-CT-2002-01612, FP7-223681, FP7-278864-2]	European Community(European Commission)	This study was supported by the European Community grants QLK-CT-2002-01612 (LONG-DRUG study), FP7-223681 (TB-PAN-NET, http://www.tbpannet.org/), and FP7-278864-2 (PathoNgenTrace, http://www.patho-ngen-trace.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Da Silva PEA, 2011, J ANTIMICROB CHEMOTH, V66, P1417, DOI 10.1093/jac/dkr173; Baranov AA, 2009, INT J TUBERC LUNG D, V13, P1288; Blom J, 2011, BIOINFORMATICS, V27, P1351, DOI 10.1093/bioinformatics/btr151; Bonnet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023081; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Caceres NE, 1997, J BACTERIOL, V179, P5046, DOI 10.1128/jb.179.16.5046-5055.1997; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Cavusoglu C, 2004, CLIN MICROBIOL INFEC, V10, P662, DOI 10.1111/j.1469-0691.2004.00917.x; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Cox HS, 2008, NEW ENGL J MED, V359, P2398, DOI 10.1056/NEJMc0805644; Cox HS, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-134; de Steenwinkel JEM, 2012, EMERG INFECT DIS, V18, P660, DOI 10.3201/eid1804.110912; DeBarber AE, 2000, P NATL ACAD SCI USA, V97, P9677, DOI 10.1073/pnas.97.17.9677; Engstrom A, 2012, J CLIN MICROBIOL; Fivian-Hughes AS, 2012, MICROBIOL-SGM, V158, P308, DOI 10.1099/mic.0.053983-0; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Heep M, 2001, J CLIN MICROBIOL, V39, P107, DOI 10.1128/JCM.39.1.107-110.2001; Kubica T, 2005, INT J TUBERC LUNG D, V9, P646; Larsen MH, 2002, MOL MICROBIOL, V46, P453, DOI 10.1046/j.1365-2958.2002.03162.x; Lee H, 2000, INT J TUBERC LUNG D, V4, P441; Mathys V, 2009, ANTIMICROB AGENTS CH, V53, P2100, DOI 10.1128/AAC.01197-08; Ngamphiw C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S9; Niemann S, 2000, EMERG INFECT DIS, V6, P548, DOI 10.3201/eid0605.000518; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Pardini M, 2009, TUBERCULOSIS, V89, P317, DOI 10.1016/j.tube.2009.04.002; Plinke C, 2009, TUBERCULOSIS, V89, P448, DOI 10.1016/j.tube.2009.09.001; Post FA, 2004, J INFECT DIS, V190, P99, DOI 10.1086/421501; Ramaswamy SV, 2003, ANTIMICROB AGENTS CH, V47, P1241, DOI 10.1128/AAC.47.4.1241-1250.2003; Ramaswamy SV, 2000, ANTIMICROB AGENTS CH, V44, P326, DOI 10.1128/AAC.44.2.326-336.2000; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Saunders NJ, 2011, J INFECTION, V62, P212, DOI 10.1016/j.jinf.2011.01.003; Schurch AC, 2010, INFECT GENET EVOL, V10, P108, DOI 10.1016/j.meegid.2009.10.002; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Stoffels K, 2012, ANTIMICROB AGENTS CH; Streicher EM, 2012, ANTIMICROB AGENTS CH, V56, P2420, DOI 10.1128/AAC.05905-11; Sun G, 2012, J INFECT DIS, V206, P1724, DOI 10.1093/infdis/jis601; Sun ZG, 2008, INT J ANTIMICROB AG, V31, P115, DOI 10.1016/j.ijantimicag.2007.10.014; Taddei F, 1997, NATURE, V387, P700, DOI 10.1038/42696; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Wang F, 2007, J EXP MED, V204, P73, DOI 10.1084/jem.20062100; Werngren J, 2003, J CLIN MICROBIOL, V41, P1520, DOI 10.1128/JCM.41.4.1520-1524.2003; WHO, 2012, WHO TUB FACT SHEET; Ying Z, 2005, ANNU REV PHARMACOL, V45, P529, DOI 10.1146/annurev.pharmtox.45.120403.100120; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320	47	88	91	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82551	10.1371/journal.pone.0082551	http://dx.doi.org/10.1371/journal.pone.0082551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324807	Green Published, Green Submitted			2022-12-25	WOS:000328566700088
J	Neves, PCC; Santos, JR; Tubarao, LN; Bonaldo, MC; Galler, R				Neves, Patricia C. C.; Santos, Juliana R.; Tubarao, Luciana N.; Bonaldo, Myrna C.; Galler, Ricardo			Early IFN-Gamma Production after YF 17D Vaccine Virus Immunization in Mice and Its Association with Adaptive Immune Responses	PLOS ONE			English	Article							DELTA-T-CELLS; YELLOW-FEVER VACCINE; DENDRITIC CELLS; NK CELLS; INNATE IMMUNITY; LISTERIA-MONOCYTOGENES; TRYPANOSOMA-CRUZI; INTERFERON-GAMMA; RHESUS MACAQUES; TNF-ALPHA	Yellow Fever vaccine is one of the most efficacious human vaccines ever made. The vaccine (YF 17D) virus induces polyvalent immune responses, with a mixed T(H)1/T(H)2 CD4(+) cell profile, which results in robust T CD8(+) responses and high titers of neutralizing antibody. In recent years, it has been suggested that early events after yellow fever vaccination are crucial to the development of adequate acquired immunity. We have previously shown that primary immunization of humans and monkeys with YF 17D virus vaccine resulted in the early synthesis of IFN-gamma. Herein we have demonstrated, for the first time that early IFN-gamma production after yellow fever vaccination is a feature also of murine infection and is much more pronounced in the C57BL/6 strain compared to the BALB/c strain. Likewise, in C57BL/6 strain, we have observed the highest CD8(+) T cells responses as well as higher titers of neutralizing antibodies and total anti-YF IgG. Regardless of this intense IFN-. response in mice, it was not possible to see higher titers of IgG2a in relation to IgG1 in both mice lineages. However, IgG2a titers were positively correlated to neutralizing antibodies levels, pointing to an important role of IFN-gamma in eliciting high quality responses against YF 17D, therefore influencing the immunogenicity of this vaccine.	[Neves, Patricia C. C.; Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil; [Santos, Juliana R.; Tubarao, Luciana N.; Bonaldo, Myrna C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Galler, R (corresponding author), Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil.	rgaller@bio.fiocruz.br	Galler, Ricardo/B-3280-2014; Bonaldo, Myrna/AAE-2799-2021		CNPq; PDTIS/FIOCRUZ [RVR03]; Instituto Nacional de Ciencia e Tecnologia em Vacinas (INCTV-CNPq/MCT); National Institutes of Health (NIH) [1 P01 AI094420-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI094420] Funding Source: NIH RePORTER	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PDTIS/FIOCRUZ; Instituto Nacional de Ciencia e Tecnologia em Vacinas (INCTV-CNPq/MCT); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from CNPq, PDTIS/FIOCRUZ (RVR03), Instituto Nacional de Ciencia e Tecnologia em Vacinas (INCTV-CNPq/MCT) and the National Institutes of Health (NIH grant: 1 P01 AI094420-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunez MI, 2001, IMMUNOL LETT, V79, P189, DOI 10.1016/S0165-2478(01)00283-8; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352; Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018; Beetz S, 2008, IMMUNOBIOLOGY, V213, P173, DOI 10.1016/j.imbio.2007.10.006; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Billiau A, 2009, CYTOKINE GROWTH F R, V20, P97, DOI 10.1016/j.cytogfr.2009.02.004; Bonaldo MC, 2000, MEM I OSWALDO CRUZ, V95, P215, DOI 10.1590/S0074-02762000000700037; Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09; Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Casetti R, 2008, CELL MOL IMMUNOL, V5, P161, DOI 10.1038/cmi.2008.20; Chan RC, 2001, LANCET, V358, P121, DOI 10.1016/S0140-6736(01)05341-7; Conti L, 2005, J IMMUNOL, V174, P252, DOI 10.4049/jimmunol.174.1.252; D'Orazio SEF, 2006, J IMMUNOL, V177, P7146, DOI 10.4049/jimmunol.177.10.7146; Neves PCD, 2009, VACCINE, V27, P5543, DOI 10.1016/j.vaccine.2009.07.028; Devilder MC, 2009, J IMMUNOL, V183, P3625, DOI 10.4049/jimmunol.0901571; Dittmer U, 2001, J VIROL, V75, P654, DOI 10.1128/JVI.75.2.654-660.2001; Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020; Fagundes CT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001449; Fang H, 2010, FEMS IMMUNOL MED MIC, V59, P71, DOI 10.1111/j.1574-695X.2010.00663.x; Gandini M, 2011, MEM I OSWALDO CRUZ, V106, P594, DOI 10.1590/S0074-02762011000500012; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Ghanem ENB, 2011, J IMMUNOL, V186, P1703, DOI 10.4049/jimmunol.1001960; Gunther VJ, 2011, VACCINE, V29, P3895, DOI 10.1016/j.vaccine.2011.03.038; HOFT DF, 1993, J IMMUNOL, V151, P7038; Ismaili J, 2002, CLIN IMMUNOL, V103, P296, DOI 10.1006/clim.2002.5218; Julander JG, 2011, VACCINE, V29, P6008, DOI 10.1016/j.vaccine.2011.06.034; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kohler S, 2012, EUR J IMMUNOL, V42, P2363, DOI 10.1002/eji.201142306; Lauzon NM, 2006, CELL IMMUNOL, V241, P102, DOI 10.1016/j.cellimm.2006.08.004; LIBLAU RS, 1995, IMMUNOL TODAY, V16, P34, DOI 10.1016/0167-5699(95)80068-9; Lieberman LA, 2002, MICROBES INFECT, V4, P1531, DOI 10.1016/S1286-4579(02)00036-9; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Liu T, 2001, J VIROL, V75, P2107, DOI 10.1128/JVI.75.5.2107-2118.2001; Liu T, 2000, CELL IMMUNOL, V202, P31, DOI 10.1006/cimm.2000.1644; Maciel M, 2008, VIROLOGY, V378, P105, DOI 10.1016/j.virol.2008.04.043; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Martino A, 2007, CURR MOL MED, V7, P658, DOI 10.2174/156652407782564345; Martins MA, 2008, VACCINE, V26, P1173, DOI 10.1016/j.vaccine.2007.12.035; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005; Munz C, 2005, J EXP MED, V202, P203, DOI 10.1084/jem.20050810; Neves PCC, 2010, VACCINE, V28, P8183, DOI 10.1016/j.vaccine.2010.09.090; Neves-Souza PCF, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-64; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nogueira RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059347; Park SJ, 2009, J IMMUNOL, V182, P4306, DOI 10.4049/jimmunol.0803462; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; Qin G, 2009, J INFECT DIS, V200, P858, DOI 10.1086/605413; Quaresma JAS, 2006, VIROLOGY, V345, P22, DOI 10.1016/j.virol.2005.09.058; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ryan EJ, 2007, VACCINE, V25, P3380, DOI 10.1016/j.vaccine.2006.12.048; Santos AP, 2008, CYTOKINE, V42, P152, DOI 10.1016/j.cyto.2008.02.007; SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015; SCHLESINGER JJ, 1995, J GEN VIROL, V76, P217, DOI 10.1099/0022-1317-76-1-217; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Siegers GM, 2011, CYTOTHERAPY, V13, P753, DOI 10.3109/14653249.2011.553595; Singh R, 2010, J INFECT DIS, V202, P223, DOI 10.1086/653486; Sivori S, 2004, P NATL ACAD SCI USA, V101, P10116, DOI 10.1073/pnas.0403744101; Soulard V, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-128; Stefano I, 1999, VACCINE, V17, P1042, DOI 10.1016/S0264-410X(98)00320-X; Tu WW, 2011, J EXP MED, V208, P1511, DOI 10.1084/jem.20110226; Verhoeven D, 2008, VIRAL IMMUNOL, V21, P99, DOI [10.1089/vim.2007.0002, 10.1089/vim.2008.0002]; Wang T, 2003, J IMMUNOL, V171, P2524, DOI 10.4049/jimmunol.171.5.2524; Watanabe H, 2004, SHOCK, V22, P460, DOI 10.1097/01.shk.0000142249.08135.e9; Wehner R, 2011, J INNATE IMMUN, V3, P258, DOI 10.1159/000323923; Weill L, 2010, NUCLEIC ACIDS RES, V38, P1367, DOI 10.1093/nar/gkp1109; Wiesel M, 2012, EUR J IMMUNOL, V42, P1080, DOI 10.1002/eji.201142205; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	73	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81953	10.1371/journal.pone.0081953	http://dx.doi.org/10.1371/journal.pone.0081953			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324734	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700055
J	Anderson, DA; Armstrong, RA; Weil, E				Anderson, David A.; Armstrong, Roy A.; Weil, Ernesto			Hyperspectral Sensing of Disease Stress in the Caribbean Reef-Building Coral, Orbicella faveolata - Perspectives for the Field of Coral Disease Monitoring	PLOS ONE			English	Article							YELLOW BAND DISEASE; SPECTRAL REFLECTANCE; GENE-EXPRESSION; SCLERACTINIAN CORAL; CLUSTER-ANALYSIS; THERMAL-STRESS; CLIMATE-CHANGE; RESPONSES; DISCRIMINATION; PIGMENTS	The effectiveness of management plans developed for responding to coral disease outbreaks is limited due to the lack of rapid methods of disease diagnosis. In order to fulfill current management guidelines for responding to coral disease outbreaks, alternative methods that significantly reduce response time must be developed. Hyperspectral sensing has been used by various groups to characterize the spectral signatures unique to asymptomatic and bleached corals. The 2010 combined bleaching and Caribbean yellow band disease outbreak in Puerto Rico provided a unique opportunity to investigate the spectral signatures associated with bleached and Caribbean yellow band-diseased colonies of Orbicella faveolata for the first time. Using derivative and cluster analyses of hyperspectral reflectance data, the present study demonstrates the proof of concept that spectral signatures can be used to differentiate between coral disease states. This method enhanced predominant visual methods of diagnosis by distinguishing between different asymptomatic conditions that are identical in field observations and photographic records. The ability to identify disease-affected tissue before lesions become visible could greatly reduce response times to coral disease outbreaks in monitoring efforts. Finally, spectral signatures associated with the poorly understood Caribbean yellow band disease are presented to guide future research on the role of pigments in the etiology.	[Anderson, David A.; Armstrong, Roy A.; Weil, Ernesto] Univ Puerto Rico, Dept Marine Sci, Mayaguez, PR 00709 USA	University of Puerto Rico; University of Puerto Rico Mayaguez	Anderson, DA (corresponding author), Univ Puerto Rico, Dept Marine Sci, Mayaguez, PR 00709 USA.	davidandersoniii@gmail.com	Weil, Ernesto/AAI-3591-2020; Weil, Ernesto/ABF-1290-2020	Weil, Ernesto/0000-0001-5275-1584; Anderson, David/0000-0001-9286-5789	NSF [OCE-1105143, IOS 1017510]; NASA [NNX07AQ19A]; National Oceanic and Atmospheric Agency [NA 170P2919]	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); National Oceanic and Atmospheric Agency	This project was partially supported under NSF-awards OCE-1105143 and IOS 1017510 to E. Weil, and NASA award (#NNX07AQ19A) to R. Armstrong. D. Anderson also received a research assistantship under National Oceanic and Atmospheric Agency - Coral Reef Ecosystem Studies grant (NA 170P2919) awarded to E. Weil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2008, J EXP MAR BIOL ECOL, V364, P63, DOI 10.1016/j.jembe.2008.06.032; Ambarsari I, 1997, MAR ECOL PROG SER, V159, P303, DOI 10.3354/meps159303; Anderson D, 2008, P 11 INT COR REEF S, V1, P211; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Beeden R, 2012, ENVIRON MANAGE, V49, P1, DOI 10.1007/s00267-011-9770-9; Bhosale P, 2007, ARCH BIOCHEM BIOPHYS, V458, P121, DOI 10.1016/j.abb.2006.10.005; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Bruckner AW, 2009, DIS AQUAT ORGAN, V87, P19, DOI 10.3354/dao02120; Bruckner AW, 2006, DIS AQUAT ORGAN, V69, P67, DOI 10.3354/dao069067; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Cervino JM, 2008, J APPL MICROBIOL, V105, P1658, DOI 10.1111/j.1365-2672.2008.03871.x; Cervino JM, 2012, DIS AQUAT ORGAN, V102, P137, DOI 10.3354/dao02541; Cervino JM, 2004, APPL ENVIRON MICROB, V70, P6855, DOI 10.1128/AEM.70.11.6855-6864.2004; Chartrand KM, 2009, MAR BIOL, V156, P1691, DOI 10.1007/s00227-009-1204-3; Clark CD, 2000, INT J REMOTE SENS, V21, P2321, DOI 10.1080/01431160050029602; Coops N, 2003, PHYTOPATHOLOGY, V93, P1524, DOI 10.1094/PHYTO.2003.93.12.1524; Cornet S, 2007, BIOLOGY LETT, V3, P284, DOI 10.1098/rsbl.2007.0003; Croquer A, 2009, DIS AQUAT ORGAN, V87, P33, DOI 10.3354/dao02164; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DeSalvo MK, 2010, MAR ECOL PROG SER, V402, P97, DOI 10.3354/meps08372; Dove S, 2006, LIMNOL OCEANOGR, V51, P1149, DOI 10.4319/lo.2006.51.2.1149; Downs CA, 2005, MAR POLLUT BULL, V51, P486, DOI 10.1016/j.marpolbul.2005.06.028; Edge SE, 2005, MAR POLLUT BULL, V51, P507, DOI 10.1016/j.marpolbul.2005.07.007; GATENO D, 2000, AQUAR SCI CONSERV, V2, P227; GLEASON DF, 1993, LIMNOL OCEANOGR, V38, P1452, DOI 10.4319/lo.1993.38.7.1452; GLEESON MW, 1995, ADV SPACE RES, V16, P151, DOI 10.1016/0273-1177(95)00396-V; Gong P, 2002, INT J REMOTE SENS, V23, P1827, DOI 10.1080/01431160110075622; Gowen AA, 2007, TRENDS FOOD SCI TECH, V18, P590, DOI 10.1016/j.tifs.2007.06.001; HARDY JT, 1992, MAR ECOL PROG SER, V88, P247, DOI 10.3354/meps088247; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Hedley JD, 2002, ADV MAR BIOL, V43, P277, DOI 10.1016/S0065-2881(02)43006-4; Heron SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012210; Hochberg EJ, 2004, CORAL REEFS, V23, P84, DOI 10.1007/s00338-003-0350-1; Hochberg EJ, 2003, REMOTE SENS ENVIRON, V85, P159, DOI 10.1016/S0034-4257(02)00201-8; Hochberg EJ, 2000, CORAL REEFS, V19, P164, DOI 10.1007/s003380000087; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Holden H, 1998, REMOTE SENS ENVIRON, V65, P217, DOI 10.1016/S0034-4257(98)00029-7; Holden H, 2002, REMOTE SENS ENVIRON, V81, P300, DOI 10.1016/S0034-4257(02)00007-X; Kenkel CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026914; Kutser T, 2006, ESTUAR COAST SHELF S, V69, P607, DOI 10.1016/j.ecss.2006.05.026; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; Leutenegger A, 2007, FEBS J, V274, P2496, DOI 10.1111/j.1742-4658.2007.05785.x; Levy O, 2006, J EXP MAR BIOL ECOL, V328, P35, DOI 10.1016/j.jembe.2005.06.018; Liu ZY, 2008, RICE SCI, V15, P232, DOI 10.1016/S1672-6308(08)60047-5; Mahlein AK, 2012, EUR J PLANT PATHOL, V133, P197, DOI 10.1007/s10658-011-9878-z; Manzello DP, 2007, P NATL ACAD SCI USA, V104, P12035, DOI 10.1073/pnas.0701194104; Maoka T, 2011, MAR DRUGS, V9, P1419, DOI 10.3390/md9081419; Maynard JA, 2011, CORAL REEFS, V30, P485, DOI 10.1007/s00338-010-0708-0; Maynard JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032175; MAZEL CH, 1995, MAR ECOL PROG SER, V120, P185, DOI 10.3354/meps120185; Muhammed HH, 2005, BIOSYST ENG, V91, P9, DOI 10.1016/j.biosystemseng.2005.02.007; Mumby PJ, 2004, CORAL REEFS, V23, P171, DOI 10.1007/s00338-004-0382-1; Mydlarz LD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001811; Mydlarz LD, 2007, COMP BIOCHEM PHYS A, V146, P54, DOI 10.1016/j.cbpa.2006.09.005; Mydlarz LD, 2010, J EXP BIOL, V213, P934, DOI 10.1242/jeb.037580; Mydlarz LD, 2009, DIS AQUAT ORGAN, V87, P67, DOI 10.3354/dao02088; Oswald F, 2007, FEBS J, V274, P1102, DOI 10.1111/j.1742-4658.2007.05661.x; Palmer CV, 2012, P ROY SOC B-BIOL SCI, V279, P4106, DOI 10.1098/rspb.2012.1477; Palmer CV, 2008, P ROY SOC B-BIOL SCI, V275, P2687, DOI 10.1098/rspb.2008.0335; Palmer CV, 2011, J EXP BIOL, V214, P4240, DOI 10.1242/jeb.061267; Palmer CV, 2010, FASEB J, V24, P1935, DOI 10.1096/fj.09-152447; Palmer CV, 2009, BIOL BULL-US, V216, P68, DOI 10.1086/BBLv216n1p68; Petersen D, 2005, CORAL REEFS, V24, P510, DOI 10.1007/s00338-005-0498-y; Pietrzykowski E, 2006, FOREST PATHOL, V36, P334, DOI 10.1111/j.1439-0329.2006.00459.x; Raymundo LJ, 2008, COR DIS HDB GUID ASS; Richardson LL, 1998, NATURE, V392, P557, DOI 10.1038/33302; Rinkevich B, 2005, ENVIRON SCI TECHNOL, V39, P4333, DOI 10.1021/es0482583; Rodriguez-Roman A, 2006, LIMNOL OCEANOGR, V51, P2702, DOI 10.4319/lo.2006.51.6.2702; Rumpf T, 2010, COMPUT ELECTRON AGR, V74, P91, DOI 10.1016/j.compag.2010.06.009; Rundquist D, 2009, GISCI REMOTE SENS, V46, P139, DOI 10.2747/1548-1603.46.2.139; Samokhvalov A, 2004, PHOTOCHEM PHOTOBIOL, V80, P84, DOI 10.1562/2004-01-18-RA-047.1; Sankaran S, 2010, COMPUT ELECTRON AGR, V72, P1, DOI 10.1016/j.compag.2010.02.007; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Severance EG, 2006, MAR BIOL, V150, P57, DOI 10.1007/s00227-006-0332-2; Smith-Keune C, 2008, MAR BIOTECHNOL, V10, P166, DOI 10.1007/s10126-007-9049-6; Soto FJ, 2012, J MAR BIOL, DOI [10.1155/2012/510962, DOI 10.1155/2012/510962]]; Stambler N, 2007, J EXP MAR BIOL ECOL, V351, P143, DOI 10.1016/j.jembe.2007.06.014; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Sweet M, 2013, J ZOO AQUAR RES, V1, P20; TAKABAYASHI M, 1995, MAR BIOL, V123, P705, DOI 10.1007/BF00349113; Torrecilla E, 2011, REMOTE SENS ENVIRON, V115, P2578, DOI 10.1016/j.rse.2011.05.014; Tsai F, 1998, REMOTE SENS ENVIRON, V66, P41, DOI 10.1016/S0034-4257(98)00032-7; Venn AA, 2006, PLANT CELL ENVIRON, V29, P2133, DOI 10.1111/j.1365-3040.2006.001587.x; Vidal-Dupiol J, 2011, J BIOL CHEM, V286, P22688, DOI 10.1074/jbc.M110.216358; Vollmer SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003718; Voolstra CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-627; Weil E, 2004, CORAL HEALTH AND DISEASE, P35; Weil E, 2009, P 11 INT COR REEF S, V1, P202; Weil E, 2009, DIS AQUAT ORGAN, V87, P45, DOI 10.3354/dao02103; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Woodley CM, 2008, FIELD MAN INV CORAL, P85; Work TM, 2008, J EXP MAR BIOL ECOL, V362, P63, DOI 10.1016/j.jembe.2008.05.011; Zhang JC, 2012, FIELD CROP RES, V134, P165, DOI 10.1016/j.fcr.2012.05.011; Zhang M., 2003, INT J APPL EARTH OBS, V4, P295, DOI 10.1016/S0303-2434(03)00008-4; Zibordi G, 2006, J OPT A-PURE APPL OP, V8, P252, DOI 10.1088/1464-4258/8/3/005	97	15	15	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81478	10.1371/journal.pone.0081478	http://dx.doi.org/10.1371/journal.pone.0081478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324697	gold, Green Submitted, Green Published			2022-12-25	WOS:000327949300093
J	Arndt, MB; John-Stewart, G; Richardson, BA; Singa, B; van Lieshout, L; Verweij, JJ; Sangare, LR; Mbogo, LW; Naulikha, JM; Walson, JL				Arndt, Michael B.; John-Stewart, Grace; Richardson, Barbra A.; Singa, Benson; van Lieshout, Lisette; Verweij, Jaco J.; Sangare, Laura R.; Mbogo, Loice W.; Naulikha, Jacqueline M.; Walson, Judd L.			Impact of Helminth Diagnostic Test Performance on Estimation of Risk Factors and Outcomes in HIV-Positive Adults	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; KATO-KATZ TECHNIQUE; SCHISTOSOMA-MANSONI; ANCYLOSTOMA-DUODENALE; ASCARIS-LUMBRICOIDES; NECATOR-AMERICANUS; HOOKWORM INFECTION; FECAL SAMPLES; ANEMIA	Background: Traditional methods using microscopy for the detection of helminth infections have limited sensitivity. Polymerase chain reaction (PCR) assays enhance detection of helminths, particularly low burden infections. However, differences in test performance may modify the ability to detect associations between helminth infection, risk factors, and sequelae. We compared these associations using microscopy and PCR. Methods: This cross-sectional study was nested within a randomized clinical trial conducted at 3 sites in Kenya. We performed microscopy and real-time multiplex PCR for the stool detection and quantification of Ascaris lumbricoides, Necator americanus, Ancylostoma duodenale, Strongyloides stercoralis, and Schistosoma species. We utilized regression to evaluate associations between potential risk factors or outcomes and infection as detected by either method. Results: Of 153 HIV-positive adults surveyed, 55(36.0%) and 20(13.1%) were positive for one or more helminth species by PCR and microscopy, respectively (p<0.001). PCR-detected infections were associated with farming (Prevalence Ratio 1.57, 95% CI: 1.02, 2.40), communal water source (PR 3.80, 95% CI: 1.01, 14.27), and no primary education (PR 1.54, 95% CI: 1.14, 2.33), whereas microscopy-detected infections were not associated with any risk factors under investigation. Microscopy-detected infections were associated with significantly lower hematocrit and hemoglobin (means of -3.56% and -0.77 g/dl) and a 48% higher risk of anemia (PR 1.48, 95% CI: 1.17, 1.88) compared to uninfected. Such associations were absent for PCR-detected infections unless infection intensity was considered, Infections diagnosed with either method were associated with increased risk of eosinophilia (PCR PR 2.42, 95% CI: 1.02, 5.76; microscopy PR 2.92, 95% CI: 1.29, 6.60). Conclusion: Newer diagnostic methods, including PCR, improve the detection of helminth infections. This heightened sensitivity may improve the identification of risk factors for infection while reducing ability to discriminate infections associated with adverse clinical outcomes. Quantitative assays can be used to differentiate infection loads and discriminate infections associated with sequelae.	[Arndt, Michael B.; John-Stewart, Grace; Walson, Judd L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [John-Stewart, Grace; Sangare, Laura R.; Walson, Judd L.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [John-Stewart, Grace; Walson, Judd L.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [John-Stewart, Grace; Walson, Judd L.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [John-Stewart, Grace] Univ Washington, Dept Allergy & Infect Dis, Seattle, WA 98195 USA; [Richardson, Barbra A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Singa, Benson; Mbogo, Loice W.; Naulikha, Jacqueline M.] Kenya Govt Med Res Ctr, Clin Res Ctr, Nairobi, Kenya; [Singa, Benson] Kenya Govt Med Res Ctr, Ctr Reprod Hlth, Nairobi, Kenya; [van Lieshout, Lisette; Verweij, Jaco J.] Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kenya Medical Research Institute; Kenya Medical Research Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Arndt, MB (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	marndt@uw.edu	John-Stewart, Grace/L-3650-2019; John-Stewart, Grace/U-3351-2019; Walson, Judd/R-7269-2019; Singa, Benson/AAF-6055-2020; Walson, Judd/HGC-4359-2022	Walson, Judd/0000-0003-4836-720X; Arndt, Michael/0000-0001-9063-0644; Verweij, Jaco J./0000-0001-8553-931X; John-Stewart, Grace/0000-0002-4301-1573	President's Emergency Fund for AIDS Relief, through a Public Health Evaluation grant from the Centers for Disease Control (CDC) and Prevention [PHE KE.07.0039]; University of Washington Center for AIDS Research (CFAR), an NIH funded program [P30 AI027757]; NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA); NICHD [K24HD054314]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD054314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	President's Emergency Fund for AIDS Relief, through a Public Health Evaluation grant from the Centers for Disease Control (CDC) and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); University of Washington Center for AIDS Research (CFAR), an NIH funded program; NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research and publication were made possible with support from the President's Emergency Fund for AIDS Relief, through a Public Health Evaluation grant (PHE KE.07.0039) from the Centers for Disease Control (CDC) and Prevention and from the University of Washington Center for AIDS Research (CFAR), an NIH funded program (P30 AI027757), which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA). Additional funding: NICHD K24HD054314. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyhun Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-21; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Booth M, 2003, PARASITOLOGY, V127, P525, DOI 10.1017/S0031182003004128; Brooker S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000291; BROOKS RM, 1979, E AFR MED J, V56, P413; Brown M, 2003, TROP DOCT, V33, P72, DOI 10.1177/004947550303300206; CROLL NA, 1981, TROP GEOGR MED, V33, P241; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Downs JA, 2011, AM J TROP MED HYG, V84, P364, DOI 10.4269/ajtmh.2011.10-0585; Ebrahim A, 1997, AM J TROP MED HYG, V57, P706, DOI 10.4269/ajtmh.1997.57.706; GUYATT HL, 1990, PARASITOLOGY, V101, P139, DOI 10.1017/S0031182000079841; Humphries D, 2011, AM J TROP MED HYG, V84, P792, DOI 10.4269/ajtmh.2011.11-0003; Jonker FAM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001555; Karanja DMS, 1997, AM J TROP MED HYG, V56, P515, DOI 10.4269/ajtmh.1997.56.515; Khalid A, 2012, INT J GYNECOL OBSTET, V116, P10, DOI 10.1016/j.ijgo.2011.08.018; Knopp S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000331; Knopp S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000681; MAHALANABIS D, 1976, AM J CLIN NUTR, V29, P1372, DOI 10.1093/ajcn/29.12.1372; Modjarrad K, 2005, AM J TROP MED HYG, V73, P777, DOI 10.4269/ajtmh.2005.73.777; Monteiro L, 1997, J CLIN MICROBIOL, V35, P995, DOI 10.1128/JCM.35.4.995-998.1997; NDAMBA J, 1993, ANN TROP MED PARASIT, V87, P553, DOI 10.1080/00034983.1993.11812810; Ndassa A, 2007, ANN TROP MED PARASIT, V101, P469, DOI 10.1179/136485907X193752; Niesters HGM, 2002, J CLIN VIROL, V25, pS3; Obeng BB, 2008, ANN TROP MED PARASIT, V102, P625, DOI 10.1179/136485908X337490; Olsen A, 2001, J BIOSOC SCI, V33, P569, DOI 10.1017/S0021932001005697; Pontes LA, 2003, AM J TROP MED HYG, V68, P652, DOI 10.4269/ajtmh.2003.68.652; Pontes LA, 2002, AM J TROP MED HYG, V66, P157, DOI 10.4269/ajtmh.2002.66.157; Sarkinfada F, 2009, J INFECT DEV COUNTR, V3, P452, DOI 10.3855/jidc.417; Schrier S, 2012, APPROACH ADULT PATIE; Smith JL, 2010, TROP MED INT HEALTH, V15, P776, DOI 10.1111/j.1365-3156.2010.02542.x; Stoltzfus RJ, 1997, NUTR REV, V55, P223, DOI 10.1111/j.1753-4887.1997.tb01609.x; Stoltzfus RJ, 2001, J NUTR, V131, p697S, DOI 10.1093/jn/131.2.697S; Sturrock RF, 1998, T R SOC TROP MED HYG, V92, P470; Tefferi A, 2005, MAYO CLIN PROC, V80, P75; ten Hove RJ, 2008, T ROY SOC TROP MED H, V102, P179, DOI 10.1016/j.trstmh.2007.10.011; van Eijk AM, 2011, LANCET INFECT DIS, V11, P190, DOI 10.1016/S1473-3099(10)70295-4; Verweij JJ, 2007, AM J TROP MED HYG, V77, P685, DOI 10.4269/ajtmh.2007.77.685; Verweij JJ, 2004, J CLIN MICROBIOL, V42, P1220, DOI 10.1128/JCM.42.3.1220-1223.2004; Walson J, 2012, LANCET INFECT DIS, V12, P925, DOI 10.1016/S1473-3099(12)70207-4; Walson JL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000644; Wiria AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057899; Wiria AE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-77; Woodburn PW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000473	43	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81915	10.1371/journal.pone.0081915	http://dx.doi.org/10.1371/journal.pone.0081915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324729	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300113
J	Lee, SY; Lee, KS; Yi, SH; Kook, SH; Lee, JC				Lee, Seung-Youp; Lee, Keun-Soo; Yi, Sea Hyun; Kook, Sung-Ho; Lee, Jeong-Chae			Acteoside Suppresses RANKL-Mediated Osteoclastogenesis by Inhibiting c-Fos Induction and NF-kappa B Pathway and Attenuating ROS Production	PLOS ONE			English	Article							REHMANNIA-GLUTINOSA; BONE-RESORPTION; MOLECULAR-BASIS; MICE LACKING; DIFFERENTIATION; CELL; MACROPHAGES; ACTIVATION; RECEPTOR; OSTEOPOROSIS	Numerous studies have reported that inflammatory cytokines are important mediators for osteoclastogenesis, thereby causing excessive bone resorption and osteoporosis. Acteoside, the main active compound of Rehmannia glutinosa, which is used widely in traditional Oriental medicine, has anti-inflammatory and antioxidant potentials. In this study, we found that acteoside markedly inhibited osteoclast differentiation and formation from bone marrow macrophages (BMMs) and RAW264.7 macrophages stimulated by the receptor activator of nuclear factor-kappaB (NF-kappa B) ligand (RANKL). Acteoside pretreatment also prevented bone resorption by mature osteoclasts in a dose-dependent manner. Acteoside (10 mu M) attenuated RANKL-stimulated activation of p38 kinase, extracellular signal-regulated kinases, and c-Jun N-terminal kinase, and also suppressed NF-kB activation by inhibiting phosphorylation of the p65 subunit and the inhibitor k beta alpha. In addition, RANKL-mediated increases in the expression of c-Fos and nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1) and in the production of tumor necrosis factor-a, interleukin (IL)-1 beta, and IL-6 were apparently inhibited by acteoside pretreatment. Further, oral acteoside reduced ovariectomy-induced bone loss and inflammatory cytokine production to control levels. Our data suggest that acteoside inhibits osteoclast differentiation and maturation from osteoclastic precursors by suppressing RANKL-induced activation of mitogen-activated protein kinases and transcription factors such as NF-kappa B, c-Fos, and NFATc1. Collectively, these results suggest that acteoside may act as an anti-resorptive agent to reduce bone loss by blocking osteoclast activation.	[Lee, Seung-Youp] Chonbuk Natl Univ, Res Inst Clin Med, Chonbuk Natl Univ Hosp, Biomed Res Inst, Jeonju, Chonbuk, South Korea; [Lee, Seung-Youp; Yi, Sea Hyun; Kook, Sung-Ho; Lee, Jeong-Chae] Chonbuk Natl Univ, Dept Orthodont, Inst Oral Biosci, Jeonju, Chonbuk, South Korea; [Lee, Seung-Youp; Yi, Sea Hyun; Kook, Sung-Ho; Lee, Jeong-Chae] Chonbuk Natl Univ, Sch Dent, Jeonju, Chonbuk, South Korea; [Lee, Keun-Soo; Lee, Jeong-Chae] Chonbuk Natl Univ, Dept Bioact Mat Sci, Res Ctr Bioact Mat, Jeonju, Chonbuk, South Korea	Jeonbuk National University; Jeonbuk National University Hospital; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University	Lee, JC (corresponding author), Chonbuk Natl Univ, Dept Orthodont, Inst Oral Biosci, Jeonju, Chonbuk, South Korea.	leejc88@jbnu.ac.kr			funds of Biomedical Research Institute, Chonbuk National University Hospital; Chonbuk National University, Jeonju, South Korea	funds of Biomedical Research Institute, Chonbuk National University Hospital; Chonbuk National University, Jeonju, South Korea	This paper was supported by funds of Biomedical Research Institute, Chonbuk National University Hospital. This work was in part supported by research funds endowed to Dr. Sung-Ho Kook from Chonbuk National University, Jeonju, South Korea, in 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson SB, 2002, RHEUMATOLOGY, V41, P972, DOI 10.1093/rheumatology/41.9.972; Bar-Shavit Z, 2007, J CELL BIOCHEM, V102, P1130, DOI 10.1002/jcb.21553; Caudrillier A, 2010, MOL PHARMACOL, V78, P569, DOI 10.1124/mol.109.063347; Cho ES, 2012, MOL CELLS, V33, P173, DOI 10.1007/s10059-012-2240-z; Cho ES, 2010, J CELL BIOCHEM, V111, P1260, DOI 10.1002/jcb.22849; Chun JC, 2002, PESTIC BIOCHEM PHYS, V72, P153, DOI 10.1016/S0048-3575(02)00008-1; Cosentino-Gomes D, 2012, INT J MOL SCI, V13, P10697, DOI 10.3390/ijms130910697; Del Fattore A, 2010, ARCH BIOCHEM BIOPHYS, V503, P28, DOI 10.1016/j.abb.2010.07.020; Fang M, 2011, J PHARM PHARMACOL, V63, P120, DOI 10.1111/j.2042-7158.2010.01162.x; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Goltzman D, 2002, NAT REV DRUG DISCOV, V1, P784, DOI 10.1038/nrd916; Ha H, 2004, EXP CELL RES, V301, P119, DOI 10.1016/j.yexcr.2004.07.035; Hwang JM, 2010, INT IMMUNOPHARMACOL, V10, P526, DOI 10.1016/j.intimp.2010.01.016; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Jules J, 2012, J BIOL CHEM, V287, P15728, DOI 10.1074/jbc.M111.296228; Kim H, 1998, INT J IMMUNOPHARMACO, V20, P231, DOI 10.1016/S0192-0561(98)00037-X; Kim HN, 2012, EUR J PHARMACOL, V691, P69, DOI 10.1016/j.ejphar.2012.07.034; Kim JH, 2009, MOL CELLS, V28, P201, DOI 10.1007/s10059-009-0123-y; Kim SS, 2005, REDOX REP, V10, P311, DOI 10.1179/135100005X83734; Kim T, 2013, J ETHNOPHARMACOL, V146, P83, DOI 10.1016/j.jep.2012.11.037; Kook SH, 2013, J PERIODONT IN PRESS; Lee JC, 2012, FREE RADICAL BIO MED, V53, P742, DOI 10.1016/j.freeradbiomed.2012.06.002; Lee JW, 2009, CYTOTECHNOLOGY, V61, P125, DOI 10.1007/s10616-010-9253-5; Lee JH, 2010, MOL PHARMACOL, V77, P17, DOI 10.1124/mol.109.057877; Li CH, 2011, J BONE MINER RES, V26, P644, DOI 10.1002/jbmr.242; Lorenzo JA, 1998, ENDOCRINOLOGY, V139, P3022, DOI 10.1210/en.139.6.3022; Lu J, 2013, TOXICOL IN VITRO, V27, P1007, DOI 10.1016/j.tiv.2013.01.011; Motojima H, 2013, J NATURAL M IN PRESS; Nakanishi A, 2013, MOL MED REP, V7, P1896, DOI 10.3892/mmr.2013.1446; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Qi W, 2012, OSTEOPOROSIS INT, V23, P2347, DOI 10.1007/s00198-011-1842-4; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Rho J, 2004, MOL CELLS, V17, P1; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Schapoval EES, 1998, J ETHNOPHARMACOL, V60, P53, DOI 10.1016/S0378-8741(97)00136-0; Son YO, 2011, J PHARM PHARMACOL, V63, P1309, DOI 10.1111/j.2042-7158.2011.01335.x; Son YO, 2009, APOPTOSIS, V14, P796, DOI 10.1007/s10495-009-0353-7; Sturge J, 2011, NAT REV CLIN ONCOL, V8, P357, DOI 10.1038/nrclinonc.2011.67; Takahashi N, 2011, FRONT BIOSCI-LANDMRK, V16, P21, DOI 10.2741/3673; Takayanagi H, 2005, J MOL MED, V83, P170, DOI 10.1007/s00109-004-0612-6; Tam DNN, 2012, TOXICOL APPL PHARM, V259, P329, DOI 10.1016/j.taap.2012.01.010; Teitelbaum SL, 2004, J CLIN INVEST, V114, P463, DOI 10.1172/JCI200422644; TOMODA M, 1994, CHEM PHARM BULL, V42, P1666, DOI 10.1248/cpb.42.1666; Tsai HY, 2008, EUR J PHARMACOL, V588, P124, DOI 10.1016/j.ejphar.2008.04.024; Xiong QB, 1998, PLANTA MED, V64, P120, DOI 10.1055/s-2006-957387; Yu JY, 2012, TOXICOL IN VITRO, V26, P561, DOI 10.1016/j.tiv.2012.01.022	47	50	55	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80873	10.1371/journal.pone.0080873	http://dx.doi.org/10.1371/journal.pone.0080873			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324641	Green Submitted, gold, Green Published			2022-12-25	WOS:000327949300052
J	Mather, JP; Roberts, PE; Pan, ZY; Chen, F; Hooley, J; Young, P; Xu, XL; Smith, DH; Easton, A; Li, PJ; Bonvini, E; Koenig, S; Moore, PA				Mather, Jennie P.; Roberts, Penelope E.; Pan, Zhuangyu; Chen, Francine; Hooley, Jeffrey; Young, Peter; Xu, Xiaolin; Smith, Douglas H.; Easton, Ann; Li, Panjing; Bonvini, Ezio; Koenig, Scott; Moore, Paul A.			Isolation of Cancer Stem Like Cells from Human Adenosquamous Carcinoma of the Lung Supports a Monoclonal Origin from a Multipotential Tissue Stem Cell	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SQUAMOUS-CELL; ADENOCARCINOMA; IDENTIFICATION; EXPRESSION; MUTATIONS; MARKER; GENES; RAS	There is increasing evidence that many solid tumors are hierarchically organized with the bulk tumor cells having limited replication potential, but are sustained by a stem-like cell that perpetuates the tumor. These cancer stem cells have been hypothesized to originate from transformation of adult tissue stem cells, or through re-acquisition of stem-like properties by progenitor cells. Adenosquamous carcinoma (ASC) is an aggressive type of lung cancer that contains a mixture of cells with squamous (cytokeratin 5+) and adenocarcinoma (cytokeratin 7+) phenotypes. The origin of these mixtures is unclear as squamous carcinomas are thought to arise from basal cells in the upper respiratory tract while adenocarcinomas are believed to form from stem cells in the bronchial alveolar junction. We have isolated and characterized cancer stem-like populations from ASC through application of selective defined culture medium initially used to grow human lung stem cells. Homogeneous cells selected from ASC tumor specimens were stably expanded in vitro. Primary xenografts and metastatic lesions derived from these cells in NSG mice fully recapitulate both the adenocarcinoma and squamous features of the patient tumor. Interestingly, while the CSLC all co-expressed cytokeratins 5 and 7, most xenograft cells expressed either one, or neither, with <10% remaining double positive. We also demonstrated the potential of the CSLC to differentiate to multi-lineage structures with branching lung morphology expressing bronchial, alveolar and neuroendocrine markers in vitro. Taken together the properties of these ASC-derived CSLC suggests that ASC may arise from a primitive lung stem cell distinct from the bronchial-alveolar or basal stem cells.	[Mather, Jennie P.; Roberts, Penelope E.; Pan, Zhuangyu; Chen, Francine; Hooley, Jeffrey; Young, Peter; Xu, Xiaolin; Smith, Douglas H.; Easton, Ann; Li, Panjing] MacroGenics Inc, San Francisco, CA USA; [Bonvini, Ezio; Koenig, Scott; Moore, Paul A.] MacroGenics Inc, Rockville, MD USA		Mather, JP (corresponding author), MacroGenics Inc, San Francisco, CA USA.	jennie.mather@gmail.com			MacroGenics, Inc.	MacroGenics, Inc.	No current external funding sources for this study. The work was fully funded by MacroGenics, Inc. through corporate fundraising from private equity. Funders were not involved in any aspect of the design or conduct of the research.	Bastide K, 2010, LUNG CANCER, V68, P1, DOI 10.1016/j.lungcan.2009.11.001; Bishop JA, 2010, HUM PATHOL, V41, P20, DOI 10.1016/j.humpath.2009.06.014; Bujas T, 2011, EUR J HISTOCHEM, V55, P39, DOI 10.4081/ejh.2011.e7; Butler MW, 2011, CANCER RES, V71, P2572, DOI 10.1158/0008-5472.CAN-10-2046; Chen J, 2012, NATURE; Chilosi M, 2010, ARCH PATHOL LAB MED, V134, P55, DOI 10.1043/1543-2165-134.1.55; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Cooke DT, 2010, ANN THORAC SURG, V90, P943, DOI 10.1016/j.athoracsur.2010.05.025; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Delgado O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022023; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Duan ZF, 2003, CLIN CANCER RES, V9, P2778; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Eramo A, 2010, ONCOGENE, V29, P4625, DOI 10.1038/onc.2010.207; Fumagalli D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-101; Giangreco A, 2009, P NATL ACAD SCI USA, V106, P9286, DOI 10.1073/pnas.0900668106; Gjerstorff MF, 2008, HUM REPROD, V23, P2194, DOI 10.1093/humrep/den262; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Hussenet T, 2010, CELL CYCLE, V9, P1480, DOI 10.4161/cc.9.8.11203; Jang SJ, 2001, CANCER RES, V61, P7959; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Kanazawa H, 2000, AM J PATHOL, V156, P1289, DOI 10.1016/S0002-9440(10)64999-1; Kang SM, 2007, CANCER, V109, P581, DOI 10.1002/cncr.22413; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Loo D, 2007, MOL CANCER THER, V6, P856, DOI 10.1158/1535-7163.MCT-06-0581; Moreira AL, 2010, MODERN PATHOL, V23, P889, DOI 10.1038/modpathol.2010.68; Nguyen Giang Huong, 2011, Cancers (Basel), V3, P1232, DOI 10.3390/cancers3011232; Niho S, 1999, JPN J CANCER RES, V90, P1244, DOI 10.1111/j.1349-7006.1999.tb00703.x; Pelotti S, 2007, GENET TEST, V11, P397, DOI 10.1089/gte.2007.0004; Pirozzi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021548; Poschmann G, 2009, MOL CELL PROTEOMICS, V8, P1105, DOI 10.1074/mcp.M800422-MCP200; Raiser DM, 2009, STEM CELLS, V27, P606, DOI 10.1002/stem.10; Ring BZ, 2009, MODERN PATHOL, V22, P1032, DOI 10.1038/modpathol.2009.60; ROBERTS PE, 1990, AM J PHYSIOL, V259, pL415, DOI 10.1152/ajplung.1990.259.6.L415; Roberts PE, 2008, METHOD CELL BIOL, V86, P325, DOI 10.1016/S0091-679X(08)00015-0; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Smith G, 2002, P NATL ACAD SCI USA, V99, P9433, DOI 10.1073/pnas.122612899; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Sullivan JP, 2010, CANCER METAST REV, V29, P61, DOI 10.1007/s10555-010-9216-5; Tochigi N, 2011, AM J CLIN PATHOL, V135, P783, DOI 10.1309/AJCP08IQZAOGYLFL; Toyooka S, 2006, INT J CANCER, V118, P1588, DOI 10.1002/ijc.21500; Uramoto H, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-92; Wang YZ, 2005, PROSTATE, V64, P149, DOI 10.1002/pros.20225	45	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e79456	10.1371/journal.pone.0079456	http://dx.doi.org/10.1371/journal.pone.0079456			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324581	Green Submitted, Green Published, gold			2022-12-25	WOS:000327949300009
J	Wu, FX; Chang, MM; Sun, YL; Xu, GH				Wu, Feixiang; Chang, Mee-mann; Sun, Yuanlin; Xu, Guanghui			A New Saurichthyiform (Actinopterygii) with a Crushing Feeding Mechanism from the Middle Triassic of Guizhou (China)	PLOS ONE			English	Article							SKELETAL ANATOMY; YUNNAN PROVINCE; FISH; INTERRELATIONSHIPS; OSTEICHTHYES; POLYPTERUS; BRAINCASE; EVOLUTION; PATTERNS; FAUNA	Background: Equipped with an effective predatory feeding mechanism enhanced by large and sharp teeth, pointed snout and elongate body, saurichthyiform fishes are considered common fish-eaters in the early Mesozoic aquatic ecosystems. Additionally, because of the similar body plan across species, saurichthyiforms are also regarded evolutionally conservative, with few morphological and ecological changes during their long history. However, their phylogenetic affinity remains unclear as to whether they are chondrostean, neopterygian or stem-actinopteran, and likewise the intrarelationships of the group have rarely been explored. Methodology/Principal Findings: Here we report a new saurichthyiform from the Middle Triassic of Guizhou, China, based on the well-preserved specimens including a 3-D braincase. The new taxon, Yelangichthys macrocephalus gen. et sp. nov., is unique among saurichthyiforms in having a peculiar neurocranium with a broad orbital tectum, paired posterior myodomes, a deep, transverse fossa in the posterodorsal part of the orbit, and a feeding mechanism structured for durophagy. Phylogenetic analysis places Yelangichthys gen. nov. at the most basal position in the Saurichthyiformes as the sister to Saurichthyidae, and a new family Yelangichthyidae is erected to include only Y. macrocephalus gen. et sp. nov. The monophyly of the Chondrostei comprising [Saurichthyiformes + Acipenseriformes] Birgeriiformes is supported, but not the monophyly of Saurichthys, the type genus of Saurichthyidae. With its outstanding osteological details, Yelangichthys gen. nov. greatly increases the neurocranial variations in saurichthyiforms, and its novel feeding structure suggests the consumption of hard-preys instead of fishes. Conclusions/Significance: Our findings highlight the detailed osteology of a saurichthyiform braincase and its feeding design. We suggest that saurichthyiforms are closely allied to the Acipenseriformes. Saurichthyiforms were very diverse in the cranial osteology and they might have undergone a rapid evolutionary radiation via, for the new material here, transforming the feeding mechanism and thus exploiting the food resources unsuitable for other saurichthyiforms.	[Wu, Feixiang; Chang, Mee-mann; Xu, Guanghui] Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origins, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China; [Wu, Feixiang; Chang, Mee-mann; Sun, Yuanlin] Peking Univ, Key Lab Orogen Belts & Crustal Evolut, Sch Earth & Space Sci, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Peking University	Wu, FX (corresponding author), Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origins, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China.	wufeixiang@ivpp.ac.cn; ylsun@pku.edu.cn			National Natural Science Foundation of China [41102011, 41172001, 40920124002]; State Key Laboratory of Palaeobiology and Stratigraphy (NIGP, CAS) [123109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Palaeobiology and Stratigraphy (NIGP, CAS)(Chinese Academy of Sciences)	This work is supported by the National Natural Science Foundation of China (grant nos. 41102011, 41172001, 40920124002) and the State Key Laboratory of Palaeobiology and Stratigraphy (NIGP, CAS) (grant no. 123109). The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Agassiz L, 1834, RECHERCHES POISSONS, V2; Allis EP, 1922, J ANAT, V56, P189; Anderson PSL, 2011, NATURE, V476, P206, DOI 10.1038/nature10207; Basden AM, 2001, J VERTEBR PALEONTOL, V21, P754, DOI 10.1671/0272-4634(2001)021[0754:APANFT]2.0.CO;2; Beltan L., 1968, FAUNE ICHTHYOLOGIQUE, P135; Beltan L., 1980, GONDW 5 P 5 INT GOND, P53; Berg L.S., 1940, TRAVAUX I ZOOLOGIQUE, V5, P1; CARROL RL, 1988, VERTEBRATE PALEONTOL; Chang M-M, 2004, RECENT ADV ORIGIN EA, P665; Chang MM, 1982, THESIS U STOCKHOLML; Chen ZQ, 2012, NAT GEOSCI, V5, P375, DOI [10.1038/NGEO1475, 10.1038/ngeo1475]; Choo B, 2011, EARTH ENV SCI T R SO, V102, P77, DOI 10.1017/S1755691011011029; Cloutier R., 2004, RECENT ADV ORIGIN EA, P217; Coates MI, 1999, PHILOS T R SOC B, V354, P435, DOI 10.1098/rstb.1999.0396; Coates MI, 1998, ZOOL J LINN SOC-LOND, V122, P27; Daegling DJ, 2001, J MORPHOL, V250, P12, DOI 10.1002/jmor.1055; Danforth CH, 1912, J MORPHOL, V23, P409, DOI 10.1002/jmor.1050230303; de Beer G., 1937, DEV VERTEBRATE SKULL; Diogo R, 2010, MUSCLES VERTEBRATES; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Gardiner BG, 2005, ZOOL J LINN SOC-LOND, V144, P511, DOI 10.1111/j.1096-3642.2005.00181.x; GARDINER BG, 1989, ZOOL J LINN SOC-LOND, V97, P135, DOI 10.1111/j.1096-3642.1989.tb00550.x; GARDINER BRIAN GEORGE, 1960, BULL BRIT MUS [NAT HIST] GEOL, V4, P239; Grande L, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011114; Grande L, 2010, COPEIA, P1; Griffith J., 1962, Palaeontology, V5, P344; Hamel MH, 2008, J VERTEBR PALEONTOL, V28, P989, DOI 10.1671/0272-4634-28.4.989; Hilton Eric J., 2011, Fieldiana-Life and Earth Sciences, V3, P1; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; JESSEN H L, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V167, P180; Jiang DY, 2009, ACTA GEOL SIN-ENGL, V83, P451, DOI 10.1111/j.1755-6724.2009.00047.x; Jin Fan, 2006, Vertebrata Palasiatica, V44, P28; Jin Fan, 2001, Vertebrata Palasiatica, V39, P168; Kogan T, 2009, FREIBERGER FORSCH C, VC532, P139; LAUDER GV, 1982, AM ZOOL, V22, P275; LAUDER GV, 1980, J MORPHOL, V163, P283, DOI 10.1002/jmor.1051630305; Lehman J. P., 1959, Ann Paleont, V45, P177; LEHMAN JEAN-PIERRE, 1952, K SVENSKA VETENSKAPS AKAD HANDL, V2, P1; Li C, 2006, NATURWISSENSCHAFTEN, V93, P200, DOI 10.1007/s00114-006-0097-y; Li C, 2004, SCIENCE, V305, P1931, DOI 10.1126/science.1100498; LIEM KF, 2001, FUNCTIONAL MORPHOLOG; Liu Xianting, 1988, Vertebrata Palasiatica, V26, P77; Marinelli W, 1973, VERGLEICHENDE ANATOM, P309; Millot J., 1958, ANATOMIE LATIMERIA C; Millot J., 1965, ANATOMIE LATIMERIA C, VII; Minikh A.V., 1981, Paleontologicheskii Zhurnal, V1981, P105; NIELSEN E, 1942, MEDDELELSER GRONLAND, V138, P1; Nielsen E., 1949, PALAEOZOOLOGICA GROE, V146, P1; Nixon KC, 2002, WINCLADIA VERSION 10; NORTHCUTT RG, 1993, BRAIN BEHAV EVOLUT, V42, pR7; PATTERSON C, 1982, AM ZOOL, V22, P241; PATTERSON C, 1975, PHILOS T R SOC B, V269, P275, DOI 10.1098/rstb.1975.0001; Poplin C., 1975, Bulletin de la Societe Geologique de France, V17(1), P26; Poplin C, 1974, ETUDE QUELQUES PALEO; Qiao T, 2010, SCI CHINA EARTH SCI, V53, P1836, DOI 10.1007/s11430-010-4089-6; Rayner DH., 1951, T ROY SOC EDINBURGH, V62, P58, DOI [DOI 10.1017/S0080456800009248, 10.1017/S0080456800009248]; RIEPPEL O, 1992, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V221, P63; Rieppel O., 1980, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1980, P43; RIEPPEL O, 1985, Schweizerische Palaeontologische Abhandlungen, V108, P1; Romano C, 2013, NAT GEOSCI, V6, P57, DOI [10.1038/ngeo1667, 10.1038/NGEO1667]; Romano C, 2012, B GEOSCI, V87, P543, DOI 10.3140/bull.geosci.1337; Romer AS, 1977, VERTEBRATE BODY, V5th; Schaeffer B., 1978, AM MUS NOVIT, V2658, P1; Schwarz W., 1970, SCHWEIZERISCHE PALAO, V89, P1; Stensio E., 1935, PALAEONTOLOGIA SIN C, V3, P1; Stensio E., 1925, KUNGLIGA SVENSKA VET, V3, P1; Stensio E.A., 1921, TRIASSIC FISHES SPIT, DOI [10.5962/bhl.title.159141, DOI 10.5962/BHL.TITLE.159141]; STENSIo ERIE A., 1932, MEDDELEL OM GRONLAND, V83, P1; Sun ZY, 2006, ACTA GEOL SIN-ENGL, V80, P621; Sun ZY, 2008, RIV ITAL PALEONTOL S, V114, P363, DOI 10.13130/2039-4942/5908; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Sytchevskaya Eugenia K., 1999, P445; THIES D, 1985, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V187, P183; TINTORI A, 1990, Rivista Italiana di Paleontologia e Stratigrafia, V96, P93; Wu FX, 2011, ACTA PALAEONTOL POL, V56, P581, DOI 10.4202/app.2010.0007; Wu FX, 2009, ACTA GEOL SIN-ENGL, V83, P440, DOI 10.1111/j.1755-6724.2009.00056.x; Wu FX, 2009, THESIS PEKING U BEIJ; Xu GH, 2011, ZOOL J LINN SOC-LOND, V161, P595, DOI 10.1111/j.1096-3642.2010.00645.x; Xu GH, 2012, CHINESE SCI BULL, V57, P111, DOI 10.1007/s11434-011-4719-1; Yu XB, 1998, J VERTEBR PALEONTOL, V18, P261, DOI 10.1080/02724634.1998.10011055; Yu XB, 1990, THESIS YALE U; Zhang QY, 2010, GEOL REV, V54, P523; Zhu M, 2002, NATURE, V418, P767, DOI 10.1038/nature00871; Zhu M, 2001, NATURE, V410, P81, DOI 10.1038/35065078	84	24	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81010	10.1371/journal.pone.0081010	http://dx.doi.org/10.1371/journal.pone.0081010			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324657	Green Published, gold			2022-12-25	WOS:000327949300066
J	Deng, XL; Liang, YX; Lu, H; Yang, ZY; Liu, RE; Wang, JK; Song, XB; Long, J; Li, Y; Lei, DQ; Feng, ZT				Deng, Xingli; Liang, Yuanxin; Lu, Hua; Yang, Zhiyong; Liu, Ru'en; Wang, Jinkun; Song, Xiaobin; Long, Jiang; Li, Yu; Lei, Deqiang; Feng, Zhongtang			Co-Transplantation of GDNF-Overexpressing Neural Stem Cells and Fetal Dopaminergic Neurons Mitigates Motor Symptoms in a Rat Model of Parkinson's Disease	PLOS ONE			English	Article							NEUROTROPHIC FACTOR GDNF; TYROSINE-HYDROXYLASE; NEUROPROTECTION; DELIVERY	Striatal transplantation of dopaminergic (DA) neurons or neural stem cells (NSCs) has been reported to improve the symptoms of Parkinson's disease (PD), but the low rate of cell survival, differentiation, and integration in the host brain limits the therapeutic efficacy. We investigated the therapeutic effects of intracranial co-transplantation of mesencephalic NSCs stably overexpressing human glial-derived neurotrophic factor (GDNF-mNSCs) together with fetal DA neurons in the 6-OHDA rat model of PD. Striatal injection of mNSCs labeled by the contrast enhancer superparamagnetic iron oxide (SPIO) resulted in a hypointense signal in the striatum on T2-weighted magnetic resonance images that lasted for at least 8 weeks post-injection, confirming the long-term survival of injected stem cells in vivo. Co-transplantation of GDNF-mNSCs with fetal DA neurons significantly reduced apomorphine-induced rotation, a behavioral endophenotype of PD, compared to sham-treated controls, rats injected with mNSCs expressing empty vector (control mNSCs) plus fetal DA neurons, or rats injected separately with either control mNSCs, GDNF-mNSCs, or fetal DA neurons. In addition, survival and differentiation of mNSCs into DA neurons was significantly greater following co-transplantation of GDNF-mNSCs plus fetal DA neurons compared to the other treatment groups as indicated by the greater number of cell expressing both the mNSCs lineage tracer enhanced green fluorescent protein (eGFP) and the DA neuron marker tyrosine hydroxylase. The success of cell-based therapies for PD may be greatly improved by co-transplantation of fetal DA neurons with mNSCs genetically modified to overexpress trophic factors such as GDNF that support differentiation into DA cells and their survival in vivo.	[Deng, Xingli; Lu, Hua; Yang, Zhiyong; Wang, Jinkun; Song, Xiaobin; Long, Jiang; Li, Yu; Feng, Zhongtang] Kunming Med Univ, Affiliated Hosp 1, Dept Neurosurg, Kunming, Yunnan, Peoples R China; [Liang, Yuanxin] Albert Einstein Coll Med, Ctr Canc, New York, NY USA; [Liu, Ru'en] China Japan Friendship Hosp, Dept Neurosurg, Beijing, Peoples R China; [Lei, Deqiang] Huazhong Univ Sci & Technol, Union Hosp, Dept Neurosurg, Wuhan 430074, Hubei, Peoples R China	Kunming Medical University; Yeshiva University; China-Japan Friendship Hospital; Huazhong University of Science & Technology	Liu, RE (corresponding author), China Japan Friendship Hosp, Dept Neurosurg, Beijing, Peoples R China.	liuruen@gmail.com			Science Research Fund of Department of Education of Yunnan Province; Doctoral Fund of 1st Affiliated Hospital of Kunming Medical University [2010BS08]	Science Research Fund of Department of Education of Yunnan Province; Doctoral Fund of 1st Affiliated Hospital of Kunming Medical University	This study was supported by Science Research Fund of Department of Education of Yunnan Province (2009) and Doctoral Fund of 1st Affiliated Hospital of Kunming Medical University (2010BS08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazan E, 2004, HISTOL HISTOPATHOL, V19, P1261, DOI 10.14670/HH-19.1261; Bjorklund Anders, 2005, V265, P174; Brundin P, 2000, CELL TRANSPLANT, V9, P179, DOI 10.1177/096368970000900205; Cesaro Pierre, 2004, NeuroRx, V1, P492, DOI 10.1007/BF03206633; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Eriksen JL, 2005, ARCH NEUROL-CHICAGO, V62, P353, DOI 10.1001/archneur.62.3.353; Fahn S, 2006, J NEURAL TRANSM-SUPP, P1; Freed CR, 2003, J NEUROL, V250, P44, DOI 10.1007/s00415-003-1308-5; Grondin R, 1998, J NEUROL, V245, pP35, DOI 10.1007/PL00007744; Haas SJP, 2007, J NEUROSCI RES, V85, P778, DOI 10.1002/jnr.21170; Haavik J, 1998, MOL NEUROBIOL, V16, P285, DOI 10.1007/BF02741387; Jin GH, 2005, NEUROSCI LETT, V386, P105, DOI 10.1016/j.neulet.2005.04.065; Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015; Kirik D, 2004, NAT NEUROSCI, V7, P105, DOI 10.1038/nn1175; Kordower JH, 2003, ANN NEUROL, V53, pS120, DOI 10.1002/ana.10485; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Li F, 2013, CELL MOL NEUROBIOL, V33, P907, DOI 10.1007/s10571-013-9957-0; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; MOUKHLES H, 1994, NEUROSCIENCE, V63, P73, DOI 10.1016/0306-4522(94)90008-6; Nikkhah G, 2009, CELL TRANSPLANT, V18, P119, DOI 10.3727/096368909788341324; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; Paul G, 2006, ADV EXP MED BIOL, V557, P221; Rogers WJ, 2006, NAT CLIN PRACT CARD, V3, P554, DOI 10.1038/ncpcardio0659; SHIMODA K, 1992, BRAIN RES, V586, P319, DOI 10.1016/0006-8993(92)91642-R; Storch A, 2004, CELL TISSUE RES, V318, P15, DOI 10.1007/s00441-004-0923-5; Sun Y, 2012, BRAIN RES, V1437, P38, DOI 10.1016/j.brainres.2011.12.021; Thorek DLJ, 2006, ANN BIOMED ENG, V34, P23, DOI 10.1007/s10439-005-9002-7; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Wang ZL, 2012, J CEREBR BLOOD F MET, V32, P387, DOI 10.1038/jcbfm.2011.156; Willenbrock S, 2012, IN VIVO, V26, P31; Winkler C, 2005, TRENDS NEUROSCI, V28, P86, DOI 10.1016/j.tins.2004.12.006; Yuan H, 2005, J NEUROSCI METH, V144, P35, DOI 10.1016/j.jneumeth.2004.10.004	33	25	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e80880	10.1371/journal.pone.0080880	http://dx.doi.org/10.1371/journal.pone.0080880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312503	Green Published, gold, Green Submitted			2022-12-25	WOS:000327947800023
J	Desmaison, A; Frongia, C; Grenier, K; Ducommun, B; Lobjois, V				Desmaison, Annaick; Frongia, Celine; Grenier, Katia; Ducommun, Bernard; Lobjois, Valerie			Mechanical Stress Impairs Mitosis Progression in Multi-Cellular Tumor Spheroids	PLOS ONE			English	Article							CANCER-CELLS; TISSUES; PROLIFERATION; HOMEOSTASIS; GEOMETRY; FORCES; MOESIN; PLANE	Growing solid tumors are subjected to mechanical stress that influences their growth rate and development. However, little is known about its effects on tumor cell biology. To explore this issue, we investigated the impact of mechanical confinement on cell proliferation in MultiCellular Tumor Spheroids (MCTS), a 3D culture model that recapitulates the microenvironment, proliferative gradient, and cell-cell interactions of a tumor. Dedicated polydimethylsiloxane (PDMS) microdevices were designed to spatially restrict MCTS growth. In this confined environment, spheroids are likely to experience mechanical stress as indicated by their modified cell morphology and density and by their relaxation upon removal from the microdevice. We show that the proliferation gradient within mechanically confined spheroids is different in comparison to MCTS grown in suspension. Furthermore, we demonstrate that a population of cells within the body of mechanically confined MCTS is arrested at mitosis. Cell morphology analysis reveals that this mitotic arrest is not caused by impaired cell rounding, but rather that confinement negatively affects bipolar spindle assembly. All together these results suggest that mechanical stress induced by progressive confinement of growing spheroids could impair mitotic progression. This study paves the way to future research to better understand the tumor cell response to mechanical cues similar to those encountered during in vivo tumor development.	[Desmaison, Annaick; Frongia, Celine; Ducommun, Bernard; Lobjois, Valerie] Univ Toulouse, ITAV USR3505, Toulouse, France; [Desmaison, Annaick; Frongia, Celine; Ducommun, Bernard; Lobjois, Valerie] CNRS, ITAV USR3505, Toulouse, France; [Grenier, Katia] CNRS, LAAS UPR81001, Toulouse, France; [Ducommun, Bernard] CHU Toulouse, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse	Ducommun, B (corresponding author), Univ Toulouse, ITAV USR3505, Toulouse, France.	bernard.ducommun@itav-recherche.fr; valerie.lobjois@itav-recherche.fr		DUCOMMUN, Bernard/0000-0002-7126-8368; Lobjois, Valerie/0000-0003-2428-2084	Association pour la Recherche contre le Cancer; CNRS; Universite Paul Sabatier; Region Midi-Pyrenees; Fondation pour la Recherche Medicale (Equipe labellisee); ANR [12-BSV5-0008-01]	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paul Sabatier; Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); Fondation pour la Recherche Medicale (Equipe labellisee)(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR))	AD is a recipient of a doctoral fellowship by the Association pour la Recherche contre le Cancer and is a fellow of the Ecole de l'Inserm Liliane Bettencourt. This work was supported by the CNRS, Universite Paul Sabatier, Region Midi-Pyrenees, Fondation pour la Recherche Medicale (Equipe labellisee) and ANR (12-BSV5-0008-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Correia AL, 2012, DRUG RESIST UPDATE, V15, P39, DOI 10.1016/j.drup.2012.01.006; Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P193, DOI 10.1016/S1040-8428(00)00086-X; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Foty RA, 1996, DEVELOPMENT, V122, P1611; Gibson WT, 2011, CELL, V144, P427, DOI 10.1016/j.cell.2010.12.035; Guevorkian K, 2011, P NATL ACAD SCI USA, V108, P13387, DOI 10.1073/pnas.1105741108; Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Hofmann M, 2006, NEOPLASIA, V8, P89, DOI 10.1593/neo.05469; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lancaster OM, 2013, DEV CELL, V25, P270, DOI 10.1016/j.devcel.2013.03.014; Laurent J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-73; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Marmottant P, 2009, P NATL ACAD SCI USA, V106, P17271, DOI 10.1073/pnas.0902085106; Minc N, 2011, CELL, V144, P414, DOI 10.1016/j.cell.2011.01.016; Odde D, 2011, CELL, V144, P325, DOI 10.1016/j.cell.2011.01.022; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Piel Matthieu, 2011, Med Sci (Paris), V27, P590, DOI 10.1051/medsci/2011276010; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Tse HTK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038986; Tse JM, 2012, P NATL ACAD SCI USA, V109, P911, DOI 10.1073/pnas.1118910109; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Yu HM, 2011, TRENDS CELL BIOL, V21, P47, DOI 10.1016/j.tcb.2010.08.015	35	39	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e80447	10.1371/journal.pone.0080447	http://dx.doi.org/10.1371/journal.pone.0080447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312473	Green Published, Green Submitted, gold			2022-12-25	WOS:000327947800011
J	Goeritz, ML; Bowers, MR; Slepian, B; Marder, E				Goeritz, Marie L.; Bowers, Matthew R.; Slepian, Brian; Marder, Eve			Neuropilar Projections of the Anterior Gastric Receptor Neuron in the Stomatogastric Ganglion of the Jonah Crab, Cancer Borealis	PLOS ONE			English	Article							NERVOUS-SYSTEM; MOTOR PATTERNS; FUNCTIONAL CONSEQUENCES; LOBSTER; COMPARTMENTALIZATION; PROPRIOCEPTOR; VARIABILITY; ACTIVATION; MECHANISMS; MORPHOLOGY	Sensory neurons provide important feedback to pattern-generating motor systems. In the crustacean stomatogastric nervous system (STNS), feedback from the anterior gastric receptor (AGR), a muscle receptor neuron, shapes the activity of motor circuits in the stomatogastric ganglion (STG) via polysynaptic pathways involving anterior ganglia. The AGR soma is located in the dorsal ventricular nerve posterior to the STG and it has been thought that its axon passes through the STG without making contacts. Using high-resolution confocal microscopy with dye-filled neurons, we show here that AGR from the crab Cancer borealis also has local projections within the STG and that these projections form candidate contact sites with STG motor neurons or with descending input fibers from other ganglia. We develop and exploit a new masking method that allows us to potentially separate presynaptic and postsynaptic staining of synaptic markers. The AGR processes in the STG show diversity in shape, number of branches and branching structure. The number of AGR projections in the STG ranges from one to three simple to multiply branched processes. The projections come in close contact with gastric motor neurons and descending neurons and may also be electrically coupled to other neurons of the STNS. Thus, in addition to well described long-loop pathways, it is possible that AGR is involved in integration and pattern regulation directly in the STG.	[Goeritz, Marie L.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; Brandeis Univ, Volen Ctr, Waltham, MA 02254 USA	Brandeis University; Brandeis University	Goeritz, ML (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	goeritz@brandeis.edu		Goeritz, Marie/0000-0002-9555-801X	National Institutes of Health [NS 17813-32]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS017813, R01NS017813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R90DA033463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by National Institutes of Health grant NS 17813-32 to Eve Marder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN DH, 1995, J COMP NEUROL, V356, P355, DOI 10.1002/cne.903560304; Barriere G, 2008, J NEUROSCI, V28, P8810, DOI 10.1523/JNEUROSCI.2095-08.2008; Bassler U, 1998, BRAIN RES REV, V27, P65, DOI 10.1016/S0165-0173(98)00006-X; Beenhakker MP, 2005, J NEUROSCI, V25, P8794, DOI 10.1523/JNEUROSCI.2663-05.2005; Blitz DM, 2011, CURR OPIN NEUROBIOL, V21, P544, DOI 10.1016/j.conb.2011.05.019; Blitz DM, 1999, J NEUROSCI, V19, P5449; Bucher D, 2007, J COMP NEUROL, V501, P185, DOI 10.1002/cne.21169; Buschges A, 2011, CURR BIOL, V21, pR513, DOI 10.1016/j.cub.2011.05.029; Buscarino A, 2012, CHAOS, V22, DOI 10.1063/1.4761962; Cabirol-Pol MJ, 2002, J NEUROBIOL, V50, P150, DOI 10.1002/neu.10023.abs; Christie AE, 1997, J EXP BIOL, V200, P2279; Clarac F, 1999, J PHYSIOLOGY-PARIS, V93, P319, DOI 10.1016/S0928-4257(00)80060-1; Clarac F, 2000, TRENDS NEUROSCI, V23, P199, DOI 10.1016/S0166-2236(99)01535-0; COLEMAN MJ, 1992, J COMP NEUROL, V325, P581, DOI 10.1002/cne.903250410; COLEMAN MJ, 1994, J NEUROSCI, V14, P6544; COMBES D, 1993, J PHYSIOL-LONDON, V460, P581, DOI 10.1113/jphysiol.1993.sp019488; COMBES D, 1995, J COMP NEUROL, V363, P221, DOI 10.1002/cne.903630205; COMBES D, 1995, J PHYSIOL-LONDON, V483P, pP191; Combes D, 1997, J PHYSIOL-LONDON, V499, P161, DOI 10.1113/jphysiol.1997.sp021918; Daur N, 2009, EUR J NEUROSCI, V30, P808, DOI 10.1111/j.1460-9568.2009.06866.x; GOLDBERG D, 1988, CELL TISSUE RES, V252, P515, DOI 10.1007/BF00216638; GOLOWASCH J, 1992, J NEUROSCI, V12, P810; GOODMAN CS, 1978, J COMP NEUROL, V182, P681, DOI 10.1002/cne.901820408; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GUTIERREZ GJ, 2009, JOVE-J VIS EXP, P14242, DOI DOI 10.3791/1207.PUBMED:19308017; HARRISWARRICK RM, 1991, ANN REV NEUROSCIENCE, P14242; Hedrich UBS, 2008, J EXP BIOL, V211, P2624, DOI 10.1242/jeb.019711; Hedrich UBS, 2009, J NEUROPHYSIOL, V102, P2866, DOI 10.1152/jn.00618.2009; Jessell TM, 2011, NEURON, V72, P419, DOI 10.1016/j.neuron.2011.10.021; Katsuki T, 2009, NEURON, V64, P188, DOI 10.1016/j.neuron.2009.08.019; Kilman VL, 1996, J COMP NEUROL, V374, P362, DOI 10.1002/(SICI)1096-9861(19961021)374:3<362::AID-CNE5>3.0.CO;2-#; KING DG, 1976, J NEUROCYTOL, V5, P207, DOI 10.1007/BF01181657; Klagges BRE, 1996, J NEUROSCI, V16, P3154; LARIMER JL, 1966, J EXP BIOL, V44, P345; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Nusbaum MP, 2001, TRENDS NEUROSCI, V24, P146, DOI 10.1016/S0166-2236(00)01723-9; NUSBAUM MP, 1989, J NEUROSCI, V9, P1591; Oginsky MF, 2010, J COMP NEUROL, V518, P255, DOI 10.1002/cne.22225; Pearson KG, 1995, CURR OPIN NEUROBIOL, V5, P786, DOI 10.1016/0959-4388(95)80107-3; Prasad T, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00054; SIMMERS J, 1988, J NEUROPHYSIOL, V59, P740, DOI 10.1152/jn.1988.59.3.740; Skiebe P, 2000, J COMP NEUROL, V420, P373; Skiebe P, 2002, J COMP NEUROL, V453, P280, DOI 10.1002/cne.10398; Smarandache CR, 2008, EUR J NEUROSCI, V28, P460, DOI 10.1111/j.1460-9568.2008.06357.x; Smarandache CR, 2007, J EXP BIOL, V210, P2912, DOI 10.1242/jeb.006874; Stein W, 2006, J EXP BIOL, V209, P1285, DOI 10.1242/jeb.02133; Stein W, 2009, J COMP PHYSIOL A, V195, P989, DOI 10.1007/s00359-009-0483-y; Wilensky AE, 2003, J COMP NEUROL, V466, P554, DOI 10.1002/cne.10903; Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010; Wu ZH, 2011, NEURON, V70, P281, DOI 10.1016/j.neuron.2011.02.050	51	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e79306	10.1371/journal.pone.0079306	http://dx.doi.org/10.1371/journal.pone.0079306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312448	Green Published, Green Submitted, gold			2022-12-25	WOS:000327947800004
J	Cornish, KE; de Villiers, SHL; Pravetoni, M; Pentel, PR				Cornish, Katherine E.; de Villiers, Sabina H. L.; Pravetoni, Marco; Pentel, Paul R.			Immunogenicity of Individual Vaccine Components in a Bivalent Nicotine Vaccine Differ According to Vaccine Formulation and Administration Conditions	PLOS ONE			English	Article							CONJUGATE VACCINE; SMOKING-CESSATION; DRUG-ABUSE; RATS; BRAIN; ANTIBODIES; IMMUNIZATION; STRATEGIES; DIPHTHERIA; DEPENDENCE	Structurally distinct nicotine immunogens can elicit independent antibody responses against nicotine when administered concurrently. Co-administering different nicotine immunogens together as a multivalent vaccine could be a useful way to generate higher antibody levels than with monovalent vaccines alone. The immunogenicity and additivity of monovalent and bivalent nicotine vaccines was studied across a range of immunogen doses, adjuvants, and routes to assess the generality of this approach. Rats were vaccinated with total immunogen doses of 12.5 - 100 mu g of 3'-aminomethyl nicotine conjugated to recombinant Pseudomonas exoprotein A (3'-AmNic-rEPA), 6-carboxymethylureido nicotine conjugated to keyhole limpet hemocyanin (6-CMUNic-KLH), or both. Vaccines were administered s.c. in alum or i.p. in Freund's adjuvant at matched total immunogen doses. When administered s.c. in alum, the contributions of the individual immunogens to total nicotine-specific antibody (NicAb) titers and concentrations were preserved across a range of doses. Antibody affinity for nicotine varied greatly among individuals but was similar for monovalent and bivalent vaccines. However when administered i.p. in Freund's adjuvant the contributions of the individual immunogens to total NicAb titers and concentrations were compromised at some doses. These results support the possibility of co-administering structurally distinct nicotine immunogens to achieve a more robust immune response than can be obtained with monovalent immunogens alone. Choice of adjuvant was important for the preservation of immunogen component activity.	[Cornish, Katherine E.; Pravetoni, Marco; Pentel, Paul R.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Cornish, Katherine E.; de Villiers, Sabina H. L.; Pravetoni, Marco; Pentel, Paul R.] Minneapolis Med Res Fdn Inc, Minneapolis, MN USA; [de Villiers, Sabina H. L.] Univ Minnesota, Ctr Global Studies & Social Responsibil, Minneapolis, MN USA; [de Villiers, Sabina H. L.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Pravetoni, Marco; Pentel, Paul R.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; Minneapolis Medical Research Foundation; University of Minnesota System; University of Minnesota Twin Cities; Karolinska Institutet; University of Minnesota System; University of Minnesota Twin Cities	Cornish, KE (corresponding author), Univ Minnesota, Dept Pharmacol, 3-249 Millard Hall, Minneapolis, MN 55455 USA.	corni026@umn.edu		Pravetoni, Marco/0000-0003-1036-0184	National Institute on Drug Abuse [NIDA DA10714, NIDA DA07097]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010714] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this study came from National Institute on Drug Abuse - NIDA DA10714 and NIDA DA07097. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton B, 2009, HUM VACCINES, V5, P214, DOI 10.4161/hv.5.4.7556; Batista-Duharte A, 2011, TOXICOL LETT, V203, P97, DOI 10.1016/j.toxlet.2011.03.001; Bogaert D, 2004, VACCINE, V22, P2209, DOI 10.1016/j.vaccine.2003.11.038; Bryan JT, 2007, VACCINE, V25, P3001, DOI 10.1016/j.vaccine.2007.01.013; Cornish KE, 2011, INT IMMUNOPHARMACOL, V11, P1809, DOI 10.1016/j.intimp.2011.07.009; Cornuz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002547; Esterlis I, 2013, AM J PSYCHIAT, V170, P399, DOI 10.1176/appi.ajp.2012.12060793; Fahim REF, 2013, EXPERT REV VACCINES, V12, P333, DOI [10.1586/erv.13.13, 10.1586/ERV.13.13]; Halperin SA, 1996, CLIN INFECT DIS, V22, P59, DOI 10.1093/clinids/22.1.59; Hatsukami DK, 2011, CLIN PHARMACOL THER, V89, P392, DOI 10.1038/clpt.2010.317; Hatsukami DK, 2005, CLIN PHARMACOL THER, V78, P456, DOI 10.1016/j.clpt.2005.08.007; Hieda Y, 2000, INT J IMMUNOPHARMACO, V22, P809, DOI 10.1016/S0192-0561(00)00042-4; Hieda Y, 1999, PSYCHOPHARMACOLOGY, V143, P150, DOI 10.1007/s002130050930; Hieda Y, 1997, J PHARMACOL EXP THER, V283, P1076; INSEL RA, 1995, ANN NY ACAD SCI, V754, P35, DOI 10.1111/j.1749-6632.1995.tb44436.x; Keyler DE, 2008, INT IMMUNOPHARMACOL, V8, P1589, DOI 10.1016/j.intimp.2008.07.001; Keyler DE, 2003, J PHARMACOL EXP THER, V305, P587, DOI 10.1124/jpet.102.046805; Keyler DE, 2005, DRUG METAB DISPOS, V33, P1056, DOI 10.1124/dmd.105.004234; Laurenzana EM, 2009, VACCINE, V27, P7011, DOI 10.1016/j.vaccine.2009.09.072; LeSage MG, 2012, PHARMACOL BIOCHEM BE, V102, P157, DOI 10.1016/j.pbb.2012.03.026; Martell BA, 2009, ARCH GEN PSYCHIAT, V66, P1116, DOI 10.1001/archgenpsychiatry.2009.128; Moreno AY, 2009, PHARMACOL BIOCHEM BE, V92, P199, DOI 10.1016/j.pbb.2009.01.015; Pentel PR, 2000, PHARMACOL BIOCHEM BE, V65, P191, DOI 10.1016/S0091-3057(99)00206-3; Pichichero ME, 1997, CLIN INFECT DIS, V25, P1378, DOI 10.1086/516154; Pitas G, 2006, DRUG METAB DISPOS, V34, P906, DOI 10.1124/dmd.105.005934; Pravetoni M, 2012, J PHARMACOL EXP THER, V341, P225, DOI 10.1124/jpet.111.189506; Pravetoni M, 2012, BIOCHEM PHARMACOL, V83, P543, DOI 10.1016/j.bcp.2011.11.004; Raupach Tobias, 2012, Drugs, V72, pe1, DOI 10.2165/11599900-000000000-00000; Shen XY, 2012, CLIN PHARMACOL THER, V91, P60, DOI 10.1038/clpt.2011.281; Stills HF, 2005, ILAR J, V46, P280, DOI 10.1093/ilar.46.3.280; Vidor E, 2007, J COMP PATHOL, V137, pS62, DOI 10.1016/j.jcpa.2007.04.014	31	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82557	10.1371/journal.pone.0082557	http://dx.doi.org/10.1371/journal.pone.0082557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312662	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500138
J	Fraisier, V; Kasri, A; Miserey-Lenkei, S; Sibarita, JB; Nair, D; Mayeux, A; Bardin, S; Toyoda, Y; Poser, I; Poznyakovskiy, A; Goud, B; Hyman, AA; Dimitrov, A				Fraisier, Vincent; Kasri, Amal; Miserey-Lenkei, Stephanie; Sibarita, Jean-Baptiste; Nair, Deepak; Mayeux, Adeline; Bardin, Sabine; Toyoda, Yusuke; Poser, Ina; Poznyakovskiy, Andrei; Goud, Bruno; Hyman, Anthony A.; Dimitrov, Ariane			C11ORF24 Is a Novel Type I Membrane Protein That Cycles between the Golgi Apparatus and the Plasma Membrane in Rab6-Positive Vesicles	PLOS ONE			English	Article							EARLY/RECYCLING ENDOSOMES; TRANSPORT; SEQUENCE; TOPOLOGY; COMPLEX; PATHWAY; GTPASE; CELLS; ROLES	The Golgi apparatus is an intracellular compartment necessary for post-translational modification, sorting and transport of proteins. It plays a key role in mitotic entry through the Golgi mitotic checkpoint. In order to identify new proteins involved in the Golgi mitotic checkpoint, we combine the results of a knockdown screen for mitotic phenotypes and a localization screen. Using this approach, we identify a new Golgi protein C11ORF24 (NP_071733.1). We show that C11ORF24 has a signal peptide at the N-terminus and a transmembrane domain in the C-terminal region. C11ORF24 is localized on the Golgi apparatus and on the trans-Golgi network. A large part of the protein is present in the lumen of the Golgi apparatus whereas only a short tail extends into the cytosol. This cytosolic tail is well conserved in evolution. By FRAP experiments we show that the dynamics of C11ORF24 in the Golgi membrane are coherent with the presence of a transmembrane domain in the protein. C11ORF24 is not only present on the Golgi apparatus but also cycles to the plasma membrane via endosomes in a pH sensitive manner. Moreover, via video-microscopy studies we show that C11ORF24 is found on transport intermediates and is colocalized with the small GTPase RAB6, a GTPase involved in anterograde transport from the Golgi to the plasma membrane. Knocking down C11ORF24 does not lead to a mitotic phenotype or an intracellular transport defect in our hands. All together, these data suggest that C11ORF24 is present on the Golgi apparatus, transported to the plasma membrane and cycles back through the endosomes by way of RAB6 positive carriers.	[Fraisier, Vincent; Kasri, Amal; Miserey-Lenkei, Stephanie; Mayeux, Adeline; Bardin, Sabine; Goud, Bruno; Dimitrov, Ariane] Inst Curie CNRS, UMR144, Paris, France; [Sibarita, Jean-Baptiste; Nair, Deepak] Univ Bordeaux, Interdisciplinary Inst Neurosci, Bordeaux, France; [Sibarita, Jean-Baptiste; Nair, Deepak] CNRS, UMR 5297, Bordeaux, France; [Toyoda, Yusuke; Poser, Ina; Poznyakovskiy, Andrei; Hyman, Anthony A.; Dimitrov, Ariane] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Max Planck Society	Dimitrov, A (corresponding author), Inst Curie CNRS, UMR144, Paris, France.	Ariane.dimitrov@gmail.com	Hyman, Anthony A/B-3917-2017; Goud, Bruno/GWC-4807-2022; Hyman, Tony/F-1923-2011	Hyman, Anthony A/0000-0003-3664-154X; Sibarita, Jean-Baptiste/0000-0002-9920-7700; Toyoda, Yusuke/0000-0003-0534-6898; Kasri, Amal/0000-0002-9656-4710; Nair, Deepak/0000-0002-2103-1653	Institut Curie; CNRS; EU [241548]; HFSP [LT000029/2010-L]	Institut Curie; CNRS(Centre National de la Recherche Scientifique (CNRS)); EU(European Commission); HFSP(Human Frontier Science Program)	This work has been supported by the Institut Curie and the CNRS. IP and AAH are supported by the EU's Seventh Framework Programme (FP7/2007-2013) under grant agreement 241548 (MitoSys Project), AD was supported by a long term fellowship from HFSP (LT000029/2010-L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONY C, 1992, J CELL SCI, V103, P785; Bachert C, 2001, MOL BIOL CELL, V12, P3152, DOI 10.1091/mbc.12.10.3152; Boulanger J, 2007, IEEE T PATTERN ANAL, V29, P1096, DOI 10.1109/TPAMI.2007.1064; Boulanger J, 2010, IEEE T MED IMAGING, V29, P442, DOI 10.1109/TMI.2009.2033991; Carcedo CH, 2004, SCIENCE, V305, P93, DOI 10.1126/science.1097775; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Dimitrov A, 2009, HUM MOL GENET, V18, P440, DOI 10.1093/hmg/ddn371; Gaudin R, 2012, J CELL BIOL, V199, P467, DOI 10.1083/jcb.201201144; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; GOUD B, 1990, NATURE, V345, P553, DOI 10.1038/345553a0; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Izeddin I, 2012, OPT EXPRESS, V20, P2081, DOI 10.1364/OE.20.002081; Kechkar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062918; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Kodani A, 2008, MOL BIOL CELL, V19, P745, DOI 10.1091/mbc.E07-08-0847; Kodani A, 2009, EMBO J, V28, P995, DOI 10.1038/emboj.2009.85; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Linstedt AD, 1997, MOL BIOL CELL, V8, P1073, DOI 10.1091/mbc.8.6.1073; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; LUCOCQ JM, 1987, EMBO J, V6, P3239, DOI 10.1002/j.1460-2075.1987.tb02641.x; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Martinez O, 1997, P NATL ACAD SCI USA, V94, P1828, DOI 10.1073/pnas.94.5.1828; Miserey-Lenkei S, 2006, EMBO J, V25, P278, DOI 10.1038/sj.emboj.7600929; Moutel S, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-14; Nizak C, 2004, TRAFFIC, V5, P284, DOI 10.1111/j.1398-9219.2004.0174.x; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; RAMBOURG A, 1987, BIOL CELL, V60, P103, DOI 10.1111/j.1768-322X.1987.tb00550.x; Rios RM, 2003, CURR OPIN CELL BIOL, V15, P60, DOI 10.1016/S0955-0674(02)00013-3; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Starr T, 2007, TRAFFIC, V8, P1265, DOI 10.1111/j.1600-0854.2007.00607.x; Sun Y, 2007, MOL BIOL CELL, V18, P4129, DOI 10.1091/mbc.E07-01-0080; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; Vasudevan C, 1998, J CELL SCI, V111, P1277; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Xiang Y, 2010, J CELL BIOL, V188, P237, DOI 10.1083/jcb.200907132	45	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82223	10.1371/journal.pone.0082223	http://dx.doi.org/10.1371/journal.pone.0082223			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312644	Green Published, gold, Green Submitted			2022-12-25	WOS:000327944500126
J	Mellergard, J; Edstrom, M; Jenmalm, MC; Dahle, C; Vrethem, M; Ernerudh, J				Mellergard, Johan; Edstrom, Mans; Jenmalm, Maria C.; Dahle, Charlotte; Vrethem, Magnus; Ernerudh, Jan			Increased B Cell and Cytotoxic NK Cell Proportions and Increased T Cell Responsiveness in Blood of Natalizumab-Treated Multiple Sclerosis Patients	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; REGULATORY CELLS; EXPRESSION; RESPONSES; DISEASE; TRANSFORMATION; PROLIFERATION; COSTIMULATION; MECHANISMS; DISABILITY	Background: Changes in the blood lymphocyte composition probably both mediate and reflect the effects of natalizumab treatment in multiple sclerosis, with implications for treatment benefits and risks. Methods: A broad panel of markers for lymphocyte populations, including states of activation and co-stimulation, as well as functional T cell responses to recall antigens and mitogens, were assessed by flow cytometry in 40 patients with relapsing multiple sclerosis before and after one-year natalizumab treatment. Results: Absolute numbers of all major lymphocyte populations increased after treatment, most markedly for NK and B cells. The fraction of both memory and presumed regulatory B cell subsets increased, as did CD3-CD56(dim) cytotoxic NK cells, whereas CD3-CD56(bright) regulatory NK cells decreased. The increase in cell numbers was further associated with a restored T cell responsiveness to recall antigens and mitogens in functional assays. Conclusions: Our data confirms that natalizumab treatment increases the number of lymphocytes in blood, likely mirroring the expression of VLA-4 being highest on NK and B cells. This finding supports reduction of lymphocyte extravasation as a main mode of action, although the differential effects on subpopulation composition suggests that cell-signalling may also be affected. The systemic increase in T cell responsiveness reflects the increase in numbers, and while augmenting anti-infectious responses systemically, localized responses may become correspondingly decreased.	[Mellergard, Johan; Vrethem, Magnus] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden; [Mellergard, Johan] Cty Council Ostergotland, Dept Neurol, Linkoping, Sweden; [Edstrom, Mans; Jenmalm, Maria C.; Ernerudh, Jan] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Unit Autoimmun & Immune Regulat, Linkoping, Sweden; [Dahle, Charlotte; Ernerudh, Jan] Cty Council Ostergotland, Dept Clin Immunol & Transfus Med, Linkoping, Sweden; [Vrethem, Magnus] Cty Council Ostergotland, Dept Neurol & Neurophysiol, Linkoping, Sweden	Linkoping University; City Council Ostergotland; Linkoping University; City Council Ostergotland; City Council Ostergotland	Mellergard, J (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden.	johan.mellergard@lio.se			Swedish Association of Persons with Neurological Disabilities, University Hospital of Linkoping; County Council of ostergotland; Linkoping University; Biogen Idec Sweden	Swedish Association of Persons with Neurological Disabilities, University Hospital of Linkoping; County Council of ostergotland; Linkoping University; Biogen Idec Sweden	The study was supported by grants from The Swedish Association of Persons with Neurological Disabilities, The University Hospital of Linkoping, The County Council of ostergotland and Linkoping University. The study was further supported by an unrestricted grant from Biogen Idec Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornsen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047578; Brisslert M, 2006, IMMUNOLOGY, V117, P548, DOI 10.1111/j.1365-2567.2006.02331.x; BROD SA, 1994, AUTOIMMUNITY, V17, P143, DOI 10.3109/08916939409014669; Campbell JJ, 2001, J IMMUNOL, V166, P6477, DOI 10.4049/jimmunol.166.11.6477; Croft M, 2009, IMMUNOL REV, V229, P173, DOI 10.1111/j.1600-065X.2009.00766.x; Disanto G, 2012, NEUROLOGY, V78, P823, DOI 10.1212/WNL.0b013e318249f6f0; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Gandhi R, 2010, J NEUROIMMUNOL, V221, P7, DOI 10.1016/j.jneuroim.2009.10.015; Haas J, 2011, J AUTOIMMUN, V37, P289, DOI 10.1016/j.jaut.2011.08.003; Harrer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031784; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; ILONEN J, 1981, J NEUROL SCI, V49, P117, DOI 10.1016/0022-510X(81)90194-5; Kessel A, 2012, AUTOIMMUN REV, V11, P670, DOI 10.1016/j.autrev.2011.11.018; Khademi M, 2009, EUR J NEUROL, V16, P528, DOI 10.1111/j.1468-1331.2009.02532.x; Kivisakk P, 2009, NEUROLOGY, V72, P1922, DOI 10.1212/WNL.0b013e3181a8266f; Knippenberg S, 2011, J NEUROIMMUNOL, V239, P80, DOI 10.1016/j.jneuroim.2011.08.019; Krumbholz M, 2008, NEUROLOGY, V71, P1350, DOI 10.1212/01.wnl.0000327671.91357.96; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McMurray RW, 1996, SEMIN ARTHRITIS RHEU, V25, P215, DOI 10.1016/S0049-0172(96)80034-5; Mellergard J, 2010, MULT SCLER J, V16, P208, DOI 10.1177/1352458509355068; Mittelbrunn M, 2004, P NATL ACAD SCI USA, V101, P11058, DOI 10.1073/pnas.0307927101; Mjosberg J, 2009, J IMMUNOL, V183, P759, DOI 10.4049/jimmunol.0803654; Moretta A, 2008, CELL DEATH DIFFER, V15, P226, DOI 10.1038/sj.cdd.4402170; Niino M, 2006, ANN NEUROL, V59, P748, DOI 10.1002/ana.20859; Ohshima Y, 1998, BLOOD, V92, P3338, DOI 10.1182/blood.V92.9.3338.421k19_3338_3345; Planas R, 2012, EUR J IMMUNOL, V42, P790, DOI 10.1002/eji.201142108; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Rice GPA, 2005, NEUROLOGY, V64, P1336, DOI 10.1212/01.WNL.0000158329.30470.D0; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; SATO T, 1995, J IMMUNOL, V155, P2938; Skarica M, 2011, J NEUROIMMUNOL, V235, P70, DOI 10.1016/j.jneuroim.2011.02.010; Stenner MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003319; Stuve O, 2006, ANN NEUROL, V59, P743, DOI 10.1002/ana.20858; Stuve O, 2006, ARCH NEUROL-CHICAGO, V63, P1383, DOI 10.1001/archneur.63.10.1383; Svahn A, 2003, J IMMUNOL METHODS, V277, P17, DOI 10.1016/S0022-1759(03)00111-X; WALKER JE, 1979, NEUROLOGY, V29, P1341, DOI 10.1212/WNL.29.10.1341; Zohren F, 2008, BLOOD, V111, P3893, DOI 10.1182/blood-2007-10-120329	39	30	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81685	10.1371/journal.pone.0081685	http://dx.doi.org/10.1371/journal.pone.0081685			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312575	Green Published, gold, Green Submitted			2022-12-25	WOS:000327944500088
J	Haricharan, S; Hein, SM; Dong, J; Toneff, MJ; Aina, OH; Rao, PH; Cardiff, RD; Li, Y				Haricharan, S.; Hein, S. M.; Dong, J.; Toneff, M. J.; Aina, O. H.; Rao, P. H.; Cardiff, R. D.; Li, Y.			Contribution of an alveolar cell of origin to the high-grade malignant phenotype of pregnancy-associated breast cancer	ONCOGENE			English	Article						pregnancy; breast cancer; alveolar cells; PABC	MAMMARY-GLAND DEVELOPMENT; CARCINOMA IN-SITU; PROGENITOR CELLS; STEM-CELLS; COLLAGEN; TARGETS; ADULT; WOMEN; ERBB2; YOUNG	Pregnancy-associated breast cancers (PABCs) are tumors diagnosed during pregnancy or up to 5 years following parturition, and are usually high-grade, connective tissue-rich, and estrogen receptor (ER)/progesterone receptor-negative. Little is known about the cellular origin of PABCs or the mechanisms by which PABCs are initiated. Using the RCAS retrovirus to deliver the ErbB2 oncogene into the mammary epithelium of our previously reported MMTV-tva transgenic mice, we detected high-grade, poorly differentiated, stroma-rich and ER-negative tumors during pregnancy and lactation. These high-grade and stroma-rich tumors were less frequent in involuted mice or in age-matched nulliparous mice. More importantly, by generating a WAP-tva transgenic line for expression of ErbB2 selectively in WAP(+) mammary alveolar cells, we found that tumors had similar morphological phenotypes (high grade, poorly differentiated, stroma-rich and ER-negative), irrespective of the time since pregnancy and even in the absence of pregnancy. These data suggest that PABCs arise preferentially from an alveolar cell population that expands during pregnancy and lactation. This somatic mouse model may also be useful for preclinical testing of new prophylactic and therapeutic strategies against PABC.	[Haricharan, S.; Hein, S. M.; Dong, J.; Toneff, M. J.; Li, Y.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Haricharan, S.; Hein, S. M.; Dong, J.; Toneff, M. J.; Li, Y.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Aina, O. H.; Cardiff, R. D.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Rao, P. H.] Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California Davis; Baylor College of Medicine	Li, Y (corresponding author), Baylor Coll Med, Lester & Sue Smith Breast Ctr, One Baylor Plaza,N1220, Houston, TX 77030 USA.	liyi@bcm.edu	Li, Yi/A-7635-2009	Li, Yi/0000-0002-9976-518X	NIH [CA124820, U54CA149196]; CDMRP [BC085050, BC073703]; NCI [U01 CA141582]; Nancy Owens Memorial Foundation; Dan L. Duncan Cancer Center [P30CA125123]; Sue & Lester Breast Center [P50-CA058183]; NATIONAL CANCER INSTITUTE [P50CA058183, R01CA124820, U54CA149196, U01CA141582, P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM084897] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CDMRP(United States Department of Defense); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Nancy Owens Memorial Foundation; Dan L. Duncan Cancer Center; Sue & Lester Breast Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the Varmus Laboratory for the resources in the generation and initial characterization of WAP-tva mice. This work was supported in part by funds from NIH CA124820 (to YL) and U54CA149196 (to YL; PI: Stephan Wong); from CDMRP BC085050 (to YL) and BC073703 (to YL); NCI U01 CA141582 (to RDC); and from the Nancy Owens Memorial Foundation (to YL); as well as by the resources from the Dan L. Duncan Cancer Center (P30CA125123) and the Sue & Lester Breast Center (P50-CA058183).	BARTOW SA, 1987, CANCER, V60, P2751, DOI 10.1002/1097-0142(19871201)60:11<2751::AID-CNCR2820601127>3.0.CO;2-M; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Brisken C, 2002, J MAMMARY GLAND BIOL, V7, P39, DOI 10.1023/A:1015718406329; Bu W, 2011, ONCOGENE, V30, P4399, DOI 10.1038/onc.2011.147; Bu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078720; Bu W, 2009, J MAMMARY GLAND BIOL, V14, P401, DOI 10.1007/s10911-009-9154-4; CAMPBELL SM, 1984, NUCLEIC ACIDS RES, V12, P8685, DOI 10.1093/nar/12.22.8685; Cruz GI, 2013, BREAST CANCER RES TR, V137, P237, DOI 10.1007/s10549-012-2313-0; Du ZJ, 2006, P NATL ACAD SCI USA, V103, P17396, DOI 10.1073/pnas.0608607103; Fornetti J, 2012, CELL CYCLE, V11, P639, DOI 10.4161/cc.11.4.19358; Foulkes WD, 2004, CLIN CANCER RES, V10, P2029, DOI 10.1158/1078-0432.CCR-03-1061; Genin AS, 2012, BREAST, V21, P550, DOI 10.1016/j.breast.2012.05.002; Holland EC, 1998, P NATL ACAD SCI USA, V95, P1218, DOI 10.1073/pnas.95.3.1218; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Keller PJ, 2012, P NATL ACAD SCI USA, V109, P2772, DOI 10.1073/pnas.1017626108; Khaled WT, 2007, DEVELOPMENT, V134, P2739, DOI 10.1242/dev.003194; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Lyons TR, 2011, NAT MED, V17, P1109, DOI 10.1038/nm.2416; Lyons TR, 2009, J MAMMARY GLAND BIOL, V14, P87, DOI 10.1007/s10911-009-9119-7; MACMAHON B, 1970, B WORLD HEALTH ORGAN, V43, P209; Mathelin C, 2008, ANTICANCER RES, V28, P2447; Medina D, 2004, CLIN CANCER RES, V10, p380S, DOI 10.1158/1078-0432.CCR-031211; Middleton LP, 2003, CANCER, V98, P1055, DOI 10.1002/cncr.11614; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Murphy CG, 2012, CANCER-AM CANCER SOC, V118, P3254, DOI 10.1002/cncr.26654; NIELSEN M, 1987, BRIT J CANCER, V56, P814, DOI 10.1038/bjc.1987.296; O'Brien J, 2011, INT J DEV BIOL, V55, P745, DOI 10.1387/ijdb.113379jo; O'Brien J, 2010, AM J PATHOL, V176, P1241, DOI 10.2353/ajpath.2010.090735; Pilewskie M, 2012, ANN SURG ONCOL, V19, P1167, DOI 10.1245/s10434-011-2104-6; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Reddy JP, 2009, J MAMMARY GLAND BIOL, V14, P405, DOI 10.1007/s10911-009-9157-1; ROBINSON GW, 1995, DEVELOPMENT, V121, P2079; Schedin P, 2006, NAT REV CANCER, V6, P281, DOI 10.1038/nrc1839; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Smith GH, 2003, CELL PROLIFERAT, V36, P3, DOI 10.1046/j.1365-2184.36.s.1.2.x; Stensheim H, 2009, J CLIN ONCOL, V27, P45, DOI 10.1200/JCO.2008.17.4110; Toneff MJ, 2010, NEOPLASIA, V12, P718, DOI 10.1593/neo.10516; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Welch HG, 1997, ANN INTERN MED, V127, P1023, DOI 10.7326/0003-4819-127-11-199712010-00014; Yamaji D, 2009, GENE DEV, V23, P2382, DOI 10.1101/gad.1840109	42	10	11	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 11	2014	33	50					5729	5739		10.1038/onc.2013.521	http://dx.doi.org/10.1038/onc.2013.521			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AW2AB	24317513	Green Accepted, Green Submitted			2022-12-25	WOS:000346089300008
J	Czech, B; Dettmer, K; Valletta, D; Saugspier, M; Koch, A; Stevens, AP; Thasler, WE; Muller, M; Oefner, PJ; Bosserhoff, AK; Hellerbrand, C				Czech, Barbara; Dettmer, Katja; Valletta, Daniela; Saugspier, Michael; Koch, Andreas; Stevens, Axel P.; Thasler, Wolfgang E.; Mueller, Martina; Oefner, Peter J.; Bosserhoff, Anja-Katrin; Hellerbrand, Claus			Expression and Function of Methylthioadenosine Phosphorylase in Chronic Liver Disease	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; NF-KAPPA-B; S-ADENOSYLMETHIONINE; HEPATOCELLULAR-CARCINOMA; OXIDATIVE STRESS; DNA METHYLATION; RAT HEPATOCYTES; DOWN-REGULATION; FIBROSIS; METHIONINE	To study expression and function of methylthioadenosine phosphorylase (MTAP), the rate-limiting enzyme in the methionine and adenine salvage pathway, in chronic liver disease. Design: MTAP expression was analyzed by qRT-PCR, Western blot and immunohistochemical analysis. Levels of MTA were determined by liquid chromatography-tandem mass spectrometry. Results: MTAP was downregulated in hepatocytes in murine fibrosis models and in patients with chronic liver disease, leading to a concomitant increase in MTA levels. In contrast, activated hepatic stellate cells (HSCs) showed strong MTAP expression in cirrhotic livers. However, also MTA levels in activated HSCs were significantly higher than in hepatocytes, and there was a significant correlation between MTA levels and collagen expression in diseased human liver tissue indicating that activated HSCs significantly contribute to elevated MTA in diseased livers. MTAP suppression by siRNA resulted in increased MTA levels, NF.B activation and apoptosis resistance, while overexpression of MTAP caused the opposite effects in HSCs. The anti-apoptotic effect of low MTAP expression and high MTA levels, respectively, was mediated by induced expression of survivin, while inhibition of survivin abolished the anti-apoptotic effect of MTA on HSCs. Treatment with a DNA demethylating agent induced MTAP and reduced survivin expression, while oxidative stress reduced MTAP levels but enhanced survivin expression in HSCs. Conclusion: MTAP mediated regulation of MTA links polyamine metabolism with NF.B activation and apoptosis in HSCs. MTAP and MTAP modulating mechanisms appear as promising prognostic markers and therapeutic targets for hepatic fibrosis.	[Czech, Barbara; Valletta, Daniela; Saugspier, Michael; Koch, Andreas; Mueller, Martina; Hellerbrand, Claus] Univ Hosp Regensburg, Dept Internal Med 1, Regensburg, Germany; [Dettmer, Katja; Stevens, Axel P.; Oefner, Peter J.] Univ Regensburg, Inst Funct Genom, D-93053 Regensburg, Germany; [Bosserhoff, Anja-Katrin] Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany; [Thasler, Wolfgang E.] Univ Munich, Grosshadern Tissue Bank, Munich, Germany; [Thasler, Wolfgang E.] Univ Munich, Ctr Liver Cell Res, Dept Surg, Munich, Germany	University of Regensburg; University of Regensburg; University of Regensburg; University of Munich; University of Munich	Hellerbrand, C (corresponding author), Univ Hosp Regensburg, Dept Internal Med 1, Regensburg, Germany.	claus.hellerbrand@ukr.de	Bosserhoff, Anja/GNH-4801-2022; Dettmer, Katja/N-4562-2016; Dettmer, Katja/D-6218-2018	Dettmer, Katja/0000-0001-7337-2380; Dettmer, Katja/0000-0001-7337-2380; Bosserhoff, Anja/0000-0001-8147-394X	German Research Association (DFG) [KFO262]; German Ministry of Education and Research (BMBF); Human Tissue and Cell Research (HTCR) Foundation	German Research Association (DFG)(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Human Tissue and Cell Research (HTCR) Foundation	This work was supported by grants (KFO262) from the German Research Association (DFG) to K. D., P.O., A. B., and C. H., and grants from the German Ministry of Education and Research (BMBF) to A. B. and C. H. The authors acknowledge the Human Tissue and Cell Research (HTCR) Foundation for supporting their research by making human liver tissue available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann T, 2009, CANCER SCI, V100, P646, DOI 10.1111/j.1349-7006.2009.01087.x; Amann T, 2009, AM J PATHOL, V174, P1544, DOI 10.2353/ajpath.2009.080596; Ansorena E, 2002, HEPATOLOGY, V35, P274, DOI 10.1053/jhep.2002.30419; Ansorena E, 2006, AM J PHYSIOL-GASTR L, V290, pG1186, DOI 10.1152/ajpgi.00282.2005; BACKLUND PS, 1981, J BIOL CHEM, V256, P1533; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bataille F, 2005, LAB INVEST, V85, P124, DOI 10.1038/labinvest.3700192; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Berasain C, 2004, BBA-MOL BASIS DIS, V1690, P276, DOI 10.1016/j.bbadis.2004.08.002; Cederbaum AI, 2010, WORLD J GASTROENTERO, V16, P1366, DOI 10.3748/wjg.v16.i11.1366; Chou WC, 2004, P NATL ACAD SCI USA, V101, P4578, DOI 10.1073/pnas.0306687101; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; Dorn C, 2010, INT J CLIN EXP PATHO, V3, P505; Elsharkawy AM, 2005, APOPTOSIS, V10, P927, DOI 10.1007/s10495-005-1055-4; Faouzi S, 1999, LAB INVEST, V79, P485; Fernandez-Irigoyen J, 2008, BIOCHEM J, V411, P457, DOI 10.1042/BJ20071569; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gabele E, 2009, BIOCHEM BIOPH RES CO, V378, P348, DOI 10.1016/j.bbrc.2008.10.155; Hellerbrand C, 2006, CARCINOGENESIS, V27, P64, DOI 10.1093/carcin/bgi201; Hellerbrand C, 2008, GUT, V57, P243, DOI 10.1136/gut.2007.129544; Hellerbrand C, 1998, AM J PHYSIOL-GASTR L, V275, pG269, DOI 10.1152/ajpgi.1998.275.2.G269; Hevia H, 2004, HEPATOLOGY, V39, P1088, DOI 10.1002/hep.20154; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kirovski G, 2011, AM J PATHOL, V178, P1145, DOI 10.1016/j.ajpath.2010.11.059; Latasa MU, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015690; Mann J, 2007, CELL DEATH DIFFER, V14, P275, DOI 10.1038/sj.cdd.4401979; Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev; Mato JM, 2008, ANNU REV NUTR, V28, P273, DOI 10.1146/annurev.nutr.28.061807.155438; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Mezzano S, 2004, NEPHROL DIAL TRANSPL, V19, P2505, DOI 10.1093/ndt/gfh207; Min JY, 2010, FEBS LETT, V584, P2427, DOI 10.1016/j.febslet.2010.04.048; Muhlbauer M, 2006, J HEPATOL, V45, P520, DOI 10.1016/j.jhep.2006.05.007; Nobori T, 1996, P NATL ACAD SCI USA, V93, P6203, DOI 10.1073/pnas.93.12.6203; Paik Yong Han, 2011, Korean J Hepatol, V17, P251, DOI 10.3350/kjhep.2011.17.4.251; Pascale RM, 2002, ALCOHOL, V27, P193, DOI 10.1016/S0741-8329(02)00227-6; Sanchez-Valle V, 2012, CURR MED CHEM, V19, P4850, DOI 10.2174/092986712803341520; Sceusi EL, 2011, HPB, V13, P369, DOI 10.1111/j.1477-2574.2011.00303.x; Simile MM, 2001, J HEPATOL, V34, P386, DOI 10.1016/S0168-8278(00)00078-7; Tamm I, 1998, CANCER RES, V58, P5315; Wright MC, 2001, GASTROENTEROLOGY, V121, P685, DOI 10.1053/gast.2001.27188; Zhao Q, 2013, J VIRAL HEPATITIS, V20, P430, DOI 10.1111/jvh.12048; Zhao Q, 2013, TOHOKU J EXP MED, V229, P35, DOI 10.1620/tjem.229.35; Ziech D, 2011, MUTAT RES-FUND MOL M, V711, P167, DOI 10.1016/j.mrfmmm.2011.02.015	44	3	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e80703	10.1371/journal.pone.0080703	http://dx.doi.org/10.1371/journal.pone.0080703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324622	gold, Green Published, Green Submitted			2022-12-25	WOS:000328566700013
J	Dolensek, J; Stozer, A; Klemen, MS; Miller, EW; Rupnik, MS				Dolensek, Jurij; Stozer, Andraz; Klemen, Masa Skelin; Miller, Evan W.; Rupnik, Marjan Slak			The Relationship between Membrane Potential and Calcium Dynamics in Glucose-Stimulated Beta Cell Syncytium in Acute Mouse Pancreas Tissue Slices	PLOS ONE			English	Article							BURSTING ELECTRICAL-ACTIVITY; CA2+ CONCENTRATION; CYTOPLASMIC CA2+; INSULIN-RELEASE; INTACT ISLETS; GAP-JUNCTIONS; B-CELLS; OSCILLATIONS; CHANNELS; LANGERHANS	Oscillatory electrical activity is regarded as a hallmark of the pancreatic beta cell glucose-dependent excitability pattern. Electrophysiologically recorded membrane potential oscillations in beta cells are associated with in-phase oscillatory cytosolic calcium activity ([Ca2+](i)) measured with fluorescent probes. Recent high spatial and temporal resolution confocal imaging revealed that glucose stimulation of beta cells in intact islets within acute tissue slices produces a [Ca2+](i) change with initial transient phase followed by a plateau phase with highly synchronized [Ca2+](i) oscillations. Here, we aimed to correlate the plateau [Ca2+](i) oscillations with the oscillations of membrane potential using patch-clamp and for the first time high resolution voltage-sensitive dye based confocal imaging. Our results demonstrated that the glucose-evoked membrane potential oscillations spread over the islet in a wave-like manner, their durations and wave velocities being comparable to the ones for [Ca2+](i) oscillations and waves. High temporal resolution simultaneous records of membrane potential and [Ca2+](i) confirmed tight but nevertheless limited coupling of the two processes, with membrane depolarization preceding the [Ca2+](i) increase. The potassium channel blocker tetraethylammonium increased the velocity at which oscillations advanced over the islet by several-fold while, at the same time, emphasized differences in kinetics of the membrane potential and the [Ca2+](i). The combination of both imaging techniques provides a powerful tool that will help us attain deeper knowledge of the beta cell network.	[Dolensek, Jurij; Stozer, Andraz; Klemen, Masa Skelin; Rupnik, Marjan Slak] Univ Maribor, Fac Med, Inst Physiol, SLO-2000 Maribor, Slovenia; [Stozer, Andraz; Rupnik, Marjan Slak] Univ Maribor, Ctr Open Innovat & Res, SLO-2000 Maribor, Slovenia; [Miller, Evan W.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Rupnik, Marjan Slak] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia	University of Maribor; University of Maribor; University of California System; University of California San Diego	Rupnik, MS (corresponding author), Univ Maribor, Fac Med, Inst Physiol, SLO-2000 Maribor, Slovenia.	marjan.rupnik@um.si	Slak Rupnik, Marjan/E-6246-2015; Rupnik, Marjan Slak/R-4738-2019	Slak Rupnik, Marjan/0000-0002-3744-4882; Rupnik, Marjan Slak/0000-0002-3744-4882	Slovenian Research Agency Programme [P3-0310-2334, J3-2290-2334]; Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins; European Regional Development Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS078561] Funding Source: NIH RePORTER	Slovenian Research Agency Programme(Slovenian Research Agency - Slovenia); Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins; European Regional Development Fund(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work presented in this paper was supported through the Slovenian Research Agency Programme (P3-0310-2334, Grant J3-2290-2334) and the Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins. The paper The Relationship between Membrane Potential and Calcium Dynamics in Glucose-Stimulated Beta Cell Syncytium in Acute Mouse Pancreas Tissue Slices was produced within the framework of the operation entitled "Centre for Open Innovation and Research of the University of Maribor". The operation is co-funded by the European Regional Development Fund and conducted within the framework of the Operational Programme for Strengthening Regional development Potentials for the period 2007-2013, development priority 1: "Competitiveness of companies and research excellence", priority axis 1.1: " Encouraging competitive potential of enterprises and research excellence". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; ATWATER I, 1979, J PHYSIOL-LONDON, V288, P561; Benninger RKP, 2008, BIOPHYS J, V95, P5048, DOI 10.1529/biophysj.108.140863; BERGSTEN P, 1994, J BIOL CHEM, V269, P8749; EDDLESTONE GT, 1984, J MEMBRANE BIOL, V77, P1, DOI 10.1007/BF01871095; Escobar AL, 1997, PFLUG ARCH EUR J PHY, V434, P615, DOI 10.1007/s004240050444; FATHERAZI S, 1991, J MEMBRANE BIOL, V120, P105, DOI 10.1007/BF01872393; Gilon P, 1999, J BIOL CHEM, V274, P20197, DOI 10.1074/jbc.274.29.20197; GILON P, 1992, J BIOL CHEM, V267, P20713; GLOOR P, 1985, J CLIN NEUROPHYSIOL, V2, P327, DOI 10.1097/00004691-198510000-00002; Goehring I, 2012, J BIOL CHEM, V287, P15706, DOI 10.1074/jbc.M111.314567; Gopel S, 1999, J PHYSIOL-LONDON, V521, P717, DOI 10.1111/j.1469-7793.1999.00717.x; HALBAN PA, 1982, ENDOCRINOLOGY, V111, P86, DOI 10.1210/endo-111-1-86; Heart E, 2007, BIOCHEM J, V403, P197, DOI 10.1042/BJ20061209; HENQUIN JC, 1990, PFLUG ARCH EUR J PHY, V416, P568, DOI 10.1007/BF00382691; Henquin JC, 2011, DIABETES RES CLIN PR, V93, pS27, DOI 10.1016/S0168-8227(11)70010-9; Hjortoe GM, 2004, ACTA DIABETOL, V41, P185, DOI 10.1007/s00592-004-0164-9; Johnson PR, 2002, CELL CALCIUM, V32, P59, DOI 10.1016/S0143-4160(02)00091-X; Kuznetsov A, 2005, AM J PHYSIOL-CELL PH, V289, pC224, DOI 10.1152/ajpcell.00004.2005; Liu YJ, 1998, J PHYSIOL-LONDON, V508, P471, DOI 10.1111/j.1469-7793.1998.471bq.x; MEARS D, 1995, J MEMBRANE BIOL, V146, P163; MEDA P, 1984, Q J EXP PHYSIOL CMS, V69, P719; MEDA P, 1983, DIABETES, V32, P858, DOI 10.2337/diabetes.32.9.858; MEISSNER HP, 1976, NATURE, V262, P502, DOI 10.1038/262502a0; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; MICHAELS RL, 1981, SCIENCE, V214, P801, DOI 10.1126/science.6117129; Miller EW, 2012, P NATL ACAD SCI USA, V109, P2114, DOI 10.1073/pnas.1120694109; Moreno AP, 2005, AM J PHYSIOL-ENDOC M, V288, pE948, DOI 10.1152/ajpendo.00216.2004; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; ORCI L, 1975, J CLIN ENDOCR METAB, V41, P841, DOI 10.1210/jcem-41-5-841; Palti Y, 1996, DIABETES, V45, P595, DOI 10.2337/diabetes.45.5.595; PEREZARMENDARIZ M, 1991, BIOPHYS J, V59, P76, DOI 10.1016/S0006-3495(91)82200-7; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Rorsman P, 2012, CELL CALCIUM, V51, P300, DOI 10.1016/j.ceca.2011.11.006; SANTOS RM, 1991, PFLUG ARCH EUR J PHY, V418, P417, DOI 10.1007/BF00550880; Serre-Beinier V, 2000, DIABETES, V49, P727, DOI 10.2337/diabetes.49.5.727; Serre-Beinier V, 2009, HUM MOL GENET, V18, P428, DOI 10.1093/hmg/ddn370; Speier S, 2003, PFLUG ARCH EUR J PHY, V446, P553, DOI 10.1007/s00424-003-1097-9; Speier S, 2007, DIABETES, V56, P1078, DOI 10.2337/db06-0232; Stoer A., 2013, ACTA MEDICO BIOTECHN, P20; Stozer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054638; VALDEOLMILLOS M, 1989, FEBS LETT, V259, P19, DOI 10.1016/0014-5793(89)81484-X; Zhang Q, 2008, PHILOS T R SOC A, V366, P3503, DOI 10.1098/rsta.2008.0110	43	45	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82374	10.1371/journal.pone.0082374	http://dx.doi.org/10.1371/journal.pone.0082374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324777	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700073
J	Li, CY; Liu, B; Li, CH; Zeng, Q; Hao, MZ; Han, ZM; Zhu, JG; Li, XG; Shen, WJ				Li, Chunyan; Liu, Biao; Li, Chunhua; Zeng, Qing; Hao, Mingzhuo; Han, Zhengmin; Zhu, Jianguo; Li, Xiaogang; Shen, Wenjing			Leaf Morphology and Ultrastructure Responses to Elevated O-3 in Transgenic Bt (cry1Ab/cry1Ac) Rice and Conventional Rice under Fully Open-Air Field Conditions	PLOS ONE			English	Article							OZONE CONCENTRATION; NORWAY SPRUCE; LEAVES; YIELD; SENSITIVITY; PERFORMANCE; CULTIVARS; IMPACTS	Background: Elevated tropospheric ozone severely affects not only yield but also the morphology, structure and physiological functions of plants. Because of concerns regarding the potential environmental risk of transgenic crops, it is important to monitor changes in transgenic insect-resistant rice under the projected high tropospheric ozone before its commercial release. Methodology/Principal Findings: Using a free-air concentration enrichment (FACE) system, we investigated the changes in leaf morphology and leaf ultrastructure of two rice varieties grown in plastic pots, transgenic Bt Shanyou 63 (Bt-SY63, carrying a fusion gene of cry1Ab and cry1Ac) and its non-transgenic counterpart (SY63), in elevated O-3 (E-O-3) versus ambient O-3 (A-O-3) after 64-DAS (Days after seeding), 85-DAS and 102-DAS. Our results indicated that E-O-3 had no significant effects on leaf length, leaf width, leaf area, stomatal length and stomatal density for both Bt-SY63 and SY63. E-O-3 increased the leaf thickness of Bt-SY63, but decreased that of SY63. O-3 stress caused early swelling of the thylakoids of chloroplasts, a significant increase in the proportion of total plastoglobule area in the entire cell area (PCAP) and a significant decrease in the proportion of total starch grain area in the entire cell area (SCAP), suggesting that E-O-3 accelerated the leaf senescence of the two rice genotypes. Compared with SY63, E-O-3 caused early swelling of the thylakoids of chloroplasts and more substantial breakdown of chloroplasts in Bt-SY63. Conclusions/Significance: Our results suggest that the incorporation of cry1Ab/Ac into SY63 could induce unintentional changes in some parts of plant morphology and that O-3 stress results in greater leaf damage to Bt-SY63 than to SY63, with the former coupled with higher O-3 sensitivity in CCAP (the proportions of total chloroplast area in the entire cell area), PCAP and SCAP. This study provides valuable baseline information for the prospective commercial release of transgenic crops under the projected future climate.	[Li, Chunyan; Hao, Mingzhuo; Han, Zhengmin] Nanjing Forestry Univ, Coll Forest Resources & Environm, Nanjing, Jiangsu, Peoples R China; [Li, Chunyan; Liu, Biao; Shen, Wenjing] Minist Environm Protect China, Nanjing Inst Environm Sci, Key Biosafety Lab, Nanjing, Jiangsu, Peoples R China; [Li, Chunhua; Zeng, Qing; Zhu, Jianguo] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Li, Chunyan] Liaoning Agr Coll, Yingkou, Jiangsu, Peoples R China; [Li, Xiaogang] Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University; Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; Institute of Soil Science, CAS	Liu, B (corresponding author), Minist Environm Protect China, Nanjing Inst Environm Sci, Key Biosafety Lab, Nanjing, Jiangsu, Peoples R China.	85287064@163.com; qzeng@issas.ac.cn	li, xiaogang/ABH-2977-2020		National Special Transgenic Project of China [2013ZX08012-005]; Knowledge Innovation Programme of Chinese Academy of Sciences [KZCX2-EW-414]; National Natural Science Foundation of China [31370544, 30770408]; Doctorate Fellowship Foundation of Nanjing Forestry University and Research [2011YB009]; Innovation Project for College Graduates of Jiangsu Province [CXZZ11_0504]	National Special Transgenic Project of China; Knowledge Innovation Programme of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctorate Fellowship Foundation of Nanjing Forestry University and Research; Innovation Project for College Graduates of Jiangsu Province	The present research was jointly supported by the National Special Transgenic Project of China (2013ZX08012-005), the Knowledge Innovation Programme of Chinese Academy of Sciences (Grant No. KZCX2-EW-414), the National Natural Science Foundation of China (31370544, 30770408), the Doctorate Fellowship Foundation of Nanjing Forestry University and Research (2011YB009) and the Innovation Project for College Graduates of Jiangsu Province (CXZZ11_0504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashmore M, 2006, NEW PHYTOL, V170, P201, DOI 10.1111/j.1469-8137.2006.01709.x; Ashmore MR, 2005, PLANT CELL ENVIRON, V28, P949, DOI 10.1111/j.1365-3040.2005.01341.x; ATHANASSIOUS R, 1980, Z PFLANZENPHYSIOL, V97, P227, DOI 10.1016/S0044-328X(80)80074-2; Avnery S, 2011, ATMOS ENVIRON, V45, P2284, DOI 10.1016/j.atmosenv.2010.11.045; BARTON R, 1966, PLANTA, V71, P314, DOI 10.1007/BF00396319; Chen GX, 2004, PHOTOSYNTHETICA, V42, P573, DOI 10.1007/S11099-005-0015-0; Emberson LD, 2009, ATMOS ENVIRON, V43, P1945, DOI 10.1016/j.atmosenv.2009.01.005; Evans LS, 1996, ENVIRON EXP BOT, V36, P229, DOI 10.1016/0098-8472(96)01002-7; Feng ZZ, 2009, ATMOS ENVIRON, V43, P1510, DOI 10.1016/j.atmosenv.2008.11.033; Ferdinand JA, 2000, ENVIRON POLLUT, V108, P297, DOI 10.1016/S0269-7491(99)00078-0; Fiscus EL, 2005, PLANT CELL ENVIRON, V28, P997, DOI 10.1111/j.1365-3040.2005.01349.x; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Gunthardt-Goerg MS, 2007, ENVIRON POLLUT, V147, P467, DOI 10.1016/j.envpol.2006.08.033; Holopainen T, 1996, CAN J BOT, V74, P67, DOI 10.1139/b96-010; Kim S, 2008, EUPHYTICA, V164, P829, DOI 10.1007/s10681-008-9739-9; Kivimaenpaa M, 2003, ANN BOT-LONDON, V92, P779, DOI 10.1093/aob/mcg202; Ladygin VG, 2004, BIOL BULL+, V31, P268, DOI 10.1023/B:BIBU.0000030148.35208.55; Li JW, 2009, FIELD CROP RES, V114, P426, DOI 10.1016/j.fcr.2009.09.009; Li Y., 2012, ADV HEMATOL, V2012; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Mills G, 2007, ATMOS ENVIRON, V41, P2630, DOI 10.1016/j.atmosenv.2006.11.016; Miyake H, 2006, NEW PHYTOL, V96, P215; Molas J, 2002, ENVIRON EXP BOT, V47, P115, DOI 10.1016/S0098-8472(01)00116-2; Oksanen E, 2005, GLOBAL CHANGE BIOL, V11, P732, DOI 10.1111/j.1365-2486.2005.00938.x; Peng SB, 2008, FIELD CROP RES, V108, P32, DOI 10.1016/j.fcr.2008.04.001; Rai R, 2008, SCI TOTAL ENVIRON, V407, P679, DOI 10.1016/j.scitotenv.2008.09.010; Reig-Arminana J, 2004, ENVIRON POLLUT, V132, P321, DOI 10.1016/j.envpol.2004.04.006; Sarkar A, 2010, ENVIRON EXP BOT, V69, P328, DOI 10.1016/j.envexpbot.2010.04.016; Shu QY, 2002, EUPHYTICA, V127, P345, DOI 10.1023/A:1020358617257; Sutinen S, 1995, ECOVIS WORLD MG SER, P73; Tang HY, 2011, ATMOS ENVIRON, V45, P6276, DOI 10.1016/j.atmosenv.2011.08.059; Wang YX, 2012, AGR ECOSYST ENVIRON, V150, P63, DOI 10.1016/j.agee.2012.01.016; Zouzoulas D, 2009, ENVIRON EXP BOT, V67, P293, DOI 10.1016/j.envexpbot.2009.05.016	33	2	3	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82199	10.1371/journal.pone.0082199	http://dx.doi.org/10.1371/journal.pone.0082199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324764	Green Published, gold, Green Submitted			2022-12-25	WOS:000328566700064
J	Maharramov, J; Meeus, I; Maebe, K; Arbetman, M; Morales, C; Graystock, P; Hughes, WOH; Plischuk, S; Lange, CE; de Graaf, DC; Zapata, N; de la Rosa, JJP; Murray, TE; Brown, MJF; Smagghe, G				Maharramov, Jafar; Meeus, Ivan; Maebe, Kevin; Arbetman, Marina; Morales, Carolina; Graystock, Peter; Hughes, William O. H.; Plischuk, Santiago; Lange, Carlos E.; de Graaf, Dirk C.; Zapata, Nelson; Perez de la Rosa, Jose Javier; Murray, Tomas E.; Brown, Mark J. F.; Smagghe, Guy			Genetic Variability of the Neogregarine Apicystis bombi, an Etiological Agent of an Emergent Bumblebee Disease	PLOS ONE			English	Article							MOLECULAR-DETECTION; APIS-MELLIFERA; PARASITE; BEES; HYMENOPTERA; TRANSMISSION; PATHOGEN; ECOLOGY; CONSERVATION; SPILLOVER	The worldwide spread of diseases is considered a major threat to biodiversity and a possible driver of the decline of pollinator populations, particularly when novel species or strains of parasites emerge. Previous studies have suggested that populations of introduced European honeybee (Apis mellifera) and bumblebee species (Bombus terrestris and Bombus ruderatus) in Argentina share the neogregarine parasite Apicystis bombi with the native bumblebee (Bombus dahlbomii). In this study we investigated whether A. bombi is acting as an emergent parasite in the non-native populations. Specifically, we asked whether A. bombi, recently identified in Argentina, was introduced by European, non-native bees. Using ITS1 and ITS2 to assess the parasite's intraspecific genetic variation in bees from Argentina and Europe, we found a largely unstructured parasite population, with only 15% of the genetic variation being explained by geographic location. The most abundant haplotype in Argentina (found in all 9 specimens of non-native species) was identical to the most abundant haplotype in Europe (found in 6 out of 8 specimens). Similarly, there was no evidence of structuring by host species, with this factor explaining only 17% of the genetic variation. Interestingly, parasites in native Bombus ephippiatus from Mexico were genetically distant from the Argentine and European samples, suggesting that sufficient variability does exist in the ITS region to identify continent-level genetic structure in the parasite. Thus, the data suggest that A. bombi from Argentina and Europe share a common, relatively recent origin. Although our data did not provide information on the direction of transfer, the absence of genetic structure across space and host species suggests that A. bombi may be acting as an emergent infectious disease across bee taxa and continents.	[Maharramov, Jafar; Meeus, Ivan; Maebe, Kevin; Smagghe, Guy] Univ Ghent, Dept Crop Protect, Fac Biosci Engn, B-9000 Ghent, Belgium; [Arbetman, Marina; Morales, Carolina] Univ Nacl Comahue, Consejo Nacl Invest Cient & Tecn, Inst Invest Biodiversidad & Medioambiente, Ctr Reg Univ Bariloche,Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina; [Arbetman, Marina] Univ Nacl Rio Negro, San Carlos De Bariloche, Rio Negro, Argentina; [Graystock, Peter] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [Hughes, William O. H.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Plischuk, Santiago; Lange, Carlos E.] Consejo Nacl Invest Cient & Tecn, Ctr Cient Tecnol La Plata, Ctr Estudios Parasitol & Vectores, La Plata, Buenos Aires, Argentina; [Plischuk, Santiago; Lange, Carlos E.] Comis Invest Cient Prov Buenos Aires, La Plata, Buenos Aires, Argentina; [de Graaf, Dirk C.] Univ Ghent, Fac Sci, Dept Physiol, B-9000 Ghent, Belgium; [Zapata, Nelson] Univ Concepcion, Fac Agron, Dept Prod Vegetal, Chillan, Chile; [Perez de la Rosa, Jose Javier] Ctr Nacl Serv Constatac Salud Anim, Jiutepec, Morelos, Mexico; [Murray, Tomas E.] Univ Halle Wittenberg, Dept Zool, Inst Biol, D-06108 Halle, Germany; [Brown, Mark J. F.] Univ London, Sch Biol Sci, Egham, Surrey, England	Ghent University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; University of Leeds; University of Sussex; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision de Investigaciones Cientificas; Ghent University; Universidad de Concepcion; Martin Luther University Halle Wittenberg; University of London; Royal Holloway University London	Smagghe, G (corresponding author), Univ Ghent, Dept Crop Protect, Fac Biosci Engn, B-9000 Ghent, Belgium.	guy.smagghe@ugent.be	Graystock, Peter/AAK-8460-2021; Smagghe, Guy/AAE-8914-2019; Arbetman, Marina/V-6886-2019; Murray, Tomás E/C-5540-2013; Graystock, Peter/H-4821-2013; de Graaf, Dirk C./HGD-4017-2022; Plischuk, Santiago/N-9764-2019	Graystock, Peter/0000-0002-0248-2571; Smagghe, Guy/0000-0001-8334-3313; Graystock, Peter/0000-0002-0248-2571; Plischuk, Santiago/0000-0001-8135-3462; Arbetman, Marina P./0000-0002-8382-2522; Zapata, Nelson/0000-0002-2773-9249; Maebe, Kevin/0000-0002-3741-2143	Research Council of Ghent University (BOF-UGent); Fund for Scientific Research-Flanders (FWO-Vlaanderen, Brussels, Belgium); IRCSET grant; BBSRC [BB/I000151/1]; Defra [BB/I000151/1]; NERC [BB/I000151/1]; Scottish Government [BB/I000151/1]; Wellcome Trust, under the Insect Pollinators Initiative [BB/I000151/1]; Natural Environment Research Council (NERC); WOHH [NE/G012113/1]; Rufford Small Grants for Conservation; Biotechnology and Biological Sciences Research Council [BB/I000151/1] Funding Source: researchfish	Research Council of Ghent University (BOF-UGent)(Ghent University); Fund for Scientific Research-Flanders (FWO-Vlaanderen, Brussels, Belgium)(FWO); IRCSET grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Scottish Government; Wellcome Trust, under the Insect Pollinators Initiative(Wellcome Trust); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); WOHH; Rufford Small Grants for Conservation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	GM and IM acknowledge support by the Research Council of Ghent University (BOF-UGent) (www.ugent.be), the Fund for Scientific Research-Flanders (FWO-Vlaanderen, Brussels, Belgium) (www.fwo.be). The Rufford Small Grants for Conservation to CLM and MPA, The National Park Administration of Argentina for sampling permits. MJFB was supported by an IRCSET grant and grant BB/I000151/1 funded jointly by BBSRC, Defra, NERC, the Scottish Government and the Wellcome Trust, under the Insect Pollinators Initiative. Funding for this study was provided by the Natural Environment Research Council (NERC) to PG and WOHH (NE/G012113/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamovich AH, 2001, REV BRAS ENTOMOL, V45, P99; Abrahamovich Alberto H., 2004, Acta Zool. Mex, V20, P99; Arbetman MP, 2013, BIOL INVASIONS, V15, P489, DOI 10.1007/s10530-012-0311-0; ARRETZ PV, 1986, BEE WORLD, V67, P15, DOI 10.1080/0005772X.1986.11098855; BANDELT HJ, 1995, GENETICS, V141, P743; Bazsalovicsova E, 2011, PARASITOL RES, V109, P125, DOI 10.1007/s00436-010-2235-x; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Clarke LA, 2001, J CLIN PATHOL-MOL PA, V54, P351, DOI 10.1136/mp.54.5.351; Colla SR, 2006, BIOL CONSERV, V129, P461, DOI 10.1016/j.biocon.2005.11.013; Cummings SM, 2010, CONSERV GENET, V11, P1095, DOI 10.1007/s10592-009-9864-6; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Eldeniz Cankaya Necda, 2006, Pakistan Journal of Biological Sciences, V9, P1282, DOI 10.3923/pjbs.2006.1282.1286; Evison SEF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030641; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D., 2010, BUMBLEBEES THEIR BEH; Graystock P, 2013, J APPL ECOL, V50, P1207, DOI 10.1111/1365-2664.12134; Graystock P, 2013, J INVERTEBR PATHOL, V114, P114, DOI 10.1016/j.jip.2013.06.005; Harris DJ, 2000, MOL BIOL EVOL, V17, P284, DOI 10.1093/oxfordjournals.molbev.a026308; Hines HM, 2008, SYST BIOL, V57, P58, DOI 10.1080/10635150801898912; LIPA JJ, 1992, APIDOLOGIE, V23, P533, DOI 10.1051/apido:19920605; Lipa JJ, 1996, APIDOLOGIE, V27, P29, DOI 10.1051/apido:19960104; LIU HJ, 1974, J INVERTEBR PATHOL, V23, P225, DOI 10.1016/0022-2011(74)90188-8; Macfarlane RP, 1995, BEE WORLD, V76, P130, DOI 10.1080/0005772X.1995.11099259; Meeus I, 2010, J APPL MICROBIOL, V109, P107, DOI 10.1111/j.1365-2672.2009.04635.x; Meeus I, 2012, J INVERTEBR PATHOL, V109, P172, DOI 10.1016/j.jip.2011.11.006; Meeus I, 2011, CONSERV BIOL, V25, P662, DOI 10.1111/j.1523-1739.2011.01707.x; Morales CL, 2013, FRONT ECOL ENVIRON, V11, P529, DOI 10.1890/120321; Morimoto T, 2013, ENV MICROBIOL REP, V5, P74, DOI 10.1111/j.1758-2229.2012.00385.x; Murray TE, 2013, BIOL CONSERV, V159, P269, DOI 10.1016/j.biocon.2012.10.021; O'Mahony EM, 2007, J EUKARYOT MICROBIOL, V54, P103, DOI 10.1111/j.1550-7408.2006.00232.x; Plischuk S, 2011, ENV MICROBIOL REP, V3, P565, DOI 10.1111/j.1758-2229.2011.00261.x; Plischuk S, 2009, J INVERTEBR PATHOL, V102, P261, DOI 10.1016/j.jip.2009.08.005; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ravoet J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072443; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Rigaud T, 2010, P ROY SOC B-BIOL SCI, V277, P3693, DOI 10.1098/rspb.2010.1163; Ruiz-Gonzalez MX, 2012, EVOLUTION, V66, P3053, DOI 10.1111/j.1558-5646.2012.01655.x; Rutrecht ST, 2008, INT J PARASITOL, V38, P799, DOI 10.1016/j.ijpara.2007.11.004; Ruz L, 2002, POLLINATING BEES CON, P155; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmid-Hempel P, 1999, EVOLUTION, V53, P426, DOI 10.1111/j.1558-5646.1999.tb03778.x; Schmid-Hempel P, 2001, NATURWISSENSCHAFTEN, V88, P147, DOI 10.1007/s001140100222; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Torres-Ruiz A, 2012, J ECON ENTOMOL, V105, P1871, DOI 10.1603/EC12171; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Vergara Carlos H., 2012, Journal of Pollination Ecology, V7, P27; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009	50	20	20	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81475	10.1371/journal.pone.0081475	http://dx.doi.org/10.1371/journal.pone.0081475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324696	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000328566700040
J	Sesen, MB; Nicholson, AE; Banares-Alcantara, R; Kadir, T; Brady, M				Sesen, M. Berkan; Nicholson, Ann E.; Banares-Alcantara, Rene; Kadir, Timor; Brady, Michael			Bayesian Networks for Clinical Decision Support in Lung Cancer Care	PLOS ONE			English	Article							INFLUENCE DIAGRAMS; EXPERT-SYSTEMS; BREAST-CANCER; MISSING DATA; FOLLOW-UP; SURVIVAL; PREDICTION; MANAGEMENT; DIAGNOSIS; MODEL	Survival prediction and treatment selection in lung cancer care are characterised by high levels of uncertainty. Bayesian Networks (BNs), which naturally reason with uncertain domain knowledge, can be applied to aid lung cancer experts by providing personalised survival estimates and treatment selection recommendations. Based on the English Lung Cancer Database (LUCADA), we evaluate the feasibility of BNs for these two tasks, while comparing the performances of various causal discovery approaches to uncover the most feasible network structure from expert knowledge and data. We show first that the BN structure elicited from clinicians achieves a disappointing area under the ROC curve of 0.75 (+/- 0.03), whereas a structure learned by the CAMML hybrid causal discovery algorithm, which adheres with the temporal restrictions, achieves 0.81 (+/- 0.03). Second, our causal intervention results reveal that BN treatment recommendations, based on prescribing the treatment plan that maximises survival, can only predict the recorded treatment plan 29% of the time. However, this percentage rises to 76% when partial matches are included.	[Sesen, M. Berkan; Banares-Alcantara, Rene] Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England; [Nicholson, Ann E.] Monash Univ, Fac Informat Technol, Clayton, Vic, Australia; [Kadir, Timor] Mirada Med, Oxford, England; [Brady, Michael] Univ Oxford, Dept Oncol, Oxford, England	University of Oxford; Monash University; University of Oxford	Sesen, MB (corresponding author), Univ Oxford, Dept Engn Sci, Parks Rd, Oxford OX1 3PJ, England.	berkan.sesen@gmail.com	Nicholson, Ann E/C-1021-2012	Nicholson, Ann/0000-0002-2269-9823	Clarendon and the New College Graduate Scholarships through the CDT in Healthcare Innovation Programme at the Biomedical Engineering Institute of the University Of Oxford; Cancer Research United Kingdom/Engineering and Physical Sciences Research Council Oxford Cancer Imaging Centre; FEDER funds and the Spanish Government (Ministerio de Ciencia e Innovacion) [TIN2010-20900-C04-03]	Clarendon and the New College Graduate Scholarships through the CDT in Healthcare Innovation Programme at the Biomedical Engineering Institute of the University Of Oxford; Cancer Research United Kingdom/Engineering and Physical Sciences Research Council Oxford Cancer Imaging Centre; FEDER funds and the Spanish Government (Ministerio de Ciencia e Innovacion)	This research has been funded by the Clarendon and the New College Graduate Scholarships through the CDT in Healthcare Innovation Programme at the Biomedical Engineering Institute of the University Of Oxford. MB acknowledges support from the Cancer Research United Kingdom/Engineering and Physical Sciences Research Council Oxford Cancer Imaging Centre. AN acknowledges funding from FEDER funds and the Spanish Government (Ministerio de Ciencia e Innovacion) through project TIN2010-20900-C04-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen S, 1999, ARTIF INTELL MED, V15, P121, DOI 10.1016/S0933-3657(98)00048-7; Andreassen S, 1986, KNOWL REPRESENT, P366; [Anonymous], 2011, BAYESIAN REASONING M; Bouckaert R. R., 2008, BAYESIAN NETWORK CLA; BUNTINE W, 1991, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, P52; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Colot O, 1994, INF CRIT ABR CHANG P, P1855; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Crino L, 2010, ANN ONCOL, V21, pv103, DOI 10.1093/annonc/mdq207; Cruz JA, 2006, CANCER INFORM, V2, P59; Cruz-Ramirez N, 2007, COMPUT BIOL MED, V37, P1553, DOI 10.1016/j.compbiomed.2007.02.003; Daly R, 2011, KNOWL ENG REV, V26, P99, DOI 10.1017/S0269888910000251; Dekker A, 2009, EIGHTH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS, PROCEEDINGS, P494, DOI 10.1109/ICMLA.2009.92; Ettinger DS, 2012, NONSMALL CELL LUNG C; Fleissig A, 2006, LANCET ONCOL, V7, P935, DOI 10.1016/S1470-2045(06)70940-8; Forsberg JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019956; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Gadewadikar J, 2009, PROCEEDINGS OF THE IEEE SOUTHEASTCON 2009, TECHNICAL PROCEEDINGS, P153; Galan SF, 2001, LECT NOTES ARTIF INT, V2101, P207; Gevaert O, 2006, BIOINFORMATICS, V22, pE184, DOI 10.1093/bioinformatics/btl230; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; HECKERMAN D, 1996, TUTORIAL LEARNING BA; Heckerman D, 1992, METHODS INF MED; Helsper EM, 2002, BUILDING BAYESIAN NE; Holmberg L, 2010, THORAX, V65, P436, DOI 10.1136/thx.2009.124222; International Classification of Diseases for Oncology, 2000, MORPH NEOPL; International Health Terminology Standards Development Organisation (IHTSDO), SNOMED CT; Janssen KJM, 2010, J CLIN EPIDEMIOL, V63, P721, DOI 10.1016/j.jclinepi.2009.12.008; Jayasurya K, 2010, MED PHYS, V37, P1401, DOI 10.1118/1.3352709; Jensen F. V., 1990, Computational Statistics Quarterly, V5, P269; Flores MJ, 2011, ARTIF INTELL MED, V53, P181, DOI 10.1016/j.artmed.2011.08.004; Kononenko I, 2001, ARTIF INTELL MED, V23, P89, DOI 10.1016/S0933-3657(01)00077-X; Korb KB., 2010, BAYESIAN ARTIFICIAL, DOI [10.1201/b10391, DOI 10.1201/B10391]; Kotsiantis S., 2006, INT J COMPUTER SCI, V1, P111; Kuschner KW, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-177; LAURITZEN SL, 1988, J ROY STAT SOC B MET, V50, P157; Lavrac N, 1999, ARTIF INTELL MED, V16, P3, DOI 10.1016/S0933-3657(98)00062-1; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Lewis D. D., 1998, LECT NOTES COMPUTER, P4, DOI DOI 10.1007/BFB0026666; Lim E, 2010, GUIDELINES RADICAL M; Lin JH, 2008, J BIOMED INFORM, V41, P1, DOI 10.1016/j.jbi.2007.06.001; Lucas PJF, 2004, ARTIF INTELL MED, V30, P201, DOI 10.1016/j.artmed.2003.11.001; Lucas PJF, 1998, METHOD INFORM MED, V37, P206; Lucas PJF, 2000, ARTIF INTELL MED, V19, P251, DOI 10.1016/S0933-3657(00)00048-8; MADIGAN D, 1995, INT STAT REV, V63, P215, DOI 10.2307/1403615; Maskery SM, 2008, J BIOMED INFORM, V41, P242, DOI 10.1016/j.jbi.2007.12.005; Mitchell T.M., 2010, MACH LEARN; Murphy Kevin P, 2001, COMPUT SCI STAT, V33; National Collaborating Centre for Cancer, 2011, DIAGN TREATM LUNG CA; Nyberg JB, 2006, CAN J FOREST RES, V36, P3104, DOI 10.1139/X06-108; Oh JH, 2011, PHYS MED BIOL, V56, P1635, DOI 10.1088/0031-9155/56/6/008; Owens DK, 1997, MED DECIS MAKING, V17, P241, DOI 10.1177/0272989X9701700301; Peake MD, 2013, SURG RES RAT LUNG CA; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Potthoff RF, 2006, STAT METHODS MED RES, V15, P213, DOI 10.1191/0962280206sm448oa; Quinlan J.R, 2014, C4 5 PROGRAMS MACHIN; Quinlan JR, 1996, J ARTIF INTELL RES, V4, P77, DOI 10.1613/jair.279; Riaz SP, 2012, EUR J CANCER, V48, P54, DOI 10.1016/j.ejca.2011.07.012; Rish I, 2003, P WORKSH EMP METH AR, P6; Rubin DL, 2005, INT SER OPER RES MAN, V70, P695, DOI 10.1007/1-4020-8066-2_27; Schafer JL, 1997, ANAL INCOMPLETE MULT, DOI DOI 10.1007/BF02680460; SHACHTER RD, 1988, OPER RES, V36, P589, DOI 10.1287/opre.36.4.589; Song D, 2011, IEEE INT CONF ROBOT, P1944; SPIEGELHALTER DJ, 1993, STAT SCI, V8, P219, DOI 10.1214/ss/1177010888; Stojadinovic A, 2013, ANN SURG ONCOL, V20, P161, DOI 10.1245/s10434-012-2555-4; Stojadinovic A, 2009, BMC SURG, V9, DOI 10.1186/1471-2482-9-12; The PostgreSQL Global Development Group, 2012, POSTGRESQL JDBC; Twardy CR., 2005, KNOWLEDGE ENG CARDIO; van der Gaag LC, 2002, ARTIF INTELL MED, V25, P123, DOI 10.1016/S0933-3657(02)00012-X; VERMA T, 1992, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, P323; Wallace C, 1999, INTELL DATA MANAG, P89; World Health Organization, 2012, CANC FACT SHEET 297; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhao D, 2011, J BIOMED INFORM, V44, P859, DOI 10.1016/j.jbi.2011.05.004	74	80	82	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82349	10.1371/journal.pone.0082349	http://dx.doi.org/10.1371/journal.pone.0082349			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324773	Green Published, gold			2022-12-25	WOS:000328566700070
J	Vierling, LA; Vierling, KT; Adam, P; Hudak, AT				Vierling, Lee A.; Vierling, Kerri T.; Adam, Patrick; Hudak, Andrew T.			Using Satellite and Airborne LiDAR to Model Woodpecker Habitat Occupancy at the Landscape Scale	PLOS ONE			English	Article							SPECIES RICHNESS; FOREST HEALTH; BIRD; SELECTION; BIODIVERSITY; SUCCESSION; QUALITY; HEIGHT; ICESAT	Incorporating vertical vegetation structure into models of animal distributions can improve understanding of the patterns and processes governing habitat selection. LiDAR can provide such structural information, but these data are typically collected via aircraft and thus are limited in spatial extent. Our objective was to explore the utility of satellite-based LiDAR data from the Geoscience Laser Altimeter System (GLAS) relative to airborne-based LiDAR to model the north Idaho breeding distribution of a forest-dependent ecosystem engineer, the Red-naped sapsucker (Sphyrapicus nuchalis). GLAS data occurred within ca. 64 m diameter ellipses spaced a minimum of 172 m apart, and all occupancy analyses were confined to this grain scale. Using a hierarchical approach, we modeled Red-naped sapsucker occupancy as a function of LiDAR metrics derived from both platforms. Occupancy models based on satellite data were weak, possibly because the data within the GLAS ellipse did not fully represent habitat characteristics important for this species. The most important structural variables influencing Red-naped Sapsucker breeding site selection based on airborne LiDAR data included foliage height diversity, the distance between major strata in the canopy vertical profile, and the vegetation density near the ground. These characteristics are consistent with the diversity of foraging activities exhibited by this species. To our knowledge, this study represents the first to examine the utility of satellite-based LiDAR to model animal distributions. The large area of each GLAS ellipse and the non-contiguous nature of GLAS data may pose significant challenges for wildlife distribution modeling; nevertheless these data can provide useful information on ecosystem vertical structure, particularly in areas of gentle terrain. Additional work is thus warranted to utilize LiDAR datasets collected from both airborne and past and future satellite platforms (e. g. GLAS, and the planned IceSAT2 mission) with the goal of improving wildlife modeling for more locations across the globe.	[Vierling, Lee A.] Univ Idaho, McCall Outdoor Sci Sch, Dept Forest Rangeland & Fire Sci, Moscow, ID 83843 USA; [Vierling, Kerri T.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA; [Adam, Patrick] Univ Idaho, Moscow, ID 83843 USA; [Hudak, Andrew T.] US Forest Serv, Rocky Mt Res Stn, Moscow, ID USA	Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; United States Department of Agriculture (USDA); United States Forest Service	Vierling, LA (corresponding author), Univ Idaho, McCall Outdoor Sci Sch, Dept Forest Rangeland & Fire Sci, Moscow, ID 83843 USA.	leev@uidaho.edu	Vierling, Kerri/N-6653-2016; Vierling, Lee/E-6428-2010	Vierling, Lee/0000-0001-5344-1983; Adam, Patrick/0000-0001-6836-5696	USGS Gap Analysis Program [08HQAG0123]; NASA	USGS Gap Analysis Program; NASA(National Aeronautics & Space Administration (NASA))	The authors would like to thank the USGS Gap Analysis Program (agreement Grant number 08HQAG0123; K. Vierling, PI) and the NASA-sponsored Idaho Space Grant Consortium (http://www.id.spacegrant.org; graduate fellowship awarded to P. Adam) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abshire JB, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024028; Aitken KEH, 2008, ECOLOGY, V89, P971, DOI 10.1890/07-0711.1; Belsley DA., 1991, CONDITIONING DIAGNOS; Bergen KM, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000883; Boelman NT, 2007, ECOL APPL, V17, P2137, DOI 10.1890/07-0004.1; Brenner A, 2003, ALGORITHM THEOERTICA; BULL EL, 1993, J WILDLIFE MANAGE, V57, P335, DOI 10.2307/3809431; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Chen Q, 2010, REMOTE SENS ENVIRON, V114, P1610, DOI 10.1016/j.rse.2010.02.016; Chen Q, 2010, ISPRS J PHOTOGRAMM, V65, P111, DOI 10.1016/j.isprsjprs.2009.09.004; Clawges R, 2008, REMOTE SENS ENVIRON, V112, P2064, DOI 10.1016/j.rse.2007.08.023; Cooke HA, 2011, FOREST ECOL MANAG, V261, P662, DOI 10.1016/j.foreco.2010.11.023; CROCKETT AB, 1975, CONDOR, V77, P365, DOI 10.2307/1366254; Dahlgren JP, 2010, ECOL LETT, V13, pE7, DOI 10.1111/j.1461-0248.2010.01460.x; DAILY GC, 1993, P NATL ACAD SCI USA, V90, P592, DOI 10.1073/pnas.90.2.592; Dochtermann NA, 2011, BEHAV ECOL SOCIOBIOL, V65, P37, DOI 10.1007/s00265-010-1039-4; Drever MC, 2008, BIOL CONSERV, V141, P624, DOI 10.1016/j.biocon.2007.12.004; Drever MC, 2010, FOREST ECOL MANAG, V259, P958, DOI 10.1016/j.foreco.2009.11.038; Dubayah RO, 2000, J FOREST, V98, P44; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Evans JS, 2007, IEEE T GEOSCI REMOTE, V45, P1029, DOI 10.1109/TGRS.2006.890412; Falkowski MJ, 2006, CAN J REMOTE SENS, V32, P153, DOI 10.5589/m06-005; Falkowski MJ, 2009, REMOTE SENS ENVIRON, V113, P946, DOI 10.1016/j.rse.2009.01.003; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Gentry DJ, 2008, AM MIDL NAT, V160, P413, DOI 10.1674/0003-0031(2008)160[413:ROWCIT]2.0.CO;2; Goetz S, 2007, REMOTE SENS ENVIRON, V108, P254, DOI 10.1016/j.rse.2006.11.016; Goetz SJ, 2010, ECOLOGY, V91, P1569, DOI 10.1890/09-1670.1; Gonzalez P, 2010, REMOTE SENS ENVIRON, V114, P1561, DOI 10.1016/j.rse.2010.02.011; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Harding DJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023471; Hill RA, 2004, INT J REMOTE SENS, V25, P4851, DOI 10.1080/0143116031000139962; Hinsley SA, 2002, FUNCT ECOL, V16, P851, DOI 10.1046/j.1365-2435.2002.00697.x; Hudak AT, 2012, REMOTE SENS ENVIRON, V123, P25, DOI 10.1016/j.rse.2012.02.023; Innes JL, 1998, GLOBAL ECOL BIOGEOGR, V7, P397, DOI 10.2307/2997712; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Lawler JJ, 2006, CONDOR, V108, P47, DOI 10.1650/0010-5422(2006)108[0047:AVATIM]2.0.CO;2; Lawler JJ, 2002, LANDSCAPE ECOL, V17, P233, DOI 10.1023/A:1020219914926; Lefsky MA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023971; Lefsky MA, 2002, BIOSCIENCE, V52, P19, DOI 10.1641/0006-3568(2002)052[0019:LRSFES]2.0.CO;2; Lefsky MA, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2795724; Lefsky MA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043622; Lesak AA, 2011, REMOTE SENS ENVIRON, V115, P2823, DOI 10.1016/j.rse.2011.01.025; Lukacs PM, 2010, ANN I STAT MATH, V62, P117, DOI 10.1007/s10463-009-0234-4; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Martin K, 2004, CONDOR, V106, P5, DOI 10.1650/7482; Martinuzzi S, 2013, BIOTROPICA, V45, P135, DOI 10.1111/j.1744-7429.2012.00904.x; Martinuzzi S, 2009, REMOTE SENS ENVIRON, V113, P2533, DOI 10.1016/j.rse.2009.07.002; Mazerolle MJ, 2005, ECOL APPL, V15, P824, DOI 10.1890/04-0502; McCallum D. Archibald, 2005, U S Forest Service General Technical Report PSW, V191, P754; McClelland BR, 2000, WILSON BULL, V112, P44, DOI 10.1676/0043-5643(2000)112[0044:RNSNTI]2.0.CO;2; McClelland BR, 1977, THESIS U MONTANA MIS; McCune B, 2002, J VEG SCI, V13, P603, DOI 10.1111/j.1654-1103.2002.tb02087.x; Muller J, 2009, J APPL ECOL, V46, P897, DOI 10.1111/j.1365-2664.2009.01677.x; Murtaugh PA, 2009, ECOL LETT, V12, P1061, DOI 10.1111/j.1461-0248.2009.01361.x; Nagendra H, 2001, INT J REMOTE SENS, V22, P2377, DOI 10.1080/01431160117096; Nelson R, 2005, REMOTE SENS ENVIRON, V96, P292, DOI 10.1016/j.rse.2005.02.012; Nelson R, 2009, CAN J FOREST RES, V39, P862, DOI 10.1139/X09-002; R Development Core Team, 2012, R LANG ENV STAT COMP; Richards SA, 2005, ECOLOGY, V86, P2805, DOI 10.1890/05-0074; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Ripper D, 2007, J WILDLIFE MANAGE, V71, P2612, DOI 10.2193/2005-487; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Sadoti G, 2010, CAN J ZOOL, V88, P527, DOI 10.1139/Z10-025; Schutz BE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024009; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Scott JM, 2002, GAP ANAL IDAHO FINAL; Seavy NE, 2009, ECOL APPL, V19, P1848, DOI 10.1890/08-1124.1; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; *USDA, 2010, GEOSP DAT GAT; Vierling KT, 2011, ECOL APPL, V21, P577, DOI 10.1890/09-2155.1; Vierling KT, 2008, FRONT ECOL ENVIRON, V6, P90, DOI 10.1890/070001; Vierling KT, 2008, J WILDLIFE MANAGE, V72, P422, DOI 10.2193/2006-212; Vogeler JC, 2013, CONDOR, V115, P614, DOI 10.1525/cond.2013.110082; Wagner MA, 2011, THESIS HUMBOLDT STAT; Walters EL, 2002, BIRDS N AM ONLINE, DOI [10.2173/bna.663, DOI 10.2173/BNA.663.ACCESSED]; WALTERS EL, 1996, THESIS U VICTORIA VI	79	29	31	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e80988	10.1371/journal.pone.0080988	http://dx.doi.org/10.1371/journal.pone.0080988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324655	gold, Green Published			2022-12-25	WOS:000328566700026
J	Espinosa-Jeffrey, A; Paez, PM; Cheli, VT; Spreuer, V; Wanner, I; de Vellis, J				Espinosa-Jeffrey, Araceli; Paez, Pablo M.; Cheli, Veronica T.; Spreuer, Vilma; Wanner, Ina; de Vellis, Jean			Impact of Simulated Microgravity on Oligodendrocyte Development: Implications for Central Nervous System Repair	PLOS ONE			English	Article							MYELIN BASIC-PROTEIN; IN-VITRO; PROGENITOR-CELL; MESSENGER-RNA; DIFFERENTIATION; MIGRATION; PROLIFERATION; EXPRESSION; GENE; PRODUCTS	We have recently established a culture system to study the impact of simulated microgravity on oligodendrocyte progenitor cells (OPCs) development. We subjected mouse and human OPCs to a short exposure of simulated microgravity produced by a 3D-Clinostat robot. Our results demonstrate that rodent and human OPCs display enhanced and sustained proliferation when exposed to simulated microgravity as assessed by several parameters, including a decrease in the cell cycle time. Additionally, OPC migration was examined in vitro using time-lapse imaging of cultured OPCs. Our results indicated that OPCs migrate to a greater extent after stimulated microgravity than in normal conditions, and this enhanced motility was associated with OPC morphological changes. The lack of normal gravity resulted in a significant increase in the migration speed of mouse and human OPCs and we found that the average leading process in migrating bipolar OPCs was significantly longer in microgravity treated cells than in controls, demonstrating that during OPC migration the lack of gravity promotes leading process extension, an essential step in the process of OPC migration. Finally, we tested the effect of simulated microgravity on OPC differentiation. Our data showed that the expression of mature oligodendrocyte markers was significantly delayed in microgravity treated OPCs. Under conditions where OPCs were allowed to progress in the lineage, simulated microgravity decreased the proportion of cells that expressed mature markers, such as CC1 and MBP, with a concomitant increased number of cells that retained immature oligodendrocyte markers such as Sox2 and NG2. Development of methodologies aimed at enhancing the number of OPCs and their ability to progress on the oligodendrocyte lineage is of great value for treatment of demyelinating disorders. To our knowledge, this is the first report on the gravitational modulation of oligodendrocyte intrinsic plasticity to increase their progenies.	[Espinosa-Jeffrey, Araceli; Wanner, Ina; de Vellis, Jean] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Intellectual & Dev Disabil Res Ctr, Los Angeles, CA 90095 USA; [Paez, Pablo M.; Cheli, Veronica T.; Spreuer, Vilma] SUNY Buffalo, Sch Med & Biomed Sci, Hunter James Kelly Res Inst, Dept Pharmacol & Toxicol,NYS Ctr Excellence, Buffalo, NY 14260 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Espinosa-Jeffrey, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Intellectual & Dev Disabil Res Ctr, Los Angeles, CA 90095 USA.	aespinosa@mednet.ucla.edu	Paez, Pablo Martin/ABI-7783-2020	Paez, Pablo Martin/0000-0001-9362-9454; Cheli, Veronica/0000-0003-4802-6560	National Multiple Sclerosis Society [PP1498]; Center grant NIH [HD-04612]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004612] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD057560] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); Center grant NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by a National Multiple Sclerosis Society grant PP1498 (www.nationalmssociety.org) and a Center grant NIH HD-04612 (www.grants.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMURUMARJEE S, 1993, J NEUROSCI RES, V36, P99, DOI 10.1002/jnr.490360111; Baron W, 2002, EMBO J, V21, P1957, DOI 10.1093/emboj/21.8.1957; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Cayre M, 2009, PROG NEUROBIOL, V88, P41, DOI 10.1016/j.pneurobio.2009.02.001; Cogoli-Greuter M., 2004, GRAV SPACE BIO B, V17, P27; de Castro F, 2005, BRAIN RES REV, V49, P227, DOI 10.1016/j.brainresrev.2004.12.034; de Castro F, 2013, CELL MOL LIFE SCI; DELOSMONTEROS AE, 1990, J NEUROSCI RES, V25, P576, DOI 10.1002/jnr.490250416; DELOSMONTEROS AE, 1988, J NEUROSCI RES, V21, P181, DOI 10.1002/jnr.490210210; DELOSMONTEROS AE, 1992, DEV NEUROSCI-BASEL, V14, P98, DOI 10.1159/000111653; Espinosa-Jeffrey A, 2002, DEV NEUROSCI-BASEL, V24, P227, DOI 10.1159/000065698; Espinosa-Jeffrey A, 2009, CURR PROTOC STEM CEL; Flusberg DA, 2001, MOL BIOL CELL, V12, P3087, DOI 10.1091/mbc.12.10.3087; Ingber D, 1999, FASEB J, V13, pS3; Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; KUMAR S, 1990, DEV NEUROSCI-BASEL, V12, P316, DOI 10.1159/000111860; Liu AX, 2003, GLIA, V44, P264, DOI 10.1002/glia.10290; Maiato H, 2004, J CELL BIOL, V167, P831, DOI 10.1083/jcb.200407090; Mallon BS, 2002, NEUROCHEM RES, V27, P1349, DOI 10.1023/A:1021623700009; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Moore CS, 2011, J NEUROSCI RES, V89, P13, DOI 10.1002/jnr.22482; Murtie JC, 2005, NEUROBIOL DIS, V19, P171, DOI 10.1016/j.nbd.2004.12.006; NOBLE M, 1984, EMBO J, V3, P2243, DOI 10.1002/j.1460-2075.1984.tb02122.x; O'Connor LT, 2000, MOL CELL NEUROSCI, V16, P396, DOI 10.1006/mcne.2000.0889; Paez PM, 2011, J NEUROSCI, V31, P3625, DOI 10.1523/JNEUROSCI.4424-10.2011; Paez PM, 2009, ASN NEURO, V1, DOI 10.1042/AN20090003; Paez PM, 2009, J NEUROSCI, V29, P6663, DOI 10.1523/JNEUROSCI.5806-08.2009; Papaseit C, 2000, P NATL ACAD SCI USA, V97, P8364, DOI 10.1073/pnas.140029597; Plett PA, 2004, EXP HEMATOL, V32, P773, DOI 10.1016/j.exphem.2004.03.014; Pouya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027925; Rajasekharan S, 2008, J NEUROSCI, V28, P13365, DOI 10.1523/JNEUROSCI.4931-08.2008; Sher F, 2008, CURR OPIN NEUROL, V21, P607, DOI 10.1097/WCO.0b013e32830f1e50; Siamwala JH, 2010, PROTOPLASMA, V242, P3, DOI 10.1007/s00709-010-0114-z; Sun Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057534; Sytkowski AJ, 2001, IN VITRO CELL DEV-AN, V37, P79; TEMPLE S, 1985, NATURE, V313, P223, DOI 10.1038/313223a0; TRAPP BD, 1989, J CELL BIOL, V109, P2417, DOI 10.1083/jcb.109.5.2417; Wanner IB, 2012, METHODS MOL BIOL, V814, P189, DOI 10.1007/978-1-61779-452-0_14; Yuge L, 2003, IN VITRO CELL DEV-AN, V39, P89; Yuge L, 2006, STEM CELLS DEV, V15, P921, DOI 10.1089/scd.2006.15.921; Yuge L, 2011, STEM CELLS DEV, V20, P893, DOI 10.1089/scd.2010.0294	43	11	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e76963	10.1371/journal.pone.0076963	http://dx.doi.org/10.1371/journal.pone.0076963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324574	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300002
J	Klintman, M; Strand, C; Ahlin, C; Beglerbegovic, S; Fjallskog, ML; Grabau, D; Gudlaugsson, E; Janssen, EAM; Lovgren, K; Skaland, I; Bendahl, PO; Malmstrom, P; Baak, JPA; Ferno, M				Klintman, Marie; Strand, Carina; Ahlin, Cecilia; Beglerbegovic, Sanda; Fjallskog, Marie-Louise; Grabau, Dorthe; Gudlaugsson, Einar; Janssen, Emiel A. M.; Lovgren, Kristina; Skaland, Ivar; Bendahl, Par-Ola; Malmstrom, Per; Baak, Jan P. A.; Ferno, Marten			The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; ESTROGEN-RECEPTOR STATUS; HISTOLOGIC GRADE; PROLIFERATION MARKER; PATIENTS YOUNGER; REPRODUCIBILITY; RECOMMENDATIONS; CARCINOMA; PHOSPHORYLATION; SUBTYPES	Proliferation, either as the main common denominator in genetic profiles, or in the form of single factors such as Ki67, is recommended for clinical use especially in estrogen receptor-positive (ER) patients. However, due to high costs of genetic profiles and lack of reproducibility for Ki67, studies on other proliferation factors are warranted. The aim of the present study was to evaluate the prognostic value of the proliferation factors mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A and Ki67, alone and in combinations. In 222 consecutive premenopausal node-negative breast cancer patients (87% without adjuvant medical treatment), MAI was assessed on whole tissue sections (predefined cut-off >= 10 mitoses), and PPH3, cyclin B1, cyclin A, and Ki67 on tissue microarray (predefined cut-offs 7th decile). In univariable analysis (high versus low) the strongest prognostic proliferation factor for 10-year distant disease-free survival was MAI (Hazard Ratio (HR)=3.3, 95% Confidence Interval (CI): 1.8-6.1), followed by PPH3, cyclin A, Ki67, and cyclin B1. A combination variable, with patients with MAI and/or cyclin A high defined as high-risk, had even stronger prognostic value (HR=4.2, 95% CI: 2.2-7). When stratifying for ER-status, MAI was a significant prognostic factor in ER-positive patients only (HR=7.0, 95% CI: 3.1-16). Stratified for histological grade, MAI added prognostic value in grade 2 (HR=7.2, 95% CI: 3.1-38) and grade 1 patients. In multivariable analysis including HER2, age, adjuvant medical treatment, ER, and one proliferation factor at a time, only MAI (HR=2.7, 95% CI: 1.1-6.7), and cyclin A (HR=2.7, 95% CI: 1.2-6.0) remained independently prognostic. In conclusion this study confirms the strong prognostic value of all proliferation factors, especially MAI and cyclin A, in all patients, and more specifically in ER-positive patients, and patients with histological grade 2 and 1. Additionally, by combining two proliferation factors, an even stronger prognostic value may be found.	[Klintman, Marie; Strand, Carina; Lovgren, Kristina; Bendahl, Par-Ola; Malmstrom, Per; Ferno, Marten] Lund Univ, Dept Clin Sci, Div Oncol, Lund, Sweden; [Klintman, Marie; Malmstrom, Per] Skane Univ Hosp, Skane Dept Oncol, Lund, Sweden; [Ahlin, Cecilia] Orebro Univ Hosp, Dept Oncol, Orebro, Sweden; [Beglerbegovic, Sanda] Vaxjo Cent Hosp, Div Pathol, Vaxjo, Sweden; [Fjallskog, Marie-Louise] Uppsala Univ, Dept Clin Sci, Div Oncol Radiol & Clin Immunol, Uppsala, Sweden; [Grabau, Dorthe] Lund Univ, Div Pathol, Dept Clin Sci, Lund, Sweden; [Grabau, Dorthe] Skane Univ Hosp, Lund, Sweden; [Gudlaugsson, Einar; Janssen, Emiel A. M.; Skaland, Ivar; Baak, Jan P. A.] Stavanger Univ Hosp, Dept Pathol, Stavanger, Norway	Lund University; Lund University; Skane University Hospital; Orebro University; Uppsala University; Lund University; Lund University; Skane University Hospital; Stavanger University Hospital	Klintman, M (corresponding author), Lund Univ, Dept Clin Sci, Div Oncol, Lund, Sweden.	marie.klintman@med.lu.se	Forsare, Carina/AAG-4690-2019; Janssen, Emiel A.M./AAM-2357-2020		Swedish Cancer Society; Swedish Research Council; Gunnar Nilsson Cancer Foundation; Mrs Berta Kamprad Foundation; Anna and Edwin Bergers Foundation; Skane County Council's Research and Development Foundation; Governmental Funding of Clinical Research within the National Health Service; Swedish Breast Cancer Association (BRO); Skane University Hospital; Skane University Hospital Research Foundation; Unit for Research and Development Kronoberg County Council in Vaxjo; Health West; Stavanger; Norway	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Gunnar Nilsson Cancer Foundation; Mrs Berta Kamprad Foundation; Anna and Edwin Bergers Foundation; Skane County Council's Research and Development Foundation; Governmental Funding of Clinical Research within the National Health Service; Swedish Breast Cancer Association (BRO); Skane University Hospital; Skane University Hospital Research Foundation; Unit for Research and Development Kronoberg County Council in Vaxjo; Health West; Stavanger; Norway	The study was supported by funds from the Swedish Cancer Society, the Swedish Research Council, the Gunnar Nilsson Cancer Foundation, the Mrs Berta Kamprad Foundation, the Anna and Edwin Bergers Foundation, Skane County Council's Research and Development Foundation, Governmental Funding of Clinical Research within the National Health Service, The Swedish Breast Cancer Association (BRO), Skane University Hospital and Skane University Hospital Research Foundation, the Unit for Research and Development Kronoberg County Council in Vaxjo, grants from Health West, Stavanger, Norway, and The Stichting Bevordering Diagnostische Morfometrie, Middelburg, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTOMAA S, 1993, ONCOLOGY-BASEL, V50, P57; Ahlin C, 2007, HISTOPATHOLOGY, V51, P491, DOI 10.1111/j.1365-2559.2007.02798.x; Ahlin C, 2009, CANCER EPIDEM BIOMAR, V18, P2501, DOI 10.1158/1055-9965.EPI-09-0169; Baak JPA, 2008, ANN ONCOL, V19, P649, DOI 10.1093/annonc/mdm535; Baak JPA, 2007, EUR J CANCER, V43, P527, DOI 10.1016/j.ejca.2006.10.001; Baak JPA, 2005, J CLIN ONCOL, V23, P5993, DOI 10.1200/JCO.2005.05.511; BAAK JPA, 1989, PATHOL RES PRACT, V185, P664, DOI 10.1016/S0344-0338(89)80213-4; Boiesen P, 2000, ACTA ONCOL, V39, P41; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gudlaugsson E, 2013, POL J PATHOL, V64, P1, DOI 10.5114/PJP.2013.34596; Gudlaugsson E, 2012, HISTOPATHOLOGY, V61, P1134, DOI 10.1111/j.1365-2559.2012.04329.x; Gudlaugsson E, 2010, BREAST CANCER RES TR, V121, P35, DOI 10.1007/s10549-009-0442-x; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; HARVEY JM, 1992, PATHOLOGY, V24, P63, DOI 10.3109/00313029209063625; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Juan G, 1998, CYTOMETRY, V32, P71, DOI 10.1002/(SICI)1097-0320(19980601)32:2<71::AID-CYTO1>3.0.CO;2-H; Klintman M, 2010, MODERN PATHOL, V23, P251, DOI 10.1038/modpathol.2009.167; Koliadi A, 2010, ACTA ONCOL, V49, P816, DOI 10.3109/02841861003691937; LEDOUSSAL V, 1989, CANCER, V64, P1914, DOI 10.1002/1097-0142(19891101)64:9<1914::AID-CNCR2820640926>3.0.CO;2-G; Lende TH, 2011, J CLIN ONCOL, V29, P852, DOI 10.1200/JCO.2009.25.0407; Liu SQ, 2001, CLIN CANCER RES, V7, P1716; Malmstrom P, 2001, J CLIN ONCOL, V19, P2010, DOI 10.1200/JCO.2001.19.7.2010; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; NIMEUSMALMSTROM E, 2009, INT J CANC; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2012, ANN ONCOL, V23, P2866, DOI 10.1093/annonc/mds080; Rudolph P, 2003, INT J CANCER, V105, P674, DOI 10.1002/ijc.11132; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Skaland I, 2008, HUM PATHOL, V39, P584, DOI 10.1016/j.humpath.2007.08.016; Skaland I, 2007, MODERN PATHOL, V20, P1307, DOI 10.1038/modpathol.3800972; Skaland I, 2010, APPL IMMUNOHISTO M M, V18, P90, DOI 10.1097/PAI.0b013e3181b0eaad; Skaland I, 2009, CELL ONCOL, V31, P261, DOI 10.3233/CLO-2009-0464; Skaland I, 2009, BREAST CANCER RES TR, V114, P39, DOI 10.1007/s10549-008-9980-x; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Strand C, 2012, BREAST CANCER RES TR, V131, P33, DOI 10.1007/s10549-011-1386-5; Suzuki T, 2007, CANCER SCI, V98, P644, DOI 10.1111/j.1349-7006.2007.00444.x; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VANDIEST PJ, 1992, HUM PATHOL, V23, P603, DOI 10.1016/0046-8177(92)90313-R; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124	46	21	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81902	10.1371/journal.pone.0081902	http://dx.doi.org/10.1371/journal.pone.0081902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324728	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300112
J	Knudby, A; Kenchington, E; Murillo, FJ				Knudby, Anders; Kenchington, Ellen; Murillo, Francisco Javier			Modeling the Distribution of Geodia Sponges and Sponge Grounds in the Northwest Atlantic	PLOS ONE			English	Article							HABITAT; WATER; PORIFERA; CORALS; OCEAN; FISH	Deep-sea sponge grounds provide structurally complex habitat for fish and invertebrates and enhance local biodiversity. They are also vulnerable to bottom-contact fisheries and prime candidates for Vulnerable Marine Ecosystem designation and related conservation action. This study uses species distribution modeling, based on presence and absence observations of Geodia spp. and sponge grounds derived from research trawl catches, as well as spatially continuous data on the physical and biological ocean environment derived from satellite data and oceanographic models, to model the distribution of Geodia sponges and sponge grounds in the Northwest Atlantic. Most models produce excellent fits with validation data although fits are reduced when models are extrapolated to new areas, especially when oceanographic regimes differ between areas. Depth and minimum bottom salinity were important predictors in most models, and a Geodia spp. minimum bottom salinity tolerance threshold in the 34.3-34.8 psu range was hypothesized on the basis of model structure. The models indicated two currently unsampled regions within the study area, the deeper parts of Baffin Bay and the Newfoundland and Labrador slopes, where future sponge grounds are most likely to be found.	[Knudby, Anders] Simon Fraser Univ, Dept Geog, Burnaby, BC V5A 1S6, Canada; [Kenchington, Ellen; Murillo, Francisco Javier] Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS, Canada; [Murillo, Francisco Javier] Inst Espaol Oceanog, Ctr Oceanog Vigo, Programa Pesquerias Lejanas, Vigo, Spain	Simon Fraser University; Bedford Institute of Oceanography; Fisheries & Oceans Canada; Spanish Institute of Oceanography	Knudby, A (corresponding author), Simon Fraser Univ, Dept Geog, Burnaby, BC V5A 1S6, Canada.	aknudby@sfu.ca	Murillo, Francisco Javier/C-7182-2019	Knudby, Anders/0000-0001-8970-8504	Canadian Department of Fisheries and Oceans Strategic Program for Ecosystem-Based Research and Advice (SPERA)	Canadian Department of Fisheries and Oceans Strategic Program for Ecosystem-Based Research and Advice (SPERA)	Funding was provided to EK and AK through the Canadian Department of Fisheries and Oceans Strategic Program for Ecosystem-Based Research and Advice (SPERA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsler MO, 2009, ANTARCT SCI, V21, P579, DOI 10.1017/S0954102009990356; Beazley L, 2013, J MAR SCI; BODC, 2009, GEBCO GRIDD GLOB BAT; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cardenas P, 2013, ZOOL J LINN SOC; Colbourne E. B., 2000, J NW ATL FISH SCI, V26, P103, DOI DOI 10.2960/J.V26.A5; Cuny J, 2005, J PHYS OCEANOGR, V35, P489, DOI 10.1175/JPO2700.1; Davies AJ, 2008, DEEP-SEA RES PT I, V55, P1048, DOI 10.1016/j.dsr.2008.04.010; de Goeij JM, 2007, LIMNOL OCEANOGR, V52, P2608, DOI 10.4319/lo.2007.52.6.2608; DFO, 2011, NAT FRAM CAN NETW MA, P31; DFO, 2009, 2009056 DFO CAN SCI; Dolan MFJ, 2008, DEEP-SEA RES PT I, V55, P1564, DOI 10.1016/j.dsr.2008.06.010; EU, 2013, MYOCEAN; FAO, 2009, FISHERIES AQUACULTUR, P98; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Ferry N., 2012, MERCATOR OCEAN Q NEW, V44, P28; Fischer J, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045321; Franklin J, 2009, MAPPING SPECIES DIST; Fuentes-Yaco C, 2007, FISH OCEANOGR, V16, P116, DOI 10.1111/j.1365-2419.2006.00402.x; Fuentes-Yaco C, 2011, HDB SATELLITE REMOTE, P155; Fuller SD, 2011, THESIS DALHOUSIE U H; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Guihen Damien, 2012, Marine Biodiversity Records, V5, pe68, DOI 10.1017/S1755267212000413; Guinan J, 2009, MAR ECOL PROG SER, V375, P125, DOI 10.3354/meps07739; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Herrnkind WF, 1997, MAR FRESHWATER RES, V48, P759, DOI 10.1071/MF97193; Hill R. T., 2004, MICROBIAL DIVERSITY, P177; Hogg M.M., 2010, DEEP SEA SPONGE GROU; Hooper JNA, 2002, SYSTEMA PORIFERA GUI; Murillo FJ, 2012, MAR BIOL RES, V8, P842, DOI 10.1080/17451000.2012.682583; Jones EP, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001141; Kenchington E, 2013, MAR ECOL PROG SER, V477, P217, DOI 10.3354/meps10127; Kenchington E, 2010, DFO CAN SCI ADVIS SE, V2010; Kenchington E, 2009, 096 NAFO SCR; Kenchington E, 2011, 1175 NAFO SCI COUNC; KINSELLA ED, 1987, J GEOPHYS RES-OCEANS, V92, P10853, DOI 10.1029/JC092iC10p10853; Klitgaard A. B., 1997, RESPONSES MARINE ORG, P129; Klitgaard AB, 2004, PROG OCEANOGR, V61, P57, DOI 10.1016/j.pocean.2004.06.002; KLITGAARD AB, 1995, SARSIA, V80, P1; Knudby A, 2010, ECOL MODEL, V221, P503, DOI 10.1016/j.ecolmodel.2009.11.008; LAZIER JRN, 1993, J PHYS OCEANOGR, V23, P659, DOI 10.1175/1520-0485(1993)023<0659:AVVITL>2.0.CO;2; Legendre P., 2012, NUMERICAL ECOLOGY; Leys SP, 2004, MAR ECOL PROG SER, V283, P133, DOI 10.3354/meps283133; LIDGREN G, 1988, J NAT PROD, V51, P1277, DOI 10.1021/np50060a041; Lutz MJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003706; Maldonado Manuel, 2002, P21; Mariani S, 2003, MAR ECOL PROG SER, V253, P67, DOI 10.3354/meps253067; Mariani S, 2006, OECOLOGIA, V149, P174, DOI 10.1007/s00442-006-0429-9; Muller WEG, 2004, ECAM, V1, P83; NASA, 2013, OCEANCOLOR; Penney AJ, 2009, MAR ECOL PROG SER, V397, P341, DOI 10.3354/meps08300; Ross RE, 2013, DIVERS DISTRIB, V19, P433, DOI 10.1111/ddi.12010; Rota CT, 2011, ECOGRAPHY, V34, P659, DOI 10.1111/j.1600-0587.2010.06433.x; Rudels B., 1986, POLAR RES-SWEDEN, V4, P161, DOI [10.3402/polar.v4i2.6929, DOI 10.3402/POLAR.V4I2.6929]; Spetland Frank, 2007, V28, P613; Stein M., 1996, Northwest Atlantic Fisheries Organization Scientific Council Studies, V25, P1; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Tripsanas EK, 2008, MAR PETROL GEOL, V25, P645, DOI 10.1016/j.marpetgeo.2007.08.002; Wareham VE, 2010, 2010058 DFO CAN SCI; Wu YS, 2012, PROG OCEANOGR, V106, P28, DOI 10.1016/j.pocean.2012.06.005	61	65	74	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82306	10.1371/journal.pone.0082306	http://dx.doi.org/10.1371/journal.pone.0082306			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324768	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300139
J	Lengler, J; Jug, F; Steger, A				Lengler, Johannes; Jug, Florian; Steger, Angelika			Reliable Neuronal Systems: The Importance of Heterogeneity	PLOS ONE			English	Article							EXCITATORY POSTSYNAPTIC POTENTIALS; FREQUENCY-DEPENDENT DEPRESSION; ANATOMICALLY IDENTIFIED BASKET; DORSOLATERAL PREFRONTAL CORTEX; FAST-SPIKING INTERNEURONS; RAT VISUAL-CORTEX; PYRAMIDAL NEURONS; IN-VITRO; INHIBITORY NEURONS; SYNAPTIC CONNECTIONS	For every engineer it goes without saying: in order to build a reliable system we need components that consistently behave precisely as they should. It is also well known that neurons, the building blocks of brains, do not satisfy this constraint. Even neurons of the same type come with huge variances in their properties and these properties also vary over time. Synapses, the connections between neurons, are highly unreliable in forwarding signals. In this paper we argue that both these fact add variance to neuronal processes, and that this variance is not a handicap of neural systems, but that instead predictable and reliable functional behavior of neural systems depends crucially on this variability. In particular, we show that higher variance allows a recurrently connected neural population to react more sensitively to incoming signals, and processes them faster and more energy efficient. This, for example, challenges the general assumption that the intrinsic variability of neurons in the brain is a defect that has to be overcome by synaptic plasticity in the process of learning.	[Lengler, Johannes; Steger, Angelika] ETH, Inst Theoret Comp Sci, Zurich, Switzerland; [Steger, Angelika] Coll Helveticum, Zurich, Switzerland; [Jug, Florian] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society	Lengler, J (corresponding author), ETH, Inst Theoret Comp Sci, Zurich, Switzerland.	johannes.lengler@inf.ethz.ch			ETH [ETH-23 08-1]	ETH(ETH Zurich)	This work was supported by funding from ETH Research Grant ETH-23 08-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviel Y, 2003, NEURAL COMPUT, V15, P1321, DOI 10.1162/089976603321780290; BARANYI A, 1993, J NEUROPHYSIOL, V69, P1865, DOI 10.1152/jn.1993.69.6.1865; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Binzegger T, 2009, NEURAL NETWORKS, V22, P1071, DOI 10.1016/j.neunet.2009.07.011; Borgers C, 2003, NEURAL COMPUT, V15, P509, DOI 10.1162/089976603321192059; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Branco T, 2009, NAT REV NEUROSCI, V10, P373, DOI 10.1038/nrn2634; Brunel N, 2000, J COMPUTATIONAL NEUR; Buhl EH, 1996, HIPPOCAMPUS, V6, P294; BUHL EH, 1995, EUR J NEUROSCI, V7, P1989, DOI 10.1111/j.1460-9568.1995.tb00721.x; Burkitt AN, 1999, NEURAL COMPUT, V11, P871, DOI 10.1162/089976699300016485; Chen N, 2006, BIOCHEM BIOPH RES CO, V340, P151, DOI 10.1016/j.bbrc.2005.11.170; Chivian E, 2008, SUSTAINING LIFE HUMA; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; Cossart R, 2002, NEURON, V35, P147, DOI 10.1016/S0896-6273(02)00753-5; Dayan P., 2001, THEORETICAL NEUROSCI; Degenetais E, 2002, CEREB CORTEX, V12, P1, DOI 10.1093/cercor/12.1.1; DEISZ RA, 1989, J PHYSIOL-LONDON, V412, P513, DOI 10.1113/jphysiol.1989.sp017629; Denker M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.074103; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Diesmann M., 2002, NEST ENV NEURAL SYST, V58, P43; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Feldmeyer D, 2000, J PHYSIOL-LONDON, V525, P31, DOI 10.1111/j.1469-7793.2000.00031.x; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Fricker D, 1999, J PHYSIOL-LONDON, V517, P791, DOI 10.1111/j.1469-7793.1999.0791s.x; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Gao WJ, 2003, J NEUROSCI, V23, P1622; Gerstner W, 1997, P NATL ACAD SCI USA, V94, P12740, DOI 10.1073/pnas.94.24.12740; Gerstner W., 2002, SPIKING NEURON MODEL; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; Golomb D, 2000, NEURAL COMPUT, V12, P1095, DOI 10.1162/089976600300015529; GOLOMB D, 1993, PHYS REV E, V48, P4810, DOI 10.1103/PhysRevE.48.4810; Gonzalez-Burgos G, 2005, J NEUROPHYSIOL, V93, P942, DOI 10.1152/jn.00787.2004; Gonzalez-Burgos G, 2004, CEREB CORTEX, V14, P530, DOI 10.1093/cercor/bhh015; Hansel D, 2003, NEURAL COMPUT, V15, P1, DOI 10.1162/089976603321043685; HANSEL D, 1995, NEURAL COMPUT, V7, P307, DOI 10.1162/neco.1995.7.2.307; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Hirase H, 1999, EUR J NEUROSCI, V11, P4373, DOI 10.1046/j.1460-9568.1999.00853.x; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Kalisman N, 2005, P NATL ACAD SCI USA, V102, P880, DOI 10.1073/pnas.0407088102; Karayannis T, 2007, CEREB CORTEX, V17, P1213, DOI 10.1093/cercor/bhl035; Khazipov R, 2006, TRENDS NEUROSCI, V29, P414, DOI 10.1016/j.tins.2006.05.007; Kremkow J, 2010, J NEUROSCI, V30, P15760, DOI 10.1523/JNEUROSCI.3874-10.2010; Kremkow J, 2010, J COMPUT NEUROSCI, V28, P579, DOI 10.1007/s10827-010-0240-9; Kriener B, 2008, NEURAL COMPUT, V20, P2185, DOI 10.1162/neco.2008.02-07-474; Kumar A, 2008, J NEUROSCI, V28, P5268, DOI 10.1523/JNEUROSCI.2542-07.2008; Kumar A, 2010, NAT REV NEUROSCI, V11, P615, DOI 10.1038/nrn2886; Kumar P, 2008, J NEUROPHYSIOL, V100, P1909, DOI 10.1152/jn.90684.2008; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Lampl I, 2009, SCHOLARPEDIA, V4, P7467; Ledergerber D, 2010, J NEUROSCI, V30, P13031, DOI 10.1523/JNEUROSCI.2254-10.2010; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Marsalek PR, 1997, P NATL ACAD SCI USA, V94, P735, DOI 10.1073/pnas.94.2.735; MASON A, 1991, J NEUROSCI, V11, P72; MASON A, 1990, J NEUROSCI, V10, P1415; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mehring C, 2003, BIOL CYBERN, V88, P395, DOI 10.1007/s00422-002-0384-4; Mejias JF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228102; Mielke N, 2007, AUDIO T IRE PROFESSI, P9; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; Motter AE, 2010, NAT PHYS, V6, P164, DOI 10.1038/nphys1609; Myme CIO, 2003, J NEUROPHYSIOL, V90, P771, DOI 10.1152/jn.00070.2003; Neltner L, 2000, NEURAL COMPUT, V12, P1607, DOI 10.1162/089976600300015286; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Ostojic S, 2009, J COMPUT NEUROSCI, V26, P369, DOI 10.1007/s10827-008-0117-3; Pawelzik H, 2003, J PHYSIOL-LONDON, V546, P701, DOI 10.1113/jphysiol.2002.035121; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Povysheva NV, 2006, CEREB CORTEX, V16, P541, DOI 10.1093/cercor/bhj002; Ranganathan GN, 2011, FRONTIERS NEURAL CIR; Reyes AD, 2003, NAT NEUROSCI, V6, P593, DOI 10.1038/nn1056; Rodriguez-Molina VM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000319; SCHOLFIELD CN, 1978, J PHYSIOL-LONDON, V275, P535, DOI 10.1113/jphysiol.1978.sp012206; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Steriade M, 1996, J NEUROSCI, V16, P392, DOI 10.1523/jneurosci.16-01-00392.1996; Steriade M, 1996, J NEUROSCI, V16, P2788; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Tamas G, 1998, J NEUROSCI, V18, P4255; Tarczy-Hornoch K, 1999, CEREB CORTEX, V9, P833, DOI 10.1093/cercor/9.8.833; Tetzlaff T, 2004, NEUROCOMPUTING, V58, P117, DOI 10.1016/j.neucom.2004.01.031; Tetzlaff T, 2003, NEUROCOMPUTING, V52-4, P949, DOI 10.1016/S0925-2312(02)00854-8; Tetzlaff T, 2004, NEUROBIOLOGY, V8; Tetzlaff T, 2008, NEURAL COMPUT, V20, P2133, DOI 10.1162/neco.2008.05-07-525; THOMSON AM, 1993, NEUROSCIENCE, V54, P347, DOI 10.1016/0306-4522(93)90257-G; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; THOMSON AM, 1994, TRENDS NEUROSCI, V17, P119, DOI 10.1016/0166-2236(94)90121-X; THOMSON AM, 1993, NEUROSCIENCE, V54, P329, DOI 10.1016/0306-4522(93)90256-F; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; TSODYKS M, 1993, PHYS REV LETT, V71, P1280, DOI 10.1103/PhysRevLett.71.1280; Tuckwell H. C., 1988, CAMBRIDGE STUDIES MA, V8; Uhlhaas PJ., 2009, FRONT INTEGR NEUROSC, P3; Urban N, 2012, NATURE, V488, P289, DOI 10.1038/488289a; van Rossum MCW, 2002, J NEUROSCI, V22, P1956, DOI 10.1523/JNEUROSCI.22-05-01956.2002; Vogels TP, 2009, NAT NEUROSCI, V12, P483, DOI 10.1038/nn.2276; Vogels TP, 2005, J NEUROSCI, V25, P10786, DOI 10.1523/JNEUROSCI.3508-05.2005; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; White JA, 1998, J COMPUT NEUROSCI, V5, P5, DOI 10.1023/A:1008841325921; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110	111	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80694	10.1371/journal.pone.0080694	http://dx.doi.org/10.1371/journal.pone.0080694			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324621	Green Submitted, Green Published, gold			2022-12-25	WOS:000327949300039
J	Siders, ZA; Westgate, AJ; Johnston, DW; Murison, LD; Koopman, HN				Siders, Zachary A.; Westgate, Andrew J.; Johnston, David W.; Murison, Laurie D.; Koopman, Heather N.			Seasonal Variation in the Spatial Distribution of Basking Sharks (Cetorhinus maximus) in the Lower Bay of Fundy, Canada	PLOS ONE			English	Article							CALANUS-FINMARCHICUS; RIGHT WHALES; SPECIES DISTRIBUTIONS; NORTHEAST ATLANTIC; FORAGING BEHAVIOR; PELAGIC SHARKS; MINKE WHALES; ZOOPLANKTON; HABITAT; CONSERVATION	The local distribution of basking sharks in the Bay of Fundy (BoF) is unknown despite frequent occurrences in the area from May to November. Defining this species' spatial habitat use is critical for accurately assessing its Special Concern conservation status in Atlantic Canada. We developed maximum entropy distribution models for the lower BoF and the northeast Gulf of Maine (GoM) to describe spatiotemporal variation in habitat use of basking sharks. Under the Maxent framework, we assessed model responses and distribution shifts in relation to known migratory behavior and local prey dynamics. We used 10 years (2002-2011) of basking shark surface sightings from July-October acquired during boat-based surveys in relation to chlorophyll-a concentration, sea surface temperature, bathymetric features, and distance to seafloor contours to assess habitat suitability. Maximum entropy estimations were selected based on AICc criterion and used to predict habitat utilizing three model-fitting routines as well as converted to binary suitable/ non-suitable habitat using the maximum sensitivity and specificity threshold. All models predicted habitat better than random (AUC values >0.796). From July-September, a majority of habitat was in the BoF, in waters >100 m deep, and in the Grand Manan Basin. In October, a majority of the habitat shifted southward into the GoM and to areas >200 m deep. Model responses suggest that suitable habitat from July - October is dependent on a mix of distance to the 0, 100, 150, and 200 m contours but in some models on sea surface temperature (July) and chlorophyll-a (August and September). Our results reveal temporally dynamic habitat use of basking sharks within the BoF and GoM. The relative importance of predictor variables suggests that prey dynamics constrained the species distribution in the BoF. Also, suitable habitat shifted minimally from July-September providing opportunities to conserve the species during peak abundance in the region.	[Siders, Zachary A.] Univ Florida, Gainesville, FL 32610 USA; [Siders, Zachary A.; Westgate, Andrew J.; Murison, Laurie D.; Koopman, Heather N.] Grand Manan Whale & Seabird Res Stn, Grand Manan, NB, Canada; [Westgate, Andrew J.; Koopman, Heather N.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA; [Johnston, David W.] Duke Univ, Nicholas Sch Environm, Beaufort, NC USA	State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Wilmington; Duke University	Siders, ZA (corresponding author), Univ Florida, Gainesville, FL 32610 USA.	zsiders@ufl.edu	Johnston, David/AAJ-5013-2020	Johnston, David/0000-0003-2424-036X; Siders, Zachary/0000-0002-0798-9515	University of North Carolina Wilmington; Grand Manan Whale and Seabird Research Station; North Atlantic Right Whale Consortium; Whales n' Sails; Sea Land Adventures (Schooner D'Sonoquoa); Deane Griffin	University of North Carolina Wilmington; Grand Manan Whale and Seabird Research Station; North Atlantic Right Whale Consortium; Whales n' Sails; Sea Land Adventures (Schooner D'Sonoquoa); Deane Griffin	This project would not have been possible without the support of the University of North Carolina Wilmington, the Grand Manan Whale and Seabird Research Station, the North Atlantic Right Whale Consortium, Whales n' Sails, Sea Land Adventures (Schooner D'Sonoquoa) and Deane Griffin. We would like to thank J. Wilson White for helpful comments and Gina Lonati for editing assistance.	Ainley DG, 2012, POLAR BIOL, V35, P281, DOI 10.1007/s00300-011-1075-1; [Anonymous], 2009, COSEWIC ASS STAT REP; Aretxabaleta AL, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004948; Aretxabaleta AL, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004480; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Ballard G, 2012, BIOL CONSERV, V156, P72, DOI 10.1016/j.biocon.2011.11.017; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Baumgartner MF, 2003, MAR ECOL PROG SER, V264, P137, DOI 10.3354/meps264137; Baumgartner MF, 2003, MAR ECOL PROG SER, V264, P123, DOI 10.3354/meps264123; Beardsley RC, 1996, DEEP-SEA RES PT II, V43, P1601, DOI 10.1016/S0967-0645(96)00050-1; Brown M. W., 2007, URBAN WHALE N ATLANT, P105; BROWN RGB, 1988, IBIS, V130, P234, DOI 10.1111/j.1474-919X.1988.tb00974.x; *COMM STAT END WIL, 2007, COSEWIC ASS STAT REP; Compagno L. J. V., 2002, FAO SPECIES CATALOGU, V2; COMPAGNO LJV, 1984, FAO FISH SYNOPSIS 1, V4; Cotton PA, 2005, FISH OCEANOGR, V14, P151, DOI 10.1111/j.1365-2419.2005.00331.x; DFO, 2008, 2008036 DFO; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Edren SMC, 2010, ECOGRAPHY, V33, P698, DOI 10.1111/j.1600-0587.2009.05901.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fish C. J., 1937, Journal of the Biological Board of Canada, V3, P189; Fowler SL, 2005, IUCN 2012 IUCN RED L; Friedlaender AS, 2011, DEEP-SEA RES PT II, V58, P1729, DOI 10.1016/j.dsr2.2010.11.018; Hirche HJ, 1996, OPHELIA, V44, P129, DOI 10.1080/00785326.1995.10429843; IUCN, 2022, IUCN RED LIST THREAT; Johnston DW, 2005, MAR ECOL PROG SER, V305, P287, DOI 10.3354/meps305287; Johnston DW, 2005, MAR ECOL PROG SER, V295, P279, DOI 10.3354/meps295279; KENNEY RD, 1985, COPEIA, P220, DOI 10.2307/1444813; LIEN J, 1986, CAN FIELD NAT, V100, P246; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; McKinney JA, 2012, MAR ECOL PROG SER, V458, P199, DOI 10.3354/meps09777; McKinstry CAE, 2013, ENDANGER SPECIES RES, V20, P195, DOI 10.3354/esr00497; Michaud Josee, 2007, Endangered Species Research, V3, P77, DOI 10.3354/esr003077; MURISON LD, 1989, CAN J ZOOL, V67, P1411, DOI 10.1139/z89-200; Owen R. E., 1984, THESIS U RHODE ISLAN; PARKER H. W., 1954, PROC ZOOL SOC LONDON, V124, P185; Pendleton Daniel E., 2012, Endangered Species Research, V18, P147, DOI 10.3354/esr00433; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Right Whale Consortium, 2012, N ATL RIGHT WHAL CON; Roberts JJ, 2010, ENVIRON MODELL SOFTW, V25, P1197, DOI 10.1016/j.envsoft.2010.03.029; Sequeira A, 2012, DIVERS DISTRIB, V18, P504, DOI 10.1111/j.1472-4642.2011.00853.x; Shepard ELC, 2006, MAR ECOL PROG SER, V328, P205, DOI 10.3354/meps328205; Sims DW, 2008, ADV MAR BIOL, V54, P171, DOI 10.1016/S0065-2881(08)00003-5; Sims DW, 2005, J ANIM ECOL, V74, P755, DOI 10.1111/j.1365-2656.2005.00971.x; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Sims DW, 1999, P ROY SOC B-BIOL SCI, V266, P1437, DOI 10.1098/rspb.1999.0798; Sims DW, 2002, FISH OCEANOGR, V11, P59, DOI 10.1046/j.1365-2419.2002.00189.x; Sims DW, 2003, MAR ECOL PROG SER, V248, P187, DOI 10.3354/meps248187; Sims DW, 2003, J MAR BIOL ASSOC UK, V83, P643, DOI 10.1017/S0025315403007598h; Skomal GB, 2009, CURR BIOL, V19, P1019, DOI 10.1016/j.cub.2009.04.019; Southall EJ, 2006, BIOL CONSERV, V132, P33, DOI 10.1016/j.biocon.2006.03.011; Southhall EJ, 2005, J MAR BIOL ASSOC UK, V85, P1083, DOI 10.1017/S0025315405012129; Stachura-Skierczynska K, 2009, FOREST ECOL MANAG, V258, P697, DOI 10.1016/j.foreco.2009.05.007; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Thorne LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043167; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; WISHNER KF, 1995, CONT SHELF RES, V15, P475, DOI 10.1016/0278-4343(94)00057-T; Witt MJ, 2012, MAR ECOL PROG SER, V459, P121, DOI 10.3354/meps09737	62	17	17	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82074	10.1371/journal.pone.0082074	http://dx.doi.org/10.1371/journal.pone.0082074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324747	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300127
J	Bishu, K; Ogut, O; Kushwaha, S; Mohammed, SF; Ohtani, T; Xu, XL; Brozovich, FV; Redfield, MM				Bishu, Kalkidan; Ogut, Ozgur; Kushwaha, Sudhir; Mohammed, Selma F.; Ohtani, Tomohito; Xu, Xiaolei; Brozovich, Frank V.; Redfield, Margaret M.			Anti-Remodeling Effects of Rapamycin in Experimental Heart Failure: Dose Response and Interaction with Angiotensin Receptor Blockade	PLOS ONE			English	Article							PRESSURE-OVERLOAD HYPERTROPHY; INDUCED CARDIAC-HYPERTROPHY; VENTRICULAR HYPERTROPHY; AKT ACTIVATION; MTOR; INHIBITION; AUTOPHAGY; MECHANISMS; KINASE; TRANSITION	While neurohumoral antagonists improve outcomes in heart failure ( HF), cardiac remodeling and dysfunction progress and outcomes remain poor. Therapies superior or additive to standard HF therapy are needed. Pharmacologic mTOR inhibition by rapamycin attenuated adverse cardiac remodeling and dysfunction in experimental heart failure ( HF). However, these studies used rapamycin doses that produced blood drug levels targeted for primary immunosuppression in human transplantation and therefore the immunosuppressive effects may limit clinical translation. Further, the relative or incremental effect of rapamycin combined with standard HF therapies targeting upstream regulators of cardiac remodeling ( neurohumoral antagonists) has not been defined. Our objectives were to determine if anti-remodeling effects of rapamycin were preserved at lower doses and whether rapamycin effects were similar or additive to a standard HF therapy (angiotensin receptor blocker (losartan)). Experimental murine HF was produced by transverse aortic constriction (TAC). At three weeks post-TAC, male mice with established HF were treated with placebo, rapamycin at a dose producing immunosuppressive drug levels (target dose), low dose (50% target dose) rapamycin, losartan or rapamycin + losartan for six weeks. Cardiac structure and function (echocardiography, catheterization, pathology, hypertrophic and fibrotic gene expression profiles) were assessed. Downstream mTOR signaling pathways regulating protein synthesis (S6K1 and S6) and autophagy (LC3B-II) were characterized. TAC-HF mice displayed eccentric hypertrophy, systolic dysfunction and pulmonary congestion. These perturbations were attenuated to a similar degree by oral rapamycin doses achieving target (13.3 +/- 2.1 ng/dL) or low (6.7 +/- 2.5 ng/dL) blood levels. Rapamycin treatment decreased mTOR mediated regulators of protein synthesis and increased mTOR mediated regulators of autophagy. Losartan monotherapy did not attenuate remodeling, whereas Losartan added to rapamycin provided no incremental benefit over rapamycin alone. These data lend support to investigation of low dose rapamycin as a novel therapy in human HF.	[Bishu, Kalkidan; Ogut, Ozgur; Kushwaha, Sudhir; Mohammed, Selma F.; Ohtani, Tomohito; Xu, Xiaolei; Brozovich, Frank V.; Redfield, Margaret M.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic	Redfield, MM (corresponding author), Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA.	redfield.margaret@mayo.edu	Mohammed, Selma/GQP-7898-2022	Mohammed, Sundos/0000-0002-8200-4210; Ohtani, Tomohito/0000-0002-2963-7895	NIH [HL76611, HL78845, HL78845-S1, HL07111-83]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107304] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH grants HL76611 to M.M.R., HL78845 and HL78845-S1 to O.O., and training-grant HL07111-83 to K.B. K.B. is a HF Clinical Research Network Clinical Research Skills Development fellow (HL-84907). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SM, 2005, J BIOL CHEM, V280, P19445, DOI 10.1074/jbc.C500125200; Baba HA, 1999, J MOL CELL CARDIOL, V31, P445, DOI 10.1006/jmcc.1998.0879; Boluyt MO, 2004, CARDIOVASC DRUG THER, V18, P257, DOI 10.1023/B:CARD.0000041245.61136.56; Boluyt MO, 1997, CIRC RES, V81, P176, DOI 10.1161/01.RES.81.2.176; BRUCKSCHLEGEL G, 1995, HYPERTENSION, V25, P250, DOI 10.1161/01.HYP.25.2.250; Buss SJ, 2009, J AM COLL CARDIOL, V54, P2435, DOI 10.1016/j.jacc.2009.08.031; Creemers EE, 2011, CARDIOVASC RES, V89, P265, DOI 10.1093/cvr/cvq308; Diez Javier, 2007, J Clin Hypertens (Greenwich), V9, P546, DOI 10.1111/j.1524-6175.2007.06626.x; Ding YH, 2011, CIRC RES, V109, P658, DOI 10.1161/CIRCRESAHA.111.248260; Diwan A, 2007, PHYSIOLOGY, V22, P56, DOI 10.1152/physiol.00033.2006; Doser TA, 2009, CIRCULATION, V119, P1941, DOI 10.1161/CIRCULATIONAHA.108.823799; Gao XM, 2006, J HYPERTENS, V24, P1663, DOI 10.1097/01.hjh.0000239304.01496.83; Hamawaki M, 1998, AM J PHYSIOL-HEART C, V274, pH868, DOI 10.1152/ajpheart.1998.274.3.H868; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Harston RK, 2011, AM J PHYSIOL-HEART C, V300, pH1696, DOI 10.1152/ajpheart.00545.2010; Hashikawa-Hobara N, 2012, DIABETES, V61, P925, DOI 10.2337/db11-1468; Holtwick R, 2002, J CARDIOVASC PHARM, V40, P723; Hu P, 2003, AM J PHYSIOL-HEART C, V285, pH1261, DOI 10.1152/ajpheart.00108.2003; Hunt Sharon Ann, 2005, J Am Coll Cardiol, V46, pe1, DOI 10.1016/j.jacc.2005.08.022; Iwai-Kanai E, 2008, AUTOPHAGY, V4, P322, DOI 10.4161/auto.5603; Jadhav R, 2011, AM J PHYSIOL-HEART C, V300, pH1938, DOI 10.1152/ajpheart.00282.2010; Kanamori H, 2013, AM J PATHOL, V182, P701, DOI 10.1016/j.ajpath.2012.11.009; Kawase Y, 2011, J AM COLL CARDIOL, V57, P1169, DOI 10.1016/j.jacc.2010.11.023; Kiatchoosakun S, 2001, J CARD FAIL, V7, P342, DOI 10.1054/jcaf.2001.29785; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kuzman JA, 2007, ENDOCRINOLOGY, V148, P3477, DOI 10.1210/en.2007-0099; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Loughran John H, 2013, Curr Heart Fail Rep, V10, P73, DOI 10.1007/s11897-012-0128-2; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; Mancini D, 2010, CIRCULATION, V122, P173, DOI 10.1161/CIRCULATIONAHA.109.858076; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; MOHABIR R, 1994, J CARDIOVASC PHARM, V23, P291, DOI 10.1097/00005344-199402000-00017; Mohammed SF, 2012, CARDIOVASC PATHOL, V21, P188, DOI 10.1016/j.carpath.2011.05.002; Mohammed SF, 2010, CIRCULATION, V122, P370, DOI 10.1161/CIRCULATIONAHA.109.915215; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Persson H, 2007, J AM COLL CARDIOL, V49, P687, DOI 10.1016/j.jacc.2006.08.062; Raichlin E, 2008, TRANSPLANTATION, V86, P1395, DOI 10.1097/TP.0b013e318189049a; REGAN CP, 1997, AM J PHYSIOL-HEART C, V272, pH2131; ROCKMAN HA, 1994, AM J PHYSIOL, V266, pH2468, DOI 10.1152/ajpheart.1994.266.6.H2468; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; SADOSHIMA J, 1995, CIRC RES, V77, P1040, DOI 10.1161/01.RES.77.6.1040; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sciarretta S, 2012, J CARDIOVASC PHARM, V60, P235, DOI 10.1097/FJC.0b013e3182575f61; Shapiro BP, 2007, HYPERTENSION, V50, P503, DOI 10.1161/HYPERTENSIONAHA.107.090092; Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Simm A, 1998, J MOL CELL CARDIOL, V30, P2059, DOI 10.1006/jmcc.1998.0768; Soesanto W, 2009, HYPERTENSION, V54, P1321, DOI 10.1161/HYPERTENSIONAHA.109.138818; Turcani M, 1998, MOL CELL BIOCHEM, V188, P225, DOI 10.1023/A:1006867227556; Villari B, 2009, CIRCULATION, V120, P2386, DOI 10.1161/CIRCULATIONAHA.108.812685; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008; Zuckermann A, 2012, AM J TRANSPLANT, V12, P2487, DOI 10.1111/j.1600-6143.2012.04131.x	56	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81325	10.1371/journal.pone.0081325	http://dx.doi.org/10.1371/journal.pone.0081325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312548	Green Submitted, Green Published, gold			2022-12-25	WOS:000327947800044
J	Tang, TF; Sui, YH; Lian, M; Li, ZP; Hua, J				Tang, Tongfang; Sui, Yongheng; Lian, Min; Li, Zhiping; Hua, Jing			Pro-Inflammatory Activated Kupffer Cells by Lipids Induce Hepatic NKT Cells Deficiency through Activation-Induced Cell Death	PLOS ONE			English	Article							KILLER T-CELLS; INNATE IMMUNE-SYSTEM; FATTY LIVER-DISEASE; INSULIN-RESISTANCE; MICE; STEATOSIS; DIET; STEATOHEPATITIS; ABNORMALITIES; PATHOGENESIS	Background: Dietary lipids play an important role in the progression of non-alcoholic fatty liver disease (NAFLD) through alternation of liver innate immune response. Aims: The present study was to investigate the effect of lipid on Kupffer cells phenotype and function in vivo and in vitro. And further to investigate the impact of lipid on ability of Kupffer cell lipid antigen presentation to activate NKT cells. Methods: Wild type male C57BL/6 mice were fed either normal or high-fat diet. Hepatic steatosis, Kupffer cell abundance, NKT cell number and cytokine gene expression were evaluated. Antigen presentation assay was performed with Kupffer cells treated with certain fatty acids in vitro and co-cultured with NKT cells. Results: High-fat diet induced hepatosteatosis, significantly increased Kupffer cells and decreased hepatic NKT cells. Lipid treatment in vivo or in vitro induced increase of pro-inflammatory cytokines gene expression and toll-like receptor 4 (TLR4) expression in Kupffer cells. Kupffer cells expressed high levels of CD1d on cell surface and only presented exogenous lipid antigen to activate NKT cells. Ability of Kupffer cells to present antigen and activate NKT cells was enhanced after lipid treatment. In addition, pro-inflammatory activated Kupffer cells by lipid treatment induced hepatic NKT cells activation-induced apoptosis and necrosis. Conclusion: High-fat diet increase Kupffer cells number and induce their pro-inflammatory status. Pro-inflammatory activated Kupfffer cells by lipid promote hepatic NKT cell over-activation and cell death, which lead to further hepatic NKT cell deficiency in the development of NAFLD.	[Tang, Tongfang; Sui, Yongheng; Lian, Min; Hua, Jing] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Shanghai Inst Digest Dis,Div Gaetroentrol & Hepat, Shanghai 200030, Peoples R China; [Li, Zhiping] Johns Hopkins Univ, Dept Med, Baltimore, MD USA	Shanghai Jiao Tong University; Johns Hopkins University	Hua, J (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Shanghai Inst Digest Dis,Div Gaetroentrol & Hepat, Shanghai 200030, Peoples R China.	hua-jing88@hotmail.com			National Natural Science Foundation of China [30971331]; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [R01-075990]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Natural Science Foundation of China Grant 30971331(JH), by National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases R01-075990 (ZL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manscript.	Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; de Wit NJW, 2012, J HEPATOL, V57, P1370, DOI 10.1016/j.jhep.2012.07.003; Diehl AM, 2002, AM J PHYSIOL-GASTR L, V282, pG1, DOI 10.1152/ajpgi.00384.2001; Dixon LJ, 2013, COMPR PHYSIOL, V3, P785, DOI 10.1002/cphy.c120026; Dong ZJ, 2007, CELL MOL IMMUNOL, V4, P241; Elinav E, 2006, J PATHOL, V209, P121, DOI 10.1002/path.1950; Figler RA, 2011, DIABETES, V60, P669, DOI 10.2337/db10-1070; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Hatano M, 2008, CELL IMMUNOL, V251, P25, DOI 10.1016/j.cellimm.2008.02.003; Hua J, 2010, J LIPID RES, V51, P1696, DOI 10.1194/jlr.M003004; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Jing H, 2007, J GASTROEN HEPATOL, V22, P862, DOI 10.1111/j.1440-1746.2007.04896.x; Kremer M, 2006, HEPATOLOGY, V44, P216, DOI 10.1002/hep.21221; Kremer M, 2010, HEPATOLOGY, V51, P130, DOI 10.1002/hep.23292; Lalor PF, 2007, SEMIN LIVER DIS, V27, P173, DOI 10.1055/s-2007-979470; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Lee JY, 2003, J BIOL CHEM, V278, P37041, DOI 10.1074/jbc.M305213200; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Leroux A, 2012, J HEPATOL, V57, P141, DOI 10.1016/j.jhep.2012.02.028; Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826; Li ZP, 2004, HEPATOLOGY, V40, P434, DOI 10.1002/hep.20320; Li ZP, 2003, CURR OPIN GASTROEN, V19, P565, DOI 10.1097/00001574-200311000-00009; Ma X, 2008, J HEPATOL, V49, P821, DOI 10.1016/j.jhep.2008.05.025; Maher JJ, 2008, HEPATOLOGY, V48, P670, DOI 10.1002/hep.22399; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Muriel P, 2003, J APPL TOXICOL, V23, P103, DOI 10.1002/jat.892; Nakashima H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049339; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; POTTER JJ, 1989, ARCH BIOCHEM BIOPHYS, V274, P548, DOI 10.1016/0003-9861(89)90469-4; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shono S, 2011, SHOCK, V36, P484, DOI 10.1097/SHK.0b013e31822dc6e4; Simoni Y, 2013, CLIN EXP IMMUNOL, V171, P8, DOI 10.1111/j.1365-2249.2012.04625.x; Skold M, 2003, INFECT IMMUN, V71, P5447, DOI 10.1128/IAI.71.10.5447-5455.2003; Syn WK, 2010, HEPATOLOGY, V51, P1998, DOI 10.1002/hep.23599; Tajiri K, 2009, EUR J GASTROEN HEPAT, V21, P673, DOI 10.1097/MEG.0b013e32831bc3d6; Trobonjaca Z, 2001, J IMMUNOL, V167, P1413, DOI 10.4049/jimmunol.167.3.1413; Yang L, 2007, LAB INVEST, V87, P927, DOI 10.1038/labinvest.3700603	42	48	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81949	10.1371/journal.pone.0081949	http://dx.doi.org/10.1371/journal.pone.0081949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312613	gold, Green Published, Green Submitted			2022-12-25	WOS:000327947800075
J	Bisel, B; Calamai, M; Vanzi, F; Pavone, FS				Bisel, Blaine; Calamai, Martino; Vanzi, Francesco; Pavone, Francesco Saverio			Decoupling Polarization of the Golgi Apparatus and GM1 in the Plasma Membrane	PLOS ONE			English	Article							LIPID RAFTS; BREFELDIN-A; GUANINE-NUCLEOTIDE; CELL-MIGRATION; LEADING-EDGE; RHO-GTPASES; EPITHELIAL-CELLS; MATRIX PROTEIN; MDCK CELLS; CDC42	Cell polarization is a process of coordinated cellular rearrangements that prepare the cell for migration. GM1 is synthesized in the Golgi apparatus and localized in membrane microdomains that appear at the leading edge of polarized cells, but the mechanism by which GM1 accumulates asymmetrically is unknown. The Golgi apparatus itself becomes oriented toward the leading edge during cell polarization, which is thought to contribute to plasma membrane asymmetry. Using quantitative image analysis techniques, we measure the extent of polarization of the Golgi apparatus and GM1 in the plasma membrane simultaneously in individual cells subject to a wound assay. We find that GM1 polarization starts just 10 min after stimulation with growth factors, while Golgi apparatus polarization takes 30 min. Drugs that block Golgi polarization or function have no effect on GM1 polarization, and, conversely, inhibiting GM1 polarization does not affect Golgi apparatus polarization. Evaluation of Golgi apparatus and GM1 polarization in single cells reveals no correlation between the two events. Our results indicate that Golgi apparatus and GM1 polarization are controlled by distinct intracellular cascades involving the Ras/Raf/MEK/ERK and the PI3K/Akt/mTOR pathways, respectively. Analysis of cell migration and invasion suggest that MEK/ERK activation is crucial for two dimensional migration, while PI3K activation drives three dimensional invasion, and no cumulative effect is observed from blocking both simultaneously. The independent biochemical control of GM1 polarity by PI3K and Golgi apparatus polarity by MEK/ERK may act synergistically to regulate and reinforce directional selection in cell migration.	[Bisel, Blaine; Calamai, Martino; Vanzi, Francesco; Pavone, Francesco Saverio] Univ Florence, European Lab Nonlinear Spect LENS, Sesto Fiorentino, Italy; [Calamai, Martino] Natl Res Council Italy CNR, Natl Inst Opt, Florence, Italy; [Vanzi, Francesco] Univ Florence, Dept Evolutionary Biol Leo Pardi, Florence, Italy	University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); University of Florence	Bisel, B (corresponding author), Univ Florence, European Lab Nonlinear Spect LENS, Sesto Fiorentino, Italy.	bisel@lens.unifi.it	Calamai, Martino/AAY-8441-2020; pavone, francesco s/F-4945-2015	Calamai, Martino/0000-0002-4031-7235; pavone, francesco saverio/0000-0002-0675-3981; Vanzi, Francesco/0000-0002-6372-7747	Fondazione Italiana per la Ricerca sul Cancro (FIRC); European Community [PIEF-GA-2009-254791]; LASERLAB-EUROPE (EC's Seventh Framework Programme) [284464]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Fondazione Italiana per la Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro); European Community(European Commission); LASERLAB-EUROPE (EC's Seventh Framework Programme); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was funded by the Fondazione Italiana per la Ricerca sul Cancro (FIRC) via a postdoctoral fellowship "Pierluigi Meneghelli" awarded to BB. The research leading to these results also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement n. PIEF-GA-2009-254791. Additional funding was provided by LASERLAB-EUROPE (grant agreement no 284464, EC's Seventh Framework Programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTANKOV G, 1993, J CELL BIOL, V120, P1449, DOI 10.1083/jcb.120.6.1449; Bannai H, 2006, NAT PROTOC, V1, P2628, DOI 10.1038/nprot.2006.429; BERGMANN JE, 1983, P NATL ACAD SCI-BIOL, V80, P1367, DOI 10.1073/pnas.80.5.1367; BERSHADSKY AD, 1994, P NATL ACAD SCI USA, V91, P5686, DOI 10.1073/pnas.91.12.5686; Bisel B, 2008, J CELL BIOL, V182, P837, DOI 10.1083/jcb.200805045; Bivona TG, 2003, CURR OPIN CELL BIOL, V15, P136, DOI 10.1016/S0955-0674(03)00016-4; Bodin S, 2005, MOL BIOL CELL, V16, P5773, DOI 10.1091/mbc.E05-04-0358; Bouzigues C, 2007, P NATL ACAD SCI USA, V104, P11251, DOI 10.1073/pnas.0702536104; Cabodi S, 2009, J CELL PHYSIOL, V218, P294, DOI 10.1002/jcp.21603; Chifflet S, 2012, INT J CELL BIOL, V2012; Clark R. A. F, 1996, MOL CELLULAR BIOL WO; Condliffe AM, 2000, NATURE, V404, P135, DOI 10.1038/35004693; Crespo PM, 2008, FEBS J, V275, P6043, DOI 10.1111/j.1742-4658.2008.06732.x; Crespo PM, 2004, J BIOL CHEM, V279, P47610, DOI 10.1074/jbc.M407181200; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Donaldson JG, 2000, CELL, V101, P693, DOI 10.1016/S0092-8674(00)80881-8; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; Drexler HG, 2002, IN VITRO CELL DEV-AN, V38, P185; Erickson JW, 1996, J BIOL CHEM, V271, P26850, DOI 10.1074/jbc.271.43.26850; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Flaherty KT, 2004, J CLIN ONCOL, V22, p711S; Folsch H, 2005, TRENDS CELL BIOL, V15, P222, DOI 10.1016/j.tcb.2005.02.006; Geiger TR, 2009, BBA-REV CANCER, V1796, P293, DOI 10.1016/j.bbcan.2009.07.006; Gomes ER, 2006, METHOD ENZYMOL, V406, P579, DOI 10.1016/S0076-6879(06)06045-9; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Halilovic E, 2010, CANCER RES, V70, P6804, DOI 10.1158/0008-5472.CAN-10-0409; Heino S, 2000, P NATL ACAD SCI USA, V97, P8375, DOI 10.1073/pnas.140218797; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Huang X, 2004, DEV BIOL, V275, P1, DOI 10.1016/j.ydbio.2004.07.033; Jaksits S, 2004, J IMMUNOL, V173, P1628, DOI 10.4049/jimmunol.173.3.1628; Jin L, 2006, BIOPHYS J, V90, P2563, DOI 10.1529/biophysj.105.072884; Jury EC, 2007, SEMIN CELL DEV BIOL, V18, P608, DOI 10.1016/j.semcdb.2007.08.002; KARRENBAUER A, 1990, CELL, V63, P259, DOI 10.1016/0092-8674(90)90159-C; Keller P, 1997, J CELL SCI, V110, P3001; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; KUPFER A, 1987, CELL MOTIL CYTOSKEL, V8, P182, DOI 10.1002/cm.970080210; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Le PU, 2000, J CELL SCI, V113, P3227; Lentini D, 2008, J NEUROCHEM, V104, P514, DOI 10.1111/j.1471-4159.2007.05005.x; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; Maccioni HJF, 1999, BBA-MOL CELL BIOL L, V1437, P101, DOI 10.1016/S1388-1981(99)00002-5; Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288; MARCUS PI, 1962, COLD SPRING HARB SYM, V27, P351, DOI 10.1101/SQB.1962.027.001.033; Marie M, 2008, CELL MOL LIFE SCI, V65, P2859, DOI 10.1007/s00018-008-8355-0; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Meiri KF, 2005, PHILOS T R SOC B, V360, P1663, DOI 10.1098/rstb.2005.1704; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nabi IR, 1999, J CELL SCI, V112, P1803; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Owen DM, 2006, BIOPHYS J, V90, pL80, DOI 10.1529/biophysj.106.084673; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Pinaud F, 2009, TRAFFIC, V10, P691, DOI 10.1111/j.1600-0854.2009.00902.x; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Puthenveedu MA, 2005, CURR OPIN CELL BIOL, V17, P369, DOI 10.1016/j.ceb.2005.06.006; Rajnicek AM, 2006, J CELL SCI, V119, P1723, DOI 10.1242/jcs.02896; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Rose JJ, 2008, J BIOMED SCI, V15, P441, DOI 10.1007/s11373-008-9239-x; Schneider IC, 2005, J CELL BIOL, V171, P883, DOI 10.1083/jcb.200509028; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Seemann J, 2002, SCIENCE, V295, P848, DOI 10.1126/science.1068064; SHIAO YJ, 1993, J BIOL CHEM, V268, P26085; Short B, 2000, CURR BIOL, V10, pR583, DOI 10.1016/S0960-9822(00)00644-8; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Tamarit B, 2013, J BIOL CHEM; Thompson N, 2005, CURR OPIN PHARMACOL, V5, P350, DOI 10.1016/j.coph.2005.04.007; Treanor B, 2005, J MICROSC-OXFORD, V217, P36, DOI 10.1111/j.0022-2720.2005.01430.x; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Ueda M, 1997, P NATL ACAD SCI USA, V94, P9674, DOI 10.1073/pnas.94.18.9674; URBANI L, 1990, J BIOL CHEM, V265, P1919; VAN MEER G, 1993, J CELL SCI, V104, P833; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Wang YZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001647; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Witte MB, 1997, SURG CLIN N AM, V77, P509, DOI 10.1016/S0039-6109(05)70566-1; Wittekind C, 2005, ONCOLOGY-BASEL, V69, P14, DOI 10.1159/000086626; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077; Yao L, 2009, HIPPOCAMPUS, V19, P855, DOI 10.1002/hipo.20569; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; Yuan CB, 2002, BIOPHYS J, V82, P2526, DOI 10.1016/S0006-3495(02)75596-3; Zhao M, 2002, FASEB J, V16, P857, DOI 10.1096/fj.01-0811fje; Zhao M, 1999, P NATL ACAD SCI USA, V96, P4942, DOI 10.1073/pnas.96.9.4942	104	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80446	10.1371/journal.pone.0080446	http://dx.doi.org/10.1371/journal.pone.0080446			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312472	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500024
J	Fang, J; Sukumaran, S; DuBois, DC; Almon, RR; Jusko, WJ				Fang, Jing; Sukumaran, Siddharth; DuBois, Debra C.; Almon, Richard R.; Jusko, William J.			Meta-Modeling of Methylprednisolone Effects on Glucose Regulation in Rats	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; RECEPTOR DOWN-REGULATION; TYROSINE AMINOTRANSFERASE INDUCTION; OBESE GENE-PRODUCT; ADIPOSE-TISSUE; CORTICOSTEROID PHARMACOGENOMICS; SKELETAL-MUSCLE; FATTY-ACIDS; DEXAMETHASONE; PHARMACODYNAMICS	A retrospective meta-modeling analysis was performed to integrate previously reported data of glucocorticoid (GC) effects on glucose regulation following a single intramuscular dose (50 mg/kg), single intravenous doses (10, 50 mg/kg), and intravenous infusions (0.1, 0.2, 0.3 and 0.4 mg/kg/h) of methylprednisolone (MPL) in normal and adrenalectomized (ADX) male Wistar rats. A mechanistic pharmacodynamic (PD) model was developed based on the receptor/gene/protein-mediated GC effects on glucose regulation. Three major target organs (liver, white adipose tissue and skeletal muscle) together with some selected intermediate controlling factors were designated as important regulators involved in the pathogenesis of GC-induced glucose dysregulation. Assessed were dynamic changes of food intake and systemic factors (plasma glucose, insulin, free fatty acids (FFA) and leptin) and tissue-specific biomarkers (cAMP, phosphoenolpyruvate carboxykinase (PEPCK) mRNA and enzyme activity, leptin mRNA, interleukin 6 receptor type 1 (IL6R1) mRNA and Insulin receptor substrate-1 (IRS-1) mRNA) after acute and chronic dosing with MPL along with the GC receptor (GR) dynamics in each target organ. Upon binding to GR in liver, MPL dosing caused increased glucose production by stimulating hepatic cAMP and PEPCK activity. In adipose tissue, the rise in leptin mRNA and plasma leptin caused reduction of food intake, the exogenous source of glucose input. Down-regulation of IRS-1 mRNA expression in skeletal muscle inhibited the stimulatory effect of insulin on glucose utilization further contributing to hyperglycemia. The nuclear drug-receptor complex served as the driving force for stimulation or inhibition of downstream target gene expression within different tissues. Incorporating information such as receptor dynamics, as well as the gene and protein induction, allowed us to describe the receptor-mediated effects of MPL on glucose regulation in each important tissue. This advanced mechanistic model provides unique insights into the contributions of major tissues and quantitative hypotheses for the multi-factor control of a complex metabolic system.	[Fang, Jing; Sukumaran, Siddharth; DuBois, Debra C.; Almon, Richard R.; Jusko, William J.] SUNY Buffalo, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Buffalo, NY 14260 USA; [DuBois, Debra C.; Almon, Richard R.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Jusko, WJ (corresponding author), SUNY Buffalo, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Buffalo, NY 14260 USA.	wjjusko@buffalo.edu	Jusko, William J/G-4885-2015		NIH [GM24211]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH Grant GM24211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Almon RR, 2007, ENDOCRINOLOGY, V148, P2209, DOI 10.1210/en.2006-0790; Almon RR, 2005, J ENDOCRINOL, V184, P219, DOI 10.1677/joe.1.05953; Araki Eiichi, 2002, Nihon Rinsho, V60 Suppl 7, P559; AROLA L, 1980, ARCH INT PHYSIOL BIO, V88, P99, DOI 10.3109/13813458009075674; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Buren J, 2008, ARCH BIOCHEM BIOPHYS, V474, P91, DOI 10.1016/j.abb.2008.02.034; D'Orazio P, 2005, CLIN CHEM, V51, P1573, DOI 10.1373/clinchem.2005.051979; Delarue J, 2007, CURR OPIN CLIN NUTR, V10, P142, DOI 10.1097/MCO.0b013e328042ba90; Fang J, 2011, J PHARMACOKINET PHAR, V38, P293, DOI 10.1007/s10928-011-9194-4; GIORGINO F, 1993, J CLIN INVEST, V91, P2020, DOI 10.1172/JCI116424; HAUGHEY DB, 1988, J CHROMATOGR-BIOMED, V430, P241, DOI 10.1016/S0378-4347(00)83159-X; Hayashi R, 2004, EUR J PHARMACOL, V500, P51, DOI 10.1016/j.ejphar.2004.07.011; Hazra A, 2008, PHARM RES-DORDR, V25, P769, DOI 10.1007/s11095-007-9371-8; Hazra A, 2007, BIOPHARM DRUG DISPOS, V28, P263, DOI 10.1002/bdd.551; Hazra A, 2007, J PHARMACOKINET PHAR, V34, P333, DOI 10.1007/s10928-007-9049-1; Hazra A, 2008, GENE REGUL SYST BIO, V2, P1; Jahng JW, 2008, EUR J PHARMACOL, V581, P64, DOI 10.1016/j.ejphar.2007.11.029; Jin JY, 2009, BIOPHARM DRUG DISPOS, V30, P21, DOI 10.1002/bdd.643; Jin JY, 2009, BIOPHARM DRUG DISPOS, V30, P35, DOI 10.1002/bdd.642; Jin JY, 2004, J PHARMACOL EXP THER, V309, P328, DOI 10.1124/jpet.103.061515; Jin JY, 2003, J PHARMACOL EXP THER, V307, P93, DOI 10.1124/jpet.103.053256; Jin JY, 2003, THESIS STATE U NEW Y; Jusko WJ, 2013, J PHARM SCI-US, V102, P2930, DOI 10.1002/jps.23590; Landersdorfer CB, 2008, CLIN PHARMACOKINET, V47, P417, DOI 10.2165/00003088-200847070-00001; Lee MJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE858, DOI 10.1152/ajpendo.00439.2006; Mager DE, 2008, CLIN PHARMACOL THER, V83, P909, DOI 10.1038/clpt.2008.52; Miell JP, 1996, HORM METAB RES, V28, P704, DOI 10.1055/s-2007-979882; Mlinar B, 2007, CLIN CHIM ACTA, V375, P20, DOI 10.1016/j.cca.2006.07.005; MURAKAMI T, 1995, BIOCHEM BIOPH RES CO, V214, P1260, DOI 10.1006/bbrc.1995.2422; Nicod N, 2003, OBES RES, V11, P625, DOI 10.1038/oby.2003.90; OGAWA A, 1992, J CLIN INVEST, V90, P497, DOI 10.1172/JCI115886; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Qi D, 2007, AM J PHYSIOL-ENDOC M, V292, pE654, DOI 10.1152/ajpendo.00453.2006; Rafacho A, 2008, PANCREAS, V36, P284, DOI 10.1097/MPA.0b013e31815ba826; Ramakrishnan R, 2002, J PHARMACOKINET PHAR, V29, P1, DOI 10.1023/A:1015765201129; Ramakrishnan R, 2002, J PHARMACOL EXP THER, V300, P245, DOI 10.1124/jpet.300.1.245; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Sesti G, 2000, Pharmacogenomics, V1, P343, DOI 10.1517/14622416.1.3.343; Shirakami A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740309; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; STOJANOVSKA L, 1990, AM J PHYSIOL, V258, pE748, DOI 10.1152/ajpendo.1990.258.5.E748; Sukumaran S, 2011, J PHARMACOL EXP THER, V337, P734, DOI 10.1124/jpet.111.179960; Sun YN, 1998, J PHARMACOKINET BIOP, V26, P289, DOI 10.1023/A:1023233409550; Sun YN, 1999, J PHARMACOL EXP THER, V288, P720; Sun YN, 1998, J PHARMACOKINET BIOP, V26, P619, DOI 10.1023/A:1020746822634; SUTHERLA.EW, 1969, DIABETES, V18, P797, DOI 10.2337/diab.18.12.797; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Walsh LJ, 1996, BRIT MED J, V313, P344, DOI 10.1136/bmj.313.7053.344; Wang P, 2008, J CELL PHYSIOL, V216, P3, DOI 10.1002/jcp.21386; Yao ZL, 2008, GENE REGUL SYST BIO, V2, P141; Yao Z, 2008, MOL PHARMACEUT, V5, P328, DOI 10.1021/mp700094s	53	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81679	10.1371/journal.pone.0081679	http://dx.doi.org/10.1371/journal.pone.0081679			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312573	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500086
J	Feng, AW; Zhou, GR; Yuan, XM; Huang, XL; Zhang, ZY; Zhang, T				Feng, Aiwen; Zhou, Guangrong; Yuan, Xiaoming; Huang, Xinli; Zhang, Zhengyuan; Zhang, Ti			Inhibitory Effect of Baicalin on iNOS and NO Expression in Intestinal Mucosa of Rats with Acute Endotoxemia	PLOS ONE			English	Article							SEVERE ACUTE-PANCREATITIS; ACTIVATED-RECEPTOR-GAMMA; NITRIC-OXIDE-SYNTHASE; PPAR-GAMMA; ULCERATIVE-COLITIS; NECROTIZING ENTEROCOLITIS; INFLAMMATION; LIPOPOLYSACCHARIDE; CELLS; SOMATOSTATIN	The mechanism by which baicalin modulated the expression of inducible nitric oxide synthase (iNOS) and nitric oxide (NO) in the mucosa of distal ileum was investigated in a rat model of acute endo-toxemia induced by intraperitoneal injection of bacterial lipopolysaccharide (LPS). The experiment demonstrated that LPS upregulated iNOS mRNA and protein expression as well as NO produc-tion (measured as the stable degradation production, nitrites). LPS not only increased toll-like receptor 4 (TLR4) and peroxisome proliferator-activated receptor gamma (PPAR gamma) content, but also activated p38 and activating transcription factor 2 (ATF2) and inactivated PPAR gamma via phosphorylation. Inhibition of p38 signalling pathway by chemical inhibitor SB202190 and small interfering RNA (siRNA) ameliorated LPS-induced iNOS generation, while suppression of PPAR gamma pathway by SR-202 boosted LPS-elicited iNOS expression. Baicalin treatment (I) attenuated LPS-induced iNOS mRNA and protein as well as nitrites generation, and (II) ameliorated LPS-elicited TLR4 and PPAR gamma production, and (III) inhibited p38/ATF2 phosphorylation leading to suppression of p38 signalling, and (IV) prevented PPAR gamma from phosphorylation contributing to maintainence of PPAR gamma bioactivity. However, SR-202 co-treatment (I) partially abrogated the inhibitory effect of baicalin on iNOS mRNA expression, and (II) partially reversed baicalin-inhibited p38 phosphorylation. In summary, baicalin could ameliorate LPS-induced iNOS and NO overproduction in mucosa of rat terminal ileum via inhibition of p38 signalling cascade and activation of PPAR gamma pathway. There existed a interplay between the two signalling pathways.	[Feng, Aiwen; Zhou, Guangrong; Yuan, Xiaoming; Zhang, Zhengyuan; Zhang, Ti] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Gastrointestinal Surg, Huaian, Peoples R China; [Huang, Xinli] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Huang, XL (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China.	fengheyan-2000@163.com			National Natural Science Foundation in China [81072032]	National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key Project of National Natural Science Foundation in China (No. 81072032) (http://www.nsfc.gov.cn/nsfc/cen/xxgk/slzz.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Al-Shabrawey M, 2003, MOL VIS, V9, P549; Alican I, 1996, AM J PHYSIOL-GASTR L, V270, pG225, DOI 10.1152/ajpgi.1996.270.2.G225; Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963; Barz T, 2006, CANCER RES, V66, P11975, DOI 10.1158/0008-5472.CAN-06-1529; Blanquart C, 2003, J STEROID BIOCHEM, V85, P267, DOI 10.1016/S0960-0760(03)00214-0; Briard N, 1998, ENDOCRINOLOGY, V139, P2662, DOI 10.1210/en.139.6.2662; Chung HL, 2007, WORLD J GASTROENTERO, V13, P5605, DOI 10.3748/wjg.v13.i42.5605; Chung S, 2006, ENDOCRINOLOGY, V147, P5340, DOI 10.1210/en.2006-0536; Dai SX, 2012, PHYTOTHER RES, V26, P498, DOI 10.1002/ptr.3581; Dallaire P, 2008, DIABETES, V57, P1999, DOI 10.2337/db08-0540; Deitch EA, 2006, FRONT BIOSCI-LANDMRK, V11, P520, DOI 10.2741/1816; Diradourian C, 2005, BIOCHIMIE, V87, P33, DOI 10.1016/j.biochi.2004.11.010; Dorn G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh044; Dou W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036075; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Emami CN, 2012, J SURG RES, V172, P18, DOI 10.1016/j.jss.2011.04.019; Eun CS, 2006, DIGEST DIS SCI, V51, P693, DOI 10.1007/s10620-006-3193-0; Furuya A, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-56; Grishin AV, 2006, J IMMUNOL, V176, P580, DOI 10.4049/jimmunol.176.1.580; Gueorguiev VD, 2006, J BIOL CHEM, V281, P10188, DOI 10.1074/jbc.M513806200; Guner YS, 2009, BIOCHEM BIOPH RES CO, V384, P221, DOI 10.1016/j.bbrc.2009.04.091; Hou JC, 2012, INT IMMUNOPHARMACOL, V14, P749, DOI 10.1016/j.intimp.2012.10.013; Ito J, 2010, AM J PHYSIOL-GASTR L, V298, pG916, DOI 10.1152/ajpgi.00429.2009; Kole L, 2011, EUR J PHARMACOL, V653, P8, DOI 10.1016/j.ejphar.2010.11.026; Kostadinova R, 2005, CURR MED CHEM, V12, P2995, DOI 10.2174/092986705774462905; Lee IA, 2011, J AGR FOOD CHEM, V59, P13165, DOI 10.1021/jf2033818; Li HY, 2010, EUR J PHARMACOL, V649, P92, DOI 10.1016/j.ejphar.2010.09.023; Li ZF, 2009, BIOMED PHARMACOTHER, V63, P120, DOI 10.1016/j.biopha.2008.01.003; Lim HA, 2012, BIOGERONTOLOGY, V13, P133, DOI 10.1007/s10522-011-9361-4; Liu Y, 2008, BRIT J NUTR, V100, P552, DOI 10.1017/S0007114508911612; Lobo SM, 2009, MED SCI MONITOR, V15, pBR37; Luo W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051008; Moraes LA, 2006, PHARMACOL THERAPEUT, V110, P371, DOI 10.1016/j.pharmthera.2005.08.007; Morin MJ, 2001, AM J PHYSIOL-GASTR L, V281, pG552, DOI 10.1152/ajpgi.2001.281.2.G552; Pinter E, 2006, PHARMACOL THERAPEUT, V112, P440, DOI 10.1016/j.pharmthera.2006.04.010; Priego T, 2005, REGUL PEPTIDES, V124, P113, DOI 10.1016/j.regpep.2004.07.001; Qiao HX, 2011, PHARM BIOL, V49, P38, DOI 10.3109/13880209.2010.493179; Sato N, 2006, AM J PHYSIOL-GASTR L, V290, pG616, DOI 10.1152/ajpgi.00248.2005; Sklyarov AY, 2011, J PHYSIOL PHARMACOL, V62, P65; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Takahashi T, 2005, Med Chem, V1, P643, DOI 10.2174/157340605774598171; Wang XF, 2013, ANTICANCER AGENTS ME; Yang MD, 2012, HEPATOLOGY, V55, P1271, DOI 10.1002/hep.24792; Zhang XP, 2008, DIGEST DIS SCI, V53, P581, DOI 10.1007/s10620-007-9868-3; Zhang XP, 2007, WORLD J GASTROENTERO, V13, P717, DOI 10.3748/wjg.v13.i5.717; Zhang XP, 2005, WORLD J GASTROENTERO, V11, P2095, DOI 10.3748/wjg.v11.i14.2095; Zhang XP, 2009, TURK J GASTROENTEROL, V20, P108; Zhang XP, 2009, J GASTROEN HEPATOL, V24, P1753, DOI 10.1111/j.1440-1746.2009.05902.x; Zuckerbraun BS, 2005, AM J PHYSIOL-GASTR L, V289, pG607, DOI 10.1152/ajpgi.00055.2005	51	17	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80997	10.1371/journal.pone.0080997	http://dx.doi.org/10.1371/journal.pone.0080997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312512	gold, Green Published, Green Submitted			2022-12-25	WOS:000327944500048
J	Pekalski, J; Zuk, PJ; Kochanczyk, M; Junkin, M; Kellogg, R; Tay, S; Lipniacki, T				Pekalski, Jakub; Zuk, Pawel J.; Kochanczyk, Marek; Junkin, Michael; Kellogg, Ryan; Tay, Savas; Lipniacki, Tomasz			Spontaneous NF-kappa B Activation by Autocrine TNF alpha Signaling: A Computational Analysis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TEMPORAL CONTROL; GENE-EXPRESSION; NUCLEAR TRANSLOCATION; NEGATIVE REGULATION; A20; RECEPTOR; MACROPHAGES; DYNAMICS; PATHWAY	NF-kappa B is a key transcription factor that regulates innate immune response. Its activity is tightly controlled by numerous feedback loops, including two negative loops mediated by NF-kappa B inducible inhibitors, I kappa B alpha and A20, which assure oscillatory responses, and by positive feedback loops arising due to the paracrine and autocrine regulation via TNF alpha, IL-1 and other cytokines. We study the NF-kappa B system of interlinked negative and positive feedback loops, combining bifurcation analysis of the deterministic approximation with stochastic numerical modeling. Positive feedback assures the existence of limit cycle oscillations in unstimulated wild-type cells and introduces bistability in A20-deficient cells. We demonstrated that cells of significant autocrine potential, i.e., cells characterized by high secretion of TNF alpha and its receptor TNFR1, may exhibit sustained cytoplasmic-nuclear NF-kappa B oscillations which start spontaneously due to stochastic fluctuations. In A20-deficient cells even a small TNF alpha expression rate qualitatively influences system kinetics, leading to long-lasting NF-kappa B activation in response to a short-pulsed TNF alpha stimulation. As a consequence, cells with impaired A20 expression or increased TNF alpha secretion rate are expected to have elevated NF-kappa B activity even in the absence of stimulation. This may lead to chronic inflammation and promote cancer due to the persistent activation of antiapoptotic genes induced by NF-kappa B. There is growing evidence that A20 mutations correlate with several types of lymphomas and elevated TNF alpha secretion is characteristic of many cancers. Interestingly, A20 loss or dysfunction also leaves the organism vulnerable to septic shock and massive apoptosis triggered by the uncontrolled TNF alpha secretion, which at high levels overcomes the antiapoptotic action of NF-kappa B. It is thus tempting to speculate that some cancers of deregulated NF-kappa B signaling may be prone to the pathogen-induced apoptosis.	[Pekalski, Jakub; Zuk, Pawel J.; Kochanczyk, Marek; Lipniacki, Tomasz] Polish Acad Sci, Inst Fundamental Technol Res, Warsaw, Poland; [Pekalski, Jakub] Polish Acad Sci, Inst Phys Chem, Warsaw, Poland; [Zuk, Pawel J.] Univ Warsaw, Fac Phys, Inst Theoret Phys, Warsaw, Poland; [Junkin, Michael; Kellogg, Ryan; Tay, Savas] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Zurich, Switzerland; [Lipniacki, Tomasz] Rice Univ, Dept Stat, Houston, TX 77251 USA	Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Physical Chemistry of the Polish Academy of Sciences; University of Warsaw; Swiss Federal Institutes of Technology Domain; ETH Zurich; Rice University	Lipniacki, T (corresponding author), Polish Acad Sci, Inst Fundamental Technol Res, Warsaw, Poland.	tlipnia@ippt.gov.pl	Żuk, Paweł/GXW-2921-2022; Pękalski, Jakub/B-6824-2017; Junkin, Michael/L-3802-2014; Kochanczyk, Marek/D-7825-2011; Lipniacki, Tomasz/AAC-6744-2019	Żuk, Paweł/0000-0003-0555-5913; Pękalski, Jakub/0000-0002-3433-0628; Junkin, Michael/0000-0001-6368-4700; Kochanczyk, Marek/0000-0003-1215-3920; Lipniacki, Tomasz/0000-0002-3488-2561	Foundation for Polish Science [2009-3/6]; Polish National Science Centre [2011/03/B/NZ2/00281]; Swiss National Science Foundation [205321_141299]	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Polish National Science Centre; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Foundation for Polish Science grant # Team 2009-3/6; Polish National Science Centre grant # 2011/03/B/NZ2/00281; Swiss National Science Foundation grant # 205321_141299. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Barken D, 2005, SCIENCE, V308, DOI 10.1126/science.1107904; Barua D, 2012, J IMMUNOL, V189, P646, DOI 10.4049/jimmunol.1102003; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEUTLER B, 1988, ANNU REV BIOCHEM, V57, P505, DOI 10.1146/annurev.bi.57.070188.002445; Bian X, 2002, J BIOL CHEM, V277, P42144, DOI 10.1074/jbc.M203891200; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Cho KH, 2003, GENOME RES, V13, P2413, DOI 10.1101/gr.1195703; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Coward WR, 2002, J IMMUNOL, V169, P5287, DOI 10.4049/jimmunol.169.9.5287; Deleault KM, 2008, MOL IMMUNOL, V45, P13, DOI 10.1016/j.molimm.2007.05.017; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Dong GH, 2011, CLIN CANCER RES, V17, P1440, DOI 10.1158/1078-0432.CCR-10-1859; Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5; Gais P, 2010, J IMMUNOL, V184, P5842, DOI 10.4049/jimmunol.0902456; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; Guergnon J, 2003, CELL MICROBIOL, V5, P709, DOI 10.1046/j.1462-5822.2003.00314.x; Guma M, 2011, J EXP MED, V208, P1889, DOI 10.1084/jem.20110242; Gutschow MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053222; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Harhaj EW, 2011, CELL RES, V21, P22, DOI 10.1038/cr.2010.166; Haseltine EL, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2062048; Hat B, 2009, IET SYST BIOL, V3, P342, DOI 10.1049/iet-syb.2008.0156; Hayakawa K, 2006, AM J PHYSIOL-RENAL, V291, pF1169, DOI 10.1152/ajprenal.00513.2005; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Honma K, 2009, BLOOD, V114, P2467, DOI 10.1182/blood-2008-12-194852; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Huang HL, 2009, BRIT J CANCER, V101, P1555, DOI 10.1038/sj.bjc.6605352; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Jaattela M, 1996, J IMMUNOL, V156, P1166; Jackson-Bernitsas DG, 2007, ONCOGENE, V26, P1385, DOI 10.1038/sj.onc.1209945; James CD, 2009, BIOMED MICRODEVICES, V11, P693, DOI 10.1007/s10544-008-9281-5; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Kuno R, 2005, J NEUROIMMUNOL, V162, P89, DOI 10.1016/j.jneuroim.2005.01.015; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; Liacini A, 2003, EXP CELL RES, V288, P208, DOI 10.1016/S0014-4827(03)00180-0; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Lipniacki T, 2006, BIOPHYS J, V90, P725, DOI 10.1529/biophysj.104.056754; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Lipniacki T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-376; Lipniacki T, 2008, J THEOR BIOL, V254, P110, DOI 10.1016/j.jtbi.2008.05.001; Lipniacki T, 2007, CARDIOVASC TOXICOL, V7, P215, DOI 10.1007/s12012-007-9003-x; Lisby S, 2007, BIOCHEM PHARMACOL, V73, P526, DOI 10.1016/j.bcp.2006.11.006; Liu HT, 2000, J IMMUNOL, V164, P4277, DOI 10.4049/jimmunol.164.8.4277; Lombardo E, 2007, J IMMUNOL, V178, P3731, DOI 10.4049/jimmunol.178.6.3731; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; Nadeau S, 2000, J NEUROSCI, V20, P3456, DOI 10.1523/JNEUROSCI.20-09-03456.2000; Nelson DE, 2005, SCIENCE, V308, DOI 10.1126/science.1108198; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Paszek P, 2010, P NATL ACAD SCI USA, V107, P11644, DOI 10.1073/pnas.0913798107; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rand U, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.17; Rushworth SA, 2011, J IMMUNOL, V187, P702, DOI 10.4049/jimmunol.1004117; Schooley K, 2003, BIOCHEM J, V369, P331, DOI 10.1042/BJ20020253; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Terry AJ, 2011, J THEOR BIOL, V290, P7, DOI 10.1016/j.jtbi.2011.08.036; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; Tsai EY, 1996, MOL CELL BIOL, V16, P459; Turner DA, 2010, J CELL SCI, V123, P2834, DOI 10.1242/jcs.069641; Udalova IA, 1998, J BIOL CHEM, V273, P21178, DOI 10.1074/jbc.273.33.21178; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Whiteside ST, 1997, EMBO J, V16, P1413, DOI 10.1093/emboj/16.6.1413; WITSELL AL, 1992, P NATL ACAD SCI USA, V89, P4754, DOI 10.1073/pnas.89.10.4754; WU S, 1993, CANCER RES, V53, P1939; Xaus J, 2000, BLOOD, V95, P3823; Yde P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-115; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	95	42	43	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78887	10.1371/journal.pone.0078887	http://dx.doi.org/10.1371/journal.pone.0078887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24324544	Green Submitted, Green Published, gold			2022-12-25	WOS:000327221600077
J	Ghatak, S; Bogatkevich, GS; Atnelishvili, I; Akter, T; Feghali-Bostwick, C; Hoffman, S; Fresco, VM; Fuchs, JC; Visconti, RP; Markwald, RR; Padhye, SB; Silver, RM; Hascall, VC; Misra, S				Ghatak, Shibnath; Bogatkevich, Galina S.; Atnelishvili, Ilia; Akter, Tanjina; Feghali-Bostwick, Carol; Hoffman, Stanley; Fresco, Victor M.; Fuchs, John C.; Visconti, Richard P.; Markwald, Roger R.; Padhye, Subhas B.; Silver, Richard M.; Hascall, Vincent C.; Misra, Suniti			Overexpression of c-Met and CD44v6 Receptors Contributes to Autocrine TGF-beta 1 Signaling in Interstitial Lung Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cd44; Collagen; Fibroblast; Pulmonary Fibrosis; Transforming Growth Factor beta (TGFbeta)	HEPATOCYTE GROWTH-FACTOR; SCLERODERMA DERMAL FIBROBLASTS; BRONCHOALVEOLAR LAVAGE FLUID; CONSTITUTIVELY REGULATES ACTIVATION; PROGRESSIVE SYSTEMIC-SCLEROSIS; FACTOR-BETA; GENE-EXPRESSION; PHOSPHOINOSITIDE 3-KINASE; COLORECTAL-CANCER; HYALURONIC-ACID	Background: CD44v6 and c-Met contribute to TGF-1 signaling in interstitial lung disease (ILD). Results: CD44v6/TGF-1 signaling regulates activation of ILD fibroblasts, whereas the HGF/Met pathway down-regulates the activation. Conclusion: Overexpression of HGF in ILD fibroblasts sustains the TGF-1-regulated CD44v6 expression that promotes collagen synthesis. Physiological concentrations of HGF are insufficient to influence its antifibrotic effect in these cells. Significance: These results should provide CD44v6 as new drug target to treat ILD. The hepatocyte growth factor (HGF) and the HGF receptor Met pathway are important in the pathogenesis of interstitial lung disease (ILD). Alternatively spliced isoforms of CD44 containing variable exon 6 (CD44v6) and its ligand hyaluronan (HA) alter cellular function in response to interaction between CD44v6 and HGF. TGF-1 is the crucial cytokine that induces fibrotic action in ILD fibroblasts (ILDFbs). We have identified an autocrine TGF-1 signaling that up-regulates both Met and CD44v6 mRNA and protein expression. Western blot analysis, flow cytometry, and immunostaining revealed that CD44v6 and Met colocalize in fibroblasts and in tissue sections from ILD patients and in lungs of bleomycin-treated mice. Interestingly, cell proliferation induced by TGF-1 is mediated through Met and CD44v6. Further, cell proliferation mediated by TGF-1/CD44v6 is ERK-dependent. In contrast, action of Met on ILDFb proliferation does not require ERK but does require p38(MAPK). ILDFbs were sorted into CD44v6(+)/Met(+) and CD44v6(-)/Met(+) subpopulations. HGF inhibited TGF-1-stimulated collagen-1 and -smooth muscle cell actin expression in both of these subpopulations by interfering with TGF-1 signaling. HGF alone markedly stimulated CD44v6 expression, which in turn regulated collagen-1 synthesis. Our data with primary lung fibroblast cultures with respect to collagen-1, CD44v6, and Met expressions were supported by immunostaining of lung sections from bleomycin-treated mice and from ILD patients. These results define the relationships between CD44v6, Met, and autocrine TGF-1 signaling and the potential modulating influence of HGF on TGF-1-induced CD44v6-dependent fibroblast function in ILD fibrosis.	[Ghatak, Shibnath; Fresco, Victor M.; Fuchs, John C.; Visconti, Richard P.; Markwald, Roger R.; Misra, Suniti] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Bogatkevich, Galina S.; Atnelishvili, Ilia; Akter, Tanjina; Feghali-Bostwick, Carol; Hoffman, Stanley; Silver, Richard M.] Med Univ S Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA; [Padhye, Subhas B.] Univ Pune, Abeda Inamdar Coll, Interdisciplinary Sci & Technol Res Acad, Pune 411001, Maharashtra, India; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn ND20, Cleveland, OH 44195 USA	Medical University of South Carolina; Medical University of South Carolina; Savitribai Phule Pune University; Cleveland Clinic Foundation	Ghatak, S (corresponding author), Med Univ S Carolina, Dept Regenerat Med & Cell Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	ghatak@musc.edu; misra@musc.edu	Visconti, Richard/AAY-3360-2020		Multidisciplinary Clinical Research Center [39919];  [1R03CA167722-01A1];  [P20RR021949];  [P20RR016434];  [P20RR16461-05];  [RO1-HL033756-24];  [P01HL107147];  [1P30AR050953];  [EPS 0903795]; NATIONAL CANCER INSTITUTE [R03CA167722] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062, TL1TR000061] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021949, P20RR016461, P20RR016434] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033756, P01HL107147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050953] Funding Source: NIH RePORTER	Multidisciplinary Clinical Research Center; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by 1R03CA167722-01A1 (to S. M. and S. G.); P20RR021949 (to S. G.), P20RR016434 (to S. M., S. G., and R. R. M.), P20RR16461-05 (to S. G. and R. R. M), RO1-HL033756-24 (to S. M., S. G., and R. R. M.), P01HL107147 and 1P30AR050953 (to V. C. H.), EPS 0903795 (to S. M.), and Multidisciplinary Clinical Research Center 39919 (to S. G. and S. M.).	Acharya PS, 2008, J CELL SCI, V121, P1393, DOI 10.1242/jcs.021683; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; BJERMER L, 1987, BRIT MED J, V295, P803, DOI 10.1136/bmj.295.6602.803; Bogatkevich GS, 2007, ARTHRITIS RHEUM-US, V56, P3468, DOI 10.1002/art.22874; Bogatkevich GS, 2007, ARTHRITIS RHEUM-US, V56, P2432, DOI 10.1002/art.22713; Cheng CH, 2006, GENE DEV, V20, P1715, DOI 10.1101/gad.1430906; Dai CS, 2004, J AM SOC NEPHROL, V15, P2637, DOI 10.1097/01.ASN.0000139479.09658.EE; Dai CS, 2004, J AM SOC NEPHROL, V15, P1402, DOI 10.1097/01.ASN.0000130568.53923.FD; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; FLOEGE J, 1993, KIDNEY INT, V43, pS47; Forbes SJ, 2004, GASTROENTEROLOGY, V126, P955, DOI 10.1053/j.gastro.2004.02.025; Foster LC, 1998, J BIOL CHEM, V273, P20341, DOI 10.1074/jbc.273.32.20341; Freitas JP, 1996, DERMATOLOGY, V192, P46, DOI 10.1159/000246314; Ghatak S, 2010, J BIOL CHEM, V285, P19821, DOI 10.1074/jbc.M110.104273; Ghatak S, 2008, CONNECT TISSUE RES, V49, P265, DOI 10.1080/03008200802147845; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; GOHDA E, 1992, CELL BIOL INT REP, V16, P917, DOI 10.1016/S0309-1651(06)80171-2; Han DC, 2000, AM J PHYSIOL-RENAL, V278, pF628, DOI 10.1152/ajprenal.2000.278.4.F628; He S, 2010, BRIT J DERMATOL, V162, P538, DOI 10.1111/j.1365-2133.2009.09511.x; HEIDER KH, 1993, J CELL BIOL, V120, P227, DOI 10.1083/jcb.120.1.227; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hsu E, 2011, ARTHRITIS RHEUM-US, V63, P783, DOI 10.1002/art.30159; Ihn H, 2001, ARTHRITIS RHEUM, V44, P474, DOI 10.1002/1529-0131(200102)44:2<474::AID-ANR67>3.3.CO;2-R; Inoue T, 2002, FASEB J, V16, P268, DOI 10.1096/fj.02-0442fje; Ishida T, 2000, SURG TODAY, V30, P28, DOI 10.1007/PL00010042; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jinnin M, 2006, BIOCHEM BIOPH RES CO, V343, P904, DOI 10.1016/j.bbrc.2006.03.037; Jinnin M, 2005, NUCLEIC ACIDS RES, V33, P3540, DOI 10.1093/nar/gki648; Jinnin M, 2005, J INVEST DERMATOL, V124, P324, DOI 10.1111/j.0022-202X.2004.23601.x; Kajihara I, 2012, BIOSCI TRENDS, V6, P136, DOI 10.5582/bst.2012.v6.3.136; Kawaguchi Y, 1999, J RHEUMATOL, V26, P1012; Kawaguchi Y, 2002, J RHEUMATOL, V29, P1877; KIKUCHI K, 1992, BIOCHEM BIOPH RES CO, V187, P45, DOI 10.1016/S0006-291X(05)81456-1; Lama Vibha N, 2006, Proc Am Thorac Soc, V3, P373, DOI 10.1513/pats.200512-133TK; Laprise P, 2004, J CELL PHYSIOL, V199, P32, DOI 10.1002/jcp.10432; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; LEVESQUE H, 1991, BRIT J DERMATOL, V124, P423; Lewington AJP, 2000, AM J PHYSIOL-REG I, V278, pR247, DOI 10.1152/ajpregu.2000.278.1.R247; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; MAEDA J, 1995, AM J RESP CRIT CARE, V152, P1587, DOI 10.1164/ajrccm.152.5.7582299; Matsumoto K, 2001, KIDNEY INT, V59, P2023, DOI 10.1046/j.1523-1755.2001.00717.x; Matsumoto K, 2000, CURR OPIN NEPHROL HY, V9, P395, DOI 10.1097/00041552-200007000-00011; MATSUMOTO K, 1992, J BIOL CHEM, V267, P24917; Misra S, 1999, P NATL ACAD SCI USA, V96, P5814, DOI 10.1073/pnas.96.10.5814; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Misra S, 1998, J BIOL CHEM, V273, P26638, DOI 10.1074/jbc.273.41.26638; Misra S, 2008, CONNECT TISSUE RES, V49, P219, DOI 10.1080/03008200802143356; Misra S, 2008, J BIOL CHEM, V283, P14335, DOI 10.1074/jbc.M703811200; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Misra S, 2013, BIOORGAN MED CHEM, V21, P2551, DOI 10.1016/j.bmc.2013.02.033; Misra S, 2011, FEBS J, V278, P1429, DOI 10.1111/j.1742-4658.2011.08071.x; Misra S, 2009, J BIOL CHEM, V284, P12432, DOI 10.1074/jbc.M806772200; MIYAKE K, 1990, J EXP MED, V172, P69, DOI 10.1084/jem.172.1.69; MIYAZAWA K, 1994, J BIOL CHEM, V269, P8966; Mizuno S, 2004, AM J PHYSIOL-RENAL, V286, pF134, DOI 10.1152/ajprenal.00199.2003; Mizuno S, 2001, KIDNEY INT, V59, P1304, DOI 10.1046/j.1523-1755.2001.0590041304.x; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Mucsi I, 1996, J BIOL CHEM, V271, P16567, DOI 10.1074/jbc.271.28.16567; Nakano N, 1998, HYPERTENSION, V32, P444, DOI 10.1161/01.HYP.32.3.444; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; Neumayer R, 1999, DIS COLON RECTUM, V42, P50, DOI 10.1007/BF02235182; Ono I, 2004, J SURG RES, V120, P47, DOI 10.1016/j.jss.2003.08.242; Ono K, 1997, CIRCULATION, V95, P2552, DOI 10.1161/01.CIR.95.11.2552; Phan SH, 2003, AM J RESP CELL MOL, V29, pS87; Sano N, 2001, NEPHRON, V89, P416, DOI 10.1159/000046113; Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002; Shukla MN, 2009, AM J RESP CELL MOL, V40, P643, DOI 10.1165/rcmb.2008-0217OC; Stern JB, 2000, CRIT CARE MED, V28, P2326, DOI 10.1097/00003246-200007000-00024; STERZEL RB, 1993, KIDNEY INT, V43, pS26; Takada S, 1996, TRANSPLANT INT, V9, P151, DOI 10.1007/BF00336393; Tokunou M, 2001, AM J PATHOL, V158, P1451, DOI 10.1016/S0002-9440(10)64096-5; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Ware LB, 2002, AM J PHYSIOL-LUNG C, V282, pL924, DOI 10.1152/ajplung.00439.2001; Wielenga VJM, 1998, SCAND J GASTROENTERO, V33, P82; WIELENGA VJM, 1993, CANCER RES, V53, P4754; Wielenga VJM, 2000, ADV CANCER RES, V77, P169; Yamada Y, 2004, CLIN EXP METASTAS, V21, P57, DOI 10.1023/B:CLIN.0000017203.71293.e0; Yamanouchi H, 1998, RESP MED, V92, P273, DOI 10.1016/S0954-6111(98)90108-1; YANAGITA K, 1992, BIOCHEM BIOPH RES CO, V182, P802, DOI 10.1016/0006-291X(92)91803-X; Yang JW, 2003, AM J PATHOL, V163, P621, DOI 10.1016/S0002-9440(10)63689-9; Yang JW, 2002, J AM SOC NEPHROL, V13, P96, DOI 10.1681/ASN.V13196; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097	87	31	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7856	7872		10.1074/jbc.M113.505065	http://dx.doi.org/10.1074/jbc.M113.505065			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24324260	Green Published, hybrid			2022-12-25	WOS:000332761500051
J	Crane, JD; Abadi, A; Hettinga, BP; Ogborn, DI; MacNeil, LG; Steinberg, GR; Tarnopolsky, MA				Crane, Justin D.; Abadi, Arkan; Hettinga, Bart P.; Ogborn, Daniel I.; MacNeil, Lauren G.; Steinberg, Gregory R.; Tarnopolsky, Mark A.			Elevated Mitochondrial Oxidative Stress Impairs Metabolic Adaptations to Exercise in Skeletal Muscle	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-A; SUPEROXIDE-DISMUTASE; COMPLEX II; LIFE-SPAN; DNA; ANTIOXIDANT; DAMAGE; REDUCTION; NEURODEGENERATION; OVEREXPRESSION	Mitochondrial oxidative stress is a complex phenomenon that is inherently tied to energy provision and is implicated in many metabolic disorders. Exercise training increases mitochondrial oxidative capacity in skeletal muscle yet it remains unclear if oxidative stress plays a role in regulating these adaptations. We demonstrate that the chronic elevation in mitochondrial oxidative stress present in Sod2(+/-) mice impairs the functional and biochemical mitochondrial adaptations to exercise. Following exercise training Sod2(+/-) mice fail to increase maximal work capacity, mitochondrial enzyme activity and mtDNA copy number, despite a normal augmentation of mitochondrial proteins. Additionally, exercised Sod2(+/-) mice cannot compensate for their higher amount of basal mitochondrial oxidative damage and exhibit poor electron transport chain complex assembly that accounts for their compromised adaptation. Overall, these results demonstrate that chronic skeletal muscle mitochondrial oxidative stress does not impact exercise induced mitochondrial biogenesis, but impairs the resulting mitochondrial protein function and can limit metabolic plasticity.	[Crane, Justin D.; Tarnopolsky, Mark A.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Crane, Justin D.; Abadi, Arkan; Hettinga, Bart P.; MacNeil, Lauren G.; Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Ogborn, Daniel I.] McMaster Univ, Dept Med Sci, Hamilton, ON, Canada; [Steinberg, Gregory R.; Tarnopolsky, Mark A.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University	Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	tarnopol@mcmaster.ca		Crane, Justin/0000-0002-5380-5676; Steinberg, Gregory/0000-0001-5425-8275	National Sciences and Engineering Research Council (NSERC) of Canada	National Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from the National Sciences and Engineering Research Council (NSERC) of Canada to M. Tarnopolsky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barja G, 1999, J BIOENERG BIOMEMBR, V31, P347, DOI 10.1023/A:1005427919188; Barreiro E, 2009, THORAX, V64, P13, DOI 10.1136/thx.2008.105163; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Boyle KE, 2013, J CLIN ENDOCR METAB, V98, pE1601, DOI 10.1210/jc.2013-1943; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Canugovi C, 2010, DNA REPAIR, V9, P1080, DOI 10.1016/j.dnarep.2010.07.009; Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101; Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Gomez-Cabrera MC, 2008, AM J CLIN NUTR, V87, P142, DOI 10.1093/ajcn/87.1.142; Gutteridge JMC, 2010, BIOCHEM BIOPH RES CO, V393, P561, DOI 10.1016/j.bbrc.2010.02.071; Higashida K, 2011, AM J PHYSIOL-ENDOC M, V301, pE779, DOI 10.1152/ajpendo.00655.2010; Ho YS, 1998, J BIOL CHEM, V273, P7765, DOI 10.1074/jbc.273.13.7765; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Ji LL, 2008, FREE RADICAL BIO MED, V44, P142, DOI 10.1016/j.freeradbiomed.2007.02.031; Kang D, 2005, ANN NY ACAD SCI, V1042, P101, DOI 10.1196/annals.1338.010; Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495; Larsen S, 2011, DIABETOLOGIA, V54, P1427, DOI 10.1007/s00125-011-2098-4; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Lee S, 2009, AGING CELL, V8, P296, DOI 10.1111/j.1474-9726.2009.00477.x; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; McKenzie S, 2000, AM J PHYSIOL-ENDOC M, V278, pE580, DOI 10.1152/ajpendo.2000.278.4.E580; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Ogborn DI, 2012, CAN J NEUROL SCI, V39, P225, DOI 10.1017/S0317167100013275; Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024; Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002; Perez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Puente-Maestu L, 2012, AM J RESP CELL MOL, V47, P358, DOI 10.1165/rcmb.2011-0382OC; Puente-Maestu L, 2011, THORAX, V66, P121, DOI 10.1136/thx.2010.153031; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Quinlivan EP, 2008, ANAL BIOCHEM, V373, P383, DOI 10.1016/j.ab.2007.09.031; Radak Z, 2008, FREE RADICAL BIO MED, V44, P153, DOI 10.1016/j.freeradbiomed.2007.01.029; Ran Q, 2007, J GERONTOL A-BIOL, V62, P932, DOI 10.1093/gerona/62.9.932; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Safdar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010778; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; Van Remmen H, 1999, ARCH BIOCHEM BIOPHYS, V363, P91, DOI 10.1006/abbi.1998.1060; Walker RB, 2009, J AGR FOOD CHEM, V57, P1156, DOI 10.1021/jf8026765; Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com; Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510; Yoshida Y, 2002, BIOCHEM BIOPH RES CO, V295, P945, DOI 10.1016/S0006-291X(02)00757-X; Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132	51	17	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81879	10.1371/journal.pone.0081879	http://dx.doi.org/10.1371/journal.pone.0081879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324727	Green Submitted, gold, Green Published			2022-12-25	WOS:000328566700053
J	Friis, H; Range, N; Changalucha, J; PrayGod, G; Jeremiah, K; Faurholt-Jepsen, D; Krarup, H; Molgaard, C; Andersen, AB				Friis, Henrik; Range, Nyagosya; Changalucha, John; PrayGod, George; Jeremiah, Kidola; Faurholt-Jepsen, Daniel; Krarup, Henrik; Molgaard, Christian; Andersen, Ase Bengaard			Vitamin D Status among Pulmonary TB Patients and Non-TB Controls: A Cross-Sectional Study from Mwanza, Tanzania	PLOS ONE			English	Article							BODY-COMPOSITION; TUBERCULOSIS PATIENTS; HIV-INFECTION; 25-HYDROXYVITAMIN-D; DISEASE; SEX	Background: Little is known about vitamin D status in low-income populations burdened with infectious diseases. Hence, there is a need for data on correlates of serum 25-hydroxy vitamin D (S-25(OH)D) and its validity during infections. Objective: To assess the role of pulmonary TB (PTB) and HIV as correlates of S-25(OH)D. Design: Age-sex-matched cross-sectional study among PTB patients and non-TB controls. Methods: PTB patients were categorized as sputum negative (PTB-) and positive (PTB+) by culture. Non-TB controls were randomly selected among age-sex-matched neighbours to PTB+ patients. Height, weight, arm circumference and triceps skinfold were measured, and body mass index (BMI), arm fat (AFA) and muscle area (AMA) computed. HIV status, and S-25(OH)D, C-reactive protein (S-CRP) and alpha(1)-acid glycoprotein (S-AGP) were determined. Linear regression analysis with controls and PTB patients combined was used to identify correlates of S-25(OH)D. Results: S-25(OH)D data were available on 97.8% (1570) of 1605 participants. Mean (SD) S-25(OH)D was 84.4 (25.6) nmol/L with 39.6% <75 nmol/L among 347 non-TB controls. Time of recruitment, sex, PTB and HIV, and elevated S-AGP were correlates of S-25(OH)D. S-25(OH)D was 24.8 (95% CI 18.6; 30.9) nmol/L higher in PTB compared to controls among females, but only 9.8 (95% CI: 4.5; 15.2) nmol/L among males (interaction p<0.0001). Females had 13.8 (95% CI: 8.2; 21.9) nmol/L lower S-25(OH)D than males, and HIV infected individuals had 8.5 (95% CI: 4.9; 12.1) higher S-25(OH)D compared to uninfected. Elevated S-AGP was a positive correlate of S-25(OH)D. Low BMI was associated with S-25(OH)D, but not with infections or SAGP in the model. Conclusion: While S-25(OH)D may decline transiently during a mild acute phase response, it may increase if the acute phase response leads to loss of fat. The validity of S-25(OH)D as a marker of vitamin D status may be affected by infections.	[Friis, Henrik; Faurholt-Jepsen, Daniel; Molgaard, Christian] Univ Copenhagen, Dept Nutr Sports & Exercise, Frederiksberg, Denmark; [Range, Nyagosya] Muhimbili Med Res Ctr, Natl Inst Med Res, Dar Es Salaam, Tanzania; [Changalucha, John; PrayGod, George; Jeremiah, Kidola] NIMR, Mwanza Med Res Ctr, Natl Inst Med Res, Mwanza, Tanzania; [Krarup, Henrik] Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark; [Andersen, Ase Bengaard] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark	University of Copenhagen; National Institute of Medical Research; National Institute of Medical Research; Aalborg University; Aalborg University Hospital; University of Southern Denmark; Odense University Hospital	Friis, H (corresponding author), Univ Copenhagen, Dept Nutr Sports & Exercise, Frederiksberg, Denmark.	hfr@life.ku.dk	Friis, Henrik/P-2891-2019; Faurholt-Jepsen, Daniel/D-9453-2012; Mølgaard, Christian/D-2052-2014; Friis, Henrik/N-2047-2014; Faurholt-Jepsen, Daniel/M-6324-2019; PrayGod, George/L-7098-2018	Friis, Henrik/0000-0002-2848-2940; Faurholt-Jepsen, Daniel/0000-0001-8561-0155; Mølgaard, Christian/0000-0002-5311-9457; Friis, Henrik/0000-0002-2848-2940; Faurholt-Jepsen, Daniel/0000-0001-8561-0155; Jeremiah, Kidola/0000-0001-7900-9689; PrayGod, George/0000-0002-0329-4839; Krarup, Henrik/0000-0001-5294-2428	Danish Council for Independent Research - Medical Sciences [22-04-0404]; Danida through the Consultative Research Committee for Development Research [104.Dan.8-898]	Danish Council for Independent Research - Medical Sciences(Det Frie Forskningsrad (DFF)); Danida through the Consultative Research Committee for Development Research	Supported by the Danish Council for Independent Research - Medical Sciences (grant 22-04-0404), by Danida through the Consultative Research Committee for Development Research (104.Dan.8-898.). The funding bodies had no role in the study design, data collection, data analysis, data interpretation, or decision to publish the findings.	[Anonymous], 2003, TREATMENT TUBERCULOS; [Anonymous], 2006, MANUAL NATL TUBERCUL; [Anonymous], 2003, MANUAL NATL TUBERCUL; [Anonymous], 2005, NATL GUIDELINES CLIN; [Anonymous], 1999, OPERATIONAL CHARACTE; BRODIE MJ, 1982, CLIN PHARMACOL THER, V32, P525, DOI 10.1038/clpt.1982.197; Durup D, 2012, J CLIN ENDOCRINOLOGY; Fischer PR, 2008, REV ENDOCR METAB DIS, V9, P181, DOI 10.1007/s11154-008-9085-1; Friis H, 2001, AM J CLIN NUTR, V73, P1058; Friis H, 2008, J NUTR, V138, P2474, DOI 10.3945/jn.108.094979; Friis Henrik, 2009, Afr J Reprod Health, V13, P61; Frisancho AR, 1990, ANTHROPOMETRIC STAND; GITHUI W, 1993, E AFR MED J, V70, P263; Hewison M, 2010, ENDOCRIN METAB CLIN, V39, P365, DOI 10.1016/j.ecl.2010.02.010; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Kotler DP, 1999, AM J CLIN NUTR, V69, P432; Kouda K, NUTRITION; Lee HA, 2013, J PEDIATR ENDOCR MET, V26, P849, DOI 10.1515/jpem-2012-0416; LOUW JA, 1992, CRIT CARE MED, V20, P934, DOI 10.1097/00003246-199207000-00007; Martineau AR, 2012, P NUTR SOC, V71, P84, DOI 10.1017/S0029665111003326; Mayhood MK, 2008, J CLIN MICROBIOL, V46, P3946, DOI 10.1128/JCM.01045-08; Mupere E, 2010, ANN EPIDEMIOL, V20, P210, DOI 10.1016/j.annepidem.2009.11.001; Newens K, 2006, T ROY SOC TROP MED H, V100, P41, DOI 10.1016/j.trstmh.2005.06.022; Nielsen NO, 2010, BRIT J NUTR, V104, P1487, DOI 10.1017/S0007114510002333; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; POLBERGER SKT, 1990, ACTA PAEDIATR SCAND, V79, P729, DOI 10.1111/j.1651-2227.1990.tb11547.x; Reid D, 2011, AM J CLIN NUTR, V93, P1006, DOI 10.3945/ajcn.110.008490; Rockett KA, 1998, INFECT IMMUN, V66, P5314, DOI 10.1128/IAI.66.11.5314-5321.1998; Sly LM, 2001, J BIOL CHEM, V276, P35482, DOI 10.1074/jbc.M102876200; Sulistyoningrum DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043159; Swaminathan S, 2008, CLIN INFECT DIS, V46, P946, DOI 10.1086/528860; Thurnham D. I., 2011, Sight and Life Magazine, V25, P38; Visnegarwala F, 2005, AM J CLIN NUTR, V82, P850; Wagner D, 2009, CLIN BIOCHEM, V42, P1549, DOI 10.1016/j.clinbiochem.2009.07.013; Wejse C, 2007, AM J CLIN NUTR, V86, P1376, DOI 10.1093/ajcn/86.5.1376	35	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81142	10.1371/journal.pone.0081142	http://dx.doi.org/10.1371/journal.pone.0081142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324666	Green Published, gold, Green Submitted			2022-12-25	WOS:000328566700030
J	Arlt, D; Low, M; Part, T				Arlt, Debora; Low, Matthew; Part, Tomas			Effect of Geolocators on Migration and Subsequent Breeding Performance of a Long-Distance Passerine Migrant	PLOS ONE			English	Article							RADIO TRANSMITTERS; SONGBIRD MIGRATION; ANNUAL CYCLE; MOVEMENTS; OENANTHE; BEHAVIOR; LOGGERS; ROUTES; BIRDS	Geolocators are small light-weight data loggers used to track individual migratory routes, and their use has increased exponentially in birds. However, the effects of geolocators on individual performance are still poorly known. We studied geolocator effects on a long-distance migrating passerine bird, the northern wheatear (Oenanthe oenanthe L.). We asked the general question of whether geolocators affect migratory behaviour and subsequent reproductive performance of small passerines by comparing arrival time, breeding time, breeding success and survival of geolocator versus control birds of known identity and breeding history. During two years geolocator birds (n=37) displayed a lower apparent survival (30%) as compared to controls (45%, n=164). Furthermore, returning geolocator birds (n=12) arrived on average 3.5 days later, started laying eggs 6.3 days later, and had lower nest success (25%) than control birds (78%). Our results suggest that geolocators affect migratory performance with carry-over effects to the timing of breeding and reproductive success in the subsequent breeding season. We discuss the implications of such geolocator effects for the study of migratory strategies of small passerines in general and suggest how to identify and investigate such effects in the future.	[Arlt, Debora; Low, Matthew; Part, Tomas] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Swedish University of Agricultural Sciences	Arlt, D (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	debora.arlt@slu.se		Part, Tomas/0000-0001-7388-6672; Low, Matthew/0000-0002-7345-6063	Swedish Research Council VR [621-2011-5608, A0698901]; FORMAS [2008-547]; Helge Ax:son Johnson's Foundation	Swedish Research Council VR(Swedish Research Council); FORMAS(Swedish Research Council Formas); Helge Ax:son Johnson's Foundation	This study was supported by the Swedish Research Council VR (http://www.vr.se/, 621-2011-5608 to TP, A0698901 to DA), FORMAS (http://www.formas.se/, 2008-547 to ML), and Helge Ax:son Johnson's Foundation (http://www.haxsonj.se/, to DA) provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2009, NEW ZEAL J ZOOL, V36, P355, DOI 10.1080/03014220909510160; Alerstam T, 2011, J ORNITHOL, V152, P5, DOI 10.1007/s10336-011-0694-1; Arlt D, 2008, AM NAT, V171, P844, DOI 10.1086/587521; Arlt D, 2008, J ANIM ECOL, V77, P211, DOI 10.1111/j.1365-2656.2007.01329.x; Arlt D, 2007, ECOLOGY, V88, P792, DOI 10.1890/06-0574; Arlt D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003006; Bairlein F, 2012, BIOL LETTERS, V8, P505, DOI 10.1098/rsbl.2011.1223; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Barron DG, 2010, METHODS ECOL EVOL, V1, P180, DOI 10.1111/j.2041-210X.2010.00013.x; Bowlin MS, 2010, METHODS ECOL EVOL, V1, P398, DOI 10.1111/j.2041-210X.2010.00043.x; Bridge ES, 2013, J FIELD ORNITHOL, V84, P121, DOI 10.1111/jofo.12011; Catry I, 2011, IBIS, V153, P154, DOI 10.1111/j.1474-919X.2010.01073.x; Cramp S., 1988, BIRDS W PALEARCTIC, V5; Delmore KE, 2012, P ROY SOC B-BIOL SCI, V279, P4582, DOI 10.1098/rspb.2012.1229; DELONG RL, 1992, MAR MAMMAL SCI, V8, P155, DOI 10.1111/j.1748-7692.1992.tb00375.x; Dierschke V, 2005, BEHAV ECOL SOCIOBIOL, V57, P470, DOI 10.1007/s00265-004-0872-8; DRENT RH, 1980, ARDEA, V68, P225; Elliott KH, 2012, MAR ECOL PROG SER, V466, P1, DOI 10.3354/meps09975; Faaborg J, 2010, ECOL APPL, V20, P398, DOI 10.1890/09-0397.1; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; GESSAMAN JA, 1988, CONDOR, V90, P662, DOI 10.2307/1368356; Gomez J, 2014, J ORNITHOL, V155, P37, DOI 10.1007/s10336-013-0984-x; Greenberg R., 2005, BIRDS 2 WORLDS ECOLO; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; Irvine RJ, 2007, WILDLIFE BIOL, V13, P238, DOI 10.2981/0909-6396(2007)13[238:COCRTA]2.0.CO;2; Lisovski S, 2012, METHODS ECOL EVOL, V3, P603, DOI 10.1111/j.2041-210X.2012.00185.x; Low M, 2010, J ANIM ECOL, V79, P214, DOI 10.1111/j.1365-2656.2009.01595.x; Metcalfe JD, 1997, NATURE, V387, P665, DOI 10.1038/42622; Naef-Daenzer Beat, 2001, Avian Science, V1, P15; Part T, 2001, ANIM BEHAV, V62, P379, DOI 10.1006/anbe.2001.1754; Pennycuick CJ, 2012, J ORNITHOL, V153, P633, DOI 10.1007/s10336-011-0781-3; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; Phillips RA, 2007, MAR ECOL PROG SER, V345, P281, DOI 10.3354/meps06991; Plummer M., 2003, P 3 INT WORKSH DISTR; Quillfeldt P, 2012, MAR BIOL, V159, P1809, DOI 10.1007/s00227-012-1971-0; R Development Core Team, 2011, R LANG ENV STAT COMP; Rae LF, 2009, J FIELD ORNITHOL, V80, P419, DOI 10.1111/j.1557-9263.2009.00249.x; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Robinson WD, 2010, FRONT ECOL ENVIRON, V8, P354, DOI 10.1890/080179; Rodriguez A, 2009, J FIELD ORNITHOL, V80, P399, DOI 10.1111/j.1557-9263.2009.00247.x; Ryder TB, 2011, AUK, V128, P448, DOI 10.1525/auk.2011.11091; Schmaljohann H, 2012, ANIM BEHAV, V84, P623, DOI 10.1016/j.anbehav.2012.06.018; Schmaljohann H, 2012, BEHAV ECOL SOCIOBIOL, V66, P915, DOI 10.1007/s00265-012-1340-5; Seavy NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034886; Stach Robert, 2013, Animal Migration, V1, P1, DOI 10.2478/ami-2012-0001; Stanley CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040688; Stutchbury BJM, 2011, P ROY SOC B-BIOL SCI, V278, P131, DOI 10.1098/rspb.2010.1220; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Tarka M., 2012, THESIS LUND U; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Wildlife telemetry fr: SD Schemnitz, 1980, WILDLIFE MANAGEMENT, V4a, p5O7; Williams T., 2012, PHYSL ADAPTATIONS BR	53	45	48	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82316	10.1371/journal.pone.0082316	http://dx.doi.org/10.1371/journal.pone.0082316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324770	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300140
J	Lian, SL; Potula, HHSK; Pillai, MR; Van Stry, M; Koyanagi, M; Chung, LD; Watanabe, M; Bix, M				Lian, Shangli; Potula, Hari Hara S. K.; Pillai, Meenu R.; Van Stry, Melanie; Koyanagi, Madoka; Chung, Linda; Watanabe, Makiko; Bix, Mark			Transcriptional Activation of Mina by Sp1/3 Factors	PLOS ONE			English	Article							MYC TARGET GENE; SQUAMOUS-CELL CARCINOMA; MEDIATED INDUCTION; EXPRESSION; BINDING; PROMOTER; CANCER; PROTEINS; FAMILY; SIGNALS	Mina is an epigenetic gene regulatory protein known to function in multiple physiological and pathological contexts, including pulmonary inflammation, cell proliferation, cancer and immunity. We showed previously that the level of Mina gene expression is subject to natural genetic variation linked to 21 SNPs occurring in the Mina 59 region [1]. In order to explore the mechanisms regulating Mina gene expression, we set out to molecularly characterize the Mina promoter in the region encompassing these SNPs. We used three kinds of assays - reporter, gel shift and chromatin immunoprecipitation to analyze a 2 kb genomic fragment spanning the upstream and intron 1 regions flanking exon 1. Here we discovered a pair of Mina promoters (P1 and P2) and a P1-specific enhancer element (E1). Pharmacologic inhibition and siRNA knockdown experiments suggested that Sp1/3 transcription factors trigger Mina expression through additive activity targeted to a cluster of four Sp1/3 binding sites forming the P1 promoter. These results set the stage for comprehensive analysis of Mina gene regulation from the context of tissue specificity, the impact of inherited genetic variation and the nature of upstream signaling pathways.	[Lian, Shangli; Potula, Hari Hara S. K.; Pillai, Meenu R.; Van Stry, Melanie; Koyanagi, Madoka; Chung, Linda; Watanabe, Makiko; Bix, Mark] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Bix, M (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	mark.bix@stjude.org		Bix, Mark/0000-0003-4617-0497; Van Stry, Melanie/0000-0002-4722-2407	American Lebanese Syrian Associated Charities; National Institutes of Health [R56AI048636-06A2, R21AI083982-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI048636, R21AI083982] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by American Lebanese Syrian Associated Charities and National Institutes of Health grants R56AI048636-06A2 and R21AI083982-02 to Mark Bix. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI N, 1992, PHARMACOL THERAPEUT, V55, P303, DOI 10.1016/0163-7258(92)90054-4; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Brightbill HD, 2000, J IMMUNOL, V164, P1940, DOI 10.4049/jimmunol.164.4.1940; Chen GY, 2006, P NATL ACAD SCI USA, V103, P16894, DOI 10.1073/pnas.0607926103; Dorado B, 2006, MOL IMMUNOL, V43, P1808, DOI 10.1016/j.molimm.2005.10.016; Dzialo-Hatton R, 2001, J IMMUNOL, V166, P4534, DOI 10.4049/jimmunol.166.7.4534; EMILI A, 1994, MOL CELL BIOL, V14, P1582, DOI 10.1128/MCB.14.3.1582; Fukahori S, 2007, J PEDIATR SURG, V42, P1831, DOI 10.1016/j.jpedsurg.2007.07.008; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; Hummelshoj T, 2006, MOL IMMUNOL, V43, P980, DOI 10.1016/j.molimm.2005.05.012; Ishizaki H, 2007, PATHOL INT, V57, P672, DOI 10.1111/j.1440-1827.2007.02156.x; Komiya K, 2010, LUNG CANCER, V69, P232, DOI 10.1016/j.lungcan.2009.10.010; Komiya K, 2010, J CANCER RES CLIN, V136, P465, DOI 10.1007/s00432-009-0679-0; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kumar AP, 1999, CANCER LETT, V137, P159, DOI 10.1016/S0304-3835(98)00351-6; Kuratomi Kettaro, 2006, Kurume Medical Journal, V53, P71, DOI 10.2739/kurumemedj.53.71; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; Ogasawara S, 2010, HEPATOL RES, V40, P330, DOI 10.1111/j.1872-034X.2009.00604.x; Okamoto M, 2009, NAT IMMUNOL, V10, P872, DOI 10.1038/ni.1747; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Teye K, 2004, AM J PATHOL, V164, P205, DOI 10.1016/S0002-9440(10)63111-2; Teye K, 2007, ONCOL REP, V18, P841; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Tone M, 2000, J IMMUNOL, V165, P286, DOI 10.4049/jimmunol.165.1.286; Tone Y, 2007, J IMMUNOL, V179, P1760, DOI 10.4049/jimmunol.179.3.1760; Tsuneoka M, 2004, CLIN CANCER RES, V10, P7347, DOI 10.1158/1078-0432.CCR-03-0543; Tsuneoka M, 2002, J BIOL CHEM, V277, P35450, DOI 10.1074/jbc.M204458200; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Xin ZT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021333; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zhang Q, 2008, INT J BIOL MARKER, V23, P83, DOI 10.1177/172460080802300204; Zhang YD, 2005, ONCOGENE, V24, P4873, DOI 10.1038/sj.onc.1208668	38	12	12	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80638	10.1371/journal.pone.0080638	http://dx.doi.org/10.1371/journal.pone.0080638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324617	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300035
J	McBride, DW; Rodgers, VGJ				McBride, Devin W.; Rodgers, Victor G. J.			Predicting the Activity Coefficients of Free-Solvent for Concentrated Globular Protein Solutions Using Independently Determined Physical Parameters	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; OSMOTIC-PRESSURE; HYDRATION; BINDING; MODEL; SUCROSE; PROGRAM; SALTS	The activity coefficient is largely considered an empirical parameter that was traditionally introduced to correct the non-ideality observed in thermodynamic systems such as osmotic pressure. Here, the activity coefficient of free-solvent is related to physically realistic parameters and a mathematical expression is developed to directly predict the activity coefficients of free-solvent, for aqueous protein solutions up to near-saturation concentrations. The model is based on the free-solvent model, which has previously been shown to provide excellent prediction of the osmotic pressure of concentrated and crowded globular proteins in aqueous solutions up to near-saturation concentrations. Thus, this model uses only the independently determined, physically realizable quantities: mole fraction, solvent accessible surface area, and ion binding, in its prediction. Predictions are presented for the activity coefficients of free-solvent for near-saturated protein solutions containing either bovine serum albumin or hemoglobin. As a verification step, the predictability of the model for the activity coefficient of sucrose solutions was evaluated. The predicted activity coefficients of free-solvent are compared to the calculated activity coefficients of free-solvent based on osmotic pressure data. It is observed that the predicted activity coefficients are increasingly dependent on the solute-solvent parameters as the protein concentration increases to near-saturation concentrations.	[McBride, Devin W.; Rodgers, Victor G. J.] Univ Calif Riverside, Dept Bioengn, Ctr Bioengn Res, Grp Biotransport & Bioreact Kinet Grp B2K, Riverside, CA 92521 USA	University of California System; University of California Riverside	Rodgers, VGJ (corresponding author), Univ Calif Riverside, Dept Bioengn, Ctr Bioengn Res, Grp Biotransport & Bioreact Kinet Grp B2K, Riverside, CA 92521 USA.	vrodgers@engr.ucr.edu	McBride, Devin/A-7214-2013; Rodgers, Victor G/G-3652-2016; Rodgers, Victor G. J./AAF-3838-2021	McBride, Devin/0000-0001-8988-3353; Rodgers, Victor G/0000-0002-1857-8025; Rodgers, Victor G. J./0000-0002-1857-8025	National Science Foundation (NSF) IGERT Video Bioinformatics Training Grant; NSF IGERT Video Bioinformatics Fellowship [DGE 0903667]	National Science Foundation (NSF) IGERT Video Bioinformatics Training Grant(National Science Foundation (NSF)); NSF IGERT Video Bioinformatics Fellowship(National Science Foundation (NSF))	Devin W. McBride was supported by the National Science Foundation (NSF) IGERT Video Bioinformatics Training Grant and was supported by an NSF IGERT Video Bioinformatics Fellowship (grant number DGE 0903667). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bujacz A, 2012, ACTA CRYSTALLOGR D, V68, P1278, DOI 10.1107/S0907444912027047; BULL HB, 1968, ARCH BIOCHEM BIOPHYS, V128, P488, DOI 10.1016/0003-9861(68)90055-6; CARR CW, 1955, P SOC EXP BIOL MED, V89, P546, DOI 10.3181/00379727-89-21870; CARR CW, 1952, ARCH BIOCHEM BIOPHYS, V40, P286, DOI 10.1016/0003-9861(52)90113-6; CARR CW, 1953, ARCH BIOCHEM BIOPHYS, V43, P147, DOI 10.1016/0003-9861(53)90094-0; De Rosa MC, 2004, BIOCHEM J, V380, P889, DOI 10.1042/BJ20031421; DICK DAT, 1967, PHYS BASES CIRCULATO, P217; Einstein A, 1956, INVESTIGATIONS THEOR; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Frazer JCW, 1916, J AM CHEM SOC, V38, P1907, DOI 10.1021/ja02267a001; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Majorek KA, 2012, MOL IMMUNOL, V52, P174, DOI 10.1016/j.molimm.2012.05.011; McBride DW, 2012, AICHE J, V58, P1012, DOI 10.1002/aic.12648; McBride DW, 2013, FURTHER UNDERSTANDIN; McBride DW, 2013, J APPL MATH UNPUB; MINTON AP, 1983, MOL CELL BIOCHEM, V55, P119, DOI 10.1007/BF00673707; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Neelagandan K, 2007, ACTA CRYSTALLOGR F, V63, P887, DOI 10.1107/S1744309107044296; Pedretti A, 2002, J MOL GRAPH MODEL, V21, P47, DOI 10.1016/S1093-3263(02)00123-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; REBOIRAS MD, 1978, BIOPHYS CHEM, V9, P37, DOI 10.1016/0301-4622(78)87013-6; REBOIRAS MD, 1986, BIOPHYS CHEM, V24, P249, DOI 10.1016/0301-4622(86)85030-X; SCATCHARD G, 1950, J AM CHEM SOC, V72, P535, DOI 10.1021/ja01157a138; Scatchard G, 1921, J AM CHEM SOC, V43, P2406, DOI 10.1021/ja01444a013; SCATCHARD G, 1957, J AM CHEM SOC, V79, P12, DOI 10.1021/ja01558a003; SEDYKH L. G., 1967, BIOFIZIKA, V12, P936; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; van Laar JJ, 1894, Z PHYS CHEM, V15, P457; VILKER VL, 1981, J COLLOID INTERF SCI, V79, P548, DOI 10.1016/0021-9797(81)90106-5; Yousef MA, 2002, AICHE J, V48, P1301, DOI 10.1002/aic.690480616; Yousef MA, 2002, AICHE J, V48, P913, DOI 10.1002/aic.690480426; Yousef MA, 1998, J COLLOID INTERF SCI, V197, P108, DOI 10.1006/jcis.1997.5262; Yousef MA, 2001, J COLLOID INTERF SCI, V243, P321, DOI 10.1006/jcis.2001.7918; Yousef MA, 1998, J COLLOID INTERF SCI, V207, P273, DOI 10.1006/jcis.1998.5789	37	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81933	10.1371/journal.pone.0081933	http://dx.doi.org/10.1371/journal.pone.0081933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324733	Green Published, gold			2022-12-25	WOS:000327949300116
J	Silva, PHD; Paul, NA; de Nys, R; Mata, L				Silva, Pedro H. de Paula; Paul, Nicholas A.; de Nys, Rocky; Mata, Leonardo			Enhanced Production of Green Tide Algal Biomass through Additional Carbon Supply	PLOS ONE			English	Article							MACROALGAE ENTEROMORPHA-PROLIFERA; INORGANIC CARBON; PHOTOSYNTHETIC PROPERTIES; CONCENTRATING MECHANISMS; BICARBONATE UTILIZATION; SEAWEED CULTIVATION; GRACILARIA SP; GROWTH; CO2; NITROGEN	Intensive algal cultivation usually requires a high flux of dissolved inorganic carbon (Ci) to support productivity, particularly for high density algal cultures. Carbon dioxide (CO2) enrichment can be used to overcome Ci limitation and enhance productivity of algae in intensive culture, however, it is unclear whether algal species with the ability to utilise bicarbonate (HCO3-) as a carbon source for photosynthesis will benefit from CO2 enrichment. This study quantified the HCO3- affinity of three green tide algal species, Cladophora coelothrix, Cladophora patentiramea and Chaetomorpha linum, targeted for biomass and bioenergy production. Subsequently, we quantified productivity and carbon, nitrogen and ash content in response to CO2 enrichment. All three species had similar high pH compensation points (9.7-9.9), and grew at similar rates up to pH 9, demonstrating HCO3- utilization. Algal cultures enriched with CO2 as a carbon source had 30% more total Ci available, supplying twenty five times more CO2 than the control. This higher Ci significantly enhanced the productivity of Cladophora coelothrix (26%), Chaetomorpha linum (24%) and to a lesser extent for Cladophora patentiramea (11%), compared to controls. We demonstrated that supplying carbon as CO2 can enhance the productivity of targeted green tide algal species under intensive culture, despite their clear ability to utilise HCO3-	[Silva, Pedro H. de Paula] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Silva, PHD (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	pedro.depaulasilva@my.jcu.edu.au	Paul, Nicholas/B-6496-2009; de Nys, Rocky/D-6741-2012; Mata, Leonardo/D-6733-2012	de Nys, Rocky/0000-0003-3869-4928; Mata, Leonardo/0000-0002-5962-2483; Paul, Nicholas/0000-0002-9275-1535	Advanced Manufacturing Cooperative Research Centre (AMCRC); Australian Government's Cooperative Research Centre Scheme; Australian Government through the Australian Renewable Energy Agency; AMCRC PhD Scholarship	Advanced Manufacturing Cooperative Research Centre (AMCRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centre Scheme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government through the Australian Renewable Energy Agency(Australian Renewable Energy Agency (ARENA)); AMCRC PhD Scholarship(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research is part of the MBD Energy Research and Development program for Biological Carbon Capture and Storage. The project is supported by the Advanced Manufacturing Cooperative Research Centre (AMCRC), funded through the Australian Government's Cooperative Research Centre Scheme. This project is also supported by the Australian Government through the Australian Renewable Energy Agency. Pedro de Paula Silva was supported by an AMCRC PhD Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andria JR, 1999, EUR J PHYCOL, V34, P497, DOI 10.1017/S0967026299002334; Aresta M, 2005, FUEL PROCESS TECHNOL, V86, P1679, DOI 10.1016/j.fuproc.2005.01.016; Axelsson L, 1999, PLANT CELL ENVIRON, V22, P969, DOI 10.1046/j.1365-3040.1999.00470.x; AXELSSON L, 1995, PLANT CELL ENVIRON, V18, P439, DOI 10.1111/j.1365-3040.1995.tb00378.x; BADGER MR, 1994, ANNU REV PLANT PHYS, V45, P369, DOI 10.1146/annurev.pp.45.060194.002101; BEER S, 1994, J PHYCOL, V30, P633, DOI 10.1111/j.0022-3646.1994.00633.x; BIDWELL RGS, 1985, J EXP MAR BIOL ECOL, V86, P15, DOI 10.1016/0022-0981(85)90040-1; Bird MI, 2012, GCB BIOENERGY, V4, P61, DOI 10.1111/j.1757-1707.2011.01109.x; Bird MI, 2011, BIORESOURCE TECHNOL, V102, P1886, DOI 10.1016/j.biortech.2010.07.106; Bruhn A, 2011, BIORESOURCE TECHNOL, V102, P2595, DOI 10.1016/j.biortech.2010.10.010; Choo KS, 2005, MAR ECOL PROG SER, V292, P127, DOI 10.3354/meps292127; Choo KS, 2002, J PHYCOL, V38, P493, DOI 10.1046/j.1529-8817.2002.t01-1-01083.x; Demetropoulos CL, 2004, AQUACULTURE, V235, P457, DOI 10.1016/j.aquaculture.2003.09.011; GAO K, 1993, J APPL PHYCOL, V5, P563, DOI 10.1007/BF02184635; GAO K, 1991, J APPL PHYCOL, V3, P355, DOI 10.1007/BF00026098; GARCIASANCHEZ MJ, 1994, PLANTA, V194, P55; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Gordillo FJL, 2001, PLANTA, V213, P64, DOI 10.1007/s004250000468; Hurd CL, 2000, J PHYCOL, V36, P453, DOI 10.1046/j.1529-8817.2000.99139.x; Israel A, 2005, AQUACULTURE, V249, P311, DOI 10.1016/j.aquaculture.2005.04.058; Israel A, 2002, GLOBAL CHANGE BIOL, V8, P831, DOI 10.1046/j.1365-2486.2002.00518.x; Israel A, 1999, J APPL PHYCOL, V11, P447, DOI 10.1023/A:1008122306268; Kubler JE, 1999, PLANT CELL ENVIRON, V22, P1303, DOI 10.1046/j.1365-3040.1999.00492.x; Larsson C, 1999, EUR J PHYCOL, V34, P79, DOI 10.1017/S0967026299001936; Lewis E., 1998, ORNLCDIAC105 US DEP; Lobban C.S., 1994, SEAWEED ECOLOGY PHYS; MABERLY SC, 1992, PLANT CELL ENVIRON, V15, P255, DOI 10.1111/j.1365-3040.1992.tb01480.x; MABERLY SC, 1990, J PHYCOL, V26, P439, DOI 10.1111/j.0022-3646.1990.00439.x; Mata L, 2007, J PHYCOL, V43, P1252, DOI 10.1111/j.1529-8817.2007.00421.x; Mata L, 2012, J PHYCOL, V48, P248, DOI 10.1111/j.1529-8817.2011.01083.x; Mercado JM, 1999, J APPL PHYCOL, V11, P455, DOI 10.1023/A:1008194223558; Migliore G, 2012, BIOMASS BIOENERG, V42, P69, DOI 10.1016/j.biombioe.2012.03.030; Murru M, 2004, J PHYCOL, V40, P837, DOI 10.1111/j.1529-8817.2004.03182.x; Neori A, 2008, J APPL PHYCOL, V20, P567, DOI 10.1007/s10811-007-9206-3; Pierri C, 2006, AQUAC RES, V37, P966, DOI 10.1111/j.1365-2109.2006.01512.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Raven J. A., 2003, WATER AIR SOIL POLL, V3, P7, DOI DOI 10.1023/A:1022167722654; Raven JA, 2008, PHILOS T R SOC B, V363, P2641, DOI 10.1098/rstb.2008.0020; RIVERS JS, 1995, MAR BIOL, V121, P747, DOI 10.1007/BF00349311; RIVERS JS, 1995, J PHYCOL, V31, P223, DOI 10.1111/j.0022-3646.1995.00223.x; Robertson-Andersson D, 2008, J APPL PHYCOL, V20, P579, DOI 10.1007/s10811-007-9239-7; Ross AB, 2008, BIORESOURCE TECHNOL, V99, P6494, DOI 10.1016/j.biortech.2007.11.036; RYTHER JH, 1962, CAN J MICROBIOL, V8, P437, DOI 10.1139/m62-057; Saunders RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036470; Silva PHD, 2012, AQUACULT ENV INTERAC, V2, P253, DOI 10.3354/aei00043; Silva PHD, 2008, AQUACULTURE, V284, P74, DOI 10.1016/j.aquaculture.2008.07.035; Taylor R, 2001, BOT MAR, V44, P327, DOI 10.1515/BOT.2001.042; Tsagkamilis P, 2010, J APPL PHYCOL, V22, P331, DOI 10.1007/s10811-009-9463-4; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Yanagisawa M, 2011, PROCESS BIOCHEM, V46, P2111, DOI 10.1016/j.procbio.2011.08.001; Zhou D, 2012, ENERG FUEL, V26, P2342, DOI 10.1021/ef201966w; Zhou D, 2010, ENERG FUEL, V24, P4054, DOI 10.1021/ef100151h; Zou DH, 2005, AQUACULTURE, V250, P726, DOI 10.1016/j.aquaculture.2005.05.014	53	13	14	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81164	10.1371/journal.pone.0081164	http://dx.doi.org/10.1371/journal.pone.0081164			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324672	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000327949300075
J	Szatkowski, C; Vallet, J; Dormishian, M; Messaddeq, N; Valet, P; Boulberdaa, M; Metzger, D; Chambon, P; Nebigil, CG				Szatkowski, Cecilia; Vallet, Judith; Dormishian, Mojdeh; Messaddeq, Nadia; Valet, Phillippe; Boulberdaa, Mounia; Metzger, Daniel; Chambon, Pierre; Nebigil, Canan G.			Prokineticin Receptor 1 as a Novel Suppressor of Preadipocyte Proliferation and Differentiation to Control Obesity	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ADIPOCYTE DIFFERENTIATION; OLFACTORY-BULB; CELL; MICE; BV8; ANGIOGENESIS; FAT; IDENTIFICATION; ADIPOGENESIS	Background: Adipocyte renewal from preadipocytes occurs throughout the lifetime and contributes to obesity. To date, little is known about the mechanisms that control preadipocyte proliferation and differentiation. Prokineticin-2 is an angiogenic and anorexigenic hormone that activate two G protein-coupled receptors (GPCRs): PKR1 and PKR2. Prokineticin-2 regulates food intake and energy metabolism via central mechanisms (PKR2). The peripheral effect of prokineticin-2 on adipocytes/preadipocytes has not been studied yet. Methodology/Principal Findings: Since adipocytes and preadipocytes express mainly prokineticin receptor-1 (PKR1), here, we explored the role of PKR1 in adipose tissue expansion, generating PKR1-null (PKR-/-) and adipocyte-specific (PKR-/-) mutant mice, and using murine and human preadipocyte cell lines. Both PKR1(-/-) and PKR1(ad-/-) had excessive abdominal adipose tissue, but only PKR1(-/-) mice showed severe obesity and diabetes-like syndrome. PKR1(ad-/-)) mice had increased proliferating preadipocytes and newly formed adipocyte levels, leading to expansion of adipose tissue. Using PKR1-knockdown in 3T3-L1 preadipocytes, we show that PKR1 directly inhibits preadipocyte proliferation and differentiation. These PKR1 cell autonomous actions appear targeted at preadipocyte cell cycle regulatory pathways, through reducing cyclin D, E, cdk2, c-Myc levels. Conclusions/Significance: These results suggest PKR1 to be a crucial player in the preadipocyte proliferation and differentiation. Our data should facilitate studies of both the pathogenesis and therapy of obesity in humans.	[Szatkowski, Cecilia; Vallet, Judith; Dormishian, Mojdeh; Boulberdaa, Mounia; Nebigil, Canan G.] Univ Strasbourg, Inst Res & Biotechnol Strasbourg, Ctr Natl Rech Sci, Medalis Labex,Drug Discovery Ctr,UMR7242, Illkirch Graffenstaden, France; [Metzger, Daniel; Chambon, Pierre] Univ Strasbourg, Inst Natl Sante & Rech Med U964, Ctr Natl Rech Sci UMR7104, Inst Genet & Mol & Cellular Biol, Illkirch Graffenstaden, France; [Valet, Phillippe] Univ Toulouse 3, INSERM, Inst Cardiovasc & Metab Dis, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Nebigil, CG (corresponding author), Univ Strasbourg, Inst Res & Biotechnol Strasbourg, Ctr Natl Rech Sci, Medalis Labex,Drug Discovery Ctr,UMR7242, Illkirch Graffenstaden, France.	nebigil@unistra.fr	Nebigil, Canan/AAK-7162-2021; Valet, Philippe/N-7472-2017	Nebigil, Canan/0000-0002-2035-5795; Valet, Philippe/0000-0001-6520-7393; Metzger, Daniel/0000-0002-5555-046X	Centre National de la Recherche Scientifique; Fondation Recherche Medical; l'Association francaise contre les myopathies; Medalis/labex and Region Alsace	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Fondation Recherche Medical; l'Association francaise contre les myopathies(Association Francaise contre les Myopathies); Medalis/labex and Region Alsace(Region Grand-Est)	This work was supported by Centre National de la Recherche Scientifique, Fondation Recherche Medical, l'Association francaise contre les myopathies, Medalis/labex and Region Alsace. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artemenko Y, 2005, J CELL PHYSIOL, V204, P646, DOI 10.1002/jcp.20314; Beale KEL, 2013, BRIT J PHARMACOL, V168, P403, DOI 10.1111/j.1476-5381.2012.02191.x; Beale KE, 2013, BR J PHARM; Bhattacharyya S, 2011, DIABETOLOGIA; Boulberdaa M, 2011, ARTERIOSCL THROM VAS, V31, P842, DOI 10.1161/ATVBAHA.110.222323; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Cawthorn WP, 2012, TRENDS ENDOCRIN MET, V23, P270, DOI 10.1016/j.tem.2012.01.003; Chandler EM, 2012, P NATL ACAD SCI USA, V109, P9786, DOI 10.1073/pnas.1121160109; Chazenbalk G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017834; Denison FC, 2008, ENDOCRINOLOGY, V149, P3470, DOI 10.1210/en.2007-1695; Dorsch M, 2005, J LEUKOCYTE BIOL, V78, P426, DOI 10.1189/jlb.0205061; Drolet R, 2008, INT J OBESITY, V32, P283, DOI 10.1038/sj.ijo.0803708; Farag YMK, 2011, NEPHROL DIAL TRANSPL, V26, P28, DOI 10.1093/ndt/gfq576; Fujiwara K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030948; Gardiner JV, 2010, DIABETES, V59, P397, DOI 10.2337/db09-1198; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Guilini C, 2010, AM J PHYSIOL-HEART C, V298, pH844, DOI 10.1152/ajpheart.00898.2009; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Jethwa PH, 2008, AM J PHYSIOL-REG I, V294, pR1968, DOI 10.1152/ajpregu.00778.2007; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Kasahara Y, 2007, BIOSCI BIOTECH BIOCH, V71, P3122, DOI 10.1271/bbb.70498; KIRKLAND JL, 1990, AM J PHYSIOL, V258, pC206, DOI 10.1152/ajpcell.1990.258.2.C206; KRIEGERBRAUER HI, 1995, BIOCHEM J, V307, P543, DOI 10.1042/bj3070543; Lane MD, 2005, BIRTH DEFECTS RES A, V73, P476, DOI 10.1002/bdra.20150; LeCouter J, 2004, P NATL ACAD SCI USA, V101, P16813, DOI 10.1073/pnas.0407697101; LeCouter J, 2003, P NATL ACAD SCI USA, V100, P2685, DOI 10.1073/pnas.0337667100; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; Lee JS, 2008, DIFFERENTIATION, V76, P478, DOI 10.1111/j.1432-0436.2007.00250.x; Lee KY, 2013, DIABETES, V62, P864, DOI 10.2337/db12-1089; Masuda Y, 2002, BIOCHEM BIOPH RES CO, V293, P396, DOI 10.1016/S0006-291X(02)00239-5; Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103; Ng KL, 2005, SCIENCE, V308, P1923, DOI 10.1126/science.1112103; Ngan ESW, 2006, ENDOCRINOLOGY, V147, P88, DOI 10.1210/en.2005-0543; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; Rigamonti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017637; Rockman HA, 2011, CIRC RES, V109, P202, DOI 10.1161/CIRCRESAHA.110.231126; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Suwa A, 2011, FEBS J, V278, P565, DOI 10.1111/j.1742-4658.2010.07980.x; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Urayama K, 2008, ARTERIOSCL THROM VAS, V28, P841, DOI 10.1161/ATVBAHA.108.162404; Urayama K, 2007, FASEB J, V21, P2980, DOI 10.1096/fj.07-8116com; Wang Y, 2005, J BIOL CHEM, V280, P34764, DOI 10.1074/jbc.M507058200; Xie Y, 2006, DIABETES OBES METAB, V8, P83, DOI 10.1111/j.1463-1326.2005.00472.x; Zhong CL, 2009, CLIN CANCER RES, V15, P2675, DOI 10.1158/1078-0432.CCR-08-1954	50	34	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81175	10.1371/journal.pone.0081175	http://dx.doi.org/10.1371/journal.pone.0081175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324673	Green Submitted, Green Published, gold			2022-12-25	WOS:000327949300076
J	Westhoff, JH; Giselbrecht, S; Schmidts, M; Schindler, S; Beales, PL; Tonshoff, B; Liebel, U; Gehrig, J				Westhoff, Jens H.; Giselbrecht, Stefan; Schmidts, Miriam; Schindler, Sebastian; Beales, Philip L.; Toenshoff, Burkhard; Liebel, Urban; Gehrig, Jochen			Development of an Automated Imaging Pipeline for the Analysis of the Zebrafish Larval Kidney	PLOS ONE			English	Article							INTRAFLAGELLAR TRANSPORT PROTEIN; CONVERTING ENZYME-INHIBITORS; NEPHROTOXICITY; ACETAMINOPHEN; EXPOSURE; SYSTEM; GENES; DRUGS; GENTAMICIN; MICROSCOPY	The analysis of kidney malformation caused by environmental influences during nephrogenesis or by hereditary nephropathies requires animal models allowing the in vivo observation of developmental processes. The zebrafish has emerged as a useful model system for the analysis of vertebrate organ development and function, and it is suitable for the identification of organotoxic or disease-modulating compounds on a larger scale. However, to fully exploit its potential in high content screening applications, dedicated protocols are required allowing the consistent visualization of inner organs such as the embryonic kidney. To this end, we developed a high content screening compatible pipeline for the automated imaging of standardized views of the developing pronephros in zebrafish larvae. Using a custom designed tool, cavities were generated in agarose coated microtiter plates allowing for accurate positioning and orientation of zebrafish larvae. This enabled the subsequent automated acquisition of stable and consistent dorsal views of pronephric kidneys. The established pipeline was applied in a pilot screen for the analysis of the impact of potentially nephrotoxic drugs on zebrafish pronephros development in the Tg(wt1b: EGFP) transgenic line in which the developing pronephros is highlighted by GFP expression. The consistent image data that was acquired allowed for quantification of gross morphological pronephric phenotypes, revealing concentration dependent effects of several compounds on nephrogenesis. In addition, applicability of the imaging pipeline was further confirmed in a morpholino based model for cilia-associated human genetic disorders associated with different intraflagellar transport genes. The developed tools and pipeline can be used to study various aspects in zebrafish kidney research, and can be readily adapted for the analysis of other organ systems.	[Westhoff, Jens H.; Schindler, Sebastian; Toenshoff, Burkhard] Heidelberg Univ, Univ Childrens Hosp, Dept Pediat 1, Heidelberg, Germany; [Giselbrecht, Stefan] Karlsruhe Inst Technol, Inst Biol Interfaces, Eggenstein Leopoldshafen, Germany; [Schmidts, Miriam; Beales, Philip L.] UCL, Birth Defects Res Ctr, Mol Med Unit, Inst Child Hlth, London, England; [Liebel, Urban] Karlsruhe Inst Technol, Inst Appl Comp Sci, Eggenstein Leopoldshafen, Germany; [Gehrig, Jochen] Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany; [Liebel, Urban; Gehrig, Jochen] Karlsruhe Inst Technol, Innovat Dept, Accelerator Lab, Eggenstein Leopoldshafen, Germany	Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Karlsruhe Institute of Technology; University of London; University College London; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Westhoff, JH (corresponding author), Heidelberg Univ, Univ Childrens Hosp, Dept Pediat 1, Heidelberg, Germany.	jens.westhoff@med.uni-heidelberg.de; urban.liebel@kit.edun; jochen.gehrig@kit.edu	Schmidts, Miriam/A-3777-2012; Giselbrecht, Stefan/H-2174-2013; Westhoff, Jens H./AAO-7185-2021; Beales, Philip L/C-7367-2009	Schmidts, Miriam/0000-0002-1714-6749; Giselbrecht, Stefan/0000-0002-1354-0167; Gehrig, Jochen/0000-0002-1193-1324	European Commission [223744, 305608, 241955]; Stiftung Landesbank Baden-Wurttemberg; Dutch Kidney foundation [CP11.18]; Innovation Department, Karlsruhe Institute of Technology (KIT), Germany; Action Medical Research UK clinical training fellowship [RTF-1411]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Karlsruhe Institute of Technology	European Commission(European CommissionEuropean Commission Joint Research Centre); Stiftung Landesbank Baden-Wurttemberg; Dutch Kidney foundation; Innovation Department, Karlsruhe Institute of Technology (KIT), Germany; Action Medical Research UK clinical training fellowship; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Karlsruhe Institute of Technology	This project was supported by the European Commission Seventh Framework Programme funded projects DOPAMINET (http://www.dopaminet.eu/; grant no. 223744) and Eurenomics (http://www.eurenomics.eu/; grant no. 305608) to UL, and SYSCILIA (http://www.syscilia.org/; grant no. 241955) to PLB, the Stiftung Landesbank Baden-Wurttemberg to JHW, the Dutch Kidney foundation (CP11.18) to PLB and MS and institutional funding from Innovation Department, Karlsruhe Institute of Technology (KIT), Germany. MS was funded by an Action Medical Research UK clinical training fellowship (RTF-1411) and PLB is a Wellcome Trust Senior Research Fellow. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Cao Y, 2009, P NATL ACAD SCI USA, V106, P21819, DOI 10.1073/pnas.0911987106; Coleman CM, 2007, AM J PHYSIOL-RENAL, V293, pF262, DOI 10.1152/ajprenal.00071.2007; d'Alencon CA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-151; De Vigan C, 1999, J CLIN EPIDEMIOL, V52, P977, DOI 10.1016/S0895-4356(99)00091-8; de Vries J, 2010, EUR J PEDIATR, V169, P77, DOI 10.1007/s00431-009-0991-3; Drukker Alfred, 2002, Paediatr Child Health, V7, P538; Drummond IA, 2005, J AM SOC NEPHROL, V16, P299, DOI 10.1681/ASN.2004090754; Drummond IA, 2010, METHOD CELL BIOL, V100, P233, DOI 10.1016/B978-0-12-384892-5.00009-8; Ebarasi L, 2011, CURR OPIN NEPHROL HY, V20, P416, DOI 10.1097/MNH.0b013e3283477797; Evensen L, 2010, CURR PHARM DESIGN, V16, P3958, DOI 10.2174/138161210794455030; FRIBERG P, 1994, KIDNEY INT, V45, P485, DOI 10.1038/ki.1994.63; Friedland-Little JM, 2011, HUM MOL GENET, V20, P3725, DOI 10.1093/hmg/ddr241; Hentschel DM, 2005, AM J PHYSIOL-RENAL, V288, pF923, DOI 10.1152/ajprenal.00386.2004; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; Kent AL, 2007, PEDIATR RES, V62, P307, DOI 10.1203/PDR.0b013e318123f6e3; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knudsen TB, 2011, BIRTH DEFECTS RES B, V92, P413, DOI 10.1002/bdrb.20315; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Koren G, 1998, NEW ENGL J MED, V338, P1128, DOI 10.1056/NEJM199804163381607; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Lessman CA, 2011, BIRTH DEFECTS RES C, V93, P268, DOI 10.1002/bdrc.20212; Liebel U, 2003, FEBS LETT, V554, P394, DOI 10.1016/S0014-5793(03)01197-9; Loria A, 2007, AM J PHYSIOL-REG I, V293, pR695, DOI 10.1152/ajpregu.00191.2007; Lunt SC, 2009, DEV DYNAM, V238, P1744, DOI 10.1002/dvdy.21999; Martinez-Salgado C, 2007, TOXICOL APPL PHARM, V223, P86, DOI 10.1016/j.taap.2007.05.004; Martinovic J, 2001, LANCET, V358, P241, DOI 10.1016/S0140-6736(01)05426-5; McCollum CW, 2011, BIRTH DEFECTS RES C, V93, P67, DOI 10.1002/bdrc.20210; McWilliam SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043809; Mylonas I, 2011, ARCH GYNECOL OBSTET, V283, P7, DOI 10.1007/s00404-010-1646-3; Neto J Andalaft, 2004, Clin Exp Obstet Gynecol, V31, P221; North TE, 2010, P NATL ACAD SCI USA, V107, P17315, DOI 10.1073/pnas.1008209107; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Pardo-Martin C, 2010, NAT METHODS, V7, P634, DOI [10.1038/NMETH.1481, 10.1038/nmeth.1481]; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Peng HC, 2010, COMP BIOCHEM PHYS C, V151, P480, DOI 10.1016/j.cbpc.2010.02.004; Pepperkok R, 2006, NAT REV MOL CELL BIO, V7, P690, DOI 10.1038/nrm1979; Peravali R, 2011, BIOTECHNIQUES, V50, P319, DOI 10.2144/000113669; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; PRYDE PG, 1993, J AM SOC NEPHROL, V3, P1575; Quan A, 2006, EARLY HUM DEV, V82, P23, DOI 10.1016/j.earlhumdev.2005.11.001; RAO SC, 2011, COCHRANE DB SYST REV, P5091; Rider SA, 2012, J PHYSIOL-LONDON, V590, P1803, DOI 10.1113/jphysiol.2011.224352; Rihel J, 2012, DEV NEUROBIOL, V72, P373, DOI 10.1002/dneu.20910; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sabaliauskas NA, 2006, METHODS, V39, P246, DOI 10.1016/j.ymeth.2006.03.001; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Shrim A, 2005, CAN FAM PHYSICIAN, V51, P1335; Sukumaran S, 2009, VISION RES, V49, P479, DOI 10.1016/j.visres.2008.12.009; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Swedlow JR, 2002, CELL STRUCT FUNCT, V27, P335, DOI 10.1247/csf.27.335; Sweileh WM, 2009, FUND CLIN PHARMACOL, V23, P515, DOI 10.1111/j.1472-8206.2009.00702.x; Tan JL, 2011, METHOD CELL BIOL, V105, P493, DOI 10.1016/B978-0-12-381320-6.00021-7; US Department of Health and Human Services, 2006, NIH PUBLICATION; Vogt A, 2009, DEV DYNAM, V238, P656, DOI 10.1002/dvdy.21892; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yang LX, 2009, REPROD TOXICOL, V28, P245, DOI 10.1016/j.reprotox.2009.04.013; Zaffanello M, 2010, J MATERN-FETAL NEO M, V23, P87, DOI 10.3109/14767058.2010.501156; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	61	33	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82137	10.1371/journal.pone.0082137	http://dx.doi.org/10.1371/journal.pone.0082137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324758	Green Submitted, Green Published, gold			2022-12-25	WOS:000327949300133
J	Nguyen, TD; Shingu, Y; Schwarzer, M; Schrepper, A; Doenst, T				Dung Nguyen, T.; Shingu, Yasushige; Schwarzer, Michael; Schrepper, Andrea; Doenst, Torsten			The E-Wave Deceleration Rate E/DT Outperforms the Tissue Doppler-Derived Index E/e ' in Characterizing Lung Remodeling in Heart Failure with Preserved Ejection Fraction	PLOS ONE			English	Article							INTRACARDIAC FILLING PRESSURE; EUROPEAN-ASSOCIATION; DIASTOLIC FUNCTION; AMERICAN-SOCIETY; PULMONARY-HYPERTENSION; DECOMPENSATED PATIENTS; ECHOCARDIOGRAPHY; GUIDELINES; RECOMMENDATIONS; PREVALENCE	Background: Diastolic dysfunction in heart failure with preserved ejection fraction (HFpEF) may result in pulmonary congestion and lung remodeling. We evaluated the usefulness of major diastolic echocardiographic parameters and of the deceleration rate of early transmitral diastolic velocity (E/DT) in predicting lung remodeling in a rat model of HFpEF. Methods and Results: Rats underwent aortic banding (AoB) to induce pressure overload (PO). Left ventricular hypertrophy fully developed 2 weeks after AoB. At 4 and 6 weeks, the lung weight-to-body weight ratio (LW/BW), a sensitive marker for pulmonary congestion and remodeling, dramatically increased despite preserved fractional shortening, indicating the presence of HFpEF. The time course of LW/BW was well reflected by E/DT, by the ratio of early to late transmitral diastolic velocity (E/A) and the deceleration time of E (DT), but not by the ratio of transmitral to mitral annular early diastolic velocity (E/e'). In agreement, the best correlation with LW/BW was found for E/DT (r = 0.76; p<.0001), followed by E/A (r = 0.69; p<0.0001), DT (r = 20.62; p<0.0001) and finally E/e' (r = 0.51; p<0.001). Furthermore, analysis of receiver-operating characteristic curves for the prediction of increased LW/BW revealed excellent area under the curve values for E/DT (AUC = 0.98) and DT (AUC = 0.95), which are significantly higher than that of E/e' (AUC = 0.82). In a second approach, we also found that the new parameter E/DT correlated well with right ventricular weight index and echocardiographic measures of right ventricular systolic function. Conclusions: The novel parameter E/DT outperforms the tissue Doppler index E/e' in detecting and monitoring lung remodeling induced by pressure overload. The results may provide a handy tool to point towards secondary lung disease in HFpEF and warrant further clinical investigations.	[Dung Nguyen, T.; Schwarzer, Michael; Schrepper, Andrea; Doenst, Torsten] Univ Jena, Jena Univ Hosp, Dept Cardiothorac Surg, Jena, Germany; [Shingu, Yasushige] Hokkaido Univ, Sch Med, Dept Cardiovasc Surg, Sapporo, Hokkaido 060, Japan	Friedrich Schiller University of Jena; Hokkaido University	Doenst, T (corresponding author), Univ Jena, Jena Univ Hosp, Dept Cardiothorac Surg, Jena, Germany.	doenst@med.uni-jena.de	Schwarzer, Michael/E-4438-2013; Shingu, Yasushige/E-1939-2012	Shingu, Yasushige/0000-0001-8471-5166; Nguyen, Tien Dung/0000-0001-9347-1511	Deutsche Forschungsgemeinschaft (DFG) [DO 602/8-1, DO 602/9-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by grants of the Deutsche Forschungsgemeinschaft (DFG) to TD. (DO 602/8-1 and 9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YJ, 2012, HYPERTENSION, V59, P1170, DOI 10.1161/HYPERTENSIONAHA.111.186072; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dokainish H, 2011, EUR J ECHOCARDIOGR, V12, P857, DOI 10.1093/ejechocard/jer157; Fang JC, 2012, J HEART LUNG TRANSPL, V31, P913, DOI 10.1016/j.healun.2012.06.002; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Hogg K, 2004, J AM COLL CARDIOL, V43, P317, DOI 10.1016/j.jacc.2003.07.046; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Little WC, 2001, EUR HEART J, V22, P1961, DOI 10.1053/euhj.2001.2665; Little WC, 2009, CIRCULATION, V120, P802, DOI 10.1161/CIRCULATIONAHA.109.869602; Mishra RK, 2007, J AM SOC ECHOCARDIOG, V20, P1300, DOI 10.1016/j.echo.2007.03.008; Mullens W, 2009, CIRCULATION, V119, P62, DOI 10.1161/CIRCULATIONAHA.108.779223; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Nagueh SF, 2009, CIRCULATION, V120, pE44, DOI 10.1161/CIRCULATIONAHA.109.856187; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Pozzoli M, 1996, J AM COLL CARDIOL, V27, P883, DOI 10.1016/0735-1097(95)00553-6; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Solomon SD, 2009, CIRCULATION, V119, P13, DOI 10.1161/CIRCULATIONAHA.108.823591; Steinberg BA, 2012, CIRCULATION, V126, P65, DOI 10.1161/CIRCULATIONAHA.111.080770; Tribouilloy C, 2008, EUR HEART J, V29, P339, DOI 10.1093/eurheartj/ehm554; Udelson JE, 2011, CIRCULATION, V124, pE540, DOI 10.1161/CIRCULATIONAHA.111.071696; Zaha V, 2003, THORAC CARDIOV SURG, V51, P211	22	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82077	10.1371/journal.pone.0082077	http://dx.doi.org/10.1371/journal.pone.0082077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312628	gold, Green Published, Green Submitted			2022-12-25	WOS:000327947800080
J	Ghoubay-Benallaoua, D; Sandali, O; Goldschmidt, P; Borderie, V				Ghoubay-Benallaoua, Djida; Sandali, Otman; Goldschmidt, Pablo; Borderie, Vincent			Kinetics of Expansion of Human Limbal Epithelial Progenitor Cells in Primary Culture of Explants Without Feeders	PLOS ONE			English	Article							SIDE-POPULATION CELLS; STEM-CELLS; OCULAR SURFACE; CORNEAL REGENERATION; AMNIOTIC MEMBRANE; SELF-RENEWAL; TRANSPLANTATION; RECONSTRUCTION; THERAPY; SERUM	The aims of this study were to determine whether human limbal explant cultures without feeder cells result in expansion of epithelial progenitors and to estimate the optimal expansion time for progenitor cells. Limbal explants from ten human corneas were cultured for 7, 9, 11, 14, 18, and 21 days. Limbal explants from two corneas were enzymatically dissociated or directly cultured for 14 days. Progenitor cells were characterized by their ability to form colonies, by immunocytochemistry, and by quantitative real-time polymerase chain reaction. Colonies were identified after 9, 11, 14, and 18 days of culture, but not after 21 days. The number of colonies per explant was significantly higher after 14 days than after 9 and 21 days. The mean percentage of seeded cells giving rise to clones was 4.03% after 14 days of culture and 0.36% for non-cultured dissociated limbal epithelial cells. The number of cells giving rise to clones per cornea significantly increased from an average of 2275 for non-cultured cells to 24266 for cells cultured for 14 days. Immunocytochemical analysis detected positive staining for cytokeratin (CK) 3, CK5/6/8/10/13/18, CK19, vimentin, p63, and p63 alpha, in both cultures and clones. CK3 expression increased significantly with culture time. Transcript expression was observed for CK3, CK19, vimentin, and Delta N p63 alpha at each culture time point, both in cultures and clones. The optimal culture time for limbal explants in cholera toxin-free Green medium without feeder cells was 14 days leading to the expansion of progenitors.	[Ghoubay-Benallaoua, Djida; Sandali, Otman; Borderie, Vincent] Univ Paris 06, INSERM, CNRS, Inst Vis,UMR S 968,U968,CHNO 15 20,UMR 7210, Paris, France; [Goldschmidt, Pablo] Lab Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France; [Borderie, Vincent] Banque Tissus, Etab Francais Sang, Site St Antoine, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Ghoubay-Benallaoua, D (corresponding author), Univ Paris 06, INSERM, CNRS, Inst Vis,UMR S 968,U968,CHNO 15 20,UMR 7210, Paris, France.	djida.ghoubay@inserm.fr	Ghoubay, Djida/AAE-3971-2022; Sandali, Otman/AFK-2642-2022; Sandali, Otman/AAF-9936-2022; Borderie, Vincent/AAT-1092-2021	Borderie, Vincent/0000-0002-1395-8483				Ang LPK, 2004, DRY EYE AND OCULAR SURFACE DISORDERS, P225; Ang LPK, 2004, INVEST OPHTH VIS SCI, V45, P1789, DOI 10.1167/iovs.03-1361; Barbaro V, 2007, J CELL BIOL, V177, P1037, DOI 10.1083/jcb.200703003; Borderie VM, 1998, BRIT J OPHTHALMOL, V82, P382, DOI 10.1136/bjo.82.4.382; Budak MT, 2005, J CELL SCI, V118, P1715, DOI 10.1242/jcs.02279; Chen SY, 2011, TISSUE ENG PART C-ME, V17, P537, DOI [10.1089/ten.TEC.2010.0609, 10.1089/ten.tec.2010.0609]; Chen YT, 2007, STEM CELLS, V25, P1995, DOI 10.1634/stemcells.2006-0677; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; CHUNG EH, 1995, INVEST OPHTH VIS SCI, V36, P1336; Daniels JT, 2007, EXPERT OPIN BIOL TH, V7, P1, DOI 10.1517/14712598.7.1.1; De Luca M, 2006, REGEN MED, V1, P45, DOI 10.2217/17460751.1.1.45; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Ghoubay-Benallaoua D, 2011, MOL VIS, V17, P341; Ghoubay-Benallaoua D, 2012, CURR EYE RES, V37, P644, DOI 10.3109/02713683.2012.669510; Grueterich M, 2002, OPHTHALMOLOGY, V109, P1547, DOI 10.1016/S0161-6420(02)01105-3; Ho TC, 2013, STEM CELLS, V31, P1775, DOI 10.1002/stem.1393; Klyce SD., 1988, CORNEA, P3; Koizumi N, 2001, OPHTHALMOLOGY, V108, P1569, DOI 10.1016/S0161-6420(01)00694-7; Li W, 2007, INVEST OPHTH VIS SCI, V48, P605, DOI 10.1167/iovs.06-0514; Liu T, 2012, INT J OPHTHALMOL-CHI, V5, P549, DOI 10.3980/j.issn.2222-3959.2012.05.02; Meyer-Blazejewska EA, 2010, INVEST OPHTH VIS SCI, V51, P765, DOI 10.1167/iovs.09-4109; Nakamura T, 2006, INVEST OPHTH VIS SCI, V47, P909, DOI 10.1167/iovs.05-1188; Nakamura T, 2004, ACTA OPHTHALMOL SCAN, V82, P468, DOI 10.1111/j.1395-3907.2004.00285.x; Pajoohesh-Ganji A, 2004, DEV DYNAM, V230, P518, DOI 10.1002/dvdy.20050; Parameswaran S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046734; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Pellegrini G, 2009, J PATHOL, V217, P217, DOI 10.1002/path.2441; Pellegrini G, 2007, SEMIN CELL DEV BIOL, V18, P805, DOI 10.1016/j.semcdb.2007.09.011; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Sangwan VS, 2003, BIOSCIENCE REP, V23, P169, DOI 10.1023/B:BIRE.0000007690.43273.73; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Seigel GM, 2003, MOL VIS, V9, P159; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shimazaki J, 2002, OPHTHALMOLOGY, V109, P1285, DOI 10.1016/S0161-6420(02)01089-8; Shortt AJ, 2007, SURV OPHTHALMOL, V52, P483, DOI 10.1016/j.survophthal.2007.06.013; Tan EK, 2011, INVEST OPHTH VIS SCI, V52, P4534, DOI 10.1167/iovs.10-6376; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; Umemoto T, 2006, STEM CELLS, V24, P86, DOI 10.1634/stemcells.2005-0064; Utheim TP, 2007, BRIT J OPHTHALMOL, V91, P797, DOI 10.1136/bjo.2006.103218; Watanabe K, 2004, FEBS LETT, V565, P6, DOI 10.1016/j.febslet.2004.03.064; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yokoo S, 2008, INVEST OPHTH VIS SCI, V49, P2438, DOI 10.1167/iovs.06-1448; Zhao X, 2002, DEV BIOL, V250, P317, DOI 10.1006/dbio.2002.0793; ZIESKE JD, 1994, EYE, V8, P163, DOI 10.1038/eye.1994.41	46	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81965	10.1371/journal.pone.0081965	http://dx.doi.org/10.1371/journal.pone.0081965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312615	gold, Green Published, Green Submitted			2022-12-25	WOS:000327947800076
J	Liu, J; Tawa, GJ; Wallqvist, A				Liu, Jin; Tawa, Gregory J.; Wallqvist, Anders			Identifying Cytochrome P450 Functional Networks and Their Allosteric Regulatory Elements	PLOS ONE			English	Article							MICROSOMAL CYTOCHROME-P450; CRYSTAL-STRUCTURE; BINDING; PROTEIN; 3A4; SUBSTRATE; RESIDUES; MONOOXYGENASE; ADAPTATIONS; METABOLISM	Cytochrome P450 (CYP) enzymes play key roles in drug metabolism and adverse drug-drug interactions. Despite tremendous efforts in the past decades, essential questions regarding the function and activity of CYPs remain unanswered. Here, we used a combination of sequence-based co-evolutionary analysis and structure-based anisotropic thermal diffusion (ATD) molecular dynamics simulations to detect allosteric networks of amino acid residues and characterize their biological and molecular functions. We investigated four CYP subfamilies (CYP1A, CYP2D, CYP2C, and CYP3A) that are involved in 90% of all metabolic drug transformations and identified four amino acid interaction networks associated with specific CYP functionalities, i.e., membrane binding, heme binding, catalytic activity, and dimerization. Interestingly, we did not detect any co-evolved substrate-binding network, suggesting that substrate recognition is specific for each subfamily. Analysis of the membrane binding networks revealed that different CYP proteins adopt different membrane-bound orientations, consistent with the differing substrate preference for each isoform. The catalytic networks were associated with conservation of catalytic function among CYP isoforms, whereas the dimerization network was specific to different CYP isoforms. We further applied low-temperature ATD simulations to verify proposed allosteric sites associated with the heme-binding network and their role in regulating metabolic fate. Our approach allowed for a broad characterization of CYP properties, such as membrane interactions, catalytic mechanisms, dimerization, and linking these to groups of residues that can serve as allosteric regulators. The presented combined co-evolutionary analysis and ATD simulation approach is also generally applicable to other biological systems where allostery plays a role.	[Liu, Jin; Tawa, Gregory J.; Wallqvist, Anders] US Army Med Res & Mat Command, Dept Def Biotechnol, High Performance Comp Software Applicat Inst, Telemed & Adv Technol Res Ctr, Ft Detrick, MD USA	United States Department of Defense; United States Army	Liu, J (corresponding author), US Army Med Res & Mat Command, Dept Def Biotechnol, High Performance Comp Software Applicat Inst, Telemed & Adv Technol Res Ctr, Ft Detrick, MD USA.	jliu@bhsai.org	wallqvist, anders/W-2584-2019	wallqvist, anders/0000-0002-9775-7469; Liu, Jin/0000-0002-1067-4063	U.S. Department of Defense Threat Reduction Agency [TMTI0004_09_BH_T]	U.S. Department of Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	Funding of this research was provided by the U.S. Department of Defense Threat Reduction Agency Grant TMTI0004_09_BH_T. The opinions and assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the US Army or the US Department of Defense. This paper has been approved for public release with unlimited distribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Atkins WM, 2005, ANNU REV PHARMACOL, V45, P291, DOI 10.1146/annurev.pharmtox.45.120403.100004; Atkins WM, 2001, CHEM RES TOXICOL, V14, P338, DOI 10.1021/tx0002132; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Bathelt CM, 2005, J AM CHEM SOC, V127, P12900, DOI 10.1021/ja0520924; Baussand J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000488; Bayburt TH, 2002, P NATL ACAD SCI USA, V99, P6725, DOI 10.1073/pnas.062565599; Berka K, 2012, NUCLEIC ACIDS RES, V40, pW222, DOI 10.1093/nar/gks363; BLACK SD, 1994, BIOCHEMISTRY-US, V33, P6945, DOI 10.1021/bi00188a025; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Cojocaru V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002152; Dai D, 2001, J PHARMACOL EXP THER, V299, P825; Davydov DR, 2007, BIOCHEMISTRY-US, V46, P7852, DOI 10.1021/bi602400y; Davydov DR, 2012, J BIOL CHEM, V287, P6797, DOI 10.1074/jbc.M111.325654; Davydov DR, 2008, EXPERT OPIN DRUG MET, V4, P1523, DOI 10.1517/17425250802500028 ; Dima RI, 2006, PROTEIN SCI, V15, P258, DOI 10.1110/ps.051767306; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fishelovitch D, 2007, J AM CHEM SOC, V129, P1602, DOI 10.1021/ja066007j; Fishelovitch D, 2009, J PHYS CHEM B, V113, P13018, DOI 10.1021/jp810386z; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; Hlavica P, 2007, CURR DRUG METAB, V8, P594; Hu G, 2010, DRUG METAB DISPOS, V38, P1976, DOI 10.1124/dmd.110.034942; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Liu J, 2008, P NATL ACAD SCI USA, V105, P901, DOI 10.1073/pnas.0707401105; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Miller WL, 2005, ENDOCRINOLOGY, V146, P2544, DOI 10.1210/en.2005-0096; OHTA Y, 1992, BIOCHEMISTRY-US, V31, P12680, DOI 10.1021/bi00165a019; Ota N, 2005, J MOL BIOL, V351, P345, DOI 10.1016/j.jmb.2005.05.043; Pratt-Hyatt M, 2010, DRUG METAB DISPOS, V38, P2075, DOI 10.1124/dmd.110.033712; Rowland P, 2006, J BIOL CHEM, V281, P7614, DOI 10.1074/jbc.M511232200; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schoch GA, 2004, J BIOL CHEM, V279, P9497, DOI 10.1074/jbc.M312516200; Sirim D, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-27; Strushkevich N, 2011, P NATL ACAD SCI USA, V108, P10139, DOI 10.1073/pnas.1019441108; Subramanian M, 2010, DRUG METAB DISPOS, V38, P1003, DOI 10.1124/dmd.109.030155; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Wester MR, 2004, J BIOL CHEM, V279, P35630, DOI 10.1074/jbc.M405427200; Williams PA, 2003, NATURE, V424, P464, DOI 10.1038/nature01862; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Woods CM, 2011, BIOCHEMISTRY-US, V50, P10041, DOI 10.1021/bi2013454; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211; Yoon MY, 2004, DRUG METAB REV, V36, P219, DOI 10.1081/DMR-120033998; Zhao YH, 2006, J BIOL CHEM, V281, P5973, DOI 10.1074/jbc.M511464200; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	49	28	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81980	10.1371/journal.pone.0081980	http://dx.doi.org/10.1371/journal.pone.0081980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312617	Green Published, gold			2022-12-25	WOS:000327947800077
J	Kooyman, RM; Rossetto, M; Sauquet, H; Laffan, SW				Kooyman, Robert M.; Rossetto, Maurizio; Sauquet, Herve; Laffan, Shawn W.			Landscape Patterns in Rainforest Phylogenetic Signal: Isolated Islands of Refugia or Structured Continental Distributions?	PLOS ONE			English	Article							ANGIOSPERM DIVERSIFICATION; COMMUNITY; ENDEMISM; DISPERSAL; EVOLUTION; TRAITS; RECORD; EXTENT; FLORA; RARE	Objectives: Identify patterns of change in species distributions, diversity, concentrations of evolutionary history, and assembly of Australian rainforests. Methods: We used the distribution records of all known rainforest woody species in Australia across their full continental extent. These were analysed using measures of species richness, phylogenetic diversity (PD), phylogenetic endemism (PE) and phylogenetic structure (net relatedness index; NRI). Phylogenetic structure was assessed using both continental and regional species pools. To test the influence of growth-form, freestanding and climbing plants were analysed independently, and in combination. Results: Species richness decreased along two generally orthogonal continental axes, corresponding with wet to seasonally dry and tropical to temperate habitats. The PE analyses identified four main areas of substantially restricted phylogenetic diversity, including parts of Cape York, Wet Tropics, Border Ranges, and Tasmania. The continental pool NRI results showed evenness (species less related than expected by chance) in groups of grid cells in coastally aligned areas of species rich tropical and sub-tropical rainforest, and in low diversity moist forest areas in the south-east of the Great Dividing Range and in Tasmania. Monsoon and drier vine forests, and moist forests inland from upland refugia showed phylogenetic clustering, reflecting lower diversity and more relatedness. Signals for evenness in Tasmania and clustering in northern monsoon forests weakened in analyses using regional species pools. For climbing plants, values for NRI by grid cell showed strong spatial structuring, with high diversity and PE concentrated in moist tropical and subtropical regions. Conclusions/Significance: Concentrations of rainforest evolutionary history (phylo-diversity) were patchily distributed within a continuum of species distributions. Contrasting with previous concepts of rainforest community distribution, our findings of continuous distributions and continental connectivity have significant implications for interpreting rainforest evolutionary history and current day ecological processes, and for managing rainforest diversity in changing circumstances.	[Kooyman, Robert M.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Rossetto, Maurizio] Royal Bot Gardens & Domain Trust, Natl Herbarium New South Wales NSW, Sydney, NSW, Australia; [Sauquet, Herve] Univ Paris 11, CNRS, UMR 8079, Ecol Lab, F-91405 Orsay, France; [Laffan, Shawn W.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	Macquarie University; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; University of New South Wales Sydney	Kooyman, RM (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	robert.kooyman@mq.edu.au	Kooyman, Robert M/H-3347-2017; Laffan, Shawn W/A-3761-2008; Sauquet, Hervé/E-7123-2016	Kooyman, Robert M/0000-0003-1985-9547; Laffan, Shawn W/0000-0002-5996-0570; Sauquet, Hervé/0000-0001-8305-3236	Macquarie University	Macquarie University	RK was partly supported by a scholarship through Macquarie University and part-time employment with Royal Botanic Gardens, Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow BA, 1981, FLORA AUSTR, V1, P25; Boyce CK, 2010, ANN MO BOT GARD, V97, P527, DOI 10.3417/2009143; Brodribb T, 1998, FUNCT ECOL, V12, P465, DOI 10.1046/j.1365-2435.1998.00213.x; Brodribb T.J., 2004, EVOLUTION PLANT PHYS, P381, DOI DOI 10.1016/B978-012339552-8/50020-2; BURBRIDGE NANCY T., 1960, AUSTRALIAN JOUR BOT, V8, P75, DOI 10.1071/BT9600075; Burnham RJ, 2009, REV BRAS PALEONTOLOG, V12, P149, DOI 10.4072/rbp.2009.2.05; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Byrne M, 2011, J BIOGEOGR, V38, P1635, DOI 10.1111/j.1365-2699.2011.02535.x; Clarke K.R, 2006, PRIMER V6 USER MANUA; CRANE PR, 1989, SCIENCE, V246, P675, DOI 10.1126/science.246.4930.675; Crayn DM, 2006, AM J BOT, V93, P1328, DOI 10.3732/ajb.93.9.1328; Crisp MD, 2001, J BIOGEOGR, V28, P183, DOI 10.1046/j.1365-2699.2001.00524.x; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Flenley JR, 1998, CLIMATIC CHANGE, V39, P177, DOI 10.1023/A:1005367822750; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Greenwood D. R., 2005, Tropical rainforests: past, present and future, P336; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hill R. S., 1994, HIST AUSTR VEGETATIO, P390; HILL RS, 1992, TRENDS ECOL EVOL, V7, P190, DOI 10.1016/0169-5347(92)90071-I; Hill RS, 2004, PHILOS T R SOC B, V359, P1537, DOI 10.1098/rstb.2004.1526; Hopkins MS, 1996, J BIOGEOGR, V23, P737, DOI 10.1111/j.1365-2699.1996.tb00035.x; HOPKINS MS, 1993, J BIOGEOGR, V20, P357, DOI 10.2307/2845585; Hyland BPM, 2003, AUSTR TROPICAL RAINF; Kembel SW, 2009, ECOL LETT, V12, P949, DOI 10.1111/j.1461-0248.2009.01354.x; Kershaw AP, 2007, PALAEOGEOGR PALAEOCL, V251, P23, DOI 10.1016/j.palaeo.2007.02.015; Kooyman Robert, 2012, Cunninghamia, V12, P177, DOI 10.7751/cunninghamia.2012.12.014; Kooyman R, 2012, BIOTROPICA, V44, P668, DOI 10.1111/j.1744-7429.2012.00861.x; Kooyman R, 2011, GLOBAL ECOL BIOGEOGR, V20, P707, DOI 10.1111/j.1466-8238.2010.00641.x; Kooyman R, 2010, J ECOL, V98, P517, DOI 10.1111/j.1365-2745.2010.01642.x; Laffan SW, 2010, ECOGRAPHY, V33, P643, DOI 10.1111/j.1600-0587.2010.06237.x; Laffan SW, 2003, J BIOGEOGR, V30, P511, DOI 10.1046/j.1365-2699.2003.00875.x; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; McPherson H, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-8; Mellick R, 2012, J BIOGEOGR, V39, P2292, DOI 10.1111/j.1365-2699.2012.02747.x; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Moritz Craig, 1997, P442; Nix H.A., 1991, RAINFOREST LEGACY AU, V2, P1; Rosauer D, 2009, MOL ECOL, V18, P4061, DOI 10.1111/j.1365-294X.2009.04311.x; Rossetto M, 2005, J ECOL, V93, P906, DOI 10.1111/j.1365-2745.2005.01046.x; Rossetto M, 2009, MOL ECOL, V18, P1422, DOI 10.1111/j.1365-294X.2009.04111.x; Rossetto M, 2008, AM J BOT, V95, P321, DOI 10.3732/ajb.95.3.321; Rossetto M, 2007, AUST J BOT, V55, P416, DOI 10.1071/BT06195; SAUQUET H, 2013, PROTEUS DATABASE REC; Sauquet H, 2009, P NATL ACAD SCI USA, V106, P221, DOI 10.1073/pnas.0805607106; Schneider CJ, 1998, MOL ECOL, V7, P487, DOI 10.1046/j.1365-294x.1998.00334.x; Sniderman JMK, 2013, P NATL ACAD SCI USA, V110, P3423, DOI 10.1073/pnas.1216747110; Sniderman JMK, 2011, J BIOGEOGR, V38, P1445, DOI 10.1111/j.1365-2699.2011.02519.x; Stevens P. F., 2012, ANGIOSPERM PHYLOGENY; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; WEBB L J, 1986, Telopea, V2, P575; WEBB LJ, 1968, ECOLOGY, V49, P296, DOI 10.2307/1934459; Webb LJ, 1981, ECOLOGICAL BIOGEOGRA, P605, DOI DOI 10.1007/978-94-009-8629-9_22; Wilf P, 2012, AM J BOT, V99, P562, DOI 10.3732/ajb.1100367; Zhu SD, 2010, OECOLOGIA, V163, P591, DOI 10.1007/s00442-010-1579-3; Ziegler AM, 2003, LETHAIA, V36, P227, DOI 10.1080/00241160310004657	59	38	38	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80685	10.1371/journal.pone.0080685	http://dx.doi.org/10.1371/journal.pone.0080685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312493	Green Submitted, gold, Green Published			2022-12-25	WOS:000327944500037
J	Sabatier, R; Wiegand, K; Meyer, K				Sabatier, Rodolphe; Wiegand, Kerstin; Meyer, Katrin			Production and Robustness of a Cacao Agroecosystem: Effects of Two Contrasting Types of Management Strategies	PLOS ONE			English	Article							ECOSYSTEM SERVICES; BIODIVERSITY; AGROFORESTRY; INTENSIFICATION; POLLINATION; LANDSCAPES; DIVERSITY; STABILITY; SYSTEMS	Ecological intensification, i.e. relying on ecological processes to replace chemical inputs, is often presented as the ideal alternative to conventional farming based on an intensive use of chemicals. It is said to both maintain high yield and provide more robustness to the agroecosystem. However few studies compared the two types of management with respect to their consequences for production and robustness toward perturbation. In this study our aim is to assess productive performance and robustness toward diverse perturbations of a Cacao agroecosystem managed with two contrasting groups of strategies: one group of strategies relying on a high level of pesticides and a second relying on low levels of pesticides. We conducted this study using a dynamical model of a Cacao agroecosystem that includes Cacao production dynamics, and dynamics of three insects: a pest (the Cacao Pod Borer, Conopomorpha cramerella) and two characteristic but unspecified beneficial insects (a pollinator of Cacao and a parasitoid of the Cacao Pod Borer). Our results showed two opposite behaviors of the Cacao agroecosystem depending on its management, i.e. an agroecosystem relying on a high input of pesticides and showing low ecosystem functioning and an agroecosystem with low inputs, relying on a high functioning of the ecosystem. From the production point of view, no type of management clearly outclassed the other and their ranking depended on the type of pesticide used. From the robustness point of view, the two types of managements performed differently when subjected to different types of perturbations. Ecologically intensive systems were more robust to pest outbreaks and perturbations related to pesticide characteristics while chemically intensive systems were more robust to Cacao production and management-related perturbation.	[Sabatier, Rodolphe; Wiegand, Kerstin; Meyer, Katrin] Univ Gottingen, Busgen Inst, Dept Ecosyst Modelling, D-37073 Gottingen, Germany	University of Gottingen	Sabatier, R (corresponding author), INRA, UMR SADAPT 1048, Paris, France.	rodolphe.sabatier@agroparistech.fr	Meyer, Katrin M/E-6839-2013	Meyer, Katrin M/0000-0002-9990-4047; Wiegand, Kerstin/0000-0003-4854-0607	DFG [PAK 569, WI1816/12]; State of Lower Saxony (Ministry of Science and Culture); State of Lower Saxony (Cluster of Excellence "Functional Biodiversity Research")	DFG(German Research Foundation (DFG)); State of Lower Saxony (Ministry of Science and Culture); State of Lower Saxony (Cluster of Excellence "Functional Biodiversity Research")	This study was part of the DFG-funded research project "Environmental and land-use change in Sulawesi, Indonesia: Socioeconomic and ecological perspectives" (PAK 569, WI1816/12). KMM was partly funded by the State of Lower Saxony (Ministry of Science and Culture; Cluster of Excellence "Functional Biodiversity Research"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri M.A., 2005, AGROECOLOGY SEARCH T; Altieri Miguel A., 2005, International Journal of Biodiversity Science & Management, V1, P191; Bambaradeniya C.N.B., 2008, Ceylon Journal of Science Biological Sciences, V37, P23; Bianchi FJJA, 2010, ECOL APPL, V20, P2322, DOI 10.1890/09-1278.1; Bommarco R, 2011, J ECON ENTOMOL, V104, P782, DOI 10.1603/EC10444; Carpenter S, 2001, ECOSYSTEMS, V4, P765, DOI 10.1007/s10021-001-0045-9; Chatterjee S, 2009, J THEOR BIOL, V258, P352, DOI 10.1016/j.jtbi.2008.11.029; Conway Gordon, 1998, DOUBLY GREEN REVOLUT; Day R, 1985, CONTROL COCOA POD BO; Drechsler M, 2001, ECOL MODEL, V137, P135, DOI 10.1016/S0304-3800(00)00423-3; Duelli P, 1999, AGR ECOSYST ENVIRON, V74, P33, DOI 10.1016/S0167-8809(99)00029-8; Entwistle P.F., 1972, PESTS OF COCOA; Fukuoka M, 2010, ONE STRAW REVOLUTION; Gliessman SR, 2012, AGROECOLOGY RES ECOL; Groeneveld JH, 2010, PERSPECT PLANT ECOL, V12, P183, DOI 10.1016/j.ppees.2010.02.005; Hassell MP, 1978, SPATIAL TEMPORAL DYN; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Ives AR, 1997, AM NAT, V149, P220, DOI 10.1086/285988; Juhrbandt J, 2011, EC VALUATION LAND US; Kessler M, 2011, J APPL ECOL, V48, P330, DOI 10.1111/j.1365-2664.2010.01932.x; Klein AM, 2006, J ANIM ECOL, V75, P315, DOI 10.1111/j.1365-2656.2006.01042.x; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Moonen AC, 2008, AGR ECOSYST ENVIRON, V127, P7, DOI 10.1016/j.agee.2008.02.013; Moser G, 2010, AGROFOREST SYST, V79, P171, DOI 10.1007/s10457-010-9303-1; Priess JA, 2007, ECOL APPL, V17, P407, DOI 10.1890/05-1795; Ricci B, 2009, LANDSCAPE ECOL, V24, P337, DOI 10.1007/s10980-008-9308-6; Ruf F, 1995, BOOMS RISES CACAO VE; Ruf FO, 2011, HUM ECOL, V39, P373, DOI 10.1007/s10745-011-9392-0; Sabatier R, 2013, BASIC APPL ECOL, V14, P115, DOI 10.1016/j.baae.2012.12.006; Schwendenmann L, 2010, GLOBAL CHANGE BIOL, V16, P1515, DOI 10.1111/j.1365-2486.2009.02034.x; Sechan Y, 1996, LUTTE NONO BLANC PLA; Steffan-Dewenter I, 2007, P NATL ACAD SCI USA, V104, P4973, DOI 10.1073/pnas.0608409104; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Swaminathan MS, 1996, SUSTAINABLE AGR EVER; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2011, J APPL ECOL, V48, P619, DOI 10.1111/j.1365-2664.2010.01939.x; Wielgoss A, 2012, J APPL ECOL, V49, P465, DOI 10.1111/j.1365-2664.2012.02122.x; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024	41	15	15	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80352	10.1371/journal.pone.0080352	http://dx.doi.org/10.1371/journal.pone.0080352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312469	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500021
J	Wang, XD; Wang, H; Long, Y; Li, DR; Yin, YT; Tian, JH; Chen, L; Liu, LZ; Zhao, WG; Zhao, YJ; Yu, LJ; Li, MT				Wang, Xiaodong; Wang, Hao; Long, Yan; Li, Dianrong; Yin, Yongtai; Tian, Jianhua; Chen, Li; Liu, Liezhao; Zhao, Weiguo; Zhao, Yajun; Yu, Longjiang; Li, Maoteng			Identification of QTLs Associated with Oil Content in a High-Oil Brassica napus Cultivar and Construction of a High-Density Consensus Map for QTLs Comparison in B. napus	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENETIC-MAP; OILSEED RAPE; AGRONOMIC TRAITS; LINKAGE MAP; SEED OIL; MICROSATELLITE MARKERS; PROTEIN CONCENTRATIONS; FLOWERING TIME; L.	Increasing seed oil content is one of the most important goals in breeding of rapeseed (B. napus L.). To dissect the genetic basis of oil content in B. napus, a large and new double haploid (DH) population containing 348 lines was obtained from a cross between 'KenC-8' and 'N53-2', two varieties with >10% difference in seed oil content, and this population was named the KN DH population. A genetic linkage map consisting of 403 markers was constructed, which covered a total length of 1783.9 cM with an average marker interval of 4.4 cM. The KN DH population was phenotyped in eight natural environments and subjected to quantitative trait loci (QTL) analysis for oil content. A total of 63 identified QTLs explaining 2.64-17.88% of the phenotypic variation were identified, and these QTLs were further integrated into 24 consensus QTLs located on 11 chromosomes using meta-analysis. A high-density consensus map with 1335 marker loci was constructed by combining the KN DH map with seven other published maps based on the common markers. Of the 24 consensus QTLs in the KN DH population, 14 were new QTLs including five new QTLs in A genome and nine in C genome. The analysis revealed that a larger population with significant differences in oil content gave a higher power detecting new QTLs for oil content, and the construction of the consensus map provided a new clue for comparing the QTLs detected in different populations. These findings enriched our knowledge of QTLs for oil content and should be a potential in marker-assisted breeding of B. napus.	[Wang, Xiaodong; Yin, Yongtai; Chen, Li; Yu, Longjiang; Li, Maoteng] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Inst Resource Biol & Biotechnol, Wuhan 430074, Peoples R China; [Long, Yan] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Wang, Hao; Li, Dianrong; Tian, Jianhua; Zhao, Weiguo; Zhao, Yajun] Natl Ctr Oil Crops Genet Improvement, Shaanxi Rapeseed Branch, Hybrid Rapeseed Res Ctr Shaanxi Prov, Dali, Peoples R China; [Liu, Liezhao] Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China	Huazhong University of Science & Technology; Huazhong Agricultural University; Southwest University - China	Li, MT (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Inst Resource Biol & Biotechnol, Wuhan 430074, Peoples R China.	limaoteng426@mail.hust.edu.cn			National Natural Science Foundation of China [31071447]; Key Natural Science Foundation of Shannxi Province [2012JZ3001]; High Technology Program of China [2011AA10A104]; Natural Science Funds for Distinguished Young Scholars of Hubei Province of China [2010CDA097]; New Century Talents Support Program of the Ministry of Education of China [NCET110172]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Natural Science Foundation of Shannxi Province; High Technology Program of China(National High Technology Research and Development Program of China); Natural Science Funds for Distinguished Young Scholars of Hubei Province of China; New Century Talents Support Program of the Ministry of Education of China	The work was supported by National Natural Science Foundation of China (31071447), the Key Natural Science Foundation of Shannxi Province (2012JZ3001), the High Technology Program of China (2011AA10A104), the Natural Science Funds for Distinguished Young Scholars of Hubei Province of China (2010CDA097) and New Century Talents Support Program of the Ministry of Education of China (NCET110172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Bradshaw HD, 1998, GENETICS, V149, P367; Burns MJ, 2003, HEREDITY, V90, P39, DOI 10.1038/sj.hdy.6800176; CHARLESWORTH B, 1988, NATURE, V332, P394, DOI 10.1038/332394a0; Chen G, 2010, EUPHYTICA, V175, P161, DOI 10.1007/s10681-010-0144-9; Chen YB, 2013, THEOR APPL GENET, V126, P2499, DOI 10.1007/s00122-013-2150-5; Cheng XM, 2009, THEOR APPL GENET, V118, P1121, DOI 10.1007/s00122-009-0967-8; Cheung WY, 1997, INT S BRASS 97 10 CR, V459, P139; Delourme R, 2006, THEOR APPL GENET, V113, P1331, DOI 10.1007/s00122-006-0386-z; Delourme R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-120; Ding GD, 2011, EUPHYTICA, V181, P305, DOI 10.1007/s10681-011-0428-8; Doerge RW, 1996, GENETICS, V142, P285; ECKE W, 1995, THEOR APPL GENET, V91, P972, DOI 10.1007/BF00223908; Feng J, 2012, NEW PHYTOL, V193, P96, DOI 10.1111/j.1469-8137.2011.03890.x; GENTZBITTEL L, 1995, THEOR APPL GENET, V90, P1079, DOI 10.1007/BF00222925; Goffinet B, 2000, GENETICS, V155, P463; Gustafson JP, 2009, THEOR APPL GENET, V118, P793, DOI 10.1007/s00122-008-0939-4; Harr B, 2002, P NATL ACAD SCI USA, V99, P12949, DOI 10.1073/pnas.202336899; JIANG CJ, 1995, GENETICS, V140, P1111; Kabelka EA, 2004, CROP SCI, V44, P784, DOI 10.2135/cropsci2004.0784; Karakousis A, 2003, AUST J AGR RES, V54, P1173, DOI 10.1071/AR02177; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kreike CM, 1997, GENOME, V40, P180, DOI 10.1139/g97-026; LANGRIDGE P, 1995, MOL BREEDING, V1, P389, DOI 10.1007/BF01248416; Li G, 2001, THEOR APPL GENET, V103, P455, DOI 10.1007/s001220100570; Li H, 2010, HEREDITY, V105, P257, DOI 10.1038/hdy.2010.56; Li YY, 2006, EUPHYTICA, V152, P25, DOI 10.1007/s10681-006-9173-9; Lombard V, 2001, THEOR APPL GENET, V103, P491, DOI 10.1007/s001220100560; Long Y, 2007, GENETICS, V177, P2433, DOI 10.1534/genetics.107.080705; Lowe AJ, 2004, THEOR APPL GENET, V108, P1103, DOI 10.1007/s00122-003-1522-7; Iniguez-Luy FL, 2009, THEOR APPL GENET, V120, P31, DOI 10.1007/s00122-009-1157-4; Mace ES, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-13; Mahmood T, 2006, THEOR APPL GENET, V113, P1211, DOI 10.1007/s00122-006-0376-1; Mangolin CA, 2004, EUPHYTICA, V137, P251, DOI 10.1023/B:EUPH.0000041588.95689.47; Matsushita S, 2003, EUPHYTICA, V134, P27, DOI 10.1023/A:1026182312730; Mauricio R, 2001, NAT REV GENET, V2, P370, DOI 10.1038/35072085; McCouch SR, 1997, RICE GENET NEWSLETT, V14, P11, DOI [DOI 10.1007/S10142-013-0328-1, DOI 10.1007/S10681-005-0449-2]; Mei DS, 2009, PLANT BREEDING, V128, P458, DOI 10.1111/j.1439-0523.2008.01528.x; Mestries E, 1998, MOL BREEDING, V4, P215, DOI 10.1023/A:1009694626992; Mokrani L, 2002, THEOR APPL GENET, V106, P149, DOI 10.1007/s00122-002-1011-4; Muchero W, 2009, P NATL ACAD SCI USA, V106, P18159, DOI 10.1073/pnas.0905886106; Orf JH, 1999, CROP SCI, V39, P1642, DOI 10.2135/cropsci1999.3961642x; Piquemal J, 2005, THEOR APPL GENET, V111, P1514, DOI 10.1007/s00122-005-0080-6; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Quijada PA, 2004, MOL BREEDING, V13, P193, DOI 10.1023/B:MOLB.0000018774.72965.2a; Raman H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-277; Sarvamangala C, 2011, FIELD CROP RES, V122, P49, DOI 10.1016/j.fcr.2011.02.010; Selvaraj MG, 2009, ELECTRON J BIOTECHN, V12, DOI 10.2225/vol12-issue2-fulltext-13; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; Si P, 2003, AUST J AGR RES, V54, P397, DOI 10.1071/AR01203; Sibov ST, 2003, HEREDITAS, V139, P96, DOI 10.1111/j.1601-5223.2003.01666.x; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Sun MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047037; The World Bank, 2008, GLOB EC PROSP 2008 T, P40; Udall JA, 2006, THEOR APPL GENET, V113, P597, DOI 10.1007/s00122-006-0324-0; Uzunova MI, 1999, PLANT BREEDING, V118, P323, DOI 10.1046/j.1439-0523.1999.00371.x; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Wang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-101; Wang S., 2007, WINDOWS QTL CARTOGRA; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Yan XY, 2009, EUPHYTICA, V170, P355, DOI 10.1007/s10681-009-0006-5; Yang XH, 2010, THEOR APPL GENET, V120, P665, DOI 10.1007/s00122-009-1184-1; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang J, 2008, EUPHYTICA, V162, P335, DOI 10.1007/s10681-007-9500-9; Zhang WK, 2004, THEOR APPL GENET, V108, P1131, DOI 10.1007/s00122-003-1527-2; Zhao JY, 2008, MOL BREEDING, V21, P115, DOI 10.1007/s11032-007-9113-y; Zhao JY, 2006, THEOR APPL GENET, V113, P33, DOI 10.1007/s00122-006-0267-5; Zhao JY, 2012, THEOR APPL GENET, V124, P407, DOI 10.1007/s00122-011-1716-3; Zhao JY, 2005, CROP SCI, V45, P51; Zhao ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045215; 王汉中, 2004, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V26, P98	73	57	63	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80569	10.1371/journal.pone.0080569	http://dx.doi.org/10.1371/journal.pone.0080569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312482	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500030
J	Goto, A; Ohno, Y; Ikuta, A; Suzuki, M; Ohira, T; Egawa, T; Sugiura, T; Yoshioka, T; Ohira, Y; Goto, K				Goto, Ayumi; Ohno, Yoshitaka; Ikuta, Akihiro; Suzuki, Miho; Ohira, Tomotaka; Egawa, Tatsuro; Sugiura, Takao; Yoshioka, Toshitada; Ohira, Yoshinobu; Goto, Katsumasa			Up-Regulation of Adiponectin Expression in Antigravitational Soleus Muscle in Response to Unloading Followed by Reloading, and Functional Overloading in Mice	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; GENE-EXPRESSION; FIBER TYPES; IN-VIVO; RECEPTORS; EXERCISE; APPL1; RECOVERY; STRETCH; ADIPOR1	The purpose of this study was to investigate the expression level of adiponectin and its related molecules in hypertrophied and atrophied skeletal muscle in mice. The expression was also evaluated in C2C12 myoblasts and myotubes. Both mRNA and protein expression of adiponectin, mRNA expression of adiponectin receptor (AdipoR) 1 and AdipoR2, and protein expression of adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain, and leucine zipper motif 1 (APPL1) were observed in C2C12 myoblasts. The expression levels of these molecules in myotubes were higher than those in myoblasts. The expression of adiponectin-related molecules in soleus muscle was observed at mRNA (adiponectin, AdipoR1, AdipoR2) and protein (adiponectin, APPL1) levels. The protein expression levels of adiponectin and APPL1 were up-regulated by 3 weeks of functional overloading. Down-regulation of AdipoR1 mRNA, but not AdipoR2 mRNA, was observed in atrophied soleus muscle. The expression of adiponectin protein, AdipoR1 mRNA, and APPL1 protein was up-regulated during regrowth of unloading-associated atrophied soleus muscle. Mechanical loading, which could increase skeletal muscle mass, might be a useful stimulus for the up-regulations of adiponectin and its related molecules in skeletal muscle.	[Goto, Ayumi; Ikuta, Akihiro; Suzuki, Miho; Ohira, Tomotaka; Egawa, Tatsuro; Goto, Katsumasa] Toyohashi SOZO Univ, Grad Sch Hlth Sci, Dept Physiol, Toyohashi, Aichi, Japan; [Ohno, Yoshitaka; Goto, Katsumasa] Toyohashi SOZO Univ, Sch Hlth Sci, Physiol Lab, Toyohashi, Aichi, Japan; [Egawa, Tatsuro] Japan Soc Promot Sci, Tokyo, Japan; [Sugiura, Takao] Yamaguchi Univ, Dept Exercise & Hlth Sci, Yamaguchi, Japan; [Yoshioka, Toshitada] Hirosaki Gakuin Univ, Aomori, Japan; [Ohira, Yoshinobu] Osaka Univ, Grad Sch Med, Osaka, Japan	Japan Society for the Promotion of Science; Yamaguchi University; Osaka University	Goto, K (corresponding author), Toyohashi SOZO Univ, Grad Sch Hlth Sci, Dept Physiol, Toyohashi, Aichi, Japan.	gotok@sepia.ocn.ne.jp	Goto, Katsumasa/T-6789-2019	Goto, Katsumasa/0000-0001-5380-4561; Egawa, Tatsuro/0000-0001-9363-1589	Japan Society for the Promotion of Science [20300218, 22240071, 19100009, 24650411, 24650407]; Science Research Promotion Fund from The Promotion and Mutual Aid Corporation for Private Schools of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Science Research Promotion Fund from The Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan)	This study was supported, in part, by Grants-in-Aid for Scientific Research (B, 20300218, K. Goto; A, 22240071, T. Yoshioka; S, 19100009, Y. Ohira) and Grants-in-Aid for challenging Exploratory Research (24650411, K. Goto; 24650407, Y. Ohira) from Japan Society for the Promotion of Science and the Science Research Promotion Fund from The Promotion and Mutual Aid Corporation for Private Schools of Japan (K. Goto). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GR, 1999, J APPL PHYSIOL, V87, P1705, DOI 10.1152/jappl.1999.87.5.1705; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bae GU, 2010, MOL BIOL CELL, V21, P2399, DOI 10.1091/mbc.E09-12-1011; Bluher M, 2006, J CLIN ENDOCR METAB, V91, P2310, DOI 10.1210/jc.2005-2556; Boudou P, 2003, EUR J ENDOCRINOL, V149, P421, DOI 10.1530/eje.0.1490421; Carson JA, 1998, AM J PHYSIOL-CELL PH, V275, pC1438, DOI 10.1152/ajpcell.1998.275.6.C1438; Cleasby ME, 2011, J ENDOCRINOL, V210, P81, DOI 10.1530/JOE-11-0039; Dapp C, 2004, PHYSIOL GENOMICS, V20, P97, DOI 10.1152/physiolgenomics.00100.2004; Debard C, 2004, DIABETOLOGIA, V47, P917, DOI 10.1007/s00125-004-1394-7; Deepa SS, 2009, AM J PHYSIOL-ENDOC M, V296, pE22, DOI 10.1152/ajpendo.90731.2008; Delaigle AM, 2004, ENDOCRINOLOGY, V145, P5589, DOI 10.1210/en.2004-0503; Desaphy JF, 2010, PHARMACOL RES, V61, P553, DOI 10.1016/j.phrs.2010.01.012; Fiaschi T, 2010, MOL BIOL CELL, V21, P848, DOI 10.1091/mbc.E09-04-0310; Fiaschi T, 2009, CELL RES, V19, P584, DOI 10.1038/cr.2009.39; Goldspink G, 1999, J ANAT, V194, P323, DOI 10.1046/j.1469-7580.1999.19430323.x; Goto K, 2004, JPN J PHYSIOL, V54, P285, DOI 10.2170/jjphysiol.54.285; Goto K, 2003, J APPL PHYSIOL, V94, P897, DOI 10.1152/japplphysiol.00408.2002; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang H, 2006, J ENDOCRINOL, V189, P643, DOI 10.1677/joe.1.06630; Hulver MW, 2002, AM J PHYSIOL-ENDOC M, V283, pE861, DOI 10.1152/ajpendo.00150.2002; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Kim SJ, 2008, J APPL PHYSIOL, V105, P1246, DOI 10.1152/japplphysiol.90668.2008; Koya T, PLOS ONE IN PRESS; Krause MP, 2008, AM J PHYSIOL-CELL PH, V295, pC203, DOI 10.1152/ajpcell.00030.2008; Locke M, 2008, ACTA PHYSIOL, V192, P403, DOI 10.1111/j.1748-1716.2007.01764.x; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Matsuba Y, 2009, ACTA PHYSIOL, V196, P329, DOI 10.1111/j.1748-1716.2008.01943.x; Min K, 2011, J APPL PHYSIOL, V111, P1459, DOI 10.1152/japplphysiol.00591.2011; Miyazaki M, 2006, MED SCI SPORT EXER, V38, P1065, DOI 10.1249/01.mss.0000222833.43520.6e; Morioka S, 2008, J PHYSIOL SCI, V58, P397, DOI 10.2170/physiolsci.RP004008; Oberbach A, 2006, EUR J ENDOCRINOL, V154, P577, DOI 10.1530/eje.1.02127; Pandorf CE, 2009, AM J PHYSIOL-REG I, V297, pR1037, DOI 10.1152/ajpregu.00349.2009; Patel SA, 2012, ENDOCRINOLOGY, V153, P5231, DOI 10.1210/en.2012-1368; PERRONE CE, 1995, J BIOL CHEM, V270, P2099, DOI 10.1074/jbc.270.5.2099; SAKUMA K, 1995, EUR J APPL PHYSIOL O, V71, P499, DOI 10.1007/BF00238551; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Staiger H, 2004, DIABETES, V53, P2195, DOI 10.2337/diabetes.53.9.2195; Stelzer JE, 2003, J APPL PHYSIOL, V95, P2425, DOI 10.1152/japplphysiol.01091.2002; TIMSON BF, 1985, J APPL PHYSIOL, V58, P619, DOI 10.1152/jappl.1985.58.2.619; Vazeille E, 2008, AM J PHYSIOL-ENDOC M, V295, pE1181, DOI 10.1152/ajpendo.90532.2008; Yamaguchi A, 1996, ACTA PHYSIOL SCAND, V158, P89, DOI 10.1046/j.1365-201X.1996.532277000.x; YAMASHITA K, 1992, PFLUG ARCH EUR J PHY, V421, P270, DOI 10.1007/BF00374837; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yang BC, 2006, BIOCHEM BIOPH RES CO, V341, P209, DOI 10.1016/j.bbrc.2005.12.172; Yasuhara K, 2011, J APPL PHYSIOL, V111, P1142, DOI 10.1152/japplphysiol.00471.2011; YOSHIOKA T, 1992, MED SPORT SCI, V37, P150; Zeng Q, 2007, LIFE SCI, V80, P454, DOI 10.1016/j.lfs.2006.09.031; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	50	28	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81929	10.1371/journal.pone.0081929	http://dx.doi.org/10.1371/journal.pone.0081929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324732	Green Submitted, Green Published, gold			2022-12-25	WOS:000328566700054
J	Ogata, S; Shimizu, C; Franco, A; Touma, R; Kanegaye, JT; Choudhury, BP; Naidu, NN; Kanda, Y; Hoang, LT; Hibberd, ML; Tremoulet, AH; Varki, A; Burns, JC				Ogata, Shohei; Shimizu, Chisato; Franco, Alessandra; Touma, Ranim; Kanegaye, John T.; Choudhury, Biswa P.; Naidu, Natasha N.; Kanda, Yutaka; Hoang, Long T.; Hibberd, Martin L.; Tremoulet, Adriana H.; Varki, Ajit; Burns, Jane C.			Treatment Response in Kawasaki Disease Is Associated with Sialylation Levels of Endogenous but Not Therapeutic Intravenous Immunoglobulin G	PLOS ONE			English	Article							BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; ANTIINFLAMMATORY ACTIVITY; IGG-FC; GLYCOSYLATION CHANGES; GAMMA-GLOBULIN; B-LYMPHOCYTES; P1 PROMOTER; DC-SIGN; CD22; GENE	Objectives: Although intravenous immunoglobulin (IVIG) is highly effective in Kawasaki disease (KD), mechanisms are not understood and 10-20% of patients are treatment-resistant, manifesting a higher rate of coronary artery aneurysms. Murine models suggest that alpha 2-6-linked sialic acid (alpha 2-6Sia) content of IVIG is critical for suppressing inflammation. However, pro-inflammatory states also up-regulate endogenous levels of beta-galactoside: alpha 2-6 sialyltransferase-I (ST6Gal-I), the enzyme that catalyzes addition of alpha 2-6Sias to N-glycans. We asked whether IVIG failures correlated with levels of alpha 2-6Sia on infused IVIG or on the patient's own endogenous IgG. Methods: We quantified levels of alpha 2-6Sia in infused IVIG and endogenous IgG from 10 IVIG-responsive and 10 resistant KD subjects using multiple approaches. Transcript levels of ST6GAL1, in patient whole blood and B cell lines were evaluated by RT-PCR. Plasma soluble (s) ST6Gal-I levels were measured by ELISA. Results: There was no consistent difference in median sialylation levels of infused IVIG between groups. However, alpha 2-6Sia levels in endogenous IgG, ST6GAL1 transcript levels, and ST6Gal-I protein in serum from IVIG-resistant KD subjects were lower than in responsive subjects at both pre-treatment and one-year time points (p < 0.001, respectively). Conclusions: Our data indicate sialylation levels of therapeutic IVIG are unrelated to treatment response in KD. Rather, lower sialylation of endogenous IgG and lower blood levels of ST6GALI mRNA and ST6Gal-I enzyme predict therapy resistance. These differences were stable over time, suggesting a genetic basis. Because IVIG-resistance increases risk of coronary artery aneurysms, our findings have important implications for the identification and treatment of such individuals.	[Ogata, Shohei; Shimizu, Chisato; Franco, Alessandra; Touma, Ranim; Kanegaye, John T.; Tremoulet, Adriana H.; Burns, Jane C.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Kanegaye, John T.; Tremoulet, Adriana H.; Burns, Jane C.] Rady Childrens Hosp San Diego, San Diego, CA USA; [Choudhury, Biswa P.; Naidu, Natasha N.; Varki, Ajit] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Kanda, Yutaka] Kyowa Hakko Kirin Calif Inc, La Jolla, CA USA; [Hoang, Long T.] Genome Inst Singapore, Div Infect Dis 1, Singapore, Singapore; [Hibberd, Martin L.] Genome Inst Singapore, Div Human Genet, Singapore, Singapore	University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Burns, JC (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA.	jcburns@ucsd.edu	Burns, Jane C/J-6167-2015; Shimizu, Chisato/J-6516-2015	Shimizu, Chisato/0000-0002-3149-2699; Hibberd, Martin/0000-0001-8587-1849	National Institutes of Health, National Heart, Lung, Blood Institute [HL69413, U54 HL108460, HL103536]; National Cancer Institute [R01CA38701]; UCSD Department of Pediatrics Intramural Research Program; UCSD Clinical Trials Research Institute [UL1TR000100]; Japan Foundation for Pediatric Research grant; NATIONAL CANCER INSTITUTE [R01CA038701] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL108460, R01HL103536, R01HL069413] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UCSD Department of Pediatrics Intramural Research Program; UCSD Clinical Trials Research Institute; Japan Foundation for Pediatric Research grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work supported in part by grants from the National Institutes of Health, National Heart, Lung, Blood Institute (HL69413 and U54 HL108460) (awarded to JCB), HL103536 (awarded to AF and JCB), National Cancer Institute grant R01CA38701 to A. V., the UCSD Department of Pediatrics Intramural Research Program and the UCSD Clinical Trials Research Institute UL1TR000100 (awarded to AHT), and the Japan Foundation for Pediatric Research grant (awarded to SO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2008, J ALLERGY CLIN IMMUN, V122, P1008, DOI 10.1016/j.jaci.2008.09.011; Acharya M, 2010, CLIN EXP IMMUNOL, V162, P12, DOI 10.1111/j.1365-2249.2010.04210.x; [Anonymous], 2009, ESSENTIALS GLYCOBIOL; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Anthony RM, 2010, J CLIN IMMUNOL, V30, pS9, DOI 10.1007/s10875-010-9405-6; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Anumula KR, 2012, J IMMUNOL METHODS, V382, P167, DOI 10.1016/j.jim.2012.05.022; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Barb AW, 2009, BIOCHEMISTRY-US, V48, P9705, DOI 10.1021/bi901430h; Blank M, 2010, BLOOD, V116, P1630, DOI 10.1182/blood-2010-06-289892; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Burton DR, 2006, SCIENCE, V313, P627, DOI 10.1126/science.1131712; Bussel JB, 2002, THROMB HAEMOSTASIS, V88, P890; Collins BE, 2006, NAT IMMUNOL, V7, P199, DOI 10.1038/ni1283; Crow AR, 2006, PEDIATR BLOOD CANCER, V47, P710, DOI 10.1002/pbc.20980; Ghosh S, 2006, INT IMMUNOL, V18, P603, DOI 10.1093/intimm/dxh402; Haas KM, 2006, J IMMUNOL, V177, P3063, DOI 10.4049/jimmunol.177.5.3063; HANASAKI K, 1994, J BIOL CHEM, V269, P10637; HANASAKI K, 1995, J BIOL CHEM, V270, P7533, DOI 10.1074/jbc.270.13.7533; HANASAKI K, 1995, J BIOL CHEM, V270, P7543, DOI 10.1074/jbc.270.13.7543; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hibbert RG, 2005, J EXP MED, V202, P751, DOI 10.1084/jem.20050811; Holland M, 2006, BBA-GEN SUBJECTS, V1760, P669, DOI 10.1016/j.bbagen.2005.11.021; Jones MB, 2012, J BIOL CHEM, V287, P15365, DOI 10.1074/jbc.M112.345710; Jones MB, 2010, J BIOL CHEM, V285, P25009, DOI 10.1074/jbc.M110.104406; Kanda Y, 2007, GLYCOBIOLOGY, V17, P104, DOI 10.1093/glycob/cwl057; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Karsten CM, 2012, NAT MED, V18, P1401, DOI 10.1038/nm.2862; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; Kobata A, 2008, BBA-GEN SUBJECTS, V1780, P472, DOI 10.1016/j.bbagen.2007.06.012; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; Kobayashi T, 2012, LANCET, V379, P1613, DOI 10.1016/S0140-6736(11)61930-2; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Lauc G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003225; LI CR, 1990, PEDIATR INFECT DIS J, V9, P544, DOI 10.1097/00006454-199008000-00003; LINDHOUT E, 1994, J EXP MED, V179, P1173, DOI 10.1084/jem.179.4.1173; Liu ZY, 2011, J BIOL CHEM, V286, P39654, DOI 10.1074/jbc.M111.276063; Lo NW, 1999, GLYCOBIOLOGY, V9, P907, DOI 10.1093/glycob/9.9.907; Lo NW, 1996, GLYCOBIOLOGY, V6, P271, DOI 10.1093/glycob/6.3.271; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; Nasirikenari M, 2006, BLOOD, V108, P3397, DOI 10.1182/blood-2006-04-014779; Nasirikenari M, 2010, J LEUKOCYTE BIOL, V87, P457, DOI 10.1189/jlb.1108704; Negi VS, 2007, J CLIN IMMUNOL, V27, P233, DOI 10.1007/s10875-007-9088-9; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Nimmerjahn F, 2007, P NATL ACAD SCI USA, V104, P8433, DOI 10.1073/pnas.0702936104; Ogata S, 2009, PEDIATR RES, V66, P577, DOI 10.1203/PDR.0b013e3181baa3c2; Popper SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r261; Prins C, 2007, ACTA DERM-VENEREOL, V87, P206, DOI 10.2340/00015555-0249; Pucic M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010090; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Saade S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029427; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Scanlan CN, 2008, P NATL ACAD SCI USA, V105, P4081, DOI 10.1073/pnas.0801192105; Selman MHJ, 2011, J PROTEOME RES, V10, P143, DOI 10.1021/pr1004373; Shimizu C, 2011, CIRC-CARDIOVASC GENE, V4, P16, DOI 10.1161/CIRCGENETICS.110.940858; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Sondermann P, 2013, P NATL ACAD SCI USA, V110, P9868, DOI 10.1073/pnas.1307864110; SPIEGLEB.HL, 1970, BIOCHEMISTRY-US, V9, P4217, DOI 10.1021/bi00823a025; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Stadlmann J, 2009, PROTEOMICS, V9, P4143, DOI 10.1002/pmic.200800931; SVENSSON EC, 1992, J BIOL CHEM, V267, P3466; TAKAHASHI N, 1987, BIOCHEMISTRY-US, V26, P1137, DOI 10.1021/bi00378a023; Tremoulet AH, 2008, J PEDIATR-US, V153, P117, DOI 10.1016/j.jpeds.2007.12.021; Tremoulet AH, 2012, J PEDIATR-US, V161, P506, DOI 10.1016/j.jpeds.2012.02.048; Varki A., 2009, ESSENTIALS GLYCOBIOL; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; WANG XC, 1993, J BIOL CHEM, V268, P4355; WANG XC, 1990, J BIOL CHEM, V265, P17849; WEINSTEIN J, 1987, J BIOL CHEM, V262, P17735; Yabe R, 2010, FEBS J, V277, P4010, DOI 10.1111/j.1742-4658.2010.07792.x; Yu XJ, 2013, J MOL BIOL, V425, P1253, DOI 10.1016/j.jmb.2013.02.006	74	45	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81448	10.1371/journal.pone.0081448	http://dx.doi.org/10.1371/journal.pone.0081448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324693	Green Accepted, gold, Green Published			2022-12-25	WOS:000328566700037
J	Terada, Y; Inoue, K; Matsumoto, T; Ishihara, M; Hamada, K; Shimamura, Y; Ogata, K; Inoue, K; Taniguchi, Y; Horino, T; Karashima, T; Tamura, K; Fukuhara, H; Fujimoto, S; Tsuda, M; Shuin, T				Terada, Yoshio; Inoue, Keiji; Matsumoto, Tatsuki; Ishihara, Masayuki; Hamada, Kazu; Shimamura, Yoshiko; Ogata, Koji; Inoue, Kosuke; Taniguchi, Yoshinori; Horino, Taro; Karashima, Takashi; Tamura, Kenji; Fukuhara, Hideo; Fujimoto, Shimpei; Tsuda, Masayuki; Shuin, Taro			5-Aminolevulinic Acid Protects against Cisplatin-Induced Nephrotoxicity without Compromising the Anticancer Efficiency of Cisplatin in Rats In Vitro and In Vivo	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; OXYGENASE-1 GENE ABLATION; HEME OXYGENASE-1; TUBULAR CELLS; INJURY; EXPRESSION; KIDNEY; APOPTOSIS; ACTIVATION; INDUCTION	Background/Aims: Nephrotoxicity is a frequent and major limitation in cisplatin (CDDP)-based chemotherapy. 5-Aminolevulinic acid (ALA) is widely distributed in animal cells, and it is a precursor of tetrapyrole compounds such as heme that is fundamentally important in aerobic energy metabolism. The aim of this study is to evaluate the protective role of ALA in CDDP-induced acute kidney injury (AKI). Method: We used CDDP-induced AKI rat model and cultured renal tubular cells (NRK-52E). We divided four groups of rats: control, CDDP only, CDDP + ALA(post);(ALA 10 mg/kg + Fe in drinking water) after CDDP, CDDP + ALA(pre & post). Result: CDDP increased Cr up to 6.5 mg/dl, BUN up to 230 mg/dl, and ALA significantly reduced these changes. ALA ameliorates CDDP-induced morphological renal damages, and reduced tubular apoptosis evaluated by TUNEL staining and cleaved caspase 3. Protein and mRNA levels of ATP5 alpha, complex(COX) IV, UCP2, PGC-1 alpha in renal tissue were significantly decreased by CDDP, and ALA ameliorates reduction of these enzymes. In contrast, Heme Oxigenase (HO)-1 level is induced by CDDP treatment, and ALA treatment further up-regulates HO-1 levels. In NRK-52E cells, the CDDP-induced reduction of protein and mRNA levels of mitochondrial enzymes was significantly recovered by ALA + Fe. CDDP-induced apoptosis were ameliorated by ALA + Fe treatment. Furthermore, we evaluated the size of transplantated bladder carcinoma to the rat skin, and ALA did not change the anti cancer effects of CDDP. Conclusion: These data suggested that the protective role of ALA in cisplatin-induced AKI is via protection of mitochondrial viability and prevents tubular apoptosis. Also there are no significant effects of ALA on anticancer efficiency of CDDP in rats. Thus, ALA has the potential to prevent CDDP nephrotoxicity without compromising its anticancer efficacy.	[Terada, Yoshio; Matsumoto, Tatsuki; Ishihara, Masayuki; Hamada, Kazu; Shimamura, Yoshiko; Ogata, Koji; Inoue, Kosuke; Taniguchi, Yoshinori; Horino, Taro; Fujimoto, Shimpei] Kochi Univ, Kochi Med Sch, Dept Endocrinol Metab & Nephrol, Nankoku, Kochi, Japan; [Inoue, Keiji; Karashima, Takashi; Tamura, Kenji; Fukuhara, Hideo; Shuin, Taro] Kochi Univ, Kochi Med Sch, Dept Urol, Nankoku, Kochi, Japan; [Tsuda, Masayuki] Kochi Univ, Kochi Med Sch, Inst Lab Anim Res, Nankoku, Kochi, Japan	Kochi University; Kochi University; Kochi University	Terada, Y (corresponding author), Kochi Univ, Kochi Med Sch, Dept Endocrinol Metab & Nephrol, Oko Cho, Nankoku, Kochi, Japan.	terada@kochi-u.ac.jp			Kidney Foundation Japan; Kochi organization for medical reformation and renewal; Ministry of Education, Science, Culture and Sports of Japan; Ministry of Health, Labour and Welfare of Japan	Kidney Foundation Japan(Kidney Foundation, Japan); Kochi organization for medical reformation and renewal; Ministry of Education, Science, Culture and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by The Kidney Foundation Japan and the Kochi organization for medical reformation and renewal (to YT); grants from the Ministry of Education, Science, Culture and Sports of Japan (to YT, KI, YS, KI, SF, TS); and a grant-in-aid for Progressive Renal Diseases Research, Research on Rare and Intractable Disease, from the Ministry of Health, Labour and Welfare of Japan (to YT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Agarwal A, 2000, J AM SOC NEPHROL, V11, P965, DOI 10.1681/ASN.V115965; Arany I, 2003, SEMIN NEPHROL, V23, P460, DOI 10.1016/S0270-9295(03)00089-5; Boulikas T, 2003, ONCOL REP, V10, P1663; BRADY HR, 1990, AM J PHYSIOL, V258, pF1181, DOI 10.1152/ajprenal.1990.258.5.F1181; Daemen MARC, 1999, J CLIN INVEST, V104, P541, DOI 10.1172/JCI6974; Ferris CD, 1999, NAT CELL BIOL, V1, P152, DOI 10.1038/11072; Hagiya Yuichiro, 2008, J Exp Ther Oncol, V7, P153; Hall AM, 2013, KIDNEY INT, V83, P72, DOI 10.1038/ki.2012.328; Inoue K, 2010, CLIN EXP NEPHROL, V14, P112, DOI 10.1007/s10157-009-0254-7; Ishihara M, 2013, AM J PHYSIOL-RENAL, V305, pF495, DOI 10.1152/ajprenal.00642.2012; Ishizuka M, 2011, INT IMMUNOPHARMACOL, V11, P358, DOI 10.1016/j.intimp.2010.11.029; Kaushal GP, 2001, KIDNEY INT, V60, P1726, DOI 10.1046/j.1523-1755.2001.00026.x; Kobayashi T, 2008, KIDNEY INT, V73, P1240, DOI 10.1038/ki.2008.74; Kobuchi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050082; Kuwana H, 2008, KIDNEY INT, V73, P430, DOI 10.1038/sj.ki.5002702; Lau AH, 1999, KIDNEY INT, V56, P1295, DOI 10.1046/j.1523-1755.1999.00687.x; Lebwohl D, 1998, EUR J CANCER, V34, P1522, DOI 10.1016/S0959-8049(98)00224-X; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Ogura Shun-Ichiro, 2011, BMC Res Notes, V4, P66, DOI 10.1186/1756-0500-4-66; Park MS, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134858; RIES F, 1986, AM J KIDNEY DIS, V8, P368, DOI 10.1016/S0272-6386(86)80112-3; SAFIRSTEIN R, 1986, AM J KIDNEY DIS, V8, P356, DOI 10.1016/S0272-6386(86)80111-1; Salahudeen AA, 2001, TRANSPLANTATION, V72, P1498, DOI 10.1097/00007890-200111150-00005; Shiraishi F, 2000, AM J PHYSIOL-RENAL, V278, pF726, DOI 10.1152/ajprenal.2000.278.5.F726; Tanabe K, 2012, AM J PHYSIOL-RENAL, V303, pF1264, DOI 10.1152/ajprenal.00227.2012; Tanaka H, 2004, J AM SOC NEPHROL, V15, P3083, DOI 10.1097/01.ASN.0000145459.54236.D3; Terada Y, 2003, J AM SOC NEPHROL, V14, P1223, DOI 10.1097/01.ASN.0000060577.94532.06; TERADA Y, 1994, J BIOL CHEM, V269, P31296; Terada Y, 2007, BIOCHEM BIOPH RES CO, V364, P1043, DOI 10.1016/j.bbrc.2007.10.122; WALLIN A, 1992, LAB INVEST, V66, P474; Zhou H, 1999, J LAB CLIN MED, V134, P649, DOI 10.1016/S0022-2143(99)90106-3	33	29	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e80850	10.1371/journal.pone.0080850	http://dx.doi.org/10.1371/journal.pone.0080850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324635	gold, Green Published, Green Submitted			2022-12-25	WOS:000328566700018
J	Zhou, Z; Miao, RD; Huang, SP; Elder, B; Quinn, T; Papasian, CJ; Zhang, JF; Fan, DP; Chen, YE; Fu, MG				Zhou, Zhou; Miao, Ruidong; Huang, Shengping; Elder, Brandon; Quinn, Tim; Papasian, Christopher J.; Zhang, Jifeng; Fan, Daping; Chen, Y. Eugene; Fu, Mingui			MCPIP1 Deficiency in Mice Results in Severe Anemia Related to Autoimmune Mechanisms	PLOS ONE			English	Article							PERNICIOUS-ANEMIA; ERYTHROPOIESIS; IRON; CELL	Autoimmune gastritis is an organ-specific autoimmune disease of the stomach associated with pernicious anemia. The previous work from us and other groups identified MCPIP1 as an essential factor controlling inflammation and immune homeostasis. MCPIP1(-/-) developed severe anemia. However, the mechanisms underlying this phenotype remain unclear. In the present study, we found that MCPIP1 deficiency in mice resulted in severe anemia related to autoimmune mechanisms. Although MCPIP1 deficiency did not affect erythropoiesis per se, the erythropoiesis in MCPIP1(-/-) bone marrow erythroblasts was significantly attenuated due to iron and vitamin B-12 (VB12) deficiency, which was mainly resulted from autoimmunity-associated gastritis and parietal cell loss. Consistently, exogenous supplement of iron and VB12 greatly improved the anemia phenotype of MCPIP1(-/-) mice. Finally, we have evidence suggesting that autoimmune hemolysis may also contribute to anemia phenotype of MCPIP1(-/-) mice. Taken together, our study suggests that MCPIP1 deficiency in mice leads to the development of autoimmune gastritis and pernicious anemia. Thus, MCPIP1(-/-) mice may be a good mouse model for investigating the pathogenesis of pernicious anemia and testing the efficacy of some potential drugs for treatment of this disease.	[Zhou, Zhou; Zhang, Jifeng; Chen, Y. Eugene] Univ Michigan, Med Ctr, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; [Miao, Ruidong; Huang, Shengping; Elder, Brandon; Quinn, Tim; Papasian, Christopher J.; Fu, Mingui] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA; [Fan, Daping] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC USA	University of Michigan System; University of Michigan; University of Missouri System; University of Missouri Kansas City; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Chen, YE (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA.	echenum@umich.edu; fum@umkc.edu	Zhou, Zhou/R-7788-2016		National Institutes of Health [HL098794, HL116626, HL068878, HL089544]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116626, R21HL098794, R01HL068878, R01HL089544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health grants (HL098794 to MF, HL116626 to DF, HL068878 and HL089544 to YEC). YEC is an Established Investigator of the American Heart Association (0840025N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderuccio F, 1998, AM J PATHOL, V153, P1311, DOI 10.1016/S0002-9440(10)65676-3; Annibale B, 2003, DIGEST LIVER DIS, V35, P288, DOI 10.1016/S1590-8658(03)00067-7; Coulon S, 2011, NAT MED, V17, P1456, DOI 10.1038/nm.2462; Gehrs BC, 2002, AM J HEMATOL, V69, P258, DOI 10.1002/ajh.10062; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x; Kato H, 2005, FASEB J, V19, P2023, DOI 10.1096/fj.05-3820fje; Kopic S, 2010, AM J PHYSIOL-CELL PH, V298, pC1, DOI 10.1152/ajpcell.00478.2009; Koury MJ, 2004, ANNU REV NUTR, V24, P105, DOI 10.1146/annurev.nutr.24.012003.132306; Lang E, 2012, INT J BIOCHEM CELL B, V44, P1236, DOI 10.1016/j.biocel.2012.04.019; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; Sica A, 2011, J MOL MED, V89, P657, DOI 10.1007/s00109-011-0724-8; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Toh BH, 1997, NEW ENGL J MED, V337, P1441, DOI 10.1056/NEJM199711133372007; Toh BH, 2004, AUTOIMMUNITY, V37, P357, DOI 10.1080/08916930410001705439; Young NS, 2006, BLOOD, V108, P2509, DOI 10.1182/blood-2006-03-010777	18	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82542	10.1371/journal.pone.0082542	http://dx.doi.org/10.1371/journal.pone.0082542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324805	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700086
J	Hawken, S; Kwong, JC; Deeks, SL; Crowcroft, NS; Ducharme, R; Manuel, DG; Wilson, K				Hawken, Steven; Kwong, Jeffrey C.; Deeks, Shelley L.; Crowcroft, Natasha S.; Ducharme, Robin; Manuel, Douglas G.; Wilson, Kumanan			Association between Birth Order and Emergency Room Visits and Acute Hospital Admissions following Pediatric Vaccination: A Self-Controlled Study	PLOS ONE			English	Article							IMMUNOGLOBULIN-E CONCENTRATION; ORIGIN IN-UTERO; ALLERGIC SENSITIZATION; SURVEILLANCE; AGE; VACCINES; EVENTS; SAFETY	Objective: We investigated the association between a child's birth order and emergency room (ER) visits and hospital admissions following 2-, 4-, 6- and 12-month pediatric vaccinations. Methods: We included all children born in Ontario between April 1st, 2006 and March 31st, 2009 who received a qualifying vaccination. We identified vaccinations, ER visits and admissions using health administrative data housed at the Institute for Clinical Evaluative Sciences. We used the self-controlled case series design to compare the relative incidence (RI) of events among 1st-born and later-born children using relative incidence ratios (RIR). Results: For the 2-month vaccination, the RIR for 1st-borns versus later-born children was 1.37 (95% CI: 1.19-1.57), which translates to 112 additional events/100,000 vaccinated. For the 4-month vaccination, the RIR for 1 st-borns vs. later-borns was 1.70 (95% CI: 1.45-1.99), representing 157 additional events/100,000 vaccinated. At 6 months, the RIR for 1st vs. later-borns was 1.27 (95% CI: 1.09-1.48), or 77 excess events/100,000 vaccinated. At the 12-month vaccination, the RIR was 1.11 (95% CI: 1.02-1.21), or 249 excess events/100,000 vaccinated. Conclusions: Birth order is associated with increased incidence of ER visits and hospitalizations following vaccination in infancy. 1 st-born children had significantly higher relative incidence of events compared to later-born children.	[Hawken, Steven; Ducharme, Robin; Manuel, Douglas G.; Wilson, Kumanan] ICES UOttawa, Ottawa, ON, Canada; [Hawken, Steven; Ducharme, Robin; Manuel, Douglas G.; Wilson, Kumanan] Ottawa Hosp Res Inst, Dept Clin Epidemiol, Ottawa, ON, Canada; [Hawken, Steven; Ducharme, Robin] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Kwong, Jeffrey C.; Deeks, Shelley L.; Crowcroft, Natasha S.] Publ Hlth Ontario, Toronto, ON, Canada; [Kwong, Jeffrey C.; Deeks, Shelley L.; Crowcroft, Natasha S.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Kwong, Jeffrey C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Crowcroft, Natasha S.] Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada; [Manuel, Douglas G.] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Wilson, Kumanan] Univ Ottawa, Dept Med, Ottawa Hosp Res Inst, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Wilson, K (corresponding author), ICES UOttawa, Ottawa, ON, Canada.	kwilson@ohri.ca	; Manuel, Doug/D-7100-2014	Ducharme, Robin/0000-0002-5665-7429; Manuel, Doug/0000-0003-0912-0845	Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care (MOHLTC)	Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This study was conducted with the support of the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results, and conclusions reported in this paper are those of the authors. No endorsement by ICES or Ontario's MOHLTC is intended or should be inferred.	Bernsen RMD, 2011, PLACENTA, V32, P922, DOI 10.1016/j.placenta.2011.05.004; Bernsen RMD, 2002, AM J EPIDEMIOL, V156, P882, DOI 10.1093/aje/kwf126; Centers for Disease Control and Prevention, 2011, GEN REC IMM REC ADV; Falagas ME, 2008, CURR MED RES OPIN, V24, P1719, DOI 10.1185/03007990802085692; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; Greene SK, 2010, AM J EPIDEMIOL, V171, P177, DOI 10.1093/aje/kwp345; Hawken S, 2012, AM J EPIDEMIOL; Karmaus W, 2002, J EPIDEMIOL COMMUN H, V56, P209, DOI 10.1136/jech.56.3.209; Karmaus W, 2001, AM J EPIDEMIOL, V154, P909, DOI 10.1093/aje/154.10.909; KUSHNIR T, 1984, J SOC PSYCHOL, V123, P123, DOI 10.1080/00224545.1984.9924520; National Advisory Committee on Immunization, 2006, CAN IMM GUID PUBL HL; Siegrist CA, 2007, J COMP PATHOL, V137, pS46, DOI 10.1016/j.jcpa.2007.04.012; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Stratton K.R., 1994, ADVERSE EVENTS ASS C; Virtanen M, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.5.e62; Warren DW, 2008, CAN J EMERG MED, V10, P224; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Wilson K, 2013, HUM VACC IMMUNOTHER, V9; Wilson K, 2012, VACCINE, V30, P6115, DOI 10.1016/j.vaccine.2012.06.004; Wilson K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027897; Wilson K, 2011, VACCINE, V29, P8267, DOI 10.1016/j.vaccine.2011.08.107; Wilson K, 2011, VACCINE, V29, P3746, DOI 10.1016/j.vaccine.2011.03.044	22	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81070	10.1371/journal.pone.0081070	http://dx.doi.org/10.1371/journal.pone.0081070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324662	Green Submitted, gold, Green Published			2022-12-25	WOS:000327949300069
J	McGrath, LJ; Becker-Dreps, S; Pate, V; Brookhart, MA				McGrath, Leah J.; Becker-Dreps, Sylvia; Pate, Virginia; Brookhart, M. Alan			Trends in Antibiotic Treatment of Acute Otitis Media and Treatment Failure in Children, 2000-2011	PLOS ONE			English	Article							PRESCRIPTION RATES; MANAGEMENT; CEFDINIR; PLACEBO	Objectives: Guidelines to treat acute otitis media (AOM) were published in 2004. Initial declines in prescribing were shown, but it's unknown if they were sustained. We examine trends in antibiotic dispensing patterns to treat AOM among a large population of children. We also document trends in antibiotic failure. Study Design: Children aged 3 months to 12 years with an AOM diagnosis, enrolled in a commercial claims database between January 1, 2000-December 31, 2011 were included. Pharmacy claims within 7 days of diagnosis were searched for antibiotic prescriptions. Antibiotic failure was defined as a dispensing of a different antibiotic class within 2-18 days after the first prescription. We analyzed trends in antibiotic use and failure by class of antibiotic and year. Results: We identified over 4 million children under 13 years with AOM. The proportion of antibiotic dispensing decreased from 66.0% in 2005 to 51.9% in 2007, after which the instances of dispensing rebounded to pre-guideline levels. However, levels began decreasing again in 2010 and the antibiotic use rate in 2011 was 57.6%. Cephalosporin prescriptions increased by 41.5% over eleven years. Antibiotic failure decreased slightly, and macrolides had the lowest proportion of failures, while all other classes had failure rates around 10%. Conclusions: In recent years, antibiotic dispensing to treat AOM remains high. In addition, the use of broad-spectrum antibiotics is increasing despite having a high rate of treatment failure. Overprescribing of antibiotics and use of non-penicillin therapy for AOM treatment could lead to the development of antibiotic-resistant infections.	[McGrath, Leah J.; Pate, Virginia; Brookhart, M. Alan] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Becker-Dreps, Sylvia] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	McGrath, LJ (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.	leah.mcgrath@unc.edu			Center for Pharmacoepidemiology at the University of North Carolina, Gillings School of Global Public Health; NIH [4K01TW008401-04]; FOGARTY INTERNATIONAL CENTER [K01TW008401] Funding Source: NIH RePORTER	Center for Pharmacoepidemiology at the University of North Carolina, Gillings School of Global Public Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This project was supported from an unrestricted fellowship from the Center for Pharmacoepidemiology at the University of North Carolina, Gillings School of Global Public Health. S.B.-D. received salary support from NIH grant # 4K01TW008401-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Belamarich PF, 2006, PEDIATRICS, V118, pE964, DOI 10.1542/peds.2006-0652; Block SL, 2004, PEDIATR INFECT DIS J, V23, P829, DOI 10.1097/01.inf.0000136868.91756.80; Block SL, 2006, CURR MED RES OPIN, V22, P1839, DOI 10.1185/030079906X132406; Cadieux G, 2007, CAN MED ASSOC J, V177, P877, DOI 10.1503/cmaj.070151; Casey JR, 2012, DRUGS, V72, P1991, DOI 10.2165/11590320-000000000-00000; Coco A, 2010, PEDIATRICS, V125, P214, DOI 10.1542/peds.2009-1115; Coco AS, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-41; Courter JD, 2010, ANN PHARMACOTHER, V44, P471, DOI 10.1345/aph.1M344; Cutrona SL, 2008, PEDIATRICS, V122, P736, DOI 10.1542/peds.2007-2928; Dagan R, 2001, J INFECT DIS, V183, P880, DOI 10.1086/319250; Finkelstein JA, 2003, PEDIATRICS, V112, P620, DOI 10.1542/peds.112.3.620; Gardner TL, 1996, NEW ZEAL MED J, V109, P69; Ginde AA, 2003, AM J EMERG MED, V21, P313, DOI 10.1016/S0735-6757(03)00084-6; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; Grubb MS, 2010, CLIN PEDIATR, V49, P970, DOI 10.1177/0009922810370363; Jansen AGSC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001480.pub3; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; McCaig LF, 2002, JAMA-J AM MED ASSOC, V287, P3096, DOI 10.1001/jama.287.23.3096; Pichichero ME, 2005, PEDIATRICS, V115, P1048, DOI 10.1542/peds.2004-1276; Quach C, 2005, PHARMACOEPIDEM DR S, V14, P163, DOI 10.1002/pds.991; Rosenfeld RM, 2004, PEDIATRICS, V113, P1412, DOI 10.1542/peds.113.5.1412; Sox CM, 2008, PEDIATRICS, V121, P674, DOI 10.1542/peds.2007-1565; Stille CJ, 2004, PEDIATRICS, V114, P1206, DOI 10.1542/peds.2004-0311; Tahtinen PA, 2011, NEW ENGL J MED, V364, P116, DOI 10.1056/NEJMoa1007174; Techasaensiri C, 2010, PEDIATR INFECT DIS J, V29, P294, DOI 10.1097/INF.0b013e3181c2a229; Vernacchio L, 2007, PEDIATRICS, V120, P281, DOI 10.1542/peds.2006-3601; Vouloumanou EK, 2009, J ANTIMICROB CHEMOTH, V64, P16, DOI 10.1093/jac/dkp166; Wroe PC, 2012, PEDIATR INFECT DIS J, V31, P249, DOI 10.1097/INF.0b013e31824214ac	30	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81210	10.1371/journal.pone.0081210	http://dx.doi.org/10.1371/journal.pone.0081210			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324680	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300082
J	Ortega-Senovilla, H; Schaefer-Graf, U; Meitzner, K; Graf, K; Abou-Dakn, M; Herrera, E				Ortega-Senovilla, Henar; Schaefer-Graf, Ute; Meitzner, Katrin; Graf, Kristof; Abou-Dakn, Michael; Herrera, Emilio			Lack of Relationship between Cord Serum Angiopoietin-Like Protein 4 (ANGPTL4) and Lipolytic Activity in Human Neonates Born by Spontaneous Delivery	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; FATTY-ACIDS; LIPOPROTEIN-LIPASE; LIPID LEVELS; PLASMA; HYPERLIPIDEMIA; STIMULATION; INHIBITOR; CORTISOL; OBESITY	Background: Ligands of peroxisome-proliferator activated receptors (PPARs), such as non-esterified fatty acids (NEFAs), induce expression of angiopoietin-like protein 4 (ANGPTL4). Recently ANGPTL4 has been reported to be a mediator of intracellular adipose lipolysis induced by glucocorticoids. Objective: To determine the concentrations of ANGPTL4 in cord serum of neonates born by spontaneous vaginal delivery (SVD) and by pre-labor cesarean section (CS) from healthy women, and to relate them to parameters of neonatal lipolytic activity at birth. Measurements: In 54 neonates born by SVD and in 56 neonates born by CS, arterial cord blood was drawn to determine insulin, cortisol, triacylglycerols (TAGs), glycerol, non-esterified fatty acids (NEFAs), individual fatty acids, ANGPTL4, adiponectin, retinol binding protein 4 (RBP4) and leptin. Results: Birth weight and neonatal fat mass in SVD and CS showed no difference, but the concentrations of glycerol, adiponectin, RBP4, NEFAs and most individual fatty acids were higher in cord serum of neonates born by SVD compared to CS, indicating a higher adipose tissue breakdown in the SVD group. The concentrations of TAG and cortisol were also higher and that of insulin was lower in cord serum of SVD compared to the CS group. However, the concentration in cord serum of ANGPTL4 did not differ between the two groups and no positive correlation with either NEFA or glycerol concentrations were detected. Conclusion: ANGPTL4 is known to stimulate lipolysis in adults, but does not appear to mediate the increased activity in SVD, indicating the presence of different regulatory inputs.	[Ortega-Senovilla, Henar; Herrera, Emilio] Univ San Pablo CEU, Fac Pharm, Dept Chem & Biochem, Madrid, Spain; [Ortega-Senovilla, Henar; Herrera, Emilio] Univ San Pablo CEU, Fac Med, Dept Chem & Biochem, Madrid, Spain; [Schaefer-Graf, Ute; Meitzner, Katrin; Abou-Dakn, Michael] St Josephs Hosp, Dept Obstet & Gynecol, Berlin Ctr Diabet Pregnancy, Berlin, Germany; [Graf, Kristof] Jewish Hosp, Dept Cardiol, Berlin, Germany	San Pablo CEU University; San Pablo CEU University	Ortega-Senovilla, H (corresponding author), Univ San Pablo CEU, Fac Pharm, Dept Chem & Biochem, Madrid, Spain.	henar@ceu.es	Herrera-Castillon, Emilio/D-9143-2012; Ortega-Senovilla, Henar/H-7431-2013	Herrera-Castillon, Emilio/0000-0002-8152-787X; Ortega-Senovilla, Henar/0000-0002-4360-4539	Spanish Ministry of Science and Innovation [SAF2012-39273]; Fundation Ramon Areces [CIVP16A 1835]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundation Ramon Areces	This study has been carried out with the financial support of the Spanish Ministry of Science and Innovation (grant SAF2012-39273) and Fundation Ramon Areces (grant CIVP16A 1835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amusquivar E, 2000, J NUTR, V130, P2855, DOI 10.1093/jn/130.11.2855; Bird JA, 1996, ARCH DIS CHILD-FETAL, V74, pF132, DOI 10.1136/fn.74.2.F132; BISTOLETTI P, 1983, AM J OBSTET GYNECOL, V147, P785, DOI 10.1016/0002-9378(83)90038-8; Brands M, 2013, J LIPID RES, V54, P615, DOI 10.1194/jlr.M030049; CARPENTER MW, 1982, AM J OBSTET GYNECOL, V144, P768, DOI 10.1016/0002-9378(82)90349-0; CATALANO PM, 1995, AM J OBSTET GYNECOL, V173, P1176, DOI 10.1016/0002-9378(95)91348-3; DIVERTIE GD, 1991, DIABETES, V40, P1228, DOI 10.2337/diabetes.40.10.1228; Folch J, 1957, J BIOL CHEM, V22, P24; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Ge HF, 2005, J LIPID RES, V46, P1484, DOI 10.1194/jlr.M500005-JLR200; Georgiadi A, 2010, CIRC RES, V106, P1712, DOI 10.1161/CIRCRESAHA.110.217380; Gitau R, 2001, EUR J OBSTET GYN R B, V98, P14, DOI 10.1016/S0301-2115(01)00298-6; Gray NE, 2012, J BIOL CHEM, V287, P8444, DOI 10.1074/jbc.M111.294124; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; HAGNEVIK K, 1984, ACTA PAEDIATR SCAND, V73, P602, DOI 10.1111/j.1651-2227.1984.tb09982.x; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Holm C, 2000, ANNU REV NUTR, V20, P365, DOI 10.1146/annurev.nutr.20.1.365; Jaquet D, 1998, J CLIN ENDOCR METAB, V83, P1243, DOI 10.1210/jc.83.4.1243; Jonker JT, 2013, AM J CLIN NUTR, V97, P255, DOI 10.3945/ajcn.112.043687; Kersten S, 2009, ARTERIOSCL THROM VAS, V29, P969, DOI 10.1161/ATVBAHA.108.182147; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; LASUNCION MA, 1987, BIOL NEONATE, V51, P86, DOI 10.1159/000242637; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; MARCUS C, 1988, J CLIN INVEST, V82, P1793, DOI 10.1172/JCI113793; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Mears Katrina, 2004, J Obstet Gynaecol, V24, P129; Miller NM, 2005, BJOG-INT J OBSTET GY, V112, P921, DOI 10.1111/j.1471-0528.2005.00620.x; Mizutani N, 2012, EXP CLIN ENDOCR DIAB, V120, P139, DOI 10.1055/s-0031-1291258; Ortega-Senovilla H, 2013, J CLIN ENDOCR METAB, V98, P3430, DOI 10.1210/jc.2013-1614; Robciuc MR, 2011, J LIPID RES, V52, P1575, DOI 10.1194/jlr.P015867; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Samra JS, 1998, J CLIN ENDOCR METAB, V83, P626, DOI 10.1210/jc.83.2.626; Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09; Shuang Z., 2010, VASCULAR BIOL PLACEN; Smith AJ, 2007, J BIOL CHEM, V282, P32424, DOI 10.1074/jbc.M703730200; Staiger H, 2009, DIABETES, V58, P579, DOI 10.2337/db07-1438; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; van Raalte DH, 2012, EXP CLIN ENDOCR DIAB, V120, P598, DOI 10.1055/s-0032-1321864; Vogl SE, 2006, BJOG-INT J OBSTET GY, V113, P441, DOI 10.1111/j.1471-0528.2006.00865.x; Voigt M, 1996, GEBURTSH FRAUENHEILK, V56, P550, DOI 10.1055/s-2007-1023283; Wang H, 2009, J BIOL CHEM, V284, P32116, DOI 10.1074/jbc.M109.006726; Wang Y, 2011, DIABETES, V60, P2041, DOI 10.2337/db11-0042; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200; Yoshimitsu N, 1999, BRIT J OBSTET GYNAEC, V106, P144, DOI 10.1111/j.1471-0528.1999.tb08214.x	47	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81201	10.1371/journal.pone.0081201	http://dx.doi.org/10.1371/journal.pone.0081201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324678	Green Submitted, Green Published, gold			2022-12-25	WOS:000327949300080
J	Silveira, CGT; Finas, D; Hunold, P; Koster, F; Stroschein, K; Canny, GO; Moldenhauer, G; Altevogt, P; Rody, A; Hornung, D				Silveira, Cassia G. T.; Finas, Dominique; Hunold, Peter; Koester, Frank; Stroschein, Katharina; Canny, Geraldine O.; Moldenhauer, Gerhard; Altevogt, Peter; Rody, Achim; Hornung, Daniela			L1 Cell Adhesion Molecule as a Potential Therapeutic Target in Murine Models of Endometriosis Using a Monoclonal Antibody Approach	PLOS ONE			English	Article							IN-VITRO; L1CAM; INNERVATION; INHIBITION; THERAPIES; MIGRATION; OUTGROWTH; PATTERNS; BINDING; FAMILY	Background/Aims: The neural cell adhesion molecule L1CAM is a transmembrane glycoprotein abnormally expressed in tumors and previously associated with cell proliferation, adhesion and invasion, as well as neurite outgrowth in endometriosis. Being an attractive target molecule for antibody-based therapy, the present study assessed the ability of the monoclonal anti-L1 antibody (anti-L1 mAb) to impair the development of endometriotic lesions in vivo and endometriosis-associated nerve fiber growth. Methods and Results: Endometriosis was experimentally induced in sexually mature B6C3F1 (n=34) and CD-1 nude (n= 21) mice by autologous and heterologous transplantation, respectively, of endometrial fragments into the peritoneal cavity. Transplantation was confirmed four weeks post-surgery by in vivo magnetic resonance imaging and laparotomy, respectively. Mice were then intraperitoneally injected with anti-L1 mAb or an IgG isotype control antibody twice weekly, over a period of four weeks. Upon treatment completion, mice were sacrificed and endometrial implants were excised, measured and fixed. Endometriosis was histologically confirmed and L1CAM was detected by immunohistochemistry. Endometriotic lesion size was significantly reduced in anti-L1-treated B6C3F1 and CD-1 nude mice compared to mice treated with control antibody (P<0.05). Accordingly, a decreased number of PCNA positive epithelial and stromal cells was detected in autologously and heterologously induced endometriotic lesions exposed to anti-L1 mAb treatment. Anti-L1-treated mice also presented a diminished number of intraperitoneal adhesions at implantation sites compared with controls. Furthermore, a double-blind counting of anti-neurofilament L stained nerves revealed significantly reduced nerve density within peritoneal lesions in anti-L1 treated B6C3F1 mice (P=0.0039). Conclusions: Local anti-L1 mAb treatment suppressed endometriosis growth in B6C3F1 and CD-1 nude mice and exerted a potent anti-neurogenic effect on induced endometriotic lesions in vivo. The findings of this preliminary study in mice provide a strong basis for further testing in in vivo models.	[Silveira, Cassia G. T.; Koester, Frank; Stroschein, Katharina; Rody, Achim; Hornung, Daniela] Univ Schleswig Holstein, Dept Gynecol & Obstet, Lubeck, Germany; [Finas, Dominique] Evangel Krankenhaus Bielefeld, Dept Gynecol & Obstet, Bielefeld, Germany; [Hunold, Peter] Univ Schleswig Holstein, Clin Radiol & Nucl Med, Lubeck, Germany; [Canny, Geraldine O.] Geneva Fdn Med Educ & Res, Versoix, Switzerland; [Moldenhauer, Gerhard; Altevogt, Peter] German Canc Res Ctr, Heidelberg, Germany; [Hornung, Daniela] Diakonissenkrankenhaus Karlsruhe Ruppurr, Dept Gynecol & Obstet, Karlsruhe, Germany	University of Kiel; Schleswig Holstein University Hospital; Evangelical Hospital Bethel (EvKB) - House Gilead I; University of Kiel; Schleswig Holstein University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ)	Hornung, D (corresponding author), Univ Schleswig Holstein, Dept Gynecol & Obstet, Lubeck, Germany.	D.Hornung@gmx.de	Silveira, Cássia G Terrassani/M-8057-2017; Köster, Frank/C-1694-2013	Köster, Frank/0000-0001-8684-3698; Canny, Geraldine/0000-0003-0632-7365	DFG [Ho 1832/6-1]; Bayer Health Care, Berlin, Germany	DFG(German Research Foundation (DFG)); Bayer Health Care, Berlin, Germany(Bayer AGBayer Healthcare Pharmaceuticals)	This study was supported by the DFG (Ho 1832/6-1) and by Bayer Health Care, Berlin, Germany (Grants for targets). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agic A, 2010, FERTIL STERIL, V94, P1102, DOI 10.1016/j.fertnstert.2009.11.050; Anaf V, 2000, HUM REPROD, V15, P1744, DOI 10.1093/humrep/15.8.1744; Arlt MJE, 2006, CANCER RES, V66, P936, DOI 10.1158/0008-5472.CAN-05-1818; Arnold J, 2012, BRAIN BEHAV IMMUN, V26, P132, DOI 10.1016/j.bbi.2011.08.004; Asante A, 2011, ANNU REV PHYSIOL, V73, P163, DOI 10.1146/annurev-physiol-012110-142158; Bajaj P, 2003, J PAIN, V4, P372, DOI 10.1016/S1526-5900(03)00720-X; Berkley KJ, 2004, P NATL ACAD SCI USA, V101, P11094, DOI 10.1073/pnas.0403663101; Blackmore M, 2006, J NEUROBIOL, V66, P1564, DOI 10.1002/neu.20311; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; Denes A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-164; Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8; Felding-Habermann B, 1997, J CELL BIOL, V139, P1567, DOI 10.1083/jcb.139.6.1567; Finas D, 2008, HUM REPROD, V23, P1053, DOI 10.1093/humrep/den044; FISCHER G, 1986, J NEUROSCI, V6, P605; Flores I, 2007, FERTIL STERIL, V87, P1180, DOI 10.1016/j.fertnstert.2006.07.1550; Grummer R, 2006, HUM REPROD UPDATE, V12, P641, DOI 10.1093/humupd/dml026; Guo SW, 2009, HUM REPROD UPDATE, V15, P441, DOI 10.1093/humupd/dmp007; Herron LR, 2009, BIOCHEM J, V419, P519, DOI 10.1042/BJ20082284; Honig MG, 2002, DEV BIOL, V243, P137, DOI 10.1006/dbio.2001.0556; Hortsch M, 2000, MOL CELL NEUROSCI, V15, P1, DOI 10.1006/mcne.1999.0809; Issa Y, 2009, J MOL MED, V87, P99, DOI 10.1007/s00109-008-0410-7; Itoh K, 2005, MOL CELL NEUROSCI, V30, P624, DOI 10.1016/j.mcn.2005.06.012; Kiefel H, 2012, CARCINOGENESIS, V33, P1919, DOI 10.1093/carcin/bgs220; Kiefel H, 2011, TRENDS MOL MED, V17, P178, DOI 10.1016/j.molmed.2010.11.005; Li YP, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-34; Long KE, 2000, J NEUROBIOL, V44, P230, DOI 10.1002/1097-4695(200008)44:2<230::AID-NEU12>3.0.CO;2-W; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Mechsner S, 2007, FERTIL STERIL, V88, P581, DOI 10.1016/j.fertnstert.2006.12.087; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Nolte C, 1999, CELL TISSUE RES, V298, P261, DOI 10.1007/s004419900063; Pelch KE, 2010, FERTIL STERIL, V93, P1615, DOI 10.1016/j.fertnstert.2009.03.086; Rawnaq T, 2012, J SURG RES, V173, P314, DOI 10.1016/j.jss.2010.10.029; Schaefer AW, 1999, J BIOL CHEM, V274, P37965, DOI 10.1074/jbc.274.53.37965; Schafer H, 2012, CANCER LETT, V319, P66, DOI 10.1016/j.canlet.2011.12.035; Shuptrine CW, 2012, SEMIN CANCER BIOL, V22, P3, DOI 10.1016/j.semcancer.2011.12.009; Silletti S, 2004, J BIOL CHEM, V279, P28880, DOI 10.1074/jbc.M404075200; Stratton P, 2011, HUM REPROD UPDATE, V17, P327, DOI 10.1093/humupd/dmq050; Taylor HS, 2011, REPROD SCI, V18, P814, DOI 10.1177/1933719111410713; Vercellini P, 2009, DRUGS, V69, P649, DOI 10.2165/00003495-200969060-00002; Wang GY, 2009, HUM REPROD, V24, P827, DOI 10.1093/humrep/den464; Weidle UH, 2009, ANTICANCER RES, V29, P4919; Whittard JD, 2006, MOL BIOL CELL, V17, P2696, DOI 10.1091/mbc.E06-01-0090; Wolterink S, 2010, CANCER RES, V70, P2504, DOI 10.1158/0008-5472.CAN-09-3730	43	10	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82512	10.1371/journal.pone.0082512	http://dx.doi.org/10.1371/journal.pone.0082512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324802	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300158
J	Vognsen, T; Moller, IR; Kristensen, O				Vognsen, Tina; Moller, Ingvar Runar; Kristensen, Ole			Crystal Structures of the Human G3BP1 NTF2-Like Domain Visualize FxFG Nup Repeat Specificity	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; TRANSPORT FACTOR-2 NTF2; BINDING-PROTEIN; ENDORIBONUCLEASE G3BP; ARGININE METHYLATION; STRESS GRANULES; MESSENGER-RNA; PHOSPHORYLATION; EXPRESSION; NUCLEOPORINS	Ras GTPase Activating Protein SH3 Domain Binding Protein (G3BP) is a potential anti-cancer drug target implicated in several cellular functions. We have used protein crystallography to solve crystal structures of the human G3BP1 NTF2-like domain both alone and in complex with an FxFG Nup repeat peptide. Despite high structural similarity, the FxFG binding site is located between two alpha helices in the G3BP1 NTF2-like domain and not at the dimer interface as observed for nuclear transport factor 2. ITC studies showed specificity towards the FxFG motif but not FG and GLFG motifs. The unliganded form of the G3BP1 NTF2-like domain was solved in two crystal forms to resolutions of 1.6 and 3.3 angstrom in space groups P2(1)2(1)2(1) and P6(3)22 based on two different constructs, residues 1-139 and 11-139, respectively. Crystal packing of the N-terminal residues against a symmetry related molecule in the P2(1)2(1)2(1) crystal form might indicate a novel ligand binding site that, however, remains to be validated. The crystal structures give insight into the nuclear transportation mechanisms of G3BP and provide a basis for future structure based drug design.	[Vognsen, Tina; Moller, Ingvar Runar; Kristensen, Ole] Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen	Kristensen, O (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth Sci, Copenhagen, Denmark.	ok@sund.ku.dk			University of Copenhagen (DANSCATT); Alfred Benzon Foundation; Lundbeck Foundation; Brdr. Hartmanns Foundation; Aase and Ejnar Danielsens Foundation; University of Copenhagen	University of Copenhagen (DANSCATT); Alfred Benzon Foundation; Lundbeck Foundation(Lundbeckfonden); Brdr. Hartmanns Foundation; Aase and Ejnar Danielsens Foundation; University of Copenhagen	The study was supported by University of Copenhagen (DANSCATT), the Alfred Benzon Foundation, the Lundbeck Foundation, Brdr. Hartmanns Foundation, Aase and Ejnar Danielsens Foundation and a University of Copenhagen Ph.D. stipend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Annibaldi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029024; Atlas R, 2004, J NEUROCHEM, V89, P613, DOI 10.1111/j.1471-4159.2004.02371.x; Barnes CJ, 2002, CANCER RES, V62, P1251; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Bayliss R, 2002, EMBO J, V21, P2843, DOI 10.1093/emboj/cdf305; Bikkavilli RK, 2012, J CELL SCI, V125, P2446, DOI 10.1242/jcs.100933; Bikkavilli RK, 2011, J CELL SCI, V124, P2310, DOI 10.1242/jcs.084046; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Chaillan-Huntington C, 2000, J BIOL CHEM, V275, P5874, DOI 10.1074/jbc.275.8.5874; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; Cui W, 2010, J CHEM INF MODEL, V50, P380, DOI 10.1021/ci900404p; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; French J, 2002, HISTOCHEM J, V34, P223, DOI 10.1023/A:1021737413055; Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3; Gallouzi IE, 1998, MOL CELL BIOL, V18, P3956, DOI 10.1128/MCB.18.7.3956; Gao XJ, 2010, FEBS LETT, V584, P3525, DOI 10.1016/j.febslet.2010.07.022; Guitard E, 2001, CANCER LETT, V162, P213, DOI 10.1016/S0304-3835(00)00638-8; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19; Irvine K, 2004, INT J DEV BIOL, V48, P1065, DOI 10.1387/ijdb.041893ki; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katsafanas GC, 2004, J BIOL CHEM, V279, P52210, DOI 10.1074/jbc.M411033200; Kennedy D, 2002, J CELL BIOCH, V187; Kim MM, 2007, ONCOGENE, V26, P4209, DOI 10.1038/sj.onc.1210212; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Parker F, 1996, MOL CELL BIOL, V16, P2561; Prigent M, 2000, J BIOL CHEM, V275, P36441, DOI 10.1074/jbc.M004751200; Shim JH, 2010, CANCER PREV RES, V3, P670, DOI 10.1158/1940-6207.CAPR-09-0185; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Stewart M, 1998, J MOL BIOL, V277, P635, DOI 10.1006/jmbi.1997.1602; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taniuchi K, 2011, MOL CANCER RES, V9, P856, DOI 10.1158/1541-7786.MCR-10-0574; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Vognsen T, 2012, BIOCHEM BIOPH RES CO, V420, P188, DOI 10.1016/j.bbrc.2012.02.140; Vognsen T, 2011, ACTA CRYSTALLOGR F, V67, P48, DOI 10.1107/S1744309110042156; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Xu C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003169; [张鹤 Zhang He], 2012, [混凝土, Concrete], P1; Zhang HZ, 2007, WORLD J GASTROENTERO, V13, P4126, DOI 10.3748/wjg.v13.i30.4126	49	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80947	10.1371/journal.pone.0080947	http://dx.doi.org/10.1371/journal.pone.0080947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324649	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300061
J	Yatagai, Y; Sakamoto, T; Masuko, H; Kaneko, Y; Yamada, H; Iijima, H; Naito, T; Noguchi, E; Hirota, T; Tamari, M; Imoto, Y; Tokunaga, T; Fujieda, S; Konno, S; Nishimura, M; Hizawa, N				Yatagai, Yohei; Sakamoto, Tohru; Masuko, Hironori; Kaneko, Yoshiko; Yamada, Hideyasu; Iijima, Hiroaki; Naito, Takashi; Noguchi, Emiko; Hirota, Tomomitsu; Tamari, Mayumi; Imoto, Yoshimasa; Tokunaga, Takahiro; Fujieda, Shigeharu; Konno, Satoshi; Nishimura, Masaharu; Hizawa, Nobuyuki			Genome-Wide Association Study for Levels of Total Serum IgE Identifies HLA-C in a Japanese Population	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; SUSCEPTIBILITY LOCI; IMMUNOGLOBULIN-E; AIRWAY RESPONSIVENESS; ITALIAN FAMILIES; LINKAGE ANALYSES; BEHCETS-DISEASE; GENE PROMOTER; ASTHMA; POLYMORPHISM	Most of the previously reported loci for total immunoglobulin E (IgE) levels are related to Th2 cell-dependent pathways. We undertook a genome-wide association study (GWAS) to identify genetic loci responsible for IgE regulation. A total of 479,940 single nucleotide polymorphisms (SNPs) were tested for association with total serum IgE levels in 1180 Japanese adults. Fine-mapping with SNP imputation demonstrated 6 candidate regions: the PYHIN1/IFI16, MHC classes I and II, LEMD2, GRAMD1B, and chr13: 60576338 regions. Replication of these candidate loci in each region was assessed in 2 independent Japanese cohorts (n = 1110 and 1364, respectively). SNP rs3130941 in the HLA-C region was consistently associated with total IgE levels in 3 independent populations, and the meta-analysis yielded genome-wide significance (P = 1.07 x 10(-10)). Using our GWAS results, we also assessed the reproducibility of previously reported gene associations with total IgE levels. Nine of 32 candidate genes identified by a literature search were associated with total IgE levels after correction for multiple testing. Our findings demonstrate that SNPs in the HLA-C region are strongly associated with total serum IgE levels in the Japanese population and that some of the previously reported genetic associations are replicated across ethnic groups.	[Yatagai, Yohei; Sakamoto, Tohru; Masuko, Hironori; Kaneko, Yoshiko; Yamada, Hideyasu; Hizawa, Nobuyuki] Univ Tsukuba, Dept Pulm Med, Fac Med, Ibaraki, Japan; [Iijima, Hiroaki; Naito, Takashi] Tsukuba Med Ctr, Ibaraki, Japan; [Noguchi, Emiko] Univ Tsukuba, Dept Med Genet, Fac Med, Ibaraki, Japan; [Hirota, Tomomitsu; Tamari, Mayumi] RIKEN, Lab Resp Dis, Ctr Genom Med, Inst Phys & Chem Res, Kanagawa, Japan; [Imoto, Yoshimasa; Tokunaga, Takahiro; Fujieda, Shigeharu] Univ Fukui, Dept Otorhinolaryngol Head & Neck Surg, Fac Med, Fukui 910, Japan; [Konno, Satoshi; Nishimura, Masaharu] Hokkaido Univ, Dept Med 1, Sch Med, Sapporo, Hokkaido 060, Japan	University of Tsukuba; University of Tsukuba; RIKEN; University of Fukui; Hokkaido University	Sakamoto, T (corresponding author), Univ Tsukuba, Dept Pulm Med, Fac Med, Ibaraki, Japan.	t-saka@md.tsukuba.ac.jp	Tamari, Mayumi/N-5378-2015; Nishimura, Masaharu/A-4062-2012	Nishimura, Masaharu/0000-0002-6456-4361; Sakamoto, Tohru/0000-0002-8876-1466	Japan Society for the Promotion of Science [24390206]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was partly supported by a Grant-in-Aid for Scientific Research (B), No. 24390206, from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adrianto I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043907; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boyton RJ, 2006, AM J RESP CRIT CARE, V173, P327, DOI 10.1164/rccm.200501-124OC; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Das A, 2010, J IMMUNOL, V185, P4698, DOI 10.4049/jimmunol.1001220; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; DIZIER MH, 1995, GENET EPIDEMIOL, V12, P93, DOI 10.1002/gepi.1370120109; Ellison-Loschmann L, 2007, CANCER EPIDEM BIOMAR, V16, P1492, DOI 10.1158/1055-9965.EPI-07-0176; Gaidano G, 2012, J CLIN INVEST, V122, P3432, DOI 10.1172/JCI64101; Goubau D, 2010, NAT IMMUNOL, V11, P984, DOI 10.1038/ni1110-984; Granada M, 2012, J ALLERGY CLIN IMMUN, V129, P840, DOI 10.1016/j.jaci.2011.09.029; Gueant-Rodriguez RM, 2008, PHARMACOGENOMICS J, V8, P162, DOI 10.1038/sj.tpj.6500456; Harada M, 2009, AM J RESP CRIT CARE, V180, P1048, DOI 10.1164/rccm.200905-0652OC; Hattori T, 2012, ALLERGY ASTHMA PROC, V33, P90, DOI 10.2500/aap.2012.33.3491; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Hizawa N, 2000, AM J RESP CRIT CARE, V161, P906, DOI 10.1164/ajrccm.161.3.9903128; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Hughes T, 2013, NAT GENET, V45, P319, DOI 10.1038/ng.2551; Isada A, 2010, J HUM GENET, V55, P167, DOI 10.1038/jhg.2010.4; Jacobsen HP, 2001, J ALLERGY CLIN IMMUN, V107, P659; Jacquet A, 2011, TRENDS MOL MED, V17, P604, DOI 10.1016/j.molmed.2011.05.014; Kalinski P, 2005, NAT REV IMMUNOL, V5, P251, DOI 10.1038/nri1569; Kim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071958; Krasznai M, 2011, EUR ARCH OTO-RHINO-L, V268, P561, DOI 10.1007/s00405-010-1424-7; LEBOWITZ MD, 1984, J ALLERGY CLIN IMMUN, V73, P259, DOI 10.1016/S0091-6749(84)80017-2; Levin AM, 2013, J ALLERGY CLIN IMMUN, V131, P1176, DOI 10.1016/j.jaci.2012.10.002; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liao M, 2013, IMMUNOGENETICS, V65, P561, DOI 10.1007/s00251-013-0706-9; Malerba G, 1999, CLIN EXP ALLERGY, V29, P27; MARSH DG, 1981, NEW ENGL J MED, V305, P1551, DOI 10.1056/NEJM198112243052603; Masuko H, 2011, INT J CHRONIC OBSTR, V6, P181, DOI 10.2147/COPD.S16383; Mathias RA, 2001, GENET EPIDEMIOL, V20, P340, DOI 10.1002/gepi.5; MEYERS DA, 1987, AM J HUM GENET, V41, P51; MILLER SP, 1984, CLIN CHEM, V30, P1467; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Onat AM, 2007, CLIN RHEUMATOL, V26, P81, DOI 10.1007/s10067-006-0335-x; Ovcina-Kurtovic Nermina, 2010, Med Arh, V64, P28; Palmer LJ, 2000, AM J RESP CRIT CARE, V161, P1836, DOI 10.1164/ajrccm.161.6.9805104; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabinovitch N, 2005, J ALLERGY CLIN IMMUN, V116, P1053, DOI 10.1016/j.jaci.2005.08.045; Sakashita M, 2010, INT ARCH ALLERGY IMM, V151, P255, DOI 10.1159/000242363; SEARS MR, 1991, NEW ENGL J MED, V325, P1067, DOI 10.1056/NEJM199110103251504; Sharma S, 2006, AM J RESP CELL MOL, V35, P488, DOI 10.1165/rcmb.2006-0084OC; Shin HD, 2004, HUM MOL GENET, V13, P397, DOI 10.1093/hmg/ddh036; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Thomas MJ, 2002, J IMMUNOL, V168, P216, DOI 10.4049/jimmunol.168.1.216; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Trabetti E, 1999, J MED GENET, V36, P323; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; Wise AL, 2013, AM J HUM GENET, V92, P643, DOI 10.1016/j.ajhg.2013.03.017; Wuthrich B, 1996, INT ARCH ALLERGY IMM, V111, P396, DOI 10.1159/000237398; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452	55	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80941	10.1371/journal.pone.0080941	http://dx.doi.org/10.1371/journal.pone.0080941			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324648	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300060
J	Kim, D; Zai, LL; Liang, P; Schaffling, C; Ahlborn, D; Benowitz, LI				Kim, Daniel; Zai, Laila; Liang, Peng; Schaffling, Colleen; Ahlborn, David; Benowitz, Larry I.			Inosine Enhances Axon Sprouting and Motor Recovery after Spinal Cord Injury	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; CENTRAL-NERVOUS-SYSTEM; LOCOMOTOR RECOVERY; CORTICOSPINAL TRACT; INTRACORTICAL DELIVERY; SEROTONIN RECEPTORS; CORTICAL INFARCT; ACID PRECURSORS; BRAIN-INJURY; ADULT RATS	Although corticospinal tract axons cannot regenerate long distances after spinal cord injury, they are able to sprout collateral branches rostral to an injury site that can help form compensatory circuits in cases of incomplete lesions. We show here that inosine enhances the formation of compensatory circuits after a dorsal hemisection of the thoracic spinal cord in mature rats and improves coordinated limb use. Inosine is a naturally occurring metabolite of adenosine that crosses the cell membrane and, in neurons, activates Mst3b, a protein kinase that is part of a signal transduction pathway that regulates axon outgrowth. Compared to saline-treated controls, rats with dorsal hemisections that were treated with inosine showed three times as many synaptic contacts between corticospinal tract collaterals and long propriospinal interneurons that project from the cervical cord to the lumbar level. Inosine-treated rats also showed stronger serotonergic reinnervation of the lumbar cord than saline-treated controls, and performed well above controls in both open-field testing and a horizontal ladder rung-walking test. Inosine was equally effective whether delivered intracranially or intravenously, and has been shown to be safe for other indications in humans. Thus, inosine might be a useful therapeutic for improving outcome after spinal cord injury.	[Kim, Daniel; Zai, Laila; Liang, Peng; Schaffling, Colleen; Ahlborn, David; Benowitz, Larry I.] Childrens Hosp, Labs Neurosci Res Neurosurg, Boston, MA 02115 USA; [Kim, Daniel; Zai, Laila; Liang, Peng; Benowitz, Larry I.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Zai, Laila; Liang, Peng; Benowitz, Larry I.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Benowitz, Larry I.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Benowitz, Larry I.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Benowitz, LI (corresponding author), Childrens Hosp, Labs Neurosci Res Neurosurg, 300 Longwood Ave, Boston, MA 02115 USA.	larry.benowitz@childrens.harvard.edu		Benowitz, Larry/0000-0002-0277-7222	Wings For Life Foundation; Translational Research Program of Boston Children's Hospital; Dana and Christopher Reeve Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; China Scholarship Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER	Wings For Life Foundation; Translational Research Program of Boston Children's Hospital; Dana and Christopher Reeve Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; China Scholarship Council(China Scholarship Council); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Wings For Life Foundation (to L. B.); The Translational Research Program of Boston Children's Hospital (to L. B.); The Dana and Christopher Reeve Foundation (to L. B.); The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (to L. B.); and The China Scholarship Council (to P. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballermann M, 2006, EUR J NEUROSCI, V23, P1988, DOI 10.1111/j.1460-9568.2006.04726.x; BARBEAU H, 1994, CURR OPIN NEUROL, V7, P517, DOI 10.1097/00019052-199412000-00008; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Benowitz L, 2012, EXP NEUROL, V233, P674, DOI 10.1016/j.expneurol.2011.09.034; Benowitz LI, 1999, P NATL ACAD SCI USA, V96, P13486, DOI 10.1073/pnas.96.23.13486; Benowitz LI, 1998, J BIOL CHEM, V273, P29626, DOI 10.1074/jbc.273.45.29626; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; Cafferty WBJ, 2006, J NEUROSCI, V26, P12242, DOI 10.1523/JNEUROSCI.3827-06.2006; Chen P, 2002, P NATL ACAD SCI USA, V99, P9031, DOI 10.1073/pnas.132076299; CORNFORD EM, 1975, BIOCHIM BIOPHYS ACTA, V394, P211, DOI 10.1016/0005-2736(75)90259-X; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; CZARNECKI W, 1989, PHARMACOL RES, V21, P587, DOI 10.1016/1043-6618(89)90200-4; Darlot F, 2012, EXP NEUROL, V236, P88, DOI 10.1016/j.expneurol.2012.04.004; Fang PC, 2010, STROKE, V41, P544, DOI 10.1161/STROKEAHA.109.572073; Fenrich KK, 2009, J NEUROSCI, V29, P12145, DOI 10.1523/JNEUROSCI.0897-09.2009; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fonoff ET, 2009, BEHAV BRAIN RES, V202, P138, DOI 10.1016/j.bbr.2009.03.018; Fouad K, 2010, J NEUROPHYSIOL, V104, P2975, DOI 10.1152/jn.00499.2010; Hasko G, 2004, TRENDS PHARMACOL SCI, V25, P152, DOI 10.1016/j.tips.2004.01.006; Hasko G, 2000, J IMMUNOL, V164, P1013, DOI 10.4049/jimmunol.164.2.1013; Haun SE, 1996, J NEUROCHEM, V67, P2051; HAVTON L, 1987, NATURE, V325, P711, DOI 10.1038/325711a0; Irwin N, 2006, P NATL ACAD SCI USA, V103, P18320, DOI 10.1073/pnas.0605135103; Jurkowitz MS, 1998, J NEUROCHEM, V71, P535; Kim DH, 1999, J NEUROSCI, V19, P6213, DOI 10.1523/JNEUROSCI.19-14-06213.1999; Kim JE, 2003, 41511 SOC NEUR; Lang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030461; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Liu F, 2006, SPINAL CORD, V44, P421, DOI 10.1038/sj.sc.3101878; Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Lorber B, 2009, NAT NEUROSCI, V12, P1407, DOI 10.1038/nn.2414; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; MARANGOS PJ, 1981, PSYCHOPHARMACOLOGY, V75, P175, DOI 10.1007/BF00432183; McEwen ML, 2006, J NEUROTRAUM, V23, P1632, DOI 10.1089/neu.2006.23.1632; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Nakagawa S, 1973, J Neurochem, V20, P1141; Oertle T, 2003, J NEUROSCI, V23, P5393; Onifer SM, 2011, NEUROTHERAPEUTICS, V8, P283, DOI 10.1007/s13311-011-0034-4; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Petrausch B, 2000, J NEUROSCI, V20, P8031; Reed WR, 2006, NEUROSCIENCE, V142, P1195, DOI 10.1016/j.neuroscience.2006.07.017; Ribotta MGY, 2000, J NEUROSCI, V20, P5144; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Rossignol S, 2007, J NEUROSCI, V27, P11782, DOI 10.1523/JNEUROSCI.3444-07.2007; Rossignol S, 2011, ANNU REV NEUROSCI, V34, P413, DOI 10.1146/annurev-neuro-061010-113746; Saruhashi Y, 1996, EXP NEUROL, V139, P203, DOI 10.1006/exnr.1996.0094; Schabitz WR, 2004, STROKE, V35, P992, DOI 10.1161/01.STR.0000119754.85848.0D; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Scott GS, 2002, P NATL ACAD SCI USA, V99, P16303, DOI 10.1073/pnas.212645999; Scott GS, 2005, P NATL ACAD SCI USA, V102, P3483, DOI 10.1073/pnas.0500307102; Shen H, 2005, STROKE, V36, P654, DOI 10.1161/01.STR.0000155747.15679.04; SKAGERBERG G, 1985, NEUROSCIENCE, V15, P445, DOI 10.1016/0306-4522(85)90225-8; Smith JM, 2007, BRAIN, V130, P915, DOI 10.1093/brain/awl393; Starling RD, 1996, MED SCI SPORT EXER, V28, P1193, DOI 10.1097/00005768-199609000-00017; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; Steward O, 2012, EXP NEUROL, V233, P662, DOI 10.1016/j.expneurol.2011.09.019; Tuszynski MH, 2003, EXP NEUROL, V181, P47, DOI 10.1016/S0014-4886(02)00055-9; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Vavrek R, 2006, BRAIN, V129, P1534, DOI 10.1093/brain/awl087; Wang XX, 2009, J NEUROTRAUM, V26, P81, DOI 10.1089/neu.2007.0464; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; Zai LL, 2011, J NEUROSCI, V31, P5977, DOI 10.1523/JNEUROSCI.4498-10.2011; Zai LL, 2009, J NEUROSCI, V29, P8187, DOI 10.1523/JNEUROSCI.0414-09.2009; ZURN AD, 1988, P NATL ACAD SCI USA, V85, P8301, DOI 10.1073/pnas.85.21.8301	69	22	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81948	10.1371/journal.pone.0081948	http://dx.doi.org/10.1371/journal.pone.0081948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312612	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500107
J	Moore, LS; Stolovicki, E; Braun, E				Moore, Lindsay S.; Stolovicki, Elad; Braun, Erez			Population Dynamics of Metastable Growth-Rate Phenotypes	PLOS ONE			English	Article							BENEFICIAL MUTATIONS; GENE-REGULATION; EPIGENETIC INHERITANCE; ADAPTATION; EVOLUTION; EXPRESSION; HEREDITY; CANCER; SPEED	Neo-Darwinian evolution has presented a paradigm for population dynamics built on random mutations and selection with a clear separation of time-scales between single-cell mutation rates and the rate of reproduction. Laboratory experiments on evolving populations until now have concentrated on the fixation of beneficial mutations. Following the Darwinian paradigm, these experiments probed populations at low temporal resolution dictated by the rate of rare mutations, ignoring the intermediate evolving phenotypes. Selection however, works on phenotypes rather than genotypes. Research in recent years has uncovered the complexity of genotype-to-phenotype transformation and a wealth of intracellular processes including epigenetic inheritance, which operate on a wide range of time-scales. Here, by studying the adaptation dynamics of genetically rewired yeast cells, we show a novel type of population dynamics in which the intracellular processes intervene in shaping the population structure. Under constant environmental conditions, we measure a wide distribution of growth rates that coexist in the population for very long durations (> 100 generations). Remarkably, the fastest growing cells do not take over the population on the time-scale dictated by the width of the growth-rate distributions and simple selection. Additionally, we measure significant fluctuations in the population distribution of various phenotypes: the fraction of exponentially-growing cells, the distributions of single-cell growth-rates and protein content. The observed fluctuations relax on time-scales of many generations and thus do not reflect noisy processes. Rather, our data show that the phenotypic state of the cells, including the growth-rate, for large populations in a constant environment is metastable and varies on time-scales that reflect the importance of long-term intracellular processes in shaping the population structure. This lack of time-scale separation between the intracellular and population processes calls for a new framework for population dynamics which is likely to be significant in a wide range of biological contexts, from evolution to cancer.	[Braun, Erez] Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; Technion Israel Inst Technol, Network Biol Res Labs, IL-32000 Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology	Braun, E (corresponding author), Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel.	erez@physics.technion.ac.il	Stolovicki, Elad/AAT-1742-2021		Israel Science Foundation [496/10]	Israel Science Foundation(Israel Science Foundation)	This work was supported by the Israel Science Foundation (grant # 496/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bataillon T, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0945; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Danchin E, 2011, NAT REV GENET, V12, P475, DOI 10.1038/nrg3028; David L, 2013, MOL BIOL EVOL, V30, P1514, DOI 10.1093/molbev/mst071; David L, 2010, HFSP J, V4, P131, DOI 10.2976/1.3353782; Desai MM, 2007, CURR BIOL, V17, P385, DOI 10.1016/j.cub.2007.01.072; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Gilbert S. F., 2009, ECOLOGICAL DEV BIOL; Gordo I, 2001, J MOL MICROB BIOTECH, V21, P20; Hallatschek O, 2011, P NATL ACAD SCI USA, V108, P1783, DOI 10.1073/pnas.1013529108; Helantera HU, 2010, PHILOS THEORY BIOL; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Jablonka E, 2012, CLIN PHARMACOL THER, V92, P683, DOI 10.1038/clpt.2012.158; Jablonka E, 2005, EVOLUTION 4 DIMENSIO; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Kao KC, 2008, NAT GENET, V40, P1499, DOI 10.1038/ng.280; Katzir Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045184; Lachmann M, 1996, J THEOR BIOL, V181, P1, DOI 10.1006/jtbi.1996.0109; Lang GI, 2011, GENETICS, V188, P647, DOI 10.1534/genetics.111.128942; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Levy SF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001325; Madhi SA, 2021, SAFETY EFFICACY CHAD, DOI 10.1101/2021.02.10.21251247; Manrubia SC, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.188102; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; PAQUIN C, 1983, NATURE, V302, P495, DOI 10.1038/302495a0; Park SC, 2010, J STAT PHYS, V138, P381, DOI 10.1007/s10955-009-9915-x; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rouzine IM, 2008, THEOR POPUL BIOL, V73, P24, DOI 10.1016/j.tpb.2007.10.004; Rozen DE, 2002, CURR BIOL, V12, P1040, DOI 10.1016/S0960-9822(02)00896-5; Salman H, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.238105; Sniegowski PD, 2010, PHILOS T R SOC B, V365, P1255, DOI 10.1098/rstb.2009.0290; Sprouffske K, 2012, CURR BIOL, V22, pR762, DOI 10.1016/j.cub.2012.06.065; Stern S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100147; Stolovicki E, 2006, GENETICS, V173, P75, DOI 10.1534/genetics.106.055442; Stolovicki E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020530; Tsimring LS, 1996, PHYS REV LETT, V76, P4440, DOI 10.1103/PhysRevLett.76.4440; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105; West-Eberhard Mary Jane, 2003, pi; Wilkins AS, 2010, BIOESSAYS, V32, P856, DOI 10.1002/bies.201000008	44	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81671	10.1371/journal.pone.0081671	http://dx.doi.org/10.1371/journal.pone.0081671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312571	Green Submitted, gold, Green Published			2022-12-25	WOS:000327944500085
J	Stapleton, S; Milosevic, M; Allen, C; Zheng, J; Dunne, M; Yeung, I; Jaffray, DA				Stapleton, Shawn; Milosevic, Michael; Allen, Christine; Zheng, Jinzi; Dunne, Michael; Yeung, Ivan; Jaffray, David A.			A Mathematical Model of the Enhanced Permeability and Retention Effect for Liposome Transport in Solid Tumors	PLOS ONE			English	Article							INTERSTITIAL FLUID PRESSURE; PHASE-II; DRUG-DELIVERY; MICROVASCULAR PERMEABILITY; STEALTH LIPOSOMES; DOXORUBICIN; CT; ANTHRACYCLINES; ACCUMULATION; CHEMOTHERAPY	The discovery of the enhanced permeability and retention (EPR) effect has resulted in the development of nanomedicines, including liposome-based formulations of drugs, as cancer therapies. The use of liposomes has resulted in substantial increases in accumulation of drugs in solid tumors; yet, significant improvements in therapeutic efficacy have yet to be achieved. Imaging of the tumor accumulation of liposomes has revealed that this poor or variable performance is in part due to heterogeneous intersubject and intratumoral liposome accumulation, which occurs as a result of an abnormal transport microenvironment. A mathematical model that relates liposome accumulation to the underlying transport properties in solid tumors could provide insight into inter and intratumoral variations in the EPR effect. In this paper, we present a theoretical framework to describe liposome transport in solid tumors. The mathematical model is based on biophysical transport equations that describe pressure driven fluid flow across blood vessels and through the tumor interstitium. The model was validated by direct comparison with computed tomography measurements of tumor accumulation of liposomes in three preclinical tumor models. The mathematical model was fit to liposome accumulation curves producing predictions of transport parameters that reflect the tumor microenvironment. Notably, all fits had a high coefficient of determination and predictions of interstitial fluid pressure agreed with previously published independent measurements made in the same tumor type. Furthermore, it was demonstrated that the model attributed intersubject heterogeneity in liposome accumulation to variations in peak interstitial fluid pressure. These findings highlight the relationship between transvascular and interstitial flow dynamics and variations in the EPR effect. In conclusion, we have presented a theoretical framework that predicts intersubject and intratumoral variations in the EPR effect based on fundamental properties of the tumor microenvironment and forms the basis for transport modeling of liposome drug delivery.	[Stapleton, Shawn; Jaffray, David A.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada; [Stapleton, Shawn; Milosevic, Michael; Zheng, Jinzi; Dunne, Michael; Yeung, Ivan; Jaffray, David A.] Princess Margaret Canc Ctr, STTARR Innovat Ctr, Toronto, ON, Canada; [Milosevic, Michael; Zheng, Jinzi; Dunne, Michael; Yeung, Ivan; Jaffray, David A.] Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada; [Milosevic, Michael; Yeung, Ivan; Jaffray, David A.] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Allen, Christine] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Jaffray, David A.] Univ Hlth Network, Techna Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Stapleton, S (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada.	shawn.stapleton@rmp.uhn.on.ca	Dunne, Michael/AAB-6107-2019; Dunne, Michael W/AAD-7418-2020	Dunne, Michael/0000-0001-6646-1051; Dunne, Michael W/0000-0001-6186-5196; Allen, Christine/0000-0002-4916-3965; Zheng, Jinzi/0000-0002-7650-3910; Milosevic, Michael/0000-0002-9620-6876; Jaffray, David/0000-0001-7378-7543	Terry Fox New Frontiers Program; Canadian Institutes of Health Research	Terry Fox New Frontiers Program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by grants from the Terry Fox New Frontiers Program and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAXTER LT, 1989, MICROVASC RES, V37, P77, DOI 10.1016/0026-2862(89)90074-5; BOUCHER Y, 1990, CANCER RES, V50, P4478; Caillou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022567; Cairns RA, 2004, CLIN EXP METASTAS, V21, P275, DOI 10.1023/B:CLIN.0000037729.75981.9e; Chauhan VP, 2011, ANNU REV CHEM BIOMOL, V2, P281, DOI 10.1146/annurev-chembioeng-061010-114300; Drummond DC, 1999, PHARMACOL REV, V51, P691; Dunne M, 2011, J CONTROL RELEASE, V154, P298, DOI 10.1016/j.jconrel.2011.05.022; El-Kareh AW, 1997, CRIT REV BIOMED ENG, V25, P503, DOI 10.1615/CritRevBiomedEng.v25.i6.20; Foster WK, 2011, PHYS MED BIOL, V56, P315, DOI 10.1088/0031-9155/56/2/002; GABIZON A, 1991, BRIT J CANCER, V64, P1125, DOI 10.1038/bjc.1991.476; GABIZON AA, 1992, CANCER RES, V52, P891; Garcia AA, 1998, ANN ONCOL, V9, P1131, DOI 10.1023/A:1008439013169; Gasselhuber A, 2010, INT J HYPERTHER, V26, P499, DOI 10.3109/02656731003623590; Gordon AN, 2001, J CLIN ONCOL, V19, P3312, DOI 10.1200/JCO.2001.19.14.3312; Halford S, 2001, ANN ONCOL, V12, P1399, DOI 10.1023/A:1012522120294; Harashima H, 1999, ADV DRUG DELIVER REV, V40, P39, DOI 10.1016/S0169-409X(99)00039-3; Harrington KJ, 2001, CLIN CANCER RES, V7, P243; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Huang H, 2012, MOL IMAGING; JAIN RK, 1987, CANCER METAST REV, V6, P559, DOI 10.1007/BF00047468; JAIN RK, 1987, CANCER RES, V47, P3039; Karathanasis E, 2009, RADIOLOGY, V250, P398, DOI 10.1148/radiol.2502080801; Laginha KM, 2005, CLIN CANCER RES, V11, P6944, DOI 10.1158/1078-0432.CCR-05-0343; Liu C, 2011, PHARMACOGENOMICS, V12, P1337, DOI [10.2217/PGS.11.71, 10.2217/pgs.11.71]; Lunt SJ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-2; Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3; Marcucci F, 2012, ADV DRUG DELIVER REV, V64, P53, DOI 10.1016/j.addr.2011.09.007; Milosevic M, 2008, MICROVASC RES, V75, P381, DOI 10.1016/j.mvr.2007.11.003; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Qin SP, 2010, MOL PHARMACEUT, V7, P12, DOI 10.1021/mp900122j; RIPPE B, 1987, ACTA PHYSIOL SCAND, V131, P411, DOI 10.1111/j.1748-1716.1987.tb08257.x; SEVICK EM, 1991, CANCER RES, V51, P1352; SIMPSONHERREN L, 1988, CANCER CHEMOTH PHARM, V22, P131; Solomon R, 2008, CLIN LYMPHOMA MYELOM, V8, P21, DOI 10.3816/CLM.2008.n.001; SWABB EA, 1974, CANCER RES, V34, P2814; Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annurev.bioeng.9.060906.151850; Thomas AL, 2001, CANCER CHEMOTH PHARM, V48, P266, DOI 10.1007/s002800100351; White SC, 2006, BRIT J CANCER, V95, P822, DOI 10.1038/sj.bjc.6603345; Wiig H, 2012, PHYSIOL REV, V92, P1005, DOI 10.1152/physrev.00037.2011; WU NZ, 1993, CANCER RES, V53, P3765; YUAN F, 1994, CANCER RES, V54, P3352; Zhao JB, 2007, MICROVASC RES, V73, P224, DOI 10.1016/j.mvr.2006.12.003; Zheng JZ, 2007, PHARM RES-DORDR, V24, P1193, DOI 10.1007/s11095-006-9220-1; Zheng J, 2009, MOL PHARMACEUT, V6, P571, DOI 10.1021/mp800234r	45	60	60	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81157	10.1371/journal.pone.0081157	http://dx.doi.org/10.1371/journal.pone.0081157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312530	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500055
J	Chaulk, SG; Lattanzi, VJ; Hiemer, SE; Fahlman, RP; Varelas, X				Chaulk, Steven G.; Lattanzi, Victoria J.; Hiemer, Samantha E.; Fahlman, Richard P.; Varelas, Xaralabos			The Hippo Pathway Effectors TAZ/YAP Regulate Dicer Expression and MicroRNA Biogenesis through Let-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell adhesion; Dicer; MicroRNA; RNA Processing; Signal Transduction; Hippo Pathway; Let-7; TAZ; YAP	CELL CONTACT INHIBITION; SIGNALING PATHWAY; STEM-CELLS; YAP; TAZ; PROLIFERATION; COACTIVATOR; PROTEIN; GROWTH; CANCER	MicroRNAs (miRNAs) are genome-encoded small double-stranded RNAs that have emerged as key regulators of gene expression and are implicated in most aspects of human development and disease. Canonical miRNA biogenesis involves processing of approximate to 70-nucleotide pre-miRNA hairpins by Dicer to generate mature approximate to 22-nucleotide miRNAs, which target complementary RNA sequences. Despite the importance of miRNA biogenesis, signaling mechanisms controlling this process are poorly defined. Here we demonstrate that the post-transcriptional regulation of Dicer is controlled by the cell density-mediated localization of the Hippo pathway effectors TAZ (transcriptional co-activator with PDZ-binding motif) and YAP (Yes-associated protein) (TAZ/YAP). We show that nuclear TAZ/YAP, which are abundant at low cell density, are required for efficient pre-miRNA processing. Knockdown of TAZ/YAP in low density cells, or density-mediated sequestration of TAZ/YAP into the cytoplasm, results in the defective processing of pre-miRNAs. Strikingly, one exception is Let-7, which accumulates upon loss of nuclear TAZ/YAP, leading to Let-7-dependent reduction in Dicer levels. Accordingly, inhibition of Let-7 rescues the miRNA biogenesis defects observed following TAZ/YAP knockdown. Thus, density-regulated TAZ/YAP localization defines a critical and previously unrecognized mechanism by which cells relay cell contact-induced cues to control miRNA biogenesis.	[Lattanzi, Victoria J.; Hiemer, Samantha E.; Varelas, Xaralabos] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Chaulk, Steven G.; Fahlman, Richard P.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Fahlman, Richard P.] Univ Alberta, Dept Oncol, Edmonton, AB T6G 2H7, Canada	Boston University; University of Alberta; University of Alberta	Fahlman, RP (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	rfahlman@ualberta.ca	Varelas, Xaralabos/ABB-9141-2020	Varelas, Xaralabos/0000-0002-2882-4541	Canadian Breast Cancer Foundation (CBCF); March of Dimes Foundation [5-FY11-578]; Concern Cancer Foundation	Canadian Breast Cancer Foundation (CBCF); March of Dimes Foundation(March of Dimes); Concern Cancer Foundation	Supported by a research grant from the Canadian Breast Cancer Foundation (CBCF). To whom correspondence may be addressed. Tel.: 780-492-9566; Fax: 780-492-0886; E-mail: rfahlman@ualberta.ca.; Supported in by Research Grant 5-FY11-578 from the March of Dimes Foundation and by funds from the Concern Cancer Foundation. To whom correspondence may be addressed: Dept. of Biochemistry, Boston University School of Medicine, Room K225, Boston, MA 02118. Tel.: 617-638-4182; Fax: 617-638-5339; E-mail: xvarelas@bu.edu.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hiemer SE, 2013, BBA-GEN SUBJECTS, V1830, P2323, DOI 10.1016/j.bbagen.2012.07.005; Hwang HW, 2009, P NATL ACAD SCI USA, V106, P7016, DOI 10.1073/pnas.0811523106; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Olive V, 2013, IMMUNOL REV, V253, P158, DOI 10.1111/imr.12054; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Varelas X, 2012, TRENDS CELL BIOL, V22, P88, DOI 10.1016/j.tcb.2011.10.002; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; WANG D, 2012, PLOS ONE, V7; Yates LA, 2013, CELL, V153, P516, DOI 10.1016/j.cell.2013.04.003; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao D, 2012, CARCINOGENESIS, V33, P59, DOI 10.1093/carcin/bgr242	31	78	78	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					1886	1891		10.1074/jbc.C113.529362	http://dx.doi.org/10.1074/jbc.C113.529362			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24324261	Green Published, hybrid			2022-12-25	WOS:000331130200001
J	Park, SJ; Shin, JH; Jeong, JI; Song, JH; Jo, YK; Kim, ES; Lee, EH; Hwang, JJ; Lee, EK; Chung, SJ; Koh, JY; Jo, DG; Cho, DH				Park, So Jung; Shin, Ji Hyun; Jeong, Jae In; Song, Ji Hoon; Jo, Yoon Kyung; Kim, Eun Sung; Lee, Eunjoo H.; Hwang, Jung Jin; Lee, Eun Kyung; Chung, Sun Ju; Koh, Jae-Young; Jo, Dong-Gyu; Cho, Dong-Hyung			Down-regulation of Mortalin Exacerbates A beta-mediated Mitochondrial Fragmentation and Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimers Disease; Cell Death; Mitochondria; Mitochondrial Apoptosis; Neurodegenerative Diseases; Drp1; Amyloid-; Mitochondrial Fission; Mortalin	DYNAMIN-RELATED GTPASE; DEPENDENT PROTEIN-KINASE; HSP70 FAMILY; PROTEOMIC IDENTIFICATION; CANCER-CELLS; DRP1; FISSION; PHOSPHORYLATION; FUSION; DISEASE	Mitochondrial dynamics greatly influence the biogenesis and morphology of mitochondria. Mitochondria are particularly important in neurons, which have a high demand for energy. Therefore, mitochondrial dysfunction is strongly associated with neurodegenerative diseases. Until now various post-translational modifications for mitochondrial dynamic proteins and several regulatory proteins have explained complex mitochondrial dynamics. However, the precise mechanism that coordinates these complex processes remains unclear. To further understand the regulatory machinery of mitochondrial dynamics, we screened a mitochondrial siRNA library and identified mortalin as a potential regulatory protein. Both genetic and chemical inhibition of mortalin strongly induced mitochondrial fragmentation and synergistically increased A-mediated cytotoxicity as well as mitochondrial dysfunction. Importantly we determined that the expression of mortalin in Alzheimer disease (AD) patients and in the triple transgenic-AD mouse model was considerably decreased. In contrast, overexpression of mortalin significantly suppressed A-mediated mitochondrial fragmentation and cell death. Taken together, our results suggest that down-regulation of mortalin may potentiate A-mediated mitochondrial fragmentation and dysfunction in AD.	[Park, So Jung; Shin, Ji Hyun; Jo, Yoon Kyung; Kim, Eun Sung; Lee, Eunjoo H.; Cho, Dong-Hyung] Kyung Hee Univ, Grad Sch East West Med Sci, Dept East West Med Sci, Yongin 446701, South Korea; [Jeong, Jae In; Jo, Dong-Gyu] Sungkyunkwan Univ, Sch Pharm, Suwon 440746, South Korea; [Chung, Sun Ju; Koh, Jae-Young] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul 138736, South Korea; [Song, Ji Hoon; Hwang, Jung Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci,Inst Innovat Canc Res, Seoul 138736, South Korea; [Lee, Eun Kyung] Catholic Univ Korea, Dept Biochem, Coll Med, Seoul 137701, South Korea	Kyung Hee University; Sungkyunkwan University (SKKU); University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Catholic University of Korea	Cho, DH (corresponding author), 1 Seocheon Dong, Yongin 446701, Gyeoggi Do, South Korea.	dhcho@khu.ac.kr	Jo, Dong-Gyu/AAN-9278-2021; Koh, Jae-Young/C-9014-2011; Hwang, Jung Jin/F-3424-2014	Jo, Dong-Gyu/0000-0003-2271-1076; Koh, Jae-Young/0000-0002-4318-495X; Lee, Eunjoo H./0000-0002-5569-0067	Korean Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea [A092042]; Korea-UK Collaborative Alzheimer's Disease Research Project, Ministry of Health & Welfare, Republic of Korea [A120196]	Korean Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea; Korea-UK Collaborative Alzheimer's Disease Research Project, Ministry of Health & Welfare, Republic of Korea	This work was supported by Korean Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea Grant A092042 and the Korea-UK Collaborative Alzheimer's Disease Research Project, Ministry of Health & Welfare, Republic of Korea Grant A120196.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; BHATTACHARYYA T, 1995, J BIOL CHEM, V270, P1705, DOI 10.1074/jbc.270.4.1705; Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86; Buizza L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029789; Burbulla LF, 2010, HUM MOL GENET, V19, P4437, DOI 10.1093/hmg/ddq370; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Chiasserini D, 2011, MOVEMENT DISORD, V26, P1639, DOI 10.1002/mds.23647; Cho DH, 2010, CELL MOL LIFE SCI, V67, P3435, DOI 10.1007/s00018-010-0435-2; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Choi J, 2004, FREE RADICAL BIO MED, V36, P1155, DOI 10.1016/j.freeradbiomed.2004.02.002; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Deocaris CC, 2007, CANCER LETT, V252, P259, DOI 10.1016/j.canlet.2006.12.038; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Dundas SR, 2005, J PATHOL, V205, P74, DOI 10.1002/path.1672; Eura Y, 2006, J CELL SCI, V119, P4913, DOI 10.1242/jcs.03253; Figueroa-Romero C, 2009, FASEB J, V23, P3917, DOI 10.1096/fj.09-136630; Gawlowski T, 2012, J BIOL CHEM, V287, P30024, DOI 10.1074/jbc.M112.390682; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004; Hooper C, 2007, NEUROSCI LETT, V415, P135, DOI 10.1016/j.neulet.2007.01.049; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Jin JH, 2006, MOL CELL PROTEOMICS, V5, P1193, DOI 10.1074/mcp.M500382-MCP200; Jo DG, 2010, NEUROBIOL AGING, V31, P917, DOI 10.1016/j.neurobiolaging.2008.07.003; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Kaul SC, 2003, EXP CELL RES, V286, P96, DOI 10.1016/S0014-4827(03)00101-0; Kaul SC, 2007, EXP GERONTOL, V42, P263, DOI 10.1016/j.exger.2006.10.020; Kawai A, 2001, J CELL SCI, V114, P3565; Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Meuer K, 2007, CELL DEATH DIFFER, V14, P651, DOI 10.1038/sj.cdd.4402087; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Osorio C, 2007, NEUROBIOL AGING, V28, P1853, DOI 10.1016/j.neurobiolaging.2006.08.011; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Palmer CS, 2011, CELL SIGNAL, V23, P1534, DOI 10.1016/j.cellsig.2011.05.021; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Park J., 2010, PLOS ONE, V5; Park SJ, 2012, FEBS LETT, V586, P4303, DOI 10.1016/j.febslet.2012.10.035; Qu MY, 2012, NEUROSCI RES, V72, P94, DOI 10.1016/j.neures.2011.09.009; Qu MY, 2011, BRAIN RES, V1368, P336, DOI 10.1016/j.brainres.2010.10.068; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Shi M, 2008, J NEUROPATH EXP NEUR, V67, P117, DOI 10.1097/nen.0b013e318163354a; Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Takano S, 1997, EXP CELL RES, V237, P38, DOI 10.1006/excr.1997.3754; Tamai S, 2008, J CELL SCI, V121, P2588, DOI 10.1242/jcs.026625; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Tondera D, 2005, J CELL SCI, V118, P3049, DOI 10.1242/jcs.02415; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; WADHWA R, 1993, J BIOL CHEM, V268, P6615; Wadhwa R, 1998, J BIOL CHEM, V273, P29586, DOI 10.1074/jbc.273.45.29586; Wadhwa R, 2000, CANCER RES, V60, P6818; Walker C, 2006, AM J PATHOL, V168, P1526, DOI 10.2353/ajpath.2006.050603; Wang AM, 2013, NAT CHEM BIOL, V9, P112, DOI [10.1038/NCHEMBIO.1140, 10.1038/nchembio.1140]; Wang XW, 2008, NAT CELL BIOL, V10, P1090, DOI 10.1038/ncb1769; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yang H, 2011, BIOCHEM BIOPH RES CO, V410, P114, DOI 10.1016/j.bbrc.2011.05.116; Yokoyama K, 2002, FEBS LETT, V516, P53, DOI 10.1016/S0014-5793(02)02470-5; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418	72	51	51	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2195	2204		10.1074/jbc.M113.492587	http://dx.doi.org/10.1074/jbc.M113.492587			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24324263	Green Published, hybrid			2022-12-25	WOS:000331130200027
J	Luo, G; Yi, JX; Ma, CL; Xiao, YJ; Yi, F; Yu, T; Zhou, JS				Luo, Guo; Yi, Jianxun; Ma, Changling; Xiao, Yajuan; Yi, Frank; Yu, Tian; Zhou, Jingsong			Defective Mitochondrial Dynamics Is an Early Event in Skeletal Muscle of an Amyotrophic Lateral Sclerosis Mouse Model	PLOS ONE			English	Article							MOTOR-NEURON DEGENERATION; SUPEROXIDE-DISMUTASE; PRIMARY TARGET; UP-REGULATION; MUTANT SOD1; ALS; TOXICITY; FISSION; EXPRESSION; RETICULUM	Mitochondria are dynamic organelles that constantly undergo fusion and fission to maintain their normal functionality. Impairment of mitochondrial dynamics is implicated in various neurodegenerative disorders. Amyotrophic lateral sclerosis (ALS) is an adult-onset neuromuscular degenerative disorder characterized by motor neuron death and muscle atrophy. ALS onset and progression clearly involve motor neuron degeneration but accumulating evidence suggests primary muscle pathology may also be involved. Here, we examined mitochondrial dynamics in live skeletal muscle of an ALS mouse model (G93A) harboring a superoxide dismutase mutation (SOD1(G93A)). Using confocal microscopy combined with overexpression of mitochondria-targeted photoactivatable fluorescent proteins, we discovered abnormal mitochondrial dynamics in skeletal muscle of young G93A mice before disease onset. We further demonstrated that similar abnormalities in mitochondrial dynamics were induced by overexpression of mutant SOD1(G93A) in skeletal muscle of normal mice, indicating the SOD1 mutation drives ALS-like muscle pathology in the absence of motor neuron degeneration. Mutant SOD1(G93A) forms aggregates inside muscle mitochondria and leads to fragmentation of the mitochondrial network as well as mitochondrial depolarization. Partial depolarization of mitochondrial membrane potential in normal muscle by carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) caused abnormalities in mitochondrial dynamics similar to that in the SOD1(G93A) model muscle. A specific mitochondrial fission inhibitor (Mdivi-1) reversed the SOD1(G93A) action on mitochondrial dynamics, indicating SOD1(G93A) likely promotes mitochondrial fission process. Our results suggest that accumulation of mutant SOD1(G93A) inside mitochondria, depolarization of mitochondrial membrane potential and abnormal mitochondrial dynamics are causally linked and cause intrinsic muscle pathology, which occurs early in the course of ALS and may actively promote ALS progression.	[Luo, Guo; Yi, Jianxun; Ma, Changling; Xiao, Yajuan; Yi, Frank; Zhou, Jingsong] Rush Univ, Sch Med, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA; [Luo, Guo; Yu, Tian] Zunyi Med Coll, Zunyi, Peoples R China	Rush University; Zunyi Medical University	Zhou, JS (corresponding author), Rush Univ, Sch Med, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA.	jingsong_zhou@rush.edu			Muscular Dystrophy Association [MDA-4351]; NIAMS/National Institutes of Health [AR057404]; National Science Foundation of China [81060266]; Zunyi Medical College; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057404] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); NIAMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zunyi Medical College; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was fully supported by Muscular Dystrophy Association (MDA-4351) and NIAMS/National Institutes of Health (AR057404) to JZ and partially supported by National Science Foundation of China (81060266) To TY. GL received a scholarship from Zunyi Medical College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel SH, 2006, EXP NEUROL, V198, P1, DOI 10.1016/j.expneurol.2005.12.025; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Carri MT, 2011, J BIOENERG BIOMEMBR, V43, P593, DOI 10.1007/s10863-011-9394-z; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Cho DH, 2010, CELL MOL LIFE SCI, V67, P3435, DOI 10.1007/s00018-010-0435-2; Cozzolino M, 2009, ANTIOXID REDOX SIGN, V11, P1547, DOI 10.1089/ARS.2009.2545; de Aguilar JLG, 2008, PHYSIOL GENOMICS, V32, P207, DOI 10.1152/physiolgenomics.00017.2007; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Dupuis L, 2003, FASEB J, V17, P2091, DOI 10.1096/fj.02-1182fje; Eisenberg B.R, 1983, QUANTITATIVE ULTRAST; Eisner V, 2013, J CELL SCI, V126, P2965, DOI 10.1242/jcs.093609; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Frey D, 2000, J NEUROSCI, V20, P2534; Givvimani S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032388; Gomez-Lazaro M, 2008, FREE RADICAL BIO MED, V44, P1960, DOI 10.1016/j.freeradbiomed.2008.03.009; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Higgins CMJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-06-j0001.2002; Huang XH, 2013, P NATL ACAD SCI USA, V110, P2846, DOI 10.1073/pnas.1300741110; Krasnianski A, 2005, BRAIN, V128, P1870, DOI 10.1093/brain/awh540; Leclerc N, 2001, NEUROMUSCULAR DISORD, V11, P722, DOI 10.1016/S0960-8966(01)00240-1; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Lu BW, 2009, CURR NEUROL NEUROSCI, V9, P212, DOI 10.1007/s11910-009-0032-7; Magrane J, 2009, HUM MOL GENET, V18, P4552, DOI 10.1093/hmg/ddp421; Mahoney DJ, 2006, MUSCLE NERVE, V33, P809, DOI 10.1002/mus.20542; Miller TM, 2006, P NATL ACAD SCI USA, V103, P19546, DOI 10.1073/pnas.0609411103; Nguyen QT, 2000, J NEUROSCI, V20, P6077, DOI 10.1523/JNEUROSCI.20-16-06077.2000; Ogata T, 1997, ANAT REC, V248, P214; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Park KHJ, 2008, BBA-MOL BASIS DIS, V1782, P462, DOI 10.1016/j.bbadis.2008.04.001; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012; Pouvreau S, 2007, P NATL ACAD SCI USA, V104, P5235, DOI 10.1073/pnas.0700748104; Song WJ, 2013, NEUROBIOL DIS, V51, P72, DOI 10.1016/j.nbd.2012.07.004; Ve Velde C., 2008, P NATL ACAD SCI USA, V105, P4022, DOI [DOI 10.1073/PNAS.0712209105, 10.1073/pnas.0712209105]; Vijayvergiya C, 2005, J NEUROSCI, V25, P2463, DOI 10.1523/JNEUROSCI.4385-04.2005; Wong M, 2010, HUM MOL GENET, V19, P2284, DOI 10.1093/hmg/ddq106; Yi JX, 2011, J BIOL CHEM, V286, P32436, DOI 10.1074/jbc.M110.217711; Zhou JS, 2010, J BIOL CHEM, V285, P705, DOI 10.1074/jbc.M109.041319	42	72	74	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82112	10.1371/journal.pone.0082112	http://dx.doi.org/10.1371/journal.pone.0082112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324755	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700061
J	Xu, HQ; Zhao, ZW; Wang, H; Ding, M; Zhou, AQ; Wang, XY; Zhang, P; Duggan, C; Hu, FB				Xu, Haiqing; Zhao, Zhiwei; Wang, Hong; Ding, Ming; Zhou, Aiqin; Wang, Xiaoyan; Zhang, Ping; Duggan, Christopher; Hu, Frank B.			Bone Mineral Density of the Spine in 11,898 Chinese Infants and Young Children: A Cross-Sectional Study	PLOS ONE			English	Article							GROWTH; GENDER; MASS; AGE	Background: Bone mineral density (BMD) increases progressively during childhood and adolescence and is affected by various genetic and environmental factors. The aim of this study was to establish reference values for lumbar BMD in healthy Chinese infants and young children and investigate its influencing factors. Methods and Findings: Healthy children aged 0 to 3 years who underwent regular physical examinations at the Child Health Care Clinic of Hubei Maternal and Child Health Hospital (N = 11,898) were recruited for this study. We also chose 379 preterm infants aged 0 to 1 years to preliminarily explore the development of BMD in this special population. BMD (g/cm(2)) measurements of the lumbar spine (L2-L4) were carried out with dual-energy X-ray absorptiometry and a questionnaire was administered to full-term children's parents to gather information on various nutritional and lifestyle factors as well as mothers' nutritional supplement use during pregnancy. Lumbar BMD significantly increased with age among both boys and girls (p < 0.05), with fastest growth observed during the first postnatal year. There was no significant difference in lumbar BMD between boys and girls of similar age (p > 0.05), either among healthy reference children or preterm infants. However, BMD values in preterm infants were significantly lower than those in term infants 3 to 8 months old (p < 0.05) after adjustment for gestational age. Multivariable linear regression analysis indicated significant positive associations between lumbar BMD of healthy children and the child's age and current weight, mother's weight gain during pregnancy, birth weight, children's outdoor activity duration and children's physical activity duration. Conclusion: Our study provides reference values of lumbar BMD for healthy Chinese children aged 0 to 3 years and identifies several influencing factors.	[Xu, Haiqing; Zhao, Zhiwei; Wang, Hong; Zhou, Aiqin; Wang, Xiaoyan; Zhang, Ping] Hubei Maternal & Child Hlth Hosp, Dept Child Hlth Care, Wuhan, Peoples R China; [Ding, Ming; Duggan, Christopher; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Duggan, Christopher] Childrens Hosp, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital	Xu, HQ (corresponding author), Hubei Maternal & Child Hlth Hosp, Dept Child Hlth Care, Wuhan, Peoples R China.	xuhaiqing9@126.com; frank.hu@channing.harvard.edu			Health Department of Hubei Province	Health Department of Hubei Province	This study was funded by the Health Department of Hubei Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabi A, 2004, BONE, V35, P1169, DOI 10.1016/j.bone.2004.06.015; Bachrach LK, 1999, J CLIN ENDOCR METAB, V84, P4702, DOI 10.1210/jc.84.12.4702; Bianchi ML, 2007, BONE, V41, P486, DOI 10.1016/j.bone.2007.07.008; Bonnick SL, 2006, BONE DENSITOMETRY TE; Cheng S, 2007, MODERN PREVENTIVE ME, V34, P4690; CHESNUT CH, 1991, AM J MED, V91, pS2, DOI 10.1016/0002-9343(91)90238-S; Chubinskaya S, 2008, GROWTH FACTORS, V26, P275, DOI 10.1080/08977190802291733; Coordinating Study Group of Nine Cities on Physical Growth and Development of Children, 2007, Zhonghua Er Ke Za Zhi, V45, P609; Dent CE, 1973, CLIN ASPECTS METABOL; FROST HM, 1979, CLIN ORTHOP RELAT R, P227; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Guan Y, 2008, CHINA PRACTICAL MED, V3, P57; Guo B, 2010, ANAL BONE MINERAL DE, P3; Horsman A, 1970, P BONE MEASUREMENT C, P365; Ichiba H, 2000, EUR J PEDIATR, V159, P215, DOI 10.1007/s004310050053; Ilich-Ernst Jasminka, 2002, Medscape Womens Health, V7, P2; Lee SH, 2007, J BONE MINER METAB, V25, P423, DOI 10.1007/s00774-007-0775-7; Li J, 2009, RES EXPLORATION LAB, V28, P30; Loud KJ, 2006, ARCH PEDIAT ADOL MED, V160, P1026, DOI 10.1001/archpedi.160.10.1026; Nelson DA, 1997, BONE, V20, P73, DOI 10.1016/S8756-3282(96)00312-2; PARFITT AM, 1994, OSTEOPOROSIS INT, V4, P382, DOI 10.1007/BF01622201; SEEMAN E, 1994, OSTEOPOROSIS INT, V4, P15; Sehoenau E, CALCIF TISSUE INT, V70, P405; Taha W, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e79; Turner CH, 2002, BONE, V27, P339; Wang YM, 2006, ENDOCRINOLOGY, V147, P4753, DOI 10.1210/en.2006-0196; Wu T, 2008, CHINESE J CHILD HLTH, V16, P179; Xu H, 2006, CHINESE J CLIN NUTR, V14, P231; [张丽茹 Zhang Liru], 2008, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V12, P7364; Zhao L, 2010, CHINESE J CHILD HLTH, V18, P340; Zheng Y, 2008, ACTA MED SINICA, V21, P579; [周迪军 ZHOU Dijun], 2008, [中国骨质疏松杂志, Chinese Journal of Osteoporosis], V14, P416; Zhou Yuechan, 2011, Wei Sheng Yan Jiu, V40, P65; Zhu X, 2000, FOREIGN MED SCI PATH, V20, P15; 周爱琴, 2007, [中国实用儿科杂志, Chinese Journal of Practical Pediatrics], V22, P783	35	24	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82098	10.1371/journal.pone.0082098	http://dx.doi.org/10.1371/journal.pone.0082098			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324752	Green Published, gold, Green Submitted			2022-12-25	WOS:000328566700059
J	Forster, D; Andres, C; Verma, R; Zundel, C; Messmer, MM; Mader, P				Forster, Dionys; Andres, Christian; Verma, Rajeev; Zundel, Christine; Messmer, Monika M.; Maeder, Paul			Yield and Economic Performance of Organic and Conventional Cotton-Based Farming Systems - Results from a Field Trial in India	PLOS ONE			English	Article							BT COTTON; FAIR TRADE; SOIL QUALITY; SUSTAINABILITY; PRODUCTIVITY; PROFITABILITY; BIODIVERSITY; AGRICULTURE; BENEFITS; IMPACTS	The debate on the relative benefits of conventional and organic farming systems has in recent time gained significant interest. So far, global agricultural development has focused on increased productivity rather than on a holistic natural resource management for food security. Thus, developing more sustainable farming practices on a large scale is of utmost importance. However, information concerning the performance of farming systems under organic and conventional management in tropical and subtropical regions is scarce. This study presents agronomic and economic data from the conversion phase (2007-2010) of a farming systems comparison trial on a Vertisol soil in Madhya Pradesh, central India. A cotton-soybean-wheat crop rotation under biodynamic, organic and conventional (with and without Bt cotton) management was investigated. We observed a significant yield gap between organic and conventional farming systems in the 1st crop cycle (cycle 1: 2007-2008) for cotton (-29%) and wheat (-27%), whereas in the 2nd crop cycle (cycle 2: 2009-2010) cotton and wheat yields were similar in all farming systems due to lower yields in the conventional systems. In contrast, organic soybean (a nitrogen fixing leguminous plant) yields were marginally lower than conventional yields (-1% in cycle 1, -11% in cycle 2). Averaged across all crops, conventional farming systems achieved significantly higher gross margins in cycle 1 (+29%), whereas in cycle 2 gross margins in organic farming systems were significantly higher (+25%) due to lower variable production costs but similar yields. Soybean gross margin was significantly higher in the organic system (+11%) across the four harvest years compared to the conventional systems. Our results suggest that organic soybean production is a viable option for smallholder farmers under the prevailing semi-arid conditions in India. Future research needs to elucidate the long-term productivity and profitability, particularly of cotton and wheat, and the ecological impact of the different farming systems.	[Forster, Dionys; Andres, Christian; Zundel, Christine] Res Inst Organ Agr FiBL, Int Div, Frick, Switzerland; [Verma, Rajeev] BioRe Assoc, Div Res, Kasrawad, Madhya Pradesh, India; [Zundel, Christine] Fed Off Agr FOAG, Ecol Grp, Bern, Switzerland; [Messmer, Monika M.; Maeder, Paul] Res Inst Organ Agr FiBL, Soil Sci Div, Frick, Switzerland		Andres, C (corresponding author), Res Inst Organ Agr FiBL, Int Div, Frick, Switzerland.	christian.andres@fibl.org		Andres, Christian/0000-0003-0576-6446	Biovision Foundation for Ecological Development; Coop Sustainability Fund; Liechtenstein Development Service (LED); Swiss Agency for Development and Cooperation (SDC)	Biovision Foundation for Ecological Development; Coop Sustainability Fund; Liechtenstein Development Service (LED); Swiss Agency for Development and Cooperation (SDC)	Biovision Foundation for Ecological Development, http://www.biovision.ch/; Coop Sustainability Fund, http://www.coop.ch/pb/site/nachhaltigkeit/node/64228018/Len/index.html; Liechtenstein Development Service (LED), http://www.led.li/en/home.html; Swiss Agency for Development and Cooperation (SDC), http://www.sdc.admin.ch/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; Aris A, 2011, REPROD TOXICOL, V31, P528, DOI 10.1016/j.reprotox.2011.02.004; Bachmann F, 2012, RENEW AGR FOOD SYST, V27, P138, DOI 10.1017/S1742170511000202; Badgley C, 2007, RENEW AGR FOOD SYST, V22, P86, DOI 10.1017/S1742170507001640; Beej SA, 2012, DECADE BT COTTON MAD; Bennett R, 2006, REV AGR ECON, V28, P59, DOI 10.1111/j.1467-9353.2006.00273.x; Birkhofer K, 2008, SOIL BIOL BIOCHEM, V40, P2297, DOI 10.1016/j.soilbio.2008.05.007; Blaise D, 2006, J AGRON CROP SCI, V192, P248, DOI 10.1111/j.1439-037X.2006.00218.x; Borlaug NE, 2000, PLANT PHYSIOL, V124, P487, DOI 10.1104/pp.124.2.487; Brookes Graham, 2011, International Journal of Biotechnology, V12, P1, DOI 10.1504/IJBT.2011.042680; Carpenter JE, 2010, NAT BIOTECHNOL, V28, P319, DOI 10.1038/nbt0410-319; Carpenter-Boggs L, 2000, SOIL SCI SOC AM J, V64, P1651, DOI 10.2136/sssaj2000.6451651x; Chada K.L, 2009, HDB HORTICULTURE; Charyulu D K, 2010, ORGANIC INPUT PRODUC, P239; Choudhary B, 2010, ISAAA SERIES BIOTECH; Crost B, 2007, J AGR ECON, V58, P24, DOI 10.1111/j.1477-9552.2007.00076.x; de Ponti T, 2012, AGR SYST, V108, P1, DOI 10.1016/j.agsy.2011.12.004; Demeter International e.V, 2012, PROD STAND US DEM BI; Eyhorn F., 2007, International Journal of Agricultural Sustainability, V5, P25; FAO, 2013, FAOSTAT DAT AGR; Finger R, 2011, SUSTAINABILITY-BASEL, V3, P743, DOI 10.3390/su3050743; Fliessbach A, 2007, AGR ECOSYST ENVIRON, V118, P273, DOI 10.1016/j.agee.2006.05.022; Forster D., 2012, AGR SUSTAINABILITY P, P21; Gattinger A, 2012, P NATL ACAD SCI USA, V109, P18226, DOI 10.1073/pnas.1209429109; Glover D, 2010, J AGRAR CHANGE, V10, P482, DOI 10.1111/j.1471-0366.2010.00283.x; Gruere G. P., 2012, IFPRI - Discussion Papers; Gruere G, 2011, J DEV STUD, V47, P316, DOI 10.1080/00220388.2010.492863; Hepperly P. R., 2006, Long-term field experiments in organic farming, P15; Herring R. J., 2012, Economic and Political Weekly, V47, P45; Herring R. J., 2008, International Journal of Multiple Research Approaches, V2, P145; IAASTD, 2009, INT ASS AGR KNOWL SC; ICAR, 2002, ALL IND COORD COTT I; IFOAM, 2006, IFOAM NORMS ORG PROD; IFOAM (, 2012, IFOAM NORMS ORG PROD; Jacobsen SE, 2013, AGRON SUSTAIN DEV, V33, P651, DOI 10.1007/s13593-013-0138-9; Kanwar JS, 1988, T INT WORKSH SWELL S, P179; Kathage J, 2012, P NATL ACAD SCI USA, V109, P11652, DOI 10.1073/pnas.1203647109; Kilcher, 2007, WORLD ORGANIC AGR ST, V89, P31; KOEPF H. H., 1976, BIODYNAMIC AGR INTRO; Konduru S, 2012, J AGR SCI TECHNOLO B, V2, P1016; Kranthi K, 2011, 10 YEARS BT INDIA 3; Krishna VV, 2012, AGR SYST, V107, P47, DOI 10.1016/j.agsy.2011.11.005; Loughin TM, 2006, CROP SCI, V46, P2492, DOI 10.2135/cropsci2006.04.0271; Lyngbaek AE, 2001, AGROFOREST SYST, V53, P205, DOI 10.1023/A:1013332722014; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Majumdar EG, 2012, CICR TECHNICAL B MEC; Makita R, 2012, GEOFORUM, V43, P1232, DOI 10.1016/j.geoforum.2012.03.009; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; Mendez VE, 2010, RENEW AGR FOOD SYST, V25, P236, DOI 10.1017/S1742170510000268; Menon M, 2003, ORGANIC COTTON REINV; Ministry of Agriculture GOI, 2011, AGR WAG IND; Ministry of Agriculture GOI, 2011, COST CULT PROD REL D; Nagarajan P, 2012, FIBER PRODUCTION REP; Nelson L, 2004, NATURE, V428, P796, DOI 10.1038/428796a; Nemes N, 2010, SEED SECURITY ORGANI; Panneerselvam P, 2012, RENEW AGR FOOD SYST, V27, P157, DOI 10.1017/S1742170511000238; Panneerselvam P, 2011, J SUSTAIN AGR, V35, P48, DOI 10.1080/10440046.2011.530506; Pimentel D, 1996, SCI TOTAL ENVIRON, V188, pS86, DOI 10.1016/0048-9697(96)05280-1; Pinheiro J, 2016, NLME LINEAR NONLINEA, DOI DOI 10.1016/S0006-3207(01)00201-4; Qaim M, 2010, BIOTECH AGR FOREST, V65, P221, DOI 10.1007/978-3-642-04796-1_12; Qaim M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064879; Qaim M, 2009, ANNU REV RESOUR ECON, V1, P665, DOI 10.1146/annurev.resource.050708.144203; R Core Team, 2012, LANG ENV STAT COMP; Radhakrishnan S, 2012, 10 YEARS BT COTTON F; Ramesh P, 2010, CURR SCI INDIA, V98, P1190; Rasul G, 2004, AGR SYST, V79, P327, DOI 10.1016/S0308-521X(03)00090-8; Reganold JP, 2012, NATURE, V485, P176, DOI 10.1038/485176a; Reganold JP, 2001, NATURE, V410, P926, DOI 10.1038/35073574; Sadashivappa P., 2009, AgBioForum, V12, P172; Seufert V, 2012, NATURE, V485, P229, DOI 10.1038/nature11069; Singh NB, 2009, REVOLUTION INDIAN CO; Singh RJ, 2013, EXP AGR, V49, P321, DOI 10.1017/S0014479713000197; Singh RB, 2000, AGR ECOSYST ENVIRON, V82, P97, DOI 10.1016/S0167-8809(00)00219-X; Stone GD, 2011, WORLD DEV, V39, P387, DOI 10.1016/j.worlddev.2010.09.008; Swezey SL, 2007, RENEW AGR FOOD SYST, V22, P30, DOI 10.1017/S1742170507001573; Teasdale JR, 2007, AGRON J, V99, P1297, DOI 10.2134/agronj2006.0362; Trewavas A, 2002, NATURE, V418, P668, DOI 10.1038/nature01013; Trewavas AJ, 2001, PLANT PHYSIOL, V125, P174, DOI 10.1104/pp.125.1.174; Valkila J, 2009, ECOL ECON, V68, P3018, DOI 10.1016/j.ecolecon.2009.07.002; Vanloqueren G, 2009, RES POLICY, V38, P971, DOI 10.1016/j.respol.2009.02.008; Venugopalan MV, 2010, INDIAN J AGR SCI, V80, P287; Watson CA, 2008, J AGR SCI-CAMBRIDGE, V146, P1, DOI 10.1017/S0021859607007460	82	47	49	1	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81039	10.1371/journal.pone.0081039	http://dx.doi.org/10.1371/journal.pone.0081039			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	265KD	24324659	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300068
J	Lim, S; Kim, KM; Kim, MJ; Woo, SJ; Choi, SH; Park, KS; Jang, HC; Meigs, JB; Wexler, DJ				Lim, Soo; Kim, Kyoung Min; Kim, Min Joo; Woo, Se Joon; Choi, Sung Hee; Park, Kyong Soo; Jang, Hak Chul; Meigs, James B.; Wexler, Deborah J.			The Association of Maximum Body Weight on the Development of Type 2 Diabetes and Microvascular Complications: MAXWEL Study	PLOS ONE			English	Article							BETA-CELL FUNCTION; LIFE-STYLE; RISK-FACTORS; OBESITY; GLUCOSE; OVERWEIGHT; DISEASE; RETINOPATHY; PREDICTORS; PREVENTION	Background: Obesity precedes the development of type 2 diabetes (T2D). However, the relationship between the magnitude and rate of weight gain to T2D development and complications, especially in non-White populations, has received less attention. Methods and Findings: We determined the association of rate and magnitude of weight gain to age at T2D diagnosis (Age(T2D)), HbA1c at T2D diagnosis (HbA1c(T2D)), microalbuminuria, and diabetic retinopathy after adjusting for sex, BMI at age 20 years, lifestyles, family history of T2D and/or blood pressure and lipids in 2164 Korean subjects aged >= 30 years and newly diagnosed with diabetes. Body weight at age 20 years (Wt(20y)) was obtained by recall or from participants' medical, school, or military records. Participants recalled their maximum weight (Wt(max)) prior to T2D diagnosis and age at maximum weight (Age(max_wt)). The rate of weight gain (Rate(max_wt)) was calculated from magnitude of weight gain (Delta Wt = Wt(max)-Wt(20y)) divided by Delta Time (Age(max_wt) -20 years). The mean Age(max_wt) and Age(T2D) were 41.5 +/- 10.9 years and 50.1 +/- 10.5 years, respectively. The Wt(20y) and Wt(max) were 59.9 +/- 10.5 kg and 72.9 +/- 11.4 kg, respectively. The Rate(max_wt) was 0.56 +/- 0.50 kg/year. After adjusting for risk factors, greater Delta Wt and higher Rate(max_wt) were significantly associated with earlier Age(T2D), higher HbA1c(T2D) after additional adjusting for Age(T2D), and microalbuminuria after further adjusting for HbA1c(T2D) and lipid profiles. Greater Delta Wt and higher Rate(max_wt) were also significantly associated with diabetic retinopathy. Conclusions: This finding supports public health recommendations to reduce the risk of T2D and its complications by preventing weight gain from early adulthood.	[Lim, Soo; Kim, Kyoung Min; Choi, Sung Hee; Jang, Hak Chul] Seoul Natl Univ, Coll Med, Dept Internal Med, Songnam, South Korea; [Lim, Soo; Kim, Kyoung Min; Woo, Se Joon; Choi, Sung Hee; Jang, Hak Chul] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea; [Woo, Se Joon] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Songnam, South Korea; [Kim, Min Joo] Korea Canc Ctr Hosp, Dept Internal Med, Seoul, South Korea; [Park, Kyong Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Lim, Soo; Meigs, James B.] Harvard Univ, Sch Med, Div Gen Med, Boston, MA USA; [Wexler, Deborah J.] Harvard Univ, Sch Med, Ctr Diabet, Boston, MA USA; [Lim, Soo; Meigs, James B.; Wexler, Deborah J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Lim, Soo; Meigs, James B.; Wexler, Deborah J.] Harvard Univ, Sch Med, Boston, MA USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National Cancer Center - Korea (NCC); Seoul National University (SNU); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Jang, HC (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Songnam, South Korea.	janghak@snu.ac.kr	Meigs, James/P-3927-2019; Wexler, Deborah/AAE-4205-2019; Park, Kyong Soo/C-2265-2008; Lim, Soo/AAU-8107-2020; Jang, Hak Chul/D-9637-2012	Meigs, James/0000-0002-2439-2657; Wexler, Deborah/0000-0001-6979-402X; Park, Kyong Soo/0000-0003-3597-342X; Lim, Soo/0000-0002-4137-1671; Jang, Hak Chul/0000-0002-4188-6536; CHOI, SUNG HEE/0000-0003-0740-8116; Kim, Kyoung Min/0000-0001-8150-0266	National Research Foundation; Korea government [2006-2005410]; Seoul National University Bundang Hospital; NIDDK [K23 DK 080228-05]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK080228] Funding Source: NIH RePORTER	National Research Foundation; Korea government(Korean Government); Seoul National University Bundang Hospital; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Research Foundation grant funded by the Korea government (2006-2005410). SL receives support from Seoul National University Bundang Hospital. DJW is supported by an NIDDK Career Development Award (K23 DK 080228-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc12-s064, 10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc11-S062]; Black E, 2005, DIABETIC MED, V22, P1199, DOI 10.1111/j.1464-5491.2005.01615.x; Brancati FL, 1999, ARCH INTERN MED, V159, P957, DOI 10.1001/archinte.159.9.957; Chalmers L, 2006, ADV CHRONIC KIDNEY D, V13, P352, DOI 10.1053/j.ackd.2006.07.010; Chiu KC, 2000, CLIN ENDOCRINOL, V53, P569, DOI 10.1046/j.1365-2265.2000.01132.x; Dirani M, 2011, INVEST OPHTH VIS SCI, V52, P4416, DOI 10.1167/iovs.11-7208; Ezzati M, 2006, J ROY SOC MED, V99, P250, DOI 10.1258/jrsm.99.5.250; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Field AE, 2004, OBES RES, V12, P267, DOI 10.1038/oby.2004.34; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; HANSON RL, 1995, DIABETES, V44, P261, DOI 10.2337/diabetes.44.3.261; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koh-Banerjee P, 2004, AM J EPIDEMIOL, V159, P1150, DOI 10.1093/aje/kwh167; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lingohr MK, 2002, TRENDS MOL MED, V8, P375, DOI 10.1016/S1471-4914(02)02377-8; Looker HC, 2001, DIABETES CARE, V24, P1917, DOI 10.2337/diacare.24.11.1917; McAdams MA, 2007, OBESITY, V15, P188, DOI 10.1038/oby.2007.504; MCCANCE DR, 1994, DIABETOLOGIA, V37, P617, DOI 10.1007/BF00403382; Oguma Y, 2005, OBES RES, V13, P945, DOI 10.1038/oby.2005.109; OLEFSKY JM, 1982, AM J PHYSIOL, V243, pE15, DOI 10.1152/ajpendo.1982.243.1.E15; Resnick HE, 2000, J EPIDEMIOL COMMUN H, V54, P596, DOI 10.1136/jech.54.8.596; Rhee EJ, 2011, DIABETES METAB J, V35, P138, DOI 10.4093/dmj.2011.35.2.138; Rutledge JC, 2010, NAT REV NEPHROL, V6, P361, DOI 10.1038/nrneph.2010.59; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Szoke E, 2008, DIABETES CARE, V31, P539, DOI 10.2337/dc07-1443; Thearle MS, 2009, DIABETES CARE, V32, P938, DOI 10.2337/dc08-1833; Truesdale KP, 2005, AM J EPIDEMIOL, V161, P1133, DOI 10.1093/aje/kwi151; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wannamethee SG, 1999, DIABETES CARE, V22, P1266, DOI 10.2337/diacare.22.8.1266; Wannamethee SG, 2005, J EPIDEMIOL COMMUN H, V59, P134, DOI 10.1136/jech.2003.015651; Waring ME, 2010, AM J EPIDEMIOL, V171, P550, DOI 10.1093/aje/kwp433; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	33	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80525	10.1371/journal.pone.0080525	http://dx.doi.org/10.1371/journal.pone.0080525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324607	Green Submitted, Green Published, gold			2022-12-25	WOS:000327949300027
J	Tang, RB; Huang, W; Yan, FH; Lu, Y; Chai, WM; Yang, GY; Chen, KM				Tang, Rongbiao; Huang, Wei; Yan, Fuhua; Lu, Yong; Chai, Wei-Min; Yang, Guo-Yuan; Chen, Ke-Min			In-Line Phase Contrast Imaging of Hepatic Portal Vein Embolization with Radiolucent Embolic Agents in Mice: A Preliminary Study	PLOS ONE			English	Article							TRIS-ACRYL GELATIN; ARTERY EMBOLIZATION; LIVER; VISUALIZATION; MICROSPHERES; ANGIOGRAPHY; HYPERTROPHY; RESECTION; ANATOMY	It is crucial to understand the distribution of embolic agents inside target liver during and after the hepatic portal vein embolization (PVE) procedure. For a long time, the problem has not been well solved due to the radiolucency of embolic agents and the resolution limitation of conventional radiography. In this study, we first reported use of fluorescent carboxyl microspheres (FCM) as radiolucent embolic agents for embolizing hepatic portal veins. The fluorescent characteristic of FCM could help to determine their approximate location easily. Additionally, the microspheres were found to be fairly good embolizing agents for PVE. After the livers were excised and fixed, they were imaged by in-line phase contrast imaging (PCI), which greatly improved the detection of the radiolucent embolic agents as compared to absorption contrast imaging (ACI). The preliminary study has for the first time shown that PCI has great potential in the pre-clinical investigation of PVE with radiolucent embolic agents.	[Tang, Rongbiao; Huang, Wei; Yan, Fuhua; Lu, Yong; Chai, Wei-Min; Chen, Ke-Min] Shanghai Jiao Tong Univ, Dept Radiol, Rui Jin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Yang, Guo-Yuan] Shanghai Jiao Tong Univ, Neurosci & Neuroengn Ctr, Med X Res Inst, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Tang, RB (corresponding author), Shanghai Jiao Tong Univ, Dept Radiol, Rui Jin Hosp, Sch Med, Shanghai 200030, Peoples R China.	tangme8688258@sina.com; keminchenrj@163.com			Natural Science Foundation of China [81301347, 81271740]; Nation Basic Research Program of China (973 Program) [2010CB834305]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nation Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research was supported by the Natural Science Foundation of China (Grant no. 81301347 and 81271740) and Nation Basic Research Program of China (973 Program 2010CB834305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla EK, 2001, BRIT J SURG, V88, P165, DOI 10.1046/j.1365-2168.2001.01658.x; Arfelli F, 2010, PHYS MED BIOL, V55, P1643, DOI 10.1088/0031-9155/55/6/008; Azoulay D, 2000, ANN SURG, V231, P480, DOI 10.1097/00000658-200004000-00005; Bravin A, 2013, PHYS MED BIOL, V58, pR1, DOI 10.1088/0031-9155/58/1/R1; Broering DC, 2002, J GASTROINTEST SURG, V6, P905, DOI 10.1016/S1091-255X(02)00122-1; Chen R-C, 2012, J SYNCHROTRON RAD, V19; Fink C, 2003, J MAGN RESON IMAGING, V18, P59, DOI 10.1002/jmri.10318; Furrer K, 2008, HEPATOLOGY, V47, P1615, DOI 10.1002/hep.22164; Gao X, 2006, COMPUT MED IMAG GRAP, V30, P339, DOI 10.1016/j.compmedimag.2006.09.003; Hartog A, 2009, BJA EDUC, V9, P1, DOI 10.1093/bjaceaccp/mkn050; Hwang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063552; Huang JY, 2006, WORLD J GASTROENTERO, V12, P408, DOI 10.3748/wjg.v12.i3.408; Kitchen MJ, 2005, BRIT J RADIOL, V78, P1018, DOI 10.1259/bjr/13024611; Kobayashi S, 2004, J HEPATOL, V40, P405, DOI 10.1016/j.jhep.2003.11.029; Laperle CM, 2008, PHYS MED BIOL, V53, P6911, DOI 10.1088/0031-9155/53/23/017; Laurent A, 2006, INVEST RADIOL, V41, P8, DOI 10.1097/01.rli.0000188027.34400.f3; Lewis RA, 2004, PHYS MED BIOL, V49, P3573, DOI 10.1088/0031-9155/49/16/005; Madoff DC, 2005, RADIOGRAPHICS, V25, pS191, DOI 10.1148/rg.25si055504; Madoff DC, 2002, RADIOGRAPHICS, V22, P1063, DOI 10.1148/radiographics.22.5.g02se161063; Osuga K, 2012, INT J CLIN ONCOL, V17, P306, DOI 10.1007/s10147-012-0445-1; Parsons DW, 2008, J ANAT, V213, P217, DOI 10.1111/j.1469-7580.2008.00950.x; Pelage JP, 2003, J VASC INTERV RADIOL, V14, P15, DOI 10.1097/01.RVI.0000052287.26939.b0; Shen DW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01697; Simpson SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053805; Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073; Tang RB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045597, 10.1371/journal.pone.0049256]; Tang RBA, 2012, PHYS MED BIOL, V57, P3051, DOI 10.1088/0031-9155/57/10/3051; Tang RB, 2011, PHYS MED BIOL, V56, P3503, DOI 10.1088/0031-9155/56/12/004; Tao Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039936; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Xi Y, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3607292; Yoon W, 2004, EXPERT OPIN PHARMACO, V5, P361, DOI 10.1517/eoph.5.2.361.26480; Zhang L, 2011, EUR J RADIOL, V80, P158, DOI 10.1016/j.ejrad.2010.08.019; Zhang X, 2008, PHYS MED BIOL, V53, P5735, DOI 10.1088/0031-9155/53/20/011; Zhang X, 2013, EUR RADIOL, V23, P417, DOI 10.1007/s00330-012-2630-z	35	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80919	10.1371/journal.pone.0080919	http://dx.doi.org/10.1371/journal.pone.0080919			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324646	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300057
J	Geifman, N; Rubin, E				Geifman, Nophar; Rubin, Eitan			The Mouse Age Phenome Knowledgebase and Disease-Specific Inter-Species Age Mapping	PLOS ONE			English	Article							OBESITY; SYSTEM	Background: Similarities between mice and humans lead to generation of many mouse models of human disease. However, differences between the species often result in mice being unreliable as preclinical models for human disease. One difference that might play a role in lowering the predictivity of mice models to human diseases is age. Despite the important role age plays in medicine, it is too often considered only casually when considering mouse models. Methods: We developed the mouse-Age Phenotype Knowledgebase, which holds knowledge about age-related phenotypic patterns in mice. The knowledgebase was extensively populated with literature-derived data using text mining techniques. We then mapped between ages in humans and mice by comparing the age distribution pattern for 887 diseases in both species. Results: The knowledgebase was populated with over 9800 instances generated by a text-mining pipeline. The quality of the data was manually evaluated, and was found to be of high accuracy (estimated precision >86%). Furthermore, grouping together diseases that share similar age patterns in mice resulted in clusters that mirror actual biomedical knowledge. Using these data, we matched age distribution patterns in mice and in humans, allowing for age differences by shifting either of the patterns. High correlation (r(2) >.0.5) was found for 223 diseases. The results clearly indicate a difference in the age mapping between different diseases: age 30 years in human is mapped to 120 days in mice for Leukemia, but to 295 days for Anemia. Based on these results we generated a mice-to-human age map which is publicly available. Conclusions: We present here the development of the mouse-APK, its population with literature-derived data and its use to map ages in mice and human for 223 diseases. These results present a further step made to bridging the gap between humans and mice in biomedical research.	[Geifman, Nophar] Ben Gurion Univ Negev, Fac Med Sci, Dept Microbiol Immunol & Genet, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Geifman, N (corresponding author), Ben Gurion Univ Negev, Fac Med Sci, Dept Microbiol Immunol & Genet, IL-84105 Beer Sheva, Israel.	gifman@post.bgu.ac.il	Rubin, Eitan/E-5256-2011	Rubin, Eitan/0000-0002-7807-4005; Geifman, Nophar/0000-0003-2956-6676	Faculty of Medical Sciences, Ben Gurion University; National Institute of Biotechnology in the Negev	Faculty of Medical Sciences, Ben Gurion University; National Institute of Biotechnology in the Negev	The work was funded by the Faculty of Medical Sciences, Ben Gurion University and by the National Institute of Biotechnology in the Negev. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedell MA, 1997, GENE DEV, V11, P1, DOI 10.1101/gad.11.1.1; BJORNTORP P, 1988, DIABETES METAB REV, V4, P615, DOI 10.1002/dmr.5610040607; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Chen GP, 2001, J BIOL CHEM, V276, P49142, DOI 10.1074/jbc.M104879200; Coenen KR, 2007, AM J PHYSIOL-ENDOC M, V293, pE492, DOI 10.1152/ajpendo.00171.2007; Dewachter I, 2001, BIOCHEM SOC SYMP, V67, P203; DIAMOND SG, 1989, NEUROLOGY, V39, P1187, DOI 10.1212/WNL.39.9.1187; Geifman N, 2013, AGE, P1; Geifman N, 2012, SPRINGERPLUS, V1, DOI 10.1186/2193-1801-1-4; Geifman N, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-229; Hasenclever D, 1998, NEW ENGL J MED, V339, P1506, DOI 10.1056/NEJM199811193392104; Hendrie HC, 1997, GERIATRICS-US, V52, pS4; Hodge WG, 1995, EPIDEMIOL REV, V17, P336, DOI 10.1093/oxfordjournals.epirev.a036197; Jin Xiao-lei, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P27; Levy Zohar, 2003, Eur J Intern Med, V14, P479, DOI 10.1016/j.ejim.2003.08.010; Luo W, 2011, ATHEROSCLEROSIS, V214, P81, DOI 10.1016/j.atherosclerosis.2010.10.009; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Morgan D, 2011, J INTERN MED, V269, P54, DOI 10.1111/j.1365-2796.2010.02315.x; Morrato EH, 2006, DIABETES CARE, V29, P543, DOI 10.2337/diacare.29.03.06.dc05-2165; OTIS EM, 1954, ANAT RECORD, V120, P33, DOI 10.1002/ar.1091200104; Pedotti R, 2003, TRENDS IMMUNOL, V24, P479, DOI 10.1016/S1471-4906(03)00233-3; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Shah KB, 2006, ARCH INTERN MED, V166, P1805, DOI 10.1001/archinte.166.17.1805; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; Vasto S, 2009, MECH AGEING DEV, V130, P40, DOI 10.1016/j.mad.2008.06.003; VECHT CJ, 1993, J NEUROL NEUROSUR PS, V56, P1259, DOI 10.1136/jnnp.56.12.1259	26	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81114	10.1371/journal.pone.0081114	http://dx.doi.org/10.1371/journal.pone.0081114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312529	Green Published, Green Submitted, gold			2022-12-25	WOS:000327947800037
J	Wang, S; Luo, XN; Wei, W; Zheng, YD; Dou, YX; Cai, XP				Wang, Shuai; Luo, Xuenong; Wei, Wei; Zheng, Yadong; Dou, Yongxi; Cai, Xuepeng			Calculation of Evolutionary Correlation between Individual Genes and Full-Length Genome: A Method Useful for Choosing Phylogenetic Markers for Molecular Epidemiology	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS-VIRUS; ANALYSIS REVEALS; SPECIES TREES; SEQUENCE; DISCORDANCE; STRAINS; PROTEINS; GENOTYPE	Individual genes or regions are still commonly used to estimate the phylogenetic relationships among viral isolates. The genomic regions that can faithfully provide assessments consistent with those predicted with full-length genome sequences would be preferable to serve as good candidates of the phylogenetic markers for molecular epidemiological studies of many viruses. Here we employed a statistical method to evaluate the evolutionary relationships between individual viral genes and full-length genomes without tree construction as a way to determine which gene can match the genome well in phylogenetic analyses. This method was performed by calculation of linear correlations between the genetic distance matrices of aligned individual gene sequences and aligned genome sequences. We applied this method to the phylogenetic analyses of porcine circovirus 2 (PCV2), measles virus (MV), hepatitis E virus (HEV) and Japanese encephalitis virus (JEV). Phylogenetic trees were constructed for comparisons and the possible factors affecting the method accuracy were also discussed in the calculations. The results revealed that this method could produce results consistent with those of previous studies about the proper consensus sequences that could be successfully used as phylogenetic markers. And our results also suggested that these evolutionary correlations could provide useful information for identifying genes that could be used effectively to infer the genetic relationships.	[Wang, Shuai; Luo, Xuenong; Wei, Wei; Zheng, Yadong; Dou, Yongxi; Cai, Xuepeng] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Dou, YX (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.	yongxid@163.com; wslanzhou@126.com	YD, Zh/HGA-5541-2022; WEI, Wei/AAK-9139-2021; Wang, Shuai/ABE-4447-2022	YD, Zh/0000-0001-6795-9978; WEI, Wei/0000-0002-6478-5973; Wang, Shuai/0000-0001-7028-8503	earmarked fund for China Agriculture Research System [CARS-40-10]; Special Fund for Agro-scientific Research in the Public Interest, China [201103008]	earmarked fund for China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest, China	This work was supported by the earmarked fund for China Agriculture Research System (No. CARS-40-10) and the Special Fund for Agro-scientific Research in the Public Interest (No. 201103008), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CNK, 2012, METHODS MOL BIOL, V856, P3, DOI 10.1007/978-1-61779-585-5_1; Chen GB, 2004, WORLD J GASTROENTERO, V10, P2045, DOI 10.3748/wjg.v10.i14.2045; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Dehesa-Violante M, 2007, ARCH MED RES, V38, P606, DOI 10.1016/j.arcmed.2007.03.001; Fan XH, 2012, J VIROL, V86, P2375, DOI 10.1128/JVI.06824-11; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Goh CS, 2002, J MOL BIOL, V324, P177, DOI 10.1016/S0022-2836(02)01038-0; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Herniou EA, 2001, J VIROL, V75, P8117, DOI 10.1128/JVI.75.17.8117-8126.2001; Juan D, 2008, P NATL ACAD SCI USA, V105, P934, DOI 10.1073/pnas.0709671105; Kann MG, 2009, J MOL BIOL, V385, P91, DOI 10.1016/j.jmb.2008.09.078; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Leifer I, 2010, J GEN VIROL, V91, P2687, DOI 10.1099/vir.0.023200-0; Lovell SC, 2010, MOL BIOL EVOL, V27, P2567, DOI 10.1093/molbev/msq144; Lu L, 2004, J MED VIROL, V74, P556, DOI 10.1002/jmv.20214; Luo CQ, 2009, J VIROL, V83, P2285, DOI 10.1128/JVI.02180-08; Magiorkinis G, 2004, J MED VIROL, V74, P369, DOI 10.1002/jmv.20187; Mankertz A, 2011, J INFECT DIS, V204, pS335, DOI 10.1093/infdis/jir101; MARIN MS, 1995, VIROLOGY, V206, P1133, DOI 10.1006/viro.1995.1038; Olvera A, 2007, VIROLOGY, V357, P175, DOI 10.1016/j.virol.2006.07.047; Olvera A, 2010, VET J, V184, P130, DOI 10.1016/j.tvjl.2009.02.015; Padhi A, 2009, J VIROL, V83, P2015, DOI 10.1128/JVI.02047-08; Pang Yan-kun, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P17; Planet PJ, 2006, J BIOMED INFORM, V39, P86, DOI 10.1016/j.jbi.2005.08.008; Press W. H., 1992, ART SCI COMPUTING; Rosenberg NA, 2002, THEOR POPUL BIOL, V61, P225, DOI 10.1006/tpbi.2001.1568; Rosenberg NA, 2008, SYST BIOL, V57, P131, DOI 10.1080/10635150801905535; Rota PA, 2009, CURR TOP MICROBIOL, V330, P129; Schaefer S, 2007, WORLD J GASTROENTERO, V13, P14, DOI 10.3748/wjg.v13.i1.14; Schlauder GG, 2001, J MED VIROL, V65, P282, DOI 10.1002/jmv.2031; Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003; Sotelo E, 2011, J GEN VIROL, V92, P2512, DOI 10.1099/vir.0.033829-0; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tatte VS, 2010, INFECT GENET EVOL, V10, P940, DOI 10.1016/j.meegid.2010.05.017; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toniutto P, 1996, J CLIN MICROBIOL, V34, P2382, DOI 10.1128/JCM.34.10.2382-2385.1996; Truong AT, 2001, VIRUS RES, V76, P71, DOI 10.1016/S0168-1702(01)00255-6; Uchil PD, 2001, AM J TROP MED HYG, V65, P242, DOI 10.4269/ajtmh.2001.65.242; Yun SM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-127; Zhai LJ, 2006, VIRUS RES, V120, P57, DOI 10.1016/j.virusres.2006.01.013	41	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81106	10.1371/journal.pone.0081106	http://dx.doi.org/10.1371/journal.pone.0081106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312527	Green Published, Green Submitted, gold			2022-12-25	WOS:000327947800035
J	Bayles, R; Baker, EK; Jowett, JBM; Barton, D; Esler, M; El-Osta, A; Lambert, G				Bayles, Richard; Baker, Emma K.; Jowett, Jeremy B. M.; Barton, David; Esler, Murray; El-Osta, Assam; Lambert, Gavin			Methylation of the SLC6a2 Gene Promoter in Major Depression and Panic Disorder	PLOS ONE			English	Article							NOREPINEPHRINE TRANSPORTER GENE; DNA METHYLATION; CHROMATIN; REUPTAKE; HYPERTENSION; EPIGENETICS; EXPRESSION; SPILLOVER; BINDING; SYSTEM	Reduced function of the noradrenaline transporter (NET) has been demonstrated in patients with major depressive disorder (MDD) and panic disorder. Attempts to explain NET dysfunction in MDD and panic disorder by genetic variation in the NET gene SLC6a2 have been inconclusive. Transcriptional silencing of the SLC6a2 gene may be an alternative mechanism which can lead to NET dysfunction independent of DNA sequence. The objective of this study was to characterise the DNA methylation state of the SLC6a2 gene promoter in patients with MDD and panic disorder. SLC6a2 promoter methylation was also analysed before and after antidepressant treatment. This study was performed with DNA from blood, using bisulphite sequencing and EpiTYPER methylation analyses. Patients with MDD or panic disorder were not found to differ significantly from healthy controls in the pattern of methylation of the SLC6a2 gene promotor. While significant correlations between methylation levels at some CpG sites and physiological measures were identified, overall the variation in DNA methylation between patients was small, and the significance of this variation remains equivocal. No significant changes in SLC6a2 promoter methylation were observed in response to antidepressant treatment. Further in-depth analysis of alternative mechanisms of transcriptional regulation of the SLC6a2 gene in human health and disease would be of value.	[Bayles, Richard; Jowett, Jeremy B. M.; Barton, David; Esler, Murray; El-Osta, Assam; Lambert, Gavin] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Baker, Emma K.] St Vincents Inst, Melbourne, Vic, Australia	Baker Heart and Diabetes Institute; St. Vincent's Institute of Medical Research	Bayles, R (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	richard.bayles@bakeridi.edu.au	Lambert, Gavin/Q-4869-2017; Lambert, Gavin W/E-7384-2010	Lambert, Gavin/0000-0003-0315-645X; Lambert, Gavin W/0000-0003-0315-645X; El-Osta, Assam/0000-0001-7968-7375; El-Osta, Assam/0000-0003-2969-9137	NHMRC; Victorian Government's OIS Program	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's OIS Program	This work was supported by grants from the NHMRC. The Baker IDI Heart & Diabetes Institute is supported in part by the Victorian Government's OIS Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarenga ME, 2006, PSYCHOSOM MED, V68, P8, DOI 10.1097/01.psy.0000195872.00987.db; Barton DA, 2007, J HYPERTENS, V25, P2117, DOI 10.1097/HJH.0b013e32829baae7; Bayles R, 2012, ARTERIOSCL THROM VAS, V32, P1910, DOI 10.1161/ATVBAHA.111.244343; Bayles R, 2010, CELL CYCLE, V9, P4600, DOI 10.4161/cc.9.22.13888; Byun HM, 2009, HUM MOL GENET, V18, P4808, DOI 10.1093/hmg/ddp445; Cassel S, 2006, MOL PHARMACOL, V70, P487, DOI 10.1124/mol.106.022301; Clark SJ, 1997, GENE, V195, P67, DOI 10.1016/S0378-1119(97)00164-9; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dawood T, 2007, HYPERTENS RES, V30, P285, DOI 10.1291/hypres.30.285; DeMarzo AM, 2003, LANCET, V361, P955, DOI 10.1016/S0140-6736(03)12779-1; Dlugos A, 2007, BIOL PSYCHIAT, V61, P1296, DOI 10.1016/j.biopsych.2006.09.031; Docherty SJ, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-3; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; El-Osta A, 2000, GENE EXPRESSION, V9, P63; Esler M, 2002, BIOGERONTOLOGY, V3, P45, DOI 10.1023/A:1015203328878; ESLER MD, 1995, AM J PHYSIOL-REG I, V268, pR278, DOI 10.1152/ajpregu.1995.268.1.R278; ESLER MD, 1991, AM J PHYSIOL, V260, pR817, DOI 10.1152/ajpregu.1991.260.4.R817; Esler Murray, 2006, J Psychopharmacol, V20, P60, DOI 10.1177/1359786806066055; Esler M, 2008, ANN NY ACAD SCI, V1148, P338, DOI 10.1196/annals.1410.064; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; HOLLER M, 1988, GENE DEV, V2, P1127, DOI 10.1101/gad.2.9.1127; Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97; Kim CH, 1999, J BIOL CHEM, V274, P6507, DOI 10.1074/jbc.274.10.6507; Kn H, 2010, J NEUROSCI, V30, P1494, DOI 10.1523/JNEUROSCI.4675-09.2010; Kundu TK, 1999, J BIOCHEM, V125, P217, DOI 10.1093/oxfordjournals.jbchem.a022276; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; MAES M, 1995, PROG NEURO-PSYCHOPH, V19, P11, DOI 10.1016/0278-5846(94)00101-M; Mata S, 2005, J NEUROIMMUNOL, V170, P134, DOI 10.1016/j.jneuroim.2005.08.007; McGowan Patrick O., 2008, Environmental Health and Preventive Medicine, V13, P16, DOI 10.1007/s12199-007-0002-0; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Mill J, 2007, MOL PSYCHIATR, V12, P799, DOI 10.1038/sj.mp.4001992; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Schlaich MP, 2004, HYPERTENSION, V43, P169, DOI 10.1161/01.HYP.0000103160.35395.9E; Schroeder C, 2012, AM J PHYSIOL-HEART C, V303, pH1273, DOI 10.1152/ajpheart.00492.2012; Teodoridis JM, 2004, DRUG RESIST UPDATE, V7, P267, DOI 10.1016/j.drup.2004.06.005; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Vanaja DK, 2009, CANCER INVEST, V27, P549, DOI 10.1080/07357900802620794	41	29	30	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e83223	10.1371/journal.pone.0083223	http://dx.doi.org/10.1371/journal.pone.0083223			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312678	Green Published, gold			2022-12-25	WOS:000327944500150
J	Nakamura, M; Koeda, Y; Tanaka, F; Onoda, T; Itai, K; Ohsawa, M; Tanno, K; Sakata, K; Omama, S; Ishibashi, Y; Makita, S; Ohta, M; Ogasawara, K; Komatsu, T; Okayama, A				Nakamura, Motoyuki; Koeda, Yorihiko; Tanaka, Fumitaka; Onoda, Toshiyuki; Itai, Kazuyoshi; Ohsawa, Masaki; Tanno, Kozo; Sakata, Kiyomi; Omama, Shinich; Ishibashi, Yasuhiro; Makita, Shinji; Ohta, Mutsuko; Ogasawara, Kuniaki; Komatsu, Takashi; Okayama, Akira			Plasma B-type Natriuretic Peptide as a Predictor of Cardiovascular Events in Subjects with Atrial Fibrillation: A Community-Based Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; RISK STRATIFICATION; NATURAL-HISTORY; HEART-FAILURE; STROKE; DISEASE; LEVEL; THROMBOEMBOLISM; EPIDEMIOLOGY; INFARCTION	Objectives: Atrial fibrillation (AF) is a significant public health issue due to its high prevalence in the general population, and is associated with an increased risk of cardiovascular (CV) events including systemic thromboembolism, heart failure, and coronary artery disease. The relationship between plasma B-type natriuretic peptide (BNP) and CV risk in real world AF subjects remains unknown. Methods: The subject of the study (n = 228; mean age = 69 years) was unselected individuals with AF in a community-based population (n = 15,394; AF prevalence rate = 1.5%). The CV event free rate within each BNP tertile was estimated, and Cox regression analysis was performed to examine the relative risk of the onset of CV events among the tertiles. The prognostic ability of BNP was compared to an established risk score for embolic events (CHADS2 score). In addition, to determine the usefulness of BNP as a predictor in addition to CHADS2 score, we calculated Net Reclassification Improvement (NRI) and Integrated Discrimination Improvement (IDI) indices. Results: During the follow-up period 58 subjects experienced CV events (52 per 1,000 person-years). The event-free ratio was significantly lower in the highest tertile (p < 0.02). After adjustment for established CV risk factors, the hazard ratio (HR) of the highest tertile was significantly higher than that of the lowest tertile (HR = 2.38; p < 0.02). The predictive abilities of plasma BNP in terms of sensitivity and specificity for general CV events were comparable to those of CHADS2 score. Adding BNP to the CHADS2 score only model improved the NRI (0.319; p < 0.05) and the IDI (0.046; p < 0.05). Conclusion: Plasma BNP is a valuable biomarker both singly or in combination with an established scoring system for assessing general CV risk including stroke, heart failure and acute coronary syndrome in real-world AF subjects.	[Nakamura, Motoyuki; Koeda, Yorihiko; Tanaka, Fumitaka; Ishibashi, Yasuhiro; Makita, Shinji; Komatsu, Takashi] Iwate Med Univ, Dept Internal Med, Morioka, Iwate 020, Japan; [Onoda, Toshiyuki; Ohsawa, Masaki; Tanno, Kozo; Sakata, Kiyomi] Iwate Med Univ, Dept Hyg & Prevent Med, Morioka, Iwate 020, Japan; [Omama, Shinich; Ogasawara, Kuniaki] Iwate Med Univ, Dept Neurosurg, Morioka, Iwate 020, Japan; [Ohta, Mutsuko] Iwate Hlth Serv Assoc, Morioka, Iwate, Japan; [Itai, Kazuyoshi; Okayama, Akira] Japan AntiTB Assoc, Inst Hlth Serv 1, Tokyo, Japan	Iwate Medical University; Iwate Medical University; Iwate Medical University	Nakamura, M (corresponding author), Iwate Med Univ, Dept Internal Med, Morioka, Iwate 020, Japan.	nkmrmoto@iwate-med.ac.jp	Tanno, Kozo/HDM-5952-2022; Tanno, Kozo/ABE-5165-2020; Ohsawa, Masaki/AAJ-5030-2020	Tanno, Kozo/0000-0002-1264-0684; Tanno, Kozo/0000-0002-1264-0684; Ohsawa, Masaki/0000-0002-1152-1958	Ministry of Education, Science, and Culture of Japan, Tokyo, Japan [23591059]; Japan Arteriosclerosis Prevention Fund (JAPF), Tokyo, Japan; Takeda Science Foundation, Osaka, Japan; Grants-in-Aid for Scientific Research [24390155, 23591059] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Arteriosclerosis Prevention Fund (JAPF), Tokyo, Japan; Takeda Science Foundation, Osaka, Japan(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by grants-in-aid from the scientific research fund of the Ministry of Education, Science, and Culture of Japan (23591059), Tokyo, Japan; the Japan Arteriosclerosis Prevention Fund (JAPF), Tokyo, Japan; and the Takeda Science Foundation, Osaka, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chugh SS, 2001, J AM COLL CARDIOL, V37, P371, DOI 10.1016/S0735-1097(00)01107-4; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Hijazi Z, 2013, J AM COLL CARDIOL, V61, P2274, DOI 10.1016/j.jacc.2012.11.082; Hijazi Z, 2012, CIRCULATION, V125, P1605, DOI 10.1161/CIRCULATIONAHA.111.038729; Igarashi Y, 2001, JPN CIRC J, V65, P788, DOI 10.1253/jcj.65.788; KANNEL WB, 1983, AM HEART J, V106, P389, DOI 10.1016/0002-8703(83)90208-9; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Kannel WB, 2009, CARDIOL CLIN, V27, P13, DOI 10.1016/j.ccl.2008.09.015; Kistorp C, 2005, JAMA-J AM MED ASSOC, V293, P1609, DOI 10.1001/jama.293.13.1609; Lee SH, 2006, CIRC J, V70, P100, DOI 10.1253/circj.70.100; Li JT, 2006, HEART VESSELS, V21, P137, DOI 10.1007/s00380-005-0884-y; Lip GYH, 2012, CHEST, V142, P1489, DOI 10.1378/chest.11-2888; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Makita S, 2009, ATHEROSCLEROSIS, V204, P234, DOI 10.1016/j.atherosclerosis.2008.07.040; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; MUKOYAMA M, 1990, NEW ENGL J MED, V323, P757; Nakamura M, 2002, HEART, V87, P131, DOI 10.1136/heart.87.2.131; Nakamura M, 2010, INT J CARDIOL, V143, P124, DOI 10.1016/j.ijcard.2009.01.076; Omama S, 2006, J NEUROL NEUROSUR PS, V77, P1345, DOI 10.1136/jnnp.2006.090373; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Sadanaga T, 2012, HEART VESSELS, V27, P280, DOI 10.1007/s00380-011-0151-3; Sakuma M, 2010, CIRC J, V74, P792, DOI 10.1253/circj.CJ-09-0834; Shimizu H, 2002, STROKE, V33, P1005, DOI 10.1161/hs0402.105657; Silvet H, 2003, AM J CARDIOL, V92, P1124, DOI 10.1016/j.amjcard.2003.07.010; Troughton RW, 2013, J AM COLL CARDIOL, V61, P2285, DOI 10.1016/j.jacc.2013.02.066; Tsutamoto T, 1997, CIRCULATION, V96, P509; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994	28	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81243	10.1371/journal.pone.0081243	http://dx.doi.org/10.1371/journal.pone.0081243			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312541	Green Published, gold, Green Submitted			2022-12-25	WOS:000327944500062
J	Zhang, LT; Liu, XL; Liu, JG; Zhang, ZF				Zhang, Litao; Liu, Xiaolong; Liu, Jianguo; Zhang, Zhifeng			Characteristics and Function of Sulfur Dioxygenase in Echiuran Worm Urechis unicinctus	PLOS ONE			English	Article							HYDROGEN-SULFIDE EXPOSURE; GLYOXALASE-II; SULFIDE/QUINONE OXIDOREDUCTASE; ARABIDOPSIS ETHE1; SULFANE SULFUR; ENZYMES; PROTEIN; ENVIRONMENT; REDUCTION; MUTATIONS	Background: Sulfide is a common toxin to animals and is abundant in coastal and aquatic sediments. Sulfur dioxygenase (SDO) is thought to be the key enzyme involved in sulfide oxidation in some organisms. The echiuran worm, Urechis unicinctus, inhabits coastal sediment and tolerates high concentrations of sulfide. The SDO is presumably important for sulfide tolerance in U. unicinctus. Results: The full-length cDNA of SDO from the echiuran worm U. unicinctus, proven to be located in the mitochondria, was cloned and the analysis of its sequence suggests that it belongs to the metallo-beta-lactamase superfamily. The enzyme was produced using an E. coli expression system and the measured activity is approximately 0.80 U mg protein(-1). Furthermore, the expression of four sub-segments of the U. unicinctus SDO was accomplished leading to preliminary identification of functional domains of the enzyme. The identification of the conserved metal I (H113, H115, H169 and D188), metal II (D117, H118, H169 and H229) as well as the potential glutathione (GSH) (R197, Y231, M279 and I283) binding sites was determined by enzyme activity and GSH affinity measurements. The key residues responsible for SDO activity were identified by analysis of simultaneous mutations of residues D117 and H118 located close to the metal II binding site. Conclusion: The recombinant SDO from U. unicinctus was produced, purified and characterized. The metal binding sites in the SDO were identified and Y231 recognized as the mostly important amino acid residue for GSH binding. Our results show that SDO is located in the mitochondria where it plays an important role in sulfide detoxification of U. unicinctus.	[Zhang, Litao; Liu, Xiaolong; Liu, Jianguo; Zhang, Zhifeng] Ocean Univ China, Key Lab Marine Genet & Breeding, Minist Educ, Qingdao, Peoples R China	Ocean University of China	Zhang, ZF (corresponding author), Ocean Univ China, Key Lab Marine Genet & Breeding, Minist Educ, Qingdao, Peoples R China.	zzfp107@ouc.edu.cn		Liu, Xiaolong/0000-0003-4384-0360	Natural Science Foundation of China [31072191]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (31072191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ARP AJ, 1992, MAR BIOL, V113, P613, DOI 10.1007/BF00349705; BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Bugg TDH, 2003, TETRAHEDRON, V59, P7075, DOI 10.1016/S0040-4020(03)00944-X; Cameron AD, 1999, STRUCTURE, V7, P1067, DOI 10.1016/S0969-2126(99)80174-9; CARRICO RJ, 1978, J BIOL CHEM, V253, P7212; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; Dal Peraro M, 2002, J BIOL INORG CHEM, V7, P704, DOI 10.1007/s00775-002-0346-2; Frazao C, 2000, NAT STRUCT BIOL, V7, P1041; Grieshaber MK, 1998, ANNU REV PHYSIOL, V60, P33, DOI 10.1146/annurev.physiol.60.1.33; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Holdorf MM, 2008, J INORG BIOCHEM, V102, P1825, DOI 10.1016/j.jinorgbio.2008.06.003; Holdorf MM, 2012, PLANT PHYSIOL, V160, P226, DOI 10.1104/pp.112.201855; Jackson MR, 2012, BIOCHEMISTRY-US, V51, P6804, DOI 10.1021/bi300778t; JORGENSEN BB, 1974, MAR BIOL, V24, P189, DOI 10.1007/BF00391893; Joyner-Matos J, 2010, PHYSIOL BIOCHEM ZOOL, V83, P356, DOI 10.1086/597529; Julian D, 2005, J EXP BIOL, V208, P4109, DOI 10.1242/jeb.01867; Kabil O, 2012, J BIOL CHEM, V287, P44561, DOI 10.1074/jbc.M112.407411; KHAN AA, 1990, TOXICOL APPL PHARM, V103, P482, DOI 10.1016/0041-008X(90)90321-K; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; LI N, 1998, BIOL BULL, V33, P12; Li N., 1995, SHANDONG FISHERES, V12, P24; Llarrull LI, 2007, J BIOL CHEM, V282, P18276, DOI 10.1074/jbc.M700742200; Ma YB, 2012, MAR BIOTECHNOL, V14, P245, DOI 10.1007/s10126-011-9408-1; Ma YB, 2011, MAR BIOTECHNOL, V13, P93, DOI 10.1007/s10126-010-9273-3; Ma ZJ, 2010, CHIN J OCEANOL LIMN, V28, P521, DOI 10.1007/s00343-010-9104-4; Ma Zhuojun, 2005, Chinese Journal of Oceanology and Limnology, V23, P104; Maiti MK, 1997, PLANT MOL BIOL, V35, P471, DOI 10.1023/A:1005891123344; Marasinghe GPK, 2005, J BIOL CHEM, V280, P40668, DOI 10.1074/jbc.M509748200; McCoy JG, 2006, ACTA CRYSTALLOGR D, V62, P964, DOI 10.1107/S0907444906020592; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Rohwerder T, 2003, MICROBIOL-SGM, V149, P1699, DOI 10.1099/mic.0.26212-0; SCHROFF G, 1977, J COMP PHYSIOL, V116, P325, DOI 10.1007/BF00689040; Szklarczyk R, 2010, PROTEOMICS, V10, P4012, DOI 10.1002/pmic.201000329; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; VANDERJAGT DL, 1993, BIOCHEM SOC T, V21, P522, DOI 10.1042/bst0210522; Wang Sifeng, 2010, Journal of Ocean University of China, V9, P157, DOI 10.1007/s11802-010-0157-y; Yamaguchi Y, 2005, J BIOL CHEM, V280, P20824, DOI 10.1074/jbc.M414314200; Yang GD, 2004, FASEB J, V18, P1782, DOI 10.1096/fj.04-2279fje	42	7	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81885	10.1371/journal.pone.0081885	http://dx.doi.org/10.1371/journal.pone.0081885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312599	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500103
J	Priyadarshini, M; Orosco, LA; Panula, PJ				Priyadarshini, Madhusmita; Orosco, Lori A.; Panula, Pertti J.			Oxidative Stress and Regulation of Pink1 in Zebrafish (Danio rerio)	PLOS ONE			English	Article							PARKINSONS-DISEASE; TYROSINE-HYDROXYLASE; MITOCHONDRIAL DYNAMICS; TRANSGENE EXPRESSION; MESSENGER-RNA; GENES; BRAIN; TOL2; SYSTEMS; GLUTATHIONE	Oxidative stress-mediated neuronal dysfunction is characteristic of several neurodegenerative disorders, including Parkinson's disease (PD). The enzyme tyrosine hydroxylase (TH) catalyzes the formation of L-DOPA, the rate-limiting step in the biosynthesis of dopamine. A lack of dopamine in the striatum is the most characteristic feature of PD, and the cause of the most dominant symptoms. Loss of function mutations in the PTEN-induced putative kinase (PINK1) gene cause autosomal recessive PD. This study explored the basic mechanisms underlying the involvement of pink1 in oxidative stress-mediated PD pathology using zebrafish as a tool. We generated a transgenic line, Tg(pink1:EGFP), and used it to study the effect of oxidative stress (exposure to H2O2) on pink1 expression. GFP expression was enhanced throughout the brain of zebrafish larvae subjected to oxidative stress. In addition to a widespread increase in pink1 mRNA expression, mild oxidative stress induced a clear decline in tyrosine hydroxylase 2 (th2), but not tyrosine hydroxylase 1 (th1) expression, in the brain of wild-type larvae. The drug L-Glutathione Reduced (LGR) has been associated with anti-oxidative and possible neuroprotective properties. Administration of LGR normalized the increased fluorescence intensity indicating pink1 transgene expression and endogenous pink1 mRNA expression in larvae subjected to oxidative stress by H2O2. In the pink1 morpholino oliogonucleotide-injected larvae, the reduction in the expression of th1 and th2 was partially rescued by LGR. The pink1 gene is a sensitive marker of oxidative stress in zebrafish, and LGR effectively normalizes the consequences of mild oxidative stress, suggesting that the neuroprotective effects of pink1 and LGR may be significant and useful in drug development.	[Priyadarshini, Madhusmita; Panula, Pertti J.] Univ Helsinki, Ctr Neurosci, Helsinki, Finland; [Priyadarshini, Madhusmita; Panula, Pertti J.] Univ Helsinki, Inst Biomed Anat, Helsinki, Finland; [Orosco, Lori A.] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21210 USA	University of Helsinki; University of Helsinki; Carnegie Institution for Science	Panula, PJ (corresponding author), Univ Helsinki, Ctr Neurosci, Helsinki, Finland.	pertti.panula@helsinki.fi	Sahu, Madhusmita Priyadarshini/ABE-2260-2020	Sahu, Madhusmita Priyadarshini/0000-0003-1318-5799; Panula, Pertti/0000-0002-1189-5132	Finnish Graduate School of Neuroscience; Magnus Ehrnrooth Foundation; Academy of Finland; Sigrid Juselius foundation	Finnish Graduate School of Neuroscience; Magnus Ehrnrooth Foundation; Academy of Finland(Academy of Finland); Sigrid Juselius foundation(Sigrid Juselius Foundation)	This project was funded by the Finnish Graduate School of Neuroscience, Magnus Ehrnrooth Foundation, Academy of Finland and Sigrid Juselius foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atakisi O, 2010, EUR REV MED PHARMACO, V14, P19; Bandmann O, 2010, NEUROBIOL DIS, V40, P58, DOI 10.1016/j.nbd.2010.05.017; Blackinton JG, 2007, BRAIN RES, V1184, P10, DOI 10.1016/j.brainres.2007.09.056; Bove J, 2012, NEUROSCIENCE, V211, P51, DOI 10.1016/j.neuroscience.2011.10.057; Bretaud S, 2011, ZEBRAFISH, V8, P103, DOI 10.1089/zeb.2011.0697; Candy J, 2005, BBA-GENE STRUCT EXPR, V1727, P35, DOI 10.1016/j.bbaexp.2004.11.005; Chen YC, 2009, HISTOCHEM CELL BIOL, V132, P375, DOI 10.1007/s00418-009-0619-8; Chien WL, 2011, J NEUROCHEM, V117, P643, DOI 10.1111/j.1471-4159.2011.07229.x; Eriksson KS, 1998, EUR J NEUROSCI, V10, P3799, DOI 10.1046/j.1460-9568.1998.00394.x; Filippi A, 2010, J COMP NEUROL, V518, P423, DOI 10.1002/cne.22213; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Haavik J, 1998, MOL NEUROBIOL, V16, P285, DOI 10.1007/BF02741387; Iida A, 2004, GENES GENET SYST, V79, P119, DOI 10.1266/ggs.79.119; JENNER P, 1989, J NEUROL NEUROSUR PS, P22; Kari G, 2007, CLIN PHARMACOL THER, V82, P70, DOI 10.1038/sj.clpt.6100223; Kaslin J, 2004, J NEUROSCI, V24, P2678, DOI 10.1523/JNEUROSCI.4908-03.2004; Kaslin J, 2001, J COMP NEUROL, V440, P342, DOI 10.1002/cne.1390; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; Klein C, 2007, LANCET NEUROL, V6, P652, DOI 10.1016/S1474-4422(07)70174-6; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mills RD, 2008, J NEUROCHEM, V105, P18, DOI 10.1111/j.1471-4159.2008.05249.x; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; NICKLAS WJ, 1987, LIFE SCI, V40, P721, DOI 10.1016/0024-3205(87)90299-2; Onyango IG, 2008, NEUROCHEM RES, V33, P589, DOI 10.1007/s11064-007-9482-y; Petit A., 2005, J BIOL CHEM, V7, P280; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Priyadarshini M, 2013, NEUROBIOL DIS, V54, P127, DOI 10.1016/j.nbd.2013.02.002; Ren GQ, 2013, J BIOL CHEM, V288, P22451, DOI 10.1074/jbc.M113.485227; Sallinen V, 2010, NEUROBIOL DIS, V40, P93, DOI 10.1016/j.nbd.2010.06.001; Sallinen V, 2009, J NEUROCHEM, V109, P403, DOI 10.1111/j.1471-4159.2009.05986.x; Santos D, 2012, MITOCHONDRION, V12, P428, DOI 10.1016/j.mito.2012.05.002; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Steele SL, 2011, J COMP PHYSIOL B, V181, P527, DOI 10.1007/s00360-010-0544-0; Taymans JM, 2006, J NEUROCHEM, V98, P951, DOI 10.1111/j.1471-4159.2006.03919.x; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Yamamoto K, 2010, MOL CELL NEUROSCI, V43, P394, DOI 10.1016/j.mcn.2010.01.006; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yoshinari N, 2012, DEV GROWTH DIFFER, V54, P818, DOI 10.1111/dgd.12013	45	17	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81851	10.1371/journal.pone.0081851	http://dx.doi.org/10.1371/journal.pone.0081851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24324558	Green Submitted, Green Published, gold			2022-12-25	WOS:000327546400093
J	Becker, EL; Cordes, EE; Macko, SA; Lee, RW; Fisher, CR				Becker, Erin L.; Cordes, Erik E.; Macko, Stephen A.; Lee, Raymond W.; Fisher, Charles R.			Using Stable Isotope Compositions of Animal Tissues to Infer Trophic Interactions in Gulf of Mexico Lower Slope Seep Communities	PLOS ONE			English	Article							LOWER CONTINENTAL-SLOPE; COLD SEEPS; FOOD WEBS; NITROGEN; CARBON; MARINE; MUSSEL; DIVERSITY; ABUNDANCE; SYMBIOSIS	We analyzed the tissue carbon, nitrogen, and sulfur stable isotope contents of macrofaunal communities associated with vestimentiferan tubeworms and bathymodiolin mussels from the Gulf of Mexico lower continental slope (970-2800 m). Shrimp in the genus Alvinocaris associated with vestimentiferans from shallow (530 m) and deep (1400-2800 m) sites were used to test the hypothesis that seep animals derive a greater proportion of their nutrition from seeps (i.e. a lower proportion from the surface) at greater depths. To account for spatial variability in the inorganic source pool, we used the differences between the mean tissue delta C-13 and delta N-15 of the shrimp in each collection and the mean delta C-13 and delta N-15 values of the vestimentiferans from the same collection, since vestimentiferans are functionally autotrophic and serve as a baseline for environmental isotopic variation. There was a significant negative relationship between this difference and depth for both delta C-13 and delta N-15 (p=0.02 and 0.007, respectively), which supports the hypothesis of higher dependence on seep nutrition with depth. The small polychaete worm Protomystides sp. was hypothesized to be a blood parasite of the vestimentiferan Escarpia laminata. There was a highly significant linear relationship between the delta C-13 values of Protomystides sp. and the E. laminata individuals to which they were attached across all collections (p < 0.001) and within a single collection (p = 0.01), although this relationship was not significant for delta N-15 and delta S-34. We made several other qualitative inferences with respect to the feeding biology of the taxa occurring in these lower slope seeps, some of which have not been described prior to this study.	[Becker, Erin L.; Fisher, Charles R.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Cordes, Erik E.] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA; [Macko, Stephen A.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Lee, Raymond W.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Virginia; Washington State University	Becker, EL (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	elb209@psu.edu	Fisher, Charles/H-7912-2012; Macko, Stephen/K-4588-2015; Cordes, Erik E/B-3293-2009	Cordes, Erik E/0000-0002-6989-2348	National Oceanographic Partnership Program (NOPP); Bureau of Ocean Energy Management (BOEM) [1435-01-05-CT-39187 (M05PC0018)]; NOAA Office of Ocean Exploration and Research	National Oceanographic Partnership Program (NOPP); Bureau of Ocean Energy Management (BOEM); NOAA Office of Ocean Exploration and Research	This work was sponsored by the National Oceanographic Partnership Program (NOPP) and funded by the Bureau of Ocean Energy Management (BOEM) contract #1435-01-05-CT-39187 (M05PC0018) and the NOAA Office of Ocean Exploration and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker EL, MAR ECOL PRO S UNPUB; Becker EL, 2010, DEEP-SEA RES PT II, V57, P1957, DOI 10.1016/j.dsr2.2010.05.002; Becker EL, 2011, NATURWISSENSCHAFTEN, V98, P169, DOI 10.1007/s00114-010-0754-z; Bergquist DC, 2003, J EXP MAR BIOL ECOL, V289, P197, DOI 10.1016/S0022-0981(03)00046-7; Blake JA, 1995, ANNELIDA 2; BROOKS JM, 1987, SCIENCE, V238, P1138, DOI 10.1126/science.238.4830.1138; CAVANAUGH CM, 1987, NATURE, V325, P346, DOI 10.1038/325346a0; CHECKLEY DM, 1985, J PLANKTON RES, V7, P553, DOI 10.1093/plankt/7.4.553; CHILDRESS JJ, 1986, SCIENCE, V233, P1306, DOI 10.1126/science.233.4770.1306; Cordes EE, 2005, MAR ECOL PROG SER, V305, P17, DOI 10.3354/meps305017; Cordes EE, 2010, LIMNOL OCEANOGR, V55, P2537, DOI 10.4319/lo.2010.55.6.2537; Cordes EE, 2010, DEEP-SEA RES PT II, V57, P1870, DOI 10.1016/j.dsr2.2010.05.010; Duperron S, 2007, ENVIRON MICROBIOL, V9, P1423, DOI 10.1111/j.1462-2920.2007.01259.x; Fisher C. R., 1993, Marine Ecology, V14, P277, DOI 10.1111/j.1439-0485.1993.tb00001.x; FISHER CR, 1994, MAR ECOL PROG SER, V103, P45, DOI 10.3354/meps103045; FISHER CR, 1990, REV AQUAT SCI, V2, P399; Fisher CR, 2000, NATURWISSENSCHAFTEN, V87, P184, DOI 10.1007/s001140050700; Flaherty EA, 2010, OIKOS, V119, P1409, DOI 10.1111/j.1600-0706.2010.18259.x; Freytag JK, 2001, P NATL ACAD SCI USA, V98, P13408, DOI 10.1073/pnas.231589498; FRY B, 1983, NATURE, V306, P51, DOI 10.1038/306051a0; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; GEARING JN, 1984, GEOCHIM COSMOCHIM AC, V48, P1089, DOI 10.1016/0016-7037(84)90199-6; HANSEN MD, 1978, HELGOLAND WISS MEER, V31, P191, DOI 10.1007/BF02296997; Jenkins CD, 2002, INVERTEBR BIOL, V121, P243; Kikuchi E, 1996, HYDROBIOLOGIA, V321, P69, DOI 10.1007/BF00018678; Lorrain A, 2009, MAR ECOL PROG SER, V391, P293, DOI 10.3354/meps08215; Matthews B, 2004, OECOLOGIA, V140, P361, DOI 10.1007/s00442-004-1579-2; McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Miglietta MP, 2010, DEEP-SEA RES PT II, V57, P1916, DOI 10.1016/j.dsr2.2010.05.007; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; PAULL CK, 1985, NATURE, V317, P709, DOI 10.1038/317709a0; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; RAU GH, 1981, SCIENCE, V213, P338, DOI 10.1126/science.213.4505.338; RAU GH, 1983, ECOLOGY, V64, P1314, DOI 10.2307/1937843; RAU GH, 1979, SCIENCE, V203, P648, DOI 10.1126/science.203.4381.648; Roberts HH, 2010, DEEP-SEA RES PT II, V57, P1837, DOI 10.1016/j.dsr2.2010.09.001; ROBERTS HH, 1994, GEO-MAR LETT, V14, P135, DOI 10.1007/BF01203725; Roberts HH, 2010, DEEP SEA RES 2, VII, P57; Rowe GT, 1969, NYO386224 WOODS HOL; SAINO T, 1987, DEEP-SEA RES, V34, P807, DOI 10.1016/0198-0149(87)90038-0; Urcuyo IA, 2003, DEEP-SEA RES PT I, V50, P763, DOI 10.1016/S0967-0637(03)00061-X; Van Dover CL, 2002, MAR ECOL PROG SER, V230, P137, DOI 10.3354/meps230137	43	22	24	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e74459	10.1371/journal.pone.0074459	http://dx.doi.org/10.1371/journal.pone.0074459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324572	Green Published, gold, Green Submitted			2022-12-25	WOS:000328566700001
J	Frison, H; Giono, G; Thebault, P; Fournier, M; Labrecque, N; Bijl, JJ				Frison, Heloise; Giono, Gloria; Thebault, Pamela; Fournier, Marilaine; Labrecque, Nathalie; Bijl, Janet J.			Hoxb4 Overexpression in CD4 Memory Phenotype T Cells Increases the Central Memory Population upon Homeostatic Proliferation	PLOS ONE			English	Article							HEMATOPOIETIC STEM; GENE-EXPRESSION; SELF-RENEWAL; IN-VITRO; SURVIVAL; NAIVE; GENERATION; EFFECTOR; MICE; BMI1	Memory T cell populations allow a rapid immune response to pathogens that have been previously encountered and thus form the basis of success in vaccinations. However, the molecular pathways underlying the development and maintenance of these cells are only starting to be unveiled. Memory T cells have the capacity to self renew as do hematopoietic stem cells, and overlapping gene expression profiles suggested that these cells might use the same self-renewal pathways. The transcription factor Hoxb4 has been shown to promote self-renewal divisions of hematopoietic stem cells resulting in an expansion of these cells. In this study we investigated whether overexpression of Hoxb4 could provide an advantage to CD4 memory phenotype T cells in engrafting the niche of T cell deficient mice following adoptive transfer. Competitive transplantation experiments demonstrated that CD4 memory phenotype T cells derived from mice transgenic for Hoxb4 contributed overall less to the repopulation of the lymphoid organs than wild type CD4 memory phenotype T cells after two months. These proportions were relatively maintained following serial transplantation in secondary and tertiary mice. Interestingly, a significantly higher percentage of the Hoxb4 CD4 memory phenotype T cell population expressed the CD62L and Ly6C surface markers, characteristic for central memory T cells, after homeostatic proliferation. Thus Hoxb4 favours the maintenance and increase of the CD4 central memory phenotype T cell population. These cells are more stem cell like and might eventually lead to an advantage of Hoxb4 T cells after subjecting the cells to additional rounds of proliferation.	[Frison, Heloise; Giono, Gloria; Thebault, Pamela; Fournier, Marilaine; Labrecque, Nathalie; Bijl, Janet J.] Hosp Maisonneuve Rosemont Res Ctr, Montreal, PQ, Canada; [Frison, Heloise; Giono, Gloria; Fournier, Marilaine; Labrecque, Nathalie] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Labrecque, Nathalie; Bijl, Janet J.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Bijl, JJ (corresponding author), Hosp Maisonneuve Rosemont Res Ctr, Montreal, PQ, Canada.	janettabijl@yahoo.ca			NSERC [342301-2008, 262146-2009]; Faculty of Medicine of the University of Montreal; Graduate School Faculty of University of Montreal	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Faculty of Medicine of the University of Montreal; Graduate School Faculty of University of Montreal	This study was supported by a discovery grant from the NSERC (342301-2008). GG is a recipient of a recruitment award from the Faculty of Medicine of the University of Montreal. MF is a recipient of a Scholarship from the Graduate School Faculty of University of Montreal. Furthermore this work was also supported by an NSERC grant of Dr. Nathalie Labrecque: 262146-2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Bijl J, 2008, ONCOGENE, V27, P6356, DOI 10.1038/onc.2008.233; Bijl J, 2006, BLOOD, V108, P116, DOI 10.1182/blood-2005-06-2245; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Bourgeois C, 2005, J IMMUNOL, V174, P5316, DOI 10.4049/jimmunol.174.9.5316; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Boyman O, 2007, CURR OPIN IMMUNOL, V19, P320, DOI 10.1016/j.coi.2007.04.015; Boyman O, 2012, CELL MOL LIFE SCI, V69, P1597, DOI 10.1007/s00018-012-0968-7; Brun ACM, 2004, BLOOD, V103, P4126, DOI 10.1182/blood-2003-10-3557; Cellot S, 2007, EXP HEMATOL, V35, P802, DOI 10.1016/j.exphem.2007.02.013; Chandele A, 2008, J IMMUNOL, V180, P5309, DOI 10.4049/jimmunol.180.8.5309; Cheung KP, 2009, J IMMUNOL, V183, P3364, DOI 10.4049/jimmunol.0900641; Faubert A, 2008, COLD SH Q B, V73, P555, DOI 10.1101/sqb.2008.73.030; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Hamilton SE, 2008, P NATL ACAD SCI USA, V105, P18484, DOI 10.1073/pnas.0806487105; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Kassiotis G, 2003, J EXP MED, V197, P1007, DOI 10.1084/jem.20021812; Kassiotis G, 2002, NAT IMMUNOL, V3, P244, DOI 10.1038/ni766; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Lacombe MH, 2005, J IMMUNOL, V175, P4400, DOI 10.4049/jimmunol.175.7.4400; Lebert-Ghali CE, 2010, EXP HEMATOL, V38, P1074, DOI 10.1016/j.exphem.2010.07.006; Leignadier J, 2008, P NATL ACAD SCI USA, V105, P20440, DOI 10.1073/pnas.0806289106; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Onodera A, 2010, J EXP MED; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Thompson A, 2003, BLOOD, V101, P1558, DOI 10.1182/blood.V101.4.1558; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; VOS Q, 1992, J IMMUNOL, V149, P1204; Whitmire JK, 2005, J EXP MED, V201, P1053, DOI 10.1084/jem.20041463; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; Yamashita M, 2008, J EXP MED, V205, P1109, DOI 10.1084/jem.20072000; Yamashita M, 2006, IMMUNITY, V24, P611, DOI 10.1016/j.immuni.2006.03.017; Yang LL, 2011, BLOOD, V118, P3039, DOI 10.1182/blood-2011-04-349746	50	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81573	10.1371/journal.pone.0081573	http://dx.doi.org/10.1371/journal.pone.0081573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324706	gold, Green Published, Green Submitted			2022-12-25	WOS:000328566700046
J	Rogers, LK; Graf, AE; Bhatia, A; Leonhart, KL; Oza-Frank, R				Rogers, Lynette K.; Graf, Amanda E.; Bhatia, Anisha; Leonhart, Karen L.; Oza-Frank, Reena			Associations between Maternal and Infant Morbidities and sRAGE within the First Week of Life in Extremely Preterm Infants	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; RECOGNITION RECEPTOR RAGE; LUNG INJURY; INFLAMMATION; EXPRESSION; HYPEROXIA; OUTCOMES; PATHWAY; ESRAGE; BIRTH	Background: Soluble RAGE (sRAGE) has been associated with multiple inflammatory responses including maternal chorioamnionitis and preeclampsia. Analysis of umbilical cord blood levels have also indicated that sRAGE levels in the infant are affected by maternal inflammation. S100b is a ligand for RAGE and increases in circulating S100b levels are associated with poor neurological outcome in preterm infants. The objective of this study was to determine whether sRAGE or s100b levels in plasma samples from extremely preterm infants at the end of the first week of life were correlated with infant morbidities and whether sRAGE and s100b levels at this time point were still associated with maternal inflammation. Methods: Plasma samples were collected from 130 preterm infants (<= 28 weeks) at days of life 5, 6, or 7. sRAGE and s100b levels were measured by ELISA and data were analyzed by Pearson's correlation or Generalized Estimating Equations. Results: sRAGE was negatively correlated with development of sepsis (p=0.024), the FiO(2) requirement of the infant at the time of sampling (p=0.030), as well as maternal preeclampsia (p=0.046), and positively correlated with maternal chorioamnionitis (p=0.006). s100b levels were positively associated with maternal chorioamnionitis (p=0.039). No correlations were observed with other infant morbidities. Conclusion: These data indicate that sRAGE could potentially be a biomarker of early severe inflammatory responses in the preterm infant. However, more studies are needed to confirm the present findings.	[Rogers, Lynette K.; Graf, Amanda E.; Bhatia, Anisha; Leonhart, Karen L.; Oza-Frank, Reena] Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH USA; [Rogers, Lynette K.; Graf, Amanda E.; Oza-Frank, Reena] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Rogers, LK (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH USA.	Lynette.Rogers@NationwideChildrens.org	Rogers, Lynette/V-6802-2019; Rogers, Lynette K/E-3973-2011; Graf, Amanda/C-7381-2014		National Institutes of Health; NCCAM/ODS [AT006880]; National Center for Complementary & Integrative Health [R01AT006880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCAM/ODS; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health, NCCAM/ODS, AT006880 (LKR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MC, 2008, CURR OPIN NEUROL, V21, P123, DOI 10.1097/WCO.0b013e3282f88bb4; Behrman RE, 2007, PRETERM BIRTH CAUSES; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bianchi R, 2011, J BIOL CHEM, V286, P7214, DOI 10.1074/jbc.M110.169342; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bopp C, 2008, CRIT CARE, V12, DOI 10.1186/cc6164; Bopp C, 2008, J SURG RES, V147, P79, DOI 10.1016/j.jss.2007.07.014; Buckley ST, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/917108; Buhimschi CS, 2009, AM J PATHOL, V175, P958, DOI 10.2353/ajpath.2009.090156; Buhimschi IA., 2007, AM J OBSTET GYNECOL, V196, pe181; Calfee CS, 2008, THORAX, V63, P1083, DOI 10.1136/thx.2008.095588; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Kwon JH, 2011, J PERINAT MED, V39, P507, DOI [10.1515/JPM.2011.055, 10.1515/jpm.2011.055]; Lizotte PP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-15; Morbini P, 2006, MODERN PATHOL, V19, P1437, DOI 10.1038/modpathol.3800661; Oliver EA, 2011, J CLIN ENDOCR METAB, V96, P689, DOI 10.1210/jc.2010-1418; Reynolds PR, 2011, AM J RESP CELL MOL, V45, P1195, DOI 10.1165/rcmb.2011-0170OC; Reynolds PR, 2010, AM J RESP CELL MOL, V42, P545, DOI 10.1165/rcmb.2008-0265OC; Rogers LK, 2012, ACTA PAEDIATR, V101, pe321, DOI 10.1111/j.1651-2227.2012.02694.x; Romero R, 2008, J PERINAT MED, V36, P388, DOI 10.1515/JPM.2008.076; Romero R, 2006, SEMIN FETAL NEONAT M, V11, P317, DOI 10.1016/j.siny.2006.05.001; Schlueter C, 2003, BBA-GENE STRUCT EXPR, V1630, P1, DOI 10.1016/j.bbaexp.2003.08.008; Stogsdill JA, 2012, AM J RESP CELL MOL, V47, P60, DOI 10.1165/rcmb.2011-0385OC; Su X, 2009, AM J PHYSIOL-LUNG C, V297, pL1, DOI 10.1152/ajplung.90546.2008; Sukkar MB, 2012, EUR RESPIR J, V39, P721, DOI 10.1183/09031936.00022011; Sukkar MB, 2012, BRIT J PHARMACOL, V167, P1161, DOI 10.1111/j.1476-5381.2012.01984.x; Thomas W, 2010, EARLY HUM DEV, V86, P593, DOI 10.1016/j.earlhumdev.2010.07.013; Viscardi RM, 2012, SEMIN FETAL NEONAT M, V17, P30, DOI 10.1016/j.siny.2011.08.002; Wang YJ, 2010, J IMMUNOL, V185, P1822, DOI 10.4049/jimmunol.0903398; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	33	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82537	10.1371/journal.pone.0082537	http://dx.doi.org/10.1371/journal.pone.0082537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324804	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700085
J	Polastri, PF; Barela, JA				Polastri, Paula F.; Barela, Jose A.			Adaptive Visual Re-Weighting in Children's Postural Control	PLOS ONE			English	Article							BODY SWAY; SOMATOSENSORY INFORMATION; SENSORY INTEGRATION; OPTIC FLOW; STANCE; INFANTS; VISION; ENVIRONMENT; ADAPTATION; LOCOMOTION	This study investigated how children's postural control adapts to changes in the visual environment and whether they use previous experience to adjust postural responses to following expositions. Four-, eight-, and twelve-year-old children (10 in each group) and 10 young adults stood upright inside of a moving room during eight trials each lasting one-minute. In the first trial, the room was stationary. In the following seven trials, the room oscillated at 0.2 Hz, amplitude of 0.5 cm, with the exception of the fifth trial, in which the room oscillated with amplitude of 3.2 cm. Body sway responses of young adults and older children down-weighted more to the increased visual stimulus amplitude when compared to younger children. In addition, four- and eight-year-old children quickly up-weighted body responses to visual stimulus in the subsequent two trials after the high amplitude trial. Sway variability decreased with age and was greatest during the high-amplitude trial. These results indicate that four year olds have already developed the adaptive capability to quickly down-weight visual influences. However, the increased gain values and residual variability observed for the younger children suggest that they have not fully calibrated their adaptive response to that of the young adults tested. Moreover, younger children do not carry over their previous experience from the sensorial environment to adapt to future changes.	[Polastri, Paula F.] Univ Estadual Paulista, UNESP, Fac Sci, Dept Phys Educ,Lab Informat Vis & Act, Bauru, SP, Brazil; [Barela, Jose A.] Cruzeiro do Sul Univ, Inst Phys Activ & Sport Sci, Sao Paulo, Brazil; [Barela, Jose A.] Univ Estadual Paulista, UNESP, Inst Biosci, Dept Phys Educ, Rio Claro, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Polastri, PF (corresponding author), Univ Estadual Paulista, UNESP, Fac Sci, Dept Phys Educ,Lab Informat Vis & Act, Bauru, SP, Brazil.	paulafpol@gmail.com	Barela, José A/F-4284-2012; POLASTRI, PAULA F/D-3859-2012	Barela, José A/0000-0003-0951-254X; POLASTRI, PAULA F/0000-0003-2007-5950	Conselho Nacional de Desenvolvimento Cientifico - PDEE-CNPq, Brazil [3133-05/2]	Conselho Nacional de Desenvolvimento Cientifico - PDEE-CNPq, Brazil	This study was supported by a scholarship to Paula Favaro Polastri (Conselho Nacional de Desenvolvimento Cientifico - PDEE-CNPq, Brazil Process # 3133-05/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison LK, 2006, EXP BRAIN RES, V175, P342, DOI 10.1007/s00221-006-0559-7; Bair WN, 2007, EXP BRAIN RES, V183, P435, DOI 10.1007/s00221-007-1057-2; Barela AMF, 2009, MOTOR CONTROL, V13, P119, DOI 10.1123/mcj.13.2.119; Barela JA, 1999, INFANT BEHAV DEV, V22, P87, DOI 10.1016/S0163-6383(99)80007-1; Barela JA, 2003, EXP BRAIN RES, V150, P434, DOI 10.1007/s00221-003-1441-5; Barela JA, 2000, INFANT BEHAV DEV, V23, P285, DOI 10.1016/S0163-6383(01)00045-5; Bertenthal BI, 2000, INFANT BEHAV DEV, V23, P299, DOI 10.1016/S0163-6383(01)00046-7; Butterworth G, 1977, PERCEPTION, V6, P256; Carver S, 2005, BIOL CYBERN, V92, P147, DOI 10.1007/s00422-004-0535-x; Carver S, 2006, BIOL CYBERN, V95, P123, DOI 10.1007/s00422-006-0069-5; DELORME A, 1989, PERCEPTION, V18, P667, DOI 10.1068/p180667; FIGURA F, 1991, J SPORT MED PHYS FIT, V31, P235; FORSSBERG H, 1982, J NEUROSCI, V2, P545; Freitas Junior PB, 2004, NEUROSCI LETT, V369, P64, DOI 10.1016/j.neulet.2004.07.075; Godoi D, 2008, DEV PSYCHOBIOL, V50, P77, DOI 10.1002/dev.20272; Higgins CI, 1996, DEV PSYCHOL, V32, P836, DOI 10.1037/0012-1649.32.5.836; Horak F, 1996, HDB PHYSIOL 12, V12, P255; Jeka J, 2000, EXP BRAIN RES, V134, P107, DOI 10.1007/s002210000412; Jeka J, 2006, EXP BRAIN RES, V174, P517, DOI 10.1007/s00221-006-0502-y; Jeka JJ, 2008, EXP BRAIN RES, V191, P453, DOI 10.1007/s00221-008-1539-x; LEE DN, 1974, PERCEPT PSYCHOPHYS, V15, P529, DOI 10.3758/BF03199297; LISHMAN JR, 1973, PERCEPTION, V2, P287, DOI 10.1068/p020287; Mergner T, 2005, EXP BRAIN RES, V167, P535, DOI 10.1007/s00221-005-0065-3; Metcalfe JS, 2005, DEV PSYCHOBIOL, V46, P19, DOI 10.1002/dev.20037; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; PETERKA RJ, 1995, EXP BRAIN RES, V105, P101; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Peterson ML, 2006, GAIT POSTURE, V23, P455, DOI 10.1016/j.gaitpost.2005.05.003; Prioli AC, 2005, GERONTOLOGY, V51, P145, DOI 10.1159/000083984; Ravaioli E, 2005, EXP BRAIN RES, V160, P450, DOI 10.1007/s00221-004-2030-y; RIACH CL, 1987, DEV MED CHILD NEUROL, V29, P650; Rinaldi NM, 2009, NEUROSCI LETT, V467, P225, DOI 10.1016/j.neulet.2009.10.042; Rival C, 2005, NEUROSCI LETT, V376, P133, DOI 10.1016/j.neulet.2004.11.042; ROSE JL, 1995, STUD PERCEPT ACTION, V3, P251; Schmuckler MA, 1996, ECOL PSYCHOL, V8, P209, DOI 10.1207/s15326969eco0803_2; Schmuckler MA, 1997, J EXP PSYCHOL HUMAN, V23, P528, DOI 10.1037/0096-1523.23.2.528; SHUMWAYCOOK A, 1985, J MOTOR BEHAV, V17, P131; Sparto PJ, 2006, EXP BRAIN RES, V168, P505, DOI 10.1007/s00221-005-0109-8; STOFFREGEN TA, 1987, PERCEPTION, V16, P113, DOI 10.1068/p160113; TAGUCHI K, 1988, INT CONGR SER, V812, P59; Van der Kooij H, 2001, BIOL CYBERN, V84, P103, DOI 10.1007/s004220000196; Wann JP, 1998, HUM MOVEMENT SCI, V17, P491, DOI 10.1016/S0167-9457(98)00011-6; Wolff DR, 1998, J ORTHOPAED RES, V16, P271, DOI 10.1002/jor.1100160215; WOOLLACOTT M, 1987, J MOTOR BEHAV, V19, P167; ZERNICKE R F, 1982, Journal of Human Movement Studies, V8, P1	45	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82215	10.1371/journal.pone.0082215	http://dx.doi.org/10.1371/journal.pone.0082215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	265KD	24324766	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300138
J	Zoia, S; Blason, L; D'Ottavio, G; Biancotto, M; Bulgheroni, M; Castiello, U				Zoia, Stefania; Blason, Laura; D'Ottavio, Giuseppina; Biancotto, Marina; Bulgheroni, Maria; Castiello, Umberto			The Development of Upper Limb Movements: From Fetal to Post-Natal Life	PLOS ONE			English	Article							HAND-MOUTH COORDINATION; TOY-ORIENTED CHANGES; KINEMATICS; EMERGENCE; INFANTS	Background: The aim of this longitudinal study was to investigate how the kinematic organization of upper limb movements changes from fetal to post-natal life. By means of off-line kinematical techniques we compared the kinematics of hand-to-mouth and hand-to-eye movements, in the same individuals, during prenatal life and early postnatal life, as well as the kinematics of hand-to-mouth and reaching-toward-object movements in the later age periods. Methodology/Principal Findings: Movements recorded at the 14th, 18th and 22nd week of gestation were compared with similar movements recorded in an ecological context at 1, 2, 3, 4, 8, and 12 months after birth. The results indicate a similar kinematic organization depending on movement type (i.e., eye, mouth) for the infants at one month and for the fetuses at 22 weeks of gestation. At two and three months such differential motor planning depending on target is lost and no statistical differences emerge. Hand to eye movements were no longer observed after the fourth month of life, therefore we compared kinematics for hand to mouth with hand to object movements. Results of these analyses revealed differences in the performance of hand to mouth and reaching to object movements in the length of the deceleration phase of the movement, depending on target. Conclusion/Significance: Data are discussed in terms of how the passage from intrauterine to extra-uterine environments modifies motor planning. These results provide novel evidence of how different types of upper extremity movements, those directed towards one's own face and those directed to external objects, develop.	[Zoia, Stefania; Blason, Laura; Biancotto, Marina] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Dept Pediat, Trieste, Italy; [D'Ottavio, Giuseppina] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Dept Obstet & Gynecol, Trieste, Italy; [Bulgheroni, Maria] Biomed Co, Ab Acus, Milan, Italy; [Castiello, Umberto] Univ Padua, Dept Gen Psychol, Fac Psychol, Padua, Italy	IRCCS Burlo Garofolo; IRCCS Burlo Garofolo; University of Padua	Zoia, S (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Dept Pediat, Trieste, Italy.	zoia@units.it	ZOIA, STEFANIA/HCI-1235-2022	Castiello, Umberto/0000-0003-0629-1286; Bulgheroni, Maria/0000-0001-8484-9834	Institute of Child Health, Istituto Di Ricovero e Cura a Carattere Scientifico, Burlo Garofolo, Trieste, Italy [R.C. 09/06, R.C. 30/11]	Institute of Child Health, Istituto Di Ricovero e Cura a Carattere Scientifico, Burlo Garofolo, Trieste, Italy	This work was supported by grants R.C. 09/06 and R.C. 30/11 of the Institute of Child Health, Istituto Di Ricovero e Cura a Carattere Scientifico, Burlo Garofolo, Trieste, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthier NE, 1996, DEV PSYCHOL, V32, P811; Berthier NE, 2006, EXP BRAIN RES, V169, P507, DOI 10.1007/s00221-005-0169-9; Bhat A, 2005, INFANT BEHAV DEV, V28, P445, DOI 10.1016/j.infbeh.2005.03.001; Bhat A, 2006, INFANT BEHAV DEV, V29, P358, DOI 10.1016/j.infbeh.2006.01.005; BLASS EM, 1989, DEV PSYCHOL, V25, P963, DOI 10.1037/0012-1649.25.6.963; Brazelton TB, 1995, CLIN DEV MED, V50; BUTTERWORTH G, 1988, BRIT J DEV PSYCHOL, V6, P303, DOI 10.1111/j.2044-835X.1988.tb01103.x; Castiello U., 2010, PLOS ONE, V5; DEVRIES JIP, 1985, EARLY HUM DEV, V12, P99, DOI 10.1016/0378-3782(85)90174-4; FETTERS L, 1987, J MOTOR BEHAV, V19, P147; Hofsten C. V., 1979, J HUMAN MOVEMENT STU, V5, P160; KONCZAK J, 1995, EXP BRAIN RES, V106, P156; Konczak J, 1997, EXP BRAIN RES, V117, P346, DOI 10.1007/s002210050228; Lew AR, 1997, INFANT BEHAV DEV, V20, P59, DOI 10.1016/S0163-6383(97)90061-8; MATHEW A, 1990, CHILD DEV, V61, P1238, DOI 10.2307/1130891; Piaget J., 1977, KNOWLEDGE DEV, P17, DOI DOI 10.1007/978-1-4684-2547-5; ROCHAT P, 1987, INFANT BEHAV DEV, V10, P435, DOI 10.1016/0163-6383(87)90041-5; Rochat P., 1993, ADV PSYCHOL, V97, P265, DOI DOI 10.1016/S0166-4115(08)60956-5; RUFF HA, 1984, DEV PSYCHOL, V20, P9, DOI 10.1037/0012-1649.20.1.9; THELEN E, 1993, CHILD DEV, V64, P1058, DOI 10.2307/1131327; VONHOFSTEN C, 1982, DEV PSYCHOL, V18, P450, DOI 10.1037/0012-1649.18.3.450; VONHOFSTEN C, 1993, EUR NETWORK, P109; VONHOFSTEN C, 1984, DEV PSYCHOL, V20, P378, DOI 10.1037/0012-1649.20.3.378; WHITE BL, 1964, CHILD DEV, V35, P349, DOI 10.1111/j.1467-8624.1964.tb05944.x; Yonas A., 1985, MEASUREMENT AUDITION, P301; Zoia S, 2007, EXP BRAIN RES, V176, P217, DOI 10.1007/s00221-006-0607-3	26	29	29	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80876	10.1371/journal.pone.0080876	http://dx.doi.org/10.1371/journal.pone.0080876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	265KD	24324642	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300053
J	Calpe, E; Purroy, N; Carpio, C; Abrisqueta, P; Carabia, J; Palacio, C; Castellvi, J; Crespo, M; Bosch, F				Calpe, Eva; Purroy, Noelia; Carpio, Cecilia; Abrisqueta, Pau; Carabia, Julia; Palacio, Carles; Castellvi, Josep; Crespo, Marta; Bosch, Francesc			ZAP-70 Promotes the Infiltration of Malignant B-Lymphocytes into the Bone Marrow by Enhancing Signaling and Migration after CXCR4 Stimulation	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; LEUKEMIA CELLS; GENE-EXPRESSION; PROTEIN-KINASE; RECEPTOR; SURVIVAL; ACTIVATION; CHEMOKINE; LIGATION; LYMPHOMA	ZAP-70 in chronic lymphocytic leukemia (CLL) is associated with enhanced response to microenvironmental stimuli. We analyzed the functional consequences of ZAP-70 ectopic expression in malignant B-cells in a xenograft mouse model of disseminated B-cell leukemia. Mice injected with B-cells expressing ZAP-70 showed a prominently higher infiltration of the bone marrow. In vitro analysis of the response of malignant B-cells to CXCL12, the main attracting chemokine regulating trafficking of lymphocytes to the bone marrow, or to bone marrow stromal cells, revealed that ZAP-70 induces an increased response in terms of signaling and migration. These effects are probably mediated by direct participation of ZAP-70 in CXCL12-CXCR4 signaling since CXCR4 stimulation led to activation of ZAP-70 and downstream signaling pathways, such as MAPK and Akt, whereas ZAP-70 did not alter the expression of the CXCR4 receptor. In addition, subclones of primary CLL cells with high expression of ZAP-70 also showed increased migrative capacity toward CXCL12. Neutralization of CXCR4 with a monoclonal antibody resulted in impaired in vitro responses to CXCL12 and bone marrow stromal cells. We conclude that ZAP-70 enhances the migration of malignant B-cells into the supportive microenvironment found in the bone marrow mainly by enhancing signaling and migration after CXCR4 stimulation.	[Calpe, Eva; Purroy, Noelia; Carpio, Cecilia; Abrisqueta, Pau; Carabia, Julia; Palacio, Carles; Crespo, Marta; Bosch, Francesc] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Hematol, Lab Expt Hematol, E-08193 Barcelona, Spain; [Castellvi, Josep] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Pathol, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Bosch, F (corresponding author), Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Hematol, Lab Expt Hematol, E-08193 Barcelona, Spain.	fbosch@vhebron.net	Bosch, Francesc/AAE-7052-2019; Castellvi, Josep/C-5092-2014	Bosch, Francesc/0000-0001-9241-2886; Castellvi, Josep/0000-0001-5745-9996; Crespo, Marta/0000-0002-7732-7808; Abrisqueta, Pau/0000-0001-9625-7422; Palacio-Garcia, Carles/0000-0002-9085-3327; Cecilia del Carmen, Carpio Segura/0000-0001-9346-0134	Instituto de Salut Carlos III, Fondo de Investigaciones Sanitarias [PI 11/00792]; Vall d'Hebron Institut de Recerca; Sociedad Espanola de Hematologia y Hemoterapia (SEHH); Ministerio de Economia y Competitividad (MINECO), Spain [RYC-2012-12018]	Instituto de Salut Carlos III, Fondo de Investigaciones Sanitarias; Vall d'Hebron Institut de Recerca; Sociedad Espanola de Hematologia y Hemoterapia (SEHH); Ministerio de Economia y Competitividad (MINECO), Spain	This work was supported by a grant from the Instituto de Salut Carlos III, Fondo de Investigaciones Sanitarias (PI 11/00792). N.P is supported by a fellowship from Vall d'Hebron Institut de Recerca. C.C is supported by a grant from Sociedad Espanola de Hematologia y Hemoterapia (SEHH). M.C holds a contract from Ministerio de Economia y Competitividad (MINECO) (RYC-2012-12018), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertilaccio MTS, 2013, LEUKEMIA, V27, P534, DOI 10.1038/leu.2012.268; Bertolini F, 2002, CANCER RES, V62, P3106; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Buchner M, 2010, BLOOD, V115, P4497, DOI 10.1182/blood-2009-07-233692; Burger JA, 2009, BLOOD, V114, P3367, DOI 10.1182/blood-2009-06-225326; Burger M, 2005, BLOOD, V106, P1824, DOI 10.1182/blood-2004-12-4918; Byrd JC, 2012, ASH ANN M, V120, P189; Caligaris-Cappio F, 2003, BRIT J HAEMATOL, V123, P380, DOI 10.1046/j.1365-2141.2003.04679.x; Calpe E, 2011, BLOOD, V118, P4401, DOI 10.1182/blood-2011-01-333682; Casamayor-Palleja M, 2002, BLOOD, V99, P1913, DOI 10.1182/blood.V99.6.1913; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Chang CH, 2005, BLOOD, V106, P4308, DOI 10.1182/blood-2005-03-1033; Chen LG, 2005, BLOOD, V105, P2036, DOI 10.1182/blood-2004-05-1715; Chen LG, 2008, BLOOD, V111, P2685, DOI 10.1182/blood-2006-12-062265; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; de Rooij MFM, 2012, BLOOD, V119, P2590, DOI 10.1182/blood-2011-11-390989; Deaglio S, 2007, BLOOD, V110, P4012, DOI 10.1182/blood-2007-06-094029; Durig J, 2003, LEUKEMIA, V17, P2426, DOI 10.1038/sj.leu.2403147; Ferretti E, 2011, LEUKEMIA, V25, P1268, DOI 10.1038/leu.2011.88; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Furman RR, 2010, BLOOD, V116, P55; Ghamlouch H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060370; Gine E, 2010, HAEMATOL-HEMATOL J, V95, P1526, DOI 10.3324/haematol.2010.022277; Gobessi S, 2007, BLOOD, V109, P2032, DOI 10.1182/blood-2006-03-011759; Guarini A, 2008, BLOOD, V112, P782, DOI 10.1182/blood-2007-12-127688; Guinamard R, 1999, J EXP MED, V189, P1461, DOI 10.1084/jem.189.9.1461; Hoellenriegel J, 2012, LEUKEMIA, V26, P1576, DOI 10.1038/leu.2012.24; ITOH K, 1989, EXP HEMATOL, V17, P145; Kremer KN, 2003, J IMMUNOL, V171, P360, DOI 10.4049/jimmunol.171.1.360; Lanham S, 2003, BLOOD, V101, P1087, DOI 10.1182/blood-2002-06-1822; Messmer BT, 2005, J CLIN INVEST, V115, P755, DOI 10.1172/JCI23409; Messmer D, 2011, BLOOD, V117, P882, DOI 10.1182/blood-2010-04-282400; Muntanola A, 2007, J CLIN ONCOL, V25, P1576, DOI 10.1200/JCO.2006.08.4194; Niedermeier M, 2009, BLOOD, V113, P5549, DOI 10.1182/blood-2008-06-165068; Nishio M, 2005, BLOOD, V106, P1012, DOI 10.1182/blood-2004-03-0889; Ponader S, 2012, BLOOD, V119, P1182, DOI 10.1182/blood-2011-10-386417; Quiroga MP, 2009, BLOOD, V114, P1029, DOI 10.1182/blood-2009-03-212837; Rassenti LZ, 2004, NEW ENGL J MED, V351, P893, DOI 10.1056/NEJMoa040857; Richardson SJ, 2006, BLOOD, V107, P3584, DOI 10.1182/blood-2005-04-1718; Stamatopoulos B, 2009, HAEMATOL-HEMATOL J, V94, P790, DOI 10.3324/haematol.2008.002626; Ticchioni M, 2007, ONCOGENE, V26, P7081, DOI 10.1038/sj.onc.1210519; Ticchioni M, 2002, BLOOD, V99, P3111, DOI 10.1182/blood.V99.9.3111; Vaisitti T, 2010, LEUKEMIA, V24, P958, DOI 10.1038/leu.2010.36; Vlad A, 2009, CANCER RES, V69, P6387, DOI 10.1158/0008-5472.CAN-08-4750; Zhao XB, 2007, BLOOD, V110, P2569, DOI 10.1182/blood-2006-12-062927; Zum Buschenfelde CM, 2010, LEUKEMIA, V24, P141, DOI 10.1038/leu.2009.216	46	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81221	10.1371/journal.pone.0081221	http://dx.doi.org/10.1371/journal.pone.0081221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312539	Green Published, Green Submitted, gold			2022-12-25	WOS:000327947800041
J	Gao, QH; Hua, BZ				Gao, Qionghua; Hua, Baozhen			Co-Evolution of the Mating Position and Male Genitalia in Insects: A Case Study of a Hangingfly	PLOS ONE			English	Article							BITTACUS MASTRILLII MECOPTERA; NUPTIAL FEEDING-BEHAVIOR; SEXUAL SELECTION; FEMALE CHOICE; EVOLUTION; CONFLICT; GENUS	Hangingflies are unique for the male providing a nuptial gift to the female during mating and taking a face-to-face hanging copulation with the female. Their male genitalia are peculiar for an extremely elongated penisfilum, a pair of well-developed epandrial lobes (9th tergum), and a pair of degenerated gonostyli. However, the co-evolution of their face-to-face copulation behavior and the male genitalia has rarely been studied hitherto. In this paper the mating behavior of the hangingfly Bittacus planus Cheng, 1949 was observed under laboratory conditions, and the morphology of the male and female external genitalia was investigated using light and scanning electron microscopy. The male provides an insect prey as a nuptial gift to the female in courtship and mating process, and commits a face-to-face copulation. During copulation, the male abdomen twists temporarily about 180 degrees to accommodate their face-to-face mating position. The aedeagal complex has an extremely elongated penisfilum, corresponding to the elongated spermathecal duct of the female. The well-developed epandrial lobes serve as claspers to grasp the female subgenital plate during copulation, replacing the function of gonostyli, which are greatly reduced in Bittacidae. The modified proctiger assists the penisfilum to stretch and to enter into the female spermathecal duct. The possible reasons why this species might mate face-to-face are briefly discussed.	[Gao, Qionghua; Hua, Baozhen] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Educ Minist,Entomol Museum, Key Lab Plant Protect Resources & Pest Management, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Hua, BZ (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Educ Minist,Entomol Museum, Key Lab Plant Protect Resources & Pest Management, Yangling, Shaanxi, Peoples R China.	huabzh@nwsuaf.edu.cn			National Natural Science Foundation of China [30970386]; Research Fund for the Doctoral Program of Higher Education [20090204110004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This research was supported by the National Natural Science Foundation of China (grant no. 30970386) and the Research Fund for the Doctoral Program of Higher Education (grant no. 20090204110004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock J., 1979, Psyche (Cambridge), V86, P213, DOI 10.1155/1979/92786; Alexander Richard D., 1997, P4, DOI 10.1017/CBO9780511721946.002; [Anonymous], 1970, TAXONOMISTS GLOSSARY; Arnqvist G, 2002, EVOLUTION, V56, P936; ARNQVIST G, 1995, P ROY SOC B-BIOL SCI, V261, P123, DOI 10.1098/rspb.1995.0126; Arnqvist G, 1997, BIOL J LINN SOC, V60, P365; BICKEL D, 1990, NEW SCI, V127, P34; BONEMISS.GF, 1966, NATURE, V209, P732; BORNEMISSZA G. F., 1966, AUSTRALIAN J ZOOL, V14, P371, DOI 10.1071/ZO9660371; BORNEMISSZA GF, 1964, NATURE, V203, P786, DOI 10.1038/203786a0; BYERS G W, 1977, Revista de Biologia Tropical, V25, P109; CARPENTER F. M., 1931, BULL MUS COMP ZOOL HARVARD COLL, V72, P205; Cayetano L, 2011, EVOLUTION, V65, P2171, DOI 10.1111/j.1558-5646.2011.01309.x; Chapman R.F., 2012, INSECTS STRUCTURE FU; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Cordoba-Aguilar A, 2005, J EVOLUTION BIOL, V18, P132, DOI 10.1111/j.1420-9101.2004.00796.x; Crampton G. C., 1922, Transactions of the American Entomological Society, V48, P207; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Eberhard WG, 1985, SEXUAL SELECTION ANI; Engqvist L, 2003, ETHOLOGY, V109, P911, DOI 10.1046/j.1439-0310.2003.00937.x; Gwynne DT, 2008, ANNU REV ENTOMOL, V53, P83, DOI 10.1146/annurev.ento.53.103106.093423; GWYNNE DT, 1984, J AUST ENTOMOL SOC, V23, P271; Hardy G. H., 1944, PROC ROY ENT SOC LONDON SER A, V19, P52; Huber BA, 2007, BIOL REV, V82, P647, DOI 10.1111/j.1469-185X.2007.00029.x; Huber BA, 2010, GENETICA, V138, P19, DOI 10.1007/s10709-008-9339-6; Issiki S., 1927, INSECTA MATSUMURANA, V2, P1; Iwasaki Y, 1998, ANN ENTOMOL SOC AM, V91, P235, DOI 10.1093/aesa/91.2.235; Iwasaki Y, 1996, ANN ENTOMOL SOC AM, V89, P869, DOI 10.1093/aesa/89.6.869; Jordan K., 1905, Zeitschrift fuer Wissenschaftliche Zoologie, Vlxxxiii, P151; LLOYD JE, 1979, FLA ENTOMOL, V62, P17, DOI 10.2307/3494039; Matsuda R., 1976, MORPHOLOGY EVOLUTION; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; Michener Charles D., 1944, ANN ENT SOC AMERICA, V37, P336; MICKOLEIT G, 1978, ENTOMOL GER, V5, P1; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Perry JC, 2012, EVOLUTION, V66, P544, DOI 10.1111/j.1558-5646.2011.01464.x; Potter Mrs. E., 1938, Transactions of the Royal Entomological Society of London, V87, P467; RICHARDS O. W., 1927, TRANS ENT SOC LONDON, V75, P233; Robson GC, 1936, VARIATION ANIMALS NA, Vi-xvi; Rowe L, 2012, EVOLUTION, V66, P40, DOI 10.1111/j.1558-5646.2011.01411.x; SETTY L. R., 1940, AMER MIDLAND NAT, V23, P257, DOI 10.2307/2420667; SHAPIRO AM, 1989, ANNU REV ENTOMOL, V34, P231, DOI 10.1146/annurev.en.34.010189.001311; SNODGRASS R. E., 1957, SMITHSONIAN MISC COLL, V135, P1; Tan Jiang-Li, 2006, Chinese Bulletin of Entomology, V43, P348; Tan JL, 2009, J NAT HIST, V43, P2937, DOI 10.1080/00222930903359628; THORNHILL R, 1980, SCI AM, V242, P162, DOI 10.1038/scientificamerican0680-162; THORNHILL R, 1984, AM ZOOL, V24, P367; Thornhill R., 1977, Occasional Papers of the Museum of Zoology University of Michigan, VNo. 677, P1; Thornhill R., 1983, pi; THORNHILL R, 1978, ANN ENTOMOL SOC AM, V71, P597, DOI 10.1093/aesa/71.4.597; THORNHILL R, 1979, SCIENCE, V205, P412, DOI 10.1126/science.205.4404.412; THORNHILL R, 1980, EVOLUTION, V34, P519, DOI 10.1111/j.1558-5646.1980.tb04841.x; THORNHILL R, 1976, AM NAT, V110, P529, DOI 10.1086/283089; THORNHILL R, 1983, AM NAT, V122, P765, DOI 10.1086/284170; Thornhill R, 1974, THESIS U MICHIGAN AN; Tjeder B, 1956, S AFR ANIM LIFE, V3, P344; Yassin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057158	57	20	22	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e80651	10.1371/journal.pone.0080651	http://dx.doi.org/10.1371/journal.pone.0080651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312490	Green Published, Green Submitted, gold			2022-12-25	WOS:000327947800018
J	Graber, MH; Helmchen, F; Hahnloser, RHR				Graber, Michael H.; Helmchen, Fritjof; Hahnloser, Richard H. R.			Activity in a Premotor Cortical Nucleus of Zebra Finches Is Locally Organized and Exhibits Auditory Selectivity in Neurons but Not in Glia	PLOS ONE			English	Article							IDENTIFIED HVC NEURONS; SONG SYSTEM NUCLEUS; AUTOGENOUS SONG; RESPONSES; PLASTICITY; SEQUENCES; NETWORKS; CIRCUITS; DYNAMICS; MICROARCHITECTURE	Motor functions are often guided by sensory experience, most convincingly illustrated by complex learned behaviors. Key to sensory guidance in motor areas may be the structural and functional organization of sensory inputs and their evoked responses. We study sensory responses in large populations of neurons and neuron-assistive cells in the songbird motor area HVC, an auditory-vocal brain area involved in sensory learning and in adult song production. HVC spike responses to auditory stimulation display remarkable preference for the bird's own song (BOS) compared to other stimuli. Using two-photon calcium imaging in anesthetized zebra finches we measure the spatio-temporal structure of baseline activity and of auditory evoked responses in identified populations of HVC cells. We find strong correlations between calcium signal fluctuations in nearby cells of a given type, both in identified neurons and in astroglia. In identified HVC neurons only, auditory stimulation decorrelates ongoing calcium signals, less for BOS than for other sound stimuli. Overall, calcium transients show strong preference for BOS in identified HVC neurons but not in astroglia, showing diversity in local functional organization among identified neuron and astroglia populations.	[Graber, Michael H.; Hahnloser, Richard H. R.] Univ Zurich, ETH Zurich, Inst Neuroinformat, Zurich, Switzerland; [Graber, Michael H.; Helmchen, Fritjof; Hahnloser, Richard H. R.] Univ Zurich, ETH Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; [Helmchen, Fritjof] Univ Zurich, Brain Res Inst, Zurich, Switzerland	ETH Zurich; University of Zurich; ETH Zurich; University of Zurich; University of Zurich	Hahnloser, RHR (corresponding author), Univ Zurich, ETH Zurich, Inst Neuroinformat, Zurich, Switzerland.	rich@ini.phys.ethz.ch	Helmchen, Fritjof/A-6255-2008	Helmchen, Fritjof/0000-0002-8867-9569; Hahnloser, Richard/0000-0002-4039-7773	Swiss National Science Foundation; advanced ERC grant [Votecom-268911]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); advanced ERC grant	This work was supported by the Swiss National Science Foundation (http://www.snf.ch) and an advanced ERC (http://erc.europa.eu/) grant (Votecom-268911). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador A, 2013, NATURE, V495, P59, DOI 10.1038/nature11967; Bauer EE, 2008, J NEUROSCI, V28, P1509, DOI 10.1523/JNEUROSCI.3838-07.2008; Blattler F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025506; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Ch'ng YH, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00020; Chase SM, 2012, J NEUROPHYSIOL, V108, P624, DOI 10.1152/jn.00371.2011; Coleman MJ, 2004, J NEUROSCI, V24, P7251, DOI 10.1523/JNEUROSCI.0947-04.2004; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hahnloser RHR, 2006, J NEUROPHYSIOL, V96, P794, DOI 10.1152/jn.01064.2005; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Huetz C, 2006, EUR J NEUROSCI, V24, P1091, DOI 10.1111/j.1460-9568.2006.04967.x; Kafitz KW, 1999, GLIA, V27, P88; KATZ LC, 1981, BRAIN RES, V221, P192, DOI 10.1016/0006-8993(81)91073-8; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Kuga N, 2011, J NEUROSCI, V31, P2607, DOI 10.1523/JNEUROSCI.5319-10.2011; Langer D, 2013, J NEUROSCI METH, V215, P38, DOI 10.1016/j.jneumeth.2013.02.006; Lehongre K, 2009, NEUROREPORT, V20, P202, DOI 10.1097/WNR.0b013e328320a6d8; LEWICKI MS, 1995, P NATL ACAD SCI USA, V92, P5582, DOI 10.1073/pnas.92.12.5582; MARGOLIASH D, 1985, P NATL ACAD SCI USA, V82, P5997, DOI 10.1073/pnas.82.17.5997; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MASSA PT, 1982, NEUROSCIENCE, V7, P523; MCCASLAND JS, 1981, P NATL ACAD SCI-BIOL, V78, P7815, DOI 10.1073/pnas.78.12.7815; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; MULLER CM, 1989, NATURE, V342, P427, DOI 10.1038/342427a0; Nealen PM, 2006, J NEUROPHYSIOL, V96, P3433, DOI 10.1152/jn.01130.2005; Niell CM, 2005, NEURON, V45, P941, DOI 10.1016/j.neuron.2005.01.047; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Oberti D, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00050; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Poole B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038173; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Roberts TF, 2012, NAT NEUROSCI, V15, P1454, DOI 10.1038/nn.3206; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; Rosen MJ, 2006, J NEUROPHYSIOL, V95, P1158, DOI 10.1152/jn.00100.2005; Rosen MJ, 2003, NEURON, V39, P177, DOI 10.1016/S0896-6273(03)00357-X; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Schmidt MF, 2003, J NEUROPHYSIOL, V90, P3931, DOI 10.1152/jn.00003.2003; Shaevitz SS, 2007, J NEUROPHYSIOL, V98, P2747, DOI 10.1152/jn.00294.2007; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; SUTTER ML, 1994, J NEUROPHYSIOL, V72, P2105, DOI 10.1152/jn.1994.72.5.2105; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Weber AP, 2007, PLOS COMPUT BIOL, V3, P2520, DOI 10.1371/journal.pcbi.0030249; Winship IR, 2007, J NEUROSCI, V27, P6268, DOI 10.1523/JNEUROSCI.4801-06.2007	57	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81177	10.1371/journal.pone.0081177	http://dx.doi.org/10.1371/journal.pone.0081177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312533	Green Published, gold, Green Accepted			2022-12-25	WOS:000327947800040
J	Hardy, AJ; Gamarra, JGP; Cross, DE; Macklin, MG; Smith, MW; Kihonda, J; Killeen, GF; Ling'ala, GN; Thomas, CJ				Hardy, Andrew J.; Gamarra, Javier G. P.; Cross, Donall E.; Macklin, Mark G.; Smith, Mark W.; Kihonda, Japhet; Killeen, Gerry F.; Ling'ala, George N.; Thomas, Chris J.			Habitat Hydrology and Geomorphology Control the Distribution of Malaria Vector Larvae in Rural Africa	PLOS ONE			English	Article							ANOPHELES-ARABIENSIS PATTON; INSECTICIDE-TREATED NETS; DAR-ES-SALAAM; ENVIRONMENTAL-FACTORS; BREEDING HABITATS; GAMBIAE COMPLEX; CLIMATE-CHANGE; TRANSMISSION; CULICIDAE; DIPTERA	Background: Larval source management is a promising component of integrated malaria control and elimination. This requires development of a framework to target productive locations through process-based understanding of habitat hydrology and geomorphology. Methods: We conducted the first catchment scale study of fine resolution spatial and temporal variation in Anopheles habitat and productivity in relation to rainfall, hydrology and geomorphology for a high malaria transmission area of Tanzania. Results: Monthly aggregates of rainfall, river stage and water table were not significantly related to the abundance of vector larvae. However, these metrics showed strong explanatory power to predict mosquito larval abundances after stratification by water body type, with a clear seasonal trend for each, defined on the basis of its geomorphological setting and origin. Conclusion: Hydrological and geomorphological processes governing the availability and productivity of Anopheles breeding habitat need to be understood at the local scale for which larval source management is implemented in order to effectively target larval source interventions. Mapping and monitoring these processes is a well-established practice providing a tractable way forward for developing important malaria management tools.	[Hardy, Andrew J.; Macklin, Mark G.] Aberystwyth Univ, Inst Geog & Earth Sci, Aberystwyth, Dyfed, Wales; [Hardy, Andrew J.; Cross, Donall E.; Kihonda, Japhet; Killeen, Gerry F.; Ling'ala, George N.] Ifakara Hlth Inst, Biomed & Environm Sci Themat Grp, Ifakara, Tanzania; [Gamarra, Javier G. P.; Cross, Donall E.; Thomas, Chris J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Smith, Mark W.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Killeen, Gerry F.] Univ Liverpool, Liverpool Sch Trop Med, Vector Biol Dept, Liverpool L3 5QA, Merseyside, England	Aberystwyth University; Ifakara Health Institute; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); University of Leeds; Liverpool School of Tropical Medicine; University of Liverpool	Thomas, CJ (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.	cjt@aber.ac.uk		G. P. Gamarra, Javier/0000-0002-1290-9559; Cross, Donall Eoin/0000-0002-4974-951X; Smith, Mark/0000-0003-4361-9527; Hardy, Andy/0000-0002-7928-8873	Natural Environment Research Council (NERC) [NE/H022740/1]; Natural Environment Research Council [NE/H022740/1] Funding Source: researchfish; NERC [NE/H022740/1] Funding Source: UKRI	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environment Research Council (NERC), grant number NE/H022740/1 (http://www.nerc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageep TB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-123; Amerasinghe PH, 1999, AM J TROP MED HYG, V60, P421, DOI 10.4269/ajtmh.1999.60.421; [Anonymous], 1968, ANOPHELINAE AFR S SA; Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-241; Balls MJ, 2004, T ROY SOC TROP MED H, V98, P400, DOI 10.1016/j.trstmh.2003.11.005; Bayoh MN, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-149; Bogh C, 2007, AM J TROP MED HYG, V76, P875; Bomblies A, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006917; Bracken LJ, 2008, HYDROL PROCESS, V22, P683, DOI 10.1002/hyp.6641; Canty A, 2012, BOOT BOOTSTRAP R S P; CHARLWOOD JD, 1995, B ENTOMOL RES, V85, P37, DOI 10.1017/S0007485300051993; Charlwood JD, 2000, AM J TROP MED HYG, V62, P726, DOI 10.4269/ajtmh.2000.62.726; CHARLWOOD JD, 1995, B ENTOMOL RES, V85, P29, DOI 10.1017/S0007485300051981; Cheng P, 2001, GEOINFORMATICS   OCT, P34; Clark TD, 2008, J INFECT DIS, V198, P393, DOI 10.1086/589778; Cohen J, 2010, MALARIA J, V9, P1, DOI [10.1186/1475-2875-9-S1-S1, DOI 10.1186/1475-2875-9-S1-S1.PUBMED:20043863]; Costantini C, 1996, MED VET ENTOMOL, V10, P203, DOI 10.1111/j.1365-2915.1996.tb00733.x; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Cuong DM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-259; Dongus S, 2009, GEOSPATIAL HEALTH, V3, P189, DOI 10.4081/gh.2009.220; DUKEEN MYH, 1986, B ENTOMOL RES, V76, P451, DOI 10.1017/S0007485300014942; Exelis, 2012, ENVI VERS 5 0; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Fillinger U, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-20; Fillinger Ulrike, 2006, Trop Med Int Health, V11, P1629, DOI 10.1111/j.1365-3156.2006.01733.x; Fillinger U, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-62; Gimnig JE, 2001, J MED ENTOMOL, V38, P282, DOI 10.1603/0022-2585-38.2.282; Githeko AK, 2012, ACTA TROP, V121, P19, DOI 10.1016/j.actatropica.2011.10.002; Gouagna LC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-96; Govella NJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-124; Gu WD, 2008, AM J TROP MED HYG, V78, P2, DOI 10.4269/ajtmh.2008.78.2; Haji H, 1996, PARASITOLOGY, V113, P425, DOI 10.1017/S0031182000081488; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Himeidan YE, 2011, PARASITE VECTOR, V4, P1; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Imbahale SS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-362; Jacob BG, 2005, J MED ENTOMOL, V42, P751, DOI 10.1603/0022-2585(2005)042[0751:EOEDFI]2.0.CO;2; Killeen GF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-121; Killeen GF, 2013, AM J TROP MED HYG, V88, P809, DOI 10.4269/ajtmh.13-0065; Killeen GF, 2006, AM J TROP MED HYG, V74, P517, DOI 10.4269/ajtmh.2006.74.517; Killeen GF, 2004, AM J TROP MED HYG, V71, P87, DOI 10.4269/ajtmh.2004.71.2_suppl.0700087; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Kitau J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031481; Kiware SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037661; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Kweka EJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-110; Magalhaes RJ, 2012, MALARIA J, V11, P1, DOI [10.1186/1475-2875-11-S1-P1., DOI 10.1186/1475-2875-11-S1-P1.PUBMED:22212246]; Majambere S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-76; Mala AO, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-25; Minakawa N, 2005, AM J TROP MED HYG, V73, P157, DOI 10.4269/ajtmh.2005.73.157; Minakawa N, 2002, AM J TROP MED HYG, V67, P32, DOI 10.4269/ajtmh.2002.67.32; Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015; Mushinzimana E, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-13; Mutuku FM, 2006, AM J TROP MED HYG, V74, P44, DOI 10.4269/ajtmh.2006.74.44; Mwangangi JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-228; Ndenga BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047975; Ndenga BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019473; Nmor JC, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-14; Oesterholt MJAM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-98; Okumu FO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-46; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; R Core Team, 2012, R LANG ENV STAT COMP; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Russell TL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-187; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Shaman J, 2002, EMERG INFECT DIS, V8, P6; SHOUSHA A. T., 1948, BULL WORLD HEALTH ORGAN, V1, P309; Sinka ME, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-69; Small J, 2003, P NATL ACAD SCI USA, V100, P15341, DOI 10.1073/pnas.2236969100; Smith MW, 2013, EARTH-SCI REV, V116, P109, DOI 10.1016/j.earscirev.2012.11.004; SMITH T, 1995, ACTA TROP, V59, P1, DOI 10.1016/0001-706X(94)00082-C; Temple PH., 1972, GEOGR ANN, V54A, P345, DOI [10.1080/04353676.1972.11879873, DOI 10.2307/520773, DOI 10.1080/04353676.1972.11879873]; Thomas C, 2004, NATURE, V427, P690, DOI 10.1038/427690b; Thomson MC, 2006, NATURE, V439, P576, DOI 10.1038/nature04503; Thomson MC, 2005, AM J TROP MED HYG, V73, P214, DOI 10.4269/ajtmh.2005.73.214; Tuno N, 2007, J VECTOR ECOL, V32, P112, DOI 10.3376/1081-1710(2007)32[112:IVIDAA]2.0.CO;2; van der Hoek W, 2003, INT J EPIDEMIOL, V32, P280, DOI 10.1093/ije/dyg055; Zhang Y, 2008, ASIA-PAC J PUBLIC HE, V20, P64, DOI 10.1177/1010539507308385; Zhou G, 2007, AM J TROP MED HYG, V77, P29, DOI 10.4269/ajtmh.2007.77.29; Zou GY, 2008, AM J EPIDEMIOL, V168, P212, DOI 10.1093/aje/kwn104	82	29	30	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81931	10.1371/journal.pone.0081931	http://dx.doi.org/10.1371/journal.pone.0081931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312606	Green Published, gold, Green Accepted			2022-12-25	WOS:000327947800068
J	Hendrikx, T; Bieghs, V; Walenbergh, SMA; van Gorp, PJ; Verheyen, F; Jeurissen, MLJ; Steinbusch, MMF; Vaes, N; Binder, CJ; Koek, GH; Stienstra, R; Netea, MG; Hofker, MH; Shiri-Sverdlov, R				Hendrikx, Tim; Bieghs, Veerle; Walenbergh, Sofie M. A.; van Gorp, Patrick J.; Verheyen, Fons; Jeurissen, Mike L. J.; Steinbusch, Mandy M. F.; Vaes, Nathalie; Binder, Christoph J.; Koek, Ger H.; Stienstra, Rinke; Netea, Mihai G.; Hofker, Marten H.; Shiri-Sverdlov, Ronit			Macrophage Specific Caspase-1/11 Deficiency Protects against Cholesterol Crystallization and Hepatic Inflammation in Hyperlipidemic Mice	PLOS ONE			English	Article							NLRP3 INFLAMMASOMES; NALP3 INFLAMMASOME; GUT MICROBIOTA; AUTOPHAGY; ACTIVATION; ATHEROSCLEROSIS; NASH; DIET; STEATOHEPATITIS; CRYSTALS	Background & Aims: While non-alcoholic steatohepatitis (NASH) is characterized by hepatic steatosis combined with inflammation, the mechanisms triggering hepatic inflammation are unknown. In Ldlr(-/-) mice, we have previously shown that lysosomal cholesterol accumulation in Kupffer cells (KCs) correlates with hepatic inflammation and cholesterol crystallization. Previously, cholesterol crystals have been shown to induce the activation of inflammasomes. Inflammasomes are protein complexes that induce the processing and release of pro-inflammatory cytokines IL-1b and IL-18 via caspase-1 activation. Whereas caspase-1 activation is independent of caspase-11 in the canonical pathway of inflammasome activation, caspase-11 was found to trigger caspase-1-dependent IL-1b and IL-18 in response to non-canonical inflammasome activators. So far, it has not been investigated whether inflammasome activation stimulates the formation of cholesterol crystals. We hypothesized that inflammasome activation in KCs stimulates cholesterol crystallization, thereby leading to hepatic inflammation. Methods: Ldlr(-/-) mice were transplanted (tp) with wild-type (Wt) or caspase-1/11(-/-) (dKO) bone marrow and fed either regular chow or a high-fat, high-cholesterol (HFC) diet for 12 weeks. In vitro, bone marrow derived macrophages (BMDM) from wt or caspase-1/11(-/-) mice were incubated with oxLDL for 24h and autophagy was assessed. Results: In line with our hypothesis, caspase-1/11(-/-)-tp mice had less severe hepatic inflammation than Wt-tp animals, as evident from liver histology and gene expression analysis in isolated KCs. Mechanistically, KCs from caspase-1/11(-/-)-tp mice showed less cholesterol crystals, enhanced cholesterol efflux and increased autophagy. In wt BMDM, oxLDL incubation led to disturbed autophagy activity whereas BMDM from caspase-1/11(-/-) mice had normal autophagy activity. Conclusion: Altogether, these data suggest a vicious cycle whereby disturbed autophagy and decreased cholesterol efflux leads to newly formed cholesterol crystals and thereby maintain hepatic inflammation during NASH by further activating the inflammasome.	[Hendrikx, Tim; Bieghs, Veerle; Walenbergh, Sofie M. A.; van Gorp, Patrick J.; Verheyen, Fons; Jeurissen, Mike L. J.; Steinbusch, Mandy M. F.; Vaes, Nathalie; Koek, Ger H.; Shiri-Sverdlov, Ronit] Maastricht Univ, Inst Maastricht, Dept Mol Genet, Maastricht, Netherlands; [Hendrikx, Tim; Bieghs, Veerle; Walenbergh, Sofie M. A.; van Gorp, Patrick J.; Verheyen, Fons; Jeurissen, Mike L. J.; Steinbusch, Mandy M. F.; Vaes, Nathalie; Koek, Ger H.; Shiri-Sverdlov, Ronit] Maastricht Univ, Inst Maastricht, Elect Microscopy & Internal Med, Maastricht, Netherlands; [Hendrikx, Tim; Bieghs, Veerle; Walenbergh, Sofie M. A.; van Gorp, Patrick J.; Verheyen, Fons; Jeurissen, Mike L. J.; Steinbusch, Mandy M. F.; Vaes, Nathalie; Koek, Ger H.; Shiri-Sverdlov, Ronit] Maastricht Univ, Inst Maastricht, Dept Nutr & Toxicol Res NUTRIM, Maastricht, Netherlands; [Hendrikx, Tim; Bieghs, Veerle; Walenbergh, Sofie M. A.; van Gorp, Patrick J.; Verheyen, Fons; Jeurissen, Mike L. J.; Steinbusch, Mandy M. F.; Vaes, Nathalie; Koek, Ger H.; Shiri-Sverdlov, Ronit] Maastricht Univ, MUMC, Maastricht, Netherlands; [Binder, Christoph J.] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Binder, Christoph J.] Austrian Acad Sci, Ctr Mol Med, A-1010 Vienna, Austria; [Stienstra, Rinke; Netea, Mihai G.] Radboud Univ Nijmegen, Dept Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Stienstra, Rinke; Netea, Mihai G.] Nijmegen Inst Infect Inflammat & Immun N4i, Nijmegen, Netherlands; [Stienstra, Rinke] Wageningen Univ, Dept Human Nutr, NL-6700 AP Wageningen, Netherlands; [Hofker, Marten H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University; Medical University of Vienna; Austrian Academy of Sciences; Radboud University Nijmegen; Radboud University Nijmegen; Wageningen University & Research; University of Groningen	Shiri-Sverdlov, R (corresponding author), Maastricht Univ, Inst Maastricht, Dept Mol Genet, Maastricht, Netherlands.	r.sverdlov@maastrichtuniversity.nl	Stienstra, Rinke/A-4763-2015; Vaes, Nathalie/AAW-4981-2021; Shiri-Sverdlov, Ronit/X-2642-2019; van Gorp, Patrick/L-9580-2018; Hendrikx, Tim/AAI-8252-2021; Shiri-Sverdlov, Ronit/E-5571-2017; Netea, Mihai/N-5155-2014; Hendrikx, Tim/AAE-2329-2020; van Gorp, Patrick/S-3892-2019	Stienstra, Rinke/0000-0001-6729-7193; Vaes, Nathalie/0000-0001-9571-3449; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; van Gorp, Patrick/0000-0002-0355-5349; Hendrikx, Tim/0000-0002-3381-2107; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; van Gorp, Patrick/0000-0002-0355-5349; Binder, Christoph J./0000-0001-8313-7050	CTMM, the Center for Translational Molecular Medicine, project PREDICCt [01C-104]; Dutch Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Maag Lever Darm Stichting (MLDS) [WO 08-16, WO 11-35]; Netherlands Organisation for Scientific Research (NWO) [Vidi 016.126.327]; NWO	CTMM, the Center for Translational Molecular Medicine, project PREDICCt; Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Maag Lever Darm Stichting (MLDS); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO(Netherlands Organization for Scientific Research (NWO))	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project PREDICCt (grant 01C-104), and also supported by the Dutch Heart Foundation, Dutch Diabetes Research Foundation, Dutch Kidney Foundation, Maag Lever Darm Stichting (MLDS) (WO 08-16 and WO 11-35) and by the Netherlands Organisation for Scientific Research (NWO) (Vidi 016.126.327). MGN was supported by a Vici grant from the NWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Akhter A, 2012, IMMUNITY, V37, P35, DOI 10.1016/j.immuni.2012.05.001; Aparicio-Vergara M, 2010, ATHEROSCLEROSIS, V213, P335, DOI 10.1016/j.atherosclerosis.2010.05.030; Bieghs V, 2013, GASTROENTEROLOGY, V144, P167, DOI 10.1053/j.gastro.2012.09.062; Bieghs V, 2012, HEPATOLOGY, V56, P894, DOI 10.1002/hep.25660; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034378; Bieghs V, 2012, ATHEROSCLEROSIS, V220, P287, DOI 10.1016/j.atherosclerosis.2011.08.041; Bieghs V, 2010, GASTROENTEROLOGY, V138, P2477, DOI 10.1053/j.gastro.2010.02.051; Cavelier C, 2006, BBA-MOL CELL BIOL L, V1761, P655, DOI 10.1016/j.bbalip.2006.04.012; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; De Nardo D, 2011, TRENDS IMMUNOL, V32, P373, DOI 10.1016/j.it.2011.05.004; Dixon LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056100; Dixon LJ, 2012, LAB INVEST, V92, P713, DOI 10.1038/labinvest.2012.45; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eskelinen EL, 2002, MOL BIOL CELL, V13, P3355, DOI 10.1091/mbc.E02-02-0114; Farrell GC, 2012, GUT LIVER, V6, P149, DOI 10.5009/gnl.2012.6.2.149; Gage J, 2012, CAN J CARDIOL, V28, P222, DOI 10.1016/j.cjca.2011.10.013; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Ioannou GN, 2013, J LIPID RES, V54, P1326, DOI 10.1194/jlr.M034876; Jansen HJ, 2012, ENDOCRINOLOGY, V153, P5866, DOI 10.1210/en.2012-1625; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; LaRocca TJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003353; Lukens JR, 2011, DISCOV MED, V11, P65; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Razani B, 2012, CELL METAB, V15, P534, DOI 10.1016/j.cmet.2012.02.011; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Singh RK, 2012, INT J OPT, V2012, DOI [10.1155/2012/282041, 10.1155/2012/832086]; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Usui F, 2012, BIOCHEM BIOPH RES CO, V425, P162, DOI 10.1016/j.bbrc.2012.07.058; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Wisse E, 2010, WORLD J GASTROENTERO, V16, P2851, DOI 10.3748/wjg.v16.i23.2851; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363	46	25	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e78792	10.1371/journal.pone.0078792	http://dx.doi.org/10.1371/journal.pone.0078792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312444	Green Published, gold, Green Submitted			2022-12-25	WOS:000327944500003
J	Kopec, G; Moertl, D; Steiner, S; Stepien, E; Mikolajczyk, T; Podolec, J; Waligora, M; Stepniewski, J; Tomkiewicz-Pajak, L; Guzik, T; Podolec, P				Kopec, Grzegorz; Moertl, Deddo; Steiner, Sabine; Stepien, Ewa; Mikolajczyk, Tomasz; Podolec, Jakub; Waligora, Marcin; Stepniewski, Jakub; Tomkiewicz-Pajak, Lidia; Guzik, Tomasz; Podolec, Piotr			Markers of Thrombogenesis and Fibrinolysis and Their Relation to Inflammation and Endothelial Activation in Patients with Idiopathic Pulmonary Arterial Hypertension	PLOS ONE			English	Article							PREVENTION GUIDELINES; POLISH FORUM; PLASMINOGEN-ACTIVATOR; PLASMA-LEVELS; OLDER MEN; COAGULATION; INTERLEUKIN-6; DYSFUNCTION; DISEASE; TISSUE	Background: Chronic anticoagulation is a standard of care in idiopathic pulmonary arterial hypertension (IPAH). However, hemostatic abnormalities in this disease remain poorly understood. Therefore, we aimed to study markers of thrombogenesis and fibrinolysis in patients with IPAH. Methods: We studied 27 consecutive patients (67% female) with IPAH aged 50.0 years (IQR: 41.0 - 65.0) and 16 controls without pulmonary hypertension. Prothrombin fragment 1+2 (F1+2) and thrombin-antithrombin (TAT) complexes were measured to assess thrombogenesis; tissue-type plasminogen activator (tPA) antigen and plasmin-anti-plasmin complex to characterize activation of fibrinolysis; plasminogen activator inhibitor 1 (PAI-1) to measure inhibition of fibrinolysis; and endothelin-1 (ET-1) and interleukin-6 (IL-6) to assess endothelial activation and systemic inflammation, respectively. In addition, in treatment-naive IPAH patients these markers were assessed after 3 months of PAH-specific therapies. Results: TPA (10.1[6.8-15.8] vs 5.2[3.3-7.3] ng/ml, p<0.001), plasmin-anti-plasmin (91.5[60.3-94.2] vs 55.8[51.1-64.9] ng/ml, p<0.001), IL-6 (4.9[2.5-7.9] vs 2.1[1.3-3.8] pg/ml, p=0.001) and ET-1 (3.7 [3.3-4.5] vs 3.4[3.1-3.5], p= 0.03) were higher in patients with IPAH than in controls. In IPAH patients plasmin-anti-plasmin and tPA correlated positively with IL-6 (r=0.39, p=0.04 and r=0.63, p<0.001, respectively) and ET-1 (r=0.55, p=0.003 and r=0.59, p=0.001, respectively). No correlation was found between tPA or plasmin-anti-plasmin and markers of thrombogenesis. Plasmin-anti-plasmin decreased after 3 months of PAH specific therapy while the other markers remained unchanged. Conclusions: In the present study we showed that markers of fibrynolysis were elevated in patients with IPAH however we did not find a clear evidence for increased thrombogenesis in this group of patients. Fibrinolysis, inflammation, and endothelial activation were closely interrelated in IPAH.	[Kopec, Grzegorz; Waligora, Marcin; Stepniewski, Jakub; Tomkiewicz-Pajak, Lidia; Podolec, Piotr] John Paul II Hosp Krakow, Dept Cardiac & Vasc Dis, Krakow, Poland; [Kopec, Grzegorz; Podolec, Jakub; Waligora, Marcin; Stepniewski, Jakub; Tomkiewicz-Pajak, Lidia; Podolec, Piotr] Jagiellonian Univ, Coll Med, Krakow, Poland; [Moertl, Deddo] Landesklini St Poelten, Dept Internal Med Cardiol & Emergency Med 3, St Polten, Austria; [Steiner, Sabine] Med Univ Vienna, Dept Internal Med 2, Div Angiol, Vienna, Austria; [Stepien, Ewa] Jagiellonian Univ, Coll Med, Dept Clin Biochem, Krakow, Poland; [Mikolajczyk, Tomasz] Jagiellonian Univ, Coll Med, Dept Internal & Agr Med, Krakow, Poland; [Podolec, Jakub] John Paul II Hosp Krakow, Dept Hemodynam & Angiocardiog, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Medical University of Vienna; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Kopec, G (corresponding author), John Paul II Hosp Krakow, Dept Cardiac & Vasc Dis, Krakow, Poland.	gkopec@szpitaljp2.krakow.pl	Moertl, Deddo/AAP-6636-2021; Stepien, Ewa/X-8089-2019; Stępień, Ewa/H-7471-2019; Guzik, Tomasz Jan/AAM-5007-2020; Mikolajczyk, Tomasz/AFQ-2278-2022; Steiner, Sabine/AAG-5804-2021; Podolec, Piotr/U-5310-2018	Moertl, Deddo/0000-0001-6408-8978; Stępień, Ewa/0000-0003-3589-1715; Mikolajczyk, Tomasz/0000-0002-7990-2896; Steiner, Sabine/0000-0002-5680-1072; Kopec, Grzegorz/0000-0001-9921-2801; Guzik, Tomasz/0000-0002-5039-7849; Podolec, Piotr/0000-0001-6101-2935; Podolec, Jakub/0000-0001-9169-3428	Polish Ministry of Science and Higher Education [N N402 387638]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This research was supported by the Polish Ministry of Science and Higher Education; Grant NO N N402 387638; http://www.ncn.gov.pl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2008, RHEUMATOLOGY, V47, pV23, DOI 10.1093/rheumatology/ken282; Budhiraja R, 2004, CIRCULATION, V109, P159, DOI 10.1161/01.CIR.0000102381.57477.50; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Chaouat A, 1996, EUR RESPIR J, V9, P356, DOI 10.1183/09031936.96.09020356; Christ G, 2001, THROMB HAEMOSTASIS, V86, P557; Cybulska B, 2008, KARDIOL POL, V66, P1239; Damas JK, 2004, CIRCULATION, V110, P999, DOI 10.1161/01.CIR.0000139859.68513.FC; Davie NJ, 2009, EUR J CLIN INVEST, V39, P38, DOI 10.1111/j.1365-2362.2009.02120.x; EISENBERG PR, 1990, CIRCULATION, V82, P841, DOI 10.1161/01.CIR.82.3.841; EMEIS JJ, 1992, ANN NY ACAD SCI, V667, P249, DOI 10.1111/j.1749-6632.1992.tb51622.x; Friedman R, 1997, CIRCULATION, V96, P2782, DOI 10.1161/01.CIR.96.9.2782; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Henkens IR, 2013, EUR RESPIR J, V41, P872, DOI 10.1183/09031936.00039212; Hiremath J, 2010, J HEART LUNG TRANSPL, V29, P137, DOI 10.1016/j.healun.2009.09.005; Hoeper MM, 1998, EUR RESPIR J, V12, P1446, DOI 10.1183/09031936.98.12061446; HUBER K, 1994, AM J RESP CRIT CARE, V150, P929, DOI 10.1164/ajrccm.150.4.7921465; Jenkins GR, 1997, BLOOD, V89, P2394, DOI 10.1182/blood.V89.7.2394; Jinnin M, 2003, RHEUMATOLOGY, V42, P240, DOI 10.1093/rheumatology/keg071; Johnson SR, 2006, EUR RESPIR J, V28, P999, DOI 10.1183/09031936.06.00015206; Johnson SR, 2012, J RHEUMATOL, V39, P276, DOI 10.3899/jrheum.110765; KAWAKAMI M, 1989, ARTHRITIS RHEUM, V32, P1427, DOI 10.1002/anr.1780321112; Kawecka-Jaszcz K, 2008, KARDIOL POL, V66, P125; Kerr R, 2001, BRIT J HAEMATOL, V115, P3, DOI 10.1046/j.1365-2141.2001.03061.x; Kozek E, 2008, KARDIOL POL, V66, P1020; Kruithof EKO, 1997, THROMB HAEMOSTASIS, V77, P905; LAFARGE CG, 1970, CARDIOVASC RES, V4, P23, DOI 10.1093/cvr/4.1.23; Levi M, 2004, CIRCULATION, V109, P2698, DOI 10.1161/01.CIR.0000131660.51520.9A; Ling Y, 2012, AM J RESP CRIT CARE, V186, P790, DOI 10.1164/rccm.201203-0383OC; Lippi G, 2006, BLOOD COAGUL FIBRIN, V17, P513, DOI 10.1097/01.mbc.0000245290.57021.46; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Miniati M, 2010, AM J RESP CRIT CARE, V181, P992, DOI 10.1164/rccm.200907-1135OC; PARAMO JA, 1995, HAEMOSTASIS, V25, P305; Paulus P, 2011, BIOMARKERS, V16, pS11, DOI 10.3109/1354750X.2011.587893; Peacock A, 2013, EUR RESPIR REV, V22, P20, DOI 10.1183/09059180.00006912; Price LC, 2012, CHEST, V141, P210, DOI 10.1378/chest.11-0793; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Savale L, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-6; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; Stacher E, 2012, AM J RESP CRIT CARE, V186, P261, DOI 10.1164/rccm.201201-0164OC; Tykarski A, 2007, KARDIOL POL, V65, P1137; van Hinsbergh VWM, 2012, SEMIN IMMUNOPATHOL, V34, P93, DOI 10.1007/s00281-011-0285-5; Wannamethee SG, 2007, J THROMB HAEMOST, V5, P1637, DOI 10.1111/j.1538-7836.2007.02643.x; Wannamethee SG, 2008, DIABETES CARE, V31, P995, DOI 10.2337/dc07-1569; Welsh CH, 1996, CHEST, V110, P710, DOI 10.1378/chest.110.3.710; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; Zahorska-Markiewicz B, 2008, KARDIOL POL, V66, P594	46	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82628	10.1371/journal.pone.0082628	http://dx.doi.org/10.1371/journal.pone.0082628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312667	Green Published, gold			2022-12-25	WOS:000327944500141
J	Pratte, D; Singh, U; Murat, G; Kressler, D				Pratte, Dagmar; Singh, Ujjwala; Murat, Guillaume; Kressler, Dieter			Mak5 and Ebp2 Act Together on Early Pre-60S Particles and Their Reduced Functionality Bypasses the Requirement for the Essential Pre-60S Factor Nsa1	PLOS ONE			English	Article							PRE-RIBOSOMAL-RNA; DEAD-BOX PROTEIN; SACCHAROMYCES-CEREVISIAE; QUALITY-CONTROL; ANGSTROM RESOLUTION; TRANSLATION INITIATION; SYNTHETIC LETHALITY; EUKARYOTIC RIBOSOME; BIOGENESIS FACTORS; CRYSTAL-STRUCTURE	Ribosomes are the molecular machines that translate mRNAs into proteins. The synthesis of ribosomes is therefore a fundamental cellular process and consists in the ordered assembly of 79 ribosomal proteins (r-proteins) and four ribosomal RNAs (rRNAs) into a small 40S and a large 60S ribosomal subunit that form the translating 80S ribosomes. Most of our knowledge concerning this dynamic multi-step process comes from studies with the yeast Saccharomyces cerevisiae, which have shown that assembly and maturation of pre-ribosomal particles, as they travel from the nucleolus to the cytoplasm, relies on a multitude (>200) of biogenesis factors. Amongst these are many energy-consuming enzymes, including 19 ATP-dependent RNA helicases and three AAA-ATPases. We have previously shown that the AAA-ATPase Rix7 promotes the release of the essential biogenesis factor Nsa1 from late nucleolar pre-60S particles. Here we show that mutant alleles of genes encoding the DEAD-box RNA helicase Mak5, the C/D-box snoRNP component Nop1 and the rRNA-binding protein Nop4 bypass the requirement for Nsa1. Interestingly, dominant-negative alleles of RIX7 retain their phenotype in the absence of Nsa1, suggesting that Rix7 may have additional nuclear substrates besides Nsa1. Mak5 is associated with the Nsa1 pre-60S particle and synthetic lethal screens with mak5 alleles identified the r-protein Rpl14 and the 60S biogenesis factors Ebp2, Nop16 and Rpf1, which are genetically linked amongst each other. We propose that these 'Mak5 cluster' factors orchestrate the structural arrangement of a eukaryote-specific 60S subunit surface composed of Rpl6, Rpl14 and Rpl16 and rRNA expansion segments ES7L and ES39L. Finally, over-expression of Rix7 negatively affects growth of mak5 and ebp2 mutant cells both in the absence and presence of Nsa1, suggesting that Rix7, at least when excessively abundant, may act on structurally defective pre-60S subunits and may subject these to degradation.	[Pratte, Dagmar; Singh, Ujjwala; Murat, Guillaume; Kressler, Dieter] Univ Fribourg, Dept Biol, Biochem Unit, CH-1700 Fribourg, Switzerland	University of Fribourg	Kressler, D (corresponding author), Univ Fribourg, Dept Biol, Biochem Unit, CH-1700 Fribourg, Switzerland.	dieter.kressler@unifr.ch	Kressler, Dieter/C-2218-2012	Murat, Guillaume/0000-0003-1288-984X; Kressler, Dieter/0000-0003-4855-3563	Swiss National Science Foundation [PP00P3_123341]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a grant from the Swiss National Science Foundation (PP00P3_123341) to DK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov A, 2011, GENE DEV, V25, P1078, DOI 10.1101/gad.2045411; Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bassler J, 2010, MOL CELL, V38, P712, DOI 10.1016/j.molcel.2010.05.024; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; BERGES T, 1994, EMBO J, V13, P3136, DOI 10.1002/j.1460-2075.1994.tb06612.x; Bussiere C, 2012, J CELL BIOL, V197, P747, DOI 10.1083/jcb.201112131; Cole SE, 2009, MOL CELL, V34, P440, DOI 10.1016/j.molcel.2009.04.017; de la Cruz J, 2004, GENETICS, V166, P1687, DOI 10.1534/genetics.166.4.1687; Decatur WA, 2003, J BIOL CHEM, V278, P695, DOI 10.1074/jbc.R200023200; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; Dez C, 2006, EMBO J, V25, P1534, DOI 10.1038/sj.emboj.7601035; Dez C, 2004, MOL CELL BIOL, V24, P6324, DOI 10.1128/MCB.24.14.6324-6337.2004; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Esaki M, 2010, BIOCHEM CELL BIOL, V88, P109, DOI [10.1139/o09-116, 10.1139/O09-116]; Fatica A, 2002, MOL CELL, V9, P341, DOI 10.1016/S1097-2765(02)00458-6; Fujii K, 2009, GENE DEV, V23, P963, DOI 10.1101/gad.1775609; Gadal O, 2001, EMBO J, V20, P3695, DOI 10.1093/emboj/20.14.3695; Galardi S, 2002, MOL CELL BIOL, V22, P6663, DOI 10.1128/MCB.22.19.6663-6668.2002; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2006, NUCLEIC ACIDS RES, V34, P3189, DOI 10.1093/nar/gkl419; Granneman S, 2011, EMBO J, V30, P4006, DOI 10.1038/emboj.2011.256; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Hinnebusch AG, 2009, GENE DEV, V23, P891, DOI 10.1101/gad.1800509; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Huber MD, 2000, J BIOL CHEM, V275, P28764, DOI 10.1074/jbc.M000594200; James P, 1996, GENETICS, V144, P1425; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jankowsky E, 2006, NUCLEIC ACIDS RES, V34, P4181, DOI 10.1093/nar/gkl410; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Jenner L, 2012, CURR OPIN STRUC BIOL, V22, P759, DOI 10.1016/j.sbi.2012.07.013; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kappel L, 2012, J CELL BIOL, V199, P771, DOI 10.1083/jcb.201205021; Karbstein K, 2013, TRENDS CELL BIOL, V23, P242, DOI 10.1016/j.tcb.2013.01.004; Karbstein K, 2011, CURR OPIN CHEM BIOL, V15, P657, DOI 10.1016/j.cbpa.2011.07.023; Kaser A, 2001, BIOL CHEM, V382, P1637, DOI 10.1515/BC.2001.199; Kossen K, 2002, J MOL BIOL, V324, P625, DOI 10.1016/S0022-2836(02)01140-3; Kressler D, 1999, MOL CELL BIOL, V19, P8633; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Kressler D, 1997, MOL CELL BIOL, V17, P7283, DOI 10.1128/MCB.17.12.7283; Kressler D, 2008, J CELL BIOL, V181, P935, DOI 10.1083/jcb.200801181; Kressler D, 2012, BBA-MOL CELL RES, V1823, P92, DOI 10.1016/j.bbamcr.2011.06.017; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; KRUISWIJK T, 1978, BIOCHIM BIOPHYS ACTA, V517, P378, DOI 10.1016/0005-2787(78)90204-6; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lafontaine DLJ, 2010, TRENDS BIOCHEM SCI, V35, P267, DOI 10.1016/j.tibs.2009.12.006; LaRiviere FJ, 2006, MOL CELL, V24, P619, DOI 10.1016/j.molcel.2006.10.008; Lebaron S, 2012, NAT STRUCT MOL BIOL, V19, P744, DOI 10.1038/nsmb.2308; Lebaron S, 2009, EMBO J, V28, P3808, DOI 10.1038/emboj.2009.335; Lebreton A, 2008, NUCLEIC ACIDS RES, V36, P4988, DOI 10.1093/nar/gkn469; Lin JZ, 2011, NATURE, V469, P559, DOI 10.1038/nature09688; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Lo KY, 2010, MOL CELL, V39, P196, DOI 10.1016/j.molcel.2010.06.018; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Martin R, 2013, RNA BIOL, V10, P4, DOI 10.4161/rna.21879; Mulder AM, 2010, SCIENCE, V330, P673, DOI 10.1126/science.1193220; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Panse VG, 2010, TRENDS BIOCHEM SCI, V35, P260, DOI 10.1016/j.tibs.2010.01.001; Pertschy B, 2009, J BIOL CHEM, V284, P35079, DOI 10.1074/jbc.M109.040774; Piekna-Przybylska D, 2007, RNA, V13, P305, DOI 10.1261/rna.373107; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rodriguez-Galan O, 2013, BBA-GENE REGUL MECH, V1829, P775, DOI 10.1016/j.bbagrm.2013.01.007; Rosado IV, 2007, MOL CELL BIOL, V27, P1207, DOI 10.1128/MCB.01523-06; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; Schutz S, 2012, NAT STRUCT MOL BIOL, V19, P861, DOI 10.1038/nsmb.2368; Shimoji K, 2012, NUCLEIC ACIDS RES, V40, P4574, DOI 10.1093/nar/gks057; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; Steffen KK, 2012, GENETICS, V191, P107, DOI 10.1534/genetics.111.136549; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Strunk BS, 2012, CELL, V150, P111, DOI 10.1016/j.cell.2012.04.044; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; SUN C, 1994, EMBO J, V13, P3127, DOI 10.1002/j.1460-2075.1994.tb06611.x; Talkington MWT, 2005, NATURE, V438, P628, DOI 10.1038/nature04261; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Tsujii R, 2000, GENES CELLS, V5, P543, DOI 10.1046/j.1365-2443.2000.00346.x; Ulbrich C, 2009, CELL, V138, P911, DOI 10.1016/j.cell.2009.06.045; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Walbott H, 2010, EMBO J, V29, P2194, DOI 10.1038/emboj.2010.102; Wang HM, 2000, EMBO J, V19, P317, DOI 10.1093/emboj/19.3.317; Wehner KA, 2002, MOL CELL, V9, P329, DOI 10.1016/S1097-2765(02)00438-0; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Young CL, 2013, P NATL ACAD SCI USA, V110, pE2668, DOI 10.1073/pnas.1302577110; Zagulski M, 2003, MOL GENET GENOMICS, V270, P216, DOI 10.1007/s00438-003-0913-4	98	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82741	10.1371/journal.pone.0082741	http://dx.doi.org/10.1371/journal.pone.0082741			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312670	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500144
J	Richard, M; Jamet, S; Fouquet, C; Dubacq, C; Boggetto, N; Pincet, F; Gourier, C; Trembleau, A				Richard, Marion; Jamet, Sophie; Fouquet, Coralie; Dubacq, Caroline; Boggetto, Nicole; Pincet, Frederic; Gourier, Christine; Trembleau, Alain			Homotypic and Heterotypic Adhesion Induced by Odorant Receptors and the beta 2-Adrenergic Receptor	PLOS ONE			English	Article							OLFACTORY SENSORY NEURONS; FUNCTIONAL EXPRESSION; E-CADHERIN; GLOMERULI; MOUSE; AXONS; BULB; CONVERGENCE; PROTEINS; SYSTEM	In the mouse olfactory system regulated expression of a large family of G Protein-Coupled Receptors (GPCRs), the Odorant Receptors (ORs), provides each sensory neuron with a single OR identity. In the wiring of the olfactory sensory neuron projections, a complex axon sorting process ensures the segregation of >1,000 subpopulations of axons of the same OR identity into homogeneously innervated glomeruli. ORs are critical determinants in axon sorting, and their presence on olfactory axons raises the intriguing possibility that they may participate in axonal wiring through direct or indirect trans-interactions mediating adhesion or repulsion between axons. In the present work, we used a biophysical assay to test the capacity of ORs to induce adhesion of cell doublets overexpressing these receptors. We also tested the beta 2 Adrenergic Receptor, a non-OR GPCR known to recapitulate the functions of ORs in olfactory axon sorting. We report here the first evidence for homo-and heterotypic adhesion between cells overexpressing the ORs MOR256-17 or M71, supporting the hypothesis that ORs may contribute to olfactory axon sorting by mediating differential adhesion between axons.	[Richard, Marion; Jamet, Sophie; Fouquet, Coralie; Dubacq, Caroline; Trembleau, Alain] Univ Paris 06, CNRS, UMR 7102, Team Dev & Plast Neural Networks, Paris, France; [Boggetto, Nicole] Univ Paris Diderot, CNRS, Inst Jacques Monod, Imaging Facil ImagoSeine, Paris, France; [Pincet, Frederic; Gourier, Christine] Univ Paris Diderot, CNRS, Univ Paris 06, Ecole Normale Super,Lab Phys Stat, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite	Trembleau, A (corresponding author), Univ Paris 06, CNRS, UMR 7102, Team Dev & Plast Neural Networks, Paris, France.	alain.trembleau@upmc.fr	Richard, Marion B/G-4866-2017	Richard, Marion B/0000-0003-0175-2637; Trembleau, Alain/0000-0002-8290-0795; PINCET, FREDERIC/0000-0002-4243-2157; DUBACQ, Caroline/0000-0003-3674-5808	Centre National de la Recherche Scientifique, Universite Pierre et Marie Curie (UPMC); Agence Nationale de la Recherche [ANR-2010-BLAN-1401-01]; Investissements d'Avenir program [ANR-11-IDEX-0004-02]; National Institute of Health [5R01DC012441]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012441] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique, Universite Pierre et Marie Curie (UPMC)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Investissements d'Avenir program(French National Research Agency (ANR)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Centre National de la Recherche Scientifique, Universite Pierre et Marie Curie (UPMC), Agence Nationale de la Recherche (grant ANR-2010-BLAN-1401-01 to AT), Investissements d'Avenir program managed by the Agence Nationale de la Recherche under reference ANR-11-IDEX-0004-02 and by National Institute of Health (grant 5R01DC012441 to AT). The team is affiliated with the Paris School of Neuroscience (Ecole des Neurosciences de Paris Ile-de-France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Bielle F, 2011, NEURON, V69, P1085, DOI 10.1016/j.neuron.2011.02.026; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chesler AT, 2007, P NATL ACAD SCI USA, V104, P1039, DOI 10.1073/pnas.0609215104; Chu YS, 2006, J BIOL CHEM, V281, P2901, DOI 10.1074/jbc.M506185200; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Dahoun T, 2011, BIOCHEMISTRY; Dal Col JA, 2007, DEVELOPMENT, V134, P2481, DOI 10.1242/dev.006346; Daoudi M, 2004, J BIOL CHEM, V279, P19649, DOI 10.1074/jbc.M313457200; Dubacq C, 2013, DEV NEUROBI IN PRESS; Dubacq C, 2009, J NEUROSCI, V29, P10184, DOI 10.1523/JNEUROSCI.2443-09.2009; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Gaffuri AL, 2012, PHARMACOLOGY, V90, P19, DOI 10.1159/000339075; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Lu M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-34; Matsunami H, 2009, ANN NY ACAD SCI, V1170, P153, DOI 10.1111/j.1749-6632.2009.03888.x; McClintock TS, 1997, MOL BRAIN RES, V48, P270, DOI 10.1016/S0169-328X(97)00099-5; Miller AM, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-20; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Nakashima A, 2013, CELL, V154, P1314, DOI 10.1016/j.cell.2013.08.033; Richard MB, 2010, P NATL ACAD SCI USA, V107, P15613, DOI 10.1073/pnas.1007931107; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; St John JA, 2003, J COMP NEUROL, V464, P131, DOI 10.1002/cne.10777; Strotmann J, 2004, J NEUROSCI, V24, P7754, DOI 10.1523/JNEUROSCI.2588-04.2004; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; Tsuboi A, 1999, J NEUROSCI, V19, P8409; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200; Zou DJ, 2009, NAT REV NEUROSCI, V10, P611, DOI 10.1038/nrn2666	38	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80100	10.1371/journal.pone.0080100	http://dx.doi.org/10.1371/journal.pone.0080100			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312457	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500012
J	Sun, XX; Xu, H; Meng, XZ; Qi, J; Cui, YY; Li, YQ; Zhang, H; Xu, LX				Sun, Xingxing; Xu, Hao; Meng, Xiangzhong; Qi, Jian; Cui, Yuanyuan; Li, Yunqing; Zhang, Hui; Xu, Lixian			Potential Use of Hyperoxygenated Solution as a Treatment Strategy for Carbon Monoxide Poisoning	PLOS ONE			English	Article							INTESTINAL ISCHEMIA-REPERFUSION; HYPERBARIC-OXYGEN THERAPY; SERUM S100B PROTEIN; ENOLASE LEVELS; INJURY; BRAIN; CARBOXYHEMOGLOBIN; INTOXICATION	Aim: Carbon monoxide (CO) poisoning can cause permanent damage in tissues that are sensitive to hypoxia. We explored the feasibility and efficacy of using a hyperoxygenated solution (HOS) to treat severe acute CO poisoning in an animal model. Methods: Male Sprague-Dawley rats were subjected to CO poisoning. The HOS was administered into the femoral vein of these rats through a catheter (10 ml/kg). Carboxyhemoglobin (COHb) and blood gases were used to assess the early damage caused by CO poisoning. S100 beta was measured to predict the development of late cognitive sequelae of CO. The Morris water maze test was performed to assess cognitive function, and Nissl staining was performed to observe histologic change. Results: The COHb concentrations rapidly decreased at 5 min after the HOS administration; however, the PaO2 and SaO(2) in rats treated with HOS increased significantly 5 min after the HOS administration. The S100 beta concentrations, which increased significantly after CO poisoning, increased at a much slower rate in the rats treated with HOS (HOS group) compared with the rats treated with O-2 inhalation (O-2 group). The escape latency in the place navigation test was shortened after CO poisoning on days 11-15 and days 26-30, and the swimming time in quadrant 4 in the spatial probe test on days 15 and 30 after CO poisoning was prolonged in the rats treated with HOS injection compared with the rats treated with oxygen inhalation or normal saline injection. The neuronal degeneration in the HOS group was alleviated than that in the CO or O-2 group. Conclusion: HOS efficiently alleviates the brain damage in acute CO-poisoned rats and thus may serve as a new way to treat human patients with CO poisoning in clinical practice.	[Sun, Xingxing; Xu, Hao; Zhang, Hui; Xu, Lixian] Fourth Mil Med Univ, Sch Stomatol, Dept Anesthesiol, Xian 710032, Peoples R China; [Xu, Hao; Qi, Jian; Cui, Yuanyuan; Li, Yunqing] Fourth Mil Med Univ, KK Leung Brain Res Ctr, Dept Anat Histol & Embryol, Xian 710032, Peoples R China; [Meng, Xiangzhong] 323 Mil Hosp Peoples Liberat Army, Dept Anesthesiol, Xian, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Li, YQ (corresponding author), Fourth Mil Med Univ, KK Leung Brain Res Ctr, Dept Anat Histol & Embryol, Xian 710032, Peoples R China.	deptanat@fmmu.edu.cn; zhanghuifmmua@yahoo.com; kqmzk@fmmu.edu.cn			National Natural Science Foundation of China [30772073]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Natural Science Foundation of China (No. 30772073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annane D, 2011, INTENS CARE MED, V37, P486, DOI 10.1007/s00134-010-2093-0; Aslan S, 2006, HUM EXP TOXICOL, V25, P439, DOI 10.1191/0960327106het645oa; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Brvar M, 2004, RESUSCITATION, V61, P357, DOI 10.1016/j.resuscitation.2004.01.009; Cakir Z, 2010, AM J EMERG MED, V28, P61, DOI 10.1016/j.ajem.2008.10.032; Dong YH, 2000, CHINESE MED J-PEKING, V113, P991; GABB G, 1987, CHEST, V92, P1074, DOI 10.1378/chest.92.6.1074; Gao CJ, 2008, J SURG RES, V146, P24, DOI 10.1016/j.jss.2007.07.008; Gao CJ, 2006, J SURG RES, V135, P268, DOI 10.1016/j.jss.2006.03.019; Gao CJ, 2005, J SURG RES, V129, P298, DOI 10.1016/j.jss.2005.06.022; Gouirand AM, 2005, PHYSIOL BEHAV, V86, P21, DOI 10.1016/j.physbeh.2005.06.027; Goulon M, 1986, J HYPERB MED, V1, P23; Hampson NB, 1996, UNDERSEA HYPERBAR M, V23, P215; HANS P, 1983, J NEUROSURG, V58, P689, DOI 10.3171/jns.1983.58.5.0689; Jay GD, 1997, UNDERSEA HYPERBAR M, V24, P165; Jespersen B, 2012, JOVE-J VIS EXP, DOI 10.3791/3496; KNOTT EK, 1948, AM J SURG, V76, P165, DOI 10.1016/0002-9610(48)90068-3; KRANTZ T, 1988, ACTA ANAESTH SCAND, V32, P278, DOI 10.1111/j.1399-6576.1988.tb02729.x; Malik A, 2012, J NEURO-OPHTHALMOL, V32, P128, DOI 10.1097/WNO.0b013e3182464c88; MIURA T, 1985, AM J NEURORADIOL, V6, P739; NORKOOL DM, 1985, ANN EMERG MED, V14, P1168, DOI 10.1016/S0196-0644(85)81023-4; Omaye ST, 2002, TOXICOLOGY, V180, P139, DOI 10.1016/S0300-483X(02)00387-6; Park E, 2012, CLIN TOXICOL, V50, P183, DOI 10.3109/15563650.2012.658918; Prockop LD, 2007, J NEUROL SCI, V262, P122, DOI 10.1016/j.jns.2007.06.037; RAPHAEL JC, 1989, LANCET, V2, P414; RODKEY FL, 1979, CLIN CHEM, V25, P1388; SAPOV I A, 1980, Fiziologicheskii Zhurnal SSSR Imeni I M Sechenova, V66, P1516; Scheinkestel CD, 1999, MED J AUSTRALIA, V170, P203, DOI 10.5694/j.1326-5377.1999.tb140318.x; Sun Yong-hua, 2004, Zhonghua Yi Xue Za Zhi, V84, P18; Thom S R, 1989, Emerg Med Clin North Am, V7, P371; Thom SR, 2004, P NATL ACAD SCI USA, V101, P13660, DOI 10.1073/pnas.0405642101; Varon J, 2001, J EMERG MED, V21, P283, DOI 10.1016/S0736-4679(01)00391-2; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Xu RF, 2008, EUR SURG RES, V41, P37, DOI 10.1159/000127731; Yamazaki Yutaka, 2006, Masui, V55, P699; Yardan T, 2009, AM J EMERG MED, V27, P838, DOI 10.1016/j.ajem.2008.04.016; Zhao Lian, 2008, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V20, P159; Zheng W, 2008, AM J EMERG MED, V26, P54, DOI 10.1016/j.ajem.2007.02.007	38	10	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81779	10.1371/journal.pone.0081779	http://dx.doi.org/10.1371/journal.pone.0081779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312588	gold, Green Published, Green Submitted			2022-12-25	WOS:000327944500098
J	Takahashi, T; Matsuda, Y; Yamashita, S; Hattori, N; Kushima, R; Lee, YC; Igaki, H; Tachimori, Y; Nagino, M; Ushijima, T				Takahashi, Takamasa; Matsuda, Yasunori; Yamashita, Satoshi; Hattori, Naoko; Kushima, Ryoji; Lee, Yi-Chia; Igaki, Hiroyasu; Tachimori, Yuji; Nagino, Masato; Ushijima, Toshikazu			Estimation of the Fraction of Cancer Cells in a Tumor DNA Sample Using DNA Methylation	PLOS ONE			English	Article							TISSUE; EXPRESSION; LUNG	Contamination of normal cells is almost always present in tumor samples and affects their molecular analyses. DNA methylation, a stable epigenetic modification, is cell type-dependent, and different between cancer and normal cells. Here, we aimed to demonstrate that DNA methylation can be used to estimate the fraction of cancer cells in a tumor DNA sample, using esophageal squamous cell carcinoma (ESCC) as an example. First, by an Infinium HumanMethylation450 BeadChip array, we isolated three genomic regions (TFAP2B, ARHGEF4, and RAPGEFL1) i) highly methylated in four ESCC cell lines, ii) hardly methylated in a pooled sample of non-cancerous mucosae, a pooled sample of normal esophageal mucosae, and peripheral leukocytes, and iii) frequently methylated in 28 ESCCs (TFAP2B, 24/28; ARHGEF4, 20/28; and RAPGEFL1, 19/28). Second, using eight pairs of cancer and non-cancer cell samples prepared by laser capture microdissection, we confirmed that at least one of the three regions was almost completely methylated in ESCC cells, and all the three regions were almost completely unmethylated in non-cancer cells. We also confirmed that DNA copy number alterations of the three regions in 15 ESCC samples were rare, and did not affect the estimation of the fraction of cancer cells. Then, the fraction of cancer cells in a tumor DNA sample was defined as the highest methylation level of the three regions, and we confirmed a high correlation between the fraction assessed by the DNA methylation fraction marker and the fraction assessed by a pathologist (r=0.85; p<0.001). Finally, we observed that, by correction of the cancer cell content, CpG islands in promoter regions of tumor-suppressor genes were almost completely methylated. These results demonstrate that DNA methylation can be used to estimate the fraction of cancer cells in a tumor DNA sample.	[Takahashi, Takamasa; Matsuda, Yasunori; Yamashita, Satoshi; Hattori, Naoko; Ushijima, Toshikazu] Natl Canc Ctr, Res Inst, Div Epigen, Tokyo, Japan; [Matsuda, Yasunori] Osaka City Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka 558, Japan; [Kushima, Ryoji] Natl Canc Ctr, Pathol & Clin Lab Div, Tokyo, Japan; [Lee, Yi-Chia] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Takahashi, Takamasa; Igaki, Hiroyasu; Tachimori, Yuji] Natl Canc Ctr, Esophageal Surg Div, Tokyo, Japan; [Takahashi, Takamasa; Nagino, Masato] Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol, Nagoya, Aichi 4648601, Japan	National Cancer Center - Japan; Osaka Metropolitan University; National Cancer Center - Japan; National Taiwan University; National Cancer Center - Japan; Nagoya University	Ushijima, T (corresponding author), Natl Canc Ctr, Res Inst, Div Epigen, Tokyo, Japan.	tushijim@ncc.go.jp	Nagino, Masato/I-7342-2014; Ushijima, Toshikazu/AAP-5742-2021	Ushijima, Toshikazu/0000-0003-3405-7817; Yamashita, Satoshi/0000-0002-8609-5797; LEE, YI-CHIA/0000-0002-8160-1216; Hattori, Naoko/0000-0002-0901-4869	Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture Sports, Science, and Technology, Japan; Foundation for Promotion of Cancer Research	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation for Promotion of Cancer Research	This study was supported by the Third-term Comprehensive Cancer Control Strategy from the Ministry of Health, Labour and Welfare, Japan (http://www.mhlw.go.jp), and by Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT) from the Ministry of Education, Culture Sports, Science, and Technology, Japan (http://p-direct.mext.go.jp). T. T. and Y.M. are recipients of a Research Resident Fellowship from the Foundation for Promotion of Cancer Research (http://www.fpcr.or.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Brait M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044951; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Goto Y, 2009, CANCER RES, V69, P9073, DOI 10.1158/0008-5472.CAN-09-1595; Gusnanto A, 2012, BIOINFORMATICS, V28, P40, DOI 10.1093/bioinformatics/btr593; Heller G, 2013, CARCINOGENESIS, V34, P513, DOI 10.1093/carcin/bgs363; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kaneda A, 2004, CANCER LETT, V212, P203, DOI 10.1016/j.canlet.2004.03.020; Kibriya MG, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-50; Kim JG, 2013, CANCER LETT, V330, P33, DOI 10.1016/j.canlet.2012.11.022; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Nancarrow DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001093; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Shen J, 2013, EPIGENETICS-US, V8, P34, DOI 10.4161/epi.23062; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Smith MJ, 2009, BRIT J CANCER, V100, P1452, DOI 10.1038/sj.bjc.6604931; Song S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045835; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Su XP, 2012, BIOINFORMATICS, V28, P2265, DOI 10.1093/bioinformatics/bts365; Suzuki H, 2010, CARCINOGENESIS, V31, P2066, DOI 10.1093/carcin/bgq203; Tureci O, 2003, FASEB J, V17, P376, DOI 10.1096/fj.02-0478com; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013; Wojdacz TK, 2009, EPIGENETICS-US, V4, P231, DOI 10.4161/epi.9020; Yau C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r92; Yu DH, 2013, MOL CELL BIOL, V33, P1845, DOI 10.1128/MCB.01124-12	27	24	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82302	10.1371/journal.pone.0082302	http://dx.doi.org/10.1371/journal.pone.0082302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312652	gold, Green Submitted, Green Published			2022-12-25	WOS:000327944500134
J	Delehouze, C; Godl, K; Loaec, N; Bruyere, C; Desban, N; Oumata, N; Galons, H; Roumeliotis, TI; Giannopoulou, EG; Grenet, J; Twitchell, D; Lahti, J; Mouchet, N; Galibert, MD; Garbis, SD; Meijer, L				Delehouze, C.; Godl, K.; Loaec, N.; Bruyere, C.; Desban, N.; Oumata, N.; Galons, H.; Roumeliotis, T. I.; Giannopoulou, E. G.; Grenet, J.; Twitchell, D.; Lahti, J.; Mouchet, N.; Galibert, M-D; Garbis, S. D.; Meijer, L.			CDK/CK1 inhibitors roscovitine and CR8 downregulate amplified MYCN in neuroblastoma cells	ONCOGENE			English	Article						cyclin-dependent kinase; casein kinase 1; roscovitine; CR8; MYCN; neuroblastoma	CYCLIN-DEPENDENT KINASE; RNA-POLYMERASE-II; DRUG DISCOVERY; CDK INHIBITORS; BREAST-CANCER; INTRACELLULAR TARGETS; THERAPEUTIC TARGETS; PYRIDOXAL KINASE; DUAL-SPECIFICITY; K/CDK12 COMPLEX	To understand the mechanisms of action of (R)-roscovitine and (S)-CR8, two related pharmacological inhibitors of cyclin-dependent kinases (CDKs), we applied a variety of '-omics' techniques to the human neuroblastoma SH-SY5Y and IMR32 cell lines: (1) kinase interaction assays, (2) affinity competition on immobilized broad-spectrum kinase inhibitors, (3) affinity chromatography on immobilized (R)-roscovitine and (S)-CR8, (4) whole genome transcriptomics analysis and specific quantitative PCR studies, (5) global quantitative proteomics approach and western blot analysis of selected proteins. Altogether, the results show that the major direct targets of these two molecules belong to the CDKs (1,2,5,7,9,12), DYRKs, CLKs and CK1s families. By inhibiting CDK7, CDK9 and CDK12, these inhibitors transiently reduce RNA polymerase 2 activity, which results in downregulation of a large set of genes. Global transcriptomics and proteomics analysis converge to a central role of MYC transcription factors downregulation. Indeed, CDK inhibitors trigger rapid and massive downregulation of MYCN expression in MYCN-amplified neuroblastoma cells as well as in nude mice xenografted IMR32 cells. Inhibition of casein kinase 1 may also contribute to the antitumoral activity of (R)-roscovitine and (S)-CR8. This dual mechanism of action may be crucial in the use of these kinase inhibitors for the treatment of MYC-dependent cancers, in particular neuroblastoma where MYCN amplification is a strong predictor factor for high-risk disease.	[Delehouze, C.; Loaec, N.; Bruyere, C.; Oumata, N.; Meijer, L.] Ctr Perharidy, Hotel Rech, ManRos Therapeut, F-29680 Roscoff, France; [Godl, K.] Evotec Munchen GmbH, Martinsried, Germany; [Loaec, N.; Desban, N.; Meijer, L.] CNRS, Prot Phosphorylat & Human Dis Grp, Roscoff, Bretagne, France; [Galons, H.] Univ Paris 05, INSERM U648, Lab Chim Organ 2, Paris, France; [Roumeliotis, T. I.; Garbis, S. D.] Univ Southampton, Inst Life Sci, Ctr Prote & Metabol Res, Southampton, Hants, England; [Giannopoulou, E. G.] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY USA; [Grenet, J.; Twitchell, D.; Lahti, J.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; [Mouchet, N.; Galibert, M-D] Univ Rennes 1, CNRS, UMR 6290, Inst Genet & Dev Rennes Equipe Express Gen & Onco, Rennes, France	Evotec; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Southampton; Cornell University; St Jude Children's Research Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Meijer, L (corresponding author), Ctr Perharidy, Hotel Rech, ManRos Therapeut, F-29680 Roscoff, France.	herve.galons@univ-paris5.fr; S.D.Garbis@soton.ac.uk; meijer@manros-therapeutics.com	Garbis, Spiros D/L-3099-2013; MEIJER, Laurent/ABE-7465-2021; Giannopoulou, Evgenia/K-9576-2019; Mouchet, Nicolas/AAP-6126-2020	Garbis, Spiros D/0000-0002-1050-0805; Mouchet, Nicolas/0000-0002-2849-9953; , laurent/0000-0003-3511-4916	EEC (FP6 Life Sciences & Health PRO-KINASE Project); Canceropole Grand-Ouest; Association France-Alzheimer Finistere; Association pour la Recherche sur le Cancer [ARC-1092]; Ligue Nationale contre le Cancer (Comite Grand-Ouest); Polycystic Kidney Disease Foundation; Fondation Jerome Lejeune; Conseil Regional de Bretagne ('Fonds de Maturation'); Institut National contre le Cancer (INCa) GLIOMER program; CCCDK8 program; EEC (TEMPO Research Project); NATIONAL CANCER INSTITUTE [P30CA021765, R01CA067938] Funding Source: NIH RePORTER	EEC (FP6 Life Sciences & Health PRO-KINASE Project); Canceropole Grand-Ouest; Association France-Alzheimer Finistere; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale contre le Cancer (Comite Grand-Ouest); Polycystic Kidney Disease Foundation; Fondation Jerome Lejeune; Conseil Regional de Bretagne ('Fonds de Maturation')(Region Bretagne); Institut National contre le Cancer (INCa) GLIOMER program; CCCDK8 program; EEC (TEMPO Research Project); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This article is dedicated to the memory of Jill Lahti and Vincent Kidd. We are grateful to Jacint Boix and Jean Benard, for the neuroblastoma cell lines. This research was supported by grants from the EEC (FP6 Life Sciences & Health PRO-KINASE and TEMPO Research Projects), the 'Canceropole Grand-Ouest', the 'Association France-Alzheimer Finistere', the 'Association pour la Recherche sur le Cancer' (ARC-1092), the 'Ligue Nationale contre le Cancer (Comite Grand-Ouest)', the Polycystic Kidney Disease Foundation, the Fondation Jerome Lejeune, the 'Conseil Regional de Bretagne' ('Fonds de Maturation' 2009) and the 'Institut National contre le Cancer' (INCa) GLIOMER and CCCDK8 programs.	Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; Aldoss IT, 2009, EXPERT OPIN INV DRUG, V18, P1957, DOI 10.1517/13543780903418445; Azevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI DOI 10.1111/J.1432-1033.1997.0518A.X; Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baumli S, 2012, STRUCTURE, V20, P1788, DOI 10.1016/j.str.2012.08.011; Becker F, 2004, CHEM BIOL, V11, P211, DOI 10.1016/j.chembiol.2004.02.001; Behrend L, 2000, ONCOGENE, V19, P5303, DOI 10.1038/sj.onc.1203939; Benson C, 2007, BRIT J CANCER, V96, P29, DOI 10.1038/sj.bjc.6603509; Bettayeb K, 2008, ONCOGENE, V27, P5797, DOI 10.1038/onc.2008.191; Bettayeb K, 2008, MOL CANCER THER, V7, P2713, DOI 10.1158/1535-7163.MCT-08-0080; Bettayeb Karima, 2010, Genes Cancer, V1, P369, DOI 10.1177/1947601910369817; Blazek D, 2012, CELL CYCLE, V11, P1049, DOI 10.4161/cc.11.6.19678; Blazek D, 2011, GENE DEV, V25, P2158, DOI 10.1101/gad.16962311; Breuer D, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-94; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Cepeda D, 2013, EMBO MOL MED, V5, P1067, DOI 10.1002/emmm.201202341; Chen Y, 2013, SURGERY, V153, P4, DOI 10.1016/j.surg.2012.03.030; Cheng SWG, 2012, MOL CELL BIOL, V32, P4691, DOI 10.1128/MCB.06267-11; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cicenas J, 2011, J CANCER RES CLIN, V137, P1409, DOI 10.1007/s00432-011-1039-4; Cirillo D, 2011, CURR MED CHEM, V18, P2854, DOI 10.2174/092986711796150496; Conradt L, 2011, NEOPLASIA, V13, P1026, DOI 10.1593/neo.111016; Dai Q, 2012, J BIOL CHEM, V287, P25344, DOI 10.1074/jbc.M111.321760; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Debdab M, 2011, J MED CHEM, V54, P4172, DOI 10.1021/jm200274d; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Eglen R, 2011, PHARMACOL THERAPEUT, V130, P144, DOI 10.1016/j.pharmthera.2011.01.007; Eglen RM, 2009, ASSAY DRUG DEV TECHN, V7, P22, DOI 10.1089/adt.2008.164; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Faisal A, 2011, MOL CANCER THER, V10, P2115, DOI 10.1158/1535-7163.MCT-11-0333; Galons H, 2013, EXPERT OPIN THER PAT, V23, P945, DOI 10.1517/13543776.2013.789861; Garrofe-Ochoa X, 2011, APOPTOSIS, V16, P660, DOI 10.1007/s10495-011-0603-3; Goga A, 2007, NAT MED, V13, P820, DOI 10.1038/nm1606; Goldstein DM, 2008, NAT REV DRUG DISCOV, V7, P391, DOI 10.1038/nrd2541; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Grotzer MA, 2009, CURR CANCER DRUG TAR, V9, P176, DOI 10.2174/156800909787580962; Grunwald V, 2002, CANCER RES, V62, P6141; Gustafson WC, 2010, ONCOGENE, V29, P1249, DOI 10.1038/onc.2009.512; Horiuchi D, 2012, J EXP MED, V209, P679, DOI 10.1084/jem.20111512; Hsieh WS, 2009, CLIN CANCER RES, V15, P1435, DOI 10.1158/1078-0432.CCR-08-1748; Hui ABY, 2009, CLIN CANCER RES, V15, P3716, DOI 10.1158/1078-0432.CCR-08-2790; Hydbring P, 2010, P NATL ACAD SCI USA, V107, P58, DOI 10.1073/pnas.0900121106; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Jorda R, 2012, CURR PHARM DESIGN, V18, P2974, DOI 10.2174/138161212800672804; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Knockaert M, 2000, CHEM BIOL, V7, P411, DOI 10.1016/S1074-5521(00)00124-1; Knockaert M, 2002, TRENDS PHARMACOL SCI, V23, P417, DOI 10.1016/S0165-6147(02)02071-0; Knockaert M, 2002, J BIOL CHEM, V277, P25493, DOI 10.1074/jbc.M202651200; Kohoutek J, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-12; Krystof V, 2012, CURR PHARM DESIGN, V18, P2883, DOI 10.2174/138161212800672750; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; Lee JH, 2012, BIOCHIP J, V6, P362, DOI 10.1007/s13206-012-6408-9; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Malumbres M, 2008, TRENDS PHARMACOL SCI, V29, P16, DOI 10.1016/j.tips.2007.10.012; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Meijer L, 2003, ACCOUNTS CHEM RES, V36, P417, DOI 10.1021/ar0201198; Meijer L, 2006, MONOGRAPHS ENZYME IN, V2, P187; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Misra RN, 2004, J MED CHEM, V47, P1719, DOI 10.1021/jm0305568; Molenaar JJ, 2009, P NATL ACAD SCI USA, V106, P12968, DOI 10.1073/pnas.0901418106; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Oumata N, 2008, J MED CHEM, V51, P5229, DOI 10.1021/jm800109e; Oumata N, 2009, ORG PROCESS RES DEV, V13, P641, DOI 10.1021/op800284k; Parry D, 2010, MOL CANCER THER, V9, P2344, DOI 10.1158/1535-7163.MCT-10-0324; Petrelli A, 2008, CURR MED CHEM, V15, P422; Popowycz F, 2009, J MED CHEM, V52, P655, DOI 10.1021/jm801340z; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Schonerr C, 2012, ONCOGENE, V31, P5193, DOI 10.1038/onc.2012.12; Schulte JH, 2013, ONCOGENE, V32, P1059, DOI 10.1038/onc.2012.106; Sharma K, 2009, NAT METHODS, V6, P741, DOI [10.1038/NMETH.1373, 10.1038/nmeth.1373]; Sjostrom SK, 2005, DEV CELL, V9, P327, DOI 10.1016/j.devcel.2005.07.014; Squires MS, 2010, MOL CANCER THER, V9, P920, DOI 10.1158/1535-7163.MCT-09-1071; Tahtouh T, 2012, J MED CHEM, V55, P9312, DOI 10.1021/jm301034u; Tang L, 2005, J BIOL CHEM, V280, P31220, DOI 10.1074/jbc.M500805200; Tanramluk D, 2009, CHEM BIOL DRUG DES, V74, P16, DOI 10.1111/j.1747-0285.2009.00832.x; Toyoshima M, 2012, P NATL ACAD SCI USA, V109, P9545, DOI 10.1073/pnas.1121119109; Trova MP, 2009, BIOORG MED CHEM LETT, V19, P6613, DOI 10.1016/j.bmcl.2009.10.011; Trova MP, 2009, BIOORG MED CHEM LETT, V19, P6608, DOI 10.1016/j.bmcl.2009.10.025; Via MC, 2011, KINASE TARGETED THER, P124; Wang LM, 2010, MINI-REV MED CHEM, V10, P1058, DOI 10.2174/1389557511009011058; Wang XY, 2011, CANCER RES, V71, P925, DOI 10.1158/0008-5472.CAN-10-1032; Weinmann H, 2005, CHEMBIOCHEM, V6, P455, DOI 10.1002/cbic.200500034; Wesierska-Gadek J, 2011, EXPERT OPIN INV DRUG, V20, P1611, DOI 10.1517/13543784.2011.628985; Whittaker SR, 2007, CELL CYCLE, V6, P3114, DOI 10.4161/cc.6.24.5142; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010	92	50	52	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 11	2014	33	50					5675	5687		10.1038/onc.2013.513	http://dx.doi.org/10.1038/onc.2013.513			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AW2AB	24317512	Green Accepted			2022-12-25	WOS:000346089300003
J	Dang, TTT; Facchini, PJ				Dang, Thu-Thuy T.; Facchini, Peter J.			CYP82Y1 Is N-Methylcanadine 1-Hydroxylase, a Key Noscapine Biosynthetic Enzyme in Opium Poppy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biosynthesis; Cytochrome P-450; Enzyme Catalysis; Gene Silencing; Metabolism; Plant Biochemistry; Secondary Metabolism	COPTIS-JAPONICA CELLS; MOLECULAR-CLONING; PAPAVER-SOMNIFERUM; HETEROLOGOUS EXPRESSION; MORPHINE BIOSYNTHESIS; ALKALOID BIOSYNTHESIS; NEIGHBORING GENES; SYNTHASE; CYTOCHROME-P450; COEXPRESSION	Noscapine is a phthalideisoquinoline alkaloid investigated for its potent pharmacological properties. Although structurally elucidated more than a century ago, the biosynthesis of noscapine has not been established. Radiotracer studies have shown that noscapine is derived from the protoberberine alkaloid (S)-scoulerine and has been proposed to proceed through (S)-N-methylcanadine. However, pathway intermediates involved in the conversion of N-methylcanadine to noscapine have not been identified. We report the isolation and characterization of the cytochrome P-450 CYP82Y1, which catalyzes the 1-hydroxylation of N-methylcanadine to 1-hydroxy-N-methylcanadine. Comparison of transcript and metabolite profiles of eight opium poppy chemotypes revealed four cytochrome P-450s, three from the CYP82 and one from the CYP719 families, that were tightly correlated with noscapine accumulation. Recombinant CYP82Y1 was the only enzyme that accepted (R,S)-N-methylcanadine as a substrate with strict specificity and high affinity. As expected, CYP82Y1 was abundantly expressed in opium poppy stems where noscapine accumulation is highest among plant organs. Suppression of CYP82Y1 using virus-induced gene silencing caused a significant reduction in the levels of noscapine, narcotoline, and a putative downstream secoberbine intermediate and also resulted in increased accumulation of the upstream pathway intermediates scoulerine, tetrahydrocolum-bamine, canadine, and N-methylcanadine. The combined biochemical and physiological data support the 1-hydroxylation of (S)-N-methylcanadine catalyzed by CYP82Y1 as the first committed step in the formation of noscapine in opium poppy.	[Dang, Thu-Thuy T.; Facchini, Peter J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Facchini, PJ (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	pfacchin@ucalgary.ca	DANG, THU-THUY/ADM-4345-2022	DANG, THU-THUY/0000-0002-6459-3664	Genome Canada; Genome Alberta; Government of Alberta; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation Leaders Opportunity Fund; Alberta Innovates Technology Futures Graduate Scholarship; Eyes High International Doctoral Scholarship from the University of Calgary	Genome Canada(Genome Canada); Genome Alberta; Government of Alberta; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation); Alberta Innovates Technology Futures Graduate Scholarship; Eyes High International Doctoral Scholarship from the University of Calgary	This work was supported through funding from Genome Canada, Genome Alberta, the Government of Alberta, the Natural Sciences and Engineering Research Council of Canada, and the Canada Foundation for Innovation Leaders Opportunity Fund.; Recipient of an Alberta Innovates Technology Futures Graduate Scholarship and an Eyes High International Doctoral Scholarship from the University of Calgary.	Anderson T, 1862, J CHEM SOC, V15, P446, DOI [10.1039/JS8621500446, DOI 10.1039/JS8621500446]; Battersby A. R., 1975, J CHEM SOC PERK T, V1, P1162; Battersby A. R., 1968, J CHEM SOC C, V17, P2163; Beaudoin GAW, 2013, BIOCHEM BIOPH RES CO, V431, P597, DOI 10.1016/j.bbrc.2012.12.129; Binutu OA, 2000, PHARM BIOL, V38, P210, DOI 10.1076/1388-0209(200007)3831-SFT210; Chavez MLD, 2011, ARCH BIOCHEM BIOPHYS, V507, P186, DOI 10.1016/j.abb.2010.11.016; Chen X., 2014, PLANT J, DOI 10.1111/tpj.12379; Dang TTT, 2014, FEBS LETT, V588, P198, DOI 10.1016/j.febslet.2013.11.037; Dang TTT, 2012, PLANT PHYSIOL, V159, P618, DOI 10.1104/pp.112.194886; Desgagne-Penix I, 2012, PLANT MOL BIOL, V79, P295, DOI 10.1007/s11103-012-9913-2; Desgagne-Penix I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-252; Dinesh-Kumar SP, 2003, METH MOL B, V236, P287; Facchini Peter J., 2007, Phytochemistry Reviews, V6, P97, DOI 10.1007/s11101-006-9042-0; Gesell A, 2009, J BIOL CHEM, V284, P24432, DOI 10.1074/jbc.M109.033373; Hagel JM, 2013, PLANT CELL PHYSIOL, V54, P647, DOI 10.1093/pcp/pct020; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Hileman LC, 2005, PLANT J, V44, P334, DOI 10.1111/j.1365-313X.2005.02520.x; Ikezawa N, 2003, J BIOL CHEM, V278, P38557, DOI 10.1074/jbc.M302470200; Ikezawa N, 2008, J BIOL CHEM, V283, P8810, DOI 10.1074/jbc.M705082200; Ikezawa N, 2007, FEBS J, V274, P1019, DOI 10.1111/j.1742-4658.2007.05652.x; KLEINSCHMIDT G, 1959, Z NATURFORSCH PT B, V14, P52, DOI 10.1515/znb-1959-0113; KRAUS PFX, 1995, P NATL ACAD SCI USA, V92, P2071, DOI 10.1073/pnas.92.6.2071; Kruse T, 2008, CHEM BIOL, V15, P149, DOI 10.1016/j.chembiol.2008.01.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JK, 2009, J KOREAN SOC APPL BI, V52, P646, DOI 10.3839/jksabc.2009.108; Lee S, 2010, P NATL ACAD SCI USA, V107, P21205, DOI 10.1073/pnas.1009975107; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Michalak P, 2008, GENOMICS, V91, P243, DOI 10.1016/j.ygeno.2007.11.002; Nguyen DT, 2010, J BIOL CHEM, V285, P16588, DOI 10.1074/jbc.M110.111757; Pauli HH, 1998, PLANT J, V13, P793, DOI 10.1046/j.1365-313X.1998.00085.x; Le PM, 2013, ANAL BIOANAL CHEM, V405, P4487, DOI 10.1007/s00216-012-6539-9; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Ro DK, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-83; SARIYAR G, 1977, PHYTOCHEMISTRY, V16, P2009, DOI 10.1016/0031-9422(77)80115-5; SARIYAR G, 1986, PHYTOCHEMISTRY, V25, P2403, DOI 10.1016/S0031-9422(00)81705-7; Sariyar G, 2002, PURE APPL CHEM, V74, P557, DOI 10.1351/pac200274040557; Takemura T, 2013, PHYTOCHEMISTRY, V91, P100, DOI 10.1016/j.phytochem.2012.02.013; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; Winzer T, 2012, SCIENCE, V336, P1704, DOI 10.1126/science.1220757	39	31	38	4	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2013	2026		10.1074/jbc.M113.505099	http://dx.doi.org/10.1074/jbc.M113.505099			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24324259	Green Published, hybrid			2022-12-25	WOS:000331130200013
J	Carvalho, L				Carvalho, Luis			Bayesian Centroid Estimation for Motif Discovery	PLOS ONE			English	Article							BINDING SITES; DNA-BINDING; IDENTIFICATION; SEQUENCES; MODEL	Biological sequences may contain patterns that signal important biomolecular functions; a classical example is regulation of gene expression by transcription factors that bind to specific patterns in genomic promoter regions. In motif discovery we are given a set of sequences that share a common motif and aim to identify not only the motif composition, but also the binding sites in each sequence of the set. We propose a new centroid estimator that arises from a refined and meaningful loss function for binding site inference. We discuss the main advantages of centroid estimation for motif discovery, including computational convenience, and how its principled derivation offers further insights about the posterior distribution of binding site configurations. We also illustrate, using simulated and real datasets, that the centroid estimator can differ from the traditional maximum a posteriori or maximum likelihood estimators.	Boston Univ, Dept Math & Stat, Boston, MA 02215 USA	Boston University	Carvalho, L (corresponding author), Boston Univ, Dept Math & Stat, Boston, MA 02215 USA.	lecarval@math.bu.edu			National Science Foundation [DMS-1107067]; Direct For Mathematical & Physical Scien [1107067] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The author is supported by National Science Foundation grant DMS-1107067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY TL, 1995, MACH LEARN, V21, P51, DOI 10.1007/BF00993379; Barbieri MM, 2004, ANN STAT, V32, P870, DOI 10.1214/009053604000000238; Berger J. O., 2013, STAT DECISION THEORY; BESAG J, 1986, J R STAT SOC B, V48, P259; Carvalho LE, 2008, P NATL ACAD SCI USA, V105, P3209, DOI 10.1073/pnas.0712329105; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Ding Y, 2005, RNA, V11, P1157, DOI 10.1261/rna.2500605; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.2307/2333639; GuhaThakurta D, 2006, NUCLEIC ACIDS RES, V34, P3585, DOI 10.1093/nar/gkl372; Hu JJ, 2005, NUCLEIC ACIDS RES, V33, P4899, DOI 10.1093/nar/gki791; LAWRENCE CE, 1990, PROTEINS, V7, P41, DOI 10.1002/prot.340070105; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Liu J.S., 2008, MONTE CARLO STRATEGI, DOI [10.1007/978-0-387-76371-2, DOI 10.1007/978-0-387-76371-2]; Liu JS, 1995, J AM STAT ASSOC, V90, P1156, DOI 10.2307/2291508; Liu X, 2001, Pac Symp Biocomput, P127; Lones MA, 2005, P WORKSH GECCO; Lones MA, 2007, IEEE ACM T COMPUT BI, V4, P403, DOI 10.1109/TCBB.2007.1044; Lones MA, 2007, IEEE C EVOL COMPUTAT, P3894, DOI 10.1109/CEC.2007.4424978; MacIsaac KD, 2006, PLOS COMPUT BIOL, V2, P201, DOI 10.1371/journal.pcbi.0020036; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NEUWALD AF, 1995, PROTEIN SCI, V4, P1618, DOI 10.1002/pro.5560040820; Newberg LA, 2007, BIOINFORMATICS, V23, P1718, DOI 10.1093/bioinformatics/btm241; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Pevzner P A, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P269; Regnier M, 2004, DISCRETE MATH THEOR, V6, P191; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Sandve GK, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-11; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Thijs G, 2002, J COMPUT BIOL, V9, P447, DOI 10.1089/10665270252935566; Thompson WA, 2007, NUCLEIC ACIDS RES, V35, pW232, DOI 10.1093/nar/gkm265; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Webb-Robertson BJM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000077; Xing EP, 2004, P NATL ACAD SCI USA, V101, P10523, DOI 10.1073/pnas.0403564101	34	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e80511	10.1371/journal.pone.0080511	http://dx.doi.org/10.1371/journal.pone.0080511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324603	Green Submitted, gold, Green Published			2022-12-25	WOS:000328566700010
J	Li, R; Yu, J; Zhang, SZ; Bao, F; Wang, PY; Huang, X; Li, J				Li, Rui; Yu, Jing; Zhang, Shouzi; Bao, Feng; Wang, Pengyun; Huang, Xin; Li, Juan			Bayesian Network Analysis Reveals Alterations to Default Mode Network Connectivity in Individuals at Risk for Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; RESTING-STATE NETWORKS; FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; AUTOBIOGRAPHICAL MEMORY; COMPONENT ANALYSIS; CINGULATE CORTEX; MRI; DEMENTIA; VERSION	Alzheimer's disease (AD) is associated with abnormal functioning of the default mode network (DMN). Functional connectivity (FC) changes to the DMN have been found in patients with amnestic mild cognitive impairment (aMCI), which is the prodromal stage of AD. However, whether or not aMCI also alters the effective connectivity (EC) of the DMN remains unknown. We employed a combined group independent component analysis (ICA) and Bayesian network (BN) learning approach to resting-state functional MRI (fMRI) data from 17 aMCI patients and 17 controls, in order to establish the EC pattern of DMN, and to evaluate changes occurring in aMCI. BN analysis demonstrated heterogeneous regional convergence degree across DMN regions, which were organized into two closely interacting subsystems. Compared to controls, the aMCI group showed altered directed connectivity weights between DMN regions in the fronto-parietal, temporo-frontal, and temporo-parietal pathways. The aMCI group also exhibited altered regional convergence degree in the right inferior parietal lobule. Moreover, we found EC changes in DMN regions in aMCI were correlated with regional FC levels, and the connectivity metrics were associated with patients' cognitive performance. This study provides novel sights into our understanding of the functional architecture of the DMN and adds to a growing body of work demonstrating the importance of the DMN as a mechanism of aMCI.	[Li, Rui; Yu, Jing; Wang, Pengyun; Huang, Xin; Li, Juan] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Ctr Aging Psychol, Beijing 100101, Peoples R China; [Li, Rui; Wang, Pengyun; Huang, Xin; Li, Juan] Chinese Acad Sci, Inst Psychol, Magnet Resonance Imaging Res Ctr, Beijing 100101, Peoples R China; [Yu, Jing] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [Zhang, Shouzi] Beijing Geriatr Hosp, Beijing, Peoples R China; [Bao, Feng] Capital Med Univ, Beijing Anding Hosp, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS; Southwest University - China; Capital Medical University	Li, J (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Ctr Aging Psychol, Beijing 100101, Peoples R China.	lijuan@psych.ac.cn	Yu, Jing/AAN-1565-2020	li, rui/0000-0002-4101-5415	National Natural Science Foundation of China [31271108, 31200847, 30911120494, 31070916]; Knowledge Innovation Project of the Chinese Academy of Sciences [KSCX2-EW-J-8]; CAS/SAFEA International Partnership Program for Creative Research Team [Y2CX131003]; Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences [Y1CX251005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); CAS/SAFEA International Partnership Program for Creative Research Team(Chinese Academy of Sciences); Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (31271108, 31200847, 30911120494 and 31070916), the Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX2-EW-J-8), the CAS/SAFEA International Partnership Program for Creative Research Team (Y2CX131003), and Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences (Y1CX251005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 1987, HDB PHYSL 1, P483; Bai F, 2008, NEUROSCI LETT, V438, P111, DOI 10.1016/j.neulet.2008.04.021; Bai F, 2009, BRAIN RES, V1302, P167, DOI 10.1016/j.brainres.2009.09.028; Bai F, 2009, BIOL PSYCHIAT, V65, P951, DOI 10.1016/j.biopsych.2008.10.017; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; D'Argembeau A, 2012, CEREB CORTEX, V22, P659, DOI 10.1093/cercor/bhr144; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Di Paola M, 2007, J NEUROL, V254, P774, DOI 10.1007/s00415-006-0435-1; Filippi M, 2011, J ALZHEIMERS DIS, V24, P455, DOI 10.3233/JAD-2011-101854; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Friston KJ, 2002, PROG NEUROBIOL, V68, P113, DOI 10.1016/S0301-0082(02)00076-X; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Geiger D., 1994, Uncertainty in Artificial Intelligence. Proceedings of the Tenth Conference (1994), P235; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Grady CL, 2003, J NEUROSCI, V23, P986, DOI 10.1523/jneurosci.23-03-00986.2003; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Jiao Q, 2011, HUM BRAIN MAPP, V32, P154, DOI 10.1002/hbm.21065; Jin MW, 2012, MAGN RESON IMAGING, V30, P48, DOI 10.1016/j.mri.2011.07.007; Koch W, 2012, NEUROBIOL AGING, V33, P466, DOI 10.1016/j.neurobiolaging.2010.04.013; Li R, 2013, AM J NEURORADIOL, V34, P340, DOI 10.3174/ajnr.A3197; Li R, 2012, HUM BRAIN MAPP, V33, P1076, DOI 10.1002/hbm.21269; Li R, 2011, NEUROIMAGE, V56, P1035, DOI 10.1016/j.neuroimage.2011.03.010; Liao W, 2011, NEUROIMAGE, V54, P2683, DOI 10.1016/j.neuroimage.2010.11.007; Liu ZY, 2012, NMR BIOMED, V25, P1311, DOI 10.1002/nbm.2803; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; McIntosh A. R., 1994, Human Brain Mapping, V2, P2; Meulenbroek O, 2010, NEUROIMAGE, V53, P331, DOI 10.1016/j.neuroimage.2010.05.082; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Ojemann GA, 2009, CEREB CORTEX, V19, P197, DOI 10.1093/cercor/bhn071; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rajapakse JC, 2007, NEUROIMAGE, V37, P749, DOI 10.1016/j.neuroimage.2007.06.003; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Ruby P, 2009, NEUROBIOL AGING, V30, P1637, DOI 10.1016/j.neurobiolaging.2007.12.014; Schmidt M., 2007, AAAI, V2, P1278; Schroder J, 2001, BIOL PSYCHIAT, V49, P426, DOI 10.1016/S0006-3223(00)00983-5; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Schwindt GC, 2009, NEUROIMAGE, V45, P181, DOI 10.1016/j.neuroimage.2008.11.024; SHACHTER RD, 1989, MANAGE SCI, V35, P527, DOI 10.1287/mnsc.35.5.527; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Soldner J, 2012, NERVENARZT, V83, P878, DOI 10.1007/s00115-011-3326-3; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; St Jacques PL, 2011, J COGNITIVE NEUROSCI, V23, P1275, DOI 10.1162/jocn.2010.21518; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wang J, 2012, BIOL PSYCHIAT, DOI DOI 10.1016/J.BI0PSYCH.2012.1003.1026; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wenk GL, 2003, J CLIN PSYCHIAT, V64, P7; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Wu X, 2011, HUM BRAIN MAPP, V32, P1868, DOI 10.1002/hbm.21153; Yan CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023460; Yew B, 2013, J ALZHEIMERS DIS, V33, P473, DOI 10.3233/JAD-2012-120769; Yu J, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-156; Zamboni G, 2013, BIOL PSYCHIAT, V74, P375, DOI 10.1016/j.biopsych.2013.04.015; Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049; Zheng XB, 2006, NEUROIMAGE, V31, P1601, DOI 10.1016/j.neuroimage.2006.01.031; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	78	26	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82104	10.1371/journal.pone.0082104	http://dx.doi.org/10.1371/journal.pone.0082104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324753	Green Submitted, Green Published, gold			2022-12-25	WOS:000328566700060
J	Perron, H; Dougier-Reynaud, HL; Lomparski, C; Popa, I; Firouzi, R; Bertrand, JB; Marusic, S; Portoukalian, J; Jouvin-Marche, E; Villiers, CL; Touraine, JL; Marche, PN				Perron, Herve; Dougier-Reynaud, Hei-Lanne; Lomparski, Christina; Popa, Iuliana; Firouzi, Reza; Bertrand, Jean-Baptiste; Marusic, Suzana; Portoukalian, Jacques; Jouvin-Marche, Evelyne; Villiers, Christian L.; Touraine, Jean-Louis; Marche, Patrice N.			Human Endogenous Retrovirus Protein Activates Innate Immunity and Promotes Experimental Allergic Encephalomyelitis in Mice	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; ANIMAL-MODELS; ENVELOPE PROTEIN; EXPRESSION; AUTOIMMUNE; CELLS; BRAIN; DEMYELINATION	Multiple sclerosis (MS) is a complex multifactorial disease of the central nervous system (CNS) for which animal models have mainly addressed downstream immunopathology but not potential inducers of autoimmunity. In the absence of a pathogen known to cause neuroinflammation in MS, Mycobacterial lysate is commonly used in the form of complete Freund's adjuvant to induce autoimmunity to myelin proteins in Experimental Allergic Encephalomyelitis (EAE), an animal model for MS. The present study demonstrates that a protein from the human endogenous retrovirus HERV-W family (MSRV-Env) can be used instead of mycobacterial lysate to induce autoimmunity and EAE in mice injected with MOG, with typical anti-myelin response and CNS lesions normally seen in this model. MSRV-Env was shown to induce proinflammatory response in human macrophage cells through TLR4 activation pathway. The present results demonstrate a similar activation of murine dendritic cells and show the ability of MSRV-Env to trigger EAE in mice. In previous studies, MSRV-Env protein was reproducibly detected in MS brain lesions within microglia and perivascular macrophages. The present results are therefore likely to provide a model for MS, in which the upstream adjuvant triggering neuroinflammation is the one detected in MS active lesions. This model now allows pre-clinical studies with therapeutic agents targeting this endogenous retroviral protein in MS.	[Perron, Herve] Geneuro, Geneva, Switzerland; [Perron, Herve; Bertrand, Jean-Baptiste] Geneuro Innovat, Lyon, France; [Perron, Herve; Firouzi, Reza; Portoukalian, Jacques; Touraine, Jean-Louis] Univ Lyon 1, F-69365 Lyon, France; [Dougier-Reynaud, Hei-Lanne; Lomparski, Christina; Jouvin-Marche, Evelyne; Villiers, Christian L.] Univ Grenoble 1, Grenoble, France; [Dougier-Reynaud, Hei-Lanne; Lomparski, Christina; Jouvin-Marche, Evelyne; Villiers, Christian L.; Marche, Patrice N.] Univ Grenoble 1, Inst Albert Bonniot, UMR S823, Grenoble, France; [Dougier-Reynaud, Hei-Lanne] ImmunAlp, Gieres, France; [Popa, Iuliana] Univ Paris 11, CNRS, UMR 8612, Chatenay Malabry, France; [Marusic, Suzana] Hook Labs, Lawrence, MA USA; [Touraine, Jean-Louis] Hosp Civils Lyon, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; CHU Lyon	Perron, H (corresponding author), Geneuro, Geneva, Switzerland.	hp@geneuro.com	JOUVIN MARCHE, Evelyne/L-8648-2013; Reynaud, Hei-lanne/L-7893-2013; Perron, Herve/AAN-5887-2020; Marche, Patrice N/K-5060-2013; VILLIERS, Christian L/K-6228-2013	JOUVIN MARCHE, Evelyne/0000-0001-8616-138X; Marche, Patrice N/0000-0002-8930-9340; VILLIERS, Christian L/0000-0002-9667-4688; portoukalian, jacques/0000-0001-6584-3234; Perron, Herve/0000-0002-2551-7685; VILLIERS, Christian/0000-0002-6548-278X	INSERM; Fondation CERA-Lyon; AFM-ARSEP, France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation CERA-Lyon; AFM-ARSEP, France	This study was funded by institutional support from INSERM and by grants from Fondation CERA-Lyon and AFM-ARSEP, France. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Baker D, 2011, MULT SCLER J, V17, P647, DOI 10.1177/1352458511398885; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; Bowman CC, 2003, GLIA, V43, P281, DOI 10.1002/glia.10256; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Burzyn D, 2004, J VIROL, V78, P576, DOI 10.1128/JVI.78.2.576-584.2004; Cherifi S, 2013, J CLIN MICROBIOL, V51, P1541, DOI 10.1128/JCM.03378-12; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Costenbader KH, 2012, AUTOIMMUN REV, V11, P604, DOI 10.1016/j.autrev.2011.10.022; Curtin F, 2012, CLIN THER, V34, P2268, DOI 10.1016/j.clinthera.2012.11.006; D'Andrea MM, 2013, INT J MED MICROBIOL; Deng C, 2003, J IMMUNOL, V170, P2833, DOI 10.4049/jimmunol.170.6.2833; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Firouzi R, 2003, J NEUROVIROL, V9, P79, DOI 10.1080/13550280390173328; Garcia-Montojo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053623; Garson J, 2005, MULT SCLER J, V11, P249, DOI 10.1191/1352458505ms1160xx; Gerondakis S, 2007, IMMUNOL CELL BIOL, V85, P471, DOI 10.1038/sj.icb.7100097; Gold R, 2000, MOL MED TODAY, V6, P88, DOI 10.1016/S1357-4310(99)01639-1; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jaubert C, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130010; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kremer D, 2012, MULT SCLER J, V18, P142; Kremer D, 2013, ANN NEUROL, V74, P721, DOI 10.1002/ana.23970; Krupovic M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049044; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002; Mackay IR, 2010, J NEUROIMMUNOL, V223, P1, DOI 10.1016/j.jneuroim.2010.03.017; Marta M, 2009, AUTOIMMUN REV, V8, P506, DOI 10.1016/j.autrev.2009.01.006; Menard A, 1997, FEBS LETT, V413, P477, DOI 10.1016/S0014-5793(97)00889-2; Mirsattari SM, 2001, NEUROLOGY, V56, P317, DOI 10.1212/WNL.56.3.317; Ngono AE, 2012, CLIN IMMUNOL, V144, P117, DOI 10.1016/j.clim.2012.05.009; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Perron H, 1997, P NATL ACAD SCI USA, V94, P7583, DOI 10.1073/pnas.94.14.7583; Perron H, 2005, J NEUROVIROL, V11, P23, DOI 10.1080/13550280590901741; Perron H, 2001, VIROLOGY, V287, P321, DOI 10.1006/viro.2001.1045; Perron H, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.1; PERRON H, 1993, J GEN VIROL, V74, P65, DOI 10.1099/0022-1317-74-1-65; PERRON H, 1991, LANCET, V337, P862, DOI 10.1016/0140-6736(91)92579-Q; Perron H, 2012, MULTIPLE SCLEROSI S4, V18, P192; Perron H, 2012, MULT SCLER J, V18, P1721, DOI 10.1177/1352458512441381; Perron H, 2010, CLIN REV ALLERG IMMU, V39, P51, DOI 10.1007/s12016-009-8170-x; Rolland A, 2006, J IMMUNOL, V176, P7636, DOI 10.4049/jimmunol.176.12.7636; Romme Christensen J, 2012, MULT SCLER; Ruprecht K, 2006, J NEUROVIROL, V12, P65, DOI 10.1080/13550280600614973; Staykova MA, 2008, J NEUROPATH EXP NEUR, V67, P543, DOI 10.1097/NEN.0b013e31817713cc; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; WEKERLE H, 1994, ANN NEUROL, V36, pS47, DOI 10.1002/ana.410360714; Wexler AG, 2013, J NEUROIMMUNOL, V255, P60, DOI 10.1016/j.jneuroim.2012.11.004; Zawada M, 2003, POL J PHARMACOL, V55, P869	52	80	81	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e80128	10.1371/journal.pone.0080128	http://dx.doi.org/10.1371/journal.pone.0080128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324591	Green Published, gold, Green Submitted			2022-12-25	WOS:000328566700004
J	Cui, ZX; Li, XH; Liu, Y; Song, CW; Hui, M; Shi, GH; Luo, DL; Li, YD				Cui, Zhaoxia; Li, Xihong; Liu, Yuan; Song, Chengwen; Hui, Min; Shi, Guohui; Luo, Danli; Li, Yingdong			Transcriptome Profiling Analysis on Whole Bodies of Microbial Challenged Eriocheir sinensis Larvae for Immune Gene Identification and SNP Development	PLOS ONE			English	Article							CHINESE MITTEN CRAB; ANTILIPOPOLYSACCHARIDE FACTOR; EXPRESSION; GENERATION; DISCOVERY; CLONING; GENOME; HEPATOPANCREAS; ANNOTATION; INFECTION	To study crab immunogenetics of individuals, newly hatched Eriocheir sinensis larvae were stimulated with a mixture of three pathogen strains (Gram-positive bacteria Micrococcus luteus, Gram-negative bacteria Vibrio alginolyticus and fungi Pichia pastoris; 10(8) cfu center dot mL(-1)). A total of 44,767,566 Illumina clean reads corresponding to 4.52 Gb nucleotides were generated and assembled into 100,252 unigenes (average length: 1,042 bp; range: 201-19,357 bp). 17,097 (26.09%) of 65,535 non-redundant unigenes were annotated in NCBI non-redundant protein (Nr) database. Moreover, 23,188 (35.38%) unigenes were assigned to three Gene Ontology (GO) categories, 15,071 (23.00%) to twenty-six Clusters of orthologous Groups (COG) and 8,574 (13.08%) to six Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, respectively. Numerous genes were further identified to be associated with multiple immune pathways, including Toll, immune deficiency (IMD), janus kinase (JAK)-signal transducers and activators of transcription (STAT) and mitogen-activated protein kinase (MAPK) pathways. Some of them, such as tumor necrosis factor receptor associated factor 6 (TRAF6), fibroblast growth factor (FGF), protein-tyrosine phosphatase (PTP), JNK-interacting protein 1 (JIP1), were first identified in E. sinensis. TRAF6 was even first discovered in crabs. Additionally, 49,555 single nucleotide polymorphisms (SNPs) were developed from over 13,309 unigenes. This is the first transcriptome report of whole bodies of E. sinensis larvae after immune challenge. Data generated here not only provide detail information to identify novel genes in genome reference-free E. sinensis, but also facilitate our understanding on host immunity and defense mechanism of the crab at whole transcriptome level.	[Cui, Zhaoxia; Li, Xihong; Liu, Yuan; Song, Chengwen; Hui, Min; Shi, Guohui; Luo, Danli; Li, Yingdong] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Li, Xihong; Song, Chengwen; Shi, Guohui; Luo, Danli] Univ Chinese Acad Sci, Beijing, Peoples R China; [Cui, Zhaoxia] Chinese Acad Sci, Inst Oceanol, Natl & Local Joint Engn Lab Ecol Mariculture, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS	Cui, ZX (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	zhxcui@qdio.ac.cn		Li, Yingdong/0000-0002-9570-3715	Chinese National '863' Project [2012AA10A409]; National Natural Science Foundation of China [41276165]	Chinese National '863' Project(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Chinese National '863' Project (number 2012AA10A409) and the National Natural Science Foundation of China (41276165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Deak T, 2013, J BIOL, V8, P1001; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Gai YC, 2008, FISH SHELLFISH IMMUN, V24, P156, DOI 10.1016/j.fsi.2007.08.006; Gai YC, 2009, FISH SHELLFISH IMMUN, V27, P670, DOI 10.1016/j.fsi.2009.08.005; Gavery MR, 2012, COMP BIOCHEM PHYS D, V7, P94, DOI 10.1016/j.cbd.2011.12.003; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053915; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; Hsu JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040950; Jiang H, 2009, COMP BIOCHEM PHYS D, V4, P227, DOI 10.1016/j.cbd.2009.05.001; Jiang H, 2009, MAR BIOTECHNOL, V11, P317, DOI 10.1007/s10126-008-9146-1; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kurokawa S, 2013, MAR BIOTECHNOL, V15, P596, DOI 10.1007/s10126-013-9511-6; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047442; Li CH, 2008, DEV COMP IMMUNOL, V32, P784, DOI 10.1016/j.dci.2007.11.008; Li FH, 2009, DEV COMP IMMUNOL, V33, P1093, DOI 10.1016/j.dci.2009.06.001; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058627, 10.1371/journal.pone.0076131]; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068233; Liu CZ, 2012, CHIN J OCEANOL LIMN, V30, P713, DOI 10.1007/s00343-012-1252-2; Liu FS, 2012, MOL BIOL REP, V39, P1927, DOI 10.1007/s11033-011-0939-3; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Meng QG, 2011, AQUACULTURE, V320, P56, DOI 10.1016/j.aquaculture.2011.08.014; Montu M, 1996, HELGOLANDER MEERESUN, V50, P223, DOI 10.1007/BF02367153; Mu CK, 2011, FISH SHELLFISH IMMUN, V31, P142, DOI 10.1016/j.fsi.2011.04.013; Mu CK, 2009, FISH SHELLFISH IMMUN, V26, P821, DOI 10.1016/j.fsi.2008.10.006; Mu CK, 2009, FISH SHELLFISH IMMUN, V26, P716, DOI 10.1016/j.fsi.2009.02.024; Ou JT, 2012, FISH SHELLFISH IMMUN, V32, P345, DOI 10.1016/j.fsi.2011.11.027; Pascual L, 2012, INSECT BIOCHEM MOLEC, V42, P557, DOI 10.1016/j.ibmb.2012.04.003; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Qin CJ, 2010, DEV COMP IMMUNOL, V34, P14, DOI 10.1016/j.dci.2009.08.006; Robinson N, 2012, MAR BIOTECHNOL, V14, P620, DOI 10.1007/s10126-012-9433-8; Rudnick DA, 2003, BASIC APPL ECOL, V4, P249, DOI 10.1078/1439-1791-00152; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sui L, 2012, J FISH DIS, V35, P359, DOI 10.1111/j.1365-2761.2012.01351.x; Sun L, 2011, COMP BIOCHEM PHYS D, V6, P195, DOI 10.1016/j.cbd.2011.03.002; Sun XD, 2012, PLANT CELL REP, V31, P1823, DOI 10.1007/s00299-012-1295-z; Sze SH, 2012, INSECT MOL BIOL, V21, P205, DOI 10.1111/j.1365-2583.2011.01127.x; Vogel H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-308; Wang LL, 2011, AFR J BIOTECHNOL, V10, P17678, DOI 10.5897/AJB11.2017; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Wang PH, 2011, DEV COMP IMMUNOL, V35, P105, DOI 10.1016/j.dci.2010.08.013; Wang ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047954; Wei JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049567; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Yuan SC, 2009, J IMMUNOL, V183, P4560, DOI 10.4049/jimmunol.0901537; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhang W, 2011, GENET MOL BIOL, V34, P136, DOI 10.1590/S1415-47572010005000099; Zhang Y, 2010, DEV COMP IMMUNOL, V34, P945, DOI 10.1016/j.dci.2010.04.002; Zhang Y, 2012, PLANT CELL REP, V31, P1637, DOI 10.1007/s00299-012-1277-1; Zhao DX, 2009, AQUACULTURE, V287, P297, DOI 10.1016/j.aquaculture.2008.10.050; Zhen Yongyun, 1998, Qilu Yuye, V15, P31; Zheng LP, 2012, MOL BIOL REP, V39, P6035, DOI 10.1007/s11033-011-1417-7	58	24	26	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82156	10.1371/journal.pone.0082156	http://dx.doi.org/10.1371/journal.pone.0082156			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324760	Green Submitted, Green Published, gold			2022-12-25	WOS:000327949300135
J	Gui, T; Wang, YM; Zhang, LX; Wang, WJ; Zhu, H; Ding, WL				Gui, Ting; Wang, Yueming; Zhang, Lixing; Wang, Wenjing; Zhu, Hao; Ding, Wenlong			Kruppel-Like Factor 6 Rendered Rat Schwann Cell More Sensitive to Apoptosis via Upregulating FAS Expression	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; FAMILY-MEMBERS; CANCER CELLS; KLF6; GROWTH; PROMOTER; BCL-2; SP1	Kruppel-like factor 6 (KLF6) is a tumor suppressor gene and play a role in the regulation of cell proliferation and apoptosis. After the peripheral nerve injury (PNI), the microenvironment created by surrounding Schwann cells (SCs) is a critical determinant of its regenerative potential. In this study, we examined the effects of KLF6 on SCs responses during PNI. Both KLF6 mRNA and protein expression levels were upregulated in the injured sciatic nerve, and immunofluorescence results showed that many KLF6-positive cells simultaneously expressed the SC markers S-100 and p75NTR. The apoptosis inducers TNF alpha and cisplatin upregulated KLF6 expression in primary cultured SCs and the SC line RSC96. Although KLF6 overexpression exacerbated cisplatin-and TNF alpha-induced apoptosis, expression levels of the apoptosis regulators Bcl2 and Bax were not significantly affected in either KLF6-overexpressing or KLF6-depleted RSC96 cells. Realtime PCR arrays and qRT-PCR demonstrated that KLF6 overexpression upregulated four pro-apoptotic genes, FAS, TNF, TNFSF12, and PYCARD, and inhibited expression of the anti-apoptotic IL10 gene expression. Further analysis revealed that FAS protein expression was positively correlated with KLF6 expression in SCs. These data suggest that KLF6 upregulation may render SCs more vulnerable to apoptosis after injury via upregulating FAS expression.	[Gui, Ting; Wang, Yueming; Wang, Wenjing; Zhu, Hao; Ding, Wenlong] Shanghai Jiao Tong Univ, Sch Med, Dept Anat, Shanghai 200030, Peoples R China; [Zhang, Lixing] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Ding, WL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Anat, Shanghai 200030, Peoples R China.	dingwL500@sina.com.cn			national natural science foundation of china [81271380]; Shanghai Science and technology foundation of China [1052nm04200]; Shanghai science and technology committee [09410706200]	national natural science foundation of china(National Natural Science Foundation of China (NSFC)); Shanghai Science and technology foundation of China; Shanghai science and technology committee(Shanghai Science & Technology Committee)	This study was supported by the national natural science foundation of china, project number: 81271380; Shanghai Science and technology foundation of China, project number: 1052nm04200; The international cooperation projects of Shanghai science and technology committee, project number: 09410706200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas O, 2006, NEUROSCIENTIST, V12, P305, DOI 10.1177/1073858405285208; Andreoli V, 2010, IUBMB LIFE, V62, P896, DOI 10.1002/iub.396; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Banck MS, 2006, FEBS LETT, V580, P6981, DOI 10.1016/j.febslet.2006.10.077; Bharhani MS, 2006, AM J PHYSIOL-GASTR L, V291, pG820, DOI 10.1152/ajpgi.00438.2005; Botella LM, 2002, BLOOD, V100, P4001, DOI 10.1182/blood.V100.12.4001; Chang HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053444; Chen Zhe, 2004, Chin J Traumatol, V7, P220; D'Astolfo DS, 2008, CELL DEATH DIFFER, V15, P613, DOI 10.1038/sj.cdd.4402299; Ghiassi-Nejad Z, 2013, HEPATOLOGY, V57, P786, DOI 10.1002/hep.26056; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748; Hall S, 2001, J HAND SURG-BRIT EUR, V26, P129, DOI 10.1054/jhsb.2000.0497; Huang XW, 2008, J BIOL CHEM, V283, P29795, DOI 10.1074/jbc.M802515200; Ito G, 2004, CANCER RES, V64, P3838, DOI 10.1158/0008-5472.CAN-04-0185; Jeong KH, 2009, NEUROSCI LETT, V453, P16, DOI 10.1016/j.neulet.2009.02.002; Jonsson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056484; Kim Y, 1998, J BIOL CHEM, V273, P33750, DOI 10.1074/jbc.273.50.33750; Lavdas AA, 2008, CURR MED CHEM, V15, P151; Lei L, 2005, GENE DEV, V19, P1354, DOI 10.1101/gad.1227705; Martini R, 2001, MUSCLE NERVE, V24, P456, DOI 10.1002/mus.1027; Mimouni-Rongy M, 2011, J NEUROIMMUNOL, V230, P17, DOI 10.1016/j.jneuroim.2010.08.010; Moore DL, 2011, DEV NEUROBIOL, V71, P1186, DOI 10.1002/dneu.20934; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Perucho J, 2010, EXP NEUROL, V221, P54, DOI 10.1016/j.expneurol.2009.09.029; Ratziu V, 1998, P NATL ACAD SCI USA, V95, P9500, DOI 10.1073/pnas.95.16.9500; Reichardt HM, 2012, CURR PHARM DESIGN, V18, P4453; Salma J, 2012, J NEUROSCI, V32, P2790, DOI 10.1523/JNEUROSCI.3609-11.2012; Siraj AK, 2011, J CLIN ENDOCR METAB, V96, pE215, DOI 10.1210/jc.2010-0790; Veldmam MB, 2010, MOL CELL NEUROSCI, V43, P370, DOI 10.1016/j.mcn.2010.01.004; Veldman MB, 2007, DEV BIOL, V312, P596, DOI 10.1016/j.ydbio.2007.09.019; Wagner R, 1996, NEUROSCIENCE, V73, P625, DOI 10.1016/0306-4522(96)00127-3; Wang WJ, 2009, J NEUROTRAUM, V26, P641, DOI 10.1089/neu.2008.0758; Warke VG, 2003, J BIOL CHEM, V278, P14812, DOI 10.1074/jbc.M300787200; Wohlleben G, 2000, GLIA, V30, P373, DOI 10.1002/(SICI)1098-1136(200006)30:4<373::AID-GLIA60>3.3.CO;2-R; Yanagi M, 2008, SCHIZOPHR RES, V100, P291, DOI 10.1016/j.schres.2007.11.042; Yuan Q, 2012, MOL CELL BIOCHEM, V365, P149, DOI 10.1007/s11010-012-1254-6; Zhu H, 2010, ANAT REC, V293, P865, DOI 10.1002/ar.21105; Zhu JW, 2013, TUMOR BIOL, V34, P1097, DOI 10.1007/s13277-013-0651-0	42	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82449	10.1371/journal.pone.0082449	http://dx.doi.org/10.1371/journal.pone.0082449			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324791	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300149
J	Haastert, B; Mellanby, RJ; Anderton, SM; O'Connor, RA				Haastert, Bettina; Mellanby, Richard J.; Anderton, Stephen M.; O'Connor, Richard A.			T Cells at the Site of Autoimmune Inflammation Show Increased Potential for Trogocytosis	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; MEMBRANE-COMPONENTS; EFFECTOR FUNCTION; IMMUNE-RESPONSES; FLOW-CYTOMETRY; IN-VIVO; B-CELL; CNS; SUPPRESSION; DISEASE	CD4+ T cells acquire membrane fragments from antigen-presenting-cells via a process termed trogocytosis. Identifying which CD4+ T cells undergo trogocytosis in co-culture with Ag-loaded APC can enrich for antigen-reactive T cells without knowledge of their fine specificity or cytokine-production profiles. We sought to assess the suitability of this method to identify disease relevant effector and regulatory T cells during autoimmune inflammation. Trogocytosis efficiently identified MBP-reactive T cells in vitro and ex-vivo following immunization. However, Foxp3+ regulatory T cells constitutively displayed a higher rate of trogocytosis than their Foxp3-counterparts which limits the potential of trogocytosis to identify antigen-reactive Treg cells. During inflammation a locally elevated rate of trogocytosis (seen in both effector and regulatory T cells isolated from the inflamed CNS) precludes the use of trogocytosis as a measure of antigenic reactivity among cells taken from inflammatory sites. Our results indicate trogocytosis detection can enrich for Ag-reactive conventional T cells in the periphery but is limited in its ability to identify Ag-reactive Treg or T effector cells at sites of inflammation. Increased trogocytosis potential at inflammatory sites also draws into the question the biological significance of this phenomenon during inflammation, in Treg mediated suppression and for the maintenance of tolerance in health and disease.	[Haastert, Bettina; Mellanby, Richard J.; Anderton, Stephen M.; O'Connor, Richard A.] Univ Edinburgh, MRC, Ctr Inflammat Res, Queens Med Res Inst, Edinburgh, Midlothian, Scotland	University of Edinburgh	O'Connor, RA (corresponding author), Univ Edinburgh, MRC, Ctr Inflammat Res, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.	roconnor@ed.ac.uk		Mellanby, Richard John/0000-0002-3467-7007; O'Connor, Richard/0000-0001-7100-0233	Wellcome Trust [087833]; MRC [G0801924]; Medical Research Council [G0801924, G0901697] Funding Source: researchfish; MRC [G0901697] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Wellcome Trust Grant No. 087833 http://www.wellcome.ac.uk/index.htm MRC Grant number G0801924 [http://www.mrc.ac.uk/index.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KA, 2011, J CELL MOL MED, V15, P1458, DOI 10.1111/j.1582-4934.2010.01008.x; Bahbouhi B, 2010, BRAIN, V133, P1622, DOI 10.1093/brain/awq074; Bahcheli D, 2011, AUTOIMMUNITY, V44, P607, DOI 10.3109/08916934.2011.571730; Beadling C, 2006, NAT MED, V12, P1208, DOI 10.1038/nm1413; Chirkova TV, 2011, CLIN VACCINE IMMUNOL, V18, P1710, DOI 10.1128/CVI.05116-11; Daubeuf S, 2006, NAT PROTOC, V1, P2536, DOI 10.1038/nprot.2006.400; Eisenberg G, 2013, J IMMUNOL, V190, P5856, DOI 10.4049/jimmunol.1202879; FAIRCHILD PJ, 1993, INT IMMUNOL, V5, P1151, DOI 10.1093/intimm/5.9.1151; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Hudrisier D, 2007, J IMMUNOL, V178, P3637, DOI 10.4049/jimmunol.178.6.3637; Huter EN, 2008, J IMMUNOL, V181, P8209, DOI 10.4049/jimmunol.181.12.8209; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Korn T, 2007, J NEUROIMMUNOL, V191, P51, DOI 10.1016/j.jneuroim.2007.09.009; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; LeMaoult J, 2007, BLOOD, V109, P2040, DOI 10.1182/blood-2006-05-024547; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; Masteller EL, 2005, J IMMUNOL, V175, P3053, DOI 10.4049/jimmunol.175.5.3053; McGeachy MJ, 2005, CYTOKINE, V32, P81, DOI 10.1016/j.cyto.2005.07.012; O'Connor RA, 2008, J NEUROIMMUNOL, V193, P1, DOI 10.1016/j.jneuroim.2007.11.016; O'Connor RA, 2007, J IMMUNOL, V179, P958, DOI 10.4049/jimmunol.179.2.958; O'Connor RA, 2010, J IMMUNOL, V185, P7235, DOI 10.4049/jimmunol.1001551; Poupot M, 2005, J IMMUNOL, V174, P1717, DOI 10.4049/jimmunol.174.3.1717; Puaux AL, 2006, EUR J IMMUNOL, V36, P779, DOI 10.1002/eji.200535407; Stephens GL, 2007, J IMMUNOL, V178, P6901, DOI 10.4049/jimmunol.178.11.6901; Stephens LA, 2009, EUR J IMMUNOL, V39, P1108, DOI 10.1002/eji.200839073; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Waschbisch A, 2009, J NEUROIMMUNOL, V209, P131, DOI 10.1016/j.jneuroim.2009.02.005; Wohlfert EA, 2007, TRENDS IMMUNOL, V28, P154, DOI 10.1016/j.it.2007.02.003; Zhou G, 2011, J IMMUNOL, V186, P2148, DOI 10.4049/jimmunol.1002917	30	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81404	10.1371/journal.pone.0081404	http://dx.doi.org/10.1371/journal.pone.0081404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324692	Green Submitted, Green Published, gold			2022-12-25	WOS:000327949300092
J	Matsushita, M; Kitoh, H; Ohkawara, B; Mishima, K; Kaneko, H; Ito, M; Masuda, A; Ishiguro, N; Ohno, K				Matsushita, Masaki; Kitoh, Hiroshi; Ohkawara, Bisei; Mishima, Kenichi; Kaneko, Hiroshi; Ito, Mikako; Masuda, Akio; Ishiguro, Naoki; Ohno, Kinji			Meclozine Facilitates Proliferation and Differentiation of Chondrocytes by Attenuating Abnormally Activated FGFR3 Signaling in Achondroplasia	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; NATRIURETIC PEPTIDE; FACTOR RECEPTOR-3; THANATOPHORIC DYSPLASIA; CONSTITUTIVE ACTIVATION; MOUSE MODEL; CELL-LINE; MUTATIONS; PHENOTYPE; DWARFISM	Achondroplasia (ACH) is one of the most common skeletal dysplasias with short stature caused by gain-of-function mutations in FGFR3 encoding the fibroblast growth factor receptor 3. We used the drug repositioning strategy to identify an FDA-approved drug that suppresses abnormally activated FGFR3 signaling in ACH. We found that meclozine, an antihistamine drug that has long been used for motion sickness, facilitates chondrocyte proliferation and mitigates loss of extracellular matrix in FGF2-treated rat chondrosarcoma (RCS) cells. Meclozine also ameliorated abnormally suppressed proliferation of human chondrosarcoma (HCS-2/8) cells that were infected with lentivirus expressing constitutively active mutants of FGFR3-K650E causing thanatophoric dysplasia, FGFR3-K650M causing SADDAN, and FGFR3-G380R causing ACH. Similarly, meclozine alleviated abnormally suppressed differentiation of ATDC5 chondrogenic cells expressing FGFR3-K650E and G380R in micromass culture. We also confirmed that meclozine alleviates FGF2-mediated longitudinal growth inhibition of embryonic tibia in bone explant culture. Interestingly, meclozine enhanced growth of embryonic tibia in explant culture even in the absence of FGF2 treatment. Analyses of intracellular FGFR3 signaling disclosed that meclozine downregulates phosphorylation of ERK but not of MEK in FGF2-treated RCS cells. Similarly, meclozine enhanced proliferation of RCS cells expressing constitutively active mutants of MEK and RAF but not of ERK, which suggests that meclozine downregulates the FGFR3 signaling by possibly attenuating ERK phosphorylation. We used the C-natriuretic peptide (CNP) as a potent inhibitor of the FGFR3 signaling throughout our experiments, and found that meclozine was as efficient as CNP in attenuating the abnormal FGFR3 signaling. We propose that meclozine is a potential therapeutic agent for treating ACH and other FGFR3-related skeletal dysplasias.	[Matsushita, Masaki; Ohkawara, Bisei; Mishima, Kenichi; Kaneko, Hiroshi; Ito, Mikako; Masuda, Akio; Ohno, Kinji] Nagoya Univ, Div Neurogenet, Ctr Neurol Dis & Canc, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Matsushita, Masaki; Kitoh, Hiroshi; Mishima, Kenichi; Kaneko, Hiroshi; Ishiguro, Naoki] Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Ohno, K (corresponding author), Nagoya Univ, Div Neurogenet, Ctr Neurol Dis & Canc, Grad Sch Med, Nagoya, Aichi 4648601, Japan.	ohnok@med.nagoya-u.ac.jp	Ishiguro, Naoki/I-1563-2012; Ohno, Kinji/H-4020-2012; Ito, Mikako/I-1941-2012; Matsushita, Masaki/M-4940-2014; Kitoh, Hiroshi/AAC-2093-2021; Masuda, Akio/H-6323-2012; Ohno, Kinji/ABD-5787-2020; KITOH, Hiroshi/I-7256-2014	Ohno, Kinji/0000-0002-1529-2750; Ohno, Kinji/0000-0002-1529-2750; Ohkawara, Bisei/0000-0002-1987-458X	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; Grants-in-Aid for Scientific Research [23710253] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the Ministry of Health, Labor, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2002, NATURE, V417, P109, DOI 10.1038/417109a; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Bartels CF, 2004, AM J HUM GENET, V75, P27, DOI 10.1086/422013; Beever JE, 2006, ANIM GENET, V37, P66, DOI 10.1111/j.1365-2052.2005.01398.x; Bian Y, 2009, HUM MOL GENET, V18, P1229, DOI 10.1093/hmg/ddp023; Chusho H, 2001, P NATL ACAD SCI USA, V98, P4016, DOI 10.1073/pnas.071389098; Dailey L, 2003, J CELL BIOL, V161, P1053, DOI 10.1083/jcb.200302075; De Bari C, 2001, ARTHRITIS RHEUM, V44, P85, DOI 10.1002/1529-0131(200101)44:1<85::AID-ANR12>3.0.CO;2-6; Emrick MA, 2001, J BIOL CHEM, V276, P46469, DOI 10.1074/jbc.M107708200; Gohil VM, 2011, HUM MOL GENET, V20, P294, DOI 10.1093/hmg/ddq464; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Heemskerk Jill, 2002, Trends in Neurosciences, V25, P494, DOI 10.1016/S0166-2236(02)02236-1; Hoogendam J, 2006, ENDOCRINOLOGY, V147, P3141, DOI 10.1210/en.2006-0075; HORTON WA, 1992, AM J MED GENET, V42, P667, DOI 10.1002/ajmg.1320420508; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; Jin M, 2012, HUM MOL GENET, V21, P5443, DOI 10.1093/hmg/dds390; Jonquoy A, 2012, HUM MOL GENET, V21, P841, DOI 10.1093/hmg/ddr514; Krejci P, 2005, J CELL SCI, V118, P5089, DOI 10.1242/jcs.02618; Krejci P, 2004, EXP CELL RES, V297, P152, DOI 10.1016/j.yexcr.2004.03.011; Krejci P, 2007, J BIOL CHEM, V282, P2929, DOI 10.1074/jbc.M606144200; Krejci P, 2010, J BIOL CHEM, V285, P20644, DOI 10.1074/jbc.M109.083626; Lorget F, 2012, AM J HUM GENET, V91, P1108, DOI 10.1016/j.ajhg.2012.10.014; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; PRINOS P, 1995, HUM MOL GENET, V4, P2097, DOI 10.1093/hmg/4.11.2097; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; TAKIGAWA M, 1989, CANCER RES, V49, P3996; Tavormina PL, 1999, AM J HUM GENET, V64, P722, DOI 10.1086/302275; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; Toydemir RM, 2006, AM J HUM GENET, V79, P935, DOI 10.1086/508433; Waller DK, 2008, AM J MED GENET A, V146A, P2385, DOI 10.1002/ajmg.a.32485; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; Yasoda A, 2009, ENDOCRINOLOGY, V150, P3138, DOI 10.1210/en.2008-1676	33	35	36	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81569	10.1371/journal.pone.0081569	http://dx.doi.org/10.1371/journal.pone.0081569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324705	Green Submitted, gold, Green Published			2022-12-25	WOS:000327949300096
J	Pietrement, C; Gorisse, L; Jaisson, S; Gillery, P				Pietrement, Christine; Gorisse, Laetitia; Jaisson, Stephane; Gillery, Philippe			Chronic Increase of Urea Leads to Carbamylated Proteins Accumulation in Tissues in a Mouse Model of CKD	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; LOW-DENSITY-LIPOPROTEIN; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; DIALYSIS PATIENTS; GENERAL-POPULATION; RISK-FACTORS; MYELOPEROXIDASE; ATHEROSCLEROSIS; COLLAGEN	Carbamylation is a general process involved in protein molecular ageing due to the nonenzymatic binding of isocyanic acid, mainly generated by urea dissociation, to free amino groups. In vitro experiments and clinical studies have suggested the potential involvement of carbamylated proteins (CPs) in chronic kidney disease (CKD) complications like atherosclerosis, but their metabolic fate in vivo is still unknown. To address this issue, we evaluated protein carbamylation in the plasma and tissues of control and 75% nephrectomised C57BL/6J mice by LC-MS/MS assay of homocitrulline, the major carbamylation-derived product (CDP). A basal level of carbamylation was evidenced under all conditions, showing that carbamylation is a physiological process of protein modification in vivo. CP plasma concentrations increased in nephrectomized vs. control mice over the 20 weeks of the experiment (e. g. 335 +/- 43 vs. 167 +/- 19 mu mol homocitrulline/mol lysine (p<0.001) 20 weeks after nephrectomy). Simultaneously, CP content increased roughly by two-fold in all tissues throughout the experiment. The progressive accumulation of CPs was specifically noted in long-lived extracellular matrix proteins, especially collagen (e. g. 1264 +/- 123 vs. 726 +/- 99 mu mol homocitrulline/mol lysine (p<0.01) in the skin of nephrectomized vs. control mice after 20 weeks of evolution). These results show that chronic increase of urea, as seen in CKD, increases the carbamylation rate of plasma and tissue proteins. These results may be considered in the perspective of the deleterious effects of CPs demonstrated in vitro and of the correlation evidenced recently between plasma CPs and cardiovascular risk or mortality in CKD patients.	[Pietrement, Christine] Univ Hosp Reims, Dept Pediat, Nephrol Unit, Reims, France; [Jaisson, Stephane; Gillery, Philippe] Univ Hosp Reims, Lab Pediat Biol & Res, Reims, France; [Pietrement, Christine; Gorisse, Laetitia; Jaisson, Stephane; Gillery, Philippe] Fac Med, FRE CNRS URCA 3481, Lab Biochem & Mol Biol, Reims, France	CHU de Reims; Universite de Reims Champagne-Ardenne; CHU de Reims; Universite de Reims Champagne-Ardenne; Centre National de la Recherche Scientifique (CNRS); Universite de Reims Champagne-Ardenne	Pietrement, C (corresponding author), Univ Hosp Reims, Dept Pediat, Nephrol Unit, Reims, France.	cpietrement@chu-reims.fr			Committee of American Memorial Hospital (Reims, France and Boston, MA, USA); University of Reims Champagne-Ardenne (URCA, France); Conseil Regional de Champagne-Ardenne (France); Centre National de la Recherche Scientifique (CNRS, France)	Committee of American Memorial Hospital (Reims, France and Boston, MA, USA); University of Reims Champagne-Ardenne (URCA, France); Conseil Regional de Champagne-Ardenne (France)(Region Grand-Est); Centre National de la Recherche Scientifique (CNRS, France)(Centre National de la Recherche Scientifique (CNRS))	Funded by Committee of American Memorial Hospital (Reims, France and Boston, MA, USA); University of Reims Champagne-Ardenne (URCA, France); Conseil Regional de Champagne-Ardenne (France); and Centre National de la Recherche Scientifique (CNRS, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolov EO, 2010, J AM SOC NEPHROL, V21, P1852, DOI 10.1681/ASN.2010040365; Baynes JW, 2000, FREE RADICAL BIO MED, V28, P1708, DOI 10.1016/S0891-5849(00)00228-8; Berg AH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005218; Collins AJ, 2003, AM J MED SCI, V325, P163, DOI 10.1097/00000441-200304000-00002; Drueke TB, 2010, NAT REV NEPHROL, V6, P723, DOI 10.1038/nrneph.2010.143; El-Gamal D, 2012, ANTIOXID REDOX SIGN, V16, P129, DOI 10.1089/ars.2011.4090; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Foley RN, 1998, J NEPHROL, V11, P239; Francis AA, 2011, EXP CLIN CARDIOL, V16, P77; Garnotel R, 2004, FEBS LETT, V563, P13, DOI 10.1016/S0014-5793(04)00233-9; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gross ML, 2011, AM J PHYSIOL-RENAL, V301, pF476, DOI 10.1152/ajprenal.00342.2010; Hazen SL, 2004, ARTERIOSCL THROM VAS, V24, P1143, DOI 10.1161/01.ATV.0000135267.82813.52; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Holzer M, 2011, ANTIOXID REDOX SIGN, V14, P2337, DOI 10.1089/ars.2010.3640; HORKKO S, 1994, KIDNEY INT, V45, P561, DOI 10.1038/ki.1994.73; Jaisson S, 2006, CHEM BIOL, V13, P149, DOI 10.1016/j.chembiol.2005.11.005; Jaisson S, 2007, MATRIX BIOL, V26, P190, DOI 10.1016/j.matbio.2006.10.008; Jaisson S, 2012, ANAL BIOANAL CHEM, V402, P1635, DOI 10.1007/s00216-011-5619-6; Jaisson S, 2011, CLIN CHEM, V57, P1499, DOI 10.1373/clinchem.2011.163188; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Koeth RA, 2013, J AM SOC NEPHROL, V24, P853, DOI 10.1681/ASN.2012030254; Kraus LM, 2001, KIDNEY INT, V59, pS102, DOI 10.1046/j.1523-1755.2001.59780102.x; Kraus LM, 2001, SWISS MED WKLY, V131, P139; KRAUS LM, 1994, J LAB CLIN MED, V123, P882; Lippi G, 2013, CLIN CHEM LAB MED, V51, P5, DOI 10.1515/cclm-2012-0449; Liu YM, 2004, JAMA-J AM MED ASSOC, V291, P451, DOI 10.1001/jama.291.4.451; Longenecker JC, 2002, J AM SOC NEPHROL, V13, P1918, DOI 10.1097/01.ASN.0000019641.41496.1E; Maizel J, 2009, CIRCULATION, V119, P306, DOI 10.1161/CIRCULATIONAHA.108.797407; Mun KC, 2000, BLOOD PURIFICAT, V18, P13, DOI 10.1159/000014403; Ok E, 2005, KIDNEY INT, V68, P173, DOI 10.1111/j.1523-1755.2005.00391.x; Parfrey PS, 1999, J AM SOC NEPHROL, V10, P1606; Priyadarshi A, 2006, SEMIN DIALYSIS, V19, P273, DOI 10.1111/j.1525-139X.2006.00172.x; Pugh-Clarke K, 2010, J RENAL CARE, V36, P191, DOI 10.1111/j.1755-6686.2010.00203.x; QUINN RP, 1973, J GERONTOL, V28, P257, DOI 10.1093/geronj/28.3.257; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Roberts JM, 2011, P NATL ACAD SCI USA, V108, P8966, DOI 10.1073/pnas.1103352108; ROXBOROUGH HE, 1995, MED HYPOTHESES, V45, P125, DOI 10.1016/0306-9877(95)90059-4; Rudolph TK, 2012, EUR HEART J, V33, P1625, DOI 10.1093/eurheartj/ehr193; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Sell DR, 1996, P NATL ACAD SCI USA, V93, P485, DOI 10.1073/pnas.93.1.485; Shaykh M, 1999, J LAB CLIN MED, V133, P302, DOI 10.1016/S0022-2143(99)90086-0; Siew ED, 2010, SEMIN DIALYSIS, V23, P378, DOI 10.1111/j.1525-139X.2010.00763.x; Sirpal S, 2009, CLIN SCI, V116, P681, DOI 10.1042/CS20080322; Sugiyama S, 2004, ARTERIOSCL THROM VAS, V24, P1309, DOI 10.1161/01.ATV.0000131784.50633.4f; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; Tang WHW, 2013, J CARD FAIL, V19, P219, DOI 10.1016/j.cardfail.2013.02.001; Vita JA, 2004, CIRCULATION, V110, P1134, DOI 10.1161/01.CIR.0000140262.20831.8F; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Witko-Sarsat V, 1999, NEPHROL DIAL TRANSPL, V14, P76, DOI 10.1093/ndt/14.suppl_1.76; Wynckel A, 2000, NEPHROL DIAL TRANSPL, V15, P1183, DOI 10.1093/ndt/15.8.1183	51	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82506	10.1371/journal.pone.0082506	http://dx.doi.org/10.1371/journal.pone.0082506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324801	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300157
J	Yu, J; Fu, XJ; Chang, MT; Zhang, LC; Chen, ZQ; Zhang, LY				Yu, Jian; Fu, XiaoJuan; Chang, MingTao; Zhang, LiangChao; Chen, ZhiQiang; Zhang, LianYang			The Effects of Intra-Abdominal Hypertension on the Secretory Function of Canine Adrenal Glands	PLOS ONE			English	Article							ABDOMINAL COMPARTMENT SYNDROME; PRESSURE; PNEUMOPERITONEUM; DEFINITIONS	Intra-abdominal hypertension (IAH) can damage multiple organ systems, but the explicit impact on the adrenal gland is unclear. To evaluate the effects of intra-abdominal pressure (IAP) on the secretory function of the adrenal glands, we established canine models of IAH. By comparing morphology; hemodynamics; plasma cortisol, aldosterone, epinephrine, and norepinephrine concentrations; and the expression of IL-1, IL-6, and TNF-alpha in adrenal gland tissue from these dogs, we found that hemodynamic instability occurred after IAH and that IAH increased the plasma cortisol, aldosterone, epinephrine, and norepinephrine concentrations. Higher IAPs resulted in more significant changes, and the above indicators gradually returned to normal 2 h after decompression. Compared with the sham-operated group, IAH significantly increased IL-1, IL-6, and TNF-alpha levels in adrenal tissue, with larger increases in the presence of higher IAPs. However, the concentrations of these markers remained higher than those in the sham-operated group despite their decrease after 2 h of decompression. Histopathological examination revealed congestion, red blood cell exudation, and neutrophil infiltration in the adrenal glands when IAP was elevated; these conditions became more significant with more severe IAH. These results suggest that the secretion of adrenal hormones and adrenal gland inflammation are positively correlated with IAP and that abdominal decompression effectively corrects adrenal gland function.	[Yu, Jian; Chang, MingTao; Zhang, LiangChao; Chen, ZhiQiang; Zhang, LianYang] Third Mil Med Univ, Ctr Trauma, State Key Lab Trauma Burns & Combined Injury, Inst Surg Res,Daping Hosp, Chongqing, Peoples R China; [Fu, XiaoJuan] Chongqing Med & Pharmaceut Coll, Chongqing, Peoples R China	Army Medical University	Zhang, LY (corresponding author), Third Mil Med Univ, Ctr Trauma, State Key Lab Trauma Burns & Combined Injury, Inst Surg Res,Daping Hosp, Chongqing, Peoples R China.	dpzhangly@163.com			"New Techniques of Trauma Care" [2012BAI11B01]; "Twelfth-Five-Year Military Vehicle Traffic Safety and Prevention" [BWS12J033]	"New Techniques of Trauma Care"; "Twelfth-Five-Year Military Vehicle Traffic Safety and Prevention"	This study was supported by grants from "New Techniques of Trauma Care" (2012BAI11B01) and "Twelfth-Five-Year Military Vehicle Traffic Safety and Prevention" (BWS12J033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mufarrej Faisal, 2012, J Intensive Care Med, V27, P145, DOI 10.1177/0885066610396156; BIESOLD D, 1989, JPN J PHYSIOL, V39, P511, DOI 10.2170/jjphysiol.39.511; Bloomfield GL, 1997, J TRAUMA, V42, P997, DOI 10.1097/00005373-199706000-00002; Bloomfield GL, 1997, CRIT CARE MED, V25, P496, DOI 10.1097/00003246-199703000-00020; Cheatham ML, 2009, CURR OPIN CRIT CARE, V15, P154, DOI 10.1097/MCC.0b013e3283297934; CHERNOW B, 1987, ARCH INTERN MED, V147, P1273, DOI 10.1001/archinte.147.7.1273; Coombs HC, 1920, AM J PHYSIOL, V61, P159; HIROSE M, 1993, ANESTH ANALG, V76, P40; KRON IL, 1984, ANN SURG, V199, P28, DOI 10.1097/00000658-198401000-00005; Malbrain MLNG, 2006, INTENS CARE MED, V32, P1722, DOI 10.1007/s00134-006-0349-5; Malbrain MLNG, 2012, CRIT CARE NURS CLIN, V24, P275, DOI [10.1016/j.cce11.2012.03.004, 10.1016/j.ccell.2012.03.004]; Malbrain MLNG, 2011, AM SURGEON, V77, pS6; Mikami O, 1998, ARCH SURG-CHICAGO, V133, P39, DOI 10.1001/archsurg.133.1.39; Pastor CM, 2001, CRIT CARE MED, V29, P1017, DOI 10.1097/00003246-200105000-00028; RICHARDS WO, 1983, ANN SURG, V197, P183, DOI 10.1097/00000658-198302000-00010; Ridings PC, 1995, J TRAUMA, V39, P1071, DOI 10.1097/00005373-199512000-00010; Sugrue M, 1999, ARCH SURG-CHICAGO, V134, P1082, DOI 10.1001/archsurg.134.10.1082; Thorington JM, 1923, AM J MED SCI, V165, P880, DOI 10.1097/00000441-192306000-00012; Vivier E, 2006, BRIT J ANAESTH, V96, P701, DOI 10.1093/bja/ael071; Windberger UB, 1999, GASTROINTEST ENDOSC, V49, P84, DOI 10.1016/S0016-5107(99)70450-5; Youssef AM, 2012, J TRAUMA ACUTE CARE, V72, P183, DOI 10.1097/TA.0b013e31822a3254	21	2	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81795	10.1371/journal.pone.0081795	http://dx.doi.org/10.1371/journal.pone.0081795			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324724	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300109
J	Cho, IK; Chang, CL; Li, QX				Cho, Il Kyu; Chang, Chiou Ling; Li, Qing X.			Diet-Induced Over-Expression of Flightless-I Protein and Its Relation to Flightlessness in Mediterranean Fruit Fly, Ceratitis capitata	PLOS ONE			English	Article							LIQUID LARVAL DIET; GELSOLIN-FAMILY; X-CHROMOSOME; DROSOPHILA; GENE; MUTANTS; LEUCINE; ENCODES; DIPTERA; MEMBER	The Mediterranean fruit fly (medfly), Ceratitis capitata is among the most economically important pests worldwide. Understanding nutritional requirement helps rearing healthy medfly for biocontrol of its population in fields. Flight ability is a high priority criterion. Two groups of medfly larvae were reared with two identical component diets except one with fatty acids (diet A) and another without it (diet B). Adults from larvae reared on diet B demonstrated 20 +/- 8% of normal flight ability, whereas those from larvae reared on diet A displayed full flight ability of 97 +/- 1%. Proteomes were profiled to compare two groups of medfly pupae using shotgun proteomics to study dietary effects on flight ability. When proteins detected in pupae A were compared with those in pupae B, 233 and 239 proteins were, respectively, under-and over-expressed in pupae B, while 167 proteins were overlapped in both pupae A and B. Differential protein profiles indicate that nutritional deficiency induced over-expression of flightless-I protein (fli-I) in medfly. All proteins were subjected to Ingenuity Pathway Analysis (IPA) to create 13 biological networks and 17 pathways of interacting protein clusters in human ortholog. Fli-I, leucine-rich repeat (LRR)-containing G protein-coupled receptor 2, LRR protein soc-2 and protein wings apart-like were over-expressed in pupae B. Inositol-1,4,5-trisphosphate receptor, protocadherin-like wing polarity protein stan and several Wnt pathway proteins were under-expressed in pupae B. These results suggest down-regulation of the Wnt/wingless signaling pathway, which consequently may result in flightlessness in pupae B. The fli-I gene is known to be located within the Smith-Magenis syndrome (SMS) region on chromosome 17, and thus, we speculate that nutritional deficiency might induce over-expression of fli-I (or fli-I gene) and be associated with human SMS. However, more evidence would be needed to confirm our speculation.	[Cho, Il Kyu; Li, Qing X.] Univ Hawaii, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Chang, Chiou Ling] US Pacific Basin Agr Res Ctr, Hilo, HI USA	University of Hawaii System	Li, QX (corresponding author), Univ Hawaii, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA.	qingl@hawaii.edu	Li, Qing/AAO-3938-2020		USDA-ARS [58-5320-8-410]; National Institute of Occupational Safety and Health grant [2U54OH007550]; National Institute on Minority Health and Health Disparities grant [G12 MD007601]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U54OH007550] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007601] Funding Source: NIH RePORTER	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institute of Occupational Safety and Health grant; National Institute on Minority Health and Health Disparities grant; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by the USDA-ARS cooperative agreement 58-5320-8-410, the National Institute of Occupational Safety and Health grant 2U54OH007550 and the National Institute on Minority Health and Health Disparities grant G12 MD007601. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SK, 2004, BIOCHEM SOC T, V32, P940, DOI 10.1042/BST0320940; Ashhurst D.E., 1977, P9; Banerjee S, 2004, J NEUROSCI, V24, P7869, DOI 10.1523/JNEUROSCI.0656-04.2004; Beenakkers A.M.T., 1985, P451; CAMPBELL HD, 1993, P NATL ACAD SCI USA, V90, P11386, DOI 10.1073/pnas.90.23.11386; Campbell HD, 2002, MOL CELL BIOL, V22, P3518, DOI 10.1128/MCB.22.10.3518-3526.2002; Candy D.J., 1989, P305; Chae J, 1999, DEVELOPMENT, V126, P5421; Chang CL, 2007, ANN ENTOMOL SOC AM, V100, P900, DOI 10.1603/0013-8746(2007)100[900:LHPOCC]2.0.CO;2; Chang CL, 2006, ANN ENTOMOL SOC AM, V99, P1191, DOI 10.1603/0013-8746(2006)99[1191:DAAOAL]2.0.CO;2; Chang Chiou Ling, 2009, Journal of Insect Science (Tucson), V9, P1; Chang CL, 2010, J INSECT PHYSIOL, V56, P356, DOI 10.1016/j.jinsphys.2009.11.014; Chang CL, 2004, ANN ENTOMOL SOC AM, V97, P524, DOI 10.1603/0013-8746(2004)097[0524:ANLLDA]2.0.CO;2; CHEN KS, 1995, AM J HUM GENET, V56, P175; Coudron TA, 2011, ARCH INSECT BIOCHEM, V76, P67, DOI 10.1002/arch.20398; DEAK II, 1982, J EMBRYOL EXP MORPH, V69, P61; DECOUET HG, 1995, GENETICS, V141, P1049; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Fong KSK, 1999, GENOMICS, V58, P146, DOI 10.1006/geno.1999.5817; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Giraldez AJ, 2003, DEVELOPMENT, V130, P6533, DOI 10.1242/dev.00904; Grodnitsky DL, 1999, FORM FUNCTION INSECT, P175; KOANA T, 1978, J EMBRYOL EXP MORPH, V45, P123; Lee SE, 2007, PROTEOMICS, V7, P2059, DOI 10.1002/pmic.200600489; Lee YH, 2006, NUCLEIC ACIDS RES, V34, P5052, DOI 10.1093/nar/gkl652; Liu YT, 1998, J BIOL CHEM, V273, P7920, DOI 10.1074/jbc.273.14.7920; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MIKLOS GLG, 1990, J NEUROGENET, V6, P133, DOI 10.3109/01677069009107106; PERRIMON N, 1989, GENETICS, V121, P313; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; TAKAHASHI N, 1985, P NATL ACAD SCI USA, V82, P1906, DOI 10.1073/pnas.82.7.1906; Tittabutr P, 2011, BIODEGRADATION, V22, P1119, DOI 10.1007/s10532-011-9468-y; Vermassen E, 2004, BIOL CELL, V96, P3, DOI 10.1016/j.biolcel.2003.11.004; Wheeler C.H., 1989, P273	34	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81099	10.1371/journal.pone.0081099	http://dx.doi.org/10.1371/journal.pone.0081099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312525	gold, Green Published			2022-12-25	WOS:000327947800033
J	Duval, C; Cassey, P; Lovell, PG; Miksik, I; Reynolds, SJ; Spencer, KA				Duval, Camille; Cassey, Phillip; Lovell, Paul G.; Miksik, Ivan; Reynolds, S. James; Spencer, Karen A.			Eggshell Appearance Does Not Signal Maternal Corticosterone Exposure in Japanese Quail: An Experimental Study with Brown-Spotted Eggs	PLOS ONE			English	Article							OXIDATIVE STRESS; ANTIOXIDANT CAPACITY; SOCIAL-ENVIRONMENT; POSTNATAL STRESS; SHELLED EGGS; BASE-LINE; COLOR; FEMALE; PIGMENTS; INVESTMENT	Reproduction is a critical period for birds as they have to cope with many stressful events. One consequence of an acute exposure to stress is the release of corticosterone, the avian stress hormone. Prolonged stress can have negative impacts on the immune system, resulting in, for example, increased oxidative stress. Through maternal effects, females are known to modulate their investment in eggs content according to their own physiological condition. Less is known about maternal investment in eggshells, especially in pigments. The two main eggshell pigments may possess opposite antioxidant properties: protoporphyrin (brown) is a pro-oxidant, whereas biliverdin (blue-green) is an antioxidant. In Japanese quail, we know that the deposition of both pigments is related to female body condition. Thus, a chronic stress response may be reflected in eggshell coloration. Using female Japanese quails that lay brown-spotted eggs, we explored whether physiological exposure to corticosterone induces a change in female basal stress and antioxidant factors, and eggshell pigment concentration, spectrophotometric reflectance, and maculation coverage. We supplemented adult females over a 2 week period with either peanut oil (control) or corticosterone (treatment). We collected pre- and post-supplementation eggs and analysed the effect of corticosterone treatment on female physiology and eggshell appearance parameters. Except for corticosterone-fed birds which laid eggs with brighter spots, supplementation had no significant effect on female physiology or eggshell pigment concentration, reflectance and maculation. The change in eggshell spot brightness was not detected by a photoreceptor noise-limited color opponent model of avian visual perception. Our data confirms that eggshell reflectance in spotted eggs varies over the laying sequence, and spot reflectance may be a key factor that is affected by females CORT exposure, even if the changes are not detected by an avian visual model.	[Duval, Camille; Reynolds, S. James] Univ Birmingham, Coll Life & Environm Sci, Sch Biosci, Ctr Ornithol, Birmingham, W Midlands, England; [Cassey, Phillip] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Lovell, Paul G.] Abertay Univ, Div Psychol, Dundee, Scotland; [Miksik, Ivan] Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic; [Spencer, Karen A.] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland	University of Birmingham; University of Adelaide; University of Abertay Dundee; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; University of St Andrews	Duval, C (corresponding author), Univ Birmingham, Coll Life & Environm Sci, Sch Biosci, Ctr Ornithol, Birmingham, W Midlands, England.	cxd909@bham.ac.uk	Miksik, Ivan/A-9178-2008; Spencer, Karen A/B-3177-2015; Reynolds, Silas James/AAM-1372-2020	Miksik, Ivan/0000-0001-5190-1827; Spencer, Karen A/0000-0002-2851-9379; Lovell, Paul George/0000-0003-2959-5370; Cassey, Phillip/0000-0002-2626-0172	Birmingham University; Biotechnology and Biological Sciences Research Council (BBSRC)	Birmingham University; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided by a Birmingham University Teaching Assistantship (to CD) and a Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship (to KAS). PC is an Australian Research Council (ARC) Future Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso S, 1999, FREE RADICAL RES, V31, P161, DOI 10.1080/10715769900300711; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Angelier F, 2009, GEN COMP ENDOCR, V163, P142, DOI 10.1016/j.ygcen.2009.03.028; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Butcher GD, 2011, SOC VET MED LARGE AN; Cassey P, 2008, NATURWISSENSCHAFTEN, V95, P713, DOI 10.1007/s00114-008-0376-x; Cassey P, 2012, J AVIAN BIOL, V43, P503, DOI 10.1111/j.1600-048X.2012.05576.x; Cassey P, 2012, METHODS ECOL EVOL, V3, P450, DOI 10.1111/j.2041-210X.2011.00152.x; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Costantini D, 2011, J COMP PHYSIOL B, V181, P447, DOI 10.1007/s00360-011-0566-2; Costantini D, 2010, J COMP PHYSIOL B, V180, P731, DOI 10.1007/s00360-010-0456-z; Costantini D, 2009, FUNCT ECOL, V23, P506, DOI 10.1111/j.1365-2435.2009.01546.x; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dearborn DC, 2012, FUNCT ECOL, V26, P912, DOI 10.1111/j.1365-2435.2012.02001.x; Ding ZK, 2002, BIOCHEMISTRY-MOSCOW+, V67, P927, DOI 10.1023/A:1019974822667; Doutrelant C, 2008, J EVOLUTION BIOL, V21, P226, DOI 10.1111/j.1420-9101.2007.01451.x; Duval C, 2013, J EXP BIOL, V216, P700, DOI 10.1242/jeb.077370; Gomez D., 2006, AVICOL PROGRAM ANAL; Gorchein A, 2009, BIOMED CHROMATOGR, V23, P602, DOI 10.1002/bmc.1158; Gosler AG, 2005, ECOL LETT, V8, P1105, DOI 10.1111/j.1461-0248.2005.00816.x; Hanley D, 2008, CONDOR, V110, P767, DOI 10.1525/cond.2008.8634; Hargitai R, 2009, BEHAV ECOL SOCIOBIOL, V63, P869, DOI 10.1007/s00265-009-0727-4; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Hayward LS, 2004, GEN COMP ENDOCR, V135, P365, DOI 10.1016/j.ygcen.2003.11.002; Holveck MJ, 2010, BIOL LETTERS, V6, P453, DOI 10.1098/rsbl.2009.1044; Kilner RM, 2006, BIOL REV, V81, P383, DOI 10.1017/S1464793106007044; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Lovell PG, 2013, CURR BIOL, V23, P260, DOI 10.1016/j.cub.2012.12.031; Lovell PG, 2005, J OPT SOC AM A, V22, P2060, DOI 10.1364/JOSAA.22.002060; Loyau A, 2007, BEHAV ECOL SOCIOBIOL, V61, P1043, DOI 10.1007/s00265-006-0337-3; Malheiros RD, 2003, POULTRY SCI, V82, P123, DOI 10.1093/ps/82.1.123; Marasco V, 2013, GEN COMP ENDOCR, V191, P239, DOI 10.1016/j.ygcen.2013.07.003; Marasco V, 2012, J EXP BIOL, V215, P3955, DOI 10.1242/jeb.071423; Martinez-de la Puente J, 2007, J AVIAN BIOL, V38, P377, DOI 10.1111/j.0908-8857.2007.03877.x; Maurer G, 2011, J ORNITHOL, V152, P209, DOI 10.1007/s10336-010-0600-2; Mazuc J, 2003, ECOL LETT, V6, P1084, DOI 10.1046/j.1461-0248.2003.00535.x; McDonagh AF, 2001, NAT STRUCT BIOL, V8, P198, DOI 10.1038/84915; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Miksik I, 1996, COMP BIOCHEM PHYS B, V113, P607, DOI 10.1016/0305-0491(95)02073-X; MILLS AD, 1991, BRIT POULTRY SCI, V32, P117, DOI 10.1080/00071669108417333; Montgomerie Robert, 2006, P90; Montgomery MK, 2012, EXP GERONTOL, V47, P211, DOI 10.1016/j.exger.2011.11.014; Morales J, 2008, BEHAV ECOL SOCIOBIOL, V63, P227, DOI 10.1007/s00265-008-0653-x; Moreno J, 2003, ECOL LETT, V6, P803, DOI 10.1046/j.1461-0248.2003.00505.x; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; NYS Y, 1991, POULTRY SCI, V70, P1236, DOI 10.3382/ps.0701236; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Saino N, 2002, J EVOLUTION BIOL, V15, P735, DOI 10.1046/j.1420-9101.2002.00448.x; Sapolsky RM, 2000, NEUROBIOL DIS, V7, P540, DOI 10.1006/nbdi.2000.0350; Scalise I, 2004, J PHOTOCH PHOTOBIO A, V162, P105, DOI 10.1016/S1010-6030(03)00317-4; SCHEIN MW, 1972, ANIM BEHAV, V20, P61, DOI 10.1016/S0003-3472(72)80173-8; Shan Y, 2000, ARCH BIOCHEM BIOPHYS, V380, P219, DOI 10.1006/abbi.2000.1921; SILVERIN B, 1986, GEN COMP ENDOCR, V64, P67, DOI 10.1016/0016-6480(86)90029-8; Sparks NHC, 2011, AVIAN BIOL RES, V4, P162, DOI 10.3184/175815511X13228269481875; Spencer KA, 2007, HORM BEHAV, V51, P273, DOI 10.1016/j.yhbeh.2006.11.001; Spencer KA, 2009, ENDOCRINOLOGY, V150, P1931, DOI 10.1210/en.2008-1471; Stearns S.C., 1992, pi; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191; WINGFIELD JC, 1994, PERSPECTIVES IN COMPARATIVE ENDOCRINOLOGY, P520	65	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e80485	10.1371/journal.pone.0080485	http://dx.doi.org/10.1371/journal.pone.0080485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312476	Green Published, gold, Green Submitted			2022-12-25	WOS:000327947800012
J	Kikuzawa, K; Seiwa, K; Lechowicz, MJ				Kikuzawa, Kihachiro; Seiwa, Kenji; Lechowicz, Martin J.			Leaf Longevity as a Normalization Constant in Allometric Predictions of Plant Production	PLOS ONE			English	Article							PHOTOSYNTHETIC CAPACITY; CARBON GAIN; TREE; LIFETIME; DECLINE; CANOPY; AREA; AGE	In metabolic scaling theory the size-dependence of plant processes is described by a power function of form Y=YoM theta where Y is a characteristic such as plant productivity that changes with plant size (M) raised to the circle minus th power and Y-o is a normalization constant that adjusts the general relationship across environments and species. In essence, the theory considers that the value of theta arises in the size-dependent relationship between leaf area and vascular architecture that influences plant function and that Y-o modulates this general relationship to account for ecological and evolutionary effects on the exchange of resources between plant and environment. Enquist and colleagues have shown from first principles that Y-o is a function of carbon use efficiency, the carbon fraction of a plant, the area-specific carbon assimilation rate of a leaf, the laminar area of a leaf, and the mass of a leaf. We show that leaf longevity provides a functional integration of these traits that can serve as a simpler normalization in scaling plant productivity for individual species and potentially for mixed-species communities as well.	[Kikuzawa, Kihachiro] Ishikawa Prefectural Univ, Plant Ecol Lab, Nonoichi, Ishikawa, Japan; [Seiwa, Kenji] Tohoku Univ, Lab Forest Ecol, Osaki, Japan; [Lechowicz, Martin J.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	Ishikawa Prefecture University; Tohoku University; McGill University	Lechowicz, MJ (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	martin.lechowicz@mcgill.ca	Lechowicz, Martin/Y-7211-2019	Lechowicz, Martin/0000-0003-2562-7136	Ministry of Education Science Sports and Culture program of the Japan Society for Promotion of Science [20370014]	Ministry of Education Science Sports and Culture program of the Japan Society for Promotion of Science	Ministry of Education Science Sports and Culture program of the Japan Society for Promotion of Science. Grant Number: 20370014 to KK. JSPS URL: http://www.jsps.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly D, 1999, OECOLOGIA, V119, P300, DOI 10.1007/s004420050790; Enquist B.J., 2012, METAB ECOL SCALING A, P164, DOI [10.1002/, DOI 10.1002/9781119968535.CH14]; Enquist BJ, 2002, TREE PHYSIOL, V22, P1045, DOI 10.1093/treephys/22.15-16.1045; Enquist BJ, 2007, NATURE, V449, P218, DOI 10.1038/nature06061; HOZUMI K, 1968, Japanese Journal of Ecology, V18, P10; Kempes CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020551; Kikuzawa K, 2004, ECOL RES, V19, P365, DOI 10.1111/j.1440-1703.2004.00657.x; KIKUZAWA K, 1991, AM NAT, V138, P1250, DOI 10.1086/285281; Kikuzawa K, 2006, AM NAT, V168, P373, DOI 10.1086/506954; Kikuzawa K, 2011, ECOL RES MONOGR, P1; Kikuzawa K, 2009, PLANT ECOL, V202, P309, DOI 10.1007/s11258-008-9486-y; KIRA TATUO, 1967, JAP J ECOL, V17, P70; Kitajima K, 2002, AM J BOT, V89, P1925, DOI 10.3732/ajb.89.12.1925; Kitajima K, 1997, AM J BOT, V84, P702, DOI 10.2307/2445906; Koyama K, 2009, AM NAT, V173, P640, DOI 10.1086/597604; Lloyd Jon, 2013, New Phytol, V199, P311, DOI 10.1111/nph.12281; Mediavilla S, 2003, NEW PHYTOL, V159, P203, DOI 10.1046/j.1469-8137.2003.00798.x; Price CA, 2012, ECOL LETT, V15, P1465, DOI 10.1111/j.1461-0248.2012.01860.x; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; Seiwa K, 2011, ECOL RES, V26, P173, DOI 10.1007/s11284-010-0774-3; Shipley B, 2006, ECOLOGY, V87, P535, DOI 10.1890/05-1051; West GB, 1997, GEN MODELS ORIG ALLO; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403	23	7	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81873	10.1371/journal.pone.0081873	http://dx.doi.org/10.1371/journal.pone.0081873			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312595	Green Published, gold, Green Submitted			2022-12-25	WOS:000327947800062
J	Paemka, L; Mahajan, VB; Skeie, JM; Sowers, LP; Ehaideb, SN; Gonzalez-Alegre, P; Sasaoka, T; Tao, H; Miyagi, A; Ueno, N; Takao, K; Miyakawa, T; Wu, S; Darbro, BW; Ferguson, PJ; Pieper, AA; Britt, JK; Wemmie, JA; Rudd, DS; Wassink, T; El-Shanti, H; Mefford, HC; Carvill, GL; Manak, JR; Bassuk, AG				Paemka, Lily; Mahajan, Vinit B.; Skeie, Jessica M.; Sowers, Levi P.; Ehaideb, Salleh N.; Gonzalez-Alegre, Pedro; Sasaoka, Toshikuni; Tao, Hirotaka; Miyagi, Asuka; Ueno, Naoto; Takao, Keizo; Miyakawa, Tsuyoshi; Wu, Shu; Darbro, Benjamin W.; Ferguson, Polly J.; Pieper, Andrew A.; Britt, Jeremiah K.; Wemmie, John A.; Rudd, Danielle S.; Wassink, Thomas; El-Shanti, Hatem; Mefford, Heather C.; Carvill, Gemma L.; Manak, J. Robert; Bassuk, Alexander G.			PRICKLE1 Interaction with SYNAPSIN I Reveals a Role in Autism Spectrum Disorders	PLOS ONE			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; LIM DOMAIN PROTEIN; MOUSE PRICKLE1; PC12 CELLS; GENE; MUTATIONS; BEHAVIOR; IDENTIFICATION; ASSOCIATION; EXPRESSION	The frequent comorbidity of Autism Spectrum Disorders (ASDs) with epilepsy suggests a shared underlying genetic susceptibility; several genes, when mutated, can contribute to both disorders. Recently, PRICKLE1 missense mutations were found to segregate with ASD. However, the mechanism by which mutations in this gene might contribute to ASD is unknown. To elucidate the role of PRICKLE1 in ASDs, we carried out studies in Prickle1(+/-) mice and Drosophila, yeast, and neuronal cell lines. We show that mice with Prickle1 mutations exhibit ASD-like behaviors. To find proteins that interact with PRICKLE1 in the central nervous system, we performed a yeast two-hybrid screen with a human brain cDNA library and isolated a peptide with homology to SYNAPSIN I (SYN1), a protein involved in synaptogenesis, synaptic vesicle formation, and regulation of neurotransmitter release. Endogenous Prickle1 and Syn1 co-localize in neurons and physically interact via the SYN1 region mutated in ASD and epilepsy. Finally, a mutation in PRICKLE1 disrupts its ability to increase the size of dense-core vesicles in PC12 cells. Taken together, these findings suggest PRICKLE1 mutations contribute to ASD by disrupting the interaction with SYN1 and regulation of synaptic vesicles.	[Paemka, Lily; Mahajan, Vinit B.; Skeie, Jessica M.; Sowers, Levi P.; Ehaideb, Salleh N.; Gonzalez-Alegre, Pedro; Wu, Shu; Darbro, Benjamin W.; Ferguson, Polly J.; Pieper, Andrew A.; Britt, Jeremiah K.; Wemmie, John A.; Rudd, Danielle S.; Wassink, Thomas; El-Shanti, Hatem; Manak, J. Robert; Bassuk, Alexander G.] Univ Iowa, Iowa City, IA 52242 USA; [Paemka, Lily; Wu, Shu; Ferguson, Polly J.; El-Shanti, Hatem; Manak, J. Robert; Bassuk, Alexander G.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Paemka, Lily; Ehaideb, Salleh N.; Rudd, Danielle S.; Manak, J. Robert; Bassuk, Alexander G.] Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA USA; [Mahajan, Vinit B.; Skeie, Jessica M.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Sowers, Levi P.; Gonzalez-Alegre, Pedro; Pieper, Andrew A.; Bassuk, Alexander G.] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Mahajan, Vinit B.; Sowers, Levi P.; Gonzalez-Alegre, Pedro; Darbro, Benjamin W.; Ferguson, Polly J.; Pieper, Andrew A.; Britt, Jeremiah K.; Wassink, Thomas; El-Shanti, Hatem; Bassuk, Alexander G.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA; [Ehaideb, Salleh N.; Manak, J. Robert] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Gonzalez-Alegre, Pedro; Wemmie, John A.] Univ Iowa, Interdisciplinary Grad Program Neurosci, Iowa City, IA USA; [Sasaoka, Toshikuni] Niigata Univ, Brain Res Inst, Ctr Bioresources, Niigata, Japan; [Tao, Hirotaka] Univ Toronto, Hosp Sick Kids, Toronto, ON, Canada; [Miyagi, Asuka; Ueno, Naoto] Natl Inst Basic Biol, Dept Dev Biol, Okazaki, Aichi 444, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Sect Behav Patterns, Okazaki, Aichi 444, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan; [Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Toyoake, Aichi, Japan; [Darbro, Benjamin W.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Manak, J. Robert; Bassuk, Alexander G.] Univ Iowa, Interdisciplinary Grad Program Mol & Cellular Bio, Iowa City, IA USA; [Pieper, Andrew A.; Britt, Jeremiah K.; Wemmie, John A.; Rudd, Danielle S.; Wassink, Thomas] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [El-Shanti, Hatem] Shafallah Med Genet Ctr, Doha, Qatar; [Mefford, Heather C.; Carvill, Gemma L.] Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98195 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Niigata University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST); Fujita Health University; University of Iowa; University of Iowa; University of Iowa; Al Shafallah Center; University of Washington; University of Washington Seattle	Bassuk, AG (corresponding author), Univ Iowa, Iowa City, IA 52242 USA.	alexander-bassuk@uiowa.edu	Pieper, Andrew A/R-5552-2016; El-Shanti, Hatem/O-5990-2014; Takao, Keizo/B-9527-2008; EL-SHANTI, HATEM/Q-4932-2016; , 笹岡俊邦/N-9152-2015; Miyakawa, Tsuyoshi/A-7741-2008	El-Shanti, Hatem/0000-0001-6230-8316; Takao, Keizo/0000-0002-4734-3583; EL-SHANTI, HATEM/0000-0001-6230-8316; , 笹岡俊邦/0000-0002-7797-4394; Miyakawa, Tsuyoshi/0000-0003-0137-8200; Wassink, Thomas/0000-0002-0952-8333; Wemmie, John/0000-0001-7531-9065; Darbro, Benjamin/0000-0001-9279-356X; Ueno, Naoto/0000-0002-8375-2317; Mahajan, Vinit/0000-0003-1886-1741; Tao, Hirotaka/0000-0002-3023-9958; Manak, John/0000-0002-6562-7694; Bassuk, Alexander/0000-0002-4067-2157; Pieper, Andrew/0000-0001-6299-6577; Paemka, Lily/0000-0001-7498-520X	NIH [R01 NS064159-01A1, 1R21MH100086-01, K08EY020530]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [K08EY020530, R01EY026682, F32EY022280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH100086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064159] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was mainly supported by NIH 1R01 NS064159-01A1 and NIH 1R21MH100086-01 (to AGB). Part of the work was supported by Grant-in-Aid for Exploratory Research and Integrative Brain Research (IBR-shien), and a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to KT and TM), and NIH Grant K08EY020530 and Research to Prevent Blindness (VBM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Azmitia EC, 2011, ANAT REC, V294, P1653, DOI 10.1002/ar.21243; Bader PL, 2011, P NATL ACAD SCI USA, V108, P15432, DOI 10.1073/pnas.1112667108; Bailey A, 1996, J CHILD PSYCHOL PSYC, V37, P89, DOI 10.1111/j.1469-7610.1996.tb01381.x; Bassuk AG, 2008, AM J HUM GENET, V83, P572, DOI 10.1016/j.ajhg.2008.10.003; Binda AV, 2005, BIOCHEM PHARMACOL, V69, P1451, DOI 10.1016/j.bcp.2005.02.015; Boccuto L, 2012, EUR J HUM GENET; Bourgeron T, 2007, COLD SPRING HARB SYM, V72, P645, DOI 10.1101/sqb.2007.72.020; Bruckner A, 2009, INT J MOL SCI, V10, P2763, DOI 10.3390/ijms10062763; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Coryell MW, 2007, BIOL PSYCHIAT, V62, P1140, DOI 10.1016/j.biopsych.2007.05.008; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Criscuolo C, 2010, MOVEMENT DISORD, V25, P2686, DOI 10.1002/mds.23350; D'Alessandro R, 2008, J NEUROCHEM, V105, P1369, DOI 10.1111/j.1471-4159.2008.05259.x; D'Souza A, 2009, BRAIN RES, V1247, P1, DOI 10.1016/j.brainres.2008.09.088; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; Dravet C, 2002, REV NEUROL-FRANCE, V158, pS33; Etholm L, 2012, EPILEPSY RES, V99, P252, DOI 10.1016/j.eplepsyres.2011.12.004; Excoffon KJDA, 2003, J VIROL, V77, P2559, DOI 10.1128/JVI.77.4.2559-2567.2003; Fassio A, 2011, HUM MOL GENET, V20, P2297, DOI 10.1093/hmg/ddr122; Feyder M, 2010, AM J PSYCHIAT, V167, P1508, DOI 10.1176/appi.ajp.2010.10040484; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Fujimura Lisa, 2012, Methods Mol Biol, V839, P173, DOI 10.1007/978-1-61779-510-7_14; Garcia CC, 2004, J MED GENET, V41, P183, DOI 10.1136/jmg.2003.013680; Glickman G, 2010, NEUROSCI BIOBEHAV R, V34, P755, DOI 10.1016/j.neubiorev.2009.11.017; Gonzalez-Alegre P, 2004, J NEUROSCI, V24, P2593, DOI 10.1523/JNEUROSCI.4461-03.2004; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Greco B, 2012, BEHAV BRAIN RES; Gubb D, 1999, GENE DEV, V13, P2315, DOI 10.1101/gad.13.17.2315; Hunt CA, 1996, J NEUROSCI, V16, P1380; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jeon CY, 2010, SYNAPSE, V64, P765, DOI 10.1002/syn.20789; Katoh M, 2003, INT J MOL MED, V11, P249; Kumar RA, 2010, J MED GENET, V47, P81, DOI 10.1136/jmg.2008.065821; Lord C, 2000, NEURON, V28, P355, DOI 10.1016/S0896-6273(00)00115-X; Matus-Amat P, 2004, J NEUROSCI, V24, P2431, DOI 10.1523/JNEUROSCI.1598-03.2004; Mei X, 2013, DIS MODELS MECH; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nakajima R, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-7; Noebels JL, 2003, EPILEPSIA, V44, P16, DOI 10.1046/j.1528-1157.44.s.2.4.x; Okuda H, 2007, FEBS LETT, V581, P4754, DOI 10.1016/j.febslet.2007.08.075; Piton A, 2008, HUM MOL GENET, V17, P3965, DOI 10.1093/hmg/ddn300; PITTMAN RN, 1993, J NEUROSCI, V13, P3669; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Randolph-Gips Mary, 2012, J Clin Bioinforma, V2, P17, DOI 10.1186/2043-9113-2-17; Rout UK, 2009, NEUROSCI RES, V64, P162, DOI 10.1016/j.neures.2009.02.009; Shiina N, 2010, J NEUROSCI, V30, P12816, DOI 10.1523/JNEUROSCI.6386-09.2010; Shimojo M, 2003, MOL CELL BIOL, V23, P9025, DOI 10.1128/MCB.23.24.9025-9031.2003; Smalley SL, 1997, AM J HUM GENET, V60, P1276, DOI 10.1086/515485; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Tao H, 2011, AM J HUM GENET, V88, P138, DOI 10.1016/j.ajhg.2010.12.012; Tao H, 2009, P NATL ACAD SCI USA, V106, P14426, DOI 10.1073/pnas.0901332106; Tsujino N, 2007, NEUROSCI RES, V57, P289, DOI 10.1016/j.neures.2006.10.018; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wojcik J, 2002, J MOL BIOL, V323, P763, DOI 10.1016/S0022-2836(02)01009-4	59	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e80737	10.1371/journal.pone.0080737	http://dx.doi.org/10.1371/journal.pone.0080737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312498	gold, Green Published, Green Submitted			2022-12-25	WOS:000327947800020
J	Mohandas, R; Sautina, L; Li, SY; Wen, XR; Huo, TY; Handberg, E; Chi, YY; Merz, CNB; Pepine, CJ; Segal, MS				Mohandas, Rajesh; Sautina, Larysa; Li, Shiyu; Wen, Xuerong; Huo, Tianyao; Handberg, Eileen; Chi, Yueh-Yun; Merz, C. Noel Bairey; Pepine, Carl J.; Segal, Mark S.			Number and Function of Bone-Marrow Derived Angiogenic Cells and Coronary Flow Reserve in Women without Obstructive Coronary Artery Disease: A Substudy of the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE)	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; CHEST-PAIN; MICROVASCULAR REACTIVITY; SUSPECTED ISCHEMIA; ANGINA-PECTORIS; PILOT PHASE; ATHEROSCLEROSIS; HEART	Background: In women with ischemia and no obstructive coronary artery disease, the Women's Ischemic Syndrome Evaluation (WISE) observed that microvascular coronary dysfunction (MCD) is the best independent predictor of adverse cardiovascular events. Since coronary microvascular tone is regulated in part by endothelium, we hypothesized that circulating endothelial cells (CEC), which reflect endothelial injury, and the number and function of bone-marrow derived angiogenic cells (BMDAC), which could help repair damaged endothelium, may serve as biomarkers for decreased coronary flow reserve (CFR) and MCD. Methods: We studied 32 women from the WISE cohort. CFR measurements in response to intracoronary adenosine were taken as an index of MCD. We enumerated BMDAC colonies and CEC in peripheral blood samples. BMDAC function was assessed by assay of migration of CD34+ cells toward SDF-1 and measurement of bioavailable nitric oxide (NO). These findings were compared with a healthy reference group and also entered into a multivariable model with CFR as the dependent variable. Results: Compared with a healthy reference group, women with MCD had lower numbers of BMDAC colonies [16 (0, 81) vs. 24 (14, 88); P = 0.01] and NO [936 (156, 1875) vs. 1168 (668, 1823); P = 0.02]. Multivariable regression analysis showed strong correlation of CFR to the combination of BMDAC colony count and CD34+ cell function (migration and NO) (R-2 = 0.45; P < 0.05). Conclusions: The BMDAC function and numbers of BMDAC colonies are decreased in symptomatic women with MCD and are independently associated with CFR. These circulating cells may provide mechanistic insights into MCD in women with ischemia.	[Mohandas, Rajesh; Sautina, Larysa; Li, Shiyu; Wen, Xuerong; Segal, Mark S.] Univ Florida, Div Nephrol Hypertens & Transplantat, Gainesville, FL 32610 USA; [Huo, Tianyao; Handberg, Eileen; Pepine, Carl J.] Univ Florida, Div Cardiovasc Med, Gainesville, FL USA; [Chi, Yueh-Yun] Univ Florida, Dept Biostat, Gainesville, FL USA; [Merz, C. Noel Bairey] Cedars Sinai Med Ctr, Barbra Streisand Womens Heart Ctr, Los Angeles, CA 90048 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Cedars Sinai Medical Center	Mohandas, R (corresponding author), Univ Florida, Div Nephrol Hypertens & Transplantat, Gainesville, FL 32610 USA.	Mohanr@ufl.edu	Mohandas, Rajesh/CAA-6727-2022; Chi, Yueh-Yun/AAL-6234-2020	Mohandas, Rajesh/0000-0002-4430-8678; Pepine, Carl/0000-0002-6011-681X; Handberg, Eileen/0000-0002-7805-9577	NHLBI [N01-HV-68161, N01-HV68162, N01HV-68163, N01HV68164, R01HL091005, U0164829, U01HL649141, U01 HL649241, T32HL69751, 1R01HL090957-01A1]; NIA [1R03AG032631NIH]; NCRR [CTSA UL1 TR000064, GCRC MO1-RR00425]; NIDDK [T32DK007518]; Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ; Women's Guild of Cedars-Sinai Medical Center, Los Angeles, CA; Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA; QMED, Inc; Laurence Harbor, NJ; Edythe L. Broad Women's Heart Research Fellowship; Cedars-Sinai Medical Center, Los Angeles, California; Barbra Streisand Women's Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles, The Society for Women's Health Research (SWHR), Washington, D.C; Division of UF Nephrology Gatorade Funds; DIVISION OF HEART AND VASCULAR DISEASES [N01HV068163] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UM1HL087366, R01HL090957, U01HL064924, R01HL091005] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ; Women's Guild of Cedars-Sinai Medical Center, Los Angeles, CA; Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA; QMED, Inc; Laurence Harbor, NJ; Edythe L. Broad Women's Heart Research Fellowship; Cedars-Sinai Medical Center, Los Angeles, California; Barbra Streisand Women's Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles, The Society for Women's Health Research (SWHR), Washington, D.C; Division of UF Nephrology Gatorade Funds; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by contracts from the NHLBI: N01-HV-68161, N01-HV68162, N01HV-68163, N01HV68164, R01HL091005, U0164829, U01HL649141, U01 HL649241, T32HL69751, 1R01HL090957-01A1; from the NIA 1R03AG032631NIH; from the NCRR: CTSA UL1 TR000064; GCRC MO1-RR00425; from NIDDK: T32DK007518. Grants from the Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ, The Women's Guild of Cedars-Sinai Medical Center, Los Angeles, CA, The Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA, and QMED, Inc., Laurence Harbor, NJ, the Edythe L. Broad Women's Heart Research Fellowship, Cedars-Sinai Medical Center, Los Angeles, California, the Barbra Streisand Women's Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles, The Society for Women's Health Research (SWHR), Washington, D.C., and Division of UF Nephrology Gatorade Funds.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bardin N, 2001, BLOOD, V98, P3677, DOI 10.1182/blood.V98.13.3677; Bellamy MF, 1998, CARDIOVASC RES, V40, P410, DOI 10.1016/S0008-6363(98)00184-9; Botker HE, 2000, THROMB RES, V97, P519, DOI 10.1016/S0049-3848(99)00205-4; Bugiardini R, 2004, CIRCULATION, V109, P2518, DOI 10.1161/01.CIR.0000128208.22378.E3; Chironi G, 2007, ATHEROSCLEROSIS, V191, P115, DOI 10.1016/j.atherosclerosis.2006.02.041; Damani S, 2012, SCI TRANSL MED, V4, P126; Douglas PS, 2011, J AM COLL CARDIOL, V58, P801, DOI 10.1016/j.jacc.2011.05.019; Fadini GP, 2006, STROKE, V37, P2277, DOI 10.1161/01.STR.0000236064.19293.79; Gulati M, 2009, ARCH INTERN MED, V169, P843, DOI 10.1001/archinternmed.2009.50; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Huang PH, 2007, HEART, V93, P1064, DOI 10.1136/hrt.2006.107763; Jespersen L, 2012, EUR HEART J, V33, P734, DOI 10.1093/eurheartj/ehr331; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Koc M, 2003, AM J KIDNEY DIS, V42, P704, DOI 10.1016/S0272-6386(03)00906-5; Kunz GA, 2006, AM HEART J, V152, P190, DOI 10.1016/j.ahj.2006.02.001; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Masuda H, 2011, CIRC RES, V109, P20, DOI 10.1161/CIRCRESAHA.110.231837; Merz CNB, 1999, J AM COLL CARDIOL, V33, P1453; Mutin M, 1999, BLOOD, V93, P2951; Pepine CJ, 2010, J AM COLL CARDIOL, V55, P2825, DOI 10.1016/j.jacc.2010.01.054; Porto I, 2011, ATHEROSCLEROSIS, V216, P355, DOI 10.1016/j.atherosclerosis.2011.02.014; Quilici J, 2004, CIRCULATION, V110, P1586, DOI 10.1161/01.CIR.0000142295.85740.98; QUYYUMI AA, 1992, CIRCULATION, V86, P1864, DOI 10.1161/01.CIR.86.6.1864; Reis SE, 1999, J AM COLL CARDIOL, V33, P1469, DOI 10.1016/S0735-1097(99)00072-8; SBARBATI R, 1991, BLOOD, V77, P764; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Segal MS, 2006, DIABETES, V55, P102, DOI 10.2337/diabetes.55.1.102; Sharaf BL, 2001, AM J CARDIOL, V87, P937, DOI 10.1016/S0002-9149(01)01424-2; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Shmilovich H, 2007, HEART, V93, P1071, DOI 10.1136/hrt.2005.077909; Tousoulis D, 2001, CLIN CARDIOL, V24, P301, DOI 10.1002/clc.4960240409; Turan RG, 2011, CIRC J, V75, P2635, DOI 10.1253/circj.CJ-10-1284; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Wang D, 1999, AM J HYPERTENS, V12, P174, DOI 10.1016/S0895-7061(98)00235-0; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Wessel TR, 2007, CLIN CARDIOL, V30, P69, DOI 10.1002/clc.19	37	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81595	10.1371/journal.pone.0081595	http://dx.doi.org/10.1371/journal.pone.0081595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312563	gold, Green Submitted, Green Published			2022-12-25	WOS:000327944500078
J	Song, YR; Gilbert, D; O'Sullivan, TN; Yang, CY; Pan, WQ; Fathalizadeh, A; Lu, L; Haines, DC; Martin, PL; Van Dyke, T				Song, Yurong; Gilbert, Debra; O'Sullivan, T. Norene; Yang, Chunyu; Pan, Wenqi; Fathalizadeh, Alisan; Lu, Lucy; Haines, Diana C.; Martin, Philip L.; Van Dyke, Terry			Carcinoma Initiation via Rb Tumor Suppressor Inactivation: A Versatile Approach to Epithelial Subtype-Dependent Cancer Initiation in Diverse Tissues	PLOS ONE			English	Article							LARGE T-ANTIGEN; RETINOBLASTOMA GENE; CHOROID-PLEXUS; G(1) CONTROL; J DOMAIN; IN-VIVO; KERATINS; PROGRESSION; MICE; DNA	Carcinomas arise in a complex microenvironment consisting of multiple distinct epithelial lineages surrounded by a variety of stromal cell types. Understanding cancer etiologies requires evaluating the relationship among cell types during disease initiation and through progression. Genetically engineered mouse (GEM) models facilitate the prospective examination of early oncogenic events, which is not possible in humans. Since most solid tumors harbor aberrations in the RB network, we developed an inducible GEM approach for the establishment and assessment of carcinoma initiation in a diverse range of epithelial tissues and subtypes upon inactivation of RB-mediated tumor suppression (RB-TS). The system allows independent assessment of epithelial subtypes that express either cytokeratins (K) 18 or 19. By Cre-dependent expression of a protein that dominantly inactivates RB and functionally redundant proteins p107 and p130, neoplasia could be initiated in either K18 or K19 expressing cells of numerous tissues. By design, because only a single pathway aberration was engineered, carcinomas developed stochastically only after long latency. Hence, this system, which allows for directed cell type-specific carcinoma initiation, facilitates further definition of events that can progress neoplasms to aggressive cancers via engineered, carcinogen-induced and/or spontaneous evolution.	[Song, Yurong; Gilbert, Debra; O'Sullivan, T. Norene; Lu, Lucy; Van Dyke, Terry] NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21701 USA; [Yang, Chunyu] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Pan, Wenqi] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA; [Fathalizadeh, Alisan] Michigan State Univ, E Lansing, MI 48824 USA; [Haines, Diana C.] SAIC Frederick, Frederick Natl Lab Canc Res, Pathol Histotechnol Lab, Frederick, MD USA; [Martin, Philip L.] SAIC Frederick, Frederick Natl Lab Canc Res, Ctr Adv Preclin Res, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Michigan State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Van Dyke, T (corresponding author), NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21701 USA.	vandyket@mail.nih.gov	Ariel, Pablo/AGJ-4118-2022; Liu, Wenjun/L-5256-2016; , Pathology Services Core/CEZ-2246-2022; Song, Yurong/GRX-9328-2022	Liu, Wenjun/0000-0001-9380-2990; 	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Department of Defense [PC050306]; Prostate Cancer Foundation; NCI [RO1-CA046283]; NATIONAL CANCER INSTITUTE [R01CA046283] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Prostate Cancer Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E, and in part by grants RO1-CA046283 from NCI and PC040619 from the Department of Defense, and Prostate Cancer Foundation to TVD. YS was supported by postdoctoral training award (PC050306) from the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	BRULET P, 1980, P NATL ACAD SCI-BIOL, V77, P4113, DOI 10.1073/pnas.77.7.4113; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; CHEN JD, 1992, ONCOGENE, V7, P1167; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; DYSON N, 1989, CELL, V58, P249, DOI 10.1016/0092-8674(89)90839-8; EWEN ME, 1989, CELL, V58, P257, DOI 10.1016/0092-8674(89)90840-4; Gauthier ML, 2007, CANCER CELL, V12, P479, DOI 10.1016/j.ccr.2007.10.017; Hill R, 2005, CANCER RES, V65, P10243, DOI 10.1158/0008-5472.CAN-05-1579; Karantza V, 2011, ONCOGENE, V30, P127, DOI 10.1038/onc.2010.456; Knudsen ES, 2012, JNCI-J NATL CANCER I, V104, P1825, DOI 10.1093/jnci/djs446; Kumar P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003027; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lu H, 2005, EUR J CELL BIOL, V84, P709, DOI 10.1016/j.ejcb.2005.04.001; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; OSHIMA RG, 1983, DEV BIOL, V99, P447, DOI 10.1016/0012-1606(83)90294-4; PIPAS JM, 1983, MOL CELL BIOL, V3, P203, DOI 10.1128/MCB.3.2.203; Reed CA, 2009, ONCOGENE, V28, P4434, DOI 10.1038/onc.2009.303; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Simin K, 2005, COLD SH Q B, V70, P283, DOI 10.1101/sqb.2005.70.038; Simin K, 2004, PLOS BIOL, V2, P194, DOI 10.1371/journal.pbio.0020022; Song Y, 2013, P NATL ACAD SCI US; Stubdal H, 1997, MOL CELL BIOL, V17, P4979, DOI 10.1128/MCB.17.9.4979; Sullivan CS, 2002, MICROBIOL MOL BIOL R, V66, P179, DOI 10.1128/MMBR.66.2.179-202.2002; Sullivan CS, 2000, MOL CELL BIOL, V20, P5749, DOI 10.1128/MCB.20.15.5749-5757.2000; SYMONDS H, 1994, CELL, V78, P703, DOI 10.1016/0092-8674(94)90534-7; Szabova L, 2012, CANCER RES, V72, P13; Viatour P, 2011, DIS MODEL MECH, V4, P581, DOI 10.1242/dmm.008060; Witkiewicz AK, 2011, AM J PATHOL, V179, P1171, DOI 10.1016/j.ajpath.2011.05.043; Xiao A, 2002, CANCER CELL, V1, P157, DOI 10.1016/S1535-6108(02)00029-6; YAN C, 1990, EMBO J, V9, P869, DOI 10.1002/j.1460-2075.1990.tb08184.x	40	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80459	10.1371/journal.pone.0080459	http://dx.doi.org/10.1371/journal.pone.0080459			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312475	gold, Green Submitted, Green Published			2022-12-25	WOS:000327944500026
J	Yu, SJ; Tseng, KY; Shen, H; Harvey, BK; Airavaara, M; Wang, Y				Yu, Seong-Jin; Tseng, Kuan-Yin; Shen, Hui; Harvey, Brandon K.; Airavaara, Mikko; Wang, Yun			Local Administration of AAV-BDNF to Subventricular Zone Induces Functional Recovery in Stroke Rats	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS VECTORS; REDUCES INFARCT SIZE; NEUROTROPHIC FACTOR; MEDIATED DELIVERY; NEUROGENESIS; EXPRESSION; ISCHEMIA; NEURONS	Migration of new neuroprogenitor cells (NPCs) from the subventricular zone (SVZ) plays an important role in neurorepair after injury. Previous studies have shown that brain derived neurotrophic factor (BDNF) enhances the migration of NPCs from SVZ explants in neonatal mice in vitro. The purpose of this study was to identify the role of BDNF in SVZ cells using AAV-BDNF in an animal model of stroke. BDNF protein production after AAV-BDNF infection was verified in primary neuronal culture. AAV-BDNF or AAV-RFP was injected into the left SVZ region of adult rats at 14 days prior to right middle cerebral artery occlusion (MCAo). SVZ tissues were collected from the brain and placed in Metrigel cultures 1 day after MCAo. Treatment with AAV-BDNF significantly increased the migration of SVZ cells in the stroke brain in vitro. In another set of animals, AAV-GFP was co-injected with AAV-BDNF or AAV-RFP to label cells in left SVZ prior to right MCAo. Local administration of AAV-BDNF significantly enhanced recovery of locomotor function and migration of GFP-positive cells from the SVZ toward the lesioned hemisphere in stroke rats. Our data suggest that focal administration of AAV-BDNF to the SVZ increases behavioral recovery post stroke, possibly through the enhancement of migration of cells from SVZ in stroke animals. Regional manipulation of BDNF expression through AAV may be a novel approach for neurorepair in stroke brains.	[Yu, Seong-Jin; Wang, Yun] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan, Taiwan; [Yu, Seong-Jin; Shen, Hui; Harvey, Brandon K.; Wang, Yun] NIDA, Neural Protect & Regenerat Sect, Intramural Res Program, Baltimore, MD USA; [Tseng, Kuan-Yin; Airavaara, Mikko] Univ Helsinki, Inst Biotechnol, Viikki Bioctr, Helsinki, Finland	National Health Research Institutes - Taiwan; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Helsinki	Wang, Y (corresponding author), Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan, Taiwan.	ywang@nhri.org.tw	Harvey, Brandon Keith/AAY-4080-2021; Harvey, Brandon K/A-5559-2010	Harvey, Brandon Keith/0000-0002-4036-1383; TSENG, KUANYIN/0000-0002-4786-0409; Airavaara, Mikko/0000-0002-2026-1609	National Institute on Drug Abuse, intramural research program; National Health Research Institutes, Taiwan; NATIONAL INSTITUTE ON DRUG ABUSE [ZICDA000555, ZIADA000443] Funding Source: NIH RePORTER	National Institute on Drug Abuse, intramural research program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institute on Drug Abuse, intramural research program and the National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson A, 2001, EUR J NEUROSCI, V14, P10, DOI 10.1046/j.0953-816x.2001.01611.x; Bagley JA, 2010, NEUROSCIENCE, V169, P1449, DOI 10.1016/j.neuroscience.2010.05.075; Bath KG, 2012, DEV PSYCHOBIOL, V54, P578, DOI 10.1002/dev.20546; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chiaramello S, 2007, EUR J NEUROSCI, V26, P1780, DOI 10.1111/j.1460-9568.2007.05818.x; Clarkson AN, 2011, J NEUROSCI, V31, P3766, DOI 10.1523/JNEUROSCI.5780-10.2011; Galvao RP, 2008, J NEUROSCI, V28, P13368, DOI 10.1523/JNEUROSCI.2918-08.2008; Grade S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055039; Harvey BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022135; Henry RA, 2007, EUR J NEUROSCI, V25, P3513, DOI 10.1111/j.1460-9568.2007.05625.x; Howard DB, 2008, VIROLOGY, V372, P24, DOI 10.1016/j.virol.2007.10.007; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Kells AP, 2004, MOL THER, V9, P682, DOI 10.1016/j.ymthe.2004.02.016; Linnarsson S, 2000, MOL BRAIN RES, V75, P61, DOI 10.1016/S0169-328X(99)00295-8; Liu HS, 2011, NEUROIMAGE, V56, P280, DOI 10.1016/j.neuroimage.2011.02.049; Lu L, 2009, BIOL PSYCHIAT, V66, P137, DOI 10.1016/j.biopsych.2009.02.009; Luo Y, 2013, J CEREBR BLOOD F MET, V33, P300, DOI 10.1038/jcbfm.2012.172; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; Petridis AK, 2011, J CLIN NEUROSCI, V18, P265, DOI 10.1016/j.jocn.2010.06.021; Ploughman M, 2009, STROKE, V40, P1490, DOI 10.1161/STROKEAHA.108.531806; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Takeshima Y, 2011, NEUROSURGERY, V68, P1334, DOI 10.1227/NEU.0b013e31820c048e; Wang Z, 2003, GENE THER, V10, P2105, DOI 10.1038/sj.gt.3302133; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Young KM, 2007, J NEUROSCI, V27, P5146, DOI 10.1523/JNEUROSCI.0654-07.2007; Zhang JY, 2011, INT J CLIN EXP PATHO, V4, P496	28	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81750	10.1371/journal.pone.0081750	http://dx.doi.org/10.1371/journal.pone.0081750			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312581	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500094
J	Brot, S; Auger, C; Bentata, R; Rogemond, V; Menigoz, S; Chounlamountri, N; Girard-Egrot, A; Honnorat, J; Moradi-Ameli, M				Brot, Sebastien; Auger, Carole; Bentata, Rabia; Rogemond, Veronique; Menigoz, Stephane; Chounlamountri, Naura; Girard-Egrot, Agnes; Honnorat, Jerome; Moradi-Ameli, Mahnaz			Collapsin Response Mediator Protein 5 (CRMP5) Induces Mitophagy, Thereby Regulating Mitochondrion Numbers in Dendrites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Cell Biology; Cell Culture; Dendrite; Mitochondria; Neurons	AUTOPHAGIC VACUOLES; NEURITE OUTGROWTH; EXPRESSION; INTERACTS; TUBULIN; PARKIN; PLASTICITY; MEMBRANES; DYNAMICS; PROMOTES	Degradation of damaged mitochondria by mitophagy is an essential process to ensure cell homeostasis. Because neurons, which have a high energy demand, are particularly dependent on the mitochondrial dynamics, mitophagy represents a key mechanism to ensure correct neuronal function. Collapsin response mediator proteins 5 (CRMP5) belongs to a family of cytosolic proteins involved in axon guidance and neurite outgrowth signaling during neural development. CRMP5, which is highly expressed during brain development, plays an important role in the regulation of neuronal polarity by inhibiting dendrite outgrowth at early developmental stages. Here, we demonstrated that CRMP5 was present in vivo in brain mitochondria and is targeted to the inner mitochondrial membrane. The mitochondrial localization of CRMP5 induced mitophagy. CRMP5 overexpression triggered a drastic change in mitochondrial morphology, increased the number of lysosomes and double membrane vesicles termed autophagosomes, and enhanced the occurrence of microtubule-associated protein 1 light chain 3 (LC3) at the mitochondrial level. Moreover, the lipidated form of LC3, LC3-II, which triggers autophagy by insertion into autophagosomes, enhanced mitophagy initiation. Lysosomal marker translocates at the mitochondrial level, suggesting autophagosome-lysosome fusion, and induced the reduction of mitochondrial content via lysosomal degradation. We show that during early developmental stages the strong expression of endogenous CRMP5, which inhibits dendrite growth, correlated with a decrease of mitochondrial content. In contrast, the knockdown or a decrease of CRMP5 expression at later stages enhanced mitochondrion numbers in cultured neurons, suggesting that CRMP5 modulated these numbers. Our study elucidates a novel regulatory mechanism that utilizes CRMP5-induced mitophagy to orchestrate proper dendrite outgrowth and neuronal function.	[Brot, Sebastien; Auger, Carole; Bentata, Rabia; Menigoz, Stephane; Chounlamountri, Naura; Honnorat, Jerome; Moradi-Ameli, Mahnaz] Fac Med Alexis Carrel, INSERM, UMR S1028, F-69372 Lyon, France; [Brot, Sebastien; Auger, Carole; Bentata, Rabia; Menigoz, Stephane; Chounlamountri, Naura; Honnorat, Jerome; Moradi-Ameli, Mahnaz] CNRS, UMR5292, F-69372 Lyon, France; [Brot, Sebastien; Auger, Carole; Bentata, Rabia; Menigoz, Stephane; Chounlamountri, Naura; Honnorat, Jerome; Moradi-Ameli, Mahnaz] Univ Lyon 1, Lyon Neurosci Res Ctr, F-69372 Lyon 08, France; [Rogemond, Veronique; Honnorat, Jerome] Hosp Civils Lyon, F-69677 Bron, France; [Menigoz, Stephane; Girard-Egrot, Agnes] Univ Lyon 1, Inst Chim & Biochim Mol & Supramol, CNRS UMR ICBMS 5246, F-69622 Villeurbanne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Moradi-Ameli, M (corresponding author), Univ Lyon 1, Fac Med Lyon Est, Lyon Neurosci Res Ctr, Rue Guillaume Paradin, F-69372 Lyon 08, France.	mahnaz.ameli-moradi@univ-lyon1.fr	Honnorat, jerome/G-6394-2017; Rogemond, Veronique/J-4824-2017; GIRARD-EGROT, Agnès/AAP-5586-2020	Honnorat, jerome/0000-0002-4721-5952; Rogemond, Veronique/0000-0003-2098-920X; GIRARD-EGROT, Agnès/0000-0003-2612-3124; BROT, Sebastien/0000-0002-4373-2135				Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Brot S, 2010, J NEUROSCI, V30, P10639, DOI 10.1523/JNEUROSCI.0059-10.2010; Burbulla LF, 2010, EUR J CLIN INVEST, V40, P1048, DOI 10.1111/j.1365-2362.2010.02354.x; Cherra SJ, 2013, AM J PATHOL, V182, P474, DOI 10.1016/j.ajpath.2012.10.027; Cho DH, 2010, CELL MOL LIFE SCI, V67, P3435, DOI 10.1007/s00018-010-0435-2; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Guillemin Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009066; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Honnorat J, 2009, J NEUROL NEUROSUR PS, V80, P412, DOI 10.1136/jnnp.2007.138016; Hotta A, 2005, MOL BIOL CELL, V16, P32, DOI 10.1091/mbc.E04-08-0679; Inatome R, 2000, J BIOL CHEM, V275, P27291; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanki T, 2010, MOL MICROBIOL, V75, P795, DOI 10.1111/j.1365-2958.2009.07035.x; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Komatsu M, 2007, CELL DEATH DIFFER, V14, P887, DOI 10.1038/sj.cdd.4402120; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lajoie P, 2005, J CELL SCI, V118, P1991, DOI 10.1242/jcs.02324; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Liu XY, 2010, MOL CELL BIOCHEM, V344, P277, DOI 10.1007/s11010-010-0552-0; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; MAGGIO B, 1994, PROG BIOPHYS MOL BIO, V62, P55, DOI 10.1016/0079-6107(94)90006-X; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Michiorri S, 2010, CELL DEATH DIFFER, V17, P962, DOI 10.1038/cdd.2009.200; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ponnusamy R, 2013, J NEUROCHEM, V125, P855, DOI 10.1111/jnc.12188; Rembutsu M, 2008, BIOCHEMISTRY-US, V47, P2153, DOI 10.1021/bi702030w; Ricard D, 2001, J NEUROSCI, V21, P7203, DOI 10.1523/JNEUROSCI.21-18-07203.2001; Rodriguez-Hernandez A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174; Rogemond V, 2008, J BIOL CHEM, V283, P14751, DOI 10.1074/jbc.M708480200; Takahashi S, 2003, GENES CELLS, V8, P81, DOI 10.1046/j.1365-2443.2003.00617.x; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Tanaka A, 2010, FEBS LETT, V584, P1386, DOI 10.1016/j.febslet.2010.02.060; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Veyrac A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023721; Wang LH, 1997, J NEUROCHEM, V69, P2261; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yamashita N, 2011, J NEUROSCI, V31, P1773, DOI 10.1523/JNEUROSCI.5337-10.2011; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Young KW, 2010, J BIOCHEM MOL TOXIC, V24, P335, DOI 10.1002/jbt.20343	51	14	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2261	2276		10.1074/jbc.M113.490862	http://dx.doi.org/10.1074/jbc.M113.490862			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24324268	Green Published, hybrid			2022-12-25	WOS:000331130200032
J	Hama, S; Kimura, Y; Mikami, A; Shiota, K; Toyoda, M; Tamura, A; Nagasaki, Y; Kanamura, K; Kajimoto, K; Kogure, K				Hama, Susumu; Kimura, Yuki; Mikami, Aya; Shiota, Kanako; Toyoda, Mao; Tamura, Atsushi; Nagasaki, Yukio; Kanamura, Kiyoshi; Kajimoto, Kazuaki; Kogure, Kentaro			Electric Stimulus Opens Intercellular Spaces in Skin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Calcium; Cell Junctions; Cell Signaling; Connexin; Iontophoresis; Transdermal Delivery; Electric Stimulus	TIGHT JUNCTIONS; BARRIER FUNCTION; DRUG-DELIVERY; CONNEXIN PHOSPHORYLATION; TRANSDERMAL DELIVERY; IONTOPHORESIS; CYTOSKELETON; CELLS; COMBINATION; INVOLVEMENT	Iontophoresis is a technology for transdermal delivery of ionic small medicines by faint electricity. Since iontophoresis can noninvasively deliver charged molecules into the skin, this technology could be a useful administration method that may enhance patient comfort. Previously, we succeeded in the transdermal penetration of positively charged liposomes (diameters: 200-400 nm) encapsulating insulin by iontophoresis (Kajimoto, K., Yamamoto, M., Watanabe, M., Kigasawa, K., Kanamura, K., Harashima, H., and Kogure, K. (2011) Int. J. Pharm. 403, 57-65). However, the mechanism by which these liposomes penetrated the skin was difficult to define based on general knowledge of principles such as electro-repulsion and electro-osmosis. In the present study, we confirmed that rigid nanoparticles could penetrate into the epidermis by iontophoresis. We further found that levels of the gap junction protein connexin 43 protein significantly decreased after faint electric stimulus (ES) treatment, although occludin, CLD-4, and ZO-1 levels were unchanged. Moreover, connexin 43 phosphorylation and filamentous actin depolymerization in vivo and in vitro were observed when permeation of charged liposomes through intercellular spaces was induced by ES. Ca2+ inflow into cells was promoted by ES with charged liposomes, while a protein kinase C inhibitor prevented ES-induced permeation of macromolecules. Consequently, we demonstrate that ES treatment with charged liposomes induced dissociation of intercellular junctions via cell signaling pathways. These findings suggest that ES could be used to regulate skin physiology.	[Hama, Susumu; Kimura, Yuki; Mikami, Aya; Shiota, Kanako; Toyoda, Mao; Kogure, Kentaro] Kyoto Pharmaceut Univ, Dept Biophys Chem, Kyoto 6078414, Japan; [Tamura, Atsushi; Nagasaki, Yukio] Univ Tsukuba, Grad Sch Pure & Appl Sci, Ibaraki 3058573, Japan; [Kanamura, Kiyoshi] TTI Ellebeau Inc, Tokyo 1400002, Japan; [Kajimoto, Kazuaki] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan	Kyoto Pharmaceutical University; University of Tsukuba; Hokkaido University	Kogure, K (corresponding author), Kyoto Pharmaceut Univ, Dept Biophys Chem, Kyoto 6078414, Japan.	kogure@mb.kyoto-phu.ac.jp	Kajimoto, Kazuaki/L-6418-2018	Kajimoto, Kazuaki/0000-0002-1636-4154; Tamura, Atsushi/0000-0003-0235-7364; Hama, Susumu/0000-0002-2989-6168	Ministry of Education, Culture, Sports, Science, and Technology of Japan [2306]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, Nanomedicine Molecular Science (No. 2306) from Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Abu Hashim II, 2010, INT J PHARMACEUT, V393, P127, DOI 10.1016/j.ijpharm.2010.04.020; Cazares-Delgadillo J, 2010, EUR J PHARM BIOPHARM, V75, P173, DOI 10.1016/j.ejpb.2010.03.011; De Vuyst E, 2009, CELL CALCIUM, V46, P176, DOI 10.1016/j.ceca.2009.07.002; Maghraby GM, 2008, EUR J PHARM SCI, V34, P203, DOI 10.1016/j.ejps.2008.05.002; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Inoue N, 2010, INT J PHARMACEUT, V391, P65, DOI 10.1016/j.ijpharm.2010.02.019; Kajimoto K, 2011, INT J PHARMACEUT, V403, P57, DOI 10.1016/j.ijpharm.2010.10.021; Kalia YN, 2004, ADV DRUG DELIVER REV, V56, P619, DOI 10.1016/j.addr.2003.10.026; Kigasawa K, 2010, INT J PHARMACEUT, V383, P157, DOI 10.1016/j.ijpharm.2009.08.036; Kigasawa K, 2012, BIOL PHARM BULL, V35, P781, DOI 10.1248/bpb.35.781; Kigasawa K, 2011, J CONTROL RELEASE, V150, P256, DOI 10.1016/j.jconrel.2011.01.018; Kigasawa K, 2009, BIOL PHARM BULL, V32, P684, DOI 10.1248/bpb.32.684; Kirn-Safran C, 2009, CELL MOL LIFE SCI, V66, P3421, DOI 10.1007/s00018-009-0096-1; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Li C, 2001, J MUSCLE RES CELL M, V22, P521, DOI 10.1023/A:1015026530258; Lurtz MM, 2003, AM J PHYSIOL-CELL PH, V285, pC1475, DOI 10.1152/ajpcell.00361.2002; Meidan VM, 2003, INT J PHARMACEUT, V264, P73, DOI 10.1016/S0378-5173(03)00390-9; Miyoshi J, 2008, BBA-BIOMEMBRANES, V1778, P670, DOI 10.1016/j.bbamem.2007.12.014; Nagasawa K, 2006, J CELL PHYSIOL, V208, P123, DOI 10.1002/jcp.20647; Ohtake K, 2003, PHARM RES, V20, P1838, DOI 10.1023/B:PHAM.0000003383.86238.d1; Park JH, 2008, CELL PROLIFERAT, V41, P786, DOI 10.1111/j.1365-2184.2008.00552.x; Peixoto EBMI, 2005, CELL STRUCT FUNCT, V29, P165, DOI 10.1247/csf.29.165; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Sonaje K, 2012, MOL PHARMACEUT, V9, P1271, DOI 10.1021/mp200572t; Tamura A, 2009, BIOMACROMOLECULES, V10, P1818, DOI 10.1021/bm900252d; Tunggal JA, 2005, EMBO J, V24, P1146, DOI 10.1038/sj.emboj.7600605; Vemulapalli V, 2008, DRUG DELIV, V15, P437, DOI [10.1080/10717540802035145, 10.1080/10717540802035145 ]; Yamamoto T, 2008, ARCH DERMATOL RES, V300, P517, DOI 10.1007/s00403-008-0868-8	31	24	24	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2450	2456		10.1074/jbc.M113.514414	http://dx.doi.org/10.1074/jbc.M113.514414			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24318878	hybrid, Green Published			2022-12-25	WOS:000331130200048
J	Alves, CH; Bossers, K; Vos, RM; Essing, AHW; Swagemakers, S; van der Spek, PJ; Verhaagen, J; Wijnholds, J				Alves, Celso Henrique; Bossers, Koen; Vos, Rogier M.; Essing, Anke H. W.; Swagemakers, Sigrid; van der Spek, Peter J.; Verhaagen, Joost; Wijnholds, Jan			Microarray and Morphological Analysis of Early Postnatal CRB2 Mutant Retinas on a Pure C57BL/6J Genetic Background	PLOS ONE			English	Article							MOUSE RETINA; PHOTORECEPTOR MORPHOGENESIS; CRUMBS COMPLEX; CELL-FATE; EXPRESSION; DROSOPHILA; DEGENERATION; DETERMINANT; DYSTROPHIES; PIGMENTOSA	In humans, the Crumbs homologue-1 (CRB1) gene is mutated in progressive types of autosomal recessive retinitis pigmentosa and Leber congenital amaurosis. The severity of the phenotype due to human CRB1 or mouse Crb1 mutations is dependent on the genetic background. Mice on C57BL/6J background with Crb1 mutations show late onset of retinal spotting phenotype or no phenotype. Recently, we showed that conditional deletion of mouse Crb2 in the retina results in early retinal disorganization leading to severe and progressive retinal degeneration with concomitant visual loss that mimics retinitis pigmentosa due to mutations in the CRB1 gene. Recent studies in the fruit fly and zebrafish suggest roles of the Crumbs (CRB) complex members in the regulation of cellular signalling pathways including the Notch1, mechanistic target of rapamycin complex 1 (mTORC1) and the Hippo pathway. Here, we demonstrate that mice backcrossed to C57BL/6J background with loss of CRB2 in the retina show a progressive disorganization and degeneration phenotype during late retinal development. We used microarray gene profiling to study the transcriptome of retinas lacking CRB2 during late retinal development. Unexpectedly, the retinas of newborn mice lacking CRB2 showed no changes in the transcriptome during retinal development. These findings suggest that loss of CRB2 in the developing retina results in retinal disorganization and subsequent degeneration without major changes in the transcriptome of the retina. These mice might be an interesting model to study the onset of retinal degeneration upon loss of CRB proteins.	[Alves, Celso Henrique; Vos, Rogier M.; Wijnholds, Jan] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Neuromed Genet, Amsterdam, Netherlands; [Bossers, Koen; Essing, Anke H. W.; Verhaagen, Joost] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Neuroregenerat, Amsterdam, Netherlands; [Swagemakers, Sigrid; van der Spek, Peter J.] Erasmus Univ, Med Ctr, Dept Bioinformat, Rotterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Erasmus University Rotterdam; Erasmus MC	Wijnholds, J (corresponding author), Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Neuromed Genet, Amsterdam, Netherlands.	j.wijnholds@nin.knaw.nl	Verhaagen, Joost/G-4773-2012; Alves, Henrique/AAH-3017-2019; Wijnholds, Jan/V-3896-2018	Alves, Henrique/0000-0001-9776-5701; Wijnholds, Jan/0000-0003-0099-460X; Bossers, Koen/0000-0002-0272-4518	Rotterdamse Vereniging Blindenbelangen; Landelijke St. voor Blinden en Slechtzienden; St. Blindenhulp; St. Oogfonds Nederland; St. Retina Nederland; Netherlands Institute for Neuroscience; Foundation Fighting Blindness [TA-GT-0811-0540-NIN]; Netherlands Organisation for Health Research and Development (ZonMw) [43200004]; European Union [HEALTH-F2-2008-200234]	Rotterdamse Vereniging Blindenbelangen; Landelijke St. voor Blinden en Slechtzienden; St. Blindenhulp; St. Oogfonds Nederland; St. Retina Nederland; Netherlands Institute for Neuroscience; Foundation Fighting Blindness(European Commission); Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); European Union(European Commission)	This work was supported by Rotterdamse Vereniging Blindenbelangen, Landelijke St. voor Blinden en Slechtzienden, St. Blindenhulp, St. Oogfonds Nederland, St. Retina Nederland, Netherlands Institute for Neuroscience, Foundation Fighting Blindness (TA-GT-0811-0540-NIN), and The Netherlands Organisation for Health Research and Development (ZonMw grant 43200004 to J.W.), European Union (HEALTH-F2-2008-200234 to J.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CH, 2013, HUM MOL GENET, V22, P35, DOI 10.1093/hmg/dds398; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI 10.2307/2346101; Bossers K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-112; Chen CL, 2010, P NATL ACAD SCI USA, V107, P15810, DOI 10.1073/pnas.1004060107; Cho SH, 2012, HUM MOL GENET, V21, P2663, DOI 10.1093/hmg/dds091; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; den Hollander AI, 2004, HUM MUTAT, V24, P355, DOI 10.1002/humu.20093; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; Diaz E, 2003, P NATL ACAD SCI USA, V100, P5491, DOI 10.1073/pnas.0831080100; Dorrell MI, 2004, INVEST OPHTH VIS SCI, V45, P1009, DOI 10.1167/iovs.03-0806; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farjo R, 2002, VISION RES, V42, P463, DOI 10.1016/S0042-6989(01)00219-X; Farkas RH, 2004, INVEST OPHTH VIS SCI, V45, P2503, DOI 10.1167/iovs.03-1391; Fu XY, 2006, DEV BIOL, V299, P424, DOI 10.1016/j.ydbio.2006.08.015; Gustincich S, 2004, P NATL ACAD SCI USA, V101, P5069, DOI 10.1073/pnas.0400913101; Herranz H, 2006, EMBO REP, V7, P297, DOI 10.1038/sj.embor.7400617; Kim S, 2010, NEURON, V66, P69, DOI 10.1016/j.neuron.2010.03.019; Liu Mu-Gen, 2008, J Ocul Biol Dis Infor, V1, P59, DOI 10.1007/s12177-008-9009-z; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Massey-Harroche D, 2007, HUM MOL GENET, V16, P529, DOI 10.1093/hmg/ddl485; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Mitsuishi Y, 2010, J BIOL CHEM, V285, P14920, DOI 10.1074/jbc.M109.038760; Mu XQ, 2004, DEVELOPMENT, V131, P1197, DOI 10.1242/dev.01010; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ohata S, 2011, NEURON, V69, P215, DOI 10.1016/j.neuron.2010.12.026; Park B, 2011, J NEUROSCI, V31, P17230, DOI 10.1523/JNEUROSCI.4430-11.2011; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Pellissier LP, 2013, PLOS GENET IN PRESS; Richard M, 2006, HUM MOL GENET, V15, pR235, DOI 10.1093/hmg/ddl195; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; van de Pavert SA, 2007, GLIA, V55, P1486, DOI 10.1002/glia.20561; van de Pavert SA, 2007, J NEUROSCI, V27, P564, DOI 10.1523/JNEUROSCI.3496-06.2007; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zhang SSM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-48; Zhang SSM, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-40; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Znoiko SL, 2005, INVEST OPHTH VIS SCI, V46, P1473, DOI 10.1167/iovs.04-0653	42	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82532	10.1371/journal.pone.0082532	http://dx.doi.org/10.1371/journal.pone.0082532			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324803	Green Published, gold, Green Submitted			2022-12-25	WOS:000328566700084
J	He, YF; Zhang, MY; Wu, X; Sun, XJ; Xu, T; He, QZ; Di, W				He, Yi-feng; Zhang, Mei-ying; Wu, Xin; Sun, Xiang-jun; Xu, Ting; He, Qi-zhi; Di, Wen			High MUC2 Expression in Ovarian Cancer Is Inversely Associated with the M1/M2 Ratio of Tumor-Associated Macrophages and Patient Survival Time	PLOS ONE			English	Article							DIFFERENTIAL-DIAGNOSIS; MUCINS; M1; CARCINOMA; RECEPTOR; M2; GROWTH; CYCLOOXYGENASE-2; INDUCTION; PHENOTYPE	Mucin 2 (MUC2) is a mucin molecule aberrantly expressed by ovarian cancer cells. Previous in vitro studies have indicated that MUC2 promotes cancer growth and metastasis through a tumor-associated macrophage (TAM)-dependent mechanism. However, this mechanism has never been linked to clinical oncology, and its prognostic significance needed to be clarified. Here, we collected 102 consecutive ovarian cancer specimens and used the multiple immuno-histo-chemical/-fluorescent technique to determine the correlations between the MUC2 expression status, the ratio of M1/M2 TAMs and the densities of cyclooxygenase-2 (COX-2)(+) TAMs and COX-2(+) cancer cells. The Kaplan-Meier survival analysis and multivariate Cox regression analysis were used to evaluate the prognostic influences of these parameters. As a result, we found that the MUC2 overexpression (immunostaining ++/+++) was significantly correlated with a reduced ratio of M1/M2 TAMs (p<0.001), an increased density of COX-2(+) TAMs (p<0.001) and an increased density of COX-2(+) cancer cells (p=0.017). Moreover, most of the M2 TAMs (93%-100%) and COX-2(+) TAMs (63%-89%) overlapped; and the COX-2(+) cancer cells were frequently observed near the COX-2(+) TAMs. In the Cox regression analysis, MUC2 overexpression was found to be an independent prognostic factor for ovarian cancer patients, of which the hazard ratio (HR) was 2.354 (95% confidence interval (CI): 1.031-10.707, p=0.005). Also, the reduced ratio of M1/M2 TAMs and the increased densities of COX-2(+) TAMs and COX-2(+) cancer cells were demonstrated to be the predictors of poor prognosis, among which the reduced M1/M2 ratio possessed the highest HR (1.767, 95% CI: 1.061-6.957, p=0.019). All these findings revealed that MUC2 can concurrently exert M2-polarizing and COX-2-inducing effects on TAMs, by which it causes an imbalanced TAM M1-/M2-polarization pattern and induces local PGE(2) synthesis (in both TAMs and cancer cells). The positive feedback between local PGE2 synthesis and TAM M2-polarization accelerates ovarian cancer progression.	[He, Yi-feng; Zhang, Mei-ying; Sun, Xiang-jun; Di, Wen] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Key Lab Gynecol Oncol, Dept Obstet & Gynecol,Sch Med, Shanghai 200030, Peoples R China; [Wu, Xin] Fudan Univ, Dept Gynecol, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China; [Xu, Ting] Fudan Univ, Dept Pathol, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China; [He, Qi-zhi] Tongji Univ, Matern & Infant Hlth Hosp 1, Dept Pathol, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Fudan University; Fudan University; Tongji University	Di, W (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Key Lab Gynecol Oncol, Dept Obstet & Gynecol,Sch Med, Shanghai 200030, Peoples R China.	diwen163@163.com			Key Disciplines and Specialties Foundation of the Shanghai Health Bureau; Key Disciplines Foundation of the Shanghai Education Commission [08YZ43]; Science Research Foundation of the Shanghai Science and Technology Commission [12411950200]; Key Discipline Project of Renji Hospital, School of Medicine, Shanghai Jiaotong University; China Post-doctoral Science Foundation [2011M500795]; National Natural Science Foundation of China [81272882, 81072137]	Key Disciplines and Specialties Foundation of the Shanghai Health Bureau; Key Disciplines Foundation of the Shanghai Education Commission; Science Research Foundation of the Shanghai Science and Technology Commission; Key Discipline Project of Renji Hospital, School of Medicine, Shanghai Jiaotong University; China Post-doctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Key Disciplines and Specialties Foundation of the Shanghai Health Bureau, the Key Disciplines Foundation of the Shanghai Education Commission (grant number 08YZ43), the Science Research Foundation of the Shanghai Science and Technology Commission (grant number 12411950200), the Key Discipline Project of Renji Hospital, School of Medicine, Shanghai Jiaotong University, the China Post-doctoral Science Foundation (grant number 2011M500795), and the National Natural Science Foundation of China (grant numbers 81272882 and 81072137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algars A, 2012, INT J CANCER, V131, P864, DOI 10.1002/ijc.26457; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Boman F, 2001, J PATHOL, V193, P339, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH798>3.0.CO;2-9; Cardillo MR, 2000, J EXP CLIN CANC RES, V19, P225; Charoentong P, 2012, CANCER IMMUNOL IMMUN, V61, P1885, DOI 10.1007/s00262-012-1354-x; Chen KW, 2013, J PROTEOME RES, V12, P1408, DOI 10.1021/pr3010474; Comamala M, 2011, BRIT J CANCER, V104, P989, DOI 10.1038/bjc.2011.34; DENNY L, 2006, STAGING CLASSIFICATI; Di Virgilio F, 2012, CANCER RES, V72, P5441, DOI 10.1158/0008-5472.CAN-12-1600; Dong Y, 1997, J PATHOL, V183, P311, DOI 10.1002/(SICI)1096-9896(199711)183:3<311::AID-PATH917>3.0.CO;2-2; du Bois A, 2005, ANN ONCOL, V16, P7, DOI 10.1093/annonc/mdi961; Edin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047045; EMI M, 1993, J BIOL CHEM, V268, P2120; Espinosa I, 2011, AM J PATHOL, V179, P2100, DOI 10.1016/j.ajpath.2011.06.021; Feng H, 2002, JPN J CLIN ONCOL, V32, P525, DOI 10.1093/jjco/hyf111; Ghosh DK, 2001, INFECT IMMUN, V69, P7703, DOI 10.1128/IAI.69.12.7703-7710.2001; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; HAMBERG M, 1971, J BIOL CHEM, V246, P6713; Harrison ML, 2008, INT J GYNECOL CANCER, V18, P209, DOI 10.1111/j.1525-1438.2007.01022.x; Hasita H, 2010, CANCER SCI, V101, P1913, DOI 10.1111/j.1349-7006.2010.01614.x; Heusinkveld M, 2011, J IMMUNOL, V187, P1157, DOI 10.4049/jimmunol.1100889; Hu XF, 2006, EXPERT REV ANTICANC, V6, P1261, DOI 10.1586/14737140.6.8.1261; Inaba T, 2003, P NATL ACAD SCI USA, V100, P2736, DOI 10.1073/pnas.0435410100; Johansson MEV, 2011, CELL MOL LIFE SCI, V68, P3635, DOI 10.1007/s00018-011-0822-3; Karavitis J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046342; Kasashima S, 2007, VIRCHOWS ARCH, V450, P397, DOI 10.1007/s00428-007-0381-z; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Ma JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-112; Maher DM, 2011, MOL CANCER RES, V9, P531, DOI 10.1158/1541-7786.MCR-10-0443; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; MANTOVANI A, 2006, DRUG DISCOV TODAY TH, V3, P361, DOI DOI 10.1016/J.DDSTR.2006.07.001; MATSUMOTO A, 1990, P NATL ACAD SCI USA, V87, P9133, DOI 10.1073/pnas.87.23.9133; Nakanishi Y, 2011, CARCINOGENESIS, V32, P1333, DOI 10.1093/carcin/bgr128; Neeman E, 2012, CLIN CANCER RES, V18, P4895, DOI 10.1158/1078-0432.CCR-12-1087; Ohri CM, 2009, EUR RESPIR J, V33, P118, DOI 10.1183/09031936.00065708; Permuth-Wey Jennifer, 2009, V472, P413, DOI 10.1007/978-1-60327-492-0_20; Redente EF, 2010, AM J PATHOL, V176, P2972, DOI 10.2353/ajpath.2010.090879; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Shen ZL, 2012, CYTOKINE, V59, P352, DOI 10.1016/j.cyto.2012.04.033; Shin JH, 2010, JPN J CLIN ONCOL, V40, P208, DOI 10.1093/jjco/hyp150; Singh AP, 2008, LANCET ONCOL, V9, P1076, DOI 10.1016/S1470-2045(08)70277-8; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; Takai H, 2009, CANCER BIOL THER, V8, P2329, DOI 10.4161/cbt.8.24.9985; TASHIRO Y, 1994, HUM PATHOL, V25, P364, DOI 10.1016/0046-8177(94)90144-9; Tornos C, 2005, AM J SURG PATHOL, V29, P1482, DOI 10.1097/01.pas.0000176429.88702.36; Torroella-Kouri M, 2009, CANCER RES, V69, P4800, DOI 10.1158/0008-5472.CAN-08-3427; Zhang BC, 2011, CLINICS, V66, P1879, DOI 10.1590/S1807-59322011001100006; Zhang J, 2010, JNCI-J NATL CANCER I, V102, P522, DOI 10.1093/jnci/djq044; Zhu XD, 2011, J BIOL CHEM, V286, P8231, DOI 10.1074/jbc.M110.145888	50	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e79769	10.1371/journal.pone.0079769	http://dx.doi.org/10.1371/journal.pone.0079769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324582	Green Submitted, Green Published, gold			2022-12-25	WOS:000328566700003
J	Huang, YJ; Lai, HH; Xu, HW; Wu, WZ; Lai, XL; Ho, GY; Ma, L; Chen, YB				Huang, Yuejun; Lai, Huihong; Xu, Hongwu; Wu, Weizhao; Lai, Xiulan; Ho, Guyu; Ma, Lian; Chen, Yunbin			Impact of Perinatal Systemic Hypoxic-Ischemic Injury on the Brain of Male Offspring Rats: An Improved Model of Neonatal Hypoxic-Ischemic Encephalopathy in Early Preterm Newborns	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; APOPTOSIS; EXPRESSION; DAMAGE; MOUSE; SEX; AGE	In this study, we attempted to design a model using Sprague-Dawley rats to better reproduce perinatal systemic hypoxic-ischemic encephalopathy (HIE) in early preterm newborns. On day 21 of gestation, the uterus of pregnant rats were exposed and the blood supply to the fetuses of neonatal HIE groups were thoroughly abscised by hemostatic clamp for 5, 10 or 15 min. Thereafter, fetuses were moved from the uterus and manually stimulated to initiate breathing in an incubator at 37 degrees C for 1 hr in air. We showed that survival rates of offspring rats were decreased with longer hypoxic time. TUNEL staining showed that apoptotic cells were significant increased in the brains of offspring rats from the 10 min and 15 min HIE groups as compared to the offspring rats in the control group at postnatal day (PND) 1, but there was no statistical difference between the offspring rats in the 5 min HIE and control groups. The perinatal hypoxic treatment resulted in decreased neurons and increased cleaved caspase-3 protein levels in the offspring rats from all HIE groups at PND 1. Platform crossing times and the percentage of the time spent in the target quadrant of Morris Water Maze test were significantly reduced in the offspring rats of all HIE groups at PND 30, which were associated with decreased brain-derived neurotrophic factor levels and neuronal cells in the hippocampus of offspring rats at PND 35. These data demonstrated that perinatal ischemic injury led to the death of neuronal cells and long-lasting impairment of memory. This model reproduced hypoxic ischemic encephalopathy in early preterm newborns and may be appropriate for investigating therapeutic interventions.	[Huang, Yuejun; Xu, Hongwu; Ma, Lian] Shantou Univ, Coll Med, Affiliated Hosp 2, Transforming Med Ctr, Shantou, Guangdong, Peoples R China; [Huang, Yuejun; Lai, Huihong; Wu, Weizhao; Lai, Xiulan; Ho, Guyu; Ma, Lian] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Pediat, Shantou, Guangdong, Peoples R China; [Xu, Hongwu] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Neurosurg, Shantou, Guangdong, Peoples R China; [Chen, Yunbin] Maternal & Child Hlth Hosp Guangdong Prov, Guangzhou, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University	Ma, L (corresponding author), Shantou Univ, Coll Med, Affiliated Hosp 2, Transforming Med Ctr, Shantou, Guangdong, Peoples R China.	malian8965@sina.com; yunbin_chen@hotmail.com	Lai, Xiula/GMX-1854-2022		National Natural Science Foundation of China [81070478]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (81070478). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cannata DJ, 2010, PEDIATR RES, V68, P393, DOI 10.1203/PDR.0b013e3181f1c048; CHAPMAN RS, 1995, CYTOMETRY, V20, P245, DOI 10.1002/cyto.990200308; de Vries LS, 2010, ARCH DIS CHILD-FETAL, V95, pF220, DOI 10.1136/adc.2008.148205; DellAnna E, 1997, NEUROSCI LETT, V223, P201, DOI 10.1016/S0304-3940(97)13411-5; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Graham EM, 2008, AM J OBSTET GYNECOL, V199, P587, DOI 10.1016/j.ajog.2008.06.094; Greenfield Antije L., 1999, Semin Musculoskelet Radiol, V3, P317, DOI 10.1055/s-2008-1080076; Han BH, 2000, NEUROBIOL DIS, V7, P38; Horn AR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-52; Huang YJ, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-22; Huang YJ, 2010, NEUROCHEM RES, V35, P1038, DOI 10.1007/s11064-010-0152-0; Hurn PD, 2005, STROKE, V36, P193, DOI 10.1161/01.STR.0000153064.41332.f6; Ireland Z, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.790; Johnston MV, 2007, DEV MED CHILD NEUROL, V49, P74, DOI 10.1017/S0012162207000199; Kanbak G, 2013, GENE, V512, P492, DOI 10.1016/j.gene.2012.10.012; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kohlhauser C, 1999, LIFE SCI, V64, P2109, DOI 10.1016/S0024-3205(99)00160-5; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; LEVINE S, 1960, AM J PATHOL, V36, P1; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Nijboer CH, 2013, NEUROBIOL DIS, V54, P432, DOI 10.1016/j.nbd.2013.01.017; Pimentel-Coelho PM, 2012, PEDIATR RES, V71, P464, DOI 10.1038/pr.2011.59; Ponsuksili S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-367; Rau TF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047877, 10.1371/journal.pone.0040881]; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rossato JI, 2007, LEARN MEMORY, V14, P36, DOI 10.1101/lm.422607; Towfighi J, 1997, DEV BRAIN RES, V100, P149, DOI 10.1016/S0165-3806(97)00036-9; Tsuji M, 2004, EXP NEUROL, V189, P58, DOI 10.1016/j.expneurol.2004.01.011; van Laerhoven H, 2013, PEDIATRICS, V131, P88, DOI 10.1542/peds.2012-1297; Vannucci RC, 1997, BIOL NEONATE, V72, P187; Walsh BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050520; Walters J, 2009, BIOCHEM J, V424, P335, DOI 10.1042/BJ20090825; Yon JH, 2005, NEUROSCIENCE, V135, P815, DOI 10.1016/j.neuroscience.2005.03.064	36	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82502	10.1371/journal.pone.0082502	http://dx.doi.org/10.1371/journal.pone.0082502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324800	gold, Green Submitted, Green Published			2022-12-25	WOS:000328566700083
J	Forcelli, PA; Kalikhman, D; Gale, K				Forcelli, Patrick A.; Kalikhman, David; Gale, Karen			Delayed Effect of Craniotomy on Experimental Seizures in Rats	PLOS ONE			English	Article							EMBRYONIC DOPAMINE NEURONS; SEVERE PARKINSONS-DISEASE; SHAM NEUROSURGICAL PROCEDURES; INTRACTABLE PARTIAL EPILEPSY; TRAUMATIC BRAIN-INJURY; ELECTRICAL-STIMULATION; DEPTH ELECTRODES; ANTERIOR NUCLEUS; GENE-EXPRESSION; CLINICAL-TRIALS	Neurosurgical therapeutic interventions include components that are presumed to be therapeutically inert, such as craniotomy and electrode implantation. Because these procedures may themselves exert neuroactive actions, with anecdotal evidence suggesting that craniotomy and electrode placement may have a particularly significant impact on epileptic seizures, the importance of their inclusion in sham control groups has become more compelling. Here we set out to test the hypothesis that craniotomy alone is sufficient to alter experimental seizures in rats. We tested adult male rats for seizures evoked by pentylenetetrazole (70 mg/kg) between 3 and 20 days following placement of bilateral craniotomies (either 2.5 or 3.5 mm in diameter) in the parietal bone of the skull, without penetrating the dura. Control (sham-operated) animals underwent anesthesia and surgery without craniotomy. We found that craniotomy significantly decreased the severity of experimental seizures on postoperative days 3, 6, and 10; this effect was dependent on the size of craniotomy. Animals with craniotomies returned to control seizure severity by 20 days post-craniotomy. These data support the hypothesis that damage to the skull is sufficient to cause a significant alteration in seizure susceptibility over an extended postoperative period, and indicate that this damage should not be considered neurologically inert.	[Forcelli, Patrick A.; Kalikhman, David; Gale, Karen] Georgetown Univ, Dept Pharmacol & Physiol, Washington, DC USA	Georgetown University	Forcelli, PA (corresponding author), Georgetown Univ, Dept Pharmacol & Physiol, Washington, DC USA.	paf22@georgetown.edu		Forcelli, Patrick/0000-0003-1763-060X	National Institutes of Health/National Institute of Child Health and Human Development [T32HD046388]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD046388] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	PAF was supported by grant number T32HD046388 from the National Institutes of Health/National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt KW, 1997, NATURE, V387, P360, DOI 10.1038/387360a0; Andrushko VA, 2008, AM J PHYS ANTHROPOL, V137, P4, DOI 10.1002/ajpa.20836; Brim RL, 2013, J MED ETHICS, V39, P703, DOI 10.1136/medethics-2012-101045; Clower WT, 2001, NEUROSURGERY, V49, P1417, DOI 10.1097/00006123-200112000-00021; Cohen PD, 2012, LANCET NEUROL, V11, P1022, DOI 10.1016/S1474-4422(12)70277-6; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Finger S, 2001, NEUROSURGERY, V48, P911, DOI 10.1097/00006123-200104000-00045; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Forcelli PA, 2011, EPILEPSIA, V52, pE20, DOI 10.1111/j.1528-1167.2010.02971.x; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Freed CR, 2011, NEUROTHERAPEUTICS, V8, P549, DOI 10.1007/s13311-011-0082-9; Galpern WR, 2012, LANCET NEUROL, V11, P643, DOI 10.1016/S1474-4422(12)70064-9; Jech R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049056; JORGENSEN JB, 1988, ACTA NEUROCHIR, V93, P3, DOI 10.1007/BF01409893; Katariwala NM, 2001, NEUROLOGY, V57, P1505, DOI 10.1212/WNL.57.8.1505; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Lim SN, 2007, EPILEPSIA, V48, P342, DOI 10.1111/j.1528-1167.2006.00898.x; LOSCHER W, 1993, NEUROCHEM RES, V18, P775, DOI 10.1007/BF00966772; LOSCHER W, 1995, BRAIN RES, V697, P197, DOI 10.1016/0006-8993(95)00843-F; Luttjohann A, 2009, PHYSIOL BEHAV, V98, P579, DOI 10.1016/j.physbeh.2009.09.005; Lv XL, 2013, WORLD NEUROSURG, V80, P897, DOI 10.1016/j.wneu.2012.08.009; Mann JM, 2009, J NEUROL NEUROSUR PS, V80, P794, DOI 10.1136/jnnp.2008.159558; Missios Symeon, 2007, Neurosurg Focus, V23, pE11; Morishita T, 2010, J NEUROSURG, V112, P491, DOI 10.3171/2009.7.JNS09150; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Ng MSM, 2006, EPILEPSY RES, V72, P97, DOI 10.1016/j.eplepsyres.2006.06.007; Olanow CW, 2001, NEW ENGL J MED, V345, P146; Panourias IG, 2005, NEUROSURGERY, V57, P181, DOI 10.1227/01.NEU.0000163416.66374.48; Papagrigorakis MJ, 2014, WORLD NEUROSURG, V81, P431, DOI 10.1016/j.wneu.2013.01.044; Redmond DE, 2001, NEW ENGL J MED, V345, P146; Schulze-Bonhage A, 2010, J NEUROL NEUROSUR PS, V81, P352, DOI 10.1136/jnnp.2009.180075; Tykocki T, 2013, STEREOT FUNCT NEUROS, V91, P12, DOI 10.1159/000342161; Verano JW, 2003, TREPANATION: HISTORY, DISCOVERY, THEORY, P223; Vonck K, 2003, ACTA NEUROL BELG, V103, P212; Wan DC, 2008, J CRANIOFAC SURG, V19, P1292, DOI 10.1097/SCS.0b013e3181843609; Wellmer J, 2012, EPILEPSIA, V53, P1322, DOI 10.1111/j.1528-1167.2012.03545.x; Wobbrock J.O., 2011, P ACM C HUM FACTORS, P143; Wu JCC, 2013, J SURG RES, V179, P138, DOI 10.1016/j.jss.2012.09.013	39	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81401	10.1371/journal.pone.0081401	http://dx.doi.org/10.1371/journal.pone.0081401			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324691	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300091
J	Hong, SW; Heo, H; Yang, JH; Han, M; Kim, DH; Kwon, YK				Hong, Sung-Woon; Heo, Hwon; Yang, Jeong-hwa; Han, Maeum; Kim, Dong-Hyun; Kwon, Yunhee Kim			Soyasaponin I Improved Neuroprotection and Regeneration in Memory Deficient Model Rats	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; ENTORHINAL CORTEX; DENTATE GYRUS; GRANULE CELLS; SEPTOTEMPORAL AXIS; SPATIAL MEMORY; STEM-CELLS; NEURONS; BRAIN; PERFORMANCE	Soy (Glycine Max Merr, family Leguminosae) has been reported to possess anti-cancer, anti-lipidemic, estrogen-like, and memory-enhancing effects. We investigated the memory-enhancing effects and the underlying mechanisms of soyasaponin I (soya-I), a major constituent of soy. Impaired learning and memory were induced by injecting ibotenic acid into the entorhinal cortex of adult rat brains. The effects of soya-I were evaluated by measuring behavioral tasks and neuronal regeneration of memory-deficient rats. Oral administration of soya-I exhibited significant memory-enhancing effects in the passive avoidance, Y-maze, and Morris water maze tests. Soya-I also increased BrdU incorporation into the dentate gyrus and the number of cell types (GAD67, ChAT, and VGluT1) in the hippocampal region of memory-deficient rats, whereas the number of reactive microglia (OX42) decreased. The mechanism underlying memory improvement was assessed by detecting the differentiation and proliferation of neural precursor cells (NPCs) prepared from the embryonic hippocampus (E16) of timed-pregnant Sprague-Dawley rats using immunocytochemical staining and immunoblotting analysis. Addition of soya-I in the cultured NPCs significantly elevated the markers for cell proliferation (Ki-67) and neuronal differentiation (NeuN, TUJ1, and MAP2). Finally, soya-I increased neurite lengthening and the number of neurites during the differentiation of NPCs. Soya-I may improve hippocampal learning and memory impairment by promoting proliferation and differentiation of NPCs in the hippocampus through facilitation of neuronal regeneration and minimization of neuro-inflammation.	[Hong, Sung-Woon; Heo, Hwon; Yang, Jeong-hwa; Han, Maeum; Kim, Dong-Hyun; Kwon, Yunhee Kim] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul, South Korea; [Heo, Hwon; Han, Maeum; Kwon, Yunhee Kim] Kyung Hee Univ, Dept Biol, Coll Sci, Seoul, South Korea	Kyung Hee University; Kyung Hee University	Kim, DH (corresponding author), Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul, South Korea.	dhkim@khu.ac.kr; kimyh@khu.ac.kr	Kwon, Yunhee Kim/AAV-8420-2021		World Class University Program through the National Research Foundation of Korea [R33-2008-000-10018-0]; National Research Foundation of Korea [2011-0019354, 2012M3A9C6049937]; Ministry of Education, Science and Technology, the Republic of Korea	World Class University Program through the National Research Foundation of Korea(National Research Foundation of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology, the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by a grant from World Class University Program through the National Research Foundation of Korea (R33-2008-000-10018-0) to DH Kim and grants from National Research Foundation of Korea (2011-0019354) and (2012M3A9C6049937) to YK Kwon, funded by the Ministry of Education, Science and Technology, the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGLETON JP, 1986, BEHAV BRAIN RES, V19, P133, DOI 10.1016/0166-4328(86)90011-2; Bansal N, 2010, J MED FOOD, V13, P1293, DOI 10.1089/jmf.2010.1132; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Cao DH, 2009, J NEUROCHEM, V111, P510, DOI 10.1111/j.1471-4159.2009.06335.x; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Coras R, 2010, BRAIN, V133, P3359, DOI 10.1093/brain/awq215; Deller T, 1996, J NEUROSCI, V16, P3322; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Donaldson J G, 2001, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0403s00; DRACHMAN DA, 1974, ARCH NEUROL-CHICAGO, V30, P113, DOI 10.1001/archneur.1974.00490320001001; Drew Michael R., 2007, CNS & Neurological Disorders-Drug Targets, V6, P205, DOI 10.2174/187152707780619353; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; File SE, 2001, PSYCHOPHARMACOLOGY, V157, P430, DOI 10.1007/s002130100845; FROTSCHER M, 1986, CELL TISSUE RES, V246, P293, DOI 10.1007/BF00215891; Fuster-Matanzo A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/260925; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Harich S, 2008, NEUROSCIENCE, V153, P918, DOI 10.1016/j.neuroscience.2008.03.017; Heo H, 2009, J ETHNOPHARMACOL, V122, P20, DOI 10.1016/j.jep.2008.11.026; Hogervorst E, 2011, BRAIN RES, V1379, P206, DOI 10.1016/j.brainres.2010.10.083; JARRARD LE, 1976, J COMP PHYSIOL PSYCH, V90, P1035, DOI 10.1037/h0078659; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Kato-Kataoka A, 2010, J CLIN BIOCHEM NUTR, V47, P246, DOI 10.3164/jcbn.10-62; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kim SL, 2006, J AGR FOOD CHEM, V54, P10003, DOI 10.1021/jf062275p; KOHLER C, 1985, J COMP NEUROL, V236, P504, DOI 10.1002/cne.902360407; LEE IA, 2010, J AGR FOOD CHEM; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lee YB, 2004, J NUTR, V134, P1827, DOI 10.1093/jn/134.7.1827; Liu YQ, 2007, NEUROSCI RES, V57, P544, DOI 10.1016/j.neures.2006.12.013; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Pan MX, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-75; Park CH, 2000, J NEUROCHEM, V74, P244, DOI 10.1046/j.1471-4159.2000.0740244.x; Park HJ, 2008, PHYTOTHER RES, V22, P1324, DOI 10.1002/ptr.2488; RUTH RE, 1982, J COMP NEUROL, V209, P69, DOI 10.1002/cne.902090107; RUTH RE, 1988, J COMP NEUROL, V270, P506, DOI 10.1002/cne.902700404; Schmadel S, 2004, NEUROSCIENCE, V128, P365, DOI 10.1016/j.neuroscience.2004.07.011; Shi J, 2004, J MED FOOD, V7, P67, DOI 10.1089/109662004322984734; Shin MH, 2002, EXP MOL MED, V34, P401, DOI 10.1038/emm.2002.57; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Snyder JS, 2009, HIPPOCAMPUS, V19, P898, DOI 10.1002/hipo.20552; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; Sun JQ, 2010, BRAIN DEV-JPN, V32, P191, DOI 10.1016/j.braindev.2009.01.004; UEKI A, 1994, J NEUROL SCI, V125, P14, DOI 10.1016/0022-510X(94)90236-4; Ueki A, 1996, J NEUROL SCI, V142, P7, DOI 10.1016/0022-510X(96)00113-X; Ueki H, 1994, Nihon Rinsho, V52, P1370; UEKI H, 1994, Z DERMATOLOGIE VENER, V45, P154, DOI DOI 10.1007/S001050050055.PUBMED:8175343; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Wati H, 2006, NEUROSCI LETT, V399, P171, DOI 10.1016/j.neulet.2006.01.056; Wen PH, 2004, EXP NEUROL, V188, P224, DOI 10.1016/j.expneurol.2004.04.002; White F, 2001, EXP NEUROL, V169, P307, DOI 10.1006/exnr.2001.7655; WITTER MP, 1988, NEUROSCI LETT, V85, P193, DOI 10.1016/0304-3940(88)90350-3; Zhang W, 2009, MOLECULES, V14, P2959, DOI 10.3390/molecules14082959; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhou ZD, 2011, CELL ADHES MIGR, V5, P280, DOI 10.4161/cam.5.4.16986	62	14	14	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81556	10.1371/journal.pone.0081556	http://dx.doi.org/10.1371/journal.pone.0081556			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324703	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300094
J	King, AJ; Furtbauer, I; Mamuneas, D; James, C; Manica, A				King, Andrew J.; Fuertbauer, Ines; Mamuneas, Diamanto; James, Charlotte; Manica, Andrea			Sex-Differences and Temporal Consistency in Stickleback Fish Boldness	PLOS ONE			English	Article							RISK-TAKING BEHAVIOR; 3-SPINED STICKLEBACK; GASTEROSTEUS-ACULEATUS; SOCIAL-CONTEXT; PERSONALITY; POPULATIONS; ECOLOGY; AGGRESSION; EVOLUTION; GUPPY	Behavioural traits that co-vary across contexts or situations often reflect fundamental trade-offs which individuals experience in different contexts (e. g. fitness trade-offs between exploration and predation risk). Since males tend to experience greater variance in reproductive success than females, there may be considerable fitness benefits associated with "bolder" behavioural types, but only recently have researchers begun to consider sex-specific and life-history strategies associated with these. Here we test the hypothesis that male three-spined sticklebacks (Gasterosteus aculeatus) show high risk but potentially high return behaviours compared to females. According to this hypothesis we predicted that male fish would show greater exploration of their environment in a foraging context, and be caught sooner by an experimenter than females. We found that the time fish spent out of cover exploring their environment was correlated over two days, and males spent significantly more time out of cover than females. Also, the order in which fish were net-caught from their holding aquarium by an experimenter prior to experiments was negatively correlated with the time spent out of cover during tests, and males tended to be caught sooner than females. Moreover, we found a positive correlation between the catch number prior to our experiments and nine months after, pointing towards consistent, long-term individual differences in behaviour.	[King, Andrew J.; Fuertbauer, Ines] Swansea Univ, Coll Sci, Dept Biosci, Swansea, W Glam, Wales; [King, Andrew J.; Mamuneas, Diamanto; James, Charlotte] Univ London Royal Vet Coll, Struct & Mot Lab, Hatfield, Herts, England; [King, Andrew J.; Manica, Andrea] Univ Cambridge, Dept Zool, Evolutionary Ecol Grp, Cambridge, England	Swansea University; University of London; University of London Royal Veterinary College; University of Cambridge	King, AJ (corresponding author), Swansea Univ, Coll Sci, Dept Biosci, Swansea, W Glam, Wales.	a.j.king@swansea.ac.uk	Manica, Andrea/B-5497-2008; Manica, Andrea/N-9013-2019	Manica, Andrea/0000-0003-1895-450X; Manica, Andrea/0000-0003-1895-450X; Furtbauer, Ines/0000-0003-1404-6280; james, charlotte/0000-0001-9415-8244	NERC Postdoctoral Fellowship [NE/H016600/2]; BBSRC; NERC [NE/H016600/3, NE/H016600/2] Funding Source: UKRI; Natural Environment Research Council [NE/H016600/3, NE/H016600/2] Funding Source: researchfish	NERC Postdoctoral Fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a NERC Postdoctoral Fellowship awarded to A.J.K (NE/H016600/2) and D.M. was supported by a BBSRC studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archard GA, 2011, BEHAV PROCESS, V86, P52, DOI 10.1016/j.beproc.2010.09.002; Bell AM, 2007, P ROY SOC B-BIOL SCI, V274, P755, DOI 10.1098/rspb.2006.0199; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Bell AM, 2004, ANIM BEHAV, V68, P1339, DOI 10.1016/j.anbehav.2004.05.007; Biro PA, 2009, TRENDS ECOL EVOL, V24, P66, DOI 10.1016/j.tree.2008.11.001; Candolin U, 1999, P ROY SOC B-BIOL SCI, V266, P785, DOI 10.1098/rspb.1999.0706; Candolin U, 2000, BEHAV ECOL SOCIOBIOL, V49, P57, DOI 10.1007/s002650000267; Carter AJ, 2013, BIOL REV, V88, P465, DOI 10.1111/brv.12007; Carter AJ, 2012, ANIM BEHAV, V84, P603, DOI 10.1016/j.anbehav.2012.06.015; Carter AJ, 2012, ANIM BEHAV, V83, P1051, DOI 10.1016/j.anbehav.2012.01.033; CHELLAPPA S, 1989, J FISH BIOL, V35, P315, DOI 10.1111/j.1095-8649.1989.tb02982.x; CLUTTONBROCK TH, 1991, NATURE, V351, P58; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Cote J, 2012, ANIM BEHAV, V83, P1469, DOI 10.1016/j.anbehav.2012.03.019; Croft DP, 2003, OECOLOGIA, V137, P62, DOI 10.1007/s00442-003-1268-6; Dammhahn M, 2012, P ROY SOC B-BIOL SCI, V279, P2645, DOI 10.1098/rspb.2012.0212; David M, 2012, ETHOLOGY, V118, P932, DOI 10.1111/j.1439-0310.2012.02085.x; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; Edenbrow M, 2011, ANIM BEHAV, V82, P731, DOI 10.1016/j.anbehav.2011.07.003; FITZGERALD GJ, 1989, EXP BIOL, V48, P295; Harcourt J, 2010, BOLDNESS SOCIAL INTE; Harcourt JL, 2010, ETHOLOGY, V116, P440, DOI 10.1111/j.1439-0310.2010.01757.x; Harcourt JL, 2009, ANIM BEHAV, V77, P1501, DOI 10.1016/j.anbehav.2009.03.004; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; Harris S, 2010, OIKOS, V119, P1711, DOI 10.1111/j.1600-0706.2010.18028.x; Hedrick AV, 2012, BEHAV ECOL SOCIOBIOL, V66, P407, DOI 10.1007/s00265-011-1286-z; Herczeg G, 2009, J EVOLUTION BIOL, V22, P544, DOI 10.1111/j.1420-9101.2008.01674.x; Huntingford FA, 2009, J FISH BIOL, V75, P1943, DOI 10.1111/j.1095-8649.2009.02420.x; HUNTINGFORD FA, 1976, ANIM BEHAV, V24, P245, DOI 10.1016/S0003-3472(76)80034-6; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; MAGURRAN AE, 1994, P ROY SOC B-BIOL SCI, V255, P31, DOI 10.1098/rspb.1994.0005; Magurran AE, 2001, BIOL J LINN SOC, V73, P1, DOI [10.1006/bijl.2000.0519, 10.1111/j.1095-8312.2001.tb01342.x]; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; Nannini MA, 2012, T AM FISH SOC, V141, P26, DOI 10.1080/00028487.2011.639268; Parker G.A., 1979, P123; Piyapong C, 2010, BEHAV ECOL, V21, P3, DOI 10.1093/beheco/arp142; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Reale D, 2010, PHILOS T R SOC B, V365, P4051, DOI 10.1098/rstb.2010.0208; Reaney LT, 2007, BEHAV ECOL, V18, P521, DOI 10.1093/beheco/arm014; Scharer L, 2012, TRENDS ECOL EVOL, V27, P260, DOI 10.1016/j.tree.2011.12.006; Schuett W, 2010, BIOL REV, V85, P217, DOI 10.1111/j.1469-185X.2009.00101.x; Sih A, 2008, ADV STUD BEHAV, V38, P227, DOI 10.1016/S0065-3454(08)00005-3; Sih A, 2011, DEV PRIMATOL-PROG PR, P313, DOI 10.1007/978-1-4614-0176-6_12; Smith C, 1999, J FISH BIOL, V54, P1132, DOI 10.1006/jfbi.1999.0940; SMITH JM, 1977, ANIM BEHAV, V25, P1, DOI 10.1016/0003-3472(77)90062-8; Smith KL, 2009, BEHAVIOUR, V146, P283, DOI 10.1163/156853909X410784; Tolulope OA, 2013, BEHAV ECOLOGY; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; van den Bos R, 2013, BEHAV BRAIN RES, V238, P95, DOI 10.1016/j.bbr.2012.10.002; van den Bos R, 2012, BEHAV BRAIN RES, V234, P375, DOI 10.1016/j.bbr.2012.07.015; van Oers K, 2005, BEHAV ECOL, V16, P716, DOI 10.1093/beheco/ari045; von Merten S, 2012, ANIM BEHAV, V84, P29, DOI 10.1016/j.anbehav.2012.04.002; Ward AJW, 2004, BEHAV ECOL, V15, P925, DOI 10.1093/beheco/arh097; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; Webster MM, 2007, BEHAVIOUR, V144, P351, DOI 10.1163/156853907780425721; Webster MM, 2011, P ROY SOC B-BIOL SCI, V278, P619, DOI 10.1098/rspb.2010.1562; Webster MM, 2011, BIOL REV, V86, P759, DOI 10.1111/j.1469-185X.2010.00169.x; Williams LJ, 2012, ANIM BEHAV, V84, P159, DOI 10.1016/j.anbehav.2012.04.025; Wilson ADM, 2011, CAN J FISH AQUAT SCI, V68, P749, DOI 10.1139/F2011-019; WILSON DS, 1993, J COMP PSYCHOL, V107, P250, DOI 10.1037/0735-7036.107.3.250; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835	63	36	36	0	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81116	10.1371/journal.pone.0081116	http://dx.doi.org/10.1371/journal.pone.0081116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324664	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300071
J	van Leuken, JPG; Havelaar, AH; van der Hoek, W; Ladbury, GAF; Hackert, VH; Swart, AN				van Leuken, Jeroen P. G.; Havelaar, Arie H.; van der Hoek, Wim; Ladbury, Georgia A. F.; Hackert, Volker H.; Swart, Arno N.			A Model for the Early Identification of Sources of Airborne Pathogens in an Outdoor Environment	PLOS ONE			English	Article							Q-FEVER EPIDEMIC; COXIELLA-BURNETII; DAIRY GOAT; NETHERLANDS; OUTBREAK; FARMS; SEROPREVALENCE; SHEEP	Background: Source identification in areas with outbreaks of airborne pathogens is often time-consuming and expensive. We developed a model to identify the most likely location of sources of airborne pathogens. Methods: As a case study, we retrospectively analyzed three Q fever outbreaks in the Netherlands in 2009, each with suspected exposure from a single large dairy goat farm. Model input consisted only of case residential addresses, day of first clinical symptoms, and human population density data. We defined a spatial grid and fitted an exponentially declining function to the incidence-distance data of each grid point. For any grid point with a fit significant at the 95% confidence level, we calculated a measure of risk. For validation, we used results from abortion notifications, voluntary (2008) and mandatory (2009) bulk tank milk sampling at large (i.e. >50 goats and/or sheep) dairy farms, and non-systematic vaginal swab sampling at large and small dairy and non-dairy goat/sheep farms. In addition, we performed a two-source simulation study. Results: Hotspots - areas most likely to contain the actual source - were identified at early outbreak stages, based on the earliest 2-10% of the case notifications. Distances between the hotspots and suspected goat farms varied from 300-1500 m. In regional likelihood rankings including all large dairy farms, the suspected goat farms consistently ranked first. The two-source simulation study showed that detection of sources is most clear if the distance between the sources is either relatively small or relatively large. Conclusions: Our model identifies the most likely location of sources in an airborne pathogen outbreak area, even at early stages. It can help to reduce the number of potential sources to be investigated by microbial testing and to allow rapid implementation of interventions to limit the number of human infections and to reduce the risk of source-to-source transmission.	[van Leuken, Jeroen P. G.; Havelaar, Arie H.] Univ Utrecht, IRAS, Utrecht, Netherlands; [van Leuken, Jeroen P. G.; Havelaar, Arie H.; van der Hoek, Wim; Swart, Arno N.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control CIb, Bilthoven, Netherlands; [Ladbury, Georgia A. F.] Univ Glasgow, Glasgow, Lanark, Scotland; [Hackert, Volker H.] Municipal Hlth Serv Zuid Limburg, Sittard Geleen, Netherlands	Utrecht University; Netherlands National Institute for Public Health & the Environment; University of Glasgow	van Leuken, JPG (corresponding author), Univ Utrecht, IRAS, Utrecht, Netherlands.	jeroen.van.leuken@rivm.nl	Havelaar, Arie H./P-8495-2014	Havelaar, Arie H./0000-0002-6456-5460; Ladbury, Georgia/0000-0003-3489-9571; Hackert, Volker/0000-0003-1025-4381	National Institute for Public Health and the Environment [S/210106/01/RQ]; ZonMW [205520010]	National Institute for Public Health and the Environment; ZonMW(Netherlands Organization for Health Research and Development)	This work was supported by the National Institute for Public Health and the Environment [project S/210106/01/RQ] (www.rivm.nl) and ZonMW [project 205520010] (www.zonmw.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Bamberg WM, 2007, VECTOR-BORNE ZOONOT, V7, P394, DOI 10.1089/vbz.2007.0104; Berri M, 2007, RES VET SCI, V83, P47, DOI 10.1016/j.rvsc.2006.11.001; Boender GJ, 2007, PLOS COMPUT BIOL, V3, P704, DOI 10.1371/journal.pcbi.0030071; Cloin M, 2011, 201130 NETH I SOC RE; de Bruin A, 2012, APPL ENVIRON MICROB, V78, P1652, DOI 10.1128/AEM.07323-11; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; Elliott P, 2004, ENVIRON HEALTH PERSP, V112, P998, DOI 10.1289/ehp.6735; Gloster J, 2010, VET J, V183, P278, DOI 10.1016/j.tvjl.2008.11.011; Hackert VH, 2012, CLIN INFECT DIS, V55, P1591, DOI 10.1093/cid/cis734; Hawker J I, 1998, Commun Dis Public Health, V1, P180; Hogerwerf L, 2011, EMERG INFECT DIS, V17, P379, DOI 10.3201/eid1703.101157; Jones RM, 2006, APPL BIOSAF, V11, P32; Maule MM, 2007, ENVIRON HEALTH PERSP, V115, P1066, DOI 10.1289/ehp.9900; Nguyen TMN, 2006, J INFECT DIS, V193, P102, DOI 10.1086/498575; Porten K, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-147; RIVM, 2021, ATL INF Q KOORTS; Roest HIJ, 2011, EPIDEMIOL INFECT, V139, P1, DOI 10.1017/S0950268810002268; Schimmer B, 2010, BMC INFECT DIS, V10; Schimmer B, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-81; Ssematimba A, 2012, PLOS ONE, V7, P1; Tissot-Dupont H, 2004, EMERG INFECT DIS, V10, P1264, DOI 10.3201/eid1007.030724; van den Brom R, 2012, VET REC, V170, P310, DOI 10.1136/vr.100304; Van den Brom R, 2009, SMALL RUMINANT RES, V86, P74, DOI 10.1016/j.smallrumres.2009.09.022; van der Hoek W, 2012, GEOSPATIAL HEALTH, V7, P127, DOI 10.4081/gh.2012.111; van der Hoek W, 2011, EMERG INFECT DIS, V17, P2360, DOI 10.3201/eid1712.110738; Van Jaarsveld JA, 2004, 500045001 RIVM; Vose D., 2008, RISK ANAL QUANTITATI; Wallensten A, 2010, EUROSURVEILLANCE, V15, P16; Ypma RJF, 2012, P ROY SOC B-BIOL SCI, V279, P444, DOI 10.1098/rspb.2011.0913	30	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80412	10.1371/journal.pone.0080412	http://dx.doi.org/10.1371/journal.pone.0080412			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324598	gold, Green Published			2022-12-25	WOS:000327949300021
J	Hagihara, K; Kita, A; Mizukura, A; Yao, M; Kitai, Y; Kunoh, T; Masuko, T; Matzno, S; Chiba, K; Sugiura, R				Hagihara, Kanako; Kita, Ayako; Mizukura, Aya; Yao, Mariko; Kitai, Yuki; Kunoh, Tatsuki; Masuko, Takashi; Matzno, Sumio; Chiba, Kenji; Sugiura, Reiko			Fingolimod (FTY720) Stimulates Ca2+/Calcineurin Signaling in Fission Yeast	PLOS ONE			English	Article							DRUG FTY720; SCHIZOSACCHAROMYCES-POMBE; IMMUNOSUPPRESSIVE AGENT; MODEL SYSTEM; CALCINEURIN; APOPTOSIS; GENE; PHOSPHORYLATION; IDENTIFICATION; SPHINGOSINE	Fingolimod hydrochloride (FTY720) is the first in class of sphingosine 1-phosphate (S1P) receptor modulator approved to treat multiple sclerosis via down-regulation of G protein-coupled S1P receptor 1 by its phosphorylated form (FTY720-P). Many studies have revealed that FTY720 exerts various biological effects, including antitumor activities, angiogenesis inhibition, Ca2+ mobilization and apoptosis, independently of S1P receptors. However, the exact mechanisms underlying their effects or signaling pathways mediated by FTY720 have not been completely established. To gain further insights into molecular mechanisms of FTY720 action, the effect of FTY720 on Ca2+ signaling in fission yeast was analyzed. The addition of Ca2+ enhanced the sensitivity induced by FTY720, and mutants lacking genes required for calcium homeostasis, including calcineurin and its downstream transcription factor, Ppb1-responsive zinc finger protein (Prz1), were hypersensitive to FTY720 and CaCl2. The effect of FTY720 on calcineurin signaling was monitored by utilizing a luciferase reporter construct fused to three tandem repeats of the calcineurin-dependent response element (CDRE), which gives an accurate measure of calcineurin activity. The addition of FTY720 increased calcineurin activity as well as Ca2+ influx in a concentration-dependent manner. Notably, the FTY720-mediated Ca2+ influx and calcineurin activation were reduced markedly by the deletion of yam(8+) or cch1(+) encoding putative subunits of a Ca2+ channel. Consistently, the deletion of Pmk1 mitogen-activated protein kinase (MAPK), which plays an important role in the activation of the Yam8/Cch1 channel, markedly decreased the intracellular Ca2+ levels upon FTY720 treatment. These results suggest that the FTY720-stimulated Ca2+/calcineurin signaling activation partly involves the Yam8/Cch1 channel in fission yeast.	[Hagihara, Kanako; Kita, Ayako; Mizukura, Aya; Yao, Mariko; Kitai, Yuki; Kunoh, Tatsuki; Sugiura, Reiko] Kinki Univ, Lab Mol Pharmacogenom, Sch Pharmaceut Sci, Higashiosaka, Osaka 577, Japan; [Masuko, Takashi] Kinki Univ, Mol Cell Biol Lab, Sch Pharmaceut Sci, Higashiosaka, Osaka 577, Japan; [Matzno, Sumio] Kinki Univ, Div Pharmaceut Educ, Fac Pharm, Higashiosaka, Osaka 577, Japan; [Chiba, Kenji] Mitsubishi Tanabe Pharma Corp, Div Res, Adv Med Res Labs, Yokohama, Kanagawa, Japan; [Hagihara, Kanako] Japan Soc Promot Sci, Tokyo, Japan	Kindai University (Kinki University); Kindai University (Kinki University); Kindai University (Kinki University); Mitsubishi Tanabe Pharma Corporation; Japan Society for the Promotion of Science	Sugiura, R (corresponding author), Kinki Univ, Lab Mol Pharmacogenom, Sch Pharmaceut Sci, Higashiosaka, Osaka 577, Japan.	sugiurar@phar.kindai.ac.jp	Kunoh, Tatsuki/AAQ-7881-2021	Kunoh, Tatsuki/0000-0002-8423-2903; Hagihara, Kanako/0000-0002-9366-6172	Ministry of Education, Culture, Sports, Science and Technology of Japan; "Antiaging" Project for Private Universities; Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [13J08110] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); "Antiaging" Project for Private Universities; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to R. S.). This work was also supported in part by the "Antiaging" Project for Private Universities, with a matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI K, 1995, BIOORG MED CHEM LETT, V5, P853, DOI 10.1016/0960-894X(95)00127-F; Azuma H, 2002, CANCER RES, V62; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; Bimbo A, 2005, EUKARYOT CELL, V4, P799, DOI 10.1128/EC.4.4.799-813.2005; Cheng H, 2002, MOL BIOL CELL, V13, P2963, DOI 10.1091/mbc.01-09-0463; Chiba K, 2005, PHARMACOL THERAPEUT, V108, P308, DOI 10.1016/j.pharmthera.2005.05.002; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Doi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061988; Estrada-Bernal A, 2012, NEURO-ONCOLOGY, V14, P405, DOI 10.1093/neuonc/nos005; GOULD KL, 1990, SCIENCE, V250, P1573, DOI 10.1126/science.1703321; Hirayama S, 2003, J BIOL CHEM, V278, P18078, DOI 10.1074/jbc.M212900200; Hisano Y, 2012, J BIOCHEM, V152, P305, DOI 10.1093/jb/mvs090; Ho JWY, 2005, MOL CANCER THER, V4, P1430, DOI 10.1158/1535-7163.MCT-05-0021; Honig SM, 2003, J CLIN INVEST, V111, P627, DOI 10.1172/JCI200316200; Imai H, 2005, PLANT CELL PHYSIOL, V46, P375, DOI 10.1093/pcp/pci023; Kanzaki M, 1999, SCIENCE, V285, P882, DOI 10.1126/science.285.5429.882; Lee TK, 2005, CLIN CANCER RES, V11, P8458, DOI 10.1158/1078-0432.CCR-05-0447; Ma Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022421; Matsuoka Y, 2003, BRIT J PHARMACOL, V138, P1303, DOI 10.1038/sj.bjp.0705182; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nagahara Y, 2000, J IMMUNOL, V165, P3250, DOI 10.4049/jimmunol.165.6.3250; Nagahara Y, 2002, BRIT J PHARMACOL, V137, P953, DOI 10.1038/sj.bjp.0704970; NAGAO K, 1995, J BACTERIOL, V177, P1536, DOI 10.1128/jb.177.6.1536-1543.1995; Nagaoka Y, 2008, BIOL PHARM BULL, V31, P1177, DOI 10.1248/bpb.31.1177; Nijnik A, 2012, J IMMUNOL, V189, P102, DOI 10.4049/jimmunol.1200282; Payne SG, 2007, BLOOD, V109, P1077, DOI 10.1182/blood-2006-03-011437; Perego P, 1998, MOL PHARMACOL, V54, P213, DOI 10.1124/mol.54.1.213; Perego P, 2000, PHARMACOL REV, V52, P477; Pernmpongkosol S, 2002, INT J CANCER, V98, P167, DOI 10.1002/ijc.10178; Pitman MR, 2012, CURR MOL MED, V12, P1207, DOI 10.2174/156652412803833599; Roberts KG, 2010, CANCER RES, V70, P5438, DOI 10.1158/0008-5472.CAN-09-2544; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sensken SC, 2010, J BIOL CHEM, V285, P6298, DOI 10.1074/jbc.M109.049692; Shinomiya T, 1997, IMMUNOLOGY, V91, P594, DOI 10.1046/j.1365-2567.1997.d01-2281.x; Simon JA, 2004, NAT REV CANCER, V4, P481, DOI 10.1038/nrc1372; Sugiura R, 2002, GENES CELLS, V7, P619, DOI 10.1046/j.1365-2443.2002.00557.x; Toda T, 1996, MOL CELL BIOL, V16, P6752; Toone WM, 1998, GENE DEV, V12, P1453, DOI 10.1101/gad.12.10.1453; Welsch CA, 2004, J BIOL CHEM, V279, P36720, DOI 10.1074/jbc.M406179200; Welsch CA, 2003, J BIOL CHEM, V278, P26976, DOI 10.1074/jbc.M213144200; Woodcock JM, 2010, CELL SIGNAL, V22, P1291, DOI 10.1016/j.cellsig.2010.04.004; Yasui H, 2005, CANCER RES, V65; Yoshino T, 2011, CELL MOL NEUROBIOL, V31, P1009, DOI 10.1007/s10571-011-9698-x	44	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81907	10.1371/journal.pone.0081907	http://dx.doi.org/10.1371/journal.pone.0081907			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312601	Green Published, Green Submitted, gold			2022-12-25	WOS:000327947800065
J	Tsang, SW; Zhang, HJ; Lin, CY; Xiao, HT; Wong, M; Shang, HC; Yang, ZJ; Lu, AP; Yung, KKL; Bian, ZX				Tsang, Siu Wai; Zhang, Hongjie; Lin, Chengyuan; Xiao, Haitao; Wong, Michael; Shang, Hongcai; Yang, Zhi-Jun; Lu, Aiping; Yung, Ken Kin-Lam; Bian, Zhaoxiang			Rhein, a Natural Anthraquinone Derivative, Attenuates the Activation of Pancreatic Stellate Cells and Ameliorates Pancreatic Fibrosis in Mice with Experimental Chronic Pancreatitis	PLOS ONE			English	Article							SONIC HEDGEHOG; TRANSFORMING GROWTH-FACTOR-BETA-1; PATHWAY ACTIVATION; BLOCKS ACTIVATION; LIVER FIBROSIS; CANCER-CELLS; NEURAL-TUBE; MECHANISMS; EXPRESSION; ANALOGS	Pancreatic fibrosis, a prominent histopathological feature of chronic pancreatitis (CP) and pancreatic ductal adenocarcinoma, is essentially a dynamic process that leads to irreversible scarring of parenchymal tissues of the pancreas. Though the exact mechanisms of its initiation and development are poorly understood, recent studies suggested that the activation of pancreatic stellate cells (PSCs) plays a critical role in eliciting such active course of fibrogenesis. Anthraquinone compounds possess anti-inflammatory bioactivities whereas its natural derivative rhein has been shown to effectively reduce tissue edema and free-radical production in rat models of inflammatory conditions. Apart from its anti-inflammatory properties, rhein actually exerts strong anti-fibrotic effects in our current in-vivo and in-vitro experiments. In the mouse model of cerulein-induced CP, prolonged administration of rhein at 50 mg/kg/day significantly decreased immunoreactivities of the principal fibrotic activators alpha-smooth muscle actin (alpha-SMA) and transforming growth factor-beta (TGF-beta) on pancreatic sections implicating the activation of PSCs, which is the central tread to fibrogenesis, was attenuated. Consequently, the overwhelmed deposition of extracellular matrix proteins fibronectin 1 (FN1) and type I collagen (COL I-alpha 1) in exocrine parenchyma was found accordingly reduced. In addition, the expression levels of sonic hedgehog (SHH), which plays important roles in molecular modulation of various fibrotic processes, and its immediate effector GLI1 in pancreatic tissues were positively correlated to the degree of cerulein-induced fibrosis. Such up-regulation of SHH signaling was restrained in rhein-treated CP mice. In cultured PSCs, we demonstrated that the expression levels of TGF-beta-stimulated fibrogenic markers including a-SMA, FN1 and COL I-a1 as well as SHH were all notably suppressed by the application of rhein at 10 mu M. The present study firstly reported that rhein attenuates PSC activation and suppresses SHH/GLI1 signaling in pancreatic fibrosis. With strong anti-fibrotic effects provided, rhein can be a potential remedy for fibrotic and/or PSC-related pathologies in the pancreas.	[Tsang, Siu Wai; Zhang, Hongjie; Lin, Chengyuan; Xiao, Haitao; Wong, Michael; Yang, Zhi-Jun; Lu, Aiping; Bian, Zhaoxiang] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon Tong, Hong Kong, Peoples R China; [Shang, Hongcai] Tianjin Univ Tradit Chinese Med, Tianjin, Peoples R China; [Yung, Ken Kin-Lam] Hong Kong Baptist Univ, Dept Biol, Kowloon Tong, Hong Kong, Peoples R China	Hong Kong Baptist University; Tianjin University of Traditional Chinese Medicine; Hong Kong Baptist University	Bian, ZX (corresponding author), Hong Kong Baptist Univ, Sch Chinese Med, Kowloon Tong, Hong Kong, Peoples R China.	bzxiang@hkbu.edu.hk	shang, hongcai/H-1257-2014; Tsang, Siu Wai/O-2748-2013; Zhang, Hongjie/N-4186-2013	Tsang, Siu Wai/0000-0001-6099-6696; Yang, Zhijun/0000-0002-6094-0438; Yung, Ken KL/0000-0002-9588-2573; Zhang, Hongjie/0000-0002-7175-5166; LIN, Chengyuan/0000-0001-7929-0212	Hong Kong Baptist University [IRMS-HKBU2011]	Hong Kong Baptist University	This work was supported by grant number IRMS-HKBU2011 from Hong Kong Baptist University awarded to ZXB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki VI, 2010, JNCI-J NATL CANCER I, V102, P1148, DOI 10.1093/jnci/djq257; Altaba AR, 2003, CURR OPIN GENET DEV, V13, P513, DOI 10.1016/j.gde.2003.08.005; Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009; Apte MV, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00344; Apte MV, 1999, GUT, V44, P534, DOI 10.1136/gut.44.4.534; Apte MV, 2004, DIGEST DIS, V22, P273, DOI 10.1159/000082799; Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Avouac J, 2012, ANN RHEUM DIS; Chang CL, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI [10.1155/2012/952504, 10.1155/2012/125247]; Cigna N, 2012, AM J PATHOL, V181, P2126, DOI 10.1016/j.ajpath.2012.08.019; Cong XD, 2012, INFLAMMATION, V35, P1031, DOI 10.1007/s10753-011-9407-4; Cuellar MJ, 2001, FITOTERAPIA, V72, P221, DOI 10.1016/S0367-326X(00)00305-1; Dahms M, 1997, DRUG METAB DISPOS, V25, P442; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; DiMagno MJ, 2011, CURR OPIN GASTROEN, V27, P452, DOI 10.1097/MOG.0b013e328349e333; Ding H, 2012, J AM SOC NEPHROL, V23, P801, DOI 10.1681/ASN.2011060614; Erkan M, 2012, CURR MOL MED, V12, P288, DOI 10.2174/156652412799218921; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Fabian SL, 2012, AM J PATHOL, V180, P1441, DOI 10.1016/j.ajpath.2011.12.039; Fernand VE, 2011, CHEM-BIOL INTERACT, V192, P220, DOI 10.1016/j.cbi.2011.03.013; Fitch PM, 2011, INT J EXP PATHOL, V92, P8, DOI 10.1111/j.1365-2613.2010.00743.x; Guo MZ, 2002, ACTA PHARMACOL SIN, V23, P739; Ha MK, 2011, BIOL PHARM BULL, V34, P1432, DOI 10.1248/bpb.34.1432; Haber PS, 1999, AM J PATHOL, V155, P1087, DOI 10.1016/S0002-9440(10)65211-X; He DY, 2011, BIOL PHARM BULL, V34, P1219, DOI 10.1248/bpb.34.1219; He ZH, 2011, PHYTOMEDICINE, V18, P470, DOI 10.1016/j.phymed.2010.10.006; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Horn A, 2012, ARTHRITIS RHEUM-US, V64, P2724, DOI 10.1002/art.34444; Horn A, 2012, ANN RHEUM DIS, V71, P785, DOI 10.1136/annrheumdis-2011-200883; Hu Q, 2009, NEPHROL DIAL TRANSPL, V24, P3033, DOI 10.1093/ndt/gfp245; Kasperczyk H, 2009, FASEB J, V23, P21, DOI 10.1096/fj.08-111096; Krantz SB, 2011, MOL CANCER RES, V9, P1294, DOI 10.1158/1541-7786.MCR-11-0023; Li H, 2011, MED HYPOTHESES, V77, P1105, DOI 10.1016/j.mehy.2011.09.013; Liu HE, 2011, SHOCK, V35, P191, DOI 10.1097/SHK.0b013e3181f0e9a8; Masamune A, 2006, J CELL BIOCHEM, V97, P1080, DOI 10.1002/jcb.20698; Masamune A, 2005, BIOCHEM PHARMACOL, V70, P869, DOI 10.1016/j.bcp.2005.06.008; Phillips P., 2012, PANCREATIC CANC TUMO; Pritchett J, 2012, HEPATOLOGY, V56, P1108, DOI 10.1002/hep.25758; Rosengren BI, 2013, AM J PHYSIOL-RENAL, V304, pF198, DOI 10.1152/ajprenal.00293.2012; Schneider A, 2005, DIGEST DIS, V23, P222, DOI 10.1159/000090169; Shek FWT, 2002, AM J PATHOL, V160, P1787, DOI 10.1016/S0002-9440(10)61125-X; Sheng XY, 2011, AM J PHYSIOL-ENDOC M, V300, pE886, DOI 10.1152/ajpendo.00332.2010; SOLOMON TE, 1984, AM J PHYSIOL, V247, pG105, DOI 10.1152/ajpgi.1984.247.1.G105; Sparmann G, 2004, AM J PHYSIOL-GASTR L, V287, pG211, DOI 10.1152/ajpgi.00347.2003; Tang D, 2013, INT J CANCER, V132, P993, DOI 10.1002/ijc.27715; VANLAETHEM JL, 1995, GASTROENTEROLOGY, V108, P1873, DOI 10.1016/0016-5085(95)90152-3; VanLaethem JL, 1996, GASTROENTEROLOGY, V110, P576, DOI 10.1053/gast.1996.v110.pm8566606; Vogelmann R, 2001, AM J PHYSIOL-GASTR L, V280, pG164, DOI 10.1152/ajpgi.2001.280.1.G164; Wallace K, 2008, BIOCHEM J, V411, P1, DOI 10.1042/BJ20071570; Wang J, 2010, PHYTOMEDICINE, V17, P684, DOI 10.1016/j.phymed.2009.10.009; Wang R, 2007, LIFE SCI, V80, P2481, DOI 10.1016/j.lfs.2007.04.010; Wang ZG, 2013, J ETHNOPHARMACOL, V145, P442, DOI 10.1016/j.jep.2012.11.008; Wehr AY, 2011, PANCREAS, V40, P557, DOI 10.1097/MPA.0b013e318214efaf; Yamasaki A, 2010, CANCER IMMUNOL IMMUN, V59, P675, DOI 10.1007/s00262-009-0783-7; Yang DY, 2004, BIOL PHARM BULL, V27, P375, DOI 10.1248/bpb.27.375; Yang XC, 2011, CHEMMEDCHEM, V6, P2294, DOI 10.1002/cmdc.201100384; Yoo BM, 2005, PANCREAS, V30, pE71, DOI 10.1097/01.mpa.0000157388.54016.0a; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281	58	39	42	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82201	10.1371/journal.pone.0082201	http://dx.doi.org/10.1371/journal.pone.0082201			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312641	Green Submitted, Green Published, gold			2022-12-25	WOS:000327947800088
J	Varasteh, Z; Aberg, O; Velikyan, I; Lindeberg, G; Sorensen, J; Larhed, M; Antoni, G; Sandstrom, M; Tolmachev, V; Orlova, A				Varasteh, Zohreh; Aberg, Ola; Velikyan, Irina; Lindeberg, Gunnar; Sorensen, Jens; Larhed, Mats; Antoni, Gunnar; Sandstrom, Mattias; Tolmachev, Vladimir; Orlova, Anna			In Vitro and In Vivo Evaluation of a F-18-Labeled High Affinity NOTA Conjugated Bombesin Antagonist as a PET Ligand for GRPR-Targeted Tumor Imaging	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PEPTIDE RECEPTOR; MEMBRANE ANTIGEN; PROSTATE-CANCER; EXPRESSION; AGONISTS; PSMA	Expression of the gastrin-releasing peptide receptor (GRPR) in prostate cancer suggests that this receptor can be used as a potential molecular target to visualize and treat these tumors. We have previously investigated an antagonist analog of bombesin (D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2, RM26) conjugated to 1,4,7-triazacyclononane-N,N',N ''-triacetic acid (NOTA) via a diethylene glycol (PEG(2)) spacer (NOTA-P2-RM26) labeled with Ga-68 and In-111. We found that this conjugate has favorable properties for in vivo imaging of GRPR-expression. The focus of this study was to develop a F-18-labelled PET agent to visualize GRPR. NOTA-P2-RM26 was labeled with F-18 using aluminum-fluoride chelation. Stability, in vitro binding specificity and cellular processing tests were performed. The inhibition efficiency (IC50) of the [F-nat]AlF-NOTA-P2-RM26 was compared to that of the Ga-nat-loaded peptide using I-125-Tyr(4)-BBN as the displacement radioligand. The pharmacokinetics and in vivo binding specificity of the compound were studied. NOTA-P2-RM26 was labeled with F-18 within 1 h (60-65% decay corrected radiochemical yield, 55 GBq/mu mol). The radiopeptide was stable in murine serum and showed high specific binding to PC-3 cells. [F-nat]AlF-NOTA-P2-RM26 showed a low nanomolar inhibition efficiency (IC50=4.4 +/- 0.8 nM). The internalization rate of the tracer was low. Less than 14% of the cell-bound radioactivity was internalized after 4 h. The biodistribution of [F-18]AlF-NOTA-P2-RM26 demonstrated rapid blood clearance, low liver uptake and low kidney retention. The tumor uptake at 3 h p. i. was 5.5 +/- 0.7 % ID/g, and the tumor-to-blood, -muscle and -bone ratios were 87 +/- 42, 159 +/- 47, 38 +/- 16, respectively. The uptake in tumors, pancreas and other GRPR-expressing organs was significantly reduced when excess amount of non-labeled peptide was co-injected. The low uptake in bone suggests a high in vivo stability of the Al-F bond. High contrast PET image was obtained 3 h p. i. The initial biological results suggest that [F-18]AlF-NOTA-P2-RM26 is a promising candidate for PET imaging of GRPR in vivo.	[Varasteh, Zohreh; Aberg, Ola; Velikyan, Irina; Antoni, Gunnar; Orlova, Anna] Uppsala Univ, Fac Pharm, Dept Med Chem, Preclin PET Platform, Uppsala, Sweden; [Velikyan, Irina; Sorensen, Jens; Tolmachev, Vladimir] Uppsala Univ, Fac Med, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden; [Lindeberg, Gunnar; Larhed, Mats] Uppsala Univ, Fac Pharm, Dept Med Chem, Uppsala, Sweden; [Velikyan, Irina; Sorensen, Jens; Antoni, Gunnar; Sandstrom, Mattias] Univ Uppsala Hosp, Ctr Med Imaging, PET Ctr, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University; Uppsala University Hospital	Varasteh, Z (corresponding author), Uppsala Univ, Fac Pharm, Dept Med Chem, Preclin PET Platform, Uppsala, Sweden.	zohreh.varasteh@pet.medchem.uu.se	Tolmachev, Vladimir/U-3107-2019; Orlova, Anna/S-9692-2019; Tolmachev, Vladimir/T-3722-2017	Tolmachev, Vladimir/0000-0002-6122-1734; Orlova, Anna/0000-0001-6120-2683; Tolmachev, Vladimir/0000-0002-6122-1734	Swedish Cancer Society (Cancerfonden); Swedish Research Council (Vetenskapsradet)	Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Swedish Research Council (Vetenskapsradet)(Swedish Research Council)	This research was financially supported by the Swedish Cancer Society (Cancerfonden) and the Swedish Research Council (Vetenskapsradet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiraj K, 2011, J NUCL MED, V52, P1970, DOI 10.2967/jnumed.111.094375; Ananias HJK, 2009, PROSTATE, V69, P1101, DOI 10.1002/pros.20957; Barrett JA, 2013, J NUCL MED, V54, P380, DOI 10.2967/jnumed.112.111203; Beer M, 2012, PROSTATE, V72, P318, DOI 10.1002/pros.21434; Bodei LFM, 2007, MEDICINE; Cescato R, 2008, J NUCL MED, V49, P318, DOI 10.2967/jnumed.107.045054; CHO ZH, 1975, J NUCL MED, V16, P1174; de Visser M, 2007, J NUCL MED, V48, P88; Dehdashti F, 2005, EUR J NUCL MED MOL I, V32, P344, DOI 10.1007/s00259-005-1764-5; Dimitrakopoulou-Strauss A, 2003, J NUCL MED, V44, P556; Eder M, 2013, EUR J NUCL MED MOL I, V40, P819, DOI 10.1007/s00259-013-2374-2; Even-Sapir E, 2005, J NUCL MED, V46, P1356; Ginj M, 2006, P NATL ACAD SCI USA, V103, P16436, DOI 10.1073/pnas.0607761103; Hillier SM, 2013, J NUCL MED, V54, P1369, DOI 10.2967/jnumed.112.116624; Holland JP, 2010, J NUCL MED, V51, P1293, DOI 10.2967/jnumed.110.076174; Jadvar H, 2013, EUR J NUCL MED MOL I, V40, pS5, DOI 10.1007/s00259-013-2361-7; Jian XY, 1999, J BIOL CHEM, V274, P11573, DOI 10.1074/jbc.274.17.11573; Kelloff GJ, 2009, AM J ROENTGENOL, V192, P1455, DOI 10.2214/AJR.09.2579; Mansi R, 2011, EUR J NUCL MED MOL I, V38, P97, DOI 10.1007/s00259-010-1596-9; Mansi R, 2009, CLIN CANCER RES, V15, P5240, DOI 10.1158/1078-0432.CCR-08-3145; Markwalder R, 1999, CANCER RES, V59, P1152; McBride WJ, 2009, J NUCL MED, V50, P991, DOI 10.2967/jnumed.108.060418; Nock B, 2003, EUR J NUCL MED MOL I, V30, P247, DOI 10.1007/s00259-002-1040-x; Pinto F, 2012, UROL INT, V88, P125, DOI 10.1159/000335205; Ruggiero A, 2011, J NUCL MED, V52, P1608, DOI 10.2967/jnumed.111.092098; Schirrmacher R, 2006, ANGEW CHEM INT EDIT, V45, P6047, DOI 10.1002/anie.200600795; Schwarzenbock S, 2012, THERANOSTICS, V2, P318, DOI 10.7150/thno.4008; Shiiba M, 2012, ANN NUCL MED, V26, P138, DOI 10.1007/s12149-011-0551-6; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Tolmachev V, 2010, BBA-GEN SUBJECTS, V1800, P487, DOI 10.1016/j.bbagen.2010.02.002; Varasteh Z, 2013, BIOCONJUGATE CHEM, V24, P1144, DOI 10.1021/bc300659k; Wangler C, 2012, NAT PROTOC, V7, P1946, DOI 10.1038/nprot.2012.109	32	36	37	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81932	10.1371/journal.pone.0081932	http://dx.doi.org/10.1371/journal.pone.0081932			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312607	Green Published, Green Submitted, gold			2022-12-25	WOS:000327947800069
J	Moreira, LGA; Pereira, LC; Drummond, PR; De Mesquita, JF				Alves Moreira, Lorenna Giannini; Pereira, Livia Costa; Drummond, Priscila Ramalho; De Mesquita, Joelma Freire			Structural and Functional Analysis of Human SOD1 in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; MUTATIONS; SEQUENCE; PROTEINS; SERVER; POLYMORPHISMS; AGGREGATION; PREDICTION; STABILITY; FEATURES	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with familial inheritance (fALS) in 5% to 10% of cases; 25% of those are caused by mutations in the superoxide dismutase 1 (SOD1) protein. More than 100 mutations in the SOD1 gene have been associated with fALS, altering the geometry of the active site, protein folding and the interaction between monomers. We performed a functional analysis of non-synonymous single nucleotide polymorphisms (nsSNPs) in 124 fALS SOD1 mutants. Eleven different algorithms were used to estimate the functional impact of the replacement of one amino acid on protein structure: SNPs&GO, PolyPhen-2, SNAP, PMUT, Sift, PhD-SNP, nsSNPAnalyzer, TANGO, WALTZ, LIMBO and FoldX. For the structural analysis, theoretical models of 124 SNPs of SOD1 were created by comparative modeling using the MHOLline workflow, which includes Modeller and Procheck. Models were aligned with the native protein by the TM-align algorithm. A human-curated database was developed using the server side include in Java, JMOL. The results of this functional analysis indicate that the majority of the 124 natural mutants are harmful to the protein structure and thus corroborate the correlation between the reported mutations and fALS. In the structural analysis, all models showed conformational changes when compared to wild-type SOD1, and the degree of structural alignment varied between them. The SOD1 database converge structural and functional analyses of SOD1; it is a vast resource for the molecular analysis of amyotrophic lateral sclerosis, which allows the user to expand his knowledge on the molecular basis of the disease. The SOD1 database is available at http://bioinfogroup.com/database.	[Alves Moreira, Lorenna Giannini; Pereira, Livia Costa; Drummond, Priscila Ramalho; De Mesquita, Joelma Freire] Fed Univ Rio De Janeiro State UNIRIO, Dept Genet & Mol Biol, Bioinformat & Computat Biol Grp, Rio De Janeiro, Brazil	Universidade Federal do Estado do Rio de Janeiro	De Mesquita, JF (corresponding author), Fed Univ Rio De Janeiro State UNIRIO, Dept Genet & Mol Biol, Bioinformat & Computat Biol Grp, Rio De Janeiro, Brazil.	jomesquita@gmail.com	De Mesquita, Joelma/W-5553-2019	De Mesquita, Joelma/0000-0003-1684-3830	Faperj [E-26/102.372/2011]; Federal University of Rio de Janeiro State (UNIRIO), Rio de Janeiro, Brazil	Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Federal University of Rio de Janeiro State (UNIRIO), Rio de Janeiro, Brazil	LGAM received a fellowship from Faperj (E-26/102.372/2011), LCP and PRD received a fellowship from the Federal University of Rio de Janeiro State (UNIRIO), Rio de Janeiro, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Amberger J, 2011, HUM MUTAT, V32, P564, DOI 10.1002/humu.21466; Andersen PM, 2006, CURR NEUROL NEUROSCI, V6, P37, DOI 10.1007/s11910-996-0008-9; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; Bao L, 2005, NUCLEIC ACIDS RES, V33, pW480, DOI 10.1093/nar/gki372; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriles PVSZ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-610; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; de Carvalho MDC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065558; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; De Baets G, 2012, NUCLEIC ACIDS RES, V40, pD935, DOI 10.1093/nar/gkr996; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Ferrer-Costa C, 2002, J MOL BIOL, V315, P771, DOI 10.1006/jmbi.2001.5255; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Garbuzova-Davis S, 2011, BRAIN RES, V1398, P113, DOI 10.1016/j.brainres.2011.04.049; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Jimenez-Lopez JC, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-43; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065287; Lill CM, 2011, AMYOTROPH LATERAL SC, V12, P238, DOI 10.3109/17482968.2011.584629; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Mistri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039122; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nordlund A, 2009, P NATL ACAD SCI USA, V106, P9667, DOI 10.1073/pnas.0812046106; Phukan J, 2009, J NEUROL, V256, P176, DOI 10.1007/s00415-009-0142-9; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Sanchez R, 1997, PROTEINS, P50; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Siddique N, 2008, PHYS MED REH CLIN N, V19, P429, DOI 10.1016/j.pmr.2008.05.001; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Van Durme J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000475; Vassall KA, 2011, P NATL ACAD SCI USA, V108, P2210, DOI 10.1073/pnas.0913021108; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	47	24	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81979	10.1371/journal.pone.0081979	http://dx.doi.org/10.1371/journal.pone.0081979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312616	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500109
J	Binder, BYK; Sondergaard, CS; Nolta, JA; Leach, JK				Binder, Bernard Y. K.; Sondergaard, Claus S.; Nolta, Jan A.; Leach, J. Kent			Lysophosphatidic Acid Enhances Stromal Cell-Directed Angiogenesis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SELF-ASSEMBLING PEPTIDES; GROWTH-FACTOR DELIVERY; SPHINGOSINE 1-PHOSPHATE; THERAPEUTIC TARGET; PROGENITOR CELLS; CARDIAC-FUNCTION; VEGF; DIFFERENTIATION; ACTIVATION	Ischemic diseases such as peripheral vascular disease (PVD) affect more than 15% of the general population and in severe cases result in ulcers, necrosis, and limb loss. While the therapeutic delivery of growth factors to promote angiogenesis has been widely investigated, large-scale implementation is limited by strategies to effectively deliver costly recombinant proteins. Multipotent adipose-derived stromal cells (ASC) and progenitor cells from other tissue compartments secrete bioactive concentrations of angiogenic molecules, making cell-based strategies for in situ delivery of angiogenic cytokines an exciting alternative to the use of recombinant proteins. Here, we show that the phospholipid lysophosphatidic acid (LPA) synergistically improves the proangiogenic effects of ASC in ischemia. We found that LPA upregulates angiogenic growth factor production by ASC under two-and three-dimensional in vitro models of serum deprivation and hypoxia (SD/H), and that these factors significantly enhance endothelial cell migration. The concurrent delivery of LPA and ASC in fibrin gels significantly improves vascularization in a murine critical hindlimb ischemia model compared to LPA or ASC alone, thus exhibiting the translational potential of this method. Furthermore, these results are achieved using an inexpensive lipid molecule, which is orders-of-magnitude less costly than recombinant growth factors that are under investigation for similar use. Our results demonstrate a novel strategy for enhancing cell-based strategies for therapeutic angiogenesis, with significant applications for treating ischemic diseases.	[Binder, Bernard Y. K.; Leach, J. Kent] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Leach, J. Kent] Univ Calif Davis, Sch Med, Dept Orthopaed Surg, Davis, CA 95616 USA; [Sondergaard, Claus S.] Univ Calif Davis, Sch Med, Dept Surg, Div Cardiothorac Surg, Sacramento, CA 95817 USA; [Nolta, Jan A.] Univ Calif Davis, Sch Med, Dept Hematol Oncol, Sacramento, CA 95817 USA; [Nolta, Jan A.] Univ Calif Davis, Sch Med, Dept Cell Biol, Sacramento, CA 95817 USA; [Nolta, Jan A.] Univ Calif Davis, Sch Med, Dept Human Anat, Sacramento, CA 95817 USA; [Nolta, Jan A.] Univ Calif Davis, Sch Med, Stem Cell Program, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Leach, JK (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	jkleach@ucdavis.edu		Nolta, Jan/0000-0003-4576-8542	National Institutes of Health [1R21AG036963]; AO Craniomaxillofacial Foundation [C10-39L]; California Institute for Regenerative Medicine UC Davis Stem Cell Training Program [CIRM T1-00006, CIRM TG2-01163]; NATIONAL INSTITUTE ON AGING [R21AG036963] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AO Craniomaxillofacial Foundation; California Institute for Regenerative Medicine UC Davis Stem Cell Training Program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by grants from the National Institutes of Health 1R21AG036963 and AO Craniomaxillofacial Foundation (C10-39L) to JKL. This project was also supported by the California Institute for Regenerative Medicine UC Davis Stem Cell Training Program (BYB, CIRM T1-00006, CIRM TG2-01163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Awojoodu AO, 2013, P NATL ACAD SCI USA, V110, P13785, DOI 10.1073/pnas.1221309110; Binder BY, 2013, TISSUE EN A IN PRESS; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Cao YH, 2010, NAT REV DRUG DISCOV, V9, P107, DOI 10.1038/nrd3055; Chamberlain G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002934; Chen JH, 2008, STEM CELLS, V26, P135, DOI 10.1634/stemcells.2007-0098; Cheung WK, 2010, CYTOTHERAPY, V12, P554, DOI 10.3109/14653241003709694; Davis HE, 2011, ACTA BIOMATER, V7, P691, DOI 10.1016/j.actbio.2010.09.007; Davis HE, 2011, ANN BIOMED ENG, V39, P1, DOI 10.1007/s10439-010-0135-y; de Villiers JA, 2009, STEM CELL REV REP, V5, P256, DOI 10.1007/s12015-009-9084-y; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fierro FA, 2011, STEM CELLS, V29, P1727, DOI 10.1002/stem.720; Guo HD, 2012, BIOCHEM BIOPH RES CO, V424, P105, DOI 10.1016/j.bbrc.2012.06.080; He JW, 2010, TISSUE ENG PT A, V16, P127, DOI [10.1089/ten.tea.2009.0255, 10.1089/ten.TEA.2009.0255]; He JW, 2010, J CELL BIOCHEM, V110, P87, DOI 10.1002/jcb.22514; Hoch AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035579; Jeon ES, 2010, EXP MOL MED, V42, P280, DOI 10.3858/emm.2010.42.4.027; Katare R, 2013, ARTERIOSCL THROM VAS, V33, P1872, DOI 10.1161/ATVBAHA.113.301217; Kim JH, 2011, BIOMATERIALS, V32, P6080, DOI 10.1016/j.biomaterials.2011.05.003; Lee J, 2006, CLIN CANCER RES, V12, P6351, DOI 10.1158/1078-0432.CCR-06-1252; Lee MJ, 2008, J CELL BIOCHEM, V104, P499, DOI 10.1002/jcb.21641; Lin K, 2008, CYTOTHERAPY, V10, P417, DOI 10.1080/14653240801982979; Liu XB, 2009, STEM CELLS DEV, V18, P947, DOI 10.1089/scd.2008.0352; Mansell JP, 2013, BBA-MOL CELL BIOL L, V1831, P105, DOI 10.1016/j.bbalip.2012.04.005; Masiello LM, 2006, BONE, V39, P72, DOI 10.1016/j.bone.2005.12.013; MOOLENAAR WH, 1995, J BIOL CHEM, V270, P12949, DOI 10.1074/jbc.270.22.12949; Murphy Kaitlin C, 2012, BMC Res Notes, V5, P423, DOI 10.1186/1756-0500-5-423; Nakagami H, 2006, J ATHEROSCLER THROMB, V13, P77, DOI 10.5551/jat.13.77; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Ozaki Harunobu, 2003, J Atheroscler Thromb, V10, P125; Park SY, 2007, CANCER LETT, V258, P63, DOI 10.1016/j.canlet.2007.08.011; Peach G, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5208; Pyne NJ, 2008, BBA-MOL CELL BIOL L, V1781, P467, DOI 10.1016/j.bbalip.2008.05.004; Riordan NH, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-29; Rivera-Lopez CM, 2008, ANGIOGENESIS, V11, P301, DOI 10.1007/s10456-008-9113-5; Saranadasa M, 2011, CYTOKINE, V53, P115, DOI 10.1016/j.cyto.2010.06.012; Shammas NW, 2007, VASC HEALTH RISK MAN, V3, P229, DOI 10.2147/vhrm.2007.3.2.229; Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x; Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Sun QH, 2010, PHARM RES-DORDR, V27, P264, DOI 10.1007/s11095-009-0014-0; Systems RD, 2012, R D SYST ANN CAT; Tigyi G, 2010, BRIT J PHARMACOL, V161, P241, DOI 10.1111/j.1476-5381.2010.00815.x; van Hinsbergh VWM, 2001, ANN NY ACAD SCI, V936, P426; Walter DH, 2007, ARTERIOSCL THROM VAS, V27, P275, DOI 10.1161/01.ATV.0000254669.12675.70; Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje	48	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82134	10.1371/journal.pone.0082134	http://dx.doi.org/10.1371/journal.pone.0082134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312635	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500119
J	Pereira, SL; Graos, M; Rodrigues, AS; Anjo, SI; Carvalho, RA; Oliveira, PJ; Arenas, E; Ramalho-Santos, J				Pereira, Sandro L.; Graos, Mario; Rodrigues, Ana Sofia; Anjo, Sandra I.; Carvalho, Rui A.; Oliveira, Paulo J.; Arenas, Ernest; Ramalho-Santos, Joao			Inhibition of Mitochondrial Complex III Blocks Neuronal Differentiation and Maintains Embryonic Stem Cell Pluripotency	PLOS ONE			English	Article							ANTIOXIDANT ENZYMES; PHASE ARREST; ANTIMYCIN-A; HYPOXIA; METABOLISM; BIOGENESIS; MECHANISM; DEFENSE; CULTURE; GROWTH	The mitochondrion is emerging as a key organelle in stem cell biology, acting as a regulator of stem cell pluripotency and differentiation. In this study we sought to understand the effect of mitochondrial complex III inhibition during neuronal differentiation of mouse embryonic stem cells. When exposed to antimycin A, a specific complex III inhibitor, embryonic stem cells failed to differentiate into dopaminergic neurons, maintaining high Oct4 levels even when subjected to a specific differentiation protocol. Mitochondrial inhibition affected distinct populations of cells present in culture, inducing cell loss in differentiated cells, but not inducing apoptosis in mouse embryonic stem cells. A reduction in overall proliferation rate was observed, corresponding to a slight arrest in S phase. Moreover, antimycin A treatment induced a consistent increase in HIF-1 alpha protein levels. The present work demonstrates that mitochondrial metabolism is critical for neuronal differentiation and emphasizes that modulation of mitochondrial functions through pharmacological approaches can be useful in the context of controlling stem cell maintenance/ differentiation.	[Pereira, Sandro L.; Rodrigues, Ana Sofia; Anjo, Sandra I.; Carvalho, Rui A.; Oliveira, Paulo J.; Ramalho-Santos, Joao] Univ Coimbra, CNC, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Pereira, Sandro L.; Rodrigues, Ana Sofia; Anjo, Sandra I.; Carvalho, Rui A.; Oliveira, Paulo J.; Ramalho-Santos, Joao] Univ Coimbra, Dept Life Sci, Fac Sci & Technol, Coimbra, Portugal; [Graos, Mario] Biocant Technol Transfer Assoc, Cantanhede, Portugal; [Arenas, Ernest] Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, Stockholm, Sweden	Universidade de Coimbra; Universidade de Coimbra; Karolinska Institutet	Ramalho-Santos, J (corresponding author), Univ Coimbra, CNC, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	jramalho@ci.uc.pt	Oliveira, Paulo J./H-1980-2011; Oliveira, Paulo J./AAQ-8943-2020; Santos, João/HHZ-5595-2022; Anjo, Sandra/P-4479-2015; Ramalho-Santos, João/F-8641-2012; Carvalho, Rui A/A-6661-2010; Grãos, Mário/O-7273-2017; Arenas, Ernest/AAO-5231-2020; Rodrigues, Ana Sofia/ABA-9042-2020	Oliveira, Paulo J./0000-0002-5201-9948; Oliveira, Paulo J./0000-0002-5201-9948; Anjo, Sandra/0000-0003-2180-3518; Ramalho-Santos, João/0000-0002-1172-4018; Carvalho, Rui A/0000-0003-1820-0353; Grãos, Mário/0000-0002-2707-1488; Arenas, Ernest/0000-0003-0197-6577; Rodrigues, Ana Sofia/0000-0001-7060-879X; Cardoso Pereira, Sandro Lino/0000-0001-9498-3965	Fundacao para a Ciencia e a Tecnologia (FCT) Portugal [PTDC/EBB-EBI/101114/2008, PTDC/EBB-EBI/120634/2010, PDTC/QUI-BIQ/120652/2010]; Compete/FEDER/National Funds; FCT [PEst-C/SAU/LA0001/2011]; Swedish Foundation for Strategic Research (SRL Program); Swedish Research Council (DBRM); Karolinska Institutet (SFO Thematic Center in Stem Cells and Regenerative Medicine); Hjarnfonden;  [SFRH/BD/37933/2007]	Fundacao para a Ciencia e a Tecnologia (FCT) Portugal(Portuguese Foundation for Science and Technology); Compete/FEDER/National Funds; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Swedish Foundation for Strategic Research (SRL Program)(Swedish Foundation for Strategic Research); Swedish Research Council (DBRM)(Swedish Research Council); Karolinska Institutet (SFO Thematic Center in Stem Cells and Regenerative Medicine); Hjarnfonden; 	The authors thank Fundacao para a Ciencia e a Tecnologia (FCT) Portugal for grant support (PTDC/EBB-EBI/101114/2008, PTDC/EBB-EBI/120634/2010 and PDTC/QUI-BIQ/120652/2010 co-funded by Compete/FEDER/National Funds; and a PhD scholarship attributed to SP (SFRH/BD/37933/2007). Center for Neuroscience and Cell Biology (CNC) funding is also supported by FCT (PEst-C/SAU/LA0001/2011). EA's work was supported by the Swedish Foundation for Strategic Research (SRL Program), Swedish Research Council (DBRM), Karolinska Institutet (SFO Thematic Center in Stem Cells and Regenerative Medicine), and Hjarnfonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral S, 2006, THERIOGENOLOGY, V66, P2056, DOI 10.1016/j.theriogenology.2006.06.006; Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307; Ataullakhanov FI, 2002, BIOSCIENCE REP, V22, P501, DOI 10.1023/A:1022069718709; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272; Branco AF, 2011, CARDIOVASC TOXICOL, V11, P191, DOI 10.1007/s12012-011-9111-5; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Byun HO, 2008, J CELL BIOCHEM, V104, P1747, DOI 10.1002/jcb.21741; Cajanek L, 2009, STEM CELLS, V27, P2917, DOI 10.1002/stem.210; Candelario KM, 2013, J NEUROCHEM, V125, P420, DOI 10.1111/jnc.12204; Carriere A, 2004, J BIOL CHEM, V279, P40462, DOI 10.1074/jbc.M407258200; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Chen CT, 2012, BBA-GEN SUBJECTS, V1820, P571, DOI 10.1016/j.bbagen.2011.09.013; Chen CT, 2010, BBA-GEN SUBJECTS, V1800, P257, DOI 10.1016/j.bbagen.2009.09.001; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Chung S, 2010, J MOL CELL CARDIOL, V48, P725, DOI 10.1016/j.yjmcc.2009.12.014; Correia SC, 2012, NEUROBIOL DIS, V45, P206, DOI 10.1016/j.nbd.2011.08.005; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Facucho-Oliveira JM, 2007, J CELL SCI, V120, P4025, DOI 10.1242/jcs.016972; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; FISCHER B, 1993, J REPROD FERTIL, V99, P673, DOI 10.1530/jrf.0.0990673; Folmes CDL, 2011, BIOMARK MED, V5, P715, DOI [10.2217/bmm.11.87, 10.2217/BMM.11.87]; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Han YH, 2008, ONCOL REP, V20, P689, DOI 10.3892/or_00000061; Han YH, 2008, LIFE SCI, V83, P346, DOI 10.1016/j.lfs.2008.06.023; Han YH, 2009, LUNG CANCER, V65, P150, DOI 10.1016/j.lungcan.2008.11.005; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kirby DM, 2009, CELL PROLIFERAT, V42, P413, DOI 10.1111/j.1365-2184.2009.00612.x; Kondoh H, 2005, CANCER RES, V65, P177; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Lonergan T, 2007, MITOCHONDRION, V7, P289, DOI 10.1016/j.mito.2007.05.002; Lonergan T, 2006, J CELL PHYSIOL, V208, P149, DOI 10.1002/jcp.20641; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Mathieu J, 2013, STEM CELLS, V31, P1737, DOI 10.1002/stem.1446; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nesti C, 2007, BIOSCIENCE REP, V27, P165, DOI 10.1007/s10540-007-9044-1; Papa S, 2004, NEUROCHEM RES, V29, P547, DOI 10.1023/B:NERE.0000014825.42365.16; Parker GC, 2009, STEM CELLS DEV, V18, P803, DOI 10.1089/scd.2009.1806.edi; Parnas D, 1998, BRAIN RES PROTOC, V2, P333, DOI 10.1016/S1385-299X(98)00009-9; Prigione A, 2010, INT J DEV BIOL, V54, P1729, DOI 10.1387/ijdb.103198ap; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Schieke SM, 2008, J BIOL CHEM, V283, P28506, DOI 10.1074/jbc.M802763200; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Spitkovsky D, 2004, FASEB J, V18, P1300, DOI 10.1096/fj.03-0520fje; St John JC, 2005, CLONING STEM CELLS, V7, P141, DOI 10.1089/clo.2005.7.141; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Varum S, 2009, STEM CELL RES, V3, P142, DOI 10.1016/j.scr.2009.07.002; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; VAYSSIERE JL, 1992, IN VITRO CELL DEV-AN, V28A, P763; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001	64	61	63	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82095	10.1371/journal.pone.0082095	http://dx.doi.org/10.1371/journal.pone.0082095			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312632	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500118
J	Reller, ME; Akoroda, U; Nagahawatte, A; Devasiri, V; Kodikaarachchi, W; Strouse, JJ; Chua, R; Hou, Y; Chow, A; Sessions, OM; Ostbye, T; Gubler, DJ; Woods, CW; Bodinayake, C				Reller, Megan E.; Akoroda, Ufuoma; Nagahawatte, Ajith; Devasiri, Vasantha; Kodikaarachchi, Wasantha; Strouse, John J.; Chua, Robert; Hou, Yan'an; Chow, Angelia; Sessions, October M.; Ostbye, Truls; Gubler, Duane J.; Woods, Christopher W.; Bodinayake, Champica			Chikungunya as a Cause of Acute Febrile Illness in Southern Sri Lanka	PLOS ONE			English	Article							DENGUE-FEVER; VIRUS; INFECTION; OUTBREAK; REEMERGENCE; FEATURES	Background: Chikungunya virus (CHIKV) re-emerged in Sri Lanka in late 2006 after a 40-year hiatus. We sought to identify and characterize acute chikungunya infection (CHIK) in patients presenting with acute undifferentiated febrile illness in unstudied rural and semi-urban southern Sri Lanka in 2007. Methodology/Principal Findings: We enrolled febrile patients >= 2 years of age, collected uniform epidemiologic and clinical data, and obtained serum samples for serology, virus isolation, and real-time reverse-transcriptase PCR (RT-PCR). Serology on paired acute and convalescent samples identified acute chikungunya infection in 3.5% (28/797) patients without acute dengue virus (DENV) infection, 64.3% (18/28) of which were confirmed by viral isolation and/or real-time RT-PCR. No CHIKV/DENV co-infections were detected among 54 patients with confirmed acute DENV. Sequencing of the E1 coding region of six temporally distinct CHIKV isolates (April through October 2007) showed that all isolates posessed the E1-226A residue and were most closely related to Sri Lankan and Indian isolates from the same time period. Except for more frequent and persistent musculoskeletal symptoms, acute chikungunya infections mimicked DENV and other acute febrile illnesses. Only 12/797 (1.5%) patients had serological evidence of past chikungunya infection. Conclusions/Significance: Our findings suggest CHIKV is a prominent cause of non-specific acute febrile illness in southern Sri Lanka.	[Reller, Megan E.] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Med Microbiol, Baltimore, MD 21205 USA; [Strouse, John J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Hematol, Baltimore, MD 21205 USA; [Nagahawatte, Ajith; Devasiri, Vasantha; Kodikaarachchi, Wasantha; Bodinayake, Champica] Univ Ruhuna, Fac Med, Galle, Sri Lanka; [Chua, Robert; Hou, Yan'an; Chow, Angelia; Sessions, October M.; Gubler, Duane J.] Duke Natl Univ, Singapore Grad Med Sch, Program Emerging Infect, Singapore, Singapore; [Ostbye, Truls] Duke Univ, Sch Med, Dept Community & Family Med, Durham, NC USA; [Woods, Christopher W.] Duke Univ, Sch Med, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27706 USA; [Akoroda, Ufuoma] Duke Univ, Sch Med, Durham, NC USA; [Reller, Megan E.; Ostbye, Truls; Woods, Christopher W.] Hubert Yeargan Ctr Global Hlth, Durham, NC USA	Johns Hopkins University; Johns Hopkins University; University Ruhuna; Duke University; Duke University; Duke University	Reller, ME (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Div Med Microbiol, Baltimore, MD 21205 USA.	mreller1@jhmi.edu	Strouse, J/A-2690-2008	Strouse, J/0000-0003-0341-1457; Bodinayake, Champica/0000-0003-1339-1883	Hubert-Yeargan Center for Global Health; Duke University Medical Center Chancellor's Tsunami Relief Fund; Johns Hopkins Center for Global Health Junior Faculty Grant; Johns Hopkins School of Medicine; National Institute of Allergy and Infectious Diseases, National Institutes of Health [K23AIO83931]; Duke-NUS Signature Research Program; Agency for Science, Technology and Research (A*STAR), Singapore; Ministry of Health, Singapore; US Navy Medical Research Unit 2 in Singapore	Hubert-Yeargan Center for Global Health; Duke University Medical Center Chancellor's Tsunami Relief Fund; Johns Hopkins Center for Global Health Junior Faculty Grant; Johns Hopkins School of Medicine(Johns Hopkins University); National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Duke-NUS Signature Research Program; Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Health, Singapore(Ministry of Health-Singapore); US Navy Medical Research Unit 2 in Singapore	Patient enrollment was supported by the Hubert-Yeargan Center for Global Health and the Duke University Medical Center Chancellor's Tsunami Relief Fund. Dr. MER was supported by a Johns Hopkins Center for Global Health Junior Faculty Grant, a Clinician Scientist Career Development Award from Johns Hopkins School of Medicine, and the National Institute of Allergy and Infectious Diseases, National Institutes of Health (K23AIO83931). All laboratory testing was done at the Duke-NUS Graduate Medical School and was supported by the Duke-NUS Signature Research Program funded by the Agency for Science, Technology and Research (A*STAR), Singapore, and the Ministry of Health, Singapore, and by funding from the US Navy Medical Research Unit #2 in Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, FIGTREE V1 4 0; Apandi Y, 2009, J GEN MOL VIROL, V1, P35; Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P1773, DOI 10.1128/CVI.05288-11; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X; Frank C, 2011, VECTOR-BORNE ZOONOT, V11, P631, DOI 10.1089/vbz.2010.0269; Gibney KB, 2011, CLIN INFECT DIS, V52, pE121, DOI 10.1093/cid/ciq214; GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158; Hapuarachchi H. A. C., 2008, CEYLON MEDICAL JOURNAL, V53, P104; Hapuarachchi HC, 2010, J GEN VIROL, V91, P1067, DOI 10.1099/vir.0.015743-0; Hertz JT, 2012, AM J TROP MED HYG, V86, P171, DOI 10.4269/ajtmh.2012.11-0393; Hochedez P, 2006, EMERG INFECT DIS, V12, P1565, DOI 10.3201/eid1210.060495; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kularatne SAM, 2009, POSTGRAD MED J, V85, P342, DOI 10.1136/pgmj.2007.066746; Kularatne SAM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/639178; Kumar NP, 2008, J GEN VIROL, V89, P1945, DOI 10.1099/vir.0.83628-0; Laoprasopwattana K, 2012, PEDIATR INFECT DIS J; Munasinghe D R, 1966, Ceylon Med J, V11, P129; NIMMANNI.S, 1966, B WORLD HEALTH ORGAN, V35, P42; Nkoghe D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001517; Panning M, 2009, MED MICROBIOL IMMUN, V198, P103, DOI 10.1007/s00430-009-0110-0; Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Reller ME, 2012, EMERG INFECT DIS, V18, P256, DOI 10.3201/eid1802.110962; Reller ME, 2011, EMERG INFECT DIS, V17, P1678, DOI [10.3201/eid1709.100915, 10.3201/eid1709.100915.]; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Shu PY, 2009, CLIN VACCINE IMMUNOL, V16, P589, DOI 10.1128/CVI.00475-08; Silvestro D., 2011, ORG DIVERS EVOL, V12, P335, DOI [10.1007/sI3127-011-0056-0, DOI 10.1007/S13127-011-0056-0]; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; Taraphdar D, 2012, AM J TROP MED HYG, V86, P720, DOI 10.4269/ajtmh.2012.11-0704; Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201	35	20	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82259	10.1371/journal.pone.0082259	http://dx.doi.org/10.1371/journal.pone.0082259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312651	Green Published, gold, Green Submitted			2022-12-25	WOS:000327944500133
J	Wang, YY; Peng, DH; Dong, ZX; Zhu, L; Guo, SX; Sun, M				Wang, Yueying; Peng, Donghai; Dong, Zhaoxia; Zhu, Lei; Guo, Suxia; Sun, Ming			Cloning and Analysis of a Large Plasmid pBMB165 from Bacillus thuringiensis Revealed a Novel Plasmid Organization	PLOS ONE			English	Article							ANTHRACIS; CEREUS; IDENTIFICATION; ZWITTERMICIN; GENOMICS; PBT9727; GENES; PAW63; PXO2; SOIL	In this study, we report a rapid cloning strategy for large native plasmids via a contig linkage map by BAC libraries. Using this method, we cloned a large plasmid pBMB165 from Bacillus thuringiensis serovar tenebrionis strain YBT-1765. Complete sequencing showed that pBMB165 is 77,627 bp long with a GC-content of 35.36%, and contains 103 open reading frames (ORFs). Sequence analysis and comparison reveals that pBMB165 represents a novel plasmid organization: it mainly consists of a pXO2-like replicon and mobile genetic elements (an inducible prophage BMBTP3 and a set of transposable elements). This is the first description of this plasmid organization pattern, which may result from recombination events among the plasmid replicon, prophage and transposable elements. This plasmid organization reveals that the prophage BMBTP3 may use the plasmid replicon to maintain its genetic stability. Our results provide a new approach to understanding co-evolution between bacterial plasmids and bacteriophage.	[Wang, Yueying; Peng, Donghai; Dong, Zhaoxia; Zhu, Lei; Guo, Suxia; Sun, Ming] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Sun, M (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	m98sun@mail.hzau.edu.cn	Ming, Sun/Q-1497-2015	Ming, Sun/0000-0001-5465-5983; Zhu, Lei/0000-0002-1800-4769	National High Technology Research and Development Program (863 Program) of China [2011AA10A203]; National Basic Research Program (973 Program) of China [2009CB118902]; National Natural Science Foundation of China [31000020, 31170047]; China 948 Program of Ministry of Agriculture [2011-G25]	National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); National Basic Research Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China 948 Program of Ministry of Agriculture	This work was supported by National High Technology Research and Development Program (863 Program) of China (Grant 2011AA10A203), National Basic Research Program (973 Program) of China (Grant 2009CB118902), National Natural Science Foundation of China (Grants 31000020 and 31170047), and China 948 Program of Ministry of Agriculture (2011-G25). The website is: http://program.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrup L, 2008, PLASMID, V59, P139, DOI 10.1016/j.plasmid.2007.11.005; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; BAUM JA, 1994, J BACTERIOL, V176, P2835, DOI 10.1128/JB.176.10.2835-2845.1994; Berry C, 2002, APPL ENVIRON MICROB, V68, P5082, DOI 10.1128/AEM.68.10.5082-5095.2002; Boltner D, 2002, J BACTERIOL, V184, P5158, DOI 10.1128/JB.184.18.5158-5169.2002; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Chikerema SM, 2012, J APPL MICROBIOL, V113, P1389, DOI 10.1111/jam.12006; Guo SX, 2008, APPL ENVIRON MICROB, V74, P6997, DOI 10.1128/AEM.01346-08; Hu XM, 2009, APPL ENVIRON MICROB, V75, P3016, DOI 10.1128/AEM.02709-08; Huang J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-270; Huang JY, 2007, ARCH MICROBIOL, V188, P47, DOI 10.1007/s00203-007-0222-0; Koehler TM, 2002, CURR TOP MICROBIOL, V271, P143; Liu XY, 2010, J BIOL CHEM, V285, P39191, DOI 10.1074/jbc.M110.148387; Loeza-Lara PD, 2005, PLASMID, V54, P229, DOI 10.1016/j.plasmid.2005.04.003; Luo Y, 2011, ANTIMICROB AGENTS CH, V55, P4161, DOI 10.1128/AAC.00111-11; Nisnevitch M, 2006, BIOCHEM BIOPH RES CO, V344, P99, DOI 10.1016/j.bbrc.2006.03.134; Nisnevitch M, 2010, CURR MICROBIOL, V61, P176, DOI 10.1007/s00284-010-9593-6; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Reyes-Ramirez A, 2008, APPL ENVIRON MICROB, V74, P125, DOI 10.1128/AEM.02133-07; Sambrook J, 2001, MOL CLONING LAB MANU; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Smeesters PR, 2011, RES MICROBIOL, V162, P446, DOI 10.1016/j.resmic.2011.02.009; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Swanson MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040683; Tanimoto K, 2008, FEMS MICROBIOL LETT, V288, P186, DOI 10.1111/j.1574-6968.2008.01342.x; Van der Auwera GA, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-103; Van der Auwera GA, 2008, PLASMID, V59, P134, DOI 10.1016/j.plasmid.2007.11.007; Wang Li, 2008, Weishengwu Xuebao, V48, P15; Wilcks A, 1998, MICROBIOL-UK, V144, P1263, DOI 10.1099/00221287-144-5-1263; Zhao CM, 2007, ARCH MICROBIOL, V187, P313, DOI 10.1007/s00203-006-0196-3; Zhong CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016025	31	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81746	10.1371/journal.pone.0081746	http://dx.doi.org/10.1371/journal.pone.0081746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312580	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500093
J	Bausch, E; Kohlhof, H; Hamm, S; Krauss, R; Baumgartner, R; Sironi, L				Bausch, Elena; Kohlhof, Hella; Hamm, Svetlana; Krauss, Rolf; Baumgartner, Roland; Sironi, Lucia			A Novel Microtubule Inhibitor 4SC-207 with Anti-Proliferative Activity in Taxane-Resistant Cells	PLOS ONE			English	Article							DRUG-RESISTANCE; ERIBULIN MESYLATE; CANCER-CELLS; MECHANISMS; DYNAMICS; AGENTS; POLYMERIZATION; CHECKPOINT; SPINDLES	Microtubule inhibitors are invaluable tools in cancer chemotherapy: taxanes and vinca alkaloids have been successfully used in the clinic over the past thirty years against a broad range of tumors. However, two factors have limited the effectiveness of microtubule inhibitors: toxicity and resistance. In particular, the latter is highly unpredictable, variable from patient to patient and is believed to be the cause of treatment failure in most cases of metastatic cancers. For these reasons, there is an increasing demand for new microtubule inhibitors that can overcome resistance mechanisms and that, at the same time, have reduced side effects. Here we present a novel microtubule inhibitor, 4SC-207, which shows strong anti-proliferative activity in a large panel of tumor cell lines with an average GI(50) of 11nM. In particular, 4SC-207 is active in multi-drug resistant cell lines, such as HCT-15 and ACHN, suggesting that it is a poor substrate for drug efflux pumps. 4SC-207 inhibits microtubule growth in vitro and in vivo and promotes, in a dose dependent manner, a mitotic delay/arrest, followed by apoptosis or aberrant divisions due to chromosome alignment defects and formation of multi-polar spindles. Furthermore, preliminary data from preclinical studies suggest low propensity towards bone marrow toxicities at concentrations that inhibit tumor growth in paclitaxel-resistant xenograft models. In summary, our results suggest that 4SC-207 may be a potential anticancer agent.	[Bausch, Elena; Sironi, Lucia] Univ Konstanz, Dept Biol, Constance, Germany; [Bausch, Elena; Sironi, Lucia] Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany; [Kohlhof, Hella; Krauss, Rolf; Baumgartner, Roland] 4SC AG, Planegg Martinsried, Germany; [Hamm, Svetlana] 4SC Discovery GmbH, Martinsried, Germany	University of Konstanz; University of Konstanz; 4SC AG	Sironi, L (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.	lucia.sironi@uni-konstanz.de			University of Konstanz, Department of Biology	University of Konstanz, Department of Biology	L.S. is supported by the University of Konstanz, Department of Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ M, 1995, J CLIN INVEST, V95, P2205, DOI 10.1172/JCI117910; Argov M, 2009, CANCER LETT, V274, P118, DOI 10.1016/j.canlet.2008.09.005; Baguley BC, 2010, MOL BIOTECHNOL, V46, P308, DOI 10.1007/s12033-010-9321-2; Cortes J, 2012, BREAST CANCER RES TR, V133, P821, DOI 10.1007/s10549-011-1875-6; Crawford J, 2004, CANCER-AM CANCER SOC, V100, P228, DOI 10.1002/cncr.11882; Daum JR, 2011, CURR BIOL, V21, P1018, DOI 10.1016/j.cub.2011.05.032; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Florian S, 2011, CELL CYCLE, V10, P3533, DOI 10.4161/cc.10.20.17817; Fojo T, 2007, ANN ONCOL, V18, pV3, DOI 10.1093/annonc/mdm172; Gascoigne KE, 2009, J CELL SCI, V122, P2579, DOI 10.1242/jcs.039719; Gaskin F, 2011, METHODS MOL BIOL, V777, P99, DOI 10.1007/978-1-61779-252-6_7; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Goodin S, 2004, J CLIN ONCOL, V22, P2015, DOI 10.1200/JCO.2004.12.001; Harrison Michael R, 2009, Clin Adv Hematol Oncol, V7, P54; Huyck TK, 2011, NAT REV DRUG DISCOV, V10, P173, DOI 10.1038/nrd3389; Jackson KL, 2009, CHEM REV, V109, P3044, DOI 10.1021/cr900016w; Jain S, 2011, CLIN CANCER RES, V17, P6615, DOI 10.1158/1078-0432.CCR-11-1807; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JORDAN MA, 1992, J CELL SCI, V102, P401; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Kurtzberg LS, 2009, CANCER CHEMOTH PHARM, V64, P1029, DOI 10.1007/s00280-009-0959-z; Lee F, 2009, CANCER CHEMOTH PHARM, V63, P201, DOI 10.1007/s00280-008-0727-5; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Magnani M, 2006, FEBS J, V273, P3301, DOI 10.1111/j.1742-4658.2006.05340.x; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Quasthoff S, 2002, J NEUROL, V249, P9, DOI 10.1007/PL00007853; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Schmidt M, 2000, ONCOGENE, V19, P2423, DOI 10.1038/sj.onc.1203546; Sironi L, 2011, CYTOSKELETON, V68, P266, DOI 10.1002/cm.20510; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Stevens D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022969; Towle MJ, 2001, CANCER RES, V61, P1013; Zheng W, 2003, STRUCTURE ACTIVITY R, P2751	35	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79594	10.1371/journal.pone.0079594	http://dx.doi.org/10.1371/journal.pone.0079594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24324550	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200074
J	Humphrys, MS; Creasy, T; Sun, YZ; Shetty, AC; Chibucos, MC; Drabek, EF; Fraser, CM; Farooq, U; Sengamalay, N; Ott, S; Shou, HZ; Bavoil, PM; Mahurkar, A; Myers, GSA				Humphrys, Michael S.; Creasy, Todd; Sun, Yezhou; Shetty, Amol C.; Chibucos, Marcus C.; Drabek, Elliott F.; Fraser, Claire M.; Farooq, Umar; Sengamalay, Naomi; Ott, Sandy; Shou, Huizhong; Bavoil, Patrik M.; Mahurkar, Anup; Myers, Garry S. A.			Simultaneous Transcriptional Profiling of Bacteria and Their Host Cells	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; CHLAMYDIA-TRACHOMATIS; GENE-EXPRESSION; RNA-SEQ; MATRIX METALLOPROTEINASES; DEVELOPMENTAL CYCLE; TENASCIN-C; SPLICE JUNCTIONS; UP-REGULATION; IN-VITRO	We developed an RNA-Seq-based method to simultaneously capture prokaryotic and eukaryotic expression profiles of cells infected with intracellular bacteria. As proof of principle, this method was applied to Chlamydia trachomatis-infected epithelial cell monolayers in vitro, successfully obtaining transcriptomes of both C. trachomatis and the host cells at 1 and 24 hours post-infection. Chlamydiae are obligate intracellular bacterial pathogens that cause a range of mammalian diseases. In humans chlamydiae are responsible for the most common sexually transmitted bacterial infections and trachoma (infectious blindness). Disease arises by adverse host inflammatory reactions that induce tissue damage & scarring. However, little is known about the mechanisms underlying these outcomes. Chlamydia are genetically intractable as replication outside of the host cell is not yet possible and there are no practical tools for routine genetic manipulation, making genome-scale approaches critical. The early timeframe of infection is poorly understood and the host transcriptional response to chlamydial infection is not well defined. Our simultaneous RNA-Seq method was applied to a simplified in vitro model of chlamydial infection. We discovered a possible chlamydial strategy for early iron acquisition, putative immune dampening effects of chlamydial infection on the host cell, and present a hypothesis for Chlamydia-induced fibrotic scarring through runaway positive feedback loops. In general, simultaneous RNA-Seq helps to reveal the complex interplay between invading bacterial pathogens and their host mammalian cells and is immediately applicable to any bacteria/host cell interaction.	[Humphrys, Michael S.; Creasy, Todd; Sun, Yezhou; Shetty, Amol C.; Chibucos, Marcus C.; Drabek, Elliott F.; Fraser, Claire M.; Farooq, Umar; Sengamalay, Naomi; Ott, Sandy; Mahurkar, Anup; Myers, Garry S. A.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Chibucos, Marcus C.; Fraser, Claire M.; Shou, Huizhong; Bavoil, Patrik M.; Myers, Garry S. A.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Bavoil, Patrik M.; Myers, Garry S. A.] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Myers, GSA (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.	gmyers@som.umaryland.edu	Chibucos, Marcus/B-1506-2015; Shetty, Amol Carl/W-7121-2019; Myers, Garry/E-7708-2011	Chibucos, Marcus/0000-0001-9586-0780; Shetty, Amol/0000-0001-8790-7649; Fraser, Claire/0000-0003-1462-2428; Myers, Garry/0000-0002-4756-4810	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, United States Department of Health and Human Services [HHSN272200900007C]; University of Maryland School of Medicine; NIAID [U19AI084044]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI084044] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, United States Department of Health and Human Services; University of Maryland School of Medicine; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Sequence data acquisition and analysis was funded in part by federal funds from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, United States Department of Health and Human Services under contract number HHSN272200900007C, and by University of Maryland School of Medicine startup funds to GM. Additional support was provided by U19AI084044 (NIAID) to PB, HS and GM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2006, EYE, V20, P362, DOI 10.1038/sj.eye.6701884; Abu El-Asrar AM, 1998, EYE, V12, P735; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Albrecht M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r98; Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ault KA, 2002, AM J OBSTET GYNECOL, V187, P1377, DOI 10.1067/mob.2002.126850; Azenabor A A, 2000, Int J Infect Dis, V4, P46, DOI 10.1016/S1201-9712(00)90066-3; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P15971, DOI 10.1073/pnas.2535394100; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Binet R, 2009, P NATL ACAD SCI USA, V106, P292, DOI 10.1073/pnas.0806768106; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Brocker Chad N., 2009, Human Genomics, V4, P43; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; Burton MJ, 2007, BRIT MED BULL, V84, P99, DOI 10.1093/bmb/ldm034; Burton MJ, 2011, INFECT IMMUN, V79, P499, DOI 10.1128/IAI.00888-10; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Cocchiaro JL, 2009, CELL MICROBIOL, V11, P1571, DOI 10.1111/j.1462-5822.2009.01364.x; Coombes BK, 2001, INFECT IMMUN, V69, P1420, DOI 10.1128/IAI.69.3.1420-1427.2001; Costello CM, 2010, AM J RESP CELL MOL, V42, P517, DOI 10.1165/rcmb.2009-0101TR; Crossley RA, 2007, APPL ENVIRON MICROB, V73, P7819, DOI 10.1128/AEM.01919-07; Darville T, 2012, INTERCELLULAR PATHOGENS I: CHLAMYDIALES, P240, DOI 10.1128/9781555817329.ch11; Darville T, 2010, J INFECT DIS, V201, pS114, DOI 10.1086/652397; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; Derrick T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002117; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eickhoff M, 2007, INFECT IMMUN, V75, P2853, DOI 10.1128/IAI.01045-06; Farkas L, 2011, AM J RESP CELL MOL, V44, P870, DOI 10.1165/rcmb.2010-0070OC; Faucher SP, 2006, P NATL ACAD SCI USA, V103, P1906, DOI 10.1073/pnas.0509183103; Giannoukos G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r23; Groot AJ, 2012, ADV EXP MED BIOL, V727, P15, DOI 10.1007/978-1-4614-0899-4_2; HATCH TP, 1986, J BACTERIOL, V165, P379, DOI 10.1128/jb.165.2.379-385.1986; Hausser HJ, 2004, OSTEOARTHR CARTILAGE, V12, P870, DOI 10.1016/j.joca.2004.07.008; Hess S, 2003, CELL MICROBIOL, V5, P785, DOI 10.1046/j.1462-5822.2003.00319.x; Hess S, 2001, ARTHRITIS RHEUM-US, V44, P2392, DOI 10.1002/1529-0131(200110)44:10<2392::AID-ART404>3.0.CO;2-I; Hu VH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002020; Illman SA, 2008, EXP DERMATOL, V17, P897, DOI 10.1111/j.1600-0625.2008.00782.x; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kronstad James W., 2006, Infectious Disorders - Drug Targets, V6, P281, DOI 10.2174/187152606778249890; Kumar R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-350; La MV, 2008, FEMS MICROBIOL REV, V32, P440, DOI 10.1111/j.1574-6976.2008.00103.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-153; Lu P, 2011, COLD SPRING HARB PER, V3; Maurer AP, 2007, PLOS PATHOG, V3, P752, DOI 10.1371/journal.ppat.0030083; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Midwood KS, 2011, CELL MOL LIFE SCI, V68, P3175, DOI 10.1007/s00018-011-0783-6; Midwood KS, 2009, J CELL COMMUN SIGNAL, V3, P287, DOI 10.1007/s12079-009-0075-1; Miller JD, 2009, MICROBIOL-SGM, V155, P2884, DOI 10.1099/mic.0.030247-0; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Motley ST, 2004, CELL MICROBIOL, V6, P849, DOI 10.1111/j.1462-5822.2004.00407.x; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Myers GSA, 2012, INTERCELLULAR PATHOGENS I: CHLAMYDIALES, P27, DOI 10.1128/9781555817329.ch2; Nagarajan UM, 2012, INTERCELLULAR PATHOGENS I: CHLAMYDIALES, P217, DOI 10.1128/9781555817329.ch10; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Neidhardt F.C., 1996, ESCHERICHIA COLI SAL, Vvol. 1; Nicholson TL, 2003, J BACTERIOL, V185, P3179, DOI 10.1128/JB.185.10.3179-3189.2003; Nookaew I., 2012, NUCL ACIDS RES; Ouellette SP, 2006, MOL MICROBIOL, V62, P1387, DOI 10.1111/j.1365-2958.2006.05465.x; Paolillo R, 2012, INT J IMMUNOPATH PH, V25, P377, DOI 10.1177/039463201202500207; Perez N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007668; Peters J, 2005, CELL MICROBIOL, V7, P1099, DOI 10.1111/j.1462-5822.2005.00534.x; PLAUNT MR, 1988, INFECT IMMUN, V56, P3021, DOI 10.1128/IAI.56.12.3021-3025.1988; Ramsey KH, 2005, INFECT IMMUN, V73, P6962, DOI 10.1128/IAI.73.10.6962-6973.2005; Rank RG, 2011, INFECT IMMUN, V79, P3291, DOI 10.1128/IAI.00200-11; Rasmussen SJ, 1997, J CLIN INVEST, V99, P77, DOI 10.1172/JCI119136; Ren Q, 2003, ANN NY ACAD SCI, V990, P701, DOI 10.1111/j.1749-6632.2003.tb07447.x; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; RICHTER G, 1993, J BACTERIOL, V175, P4045, DOI 10.1128/JB.175.13.4045-4051.1993; RICHTER G, 1992, J BACTERIOL, V174, P4050, DOI 10.1128/jb.174.12.4050-4056.1992; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosario CJ, 2012, MOL MICROBIOL, V84, P1097, DOI 10.1111/j.1365-2958.2012.08077.x; Rossetti Carlos A, 2010, BMC Res Notes, V3, P244, DOI 10.1186/1756-0500-3-244; Sbardella D, 2012, MOL ASPECTS MED, V33, P119, DOI 10.1016/j.mam.2011.10.015; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schrader S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2209; Scidmore-Carlson MA, 1999, MOL MICROBIOL, V33, P753, DOI 10.1046/j.1365-2958.1999.01523.x; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Sorber K, 2011, NUCLEIC ACIDS RES, V39, P3820, DOI 10.1093/nar/gkq1223; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; TAM JE, 1994, CAN J MICROBIOL, V40, P583, DOI 10.1139/m94-093; Tan C, 2009, INFECT IMMUN, V77, P3218, DOI 10.1128/IAI.01566-08; Thompson CC, 2012, P NATL ACAD SCI USA, V109, P10546, DOI 10.1073/pnas.1201398109; Tjaden J, 1999, J BACTERIOL, V181, P1196, DOI 10.1128/JB.181.4.1196-1202.1999; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Virok D, 2003, J INFECT DIS, V188, P1310, DOI 10.1086/379047; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang AY, 2013, CELL MICROBIOL, V15, P779, DOI 10.1111/cmi.12071; Wang AY, 2010, J BACTERIOL, V192, P2809, DOI 10.1128/JB.01462-09; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; White JM, 2003, CURR OPIN CELL BIOL, V15, P598, DOI 10.1016/j.ceb.2003.08.001; WICHLAN DG, 1993, J BACTERIOL, V175, P2936, DOI 10.1128/JB.175.10.2936-2942.1993; Wight TN, 2011, AM J PHYSIOL-GASTR L, V301, pG950, DOI 10.1152/ajpgi.00132.2011; Wordinger RJ, 2008, EXP EYE RES, V87, P78, DOI 10.1016/j.exer.2007.11.016; Worst DJ, 1998, J BACTERIOL, V180, P1473, DOI 10.1128/JB.180.6.1473-1479.1998; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wyrick PB, 2010, J INFECT DIS, V201, pS88, DOI 10.1086/652394; Xia MS, 2003, J INFECT DIS, V187, P424, DOI 10.1086/367962; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zheng X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017987	114	82	83	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80597	10.1371/journal.pone.0080597	http://dx.doi.org/10.1371/journal.pone.0080597			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324615	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300034
J	Liao, WJ; Liu, WL; Yuan, Q; Liu, X; Ou, Y; He, SQ; Yuan, SG; Qin, LL; Chen, Q; Nong, KT; Mei, MH; Huang, J				Liao, Weijia; Liu, Weilong; Yuan, Qing; Liu, Xing; Ou, Ying; He, Songqing; Yuan, Shengguang; Qin, Liling; Chen, Qian; Nong, Kate; Mei, Minghui; Huang, Jian			Silencing of DLGAP5 by siRNA Significantly Inhibits the Proliferation and Invasion of Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							POOR-PROGNOSIS; UP-REGULATION; EXPRESSION; GENE; METASTASIS; RECURRENCE; RESECTION; GROWTH; LIVER; HURP	Background: The dysregulation of oncogenes and tumor suppressor genes plays an important role in many cancers, including hepatocellular carcinoma (HCC), which is one of the most common cancers in the world. In a previous microarray experiment, we found that DLGAP5 is overexpressed in HCCs. However, whether the up-regulation of DLGAP5 contributes to hepatocarcinogenesis remains unclear. Methodology/Principal Findings: In this study, we showed that DLGAP5 was significantly up-regulated in 76.4% (168 of 220) of the analyzed HCC specimens when compared with adjacent liver tissue. DLGAP5 overexpression was evident in 25% (22 of 88) of the HCC specimens without AFP expression, suggesting that DLGAP5 may be a novel biomarker for HCC pathogenesis. The silencing of DLGAP5 gene expression by RNA interference significantly suppressed cell growth, migration and colony formation in vitro. The expression level of DLGAP5 was also found to be related to the methylation level of its promoter in the HCC specimens. Conclusions/Significance: Taken together, these data suggest that the expression of DLGAP5 is regulated by methylation and that the up-regulation of DLGAP5 contributes to HCC tumorigenesis by promoting cell proliferation.	[Liao, Weijia; He, Songqing; Yuan, Shengguang; Qin, Liling; Chen, Qian; Nong, Kate; Mei, Minghui; Huang, Jian] Guilin Med Univ, Guangxi Key Lab Mol Med, Inst Hepatobiliary Surg, Hosp Affiliated,Peoples Republ China Liver Injury, Guilin, Guangxi Zhuang, Peoples R China; [Liu, Weilong; Huang, Jian] Shenzhen Third Peoples Hosp, Guangdong Key Lab Emerging Infect Dis, Shenzhen, Guangdong, Peoples R China; [Yuan, Qing; Liu, Xing; Ou, Ying; Huang, Jian] Natl Engn Ctr Biochip Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai, Peoples R China	Guilin Medical University	Huang, J (corresponding author), Guilin Med Univ, Guangxi Key Lab Mol Med, Inst Hepatobiliary Surg, Hosp Affiliated,Peoples Republ China Liver Injury, Guilin, Guangxi Zhuang, Peoples R China.	huangjchgc@hotmail.com		Liao, Weijia/0000-0002-8906-8612	Chinese National Key Program on Basic Research (973 Program) [2010CB529206]; National High Technology Research and Development Program of China (863 Program) [2012AA02A205]; National Natural Science Foundation of China [81260328]; Program of Shanghai Subject Chief Scientist [12XD1421400]; Guilin Scientific Research and Technological Development Project [20100128-5]	Chinese National Key Program on Basic Research (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Subject Chief Scientist; Guilin Scientific Research and Technological Development Project	The authors gratefully acknowledge grant support from the Chinese National Key Program on Basic Research (973 Program, 2010CB529206), the National High Technology Research and Development Program of China (863 Program, 2012AA02A205), the National Natural Science Foundation of China (81260328), the Program of Shanghai Subject Chief Scientist (12XD1421400), and the Guilin Scientific Research and Technological Development Project (20100128-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Du RQ, 2012, J HUM GENET, V57, P545, DOI 10.1038/jhg.2012.66; Fragoso MCBV, 2012, EUR J ENDOCRINOL, V166, P61, DOI 10.1530/EJE-11-0806; Huang J, 2007, CARCINOGENESIS, V28, P1094, DOI 10.1093/carcin/bgl215; Huang J, 2006, FEBS LETT, V580, P3571, DOI 10.1016/j.febslet.2006.05.032; Huang J, 2010, J CLIN INVEST, V120, P223, DOI 10.1172/JCI38012; Kobayashi A, 2006, HEPATO-GASTROENTEROL, V53, P736; Kuo TC, 2012, BIOCHEM PHARMACOL, V83, P758, DOI 10.1016/j.bcp.2011.12.034; Li JC, 2010, GASTROENTEROLOGY, V139, P2146, DOI 10.1053/j.gastro.2010.08.004; [李雁 Li Yan], 2002, [中华医学杂志, National Medical Journal of China], V82, P601; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Minagawa M, 2003, ANN SURG, V238, P703, DOI 10.1097/01.sla.0000094549.11754.e6; Poon RTP, 1999, ANN SURG, V229, P216, DOI 10.1097/00000658-199902000-00009; Ryu HS, 2011, GUT LIVER, V5, P204, DOI 10.5009/gnl.2011.5.2.204; Shi GM, 2010, HEPATOLOGY, V52, P183, DOI 10.1002/hep.23661; Sun BS, 2008, HEPATOLOGY, V48, P1834, DOI 10.1002/hep.22531; Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1; Tian J, 1999, BRIT J CANCER, V81, P814, DOI 10.1038/sj.bjc.6690769; Tralhao JG, 2007, EJSO-EUR J SURG ONC, V33, P746, DOI 10.1016/j.ejso.2006.11.015; Tsou AP, 2003, ONCOGENE, V22, P298, DOI 10.1038/sj.onc.1206129; Verslype C, 2012, ANN ONCOL, V23, P41, DOI 10.1093/annonc/mds225; Wu K, 2012, HEPATOLOGY, V56, P2255, DOI 10.1002/hep.26007; Xiao QY, 2013, GUT, V62, P440, DOI 10.1136/gutjnl-2011-300781; Xu XR, 2001, P NATL ACAD SCI USA, V98, P15089, DOI 10.1073/pnas.241522398; Yang XR, 2010, GUT, V59, P953, DOI 10.1136/gut.2008.176271; Zhao L, 2004, J CANCER RES CLIN, V130, P719, DOI 10.1007/s00432-004-0595-2	25	54	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80789	10.1371/journal.pone.0080789	http://dx.doi.org/10.1371/journal.pone.0080789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324629	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300045
J	Sawahata, Y; Komine, K; Morita, T; Hiruma, N				Sawahata, Yasuhito; Komine, Kazuteru; Morita, Toshiya; Hiruma, Nobuyuki			Decoding Humor Experiences from Brain Activity of People Viewing Comedy Movies	PLOS ONE			English	Article							SPEECH COMPREHENSION; FMRI ACTIVITY; REWARD; APPRECIATION; MECHANISMS; FUNNY	Humans naturally have a sense of humor. Experiencing humor not only encourages social interactions, but also produces positive physiological effects on the human body, such as lowering blood pressure. Recent neuro-imaging studies have shown evidence for distinct mental state changes at work in people experiencing humor. However, the temporal characteristics of these changes remain elusive. In this paper, we objectively measured humor-related mental states from single-trial functional magnetic resonance imaging (fMRI) data obtained while subjects viewed comedy TV programs. Measured fMRI data were labeled on the basis of the lag before or after the viewer's perception of humor (humor onset) determined by the viewer-reported humor experiences during the fMRI scans. We trained multiple binary classifiers, or decoders, to distinguish between fMRI data obtained at each lag from ones obtained during a neutral state in which subjects were not experiencing humor. As a result, in the right dorsolateral prefrontal cortex and the right temporal area, the decoders showed significant classification accuracies even at two seconds ahead of the humor onsets. Furthermore, given a time series of fMRI data obtained during movie viewing, we found that the decoders with significant performance were also able to predict the upcoming humor events on a volume-by-volume basis. Taking into account the hemodynamic delay, our results suggest that the upcoming humor events are encoded in specific brain areas up to about five seconds before the awareness of experiencing humor. Our results provide evidence that there exists a mental state lasting for a few seconds before actual humor perception, as if a viewer is expecting the future humorous events.	[Sawahata, Yasuhito; Komine, Kazuteru; Morita, Toshiya; Hiruma, Nobuyuki] NHK Japan Broadcasting Corp, Sci & Tech Res Labs, Setagaya Ku, Tokyo 157, Japan	NHK Japan Broadcasting Corp	Sawahata, Y (corresponding author), NHK Japan Broadcasting Corp, Sci & Tech Res Labs, Setagaya Ku, Tokyo 157, Japan.	sawahata.y-jq@nhk.or.jp		Sawahata, Yasuhito/0000-0002-2212-8780				Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Bartolo A, 2006, J COGNITIVE NEUROSCI, V18, P1789, DOI 10.1162/jocn.2006.18.11.1789; Bekinschtein TA, 2011, J NEUROSCI, V31, P9665, DOI 10.1523/JNEUROSCI.5058-10.2011; Berns GS, 2004, TRENDS COGN SCI, V8, P193, DOI 10.1016/j.tics.2004.03.007; Chan YC, 2013, NEUROIMAGE, V66, P169, DOI 10.1016/j.neuroimage.2012.10.019; Chan YC, 2012, NEUROIMAGE, V61, P899, DOI 10.1016/j.neuroimage.2012.03.052; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Franklin RG, 2011, COGN AFFECT BEHAV NE, V11, P508, DOI 10.3758/s13415-011-0049-7; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Goel V, 2001, NAT NEUROSCI, V4, P237, DOI 10.1038/85076; Goel V, 2007, J COGNITIVE NEUROSCI, V19, P1574, DOI 10.1162/jocn.2007.19.9.1574; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Horenstein C, 2009, HUM BRAIN MAPP, V30, P1397, DOI 10.1002/hbm.20610; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; McCreaddie M, 2008, J ADV NURS, V61, P584, DOI 10.1111/j.1365-2648.2007.04548.x; Mobbs D, 2005, P NATL ACAD SCI USA, V102, P16502, DOI 10.1073/pnas.0408457102; Mobbs D, 2003, NEURON, V40, P1041, DOI 10.1016/S0896-6273(03)00751-7; Moran JM, 2004, NEUROIMAGE, V21, P1055, DOI 10.1016/j.neuroimage.2003.10.017; Naselaris T, 2011, NEUROIMAGE, V56, P400, DOI 10.1016/j.neuroimage.2010.07.073; Neely MN, 2012, J NEUROSCI, V32, P1784, DOI 10.1523/JNEUROSCI.4172-11.2012; Rodd JM, 2005, CEREB CORTEX, V15, P1261, DOI 10.1093/cercor/bhi009; Rothermich K, 2013, NEUROIMAGE, V70, P89, DOI 10.1016/j.neuroimage.2012.12.013; Samson AC, 2008, SOC NEUROSCI-UK, V3, P125, DOI 10.1080/17470910701745858; Samson AC, 2009, NEUROPSYCHOLOGIA, V47, P1023, DOI 10.1016/j.neuropsychologia.2008.10.028; Suls JM., 1972, PSYCHOL HUMOR THEORE, V1, P81, DOI 10.1016/B978-0-12-288950-9.50010-9; Wild B, 2006, NEUROLOGY, V66, P887, DOI 10.1212/01.wnl.0000203123.68747.02; WYER RS, 1992, PSYCHOL REV, V99, P663, DOI 10.1037/0033-295X.99.4.663; Yamashita O, 2008, NEUROIMAGE, V42, P1414, DOI 10.1016/j.neuroimage.2008.05.050	34	9	9	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81009	10.1371/journal.pone.0081009	http://dx.doi.org/10.1371/journal.pone.0081009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	265KD	24324656	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300065
J	Vrsansky, P; van de Kamp, T; Azar, D; Prokin, A; Vidlicka, L; Vagovic, P				Vrsansky, Peter; van de Kamp, Thomas; Azar, Dany; Prokin, Alexander; Vidlicka, L'ubomir; Vagovic, Patrik			Cockroaches Probably Cleaned Up after Dinosaurs	PLOS ONE			English	Article							COLEOPTERA SCARABAEOIDEA; MEDICINE FORMATION; DUNG-BEETLES; COPROLITES; EVOLUTION; BLATTARIA; PENTASTOMIDA; INSECTS; AMBER; EXPLOITATION	Dinosaurs undoubtedly produced huge quantities of excrements. But who cleaned up after them? Dung beetles and flies with rapid development were rare during most of the Mesozoic. Candidates for these duties are extinct cockroaches (Blattulidae), whose temporal range is associated with herbivorous dinosaurs. An opportunity to test this hypothesis arises from coprolites to some extent extruded from an immature cockroach preserved in the amber of Lebanon, studied using synchrotron X-ray microtomography. 1.06% of their volume is filled by particles of wood with smooth edges, in which size distribution directly supports their external pre-digestion. Because fungal pre-processing can be excluded based on the presence of large particles (combined with small total amount of wood) and absence of damages on wood, the likely source of wood are herbivore feces. Smaller particles were broken down biochemically in the cockroach hind gut, which indicates that the recent lignin-decomposing termite and cockroach endosymbionts might have been transferred to the cockroach gut upon feeding on dinosaur feces.	[Vrsansky, Peter] Slovak Acad Sci, Inst Geol, Bratislava, Slovakia; [Vrsansky, Peter] Russian Acad Sci, Inst Paleontol, Arthropoda Lab, Moscow V71, Russia; [van de Kamp, Thomas; Vagovic, Patrik] KIT, ANKA Inst Photon Sci & Synchrotron Radiat IPS, Eggenstein Leopoldshafen, Germany; [Azar, Dany] Lebanese Univ, Dept Nat Sci, Fac Sci 2, Fanar, Fanar Matn, Lebanon; [Prokin, Alexander] Russian Acad Sci, ID Papanin Inst Biol Inland Waters, Borok, Russia; [Prokin, Alexander] Voronezh State Univ, Voronezh 394693, Russia; [Vidlicka, L'ubomir] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia; [Vidlicka, L'ubomir] Comenius Univ, Fac Educ, Dept Biol, Bratislava, Slovakia; [Vagovic, Patrik] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 980, Japan	Slovak Academy of Sciences; Russian Academy of Sciences; Helmholtz Association; Karlsruhe Institute of Technology; Lebanese University; Papanin Institute for Biology of Inland Waters; Russian Academy of Sciences; Voronezh State University; Slovak Academy of Sciences; Comenius University Bratislava; Tohoku University	Vrsansky, P (corresponding author), Slovak Acad Sci, Inst Geol, Bratislava, Slovakia.	geolvrsa@savba.sk	van de Kamp, Thomas/G-1440-2016; Azar, Dany/AAF-7387-2020; Vršanský, Peter/ABE-7173-2020; Prokin, Alexander A/Q-6136-2016	van de Kamp, Thomas/0000-0001-7390-1318; Azar, Dany/0000-0002-4485-197X; Prokin, Alexander A/0000-0002-9345-5607; Vidlicka, Lubomir/0000-0002-4207-7300	UNESCO-Amba (MVTS); Literary fund; Schwarz stipend; Slovak Research and Development Agency [APVV-0436-12]; Lebanese University [ER023];  [VEGA 6002];  [02/0152];  [2/0186/13]	UNESCO-Amba (MVTS); Literary fund; Schwarz stipend; Slovak Research and Development Agency(Slovak Research and Development Agency); Lebanese University; ; ; 	Supported by UNESCO-Amba (MVTS), VEGA 6002, 02/0152, 2/0186/13, Literary fund, Schwarz stipend. This work was supported by the Slovak Research and Development Agency under the contract No. APVV-0436-12. This paper is a contribution to the team project (ER023: Biodiversity: Origin, Structure, Evolution and Geology) awarded to DA by the Lebanese University. Most funds covered the home institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulali H., 1942, JOUR BOMBAY NAT HIST SOC, V43, P446; ALI JH, 1983, PARASITOLOGY, V86, P147, DOI 10.1017/S0031182000057255; Almeida W. O., 2006, Braz. J. Biol., V66, P1137, DOI 10.1590/S1519-69842006000600022; Anisyutkin LN, 2008, PALEONTOL J+, V42, P43, DOI 10.1134/S0031030108010061; Annandale N., 1900, Entomologist's Record, Vxii, P75; [Anonymous], 1995, ADAPTATION NATURAL S, DOI DOI 10.4159/HARVARD.9780674419070; Arillo A, 2007, GEOL ACTA, V5, P159; Arillo A, 2008, J NAT HIST, V42, P1405, DOI 10.1080/00222930802105130; Azar Dany, 2010, P271; Bai M, 2012, INSECT SCI, V19, P159, DOI 10.1111/j.1744-7917.2011.01460.x; Ball ED, 1942, U ARIZONA COLL AGR E, V93, P257; Ballor NR, 2012, MICROB ECOL, V63, P586, DOI 10.1007/s00248-011-9941-5; Barton DP, 2004, COMP PARASITOL, V71, P251, DOI 10.1654/4134; Beatty H.A., 1944, J AGR U PR, V28, P103; BELAND P, 1978, CAN J EARTH SCI, V15, P1012, DOI 10.1139/e78-109; Bell W. J., 2007, COCKROACHES ECOLOGY; Blatchley WS., 1920, ORTHOPTERA NE AM; Bonse U, 1996, PROG BIOPHYS MOL BIO, V65, P133, DOI 10.1016/S0079-6107(96)00011-9; BORNEMISSZA G. F., 1960, JOUR AUSTRALIAN INST AGRIC SCI, V26, P54; Buffetaut E, 2006, NATURWISSENSCHAFTEN, V93, P440, DOI 10.1007/s00114-006-0124-z; Caudell A. N., 1924, Insecutor Inscitiae Menstruus, V12, P133; CHANDLER ASA C., 1926, INDIAN MED GAZ, V61, P209; Chilingaryan S, 2011, IEEE T NUCL SCI, V58, P1447, DOI 10.1109/TNS.2011.2141686; Chin K, 1996, PALAIOS, V11, P280, DOI 10.2307/3515235; Chin K, 2007, PALAIOS, V22, P554, DOI 10.2110/palo.2006.p06-087r; Chin K, 2009, LETHAIA, V42, P185, DOI 10.1111/j.1502-3931.2008.00131.x; Chopard L., 1936, Archives de Zoologie Experimentale et Generale Paris, V78, P195; CHOPARD L., 1949, MEM INST SCI MADAGASCAR SER A, V3, P41; Chopard L., 1919, Memoirs of the Asiatic Society of Bengal, V6; Chopard L, 1929, J FEDERATED MALAY ST, V14, P366; Chopard L, 1938, ENCY ENT PARIS A, V20; Christoffersen M. L., 2013, Zoologische Mededelingen (Leiden), V87, P1; Colin Jean-Paul, 2011, Revue de Micropaleontologie, V54, P129, DOI 10.1016/j.revmic.2011.06.001; Conwentz H., 1890, MONOGRAPHIE BALTISCH; Darlington Johanna P. E. C., 1995, Studies in Speleology, V10, P65; Darlington JPEC, 1970, THESIS U W INDIES TR; DeCoursey JD, 1957, EGYPT J NEW YORK ENT, V64, P157; DeCoursey JD, 1956, 0050506001 NM US NAV; Dolezych M, 2012, Z DTSCH GES GEOWISS, V163, P283, DOI 10.1127/1860-1804/2012/0163-0283; Engel Michael S., 2011, Palaeodiversity, P39; Engel MS, 2009, AM MUS NOVIT, P1, DOI 10.1206/651.1; Gautier J.-V., 1974, Revue Comport Anim, V9, P237; Gautier JY, 1974, THESIS U RENNES; Gnaspini P, 2000, ECOSY WORLD, V30, P251; Grimaldi D., 1996, AMBER WINDOW; HALFFTER GONZALO, 1966, FOLIA ENTOMOL MEX, V12/14, P1; HANITSCH R., 1929, TIJDSCHR VOOR ENT, V72, P263; Hanski I., 1991, P305; Hebard M., 1917, Memoirs of the American Entomological Society, V2; Jefferey J, 1985, MALAYSIAN J MED LAB, V2, P83; JOHANNES RE, 1966, LIMNOL OCEANOGR, V11, P191, DOI 10.4319/lo.1966.11.2.0191; Kaddumi HF, 2005, PUBLICATIONS ETERNAL; Kirejtshuk A. G., 2011, ZOOSYSTEMATICA ROSSICA, V20, P63; KRELL FT, 2006, COLEOPT SOC MONO DEC, P120, DOI DOI 10.1649/0010-065X(2006)60[; LELEUP N., 1956, ANN MUS CONGO BEIGE TERVUREN IN 8[DEGREE] ZOOL, V46, P1; Lin Q.B., 1980, DIVISION CORRELATION, P211; Macfie J. W., 1922, Annals of Tropical Medicine and Parasitology, V16, P441; MCBRAYER JF, 1973, PEDOBIOLOGIA, V13, P90; Morischita K, 1926, TAIWAN IGAKKAI ZASSH, V255, P566; Moulton JC, 1912, ENTOMOLOGIST, V45, P246; Nikolaev GV, 2007, MESOZOIC STAGE SCARA; Nikolajev G.V., 2008, Caucasian Entomological Bulletin, V4, P291; Nikolajev GV, 2010, ACTA GEOL SIN-ENGL, V84, P673, DOI 10.1111/j.1755-6724.2010.00260.x; Nikolajev GV., 1992, PALEONTOL J+, V26, P96; Nuorteva M, 2008, B GEOL SOC FINLAND, V80, P105, DOI 10.17741/bgsf/80.2.003; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Paulian R, 1948, P 8 INT C ENT STOCKH, P454; Poinar G, 2006, PARASITOLOGY, V133, P245, DOI 10.1017/S0031182006000138; Poinar George Jr, 1998, Ichnos, V6, P47; Ponomarenko AG, 2010, HER RUSS ACAD SCI+, V80, P438, DOI 10.1134/S1019331610050035; Ponomarenko AG, 2006, EVOLYUTSIYA BIOSFERY, P257; Porter A., 1918, S Afric Inst Med Res, VNo. 11; Poulson TL, 2000, ECOSY WORLD, V30, P231; Prasad V, 2005, SCIENCE, V310, P1177, DOI 10.1126/science.1118806; PRINCIS K., 1955, OPUSCULA ENTOMOL, V20, P149; Rajamanickam C, 1965, MED J MALAYSIA, V20, P171; Rehn JAG, 1914, J NEW YORK ENTOMOL S, V22, P96; REHN JAMES A. G., 1965, NOTULAE NATUR, V374, P1; RICHARDS AM, 1971, J ZOOL, V164, P1; Rogers K.L., 1985, Journal of Vertebrate Paleontology, V5, P371; ROTH LM, 1973, P ENTOMOL SOC WASH, V75, P1; Roth LM, 2003, J ORTHOP RES, V12, P57; ROTH LOUIS M., 1960, SMITHSONIAN MISC COLL, V141, P1; Sahney S, 2010, BIOL LETTERS, V6, P544, DOI 10.1098/rsbl.2009.1024; SCHAL C, 1982, SCIENCE, V218, P170, DOI 10.1126/science.218.4568.170; Schmidt AR, 2010, PALAEONTOGR ABT B, V283, P157, DOI 10.1127/palb/283/2010/157; SCHOENLY K, 1983, ANN ENTOMOL SOC AM, V76, P790, DOI 10.1093/aesa/76.4.790; Slaney DP, 2001, J NAT HIST, V35, P1001, DOI 10.1080/002229301300323901; Takahashi R., 1926, Dobuts Zasshi [Zool Mag] Tokyo, V38, P89; Tomassen HBM, 2005, CAN J BOT, V83, P1046, DOI 10.1139/B05-051; van Baaren J, 2002, AMAZONIANA, V17, P243; Vidlicka L, 2001, BLATTARIA SVABY MANT; Vishniakova V.N., 1968, P55; VISHNYAKOVA V N, 1982, Paleontologicheskii Zhurnal, P69; Vrsansky P, 2005, GEOL CARPATH, V56, P473; Vrsansky P., 2000, PALEONTOL J, V34, P374; Vrsansky P, 2014, EUR J ENTOM IN PRESS, V111; Vrsansky P, 2008, DEUT ENTOMOL Z, V55, P215, DOI 10.1002/mmnd.200800022; Vrsansky P, 2008, GEOL CARPATH, V59, P269; Vrsansky Peter, 2005, Entomological Problems, V35, P115; Vrsansky Peter, 2004, Entomological Problems, V34, P49; Vrsansky Peter, 2003, Entomological Problems, V33, P119; Vrsansky P, 2013, NATURWISSENSCHAFTEN, V100, P1099, DOI 10.1007/s00114-013-1100-z; Vrsansky P, 2012, NATURWISSENSCHAFTEN, V99, P739, DOI 10.1007/s00114-012-0956-7; Vrsansky P, 2010, ACTA GEOL SIN-ENGL, V84, P793, DOI 10.1111/j.1755-6724.2010.00261.x; Vrsansky P, 2009, GEODIVERSITAS, V31, P73, DOI 10.5252/g2009n1a7; Wang Tian-Tian, 2007, Zootaxa, V1443, P17; Wang TT, 2007, ANN ZOOL, V57, P483; Webster J.W., 1995, FUNGAL ECOL; Weidner H., 1956, Veroeffentlichungen aus dem Ueberseemuseum in Bremen, V2A, P363; Weitkamp T, 2011, J SYNCHROTRON RADIAT, V18, P617, DOI 10.1107/S0909049511002895; Wilkinson DM, 2012, CURR BIOL, V22, pR292, DOI 10.1016/j.cub.2012.03.042; Wolcott G. N., 1950, Journal of Agriculture of the University of Puerto Rico, V32, P1; Zherikhin V.V., 2002, P331; Zherikhin V.V, 1978, P PALEONTOLOGICAL I, V165, P1	115	19	19	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80560	10.1371/journal.pone.0080560	http://dx.doi.org/10.1371/journal.pone.0080560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324610	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300030
J	Blake, JG; Loiselle, BA				Blake, John G.; Loiselle, Bette A.			Apparent Survival Rates of Forest Birds in Eastern Ecuador Revisited: Improvement in Precision but No Change in Estimates	PLOS ONE			English	Article							NEOTROPICAL BIRDS; COMMUNITY; MANAKINS; HABITAT	Knowledge of survival rates of Neotropical landbirds remains limited, with estimates of apparent survival available from relatively few sites and species. Previously, capture-mark-recapture models were used to estimate apparent survival of 31 species (30 passerines, 1 Trochilidae) from eastern Ecuador based on data collected from 2001 to 2006. Here, estimates are updated with data from 2001-2012 to determine how additional years of data affect estimates; estimates for six additional species are provided. Models assuming constant survival had highest support for 19 of 31 species when based on 12 years of data compared to 27 when based on six; models incorporating effects of transients had the highest support for 12 of 31 species compared to four when based on 12 and six years, respectively. Average apparent survival based on the most highly-supported model (based on model averaging, when appropriate) was 0.59 (+/- 0.02 SE) across 30 species of passerines when based on 12 years and 0.57 (+/- 0.02) when based on six. Standard errors of survival estimates based on 12 years were approximately half those based on six years. Of 31 species in both data sets, estimates of apparent survival were somewhat lower for 13, somewhat higher for 17, and remained unchanged for one; confidence intervals for estimates based on six and 12 years of data overlapped for all species. Results indicate that estimates of apparent survival are comparable but more precise when based on longer-term data sets; standard error of the estimates was negatively correlated with numbers of captures (r(s) = -0.72) and recaptures (r(s) = -0.93, P<0.001 in both cases). Thus, reasonable estimates of apparent survival may be obtained with relatively few years of data if sample sizes are sufficient.	[Blake, John G.; Loiselle, Bette A.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32610 USA; [Loiselle, Bette A.] Univ Florida, Ctr Latin Amer Studies, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Blake, JG (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32610 USA.	john.blake@ufl.edu	Loiselle, Bette/O-7106-2016	Loiselle, Bette/0000-0003-1434-4173	National Science Foundation [IBN 0235141, DEB 0304909]; National Geographic Society [7113-01]; Fulbright U.S. Scholars Program; University of Florida; University of Missouri St. Louis	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Fulbright U.S. Scholars Program; University of Florida(University of Florida); University of Missouri St. Louis	Research has been supported by the National Science Foundation (IBN 0235141 and DEB 0304909), National Geographic Society (7113-01), Fulbright U.S. Scholars Program, University of Missouri St. Louis, and University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, PROGRAM MARK GENTLE; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Blake JG, 2002, AUK, V119, P132, DOI 10.1642/0004-8038(2002)119[0132:MPISGA]2.0.CO;2; Blake JG, 2008, BIOTROPICA, V40, P485, DOI 10.1111/j.1744-7429.2007.00395.x; Blake JG, 2009, BIOTROPICA, V41, P85, DOI 10.1111/j.1744-7429.2008.00445.x; Brawn JD, 1999, INT ORN C, V22, P297; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cloquet R, 2005, U CARE 2 2 USERS MAN; Faaborg J, 1995, AUK, V112, P503, DOI 10.2307/4088741; Francis CM, 1999, INT ORNITHOL C, P326; Johnston JP, 1997, AM NAT, V150, P771, DOI 10.1086/286093; Jullien M, 2000, ECOLOGY, V81, P3416, DOI 10.1890/0012-9658(2000)081[3416:TSVOFI]2.0.CO;2; KARR JR, 1990, AM NAT, V136, P277, DOI 10.1086/285098; MacDonald DB, 1993, BEHAV ECOL, V4, P297; Parker TH, 2006, BIOTROPICA, V38, P764, DOI 10.1111/j.1744-7429.2006.00210.x; Pearce-Higgins JW, 2007, CONDOR, V109, P167, DOI 10.1650/0010-5422(2007)109[167:SOBM]2.0.CO;2; Pollock KH, 1990, WILDLIFE MONOGR, V107, P3; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; Remsen Jr J.V., 2013, CLASSIFICATION BIRD; Robinson WD, 2010, AUK, V127, P253, DOI 10.1525/auk.2010.127.2.253; Robinson WD, 2000, ECOL MONOGR, V70, P209, DOI 10.1890/0012-9615(2000)070[0209:FBCSIC]2.0.CO;2; Ruiz-Gutierrez V, 2012, AUK, V129, P500, DOI 10.1525/auk.2012.11171; Sandercock BK, 2006, J WILDLIFE MANAGE, V70, P1504, DOI 10.2193/0022-541X(2006)70[1504:EODPFL]2.0.CO;2; SNOW D. W., 1962, ZOOLOGICA [NEW YORK], V47, P65; SNOW DW, 1974, CONDOR, V76, P262, DOI 10.2307/1366339; TERBORGH J, 1990, ECOL MONOGR, V60, P213, DOI 10.2307/1943045; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilson S, 2011, ORNITOL NEOTROP, V22, P421	28	15	17	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81028	10.1371/journal.pone.0081028	http://dx.doi.org/10.1371/journal.pone.0081028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312519	Green Published, gold, Green Submitted			2022-12-25	WOS:000327944500051
J	Mizuta, R; Araki, S; Furukawa, M; Furukawa, Y; Ebara, S; Shiokawa, D; Hayashi, K; Tanuma, S; Kitamura, D				Mizuta, Ryushin; Araki, Shinsuke; Furukawa, Makoto; Furukawa, Yuki; Ebara, Syota; Shiokawa, Daisuke; Hayashi, Katsuhiko; Tanuma, Sei-ichi; Kitamura, Daisuke			DNase gamma Is the Effector Endonuclease for Internucleosomal DNA Fragmentation in Necrosis	PLOS ONE			English	Article							CELL-DEATH; DEOXYRIBONUCLEASE-I; MEDIATED APOPTOSIS; MOUSE HEPATOCYTES; MICE; DEGRADATION; INVOLVEMENT; ACTIVATION; EXPRESSION; CLEAVAGE	Apoptosis and necrosis, two major forms of cell death, can be distinguished morphologically and biochemically. Internucleosomal DNA fragmentation (INDF) is a biochemical hallmark of apoptosis, and caspase-activated DNase (CAD), also known as DNA fragmentation factor 40 kDa (DFF40), is one of the major effector endonucleases. DNase gamma, a Mg2+/Ca2+-dependent endonuclease, is also known to generate INDF but its role among other apoptosis-associated endonucleases in cell death is unclear. Here we show that (i) INDF occurs even during necrosis in cell lines, primary cells, and in tissues of mice in vivo, and (ii) DNase gamma, but not CAD, is the effector endonuclease for INDF in cells undergoing necrosis. These results document a previously unappreciated role for INDF in necrosis and define its molecular basis.	[Mizuta, Ryushin; Araki, Shinsuke; Furukawa, Makoto; Furukawa, Yuki; Ebara, Syota; Hayashi, Katsuhiko; Kitamura, Daisuke] Tokyo Univ Sci, Res Inst Biomed Sci, Noda, Chiba 278, Japan; [Araki, Shinsuke; Shiokawa, Daisuke; Tanuma, Sei-ichi] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Biochem, Noda, Chiba 278, Japan; [Kitamura, Daisuke] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Mol Immunol, Noda, Chiba 278, Japan	Tokyo University of Science; Tokyo University of Science; Tokyo University of Science	Mizuta, R (corresponding author), Tokyo Univ Sci, Res Inst Biomed Sci, Noda, Chiba 278, Japan.	mizuta@rs.noda.tus.ac.jp; kitamura@rs.noda.tus.ac.jp	Araki, Shinsuke/M-3983-2018	Araki, Shinsuke/0000-0002-9936-1417	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21590542, 24590587]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grants-in-Aid for Scientific Research (C) 21590542 and 24590587 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (R. M.); and Takeda Science Foundation (D. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulares AH, 2002, CANCER RES, V62, P4439; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Didenko VV, 2003, AM J PATHOL, V162, P1571, DOI 10.1016/S0002-9440(10)64291-5; Dobos KM, 2000, INFECT IMMUN, V68, P6300, DOI 10.1128/IAI.68.11.6300-6310.2000; Dong Z, 1997, AM J PATHOL, V151, P1205; Irvine RA, 2005, MOL CELL BIOL, V25, P294, DOI 10.1128/MCB.25.1.294-302.2005; KAMINSKAS E, 1989, BIOCHEM J, V261, P17, DOI 10.1042/bj2610017; Kok YJ, 2002, BIOCHEM BIOPH RES CO, V294, P934, DOI 10.1016/S0006-291X(02)00587-9; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lecoeur H, 2002, EXP CELL RES, V277, P1, DOI 10.1006/excr.2002.5537; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; McIlroy D, 2000, GENE DEV, V14, P549; Mizuta R, 2006, BIOCHEM BIOPH RES CO, V345, P560, DOI 10.1016/j.bbrc.2006.04.107; MORITA M, 1995, HEPATOLOGY, V21, P1585, DOI 10.1016/0270-9139(95)90463-8; Nagata S, 2003, CELL DEATH DIFFER, V10, P108, DOI 10.1038/sj.cdd.4401161; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Napirei M, 2006, HEPATOLOGY, V43, P297, DOI 10.1002/hep.21034; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; NI R, 1994, EXP CELL RES, V215, P332, DOI 10.1006/excr.1994.1349; Nishikawa A, 1997, BIOCHEM BIOPH RES CO, V231, P305, DOI 10.1006/bbrc.1997.6091; Okamoto M, 2005, BIOCHEM BIOPH RES CO, V327, P76, DOI 10.1016/j.bbrc.2004.11.142; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Rodriguez AM, 1997, GENOMICS, V42, P507, DOI 10.1006/geno.1997.4748; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Shiokawa D, 2007, CELL DEATH DIFFER, V14, P992, DOI 10.1038/sj.cdd.4402086; Shiokawa D, 2004, CELL DEATH DIFFER, V11, P1112, DOI 10.1038/sj.cdd.4401454; Shiokawa D, 2002, J BIOL CHEM, V277, P31031, DOI 10.1074/jbc.M204038200; Shiokawa D, 2001, BIOCHEMISTRY-US, V40, P143, DOI 10.1021/bi001041a; Shiokawa D, 1998, BIOCHEM J, V332, P713, DOI 10.1042/bj3320713; Soeda J, 2001, AM J PHYSIOL-GASTR L, V281, pG1115, DOI 10.1152/ajpgi.2001.281.4.G1115; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tone S, 2007, EXP CELL RES, V313, P3635, DOI 10.1016/j.yexcr.2007.06.018; Widlak P, 2005, J CELL BIOCHEM, V94, P1078, DOI 10.1002/jcb.20409; Wilber A, 2002, MOL THER, V6, P35, DOI 10.1006/mthe.2002.0625; Wu XW, 2001, ARTHRITIS RHEUM, V44, P2642, DOI 10.1002/1529-0131(200111)44:11<2642::AID-ART444>3.0.CO;2-8; Yakovlev AG, 1999, NUCLEIC ACIDS RES, V27, P1999, DOI 10.1093/nar/27.9.1999	37	34	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80223	10.1371/journal.pone.0080223	http://dx.doi.org/10.1371/journal.pone.0080223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312463	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500017
J	Neidert, MC; Sprenger, M; Wernli, H; Burkhardt, JK; Krayenbuhl, N; Bozinov, O; Regli, L; Woernle, CM				Neidert, Marian Christoph; Sprenger, Michael; Wernli, Heini; Burkhardt, Jan-Karl; Krayenbuehl, Niklaus; Bozinov, Oliver; Regli, Luca; Woernle, Christoph Michael			Meteorological Influences on the Incidence of Aneurysmal Subarachnoid Hemorrhage - A Single Center Study of 511 Patients	PLOS ONE			English	Article							RISK-FACTORS; SEASONAL-VARIATION; BAROMETRIC-PRESSURE; CASE-FATALITY; STROKE; ASSOCIATION; MORTALITY; RUPTURE; WEATHER	Objective: To assess the potential meteorological influence on the incidence of aneurysmal subarachnoid hemorrhage (SAH). Previous studies used inhomogeneous patient groups, insufficient study periods or inappropriate statistics. Patients and Methods: We analyzed 511 SAH admissions between 2004 and 2012 for which aneurysmal rupture occurred within the Zurich region. The hourly meteorological parameters considered are: surface pressure, 2-m temperature, relative humidity and wind gusts, sunshine, and precipitation. For all parameters we investigate three complementary statistical measures: i) the time evolution from 5 days before to 5 days after the SAH occurrence; ii) the deviation from the 10-year monthly mean; and iii) the change relative to the parameter's value two days before SAH occurrence. The statistical significance of the results is determined using a Monte Carlo simulation combined with a re-sampling technique (1000x). Results: Regarding the meteorological parameters considered, no statistically significant signal could be found. The distributions of deviations relative to the climatology and of the changes during the two days prior to SAH events agree with the distributions for the randomly chosen days. The analysis was repeated separately for winter and summer to exclude compensating effects between the seasons. Conclusion: By using high-quality meteorological data analyzed with a sophisticated and robust statistical method no clearly identifiable meteorological influence for the SAH events considered can be found. Further studies on the influence of the investigated parameters on SAH incidence seem redundant.	[Neidert, Marian Christoph; Burkhardt, Jan-Karl; Krayenbuehl, Niklaus; Bozinov, Oliver; Regli, Luca; Woernle, Christoph Michael] Univ Zurich Hosp, Dept Neurosurg, CH-8091 Zurich, Switzerland; [Sprenger, Michael; Wernli, Heini] ETH, Inst Atmospher & Climate Sci, Zurich, Switzerland	University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich	Neidert, MC (corresponding author), Univ Zurich Hosp, Dept Neurosurg, CH-8091 Zurich, Switzerland.	marian.neidert@usz.ch	Wernli, Heini/F-1099-2016	Wernli, Heini/0000-0001-9674-4837; Bozinov, Oliver/0000-0002-4620-3992; Krayenbuehl, Niklaus/0000-0003-1089-221X; Sprenger, Michael/0000-0002-9317-8822				Abe T, 2008, J CLIN NEUROSCI, V15, P1005, DOI 10.1016/j.jocn.2007.07.081; Beseoglu K, 2008, NEUROSURGERY, V62, P1033, DOI 10.1227/01.neu.0000325864.91584.c7; BILLER J, 1988, NEUROEPIDEMIOLOGY, V7, P89, DOI 10.1159/000110140; Broderick JP, 2003, STROKE, V34, P1375, DOI 10.1161/01.STR.0000074572.91827.F4; Buxton N, 2001, J NEUROSURG, V95, P391, DOI 10.3171/jns.2001.95.3.0391; CAPON A, 1992, STROKE, V23, P24, DOI 10.1161/01.STR.23.1.24; CHYATTE D, 1994, J NEUROSURG, V81, P525, DOI 10.3171/jns.1994.81.4.0525; Cowperthwaite MC, 2011, NEUROSURGERY, V68, P132, DOI 10.1227/NEU.0b013e3181fe23a1; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Feigin VL, 2001, STROKE, V32, P613, DOI 10.1161/01.STR.32.3.613; Field TS, 2002, STROKE, V33, P1751, DOI 10.1161/01.STR.0000020384.92499.59; Fischer T, 2005, NEUROEPIDEMIOLOGY, V24, P32, DOI 10.1159/000081047; Hakan T, 2003, SWISS MED WKLY, V133, P267; Johnston SC, 1998, NEUROLOGY, V50, P1413, DOI 10.1212/WNL.50.5.1413; KNEKT P, 1991, J CLIN EPIDEMIOL, V44, P933, DOI 10.1016/0895-4356(91)90056-F; Landers AT, 1997, BRIT J NEUROSURG, V11, P191, DOI 10.1080/02688699746230; LEJEUNE JP, 1994, STROKE, V25, P338, DOI 10.1161/01.STR.25.2.338; Litch JA, 1997, WESTERN J MED, V167, P180; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; McDonald RJ, 2012, AM J NEURORADIOL, V33, P1663, DOI 10.3174/ajnr.A3059; Nyquist PA, 2001, NEUROLOGY, V56, P190, DOI 10.1212/WNL.56.2.190; Qureshi AI, 2001, NEUROSURGERY, V49, P607, DOI 10.1097/00006123-200109000-00014; Rothwell PM, 1996, LANCET, V347, P934, DOI 10.1016/S0140-6736(96)91415-4; Sandvei MS, 2011, NEUROLOGY, V77, P1833, DOI 10.1212/WNL.0b013e3182377de3; Sandvei MS, 2009, STROKE, V40, P1958, DOI 10.1161/STROKEAHA.108.539544; SCHIEVINK WI, 1995, J NEUROSURG, V82, P912; Setzer M, 2007, SURG NEUROL, V67, P264, DOI 10.1016/j.surneu.2006.06.060; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Teunissen LL, 1996, STROKE, V27, P544, DOI 10.1161/01.STR.27.3.544; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249	31	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81621	10.1371/journal.pone.0081621	http://dx.doi.org/10.1371/journal.pone.0081621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312565	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500080
J	Wood, WE; Osseward, PJ; Roseberry, TK; Perkel, DJ				Wood, William E.; Osseward, Peter J., II; Roseberry, Thomas K.; Perkel, David J.			A Daily Oscillation in the Fundamental Frequency and Amplitude of Harmonic Syllables of Zebra Finch Song	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; MELATONIN AFFECTS; HTR2 RECEPTORS; SEROTONIN; DYNAMICS; VARIABILITY; PERFORMANCE; FEEDBACK; LESIONS; SYSTEM	Complex motor skills are more difficult to perform at certain points in the day (for example, shortly after waking), but the daily trajectory of motor-skill error is more difficult to predict. By undertaking a quantitative analysis of the fundamental frequency (FF) and amplitude of hundreds of zebra finch syllables per animal per day, we find that zebra finch song follows a previously undescribed daily oscillation. The FF and amplitude of harmonic syllables rises across the morning, reaching a peak near mid-day, and then falls again in the late afternoon until sleep. This oscillation, although somewhat variable, is consistent across days and across animals and does not require serotonin, as animals with serotonergic lesions maintained daily oscillations. We hypothesize that this oscillation is driven by underlying physiological factors which could be shared with other taxa. Song production in zebra finches is a model system for studying complex learned behavior because of the ease of gathering comprehensive behavioral data and the tractability of the underlying neural circuitry. The daily oscillation that we describe promises to reveal new insights into how time of day affects the ability to accomplish a variety of complex learned motor skills.	[Wood, William E.] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; [Perkel, David J.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Osseward, Peter J., II; Roseberry, Thomas K.; Perkel, David J.] Univ Washington, Dept Otolaryngol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Perkel, DJ (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	perkel@uw.edu			National Institute of Mental Health [R01MH066128, F31MH092943]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH092943, R01MH066128] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding was provided by the National Institute of Mental Health through awards R01MH066128 and F31MH092943. http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador A, 2013, J NEUROSCI, V33, P11136, DOI 10.1523/JNEUROSCI.5906-12.2013; Aronov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047856; Atkinson G, 1998, PERCEPT MOTOR SKILL, V86, P1335, DOI 10.2466/pms.1998.86.3c.1335; Carrier J, 2000, CHRONOBIOL INT, V17, P719, DOI 10.1081/CBI-100102108; Compan V, 1998, BRAIN RES, V793, P103, DOI 10.1016/S0006-8993(98)00168-1; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Deregnaucourt S, 2012, J PINEAL RES, V53, P245, DOI 10.1111/j.1600-079X.2012.00993.x; Gahr M, 1996, J COMP NEUROL, V367, P308; GATES A, 1916, VARIATION EFFICIENCY, V2, P1; Glaze CM, 2006, J NEUROSCI, V26, P991, DOI 10.1523/JNEUROSCI.3387-05.2006; Goller F, 2004, ANN NY ACAD SCI, V1016, P130, DOI 10.1196/annals.1298.009; Jansen R, 2005, FASEB J, V19, P848, DOI 10.1096/fj.04-2874fje; Kao MH, 2006, J NEUROPHYSIOL, V96, P1441, DOI 10.1152/jn.01138.2005; KLEITMAN N, 1950, J APPL PHYSIOL, V3, P309, DOI 10.1152/jappl.1950.3.6.309; Leblois A, 2010, J NEUROSCI, V30, P5730, DOI 10.1523/JNEUROSCI.5974-09.2010; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Mistlberger RE, 1998, BEHAV BRAIN RES, V96, P93, DOI 10.1016/S0166-4328(98)00007-2; Monti JM, 2010, DRUG TODAY, V46, P183, DOI 10.1358/dot.2010.46.3.1437247; Morin LP, 1999, ANN MED, V31, P12, DOI 10.3109/07853899909019259; MORIN LP, 1991, BRAIN RES, V566, P173, DOI 10.1016/0006-8993(91)91696-X; Neumaier JF, 1996, BRAIN RES, V722, P50, DOI 10.1016/0006-8993(96)00178-3; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; Paulus EV, 2012, PHYSIOL BEHAV, V105, P257, DOI 10.1016/j.physbeh.2011.08.032; Reilly T, 1981, Br J Sports Med, V15, P122; Sober SJ, 2008, J NEUROSCI, V28, P10370, DOI 10.1523/JNEUROSCI.2448-08.2008; Sober SJ, 2009, NAT NEUROSCI, V12, P927, DOI 10.1038/nn.2336; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Wood WE, 2013, J NEUROSCI, V33, P2908, DOI 10.1523/JNEUROSCI.4291-12.2013; Wood WE, 2011, J NEUROSCI, V31, P13808, DOI 10.1523/JNEUROSCI.2281-11.2011; Wu W, 2008, J NEUROSCI METH, V174, P147, DOI 10.1016/j.jneumeth.2008.06.033; ZEIGLER P, 2004, ANN NY ACAD SCI, V1016, P1, DOI DOI 10.1196/ANNALS.1298.029; Zollinger SA, 2012, ANIM BEHAV, V84, pE1, DOI 10.1016/j.anbehav.2012.04.026	35	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82327	10.1371/journal.pone.0082327	http://dx.doi.org/10.1371/journal.pone.0082327			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312654	Green Submitted, gold, Green Published			2022-12-25	WOS:000327944500136
J	Tarafdar, A; Dobbin, E; Corrigan, P; Freeburn, R; Wheadon, H				Tarafdar, Anuradha; Dobbin, Edwina; Corrigan, Pamela; Freeburn, Robin; Wheadon, Helen			Canonical Wnt Signaling Promotes Early Hematopoietic Progenitor Formation and Erythroid Specification during Embryonic Stem Cell Differentiation	PLOS ONE			English	Article							BETA-CATENIN; SELF-RENEWAL; MOUSE EMBRYO; TRANSCRIPTION FACTOR; IN-VIVO; LATERAL MESODERM; GENE-EXPRESSION; GAMMA-CATENIN; PROTEIN LMO2; ES CELLS	The generation of hematopoietic stem cells (HSCs) during development is a complex process linked to morphogenic signals. Understanding this process is important for regenerative medicine applications that require in vitro production of HSC. In this study we investigated the effects of canonical Wnt/beta-catenin signaling during early embryonic differentiation and hematopoietic specification using an embryonic stem cell system. Our data clearly demonstrates that following early differentiation induction, canonical Wnt signaling induces a strong mesodermal program whilst maintaining a degree of stemness potential. This involved a complex interplay between beta-catenin/TCF/LEF/Brachyury/Nanog. beta-catenin mediated up-regulation of TCF/LEF resulted in enhanced brachyury levels, which in-turn lead to Nanog up-regulation. During differentiation, active canonical Wnt signaling also up-regulated key transcription factors and cell specific markers essential for hematopoietic specification, in particular genes involved in establishing primitive erythropoiesis. This led to a significant increase in primitive erythroid colony formation. similar to-catenin signaling also augmented early hematopoietic and multipotent progenitor (MPP) formation. Following culture in a MPP specific cytokine cocktail, activation of beta-catenin suppressed differentiation of the early hematopoietic progenitor population, with cells displaying a higher replating capacity and a propensity to form megakaryocytic erythroid progenitors. This bias towards erythroid lineage commitment was also observed when hematopoietic progenitors were directed to undergo myeloid colony formation. Overall this study underscores the importance of canonical Wnt/beta-catenin signaling in mesodermal specification, primitive erythropoiesis and early hematopietic progenitor formation during hematopoietic induction.	[Tarafdar, Anuradha; Wheadon, Helen] Univ Glasgow, Paul OGorman Leukaemia Res Ctr, Glasgow G12 8QQ, Lanark, Scotland; [Tarafdar, Anuradha; Corrigan, Pamela] Univ Ulster, Inst Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland; [Dobbin, Edwina] Western Gen Hosp, Dept Haematol, Edinburgh EH4 2XU, Midlothian, Scotland; [Freeburn, Robin] Univ West Scotland, Sch Sci, Paisley, Renfrew, Scotland	University of Glasgow; Ulster University; University of Edinburgh; University of West Scotland	Wheadon, H (corresponding author), Univ Glasgow, Paul OGorman Leukaemia Res Ctr, Glasgow G12 8QQ, Lanark, Scotland.	helen.wheadon@glasgow.ac.uk		Tarafdar, Anuradha/0000-0003-2580-9394; Wheadon, Helen/0000-0001-9902-3170	Northern Ireland Leukaemia Research Fund; Leukeamia and Lymphoma Research; NC3Rs; Friends of Paul O'Gorman; Vice Chancellor Scholarship University of Ulster; Department of Education and Learning Scholarship Northern Ireland; Kay Kendall Leukaemia Fund [KKL501]	Northern Ireland Leukaemia Research Fund; Leukeamia and Lymphoma Research; NC3Rs(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Friends of Paul O'Gorman; Vice Chancellor Scholarship University of Ulster; Department of Education and Learning Scholarship Northern Ireland; Kay Kendall Leukaemia Fund	This work was supported by grants from the Northern Ireland Leukaemia Research Fund, Leukeamia and Lymphoma Research, NC3Rs, Friends of Paul O'Gorman, Vice Chancellor Scholarship University of Ulster, Department of Education and Learning Scholarship Northern Ireland. FACS and Sorting experiments were supported by a project grant from Kay Kendall Leukaemia Fund (KKL501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Anton R, 2007, FEBS LETT, V581, P5247, DOI 10.1016/j.febslet.2007.10.012; Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Austin TW, 1997, BLOOD, V89, P3624, DOI 10.1182/blood.V89.10.3624.3624_3624_3635; Baba Y, 2005, IMMUNITY, V23, P599, DOI 10.1016/j.immuni.2005.10.009; Baik J, 2012, EXP HEMATOL, V40, P837, DOI 10.1016/j.exphem.2012.06.007; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Boulet AM, 2004, DEV BIOL, V273, P361, DOI 10.1016/j.ydbio.2004.06.012; Cheng X, 2008, DEVELOPMENT, V135, P3447, DOI 10.1242/dev.025916; Choi K, 1998, DEVELOPMENT, V125, P725; Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Corrigan PM, 2009, STEM CELLS DEV, V18, P759, DOI 10.1089/scd.2008.0270; Crispino JD, 1999, MOL CELL, V3, P219, DOI 10.1016/S1097-2765(00)80312-3; de Andres B, 2002, BLOOD, V100, P4074, DOI 10.1182/blood-2002-03-0809; Dobbin E, 2008, LEUKEMIA RES, V32, P1554, DOI 10.1016/j.leukres.2008.02.007; Dzierzak E, 2003, CURR OPIN HEMATOL, V10, P229, DOI 10.1097/00062752-200305000-00006; Ema H, 2000, BLOOD, V95, P2284, DOI 10.1182/blood.V95.7.2284.007k14_2284_2288; Ema M, 2006, BLOOD, V108, P4018, DOI 10.1182/blood-2006-03-012872; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Gordon MK, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Huang C, 2010, J GENET GENOMICS, V37, P441, DOI 10.1016/S1673-8527(09)60063-1; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Keller G, 1999, EXP HEMATOL, V27, P777, DOI 10.1016/S0301-472X(99)00024-7; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kingsley PD, 2004, BLOOD, V104, P19, DOI 10.1182/blood-2003-12-4162; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Lacaud G, 2001, ANN NY ACAD SCI, V938, P96; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Luis TC, 2009, ANN NY ACAD SCI, V1176, P70, DOI 10.1111/j.1749-6632.2009.04566.x; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Malhotra S, 2008, J IMMUNOL, V181, P3955, DOI 10.4049/jimmunol.181.6.3955; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Nielsen PJ, 1997, BLOOD, V89, P1058, DOI 10.1182/blood.V89.3.1058; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Robertson SM, 2000, DEVELOPMENT, V127, P2447; Rojas A, 2005, DEVELOPMENT, V132, P3405, DOI 10.1242/dev.01913; Ruiz-Herguido C, 2012, J EXP MED, V209, P1457, DOI 10.1084/jem.20120225; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Saijoh Y, 1999, GENE DEV, V13, P259, DOI 10.1101/gad.13.3.259; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Shimizu R, 2001, EMBO J, V20, P5250, DOI 10.1093/emboj/20.18.5250; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Singla DK, 2006, BIOCHEM BIOPH RES CO, V345, P789, DOI 10.1016/j.bbrc.2006.04.125; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Suzuki A, 2006, NAT CLIN PRACT CARD, V3, P114; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Takao Y, 2007, BIOCHEM BIOPH RES CO, V353, P699, DOI 10.1016/j.bbrc.2006.12.072; Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002; Tanaka Y, 2012, DEV BIOL, V366, P404, DOI 10.1016/j.ydbio.2012.03.024; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Tran HT, 2010, P NATL ACAD SCI USA, V107, P16160, DOI 10.1073/pnas.1007725107; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; Van den Berg DJ, 1998, BLOOD, V92, P3189, DOI 10.1182/blood.V92.9.3189.421k45_3189_3202; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wardle FC, 2008, CURR OPIN GENET DEV, V18, P418, DOI 10.1016/j.gde.2008.07.017; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; WILES MV, 1991, DEVELOPMENT, V111, P259; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; Ysebaert L, 2006, LEUKEMIA, V20, P1211, DOI 10.1038/sj.leu.2404239; Yuen D, 1998, BLOOD, V91, P3202, DOI 10.1182/blood.V91.9.3202.3202_3202_3209; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	75	13	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81030	10.1371/journal.pone.0081030	http://dx.doi.org/10.1371/journal.pone.0081030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24324557	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000327546400046
J	Kreis, NN; Sanhaji, M; Rieger, MA; Louwen, F; Yuan, J				Kreis, N-N; Sanhaji, M.; Rieger, M. A.; Louwen, F.; Yuan, J.			p21Waf1/Cip1 deficiency causes multiple mitotic defects in tumor cells	ONCOGENE			English	Article						p21; Cdk1; Aurora B; chromosome segregation; cytokinesis	SMALL-MOLECULE INHIBITOR; DNA-REPLICATION; CYCLIN B1; P21; PHOSPHORYLATION; CANCER; P21(WAF1/CIP1); MITOSIS; ARREST; PRC1	As a multifaceted molecule, p21 plays multiple critical roles in cell cycle regulation, differentiation, apoptosis, DNA repair, senescence, aging and stem cell reprogramming. The important roles of p21 in the interphase of the cell cycle have been intensively investigated. The function of p21 in mitosis has been proposed but not systematically studied. We show here that p21 is abundant in mitosis and binds to and inhibits the activity of Cdk1/cyclin B1. Deficiency of p21 prolongs the duration of mitosis by extending metaphase, anaphase and cytokinesis. The activity of Aurora B is reduced and the localization of Aurora B on the central spindle is disturbed in anaphase cells without p21. Moreover, HCT116 p21(-/-), HeLa and Saos-2 cells depleted of p21 encounter problems in chromosome segregation and cytokinesis. Gently inhibiting the mitotic Cdk1 or add-back of p21 rescues segregation defect in HCT116 p21(-/-) cells. Our data demonstrate that p21 is important for a fine-tuned control of the Cdk1 activity in mitosis, and its proper function facilitates a smooth mitotic progression. Given that p21 is downregulated in the majority of tumors, either by the loss of tumor suppressors like p53 or by hyperactive oncogenes such as c-myc, this finding also sheds new light on the molecular mechanisms by which p21 functions as a tumor suppressor.	[Kreis, N-N; Sanhaji, M.; Louwen, F.; Yuan, J.] Dept Gynecol & Obstet, Frankfurt, Germany; [Rieger, M. A.] Goethe Univ Frankfurt, Dept Hematol Oncol, D-60590 Frankfurt, Germany; [Rieger, M. A.] Georg Speyer Haus, Frankfurt, Germany; [Rieger, M. A.] German Canc Consortium DKTK, Heidelberg, Germany; [Rieger, M. A.] German Canc Res Ctr, Heidelberg, Germany	Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Yuan, J (corresponding author), Goethe Univ Frankfurt, Sch Med, Dept Gynecol & Obstet, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	yuan@em.uni-frankfurt.de	Rieger, Michael A/L-8324-2017; Strebhardt, Klaus/E-8765-2011; Kreis, Nina-Naomi/AAF-5407-2019	Rieger, Michael A/0000-0002-4158-5872; Kreis, Nina-Naomi/0000-0003-4304-0160; Yuan, Juping/0000-0003-0694-0565	Deutsche Krebshilfe [108553, 109672]; Deutsche Forschungsgemeinschaft [Yu 156/2-1]; LOEWE Center for Cell and Gene Therapy Frankfurt [III L 4-518/17.004 (2010)]	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE Center for Cell and Gene Therapy Frankfurt	The work was supported by Deutsche Krebshilfe (#108553 and #109672 to JY), Deutsche Forschungsgemeinschaft (#Yu 156/2-1 to JY) and by the LOEWE Center for Cell and Gene Therapy Frankfurt (III L 4-518/17.004 (2010) to MAR). We thank Dr TU Mayer, University of Konstanz, for kindly providing the MKLP2 antibody. We are grateful to Drs KW Kinzler and B Vogelstein, Ludwig Center at Johns Hopkins, Howard Hughes Medical Institute, Baltimore, for the cell lines HCT116 p21 +/+ and HCT116 p21 -/-.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Adnane J, 2000, ONCOGENE, V19, P5338, DOI 10.1038/sj.onc.1203956; Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Barrett RMA, 2009, CELL CYCLE, V8, P278, DOI 10.4161/cc.8.2.7587; Bates S, 1998, ONCOGENE, V17, P1691, DOI 10.1038/sj.onc.1202104; Baus F, 2003, EMBO J, V22, P3992, DOI 10.1093/emboj/cdg387; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bloom J, 2004, CELL CYCLE, V3, P138; Brugarolas J, 1998, J CELL BIOL, V141, P503, DOI 10.1083/jcb.141.2.503; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Charrier-Savournin FB, 2004, MOL BIOL CELL, V15, P3965, DOI 10.1091/mbc.E03-12-0871; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Dash BC, 2005, MOL CELL BIOL, V25, P3364, DOI 10.1128/MCB.25.8.3364-3387.2005; Date D, 2012, J BIOCHEM, V151, P361, DOI 10.1093/jb/mvs015; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; Dulic V, 1998, MOL CELL BIOL, V18, P546, DOI 10.1128/MCB.18.1.546; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Franklin DS, 2000, MOL CELL BIOL, V20, P6147, DOI 10.1128/MCB.20.16.6147-6158.2000; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gartel AL, 2009, BIOFACTORS, V35, P161, DOI 10.1002/biof.26; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Hall CC, 1995, BIOCHEM BIOPH RES CO, V217, P728, DOI 10.1006/bbrc.1995.2833; HARPER JW, 1993, CELL, V75, P805; Hu CK, 2012, MOL BIOL CELL, V23, P2702, DOI 10.1091/mbc.E12-01-0058; Hummer S, 2009, CURR BIOL, V19, P607, DOI 10.1016/j.cub.2009.02.046; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Kreis NN, 2010, ONCOGENE, V29, P5591, DOI 10.1038/onc.2010.290; Kreis NN, 2009, CELL CYCLE, V8, P460, DOI 10.4161/cc.8.3.7651; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Lindqvist A, 2007, PLOS BIOL, V5, P1127, DOI 10.1371/journal.pbio.0050123; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Medema RH, 1998, ONCOGENE, V16, P431, DOI 10.1038/sj.onc.1201558; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Nakajima Y, 2011, J CELL BIOL, V194, P137, DOI 10.1083/jcb.201009137; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; Pomerening JR, 2008, MOL BIOL CELL, V19, P3426, DOI 10.1091/mbc.E08-02-0172; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Sanhaji M, 2013, CELL CYCLE, V12, P1340, DOI 10.4161/cc.24573; Sanhaji M, 2010, MOL CELL BIOL, V30, P2594, DOI 10.1128/MCB.00098-10; Smits VAJ, 2000, J BIOL CHEM, V275, P30638, DOI 10.1074/jbc.M005437200; Trakala M, 2013, CELL CYCLE, V12, P1030, DOI 10.4161/cc.24004; Tsukahara T, 2010, NATURE, V467, P719, DOI 10.1038/nature09390; van der Waal MS, 2012, EXP CELL RES, V318, P1407, DOI 10.1016/j.yexcr.2012.03.015; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; WALDMAN T, 1995, CANCER RES, V55, P5187; Wolf F, 2007, CELL CYCLE, V6, P1408; Wolf F, 2006, EMBO J, V25, P2802, DOI 10.1038/sj.emboj.7601163; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Xu ZJ, 2009, J CELL BIOL, V187, P637, DOI 10.1083/jcb.200906053; Yang WC, 2001, CANCER RES, V61, P6297; Yuan JP, 2002, ONCOGENE, V21, P8282, DOI 10.1038/sj.onc.1206011; Yuan JP, 2011, AM J PATHOL, V179, P2091, DOI 10.1016/j.ajpath.2011.06.031; Zimniak T, 2012, CURR BIOL, V22, P787, DOI 10.1016/j.cub.2012.03.007	60	33	36	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 11	2014	33	50					5716	5728		10.1038/onc.2013.518	http://dx.doi.org/10.1038/onc.2013.518			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AW2AB	24317508				2022-12-25	WOS:000346089300007
J	Koh, KH; Pan, X; Shen, HW; Arnold, SLM; Yu, AM; Gonzalez, FJ; Isoherranen, N; Jeong, H				Koh, Kwi Hye; Pan, Xian; Shen, Hong-Wu; Arnold, Samuel L. M.; Yu, Ai-Ming; Gonzalez, Frank J.; Isoherranen, Nina; Jeong, Hyunyoung			Altered Expression of Small Heterodimer Partner Governs Cytochrome P450 (CYP) 2D6 Induction during Pregnancy in CYP2D6-humanized Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytochrome P450; Drug Metabolism; Pregnancy; Retinoid; Transgenic Mice; HNF4; SHP	NUCLEAR FACTOR 4-ALPHA; BILE-ACID CONCENTRATIONS; GENE-EXPRESSION; MOLECULAR-BASIS; X-RECEPTOR; TRANSCRIPTIONAL REGULATION; LIPID HOMEOSTASIS; DRUG-METABOLISM; HUMANIZED MOUSE; HEPATOCYTE-NUCLEAR-FACTOR-4-ALPHA	Background: CYP2D6-mediated drug metabolism is enhanced during pregnancy, but the underlying mechanisms remain unknown. Results: In CYP2D6-humanized mice, CYP2D6 induction during pregnancy was linked to decreased expression of SHP, a repressor of CYP2D6 expression. Conclusion: Decreased SHP expression may account for CYP2D6 induction during pregnancy. Significance: This may provide a mechanistic basis in designing optimal dosage regimens in pregnant women. Substrates of a major drug-metabolizing enzyme CYP2D6 display increased elimination during pregnancy, but the underlying mechanisms are unknown in part due to a lack of experimental models. Here, we introduce CYP2D6-humanized (Tg-CYP2D6) mice as an animal model where hepatic CYP2D6 expression is increased during pregnancy. In the mouse livers, expression of a known positive regulator of CYP2D6, hepatocyte nuclear factor 4 (HNF4), did not change during pregnancy. However, HNF4 recruitment to CYP2D6 promoter increased at term pregnancy, accompanied by repressed expression of small heterodimer partner (SHP). In HepG2 cells, SHP repressed HNF4 transactivation of CYP2D6 promoter. In transgenic (Tg)-CYP2D6 mice, SHP knockdown led to a significant increase in CYP2D6 expression. Retinoic acid, an endogenous compound that induces SHP, exhibited decreased hepatic levels during pregnancy in Tg-CYP2D6 mice. Administration of all-trans-retinoic acid led to a significant decrease in the expression and activity of hepatic CYP2D6 in Tg-CYP2D6 mice. This study provides key insights into mechanisms underlying altered CYP2D6-mediated drug metabolism during pregnancy, laying a foundation for improved drug therapy in pregnant women.	[Koh, Kwi Hye; Jeong, Hyunyoung] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL 60612 USA; [Pan, Xian; Jeong, Hyunyoung] Univ Illinois, Coll Pharm, Dept Biopharmaceut Sci, Chicago, IL 60612 USA; [Shen, Hong-Wu; Yu, Ai-Ming] Univ Calif Davis, Med Ctr, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Arnold, Samuel L. M.; Isoherranen, Nina] Univ Washington, Sch Pharm, Dept Pharmaceut, Seattle, WA 98195 USA; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Davis; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Jeong, H (corresponding author), Univ Illinois, Dept Pharm Practice MC 886, 833 S Wood St, Chicago, IL 60612 USA.	yjeong@uic.edu		Yu, Aiming/0000-0003-1441-4012	National Institutes of Health [HD065532, K12HK055892]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065532, K12HD055892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD065532 and Fellowship K12HK055892 (NICHD; to H. J.).	Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; Arnold SLM, 2012, J LIPID RES, V53, P587, DOI 10.1194/jlr.D019745; Bagamasbad P, 2012, ENDOCRINOLOGY, V153, P5334, DOI 10.1210/en.2012-1303; Boulias K, 2005, EMBO J, V24, P2624, DOI 10.1038/sj.emboj.7600728; Cai SY, 2010, J LIPID RES, V51, P2265, DOI 10.1194/jlr.M005546; Cairns W, 1996, J BIOL CHEM, V271, P25269, DOI 10.1074/jbc.271.41.25269; Carcillo JA, 2003, CLIN PHARMACOL THER, V73, P456, DOI 10.1016/S0009-9236(03)00055-9; Chanda D, 2008, ENDOCR J, V55, P253, DOI 10.1507/endocrj.K07E-103; Choi SY, 2013, DRUG METAB DISPOS, V41, P263, DOI 10.1124/dmd.112.046276; Corchero J, 2001, MOL PHARMACOL, V60, P1260, DOI 10.1124/mol.60.6.1260; Dickmann LJ, 2008, BIOCHEM PHARMACOL, V75, P1677, DOI 10.1016/j.bcp.2008.01.012; Dickmann LJ, 2013, DRUG METAB DISPOS, V41, P270, DOI 10.1124/dmd.112.047118; Fang SS, 2007, MOL CELL BIOL, V27, P1407, DOI 10.1128/MCB.00944-06; Felmlee MA, 2008, DRUG METAB DISPOS, V36, P435, DOI 10.1124/dmd.107.018838; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Glover DD, 2003, AM J OBSTET GYNECOL, V188, P1039, DOI 10.1067/mob.2003.223; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Goodwin B, 2003, MOL ENDOCRINOL, V17, P386, DOI 10.1210/me.2002-0246; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; HEIKKINEN J, 1981, BRIT J OBSTET GYNAEC, V88, P240, DOI 10.1111/j.1471-0528.1981.tb00975.x; HOGSTEDT S, 1985, CLIN PHARMACOL THER, V37, P688; Isoherranen N, 2013, DRUG METAB DISPOS, V41, P256, DOI 10.1124/dmd.112.050245; Jover R, 2009, CURR DRUG METAB, V10, P508, DOI 10.2174/138920009788898000; Koh KH, 2011, DRUG METAB DISPOS, V39, P165, DOI 10.1124/dmd.110.035790; KURTH MC, 1993, AM J MED GENET, V48, P166, DOI 10.1002/ajmg.1320480311; Lai KD, 2003, J BIOL CHEM, V278, P36418, DOI 10.1074/jbc.M303913200; Lee SS, 2008, HEPATOLOGY, V48, P635, DOI 10.1002/hep.22396; Lee YJ, 2012, EXP MOL MED, V44, P642, DOI 10.3858/emm.2012.44.11.073; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Malone CMP, 2011, EXP CELL RES, V317, P1590, DOI 10.1016/j.yexcr.2011.03.023; Martinez-Jimenez CP, 2010, MOL CELL BIOL, V30, P565, DOI 10.1128/MCB.00927-09; Milona A, 2010, HEPATOLOGY, V52, P1341, DOI 10.1002/hep.23849; Nelson BR, 2009, DEV DYNAM, V238, P2163, DOI 10.1002/dvdy.21848; Nikolaidou-Neokosmidou V, 2006, BIOCHEM J, V398, P439, DOI 10.1042/BJ20060169; Ohtsuki S, 2012, DRUG METAB DISPOS, V40, P83, DOI 10.1124/dmd.111.042259; Rizzo G, 2005, MOL PHARMACOL, V68, P551, DOI 10.1124/mol.105.012104; Shimamoto Y, 2004, J BIOL CHEM, V279, P7770, DOI 10.1074/jbc.M310577200; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Sit DK, 2008, J CLIN PSYCHIAT, V69, P652, DOI 10.4088/JCP.v69n0419; Sweeney TR, 2006, AM J PHYSIOL-ENDOC M, V290, pE1313, DOI 10.1152/ajpendo.00071.2005; Temesvari M, 2012, J PHARMACOL EXP THER, V341, P294, DOI 10.1124/jpet.111.189597; Thatcher JE, 2009, EXPERT OPIN DRUG MET, V5, P875, DOI 10.1517/17425250903032681; Topletz AR, 2013, DRUG METAB DISPOS, V41, P312, DOI 10.1124/dmd.112.049379; Tracy TS, 2005, AM J OBSTET GYNECOL, V192, P633, DOI 10.1016/j.ajog.2004.08.030; Wadelius M, 1997, CLIN PHARMACOL THER, V62, P400, DOI 10.1016/S0009-9236(97)90118-1; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Xie XF, 2009, MOL ENDOCRINOL, V23, P434, DOI 10.1210/me.2007-0531; Yu AM, 2004, DRUG METAB REV, V36, P243, DOI 10.1081/DMR-120034000; Yu AM, 2003, PHARMACOGENETICS, V13, P173, DOI 10.1097/00008571-200303000-00007; Zanger UM, 2004, N-S ARCH PHARMACOL, V369, P23, DOI 10.1007/s00210-003-0832-2; Zhang M, 2001, J BIOL CHEM, V276, P41690, DOI 10.1074/jbc.M105117200	51	35	36	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3105	3113		10.1074/jbc.M113.526798	http://dx.doi.org/10.1074/jbc.M113.526798			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24318876	hybrid, Green Published			2022-12-25	WOS:000331368700001
J	Gregory, C; Veeman, M				Gregory, Clint; Veeman, Michael			3D-Printed Microwell Arrays for Ciona Microinjection and Timelapse Imaging	PLOS ONE			English	Article							ASCIDIANS; PLATFORM; CELLS; SHAPE; CHIP	Ascidians such as Ciona are close chordate relatives of the vertebrates with small, simple embryonic body plans and small, simple genomes. The tractable size of the embryo offers considerable advantages for in toto imaging and quantitative analysis of morphogenesis. For functional studies, Ciona eggs are considerably more challenging to microinject than the much larger eggs of other model organisms such as zebrafish and Xenopus. One of the key difficulties is in restraining the eggs so that the microinjection needle can be easily introduced and withdrawn. Here we develop and test a device to cast wells in agarose that are each sized to hold a single egg. This injection mold is fabricated by micro-resolution stereolithography with a grid of egg-sized posts that cast corresponding wells in agarose. This 3D printing technology allows the rapid and inexpensive testing of iteratively refined prototypes. In addition to their utility in microinjection, these grids of embryo-sized wells are also valuable for timelapse imaging of multiple embryos.	[Gregory, Clint; Veeman, Michael] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA	Kansas State University	Veeman, M (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.	veeman@ksu.edu			Kansas State University; Kansas INBRE [NIH P20 RR016475]; Kansas INBRE (National Institutes of Health) [P20 GM103418]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418] Funding Source: NIH RePORTER	Kansas State University; Kansas INBRE; Kansas INBRE (National Institutes of Health); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MV acknowledges support from Kansas State University and the Kansas INBRE (NIH P20 RR016475 and National Institutes of Health P20 GM103418). Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker H, 2008, ANAL BIOANAL CHEM, V390, P89, DOI 10.1007/s00216-007-1692-2; Chin VI, 2004, BIOTECHNOL BIOENG, V88, P399, DOI 10.1002/bit.20254; Chung K, 2011, NAT METHODS, V8, P171, DOI 10.1038/NMETH.1548; Deutsch M, 2006, LAB CHIP, V6, P995, DOI 10.1039/b603961h; FRANKS RR, 1988, DEVELOPMENT, V102, P287; Han C, 2010, LAB CHIP, V10, P2848, DOI 10.1039/c005296e; Hopkinson N, 2006, RAPID MANUFACTURING: AN INDUSTRIAL REVOLUTION FOR THE DIGITAL AGE, P1; Lindstrom S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006997; Malek CGK, 2006, ANAL BIOANAL CHEM, V385, P1362, DOI 10.1007/s00216-006-0517-z; Malek CGK, 2006, ANAL BIOANAL CHEM, V385, P1351, DOI 10.1007/s00216-006-0514-2; Munro E, 2006, CURR OPIN GENET DEV, V16, P399, DOI 10.1016/j.gde.2006.06.004; Nakamura MJ, 2012, DEV BIOL, V372, P274, DOI 10.1016/j.ydbio.2012.09.007; Rettig JR, 2005, ANAL CHEM, V77, P5628, DOI 10.1021/ac0505977; Revzin A, 2005, LAB CHIP, V5, P30, DOI 10.1039/b405557h; Sardet C, 2011, METHODS MOL BIOL, V770, P365, DOI 10.1007/978-1-61779-210-6_14; Sherrard K, 2010, CURR BIOL, V20, P1499, DOI 10.1016/j.cub.2010.06.075; Tassy O, 2006, CURR BIOL, V16, P345, DOI 10.1016/j.cub.2005.12.044; Taylor LC, 2000, ANAL BIOCHEM, V278, P132, DOI 10.1006/abio.1999.4440; Tokilmitsu Y, 2007, CYTOM PART A, V71A, P1003, DOI 10.1002/cyto.a.20478; Vajrala VS, 2013, ANAL BIOANAL CHEM; Veeman MT, 2013, DEV BIOL, V373, P281, DOI 10.1016/j.ydbio.2012.11.009; Veeman MT, 2011, METHODS MOL BIOL, V770, P401, DOI 10.1007/978-1-61779-210-6_15; Wielhouwer EM, 2011, LAB CHIP, V11, P1815, DOI 10.1039/c0lc00443j; Zaouk Rabih, 2006, Methods Mol Biol, V321, P17	24	9	9	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82307	10.1371/journal.pone.0082307	http://dx.doi.org/10.1371/journal.pone.0082307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324769	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700067
J	Fan, F; Sun, CW; Maier, KG; Williams, JM; Pabbidi, MR; Didion, SP; Falck, JR; Zhuo, JL; Roman, RJ				Fan, Fan; Sun, Cheng-Wen; Maier, Kristopher G.; Williams, Jan M.; Pabbidi, Malikarjuna R.; Didion, Sean P.; Falck, John R.; Zhuo, Jialong; Roman, Richard J.			20-Hydroxyeicosatetraenoic Acid Contributes to the Inhibition of K plus Channel Activity and Vasoconstrictor Response to Angiotensin II in Rat Renal Microvessels	PLOS ONE			English	Article							AFFERENT ARTERIOLAR RESPONSES; CYTOCHROME-P450 METABOLITES; ARACHIDONIC-ACID; 20-HETE; RECEPTOR; MODULATION; ACTIVATION; KINASE; EXPRESSION; CA2+	The present study examined whether 20-hydroxyeicosatetraenoic acid (HETE) contributes to the vasoconstrictor effect of angiotensin II (ANG II) in renal microvessels by preventing activation of the large conductance Ca2+-activated K+ channel (K-Ca) in vascular smooth muscle (VSM) cells. ANG II increased the production of 20-HETE in rat renal microvessels. This response was attenuated by the 20-HETE synthesis inhibitors, 17-ODYA and HET0016, a phospholipase A(2) inhibitor AACOF(3), and the AT(1) receptor blocker, Losartan, but not by the AT(2) receptor blocker, PD123319. ANG II (10(-11) to 10(-6) M) dose-dependently decreased the diameter of renal microvessels by 41 +/- 5%. This effect was blocked by 17-ODYA. ANG II (10(-7) M) did not alter K-Ca channel activity recorded from cell-attached patches on renal VSM cells under control conditions. However, it did reduce the NPo of the K-Ca channel by 93.4 +/- 3.1% after the channels were activated by increasing intracellular calcium levels with ionomycin. The inhibitory effect of ANG II on K-Ca channel activity in the presence of ionomycin was attenuated by 17-ODYA, AACOF3, and the phospholipase C (PLC) inhibitor U-73122. ANG II induced a peak followed by a steady-state increase in intracellular calcium concentration in renal VSM cells. 17-ODYA (10(-5) M) had no effect on the peak response, but it blocked the steady-state increase. These results indicate that ANG II stimulates the formation of 20-HETE in rat renal microvessels via the AT(1) receptor activation and that 20-HETE contributes to the vasoconstrictor response to ANG II by blocking activation of K-Ca channel and facilitating calcium entry.	[Fan, Fan; Williams, Jan M.; Pabbidi, Malikarjuna R.; Didion, Sean P.; Zhuo, Jialong; Roman, Richard J.] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA; [Sun, Cheng-Wen] N Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA; [Maier, Kristopher G.] SUNY Upstate Med Univ, Div Vasc Surg & Endovasc Serv, Syracuse, NY 13210 USA; [Falck, John R.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Mississippi; University of Mississippi Medical Center; North Dakota State University Fargo; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Roman, RJ (corresponding author), Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA.	rroman@umc.edu	Sun, Chengwen/AAC-4522-2019; Zhuo, Jia/ABB-9931-2021	Sun, Chengwen/0000-0001-5889-8448; 	National Institutes of Health [HL36279, HL29587, RO1DK067299, HL089884, HL107632]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036279, R37HL036279, P01HL029587, R01HL089884, R01HL107632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by grants HL36279, HL29587 (RJR), RO1DK067299 (JZ) and HL089884 and HL107632 (SPD) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akishita M, 1999, J CLIN INVEST, V103, P63, DOI 10.1172/JCI5182; Alonso-Galicia M, 1999, STROKE, V30, P2727, DOI 10.1161/01.STR.30.12.2727; Alonso-Galicia M, 1999, AM J PHYSIOL-RENAL, V277, pF790, DOI 10.1152/ajprenal.1999.277.5.F790; Alonso-Galicia M, 2002, AM J PHYSIOL-REG I, V283, pR60, DOI 10.1152/ajpregu.00664.2001; Amlal H, 1998, AM J PHYSIOL-CELL PH, V274, pC1047, DOI 10.1152/ajpcell.1998.274.4.C1047; BOULAY G, 1992, MOL PHARMACOL, V41, P809; Cheng J, 2010, J PHARMACOL EXP THER, V332, P57, DOI 10.1124/jpet.109.159863; Chu ZM, 2000, CLIN SCI, V98, P277, DOI 10.1042/CS19990217; Croft KD, 2000, AM J PHYSIOL-RENAL, V279, pF544, DOI 10.1152/ajprenal.2000.279.3.F544; DEMONTELLANO PRO, 1984, J BIOL CHEM, V259, P4136; Dunn KM, 2008, AM J PHYSIOL-HEART C, V295, pH2455, DOI 10.1152/ajpheart.00512.2008; Fellner SK, 2005, AM J PHYSIOL-RENAL, V288, pF785, DOI 10.1152/ajprenal.00372.2004; GUO DF, 1994, BBA-GENE STRUCT EXPR, V1218, P91, DOI 10.1016/0167-4781(94)90105-8; Harder DR, 1997, J VASC RES, V34, P237, DOI 10.1159/000159228; Harder DR, 1996, CIRC RES, V79, P54, DOI 10.1161/01.RES.79.1.54; Horvath Beata, 2004, Exp Clin Cardiol, V9, P31; IMIG JD, 1994, AM J PHYSIOL, V266, pH1879, DOI 10.1152/ajpheart.1994.266.5.H1879; Imig JD, 1997, AM J PHYSIOL-RENAL, V273, pF274, DOI 10.1152/ajprenal.1997.273.2.F274; Imig JD, 1996, AM J PHYSIOL-REG I, V270, pR217, DOI 10.1152/ajpregu.1996.270.1.R217; Imig JD, 2013, PROSTAG OTH LIPID M, V104, P2, DOI 10.1016/j.prostaglandins.2013.01.002; Inscho EW, 1997, HYPERTENSION, V29, P222, DOI 10.1161/01.HYP.29.1.222; Ito O, 1999, AM J PHYSIOL-REG I, V276, pR1749, DOI 10.1152/ajpregu.1999.276.6.R1749; Jackson WF, 2000, HYPERTENSION, V35, P173, DOI 10.1161/01.HYP.35.1.173; JUNCOS LA, 1994, HYPERTENSION, V23, pI54, DOI 10.1161/01.HYP.23.1_Suppl.I54; Kaley G, 2000, CIRC RES, V87, P4, DOI 10.1161/01.RES.87.1.4; Kim S, 2000, PHARMACOL REV, V52, P11; Kohagura K, 2001, HYPERTENS RES, V24, P551, DOI 10.1291/hypres.24.551; KOIKE G, 1994, BIOCHEM BIOPH RES CO, V203, P1842, DOI 10.1006/bbrc.1994.2402; Lubbers DW, 1997, KIDNEY INT, V51, P372, DOI 10.1038/ki.1997.49; MA YH, 1993, CIRC RES, V72, P126, DOI 10.1161/01.RES.72.1.126; Mifune M, 2000, HYPERTENSION, V36, P845, DOI 10.1161/01.HYP.36.5.845; Miyata N, 2001, BRIT J PHARMACOL, V133, P325, DOI 10.1038/sj.bjp.0704101; Nowicki S, 1997, J CLIN INVEST, V99, P1224, DOI 10.1172/JCI119279; Parmentier JH, 2001, HYPERTENSION, V37, P623, DOI 10.1161/01.HYP.37.2.623; Randriamboavonjy V, 2003, HYPERTENSION, V41, P801, DOI 10.1161/01.HYP.0000047240.33861.6B; Roman RJ, 2000, CLIN EXP PHARMACOL P, V27, P855, DOI 10.1046/j.1440-1681.2000.03349.x; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Roman RJ, 1999, NEWS PHYSIOL SCI, V14, P238; Sadoshima J, 1998, CIRC RES, V82, P1352, DOI 10.1161/01.RES.82.12.1352; Sun CW, 1999, HYPERTENSION, V33, P414, DOI 10.1161/01.HYP.33.1.414; Zanetta L, 2000, INT J CANCER, V85, P281, DOI 10.1002/(SICI)1097-0215(20000115)85:2<281::AID-IJC21>3.0.CO;2-3; ZOU AP, 1994, J PHARMACOL EXP THER, V268, P474; Zou AP, 1996, AM J PHYSIOL-REG I, V270, pR228, DOI 10.1152/ajpregu.1996.270.1.R228	43	41	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82482	10.1371/journal.pone.0082482	http://dx.doi.org/10.1371/journal.pone.0082482			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324797	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300153
J	Hanazuka, Y; Shimahara, N; Tokuda, Y; Midorikawa, A				Hanazuka, Yuki; Shimahara, Naoki; Tokuda, Yukie; Midorikawa, Akira			Orangutans (Pongo pygmaeus) Remember Old Acquaintances	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; MONKEYS MACACA-MULATTA; FACE RECOGNITION; DISCRIMINATION; FAMILIAR; INFANT; PERCEPTION; PRIMATES	Many social animals can discriminate between familiar and unfamiliar faces. Orangutans, however, lead a semi-solitary life and spend much of the day alone. As such, they may be less adept at recognizing conspecifics and are a good model for determining how social structure influences the evolution of social cognition such as facial recognition. The present study is the first report of whether orangutans can distinguish among individual faces. We adopted a preferential looking method and found that orangutans used facial discrimination to identify known conspecifics. This suggests that frequent and intense social interaction is not necessary for facial discrimination, although our findings were limited by the small number of stimuli and the unequal numbers of male and female orangutans depicted in the stimuli.	[Hanazuka, Yuki] Chuo Univ, Grad Sch Letters, Dept Psychol, Hachioji, Tokyo, Japan; [Shimahara, Naoki; Tokuda, Yukie] Tama Zool Pk, Hino, Tokyo, Japan; [Midorikawa, Akira] Chuo Univ, Fac Letters, Dept Psychol, Hachioji, Tokyo, Japan	Chuo University; Chuo University	Hanazuka, Y (corresponding author), Chuo Univ, Grad Sch Letters, Dept Psychol, 742-1 Higashi Nakano, Hachioji, Tokyo, Japan.	yuki.hanazuka@gmail.com	Midorikawa, Akira/F-7382-2015	Midorikawa, Akira/0000-0003-3340-4741				Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bird CD, 2008, ANIM BEHAV, V76, P679, DOI 10.1016/j.anbehav.2008.04.014; BOYSEN ST, 1989, J COMP PSYCHOL, V103, P215, DOI 10.1037/0735-7036.103.3.215; Brown DA, 2000, J COMP PSYCHOL, V114, P392, DOI 10.1037/0735-7036.114.4.392; BRUCK M, 1991, MEM COGNITION, V19, P221, DOI 10.3758/BF03211146; Chittka L, 2012, NATURE, V481, P154, DOI 10.1038/481154a; Coulon M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004441; FANTZ RL, 1961, SCI AM, V204, P66, DOI 10.1038/scientificamerican0561-66; Gothard KM, 2004, ANIM COGN, V7, P25, DOI 10.1007/s10071-003-0179-6; Hanazuka Y, 2012, PERCEPT MOTOR SKILL, V114, P429, DOI 10.2466/22.24.PMS.114.2.429-432; HARVEY PH, 1985, EVOLUTION, V39, P559, DOI 10.1111/j.1558-5646.1985.tb00395.x; Hunter M.A., 1988, ADV INFANCY RES, V5, P69, DOI DOI 10.1037/0012-1649.19.3.338; Kendrick KM, 2001, NATURE, V414, P165, DOI 10.1038/35102669; Murai C, 2011, DEV PSYCHOBIOL, V53, P732, DOI 10.1002/dev.20548; Myowa-Yamakoshi M, 2005, COGNITIVE DEV, V20, P49, DOI 10.1016/j.cogdev.2004.12.002; Myowa-Yamakoshi M, 2001, INFANT BEHAV DEV, V24, P215, DOI 10.1016/S0163-6383(01)00076-5; Parr LA, 2000, J COMP PSYCHOL, V114, P47, DOI 10.1037//0735-7036.114.1.47; Parr LA, 2010, J COMP PSYCHOL, V124, P343, DOI 10.1037/a0020545; Pokorny JJ, 2009, J COMP PSYCHOL, V123, P151, DOI 10.1037/a0014073; Racca A, 2010, ANIM COGN, V13, P525, DOI 10.1007/s10071-009-0303-3; Rossion B, 2003, NEUROIMAGE, V19, P877, DOI 10.1016/S1053-8119(03)00105-8; Russon A, 2009, CURR BIOL, V19, pR925, DOI 10.1016/j.cub.2009.08.009; van Noordwijk MA, 2012, BEHAV ECOL SOCIOBIOL, V66, P823, DOI 10.1007/s00265-012-1330-7	24	9	9	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82073	10.1371/journal.pone.0082073	http://dx.doi.org/10.1371/journal.pone.0082073			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324746	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300126
J	Lenstra, TL; Tudek, A; Clauder, S; Xu, ZY; Pachis, ST; van Leenen, D; Kemmeren, P; Steinmetz, LM; Libri, D; Holstege, FCP				Lenstra, Tineke L.; Tudek, Agnieszka; Clauder, Sandra; Xu, Zhenyu; Pachis, Spyridon T.; van Leenen, Dik; Kemmeren, Patrick; Steinmetz, Lars M.; Libri, Domenico; Holstege, Frank C. P.			The Role of Ctk1 Kinase in Termination of Small Non-Coding RNAs	PLOS ONE			English	Article							CRYPTIC UNSTABLE TRANSCRIPTS; POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; PROCESSING FACTORS; DOMAIN KINASE; NUCLEAR DEGRADATION; CTD CODE; YEAST; PHOSPHORYLATION; RECRUITMENT	Transcription termination in Saccharomyces cerevisiae can be performed by at least two distinct pathways and is influenced by the phosphorylation status of the carboxy-terminal domain (CTD) of RNA polymerase II (Pol II). Late termination of mRNAs is performed by the CPF/CF complex, the recruitment of which is dependent on CTD-Ser2 phosphorylation (Ser2P). Early termination of shorter cryptic unstable transcripts (CUTs) and small nucleolar/nuclear RNAs (sno/snRNAs) is performed by the Nrd1-Nab3-Sen1 (NNS) complex that binds phosphorylated CTD-Ser5 (Ser5P) via the CTD-interacting domain (CID) of Nrd1p. In this study, mutants of the different termination pathways were compared by genome-wide expression analysis. Surprisingly, the expression changes observed upon loss of the CTD-Ser2 kinase Ctk1p are more similar to those derived from alterations in the Ser5P-dependent NNS pathway, than from loss of CTD-Ser2P binding factors. Tiling array analysis of ctk1 Delta cells reveals readthrough at snoRNAs, at many cryptic unstable transcripts (CUTs) and stable uncharacterized transcripts (SUTs), but only at some mRNAs. Despite the suggested predominant role in termination of mRNAs, we observed that a CTK1 deletion or a Pol II CTD mutant lacking all Ser2 positions does not result in a global mRNA termination defect. Rather, termination defects in these strains are widely observed at NNS-dependent genes. These results indicate that Ctk1p and Ser2 CTD phosphorylation have a wide impact in termination of small non-coding RNAs but only affect a subset of mRNA coding genes.	[Lenstra, Tineke L.; Pachis, Spyridon T.; van Leenen, Dik; Kemmeren, Patrick; Holstege, Frank C. P.] Univ Utrecht, Med Ctr, Utrecht, Netherlands; [Tudek, Agnieszka; Libri, Domenico] CNRS, Ctr Genet Mol, LEA Lab Nucl RNA Metab, UPR3404, Gif Sur Yvette, France; [Clauder, Sandra; Xu, Zhenyu; Steinmetz, Lars M.] European Mol Biol Lab, Genome Biol Unit, D-69012 Heidelberg, Germany	Utrecht University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; European Molecular Biology Laboratory (EMBL)	Libri, D (corresponding author), CNRS, Ctr Genet Mol, LEA Lab Nucl RNA Metab, UPR3404, Gif Sur Yvette, France.	libri@cgm.cnrs-gif.fr; f.c.p.holstege@umcutrecht.nl	Lenstra, Tineke/L-3958-2016; Holstege, Frank/AAM-9944-2021; Tudek, Agnieszka/ABE-7845-2020	Lenstra, Tineke/0000-0002-4440-9962; Tudek, Agnieszka/0000-0002-6085-1072; Clauder-Muenster, Sandra/0000-0002-9530-2938; Steinmetz, Lars/0000-0002-3962-2865; Pachis, Spyridon Thomas/0000-0002-1413-6326; Kemmeren, Patrick/0000-0003-2237-7354	Netherlands Organization of Scientific Research (NWO) [016108607, 81702015, 05071057, 021002035]; CNRS; Danish National Research Foundation; ANR [ANR-08-Blan-0038-01]	Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Danish National Research Foundation(Danmarks Grundforskningsfond); ANR(French National Research Agency (ANR))	This work was supported by the Netherlands Organization of Scientific Research (NWO, http://www.nwo.nl/) grants 016108607 (FCPH), 81702015 (FCPH), 05071057 (FCPH) and 021002035 (TLL), the CNRS (http://www.cnrs.fr/)(D.L) the Danish National Research Foundation (http://dg.dk/) (DL), the ANR (http://www.agence-nationale-recherche.fr/) (ANR-08-Blan-0038-01) (DL). This research was carried out within the scope of the Associated European Laboratory LEA 'Laboratory of Nuclear RNA Metabolism' (DL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2009, EMBO J, V28, P205, DOI 10.1038/emboj.2008.280; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Ballarino M, 2005, MOL CELL BIOL, V25, P5396, DOI 10.1128/MCB.25.13.5396-5403.2005; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Carroll KL, 2004, MOL CELL BIOL, V24, P6241, DOI 10.1128/MCB.24.14.6241-6252.2004; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Drouin S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001173; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Grzechnik P, 2008, MOL CELL, V32, P247, DOI 10.1016/j.molcel.2008.10.003; Gudipati RK, 2008, NAT STRUCT MOL BIOL, V15, P786, DOI 10.1038/nsmb.1460; Gudipati RK, 2012, MOL CELL, V48, P409, DOI 10.1016/j.molcel.2012.08.018; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Hazelbaker DZ, 2013, MOL CELL, V49, P55, DOI 10.1016/j.molcel.2012.10.014; Hermand D, 2012, TRANSCRIPTION, V3; Huber W, 2006, BIOINFORMATICS, V22, P1963, DOI 10.1093/bioinformatics/btl289; Jenks MH, 2008, MOL CELL BIOL, V28, P3883, DOI 10.1128/MCB.00380-08; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Kubicek K, 2011, BIOMOL NMR ASSIGN, V5, P203, DOI 10.1007/s12104-011-9300-y; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Margaritis T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.21; Marquardt S, 2011, TRANSCR-AUSTIN, V2, P145, DOI 10.4161/trns.2.3.16298; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ostapenko D, 2005, MOL CELL BIOL, V25, P3906, DOI 10.1128/MCB.25.10.3906-3913.2005; Porrua O, 2012, EMBO J, V31, P3935, DOI 10.1038/emboj.2012.237; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Rodriguez CR, 2000, MOL CELL BIOL, V20, P104, DOI 10.1128/MCB.20.1.104-112.2000; Sheldon KE, 2005, MOL CELL, V20, P225, DOI 10.1016/j.molcel.2005.08.026; Singh N, 2009, MOL CELL, V36, P255, DOI 10.1016/j.molcel.2009.08.018; Steinmetz EJ, 2006, MOL CELL BIOL, V26, P2688, DOI 10.1128/MCB.26.7.2688-2696.2006; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Thiebaut M, 2006, MOL CELL, V23, P853, DOI 10.1016/j.molcel.2006.07.029; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; van de Peppel J, 2003, EMBO REP, V4, P387, DOI 10.1038/sj.embor.embor798; van Wageningen S, 2010, CELL, V143, P991, DOI 10.1016/j.cell.2010.11.021; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503	58	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80495	10.1371/journal.pone.0080495	http://dx.doi.org/10.1371/journal.pone.0080495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324601	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300022
J	Marivaux, L; Ramdarshan, A; Essid, E; Marzougui, W; Ammar, HK; Lebrun, R; Marandat, B; Merzeraud, G; Tabuce, R; Vianey-Liaud, M				Marivaux, Laurent; Ramdarshan, Anusha; Essid, El Mabrouk; Marzougui, Wissem; Ammar, Hayet Khayati; Lebrun, Renaud; Marandat, Bernard; Merzeraud, Gilles; Tabuce, Rodolphe; Vianey-Liaud, Monique			Djebelemur, a Tiny Pre-Tooth-Combed Primate from the Eocene of Tunisia: A Glimpse into the Origin of Crown Strepsirhines	PLOS ONE			English	Article							LATE MIDDLE EOCENE; EARLIEST LATE EOCENE; ANTHROPOID PRIMATE; MAMMALIAN BIOGEOGRAPHY; INFRAORBITAL FORAMEN; DENTAL MICROWEAR; FOSSIL PRIMATES; LATE MIOCENE; EVOLUTION; MORPHOLOGY	Background: Molecular clock estimates of crown strepsirhine origins generally advocate an ancient antiquity for Malagasy lemuriforms and Afro-Asian lorisiforms, near the onset of the Tertiary but most often extending back to the Late Cretaceous. Despite their inferred early origin, the subsequent evolutionary histories of both groups (except for the Malagasy aye-aye lineage) exhibit a vacuum of lineage diversification during most part of the Eocene, followed by a relative acceleration in diversification from the late Middle Eocene. This early evolutionary stasis was tentatively explained by the possibility of unrecorded lineage extinctions during the early Tertiary. However, this prevailing molecular view regarding the ancient origin and early diversification of crown strepsirhines must be viewed with skepticism due to the new but still scarce paleontological evidence gathered in recent years. Methodological/Principal Findings: Here, we describe new fossils attributable to Djebelemur martinezi, a approximate to 50 Ma primate from Tunisia (Djebel Chambi). This taxon was originally interpreted as a cercamoniine adapiform based on limited information from its lower dentition. The new fossils provide anatomical evidence demonstrating that Djebelemur was not an adapiform but clearly a distant relative of lemurs, lorises and galagos. Cranial, dental and postcranial remains indicate that this diminutive primate was likely nocturnal, predatory (primarily insectivorous), and engaged in a form of generalized arboreal quadrupedalism with frequent horizontal leaping. Djebelemur did not have an anterior lower dentition as specialized as that characterizing most crown strepsirhines (i.e., tooth-comb), but it clearly exhibited a transformed antemolar pattern representing an early stage of a crown strepsirhine-like adaptation ("pre-tooth-comb"). Conclusions/Significance: These new fossil data suggest that the differentiation of the tooth-comb must postdate the djebelemurid divergence, a view which hence constrains the timing of crown strepsirhine origins to the Middle Eocene, and then precludes the existence of unrecorded lineage extinctions of tooth-combed primates during the earliest Tertiary.	[Marivaux, Laurent; Ramdarshan, Anusha; Lebrun, Renaud; Marandat, Bernard; Tabuce, Rodolphe; Vianey-Liaud, Monique] Univ Montpellier 2, Lab Paleontol, Inst Sci Evolut Montpellier, ISE M,UMR CNRS 5554, Montpellier, France; [Ramdarshan, Anusha] Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA USA; [Essid, El Mabrouk; Marzougui, Wissem; Ammar, Hayet Khayati] Off Natl Mines, Tunis, Tunisia; [Merzeraud, Gilles] Univ Montpellier 2, Geosci Montpellier UMR CNRS 5243, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Office National des Mines; Universite de Montpellier	Marivaux, L (corresponding author), Univ Montpellier 2, Lab Paleontol, Inst Sci Evolut Montpellier, ISE M,UMR CNRS 5554, Montpellier, France.	Laurent.Marivaux@univ-montp2.fr		Lebrun, Renaud/0000-0002-5819-2653; Tabuce, Rodolphe/0000-0002-4713-3981	French ANR-ERC PALASIAFRICA Program [ANR-08-JCJC-0017]	French ANR-ERC PALASIAFRICA Program(French National Research Agency (ANR))	This research was supported by the French ANR-ERC PALASIAFRICA Program (ANR-08-JCJC-0017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ali JR, 2010, NATURE, V463, P653, DOI 10.1038/nature08706; ANTHONY MRL, 1993, AM J SCI, V293A, P356, DOI 10.2475/ajs.293.A.356; Anthony R., 1931, Bull Mus Hist nat Paris, V3, P566; Beard KC, 2008, P NATL ACAD SCI USA, V105, P3815, DOI 10.1073/pnas.0710180105; Beard KC, 2006, DEV PRIMATOL, P439, DOI 10.1007/0-387-31710-4_15; Beard KC, 1996, SCIENCE, V272, P82, DOI 10.1126/science.272.5258.82; BEARD KC, 1988, NATURE, V331, P712, DOI 10.1038/331712a0; Beard KC, 2002, CAM S BIO EVOL ANTHR, V33, P133; BEARD KC, 1994, NATURE, V368, P604, DOI 10.1038/368604a0; Benoit J, 2013, J HUM EVOL, V65, P551, DOI 10.1016/j.jhevol.2013.06.014; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Boyer DM, 2013, AM J PHYS ANTHROPOL, V151, P420, DOI 10.1002/ajpa.22283; Boyer DM, 2010, AM J PHYS ANTHROPOL, V143, P383, DOI 10.1002/ajpa.21328; Burrows AM, 2010, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/978-1-4419-6661-2; Burrows AM, 2010, DEV PRIMATOL-PROG PR, P211, DOI 10.1007/978-1-4419-6661-2_11; Chaimanee Y, 1997, NATURE, V385, P429, DOI 10.1038/385429a0; Chaimanee Y, 2012, P NATL ACAD SCI USA, V109, P10293, DOI 10.1073/pnas.1200644109; Chatterjee HJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-259; CONROY GC, 1987, INT J PRIMATOL, V8, P115, DOI 10.1007/BF02735160; Coster P, 2012, GEOL SOC AM BULL, V124, P1590, DOI 10.1130/B30565.1; COURT N, 1992, PALAEONTOLOGY, V35, P309; Crottini A, 2012, P NATL ACAD SCI USA, V109, P5358, DOI 10.1073/pnas.1112487109; DAGOSTO M, 1992, INT J PRIMATOL, V13, P307, DOI 10.1007/BF02547818; DEBONIS L, 1988, CR ACAD SCI II, V306, P929; EAGLEN RH, 1986, AM J PHYS ANTHROPOL, V71, P185, DOI 10.1002/ajpa.1330710206; Eizirik Eduardo, 2004, P45; Fabre PH, 2009, MOL PHYLOGENET EVOL, V53, P808, DOI 10.1016/j.ympev.2009.08.004; Gebo DL, 2011, AM J PHYS ANTHROPOL, V146, P323, DOI 10.1002/ajpa.21595; GEBO DL, 1988, FOLIA PRIMATOL, V50, P3, DOI 10.1159/000156332; Gebo DL, 2002, CAM S BIO EVOL ANTHR, V33, P21; Gebo DL, 2001, AM J PHYS ANTHROPOL, V116, P83, DOI 10.1002/ajpa.1105; Gheerbrant Emmanuel, 1993, Palaeovertebrata (Montpellier), V22, P141; Gheerbrant Emmanuel, 1998, Palaeovertebrata (Montpellier), V27, P155; Gingerich P.D., 1980, P123; Gingerich PD, 2006, TRENDS ECOL EVOL, V21, P246, DOI 10.1016/j.tree.2006.03.006; Godfrey LR, 2008, DEV PRIMATOL-PROG PR, P361, DOI 10.1007/978-0-387-73896-3_24; Godfrey LR, 2002, CAM S BIO EVOL ANTHR, V33, P97; Godinot M, 1998, FOLIA PRIMATOL, V69, P218, DOI 10.1159/000052715; GODINOT M, 1994, CR ACAD SCI II, V319, P357; GODINOT M, 1992, NATURE, V357, P324, DOI 10.1038/357324a0; Godinot M, 1988, EOCENE LAKE MESSEL; Godinot M, 2006, FOLIA PRIMATOL, V77, P446, DOI 10.1159/000095391; Godinot Marc, 1994, P235; Godinot Marc, 2010, P319; Hartenberger J.-L., 1992, Human Evolution, V7, P9, DOI 10.1007/BF02437474; Hartenberger Jean-Louis, 1997, Memoires et Travaux de l'Institut de Montpellier de l'Ecole Pratique des Hautes Etudes, V21, P263; Hartenberger JL, 2001, T GEOBIOL, V18, P237; Hartwig WC, 2002, PRIMATE FOSSIL RECOR; Horvath JE, 2008, GENOME RES, V18, P489, DOI 10.1101/gr.7265208; Horvath JE, 2007, TRENDS GENET, V23, P173, DOI 10.1016/j.tig.2007.02.007; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jaeger JJ, 2010, NATURE, V467, P1096, DOI 10.1038/nature09425; Jaeger JJ, 2005, SCIENCE, V310, P244, DOI 10.1126/science.1118124; Jaeger JJ, 1999, SCIENCE, V286, P528, DOI 10.1126/science.286.5439.528; Kay R.F., 1980, International Journal of Primatology, V1, P21, DOI 10.1007/BF02692256; Kay R.F., 1984, P467; Kay RF, 2000, AM J PHYS ANTHROPOL, V113, P235, DOI 10.1002/1096-8644(200010)113:2<235::AID-AJPA7>3.0.CO;2-9; KAY RF, 1975, AM J PHYS ANTHROPOL, V43, P195, DOI 10.1002/ajpa.1330430207; Kay RF, 1997, SCIENCE, V275, P797, DOI 10.1126/science.275.5301.797; KAY RF, 1977, AM J PHYS ANTHROPOL, V46, P327, DOI 10.1002/ajpa.1330460213; Kay Richard F., 2004, P91; Kirk EC, 2001, J HUM EVOL, V40, P203, DOI 10.1006/jhev.2000.0450; Lebrun Renaud, 2012, Palaeobiodiversity Palaeoenvironments, V92, P527, DOI 10.1007/s12549-012-0099-z; Lebrun R, 2010, J ANAT, V216, P368, DOI 10.1111/j.1469-7580.2009.01177.x; Malinzak MD, 2012, P NATL ACAD SCI USA, V109, P17914, DOI 10.1073/pnas.1206139109; Marivaux L, 2005, P NATL ACAD SCI USA, V102, P8436, DOI 10.1073/pnas.0503469102; Marivaux Laurent, 2006, Palaeovertebrata (Montpellier), V34, P29; Marivaux L, 2011, J HUM EVOL, V61, P447, DOI 10.1016/j.jhevol.2011.05.013; MARTIN RD, 1972, PHILOS T ROY SOC B, V264, P295, DOI 10.1098/rstb.1972.0013; McCall RA, 1997, P ROY SOC B-BIOL SCI, V264, P663, DOI 10.1098/rspb.1997.0094; Merceron G, 2005, PALAIOS, V20, P551, DOI 10.2110/palo.2004.p04-17; Merceron G, 2004, PALAEOGEOGR PALAEOCL, V207, P143, DOI 10.1016/j.palaeo.2004.02.008; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Muchlinski MN, 2008, ANAT REC, V291, P1221, DOI 10.1002/ar.20742; Muchlinski MN, 2010, AM J PHYS ANTHROPOL, V141, P131, DOI 10.1002/ajpa.21137; Napier JR, 1967, HDB LIVING PRIMATES; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Pickford Martin, 2008, Geological Survey of Namibia Memoir, V20, P465; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Ramdarshan A, 2011, ADAPTIVE RAD ECOLOGI, V2; Ramdarshan Anusha, 2011, P137; Ramdarshan A, 2012, AM J PHYS ANTHROPOL, V147, P201, DOI 10.1002/ajpa.21638; Ramdarshan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027392; Rasmussen DT, 1998, FOLIA PRIMATOL, V69, P250; Roos C, 2004, P NATL ACAD SCI USA, V101, P10650, DOI 10.1073/pnas.0403852101; Rose KD, 2011, AM J PHYS ANTHROPOL, V146, P281, DOI 10.1002/ajpa.21579; Rose Kenneth D., 1994, P1; Rosenberger A.L., 1985, Primates, V26, P73, DOI 10.1007/BF02389048; Rosenberger AL, 2011, ANAT REC, V294, P797, DOI 10.1002/ar.21367; Rosenberger AL, 2010, DEV PRIMATOL-PROG PR, P273, DOI 10.1007/978-1-4419-6661-2_14; Seiffert ER, 2005, SCIENCE, V310, P300, DOI 10.1126/science.1116569; Seiffert ER, 2005, P NATL ACAD SCI USA, V102, P11396, DOI 10.1073/pnas.0505310102; Seiffert ER, 2003, NATURE, V422, P421, DOI 10.1038/nature01489; Seiffert ER, 2007, AM J PRIMATOL, V69, P27, DOI 10.1002/ajp.20324; Seiffert ER, 2012, EVOL ANTHROPOL, V21, P239, DOI 10.1002/evan.21335; Seiffert Erik R., 2010, P369; Seiffert ER, 2010, P NATL ACAD SCI USA, V107, P9712, DOI 10.1073/pnas.1001393107; Seiffert ER, 2009, NATURE, V461, P1118, DOI 10.1038/nature08429; Senut Brigitte, 2011, P153; SIGE B, 1990, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V214, P31; SIMONS EL, 1994, P NATL ACAD SCI USA, V91, P9946, DOI 10.1073/pnas.91.21.9946; Simons EL, 1995, J HUM EVOL, V29, P577, DOI 10.1006/jhev.1995.1076; Simons EL, 1997, P NATL ACAD SCI USA, V94, P180, DOI 10.1073/pnas.94.1.180; SIMONS EL, 1992, P NATL ACAD SCI USA, V89, P10743, DOI 10.1073/pnas.89.22.10743; SIMONS EL, 1995, SCIENCE, V268, P1885, DOI 10.1126/science.7604261; Simons EL, 2001, FOLIA PRIMATOL, V72, P316, DOI 10.1159/000052748; SIMONS EL, 1989, P NATL ACAD SCI USA, V86, P9956, DOI 10.1073/pnas.86.24.9956; Simons EL, 1997, P NATL ACAD SCI USA, V94, P14970, DOI 10.1073/pnas.94.26.14970; Simons EL, 1997, P NATL ACAD SCI USA, V94, P7993, DOI 10.1073/pnas.94.15.7993; Simons Elwyn L., 1994, Evolutionary Anthropology, V3, P128, DOI 10.1002/evan.1360030407; SLOWINSKI JB, 1993, SYST BIOL, V42, P155, DOI 10.2307/2992538; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Smith T, 2006, P NATL ACAD SCI USA, V103, P11223, DOI 10.1073/pnas.0511296103; Springer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049521; Springer MS, 2001, P NATL ACAD SCI USA, V98, P6241, DOI 10.1073/pnas.111551998; Steiper ME, 2012, P NATL ACAD SCI USA, V109, P6006, DOI 10.1073/pnas.1119506109; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; SZALAY FS, 1977, FOLIA PRIMATOL, V27, P75, DOI 10.1159/000155778; Tabuce R, 2005, B SOC GEOL FR, V176, P381, DOI 10.2113/176.4.381; Tabuce R, 2009, P ROY SOC B-BIOL SCI, V276, P4087, DOI 10.1098/rspb.2009.1339; VISCHER NOE, 1994, BINARY-COMPUT MICROB, V6, P160; Yoder AD, 2004, MOL ECOL, V13, P757, DOI 10.1046/j.1365-294X.2004.02106.x; Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588	126	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80778	10.1371/journal.pone.0080778	http://dx.doi.org/10.1371/journal.pone.0080778			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324627	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300044
J	Novotna, J; Olsovska, J; Novak, P; Mojzes, P; Chaloupkova, R; Kamenik, Z; Spizek, J; Kutejova, E; Mareckova, M; Tichy, P; Damborsky, J; Janata, J				Novotna, Jitka; Olsovska, Jana; Novak, Petr; Mojzes, Peter; Chaloupkova, Radka; Kamenik, Zdenek; Spizek, Jaroslav; Kutejova, Eva; Mareckova, Marketa; Tichy, Pavel; Damborsky, Jiri; Janata, Jiri			Lincomycin Biosynthesis Involves a Tyrosine Hydroxylating Heme Protein of an Unusual Enzyme Family	PLOS ONE			English	Article							HORSERADISH-PEROXIDASE; HETEROLOGOUS EXPRESSION; STABLE-ISOTOPES; ACID; PEROXYGENASE; MECHANISMS; CHLOROPEROXIDASE; CYTOCHROME-P450; TOMAYMYCIN; OXIDATION	The gene lmbB2 of the lincomycin biosynthetic gene cluster of Streptomyces lincolnensis ATCC 25466 was shown to code for an unusual tyrosine hydroxylating enzyme involved in the biosynthetic pathway of this clinically important antibiotic. LmbB2 was expressed in Escherichia coli, purified near to homogeneity and shown to convert tyrosine to 3,4-dihydroxyphenylalanine (DOPA). In contrast to the well-known tyrosine hydroxylases (EC 1.14.16.2) and tyrosinases (EC 1.14.18.1), LmbB2 was identified as a heme protein. Mass spectrometry and Soret band-excited Raman spectroscopy of LmbB2 showed that LmbB2 contains heme b as prosthetic group. The CO-reduced differential absorption spectra of LmbB2 showed that the coordination of Fe was different from that of cytochrome P450 enzymes. LmbB2 exhibits sequence similarity to Orf13 of the anthramycin biosynthetic gene cluster, which has recently been classified as a heme peroxidase. Tyrosine hydroxylating activity of LmbB2 yielding DOPA in the presence of (6R)-5,6,7,8-tetrahydro-L-biopterin (BH4) was also observed. Reaction mechanism of this unique heme peroxidases family is discussed. Also, tyrosine hydroxylation was confirmed as the first step of the amino acid branch of the lincomycin biosynthesis.	[Novotna, Jitka; Olsovska, Jana; Novak, Petr; Kamenik, Zdenek; Spizek, Jaroslav; Kutejova, Eva; Tichy, Pavel; Janata, Jiri] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic; [Novotna, Jitka] Cent European Technol Inst, Brno, Czech Republic; [Novotna, Jitka; Mareckova, Marketa] Crop Res Inst, Drnovska Prague, Czech Republic; [Mojzes, Peter] Charles Univ Prague, Fac Math & Phys, Inst Phys, Prague, Czech Republic; [Chaloupkova, Radka; Damborsky, Jiri] Inst Expt Biol, Loschmidt Labs, Brno, Czech Republic; [Chaloupkova, Radka; Damborsky, Jiri] Natl Ctr Biomol Res, Brno, Czech Republic; [Kutejova, Eva] Slovak Acad Sci, Inst Mol Biol, Bratislava 84251, Slovakia	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Crop Research Institute (CRI); Charles University Prague; Masaryk University Brno; Slovak Academy of Sciences	Novotna, J (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic.	jinov1@mail.muni.cz	Kutejova, Eva/K-6550-2014; Damborsky, Jiri/H-3799-2012; Janata, Jiri/K-4554-2014; Kamenik, Zdenek/A-6620-2010; Mojzes, Peter/A-9453-2008; Chaloupkova, Radka/M-5565-2016; Novotna, Jitka/G-2891-2017; Novak, Petr/F-9655-2014; Mareckova, Marketa/AAD-7361-2021; Mojzes, Peter/ABF-4898-2021; Kutejova, Eva/AAI-2544-2021; Mareckova, Marketa/D-9898-2017	Kutejova, Eva/0000-0002-0973-679X; Damborsky, Jiri/0000-0002-7848-8216; Janata, Jiri/0000-0002-4582-2062; Mojzes, Peter/0000-0002-9952-6939; Chaloupkova, Radka/0000-0002-3539-7445; Novotna, Jitka/0000-0002-5636-0609; Novak, Petr/0000-0001-8688-529X; Mareckova, Marketa/0000-0002-0331-8570; Mojzes, Peter/0000-0002-9952-6939; Kutejova, Eva/0000-0002-0973-679X; Mareckova, Marketa/0000-0002-0331-8570; Olsovska, Jana/0000-0003-4938-3666	Ministry of Education, Youth and Sports of the Czech Republic [CZ.1.07/2.3.00/20.0055, CZ.1.07/2.3.00/30.0003, MSM0021620835, MSM0021622412, LC06010]; Grant Agency of the Charles University in Prague [204/2006/B-FYZ/MFF]; Grant Agency of the Academy of Sciences of the Czech Republic [IAA500200810]; Ministry of Agriculture of the Czech Republic, National Agency for Agriculture Research [QH92151]; Slovak Grant Agency [VEGA 2/0122/11]; European Regional Development fund [CZ.1.05/1.1.00/02.0068]; Institutional Research Concept AV OZ [50200510]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Charles University in Prague; Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Ministry of Agriculture of the Czech Republic, National Agency for Agriculture Research; Slovak Grant Agency(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); European Regional Development fund(European Commission); Institutional Research Concept AV OZ	This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic (CZ.1.07/2.3.00/20.0055, CZ.1.07/2.3.00/30.0003, MSM0021620835, MSM0021622412, and LC06010) URL: http://www.msmt.cz/index.php?lang=2; the Grant Agency of the Charles University in Prague (204/2006/B-FYZ/MFF) URL: http://www.cuni.cz/UKENG-33.html; Grant Agency of the Academy of Sciences of the Czech Republic (IAA500200810) URL: http://www.gaav.cz/index2.html; Ministry of Agriculture of the Czech Republic, National Agency for Agriculture Research (QH92151) URL: http://www.ldf.mendelu.cz/en/projekty/resene_projekty/grantove_prilezitosti/nazv; Slovak Grant Agency (Grant VEGA 2/0122/11), the European Regional Development fund (CZ.1.05/1.1.00/02.0068 (CEITEC)) and Institutional Research Concept AV OZ 50200510 URL: http://www.biomed.cas.cz/mbu/new/index.php?p=projekty&site=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ausubel A, 1998, CURRENT PROTOCOLS MO; Babcock G. T., 1988, BIOL APPLICATIONS RA, V3, P293; Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V500, P21, DOI 10.1016/j.abb.2010.03.002; BRAHME NM, 1984, J AM CHEM SOC, V106, P7873, DOI 10.1021/ja00337a038; BRAHME NM, 1984, J AM CHEM SOC, V106, P7878, DOI 10.1021/ja00337a039; Capeillere-Blandin C, 2005, BIOCHEM J, V392, P583, DOI 10.1042/BJ20050437; Connor KL, 2011, BIOCHEMISTRY-US, V50, P8926, DOI 10.1021/bi201148a; Courteix A, 1995, ENZYME MICROB TECH, V17, P1087, DOI 10.1016/0141-0229(95)00037-2; Fitzpatrick PF, 2003, BIOCHEMISTRY-US, V42, P14083, DOI 10.1021/bi035656u; Fu R, 2011, J BIOL CHEM, V286, P26541, DOI 10.1074/jbc.M111.253237; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Grobe G, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-31; Guengerich F P, 1998, Methods Mol Biol, V107, P35; Hanano A, 2006, J BIOL CHEM, V281, P33140, DOI 10.1074/jbc.M605395200; Harnastai IN, 2006, PROTEIN EXPRES PURIF, V46, P47, DOI 10.1016/j.pep.2005.07.006; Hayashi Seiko, 2005, Drug Metab Pharmacokinet, V20, P14, DOI 10.2133/dmpk.20.14; Hersleth HP, 2006, J INORG BIOCHEM, V100, P460, DOI 10.1016/j.jinorgbio.2006.01.018; Hildebrandt A G, 1978, Methods Enzymol, V52, P342; Hofer I, 2011, CHEM BIOL, V18, P381, DOI 10.1016/j.chembiol.2010.12.018; Hrycay EG, 2012, ARCH BIOCHEM BIOPHYS, V522, P71, DOI 10.1016/j.abb.2012.01.003; Hu Y, 2007, CHEM BIOL, V14, P691, DOI 10.1016/j.chembiol.2007.05.009; HURLEY LH, 1980, ACCOUNTS CHEM RES, V13, P263, DOI 10.1021/ar50152a003; Koberska M, 2008, FOLIA MICROBIOL, V53, P395, DOI 10.1007/s12223-008-0060-8; KUO MS, 1992, J ANTIBIOT, V45, P1773, DOI 10.7164/antibiotics.45.1773; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li W, 2009, APPL ENVIRON MICROB, V75, P2958, DOI 10.1128/AEM.02325-08; Li W, 2009, APPL ENVIRON MICROB, V75, P2869, DOI 10.1128/AEM.02326-08; Matsunaga I, 2002, FEBS LETT, V528, P90, DOI 10.1016/S0014-5793(02)03261-1; Mishin V, 2010, FREE RADICAL BIO MED, V48, P1485, DOI 10.1016/j.freeradbiomed.2010.02.030; Munro AW, 2007, NAT PROD REP, V24, P585, DOI 10.1039/b604190f; Neusser D, 1998, ARCH MICROBIOL, V169, P322, DOI 10.1007/s002030050578; Notomista E, 2003, J MOL EVOL, V56, P435, DOI 10.1007/s00239-002-2414-1; Novotna J, 2004, EUR J BIOCHEM, V271, P3678, DOI 10.1111/j.1432-1033.2004.04308.x; OGURA T, 1985, BIOCHEMISTRY-US, V24, P7746, DOI 10.1021/bi00347a037; Olsovska J, 2007, BIOMED CHROMATOGR, V21, P1252, DOI 10.1002/bmc.880; Park J, 1998, J MOL BIOL, V284, P1201, DOI 10.1006/jmbi.1998.2221; Poulos T. L., 2005, CYTOCHROME P450 STRU, P87; REMBA RD, 1979, BIOCHEMISTRY-US, V18, P2280, DOI 10.1021/bi00578a023; ROUSSEAU DL, 1983, J BIOL CHEM, V258, P1740; SARIASLANI FS, 1989, CRIT REV BIOTECHNOL, V9, P171, DOI 10.3109/07388558909036736; Spiro TG, 1988, BIOL APPL RAMAN SPEC, V3, P1; Spizek J, 2004, APPL MICROBIOL BIOT, V63, P510, DOI 10.1007/s00253-003-1431-3; Tanaka M, 1996, BIOCHEM BIOPH RES CO, V227, P393, DOI 10.1006/bbrc.1996.1518; Tanaka M, 1997, BIOCHEMISTRY-US, V36, P9889, DOI 10.1021/bi970906q; Tang MC, 2012, J BIOL CHEM, V287, P5112, DOI 10.1074/jbc.M111.306316; Ullrich R, 2007, CELL MOL LIFE SCI, V64, P271, DOI 10.1007/s00018-007-6362-1; Vlasits J, 2010, ARCH BIOCHEM BIOPHYS, V500, P74, DOI 10.1016/j.abb.2010.04.018; Yasui Hiroyuki, 2002, Drug Metab Pharmacokinet, V17, P416, DOI 10.2133/dmpk.17.416; Yi XW, 1999, P NATL ACAD SCI USA, V96, P12412, DOI 10.1073/pnas.96.22.12412	51	22	24	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e79974	10.1371/journal.pone.0079974	http://dx.doi.org/10.1371/journal.pone.0079974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324587	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300014
J	Sorqvist, P; Hedblom, D; Holmgren, M; Haga, A; Langeborg, L; Nostl, A; Kagstrom, J				Sorqvist, Patrik; Hedblom, Daniel; Holmgren, Mattias; Haga, Andreas; Langeborg, Linda; Nostl, Anatole; Kagstrom, Jonas			Who Needs Cream and Sugar When There Is Eco-Labeling? Taste and Willingness to Pay for "Eco-Friendly" Coffee	PLOS ONE			English	Article							ENVIRONMENTAL ATTITUDES; CONSUMERS; FOOD; PERCEPTION; BEHAVIOR; EXPECTATION; PREFERENCES; INFORMATION; CONSUMPTION; PRODUCTS	Participants tasted two cups of coffee, decided which they preferred, and then rated each coffee. They were told (in lure) that one of the cups contained "eco-friendly" coffee while the other did not, although the two cups contained identical coffee. In Experiments 1 and 3, but not in Experiment 2, the participants were also told which cup contained which type of coffee before they tasted. The participants preferred the taste of, and were willing to pay more for, the "eco-friendly" coffee, at least those who scored high on a questionnaire on attitudes toward sustainable consumer behavior (Experiment 1). High sustainability consumers were also willing to pay more for "eco-friendly" coffee, even when they were told, after their decision, that they preferred the non-labeled alternative (Experiment 2). Moreover, the eco-label effect does not appear to be a consequence of social desirability, as participants were just as biased when reporting the taste estimates and willingness to pay anonymously (Experiment 3). Eco labels not only promote a willingness to pay more for the product but also lead to a more favorable perceptual experience of it.	[Sorqvist, Patrik; Holmgren, Mattias; Haga, Andreas; Nostl, Anatole] Univ Gavle, Dept Bldg Energy & Environm Engn, Gavle, Sweden; [Sorqvist, Patrik] Linkoping Univ, Swedish Inst Disabil Res, Linnaeus Ctr Res Hearing & Deafness, Linkoping, Sweden; [Hedblom, Daniel] Univ Chicago, Dept Econ, Chicago, IL 60637 USA; [Hedblom, Daniel] Res Inst Ind Econ, Stockholm, Sweden; [Langeborg, Linda] Univ Gavle, Dept Social Work & Psychol, Gavle, Sweden; [Kagstrom, Jonas] Univ Gavle, Dept Business & Econ Studies, Gavle, Sweden	University of Gavle; Linkoping University; University of Chicago; Research Institute of Industrial Economics (IFN); University of Gavle; University of Gavle	Sorqvist, P (corresponding author), Univ Gavle, Dept Bldg Energy & Environm Engn, Gavle, Sweden.	patrik.sorqvist@hig.se	Kågström, Jonas/AAB-1727-2022	Kågström, Jonas/0000-0002-0044-1354; Sorqvist, Patrik/0000-0002-7584-2275	University of Gavle, Sweden	University of Gavle, Sweden	These authors have no current external funding sources for this study. The funders (University of Gavle, Sweden, www.hig.se) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MW, 2008, J CONSUM RES, V35, P294, DOI 10.1086/590319; ALLISON RI, 1964, J MARKETING RES, V1, P36, DOI 10.2307/3150054; Balcetis E, 2007, PSYCHOL SCI, V18, P917, DOI 10.1111/j.1467-9280.2007.02000.x; Bamberg S, 2003, J ENVIRON PSYCHOL, V23, P21, DOI 10.1016/S0272-4944(02)00078-6; Bar M., 2008, J CONSUMER BEHAVIOUR, V7, P319, DOI [10.1002/cb.254, DOI 10.1002/CB.254]; Biel A, 2005, AMBIO, V34, P360, DOI 10.1639/0044-7447(2005)034[0360:HAVPB]2.0.CO;2; Bohner G, 2011, ANNU REV PSYCHOL, V62, P391, DOI 10.1146/annurev.psych.121208.131609; Bougherara D, 2009, EUR REV AGRIC ECON, V36, P321, DOI 10.1093/erae/jbp023; Breneiser J., 2011, N AM J PSYCHOL, V13, P281; Dahm MJ, 2009, J AM COLL HEALTH, V58, P195, DOI 10.1080/07448480903295292; De Pelsmacker P, 2005, J CONSUM AFF, V39, P363, DOI 10.1111/j.1745-6606.2005.00019.x; Deliza R, 1996, J SENS STUD, V11, P103, DOI 10.1111/j.1745-459X.1996.tb00036.x; Didier T, 2008, INT J CONSUM STUD, V32, P479, DOI 10.1111/j.1470-6431.2008.00714.x; Dinis I, 2011, SPAN J AGRIC RES, V9, P351; Dunning D, 2007, J CONSUM PSYCHOL, V17, P237, DOI 10.1016/S1057-7408(07)70033-5; Elder RS, 2010, J CONSUM RES, V36, P748, DOI 10.1086/605327; Felonneau ML, 2008, REV INT PSYCHOL SOC, V21, P25; Feuz DM, 2004, J AGR RESOUR ECON, V29, P501; Fillion L., 2002, Nutrition and Food Science, V32, P153, DOI 10.1108/00346650210436262; Fotopoulos C., 2002, British Food Journal, V104, P233, DOI 10.1108/00070700210425697; Gil JM., 2000, INT FOOD AGRIBUS MAN, V3, P207, DOI [10.1016/S1096-7508(01)00040-4, DOI 10.1016/S1096-7508(01)00040-4]; Grankvist G, 2001, J ENVIRON PSYCHOL, V21, P405, DOI 10.1006/jevp.2001.0234; Grunert KG, 2005, EUR REV AGRIC ECON, V32, P369, DOI 10.1093/eurrag/jbi011; Honkanen P., 2006, J CONSUM BEHAV INT R, V5, P420, DOI [10.1002/cb.190, DOI 10.1002/CB.190]; Johnston RJ, 2006, J AGR RESOUR ECON, V31, P283; KAHNEMAN D, 1990, J POLIT ECON, V98, P1325, DOI 10.1086/261737; Krystallis A, 2005, BRIT FOOD J, V107, P320, DOI 10.1108/00070700510596901; Larceneux F, 2012, J CONSUM POLICY, V35, P85, DOI 10.1007/s10603-011-9186-1; Larson BA, 2003, ENVIRON DEV ECON, V8, P529, DOI 10.1017/S1355770X0300287; Lee L, 2006, PSYCHOL SCI, V17, P1054, DOI 10.1111/j.1467-9280.2006.01829.x; LEVIN IP, 1988, J CONSUM RES, V15, P374, DOI 10.1086/209174; Litt A, 2012, J CONSUM PSYCHOL, V22, P55, DOI 10.1016/j.jcps.2011.11.007; Loureiro ML, 2005, ENVIRON RESOUR ECON, V30, P49, DOI 10.1007/s10640-004-1149-4; Maison D, 2004, J CONSUM PSYCHOL, V14, P405, DOI 10.1207/s15327663jcp1404_9; Mallett RK, 2012, ECOPSYCHOLOGY, V4, P223, DOI [10.1089/eco.2012.0031, DOI 10.1089/ECO.2012.0031]; Masson MEJ, 2011, BEHAV RES METHODS, V43, P679, DOI 10.3758/s13428-010-0049-5; Mazar N, 2010, PSYCHOL SCI, V21, P494, DOI 10.1177/0956797610363538; McCluskey J.J., 2003, J FOOD DISTRIBUTION, V34, P95; McFadden D, 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; Nelson KA, 2004, J CONSUM PSYCHOL, V14, P28, DOI 10.1207/s15327663jcp1401&2_5; Newhouse Nancy., 1990, J ENVIRON EDUC, V22, P26, DOI DOI 10.1080/00958964.1990.9943043; Oerke B, 2013, INT J SCI EDUC, V35, P713, DOI 10.1080/09500693.2011.566897; Paasovaara R, 2012, J CONSUM BEHAV, V11, P11, DOI 10.1002/cb.356; Pearson D, 2011, RENEW AGR FOOD SYST, V26, P171, DOI 10.1017/S1742170510000499; PECHMANN C, 1992, J CONSUM RES, V19, P373, DOI 10.1086/209308; Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Robinson TN, 2007, ARCH PEDIAT ADOL MED, V161, P792, DOI 10.1001/archpedi.161.8.792; Sachdeva S, 2009, PSYCHOL SCI, V20, P523, DOI 10.1111/j.1467-9280.2009.02326.x; Schuldt JP, 2012, SOC PSYCHOL PERS SCI, V3, P581, DOI 10.1177/1948550611431643; Shepherd R, 1991, FOOD QUAL PREFER, V3, P147, DOI DOI 10.1016/0950-3293(91)90051-F; Vermeir I, 2006, J AGR ENVIRON ETHIC, V19, P169, DOI 10.1007/s10806-005-5485-3; Wansink B, 2003, J FOOD SCI, V68, P2604, DOI 10.1111/j.1365-2621.2003.tb07068.x; White K, 2009, J CONSUM PSYCHOL, V19, P313, DOI 10.1016/j.jcps.2009.03.007; Yiridoe EK, 2005, RENEW AGR FOOD SYST, V20, P193, DOI 10.1079/RAF2005113; Zander K, 2010, FOOD QUAL PREFER, V21, P495, DOI 10.1016/j.foodqual.2010.01.006	56	98	98	7	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80719	10.1371/journal.pone.0080719	http://dx.doi.org/10.1371/journal.pone.0080719			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	265KD	24324623	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300040
J	Verma, RK; Gunda, V; Pawar, SC; Sudhakar, YA				Verma, Raj K.; Gunda, Venugopal; Pawar, Smita C.; Sudhakar, Yakkanti Akul			Extra Cellular Matrix Derived Metabolite Regulates Angiogenesis by FasL Mediated Apoptosis	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; IV COLLAGEN; NONCOLLAGENOUS DOMAIN; ALPHA-3 CHAIN; NC1 DOMAIN; TUMSTATIN; CANCER; ALPHA(V)BETA(3); ALPHA-V-BETA-3; RANIBIZUMAB	Object: Antiangiogenic treatments are beginning to give promising outcomes in many vascular diseases including tumor angiogenesis. In this current study the antiangiogenic and pro-apoptotic actions of alpha 1(IV)NC1 and its N- and C-peptides alpha 1S1(IV)NC1, alpha 1S2(IV) NC1 were investigated in-vitro and in-vivo. Study Method: Endothelial cells (ECs) were treated with alpha 1(IV)NC1, alpha 1S1(IV)NC1, alpha 1S2(IV)NC1 and in-vitro proliferation, migration, tube formation and apoptotic assays were executed. FasL, Fas, Caspase-8, -3 and PARP activations were studied using immunoblotting analysis using specific antibodies. Also the in-vivo antiangiogenic and pro-apoptotic effects were tested using alpha 1(IV)NC1 in a mice model. Results: Like alpha 1(IV)NC1, its N- and C-terminal alpha 1S2(IV)NC1 and alpha 1S1(IV)NC1 domains posses anti-proliferative, proapoptotic activity and inhibit ECs migration and tube formation in-vitro. Both alpha 1S1(IV)NC1 and alpha 1S2(IV)NC1 domains promote apoptosis by activating FasL and down stream apoptotic events including activation of caspase-8, -3 and PARP cleavage in a dose dependent manner in-vitro in ECs. Tumors in mice showed apoptotic TUNEL positive microvasculature upon alpha 1(IV)NC1 treatment, indicating inhibition of tumor angiogenesis and tumor growth. Further, the antitumor activity of alpha 1(IV)NC1 was abrogated when caspase-3 inhibitor was used. These results conform additional properties of alpha 1(IV)NC1 as an endogenous angioinhibitor that induces apoptosis in-vitro and in-vivo by activating FasL mediated caspase-3. Significance: alpha 1(IV)NC1 and its N-and C-terminal alpha 1S1(IV)NC1 and alpha 1S2(IV)NC1 domains also posses pro-apoptotic and angioinhibitory activity in-vitro and in-vivo. alpha 1(IV)NC1 regulates tumor angiogenesis by activating FasL mediated apoptosis in-vitro and in-vivo. These results demonstrate that alpha 1(IV)NC1 and its peptides inhibit neo-vascular diseases.	[Verma, Raj K.] Texas A&M Hlth Sci Ctr, Irma Lerma Rangel Coll Pharm, Kingsville, TX USA; [Gunda, Venugopal] Univ Nebraska Med Ctr, Eppley Inst Canc & Allied Dis, Omaha, NE USA; [Pawar, Smita C.] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India; [Sudhakar, Yakkanti Akul] SRI Int, Biosci Div, Ctr Canc & Metab, Cell Signaling Lab, Menlo Pk, CA USA; [Sudhakar, Yakkanti Akul] Boys Town Natl Res Hosp, Dept Genet, Cell Signaling & Tumor Angiogenesis Lab, Omaha, NE 68131 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Nebraska System; University of Nebraska Medical Center; Osmania University; SRI International; Boys Town National Research Hospital	Sudhakar, YA (corresponding author), SRI Int, Biosci Div, Ctr Canc & Metab, Cell Signaling Lab, Menlo Pk, CA USA.	sudhakar.yakkanti@sri.com						Boosani CS, 2009, INVEST OPHTH VIS SCI, V50, P4567, DOI 10.1167/iovs.09-3473; Boosani CS, 2007, BLOOD, V110, P1168, DOI 10.1182/blood-2007-01-066282; Boosani CS, 2006, PROTEIN EXPRES PURIF, V49, P211, DOI 10.1016/j.pep.2006.03.007; BORZA CM, 2006, J BIOL CHEM; Campochiaro PA, 2006, HUM GENE THER, V17, P167, DOI 10.1089/hum.2006.17.167; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chow J, 2001, DEV BRAIN RES, V130, P123, DOI 10.1016/S0165-3806(01)00220-6; Colorado PC, 2000, CANCER RES, V60, P2520; Deissler HL, 2008, KLIN MONATSBL AUGENH, V225, P863, DOI 10.1055/s-2008-1027767; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FOLKMAN J, 1980, T OPHTHAL SOC UK, V100, P346; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; GARNER A, 1986, INT REV EXP PATHOL, V28, P249; Gunda V, 2013, INVEST OPHT IN PRESS; Gunda V, 2012, PROTEIN PEPTIDE LETT, V19, P1112, DOI 10.2174/092986612802762750; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; Huang Q, 2008, AM J PHYSIOL-CELL PH, V295, pC1647, DOI 10.1152/ajpcell.00322.2008; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; INGBER D, 1988, LAB INVEST, V59, P44; JAMPOL LM, 1994, SURV OPHTHALMOL, V38, P519, DOI 10.1016/0039-6257(94)90146-5; Konstantinidis L, 2008, GRAEFES ARCH CLIN EX; Lu F, 2009, GRAEF ARCH CLIN EXP, V247, P171, DOI 10.1007/s00417-008-0936-y; Maeshima Y, 2000, J BIOL CHEM, V275, P23745, DOI 10.1074/jbc.C000186200; Maeshima Y, 2002, SCIENCE, V295, P140, DOI 10.1126/science.1065298; Mantel I, 2008, OPHTHALMOLOGICA, V222, P321, DOI 10.1159/000144075; MARAGOUDAKIS ME, 1993, KIDNEY INT, V43, P147, DOI 10.1038/ki.1993.24; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Morabito A, 2006, ONCOLOGIST, V11, P753, DOI 10.1634/theoncologist.11-7-753; Nguyen QD, 2006, OPHTHALMOLOGY, V113, P1522, DOI 10.1016/j.ophtha.2006.05.055; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; Nyberg P, 2008, EXP CELL RES, V314, P3292, DOI 10.1016/j.yexcr.2008.08.011; PAULSSON M, 1992, CRIT REV BIOCHEM MOL, V27, P93; Pedchenko V, 2004, J BIOL CHEM, V279, P2772, DOI 10.1074/jbc.M311901200; Siemann DW, 2008, ANTICANCER RES, V28, P2027; Silva RLE, 2006, J CELL PHYSIOL, V208, P161, DOI 10.1002/jcp.20645; Su XJ, 2003, MOL VIS, V9, P171; Sudhakar A, 2005, J CLIN INVEST, V115, P2801, DOI 10.1172/JCI24813; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; Sudhakar A, 2009, J BIOEQUI AVAILAB, V1; Sudhakar A, 2007, GENE REGUL SYST BIO, V1, P217; Sudhakar A, 2008, PHARM RES-DORD, V25, P2731, DOI 10.1007/s11095-008-9634-z	41	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80555	10.1371/journal.pone.0080555	http://dx.doi.org/10.1371/journal.pone.0080555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324608	Green Submitted, Green Published, gold			2022-12-25	WOS:000327949300028
J	Vik, R; Busnelli, M; Parolini, C; Bjorndal, B; Holm, S; Bohov, P; Halvorsen, B; Brattelid, T; Manzini, S; Ganzetti, GS; Dellera, F; Nygard, OK; Aukrust, P; Sirtori, CR; Chiesa, G; Berge, RK				Vik, Rita; Busnelli, Marco; Parolini, Cinzia; Bjorndal, Bodil; Holm, Sverre; Bohov, Pavol; Halvorsen, Bente; Brattelid, Trond; Manzini, Stefano; Ganzetti, Giulia S.; Dellera, Federica; Nygard, Ottar K.; Aukrust, Pal; Sirtori, Cesare R.; Chiesa, Giulia; Berge, Rolf K.			An Immunomodulating Fatty Acid Analogue Targeting Mitochondria Exerts Anti-Atherosclerotic Effect beyond Plasma Cholesterol-Lowering Activity in apoE(-/-) Mice	PLOS ONE			English	Article							TETRADECYLTHIOACETIC ACID; RAT-LIVER; CARNITINE PALMITOYLTRANSFERASE; METABOLIC SYNDROME; GENE-EXPRESSION; BETA-OXIDATION; LOCAL-DELIVERY; INHIBITION; PEROXISOMES; LIPOPROTEIN	Tetradecylthioacetic acid (TTA) is a hypolipidemic antioxidant with immunomodulating properties involving activation of peroxisome proliferator-activated receptors (PPARs) and proliferation of mitochondria. This study aimed to penetrate the effect of TTA on the development of atherosclerotic lesions in apolipoprotein (apo)-E-/- mice fed a high-fat diet containing 0.3% TTA for 12 weeks. These mice displayed a significantly less atherosclerotic development vs control. Plasma cholesterol was increased by TTA administration and triacylglycerol (TAG) levels in plasma and liver were decreased by TTA supplementation, the latter, probably due to increased mitochondrial fatty acid oxidation and reduced lipogenesis. TTA administration also changed the fatty acid composition in the heart, and the amount of arachidonic acid (ARA) and eicosapentaenoic acid (EPA) was reduced and increased, respectively. The heart mRNA expression of inducible nitric oxidase (NOS)-2 was decreased in TTA-treated mice, whereas the mRNA level of catalase was increased. Finally, reduced plasma levels of inflammatory mediators as IL-1 alpha, IL-6, IL-17, TNF-alpha and IFN-gamma were detected in TTA-treated mice. These data show that TTA reduces atherosclerosis in apoE(-/-) mice and modulates risk factors related to atherosclerotic disorders. TTA probably acts at both systemic and vascular levels in a manner independent of changes in plasma cholesterol, and triggers TAG catabolism through improved mitochondrial function.	[Vik, Rita; Bjorndal, Bodil; Bohov, Pavol; Nygard, Ottar K.; Berge, Rolf K.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Busnelli, Marco; Parolini, Cinzia; Manzini, Stefano; Ganzetti, Giulia S.; Dellera, Federica; Sirtori, Cesare R.; Chiesa, Giulia] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Holm, Sverre; Halvorsen, Bente; Aukrust, Pal] Univ Oslo, Internal Med Res Inst, Oslo Univ Hosp Rikshosp, Oslo, Norway; [Halvorsen, Bente; Aukrust, Pal] Univ Oslo, Inst Clin Med, Oslo, Norway; [Brattelid, Trond] NIFES, Natl Inst Nutr & Seafood Res, Bergen, Norway; [Nygard, Ottar K.; Berge, Rolf K.] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway; [Aukrust, Pal] Univ Oslo, Oslo Univ Hosp Rikshosp, Sect Clin Immunol & Infect Dis, Oslo, Norway; [Aukrust, Pal] Univ Oslo, KG Jebsen Inflammat Res Ctr, Oslo, Norway	University of Bergen; University of Milan; University of Oslo; National Hospital Norway; University of Oslo; University of Bergen; Haukeland University Hospital; University of Oslo; National Hospital Norway; University of Oslo	Vik, R (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	Rita.Vik@k2.uib.no	Bjørndal, Bodil/H-6143-2017; Manzini, Stefano/H-7123-2014; Chiesa, Giulia/G-8987-2012; Parolini, Cinzia/G-8984-2012; Busnelli, Marco/AAO-6981-2021; Bjørndal, Bodil/HDN-4287-2022	Bjørndal, Bodil/0000-0001-9718-5117; Manzini, Stefano/0000-0002-1232-2635; Chiesa, Giulia/0000-0001-5553-1210; Parolini, Cinzia/0000-0002-5699-0918; Busnelli, Marco/0000-0003-3245-2872; Holm, Sverre/0000-0003-1064-3926	NordForsk [070010]; Research Council of Norway [190287/110]; European Community [201668]; MitoHealth	NordForsk; Research Council of Norway(Research Council of Norway); European Community(European Commission); MitoHealth	This work was supported by grants from NordForsk, grant no. 070010, MitoHealth; the Research Council of Norway, grant no. 190287/110; and the European Community's Seventh Framework Programme (FP7/2007-2013) AtheroRemo, grant no. 201668. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aukrust P, 2008, ARTERIOSCL THROM VAS, V28, P1909, DOI 10.1161/ATVBAHA.107.161240; Berge RK, 2005, BIOCHIMIE, V87, P15, DOI 10.1016/j.biochi.2004.11.011; BERGE RK, 1984, EUR J BIOCHEM, V141, P637, DOI 10.1111/j.1432-1033.1984.tb08239.x; Bjorndal B, 2012, METABOLISM, V61, P1461, DOI 10.1016/j.metabol.2012.03.012; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BREMER J, 1981, BIOCHIM BIOPHYS ACTA, V665, P628, DOI 10.1016/0005-2760(81)90282-4; Burri L, 2011, LIPIDS, V46, P679, DOI 10.1007/s11745-011-3536-2; Dyroy E, 2005, ARTERIOSCL THROM VAS, V25, P1364, DOI 10.1161/01.ATV.0000171982.57713.96; Elholm M, 2000, J LIPID RES, V41, P538; Gjoen T, 2007, COMP BIOCHEM PHYS B, V148, P103, DOI 10.1016/j.cbpb.2007.04.021; Gudbrandsen OA, 2005, CHEM-BIOL INTERACT, V155, P71, DOI 10.1016/j.cbi.2005.04.007; Hafstad AD, 2009, CARDIOVASC RES, V83, P519, DOI 10.1093/cvr/cvp132; Helledie T, 2000, J LIPID RES, V41, P1740; Kolovou G, 2008, CURR PHARM DESIGN, V14, P338, DOI 10.2174/138161208783497769; KRYVI H, 1990, J STRUCT BIOL, V103, P257, DOI 10.1016/1047-8477(90)90044-D; Lakshmi SVV, 2009, INDIAN J BIOCHEM BIO, V46, P421; Lovas K, 2009, DIABETES OBES METAB, V11, P304, DOI 10.1111/j.1463-1326.2008.00958.x; LUIS AJ, 2004, GENOMICS HUMAN GENET, V5, P189, DOI DOI 10.1146/ANNUREV.GEN0M.5.061903.175930; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Madsen L, 1999, LIPIDS, V34, P951, DOI 10.1007/s11745-999-0445-x; Madsen L, 1999, BIOCHEM PHARMACOL, V57, P1011, DOI 10.1016/S0006-2952(99)00004-0; Madsen L, 2002, J LIPID RES, V43, P742; Mamalakis G, 1998, J AM COLL NUTR, V17, P239, DOI 10.1080/07315724.1998.10718753; Morken T, 2011, SCAND J CLIN LAB INV, V71, P269, DOI 10.3109/00365513.2011.559552; Muna ZA, 2002, BIOCHEM PHARMACOL, V63, P1127, DOI 10.1016/S0006-2952(01)00934-0; Muna ZA, 1997, ARTERIOSCL THROM VAS, V17, P3255, DOI 10.1161/01.ATV.17.11.3255; Pettersen RJ, 2012, SCAND CARDIOVASC J, V46, P366, DOI 10.3109/14017431.2012.725477; Pettersen RJ, 2001, CARDIOVASC RES, V52, P306, DOI 10.1016/S0008-6363(01)00404-7; Raspe E, 1999, J LIPID RES, V40, P2099; Rekawiecki R, 2012, REPROD BIOL, V12, P362, DOI 10.1016/j.repbio.2012.10.010; ROSEKAHN G, 1985, J BIOL CHEM, V260, P8411; SKORVE J, 1993, J LIPID RES, V34, P1177; SKREDE S, 1995, BIOCHEM J, V305, P591, DOI 10.1042/bj3050591; Smith JD, 1997, J INTERN MED, V242, P99, DOI 10.1046/j.1365-2796.1997.00197.x; SPYDEVOLD O, 1989, BIOCHIM BIOPHYS ACTA, V1003, P72, DOI 10.1016/0005-2760(89)90101-X; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Thakur ML, 2012, ATHEROSCLEROSIS, V223, P507, DOI 10.1016/j.atherosclerosis.2012.06.005; Vaagenes H, 1998, BIOCHEM PHARMACOL, V56, P1571, DOI 10.1016/S0006-2952(98)00193-2; VIGERUST NF, 2012, EUR J NUTR; Wergedahl Hege, 2008, Drug Metab Lett, V2, P138, DOI 10.2174/187231208784041013	40	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81963	10.1371/journal.pone.0081963	http://dx.doi.org/10.1371/journal.pone.0081963			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324736	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300117
J	Zetterstrom, CE; Hasselgren, J; Salin, O; Davis, RA; Quinn, RJ; Sundin, C; Elofsson, M				Zetterstrom, Caroline E.; Hasselgren, Jenny; Salin, Olli; Davis, Rohan A.; Quinn, Ronald J.; Sundin, Charlotta; Elofsson, Mikael			The Resveratrol Tetramer (-)- Hopeaphenol Inhibits Type III Secretion in the Gram-Negative Pathogens Yersinia pseudotuberculosis and Pseudomonas aeruginosa	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; PSEUDOCERAMINES A-D; SALICYLIDENE ACYLHYDRAZIDE; CHLAMYDIA-TRACHOMATIS; BACTERIAL VIRULENCE; SYSTEM INHIBITORS; PROTEIN SECRETION; NATURAL-PRODUCTS; BETA-LACTAMASE; TRANSLOCATION	Society faces huge challenges, as a large number of bacteria have developed resistance towards many or all of the antibiotics currently available. Novel strategies that can help solve this problem are urgently needed. One such strategy is to target bacterial virulence, the ability to cause disease e. g., by inhibition of type III secretion systems (T3SSs) utilized by many clinically relevant gram-negative pathogens. Many of the antibiotics used today originate from natural sources. In contrast, most virulence-blocking compounds towards the T3SS identified so far are small organic molecules. A recent high-throughput screening of a prefractionated natural product library identified the resveratrol tetramer (-)-hopeaphenol as an inhibitor of the T3SS in Yersinia pseudotuberculosis. In this study we have investigated the virulence blocking properties of (-)-hopeaphenol in three different gram-negative bacteria. (-)-Hopeaphenol was found to have micromolar activity towards the T3SSs in Yersinia pseudotuberculosis and Pseudomonas aeruginosa in cell-based infection models. In addition (-)-hopeaphenol reduced cell entry and subsequent intracellular growth of Chlamydia trachomatis.	[Zetterstrom, Caroline E.; Salin, Olli; Elofsson, Mikael] Umea Univ, Dept Chem, Labs Infect Med Sweden, Umea Ctr Microbial Res, Umea, Sweden; [Hasselgren, Jenny; Sundin, Charlotta] Creat Antibiot Sweden AB, Umea, Sweden; [Salin, Olli] Umea Univ, Dept Clin Microbiol, Umea, Sweden; [Davis, Rohan A.; Quinn, Ronald J.] Griffith Univ, Eskitis Inst, Brisbane, Qld 4111, Australia; [Elofsson, Mikael] Umea Univ, Dept Chem, Labs Chem Biol Umea, Umea, Sweden	Umea University; Umea University; Griffith University; Umea University	Sundin, C (corresponding author), UmanDiagnost AB, Umea, Sweden.	charlotta.sundin@chem.umu.se; mikael.elofsson@chem.umu.se	Quinn, Ronald J/A-7931-2008; Davis, Rohan A/B-1689-2008	Quinn, Ronald J/0000-0002-4022-2623; Davis, Rohan A/0000-0003-4291-7573; Elofsson, Mikael/0000-0002-3219-4669	Swedish Research Council; Kempe Foundations; Australian Research Council [LP120200339]; ARC [LE0668477, LE0237908]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe Foundations; Australian Research Council(Australian Research Council); ARC(Australian Research Council)	Funding provided by the Swedish Research Council, www.vr.se, The Kempe Foundations, www.kempe.com, The Australian Research Council (linkage grant # LP120200339, ARC Grant LE0668477 and LE0237908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello D, 2010, ANTIMICROB AGENTS CH, V54, P1988, DOI 10.1128/AAC.01598-09; Akopyan K, 2011, P NATL ACAD SCI USA, V108, P1639, DOI 10.1073/pnas.1013888108; Arnoldo A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000005; Bailey L, 2007, FEBS LETT, V581, P587, DOI 10.1016/j.febslet.2007.01.013; BODEY GP, 1983, REV INFECT DIS, V5, P279; BOLIN I, 1984, INFECT IMMUN, V43, P72; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Camp D, 2012, J NAT PROD, V75, P72, DOI 10.1021/np200687v; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Chu H, 2010, INT J ANTIMICROB AG, V36, P145, DOI 10.1016/j.ijantimicag.2010.03.018; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Dahlgren MK, 2007, J MED CHEM, V50, P6177, DOI 10.1021/jm070741b; Dahlgren MK, 2010, BIOORGAN MED CHEM, V18, P2686, DOI 10.1016/j.bmc.2010.02.022; Duncan MC, 2012, ANTIMICROB AGENTS CH, V56, P5433, DOI 10.1128/AAC.00975-12; Enquist PA, 2012, BIOORG MED CHEM LETT, V22, P3550, DOI 10.1016/j.bmcl.2012.03.096; Felise HB, 2008, CELL HOST MICROBE, V4, P325, DOI 10.1016/j.chom.2008.08.001; FORSBERG A, 1993, INFECT AGENT DIS, V2, P275; Forthal DN, 2012, INT J ANTIMICROB AG, V40, P354, DOI 10.1016/j.ijantimicag.2012.05.023; FRANK DW, 1994, INFECT IMMUN, V62, P554, DOI 10.1128/IAI.62.2.554-563.1994; Frank DW, 1997, MOL MICROBIOL, V26, P621, DOI 10.1046/j.1365-2958.1997.6251991.x; Garrity-Ryan LK, 2010, INFECT IMMUN, V78, P4683, DOI 10.1128/IAI.01305-09; Gauthier A, 2005, ANTIMICROB AGENTS CH, V49, P4101, DOI 10.1128/AAC.49.10.4101-4109.2005; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Harmon DE, 2010, ANTIMICROB AGENTS CH, V54, P3241, DOI 10.1128/AAC.00364-10; Heinzen RA, 1997, INFECT IMMUN, V65, P1088, DOI 10.1128/IAI.65.3.1088-1094.1997; Hillgren JM, 2012, ORG BIOMOL CHEM, V10, P1246, DOI 10.1039/c1ob06722b; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Iwatsuki M, 2008, J ANTIBIOT, V61, P222, DOI 10.1038/ja.2008.32; Iwatsuki M, 2008, J ANTIBIOT, V61, P230, DOI 10.1038/ja.2008.33; Kanj SS, 2011, MAYO CLIN PROC, V86, P250, DOI 10.4065/mcp.2010.0674; Kauppi AM, 2003, ADV EXP MED BIOL, V529, P97; Kauppi AM, 2003, CHEM BIOL, V10, P241, DOI 10.1016/S1074-5521(03)00046-2; Kauppi AM, 2007, BIOORGAN MED CHEM, V15, P6994, DOI 10.1016/j.bmc.2007.07.047; Keyser P, 2008, J INTERN MED, V264, P17, DOI 10.1111/j.1365-2796.2008.01941.x; Kimura K, 2010, J ANTIBIOT, P1; Kline T, 2012, CURR DRUG TARGETS, V13, P338, DOI 10.2174/138945012799424642; Kondratyuk TP, 2004, PHARM BIOL, V42, P46, DOI 10.3109/13880200490893519; Larzabal M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009046; Li Y, 2009, APPL ENVIRON MICROB, V75, P1223, DOI 10.1128/AEM.02015-08; Linington RG, 2006, J NAT PROD, V69, P173, DOI 10.1021/np050192h; Linington RG, 2002, ORG LETT, V4, P4089, DOI 10.1021/ol0268337; Liu JY, 2005, HELV CHIM ACTA, V88, P2910, DOI 10.1002/hlca.200590234; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Muschiol S, 2006, P NATL ACAD SCI USA, V103, P14566, DOI 10.1073/pnas.0606412103; Negrea A, 2007, ANTIMICROB AGENTS CH, V51, P2867, DOI 10.1128/AAC.00223-07; Nicolaou KC, 2009, ANGEW CHEM INT EDIT, V48, P3440, DOI 10.1002/anie.200900438; Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; Pan NJ, 2009, ANTIMICROB AGENTS CH, V53, P385, DOI 10.1128/AAC.00670-08; PARMEGGIANI A, 1985, ANNU REV MICROBIOL, V39, P557, DOI 10.1146/annurev.mi.39.100185.003013; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; SIEMANN EH, 1992, AM J ENOL VITICULT, V43, P49; Slepenkin A, 2011, J INFECT DIS, V204, P1313, DOI 10.1093/infdis/jir552; Snyder SA, 2007, ANGEW CHEM INT EDIT, V46, P8186, DOI 10.1002/anie.200703333; Snyder SA, 2009, J AM CHEM SOC, V131, P1753, DOI 10.1021/ja806183r; Svensson A, 2001, CHEMBIOCHEM, V2, P915, DOI 10.1002/1439-7633(20011203)2:12<915::AID-CBIC915>3.3.CO;2-D; Swietnicki W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019716; Tree JJ, 2009, INFECT IMMUN, V77, P4209, DOI 10.1128/IAI.00562-09; Tsou LK, 2013, MEDCHEMCOMM, V4, P68, DOI 10.1039/c2md20213a; Ur-Rehman T, 2012, ADV EXP MED BIOL, V954, P349, DOI 10.1007/978-1-4614-3561-7_42; Veenendaal AKJ, 2009, J BACTERIOL, V191, P563, DOI 10.1128/JB.01004-08; Wang D, 2011, J BIOL CHEM, V286, P29922, DOI 10.1074/jbc.M111.233858; Wolf K, 2006, MOL MICROBIOL, V61, P1543, DOI 10.1111/j.1365-2958.2006.05347.x; Yamazaki A, 2012, ANTIMICROB AGENTS CH, V56, P36, DOI 10.1128/AAC.00732-11; Yang F, 2013, MOL PLANT PATHOL, DOI [10.1111/mpp.12064, DOI 10.1111/MPP.12064.PUBMED:23915008]; Yin S, 2011, ORG BIOMOL CHEM, V9, P6755, DOI 10.1039/c1ob05581j	69	55	56	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81969	10.1371/journal.pone.0081969	http://dx.doi.org/10.1371/journal.pone.0081969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324737	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300118
J	Liu, WH; Xu, JM; Wu, SP; Liu, YL; Yu, XP; Chen, J; Tang, X; Wang, Z; Zhu, XH; Li, X				Liu, Weihua; Xu, Jinmei; Wu, Shaoping; Liu, Yilun; Yu, Xiaoping; Chen, Juan; Tang, Xi; Wang, Zhi; Zhu, Xiaohu; Li, Xin			Selective Anti-Proliferation of HER2-Positive Breast Cancer Cells by Anthocyanins Identified by High-Throughput Screening	PLOS ONE			English	Article							METHYL PROTODIOSCIN; LEONURINE PROTECTS; CYCLE ARREST; ANTIOXIDANT; QUERCETIN; PHENOLICS; PIGMENTS; LINES	Overexpressed Human epidermal growth factor receptor 2 (HER2) drives the biology of 20% breast cancer and is a prediction of a poor prognosis for patients. HER2-targeted therapies significantly improve outcomes for HER2-positive patients. Traditional Chinese herbs/medicines have been used to treat breast cancer patients including HER2-positive patients in Asia for decades. Although the traditional medicines demonstrate efficacy in clinics for HER2-positive patients, the mechanism is largely unknown. In this article, we screened a 10,000 natural product library in 6 different cell lines representing breast cancer, and assessed the ability of each drug to cause cytotoxicity through a high-throughput screening approach. We have identified eight natural compounds that selectively inhibit the proliferation of HER2-positive cells. Two of the hit compounds, peonidin-3-glucoside and cyaniding-3-glucoside, are both extracts from black rice. They inhibit the phospho-HER2 and phospho-AKT and were confirmed to induce HER2-psotive breast cancer cells apoptosis both in vitro and in vivo. Peonidin-3-glucoside and cyaniding-3-glucoside treatments significantly reduced the tumor size and volume in vivo compared to the control group. There is no significant difference of antitumorgenic effects between peonidin-3-glucoside and cyaniding-3-glucoside treatments.	[Liu, Weihua; Xu, Jinmei; Wu, Shaoping; Liu, Yilun; Tang, Xi; Wang, Zhi] Chengdu Med Coll, Affiliated Hosp 1, Dept Sci Res, Chengdu, Sichuan Provinc, Peoples R China; [Yu, Xiaoping] Chengdu Med Coll, Dept Publ Hlth, Chengdu, Sichuan Provinc, Peoples R China; [Zhu, Xiaohu] Chengdu Med Coll, Affiliated Hosp 1, Dept Med Image, Chengdu, Sichuan Provinc, Peoples R China; [Li, Xin] Chengdu Med Coll, Adm Off, Chengdu, Sichuan Provinc, Peoples R China; [Chen, Juan] Xindu Hosp Tradit Chinese Med, Dept Acupuncture & Moxibust, Chengdu, Sichuan Provinc, Peoples R China	Chengdu Medical College; Chengdu Medical College; Chengdu Medical College; Chengdu Medical College	Li, X (corresponding author), Chengdu Med Coll, Adm Off, Chengdu, Sichuan Provinc, Peoples R China.	xinlijournal@live.com	liu, yi/GXE-9662-2022		Sichuan Province Health Bureau [110465]; National Natural Science Foundation of China [81273074]	Sichuan Province Health Bureau; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Sichuan Province Health Bureau (110465) and by the National Natural Science Foundation of China (81273074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Z, 2013, NAT PROD COMMUN, V8, P323; Bunea A, 2013, PHYTOCHEMISTRY; Calero C. I., 2013, EUR J PHARM, DOI 10.1016/j.ejphar.2013.07.044; Cao X, 2010, PHARMAZIE, V65, P359, DOI 10.1691/ph.2010.9785; Chen XQ, 2012, FOOD CHEM, V135, P2783, DOI 10.1016/j.foodchem.2012.06.098; Dong Z, 2013, PHYTOMEDICINE, V20, P1023, DOI 10.1016/j.phymed.2013.04.007; Feng Y, 2013, BIOMED CHROMATOGR; Fernandes I, 2013, FOOD CHEM, V141, P2923, DOI 10.1016/j.foodchem.2013.05.033; Fernandes I, 2010, J AGR FOOD CHEM, V58, P3785, DOI 10.1021/jf903714z; Heinonen M, 2007, MOL NUTR FOOD RES, V51, P684, DOI 10.1002/mnfr.200700006; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Hu K, 1997, PLANTA MED, V63, P161, DOI 10.1055/s-2006-957636; Hu K, 2003, CANCER INVEST, V21, P389, DOI 10.1081/CNV-120018230; Hu Y, 2013, J ETHNOPHARMACOL; Huang C, 2013, J AGR FOOD CHEM, V61, P6430, DOI 10.1021/jf305253m; Inglese J, 2007, NAT CHEM BIOL, V3, P438, DOI 10.1038/nchembio0807-438; Iriti M, 2013, NUTRIENTS, V5, P2564, DOI 10.3390/nu5072564; Kamenickova A, 2013, TOXICOL LETT, V221, P1, DOI 10.1016/j.toxlet.2013.05.007; Kapoor S, 2013, J PEDIAT HEMATOL ONC; Kubesova HM, 2013, WIEN KLIN WOCHENSCHR; Lee DE, 2013, J FOOD SCI; Liang M, 2010, BIOCONJUGATE CHEM, V21, P1385, DOI 10.1021/bc100081h; Liu HC, 2012, BRAIN RES, V1474, P73, DOI 10.1016/j.brainres.2012.07.028; Liu XH, 2013, FREE RADICAL BIO MED, V54, P93, DOI 10.1016/j.freeradbiomed.2012.10.555; Liu XH, 2012, ATHEROSCLEROSIS, V222, P34, DOI 10.1016/j.atherosclerosis.2011.04.027; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Moffett BS, 2013, INT J CLIN PHARM; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Norata GD, 2012, ATHEROSCLEROSIS, V224, P37, DOI 10.1016/j.atherosclerosis.2012.02.036; Pungitore CR, 2007, BIOORG MED CHEM LETT, V17, P1332, DOI 10.1016/j.bmcl.2006.11.086; Sand CR, 2013, ARQ BRAS CARDIOL; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Vrbic S, 2013, J BUON, V18, P4; Wang G, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.242; Wang G, 2006, CANCER LETT, V241, P102, DOI 10.1016/j.canlet.2005.10.050; Wang Z, 2001, BIOL PHARM BULL, V24, P159, DOI 10.1248/bpb.24.159; Wu Xue-Qing, 2012, Zhongguo Zhong Xi Yi Jie He Za Zhi, V32, P1526; Ziegler RG, 2008, J NATL CANCER I, V100, P1339, DOI 10.1093/jnci/djn330	38	27	28	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81586	10.1371/journal.pone.0081586	http://dx.doi.org/10.1371/journal.pone.0081586			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312561	Green Published, gold, Green Submitted			2022-12-25	WOS:000327947800050
J	Mukherjee, D; Botelho, D; Gow, AJ; Zhang, JF; Georgopoulos, PG				Mukherjee, Dwaipayan; Botelho, Danielle; Gow, Andrew J.; Zhang, Junfeng; Georgopoulos, Panos G.			Computational Multiscale Toxicodynamic Modeling of Silver and Carbon Nanoparticle Effects on Mouse Lung Function	PLOS ONE			English	Article							SURFACTANT PROTEIN-A; PULMONARY SURFACTANT; ALVEOLAR MACROPHAGES; MATHEMATICAL-MODEL; LAMELLAR BODIES; IN-VITRO; II CELLS; SECRETION; PHOSPHATIDYLCHOLINE; SIZE	A computational, multiscale toxicodynamic model has been developed to quantify and predict pulmonary effects due to uptake of engineered nanomaterials (ENMs) in mice. The model consists of a collection of coupled toxicodynamic modules, that were independently developed and tested using information obtained from the literature. The modules were developed to describe the dynamics of tissue with explicit focus on the cells and the surfactant chemicals that regulate the process of breathing, as well as the response of the pulmonary system to xenobiotics. Alveolar type I and type II cells, and alveolar macrophages were included in the model, along with surfactant phospholipids and surfactant proteins, to account for processes occurring at multiple biological scales, coupling cellular and surfactant dynamics affected by nanoparticle exposure, and linking the effects to tissue-level lung function changes. Nanoparticle properties such as size, surface chemistry, and zeta potential were explicitly considered in modeling the interactions of these particles with biological media. The model predictions were compared with in vivo lung function response measurements in mice and analysis of mice lung lavage fluid following exposures to silver and carbon nanoparticles. The predictions were found to follow the trends of observed changes in mouse surfactant composition over 7 days post dosing, and are in good agreement with the observed changes in mouse lung function over the same period of time.	[Mukherjee, Dwaipayan; Georgopoulos, Panos G.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Environm & Occupat Med, Piscataway, NJ 08854 USA; [Mukherjee, Dwaipayan; Georgopoulos, Panos G.] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA; [Botelho, Danielle; Gow, Andrew J.] Rutgers State Univ, Dept Pharmacol & Toxicol, Piscataway, NJ 08854 USA; [Zhang, Junfeng] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Southern California	Georgopoulos, PG (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Environm & Occupat Med, Piscataway, NJ 08854 USA.	panosg@ccl.rutgers.edu	Gow, Andrew/N-8566-2013; Mukherjee, Dwaipayan/AAN-6736-2020; Gow, Andrew/AAR-2309-2020; Zhang, Junfeng/AAJ-9183-2020	Gow, Andrew/0000-0003-0876-5158; Mukherjee, Dwaipayan/0000-0002-3918-3188; Gow, Andrew/0000-0003-0876-5158; Zhang, Junfeng/0000-0003-3759-6672	NIEHS [U19ES019536-01]; NIEHS at EOHSI [NIEHS P30E5S005022]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007148, U19ES019536, P30ES005022] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS at EOHSI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Support for this work has been primarily provided by the NIEHS funded RESAC Center (Respiratory Effects of Silver and Carbon Nanomaterials - Grant Number U19ES019536-01). Additional support has been provided by the NIEHS sponsored Center for Environmental Exposures and Disease (CEED - Grant Number NIEHS P30E5S005022) at EOHSI. This work has not been reviewed by and does not represent the opinions of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva AV, 2007, AM J PHYSIOL-LUNG C, V293, pL259, DOI 10.1152/ajplung.00112.2007; ARCHIE JP, 1968, DIS CHEST, V53, P759; ARCHIE JP, 1973, INT J ENG SCI, V11, P659, DOI 10.1016/0020-7225(73)90027-X; Bakshi MS, 2008, BIOPHYS J, V94, P855, DOI 10.1529/biophysj.107.106971; BASTACKY J, 1995, J APPL PHYSIOL, V79, P1615, DOI 10.1152/jappl.1995.79.5.1615; Bates SR, 2003, AM J PHYSIOL-LUNG C, V285, pL1055, DOI 10.1152/ajplung.00271.2002; Beduneau A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004343; Bourbon J, 1991, PULMONARY SURFACXTAN; Chen JW, 2004, LAB INVEST, V84, P727, DOI 10.1038/labinvest.3700095; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Clegg GR, 2005, AM J PHYSIOL-LUNG C, V289, pL382, DOI 10.1152/ajplung.00476.2004; Fisher AB, 2010, AM J PHYSIOL-LUNG C, V299, pL51, DOI 10.1152/ajplung.00066.2010; FROH D, 1993, AM J RESP CELL MOL, V8, P556, DOI 10.1165/ajrcmb/8.5.556; Goerke J, 1998, BBA-MOL BASIS DIS, V1408, P79, DOI 10.1016/S0925-4439(98)00060-X; Gurel O, 2001, AM J PHYSIOL-LUNG C, V280, pL1266, DOI 10.1152/ajplung.2001.280.6.L1266; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Harush-Frenkel O, 2007, BIOCHEM BIOPH RES CO, V353, P26, DOI 10.1016/j.bbrc.2006.11.135; HAWGOOD S, 1985, BIOCHEMISTRY-US, V24, P184, DOI 10.1021/bi00322a026; HAWGOOD S, 1991, ANNU REV PHYSIOL, V53, P375, DOI 10.1146/annurev.ph.53.030191.002111; HILDEBRA.J, 1970, J APPL PHYSIOL, V28, P365, DOI 10.1152/jappl.1970.28.3.365; Jang Jiyoung, 2010, Immune Netw, V10, P85, DOI 10.4110/in.2010.10.3.85; JOHANSSON J, 1994, EUR RESPIR J, V7, P372, DOI 10.1183/09031936.94.07020372; Kemp SJ, 2008, AM J RESP CELL MOL, V39, P591, DOI 10.1165/rcmb.2007-0334OC; Kendall M, 2004, INHAL TOXICOL, V16, P99, DOI 10.1080/08958370490443187; Knust J, 2009, ANAT REC, V292, P113, DOI 10.1002/ar.20747; Kubota Y, 1999, CLIN DIAGN LAB IMMUN, V6, P452, DOI 10.1128/CDLI.6.4.452-456.1999; Lai YR, 2008, NANOSCALE RES LETT, V3, P321, DOI 10.1007/s11671-008-9160-2; Love SA, 2012, ANNU REV ANAL CHEM, V5, P181, DOI 10.1146/annurev-anchem-062011-143134; Martini WZ, 1999, AM J PHYSIOL-ENDOC M, V277, pE187, DOI 10.1152/ajpendo.1999.277.1.E187; Meyer KC, 2000, CHEST, V118, P164, DOI 10.1378/chest.118.1.164; MOESSINGER AC, 1990, J CLIN INVEST, V86, P1270, DOI 10.1172/JCI114834; MORGAN A, 1992, ENVIRON HEALTH PERSP, V97, P177, DOI 10.2307/3431350; Muller B, 2003, THORAX, V58, P127, DOI 10.1136/thorax.58.2.127; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; NOTTER RH, 2000, LUNG BIOL HLTH DIS, V149; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; OOSTERLAKENDIJKSTERHUIS MA, 1991, BIOCHEM J, V274, P115, DOI 10.1042/bj2740115; OTIS AB, 1956, J APPL PHYSIOL, V8, P427, DOI 10.1152/jappl.1956.8.4.427; PETTENAZZO A, 1988, J APPL PHYSIOL, V65, P2151, DOI 10.1152/jappl.1988.65.5.2151; Possmayer F, 2001, COMP BIOCHEM PHYS A, V129, P209, DOI 10.1016/S1095-6433(01)00317-8; Raabe OG, 1988, ANN OCCUP HYG, V32, P53, DOI DOI 10.1093/ANNHYG/32.INHALED_; ROBERTSON B, 1992, PULMONARY SURFACTANT; ROONEY SA, 1994, FASEB J, V8, P957, DOI 10.1096/fasebj.8.12.8088461; Rudiger M, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-40; Ruge CA, 2011, NANOMED-NANOTECHNOL, V7, P690, DOI 10.1016/j.nano.2011.07.009; Schleh Carsten, 2009, Inhal Toxicol, V21 Suppl 1, P97, DOI 10.1080/08958370903005744; SHELLEY SA, 1975, J LIPID RES, V16, P224; SIMIONESCU D, 1983, MICROVASC RES, V25, P85, DOI 10.1016/0026-2862(83)90045-6; Su D, 2010, MED BIOL ENG COMPUT, V48, P853, DOI 10.1007/s11517-010-0615-0; SUZUKI Y, 1989, AM REV RESPIR DIS, V140, P75, DOI 10.1164/ajrccm/140.1.75; TABATA Y, 1988, BIOMATERIALS, V9, P356, DOI 10.1016/0142-9612(88)90033-6; Takenaka S, 2001, ENV HLTH PERSPECT S4, V109; Thamrin C, 2004, ANN BIOMED ENG, V32, P815, DOI 10.1023/B:ABME.0000030257.88945.81; Walters RW, 2000, BIOPHYS J, V78, P257, DOI 10.1016/S0006-3495(00)76589-1; Wijnhoven SWP, 2009, NANOTOXICOLOGY, V3, P109, DOI 10.1080/17435390902725914; WRIGHT JR, 1991, ANNU REV PHYSIOL, V53, P395, DOI 10.1146/annurev.physiol.53.1.395; Wu L, 2008, MED PHYS, V35, P3759, DOI 10.1118/1.2952647; YOUNG SL, 1981, J APPL PHYSIOL, V51, P248, DOI 10.1152/jappl.1981.51.2.248	58	8	8	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e80917	10.1371/journal.pone.0080917	http://dx.doi.org/10.1371/journal.pone.0080917			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312506	Green Submitted, gold, Green Published			2022-12-25	WOS:000327947800024
J	Sardar, T; Mukhopadhyay, S; Bhowmick, AR; Chattopadhyay, J				Sardar, Tridip; Mukhopadhyay, Soumalya; Bhowmick, Amiya Ranjan; Chattopadhyay, Joydev			An Optimal Cost Effectiveness Study on Zimbabwe Cholera Seasonal Data from 2008-2011	PLOS ONE			English	Article							INFECTIOUS-DISEASE; ENDEMIC CHOLERA; VIBRIO-CHOLERAE; GLOBAL CLIMATE; EPIDEMIC; DYNAMICS; STRATEGIES; VACCINE; SPREAD; TRENDS	Incidence of cholera outbreak is a serious issue in underdeveloped and developing countries. In Zimbabwe, after the massive outbreak in 2008-09, cholera cases and deaths are reported every year from some provinces. Substantial number of reported cholera cases in some provinces during and after the epidemic in 2008-09 indicates a plausible presence of seasonality in cholera incidence in those regions. We formulate a compartmental mathematical model with periodic slow-fast transmission rate to study such recurrent occurrences and fitted the model to cumulative cholera cases and deaths for different provinces of Zimbabwe from the beginning of cholera outbreak in 2008-09 to June 2011. Daily and weekly reported cholera incidence data were collected from Zimbabwe epidemiological bulletin, Zimbabwe Daily cholera updates and Office for the Coordination of Humanitarian Affairs Zimbabwe (OCHA, Zimbabwe). For each province, the basic reproduction number (R-0) in periodic environment is estimated. To the best of our knowledge, this is probably a pioneering attempt to estimate R-0 in periodic environment using real-life data set of cholera epidemic for Zimbabwe. Our estimates of R-0 agree with the previous estimate for some provinces but differ significantly for Bulawayo, Mashonaland West, Manicaland, Matabeleland South and Matabeleland North. Seasonal trend in cholera incidence is observed in Harare, Mashonaland West, Mashonaland East, Manicaland and Matabeleland South. Our result suggests that, slow transmission is a dominating factor for cholera transmission in most of these provinces. Our model projects 6340(5565-7264) cholera cases and 271(238-309) cholera deaths during the end of the epidemic in 2008-09 to January 1, 2012. We also determine an optimal cost-effective control strategy among the four government undertaken interventions namely promoting hand-hygiene & clean water distribution, vaccination, treatment and sanitation for each province.	[Sardar, Tridip; Bhowmick, Amiya Ranjan; Chattopadhyay, Joydev] Indian Stat Inst, Agr & Ecol Res Unit, Kolkata, W Bengal, India; [Mukhopadhyay, Soumalya] Visva Bharati Univ, Dept Stat, Santini Ketan, W Bengal, India	Indian Statistical Institute; Indian Statistical Institute Kolkata; Visva Bharati University	Chattopadhyay, J (corresponding author), Indian Stat Inst, Agr & Ecol Res Unit, Kolkata, W Bengal, India.	joydev@isical.ac.in	Bhowmick, Amiya R/T-3754-2019; Mukhopadhyay, Soumalya/AAV-3210-2020	Bhowmick, Amiya R/0000-0002-7124-2213; sardar, tridip/0000-0002-5172-2412	Council of Scientific and Industrial Research (CSIR), Government of India	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	Tridip Sardar and Amiya Ranjan Bhowmick are supported by a research fellowship from Council of Scientific and Industrial Research (CSIR), Government of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2006, APPL ENVIRON MICROB, V72, P4096, DOI 10.1128/AEM.00066-06; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; ANDERSON R M, 1991; ANDERSON RM, 1982, SCIENCE, V215, P1053, DOI 10.1126/science.7063839; Andrews JR, 2011, LANCET, V377, P1248, DOI 10.1016/S0140-6736(11)60273-0; [Anonymous], 2008, DAILY NEWS 1219; Bouma MJ, 2001, HYDROBIOLOGIA, V460, P147, DOI 10.1023/A:1013165215074; Chaignat CL, 2007, J HEALTH POPUL NUTR, V25, P244; Chowell G, 2007, MATH BIOSCI ENG, V4, P457, DOI 10.3934/mbe.2007.4.457; Codeco CT, 2001, BMC INFECT DIS, V1, DOI 10.1186/1471-2334-1-1; Colwell R, 2001, HYDROBIOLOGIA, V460, P141, DOI 10.1023/A:1013111016642; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Cyranoski D, 2011, NATURE, V469, P273, DOI 10.1038/469273a; Dodge E, 2011, WATER SANITATION REL; EPSTEIN PR, 1993, BIOSYSTEMS, V31, P209, DOI 10.1016/0303-2647(93)90050-M; Farmer P, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001145; Geweke J.F., 1991, EVALUATING ACCURACY; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; Hartley DM, 2006, PLOS MED, V3, P63, DOI 10.1371/journal.pmed.0030007; Huq A., 1996, Eastern Mediterranean Health Journal, V2, P37; ISLAM MS, 1994, J DIARRHOEAL DIS RES, V12, P245; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Keeling M.J., 2008, MODELLING INFECT DIS; King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084; Kirigia JM, 2009, BMC INT HEALTH HUM R, V9, P1; Kirk D. E, 2004, OPTIMAL CONTROL THEO; Laine M, 2008, FINNISH METEOROLOGIC, V69, P1; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; Longini IM, 2002, J INFECT DIS, V186, P246, DOI 10.1086/341206; Magny GC, 2012, PLOS ONE, V7, P1; Magombeyi MS, 2012, J ENV SCI WATER RESO, V1, P251; Merrell DS, 2002, NATURE, V417, P642, DOI 10.1038/nature00778; Mudzengerere F.H., 2012, J SUSTAINABLE DEV AF, V14, P228; Mukandavire Z, 2011, P NATL ACAD SCI USA, V108, P8767, DOI 10.1073/pnas.1019712108; Naficy A, 1998, JAMA-J AM MED ASSOC, V279, P521, DOI 10.1001/jama.279.7.521; Neilan RLM, 2010, B MATH BIOL, V72, P2004, DOI 10.1007/s11538-010-9521-8; Nelson EJ, 2011, NEW ENGL J MED, V364, P5, DOI 10.1056/NEJMp1013771; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Pascual M, 2002, MICROBES INFECT, V4, P237, DOI 10.1016/S1286-4579(01)01533-7; Pontryagin LS, 1967, MATH THEORY OPTICAL; RAHAMAN MM, 1976, ANTIMICROB AGENTS CH, V10, P610, DOI 10.1128/AAC.10.4.610; Rinaldo A, 2012, P NATL ACAD SCI USA, V109, P6602, DOI 10.1073/pnas.1203333109; ROGER JH, 1977, BIOMETRIKA, V64, P152, DOI 10.2307/2335789; Sack RB, 2003, J INFECT DIS, V187, P96, DOI 10.1086/345865; Saha D, 2006, NEW ENGL J MED, V354, P2452, DOI 10.1056/NEJMoa054493; Schaetti C, 2012, PLOS NEGLECT TROP D, V6, P1; United Nations Department of Humanitarian Affairs, 2008, DAIL CHOL UPD 24 NOV; United Nations Department of Humanitarian Affairs, 2009, ZIMB MONTHL SIT REP; Wang WD, 2008, J DYN DIFFER EQU, V20, P699, DOI 10.1007/s10884-008-9111-8; WHO, 2008, CHOL ZIMB EP B, V1-117; World Health Organization, 2009, ZIMB CHOL CONTR GUID; World Health Organization, 2009, GLOB TASK FORC CHOL; World Health Organization, 2009, EPIDEMIOLOGICAL B, V5; World Health Organization, 2011, ZIMB WEEKL EP B, V135	55	25	25	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81231	10.1371/journal.pone.0081231	http://dx.doi.org/10.1371/journal.pone.0081231			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312540	Green Published, Green Submitted, gold			2022-12-25	WOS:000327947800042
J	Bastani, M; Vos, L; Asgarian, N; Deschenes, J; Graham, K; Mackey, J; Greiner, R				Bastani, Meysam; Vos, Larissa; Asgarian, Nasimeh; Deschenes, Jean; Graham, Kathryn; Mackey, John; Greiner, Russell			A Machine Learned Classifier That Uses Gene Expression Data to Accurately Predict Estrogen Receptor Status	PLOS ONE			English	Article							BREAST-CANCER; MOLECULAR PORTRAITS; PROGNOSIS; CHEMOTHERAPY; RELEVANCE; PROFILES; SURVIVAL; GATA3	Background: Selecting the appropriate treatment for breast cancer requires accurately determining the estrogen receptor (ER) status of the tumor. However, the standard for determining this status, immunohistochemical analysis of formalin-fixed paraffin embedded samples, suffers from numerous technical and reproducibility issues. Assessment of ER-status based on RNA expression can provide more objective, quantitative and reproducible test results. Methods: To learn a parsimonious RNA-based classifier of hormone receptor status, we applied a machine learning tool to a training dataset of gene expression microarray data obtained from 176 frozen breast tumors, whose ER-status was determined by applying ASCO-CAP guidelines to standardized immunohistochemical testing of formalin fixed tumor. Results: This produced a three-gene classifier that can predict the ER-status of a novel tumor, with a cross-validation accuracy of 93.17 +/- 2.44%. When applied to an independent validation set and to four other public databases, some on different platforms, this classifier obtained over 90% accuracy in each. In addition, we found that this prediction rule separated the patients' recurrence-free survival curves with a hazard ratio lower than the one based on the IHC analysis of ER-status. Conclusions: Our efficient and parsimonious classifier lends itself to high throughput, highly accurate and low-cost RNA-based assessments of ER-status, suitable for routine high-throughput clinical use. This analytic method provides a proof-of-principle that may be applicable to developing effective RNA-based tests for other biomarkers and conditions.	[Bastani, Meysam; Asgarian, Nasimeh; Greiner, Russell] Univ Alberta, Dept Computing Sci, Edmonton, AB, Canada; [Vos, Larissa; Graham, Kathryn; Mackey, John] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Asgarian, Nasimeh; Greiner, Russell] Alberta Innovates Ctr Machine Learning, Edmonton, AB, Canada; [Deschenes, Jean] Univ Alberta, Dept Pathol & Lab Med, Edmonton, AB, Canada; [Deschenes, Jean; Graham, Kathryn; Mackey, John] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada	University of Alberta; University of Alberta; Alberta Innovates; University of Alberta; University of Alberta	Greiner, R (corresponding author), Univ Alberta, Dept Computing Sci, Edmonton, AB, Canada.	rgreiner@ualberta.ca	Greiner, Russell/AAQ-4502-2020	Greiner, Russell/0000-0001-8327-934X; Deschenes, Jean/0000-0001-5226-791X	Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Centre for Machine Learning; Alberta Cancer Foundation; Canadian Breast Cancer Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Centre for Machine Learning; Alberta Cancer Foundation; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	Funding for this project was provided by The Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca/index_eng.asp), Alberta Innovates Centre for Machine Learning (www.aicml.ca), Alberta Cancer Foundation (http://albertacancer.ca) and the Canadian Breast Cancer Foundation (www.cbcf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Cameron MA, 2009, COMMISSION INQUIRY H; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Germain DR, 2011, BREAST CANCER RES TR, V127, P53, DOI 10.1007/s10549-010-0943-7; Gong Y, 2007, PHARMACOGENOMICS, V8, P1359, DOI 10.2217/14622416.8.10.1359; Gong Y, 2007, LANCET ONCOL, V8, P203, DOI 10.1016/S1470-2045(07)70042-6; Gruvberger S, 2001, CANCER RES, V61, P5979; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; Herbrich R., 2002, LEARNING KERNEL CLAS; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Huang E, 2003, RECENT PROG HORM RES, V58, P55, DOI 10.1210/rp.58.1.55; Jumppanen M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1649; Kun Y, 2003, HUM MOL GENET, V12, P3245, DOI 10.1093/hmg/ddg347; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mehra R, 2005, CANCER RES, V65, P11259, DOI 10.1158/0008-5472.CAN-05-2495; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; Paik S, 2006, CURR OPIN OBSTET GYN, V18, P59, DOI 10.1097/01.gco.0000192970.52320.29; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sabatier R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027656; SLAMON DJ, 1987, NEW ENGL J MED, V317, P955, DOI 10.1056/NEJM198710083171509; Smid M, 2006, J CLIN ONCOL, V24, P2261, DOI 10.1200/JCO.2005.03.8802; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Stabach PR, 2005, J SURG RES, V126, P86, DOI 10.1016/j.jss.2005.02.006; Stretch C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065380; Takahashi S, 2008, CANCER SCI, V99, P324, DOI 10.1111/j.1349-7006.2007.00691.x; Thomas MC, 2006, ELEMENTS INFORM THEO; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Witten IH, 2011, MOR KAUF D, P1	44	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82144	10.1371/journal.pone.0082144	http://dx.doi.org/10.1371/journal.pone.0082144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312637	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500121
J	Brimijoin, WO; Boyd, AW; Akeroyd, MA				Brimijoin, W. Owen; Boyd, Alan W.; Akeroyd, Michael A.			The Contribution of Head Movement to the Externalization and Internalization of Sounds	PLOS ONE			English	Article							HEADPHONE SIMULATION; LOCALIZATION; HEARING; CUES; REVERBERATION; VENTRILOQUISM; PERCEPTION; LISTENERS; SPEECH	Background: When stimuli are presented over headphones, they are typically perceived as internalized; i.e., they appear to emanate from inside the head. Sounds presented in the free-field tend to be externalized, i.e., perceived to be emanating from a source in the world. This phenomenon is frequently attributed to reverberation and to the spectral characteristics of the sounds: those sounds whose spectrum and reverberation matches that of free-field signals arriving at the ear canal tend to be more frequently externalized. Another factor, however, is that the virtual location of signals presented over headphones moves in perfect concert with any movements of the head, whereas the location of free-field signals moves in opposition to head movements. The effects of head movement have not been systematically disentangled from reverberation and/or spectral cues, so we measured the degree to which movements contribute to externalization. Methodology/Principal Findings: We performed two experiments: 1) Using motion tracking and free-field loudspeaker presentation, we presented signals that moved in their spatial location to match listeners' head movements. 2) Using motion tracking and binaural room impulse responses, we presented filtered signals over headphones that appeared to remain static relative to the world. The results from experiment 1 showed that free-field signals from the front that move with the head are less likely to be externalized (23%) than those that remain fixed (63%). Experiment 2 showed that virtual signals whose position was fixed relative to the world are more likely to be externalized (65%) than those fixed relative to the head (20%), regardless of the fidelity of the individual impulse responses. Conclusions/Significance: Head movements play a significant role in the externalization of sound sources. These findings imply tight integration between binaural cues and self motion cues and underscore the importance of self motion for spatial auditory perception.	[Brimijoin, W. Owen; Boyd, Alan W.; Akeroyd, Michael A.] MRC, Inst Hearing Res, Scottish Sect, Glasgow, Lanark, Scotland		Brimijoin, WO (corresponding author), MRC, Inst Hearing Res, Scottish Sect, Glasgow, Lanark, Scotland.	owen@ihr.gla.ac.uk	Akeroyd, Michael A/N-3978-2014	Akeroyd, Michael A/0000-0002-7182-9209; Brimijoin, W. Owen/0000-0001-6124-3987	Medical Research Council [U135097131]; Chief Scientist Office (Scotland); Medical Research Council [MC_U135097131] Funding Source: researchfish; Chief Scientist Office [IHR] Funding Source: researchfish; MRC [MC_U135097131] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office (Scotland); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by intramural funding from the Medical Research Council (U135097131) [www.mrc.ac.uk] and the Chief Scientist Office (Scotland) [http://www.cso.scot.nhs.uk/]. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGAULT DR, 1993, HUM FACTORS, V35, P361, DOI 10.1177/001872089303500210; Begault DR, 2001, J AUDIO ENG SOC, V49, P904; BEGAULT DR, 1992, J AUDIO ENG SOC, V40, P895; Berdahl EJ, 2007, TRANSFER FUNCTION ME; Blauert J., 1997, SPATIAL HEARING PSYC; Boyd AW, 2012, J ACOUST SOC AM, V131, pEL268, DOI 10.1121/1.3687015; Brimijoin WO, 2012, I-PERCEPTION, V3, P179, DOI 10.1068/i7173sas; Brindza J, 2009, FRONT ED C 2009 FIE, P1, DOI [10.1109/FIE.2009.5350509, DOI 10.1109/FIE.2009.5350509]; Durlach N. I., 1992, PRESENCE, V1, P251, DOI [10.1162/pres.1992.1.2.251, DOI 10.1162/PRES.1992.1.2.251]; Hartmann WM, 1996, J ACOUST SOC AM, V99, P3678, DOI 10.1121/1.414965; JACK CE, 1973, PERCEPT MOTOR SKILL, V37, P967, DOI 10.2466/pms.1973.37.3.967; JONGKEES L B, 1958, Acta Otolaryngol, V49, P119, DOI 10.3109/00016485809134735; Kawaura J., 1991, Journal of the Acoustical Society of Japan (E), V12, P203, DOI 10.1250/ast.12.203; Kim C, 2013, J AUDIO ENG SOC, V61, P425; Kim SM, 2005, J ACOUST SOC AM, V117, P3657, DOI 10.1121/1.1921548; KLENSCH H, 1948, PFLUG ARCH GES PHYS, V250, P492, DOI 10.1007/BF00369954; KONIG G, 1955, Arch Ohren Nasen Kehlkopfheilkd, V167, P303, DOI 10.1007/BF02107754; Kulkarni A, 1998, NATURE, V396, P747, DOI 10.1038/25526; Kulkarni A, 2000, J ACOUST SOC AM, V107, P1071, DOI 10.1121/1.428571; LEVY E T, 1978, Journal of Auditory Research, V18, P41; LOOMIS JM, 1990, J ACOUST SOC AM, V88, P1757, DOI 10.1121/1.400250; Minnaar P, 2001, INT C AUD DISPL ESP; Munsterberg H, 1894, PSYCHOL REV, V1, P461; Noble W, 2006, INT J AUDIOL, V45, P172, DOI 10.1080/14992020500376933; Ohl B, 2010, FORTSCHRITTE AKUSTIK, P136; Perrett S, 1997, PERCEPT PSYCHOPHYS, V59, P1018, DOI 10.3758/BF03205517; PLENGE G, 1972, ACUSTICA, V26, P241; PLENGE G, 1974, J ACOUST SOC AM, V56, P944, DOI 10.1121/1.1903353; RADEAU M, 1977, PERCEPT PSYCHOPHYS, V22, P137, DOI 10.3758/BF03198746; SAKAMOTO N, 1976, J AUDIO ENG SOC, V24, P711; Schirmer W, 1966, ACUSTICA, V18, P228; Sone T, 1968, 6 ICA, V3-6, pA29; Speigle J. M., 1993, Proceedings IEEE 1993 Symposium on Research Frontiers in Virtual Reality (Cat. No.93TH0585-0), P92, DOI 10.1109/VRAIS.1993.378257; THURLOW WR, 1967, J ACOUST SOC AM, V42, P489, DOI 10.1121/1.1910605; TOOLE FE, 1970, J ACOUST SOC AM, V48, P943, DOI 10.1121/1.1912233; Wallach H, 1940, J EXP PSYCHOL, V27, P339, DOI 10.1037/h0054629; WENZEL EM, 1993, J ACOUST SOC AM, V94, P111, DOI 10.1121/1.407089; Wightman FL, 1999, J ACOUST SOC AM, V105, P2841, DOI 10.1121/1.426899; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P868, DOI 10.1121/1.397558; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P858, DOI 10.1121/1.397557; Young PT, 1931, J EXP PSYCHOL, V14, P95, DOI 10.1037/h0075721; Zahorik P, 2005, ACTA ACUST UNITED AC, V91, P409	42	50	50	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e83068	10.1371/journal.pone.0083068	http://dx.doi.org/10.1371/journal.pone.0083068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312677	gold, Green Published, Green Submitted			2022-12-25	WOS:000327944500149
J	Dweep, H; Georgiou, GD; Gretz, N; Deltas, C; Voskarides, K; Felekkis, K				Dweep, Harsh; Georgiou, George D.; Gretz, Norbert; Deltas, Constantinos; Voskarides, Konstantinos; Felekkis, Kyriacos			CNVs-microRNAs Interactions Demonstrate Unique Characteristics in the Human Genome. An Interspecies in silico Analysis	PLOS ONE			English	Article							COPY NUMBER VARIATION; GENES; EVOLUTION	MicroRNAs (miRNAs) and copy number variations (CNVs) represent two classes of newly discovered genomic elements that were shown to contribute to genome plasticity and evolution. Recent studies demonstrated that miRNAs and CNVs must have co-evolved and interacted in an attempt to maintain the balance of the dosage sensitive genes and at the same time increase the diversity of dosage non-sensitive genes, contributing to species evolution. It has been previously demonstrated that both the number of miRNAs that target genes found in CNV regions as well as the number of miRNA binding sites are significantly higher than those of genes found in non-CNV regions. These findings raise the possibility that miRNAs may have been created under evolutionary pressure, as a mechanism for increasing the tolerance to genome plasticity. In the current study, we aimed in exploring the differences of miRNAs-CNV functional interactions between human and seven others species. By performing in silico whole genome analysis in eight different species (human, chimpanzee, macaque, mouse, rat, chicken, dog and cow), we demonstrate that miRNAs targeting genes located within CNV regions in humans have special functional characteristics that provide an insight into the differences between humans and other species.	[Dweep, Harsh; Gretz, Norbert] Heidelberg Univ, Med Res Ctr, Mannheim, Germany; [Georgiou, George D.; Felekkis, Kyriacos] Univ Nicosia, Dept Life & Hlth Sci, Nicosia, Cyprus; [Deltas, Constantinos; Voskarides, Konstantinos] Univ Cyprus, Mol Med Res Ctr, Nicosia, Cyprus; [Deltas, Constantinos; Voskarides, Konstantinos] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus; [Felekkis, Kyriacos] Univ Nicosia, St Georges Univ London, Sch Med, Nicosia, Cyprus	Ruprecht Karls University Heidelberg; University of Nicosia; University of Cyprus; University of Cyprus; University of Nicosia	Felekkis, K (corresponding author), Univ Nicosia, Dept Life & Hlth Sci, Nicosia, Cyprus.	felekkis.k@unic.ac.cy	Voskarides, Konstantinos/A-4669-2013; Deltas, Constantinos/A-4936-2013	Voskarides, Konstantinos/0000-0002-3705-3451; Deltas, Constantinos/0000-0001-5549-9169; Felekkis, Kyriacos/0000-0002-0919-0037	Research Promotion Foundation [NEW INFRASTRUCTURE/STRATEGIC/0308/24]	Research Promotion Foundation	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was funded by a program of the Research Promotion Foundation NEW INFRASTRUCTURE/STRATEGIC/0308/24 to CD (support salary of KV).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776; Church DM, 2010, NAT GENET, V42, P813, DOI 10.1038/ng1010-813; Dweep H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053780; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Felekkis K, 2011, MOL BIOL EVOL, V28, P2421, DOI 10.1093/molbev/msr078; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gazave E, 2011, GENOME RES, V21, P1626, DOI 10.1101/gr.117242.110; Gokcumen O, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r52; Hu HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002327; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Janga SC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-239; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lutter D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-224; Marcinkowska M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-183; Papagregoriou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031021; Rison SCG, 2002, CURR OPIN STRUC BIOL, V12, P374, DOI 10.1016/S0959-440X(02)00331-7; Somel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001214; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Woodwark C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014814; Wu XD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-707; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	24	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81204	10.1371/journal.pone.0081204	http://dx.doi.org/10.1371/journal.pone.0081204			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312536	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500059
J	Nahon, S; Richoux, NB; Kolasinski, J; Desmalades, M; Pages, CF; Lecellier, G; Planes, S; Lecellier, VB				Nahon, Sarah; Richoux, Nicole B.; Kolasinski, Joanna; Desmalades, Martin; Pages, Christine Ferrier; Lecellier, Gael; Planes, Serge; Lecellier, Veronique Berteaux			Spatial and Temporal Variations in Stable Carbon (delta C-13) and Nitrogen (delta N-15) Isotopic Composition of Symbiotic Scleractinian Corals	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CONTINENTAL SHELF TRENDS; STYLOPHORA-PISTILLATA; FOOD-CHAINS; TISSUE; ZOOXANTHELLAE; LIGHT; N-15; ASSIMILATION; MARINE	Tropical scleractinian corals are considered autotrophic as they rely mainly on photosynthesis-derived nutrients transferred from their photosymbionts. Corals are also able to capture and ingest suspended particulate organic matter, so heterotrophy can be an important supplementary trophic pathway to optimize coral fitness. The aim of this in situ study was to elucidate the trophic status of 10 coral species under contrasted environmental conditions in a French Polynesian lagoon. Carbon (delta C-13) and nitrogen (delta N-15) isotopic compositions of coral host tissues and photosymbionts were determined at 3 different fringing reefs during wet and dry seasons. Our results highlighted spatial variability in stable isotopic compositions of both coral host tissues and photosymbionts. Samples from the site with higher level of suspended particulate matter were C-13-depleted and N-15-enriched relative to corals and photosymbionts from less turbid sites. However, differences in both delta C-13 and delta N-15 between coral host tissues and their photosymbionts (Delta(host-photosymbionts) C-13 and Delta(host-photosymbionts) N-15) were small (0.27 +/- 0.76 parts per thousand and 1.40 +/- 0.90 parts per thousand, respectively) and similar at all sites, thus indicating no general increases in the heterotrophic pathway. Depleted delta C-13 and enriched N-delta 15 values of coral host tissues measured at the most turbid site were explained by changes in isotopic composition of the inorganic nutrients taken up by photosymbionts and also by changes in rate of isotopic fractionation with environmental conditions. Our results also highlighted a lack of significant temporal variations in delta C-13 and delta N-15 values of coral host and photosymbiont tissues and in Delta Chost-photosymbionts 13 and Delta Nhost-photosymbionts 15 values. This temporal stability indicated that corals remained principally autotrophic even during the wet season when photosymbiont densities were lower and the concentrations of phytoplankton were higher. Increased coral heterotrophy with higher food availability thus appears to be species-specific.	[Nahon, Sarah; Desmalades, Martin; Lecellier, Gael; Planes, Serge; Lecellier, Veronique Berteaux] Ctr Rech Insulaires & Observ Environm, USR CNRS EPHE 3278, Lab Excellence CORAIL, Papetoai, Moorea, France; [Nahon, Sarah; Richoux, Nicole B.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa; [Kolasinski, Joanna] Rhodes Univ, IsoEnvironm Lab, Dept Bot, ZA-6140 Grahamstown, South Africa; [Kolasinski, Joanna] Univ La Reunion, Lab Ecol Marine, St Denis, Reunion, France; [Lecellier, Gael] Univ Versailles, F-78000 Versailles, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Rhodes University; Rhodes University; University of La Reunion; UDICE-French Research Universities; Universite Paris Saclay	Nahon, S (corresponding author), Ctr Rech Insulaires & Observ Environm, USR CNRS EPHE 3278, Lab Excellence CORAIL, Papetoai, Moorea, France.	nahon.sarah@gmail.com	Lecellier, Gael/D-3782-2009; PLANES, Serge/ABF-1360-2021; BERTEAUX-LECELLIER, Veronique/P-6456-2019; Berteaux-Lecellier, Veronique/O-4767-2018	Lecellier, Gael/0000-0003-3331-6311; BERTEAUX-LECELLIER, Veronique/0000-0003-2152-6231; Berteaux-Lecellier, Veronique/0000-0003-2152-6231; Richoux, Nicole/0000-0002-9501-6368	Total Foundation; Ministere de l'Environnement et du Developpement Durable; Ministere de l'Outre-Mer; contrat de projet Etat-Polynesie	Total Foundation(Total SA); Ministere de l'Environnement et du Developpement Durable; Ministere de l'Outre-Mer; contrat de projet Etat-Polynesie	This work was funded by the Total Foundation, the Ministere de l'Environnement et du Developpement Durable, the Ministere de l'Outre-Mer and the contrat de projet Etat-Polynesie. S.N. has been supported by the Total Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamaru A, 2009, GEOCHIM COSMOCHIM AC, V73, P5333, DOI 10.1016/j.gca.2009.06.018; Anderson MJ, 2008, PERMANOVA PRIMER GUI, P214; Anthony KRN, 2000, CORAL REEFS, V19, P59, DOI 10.1007/s003380050227; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Baker DM, 2011, CORAL REEFS, V30, P709, DOI 10.1007/s00338-011-0759-x; BATTEY JF, 1987, MAR BIOL, V95, P37, DOI 10.1007/BF00447483; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; CHALKER BE, 1983, J EXP MAR BIOL ECOL, V73, P37, DOI 10.1016/0022-0981(83)90004-7; CLINE J D, 1975, Marine Chemistry, V3, P271, DOI 10.1016/0304-4203(75)90009-2; CUMMINGS CE, 1982, GEOCHIM COSMOCHIM AC, V46, P1125, DOI 10.1016/0016-7037(82)90064-3; DAVIES PS, 1984, CORAL REEFS, V2, P181; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Domart-Coulon I, 2004, J EXP MAR BIOL ECOL, V309, P199, DOI 10.1016/j.jembe.2004.03.021; Edmunds PJ, 2002, CORAL REEFS, V21, P193, DOI 10.1007/s00338-002-0214-0; Einbinder S, 2009, MAR ECOL PROG SER, V381, P167, DOI 10.3354/meps07908; Ferrier-Pages C, 1998, MICROBIAL ECOL, V35, P46, DOI 10.1007/s002489900059; France RL, 1997, RES POPUL ECOL, V39, P121, DOI 10.1007/BF02765257; FRY B, 1984, CONTRIB MAR SCI, V27, P13; Goericke R., 1994, STABLE ISOTOPES ECOL, P187; Grottoli AG, 1999, CORAL REEFS, V18, P29, DOI 10.1007/s003380050150; Grottoli AG, 2011, CORAL REEFS, V30, P687, DOI 10.1007/s00338-011-0756-0; Heikoop JM, 2000, CORAL REEFS, V19, P189, DOI 10.1007/s003380000092; Heikoop JM, 1998, LIMNOL OCEANOGR, V43, P909, DOI 10.4319/lo.1998.43.5.0909; Heikoop JM, 2000, MAR POLLUT BULL, V40, P628, DOI 10.1016/S0025-326X(00)00006-0; Hoegh-Guldberg O, 2004, MAR ECOL PROG SER, V280, P105, DOI 10.3354/meps280105; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Lamb K, 2012, B MAR SCI, V88, P119, DOI 10.5343/bms.2010.1105; LAND LS, 1975, LIMNOL OCEANOGR, V20, P283, DOI 10.4319/lo.1975.20.2.0283; Maier C, 2010, MAR ECOL PROG SER, V412, P103, DOI 10.3354/meps08674; MCCLOSKEY LR, 1984, PROC R SOC SER B-BIO, V222, P215, DOI 10.1098/rspb.1984.0060; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Mendes J.M., 1997, P1869; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Muscatine L., 1994, Pacific Science, V48, P304; Muscatine L, 2005, P NATL ACAD SCI USA, V102, P1525, DOI 10.1073/pnas.0408921102; Muscatine L., 1980, Environmental Science Research, V19, P381; MUSCATINE L, 1989, MAR BIOL, V100, P185, DOI 10.1007/BF00391957; MUSCATINE L, 1969, BIOL BULL-US, V137, P506, DOI 10.2307/1540172; Palardy JE, 2008, J EXP MAR BIOL ECOL, V367, P180, DOI 10.1016/j.jembe.2008.09.015; Palardy JE, 2005, MAR ECOL PROG SER, V300, P79, DOI 10.3354/meps300079; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Rau GH, 1996, MAR ECOL PROG SER, V133, P275, DOI 10.3354/meps133275; Reynaud S, 2002, MAR ECOL PROG SER, V238, P81, DOI 10.3354/meps238081; Reynaud S, 2009, MAR ECOL PROG SER, V392, P103, DOI 10.3354/meps08195; Risk MJ, 2009, MAR POLLUT BULL, V58, P793, DOI 10.1016/j.marpolbul.2009.02.008; RISK MJ, 1994, MAR ECOL PROG SER, V106, P121, DOI 10.3354/meps106121; Ritchie RJ, 2008, PHOTOSYNTHETICA, V46, P115, DOI 10.1007/s11099-008-0019-7; Sammarco PW, 1999, MAR ECOL PROG SER, V180, P131, DOI 10.3354/meps180131; SLOTH NP, 1995, MAR ECOL PROG SER, V116, P163, DOI 10.3354/meps116163; SMITH FA, 1980, NEW PHYTOL, V86, P245, DOI 10.1111/j.1469-8137.1980.tb00785.x; Strickland J.D.H., 1972, PRACTICAL HDB SEWATE, DOI [10.2307/1979241, DOI 10.2307/1979241]; Swart PK, 2005, LIMNOL OCEANOGR, V50, P1049, DOI 10.4319/lo.2005.50.4.1049; Swart PK, 2005, GEOCHIM COSMOCHIM AC, V69, P1495, DOI 10.1016/j.gca.2004.09.004; Swart PK, 1996, GEOCHIM COSMOCHIM AC, V60, P2871, DOI 10.1016/0016-7037(96)00119-6; Titlyanov EA, 2008, MAR BIOL, V155, P353, DOI 10.1007/s00227-008-1025-9; Torreton JP, 2010, MAR POLLUT BULL, V61, P335, DOI 10.1016/j.marpolbul.2010.06.019; WADA E, 1976, GEOCHIM COSMOCHIM AC, V40, P249, DOI 10.1016/0016-7037(76)90183-6; Wasmund N, 2006, OCEANOLOGIA, V48, P125; YAMAMURO M, 1995, LIMNOL OCEANOGR, V40, P617, DOI 10.4319/lo.1995.40.3.0617	61	34	35	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81247	10.1371/journal.pone.0081247	http://dx.doi.org/10.1371/journal.pone.0081247			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312542	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500063
J	Valdmanis, PN; Roy-Chaudhuri, B; Kim, HK; Sayles, LC; Zheng, Y; Chuang, CH; Caswell, DR; Chu, K; Zhang, Y; Winslow, MM; Sweet-Cordero, EA; Kay, MA				Valdmanis, P. N.; Roy-Chaudhuri, B.; Kim, H. K.; Sayles, L. C.; Zheng, Y.; Chuang, C-H; Caswell, D. R.; Chu, K.; Zhang, Y.; Winslow, M. M.; Sweet-Cordero, E. A.; Kay, M. A.			Upregulation of the microRNA cluster at the Dlkl-Dio3 locus in lung adenocarcinoma	ONCOGENE			English	Article						lung adenocarcinorna; NSCLC; RNAseq; nnicroRNAs	K-RAS ONCOGENE; PROMOTER HYPERMETHYLATION; HEPATOCELLULAR-CARCINOMA; SOMATIC MUTATIONS; IMPRINTED GENES; NEVER SMOKERS; CANCER; RNA; EXPRESSION; ACTIVATION	Mice in which lung epithelial cells can be induced to express an oncogenic Kras(G12D) develop lung adenocarcinomas in a manner analogous to humans. A myriad of genetic changes accompany lung adenocarcinomas, many of which are poorly understood. To get a comprehensive understanding of both the transcriptional and post-transcriptional changes that accompany lung adenocarcinomas, we took an omics approach in profiling both the coding genes and the non-coding small RNAs in an induced mouse model of lung adenocarcinoma. RNAseq transcriptome analysis of Kras(G12D) tumors from F1 hybrid mice revealed features specific to tumor samples. This includes the repression of a network of GTPase-related genes (Prkg1, Gnao1 and Rgs9) in tumor samples and an enrichment of Apobec1-mediated cytosine to uridine RNA editing. Furthermore, analysis of known single-nucleotide polymorphisms revealed not only a change in expression of Cd22 but also that its expression became allele specific in tumors. The most salient finding, however, came from small RNA sequencing of the tumor samples, which revealed that a cluster of 53 microRNAs and mRNAs at the Dlk1-Dio3 locus on mouse chromosome 12qF1 was markedly and consistently increased in tumors. Activation of this locus occurred specifically in sorted tumor-originating cancer cells. Interestingly, the 12qF1 RNAs were repressed in cultured Kras(G12D) tumor cells but reactivated when transplanted in vivo. These microRNAs have been implicated in stem cell pleuripotency and proteins targeted by these microRNAs are involved in key pathways in cancer as well as embryogenesis. Taken together, our results strongly imply that these microRNAs represent key targets in unraveling the mechanism of lung oncogenesis.	[Valdmanis, P. N.; Roy-Chaudhuri, B.; Kim, H. K.; Chu, K.; Zhang, Y.; Sweet-Cordero, E. A.; Kay, M. A.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Valdmanis, P. N.; Roy-Chaudhuri, B.; Kim, H. K.; Chuang, C-H; Caswell, D. R.; Chu, K.; Zhang, Y.; Winslow, M. M.; Kay, M. A.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Sayles, L. C.; Zheng, Y.; Sweet-Cordero, E. A.] Stanford Univ, Dept Pediat, Div Hematol Oncol, Stanford, CA 94305 USA; [Chuang, C-H; Caswell, D. R.; Winslow, M. M.] Stanford Univ, Canc Biol Program, Stanford, CA 94305 USA; [Chuang, C-H; Caswell, D. R.; Winslow, M. M.; Sweet-Cordero, E. A.] Stanford Univ, Stanford Canc Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University	Kay, MA (corresponding author), Stanford Univ, Dept Pediat & Genet, 269 Campus Dr,CCSR 2105, Stanford, CA 94305 USA.	markay@stanford.edu		Valdmanis, Paul/0000-0001-8840-6969; Kay, Mark/0000-0002-2799-2615	Baxter Foundation Scholar Award; Stanford Dean's Fellowship; Canadian Institutes of Health Research;  [R01 DK078424]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078424] Funding Source: NIH RePORTER	Baxter Foundation Scholar Award; Stanford Dean's Fellowship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	PNV is a Banting Postdoctoral Fellow supported by the Canadian Institutes of Health Research. MMW is funded by a Baxter Foundation Scholar Award and C-HC is supported by a Stanford Dean's Fellowship. We thank Julien Sage for SCLC samples. This work was supported by grant R01 DK078424 (MAK).	Al-Mulla F, 1999, J PATHOL, V187, P433, DOI 10.1002/(SICI)1096-9896(199903)187:4<433::AID-PATH273>3.0.CO;2-E; Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Benetatos L, 2012, CRIT REV EUKAR GENE, V22, P1; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Chess A, 2012, NAT REV GENET, V13, P421, DOI 10.1038/nrg3239; Danecek P, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r26; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia-Marcos M, 2011, ONCOGENE, V30, P2691, DOI 10.1038/onc.2010.645; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Hagan JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004352; Haller F, 2010, J PATHOL, V220, P71, DOI 10.1002/path.2610; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kaneda A, 2004, CANCER LETT, V212, P203, DOI 10.1016/j.canlet.2004.03.020; Kim JH, 2011, BMB REP, V44, P523, DOI 10.5483/BMBRep.2011.44.8.523; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee Jennifer, 2010, Genes Cancer, V1, P690, DOI 10.1177/1947601910382899; Lee S, 2009, INT J ONCOL, V34, P161, DOI 10.3892/ijo_00000138; Leung SO, 1995, MOL IMMUNOL, V32, P1413, DOI 10.1016/0161-5890(95)00080-1; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Luk JM, 2011, J BIOL CHEM, V286, P30706, DOI 10.1074/jbc.M111.229831; Ma Y, 2007, P NATL ACAD SCI USA, V104, P4089, DOI 10.1073/pnas.0606537104; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mita H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-198; Mosakhani N, 2012, GENE CHROMOSOME CANC, V51, P1, DOI 10.1002/gcc.20925; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Ricketts SL, 2003, MOL CARCINOGEN, V36, P90, DOI 10.1002/mc.10101; Riely GJ, 2008, CLIN CANCER RES, V14, P5731, DOI 10.1158/1078-0432.CCR-08-0646; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; ROGGE RD, 1991, CELL, V64, P39, DOI 10.1016/0092-8674(91)90207-F; Rosenberg BR, 2011, NAT STRUCT MOL BIOL, V18, P230, DOI 10.1038/nsmb.1975; SANTOS E, 1984, SCIENCE, V223, P661, DOI 10.1126/science.6695174; Sekita Y, 2006, CYTOGENET GENOME RES, V113, P223, DOI 10.1159/000090836; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; SIMON MA, 1993, CELL, V73, P169, DOI 10.1016/0092-8674(93)90169-Q; Son JW, 2011, RESPIROLOGY, V16, P1203, DOI 10.1111/j.1440-1843.2011.01994.x; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Takahashi N, 2009, HUM MOL GENET, V18, P1879, DOI 10.1093/hmg/ddp108; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuscano JM, 2012, CANCER RES, V72, P5556, DOI 10.1158/0008-5472.CAN-12-0173; Uckun FM, 2010, P NATL ACAD SCI USA, V107, P16852, DOI 10.1073/pnas.1007896107; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483	65	35	37	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 2	2015	34	1					94	103		10.1038/onc.2013.523	http://dx.doi.org/10.1038/onc.2013.523			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB6MC	24317514	Green Accepted, Green Submitted			2022-12-25	WOS:000349740100009
J	Rai, R; Tate, JJ; Georis, I; Dubois, E; Cooper, TG				Rai, Rajendra; Tate, Jennifer J.; Georis, Isabelle; Dubois, Evelyne; Cooper, Terrance G.			Constitutive and Nitrogen Catabolite Repression-sensitive Production of Gat1 Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gata; Glutamine; Nitrogen Metabolism; Protein Structure; TOR Complex (TORC); Transcription Initiation Factors; Gat1; Nitrogen Catabolite Repression; Rapamycin	METHIONINE SULFOXIMINE TREATMENT; TOR SIGNALING PATHWAY; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; REGULATED TRANSCRIPTION; GLN3 PHOSPHORYLATION; NUCLEAR-LOCALIZATION; RAPAMYCIN INHIBITION; CARBON STARVATION; FACTOR RESPONSES	Background:GAT1 transcription is nitrogen-responsive, whereas Gat1 isoforms (IsoA, IsoB) are produced constitutively. Results: IsoA/B initiate at different methionines. Gln3-dependent IsoA/B production is unresponsive to nitrogen, whereas Gat1(M1-S233) peptide production is nitrogen-responsive. Conclusion: Wild type and Gat1(M1-S233) protein production is nonparallel. Significance: This is the first instance of Gln3-dependent protein production failing to be nitrogen-responsive, suggesting additional level of Gat1 regulation. Nitrogen catabolite repression (NCR)-sensitive transcription is activated by Gln3 and Gat1. In nitrogen excess, Gln3 and Gat1 are cytoplasmic, and transcription is minimal. In poor nitrogen, Gln3 and Gat1 become nuclear and activate transcription. A long standing paradox has surrounded Gat1 production. Gat1 was first reported as an NCR-regulated activity mediating NCR-sensitive transcription in gln3 deletion strains. Upon cloning, GAT1 transcription was, as predicted, NCR-sensitive and Gln3- and Gat1-activated. In contrast, Western blots of Gat1-Myc(13) exhibited two constitutively produced species. Investigating this paradox, we demonstrate that wild type Gat1 isoforms (IsoA and IsoB) are initiated at Gat1 methionines 40, 95, and/or 102, but not at methionine 1. Their low level production is the same in rich and poor nitrogen conditions. When the Myc(13) tag is placed after Gat1 Ser-233, four N-terminal Gat1 isoforms (IsoC-F) are also initiated at methionines 40, 95, and/or 102. However, their production is highly NCR-sensitive, being greater in proline than glutamine medium. Surprisingly, all Gat1 isoforms produced in sufficient quantities to be confidently analyzed (IsoA, IsoC, and IsoD) require Gln3 and UAS(GATA) promoter elements, both requirements typical of NCR-sensitive transcription. These data demonstrate that regulated Gat1 production is more complex than previously recognized, with wild type versus truncated Gat1 proteins failing to be regulated in parallel. This is the first reported instance of Gln3 UAS(GATA)-dependent protein production failing to derepress in nitrogen poor conditions. A Gat1-lacZ ORF swap experiment indicated sequence(s) responsible for the nonparallel production are downstream of Gat1 leucine 61.	[Rai, Rajendra; Tate, Jennifer J.; Cooper, Terrance G.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Georis, Isabelle; Dubois, Evelyne] Univ Libre Brussels, Inst Rech Microbiol Jean Marie Wiame, B-1070 Brussels, Belgium	University of Tennessee System; University of Tennessee Health Science Center; Universite Libre de Bruxelles	Cooper, TG (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA.	tcooper@uthsc.edu		Cooper, Terrance G./0000-0002-7651-9963	National Institutes of Health [GM-35642]; Commission Communautaire Francaise; Fonds de la Recherche Fondamentale Collective Grant [2.4547.11]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commission Communautaire Francaise; Fonds de la Recherche Fondamentale Collective Grant(Fonds de la Recherche Scientifique - FNRS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-35642 (to J. J. T., R. R., and T. G. C.). This work was also supported by the Commission Communautaire Francaise and Fonds de la Recherche Fondamentale Collective Grant 2.4547.11 (to I. G. and E. D.).	Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2002, MOL CELL BIOL, V22, P1246, DOI 10.1128/MCB.22.4.1246-1252.2002; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Blinder D, 1996, J BACTERIOL, V178, P4734, DOI 10.1128/jb.178.15.4734-4736.1996; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Carvalho J, 2003, J BIOL CHEM, V278, P16878, DOI 10.1074/jbc.M300429200; Chen EJ, 2003, J CELL BIOL, V161, P333, DOI 10.1083/jcb.200210141; Coffman J, 1996, FOLIA MICROBIOL, V41, P85, DOI 10.1007/BF02816348; Coffman JA, 1996, MOL CELL BIOL, V16, P847; Coffman JA, 1997, J BACTERIOL, V179, P3416, DOI 10.1128/jb.179.11.3416-3429.1997; COFFMAN JA, 1994, J BACTERIOL, V176, P7476, DOI 10.1128/JB.176.24.7476-7483.1994; COFFMAN JA, 1995, J BACTERIOL, V177, P6910, DOI 10.1128/jb.177.23.6910-6918.1995; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Cooper TG, 2004, TOP CURR GENET, V7, P225; Cox KH, 2004, J BIOL CHEM, V279, P10270, DOI 10.1074/jbc.M312023200; Cox KH, 2002, J BIOL CHEM, V277, P37559, DOI 10.1074/jbc.M204879200; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; CUNNINGHAM TS, 1993, J BACTERIOL, V175, P5851, DOI 10.1128/JB.175.18.5851-5861.1993; Cunningham TS, 1996, J BACTERIOL, V178, P3470, DOI 10.1128/jb.178.12.3470-3479.1996; DAUGHERTY JR, 1993, J BACTERIOL, V175, P64, DOI 10.1128/JB.175.1.64-73.1993; Feller A, 2013, J BIOL CHEM, V288, P1841, DOI 10.1074/jbc.M112.385054; Fournier CT, 2012, J PROTEOME RES, V11, P5712, DOI 10.1021/pr300538f; Frederiks F, 2009, NUCLEIC ACIDS RES, V37, P7047, DOI 10.1093/nar/gkp765; Georis I, 2008, J BIOL CHEM, V283, P8919, DOI 10.1074/jbc.M708811200; Georis I, 2011, J BIOL CHEM, V286, P44897, DOI 10.1074/jbc.M111.290577; Georis I, 2011, MOL CELL BIOL, V31, P92, DOI 10.1128/MCB.00482-10; Georis I, 2009, GENETICS, V181, P861, DOI 10.1534/genetics.108.099051; Georis I, 2009, MOL CELL BIOL, V29, P3803, DOI 10.1128/MCB.00399-09; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Kulkarni A, 2006, FEMS YEAST RES, V6, P218, DOI 10.1111/j.1567-1364.2006.00031.x; Kuruvilla FG, 2001, P NATL ACAD SCI USA, V98, P7283, DOI 10.1073/pnas.121186898; Liu ZC, 2008, MOL CELL BIOL, V28, P551, DOI 10.1128/MCB.00929-07; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Mauro VR, 2007, METHOD ENZYMOL, V429, P323, DOI 10.1016/S0076-6879(07)29015-9; Miller JH, 1972, EXPT MOL GENETICS, P403; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; PARK HD, 1992, NUCLEIC ACIDS RES, V20, P1909, DOI 10.1093/nar/20.8.1909; Rai R, 2013, J BIOL CHEM, V288, P2789, DOI 10.1074/jbc.M112.421826; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; Rowen DW, 1997, J BACTERIOL, V179, P3761, DOI 10.1128/jb.179.11.3761-3766.1997; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; SMITH CL, 1989, J VIROL, V63, P1569, DOI 10.1128/JVI.63.4.1569-1577.1989; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Soussi-Boudekou S, 1999, MOL MICROBIOL, V31, P753, DOI 10.1046/j.1365-2958.1999.01187.x; SoussiBoudekou S, 1997, MOL MICROBIOL, V23, P1157, DOI 10.1046/j.1365-2958.1997.3021665.x; STANBROUGH M, 1995, J BACTERIOL, V177, P94, DOI 10.1128/jb.177.1.94-102.1995; STANBROUGH M, 1995, P NATL ACAD SCI USA, V92, P9450, DOI 10.1073/pnas.92.21.9450; Tate JJ, 2006, J BIOL CHEM, V281, P37980, DOI 10.1074/jbc.M606973200; Tate JJ, 2006, J BIOL CHEM, V281, P28460, DOI 10.1074/jbc.M604171200; Tate JJ, 2013, J BIOL CHEM, V288, P27243, DOI 10.1074/jbc.M113.484386; Tate JJ, 2010, J BIOL CHEM, V285, P17880, DOI 10.1074/jbc.M109.085712; Tate JJ, 2009, J BIOL CHEM, V284, P2522, DOI 10.1074/jbc.M806162200; Tate JJ, 2005, J BIOL CHEM, V280, P27195, DOI 10.1074/jbc.M504052200; Vilela C, 1998, NUCLEIC ACIDS RES, V26, P1150, DOI 10.1093/nar/26.5.1150; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072	64	8	9	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2918	2933		10.1074/jbc.M113.516740	http://dx.doi.org/10.1074/jbc.M113.516740			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24324255	Green Published, hybrid			2022-12-25	WOS:000333403000040
J	Chen, F; Fasoli, M; Tornielli, GB; Dal Santo, S; Pezzotti, M; Zhang, LS; Cai, B; Cheng, ZM				Chen, Fei; Fasoli, Marianna; Tornielli, Giovanni Battista; Dal Santo, Silvia; Pezzotti, Mario; Zhang, Liangsheng; Cai, Bin; Cheng, Zong-Ming			The Evolutionary History and Diverse Physiological Roles of the Grapevine Calcium-Dependent Protein Kinase Gene Family	PLOS ONE			English	Article							PLANT; ARABIDOPSIS; EXPRESSION; GROWTH; CDPK	Calcium-dependent protein kinases (CDPKs) are molecular switches that bind Ca2+, ATP, and protein substrates, acting as sensor relays and responders that convert Ca2+ signals, created by developmental processes and environmental stresses, into phosphorylation events. The precise functions of the CDPKs in grapevine (Vitis vinifera) are largely unknown. We therefore investigated the phylogenetic relationships and expression profiles of the 17 CDPK genes identified in the 12x grapevine genome sequence, resolving them into four subfamilies based on phylogenetic tree topology and gene structures. The origins of the CDPKs during grapevine evolution were characterized, involving 13 expansion events. Transcriptomic analysis using 54 tissues and developmental stages revealed three types of CDPK gene expression profiles: constitutive (housekeeping CDPKs), partitioned functions, and prevalent in pollen/stamen. We identified two duplicated CDPK genes that had evolved from housekeeping to pollen-prevalent functions and whose origin correlated with that of seed plants, suggesting neofunctionalization with an important role in pollen development and also potential value in the breeding of seedless varieties. We also found that CDPKs were involved in three abiotic stress signaling pathways and could therefore be used to investigate the crosstalk between stress responses.	[Chen, Fei; Cai, Bin; Cheng, Zong-Ming] Nanjing Agr Univ, Coll Hort, Fruit Crop Syst Biol Lab, Nanjing, Jiangsu, Peoples R China; [Fasoli, Marianna; Tornielli, Giovanni Battista; Dal Santo, Silvia; Pezzotti, Mario] Univ Verona, Dipartimento Biotecnol, I-37100 Verona, Italy; [Zhang, Liangsheng] Penn State Univ, Dept Biol, Huck Inst Life Sci, University Pk, PA 16802 USA; [Cheng, Zong-Ming] Univ Tennessee, Dept Plant Sci, Knoxville, TN USA	Nanjing Agricultural University; University of Verona; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Cheng, ZM (corresponding author), Nanjing Agr Univ, Coll Hort, Fruit Crop Syst Biol Lab, Nanjing, Jiangsu, Peoples R China.	zmc@njau.edu.cn	, 张亮生/AAQ-8574-2020; Tornielli, Giovanni Battista/AAG-1735-2019	, 张亮生/0000-0003-1919-3677; Tornielli, Giovanni Battista/0000-0001-5027-0269; Chen, Fei/0000-0002-4346-6906; Fasoli, Marianna/0000-0003-1101-8129; Dal Santo, Silvia/0000-0001-5012-1140	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [130809001]; Chinese Ministry of Agriculture "948" project [G2011-21]	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Chinese Ministry of Agriculture "948" project	The project was funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), No. 130809001, and by the Chinese Ministry of Agriculture "948" project #G2011-21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors declare no financial conflict with this project.	Boudsocq M, 2012, TRENDS PLANT SCI, P1; Champion A., 2004, Functional & Integrative Genomics, V4, P163, DOI 10.1007/s10142-003-0096-4; Chandran V, 2006, J MOL BIOL, V357, P400, DOI 10.1016/j.jmb.2005.11.093; Chaves MM, 2010, ANN BOT-LONDON, V105, P661, DOI 10.1093/aob/mcq030; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fasoli M, 2012, PLANT CELL, V24, P3489, DOI 10.1105/tpc.112.100230; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Hegeman AD, 2006, PROTEOMICS, V6, P3649, DOI 10.1002/pmic.200500926; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jansen RK, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-32; Jiao YN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r3; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Klimecka M, 2007, ACTA BIOCHIM POL, V54, P219, DOI 10.18388/abp.2007_3242; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Lehti-Shiu MD, 2012, PHILOS T R SOC B, V367, P2619, DOI 10.1098/rstb.2012.0003; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; LINDZEN E, 1995, PLANT MOL BIOL, V28, P785, DOI 10.1007/BF00042065; Malacarne G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029762; Ohno S., 1970, P1; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Remarkers C, 2003, NEUROSCI LETT, V339, P2003; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wernimont AK, 2010, NAT STRUCT MOL BIOL, V17, P596, DOI 10.1038/nsmb.1795; Yang XH, 2006, PLANT PHYSIOL, V142, P820, DOI 10.1104/pp.106.083642; Ye SF, 2009, PLANT MOL BIOL, V70, P311, DOI 10.1007/s11103-009-9475-0; Yoon GM, 2006, PLANT CELL, V18, P867, DOI 10.1105/tpc.105.037135; Yu XC, 2007, PLANT MOL BIOL, V64, P531, DOI 10.1007/s11103-007-9172-9; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	33	49	52	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e80818	10.1371/journal.pone.0080818	http://dx.doi.org/10.1371/journal.pone.0080818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324631	gold, Green Submitted, Green Published			2022-12-25	WOS:000328566700017
J	Weiss, RF; Miller, MG; Cronin, JF				Weiss, Robert F.; Miller, Merlin G.; Cronin, John F.			Immune Response to Combination Therapy for Non-Hodgkin Lymphomas	PLOS ONE			English	Article							B-CELL LYMPHOMA; FOLLICULAR LYMPHOMA; TRANSFORMATION	A parametric model of tumor response to combination therapy in the presence of an immune system is described. Synergistic mechanisms which induce tumor regression are simulated with a coupled set of equations. The simulations are first compared to tumor history data obtained with a SCID mouse model to determine key parameters; predictions are then made for an immune-competent animal. The minimum immune cell birth rate relative to malignant B-cell birth rate necessary to induce tumor regression is determined, and optimization of drug combinations in the presence of an immune response is explored. The delayed effect of an immune response relative to drug scheduling is examined, and a mechanism for disease transformation in heterogeneous tumors is proposed.	[Weiss, Robert F.; Miller, Merlin G.] Back Bay Biosci LLC, Boston, MA USA; [Cronin, John F.] Phys Sci Inc, Andover, MA 01810 USA	Physical Sciences Inc.	Weiss, RF (corresponding author), Back Bay Biosci LLC, Boston, MA USA.	RFDWeiss@outlook.com						Al-Tourah A, 2005, ANN ONCOL, V16, P64; Carlotti E, 2009, BLOOD, V113, P3553, DOI 10.1182/blood-2008-08-174839; de Pillis LG, 2005, CANCER RES, V65, P7950, DOI 10.1158/0008-5472.CAN-05-0564; Kim PS, 2008, PLOS COMPUTATIONAL B, DOI [10.1371/journal.pcbi.1000095, DOI 10.1371/J0URNAL.PCBI.1000095]; Link BK, 2013, J CLIN ONCOL, V31, P3272, DOI 10.1200/JCO.2012.48.3990; Montoto S, 2007, J CLIN ONCOL, V25, P2426, DOI 10.1200/JCO.2006.09.3260; Pro B, 2008, BRIT J HAEMATOL, V143, P355, DOI 10.1111/j.1365-2141.2008.07353.x; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Smith MR, 2007, CLIN CANCER RES, V13, p5528S, DOI 10.1158/1078-0432.CCR-07-0982; Smith MR, 2004, MOL CANCER THER, V3, P1693; U.S. Food and Drug Administration, 2011, FDA APPR RIT FRONT L; Weiss RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051736; YUEN AR, 1995, J CLIN ONCOL, V13, P1726, DOI 10.1200/JCO.1995.13.7.1726	13	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81672	10.1371/journal.pone.0081672	http://dx.doi.org/10.1371/journal.pone.0081672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324715	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700050
J	Wu, GY; Zong, GJ; Chen, JK; Xia, Y; Chen, MQ; Wang, X; Wang, XY; Wang, LL; Wang, TX				Wu, Gang-Yong; Zong, Gang-Jun; Chen, Jing-Kai; Xia, Yang; Chen, Man-Qing; Wang, Xiao; Wang, Xiao-Ying; Wang, Lu-Lu; Wang, Tian-Xiao			Changes of Plasma B-Type Natriuretic Peptide Levels after High-Pressure Post-Dilation following Coronary Stent Deployment	PLOS ONE			English	Article								Objective: To evaluate the changes of plasma B-type natriuretic peptide(BNP) levels after high-pressure post-dilation following coronary stent deployment. Methods: A total of 173 patients undergoing percutaneous coronary intervention for the left anterior descending artery were enrolled into the study. All patients were divided into two groups: the conventional group and the post-dilation group. The plasma BNP, troponin I(TnI), myocardial band isoenzyme of creatine kinase(CK-MB) levels and the serum high sensitive C-reactive protein(hs-CRP) levels immediately before and 24 hours after the interventional procedures were compared between the two groups. Results: There were no significant differences between the two groups in terms of clinical features, clinical and biochemical parameters, stent parameters, pre-procedural plasma BNP and TnI levels, pre-procedural serum hs-CRP levels, as well as pre-and post-procedural CK-MB levels (all P > 0.05). In the conventional group, post-procedural plasma BNP levels were significantly reduced when compared with the pre-procedural levels, median(25th, 75th) were 32.5 ng/L(15.0,52.4) vs. 37.7 ng/L(18.2,67.3), P=0.001. In the post-dilation group, post-procedural plasma BNP levels were significantly increased when compared with the pre-procedural levels, median(25th, 75th) were 53.5 ng/L(29.6,82.8) vs. 44.2 ng/L(17.15,70.7), P < 0.0001. Post-procedural plasma TnI levels were also significantly increased when compared with the pre-procedural levels in both groups, median(25th, 75th) were 0.02 ng/L(0.01,0.08) vs. 0.01 ng/L(0.01,0.01), 0.05 ng/L(0.01,0.35) vs. 0.01 ng/ L(0.01,0.01), respectively, P, 0.0001, so were the serum hs-CRP levels, median(25th, 75th) were 3.3 mg/L(2.4,4.7) vs. 2.2 mg/ L(1.4,3.3), 4.2 mg/L(3.175,5.825) vs. 2.3 mg/L(1.45,3.6), respectively, P < 0.0001. Post-procedural plasma BNP, TnI and serum hs-CRP levels in the post-dilation group were significantly higher than those in the conventional group(all P < 0.0001). Conclusion: High-pressure post-dilation following coronary stent deployment resulted in a significant increase of plasma BNP levels, as well as plasma TnI levels and serum hs-CRP levels, which may be related to myocardial perfusion, more myocardial injury and more inflammation.	[Wu, Gang-Yong; Zong, Gang-Jun; Chen, Jing-Kai; Xia, Yang; Chen, Man-Qing; Wang, Xiao; Wang, Xiao-Ying; Wang, Lu-Lu; Wang, Tian-Xiao] 101 Hosp PLA, Dept Cardiol, Wuxi, Jiangsu, Peoples R China		Zong, GJ (corresponding author), 101 Hosp PLA, Dept Cardiol, Wuxi, Jiangsu, Peoples R China.	1354920456@qq.com						Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Frobert O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056348; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hoye A, 2006, J AM COLL CARDIOL, V47, P1949, DOI 10.1016/j.jacc.2005.11.083; Maisel A, 2008, EUR J HEART FAIL, V10, P824, DOI 10.1016/j.ejheart.2008.07.014; Mehrle A, 2007, CATHETER CARDIO INTE, V69, P989, DOI 10.1002/ccd.21027; Ormiston JA, 2006, CATHETER CARDIO INTE, V67, P49, DOI 10.1002/ccd.20453; Pitney M, 2011, EUROINTERVENTION, V7, P256, DOI 10.4244/EIJV7I2A41; Romagnoli E, 2008, JACC-CARDIOVASC INTE, V1, P22, DOI 10.1016/j.jcin.2007.10.005; Roy P, 2008, EUR HEART J, V29, P1851, DOI 10.1093/eurheartj/ehn249; Sacks David B, 2011, Diabetes Care, V34, pe61, DOI 10.2337/dc11-9998; Zhang ZJ, 2010, AM HEART J, V160, P979, DOI 10.1016/j.ahj.2010.07.007	12	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82357	10.1371/journal.pone.0082357	http://dx.doi.org/10.1371/journal.pone.0082357			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324775	Green Published, gold			2022-12-25	WOS:000328566700072
J	Yang, H; Li, ZJ; Lu, L; Long, J; Liang, YC				Yang, Hua; Li, Zhaojun; Lu, Lu; Long, Jian; Liang, Yongchao			Cross-Species Extrapolation of Prediction Models for Cadmium Transfer from Soil to Corn Grain	PLOS ONE			English	Article							ECOLOGICAL RISK-ASSESSMENT; HEAVY-METAL ACCUMULATION; ORGANIC-MATTER; PH; ZINC; PHYTOAVAILABILITY; TOXICITY; SORPTION; NICKEL; CD	Cadmium (Cd) is a highly toxic heavy metal for both plants and animals. The presence of Cd in agricultural soils is of great concern regarding its transfer in the soil-plant system. This study investigated the transfer of Cd (exogenous salts) from a wide range of Chinese soils to corn grain (Zhengdan 958). Through multiple stepwise regressions, prediction models were developed, with the combination of Cd bioconcentration factor (BCF) of Zhengdan 958 and soil pH, organic matter (OM) content, and cation exchange capacity (CEC). Moreover, these prediction models from Zhengdan 958 were applied to other non-model corn species through cross-species extrapolation approach. The results showed that the pH of the soil was the most important factor that controlled Cd uptake and lower pH was more favorable for Cd bioaccumulation in corn grain. There was no significant difference among three prediction models in the different Cd levels. When the prediction models were applied to other non-model corn species, the ratio ranges between the predicted BCF values and the measured BCF values were within an interval of 2 folds and close to the solid line of 1: 1 relationship. Furthermore, these prediction models also reduced the measured BCF intra-species variability for all non-model corn species. Therefore, the prediction models established in this study can be applied to other non-model corn species and be useful for predicting the Cd bioconcentration in corn grain and assessing the ecological risk of Cd in different soils.	[Yang, Hua; Li, Zhaojun; Liang, Yongchao] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Plant Nutr & Fertilizer, Minist Agr, Beijing 100193, Peoples R China; [Yang, Hua; Long, Jian] Guizhou Normal Univ, Guizhou Key Lab Mt Environm, Guiyang, Peoples R China; [Lu, Lu] Chinese Acad Agr Sci, Grad Sch, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Guizhou Normal University; Chinese Academy of Agricultural Sciences; Graduate School, CAAS	Li, ZJ (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Plant Nutr & Fertilizer, Minist Agr, Beijing 100193, Peoples R China.	lizhaojun@caas.cn	Liang, Yongchao/D-5809-2012; Li, zhaojun/E-5735-2012; Liang, Yongchao/S-9281-2019	Liang, Yongchao/0000-0002-0501-2823; Liang, Yongchao/0000-0002-0501-2823	Special Fund of Public Industry in China [200903015]; Natural Science Foundation of Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences [2013-9]	Special Fund of Public Industry in China; Natural Science Foundation of Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences	This work was jointly supported by the Special Fund of Public Industry in China (Agriculture, project No. 200903015; website: http://www.most.gov.cn/) and the Natural Science Foundation of Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences (Project No. 2013-9; website: http://www.iarrp.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ML, 2004, J ENVIRON QUAL, V33, P532, DOI 10.2134/jeq2004.0532; Allard Patrick, 2010, Integrated Environmental Assessment and Management, V6, P28, DOI 10.1897/IEAM_2009-010.1; Antoniadis V, 2008, CHEMOSPHERE, V71, P759, DOI 10.1016/j.chemosphere.2007.10.015; Badawy SH, 2002, J ENVIRON QUAL, V31, P162, DOI 10.2134/jeq2002.0162; BAKER AJM, 1994, NEW PHYTOL, V127, P61, DOI 10.1111/j.1469-8137.1994.tb04259.x; BALL DF, 1964, J SOIL SCI, V15, P84, DOI 10.1111/j.1365-2389.1964.tb00247.x; Bang JS, 2004, J ENVIRON QUAL, V33, P891, DOI 10.2134/jeq2004.0891; Barancikova Gabriela, 2004, Journal of Soils and Sediments, V4, P37, DOI 10.1007/BF02990827; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Brown SL, 1998, J ENVIRON QUAL, V27, P1071, DOI 10.2134/jeq1998.00472425002700050012x; Chapman EEV, 2013, ENVIRON POLLUT, V179, P326, DOI 10.1016/j.envpol.2013.04.027; Chien CC, 2008, J ENVIRON SCI, V20, P359, DOI 10.1016/S1001-0742(08)60056-X; CHRISTENSEN TH, 1984, WATER AIR SOIL POLL, V21, P105, DOI 10.1007/BF00163616; De Schamphelaere KAC, 2006, ECOTOX ENVIRON SAFE, V63, P189, DOI 10.1016/j.ecoenv.2005.07.012; DELCASTILHO P, 1995, PLANT SOIL, V171, P263, DOI 10.1007/BF00010280; Deleebeeck NME, 2007, AQUAT TOXICOL, V84, P223, DOI 10.1016/j.aquatox.2007.03.025; Deleebeeck NME, 2007, ECOTOX ENVIRON SAFE, V67, P1, DOI 10.1016/j.ecoenv.2006.10.001; Dohrmann R, 2006, APPL CLAY SCI, V34, P38, DOI 10.1016/j.clay.2006.02.009; Du Laing G, 2009, SCI TOTAL ENVIRON, V407, P3972, DOI 10.1016/j.scitotenv.2008.07.025; ERIKSSON JE, 1988, WATER AIR SOIL POLL, V40, P359; Ge Y, 2000, ENVIRON POLLUT, V107, P137, DOI 10.1016/S0269-7491(99)00119-0; Hao XZ, 2012, PEDOSPHERE, V22, P631, DOI 10.1016/S1002-0160(12)60048-4; Harter RD, 2001, SOIL SCI SOC AM J, V65, P597, DOI 10.2136/sssaj2001.653597x; Hettiarachchi GM, 2003, J ENVIRON QUAL, V32, P1684, DOI 10.2134/jeq2003.1684; HINESLY TD, 1984, J AGR FOOD CHEM, V32, P155, DOI 10.1021/jf00121a037; Hu JL, 2013, ECOTOX ENVIRON SAFE, V91, P18, DOI 10.1016/j.ecoenv.2013.01.001; Huang ML, 2008, SCI TOTAL ENVIRON, V405, P54, DOI 10.1016/j.scitotenv.2008.07.004; Jamali MK, 2009, J HAZARD MATER, V164, P1386, DOI 10.1016/j.jhazmat.2008.09.056; Jung MC, 2008, SENSORS-BASEL, V8, P2413, DOI 10.3390/s8042413; Kim KR, 2009, AUST J SOIL RES, V47, P166, DOI 10.1071/SR08054; KIM SJ, 1988, J ENVIRON QUAL, V17, P568, DOI 10.2134/jeq1988.00472425001700040008x; Kirkham MB, 2006, GEODERMA, V137, P19, DOI 10.1016/j.geoderma.2006.08.024; [李琼 LI Qiong], 2009, [农业环境科学学报, Journal of Agro-Environment Science], V28, P2042; Li ZJ, 2006, CHEMOSPHERE, V62, P1374, DOI 10.1016/j.chemosphere.2005.07.050; McBride M, 2002, SOIL SCI, V167, P62, DOI 10.1097/00010694-200201000-00006; McLaughlin MJ., 1999, DEV PLANT SOIL SCI, P1, DOI [10.1007/978-94-011-4473-5_1, DOI 10.1007/978-94-011-4473-5_1]; Mertens J, 2005, ENVIRON POLLUT, V138, P1, DOI 10.1016/j.envpol.2005.01.002; Muhlbachova G, 2005, PLANT SOIL ENVIRON, V51, P26, DOI 10.17221/3552-PSE; Mushtakova VM, 2005, BIOL BULL+, V32, P276, DOI 10.1007/s10525-005-0102-6; NAIDU R, 1994, EUR J SOIL SCI, V45, P419, DOI 10.1111/j.1365-2389.1994.tb00527.x; Pinto AP, 2004, SCI TOTAL ENVIRON, V326, P239, DOI 10.1016/j.scitotenv.2004.01.004; Raskin Ilya, 1994, Current Opinion in Biotechnology, V5, P285, DOI 10.1016/0958-1669(94)90030-2; Rezvani M., 2011, AUSTR J AGR ENG AJAE, V2, P114; Sarwar N, 2010, J SCI FOOD AGR, V90, P925, DOI 10.1002/jsfa.3916; Schlekat CE, 2010, SCI TOTAL ENVIRON, V408, P6148, DOI 10.1016/j.scitotenv.2010.09.012; Smical AI, 2008, ENVIRON ENG MANAG J, V7, P609, DOI 10.30638/eemj.2008.085; Solomon KR, 1996, ENVIRON TOXICOL CHEM, V15, P31, DOI [10.1002/etc.5620150105, 10.1897/1551-5028(1996)015&lt;0031:ERAOAI&gt;2.3.CO;2]; Sparks DL, 1996, METHODS SOIL ANLYS 3; Steen RJCA, 1999, ENVIRON TOXICOL CHEM, V18, P1574, DOI 10.1897/1551-5028(1999)018&lt;1574:ERAOAI&gt;2.3.CO;2; Sukreeyapongse O, 2002, J ENVIRON QUAL, V31, P1901, DOI 10.2134/jeq2002.1901; Tudoreanu L, 2004, J SCI FOOD AGR, V84, P845, DOI 10.1002/jsfa.1730; Van Sprang PA, 2009, SCI TOTAL ENVIRON, V407, P5373, DOI 10.1016/j.scitotenv.2009.06.029; Wang AS, 2006, PLANT SOIL, V281, P325, DOI 10.1007/s11104-005-4642-9; Wang J, 2009, GEODERMA, V148, P299, DOI 10.1016/j.geoderma.2008.10.015; Wang XP, 2004, CHEMOSPHERE, V55, P811, DOI 10.1016/j.chemosphere.2003.12.003; Wang XQ, 2012, ECOLOGICAL THRESHOLD; Zarcinas BA, 1996, COMMUN SOIL SCI PLAN, V27, P1331, DOI 10.1080/00103629609369636; Zeng F, 2001, ENVIRON POLLUT, V159, P84; Zhang CB, 2006, GEODERMA, V136, P555, DOI 10.1016/j.geoderma.2006.04.011; Zhao KL, 2010, J HAZARD MATER, V181, P778, DOI 10.1016/j.jhazmat.2010.05.081	61	17	18	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e80855	10.1371/journal.pone.0080855	http://dx.doi.org/10.1371/journal.pone.0080855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324636	gold, Green Published, Green Submitted			2022-12-25	WOS:000328566700019
J	Crabbe, A; Nielsen-Preiss, SM; Woolley, CM; Barrila, J; Buchanan, K; McCracken, J; Inglis, DO; Searles, SC; Nelman-Gonzalez, MA; Ott, CM; Wilson, JW; Pierson, DL; Stefanyshyn-Piper, HM; Hyman, LE; Nickerson, CA				Crabbe, Aurelie; Nielsen-Preiss, Sheila M.; Woolley, Christine M.; Barrila, Jennifer; Buchanan, Kent; McCracken, James; Inglis, Diane O.; Searles, Stephen C.; Nelman-Gonzalez, Mayra A.; Ott, C. Mark; Wilson, James W.; Pierson, Duane L.; Stefanyshyn-Piper, Heidemarie M.; Hyman, Linda E.; Nickerson, Cheryl A.			Spaceflight Enhances Cell Aggregation and Random Budding in Candida albicans	PLOS ONE			English	Article							SHEAR MODELED MICROGRAVITY; BACTERIAL GENE-EXPRESSION; SM-LIKE PROTEINS; SACCHAROMYCES-CEREVISIAE; BIOFILM FORMATION; SPACE-FLIGHT; LSM PROTEINS; REDUCED SUSCEPTIBILITY; FILAMENTOUS GROWTH; HYPHAL DEVELOPMENT	This study presents the first global transcriptional profiling and phenotypic characterization of the major human opportunistic fungal pathogen, Candida albicans, grown in spaceflight conditions. Microarray analysis revealed that C. albicans subjected to short-term spaceflight culture differentially regulated 452 genes compared to synchronous ground controls, which represented 8.3% of the analyzed ORFs. Spaceflight-cultured C. albicans-induced genes involved in cell aggregation (similar to flocculation), which was validated by microscopic and flow cytometry analysis. We also observed enhanced random budding of spaceflight-cultured cells as opposed to bipolar budding patterns for ground samples, in accordance with the gene expression data. Furthermore, genes involved in antifungal agent and stress resistance were differentially regulated in spaceflight, including induction of ABC transporters and members of the major facilitator family, downregulation of ergosterol-encoding genes, and upregulation of genes involved in oxidative stress resistance. Finally, downregulation of genes involved in actin cytoskeleton was observed. Interestingly, the transcriptional regulator Cap1 and over 30% of the Cap1 regulon was differentially expressed in spaceflight-cultured C. albicans. A potential role for Cap1 in the spaceflight response of C. albicans is suggested, as this regulator is involved in random budding, cell aggregation, and oxidative stress resistance; all related to observed spaceflight-associated changes of C. albicans. While culture of C. albicans in microgravity potentiates a global change in gene expression that could induce a virulence-related phenotype, no increased virulence in a murine intraperitoneal (i.p.) infection model was observed under the conditions of this study. Collectively, our data represent an important basis for the assessment of the risk that commensal flora could play during human spaceflight missions. Furthermore, since the low fluid-shear environment of microgravity is relevant to physical forces encountered by pathogens during the infection process, insights gained from this study could identify novel infectious disease mechanisms, with downstream benefits for the general public.	[Nickerson, Cheryl A.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85069 USA; [Crabbe, Aurelie; Barrila, Jennifer; Wilson, James W.; Nickerson, Cheryl A.] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ USA; [Nielsen-Preiss, Sheila M.; Woolley, Christine M.; Searles, Stephen C.; Hyman, Linda E.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA; [Buchanan, Kent] Oklahoma City Univ, Dept Biol, Oklahoma City, OK USA; [Buchanan, Kent; McCracken, James; Wilson, James W.] Tulane Univ, Program Mol Pathogenesis & Immun, Dept Microbiol & Immunol, Hlth Sci Ctr, New Orleans, LA 70118 USA; [McCracken, James] Univ Louisville, Diabet & Obes Ctr, Louisville, KY 40292 USA; [Inglis, Diane O.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA USA; [Nelman-Gonzalez, Mayra A.] Wyle Sci Technol & Engn Grp, Houston, TX USA; [Ott, C. Mark; Pierson, Duane L.] NASA, Biomed Res & Environm Sci Div, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Wilson, James W.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA; [Stefanyshyn-Piper, Heidemarie M.] NASA, Astronaut Off, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Hyman, Linda E.] Boston Univ, Sch Med, Boston, MA 02118 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Montana State University System; Montana State University Bozeman; Tulane University; University of Louisville; Stanford University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Villanova University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Boston University	Nickerson, CA (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85069 USA.	cheryl.nickerson@asu.edu		Crabbe, Aurelie/0000-0003-3084-4418; Hyman, Linda/0000-0002-2511-2928; Barrila, Jennifer/0000-0002-6597-3001; Ott, Mark/0000-0002-3101-4806; Inglis, Diane/0000-0003-3166-4638	National Aeronautics and Space Administration [NCC2-1362, NNX09AH40G, NNX10AO52G]	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	This work was supported by National Aeronautics and Space Administration grants NCC2-1362, NNX09AH40G, and NNX10AO52G (to C.A.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fattani MA, 2006, J MED MICROBIOL, V55, P999, DOI 10.1099/jmm.0.46569-0; Altenburg Sara D., 2008, Genomics Proteomics & Bioinformatics, V6, P42, DOI 10.1016/S1672-0229(08)60019-4; [Anonymous], 2012, INT J MICROBIOL, DOI DOI 10.1155/2012/528521; Baillie GS, 2000, J ANTIMICROB CHEMOTH, V46, P397, DOI 10.1093/jac/46.3.397; Banerjee M, 2013, EUKARYOT CELL, V12, P224, DOI 10.1128/EC.00163-12; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Bauer J, 2007, EUKARYOT CELL, V6, P1736, DOI 10.1128/EC.00236-07; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERRY D, 1979, APPL ENVIRON MICROB, V38, P751, DOI 10.1128/AEM.38.4.751-753.1979; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Silvia B, 2010, BBA-MOL CELL RES, V1803, P1376, DOI 10.1016/j.bbamcr.2010.07.007; Brown V, 2006, EUKARYOT CELL, V5, P1726, DOI 10.1128/EC.00186-06; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Castro SL, 2011, APPL ENVIRON MICROB, V77, P6368, DOI 10.1128/AEM.00175-11; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Chant T, 1999, ANNU REV CELL DEV BI, V15, P365, DOI 10.1146/annurev.cellbio.15.1.365; Coenye T., 2011, The Open Mycology Journal, V5, P9, DOI 10.2174/1874437001105010009; Crabbe A, 2008, ENVIRON MICROBIOL, V10, P2098, DOI 10.1111/j.1462-2920.2008.01631.x; Crabbe A, 2011, APPL ENVIRON MICROB, V77, P1221, DOI 10.1128/AEM.01582-10; Crabbe A, 2010, ENVIRON MICROBIOL, V12, P1545, DOI 10.1111/j.1462-2920.2010.02184.x; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Di Talia S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000221; Dickson K J, 1991, ASGSB Bull, V4, P151; Fillman C, 2005, CURR OPIN CELL BIOL, V17, P326, DOI 10.1016/j.ceb.2005.04.002; FREEMAN NL, 1995, J BIOL CHEM, V270, P5680, DOI 10.1074/jbc.270.10.5680; Fu Y, 2002, MOL MICROBIOL, V44, P61, DOI 10.1046/j.1365-2958.2002.02873.x; GIMENO CJ, 1992, SCIENCE, V257, P626, DOI 10.1126/science.1496375; Granger BL, 2005, MICROBIOL-SGM, V151, P1631, DOI 10.1099/mic.0.27663-0; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Guisbert E, 2007, J BACTERIOL, V189, P1963, DOI 10.1128/JB.01243-06; Guo P, 2000, AM J PHYSIOL-RENAL, V279, pF698, DOI 10.1152/ajprenal.2000.279.4.F698; Gutierrez-Escribano P, 2011, MOL BIOL CELL, V22, P2458, DOI 10.1091/mbc.E11-03-0205; HARTWELL LH, 1977, J CELL BIOL, V75, P422, DOI 10.1083/jcb.75.2.422; Hawser SP, 1998, J MED MICROBIOL, V47, P253, DOI 10.1099/00222615-47-3-253; Hollander J, 1998, FREE RADICAL BIO MED, V24, P385, DOI 10.1016/S0891-5849(97)00278-5; Horneck G, 2010, MICROBIOL MOL BIOL R, V74, P121, DOI 10.1128/MMBR.00016-09; Huang Y, 2012, J APPL MICROBIOL, V112, P683, DOI 10.1111/j.1365-2672.2012.05251.x; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; Inglis DO, 2012, NUCLEIC ACIDS RES, V40, pD667, DOI 10.1093/nar/gkr945; Johanson K, 2002, J APPL PHYSIOL, V93, P2171, DOI 10.1152/japplphysiol.01087.2001; Kaur I, 2005, BRAIN BEHAV IMMUN, V19, P547, DOI 10.1016/j.bbi.2004.12.006; Kelly MT, 2004, MOL MICROBIOL, V53, P969, DOI 10.1111/j.1365-2958.2004.04185.x; Khusial P, 2005, TRENDS BIOCHEM SCI, V30, P522, DOI 10.1016/j.tibs.2005.07.006; Kim W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062437; Klotz SA, 2007, MED MYCOL, V45, P363, DOI 10.1080/13693780701299333; LaFleur MD, 2006, ANTIMICROB AGENTS CH, V50, P3839, DOI 10.1128/AAC.00684-06; Lim CSY, 2012, EUR J CLIN MICROBIOL, V31, P21, DOI 10.1007/s10096-011-1273-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeb JDJ, 1999, MOL CELL BIOL, V19, P4019; Lynch SV, 2006, APPL ENVIRON MICROB, V72, P7701, DOI 10.1128/AEM.01294-06; Mayes AE, 1999, EMBO J, V18, P4321, DOI 10.1093/emboj/18.15.4321; McCullough MJ, 1996, INT J ORAL MAX SURG, V25, P136, DOI 10.1016/S0901-5027(96)80060-9; Mikulecky PJ, 2004, NAT STRUCT MOL BIOL, V11, P1206, DOI 10.1038/nsmb858; Mitchell AP, 1998, CURR OPIN MICROBIOL, V1, P687, DOI 10.1016/S1369-5274(98)80116-1; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Monge RA, 2006, MICROBIOL-SGM, V152, P905, DOI 10.1099/mic.0.28616-0; Nailis H, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-25; NASMYTH KA, 1982, ANNU REV GENET, V16, P439, DOI 10.1146/annurev.ge.16.120182.002255; Nauman EA, 2007, APPL ENVIRON MICROB, V73, P699, DOI 10.1128/AEM.02428-06; Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147; Nickerson CA, 2004, MICROBIOL MOL BIOL R, V68, P345, DOI 10.1128/MMBR.68.2.345-361.2004; Nickerson CA, 2003, J MICROBIOL METH, V54, P1, DOI 10.1016/S0167-7012(03)00018-6; Nickerson CA, 2000, INFECT IMMUN, V68, P3147, DOI 10.1128/IAI.68.6.3147-3152.2000; Nobile CJ, 2006, CELL MICROBIOL, V8, P1382, DOI 10.1111/j.1462-5822.2006.00761.x; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Nobile CJ, 2012, CELL, V148, P126, DOI 10.1016/j.cell.2011.10.048; PIERSON DL, 1995, J MED VET MYCOL, V33, P145; Pietsch J, 2011, CURR MOL MED, V11, P350, DOI 10.2174/156652411795976600; Purevdorj-Gage B, 2006, APPL ENVIRON MICROB, V72, P4569, DOI 10.1128/AEM.03050-05; Ramage G, 2009, CRIT REV MICROBIOL, V35, P340, DOI 10.3109/10408410903241436; Rizzo AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032361; Rosado H, 2010, ACTA ASTRONAUT, V66, P408, DOI 10.1016/j.actaastro.2009.06.007; Sanglard D, 2009, FEMS YEAST RES, V9, P1029, DOI 10.1111/j.1567-1364.2009.00578.x; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Schwarz R. P, 1992, US Patent, Patent No. [5,153,131, 5153131]; Searles SC, 2011, ASTROBIOLOGY, V11, P825, DOI 10.1089/ast.2011.0664; SERAPHIN B, 1995, EMBO J, V14, P2089, DOI 10.1002/j.1460-2075.1995.tb07200.x; Sexton JA, 2007, YEAST, V24, P847, DOI 10.1002/yea.1514; Sheehan KB, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-3; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; SMALE ST, 1985, MOL CELL BIOL, V5, P352, DOI 10.1128/MCB.5.2.352; Smith SM, 2005, J NUTR, V135, P437, DOI 10.1093/jn/135.3.437; Sobti M, 2010, BIOCHEMISTRY-US, V49, P2335, DOI 10.1021/bi901767w; Soll DR, 2002, ACTA TROP, V81, P101, DOI 10.1016/S0001-706X(01)00200-5; Sonnenfeld G, 2005, CURR PHARM BIOTECHNO, V6, P343, DOI 10.2174/1389201054553699; Spiller MP, 2007, J CELL SCI, V120, P4310, DOI 10.1242/jcs.019943; Stein TP, 2002, NUTRITION, V18, P867, DOI 10.1016/S0899-9007(02)00938-3; Taff HT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002848; TAYLOR GR, 1974, AEROSPACE MED, V45, P824; Van Mulders SE, 2011, ASTROBIOLOGY, V11, P45, DOI 10.1089/ast.2010.0518; Vandeputte P, 2008, ANTIMICROB AGENTS CH, V52, P3701, DOI 10.1128/AAC.00423-08; Vandeputte P, 2007, ANTIMICROB AGENTS CH, V51, P982, DOI 10.1128/AAC.01510-06; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; Vesper SJ, 2008, RES MICROBIOL, V159, P432, DOI 10.1016/j.resmic.2008.06.001; Vinces MD, 2006, EUKARYOT CELL, V5, P825, DOI 10.1128/EC.5.5.825-835.2006; Walther I, 1996, J BIOTECHNOL, V47, P113, DOI 10.1016/0168-1656(96)01375-2; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; Wilson JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003923; Wilson JW, 2002, APPL ENVIRON MICROB, V68, P5408, DOI 10.1128/AEM.68.11.5408-5416.2002; Wilson JW, 2002, P NATL ACAD SCI USA, V99, P13807, DOI 10.1073/pnas.212387899; Wilusz CJ, 2005, NAT STRUCT MOL BIOL, V12, P1031, DOI 10.1038/nsmb1037; Zelicof A, 1996, J BIOL CHEM, V271, P18243, DOI 10.1074/jbc.271.30.18243; Zheng XD, 2004, EMBO J, V23, P1845, DOI 10.1038/sj.emboj.7600195; Znaidi S, 2009, EUKARYOT CELL, V8, P806, DOI 10.1128/EC.00002-09	107	51	54	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80677	10.1371/journal.pone.0080677	http://dx.doi.org/10.1371/journal.pone.0080677			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324620	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300038
J	Lambert, LJ; Walker, S; Feltham, J; Lee, HJ; Reik, W; Houseley, J				Lambert, Laurens J.; Walker, Simon; Feltham, Jack; Lee, Heather J.; Reik, Wolf; Houseley, Jonathan			Etoposide Induces Nuclear Re-Localisation of AID	PLOS ONE			English	Article							INDUCED CYTIDINE DEAMINASE; CLASS-SWITCH RECOMBINATION; ACTIVE DNA DEMETHYLATION; SOMATIC HYPERMUTATION; TOPOISOMERASE-II; STRAND BREAKS; CELL; GLYCOSYLASE; ENZYME; EXPORT	During B cell activation, the DNA lesions that initiate somatic hypermutation and class switch recombination are introduced by activation-induced cytidine deaminase (AID). AID is a highly mutagenic protein that is maintained in the cytoplasm at steady state, however AID is shuttled across the nuclear membrane and the protein transiently present in the nucleus appears sufficient for targeted alteration of immunoglobulin loci. AID has been implicated in epigenetic reprogramming in primordial germ cells and cell fusions and in induced pluripotent stem cells (iPS cells), however AID expression in non-B cells is very low. We hypothesised that epigenetic reprogramming would require a pathway that instigates prolonged nuclear residence of AID. Here we show that AID is completely re-localised to the nucleus during drug withdrawal following etoposide treatment, in the period in which double strand breaks (DSBs) are repaired. Re-localisation occurs 2-6 hours after etoposide treatment, and AID remains in the nucleus for 10 or more hours, during which time cells remain live and motile. Re-localisation is cell-cycle dependent and is only observed in G2. Analysis of DSB dynamics shows that AID is re-localised in response to etoposide treatment, however re-localisation occurs substantially after DSB formation and the levels of re-localisation do not correlate with gamma H2AX levels. We conclude that DSB formation initiates a slow-acting pathway which allows stable long-term nuclear localisation of AID, and that such a pathway may enable AID-induced DNA demethylation during epigenetic reprogramming.	[Lambert, Laurens J.; Walker, Simon; Feltham, Jack; Lee, Heather J.; Reik, Wolf; Houseley, Jonathan] Babraham Inst, Epigenet Programme, Cambridge, England; [Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge, England; [Reik, Wolf] Wellcome Trust Sanger Inst, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; Wellcome Trust Sanger Institute	Houseley, J (corresponding author), Babraham Inst, Epigenet Programme, Cambridge, England.	jon.houseley@babraham.ac.uk	Lee, Heather/M-2670-2019; Reik, Wolf/I-6794-2012; Houseley, Jon/AAF-7409-2021	Lee, Heather/0000-0002-6482-0337; Houseley, Jonathan/0000-0001-8509-1500; Walker, Simon/0000-0001-9185-4922; Reik, Wolf/0000-0003-0216-9881	Wellcome Trust [088335/Z/09/Z, 095645/Z/11/Z]; BBSRC; EU BLUEPRINT; Erasmus Lifelong Learning Programme; Wellcome Trust Vacation Scholarship; BBSRC [BBS/E/B/0000H247, BBS/E/B/000C0403] Funding Source: UKRI; MRC [G0700098] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0403, BBS/E/B/0000H247] Funding Source: researchfish; Medical Research Council [G0700098] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU BLUEPRINT; Erasmus Lifelong Learning Programme; Wellcome Trust Vacation Scholarship(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Wellcome Trust [088335/Z/09/Z] (www.wellcome.ac.uk). WR is funded by the Wellcome Trust [095645/Z/11/Z], the BBSRC (www.bbsrc.ac.uk), and EU BLUEPRINT (www.blueprint-epigenome.eu). HL is funded by EU BLUEPRINT. LL was funded by the Erasmus Lifelong Learning Programme (www.lifelonglearningprogramme.org.uk). JF is funded by a Wellcome Trust Vacation Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoufouchi S, 2008, J EXP MED, V205, P1357, DOI 10.1084/jem.20070950; Arakawa H, 2006, PLOS BIOL, V4, P1947, DOI 10.1371/journal.pbio.0040366; Arudchandran A, 2004, J IMMUNOL, V173, P3223, DOI 10.4049/jimmunol.173.5.3223; Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Bhutani N, 2013, FASEB J, V27, P1107, DOI 10.1096/fj.12-222125; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Boboila C, 2012, ADV IMMUNOL, V116, P1, DOI 10.1016/B978-0-12-394300-2.00001-6; Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200; Cattoretti G, 2006, BLOOD, V107, P3967, DOI 10.1182/blood-2005-10-4170; CHOW KC, 1987, MOL CELL BIOL, V7, P3119, DOI 10.1128/MCB.7.9.3119; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Ellyard JI, 2011, EUR J IMMUNOL, V41, P485, DOI 10.1002/eji.201041011; Faili A, 2004, J EXP MED, V199, P265, DOI 10.1084/jem.20031831; Geisberger R, 2009, P NATL ACAD SCI USA, V106, P6736, DOI 10.1073/pnas.0810808106; Guikema JEJ, 2007, J EXP MED, V204, P3017, DOI 10.1084/jem.20071289; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hasler J, 2011, P NATL ACAD SCI USA, V108, P18366, DOI 10.1073/pnas.1106729108; Hajji N, 2003, MUTAT RES-FUND MOL M, V530, P35, DOI 10.1016/S0027-5107(03)00135-0; Hasham MG, 2010, NAT IMMUNOL, V11, P820, DOI 10.1038/ni.1909; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huang KC, 2001, J BIOL CHEM, V276, P44488, DOI 10.1074/jbc.M104383200; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; KIM YJ, 2012, CURR MOL PHARMACOL, V3, P3, DOI DOI 10.2174/1874467211205010003.PUBMED:22122461; Kumar R, 2013, NATURE, V500, P89, DOI 10.1038/nature12299; Maeda K, 2010, J BIOL CHEM, V285, P23945, DOI 10.1074/jbc.M110.131441; Martin A, 2003, J EXP MED, V198, P1171, DOI 10.1084/jem.20030880; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Martomo SA, 2004, J EXP MED, V200, P61, DOI 10.1084/jem.20040691; Masani S, 2013, MOL CELL BIOL, V33, P1468, DOI 10.1128/MCB.00026-13; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Mu YX, 2012, J BIOL CHEM, V287, P28007, DOI 10.1074/jbc.M112.370189; Munoz DP, 2013, P NATL ACAD SCI USA, V110, pE2977, DOI 10.1073/pnas.1301021110; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rada C, 2002, P NATL ACAD SCI USA, V99, P7003, DOI 10.1073/pnas.092160999; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rangam G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043279; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; Rush JS, 2004, INT IMMUNOL, V16, P549, DOI 10.1093/intimm/dxh057; Schreck S, 2006, J PATHOL, V210, P26, DOI 10.1002/path.2014; Smith HC, 2012, SEMIN CELL DEV BIOL, V23, P258, DOI 10.1016/j.semcdb.2011.10.004; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Uchimura Y, 2011, J EXP MED, V208, P2385, DOI 10.1084/jem.20110856; WARD JF, 1987, BR J CANC S, V8, P105; Wijesinghe P, 2012, NUCLEIC ACIDS RES, V40, P9206, DOI 10.1093/nar/gks685; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Zaprazna K, 2012, MOL CELL BIOL, V32, P1542, DOI 10.1128/MCB.05989-11	60	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82110	10.1371/journal.pone.0082110	http://dx.doi.org/10.1371/journal.pone.0082110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324754	Green Published, gold			2022-12-25	WOS:000327949300131
J	Zuo, QF; Yang, LY; Feng, Q; Lu, DS; Dong, YD; Cai, CZ; Wu, Y; Guo, Y; Gu, J; Zeng, H; Zou, QM				Zuo, Qian-Fei; Yang, Liu-Yang; Feng, Qiang; Lu, Dong-Shui; Dong, Yan-Dong; Cai, Chang-Zhi; Wu, Yi; Guo, Ying; Gu, Jiang; Zeng, Hao; Zou, Quan-Ming			Evaluation of the Protective Immunity of a Novel Subunit Fusion Vaccine in a Murine Model of Systemic MRSA Infection	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS INFECTIONS; CLUMPING FACTOR-A; CAPSULAR POLYSACCHARIDE; MEDICAL PROGRESS; NASAL CARRIAGE; UNITED-STATES; ALPHA-TOXIN; MICE; DETERMINANT; PROTEIN	Staphylococcus aureus is a common commensal organism in humans and a major cause of bacteremia and hospital acquired infection. Because of the spread of strains resistant to antibiotics, these infections are becoming more difficult to treat. Therefore, exploration of anti-staphylococcal vaccines is currently a high priority. Iron surface determinant B (IsdB) is an iron-regulated cell wall-anchored surface protein of S. aureus. Alpha-toxin (Hla) is a secreted cytolytic pore-forming toxin. Previous studies reported that immunization with IsdB or Hla protected animals against S. aureus infection. To develop a broadly protective vaccine, we constructed chimeric vaccines based on IsdB and Hla. Immunization with the chimeric bivalent vaccine induced strong antibody and T cell responses. When the protective efficacy of the chimeric bivalent vaccine was compared to that of individual proteins in a murine model of systemic S. aureus infection, the bivalent vaccine showed a stronger protective immune response than the individual proteins (IsdB or Hla). Based on the results presented here, the chimeric bivalent vaccine affords higher levels of protection against S. aureus and has potential as a more effective candidate vaccine.	[Zuo, Qian-Fei; Yang, Liu-Yang; Feng, Qiang; Lu, Dong-Shui; Dong, Yan-Dong; Cai, Chang-Zhi; Wu, Yi; Guo, Ying; Gu, Jiang; Zeng, Hao; Zou, Quan-Ming] Third Mil Med Univ, Coll Med Lab Sci, Dept Clin Microbiol & Immunol, Chongqing, Peoples R China	Army Medical University	Zeng, H (corresponding author), Third Mil Med Univ, Coll Med Lab Sci, Dept Clin Microbiol & Immunol, Chongqing, Peoples R China.	zeng1109@163.com; qmzou2007@163.com	yang, liu/GVU-8760-2022; liu, yang/HHY-8583-2022; Gu, Jiang/AAT-2432-2021	Gu, Jiang/0000-0001-8035-4551	National Natural Science Foundation of China [81172892]; NSFC-NIH [81261120396]; Natural Science Foundation of Chongqing [CSTC2011jjA10071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-NIH; Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing)	This research was supported by National Natural Science Foundation of China (Grant NO: 81172892) and by NSFC-NIH International Cooperation Grant (NO: 81261120396) and by Natural Science Foundation of Chongqing (Grant NO: CSTC2011jjA10071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrecubieta C, 2008, J INFECT DIS, V198, P571, DOI 10.1086/590210; Clarke SR, 2006, J INFECT DIS, V193, P1098, DOI 10.1086/501471; DeDent A, 2012, SEMIN IMMUNOPATHOL, V34, P317, DOI 10.1007/s00281-011-0299-z; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Durai R, 2010, AORN J, V91, P7; Durai Rajaraman, 2010, AORN J, V91, P599, DOI 10.1016/j.aorn.2009.11.065; Ebert Tim, 2010, Human Antibodies, V19, P113, DOI 10.3233/HAB-2010-0235; FATTOM A, 1990, INFECT IMMUN, V58, P2367, DOI 10.1128/IAI.58.7.2367-2374.1990; Fattom AI, 1996, INFECT IMMUN, V64, P1659, DOI 10.1128/IAI.64.5.1659-1665.1996; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430; Joshi A, 2012, HUM VACC IMMUNOTHER, V8, P336, DOI DOI 10.4161/HV.18946; Kaslow DC, 2011, ANNU REV MED, V62, P201, DOI 10.1146/annurev-med-051109-101544; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Lee JC, 1997, INFECT IMMUN, V65, P4146, DOI 10.1128/IAI.65.10.4146-4151.1997; Liang XD, 2006, CELL MICROBIOL, V8, P1656, DOI 10.1111/j.1462-5822.2006.00740.x; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Maira-Litran T, 2005, INFECT IMMUN, V73, P6752, DOI 10.1128/IAI.73.10.6752-6762.2005; MAMO W, 1994, VACCINE, V12, P988, DOI 10.1016/0264-410X(94)90333-6; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Narita K, 2010, INFECT IMMUN, V78, P4234, DOI 10.1128/IAI.00447-10; Nilsson IM, 1998, J CLIN INVEST, V101, P2640, DOI 10.1172/JCI1823; Proctor RA, 2012, VACCINE, V30, P2921, DOI 10.1016/j.vaccine.2011.11.006; Schaffer AC, 2006, INFECT IMMUN, V74, P2145, DOI 10.1128/IAI.74.4.2145-2153.2006; SCHLIEVERT PM, 1981, J INFECT DIS, V143, P509, DOI 10.1093/infdis/143.4.509; Spellberg B, 2012, SEMIN IMMUNOPATHOL, V34, P335, DOI 10.1007/s00281-011-0293-5; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Valeva A, 1996, EMBO J, V15, P1857, DOI 10.1002/j.1460-2075.1996.tb00536.x; Verkaik NJ, 2011, IMMUNOTHERAPY-UK, V3, P1063, DOI [10.2217/imt.11.84, 10.2217/IMT.11.84]; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Zhao YX, 1998, IMMUNOLOGY, V93, P80	36	19	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81212	10.1371/journal.pone.0081212	http://dx.doi.org/10.1371/journal.pone.0081212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324681	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300083
J	Culot, M; Fabulas-da Costa, A; Sevin, E; Szorath, E; Martinsson, S; Renftel, M; Yan, HM; Cecchelli, R; Lundquist, S				Culot, Maxime; Fabulas-da Costa, Anaelle; Sevin, Emmanuel; Szorath, Erica; Martinsson, Stefan; Renftel, Mila; Yan Hongmei; Cecchelli, Romeo; Lundquist, Stefan			A Simple Method for Assessing Free Brain/Free Plasma Ratios Using an In Vitro Model of the Blood Brain Barrier	PLOS ONE			English	Article							DRUG DISCOVERY; DELIVERY; EXTENT	Historically, the focus has been to use in vitro BBB models to optimize rate of drug delivery to the CNS, whereas total in vivo brain/plasma ratios have been used for optimizing extent. However, these two parameters do not necessarily show good correlations with receptor occupancy data or other pharmacological readouts. In line with the free drug hypothesis, the use of unbound brain concentrations (Cu,br) has been shown to provide the best correlations with pharmacological data. However, typically the determination of this parameter requires microdialysis, a technique not ideally suited for screening in early drug development. Alternative, and less resource-demanding methodologies to determine Cu, br employ either equilibrium dialysis of brain homogenates or incubations of brain slices in buffer to determine fraction unbound brain (fu,br), which is subsequently multiplied by the total brain concentration to yield Cu, br. To determine Cu,br/Cu,pl ratios this way, still requires both in vitro and in vivo experiments that are quite time consuming. The main objective of this study was to explore the possibility to directly generate Cu, br/Cu, pl ratios in a single in vitro model of the BBB, using a co-culture of brain capillary endothelial and glial cells in an attempt to mimick the in vivo situation, thereby greatly simplifying existing experimental procedures. Comparison to microdialysis brain concentration profiles demonstrates the possibility to estimate brain exposure over time in the BBB model. A stronger correlation was found between in vitro Cu, br/Cu, pl ratios and in vivo Cu, br/Cu, pl obtained using fu, br from brain slice than with fu, br from brain homogenate for a set of 30 drugs. Overall, Cu, br/Cu, pl ratios were successfully predicted in vitro for 88% of the 92 studied compounds. This result supports the possibility to use this methodology for identifying compounds with a desirable in vivo response in the CNS early on in the drug discovery process.	[Culot, Maxime; Fabulas-da Costa, Anaelle; Sevin, Emmanuel; Cecchelli, Romeo] IMPRT IFR114 Univ Lille Nord France, BBB Lab EA 2465, Uartois, Lens, France; [Szorath, Erica; Martinsson, Stefan; Renftel, Mila; Yan Hongmei; Lundquist, Stefan] AstraZeneca R&D, DMPK Dept, Sodertalje, Sweden	AstraZeneca	Culot, M (corresponding author), IMPRT IFR114 Univ Lille Nord France, BBB Lab EA 2465, Uartois, Lens, France.	maxime.culot@univ-artois.fr		CULOT, Maxime/0000-0001-7452-0867	DMPK, AstraZeneca R&D, Sodertalje, Sweden; Conseil Regional du Nord-Pas-de-Calais; Pole de recherche interdisciplinaire sur le medicament - PRIM	DMPK, AstraZeneca R&D, Sodertalje, Sweden; Conseil Regional du Nord-Pas-de-Calais(Region Hauts-de-FranceRegion Ile-de-France); Pole de recherche interdisciplinaire sur le medicament - PRIM	This work was supported by DMPK, AstraZeneca R&D, Sodertalje, S-151 85, Sweden and the 'Conseil Regional du Nord-Pas-de-Calais' (fellowship to A. da Costa and support from Pole de recherche interdisciplinaire sur le medicament - PRIM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker S, 2006, DRUG METAB DISPOS, V34, P855, DOI 10.1124/dmd.105.007914; BOOHER J, 1972, Neurobiology (Copenhagen), V2, P97; Cecchelli R, 1999, ADV DRUG DELIVER REV, V36, P165, DOI 10.1016/S0169-409X(98)00083-0; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; DEHOUCK MP, 1990, J NEUROCHEM, V54, P1798, DOI 10.1111/j.1471-4159.1990.tb01236.x; Friden M, 2007, DRUG METAB DISPOS, V35, P1711, DOI 10.1124/dmd.107.015222; Friden M, 2011, DRUG METAB DISPOS, V39, P353, DOI 10.1124/dmd.110.035998; Hammarlund-Udenaes M, 2000, ADV DRUG DELIVER REV, V45, P283, DOI 10.1016/S0169-409X(00)00109-5; Hammarlund-Udenaes M, 2008, PHARM RES-DORDR, V25, P1737, DOI 10.1007/s11095-007-9502-2; Kalvass JC, 2007, DRUG METAB DISPOS, V35, P660, DOI 10.1124/dmd.106.012294; Kalvass JC, 2002, BIOPHARM DRUG DISPOS, V23, P327, DOI 10.1002/bdd.325; Liu XR, 2006, DRUG METAB DISPOS, V34, P1443, DOI 10.1124/dmd.105.008201; Toth Andrea, 2011, Recent Pat CNS Drug Discov, V6, P107	13	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e80634	10.1371/journal.pone.0080634	http://dx.doi.org/10.1371/journal.pone.0080634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312489	gold, Green Published, Green Submitted			2022-12-25	WOS:000327947800017
J	Kinjo, A; Koito, T; Kawaguchi, S; Inoue, K				Kinjo, Azusa; Koito, Tomoko; Kawaguchi, So; Inoue, Koji			Evolutionary History of the GABA Transporter (GAT) Group Revealed by Marine Invertebrate GAT-1	PLOS ONE			English	Article							TAURINE TRANSPORTER; CREATINE TRANSPORTER; EXPRESSION; CLONING; RAT; LOCALIZATION; HETEROGENEITY; PHARMACOLOGY; ALIGNMENT; ENCODES	The GABA transporter (GAT) group is one of the major subgroups in the solute career 6 (SLC6) family of transmembrane proteins. The GAT group, which has been well studied in mammals, has 6 known members, i.e., a taurine transporter (TAUT), four GABA transporters (GAT-1, -2, -3, -4), and a creatine transporter (CT1), which have important roles in maintaining physiological homeostasis. However, the GAT group has not been extensively investigated in invertebrates; only TAUT has been reported in marine invertebrates such as bivalves and krills, and GAT-1 has been reported in several insect species and nematodes. Thus, it is unknown how transporters in the GAT group arose during the course of animal evolution. In this study, we cloned GAT-1 cDNAs from the deep-sea mussel, Bathymodiolus septemdierum, and the Antarctic krill, Euphausia superba, whose TAUT cDNA has already been cloned. To understand the evolutionary history of the GAT group, we conducted phylogenetic and synteny analyses on the GAT group transporters of vertebrates and invertebrates. Our findings suggest that transporters of the GAT group evolved through the following processes. First, GAT-1 and CT1 arose by tandem duplication of an ancestral transporter gene before the divergence of Deuterostomia and Protostomia; next, the TAUT gene arose and GAT-3 was formed by the tandem duplication of the TAUT gene; and finally, GAT-2 and GAT-4 evolved from a GAT-3 gene by chromosomal duplication in the ancestral vertebrates. Based on synteny and phylogenetic evidence, the present naming of the GAT group members does not accurately reflect the evolutionary relationships.	[Kinjo, Azusa; Inoue, Koji] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Kinjo, Azusa; Inoue, Koji] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan; [Koito, Tomoko] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan; [Kawaguchi, So] Australian Antarctic Div, Kingston, Tas, Australia	University of Tokyo; University of Tokyo; Nihon University; Australian Antarctic Division	Kinjo, A (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan.	kinjoa-10a@nenv.k.u-tokyo.ac.jp		Kawaguchi, So/0000-0002-2042-5095	JSPS KAKENHI [22380107, 19380110]; Salt Science Research Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Salt Science Research Foundation	The work was supported by the following: JSPS KAKENHI Grant Number 22380107 & 19380110 URL:http://www.jsps.go.jp/english/index.html; and Salt Science Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; BORDEN LA, 1992, J BIOL CHEM, V267, P21098; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; Broer S, 2006, NEUROCHEM INT, V48, P559, DOI 10.1016/j.neuint.2005.11.021; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Christiansen B, 2007, J BIOL CHEM, V282, P19331, DOI 10.1074/jbc.M702111200; Conti F, 2004, BRAIN RES REV, V45, P196, DOI 10.1016/j.brainresrev.2004.03.003; Dalby NO, 2003, EUR J PHARMACOL, V479, P127, DOI 10.1016/j.ejphar.2003.08.063; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; HOLLAND PWH, 1994, DEVELOPMENT, P125; Hosoi M, 2005, J EXP BIOL, V208, P4203, DOI 10.1242/jeb.01868; Hosoi M, 2007, FISHERIES SCI, V73, P385, DOI 10.1111/j.1444-2906.2007.01346.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inoue K, 2008, FEBS LETT, V582, P1542, DOI 10.1016/j.febslet.2008.03.052; Jiang GL, 2005, J BIOL CHEM, V280, P2065, DOI 10.1074/jbc.M408470200; Jin XT, 2011, EUR J NEUROSCI, V33, P1504, DOI 10.1111/j.1460-9568.2011.07636.x; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kawaguchi S, 2011, BIOL LETTERS, V7, P288, DOI 10.1098/rsbl.2010.0777; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; Koito T, 2010, FISHERIES SCI, V76, P381, DOI 10.1007/s12562-010-0219-5; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Mari SA, 2006, CELL MOL LIFE SCI, V63, P100, DOI 10.1007/s00018-005-5512-6; MBUNGU D, 1995, ARCH BIOCHEM BIOPHYS, V318, P489, DOI 10.1006/abbi.1995.1258; Mullen GP, 2006, MOL BIOL CELL, V17, P3021, DOI 10.1091/mbc.E06-02-0155; Neckameyer W. S., 1998, Invertebrate Neuroscience, V3, P279, DOI 10.1007/BF02577688; Ohno S., 1970, EVOLUTION GENE DUPLI; PANTANOWITZ S, 1993, J BIOL CHEM, V268, P3222; Peral MJ, 2002, J PHYSIOL-LONDON, V545, P133, DOI 10.1113/jphysiol.2002.026377; SMITH KE, 1992, MOL PHARMACOL, V42, P563; Snow RJ, 2001, MOL CELL BIOCHEM, V224, P169, DOI 10.1023/A:1011908606819; SORA I, 1994, BIOCHEM BIOPH RES CO, V204, P419, DOI 10.1006/bbrc.1994.2475; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Takeuchi K, 2000, BBA-BIOMEMBRANES, V1464, P219, DOI 10.1016/S0005-2736(00)00158-9; Takeuchi K, 2001, FISH PHYSIOL BIOCHEM, V23, P178; Thimgan MS, 2006, J EXP BIOL, V209, P3383, DOI 10.1242/jeb.02328; VANPILSUM JF, 1975, COMP BIOCHEM PHYS A, V51, P611, DOI 10.1016/0300-9629(75)90349-7; YAMAUCHI A, 1992, J BIOL CHEM, V267, P649	38	15	15	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82410	10.1371/journal.pone.0082410	http://dx.doi.org/10.1371/journal.pone.0082410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312660	Green Published, gold, Green Submitted			2022-12-25	WOS:000327947800100
J	Wang, CC; Wei, Q; Zhang, K; Wang, L; Liu, FX; Zhao, LN; Tan, YJ; Di, C; Yan, H; Yu, JJ; Sun, CQ; Chen, WQJ; Xu, WY; Su, Z				Wang, Chunchao; Wei, Qiang; Zhang, Kang; Wang, Ling; Liu, Fengxia; Zhao, Linna; Tan, Yuanjun; Di, Chao; Yan, Hong; Yu, Jingjuan; Sun, Chuanqing; Chen, Wenqiong J.; Xu, Wenying; Su, Zhen			Down-Regulation of OsSPX1 Causes High Sensitivity to Cold and Oxidative Stresses in Rice Seedlings	PLOS ONE			English	Article							PHO1 GENE FAMILY; CELL-SURFACE RECEPTOR; PHOSPHATE HOMEOSTASIS; SPX DOMAIN; INORGANIC-PHOSPHATE; HYDROGEN-PEROXIDE; REACTIVE OXYGEN; OF-FUNCTION; ARABIDOPSIS; EXPRESSION	Rice SPX domain gene, OsSPX1, plays an important role in the phosphate (Pi) signaling network. Our previous work showed that constitutive overexpression of OsSPX1 in tobacco and Arabidopsis plants improved cold tolerance while also decreasing total leaf Pi. In the present study, we generated rice antisense and sense transgenic lines of OsSPX1 and found that down-regulation of OsSPX1 caused high sensitivity to cold and oxidative stresses in rice seedlings. Compared to wild-type and OsSPX1-sense transgenic lines, more hydrogen peroxide accumulated in seedling leaves of OsSPX1-antisense transgenic lines for controls, cold and methyl viologen (MV) treatments. Glutathione as a ROS scavenger could protect the antisense transgenic lines from cold and MV stress. Rice whole genome GeneChip analysis showed that some oxidative-stress marker genes (e. g. glutathione S-transferase and P450s) and Pi-signaling pathway related genes (e. g. OsPHO2) were significantly down-regulated by the antisense of OsSPX1. The microarray results were validated by real-time RT-PCR. Our study indicated that OsSPX1 may be involved in cross-talks between oxidative stress, cold stress and phosphate homeostasis in rice seedling leaves.	[Wang, Chunchao; Wei, Qiang; Zhang, Kang; Wang, Ling; Liu, Fengxia; Tan, Yuanjun; Di, Chao; Yan, Hong; Sun, Chuanqing; Xu, Wenying; Su, Zhen] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China; [Liu, Fengxia; Sun, Chuanqing] China Agr Univ, Dept Plant Genet & Breeding, Beijing 100094, Peoples R China; [Liu, Fengxia; Sun, Chuanqing] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Zhao, Linna; Yu, Jingjuan] China Agr Univ, Coll Biol Sci, State Key Lab Agr Biotechnol, Beijing 100094, Peoples R China; [Chen, Wenqiong J.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	China Agricultural University; China Agricultural University; China Agricultural University; China Agricultural University; California State University System; San Diego State University	Xu, WY (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China.	x_wenying@yahoo.com; zhensu@cau.edu.cn	Di, Chao/G-1130-2015		Ministry of Science and Technology of China [31071125]; Ministry of Education of China [NCET-09-0735]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education of China(Ministry of Education, China)	This work was supported by grants from the Ministry of Science and Technology of China (31071125) and the Ministry of Education of China (NCET-09-0735). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Battini JL, 1999, P NATL ACAD SCI USA, V96, P1385, DOI 10.1073/pnas.96.4.1385; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; de Pinto MC, 2006, PLANT J, V48, P784, DOI 10.1111/j.1365-313X.2006.02919.x; Duan K, 2008, PLANT J, V54, P965, DOI 10.1111/j.1365-313X.2008.03460.x; Hamburger D, 2002, PLANT CELL, V14, P889, DOI 10.1105/tpc.000745; Heitz T, 2012, J BIOL CHEM, V287, P6296, DOI 10.1074/jbc.M111.316364; Hu B, 2011, PLANT PHYSIOL, V156, P1101, DOI 10.1104/pp.110.170209; Hurlimann HC, 2009, EMBO REP, V10, P1003, DOI 10.1038/embor.2009.105; Hurry V, 2000, PLANT J, V24, P383, DOI 10.1046/j.1365-313x.2000.00888.x; Jambunathan N, 2010, METHODS MOL BIOL, V639, P291, DOI 10.1007/978-1-60761-702-0_18; Jia HF, 2011, PLANT PHYSIOL, V156, P1164, DOI 10.1104/pp.111.175240; Jiang JL, 2012, PLANT PHYSIOL BIOCH, V53, P84, DOI 10.1016/j.plaphy.2012.01.017; Kandel S, 2005, J BIOL CHEM, V280, P35881, DOI 10.1074/jbc.M500918200; Kong L, 2005, GENOME, V48, P29, DOI 10.1139/G04-097; Koo AJK, 2011, P NATL ACAD SCI USA, V108, P9298, DOI 10.1073/pnas.1103542108; Lee M, 2000, MOL MICROBIOL, V38, P411, DOI 10.1046/j.1365-2958.2000.02140.x; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Liang LZ, 2002, BBA-GENE STRUCT EXPR, V1579, P64, DOI 10.1016/S0167-4781(02)00507-9; Lim CE, 2008, MOL CELLS, V25, P368; Liu F, 2010, PLANT J, V62, P508, DOI 10.1111/j.1365-313X.2010.04170.x; Liu FX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008632; MacIntosh GC, 2010, MOL GENET GENOMICS, V283, P381, DOI 10.1007/s00438-010-0524-9; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Mittler R, 2006, FEBS LETT, V580, P6537, DOI 10.1016/j.febslet.2006.11.002; Nilsson L, 2010, PHYSIOL PLANTARUM, V139, P129, DOI 10.1111/j.1399-3054.2010.01356.x; Ribot C, 2008, PLANTA, V227, P1025, DOI 10.1007/s00425-007-0677-x; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Secco D, 2012, NEW PHYTOL, V193, P842, DOI 10.1111/j.1469-8137.2011.04002.x; Shin JH, 2009, MOL CELLS, V27, P67, DOI 10.1007/s10059-009-0006-2; SPAIN BH, 1995, J BIOL CHEM, V270, P25435, DOI 10.1074/jbc.270.43.25435; Stefanovic A, 2007, PLANT J, V50, P982, DOI 10.1111/j.1365-313X.2007.03108.x; Tailor CS, 1999, P NATL ACAD SCI USA, V96, P927, DOI 10.1073/pnas.96.3.927; TAYLOR CB, 1993, P NATL ACAD SCI USA, V90, P5118, DOI 10.1073/pnas.90.11.5118; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Voicu PM, 2007, YEAST, V24, P121, DOI 10.1002/yea.1433; Wang C, 2009, PLANT J, V57, P895, DOI 10.1111/j.1365-313X.2008.03734.x; Wang XM, 2006, PLANT CELL ENVIRON, V29, P1924, DOI 10.1111/j.1365-3040.2006.01568.x; Wang Y, 2004, PLANT PHYSIOL, V135, P400, DOI 10.1104/pp.103.037945; Wang Y, 2012, J EXP BOT, V63, P2171, DOI 10.1093/jxb/err447; Wang Y, 2008, PLANT PHYSIOL, V146, P646, DOI 10.1104/pp.107.108548; Wang ZY, 2009, J INTEGR PLANT BIOL, V51, P663, DOI 10.1111/j.1744-7909.2009.00834.x; WINGSLE G, 1993, J EXP BOT, V44, P463, DOI 10.1093/jxb/44.2.463; Zhao L, 2009, PLANT BIOTECHNOL J, V7, P550, DOI 10.1111/j.1467-7652.2009.00423.x; Zhou J, 2008, PLANT PHYSIOL, V146, P1673, DOI 10.1104/pp.107.111443; Zhou X, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-246	51	6	8	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81849	10.1371/journal.pone.0081849	http://dx.doi.org/10.1371/journal.pone.0081849			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312593	Green Published, Green Submitted, gold			2022-12-25	WOS:000327947800061
J	Divakar, PK; Kauff, F; Crespo, A; Leavitt, SD; Lumbsch, HT				Divakar, Pradeep K.; Kauff, Frank; Crespo, Ana; Leavitt, Steven D.; Lumbsch, H. Thorsten			Understanding Phenotypical Character Evolution in Parmelioid Lichenized Fungi (Parmeliaceae, Ascomycota)	PLOS ONE			English	Article							CARBON-DIOXIDE EXCHANGE; STATE RECONSTRUCTION; PHYLOGENETIC-RELATIONSHIPS; MAXIMUM-LIKELIHOOD; SPECIES SELECTION; GENERIC CONCEPTS; PLANT DEFENSE; MAJOR CLADES; DIVERSIFICATION; KEY	Parmelioid lichens form a species-rich group of predominantly foliose and fruticose lichenized fungi encompassing a broad range of morphological and chemical diversity. Using a multilocus approach, we reconstructed a phylogeny including 323 OTUs of parmelioid lichens and employed ancestral character reconstruction methods to understand the phenotypical evolution within this speciose group of lichen-forming fungi. Specifically, we were interested in the evolution of growth form, epicortex structure, and cortical chemistry. Since previous studies have shown that results may differ depending on the reconstruction method used, here we employed both maximum-parsimony and maximum-likelihood approaches to reconstruct ancestral character states. We have also implemented binary and multistate coding of characters and performed parallel analyses with both coding types to assess for potential coding-based biases. We reconstructed the ancestral states for nine well-supported major clades in the parmelioid group, two higher-level sister groups and the ancestral character state for all parmelioid lichens. We found that different methods for coding phenotypical characters and different ancestral character state reconstruction methods mostly resulted in identical reconstructions but yield conflicting inferences of ancestral states, in some cases. However, we found support for the ancestor of parmelioid lichens having been a foliose lichen with a non-pored epicortex and pseudocyphellae. Our data suggest that some traits exhibit patterns of evolution consistent with adaptive radiation.	[Divakar, Pradeep K.; Crespo, Ana] Univ Complutense Madrid, Fac Farm, Dept Biol Vegetal 2, Madrid, Spain; [Kauff, Frank] TU Kaiserslautern, FB Biol, Kaiserslautern, Germany; [Leavitt, Steven D.; Lumbsch, H. Thorsten] Field Museum, Chicago, IL 60605 USA	Complutense University of Madrid; University of Kaiserslautern; Field Museum of Natural History (Chicago)	Lumbsch, HT (corresponding author), Field Museum, Chicago, IL 60605 USA.	tlumbsch@fieldmuseum.org	Crespo, Ana/N-6236-2014; Divakar, Pradeep K/E-5603-2014; Leavitt, Steven D./AAC-6462-2021	Crespo, Ana/0000-0002-5271-0157; Divakar, Pradeep K/0000-0002-0300-0124; Leavitt, Steven D./0000-0002-5034-9724	Spanish Ministerio de Ciencia e Innovacion [CGL 2010-21646/BOS]; Ramon y Cajal [RYC02007-01576]; Universidad Complutense-Banco Santander [GR 35/10A]; National Science Foundation [DEB-0949147]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ramon y Cajal(Spanish Government); Universidad Complutense-Banco Santander; National Science Foundation(National Science Foundation (NSF))	This study was supported by the Spanish Ministerio de Ciencia e Innovacion (CGL 2010-21646/BOS) and Ramon y Cajal grant (RYC02007-01576) to PKD, the Universidad Complutense-Banco Santander (GR 35/10A), and the National Science Foundation ("Hidden diversity in parmelioid lichens", DEB-0949147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2008, ENTOMOL EXP APPL, V128, P126, DOI 10.1111/j.1570-7458.2008.00690.x; Agrawal AA, 2009, P NATL ACAD SCI USA, V106, P18067, DOI 10.1073/pnas.0904862106; de Paz GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039683; de Paz GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028161; Baloch E, 2010, TAXON, V59, P1483, DOI 10.1002/tax.595013; Beltman H. A., 1978, BIBLIOTHECA LICHENOL, V11, P1; Blanco O, 2006, MOL PHYLOGENET EVOL, V39, P52, DOI 10.1016/j.ympev.2005.12.015; Blanco O, 2004, TAXON, V53, P959, DOI 10.2307/4135563; Bromham L, 2002, MOL BIOL EVOL, V19, P302, DOI 10.1093/oxfordjournals.molbev.a004083; Buschbom J, 2006, SYST BIOL, V55, P471, DOI 10.1080/10635150600697465; Cardinal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021086; Crespo A, 1999, PLANT SYST EVOL, V217, P177, DOI 10.1007/BF00984363; Crespo A, 2004, LICHENOLOGIST, V36, P299, DOI 10.1017/S0024282904014434; Crespo A, 2001, TAXON, V50, P807, DOI 10.2307/1223708; Crespo A, 2007, MOL PHYLOGENET EVOL, V44, P812, DOI 10.1016/j.ympev.2006.11.029; Crespo A, 2011, LICHENOLOGIST, V43, P511, DOI 10.1017/S0024282911000570; Crespo A, 2010, TAXON, V59, P1735, DOI 10.1002/tax.596008; Cunningham CW, 1999, SYST BIOL, V48, P665, DOI 10.1080/106351599260238; Davies TJ, 2006, EVOLUTION, V60, P476; DIVAKAR PK, 2010, AM J BOT IN PRESS, V97; Divakar PK., 2005, PARMELIOID LICHENS I, P488; Divakar PK, 2006, MOL PHYLOGENET EVOL, V40, P448, DOI 10.1016/j.ympev.2006.03.024; Divakar PK, 2012, AM J BOT, V99, P2014, DOI 10.3732/ajb.1200258; Ekman S, 2008, SYST BIOL, V57, P141, DOI 10.1080/10635150801910451; ELIX JA, 1993, BRYOLOGIST, V96, P359, DOI 10.2307/3243867; FARRELL BD, 1991, AM NAT, V138, P881, DOI 10.1086/285258; Gauslaa Y, 2005, OECOLOGIA, V143, P94, DOI 10.1007/s00442-004-1768-z; Goldberg EE, 2008, EVOLUTION, V62, P2727, DOI 10.1111/j.1558-5646.2008.00505.x; GREEN TGA, 1981, PHYSIOL PLANTARUM, V52, P411, DOI 10.1111/j.1399-3054.1981.tb02709.x; GREEN TGA, 1982, LICHENOLOGIST, V14, P255, DOI 10.1017/S0024282982000450; Gueidan C, 2007, MYCOL RES, V111, P1145, DOI 10.1016/j.mycres.2007.08.010; Hale BW, 1999, BRYOLOGIST, V102, P462, DOI 10.2307/3244234; Hale Jr M. E., 1973, SMITHSONIAN CONTRIBU, V10, P1, DOI DOI 10.5479/SI.0081024X.10; HALE ME, 1981, LICHENOLOGIST, V13, P1, DOI 10.1017/S0024282981000030; Hawksworth DL, 1976, LICHENOLOGY PROGR PR, P139; Henssen A, 1974, LICHENES EINFUHRUNG; Hibbett DS, 2004, SYST BIOL, V53, P889, DOI 10.1080/10635150490522610; Hibbett DS, 2001, SYST BIOL, V50, P215, DOI 10.1080/10635150151125879; Hodges SA, 1995, P ROY SOC B-BIOL SCI, V262, P343, DOI 10.1098/rspb.1995.0215; HUNECK S, 1996, IDENTIFICATION LICHE, V9, P493; Ihlen PG, 2002, BIOL J LINN SOC, V77, P535, DOI 10.1046/j.1095-8312.2002.00127.x; Jablonski D, 2008, ANNU REV ECOL EVOL S, V39, P501, DOI 10.1146/annurev.ecolsys.39.110707.173510; Jahns HM, 1988, CRC HDB LICHENOLOGY, VI, P95, DOI DOI 10.1201/9780429291784-4; Lai MingJou, 2001, Fungal Science, V16, P39; Leavitt SD, 2012, BIOL J LINN SOC, V107, P920, DOI 10.1111/j.1095-8312.2012.01978.x; Leavitt SD, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-176; LICHENS THE, 1973, LICHENS, P3; Lumbsch HT, 2006, BIOL J LINN SOC, V89, P615, DOI 10.1111/j.1095-8312.2006.00696.x; Lumbsch HT, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-257; LUMBSCH HT, 1992, MYCOTAXON, V43, P277; Lumbsch HT, 1998, LICHENOLOGIST, V30, P357, DOI 10.1006/lich.1998.0147; Lumbsch HT, 1998, CHEMICAL FUNGAL TAXONOMY, P345; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Lutzoni F, 2000, AM ZOOL, V40, P1111; Lutzoni F, 1997, P NATL ACAD SCI USA, V94, P11422, DOI 10.1073/pnas.94.21.11422; Maddison WP, 2009, MESQUITE MODULAR SYS; Mank JE, 2007, J EVOLUTION BIOL, V20, P597, DOI 10.1111/j.1420-9101.2006.01251.x; McEvoy M, 2007, NEW PHYTOL, V175, P271, DOI 10.1111/j.1469-8137.2007.02096.x; MEYER A, 1994, NATURE, V368, P539, DOI 10.1038/368539a0; Moles AT, 2005, P NATL ACAD SCI USA, V102, P10540, DOI 10.1073/pnas.0501473102; Molnar K, 2010, Z NATURFORSCH C, V65, P157; NASH TH, 2008, LICHEN BIOL, V9, P486; Nimis PL, 2006, ENVIRON EXP BOT, V55, P175, DOI 10.1016/j.envexpbot.2004.10.011; NIMIS PL, 2002, MONITORING LICHENS M, V9, P408; Omland KE, 1997, EVOLUTION, V51, P1381, DOI [10.2307/2411190, 10.1111/j.1558-5646.1997.tb01461.x]; Otalora MAG, 2010, MYCOLOGIA, V102, P279, DOI 10.3852/09-114; OTT S, 2001, THE MYCOTA IX FUNGAL, P189; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pauls SU, 2008, MOL PHYLOGENET EVOL, V46, P776, DOI 10.1016/j.ympev.2007.11.003; Persoh Derek, 2002, Mycological Progress, V1, P43, DOI 10.1007/s11557-006-0004-0; Poelt J., 1974, LICHENS, P599; Rabosky DL, 2010, TRENDS ECOL EVOL, V25, P68, DOI 10.1016/j.tree.2009.07.002; Ree RH, 2005, EVOLUTION, V59, P257; Rikkinen J, 1995, BRYOBROTHERA, V4, P1; Ryberg M, 2010, MOL PHYLOGENET EVOL, V55, P431, DOI 10.1016/j.ympev.2010.02.011; SANDERSON MJ, 1994, SCIENCE, V264, P1590, DOI 10.1126/science.264.5165.1590; Sargent RD, 2004, P ROY SOC B-BIOL SCI, V271, P603, DOI 10.1098/rspb.2003.2644; Schmitt I, 2009, MOL PHYLOGENET EVOL, V52, P34, DOI 10.1016/j.ympev.2009.03.017; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Seddon N, 2008, AM NAT, V171, P620, DOI 10.1086/587071; Simon MF, 2009, P NATL ACAD SCI USA, V106, P20359, DOI 10.1073/pnas.0903410106; Solhaug KA, 2009, FLORA, V204, P40, DOI 10.1016/j.flora.2007.12.002; Thell A, 2012, NORD J BOT, V30, P641, DOI 10.1111/j.1756-1051.2012.00008.x; Vanderpoorten A, 2006, SYSTEMATIC BIOL, V55, P957, DOI 10.1080/10635150601088995	85	32	33	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e83115	10.1371/journal.pone.0083115	http://dx.doi.org/10.1371/journal.pone.0083115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312438	gold, Green Published, Green Submitted			2022-12-25	WOS:000327670300088
J	Dong, DX; Zhang, YG; Sutaria, S; Konarov, A; Chen, P				Dong, Dexian; Zhang, Yongguang; Sutaria, Sanjana; Konarov, Aishuak; Chen, Pu			Binding Mechanism and Electrochemical Properties of M13 Phage-Sulfur Composite	PLOS ONE			English	Article							BATTERIES	Self-assembly of nanostructured materials has been proven a powerful technique in material design and synthesis. By phage display screening, M13 phage was found to strongly bind sulfur particles. Fourier transform infrared and X-ray photoelectron spectroscopy measurements indicated that the strong sulfur-binding ability of M13 phage derives from newly generated S-O and C-S bonds. Using this phage assembled sulfur composite in a lithium battery, the first discharge capacity reached 1117 mAh g(-1), which is more than twice that of the sulfur only cathode. Besides, the negative polysulfide shuttle effect in a lithium-sulfur battery was significantly suppressed.	[Dong, Dexian; Zhang, Yongguang; Sutaria, Sanjana; Konarov, Aishuak; Chen, Pu] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Chen, P (corresponding author), Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.	p4chen@uwaterloo.ca	Konarov, Aishuak/AAO-6207-2020	Konarov, Aishuak/0000-0001-9352-8602	Positec; Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Foundation for Innovation (CFI); Canada Research Chairs (CRC) program	Positec; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canada Research Chairs (CRC) program(Canada Research Chairs)	This research was financially supported by Positec, the Natural Sciences and Engineering Research Council of Canada (NSERC), Canadian Foundation for Innovation (CFI) and the Canada Research Chairs (CRC) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akridge JR, 2004, SOLID STATE IONICS, V175, P243, DOI 10.1016/j.ssi.2004.07.070; Ami Diletta, 2012, Methods Mol Biol, V895, P85, DOI 10.1007/978-1-61779-927-3_7; Barchasz C, 2012, ANAL CHEM, V84, P3973, DOI 10.1021/ac2032244; Bissessur R, 2006, SYNTHETIC MET, V156, P1023, DOI 10.1016/j.synthmet.2006.06.024; Cairns EJ, 2010, ANNU REV CHEM BIOMOL, V1, P299, DOI 10.1146/annurev-chembioeng-073009-100942; Cao BR, 2011, MICROSC RES TECHNIQ, V74, P627, DOI 10.1002/jemt.21030; Cheng FY, 2011, ADV MATER, V23, P1695, DOI 10.1002/adma.201003587; Dang XN, 2011, NAT NANOTECHNOL, V6, P377, DOI [10.1038/nnano.2011.50, 10.1038/NNANO.2011.50]; Dong DX, 2013, APPL MICROBIOL BIOT, V97, P8023, DOI 10.1007/s00253-013-5049-9; Evers S, 2013, ACCOUNTS CHEM RES, V46, P1135, DOI 10.1021/ar3001348; Hajitou A, 2006, CELL, V125, P385, DOI 10.1016/j.cell.2006.02.042; Hemminga MA, 2010, EUR BIOPHYS J BIOPHY, V39, P541, DOI 10.1007/s00249-009-0523-0; Jena KK, 2007, EUR POLYM J, V43, P1825, DOI 10.1016/j.eurpolymj.2007.02.042; Ji XL, 2009, NAT MATER, V8, P500, DOI [10.1038/NMAT2460, 10.1038/nmat2460]; Lee YJ, 2009, SCIENCE, V324, P1051, DOI [10.1126/science.1171541, 10.1126/science.1169041]; Liu Z, 2012, CHEM SOC REV, V41, P6178, DOI 10.1039/c2cs35108k; Manthiram A, 2012, ACCOUNTS CHEM RES, DOI [10.1021/ar300179v., DOI 10.1021/AR300179V.PUBMED:23095063]; Mikhaylik YV, 2004, J ELECTROCHEM SOC, V151, pA1969, DOI 10.1149/1.1806394; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; Nakamoto K, 2009, INFRARED RAMAN SPECT, P292; Nam KT, 2006, SCIENCE, V312, P885, DOI 10.1126/science.1122716; Nam YS, 2010, NAT NANOTECHNOL, V5, P340, DOI [10.1038/NNANO.2010.57, 10.1038/nnano.2010.57]; Nie ZH, 2010, NAT NANOTECHNOL, V5, P15, DOI [10.1038/NNANO.2009.453, 10.1038/nnano.2009.453]; Nuraje N, 2012, ADV MATER, V24, P2885, DOI 10.1002/adma.201200114; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; Stavis C, 2011, P NATL ACAD SCI USA, V108, P983, DOI 10.1073/pnas.1006660107; Su YS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2163; Tauson VL, 2012, EUR J MINERAL, V24, P133, DOI 10.1127/0935-1221/2011/0023-2132; Wei Seh Zhi, 2013, Nat Commun, V4, P1331, DOI 10.1038/ncomms2327; Yan Y, 2011, SOFT MATTER, V7, P6385, DOI 10.1039/c1sm05030c; Yang Y, 2010, NANO LETT, V10, P1486, DOI 10.1021/nl100504q; Zhang Y., 2011, OPEN MAT SCI J, V5, P215, DOI [DOI 10.2174/1874088X01105010215, 10.2174/1874088X01105010215]	32	14	14	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e82332	10.1371/journal.pone.0082332	http://dx.doi.org/10.1371/journal.pone.0082332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24324560	gold, Green Submitted, Green Published			2022-12-25	WOS:000327546400100
J	Diaferia, GR; Cirulli, V; Biunno, I				Diaferia, Giuseppe R.; Cirulli, Vincenzo; Biunno, Ida			SEL1L Regulates Adhesion, Proliferation and Secretion of Insulin by Affecting Integrin Signaling	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SMALL HETERODIMER PARTNER; CELL-MATRIX INTERACTIONS; HUMAN BETA-CELLS; DIABETES-MELLITUS; GENE-EXPRESSION; TRANSCRIPTION FACTORS; MOLECULAR-MECHANISMS; PANCREATIC-ISLETS; CANDIDATE GENE	SEL1L, a component of the endoplasmic reticulum associated degradation (ERAD) pathway, has been reported to regulate the (i) differentiation of the pancreatic endocrine and exocrine tissue during the second transition of mouse embryonic development, (ii) neural stem cell self-renewal and lineage commitment and (iii) cell cycle progression through regulation of genes related to cell-matrix interaction. Here we show that in the pancreas the expression of SEL1L is developmentally regulated, such that it is readily detected in developing islet cells and in nascent acinar clusters adjacent to basement membranes, and becomes progressively restricted to the islets of Langherans in post-natal life. This peculiar expression pattern and the presence of two inverse RGD motifs in the fibronectin type II domain of SEL1L protein indicate a possible interaction with cell adhesion molecules to regulate islets architecture. Co-immunoprecipitation studies revealed SEL1L and beta 1-integrin interaction and, down-modulation of SEL1L in pancreatic beta-cells, negatively influences both cell adhesion on selected matrix components and cell proliferation likely due to altered ERK signaling. Furthermore, the absence of SEL1L protein strongly inhibits glucose-stimulated insulin secretion in isolated mouse pancreatic islets unveiling an important role of SEL1L in insulin trafficking. This phenotype can be rescued by the ectopic expression of the beta 1-integrin subunit confirming the close interaction of these two proteins in regulating the cross-talk between extracellular matrix and insulin signalling to create a favourable micro-environment for beta-cell development and function.	[Diaferia, Giuseppe R.] Integrated Syst Engn, Milan, Italy; [Cirulli, Vincenzo] Univ Washington, Dept Med, Inst Stem Cells & Regenerat Med, Seattle, WA 98195 USA; [Biunno, Ida] IRCCS Multimed, Stem Cell Sci Unit, Milan, Italy; [Biunno, Ida] CNR, Inst Genet & Biomed Res IRGB, Milan, Italy	University of Washington; University of Washington Seattle; IRCCS Multimedica; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR)	Cirulli, V (corresponding author), Univ Washington, Dept Med, Inst Stem Cells & Regenerat Med, Seattle, WA 98195 USA.	vcirulli@uw.edu; ida.biunno@irgb.cnr.it	Diaferia, Giuseppe/AAN-5910-2020	Diaferia, Giuseppe/0000-0003-4022-8483; , IDA_2/0000-0002-1068-4763	Ministero Istruzione Universita e Ricerca [FIRB:RBIPO64CRT-005]	Ministero Istruzione Universita e Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by funds from Ministero Istruzione Universita e Ricerca, FIRB:RBIPO64CRT-005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altirriba J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-406; BEATTIE GM, 1991, J CLIN ENDOCR METAB, V73, P93, DOI 10.1210/jcem-73-1-93; Bernasconi R, 2012, MOL CELL, V46, P809, DOI 10.1016/j.molcel.2012.04.017; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Biunno I, 1997, GENOMICS, V46, P284, DOI 10.1006/geno.1997.5018; Biunno I, 2006, J CELL PHYSIOL, V208, P23, DOI 10.1002/jcp.20574; Biunno Ida, 2002, OMICS A Journal of Integrative Biology, V6, P187, DOI 10.1089/153623102760092788; Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233; Calabrese A, 2003, DIABETES, V52, P417, DOI 10.2337/diabetes.52.2.417; Cattaneo M, 2005, NEOPLASIA, V7, P1030, DOI 10.1593/neo.05451; Cattaneo M, 2004, GENE, V326, P149, DOI 10.1016/j.gene.2003.10.021; Cattaneo M, 2008, J CELL PHYSIOL, V215, P794, DOI 10.1002/jcp.21364; Cattaneo M, 2012, J CELL PHYSIOL, V227, P1226, DOI 10.1002/jcp.22856; Chothia C, 1997, ANNU REV BIOCHEM, V66, P823, DOI 10.1146/annurev.biochem.66.1.823; Chuman Y, 2004, PEPTIDES, V25, P1831, DOI 10.1016/j.peptides.2004.07.010; Cirulli V, 2000, J CELL BIOL, V150, P1445, DOI 10.1083/jcb.150.6.1445; Diaferia G, 2004, DNA CELL BIOL, V23, P510, DOI 10.1089/1044549041562320; Diaferia GR, 2013, DEVELOPMENT, V140, P3360, DOI 10.1242/dev.098533; Donoviel DB, 1999, GENOMICS, V56, P232, DOI 10.1006/geno.1998.5534; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Field LL, 1996, GENOMICS, V33, P1, DOI 10.1006/geno.1996.0153; Francisco AB, 2011, J BIOL CHEM, V286, P22275, DOI 10.1074/jbc.M111.239418; Francisco AB, 2010, J BIOL CHEM, V285, P13694, DOI 10.1074/jbc.M109.085340; Frayling TM, 2001, DIABETES, V50, pS94, DOI 10.2337/diabetes.50.2007.S94; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; HAYEK A, 1995, DIABETES, V44, P1458, DOI 10.2337/diabetes.44.12.1458; Humphries MJ, 1996, CURR OPIN CELL BIOL, V8, P632, DOI 10.1016/S0955-0674(96)80104-9; Kaido T, 2004, J BIOL CHEM, V279, P53762, DOI 10.1074/jbc.M411202200; Kaido T, 2006, DIABETES, V55, P2723, DOI 10.2337/db06-0120; Kaido TJ, 2010, J CELL PHYSIOL, V224, P101, DOI 10.1002/jcp.22101; Kaneko M, 2007, FEBS LETT, V581, P5355, DOI 10.1016/j.febslet.2007.10.033; Kim SH, 2003, DIABETES, V52, P2182, DOI 10.2337/diabetes.52.8.2182; KOIVUNEN E, 1993, J BIOL CHEM, V268, P20205; Kyostila K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002759; Larsen ZM, 2001, ACTA DIABETOL, V38, P191, DOI 10.1007/s592-001-8078-0; Li SA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-19; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Liu Q, 2012, MOL CARCINOGEN, V51, P433, DOI 10.1002/mc.20808; Malecki MT, 1999, NAT GENET, V23, P323, DOI 10.1038/15500; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Orlandi R, 2002, INT J BIOL MARKER, V17, P104, DOI 10.1177/172460080201700205; Park KG, 2007, DIABETES, V56, P431, DOI 10.2337/db06-0753; Pociot F, 2001, DIABETES-METAB RES, V17, P292, DOI 10.1002/dmrr.201; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Rusnati M, 1997, MOL BIOL CELL, V8, P2449, DOI 10.1091/mbc.8.12.2449; Saltini G, 2004, MUTAT RES-FUND MOL M, V554, P159, DOI 10.1016/j.mrfmmm.2004.04.007; SCHOUMACHER RA, 1990, P NATL ACAD SCI USA, V87, P4012, DOI 10.1073/pnas.87.10.4012; Seo HY, 2008, ENDOCRINOLOGY, V149, P3832, DOI 10.1210/en.2008-0015; Steffensen B, 1998, J BIOL CHEM, V273, P20622, DOI 10.1074/jbc.273.32.20622; SUTTON R, 1986, TRANSPLANTATION, V42, P689, DOI 10.1097/00007890-198612000-00022; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tyler RE, 2012, MOL BIOL CELL, V23, P4668, DOI 10.1091/mbc.E12-06-0428; Yagishita N, 2005, J BIOL CHEM, V280, P7909, DOI 10.1074/jbc.M410863200; YAMADA KM, 1987, J CELL PHYSIOL, V130, P21, DOI 10.1002/jcp.1041300105; Yebra M, 2003, DEV CELL, V5, P695, DOI 10.1016/S1534-5807(03)00330-7; Yebra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022750; Yu CR, 2004, J IMMUNOL, V173, P737, DOI 10.4049/jimmunol.173.2.737; Zhou P, 2012, CL LYMPH MYELOM LEUK, V12, P49, DOI 10.1016/j.clml.2011.09.217	62	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79458	10.1371/journal.pone.0079458	http://dx.doi.org/10.1371/journal.pone.0079458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24324549	Green Published, Green Submitted, gold			2022-12-25	WOS:000327313100022
J	Lindgren, A; Levin, M; Blomqvist, SR; Wikstrom, J; Ahnmark, A; Mogensen, C; Bottcher, G; Bohlooly-Y, M; Boren, J; Gan, LM; Linden, D				Lindgren, Anna; Levin, Malin; Blomqvist, Sandra Rodrigo; Wikstrom, Johannes; Ahnmark, Andrea; Mogensen, Christina; Bottcher, Gerhard; Bohlooly-Y, Mohammad; Boren, Jan; Gan, Li-Ming; Linden, Daniel			Adiponectin Receptor 2 Deficiency Results in Reduced Atherosclerosis in the Brachiocephalic Artery in Apolipoprotein E Deficient Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ADIPOSE-SPECIFIC PROTEIN; INSULIN-RESISTANCE; STIMULATES ANGIOGENESIS; TARGETED DISRUPTION; LIPID-ACCUMULATION; LESION DEVELOPMENT; GENETIC-VARIATION; PLASMA-PROTEIN; CD36 PROTECTS	Adiponectin has been shown to have beneficial cardiovascular effects and to signal through the adiponectin receptors, AdipoR1 and AdipoR2. The original aim of this study was to investigate the effect of combined AdipoR1 and AdipoR2 deficiency (AdipoR1(-/-)AdipoR2(-/-)) on atherosclerosis. However, we made the interesting observation that AdipoR1(-/-)AdipoR2(-/-) leads to embryonic lethality demonstrating the critical importance of the adiponectin signalling system during development. We then investigated the effect of AdipoR2-ablation on the progression of atherosclerosis in apolipoprotein E deficient (ApoE(-/-)) mice. AdipoR2(-/-)ApoE(-/-) mice fed an atherogenic diet had decreased plaque area in the brachiocephalic artery compared with AdipoR2(+/+)ApoE(-/-) littermate controls as visualized in vivo using an ultrasound biomicroscope and confirmed by histological analyses. The decreased plaque area in the brachiocephalic artery could not be explained by plasma cholesterol levels or inflammatory status. However, accumulation of neutral lipids was decreased in peritoneal macrophages from AdipoR2(-/-)ApoE(-/-) mice after incubation with oxidized LDL. This effect was associated with lower CD36 and higher ABCA1 mRNA levels in peritoneal macrophages from AdipoR2(-/-)ApoE(-/-) mice compared with AdipoR2(+/+)ApoE(-/-) controls after incubation with oxidized LDL. In summary, we show that adiponectin receptors are crucial during embryonic development and that AdipoR2-deficiency slows down the progression of atherosclerosis in the brachiocephalic artery of ApoE-deficient mice.	[Lindgren, Anna; Wikstrom, Johannes; Ahnmark, Andrea; Mogensen, Christina; Gan, Li-Ming; Linden, Daniel] AstraZeneca R&D, Cardiovasc & Metab Dis Innovat Med, Molndal, Sweden; [Levin, Malin; Boren, Jan] Univ Gothenburg, Wallenberg Lab Cardiovasc Res, Sahlgrenska Acad, Gothenburg, Sweden; [Blomqvist, Sandra Rodrigo; Bohlooly-Y, Mohammad] AstraZeneca R&D, Transgen, Discovery Sci, Molndal, Sweden; [Bottcher, Gerhard] AstraZeneca R&D, Pathol Sci, Global Safety Assessment, Molndal, Sweden	AstraZeneca; University of Gothenburg; AstraZeneca; AstraZeneca	Linden, D (corresponding author), AstraZeneca R&D, Cardiovasc & Metab Dis Innovat Med, Molndal, Sweden.	daniel.linden@astrazeneca.com		Levin, Malin/0000-0003-1069-5275	AstraZeneca; Novo Nordisk Fonden [NNF13OC0004973] Funding Source: researchfish	AstraZeneca(AstraZeneca); Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was funded by AstraZeneca. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Almabouada F, 2013, J BIOL CHEM, V288, P3112, DOI 10.1074/jbc.M112.404624; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010; Bjursell M, 2007, DIABETES, V56, P583, DOI 10.2337/db06-1432; Febbraio M, 2004, ARTERIOSCL THROM VAS, V24, P2333, DOI 10.1161/01.ATV.0000148007.06370.68; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gan LM, 2007, ATHEROSCLEROSIS, V190, P313, DOI 10.1016/j.atherosclerosis.2006.03.035; Guy E, 2007, ATHEROSCLEROSIS, V192, P123, DOI 10.1016/j.atherosclerosis.2006.07.015; Halvatsiotis I, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-10; Homan R, 1998, J CHROMATOGR B, V708, P21, DOI 10.1016/S0378-4347(97)00651-8; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Kato H, 2006, ARTERIOSCL THROM VAS, V26, P224, DOI 10.1161/01.ATV.0000194076.84568.81; Kotronen A, 2009, EUR J ENDOCRINOL, V160, P593, DOI 10.1530/EJE-08-0900; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Kuchibhotla S, 2008, CARDIOVASC RES, V78, P185, DOI 10.1093/cvr/cvm093; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Liu YF, 2007, ENDOCRINOLOGY, V148, P683, DOI 10.1210/en.2006-0708; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Matsuda M, 2002, J BIOL CHEM, V277, P37487, DOI 10.1074/jbc.M206083200; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nawrocki AR, 2010, ARTERIOSCL THROM VAS, V30, P1159, DOI 10.1161/ATVBAHA.109.195826; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Reardon CA, 2001, ARTERIOSCL THROM VAS, V21, P1011, DOI 10.1161/01.ATV.21.6.1011; Rosenfeld ME, 2000, ARTERIOSCL THROM VAS, V20, P2587, DOI 10.1161/01.ATV.20.12.2587; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Schreyer SA, 2002, AM J PHYSIOL-ENDOC M, V282, pE207, DOI 10.1152/ajpendo.2002.282.1.E207; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Tian L, 2009, ATHEROSCLEROSIS, V202, P152, DOI 10.1016/j.atherosclerosis.2008.04.011; Tsubakio-Yamamoto K, 2008, BIOCHEM BIOPH RES CO, V375, P390, DOI 10.1016/j.bbrc.2008.08.009; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Vaxillaire M, 2006, DIABETES, V55, P856, DOI 10.2337/diabetes.55.03.06.db05-0665; Williams H, 2002, ARTERIOSCL THROM VAS, V22, P788, DOI 10.1161/01.ATV.0000014587.66321.B4; Witting PK, 2000, ARTERIOSCL THROM VAS, V20, pE26, DOI 10.1161/01.ATV.20.8.e26; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Zhu WD, 2008, CLIN SCI, V114, P361, DOI 10.1042/CS20070347	50	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80330	10.1371/journal.pone.0080330	http://dx.doi.org/10.1371/journal.pone.0080330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24324556	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100142
J	Ye, CQ; Lou, WJ; Li, YR; Chatzispyrou, IA; Huttemann, M; Lee, I; Houtkooper, RH; Vaz, FM; Chen, SL; Greenberg, ML				Ye, Cunqi; Lou, Wenjia; Li, Yiran; Chatzispyrou, Iliana A.; Huettemann, Maik; Lee, Icksoo; Houtkooper, Riekelt H.; Vaz, Frederic M.; Chen, Shuliang; Greenberg, Miriam L.			Deletion of the Cardiolipin-specific Phospholipase Cld1 Rescues Growth and Life Span Defects in the Tafazzin Mutant IMPLICATIONS FOR BARTH SYNDROME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiolipin; Mitochondria; Phospholipase; Phospholipid; Respiration; Barth Syndrome; Tafazzin	CYTOCHROME-C-OXIDASE; SUPPRESSES TEMPERATURE SENSITIVITY; LINKED CARDIOSKELETAL MYOPATHY; ADP/ATP CARRIER PROTEIN; RESPIRATORY-CHAIN; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL-DNA; MASS-SPECTROMETRY; BC(1) COMPLEX; UP-REGULATION	Background: Cardiolipin (CL) is deacylated by Cld1 to monolysocardiolipin, which is transacylated by tafazzin (Taz1) to form unsaturated CL. Results: Deletion of CLD1 rescues growth and respiration defects in taz1, whereas overexpression is deleterious to growth and respiration. Conclusion: Decreased CL/MLCL, not decreased unsaturated CL, causes defects in tafazzin-deficient cells. Significance: Attenuation of CL phospholipases may potentially treat Barth syndrome. Cardiolipin (CL) that is synthesized de novo is deacylated to monolysocardiolipin (MLCL), which is reacylated by tafazzin. Remodeled CL contains mostly unsaturated fatty acids. In eukaryotes, loss of tafazzin leads to growth and respiration defects, and in humans, this results in the life-threatening disorder Barth syndrome. Tafazzin deficiency causes a decrease in the CL/MLCL ratio and decreased unsaturated CL species. Which of these biochemical outcomes contributes to the physiological defects is not known. Yeast cells have a single CL-specific phospholipase, Cld1, that can be exploited to distinguish between these outcomes. The cld1 mutant has decreased unsaturated CL, but the CL/MLCL ratio is similar to that of wild type cells. We show that cld1 rescues growth, life span, and respiratory defects of the taz1 mutant. This suggests that defective growth and respiration in tafazzin-deficient cells are caused by the decreased CL/MLCL ratio and not by a deficiency in unsaturated CL. CLD1 expression is increased during respiratory growth and regulated by the heme activator protein transcriptional activation complex. Overexpression of CLD1 leads to decreased mitochondrial respiration and growth and instability of mitochondrial DNA. However, ATP concentrations are maintained by increasing glycolysis. We conclude that transcriptional regulation of Cld1-mediated deacylation of CL influences energy metabolism by modulating the relative contribution of glycolysis and respiration.	[Chen, Shuliang; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Huettemann, Maik] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Huettemann, Maik] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI 48201 USA; [Lee, Icksoo] Dankook Univ, Coll Med, Cheonan Si 330714, Chungcheongnam, South Korea; [Chatzispyrou, Iliana A.; Houtkooper, Riekelt H.; Vaz, Frederic M.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands	Wayne State University; Wayne State University; Wayne State University; Dankook University; University of Amsterdam; Academic Medical Center Amsterdam	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	mlgreen@sun.science.wayne.edu	lou, wenjia/I-7612-2019; Chen, Shuliang/N-9498-2013; Houtkooper, Riekelt/P-5001-2019	lou, wenjia/0000-0003-3772-4830; Chen, Shuliang/0000-0002-7175-7604; Vaz, Frederic/0000-0002-9048-1041; Houtkooper, Riekelt/0000-0001-9961-0842; Huttemann, Maik/0000-0001-6310-7081	Barth Syndrome Foundation; Barth Syndrome Foundation of Canada; Association Barth France; Wayne State University Thomas C. Rumble University Fellowship; Wayne State University Summer Dissertation Fellowship; Wayne State University; Academisch Medisch Centrum Ph.D. fellowship; ZonMw/Veni [91613050]; AMC	Barth Syndrome Foundation; Barth Syndrome Foundation of Canada; Association Barth France; Wayne State University Thomas C. Rumble University Fellowship; Wayne State University Summer Dissertation Fellowship; Wayne State University; Academisch Medisch Centrum Ph.D. fellowship; ZonMw/Veni; AMC	This work was supported by grants from the Barth Syndrome Foundation, Barth Syndrome Foundation of Canada, and Association Barth France (to M. L. G.), Wayne State University Thomas C. Rumble University Fellowship and Summer Dissertation Fellowship (to C. Y.), Wayne State University graduate enhancement research funds (to C. Y., W. L., and Y. L.), Academisch Medisch Centrum Ph.D. fellowship (to I. A. C.), and ZonMw/Veni Grant 91613050 and AMC postdoctoral fellowship (to R. H. H.).	Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733; Baile MG, 2013, MOL BIOL CELL, V24, P2008, DOI 10.1091/mbc.E13-03-0121; Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Barth PG, 1999, J INHERIT METAB DIS, V22, P555, DOI 10.1023/A:1005568609936; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; Bu Y, 1998, NUCLEIC ACIDS RES, V26, P1002, DOI 10.1093/nar/26.4.1002; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; Chen SL, 2010, J BIOL CHEM, V285, P10397, DOI 10.1074/jbc.M110.100784; Chen S, 2008, MOL BIOL CELL, V19, P5047, DOI 10.1091/mbc.E08-05-0486; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497; EBLE KS, 1990, J BIOL CHEM, V265, P19434; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fontanesi F, 2008, HUM MOL GENET, V17, P775, DOI 10.1093/hmg/ddm349; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gohil VM, 2004, J BIOL CHEM, V279, P42612, DOI 10.1074/jbc.M402545200; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; HOSTETLER KY, 1972, BIOCHIM BIOPHYS ACTA, V260, P507, DOI 10.1016/0005-2760(72)90065-3; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Houtkooper RH, 2006, FEBS LETT, V580, P3059, DOI 10.1016/j.febslet.2006.04.054; Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032; Hsu Y. H., 2013, PLOS ONE, V8; Hu Jia, 2013, Methods Mol Biol, V965, P463, DOI 10.1007/978-1-62703-239-1_30; Huttemann M, 2012, ADV EXP MED BIOL, V748, P237, DOI 10.1007/978-1-4614-3573-0_10; JAKOVCIC S, 1971, J CELL BIOL, V48, P490, DOI 10.1083/jcb.48.3.490; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; KELLY BL, 1990, BIOCHIM BIOPHYS ACTA, V1046, P144, DOI 10.1016/0005-2760(90)90181-V; Kiebish MA, 2013, J LIPID RES, V54, P1312, DOI 10.1194/jlr.M034728; Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; Kwast KE, 1999, P NATL ACAD SCI USA, V96, P5446, DOI 10.1073/pnas.96.10.5446; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; LECOCQ J, 1964, BIOCHEMISTRY-US, V3, P976, DOI 10.1021/bi00895a023; Lee I, 2010, BBA-MOL BASIS DIS, V1802, P275, DOI 10.1016/j.bbadis.2009.10.005; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; Ocampo A, 2012, CELL METAB, V16, P55, DOI 10.1016/j.cmet.2012.05.013; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Palsdottir H, 2003, J BIOL CHEM, V278, P31303, DOI 10.1074/jbc.M302195200; PANGBORN MC, 1947, J BIOL CHEM, V168, P351; Paradies G, 2001, MITOCHONDRION, V1, P151, DOI 10.1016/S1567-7249(01)00011-3; Paradies G, 1998, FEBS LETT, V424, P155, DOI 10.1016/S0014-5793(98)00161-6; Paradies G, 2000, FEBS LETT, V466, P323, DOI 10.1016/S0014-5793(00)01082-6; Petrosillo G, 2007, BBA-BIOENERGETICS, V1767, P1260, DOI 10.1016/j.bbabio.2007.07.011; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Su XF, 2006, MOL CELL BIOL, V26, P743, DOI 10.1128/MCB.26.3.743-753.2006; Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908; TAMAI KT, 1990, BIOCHIM BIOPHYS ACTA, V1046, P214, DOI 10.1016/0005-2760(90)90192-Z; Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; Valianpour F, 2003, J LIPID RES, V44, P560, DOI 10.1194/jlr.M200217-JLR200; Valianpour F, 2002, CLIN CHEM, V48, P1390; Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Wu JP, 1998, YEAST, V14, P985, DOI 10.1002/(SICI)1097-0061(199808)14:11<985::AID-YEA294>3.3.CO;2-3; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zhong Q, 2005, MOL BIOL CELL, V16, P665, DOI 10.1091/mbc.E04-09-0808; Zhong Q, 2007, J BIOL CHEM, V282, P15946, DOI 10.1074/jbc.M701055200; Zhou JM, 2009, J BIOL CHEM, V284, P18106, DOI 10.1074/jbc.M109.003236	87	41	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2014	289	6					3114	3125		10.1074/jbc.M113.529487	http://dx.doi.org/10.1074/jbc.M113.529487			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA8TU	24318983	Green Published, hybrid			2022-12-25	WOS:000331368700002
J	Santos, E; Lazaro, JM; Perez-Arnaiz, P; Salas, M; de Vega, M				Santos, Eugenia; Lazaro, Jose M.; Perez-Arnaiz, Patricia; Salas, Margarita; de Vega, Miguel			Role of the LEXE Motif of Protein-primed DNA Polymerases in the Interaction with the Incoming Nucleotide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteriophage; DNA Polymerase; DNA Replication; Nucleic Acid Synthesis; Viral Polymerase	CRYSTAL-STRUCTURE; REPLICATION FIDELITY; EXONUCLEASE ACTIVITY; STRAND DISPLACEMENT; TERNARY COMPLEXES; TERMINAL PROTEIN; STRUCTURAL BASIS; RNA-POLYMERASES; T7 DNA; MECHANISM	Background: LEXE motif is conserved among the eukaryotic DNA polymerases. Results: Substitutions at LEXE residues decrease the replication and pyrophosphorolytic activities of 29 DNA polymerase and compromise nucleotide insertion fidelity. Conclusion: The results suggest a role for LEXE residues in making interactions with the incoming nucleotide. Significance: Results support the proposal of a third metal ion as a general feature of the two-metal ion mechanism. The LEXE motif, conserved in eukaryotic type DNA polymerases, is placed close to the polymerization active site. Previous studies suggested that the second Glu was involved in binding a third noncatalytic ion in bacteriophage RB69 DNA polymerase. In the protein-primed DNA polymerase subgroup, the LEXE motif lacks the first Glu in most cases, but it has a conserved Phe/Trp and a Gly preceding that position. To ascertain the role of those residues, we have analyzed the behavior of mutants at the corresponding phi 29 DNA polymerase residues Gly-481, Trp-483, Ala-484, and Glu-486. We show that mutations at Gly-481 and Trp-483 hamper insertion of the incoming dNTP in the presence of Mg2+ ions, a reaction highly improved when Mn2+ was used as metal activator. These results, together with previous crystallographic resolution of phi 29 DNA polymerase ternary complex, allow us to infer that Gly-481 and Trp-483 could form a pocket that orients Val-250 to interact with the dNTP. Mutants at Glu-486 are also defective in polymerization and, as mutants at Gly-481 and Trp-483, in the pyrophosphorolytic activity with Mg2+. Recovery of both reactions with Mn2+ supports a role for Glu-486 in the interaction with the pyrophosphate moiety of the dNTP.	[Santos, Eugenia; Lazaro, Jose M.; Perez-Arnaiz, Patricia; Salas, Margarita; de Vega, Miguel] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Inst Biol Mol Eladio Vinuela, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Salas, M (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Inst Biol Mol Eladio Vinuela, C Nicolas Cabrera 1, E-28049 Madrid, Spain.	msalas@cbm.uam.es	Salas, Margarita/J-9873-2014; de Vega, Miguel/K-2878-2014; Arnaiz, Patricia Perez/AAH-3763-2019	Salas, Margarita/0000-0001-5939-3441; de Vega, Miguel/0000-0003-1285-7549; Arnaiz, Patricia Perez/0000-0001-9089-6223	Spanish Ministry of Economy and Competitiveness [BFU2011-23645]; Spanish Ministry of Science and Innovation [Consolider-Ingenio CSD2007-00015]; Autonomous Community of Madrid [S2009MAT-1507]; Fundacion Ramon Areces	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Autonomous Community of Madrid; Fundacion Ramon Areces	This work was supported by Spanish Ministry of Economy and Competitiveness Grant BFU2011-23645 (to M. S.), Spanish Ministry of Science and Innovation Grant Consolider-Ingenio CSD2007-00015 (to M. S.), Autonomous Community of Madrid Grant S2009MAT-1507 (to M. S.), and by an institutional grant from Fundacion Ramon Areces to the Centro de Biologia Molecular "Severo Ochoa."	ARNOLD E, 1995, CURR OPIN STRUC BIOL, V5, P27, DOI 10.1016/0959-440X(95)80006-M; Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Berman AJ, 2007, EMBO J, V26, P3494, DOI 10.1038/sj.emboj.7601780; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; BLANCO L, 1985, NUCLEIC ACIDS RES, V13, P1239, DOI 10.1093/nar/13.4.1239; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Blanco L, 1996, J BIOL CHEM, V271, P8509, DOI 10.1074/jbc.271.15.8509; BLASCO MA, 1991, J BIOL CHEM, V266, P7904; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; Creighton S, 1995, METHOD ENZYMOL, V262, P232; de Vega M, 1998, J BIOL CHEM, V273, P28966, DOI 10.1074/jbc.273.44.28966; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; GARMENDIA C, 1992, J BIOL CHEM, V267, P2594; Hopfner KP, 1999, P NATL ACAD SCI USA, V96, P3600, DOI 10.1073/pnas.96.7.3600; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Jager Joachim, 1999, Current Opinion in Structural Biology, V9, P21, DOI 10.1016/S0959-440X(99)80004-9; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kamtekar S, 2004, MOL CELL, V16, P609, DOI 10.1016/j.molcel.2004.10.019; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Lazaro JM, 1995, METHOD ENZYMOL, V262, P42; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Longas E, 2006, NUCLEIC ACIDS RES, V34, P6051, DOI 10.1093/nar/gkl769; MCDONELL MW, 1977, J MOL BIOL, V110, P119, DOI 10.1016/S0022-2836(77)80102-2; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Patel PH, 2001, J MOL BIOL, V308, P823, DOI 10.1006/jmbi.2001.4619; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; PENALVA MA, 1982, P NATL ACAD SCI-BIOL, V79, P5522, DOI 10.1073/pnas.79.18.5522; Perez-Arnaiz P, 2010, J MOL BIOL, V395, P223, DOI 10.1016/j.jmb.2009.10.061; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; SALAS M, 1991, ANNU REV BIOCHEM, V60, P39, DOI 10.1146/annurev.bi.60.070191.000351; Salas M, 1999, GENET ENG P, V21, P159; Salas M., 2008, ENCY VIROLOGY, P339; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; STEITZ TA, 1994, SCIENCE, V266, P2022, DOI 10.1126/science.7528445; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Zakharova E, 2004, BIOCHEMISTRY-US, V43, P6587, DOI 10.1021/bi049615p	48	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2888	2898		10.1074/jbc.M113.530980	http://dx.doi.org/10.1074/jbc.M113.530980			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24324256	Green Published, hybrid			2022-12-25	WOS:000333403000037
J	Reis-Alves, SC; Traina, F; Harada, G; Campos, PM; Saad, STO; Metze, K; Lorand-Metze, I				Reis-Alves, Suiellen C.; Traina, Fabiola; Harada, Guilherme; Campos, Paula M.; Saad, Sara T. O.; Metze, Konradin; Lorand-Metze, Irene			Immunophenotyping in Myelodysplastic Syndromes Can Add Prognostic Information to Well-Established and New Clinical Scores	PLOS ONE			English	Article							FLOW-CYTOMETRIC ANALYSIS; SCORING SYSTEM; BONE-MARROW; HEMATOPOIETIC-CELLS; WORKING CONFERENCE; FRACTAL DIMENSION; MYELOID NEOPLASMS; SURVIVAL; DIAGNOSIS; LEUKEMIA	Background: myelodysplastic syndromes (MDS) are a heterogeneous group of hematopoietic clonal disorders. So, prognostic variables are important to separate patients with a similar biology and clinical outcome. We compared the importance of risk stratification in primary MDS of IPSS and WPSS with the just described revision of IPSS (IPSS-R), and examined if variables obtained by bone marrow immunophenotyping could add prognostic information to any of the scores. Methods: In this prospective study of 101 cases of primary MDS we compared the relation of patients' overall survival with WHO types, IPSS, IPSS-R, WPSS and phenotypic abnormalities of hematopoietic precursors. We examined aberrancies in myelomonocytic precursors and CD34(+) cells. Patients were censored when receiving chemotherapy or BM transplantation. Survival analysis was made by Cox regressions and stability of the models was examined by bootstrap resampling. Results: median age: 64 years (15-93). WHO types: 2 cases of 5q-syndrome, 7 of RA, 64 of RCDM and 28 of RAEB. In the univariate Cox analysis, increasing risk category of all scores, degree of anemia, higher percentage of BM blasts, higher number of CD34(+) cells and their myeloid fractions besides increasing number of phenotypic abnormalities detected were significantly associated with a shorter survival. In the multivariate analysis comparing the three scores, IPSS-R was the only independent risk factor. Comparing WPSS with phenotypic variables (CD34(+)/CD13(+) cells, CD34(+)/CD13(-) cells and "total alterations'') the score and "CD34(+)/CD13(+) cells'' remained in the model. When IPSS was tested together with these phenotypic variables, only "CD34(+)/CD13(+) cells'', and "total alterations'' remained in the model. Testing IPSS-R with the phenotypic variables studied, only the score and "CD34(+)/CD13(+) cells'' entered the model. Conclusions: Immunophenotypic analysis of myelomonocytic progenitors provides additional prognostic information to all clinical scores studied. IPSS-R improved risk stratification in MDS compared to the former scores.	[Reis-Alves, Suiellen C.; Traina, Fabiola; Saad, Sara T. O.; Lorand-Metze, Irene] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Sao Paulo, Brazil; [Harada, Guilherme; Campos, Paula M.; Saad, Sara T. O.; Metze, Konradin; Lorand-Metze, Irene] Univ Estadual Campinas, Fac Med, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Lorand-Metze, I (corresponding author), Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Sao Paulo, Brazil.	ilmetze@unicamp.br	Traina, Fabiola/U-1451-2019; De Melo Campos, Paula/HIK-1076-2022; Traina, Fabiola/L-3809-2014; CTC USP, CEPID 13 18/J-8951-2014	Traina, Fabiola/0000-0003-4258-289X; Traina, Fabiola/0000-0003-4258-289X; CTC USP, CEPID 13 18/0000-0002-7123-9524; Metze, Konradin/0000-0003-0742-8846; Lorand-Metze, Irene/0000-0002-6516-1265	FAPESP (Research Funding Agency of the State of Sao Paulo) [proc. 04/08882-3]; CNPq/INCTS (National Reseach Council/Funding for Research Excellence Centers) [proc.2008-57895/1]; FAEPEX (Research Fund of the University of Campinas) [proc 1208/11]; MDS Foundation; CNPq [302277/2009-9, proc 307270/2010-6, 301483/2008-6]	FAPESP (Research Funding Agency of the State of Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); CNPq/INCTS (National Reseach Council/Funding for Research Excellence Centers); FAEPEX (Research Fund of the University of Campinas); MDS Foundation; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Grants: FAPESP (Research Funding Agency of the State of Sao Paulo) proc. 04/08882-3, CNPq/INCTS (National Reseach Council/Funding for Research Excellence Centers) proc.2008-57895/1, FAEPEX (Research Fund of the University of Campinas) proc 1208/11 and MDS Foundation (Tito Bastianello Young Investigator grant 2009). Irene Lorand-Metze, Konradin Metze and Sara T.O. Saad have research grants from CNPq (302277/2009-9, proc 307270/2010-6, and 301483/2008-6 respectively). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RL, 2006, CELL ONCOL, V28, P55; Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Bedin V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-260; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x; Choodari-Oskooei B, 2012, STAT MED, V31, P2627, DOI 10.1002/sim.4242; Chu SC, 2011, LEUKEMIA RES, V35, P868, DOI 10.1016/j.leukres.2011.02.016; Clark TG, 2003, BRIT J CANCER, V89, P781, DOI 10.1038/sj.bjc.6601117; Delamain MT, 2008, TRANSFUSION, V48, P1133, DOI 10.1111/j.1537-2995.2008.01687.x; Delamain MT, 2006, TRANSFUS APHER SCI, V34, P33, DOI 10.1016/j.transci.2005.09.004; Doehring LC, 2010, AM J PATHOL, V177, P473, DOI 10.2353/ajpath.2010.090758; Elston LB, 2009, VET PATHOL, V46, P362, DOI 10.1354/vp.46-2-362; Ferro DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020706; Gaipa G, 2002, HAEMATOLOGICA, V87, P347; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Hellstrom-Lindberg E, 2008, SEMIN HEMATOL, V45, P14, DOI 10.1053/j.seminhematol.2007.10.004; HIDDEMANN W, 1982, BLOOD, V59, P216; Kern W, 2010, CANCER-AM CANCER SOC, V116, P4549, DOI 10.1002/cncr.25353; Lorand-Metze I, 2008, LEUKEMIA RES, V32, P211, DOI 10.1016/j.leukres.2007.06.014; Lorand-Metze I, 2004, LEUKEMIA RES, V28, P587, DOI 10.1016/j.leukres.2003.11.001; Lorand-Metze I, 2007, LEUKEMIA RES, V31, P147, DOI 10.1016/j.leukres.2006.04.010; Lourenco GJ, 2010, LEUKEMIA LYMPHOMA, V51, P2215, DOI 10.3109/10428194.2010.527402; Maftoun-Banankhah S, 2008, AM J CLIN PATHOL, V129, P300, DOI 10.1309/4W2G3NDXUPG5J33N; Malcovati L, 2011, HAEMATOL-HEMATOL J, V96, P1433, DOI 10.3324/haematol.2011.044602; Matarraz S, 2008, LEUKEMIA, V22, P1175, DOI 10.1038/leu.2008.49; Matarraz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044321; Metze K, 2008, PATHOL RES PRACT, V204, P213, DOI 10.1016/j.prp.2007.12.002; Metze K, 2011, LANCET ONCOL, V12, P1095, DOI 10.1016/S1470-2045(11)70309-6; Metze K, 2011, J AM COLL SURGEONS, V212, P132, DOI 10.1016/j.jamcollsurg.2010.10.004; Oliveira GB, 2001, CYTOMETRY, V46, P329, DOI 10.1002/cyto.10031; Ossenkoppele GJ, 2011, BRIT J HAEMATOL, V153, P421, DOI 10.1111/j.1365-2141.2011.08595.x; Pardanani A, 2012, J CLIN ONCOL, V30, P2703, DOI 10.1200/JCO.2012.42.5033; Pinheiro RF, 2009, LEUKEMIA RES, V33, P1308, DOI 10.1016/j.leukres.2009.03.008; Reis SC, 2009, NEOPLASMA, V56, P435, DOI 10.4149/neo_2009_05_435; Reis-Alves SC, 2010, NEOPLASMA, V57, P530, DOI 10.4149/neo_2010_06_530; Ribeiro E, 2006, LEUKEMIA RES, V30, P9, DOI 10.1016/j.leukres.2005.05.019; Ribeiro E, 2004, LEUKEMIA LYMPHOMA, V45, P309, DOI 10.1080/10428190310001598044; Rybka MO, 2008, INT J DERMATOL, V47, P1240, DOI 10.1111/j.1365-4632.2008.03808.x; Satoh C, 2008, LEUKEMIA RES, V32, P699, DOI 10.1016/j.leukres.2007.08.022; SAUERBREI W, 1992, STAT MED, V11, P2093, DOI 10.1002/sim.4780111607; Schanz J, 2012, J CLIN ONCOL, V30, P820, DOI 10.1200/JCO.2011.35.6394; Senent L, 2013, HAEMATOLOGICA, V98, P568, DOI 10.3324/haematol.2012.071449; Shaffer LG, 2009, ISCN 2013 INT SYSTEM; Shao LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051339; Smith T, 2003, P 28 ANN SAS US GROU, P254; Stetler-Stevenson M, 2009, LEUKEMIA RES, V33, P1020, DOI 10.1016/j.leukres.2009.02.029; Swerdlow E., 2008, WHO CLASSIFICATION T; Thol F, 2012, ANN HEMATOL, V91, P1221, DOI 10.1007/s00277-012-1457-7; Valent P, 2007, LEUKEMIA RES, V31, P727, DOI 10.1016/j.leukres.2006.11.009; van de Loosdrecht AA, 2008, BLOOD, V111, P1067, DOI 10.1182/blood-2007-07-098764; van de Loosdrecht AA, 2009, HAEMATOL-HEMATOL J, V94, P1124, DOI 10.3324/haematol.2009.005801; Vido JR, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-93; Wells DA, 2003, BLOOD, V102, P394, DOI 10.1182/blood-2002-09-2768; Westers TM, 2012, LEUKEMIA, V26, P1730, DOI 10.1038/leu.2012.30; Yin CC, 2010, INT J LAB HEMATOL, V32, P461, DOI 10.1111/j.1751-553X.2010.01246.x	56	19	21	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81048	10.1371/journal.pone.0081048	http://dx.doi.org/10.1371/journal.pone.0081048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324660	Green Published, gold, Green Submitted			2022-12-25	WOS:000328566700027
J	Huang, YH; Sramkoski, RM; Jacobberger, JW				Huang, Yehong; Sramkoski, R. Michael; Jacobberger, James W.			The Kinetics of G2 and M Transitions Regulated by B Cyclins	PLOS ONE			English	Article							CHROMOSOMAL DNA-REPLICATION; CELL-CYCLE; MAMMALIAN-CELLS; DEPENDENT KINASES; NUCLEAR EXPORT; CDC2 KINASE; GOLGI-APPARATUS; SOMATIC-CELLS; MITOSIS; LOCALIZATION	B cyclins regulate G2-M transition. Because human somatic cells continue to cycle after reduction of cyclin B1 (cycB1) or cyclin B2 (cycB2) by RNA interference (RNAi), and because cycB2 knockout mice are viable, the existence of two genes should be an optimization. To explore this idea, we generated HeLa BD (TM) Tet-Off cell lines with inducible cyclin B1- or B2-EGFP that were RNAi resistant. Cultures were treated with RNAi and/or doxycycline (Dox) and bromodeoxyuridine. We measured G2 and M transit times and 4C cell accumulation. In the absence of ectopic B cyclin expression, knockdown (kd) of either cyclin increased G2 transit. M transit was increased by cycB1 kd but decreased by cycB2 depletion. This novel difference was further supported by time-lapse microscopy. This suggests that cycB2 tunes mitotic timing, and we speculate that this is through regulation of a Golgi checkpoint. In the presence of endogenous cyclins, expression of active B cyclin-EGFPs did not affect G2 or M phase times. As previously shown, B cyclin co-depletion induced G2 arrest. Expression of either B cyclin-EGFP completely rescued knockdown of the respective endogenous cyclin in single kd experiments, and either cyclin-EGFP completely rescued endogenous cyclin co-depletion. Most of the rescue occurred at relatively low levels of exogenous cyclin expression. Therefore, cycB1 and cycB2 are interchangeable for ability to promote G2 and M transition in this experimental setting. Cyclin B1 is thought to be required for the mammalian somatic cell cycle, while cyclin B2 is thought to be dispensable. However, residual levels of cyclin B1 or cyclin B2 in double knockdown experiments are not sufficient to promote successful mitosis, yet residual levels are sufficient to promote mitosis in the presence of the dispensible cyclin B2. We discuss a simple model that would explain most data if cyclin B1 is necessary.	[Huang, Yehong; Jacobberger, James W.] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Sramkoski, R. Michael; Jacobberger, James W.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Jacobberger, JW (corresponding author), Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.	jwj@case.edu	Jacobberger, James/P-9183-2014	Jacobberger, James/0000-0002-3092-5157	NIH [R01-CA473413, P30-CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH R01-CA473413 and NIH P30-CA43703 (nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki H, 2010, CURR OPIN CELL BIOL, V22, P766, DOI 10.1016/j.ceb.2010.07.015; Avva J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038275; Bellanger S, 2007, ONCOGENE, V26, P7175, DOI 10.1038/sj.onc.1210539; Bentley AM, 2007, MOL BIOL CELL, V18, P4847, DOI 10.1091/mbc.E06-06-0539; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Brandeis M, 1998, P NATL ACAD SCI USA, V95, P4344, DOI 10.1073/pnas.95.8.4344; Cervigni Romina Ines, 2011, Bioarchitecture, V1, P61; Chang DC, 2003, J BIOL CHEM, V278, P37865, DOI 10.1074/jbc.M306376200; CHAPMAN DL, 1993, DEVELOPMENT, V118, P229; Corda D, 2012, IUBMB LIFE, V64, P661, DOI 10.1002/iub.1054; Deibler RW, 2010, MOL CELL, V37, P753, DOI 10.1016/j.molcel.2010.02.023; Draviam VM, 2001, J CELL BIOL, V152, P945, DOI 10.1083/jcb.152.5.945; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FORSBURG SL, 1991, ANNU REV CELL BIOL, V7, P227, DOI 10.1146/annurev.cb.07.110191.001303; Furukawa Y, 2000, J BIOL CHEM, V275, P21661, DOI 10.1074/jbc.M906893199; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gong DQ, 2007, CURR BIOL, V17, P85, DOI 10.1016/j.cub.2006.11.066; Hagting A, 1999, CURR BIOL, V9, P680, DOI 10.1016/S0960-9822(99)80308-X; Hagting A, 1998, EMBO J, V17, P4127, DOI 10.1093/emboj/17.14.4127; Hunt T, 1991, Semin Cell Biol, V2, P213; JACKMAN M, 1995, EMBO J, V14, P1646, DOI 10.1002/j.1460-2075.1995.tb07153.x; Laronne A, 2003, MOL BIOL CELL, V14, P3730, DOI 10.1091/mbc.E02-12-0850; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Loyer P, 2005, CELL SIGNAL, V17, P1033, DOI 10.1016/j.cellsig.2005.02.005; Lozano JC, 2002, BIOCHEM BIOPH RES CO, V291, P406, DOI 10.1006/bbrc.2002.6458; MINSHULL J, 1990, EMBO J, V9, P2865, DOI 10.1002/j.1460-2075.1990.tb07476.x; Nguyen TB, 2002, J BIOL CHEM, V277, P41960, DOI 10.1074/jbc.M203951200; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; Oikonomou C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020788; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Pagliuca FW, 2011, MOL CELL, V43, P406, DOI 10.1016/j.molcel.2011.05.031; PINES J, 1993, TRENDS BIOCHEM SCI, V18, P195, DOI 10.1016/0968-0004(93)90185-P; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; Pines J, 2011, PHILOS T R SOC B, V366, P3625, DOI 10.1098/rstb.2011.0080; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; RIABOWOL K, 1989, CELL, V57, P393, DOI 10.1016/0092-8674(89)90914-8; Sacco E, 2012, BIOTECHNOL ADV, V30, P73, DOI 10.1016/j.biotechadv.2011.09.009; SCHIMENTI KJ, 1992, CYTOMETRY, V13, P48, DOI 10.1002/cyto.990130109; SHERR CJ, 1994, COLD SPRING HARB SYM, V59, P11, DOI 10.1101/SQB.1994.059.01.004; Soni DV, 2008, CELL CYCLE, V7, P1285, DOI 10.4161/cc.7.9.5711; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Yoshimura S, 2005, J BIOL CHEM, V280, P23048, DOI 10.1074/jbc.M502442200	51	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80861	10.1371/journal.pone.0080861	http://dx.doi.org/10.1371/journal.pone.0080861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324638	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300050
J	Liang, MJ; Zhou, Q; Yang, KR; Yang, XL; Fang, J; Chen, WL; Huang, Z				Liang, Min-Jie; Zhou, Quan; Yang, Kan-Rong; Yang, Xiao-Ling; Fang, Jin; Chen, Wen-Li; Huang, Zheng			Identify Changes of Brain Regional Homogeneity in Bipolar Disorder and Unipolar Depression Using Resting-State fMRI	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; INDEPENDENT COMPONENT ANALYSIS; MAJOR DEPRESSION; FUNCTIONAL CONNECTIVITY; CLINICAL-SIGNIFICANCE; PARKINSONS-DISEASE; CINGULATE CORTEX; RATING-SCALE; LATE-ONSET; MRI	Background: To identify changes in brain activation patterns in bipolar disorder (BD) and unipolar depression (UD) patients. Methodology/Principal Findings: Resting-state fMRI scans of 16 healthy controls, 17 BD and 16 UD patients were obtained. T-test of normalized regional homogeneity (ReHo) was performed in a voxel-by-voxel manner. A combined threshold of a = 0.05, minimum cluster volume of V = 10503 mm(3) (389 voxels) were used to determine ReHo differences between groups. In UD group, fMRI revealed ReHo increases in the left middle occipital lobe, right inferior parietal lobule, right precuneus and left convolution; and ReHo decreases in the left parahippocampalgyrus, right precentralgyrus, left postcentralgyrus, left precentralgyrus and left cingulated. In BD group, ReHo increases in the right insular cortex, left middle frontal gyrus, left precuneus, left occipital lobe, left parietal, left superior frontal gyrus and left thalamus; and ReHo decreases in the right anterior lobe of cerebellum, pons, right precentralgyrus, left postcentralgyrus, left inferior frontal gyrus, and right cingulate. There were some overlaps in ReHo profiles between UD and BD groups, but a marked difference was seen in the thalamus of BD. Conclusions/Significance: The resting-state fMRI and ReHo mapping are a promising tool to assist the detection of functional deficits and distinguish clinical and pathophysiological signs of BD and UD.	[Liang, Min-Jie; Zhou, Quan; Yang, Kan-Rong; Yang, Xiao-Ling; Fang, Jin] Jinan Univ, Affiliated Hosp 1, Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China; [Chen, Wen-Li] S China Normal Univ, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China; [Chen, Wen-Li] S China Normal Univ, Inst Laser Life Sci, Guangzhou, Guangdong, Peoples R China; [Huang, Zheng] Univ Colorado Denver, Dept Elect Engn, Aurora, CO USA; [Huang, Zheng] Univ Colorado Denver, CAPT Lab, Aurora, CO USA	Jinan University; South China Normal University; South China Normal University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Zhou, Q (corresponding author), Jinan Univ, Affiliated Hosp 1, Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China.	tzq@jnu.edu.cn			Medical Imaging Center of First Affiliated Hospital of Jinan University; Jinan University in China [4004714]	Medical Imaging Center of First Affiliated Hospital of Jinan University; Jinan University in China	This study was supported by Medical Imaging Center of First Affiliated Hospital of Jinan University (Informal, without grant number) and the postgraduate fund of Jinan University in China (grant no. 4004714). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CM, 2006, CNS SPECTRUMS, V11, P312, DOI 10.1017/S1092852900020800; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Angst J, 1998, J AFFECT DISORDERS, V50, P143, DOI 10.1016/S0165-0327(98)00142-6; Bearden CE, 2006, PSYCHIAT RES, V142, P139, DOI 10.1016/j.psychres.2005.08.010; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bowden CL, 2001, PSYCHIAT SERV, V52, P51, DOI 10.1176/appi.ps.52.1.51; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Cavanna AE, 2007, CNS SPECTRUMS, V12, P545, DOI 10.1017/S1092852900021295; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; DEIBER MP, 1991, EXP BRAIN RES, V84, P393; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Graff-Guerrero A, 2004, J AFFECT DISORDERS, V80, P55, DOI 10.1016/S0165-0327(03)00049-1; GRAFTON ST, 1992, J NEUROSCI, V12, P2542; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grimm S, 2009, HUM BRAIN MAPP, V30, P2617, DOI 10.1002/hbm.20693; Hales SA, 2011, BIPOLAR DISORD, V13, P651, DOI 10.1111/j.1399-5618.2011.00954.x; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Houenou J, 2011, J AFFECT DISORDERS, V132, P344, DOI 10.1016/j.jad.2011.03.016; Keck PE, 2008, J PSYCHIATR PRACT, V14, P31, DOI 10.1097/01.pra.0000320124.91799.2a; Keener Matthew T, 2007, Curr Psychiatry Rep, V9, P512, DOI 10.1007/s11920-007-0070-2; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kenny ER, 2010, AM J GERIAT PSYCHIAT, V18, P643, DOI 10.1097/JGP.0b013e3181cabd0e; Kiviniemi V, 2008, HUM BRAIN MAPP, V29, P810, DOI 10.1002/hbm.20582; Liu CH, 2013, J AFFECT DISORDERS, V149, P299, DOI 10.1016/j.jad.2013.02.002; Liu CH, 2013, PROG NEURO-PSYCHOPH, V41, P52, DOI 10.1016/j.pnpbp.2012.11.010; Liu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048181; Liu CH, 2012, NEUROSCI LETT, V516, P202, DOI 10.1016/j.neulet.2012.03.083; Liu DQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00024; Liu YY, 1999, NATURE, V400, P364, DOI 10.1038/22547; Lockwood KA, 2002, AM J PSYCHIAT, V159, P1119, DOI 10.1176/appi.ajp.159.7.1119; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; Lui S, 2011, AM J PSYCHIAT, V168, P642, DOI 10.1176/appi.ajp.2010.10101419; MacFall JR, 2001, BIOL PSYCHIAT, V49, P803, DOI 10.1016/S0006-3223(00)01113-6; Malhi GS, 2007, J AFFECT DISORDERS, V97, P109, DOI 10.1016/j.jad.2006.06.005; Mankinen K, 2011, BRAIN RES, V1373, P221, DOI 10.1016/j.brainres.2010.12.004; MAYBERG HS, 1990, ANN NEUROL, V28, P57, DOI 10.1002/ana.410280111; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P368, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<368::AID-HBM7>3.0.CO;2-E; Middleton FA, 2001, J NEUROSCI, V21, P700, DOI 10.1523/JNEUROSCI.21-02-00700.2001; Narrow WE, 2002, ARCH GEN PSYCHIAT, V59, P115, DOI 10.1001/archpsyc.59.2.115; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Parker G, 2000, AM J PSYCHIAT, V157, P1195, DOI 10.1176/appi.ajp.157.8.1195; Pearson JM, 2011, TRENDS COGN SCI, V15, P143, DOI 10.1016/j.tics.2011.02.002; Peng DH, 2011, CHINESE MED J-PEKING, V124, P369, DOI 10.3760/cma.j.issn.0366-6999.2011.03.009; Perico CAM, 2005, NEUROSCI LETT, V384, P265, DOI 10.1016/j.neulet.2005.04.088; Qiu CJ, 2011, PSYCHIAT RES-NEUROIM, V194, P47, DOI 10.1016/j.pscychresns.2011.01.010; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Rapp MA, 2005, AM J PSYCHIAT, V162, P691, DOI 10.1176/appi.ajp.162.4.691; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; Sasayama D, 2012, J AFFECT DISORDERS, V136, P1047, DOI 10.1016/j.jad.2011.11.031; Savitz J, 2010, NEUROIMAGE, V49, P2966, DOI 10.1016/j.neuroimage.2009.11.025; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Shippee ND, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-90; Strakowski SM, 2005, MOL PSYCHIATR, V10, P105, DOI 10.1038/sj.mp.4001585; THASE ME, 1991, PSYCHOPHARMACOL BULL, V27, P17; Tononi G, 1998, NEUROIMAGE, V7, P133, DOI 10.1006/nimg.1997.0313; Wakefield JC, 1997, BEHAV RES THER, V35, P633, DOI 10.1016/S0005-7967(97)00018-1; Wen XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063691; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Xiao Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057978; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Yu RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057516; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049; Zhou Y, 2010, J AFFECT DISORDERS, V121, P220, DOI 10.1016/j.jad.2009.05.029; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	74	95	111	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e79999	10.1371/journal.pone.0079999	http://dx.doi.org/10.1371/journal.pone.0079999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324588	Green Submitted, gold, Green Published			2022-12-25	WOS:000327949300015
J	Chen, D; Chen, ZJ; Jin, Y; Dragas, D; Zhang, LT; Adjei, BS; Wang, AX; Dai, Y; Zhou, XF				Chen, Dan; Chen, Zujian; Jin, Yi; Dragas, Dragan; Zhang, Leitao; Adjei, Barima S.; Wang, Anxun; Dai, Yang; Zhou, Xiaofeng			MicroRNA-99 Family Members Suppress Homeobox A1 Expression in Epithelial Cells	PLOS ONE			English	Article							MAMMARY-CARCINOMA CELLS; HUMAN GROWTH-HORMONE; ONCOGENIC TRANSFORMATION; DOWN-REGULATION; AXIAL SKELETON; UP-REGULATION; HOX GENES; CANCER; MIR-100; METASTASIS	The miR-99 family is one of the evolutionarily most ancient microRNA families, and it plays a critical role in developmental timing and the maintenance of tissue identity. Recent studies, including reports from our group, suggested that the miR-99 family regulates various physiological processes in adult tissues, such as dermal wound healing, and a number of disease processes, including cancer. By combining 5 independent genome-wide expression profiling experiments, we identified a panel of 266 unique transcripts that were down-regulated in epithelial cells transfected with miR-99 family members. A comprehensive bioinformatics analysis using 12 different sequence-based microRNA target prediction algorithms revealed that 81 out of these 266 down-regulated transcripts are potential direct targets for the miR-99 family. Confirmation experiments and functional analyses were performed to further assess 6 selected miR-99 target genes, including mammalian Target of rapamycin (mTOR), Homeobox A1 (HOXA1), CTD small phosphatase-like (CTDSPL), N-myristoyl-transferase 1 (NMT1), Transmembrane protein 30A (TMEM30A), and SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (SMARCA5). HOXA1 is a known proto-oncogene, and it also plays an important role in embryonic development. The direct targeting of the miR-99 family to two candidate binding sequences located in the HOXA1 mRNA was confirmed using a luciferase reporter gene assay and a ribonucleoprotein-immunoprecipitation (RIP-IP) assay. Ectopic transfection of miR-99 family reduced the expression of HOXA1, which, in consequence, down-regulated the expression of its downstream gene (i.e., Bcl-2) and led to reduced proliferation and cell migration, as well as enhanced apoptosis. In summary, we identified a number of high-confidence miR-99 family target genes, including proto-oncogene HOXA1, which may play an important role in regulating epithelial cell proliferation and migration during physiological disease processes, such as dermal wound healing and tumorigenesis.	[Chen, Dan; Chen, Zujian; Jin, Yi; Dragas, Dragan; Zhang, Leitao; Adjei, Barima S.; Wang, Anxun; Zhou, Xiaofeng] Univ Illinois, Coll Dent, Ctr Mol Biol Oral Dis, Chicago, IL 60607 USA; [Chen, Dan; Wang, Anxun] Sun Yat Sen Univ, Dept Oral & Maxillofacial Surg, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Zujian] Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Zhang, Leitao] Southern Med Univ, Nan Fang Hosp, Dept Oral & Maxillofacial Surg, Guangzhou, Guangdong, Peoples R China; [Dai, Yang] Univ Illinois, Dept Bioengn, Coll Engn, Chicago, IL USA; [Zhou, Xiaofeng] Univ Illinois, UIC Canc Ctr, Chicago, IL USA; [Zhou, Xiaofeng] Univ Illinois, Dept Periodont, Coll Dent, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Sun Yat Sen University; Rush University; Southern Medical University - China; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zhou, XF (corresponding author), Univ Illinois, Coll Dent, Ctr Mol Biol Oral Dis, Chicago, IL 60607 USA.	xfzhou@uic.edu			National Institutes of Health (NIH) PHS grants [CA139596, CA171436]; National Natural Science Foundation of China [81072228, 81272953]; Science and Technology Planning Project of Guangdong Province, China [A2010147]; CMBOD Oral Cancer Research Program (UIC College of Dentistry); University of Illinois Cancer Center; T32 training grant [DE018381]; NIH/National Institute of Dental and Craniofacial Research [DE022675]; University of Illinois at Chicago; NATIONAL CANCER INSTITUTE [R03CA171436, R01CA139596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R25DE022675, T32DE018381] Funding Source: NIH RePORTER	National Institutes of Health (NIH) PHS grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China; CMBOD Oral Cancer Research Program (UIC College of Dentistry); University of Illinois Cancer Center; T32 training grant; NIH/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); University of Illinois at Chicago; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by National Institutes of Health (NIH) PHS grants (CA139596 and CA171436), National Natural Science Foundation of China grants (81072228, 81272953), a grant from Science and Technology Planning Project of Guangdong Province, China (A2010147), a seed grant from CMBOD Oral Cancer Research Program (UIC College of Dentistry), and a Cancer Research Pilot Project grant from University of Illinois Cancer Center. Y.J. is supported by a T32 training grant (DE018381), and D. D. is supported by a R25 grant (DE022675) from NIH/National Institute of Dental and Craniofacial Research. The open access publication fee is supported by the Research Open Access Publishing (ROAAP) fund of the University of Illinois at Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Bitu CC, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-146; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chen ZJ, 2012, ORAL ONCOL, V48, P686, DOI 10.1016/j.oraloncology.2012.02.020; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Dai Yang, 2010, Open Access Bioinformatics, V2, P29; Delehedde M, 2001, J INVEST DERMATOL, V116, P366, DOI 10.1046/j.1523-1747.2001.01260.x; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Ducker CE, 2005, MOL CANCER RES, V3, P463, DOI 10.1158/1541-7786.MCR-05-0037; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Gebeshuber C.A., 2012, ONCOGENE; Hassan NMM, 2006, ONCOL RES, V16, P217, DOI 10.3727/000000006783981080; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Hertel J, 2012, RNA BIOL, V9, P231, DOI 10.4161/rna.18974; Iimura T, 2009, CURR TOP DEV BIOL, V88, P201, DOI 10.1016/S0070-2153(09)88007-1; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Jiang L, 2010, INT J CANCER, V127, P505, DOI 10.1002/ijc.25320; Jin Y, 2012, METHOD MOL BIOL, V936, P117; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064434; Jin Y, 2011, J BIOL CHEM, V286, P40104, DOI 10.1074/jbc.C111.296707; Kachgal S, 2012, CELL ADHES MIGR, V6, P457, DOI 10.4161/cam.22164; Kato U, 2013, J BIOL CHEM, V288, P4922, DOI 10.1074/jbc.M112.402701; KRAUSE CJ, 1981, ARCH OTOLARYNGOL, V107, P703; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lerman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020916; Li BH, 2011, EUR J CANCER, V47, P2166, DOI 10.1016/j.ejca.2011.04.037; Liu XQ, 2011, BIOCHEM J, V440, P23, DOI 10.1042/BJ20111006; Liu XQ, 2009, CANCER LETT, V286, P217, DOI 10.1016/j.canlet.2009.05.030; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mohankumar KM, 2007, ONCOGENE, V26, P3998, DOI 10.1038/sj.onc.1210180; Mohankumar KM, 2008, ENDOCRINOLOGY, V149, P2219, DOI 10.1210/en.2007-1320; Mueller AC, 2013, ONCOGENE, V32, P1164, DOI 10.1038/onc.2012.131; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Nakayama Shuko, 1998, Invasion and Metastasis, V18, P219, DOI 10.1159/000024515; Ohuchida K, 2012, ANN SURG ONCOL, V19, P2394, DOI 10.1245/s10434-012-2252-3; Perinpanayagam MA, 2013, FASEB J, V27, P811, DOI 10.1096/fj.12-214924; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Sun J, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0411-9; Tovar V, 2010, J HEPATOL, V52, P550, DOI 10.1016/j.jhep.2010.01.015; Vigneswaran N, 2003, ORAL ONCOL, V39, P559, DOI 10.1016/S1368-8375(03)00038-1; Weiss FU, 2009, GASTROENTEROLOGY, V137, P2136, DOI 10.1053/j.gastro.2009.08.065; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wreesmann VB, 2004, HEAD NECK-J SCI SPEC, V26, P10, DOI 10.1002/hed.10344; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yin VP, 2008, GENE DEV, V22, P728, DOI 10.1101/gad.1641808; Zha TZ, 2012, TUMOR BIOL, V33, P2125, DOI 10.1007/s13277-012-0472-6; Zhang X, 2006, J BIOL CHEM, V281, P6471, DOI 10.1074/jbc.M512666200; Zhang X, 2003, J BIOL CHEM, V278, P7580, DOI 10.1074/jbc.M212050200; Zheng YS, 2012, ONCOGENE, V31, P80, DOI 10.1038/onc.2011.208; Zhu T, 2005, CANCER RES, V65, P317	54	27	30	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e80625	10.1371/journal.pone.0080625	http://dx.doi.org/10.1371/journal.pone.0080625			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312487	Green Submitted, Green Published, gold			2022-12-25	WOS:000327947800016
J	Jacobs, DS; Babiker, H; Bastian, A; Kearney, T; van Eeden, R; Bishop, JM				Jacobs, David S.; Babiker, Hassan; Bastian, Anna; Kearney, Teresa; van Eeden, Rowen; Bishop, Jacqueline M.			Phenotypic Convergence in Genetically Distinct Lineages of a Rhinolophus Species Complex ( Mammalia, Chiroptera)	PLOS ONE			English	Article							INSECTIVOROUS BATS; CHARACTER DISPLACEMENT; RODENTIA MURIDAE; SOUTHERN AFRICA; MYOTIS MYOTIS; BODY-SIZE; ECHOLOCATION; EVOLUTION; DIVERGENCE; DIVERSITY	Phenotypes of distantly related species may converge through adaptation to similar habitats and/or because they share biological constraints that limit the phenotypic variants produced. A common theme in bats is the sympatric occurrence of cryptic species that are convergent in morphology but divergent in echolocation frequency, suggesting that echolocation may facilitate niche partitioning, reducing competition. If so, allopatric populations freed from competition, could converge in both morphology and echolocation provided they occupy similar niches or share biological constraints. We investigated the evolutionary history of a widely distributed African horseshoe bat, Rhinolophus darlingi, in the context of phenotypic convergence. We used phylogenetic inference to identify and date lineage divergence together with phenotypic comparisons and ecological niche modelling to identify morphological and geographical correlates of those lineages. Our results indicate that R. darlingi is paraphyletic, the eastern and western parts of its distribution forming two distinct non-sister lineages that diverged similar to 9.7 Mya. We retain R. darlingi for the eastern lineage and argue that the western lineage, currently the sub-species R. d. damarensis, should be elevated to full species status. R. damarensis comprises two lineages that diverged similar to 5 Mya. Our findings concur with patterns of divergence of other co-distributed taxa which are associated with increased regional aridification between 7-5 Mya suggesting possible vicariant evolution. The morphology and echolocation calls of R. darlingi and R. damarensis are convergent despite occupying different biomes. This suggests that adaptation to similar habitats is not responsible for the convergence. Furthermore, R. darlingi forms part of a clade comprising species that are bigger and echolocate at lower frequencies than R. darlingi, suggesting that biological constraints are unlikely to have influenced the convergence. Instead, the striking similarity in morphology and sensory biology are probably the result of neutral evolutionary processes, resulting in the independent evolution of similar phenotypes.	[Jacobs, David S.; Babiker, Hassan; Bastian, Anna; van Eeden, Rowen; Bishop, Jacqueline M.] Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, South Africa; [Kearney, Teresa] Ditsong Museum Nat Hist, Pretoria, South Africa	University of Cape Town	Jacobs, DS (corresponding author), Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, South Africa.	david.jacobs@uct.ac.za	Jacobs, David Steve/L-9118-2013; Bastian, Anna/B-1173-2018	Jacobs, David Steve/0000-0002-3243-8571; Bastian, Anna/0000-0001-7236-8670; Kearney, Teresa/0000-0002-0050-4060	South African Research Chair Initiative of the Department of Science and Technology; National Research Foundation [GUN 64798]; University Research Committee (University of Cape Town)	South African Research Chair Initiative of the Department of Science and Technology; National Research Foundation; University Research Committee (University of Cape Town)	This study was funded by a grant to DSJ from the South African Research Chair Initiative of the Department of Science and Technology, administered by the National Research Foundation (GUN 64798) and by the University Research Committee (University of Cape Town) Postdoctoral Fellowship to AB. NRF URL: http://www.nrf.ac.za/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE HDJN, 1987, J ANIM ECOL, V56, P763, DOI 10.2307/4947; Amezquita A, 2006, EVOLUTION, V60, P1874; Arbogast BS, 2001, J BIOGEOGR, V28, P819, DOI 10.1046/j.1365-2699.2001.00594.x; Arlettaz R, 1997, J ANIM ECOL, V66, P897, DOI 10.2307/6005; BAKER BH, 1971, NATURE, V229, P538, DOI 10.1038/229538a0; BARCLAY RMR, 1991, AM NAT, V137, P693, DOI 10.1086/285188; Barlow KE, 1997, J ZOOL, V243, P597, DOI 10.1111/j.1469-7998.1997.tb02804.x; Barratt EM, 1997, NATURE, V387, P138, DOI 10.1038/387138b0; Bauer FU, 2010, INT J EARTH SCI, V99, P1575, DOI 10.1007/s00531-010-0549-7; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Calendini F., 2005, PAUPUP V1 0 3 1 FREE; Coetzee J. A., 1978, Palaeoecology of Africa; Volume 10, P13; Colborn J, 2001, EVOLUTION, V55, P807, DOI 10.1554/0014-3820(2001)055[0807:TEEOBA]2.0.CO;2; Csorba G, 2003, HORSESHOE BATS WORLD; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; deMenocal PB, 2011, SCIENCE, V331, P540, DOI 10.1126/science.1190683; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; du Toit N, 2012, MOL PHYLOGENET EVOL, V65, P75, DOI 10.1016/j.ympev.2012.05.036; DUELLMAN WE, 1983, COPEIA, P639, DOI 10.2307/1444328; Eick GN, 2005, MOL BIOL EVOL, V22, P1869, DOI 10.1093/molbev/msi180; Fenton MB, 2002, CAN J ZOOL, V80, P1004, DOI 10.1139/Z02-083; FREEMAN PW, 1981, J MAMMAL, V62, P166, DOI 10.2307/1380489; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; Gause G. F., 1934, STRUGGLE EXISTENCE; Goodier SAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028775; Goodman SM, 2012, ZOOTAXA, P1; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Hadley A, 2010, COMBINEZP SOFTWARE P; Happold M, 2013, MAMMALS AFRICA, VIV, P301; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Harmon LJ, 2005, EVOLUTION, V59, P409; HELLER KG, 1989, OECOLOGIA, V80, P178, DOI 10.1007/BF00380148; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUSAR SL, 1976, J MAMMAL, V57, P331, DOI 10.2307/1379692; Jacobs DS, 2007, OECOLOGIA, V152, P583, DOI 10.1007/s00442-007-0679-1; Jacobs DS, 2006, J MAMMAL, V87, P161, DOI 10.1644/04-MAMM-A-132R2.1; JANIS CM, 1993, ANNU REV ECOL SYST, V24, P467, DOI 10.1146/annurev.es.24.110193.002343; Jiang TL, 2008, PROG NAT SCI-MATER, V18, P523, DOI 10.1016/j.pnsc.2007.12.005; JONES G, 1993, P ROY SOC B-BIOL SCI, V251, P119, DOI 10.1098/rspb.1993.0017; Jones G, 1999, J EXP BIOL, V202, P3359; Jones G., 2004, ECHOLOCATION BATS DO, P345; Jones G, 2008, CURR BIOL, V18, pR34, DOI 10.1016/j.cub.2007.10.056; Jones G, 1997, ADV STUD BEHAV, V26, P317, DOI 10.1016/S0065-3454(08)60383-6; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kingston T, 2004, NATURE, V429, P654, DOI 10.1038/nature02487; Kingston T, 2001, P ROY SOC B-BIOL SCI, V268, P1381, DOI 10.1098/rspb.2001.1630; Lamb T, 2000, AFR ZOOL, V35, P55; Losos JB, 2011, EVOLUTION, V65, P1827, DOI 10.1111/j.1558-5646.2011.01289.x; Matthee CA, 2002, MOL ECOL, V11, P465, DOI 10.1046/j.0962-1083.2001.01458.x; Matthee CA, 2001, SYST BIOL, V50, P367, DOI 10.1080/106351501300317987; Mayer F, 2001, BIOL J LINN SOC, V74, P365, DOI 10.1006/bijl.2001.0586; Monadjem A, 2010, BATS SO CENTRAL AFRI; Mucina Ladislav, 2006, V19, P2; NEUWEILER G, 1990, PHYSIOL REV, V70, P615, DOI 10.1152/physrev.1990.70.3.615; Nogueira MR, 2009, FUNCT ECOL, V23, P715, DOI 10.1111/j.1365-2435.2009.01549.x; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Omland KE, 2000, P ROY SOC B-BIOL SCI, V267, P2475, DOI 10.1098/rspb.2000.1308; PATTERSON BD, 1982, J MAMMAL, V63, P1, DOI 10.2307/1380665; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Roberts A, 1946, ANN TRANSVAAL MUS, V10, P59; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruedi M, 2001, MOL PHYLOGENET EVOL, V21, P436, DOI 10.1006/mpev.2001.1017; Russo IRM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-307; SAUNDERS MB, 1992, ECOLOGY, V73, P1335, DOI 10.2307/1940680; Scott L., 1997, P62; Sedlock JL, 2009, J ZOOL, V279, P388, DOI 10.1111/j.1469-7998.2009.00634.x; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Solick DI, 2006, J MAMMAL, V87, P1020, DOI 10.1644/06-MAMM-A-044R1.1; Sponer R, 2002, EVOLUTION, V56, P1954; StatSoft Inc., 2011, STAT DAT AN SOFTW SY; Stayton CT, 2008, J THEOR BIOL, V252, P1, DOI 10.1016/j.jtbi.2008.01.008; Stoffberg S, 2007, THESIS U CAPE TOWN; Stoffberg S, 2011, J MAMM EVOL, V18, P117, DOI 10.1007/s10914-011-9158-x; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041744; Thabah A, 2006, BIOL J LINN SOC, V88, P119, DOI 10.1111/j.1095-8312.2006.00602.x; Wojczulanis-Jakubas K, 2011, POLAR BIOL, V34, P847, DOI 10.1007/s00300-010-0941-6; Yoder AD, 2000, P NATL ACAD SCI USA, V97, P11325, DOI 10.1073/pnas.200121897; Zhou ZM, 2009, J MAMMAL, V90, P57, DOI 10.1644/08-MAMM-A-048.1	83	27	27	1	160	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82614	10.1371/journal.pone.0082614	http://dx.doi.org/10.1371/journal.pone.0082614			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312666	Green Published, gold, Green Submitted			2022-12-25	WOS:000327947800102
J	Yin, Y; Zhuo, W; Zhao, Y; Chen, SJ; Li, J; Wang, L; Zhou, TH; Si, JM				Yin, Ying; Zhuo, Wei; Zhao, Yuan; Chen, Shujie; Li, Jun; Wang, Lan; Zhou, Tianhua; Si, Jian-Min			Converting a Microarray Signature into a Diagnostic Test: A Trial of Custom 74 Gene Array for Clarification and Prediction the Prognosis of Gastric Cancer	PLOS ONE			English	Article							BREAST-CANCER; CDNA MICROARRAY; EXPRESSION; COLLAGEN; CARCINOGENESIS; STATISTICS; CARCINOMA; LESIONS; IMPACT	Background: Gastric cancer (GC) is associated with high mortality rates and an unfavorable prognosis at advanced stages. In addition, there are no effective methods for diagnosing gastric cancer at an early stage or for predicting the outcome for the purpose of selecting patient-specific treatment options. Therefore, it is important to investigate new methods for GC diagnosis. Methodology/Principal Findings: To facilitate its use in a diagnostic setting, a group of 74 genes with diagnostic and prognostic information was translated into a customized microarray containing a reduced set of 1,042 probes suitable for high throughput processing. In this report, we demonstrate for the first time that the custom mini-array can be used as a reliable diagnostic tool in gastric cancer. With an AUC value of 0.565 (95% CI 0.305-0.825) indicating a perfect test, the sensitivity and specificity of diagnosis from the ROC curve were calculated to be 70% and 80%, respectively. Conclusions/Significance: The data clearly demonstrate the reproducibility and robustness of the small custom-made microarray. The array is an excellent tool for classifying and predicting the outcome of disease in gastric cancer patients.	[Yin, Ying; Zhao, Yuan; Chen, Shujie; Li, Jun; Wang, Lan; Si, Jian-Min] Zhejiang Univ, Sch Med, Sir Runrun Shaw Hosp, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Yin, Ying; Zhuo, Wei; Zhao, Yuan; Chen, Shujie; Li, Jun; Wang, Lan; Zhou, Tianhua; Si, Jian-Min] Zhejiang Univ, Inst Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhuo, Wei; Zhou, Tianhua] Zhejiang Univ, Sch Med, Dept Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhuo, Wei; Zhou, Tianhua] Zhejiang Univ, Sch Med, Program Mol Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Si, JM (corresponding author), Zhejiang Univ, Sch Med, Sir Runrun Shaw Hosp, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.	Sijm@zju.edu.cn	zhou, tianhua/K-4908-2013	zhou, tianhua/0000-0002-1791-2124	National Natural Science Foundation of China [81302070, 81272678, 81071961]; National Basic Research Program of China (973 Program) [2012CB945004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (81302070, 81272678, 81071961) (http://www.nsfc.gov.cn), National Basic Research Program of China (973 Program) (2012CB945004) (www.973.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carvajal A, 2003, BMJ-BRIT MED J, V327, P1050, DOI 10.1136/bmj.327.7422.1050-c; Cho WCS, 2011, EXPERT REV MOL DIAGN, V11, P9, DOI [10.1586/erm.10.111, 10.1586/ERM.10.111]; CORREA P, 1992, CANCER RES, V52, P6735; ENDO M, 1990, HEPATO-GASTROENTEROL, V37, P408; Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jinawath N, 2004, ONCOGENE, V23, P6830, DOI 10.1038/sj.onc.1207886; KAMPSCHOER GHM, 1989, SCAND J GASTROENTERO, V24, P813, DOI 10.3109/00365528909089219; Kim JM, 2005, CLIN CANCER RES, V11, P473; Kinoshita J, 2010, ONCOL LETT, V1, P989, DOI 10.3892/ol.2010.181; Lee HJ, 2010, GASTROENTEROLOGY, V139, P213, DOI 10.1053/j.gastro.2010.04.008; Lee KS, 2010, TUMOR BIOL, V31, P165, DOI 10.1007/s13277-010-0022-z; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; Nardone G, 2004, ALIMENT PHARM THER, V20, P261, DOI 10.1111/j.1365-2036.2004.02075.x; OHTA H, 1987, CANCER, V60, P1099, DOI 10.1002/1097-0142(19870901)60:5<1099::AID-CNCR2820600530>3.0.CO;2-F; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Roshanaei G, 2011, ASIAN PAC J CANCER P, V12, P3005; SANTORO E, 1991, HEPATO-GASTROENTEROL, V38, P427; Sentani K, 2012, CARCINOGENESIS, V33, P1081, DOI 10.1093/carcin/bgs121; Sipponen Pentti, 2002, Gastric Cancer, V5, P213, DOI 10.1007/s101200200037; Tahara Eiichi, 2004, IARC Sci Publ, P327; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Xu JB, 2012, INT J CANCER, V130, P787, DOI 10.1002/ijc.26035; Yang DY, 2011, J GASTROINTEST ONCOL, V2, P77, DOI 10.3978/j.issn.2078-6891.2010.025; Yin Y, 2009, MED HYPOTHESES, V72, P163, DOI 10.1016/j.mehy.2008.09.010; Yoshida S, 2006, BEST PRACT RES CL GA, V20, P745, DOI 10.1016/j.bpg.2006.01.001; Yu J, 2009, GASTROENTEROLOGY, V136, P640, DOI 10.1053/j.gastro.2008.10.050; Yuasa Y, 2003, NAT REV CANCER, V3, P592, DOI 10.1038/nrc1141; Zhao Y, 2009, ANAT REC, V292, P692, DOI 10.1002/ar.20874	30	10	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81561	10.1371/journal.pone.0081561	http://dx.doi.org/10.1371/journal.pone.0081561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312559	Green Published, gold, Green Submitted			2022-12-25	WOS:000327947800048
J	Baum, E; Badu, K; Molina, DM; Liang, XW; Felgner, PL; Yan, GY				Baum, Elisabeth; Badu, Kingsley; Molina, Douglas M.; Liang, Xiaowu; Felgner, Philip L.; Yan, Guiyun			Protein Microarray Analysis of Antibody Responses to Plasmodium falciparum in Western Kenyan Highland Sites with Differing Transmission Levels	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSES; EAST-AFRICAN HIGHLANDS; MALARIA TRANSMISSION; SPATIAL-DISTRIBUTION; CLIMATE-CHANGE; ANTIGENS; PATTERNS; ARRAY; AREA; IDENTIFICATION	Malaria represents a major public health problem in Africa. In the East African highlands, the high-altitude areas were previously considered too cold to support vector population and parasite transmission, rendering the region particularly prone to epidemic malaria due to the lack of protective immunity of the population. Since the 1980's, frequent malaria epidemics have been reported and these successive outbreaks may have generated some immunity against Plasmodium falciparum amongst the highland residents. Serological studies reveal indirect evidence of human exposure to the parasite, and can reliably assess prevalence of exposure and transmission intensity in an endemic area. However, the vast majority of serological studies of malaria have been, hereto, limited to a small number of the parasite's antigens. We surveyed and compared the antibody response profiles of age-stratified sera from residents of two endemic areas in the western Kenyan highlands with differing malaria transmission intensities, during two distinct seasons, against 854 polypeptides of P. falciparum using high-throughput proteomic microarray technology. We identified 107 proteins as serum antibody targets, which were then characterized for their gene ontology biological process and cellular component of the parasite, and showed significant enrichment for categories related to immune evasion, pathogenesis and expression on the host's cell and parasite's surface. Additionally, we calculated age-fitted annual seroconversion rates for the immunogenic proteins, and contrasted the age-dependent antibody acquisition for those antigens between the two sampling sites. We observed highly immunogenic antigens that produce stable antibody responses from early age in both sites, as well as less immunogenic proteins that require repeated exposure for stable responses to develop and produce different seroconversion rates between sites. We propose that a combination of highly and less immunogenic proteins could be used in serological surveys to detect differences in malaria transmission levels, distinguishing sites of unstable and stable transmission.	[Baum, Elisabeth; Felgner, Philip L.] Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92717 USA; [Badu, Kingsley] Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Sci, Dept Immunol, Accra, Ghana; [Molina, Douglas M.; Liang, Xiaowu] Antigen Discovery Inc, Irvine, CA USA; [Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA USA	University of California System; University of California Irvine; University of Ghana; University of California System; University of California Irvine	Baum, E (corresponding author), Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92717 USA.	ebaum@uci.edu	Badu, Kingsley/AAE-8418-2020	Badu, Kingsley/0000-0002-7886-5528; Baum-Jones, Elisabeth/0000-0001-6348-3378	NIH [R01 AI050243, D43 TW001505]; SBIR [2R44AI066791, R01 AI95916, U19 AI89686, 5R43AI075692]; FOGARTY INTERNATIONAL CENTER [D43TW001505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089686, R43AI075692, R01AI050243, R44AI066791, R01AI095916] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SBIR; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by NIH grants R01 AI050243 and D43 TW001505 (GY); SBIR 2R44AI066791, R01 AI95916 and U19 AI89686 (PF); and SBIR 5R43AI075692 (XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-241; Badu K, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-50; Baliraine FN, 2009, J INFECT DIS, V200, P66, DOI 10.1086/599317; Barbour AG, 2008, INFECT IMMUN, V76, P3374, DOI 10.1128/IAI.00048-08; Barry AE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008326; Beare PA, 2008, CLIN VACCINE IMMUNOL, V15, P1771, DOI 10.1128/CVI.00300-08; Benet A, 2004, MOL BIOCHEM PARASIT, V134, P275, DOI 10.1016/j.molbiopara.2003.12.005; Bodker R, 2003, J MED ENTOMOL, V40, P706, DOI 10.1603/0022-2585-40.5.706; Bouma MJ, 2011, TRENDS PARASITOL, V27, P421, DOI 10.1016/j.pt.2011.07.003; Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; Chaves LF, 2012, PARASITOLOGY, V139, P14, DOI 10.1017/S0031182011001685; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Costa RM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-100; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Doolan DL, 2011, INT J PARASITOL, V41, P3, DOI 10.1016/j.ijpara.2010.08.002; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Doolan DL, 2008, PROTEOMICS, V8, P4680, DOI 10.1002/pmic.200800194; Drakeley C, 2009, ADV PARASIT, V69, P299, DOI 10.1016/S0065-308X(09)69005-9; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eyles JE, 2007, PROTEOMICS, V7, P2172, DOI 10.1002/pmic.200600985; Felgner PL, 2009, P NATL ACAD SCI USA, V106, P13499, DOI 10.1073/pnas.0812080106; Fontaine A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-276; Githeko AK, 2012, ACTA TROP, V121, P19, DOI 10.1016/j.actatropica.2011.10.002; GITHEKO AK, 1992, T ROY SOC TROP MED H, V86, P355, DOI 10.1016/0035-9203(92)90216-Y; Githeko AK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-107; Hashizume M, 2009, P NATL ACAD SCI USA, V106, P1857, DOI 10.1073/pnas.0806544106; Hay SI, 2002, EMERG INFECT DIS, V8, P543, DOI 10.3201/eid0806.010309; Hill AVS, 2011, PHILOS T R SOC B, V366, P2806, DOI 10.1098/rstb.2011.0091; Himeidan YE, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00315; Imbahale SS, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/912408; Koncarevic S, 2007, PROTEOMICS, V7, P711, DOI 10.1002/pmic.200600552; Kristan M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-231; Kulkarni MA, 2006, J MED ENTOMOL, V43, P580, DOI 10.1603/0022-2585(2006)43[580:EEOMVA]2.0.CO;2; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; Mbengue A, 2013, MOL MICROBIOL, V88, P425, DOI 10.1111/mmi.12193; McClave J. T., 2012, STATISTICS; Minakawa N, 2005, AM J TROP MED HYG, V73, P157, DOI 10.4269/ajtmh.2005.73.157; Molina DM, 2010, VACCINE, V28, P3014, DOI 10.1016/j.vaccine.2009.12.020; Munyekenye OG, 2005, EMERG INFECT DIS, V11, P1571, DOI 10.3201/eid1110.050106; Nnedu ON, 2011, PROTEOM CLIN APPL, V5, P613, DOI 10.1002/prca.201100021; Nogaro SI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025582; Noland GS, 2008, INFECT IMMUN, V76, P5721, DOI 10.1128/IAI.00591-08; Orlandi-Pradines E, 2006, AM J TROP MED HYG, V74, P979; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Pascual M, 2008, P ROY SOC B-BIOL SCI, V275, P123, DOI 10.1098/rspb.2007.1068; Reddy SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032242; Rolfes MA, 2012, AM J TROP MED HYG, V87, P806, DOI 10.4269/ajtmh.2012.11-0530; Segeja MD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-55; Shanks GD, 2005, EMERG INFECT DIS, V11, P1425, DOI 10.3201/eid1109.041131; Shonhai A, 2007, PROTEIN SCI, V16, P1803, DOI 10.1110/ps.072918107; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Spielmann T, 2006, MOL MICROBIOL, V59, P779, DOI 10.1111/j.1365-2958.2005.04983.x; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Tan XL, 2011, J INFECT DIS, V204, P1750, DOI 10.1093/infdis/jir638; Trieu A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007948; Vestergaard LS, 2008, INFECT IMMUN, V76, P2706, DOI 10.1128/IAI.01401-06; Wanjala CL, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-81; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Wickramarachchi T, 2009, INT J PARASITOL, V39, P763, DOI 10.1016/j.ijpara.2008.12.004; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Woodberry T, 2008, J INFECT DIS, V198, P134, DOI 10.1086/588711; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100; Zhou GF, 2004, J MED ENTOMOL, V41, P1001, DOI 10.1603/0022-2585-41.6.1001; Zhou GF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020318	66	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82246	10.1371/journal.pone.0082246	http://dx.doi.org/10.1371/journal.pone.0082246			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312649	gold, Green Published			2022-12-25	WOS:000327944500132
J	Hosseini, PR; Fuller, T; Harrigan, R; Zhao, DL; Arriola, CS; Gonzalez, A; Miller, MJ; Xiao, XM; Smith, TB; Jones, JH; Daszak, P				Hosseini, Parviez Rana; Fuller, Trevon; Harrigan, Ryan; Zhao, Delong; Arriola, Carmen Sofia; Gonzalez, Armandoe; Miller, Matthew Joshua; Xiao, Xiangming; Smith, Tom B.; Jones, Jamie Holland; Daszak, Peter			Metapopulation Dynamics Enable Persistence of Influenza A, Including A/H5N1, in Poultry	PLOS ONE			English	Article							AVIAN INFLUENZA; VIRUS H5N1; HONG-KONG; BACKYARD POULTRY; OUTBREAK; TRANSMISSION; EVOLUTION; EPIDEMIC; INFECTION; MIGRATION	Highly pathogenic influenza A/H5N1 has persistently but sporadically caused human illness and death since 1997. Yet it is still unclear how this pathogen is able to persist globally. While wild birds seem to be a genetic reservoir for influenza A, they do not seem to be the main source of human illness. Here, we highlight the role that domestic poultry may play in maintaining A/H5N1 globally, using theoretical models of spatial population structure in poultry populations. We find that a metapopulation of moderately sized poultry flocks can sustain the pathogen in a finite poultry population for over two years. Our results suggest that it is possible that moderately intensive backyard farms could sustain the pathogen indefinitely in real systems. This fits a pattern that has been observed from many empirical systems. Rather than just employing standard culling procedures to control the disease, our model suggests ways that poultry production systems may be modified.	[Hosseini, Parviez Rana; Daszak, Peter] EcoHealth Alliance, New York, NY USA; [Fuller, Trevon; Harrigan, Ryan; Smith, Tom B.] Univ Calif Los Angeles, Inst Environm, Ctr Trop Res, Los Angeles, CA USA; [Harrigan, Ryan; Smith, Tom B.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Zhao, Delong; Xiao, Xiangming] Univ Oklahoma, Dept Bot & Microbiol, Ctr Spatial Anal, Norman, OK 73019 USA; [Arriola, Carmen Sofia; Gonzalez, Armandoe] San Marcos Major Natl Univ, Sch Vet Med, Lab Prevent Vet Med, Lima, Peru; [Miller, Matthew Joshua] Smithsonian Trop Res Inst, Panama City, Panama; [Jones, Jamie Holland] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Jones, Jamie Holland] Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Oklahoma System; University of Oklahoma - Norman; Universidad Nacional Mayor de San Marcos; Smithsonian Institution; Smithsonian Tropical Research Institute; Stanford University; Stanford University	Hosseini, PR (corresponding author), EcoHealth Alliance, New York, NY USA.	hosseini@ecohealthalliance.org	xiao, xiang/GWU-6035-2022; daszak, peter/U-4588-2017; Fuller, Trevon/B-8087-2014; Miller, Matthew/B-4560-2008	daszak, peter/0000-0002-2046-5695; Gonzalez, Armando/0000-0003-1909-1873; Jones, James/0000-0003-1680-6757; Fuller, Trevon/0000-0001-9954-4267; Miller, Matthew/0000-0002-2939-0239; Xiao, Xiangming/0000-0003-0956-7428	National Institutes of Health/National Science Foundation Ecology and Evolution of Infectious Diseases award from the Fogarty International Center [3R01-TW005869]; Office of the Secretary of the Department of Health and Human Services; FOGARTY INTERNATIONAL CENTER [R01TW005869] Funding Source: NIH RePORTER	National Institutes of Health/National Science Foundation Ecology and Evolution of Infectious Diseases award from the Fogarty International Center; Office of the Secretary of the Department of Health and Human Services; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work is supported by a National Institutes of Health/National Science Foundation Ecology and Evolution of Infectious Diseases award from the Fogarty International Center 3R01-TW005869, and was conducted in the context of Zoonotic Influenza Collaborative Network, led by the Fogarty International Center, National Institutes of Health. The Collaborative Network is supported by International Influenza Funds from the Office of the Secretary of the Department of Health and Human Services. While the funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript, Zoonotic Influenza Collaborative Network, led by the Fogarty International Center, National Institutes of Health co-ordinated and participated in the discussions which led to the study design.	Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; Aly MM, 2008, AVIAN DIS, V52, P269, DOI 10.1637/8166-103007-Reg.1; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barral M, 2008, BMC VET RES, P4; Bavinck V, 2009, PREV VET MED, V88, P247, DOI 10.1016/j.prevetmed.2008.10.007; Berns KI, 2012, SCIENCE, V335, P660, DOI 10.1126/science.1217994; Beyer HL, 2011, P ROY SOC B-BIOL SCI, V278, P2182, DOI 10.1098/rspb.2010.2312; Biswas PK, 2009, EMERG INFECT DIS, V15, P1931, DOI 10.3201/eid1512.090643; Biswas PK, 2008, EMERG INFECT DIS, V14, P1909, DOI 10.3201/eid1412.071567; Bouma A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000281; Breban R, 2009, PLOS COMPUTATIONAL B, P5; Breed AC, 2010, AVIAN DIS, V54, P399, DOI 10.1637/8950-053109-Reg.1; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Courcoul A, 2010, VET MICROBIOL, V142, P119, DOI 10.1016/j.vetmic.2009.09.052; Cristalli A, 2007, AVIAN DIS, V51, P461, DOI 10.1637/7564-033106R.1; Cumming GS, 2011, ECOHEALTH, V8, P4, DOI 10.1007/s10393-011-0684-z; Phuong DQ, 2011, VET MICROBIOL, V148, P168, DOI 10.1016/j.vetmic.2010.09.007; Doob JL, 1942, T AM MATH SOC, V52, P37, DOI 10.2307/1990152; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Ellner SP, 2001, NATURE, V412, P538, DOI 10.1038/35087580; *EMPRES, 2009, GLOB AN DIS INF SYST; FAO and OIE in collaboration with WHO, 2005, GLOB STRAT PROGR CON; Fasina FO, 2011, PREV VET MED, V98, P204, DOI 10.1016/j.prevetmed.2010.11.007; Ferrari MJ, 2010, P ROY SOC B-BIOL SCI, V277, P2775, DOI 10.1098/rspb.2010.0536; Fielding R, 2007, EMERG INFECT DIS, V13, P1065, DOI 10.3201/eid1307.061031; Gauthier-Clerc M, 2007, IBIS, V149, P202, DOI 10.1111/j.1474-919X.2007.00699.x; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Gilbert M, 2007, AGR ECOSYST ENVIRON, V119, P409, DOI 10.1016/j.agee.2006.09.001; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650, DOI 10.3201/eid1211.060223; Gilbert M, 2010, ECOHEALTH, V7, P448, DOI 10.1007/s10393-010-0672-8; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Graham JP, 2008, PUBLIC HEALTH REP, V123, P282, DOI 10.1177/003335490812300309; Guan Y, 2009, REV SCI TECH OIE, V28, P39, DOI 10.20506/rst.28.1.1868; Hafez MH, 2010, POULTRY SCI, V89, P1609, DOI 10.3382/ps.2010-00708; HANSKI I, 1997, METAPOPULATION BIOL; Hien ND, 2009, EMERG INFECT DIS, V15, P19, DOI 10.3201/eid1501.080073; Hosny FA, 2006, EGYPT POULTRY SECTOR; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1267, DOI 10.3201/eid1408.080078; Kandeel A, 2010, EMERG INFECT DIS, V16, P1101, DOI 10.3201/eid1607.091695; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Lebarbenchon C, 2009, PLOS ONE, P4; Lee CW, 2004, J VIROL, V78, P8372, DOI [10.1128/JVI.78.15.8372-8381.2004, 10.1128/jvi.78.15.8372-8381.2004]; Leibler JH, 2009, ECOHEALTH, V6, P58, DOI 10.1007/s10393-009-0226-0; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; Monne I, 2008, EMERG INFECT DIS, V14, P637, DOI 10.3201/eid1404.071178; Moore SM, 2011, B MATH BIOL, V73, P2707, DOI 10.1007/s11538-011-9654-4; Nagy A, 2009, VET MICROBIOL, V133, P257, DOI 10.1016/j.vetmic.2008.07.013; Nicita A., 2008, AVIAN INFLUENZA POUL; OIE, 2012, UPD AV INFL AN TYP H; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Ray K, 2008, VIRUS GENES, V36, P345, DOI 10.1007/s11262-007-0195-8; Reperant LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000854; Saad MD, 2007, EMERG INFECT DIS, V13, P1120, DOI 10.3201/eid1307.061222; Sakoda Y, 2010, VIROLOGY, V406, P88, DOI 10.1016/j.virol.2010.07.007; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Shortridge KF, 1999, VACCINE, V17, pS26, DOI 10.1016/S0264-410X(99)00102-4; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Szeleczky Z, 2009, VET MICROBIOL, V139, P24, DOI 10.1016/j.vetmic.2009.04.017; Takekawa JY, 2010, AVIAN DIS, V54, P466, DOI 10.1637/8914-043009-Reg.1; Thrall PH, 1999, EVOL ECOL RES, V1, P681; Tiensin T, 2007, J INFECT DIS, V196, P1679, DOI 10.1086/522007; Truscott J, 2007, P ROY SOC B-BIOL SCI, V274, P2287, DOI 10.1098/rspb.2007.0542; Van Kerkhove MD, 2008, INFLUENZA OTHER RESP, V2, P155, DOI 10.1111/j.1750-2659.2008.00052.x; Viseshakul N, 2004, VIROLOGY, V328, P169, DOI 10.1016/j.virol.2004.06.045; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2012, EP PAND AL RESP AV I; Williams RAJ, 2011, GEOSPATIAL HEALTH, V5, P247, DOI 10.4081/gh.2011.177; Xiao XM, 2007, J WILDLIFE DIS, V43, pS40; Zohari S, 2008, VIRUS GENES, V36, P117, DOI 10.1007/s11262-007-0188-7	74	9	9	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80091	10.1371/journal.pone.0080091	http://dx.doi.org/10.1371/journal.pone.0080091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312455	gold, Green Published, Green Submitted			2022-12-25	WOS:000327944500010
J	Ketko, AK; Lin, CH; Moore, BB; LeVine, AM				Ketko, Anastasia K.; Lin, Chinhong; Moore, Bethany B.; LeVine, Ann Marie			Surfactant Protein A Binds Flagellin Enhancing Phagocytosis and IL-1 beta Production	PLOS ONE			English	Article							ALVEOLAR MACROPHAGE PHAGOCYTOSIS; GRAM-NEGATIVE BACTERIA; KAPPA-B-ALPHA; PSEUDOMONAS-AERUGINOSA; CYTOKINE PRODUCTION; DEFICIENT MICE; ACTIVATION; CASPASE-1; REQUIRES; INTERLEUKIN-1-BETA	Surfactant protein A (SP-A), a pulmonary collectin, plays a role in lung innate immune host defense. In this study the role of SP-A in regulating the inflammatory response to the flagella of Pseudomonas aeruginosa (PA) was examined. Intra-tracheal infection of SP-A deficient (SP-A-/-) C57BL/6 mice with wild type flagellated PA (PAK) resulted in an increase in inflammatory cell recruitment and increase in pro-inflammatory cytokines IL-6 and TNF-alpha, which was not observed with a mutant pseudomonas lacking flagella (fliC). SP-A directly bound flagellin, via the N-linked carbohydrate moieties and collagen-like domain, in a concentration dependent manner and enhanced macrophage phagocytosis of flagellin and wild type PAK. IL-1 beta was reduced in the lungs of SP-A-/- mice following PAK infection. MH-s cells, a macrophage cell line, generated greater IL-1 beta when stimulated with flagellin and SP-A. Historically flagella stimulate IL-1 beta production through the toll-like receptor 5 (TLR-5) pathway and through a caspase-1 activating inflammasome pathway. IL-1 beta expression became non-detectable in SP-A and flagellin stimulated MH-s cells in which caspase-1 was silenced, suggesting SP-A induction of IL-1 beta appears to be occurring through the inflammasome pathway. SP-A plays an important role in the pathogenesis of PA infection in the lung by binding flagellin, enhancing its phagocytosis and modifying the macrophage inflammatory response.	[Ketko, Anastasia K.; Lin, Chinhong; LeVine, Ann Marie] Univ Michigan, Dept Pediat, Div Neonatol, Div Pediat Crit Care Med, Ann Arbor, MI 48109 USA; [Moore, Bethany B.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	LeVine, AM (corresponding author), Univ Michigan, Dept Pediat, Div Neonatol, Div Pediat Crit Care Med, Ann Arbor, MI 48109 USA.	AnnMarie.Levine@nemours.org		Moore, Bethany/0000-0003-3051-745X	National Institutes of Health [HL R56065543]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI065543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding came from a National Institutes of Health grant (HL R56065543). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2004, AM J PHYSIOL-LUNG C, V286, pL129, DOI 10.1152/ajplung.00427.2002; Byrne BG, 2013, MBIO, V4, DOI 10.1128/mBio.00620-12; Descamps D, 2012, P NATL ACAD SCI USA, V109, P1619, DOI 10.1073/pnas.1108464109; Domingo-Gonzalez R, 2013, J IMMUNOL, V190, P5809, DOI 10.4049/jimmunol.1203274; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gil M, 2009, J BIOL CHEM, V284, P7495, DOI 10.1074/jbc.M808643200; Guillot L, 2002, J IMMUNOL, V168, P5989, DOI 10.4049/jimmunol.168.12.5989; HAAGSMAN HP, 1987, J BIOL CHEM, V262, P13877; Halff EF, 2012, J BIOL CHEM, V287, P38460, DOI 10.1074/jbc.M112.393512; Honko AN, 2004, INFECT IMMUN, V72, P6676, DOI 10.1128/IAI.72.11.6676-6679.2004; Kabha K, 1997, AM J PHYSIOL-LUNG C, V272, pL344, DOI 10.1152/ajplung.1997.272.2.L344; Korfhagen TR, 1996, P NATL ACAD SCI USA, V93, P9594, DOI 10.1073/pnas.93.18.9594; Kremlev SG, 1997, AM J PHYSIOL-LUNG C, V272, pL996, DOI 10.1152/ajplung.1997.272.5.L996; LeVine AM, 1999, AM J RESP CELL MOL, V20, P279, DOI 10.1165/ajrcmb.20.2.3303; LeVine AM, 1997, J IMMUNOL, V158, P4336; LeVine AM, 1998, AM J RESP CELL MOL, V19, P700, DOI 10.1165/ajrcmb.19.4.3254; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; MAHENTHIRALINGAM E, 1995, INFECT IMMUN, V63, P4519, DOI 10.1128/IAI.63.11.4519-4523.1995; MANZKEINKE H, 1992, EUR J CELL BIOL, V57, P95; Mariencheck WI, 1999, AM J PHYSIOL-LUNG C, V277, pL777, DOI 10.1152/ajplung.1999.277.4.L777; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; McIntosh JC, 1996, AM J PHYSIOL-LUNG C, V271, pL310, DOI 10.1152/ajplung.1996.271.2.L310; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Moulakakis C, 2007, J IMMUNOL, V179, P4480, DOI 10.4049/jimmunol.179.7.4480; Perez-Lopez A, 2013, J IMMUNOL, V190, P1201, DOI 10.4049/jimmunol.1200415; PIKAAR JC, 1995, J INFECT DIS, V172, P481, DOI 10.1093/infdis/172.2.481; Ramphal R, 2008, J IMMUNOL, V181, P586, DOI 10.4049/jimmunol.181.1.586; Raoust E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007259; Rosseau S, 1999, J IMMUNOL, V163, P4495; Sano H, 1999, J IMMUNOL, V163, P387; Sano H, 2000, J BIOL CHEM, V275, P22442, DOI 10.1074/jbc.M001107200; Schagat TL, 1999, INFECT IMMUN, V67, P4693, DOI 10.1128/IAI.67.9.4693-4699.1999; Sever-Chroneos Z, 2011, J BIOL CHEM, V286, P4854, DOI 10.1074/jbc.M110.125567; Shang FF, 2011, J BIOL CHEM, V286, P757, DOI 10.1074/jbc.M110.175265; Tino MJ, 1999, AM J PHYSIOL-LUNG C, V276, pL164, DOI 10.1152/ajplung.1999.276.1.L164; VANIWAARDEN F, 1990, AM J RESP CELL MOL, V2, P91, DOI 10.1165/ajrcmb/2.1.91; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Wu YD, 2004, AM J RESP CELL MOL, V31, P587, DOI 10.1165/rcmb.2004-0003OC; Zhang SP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000564	41	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82680	10.1371/journal.pone.0082680	http://dx.doi.org/10.1371/journal.pone.0082680			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312669	gold, Green Submitted, Green Published			2022-12-25	WOS:000327944500143
J	Kirkland, JI; Alcala, L; Loewen, MA; Espilez, E; Mampel, L; Wiersma, JP				Kirkland, James I.; Alcala, Luis; Loewen, Mark A.; Espilez, Eduardo; Mampel, Luis; Wiersma, Jelle P.			The Basal Nodosaurid Ankylosaur Europelta carbonensis n. gen., n. sp from the Lower Cretaceous (Lower Albian) Escucha Formation of Northeastern Spain	PLOS ONE			English	Article							CEDAR-MOUNTAIN FORMATION; DINOSAUR POLACANTHUS; ARMORED DINOSAUR; SKELETAL RECONSTRUCTION; HUNGAROSAURUS-TORMAI; DERMAL ARMOR; ORNITHISCHIA; SKULL; REDESCRIPTION; BASIN	Nodosaurids are poorly known from the Lower Cretaceous of Europe. Two associated ankylosaur skeletons excavated from the lower Albian carbonaceous member of the Escucha Formation near Arino in northeastern Teruel, Spain reveal nearly all the diagnostic recognized character that define nodosaurid ankylosaurs. These new specimens comprise a new genus and species of nodosaurid ankylosaur and represent the single most complete taxon of ankylosaur from the Cretaceous of Europe. These two specimens were examined and compared to all other known ankylosaurs. Comparisons of these specimens document that Europelta carbonensis n. gen., n. sp. is a nodosaur and is the sister taxon to the Late Cretaceous nodosaurids Anoplosaurus, Hungarosaurus, and Struthiosaurus, defining a monophyletic clade of European nodosaurids- the Struthiosaurinae.	[Kirkland, James I.] Utah Geol Survey, Salt Lake City, UT USA; [Alcala, Luis; Espilez, Eduardo; Mampel, Luis] Fdn Conjunto Paleontol Teruel Dinopolis, Museo Aragones Paleontol, Teruel, Spain; [Loewen, Mark A.; Wiersma, Jelle P.] Nat Hist Museum Utah, Salt Lake City, UT USA; [Loewen, Mark A.; Wiersma, Jelle P.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Kirkland, JI (corresponding author), Utah Geol Survey, Salt Lake City, UT USA.	jameskirkland@utah.gov	Alcalá, Luis/A-7413-2009; Alcalá, Luis/P-5793-2014	Alcalá, Luis/0000-0002-6369-6186; /0000-0002-0329-7319; Wiersma, Jelle P./0000-0003-0009-5890	Direccion General de Patrimonio Cultural [201/2010, 201/10-2011, 201/10-11-2011]; Ministerio de Ciencia e Innovacion [CGL2009-07792]; FEDER Funds [CGL2009-07792]; FOCONTUR (Grupo de Investigacion Consolidado E-62, Departamento de Industria e Innovacion Ciencia, Tecnologia y Universidad, Gobierno de Aragon); Instituto Aragones de Fomento, Fundacion SAMCA; Fundacion Conjunto Paleontologico de Teruel-Dinopolis; Craig Wilkerson through the Utah Friends of Paleontology	Direccion General de Patrimonio Cultural; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FEDER Funds(European Commission); FOCONTUR (Grupo de Investigacion Consolidado E-62, Departamento de Industria e Innovacion Ciencia, Tecnologia y Universidad, Gobierno de Aragon); Instituto Aragones de Fomento, Fundacion SAMCA; Fundacion Conjunto Paleontologico de Teruel-Dinopolis; Craig Wilkerson through the Utah Friends of Paleontology	This study is part of the paleontology research projects of Departamento de Educacion, Universidad, Cultura y Deporte, Gobierno de Aragon and has been supported by its Direccion General de Patrimonio Cultural (exp. 201/2010, 201/10-2011, 201/10-11-2011), DINOSARAGON CGL2009-07792 R&D project (Ministerio de Ciencia e Innovacion and FEDER Funds), FOCONTUR (Grupo de Investigacion Consolidado E-62, Departamento de Industria e Innovacion Ciencia, Tecnologia y Universidad, Gobierno de Aragon), Instituto Aragones de Fomento, Fundacion SAMCA, and Fundacion Conjunto Paleontologico de Teruel-Dinopolis. Partial funding for this project was provided by Craig Wilkerson through the Utah Friends of Paleontology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar M.J., 1971, ESTUD GEOL-MADRID, V27, P497; Alcala L, 2012, GEOHERITAGE, V4, P275, DOI 10.1007/s12371-012-0068-y; [Anonymous], 1865, ILLUSTRATED LON 0916, V47, P270; [Anonymous], 1923, FORTSCHRITTE GEOLOGI; Arbour VM, 2013, ACTA PALAEONTOL POL, V58, P55, DOI 10.4202/app.2011.0081; Arbour VM, 2011, J PALEONTOL, V85, P298, DOI 10.1666/10-071.1; Arbour VM, 2009, J VERTEBR PALEONTOL, V29, P1117, DOI 10.1671/039.029.0405; Ardevol LL, 1983, ESTUDIO ESTRATIGRAFI; Bakker RT, 1986, HUNTERIA, V1, P1; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Blows WT, 2014, ACTA PALAEONTOL POL, V59, P835, DOI 10.4202/app.2012.0131; Blows WT, 2001, LIFE O PAST, P363; BLOWS WT, 1987, PALAEONTOLOGY, V30, P557; Blows WT, 1996, GEOL MAG, V133, P671, DOI 10.1017/S0016756800024535; Bodily N. M., 1969, Geology Studies Brigham Young University, V16, P35; Brown B, 1908, B AM MUS NAT HIST, V24, P187; Buffetaut Eric, 1999, Geologie de la France, V1, P49; Bunzel E., 1871, ABHANDLUNGEN KAISERL, V5, P1; Bunzel E, 1870, Q J GEOL SOC LOND, V26, P394, DOI [DOI 10.1144/GSL.JGS.1870.026.01-02.35, 10.1144/GSL.JGS.1870.026.01-02.35]; Burns ME, 2014, J VERTEBRAT IN PRESS, V34; Burns ME, 2011, CRETACEOUS RES, V32, P174, DOI 10.1016/j.cretres.2010.11.007; Burns ME, 2008, J VERTEBR PALEONTOL, V28, P1102, DOI 10.1671/0272-4634-28.4.1102; Burton D., 2006, GEOLOGICAL SOC AM AB, V38, P52; Carpenter K, 2004, CAN J EARTH SCI, V41, P961, DOI 10.1139/E04-043; Carpenter K, 2011, PALAEONTOGR ABT A, V294, P1; Carpenter K, 2001, LIFE O PAST, P455; Carpenter K, 2001, LIFE O PAST, P211; Carpenter K, 1998, NATURE, V393, P782, DOI 10.1038/31684; CARPENTER K, 1984, CAN J EARTH SCI, V21, P1491, DOI 10.1139/e84-154; Carpenter K., 1990, P281, DOI 10.1017/CBO9780511608377.024; CARPENTER K, 1995, J VERTEBR PALEONTOL, V15, P275, DOI 10.1080/02724634.1995.10011230; Carpenter K, 1999, UTAH GEOLOGICAL SURV, V9, P243; Carpenter K., 1998, NEW MEXICO MUSEUM NA, V14, P249; Carpenter K, 2008, J VERTEBR PALEONTOL, V28, P1089, DOI 10.1671/0272-4634-28.4.1089; Carpenter Kenneth, 2007, Transactions of the Kansas Academy of Science, V110, P1, DOI 10.1660/0022-8443(2007)110[1:SOTANC]2.0.CO;2; Cervera A, 1976, TECNITERRAE, V3, P25; Chen RJ, 2013, ACTA GEOL SIN-ENGL, V87, P658, DOI 10.1111/1755-6724.12077; Coombs W, 1971, THESIS COLUMBIA U NE; Coombs W.P. Jr, 1990, P456; COOMBS W P JR, 1978, Palaeontology (Oxford), V21, P143; Coombs W.P. Jr, 1986, Journal of Vertebrate Paleontology, V6, P162; Coombs W.P. Jr, 1990, P269, DOI 10.1017/CBO9780511608377.023; COOMBS WP, 1978, J PALEONTOL, V52, P642; COOMBS WP, 1979, J PALEONTOL, V53, P666; COOMBS WP, 1995, CAN J EARTH SCI, V32, P902, DOI 10.1139/e95-075; COOMBS WP, 1995, J VERTEBR PALEONTOL, V15, P298, DOI 10.1080/02724634.1995.10011231; de Gea G.A., 2008, Geogaceta, V44, P115; DOYLE JA, 1992, CRETACEOUS RES, V13, P337, DOI 10.1016/0195-6671(92)90039-S; Eaton T. H. Jr., 1960, Paleontological Contributions University Kansas Vertebrata, V8, P1; ERBA E, 1994, PALEOCEANOGRAPHY, V9, P483, DOI 10.1029/94PA00258; Ford TL, 2001, LIFE O PAST, P239; Ford Tracy L., 2000, Bulletin of the New Mexico Museum of Natural History and Science, V17, P157; Friis EM, 2010, REV PALAEOBOT PALYNO, V162, P341, DOI 10.1016/j.revpalbo.2009.11.009; Friis EM, 2000, INT J PLANT SCI, V161, pS169, DOI 10.1086/317570; Galobart Angel, 2011, P1; GALTON P M, 1980, Geobios (Villeurbanne), V13, P825, DOI 10.1016/S0016-6995(80)80038-6; Galton P.M., 1983, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1983, P141; Galton P.M., 1983, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V182, P1; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P343; Garcia G, 2003, J VERTEBR PALEONTOL, V23, P156, DOI 10.1671/0272-4634(2003)23[156:ANSOSD]2.0.CO;2; Gaston RW, 2001, LIFE O PAST, P386; Gilmore C. W., 1930, Proceedings of the United States National Museum, V77, P1; Gilmore C. W., 1924, Bull No 1 Dept of Geol University of Alberta, P1; Gilmore CW, 1914, B US NATN MUS, V89, P1; GODFREY SJ, 1994, CAN J EARTH SCI, V31, P1661, DOI 10.1139/e94-148; Grandstein SR, 2012, GEOLOGICAL TIMESCALE, P233; Hawakaya H, 2005, J VERTEBR PALEONTOL, V25, P240, DOI 10.1671/0272-4634(2005)025[0240:NAFTCO]2.0.CO;2; Hayashi S, 2010, ACTA PALAEONTOL POL, V55, P213, DOI 10.4202/app.2009.0103; HICKEY LJ, 1977, BOT REV, V43, P3, DOI 10.1007/BF02860849; Hulke JW, 1888, PHILOS T ROY SOC LON, V178, P169; Hulke JW, 1882, PHILOS T ROY SOC LON, V172, P653; Huxley TH, 1867, GEOLOGICAL MAGAZINE, V4, P65, DOI 10.1017/S001675680017102X; Jenkyns HC, 2003, PHILOS T R SOC A, V361, P1885, DOI 10.1098/rsta.2003.1240; Kilbourne B, 2005, NEUES JAHRB GEOL P-A, V237, P111, DOI 10.1127/njgpa/237/2005/111; Kirkland James I., 1998, Bulletin of the New Mexico Museum of Natural History and Science, V14, P271; Kirkland James I., 1998, Modern Geology, V23, P145; Kirkland James I., 1994, Brigham Young University Geology Studies, V40, P25; Kirkland JI, 2007, UTAH GEOLOGICAL ASS, V35, P1; Kirkland JI, 1998, NEW MEXICO MUSEUM NA, V14, P67; Lambe LM, 1919, T ROY SOC CAN SECT 3, V13, P39; Larson RL, 1999, PALEOCEANOGRAPHY, V14, P663, DOI 10.1029/1999PA900040; Lee YN, 1996, J VERTEBR PALEONTOL, V16, P232, DOI 10.1080/02724634.1996.10011311; Lu J, 2007, ACTA GEOL SINICA, V81, P334; Ludvigson GA, 2010, J SEDIMENT RES, V80, P955, DOI 10.2110/jsr.2010.086; Lull RS, 1921, AM J SCI, V1, P97; Maidment SCR, 2006, J VERTEBR PALEONTOL, V26, P944, DOI 10.1671/0272-4634(2006)26[944:ROTPSO]2.0.CO;2; Main RP, 2005, PALEOBIOLOGY, V31, P291, DOI 10.1666/0094-8373(2005)031[0291:TEAFOT]2.0.CO;2; Mantell GA, 1849, PHILOS T ROY SOC LON, V1849, P271; Mantell GA, 1841, PHILISOPHICAL T ROYA, V1841, P131; Mantell GA, 1833, GEOLOGY S E ENGLAND, P1; Marsh O.C., 1890, AM J SCI, V39, P418, DOI DOI 10.2475/AJS.S3-39.233.418; Marsh OC., 1888, AM J SCI, V35, P89, DOI [10.2475/ajs.s3-35.205.89, DOI 10.2475/AJS.S3-35.205.89]; Maryanska T, 1971, PALAEONTOLOGIA POLON, V25, P45; Maryanska T, 1977, ACTA PALAEONTOLOGICA, V37, P87; Matthew W, 1922, NAT HIST, V22, P333; Mcdonald AT, 2012, ZOOTAXA, P61; McElwain JC, 2005, ECOL STU AN, V177, P133; Mehl M. G., 1936, Journal of the Scientific Laboratories of Denison University, V31, P1; Gasulla JM, 2011, AMEGHINIANA, V48, P508, DOI 10.5710/AMGH.v48i4(276); Miles CA, 2009, CURR SCI INDIA, V96, P65; Miyashita T, 2011, J ANAT, V219, P661, DOI 10.1111/j.1469-7580.2011.01427.x; Molnar RE, 2001, LIFE O PAST, P341; Molnar RE, 1996, MEMOIRS QUEENSLAND M, V39, P653; Moodie RL, 1910, KANSAS U SCI B, V14, P257; Naish Darren, 2001, Palaeontological Association Field Guides to Fossils, V10, P147; Nopcsa Baron F., 1928, Palaeobiologica Wien, V1, P163; Nopcsa F., 1929, Geologica Hungarica Ser Palaeont, Vpt. 4, P1; Nopcsa F., 1923, Geological Magazine London, V60, P193; Nopcsa F, 1905, GEOLOGICAL MAGAZINE, V2, P241, DOI 10.1017/S001675680013225X; Nopcsa FB., 1915, COMMUNICATIONS YB RO, V23, P1; Osi A, 2009, PALAEONTOL Z, V83, P227, DOI 10.1007/s12542-009-0017-5; Ogg JG, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P793, DOI 10.1016/B978-0-444-59425-9.00027-5; Osborn H. F., 1923, American Museum Novitates, V95, P1; Osi A, 2005, J VERTEBR PALEONTOL, V25, P370, DOI 10.1671/0272-4634(2005)025[0370:HTANAD]2.0.CO;2; Osi A, 2013, CRETACEOUS RES, V44, P58, DOI 10.1016/j.cretres.2013.03.006; Ostrom JH., 1970, PEABODY MUSEUM B, V35, P1; Owen R, 1857, PALAEONTOGRAPHICAL S, V10, P8; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Pardo G, 1979, THESIS ZARAGOZA U ZA; Pardo G, 1987, FORMACIONES ESCUHA U; Rodriguez-Lopez JP, 2009, REV SOC GEOL ESPANA, V22, P163; Pereda Suberbiola X., 1999, Estudios Geologicos (Madrid), V55, P267; Pereda Suberbiola X., 2012, BERNISSART DINOSAURS, P379; Pereda Suberbiola X., 1995, B SOC GEOLOGIQUE FRA, V166, P105; Pereda Suberbiola Xabier, 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P273; Pereda-Suberbiola Javier, 1994, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V191, P173; Pereda-Suberbiola X, 2004, ACT 4 JORN INT PAL D, P263; Pereda-Suberbiola X, 1994, PALAEONTOGRAPH A, V232, P133; Pereda-Suberbiola X, 2006, ACT 3 JORN INT DIN E, P85; Pereda-Suberbiola X, 1997, SCI NATURAE, V17, P203; Pereda-Suberbiola X, 2001, ACT 1 JORN INT PAL D, P147; Pereda-Suberbiola X, 2007, CRETACEOUS RES, V28, P583, DOI 10.1016/j.cretres.2006.09.001; PEREDASUBERBIOLA J, 1993, GEOL MAG, V130, P767, DOI 10.1017/S0016756800023141; Peyrot Daniel, 2007, Revista Espanola de Micropaleontologia, V39, P135; Peyrot D, 2007, CR PALEVOL, V6, P469, DOI 10.1016/j.crpv.2007.09.014; QUEROL X, 1989, INT J COAL GEOL, V11, P171, DOI 10.1016/0166-5162(89)90004-9; Querol X., 1992, GSA GEOL SOC AM SPEC, V267, P193; Querol X, 1988, THESIS U BARCELONA B; Rodriguez-Lopez JP, 2007, SEDIMENT GEOL, V201, P461, DOI 10.1016/j.sedgeo.2007.07.009; Russell LS, 1940, U TORONTO STUDIES G, V43, P3; Salas R, 1987, THESIS U BARCELONA B; SANZ JL, 1983, GEOBIOS-LYON, V16, P615, DOI 10.1016/S0016-6995(83)80038-2; Sarjeant WAS, 1997, ENCY DINOSAURS, P161; Schudack U, 2009, J IBER GEOL, V35, P141; Seeley H. G., 1869, INDEX FOSSIL REMAINS, P1; Seeley H.G., 1881, Q J GEOLOGICAL SOC, V37, P620, DOI [DOI 10.1144/GSL.JGS.1881.037.01-04.49, 10.1144/GSL.JGS.1881.037.01-04.49]; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Seeley HG, 1879, Q J GEOL SOC LOND, V35, P591, DOI DOI 10.1144/GSL.JGS.1879.035.01-04.42; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Shelton Sally Y., 1994, P3; Stanford R, 2011, J PALEONTOL, V85, P916, DOI 10.1666/10-113.1; Stanford Ray, 2007, Ichnos, V14, P155, DOI 10.1080/10420940601049404; Suberbiola XP, 2001, LIFE O PAST, P173; Suberbiola XP, 1999, SPEC PAP PALAEONTOL, P177; Sweetman Steven C., 2011, Palaeontological Association Field Guides to Fossils, V14, P52; Sweetman SC, 2010, PALAEOGEOGR PALAEOCL, V292, P409, DOI 10.1016/j.palaeo.2010.03.055; Thompson RS, 2012, J SYST PALAEONTOL, V10, P301, DOI 10.1080/14772019.2011.569091; Tibert NE, 2013, MICROPALEONTOLOGY, V59, P83; Tumanova TA, 1983, T SOVM SOV MONG PAL, V24, P110; Tumanova TA, 1985, DINOSAURES CHINE FRA, P73; Tumanova Tat'yana A., 2000, P517; Vickaryous MK, 2004, DINOSAURIA, 2ND EDITION, P363; Vickaryous MK, 2003, ZOOL J LINN SOC-LOND, V137, P157, DOI 10.1046/j.1096-3642.2003.00045.x; Vickaryous MK, 2001, LIFE O PAST, P318; Vickaryous MK, 2001, CAN J EARTH SCI, V38, P1767, DOI 10.1139/e01-051; Warren D, 2004, J VERTEBR PALEONTOL, V24, p126A; Weissert H, 2004, J GEOL SOC LONDON, V161, P695, DOI 10.1144/0016-764903-087; Wieland GR, 1909, AM J SCI, V27, P250; Wifland GR, 1911, AM J SCI, V31, P112; Witmer LM, 2008, ANAT REC, V291, P1662; Xu Li, 2007, Dizhi Xuebao, V81, P433; Yang Jing-Tao, 2013, Vertebrata Palasiatica, V51, P265; Zaleha MJ, 2006, GEOL SOC AM BULL, V118, P886, DOI 10.1130/B25715.1; Zarra L, 1989, N CAROLINA GEOLOGICA, V89-5, P1	175	41	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80405	10.1371/journal.pone.0080405	http://dx.doi.org/10.1371/journal.pone.0080405			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312471	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500023
J	Sheng, ZL; Yao, YY; Li, YF; Yan, FD; Huang, J; Ma, GS				Sheng, Zulong; Yao, Yuyu; Li, Yefei; Yan, Fengdi; Huang, Jie; Ma, Genshan			Bradykinin Preconditioning Improves Therapeutic Potential of Human Endothelial Progenitor Cells in Infarcted Myocardium	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CARDIAC-FUNCTION; BONE-MARROW; HEART; APOPTOSIS; SURVIVAL; NEOVASCULARIZATION; OVEREXPRESSION; STIMULATION; DYSFUNCTION	Objectives: Stem cell preconditioning (PC) is a powerful approach in reducing cell death after transplantation. We hypothesized that PC human endothelial progenitor cells (hEPCs) with bradykinin (BK) enhance cell survival, inhibit apoptosis and repair the infarcted myocardium. Methods: The hEPCs were preconditioned with or without BK. The hEPCs apoptosis induced by hypoxia along with serum deprivation was determined by annexin V-fluorescein isothiocyanate/propidium iodide staining. Cleaved caspase-3, Akt and eNOS expressions were determined by Western blots. Caspase-3 activity and vascular endothelial growth factor (VEGF) levels were assessed in hEPCs. For in vivo studies, the survival and cardiomyocytes apoptosis of transplanted hEPCs were assessed using 1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine, 4-chlorobenzenesul-fonate salt labeled hEPCs and TUNEL staining. Infarct size and cardiac function were measured at 10 days after transplantation, and the survival of transplanted hEPCs were visualized using near-infrared optical imaging. Results: In vitro data showed a marked suppression in cell apoptosis following BK PC. The PC reduced caspase-3 activation, increased the Akt, eNOS phosphorylation and VEGF levels. In vivo data in preconditioned group showed a robust cell anti-apoptosis, reduction in infarct size, and significant improvement in cardiac function. The effects of BK PC were abrogated by the B2 receptor antagonist HOE140, the Akt and eNOS antagonists LY294002 and L-NAME, respectively. Conclusions: The activation of B2 receptor-dependent PI3K/Akt/eNOS pathway by BK PC promotes VEGF secretion, hEPC survival and inhibits apoptosis, thereby improving cardiac function in vivo. The BK PC hEPC transplantation for stem cell-based therapies is a novel approach that has potential for clinical used.	[Sheng, Zulong; Yao, Yuyu; Li, Yefei; Yan, Fengdi; Huang, Jie; Ma, Genshan] Southeast Univ, Sch Med, Zhongda Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Yao, YY (corresponding author), Southeast Univ, Sch Med, Zhongda Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	yaoyuyunj@hotmail.com; magenshan@hotmail.com			National Nature Science Foundation of the People's Republic of China [30871071, 81070085]; National Undergraduate Students' Innovative Training Program [1210286094]	National Nature Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); National Undergraduate Students' Innovative Training Program	This work was supported by the National Nature Science Foundation of the People's Republic of China (No. 30871071, No. 81070085 for Yuyu Yao) and the National Undergraduate Students' Innovative Training Program (No. 1210286094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal MR, 2010, ANTIOXID REDOX SIGN, V12, P693, DOI 10.1089/ars.2009.2755; Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138; Baxter GF, 2002, BRIT J PHARMACOL, V135, P843, DOI 10.1038/sj.bjp.0704548; Belichard P, 1996, BRIT J PHARMACOL, V117, P1565, DOI 10.1111/j.1476-5381.1996.tb15322.x; Bell RM, 2003, J MOL CELL CARDIOL, V35, P185, DOI 10.1016/S0022-2828(02)00310-3; Buikema H, 2000, BRIT J PHARMACOL, V130, P1999, DOI 10.1038/sj.bjp.0703498; Dai Y, 2007, J MOL CELL CARDIOL, V42, P1036, DOI 10.1016/j.yjmcc.2007.04.001; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Divald A, 2010, CIRC RES, V106, P1829, DOI 10.1161/CIRCRESAHA.110.219485; Feng J, 2005, CIRCULATION, V112, pI190, DOI 10.1161/CIRCULATIONAHA.104.524454; Feng J, 2000, ANN THORAC SURG, V70, P2119, DOI 10.1016/S0003-4975(00)02148-2; Groger M, 2005, J CEREBR BLOOD F MET, V25, P978, DOI 10.1038/sj.jcbfm.9600096; Haider HK, 2008, J MOL CELL CARDIOL, V45, P554, DOI 10.1016/j.yjmcc.2008.05.004; Hung HS, 2009, CELL TRANSPLANT, V18, P1003, DOI 10.3727/096368909X12483162196683; Kositprapa C, 2001, J MOL CELL CARDIOL, V33, P1355, DOI 10.1006/jmcc.2000.1396; Krankel N, 2008, CIRC RES, V103, P1335, DOI 10.1161/CIRCRESAHA.108.179952; Leesar MA, 1999, J AM COLL CARDIOL, V34, P639, DOI 10.1016/S0735-1097(99)00297-1; Liang JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046158; Manolis AJ, 2010, HYPERTENS RES, V33, P772, DOI 10.1038/hr.2010.82; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; Sutton EJ, 2008, EUR RADIOL, V18, P2021, DOI 10.1007/s00330-008-0984-z; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Trachtenberg B, 2011, AM HEART J, V161, P487, DOI 10.1016/j.ahj.2010.11.024; Valen G, 2003, ANN THORAC SURG, V75, pS656, DOI 10.1016/S0003-4975(02)04687-8; Wang N, 2011, ATHEROSCLEROSIS, V218, P543, DOI 10.1016/j.atherosclerosis.2011.08.002; Yan FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037948; Yao YY, 2008, CARDIOVASC RES, V80, P354, DOI 10.1093/cvr/cvn223; Yao YY, 2011, MOL IMAGING BIOL, V13, P303, DOI 10.1007/s11307-010-0359-0; Yeh CH, 2010, J SURG RES, V163, pE1, DOI 10.1016/j.jss.2010.04.005	29	24	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81505	10.1371/journal.pone.0081505	http://dx.doi.org/10.1371/journal.pone.0081505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312554	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500071
J	Ibarra, AMS; Ryan, SJ; Beltran, E; Mejia, R; Silva, M; Munoz, A				Ibarra, Anna M. Stewart; Ryan, Sadie J.; Beltran, Efrain; Mejia, Raul; Silva, Mercy; Munoz, Angel			Dengue Vector Dynamics (Aedes aegypti) Influenced by Climate and Social Factors in Ecuador: Implications for Targeted Control	PLOS ONE			English	Article							ENVIRONMENTAL DETERMINANTS; TEMPERATURE-FLUCTUATIONS; VIRUS TRANSMISSION; NORTH QUEENSLAND; PUERTO-RICO; DIPTERA; CULICIDAE; FEVER; EPIDEMICS; CONTAINER	Background: Dengue fever, a mosquito-borne viral disease, is now the fastest spreading tropical disease globally. Previous studies indicate that climate and human behavior interact to influence dengue virus and vector (Aedes aegypti) population dynamics; however, the relative effects of these variables depends on local ecology and social context. We investigated the roles of climate and socio-ecological factors on Ae. aegypti population dynamics in Machala, a city in southern coastal Ecuador where dengue is hyper-endemic. Methods/Principal findings: We studied two proximate urban localities where we monitored weekly Ae. aegypti oviposition activity (Nov. 2010-June 2011), conducted seasonal pupal surveys, and surveyed household to identify dengue risk factors. The results of this study provide evidence that Ae. aegypti population dynamics are influenced by social risk factors that vary by season and lagged climate variables that vary by locality. Best-fit models to predict the presence of Ae. aegypti pupae included parameters for household water storage practices, access to piped water, the number of households per property, condition of the house and patio, and knowledge and perceptions of dengue. Rainfall and minimum temperature were significant predictors of oviposition activity, although the effect of rainfall varied by locality due to differences in types of water storage containers. Conclusions: These results indicate the potential to reduce the burden of dengue in this region by conducting focused vector control interventions that target high-risk households and containers in each season and by developing predictive models using climate and non-climate information. These findings provide the region's public health sector with key information for conducting time and location-specific vector control campaigns, and highlight the importance of local socio-ecological studies to understand dengue dynamics. See Text S1 for an executive summary in Spanish.	[Ibarra, Anna M. Stewart; Ryan, Sadie J.] SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, Syracuse, NY 13210 USA; [Ibarra, Anna M. Stewart; Ryan, Sadie J.] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA; [Ibarra, Anna M. Stewart; Beltran, Efrain; Silva, Mercy] Natl Serv Control Vector Borne Dis, Minist Hlth, Machala, Ecuador; [Ibarra, Anna M. Stewart; Mejia, Raul] Natl Inst Meteorol & Hydrol, Guayaquil, Ecuador; [Ryan, Sadie J.] Univ KwaZulu Natal, Sch Life Sci, Dept Agr Engn & Sci, Pietermaritzburg, South Africa; [Munoz, Angel] Columbia Univ, Int Inst Climate & Soc, New York, NY USA; [Munoz, Angel] Univ Zulia, Ctr Modelado Cient, Maracaibo 4011, Venezuela	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; University of Kwazulu Natal; Columbia University	Ibarra, AMS (corresponding author), SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, Syracuse, NY 13210 USA.	stewarta@upstate.edu	Ryan, Sadie Jane/H-7488-2019	Ryan, Sadie Jane/0000-0002-4308-6321; Stewart-Ibarra, Anna/0000-0002-3383-4672; Munoz, Angel G/0000-0002-2212-6654	Fulbright fellowship; Ecuadorian Ministry of Health	Fulbright fellowship; Ecuadorian Ministry of Health	This research was supported in part by a Fulbright fellowship to AMS and the Ecuadorian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Alava A., 2005, REV ECUAT HIG MED TR, V42, P11; Aldstadt J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000940; Andrighetti M. T. M., 2009, Dengue Bulletin, V33, P167; BAR-ZEEV MICHA, 1958, BULL ENT RES, V49, P157, DOI 10.1017/S0007485300053499; Barrera R, 2008, MED VET ENTOMOL, V22, P62, DOI 10.1111/j.1365-2915.2008.00720.x; Barrera R., 2002, Dengue Bulletin, V26, P84; Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378; Bohra Alpana, 2001, Dengue Bulletin, V25, P92; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Calcagno V, 2010, J STAT SOFTW, V34, P1; Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824; Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242; Chowell G, 2008, EPIDEMIOL INFECT, V136, P1667, DOI 10.1017/S0950268808000290; Chowell G, 2006, J ENVIRON HEALTH, V68, P40; Chowell G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-164; Colon-Gonzalez FJ, 2011, AM J TROP MED HYG, V84, P757, DOI 10.4269/ajtmh.2011.10-0609; de Almeida AS, 2009, REV SAUDE PUBL, V43, P666, DOI 10.1590/S0034-89102009000400013; Almeida MCD, 2007, J URBAN HEALTH, V84, P334, DOI 10.1007/s11524-006-9154-2; Diaz-Quijano FA, 2012, AM J TROP MED HYG, V86, P328, DOI 10.4269/ajtmh.2012.11-0074; FAY R. W., 1966, MOSQUITO NEWS, V26, P531; Focks D. A., 2007, Dengue Bulletin, V31, P83; Focks D.A., 2004, REV ENTOMOLOGICAL SA; Focks DA, 2006, MULTICOUNTRY STUDY A; Gagnon AS, 2001, CLIM RES, V19, P35, DOI 10.3354/cr019035; Hayden MH, 2010, ECOHEALTH, V7, P64, DOI 10.1007/s10393-010-0288-z; Hurtado-Diaz M, 2007, TROP MED INT HEALTH, V12, P1327, DOI 10.1111/j.1365-3156.2007.01930.x; Kay BH, 2000, J MED ENTOMOL, V37, P846, DOI 10.1603/0022-2585-37.6.846; Koenraadt CJM, 2008, J MED ENTOMOL, V45, P28, DOI 10.1603/0022-2585(2008)45[28:FEOROC]2.0.CO;2; Kuhn K., 2005, USING CLIMATE PREDIC; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Lenhart AE, 2005, ACTA TROP, V96, P56, DOI 10.1016/j.actatropica.2005.06.020; Lowe R, 2013, STAT MED, V32, P864, DOI 10.1002/sim.5549; Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056; Montgomery BL, 2002, AM J TROP MED HYG, V67, P244, DOI 10.4269/ajtmh.2002.67.244; MOORE CG, 1978, AM J TROP MED HYG, V27, P1225, DOI 10.4269/ajtmh.1978.27.1225; Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123; Munoz AG, 2010, B AM METEOROL SOC, V91, P1645, DOI 10.1175/2010BAMS2958.1; Nagao Y, 2003, TROP MED INT HEALTH, V8, P650, DOI 10.1046/j.1365-3156.2003.01075.x; Nogueira LA, 2005, AM J TROP MED HYG, V73, P309, DOI 10.4269/ajtmh.2005.73.309; Padmanabha H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001799; PAHO, 1995, NUMB REP CAS DENG SE; PANT CP, 1973, J MED ENTOMOL, V10, P219, DOI 10.1093/jmedent/10.2.219; Parks W., 2004, PLANNING SOCIAL MOBI; Pontes RJS, 2000, AM J TROP MED HYG, V62, P378, DOI 10.4269/ajtmh.2000.62.378; Pourrut P, 1995, AGUA ECUADOR CLIMA P; Quintero J, 2009, CAD SAUDE PUBLICA, V25, pS93, DOI 10.1590/S0102-311X2009001300009; Ramos MM, 2008, AM J TROP MED HYG, V78, P364; Real J, 2012, DETECCION VIRUS DENG; REITER P, 1991, J AM MOSQUITO CONTR, V7, P52; Romero-Vivas CME, 2007, J MED ENTOMOL, V44, P930, DOI 10.1603/0022-2585(2007)44[930:TCFATA]2.0.CO;2; Rossel F., 1999, REV SCI EAU, V12, P183, DOI [DOI 10.7202/705348AR, 10.7202/705348ar]; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; San Martin JL, 2006, DELIVERY ISSUES RELA; Sant'ana AL, 2006, J MED ENTOMOL, V43, P214, DOI 10.1603/0022-2585(2006)043[0214:COGIAO]2.0.CO;2; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; SOPER FL, 1967, B WORLD HEALTH ORGAN, V36, P536; Spiegel JM, 2007, TROP MED INT HEALTH, V12, P503, DOI 10.1111/j.1365-3156.2007.01818.x; Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478; Thu Hlaing Myat, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P280; Tran HP, 2012, AM J TROP MED HYG, V87, P631, DOI 10.4269/ajtmh.2012.12-0335; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; TunLin W, 1995, AM J TROP MED HYG, V53, P591, DOI 10.4269/ajtmh.1995.53.591; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319	65	109	112	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78263	10.1371/journal.pone.0078263	http://dx.doi.org/10.1371/journal.pone.0078263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24324542	Green Published, gold			2022-12-25	WOS:000327252100015
J	Sulahian, R; Casey, F; Shen, J; Qian, ZR; Shin, H; Ogino, S; Weir, BA; Vazquez, F; Liu, XS; Hahn, WC; Bass, AJ; Chan, V; Shivdasani, RA				Sulahian, R.; Casey, F.; Shen, J.; Qian, Z. R.; Shin, H.; Ogino, S.; Weir, B. A.; Vazquez, F.; Liu, X. S.; Hahn, W. C.; Bass, A. J.; Chan, V.; Shivdasani, R. A.			An integrative analysis reveals functional targets of GATA6 transcriptional regulation in gastric cancer	ONCOGENE			English	Article						transcriptional control of cancer; synexpression groups; somatic copy number alterations; ChIP-seq; GATA transcription factors	LINEAGE-SURVIVAL ONCOGENE; GENE-EXPRESSION; STEM-CELLS; PATTERNS; STOMACH; GENOME; DIFFERENTIATION; AMPLIFICATION; INTESTINE; FAMILY	Lineage-restricted transcription factors (TFs) are frequently mutated or overexpressed in cancer and contribute toward malignant behaviors; however, the molecular bases of their oncogenic properties are largely unknown. As TF activities are difficult to inhibit directly with small molecules, the genes and pathways they regulate might represent more tractable targets for drug therapy. We studied GATA6, a TF gene that is frequently amplified or overexpressed in gastric, esophageal and pancreatic adenocarcinomas. GATA6-overexpressing gastric cancer cell lines cluster in gene expression space, separate from non-overexpressing lines. This expression clustering signifies a shared pathogenic group of genes that GATA6 may regulate through direct cis-element binding. We used chromatin immunoprecipitation and sequencing (ChIP-seq) to identify GATA6-bound genes and considered TF occupancy in relation to genes that respond to GATA6 depletion in cell lines and track with GATA6 mRNA (synexpression groups) in primary gastric cancers. Among other cellular functions, GATA6-occupied genes control apoptosis and govern the M-phase of the cell cycle. Depletion of GATA6 reduced the levels of the latter transcripts and arrested cells in G2 and M phases of the cell cycle. Synexpression in human tumor samples identified likely direct transcriptional targets substantially better than consideration only of transcripts that respond to GATA6 loss in cultured cells. Candidate target genes responded to the loss of GATA6 or its homolog GATA4 and even more to the depletion of both proteins. Many GATA6-dependent genes lacked nearby binding sites but several strongly dependent, synexpressed and GATA6-bound genes encode TFs such as MYC, HES1, RARB and CDX2. Thus, many downstream effects occur indirectly through other TFs and GATA6 activity in gastric cancer is partially redundant with GATA4. This integrative analysis of locus occupancy, gene dependency and synexpression provides a functional signature of GATA6-overexpressing gastric cancers, revealing both limits and new therapeutic directions for a challenging and frequently fatal disease.	[Sulahian, R.; Qian, Z. R.; Ogino, S.; Weir, B. A.; Vazquez, F.; Hahn, W. C.; Bass, A. J.; Shivdasani, R. A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Sulahian, R.; Hahn, W. C.; Bass, A. J.; Shivdasani, R. A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Casey, F.; Shen, J.; Chan, V.] Novartis Inst Biomed Res, Emeryville, CA USA; [Qian, Z. R.; Ogino, S.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA USA; [Qian, Z. R.; Ogino, S.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Shin, H.; Liu, X. S.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Hahn, W. C.; Bass, A. J.; Shivdasani, R. A.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Novartis; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Shivdasani, RA (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA.	ramesh_shivdasani@dfci.harvard.edu			Dana-Farber Cancer Institute-Novartis Drug Discovery Program; National Institutes of Health [R01CA151993, R01HG4069, K08CA134931]; SPORE program in GI cancers [P50 CA127003]; NATIONAL CANCER INSTITUTE [P50CA127003, K08CA134931, U01CA176058, R01CA151993] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004069] Funding Source: NIH RePORTER	Dana-Farber Cancer Institute-Novartis Drug Discovery Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPORE program in GI cancers; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by the Dana-Farber Cancer Institute-Novartis Drug Discovery Program and National Institutes of Health awards R01CA151993 (SO), R01HG4069 (XSL), K08CA134931 (AJB) and the SPORE program in GI cancers P50 CA127003. Data associated with this study are available in the GEO, GSE51936.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Alvarez H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001356; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Beck F, 1999, P NATL ACAD SCI USA, V96, P7318, DOI 10.1073/pnas.96.13.7318; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beuling E, 2011, GASTROENTEROLOGY, V140, P1219, DOI 10.1053/j.gastro.2011.01.033; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Dulak AM, 2012, CANCER RES, V72, P4383, DOI 10.1158/0008-5472.CAN-11-3893; Eeckhoute J, 2009, GENOME RES, V19, P372, DOI 10.1101/gr.084582.108; Fang RX, 2006, GENE EXPR PATTERNS, V6, P426, DOI 10.1016/j.modgep.2005.09.003; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fu BJ, 2008, CANCER BIOL THER, V7, P1593, DOI 10.4161/cbt.7.10.6565; Gao XP, 1998, MOL CELL BIOL, V18, P2901, DOI 10.1128/MCB.18.5.2901; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Guiu J, 2013, J EXP MED, V210, P71, DOI 10.1084/jem.20120993; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Holtzinger A, 2005, DEVELOPMENT, V132, P4005, DOI 10.1242/dev.01978; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jang JH, 2001, CANCER RES, V61, P3541; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kim TH, 2011, J EXP MED, V208, P677, DOI 10.1084/jem.20101737; Kunii K, 2008, CANCER RES, V68, P2340, DOI 10.1158/0008-5472.CAN-07-5229; Kwei KA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000081; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; Lennerz JK, 2011, J CLIN ONCOL, V29, P4803, DOI 10.1200/JCO.2011.35.4928; Lin L, 2012, P NATL ACAD SCI USA, V109, P4251, DOI 10.1073/pnas.1011989109; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Matsuda A, 2012, JPN J CLIN ONCOL, V42, P154, DOI 10.1093/jjco/hys004; Nakajima M, 1999, CANCER, V85, P1894; Okines A, 2011, NAT REV CLIN ONCOL, V8, P492, DOI 10.1038/nrclinonc.2011.45; Redell MS, 2005, CURR PHARM DESIGN, V11, P2873, DOI 10.2174/1381612054546699; Robinson JT, 2012, GUT, V61, P673; Ross J, 2012, MOL CELL BIOL, V32, P3624, DOI 10.1128/MCB.00163-12; Schmidt PH, 1999, LAB INVEST, V79, P639; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; TAMURA S, 1994, P NATL ACAD SCI USA, V91, P4609, DOI 10.1073/pnas.91.10.4609; Verzi MP, 2011, MOL CELL BIOL, V31, P2026, DOI 10.1128/MCB.01250-10; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013	49	44	46	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 4	2014	33	49					5637	5648		10.1038/onc.2013.517	http://dx.doi.org/10.1038/onc.2013.517			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AW1ZW	24317510	Green Submitted, Green Accepted			2022-12-25	WOS:000346088700008
J	Li, SS; Priceman, SJ; Xin, H; Zhang, W; Deng, JH; Liu, Y; Huang, JB; Zhu, WS; Chen, MJ; Hu, W; Deng, XM; Zhang, J; Yu, H; He, GY				Li, Shasha; Priceman, Saul J.; Xin, Hong; Zhang, Wang; Deng, Jiehui; Liu, Yong; Huang, Jiabin; Zhu, Wenshan; Chen, Mingjie; Hu, Wei; Deng, Xiaomin; Zhang, Jian; Yu, Hua; He, Guangyuan			Icaritin Inhibits JAK/STAT3 Signaling and Growth of Renal Cell Carcinoma	PLOS ONE			English	Article							INTERFERON-ALPHA; TRANSCRIPTIONAL ACTIVATION; CONSTITUTIVE ACTIVATION; PHASE-I/II; STAT3; CANCER; APOPTOSIS; SUNITINIB; SURVIVAL; DIFFERENTIATION	Signal transducer and activator of transcription-3 (STAT3) is critical for cancer progression by regulating tumor cell survival, proliferation, and angiogenesis. Herein, we investigated the regulation of STAT3 activation and the therapeutic effects of Icaritin, a prenyl flavonoid derivative from Epimedium Genus, in renal cell carcinoma (RCC). Icaritin showed significant antitumor activity in the human and mouse RCC cell lines, 786-O and Renca, respectively. Icaritin inhibited both constitutive and IL-6-induced phospho-STAT3 (STAT3(Y705)) and reduced the level of STAT3-regulated proteins Bcl-xL, Mcl-1, Survivin, and CyclinD1 in a dose-dependent manner. Icaritin also inhibited activation of Janus-activated kinase-2 (JAK2), while it showed minimal effects on the activation of other key signaling pathways, including AKT and MAPK. Expression of the constitutively active form of STAT3 blocked Icaritin-induced apoptosis, while siRNA directed against STAT3 potentiated apoptosis. Finally, Icaritin significantly blunted RCC tumor growth in vivo, reduced STAT3 activation, and inhibited Bcl-xL and Cyclin E, as well as VEGF expression in tumors, which was associated with reduced tumor angiogenesis. Overall, these results suggest that Icaritin strongly inhibits STAT3 activation and is a potentially effective therapeutic option for the treatment of renal cell carcinoma.	[Li, Shasha; Huang, Jiabin; Zhu, Wenshan; Chen, Mingjie; Hu, Wei; Deng, Xiaomin; Zhang, Jian; He, Guangyuan] Huazhong Univ Sci & Technol, Genet Engn Int Cooperat Base, Chinese Minist Sci & Technol, Key Lab Mol Biophys,Chinese Minist Educ,Coll Life, Wuhan 430074, Hubei, Peoples R China; [Priceman, Saul J.; Xin, Hong; Zhang, Wang; Deng, Jiehui; Liu, Yong; Yu, Hua] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA 91010 USA; [Priceman, Saul J.; Xin, Hong; Zhang, Wang; Deng, Jiehui; Liu, Yong; Yu, Hua] City Hope Comprehens Canc Ctr, Duarte, CA 91010 USA	Huazhong University of Science & Technology; City of Hope; Beckman Research Institute of City of Hope; City of Hope	Yu, H (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA 91010 USA.	HYu@coh.org; hegy@mail.hust.edu.cn	LI, SHASHA/AAT-6809-2021	LI, SHASHA/0000-0002-3523-6801; Deng, Jiehui/0000-0001-7986-8643; YU, Hua/0000-0003-0931-1000	China Scholarship Council (CSC); National Science and Technology Major Project of China [2011ZX08002-004, 2011ZX08010-004]; International S & T Cooperation Key Projects of MoST [2009DFB30340]	China Scholarship Council (CSC)(China Scholarship Council); National Science and Technology Major Project of China; International S & T Cooperation Key Projects of MoST	The first author would like to thank the China Scholarship Council (CSC) for the financial support during her period of study in USA. This work was supported by the National Science and Technology Major Project of China (2011ZX08002-004; 2011ZX08010-004), International S & T Cooperation Key Projects of MoST (2009DFB30340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Cheng FD, 2003, IMMUNITY, V19, P425, DOI 10.1016/S1074-7613(03)00232-2; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Darnell JE, 1998, J INTERF CYTOK RES, V18, P549, DOI 10.1089/jir.1998.18.549; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Decker T, 1999, CELL MOL LIFE SCI, V55, P1535, DOI 10.1007/s000180050393; El-Hashemite N, 2005, AM J RESP CELL MOL, V33, P227, DOI 10.1165/rcmb.2005-0152RC; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Escudier B, 2009, J CLIN ONCOL, V27, P1280, DOI 10.1200/JCO.2008.19.3342; Figlin R, 2012, J UROLOGY, V188, P707, DOI 10.1016/j.juro.2012.04.108; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Guo C, 2009, AM J TRANSL RES, V1, P283; Guo YM, 2011, EUR J PHARMACOL, V658, P114, DOI 10.1016/j.ejphar.2011.02.005; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Horiguchi A, 2002, KIDNEY INT, V61, P926, DOI 10.1046/j.1523-1755.2002.00206.x; Horiguchi A, 2002, J UROLOGY, V168, P762, DOI 10.1016/S0022-5347(05)64741-6; Horiguchi A, 2010, BRIT J CANCER, V102, P1592, DOI 10.1038/sj.bjc.6605691; Huang J, 2007, LIFE SCI, V81, P832, DOI 10.1016/j.lfs.2007.07.015; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Khwaja A, 1999, NATURE, V401, P33, DOI 10.1038/43354; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu M, 2013, INT J CLIN EXP PATHO, V6, P686; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Luo C, 2004, DRUG DISCOV TODAY, V9, P268, DOI 10.1016/S1359-6446(03)03014-9; Mora LB, 2002, CANCER RES, V62, P6659; Motzer RJ, 2000, J UROLOGY, V163, P408, DOI 10.1016/S0022-5347(05)67889-5; Motzer RJ, 2007, J CLIN ONCOL, V25, P3958, DOI 10.1200/JCO.2006.10.5916; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Niu G, 2002, ONCOGENE, V21, P7001, DOI 10.1038/sj.onc.1205859; O'Shea JJ, 2004, NAT REV DRUG DISCOV, V3, P555, DOI 10.1038/nrd1441; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Rossi JF, 2010, BRIT J CANCER, V103, P1154, DOI 10.1038/sj.bjc.6605872; Shang D, 2007, CANCER SCI, V98, P1259, DOI 10.1111/j.1349-7006.2007.00526.x; Shang DH, 2011, CANCER INVEST, V29, P347, DOI 10.3109/07357907.2011.568566; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Tong JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016781; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wang Z, 2007, NEUROSCIENCE, V145, P911, DOI 10.1016/j.neuroscience.2006.12.059; Wang ZQ, 2009, CHEM-BIOL INTERACT, V179, P375, DOI 10.1016/j.cbi.2008.12.007; Wo YB, 2008, J CELL BIOCHEM, V103, P1536, DOI 10.1002/jcb.21541; Xin H, 2009, CANCER RES, V69, P2506, DOI 10.1158/0008-5472.CAN-08-4323; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhu JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023720	55	82	90	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81657	10.1371/journal.pone.0081657	http://dx.doi.org/10.1371/journal.pone.0081657			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324713	Green Published, gold, Green Submitted			2022-12-25	WOS:000328566700048
J	Ogawa, K; Ohtsuki, K; Shibata, T; Aoki, M; Nakayama, M; Kitamura, Y; Ono, M; Ueda, M; Doue, T; Onoguchi, M; Shiba, K; Odani, A				Ogawa, Kazuma; Ohtsuki, Katsuichi; Shibata, Tomomi; Aoki, Miho; Nakayama, Morio; Kitamura, Yoji; Ono, Masahiro; Ueda, Masashi; Doue, Tomoki; Onoguchi, Masahisa; Shiba, Kazuhiro; Odani, Akira			Development and Evaluation of a Novel Tc-99m-Labeled Annexin A5 for Early Detection of Response to Chemotherapy	PLOS ONE			English	Article							IN-VIVO; APOPTOSIS; FUTURE	Tc-99m-HYNIC-annexin A5 can be considered as a benchmark in the field of apoptosis imaging. However, Tc-99m-HYNIC-annexin A5 has characteristics of high uptake and long retention in non-target tissues such as kidney and liver. To minimize this problem, we developed a novel Tc-99m-labeled annexin A5 using a bis(hydroxamamide) derivative [C-3(BHam)(2)] as a bifunctional chelating agent, and evaluated its usefulness as an imaging agent for detecting apoptosis. The amino group of C-3(BHam)(2) was converted to a maleimide group, and was coupled to thiol groups of annexin A5 pretreated with 2-iminothiolane. Tc-99m labeling was performed by a ligand exchange reaction with Tc-99m-glucoheptonate. Biodistribution experiments for both Tc-99m-C-3(BHam)(2)-annexin A5 and Tc-99m-HYNIC-annexin A5 were performed in normal mice. In addition, in tumor-bearing mice, the relationship between the therapeutic effects of chemotherapy (5-FU) and the tumor accumulation of Tc-99m-C-3(BHam)(2)-annexin A5 just after the first treatment of 5-FU was evaluated. Tc-99m-C-3(BHam)(2)-annexin A5 was prepared with a radiochemical purity of over 95%. In biodistribution experiments, Tc-99m-C-3(BHam)(2)-annexin A5 had a much lower kidney accumulation of radioactivity than Tc-99m-HYNIC-annexin A5. In the organs for metabolism, such as liver and kidney, radioactivity after the injection of Tc-99m-HYNIC-annexin A5 was residual for a long time. On the other hand, radioactivity after the injection of Tc-99m-C-3(BHam)(2)-annexin A5 gradually decreased. In therapeutic experiments, tumor growth in the mice treated with 5-FU was significantly inhibited. Accumulation of Tc-99m-C-3(BHam)(2)-annexin A5 in tumors significantly increased after 5-FU treatment. The accumulation of radioactivity in tumor correlated positively with the counts of TUNEL-positive cells. These findings suggest that Tc-99m-C-3(BHam)(2)-annexin A5 may contribute to the efficient detection of apoptotic tumor response after chemotherapy.	[Ogawa, Kazuma; Shibata, Tomomi; Aoki, Miho; Onoguchi, Masahisa; Odani, Akira] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Ohtsuki, Katsuichi] Kameoka Hosp, Dept Cardiovasc Med, Kameoka, Japan; [Nakayama, Morio] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Kitamura, Yoji; Shiba, Kazuhiro] Kanazawa Univ, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan; [Ono, Masahiro] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Ueda, Masashi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Doue, Tomoki] Rinku Gen Med Ctr, Dept Cardiol, Izumisano, Japan	Kanazawa University; Nagasaki University; Kanazawa University; Kyoto University; Okayama University	Ogawa, K (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan.	kogawa@p.kanazawa-u.ac.jp	ODANI, Akira/B-3043-2011; Ogawa, Kazuma/D-8406-2015; Ueda, Masashi/K-4096-2013	ODANI, Akira/0000-0003-3786-6740; Ogawa, Kazuma/0000-0002-1691-7302; Ueda, Masashi/0000-0001-7027-1568	Ministry of Education, Culture, Sports, Science and Technology of Japan [18790879]; Grants-in-Aid for Scientific Research [23591756] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Young Scientists (B) (KAKENHI Grant Number 18790879) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Boersma HH, 2005, J NUCL MED, V46, P2035; D'Alessandria C, 2010, MOL IMAGING BIOL, V12, P539, DOI 10.1007/s11307-009-0285-1; de Geus-Oei LF, 2011, J NUCL MED, V52, P560, DOI 10.2967/jnumed.110.082784; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GRASSETTI DR, 1967, ARCH BIOCHEM BIOPHYS, V119, P41, DOI 10.1016/0003-9861(67)90426-2; HNATOWICH DJ, 1993, J NUCL MED, V34, P109; Ke S, 2004, J NUCL MED, V45, P108; Kemerink GJ, 2001, EUR J NUCL MED, V28, P1373, DOI 10.1007/s002590100578; King RC, 2007, DALTON T, P4998, DOI 10.1039/b705111e; Lahorte CMM, 2004, EUR J NUCL MED MOL I, V31, P887, DOI 10.1007/s00259-004-1555-4; Mochizuki T, 2003, J NUCL MED, V44, P92; Narula J, 2001, NAT MED, V7, P1347, DOI 10.1038/nm1201-1347; Ohtsuki K, 1999, EUR J NUCL MED, V26, P1251, DOI 10.1007/s002590050580; Ono M, 1999, BIOCONJUGATE CHEM, V10, P386, DOI 10.1021/bc980105f; Tait JF, 2002, BIOCONJUGATE CHEM, V13, P1119, DOI 10.1021/bc025545s; Xu LC, 1999, BIOCONJUGATE CHEM, V10, P9, DOI 10.1021/bc980024j; Xu LC, 1998, NUCL MED BIOL, V25, P295, DOI 10.1016/S0969-8051(97)00208-4; Yamamura N, 1999, BIOCONJUGATE CHEM, V10, P489, DOI 10.1021/bc9801528; Yoshii Y, 2009, CANCER SCI, V100, P821, DOI 10.1111/j.1349-7006.2009.01099.x	19	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81191	10.1371/journal.pone.0081191	http://dx.doi.org/10.1371/journal.pone.0081191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324676	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300079
J	Sokolowski, M; Deharo, D; Christian, CM; Kines, KJ; Belancio, VP				Sokolowski, Mark; deHaro, Dawn; Christian, Claiborne M.; Kines, Kristine J.; Belancio, Victoria P.			Characterization of L1 ORF1p Self-Interaction and Cellular Localization Using a Mammalian Two-Hybrid System	PLOS ONE			English	Article							RIBONUCLEOPROTEIN PARTICLE FORMATION; TRIMERIC STRUCTURE; PROTEIN; RNA; RETROTRANSPOSITION; GENE; TRANSLATION; INITIATION; SEQUENCES; INSERTION	Long INterspersed Element-1 (LINE-1, L1) is an active retrotransposon that mobilizes using a ribonucleoprotein particle (RNP) intermediate composed of the full-length bicistronic L1 mRNA and the two proteins (ORF1p and ORF2p) encoded by that mRNA. ORF1p and ORF2p demonstrate cis-preference for their encoding mRNA. Previous studies of ORF1p, purified from bacterial and insect cells demonstrated that this protein forms trimers in vitro. While valuable for understanding ORF1p function, these in vitro approaches do not provide any information on ORF1p self-interaction in the context of mammalian cells. We used a mammalian two-hybrid (M2H) system in order to study L1 ORF1p self-interaction in human and mouse cells. We demonstrate that the M2H system successfully detects human and mouse ORF1p self-interactions in transiently transfected mammalian cells. We also generated mouse and human ORF1p-specific antibodies to characterize the expression of ORF1p fusion proteins used in the M2H system. Using these antibodies, we demonstrate that ORF1p interaction in trans leads to the formation of heterodimers that are expected to produce a positive signal in the M2H system. Although the role for L1 ORF1p cis-preference in L1 mobilization is established, the impact of ability of ORF1pto interact in trans on the L1 replication cycle is not known. Furthermore, western blot analysis of ORF1p generated by a full-length L1, wild type ORF1, or a codon-optimized ORF1 expression vector is detected in the nucleus. In contrast, the addition of a tag to the N-terminus of the mouse and human ORF1 proteins can significantly alter the subcellular localization in a tag-specific manner. These data support that nuclear localization of ORF1p may contribute to L1 (and potentially the SINE Alu) RNP nuclear access in the host cell.	[Sokolowski, Mark; deHaro, Dawn; Christian, Claiborne M.; Kines, Kristine J.; Belancio, Victoria P.] Tulane Ctr Aging, Tulane Canc Ctr, Tulane Sch Med, Dept Struct & Cellular Biol, New Orleans, LA USA	Tulane University	Belancio, VP (corresponding author), Tulane Ctr Aging, Tulane Canc Ctr, Tulane Sch Med, Dept Struct & Cellular Biol, New Orleans, LA USA.	vperepe@tulane.edu		Sokolowski, Mark/0000-0002-2385-5373	NIH/NIA [K01AG030074]; NIH/NCRR/GM/COBRE [8 P20 GM103518]; Louisiana State Board of Regents Graduate Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG030074] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NCRR/GM/COBRE; Louisiana State Board of Regents Graduate Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	VPB is supported by NIH/NIA K01AG030074 and NIH/NCRR/GM/COBRE 8 P20 GM103518, MS is supported by Louisiana State Board of Regents Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisch RS, 2006, GENE DEV, V20, P210, DOI 10.1101/gad.1380406; Basame S, 2006, J MOL BIOL, V357, P351, DOI 10.1016/j.jmb.2005.12.063; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Belancio VP, 2008, GENOME RES, V18, P343, DOI 10.1101/gr.5558208; Belancio VP, 2011, ANAL BIOCHEM, V417, P159, DOI 10.1016/j.ab.2011.05.035; Belancio VP, 2006, NUCLEIC ACIDS RES, V34, P1512, DOI 10.1093/nar/gkl027; Callahan KE, 2012, NUCLEIC ACIDS RES, V40, P813, DOI 10.1093/nar/gkr728; Chen L, 2012, BREAST CANCER RES TR, V136, P129, DOI 10.1007/s10549-012-2246-7; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Dmitriev SE, 2007, MOL CELL BIOL, V27, P4685, DOI 10.1128/MCB.02138-06; Ewing AD, 2011, GENOME RES, V21, P985, DOI 10.1101/gr.114777.110; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; Gasior SL, 2007, GENE, V390, P190, DOI 10.1016/j.gene.2006.08.024; Goodier JL, 2004, HUM MOL GENET, V13, P1041, DOI 10.1093/hmg/ddh118; GOODIER JL, 2013, NUCL ACIDS RES; Goodier JL, 2007, MOL CELL BIOL, V27, P6469, DOI 10.1128/MCB.00332-07; Goodier JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002941; Han JS, 2004, NATURE, V429, P314, DOI 10.1038/nature02535; Harris Chris R, 2010, Genes Cancer, V1, P115, DOI 10.1177/1947601909360812; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Khazina E, 2011, NAT STRUCT MOL BIOL, V18, P1006, DOI 10.1038/nsmb.2097; Kolosha VO, 1997, P NATL ACAD SCI USA, V94, P10155, DOI 10.1073/pnas.94.19.10155; Konkel MK, 2007, GENE, V390, P28, DOI 10.1016/j.gene.2006.07.040; Kulpa DA, 2005, HUM MOL GENET, V14, P3237, DOI 10.1093/hmg/ddi354; Kulpa DA, 2006, NAT STRUCT MOL BIOL, V13, P655, DOI 10.1038/nsmb1107; Luan DD, 1996, MOL CELL BIOL, V16, P4726; Martin SL, 2010, RNA BIOL, V7, P706, DOI 10.4161/rna.7.6.13766; Martin SL, 2003, P NATL ACAD SCI USA, V100, P13815, DOI 10.1073/pnas.2336221100; Martin SL, 2001, MOL CELL BIOL, V21, P467, DOI 10.1128/MCB.21.2.467-475.2001; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Naas TP, 1998, EMBO J, V17, P590, DOI 10.1093/emboj/17.2.590; Ostertag EM, 2003, AM J HUM GENET, V73, P1444, DOI 10.1086/380207; Penzkofer T, 2005, NUCLEIC ACIDS RES, V33, pD498, DOI 10.1093/nar/gki044; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Tavare JM, 2001, J ENDOCRINOL, V170, P297, DOI 10.1677/joe.0.1700297; Wallace N, 2008, GENE, V419, P1, DOI 10.1016/j.gene.2008.04.007; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; WOODSAMUELS P, 1989, GENOMICS, V4, P290, DOI 10.1016/0888-7543(89)90332-7; 2001, NATURE, V409, P860, DOI DOI 10.1038/35057062.PUBMED:11237011	42	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82021	10.1371/journal.pone.0082021	http://dx.doi.org/10.1371/journal.pone.0082021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324740	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300121
J	Lima, RB; Salvador, VH; dos Santos, WD; Bubna, GA; Finger-Teixeira, A; Soares, AR; Marchiosi, R; Ferrarese, MDL; Ferrarese, O				Lima, Rogerio Barbosa; Salvador, Victor Hugo; dos Santos, Wanderley Dantas; Bubna, Gisele Adriana; Finger-Teixeira, Aline; Soares, Anderson Ricardo; Marchiosi, Rogerio; Lucio Ferrarese, Maria de Lourdes; Ferrarese-Filho, Osvaldo			Enhanced Lignin Monomer Production Caused by Cinnamic Acid and Its Hydroxylated Derivatives Inhibits Soybean Root Growth	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; CUCUMBER ROOTS; FERULIC ACID; LIGNIFICATION; ACCUMULATION; GERMINATION; ETHYLENE	Cinnamic acid and its hydroxylated derivatives (p-coumaric, caffeic, ferulic and sinapic acids) are known allelochemicals that affect the seed germination and root growth of many plant species. Recent studies have indicated that the reduction of root growth by these allelochemicals is associated with premature cell wall lignification. We hypothesized that an influx of these compounds into the phenylpropanoid pathway increases the lignin monomer content and reduces the root growth. To confirm this hypothesis, we evaluated the effects of cinnamic, p-coumaric, caffeic, ferulic and sinapic acids on soybean root growth, lignin and the composition of p-hydroxyphenyl (H), guaiacyl (G) and syringyl (S) monomers. To this end, three-day-old seedlings were cultivated in nutrient solution with or without allelochemical (or selective enzymatic inhibitors of the phenylpropanoid pathway) in a growth chamber for 24 h. In general, the results showed that 1) cinnamic, p-coumaric, caffeic and ferulic acids reduced root growth and increased lignin content; 2) cinnamic and p-coumaric acids increased p-hydroxyphenyl (H) monomer content, whereas p-coumaric, caffeic and ferulic acids increased guaiacyl (G) content, and sinapic acid increased sinapyl (S) content; 3) when applied in conjunction with piperonylic acid (PIP, an inhibitor of the cinnamate 4-hydroxylase, C4H), cinnamic acid reduced H, G and S contents; and 4) when applied in conjunction with 3,4( methylenedioxy) cinnamic acid (MDCA, an inhibitor of the 4-coumarate: CoA ligase, 4CL), p-coumaric acid reduced H, G and S contents, whereas caffeic, ferulic and sinapic acids reduced G and S contents. These results confirm our hypothesis that exogenously applied allelochemicals are channeled into the phenylpropanoid pathway causing excessive production of lignin and its main monomers. By consequence, an enhanced stiffening of the cell wall restricts soybean root growth.	[Lima, Rogerio Barbosa; Salvador, Victor Hugo; dos Santos, Wanderley Dantas; Bubna, Gisele Adriana; Finger-Teixeira, Aline; Soares, Anderson Ricardo; Marchiosi, Rogerio; Lucio Ferrarese, Maria de Lourdes; Ferrarese-Filho, Osvaldo] Univ Maringa, Lab Plant Biochem, Maringa, Parana, Brazil		Ferrarese, O (corresponding author), Univ Maringa, Lab Plant Biochem, Maringa, Parana, Brazil.	osferrarese@gmail.com	Santos, Wanderley Dantas dos/A-9019-2013; Ferrarese-Filho, Osvaldo/J-1829-2012; /L-5229-2019; MARCHIOSI, ROGERIO/A-8101-2019; Marchiosi, Rogério/ABG-3227-2020; Santos, Wanderley Dantas dos/AAT-7860-2020; Lima, Rogerio/N-2693-2013	Ferrarese-Filho, Osvaldo/0000-0002-3477-4544; MARCHIOSI, ROGERIO/0000-0002-8386-2524; Marchiosi, Rogério/0000-0002-8386-2524; Santos, Wanderley Dantas dos/0000-0002-6072-2860; Lima, Rogerio/0000-0001-9453-3454	CNPq (The Brazilian Council for Scientific and Technological Development); Araucaria Foundation	CNPq (The Brazilian Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Araucaria Foundation(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA)	This work was supported by CNPq (The Brazilian Council for Scientific and Technological Development) and the Araucaria Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appert C, 2003, PHYTOCHEMISTRY, V62, P415, DOI 10.1016/S0031-9422(02)00561-7; Baleroni CRS, 2000, SEED SCI TECHNOL, V28, P201; Batish DR, 2008, J PLANT PHYSIOL, V165, P297, DOI 10.1016/j.jplph.2007.05.003; Bohm PAF, 2006, BIOL PLANTARUM, V50, P315, DOI 10.1007/s10535-006-0029-x; Bubna GA, 2011, J PLANT PHYSIOL, V168, P1627, DOI 10.1016/j.jplph.2011.03.005; Cabane M, 2012, ADV BOT RES, V61, P219, DOI 10.1016/B978-0-12-416023-1.00007-0; Chakraborty M, 2009, J PLANT PHYSIOL, V166, P63, DOI 10.1016/j.jplph.2008.02.004; CHENG HH, 1995, ACS SYM SER, V582, P132; Devi SR, 1996, BIOL PLANTARUM, V38, P387, DOI 10.1007/BF02896668; Donaldson LA, 2001, PHYTOCHEMISTRY, V57, P859, DOI 10.1016/S0031-9422(01)00049-8; dos Santos WD, 2008, J CHEM ECOL, V34, P1230, DOI 10.1007/s10886-008-9522-3; dos Santos WD, 2004, J CHEM ECOL, V30, P1203, DOI 10.1023/B:JOEC.0000030272.83794.f0; Grabber JH, 2005, CROP SCI, V45, P820, DOI 10.2135/cropsci2004.0191; Hamada K, 2003, J WOOD SCI, V49, P366, DOI 10.1007/s10086-002-0475-9; Zanardo DIL, 2009, ENVIRON EXP BOT, V66, P25, DOI 10.1016/j.envexpbot.2008.12.014; MACIAS FA, 1995, ALLELOPATHY ORGANISM, P311; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; Ng PLL, 2003, SEED SCI TECHNOL, V31, P39, DOI 10.15258/sst.2003.31.1.05; Politycka B, 2007, ALLELOPATHY J, V19, P451; Politycka B, 1999, ACTA SOC BOT POL, V68, P123, DOI 10.5586/asbp.1999.018; Reigosa MJ, 2007, J CHEM ECOL, V33, P1456, DOI 10.1007/s10886-007-9318-x; Schoch GA, 2002, PLANT PHYSIOL, V130, P1022, DOI 10.1104/pp.004309; Singh HP, 2009, PLANT GROWTH REGUL, V57, P21, DOI 10.1007/s10725-008-9314-3; SIQUEIRA JO, 1991, CRIT REV PLANT SCI, V10, P63, DOI 10.1080/07352689109382307; Soares AR, 2011, J CHEM ECOL, V37, P891, DOI 10.1007/s10886-011-9988-2; Vanholme R, 2012, NEW PHYTOL, V196, P978, DOI 10.1111/j.1469-8137.2012.04337.x; VAUGHAN D, 1990, J SCI FOOD AGR, V52, P289, DOI 10.1002/jsfa.2740520302; Weir TL, 2004, CURR OPIN PLANT BIOL, V7, P472, DOI 10.1016/j.pbi.2004.05.007; Yamauchi K, 2004, CR BIOL, V327, P791, DOI 10.1016/j.crvi.2004.07.012	29	33	34	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e80542	10.1371/journal.pone.0080542	http://dx.doi.org/10.1371/journal.pone.0080542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312480	Green Submitted, gold, Green Published			2022-12-25	WOS:000327947800014
J	Liu, IJ; Tsai, WT; Hsieh, LE; Chueh, LL				Liu, I-Jung; Tsai, Wan-Ting; Hsieh, Li-En; Chueh, Ling-Ling			Peptides Corresponding to the Predicted Heptad Repeat 2 Domain of the Feline Coronavirus Spike Protein Are Potent Inhibitors of Viral Infection	PLOS ONE			English	Article							PERITONITIS VIRUS-REPLICATION; MEMBRANE-FUSION; IMMUNODEFICIENCY-VIRUS; ALPHA-INTERFERON; STRUCTURAL BASIS; ENTRY; SARS; RIBAVIRIN; REGIONS; HIV	Background: Feline infectious peritonitis (FIP) is a lethal immune-mediated disease caused by feline coronavirus (FCoV). Currently, no therapy with proven efficacy is available. In searching for agents that may prove clinically effective against FCoV infection, five analogous overlapping peptides were designed and synthesized based on the putative heptad repeat 2 (HR2) sequence of the spike protein of FCoV, and the antiviral efficacy was evaluated. Methods: Plaque reduction assay and MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cytotoxicity assay were performed in this study. Peptides were selected using a plaque reduction assay to inhibit Feline coronavirus infection. Results: The results demonstrated that peptide (FP5) at concentrations below 20 mu M inhibited viral replication by up to 97%. The peptide (FP5) exhibiting the most effective antiviral effect was further combined with a known anti-viral agent, human interferon-alpha (IFN-alpha), and a significant synergistic antiviral effect was observed. Conclusion: Our data suggest that the synthetic peptide FP5 could serve as a valuable addition to the current FIP prevention methods.	[Liu, I-Jung] Cardinal Tien Jr Coll Healthcare & Management, Dept Nursing, New Taipei City, Taiwan; [Tsai, Wan-Ting; Hsieh, Li-En; Chueh, Ling-Ling] Natl Taiwan Univ, Sch Vet Med, Grad Inst Vet Med, Taipei 10764, Taiwan	National Taiwan University	Chueh, LL (corresponding author), Natl Taiwan Univ, Sch Vet Med, Grad Inst Vet Med, Taipei 10764, Taiwan.	linglingchueh@ntu.edu.tw			Department of Ministry of Education, Government of Taiwan	Department of Ministry of Education, Government of Taiwan	This work was supported by Department of Ministry of Education, Government of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball RA, 2003, J AM ACAD DERMATOL, V49, P826, DOI 10.1016/S0190-9622(03)02099-1; Ballesteros ML, 1997, VIROLOGY, V227, P378, DOI 10.1006/viro.1996.8344; Balzarini J, 2006, J ANTIMICROB CHEMOTH, V57, P472, DOI 10.1093/jac/dki481; Bosch BJ, 2004, P NATL ACAD SCI USA, V101, P8455, DOI 10.1073/pnas.0400576101; Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Carstens EB, 2010, ARCH VIROL, V155, P133, DOI 10.1007/s00705-009-0547-x; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Fehr D, 1997, VACCINE, V15, P1101, DOI 10.1016/S0264-410X(97)00006-6; Haagmans BL, 2006, ANTIVIR RES, V71, P397, DOI 10.1016/j.antiviral.2006.05.019; Hartmann K, 2008, VET IMMUNOL IMMUNOP, V123, P172, DOI 10.1016/j.vetimm.2008.01.026; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; Henkel J, 1999, FDA Consum, V33, P12; HO DD, 1995, NEW ENGL J MED, V333, P450, DOI 10.1056/NEJM199508173330710; Hsieh LE, 2010, ANTIVIR RES, V88, P25, DOI 10.1016/j.antiviral.2010.06.010; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Kilby JM, 2002, AIDS RES HUM RETROV, V18, P685, DOI 10.1089/088922202760072294; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Lambert DM, 1996, P NATL ACAD SCI USA, V93, P2186, DOI 10.1073/pnas.93.5.2186; Lin Chao-Nan, 2009, Taiwan Veterinary Journal, V35, P145; Liu IJ, 2009, ANTIVIR RES, V81, P82, DOI 10.1016/j.antiviral.2008.10.001; Liu SW, 2004, LANCET, V363, P938, DOI 10.1016/S0140-6736(04)15788-7; McDonagh P, 2011, VET MICROBIOL, V150, P220, DOI 10.1016/j.vetmic.2011.01.023; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Medinas RJ, 2002, J VIROL, V76, P9079, DOI 10.1128/JVI.76.18.9079-9086.2002; Miller EH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207084; Pan C, 2009, AIDS, V23, P639, DOI 10.1097/QAD.0b013e328325a4cd; Pang Wei, 2009, Antivir Chem Chemother, V20, P1, DOI 10.3851/IMP1369; PEDERSEN NC, 1981, AM J VET RES, V42, P363; Pedersen NC, 2009, J FELINE MED SURG, V11, P225, DOI 10.1016/j.jfms.2008.09.008; Porotto M, 2010, J VIROL, V84, P6760, DOI 10.1128/JVI.00135-10; Regan AD, 2008, VET MICROBIOL, V132, P235, DOI 10.1016/j.vetmic.2008.05.019; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; van der Meer FJUM, 2007, J ANTIMICROB CHEMOTH, V60, P741, DOI 10.1093/jac/dkm301; Vogel L, 2010, VET RES, V41, DOI 10.1051/vetres/2010043; Watanabe S, 2000, J VIROL, V74, P10194, DOI 10.1128/JVI.74.21.10194-10201.2000; WEISS RC, 1988, AM J VET RES, V49, P1329; WEISS RC, 1989, VET MICROBIOL, V20, P255, DOI 10.1016/0378-1135(89)90049-7; WEISS RC, 1993, J VET PHARMACOL THER, V16, P301, DOI 10.1111/j.1365-2885.1993.tb00177.x; Weissenhorn W, 1999, MOL MEMBR BIOL, V16, P3, DOI 10.1080/096876899294706; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Xu YH, 2004, J BIOL CHEM, V279, P30514, DOI 10.1074/jbc.M403760200; Yuan KH, 2004, BIOCHEM BIOPH RES CO, V319, P746, DOI 10.1016/j.bbrc.2004.05.046	43	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82081	10.1371/journal.pone.0082081	http://dx.doi.org/10.1371/journal.pone.0082081			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312629	Green Published, Green Submitted, gold			2022-12-25	WOS:000327947800081
J	Taylor, LA; Kaiser, TM; Schwitzer, C; Muller, DWH; Codron, D; Clauss, M; Schulz, E				Taylor, Lucy A.; Kaiser, Thomas M.; Schwitzer, Christoph; Mueller, Dennis W. H.; Codron, Daryl; Clauss, Marcus; Schulz, Ellen			Detecting Inter-Cusp and Inter-Tooth Wear Patterns in Rhinocerotids	PLOS ONE			English	Article							BLACK RHINOCEROS; FEEDING ECOLOGY; MESOWEAR ANALYSIS; WHITE RHINOCEROS; ELEPHAS-MAXIMUS; HABITAT USE; DRY SEASON; UNICORNIS; EVOLUTION; NEPAL	Extant rhinos are the largest extant herbivores exhibiting dietary specialisations for both browse and grass. However, the adaptive value of the wear-induced tooth morphology in rhinos has not been widely studied, and data on individual cusp and tooth positions have rarely been published. We evaluated upper cheek dentition of browsing Diceros bicornis and Rhinoceros sondaicus, mixed-feeding R. unicornis and grazing Ceratotherium simum using an extended mesowear method adapted for rhinos. We included single cusp scoring (EM(R)-S) to investigate inter-cusp and inter-tooth wear patterns. In accordance with previous reports, general mesowear patterns in D. bicornis and R. sondaicus were attrition-dominated and C. simum abrasion-dominated, reflecting their respective diets. Mesowear patterns for R. unicornis were more attrition-dominated than anticipated by the grass-dominated diet, which may indicate a low intake of environmental abrasives. EM(R)-S increased differentiation power compared to classical mesowear, with significant inter-cusp and inter-tooth differences detected. In D. bicornis, the anterior cusp was consistently more abrasion-dominated than the posterior. Wear differences in cusp position may relate to morphological adaptations to dietary regimes. Heterogeneous occlusal surfaces may facilitate the comminution of heterogeneous browse, whereas uniform, broad grinding surfaces may enhance the comminution of physically more homogeneous grass. A negative tooth wear gradient was found in D. bicornis, R. sondaicus and R. unicornis, with wear patterns becoming less abrasion-dominated from premolars to molars. No such gradients were evident in C. simum which displayed a uniform wear pattern. In browsers, premolars may be exposed to higher relative grit loads, which may result in the development of wear gradients. The second premolar may also have a role in food cropping. In grazers, high absolute amounts of ingested abrasives may override other signals, leading to a uniform wear pattern and dental function along the tooth row, which could relate to the observed evolution towards homodonty.	[Taylor, Lucy A.; Schwitzer, Christoph] Bristol Conservat & Sci Fdn, Bristol, Avon, England; [Taylor, Lucy A.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Kaiser, Thomas M.; Schulz, Ellen] Univ Hamburg, Bioctr Grindel & Zool Museum, Hamburg, Germany; [Mueller, Dennis W. H.; Codron, Daryl; Clauss, Marcus] Univ Zurich, Vetsuisse Fac, Clin Zoo Anim Exot Pets & Wildlife, Zurich, Switzerland; [Mueller, Dennis W. H.] Natl Pk Bavarian Forest, Grafenau, Germany; [Codron, Daryl] Natl Museum, Florisbad Quaternary Res Dept, Bloemfontein, South Africa	University of Bristol; University of Hamburg; University of Zurich	Taylor, LA (corresponding author), Bristol Conservat & Sci Fdn, Bristol Zoo Gardens, Bristol, Avon, England.	ltaylor@bristolzoo.org.uk	Schulz-Kornas, Ellen/B-8505-2013; Clauss, Marcus/A-4710-2008; Clauss, Marcus/GRR-7996-2022; Clauss, Marcus/M-8702-2019; Taylor, Lucy/K-8010-2019; Codron, Daryl/B-8867-2008; Kaiser, Thomas/G-8883-2015	Schulz-Kornas, Ellen/0000-0003-1657-8256; Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Taylor, Lucy/0000-0003-4443-9456; Codron, Daryl/0000-0001-5223-9513; Kaiser, Thomas/0000-0002-8154-1751	British Society of Animal Science; Forschungskredit der Universitat Zurich; University of Zurich; 'Deutsche Forschungsgemeinschaft' (DFG, German Research Foundation) [KA 1525/8-1]	British Society of Animal Science; Forschungskredit der Universitat Zurich; University of Zurich; 'Deutsche Forschungsgemeinschaft' (DFG, German Research Foundation)(German Research Foundation (DFG))	LT was supported by the Sir Kenneth Blaxter scholarship from the British Society of Animal Science (http://www.bsas.org.uk/). DM was supported by a 'Forschungskredit der Universitat Zurich' (Research funding of the University of Zurich, www.researchers.uzh.ch), 'Comparative analysis of tooth wear in free-ranging and captive ungulates', loan number 55220702. This research was supported by the 'Deutsche Forschungsgemeinschaft' (DFG, German Research Foundation, KA 1525/8-1, http://www.dfg.de) and is publication no. 57 of the DFG Research Unit 771 'Function and performance enhancement in the mammalian dentition - phylogenetic and ontogenetic impact on the masticatory apparatus'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammann H, 1985, CONTRIBUTIONS ECOLOG; [Anonymous], [No title captured]; BOYDE A, 1986, ZOOL J LINN SOC-LOND, V87, P181, DOI 10.1111/j.1096-3642.1986.tb01336.x; Buk KG, 2010, AFR J ECOL, V48, P1064, DOI 10.1111/j.1365-2028.2010.01213.x; BUTLER PM, 1972, EVOLUTION, V26, P474, DOI 10.1111/j.1558-5646.1972.tb01951.x; Clauss M, 2005, COMP BIOCHEM PHYS A, V140, P67, DOI 10.1016/j.cbpb.2004.11.005; Clauss M, 2007, J ZOO WILDLIFE MED, V38, P433, DOI 10.1638/06-032.1; Codron D, 2007, J ZOOL, V273, P21, DOI 10.1111/j.1469-7998.2007.00292.x; Dragulescu A. A, 2012, XLSX READ WRITE FORM; Fortelius M., 1985, ACTA ZOOL FENN, V180, P1; Fortelius M, 1982, TEETH FORM FUNCTION; Fortelius Mikael, 2000, American Museum Novitates, V3301, P1, DOI 10.1206/0003-0082(2000)301<0001:FCOUMU>2.0.CO;2; Gentry AW, 1990, TURKEY J HUMAN EVOLU, V1990, P529; Groves CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009703; Hall-Martin HJ, 1982, KOEDOE, V25, P63; Hennig J, 2001, FEEDING HABITS DESER, P311; Hernesniemi E., 2011, PALAEONTOL ELECTRON, V14, P1; Hojsgaard S, 2012, DOBY DOBY GROUPWISE; Hoogerwerf A, 1970, UDJUNT KULON LAND LA; Hummel J, 2011, P ROY SOC B-BIOL SCI, V278, P1742, DOI 10.1098/rspb.2010.1939; JANIS C, 1982, BIOL REV, V57, P261, DOI 10.1111/j.1469-185X.1982.tb00370.x; Janis C, 2007, ICONS EVOLUTION; Janis C. M., 1988, ESTIMATION TOOTH V C, V53, P367; Jnawali SR, 1995, POPULATION ECOLOGY G; JOUBERT E, 1971, Madoqua, V1, P5; Kahlke RD, 2011, QUATERNARY SCI REV, V30, P2250, DOI 10.1016/j.quascirev.2009.12.012; Kaiser TM, 2011, VERTEBR PALEOBIOL PA, P329, DOI 10.1007/978-90-481-9956-3_16; Kaiser Thomas M., 2000, Carolinea, V58, P103; Kaiser TM, 2009, MAMM BIOL, V74, P425, DOI 10.1016/j.mambio.2008.09.003; Kaiser TM, 2003, GEODIVERSITAS, V25, P321; Kaiser TM, 2003, J MORPHOL, V258, P67, DOI 10.1002/jmor.10125; Kandel Ram Chandra, 2008, Journal of the Bombay Natural History Society, V105, P5; LAURIE A, 1982, J ZOOL, V196, P307; Louys J, 2011, J ARCHAEOL SCI, V38, P1485, DOI 10.1016/j.jas.2011.02.011; MacFadden B.J., 1992, FOSSIL HORSES SYSTEM; Mendoza M, 2008, J ZOOL, V274, P134, DOI 10.1111/j.1469-7998.2007.00365.x; MUKINYA JG, 1977, E AFR WILDL J, V15, P125; OLOO TW, 1994, AFR J ECOL, V32, P142, DOI 10.1111/j.1365-2028.1994.tb00565.x; Owen-Smith N, 1997, Z SAUGETIERKD, V62, P176; Owen-Smith R.N., 1988, P1; Patar KC, 1977, FOOD PREFERENCES ONE; Payne S., 1973, ANATOL STUD, V23, P281, DOI 10.2307/3642547; Pienaar DJ, 1994, HABITAT PREFERENCE W; Popowics TE, 1997, ANN ZOOL FENN, P103; Pradhan NMB, 2008, WILDLIFE BIOL, V14, P147, DOI 10.2981/0909-6396(2008)14[147:FEOTES]2.0.CO;2; R Core Team, 2012, R LANG ENV STAT COMP; RENSBERGER JM, 1984, PALEOBIOLOGY, V10, P439, DOI 10.1017/S0094837300008447; Rensberger JM, 1983, SUCCESSIONS MENISCOM; Rivals F, 2007, J VERTEBR PALEONTOL, V27, P763, DOI 10.1671/0272-4634(2007)27[763:EOODIF]2.0.CO;2; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Schenkel R., 1969, Acta Tropica, V26, P97; Schulz E, 2013, MAMMAL REV, V43, P111, DOI 10.1111/j.1365-2907.2012.00210.x; Schulz E, 2010, SCANNING, V32, P162, DOI 10.1002/sca.20181; Shrader AM, 2006, FUNCT ECOL, V20, P376, DOI 10.1111/j.1365-2435.2006.01107.x; Steinheim G, 2005, J ZOOL, V265, P377, DOI 10.1017/S0952836905006448; Thenius E, 1980, GRUNDZUGE FAUNEN VER, P375; Ungar P.S., 2010, MAMMAL TEETH ORIGIN; van Lieverloo RJ, 2009, EUR J WILDLIFE RES, V55, P505, DOI 10.1007/s10344-009-0264-5; Winkler Daniela E., 2011, Verhandlungen des Naturwissenschaftlichen Vereins in Hamburg, V46, P331	60	25	25	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e80921	10.1371/journal.pone.0080921	http://dx.doi.org/10.1371/journal.pone.0080921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312507	gold, Green Published, Green Accepted			2022-12-25	WOS:000327947800025
J	Ferguson, AL; Falkowska, E; Walker, LM; Seaman, MS; Burton, DR; Chakraborty, AK				Ferguson, Andrew L.; Falkowska, Emilia; Walker, Laura M.; Seaman, Michael S.; Burton, Dennis R.; Chakraborty, Arup K.			Computational Prediction of Broadly Neutralizing HIV-1 Antibody Epitopes from Neutralization Activity Data	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; B-CELL EPITOPES; GP120 ENVELOPE GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; MUTUAL INFORMATION; BINDING-AFFINITY; PEPTIDE BINDING; IN-VITRO; VACCINE; PROTECTION	Broadly neutralizing monoclonal antibodies effective against the majority of circulating isolates of HIV-1 have been isolated from a small number of infected individuals. Definition of the conformational epitopes on the HIV spike to which these antibodies bind is of great value in defining targets for vaccine and drug design. Drawing on techniques from compressed sensing and information theory, we developed a computational methodology to predict key residues constituting the conformational epitopes on the viral spike from cross-clade neutralization activity data. Our approach does not require the availability of structural information for either the antibody or antigen. Predictions of the conformational epitopes of ten broadly neutralizing HIV-1 antibodies are shown to be in good agreement with new and existing experimental data. Our findings suggest that our approach offers a means to accelerate epitope identification for diverse pathogenic antigens.	[Ferguson, Andrew L.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL USA; [Falkowska, Emilia; Burton, Dennis R.; Chakraborty, Arup K.] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA; [Falkowska, Emilia; Burton, Dennis R.; Chakraborty, Arup K.] Harvard Univ, Boston, MA 02115 USA; [Falkowska, Emilia; Walker, Laura M.; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Falkowska, Emilia; Walker, Laura M.; Burton, Dennis R.] Scripps Res Inst, Int AIDS Vaccine Initiat, Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Falkowska, Emilia; Walker, Laura M.; Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Design, La Jolla, CA 92037 USA; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; [Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA	University of Illinois System; University of Illinois Urbana-Champaign; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Harvard University; Beth Israel Deaconess Medical Center; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Chakraborty, AK (corresponding author), MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA.	arupc@mit.edu		Ferguson, Andrew/0000-0002-8829-9726	Ragon Institute; National Institutes of Health; Ragon Postdoctoral Fellowship	Ragon Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Postdoctoral Fellowship	Financial support for this work was provided by the Ragon Institute (A. K. C.; http://www.ragoninstitute.org), a National Institutes of Health Director's Pioneers Award (A. K. C.; https://commonfund.nih.gov/pioneer), and a Ragon Postdoctoral Fellowship (A. L. F.; http://www.ragoninstitute.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlQuraishi M, 2011, P NATL ACAD SCI USA, V108, P14819, DOI 10.1073/pnas.1106460108; Amanna IJ, 2008, HUM VACCINES, V4, P316, DOI 10.4161/hv.4.4.5751; Baraniuk RG, 2007, IEEE SIGNAL PROC MAG, V24, P118, DOI 10.1109/MSP.2007.4286571; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhasin M, 2004, VACCINE, V22, P3195, DOI 10.1016/j.vaccine.2004.02.005; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; Bublil EM, 2007, PROTEINS, V68, P294, DOI 10.1002/prot.21387; Bublil EM, 2006, FASEB J, V20, P1762, DOI 10.1096/fj.05-5509rev; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731; Crawley M. J., 2011, STAT INTRO USING R; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; Davies MN, 2007, DRUG DISCOV TODAY, V12, P389, DOI 10.1016/j.drudis.2007.03.010; De Cock KM, 2011, EMERG INFECT DIS, V17, P1044, DOI [10.3201/eid/1706.100184, 10.3201/eid1706.100184]; Divekar A., 2010, THESIS PURDUE U W LA; Dossal C, 2010, LINEAR ALGEBRA APPL, V432, P1663, DOI 10.1016/j.laa.2009.11.022; Doytchinova IA, 2005, J COMPUT AID MOL DES, V19, P203, DOI 10.1007/s10822-005-3993-x; Doytchinova IA, 2002, J PROTEOME RES, V1, P263, DOI 10.1021/pr015513z; Doytchinova IA, 2007, J CHEM INF MODEL, V47, P234, DOI 10.1021/ci600318z; Duarte MF, 2008, IEEE SIGNAL PROC MAG, V25, P83, DOI 10.1109/MSP.2007.914730; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Enshell-Seijffers D, 2003, J MOL BIOL, V334, P87, DOI 10.1016/j.jmb.2003.09.002; Figueiredo MAT, 2007, IEEE J-STSP, V1, P586, DOI 10.1109/JSTSP.2007.910281; Hastie T., 2009, UNSUPERVISED LEARNIN; Hay FC., 2001, EPITOPE MAPPING PRAC; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hoffman NG, 2003, VIROLOGY, V314, P536, DOI 10.1016/S0042-6822(03)00484-7; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kalia V, 2005, J VIROL, V79, P2097, DOI 10.1128/JVI.79.4.2097-2107.2005; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lafuente EM, 2009, CURR PHARM DESIGN, V15, P3209, DOI 10.2174/138161209789105162; LAVOIE TB, 1989, IMMUNE RESPONSE TO STRUCTURALLY DEFINED PROTEINS : THE LYSOZYME MODEL, P151; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mayrose I, 2007, NUCLEIC ACIDS RES, V35, P69, DOI 10.1093/nar/gkl975; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Nishimura Y, 2003, P NATL ACAD SCI USA, V100, P15131, DOI 10.1073/pnas.2436476100; Paes C, 2009, J AM CHEM SOC, V131, P6952, DOI 10.1021/ja900186n; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Perez-Sweeney B, 2010, INFECT GENET EVOL, V10, P1155, DOI 10.1016/j.meegid.2010.07.010; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Ponomarenko JV, 2009, STRUCTURAL BIOINFORM, V2, P849; Postler TS, 2013, J VIROL, V87, P2, DOI 10.1128/JVI.02053-12; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; ROBBINS JB, 1995, J INFECT DIS, V171, P1387, DOI 10.1093/infdis/171.6.1387; Rossi F, 2006, CHEMOMETR INTELL LAB, V80, P215, DOI 10.1016/j.chemolab.2005.06.010; Salvador S, 2004, PROC INT C TOOLS ART, P576; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; Sjostrand K., 2005, INFORM MATH MODELLIN; Sok D, PROMISCUOUS GL UNPUB; Sollner J, 2006, J MOL RECOGNIT, V19, P209, DOI 10.1002/jmr.770; Sollner J, 2006, J MOL RECOGNIT, V19, P200, DOI 10.1002/jmr.771; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Taylor PD., 2007, SILICO IMMUNOL, P23; Thomas MC, 2006, ELEMENTS INFORM THEO; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Wu TT, 2004, DRUG TODAY, V40, P949, DOI 10.1358/dot.2004.40.11.872583; Yamaguchi-Kabata Y, 2000, J VIROL, V74, P4335, DOI 10.1128/JVI.74.9.4335-4350.2000; Yasser E. -M., 2010, IMMUNOME RES, V6, P1; You LW, 2007, LECT NOTES COMPUT SC, V4774, P337; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	79	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80562	10.1371/journal.pone.0080562	http://dx.doi.org/10.1371/journal.pone.0080562			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312481	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500029
J	Abramov, SM; Sadraddinova, ER; Shestakov, AI; Voronin, OG; Karyakin, AA; Zorin, NA; Netrusov, AI				Abramov, Sergey M.; Sadraddinova, Elmira R.; Shestakov, Andrey I.; Voronin, Oleg G.; Karyakin, Arkadiy A.; Zorin, Nikolay A.; Netrusov, Alexander I.			Turning Cellulose Waste Into Electricity: Hydrogen Conversion by a Hydrogenase Electrode	PLOS ONE			English	Article							FERMENTATION; CLOSTRIDIUM; CELL; PH	Hydrogen-producing thermophilic cellulolytic microorganisms were isolated from cow faeces. Rates of cellulose hydrolysis and hydrogen formation were 0.2 mM L-1 h(-1) and 1 mM L-1 h(-1), respectively. An enzymatic fuel cell (EFC) with a hydrogenase anode was used to oxidise hydrogen produced in a microbial bioreactor. The hydrogenase electrode was exposed for 38 days (912 h) to a thermophilic fermentation medium. The hydrogenase activity remaining after continuous operation under load was 73% of the initial value.	[Abramov, Sergey M.; Sadraddinova, Elmira R.; Shestakov, Andrey I.; Netrusov, Alexander I.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Voronin, Oleg G.; Karyakin, Arkadiy A.] Moscow MV Lomonosov State Univ, Fac Chem, Moscow 117234, Russia; [Zorin, Nikolay A.] Inst Basic Problems Biol RAS, Pushchino, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University	Abramov, SM (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia.	abramov_sergei@inbox.ru	Netrusov, Alexander/A-8958-2016; netrusov, alexander/AAJ-7736-2021; Karyakin, Arkady A/I-6000-2012; Abramov, Sergey/E-7830-2014	Netrusov, Alexander/0000-0002-2803-3037; netrusov, alexander/0000-0002-2803-3037; Karyakin, Arkady A/0000-0002-0457-7638; Abramov, Sergey/0000-0001-7367-8259	Ministry of Education and Science of the Russian Federation [16.516.11.6013]	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	The financial support was provided through The Ministry of Education and Science of the Russian Federation (contract GK No 16.516.11.6013) URL: http://mon.gov.ru. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carver SM, 2012, BIORESOURCE TECHNOL, V104, P424, DOI 10.1016/j.biortech.2011.11.013; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Cosnier S, 1997, J ELECTROANAL CHEM, V433, P113, DOI 10.1016/S0022-0728(97)00207-6; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Desvaux M, 2005, FEMS MICROBIOL REV, V29, P741, DOI 10.1016/j.femsre.2004.11.003; Gassanova LG, 2006, DESALINATION, V198, P56, DOI 10.1016/j.desal.2006.09.009; He DL, 2005, J POWER SOURCES, V141, P19, DOI 10.1016/j.jpowsour.2004.09.002; Islam R, 2006, APPL MICROBIOL BIOT, V72, P576, DOI 10.1007/s00253-006-0316-7; KOVACS KL, 1988, BIOCHIM BIOPHYS ACTA, V935, P166, DOI 10.1016/0005-2728(88)90213-7; Lapinsonniere L, 2012, CHEMSUSCHEM, V5, P995, DOI 10.1002/cssc.201100835; Lin CY, 2006, PROCESS BIOCHEM, V41, P1383, DOI 10.1016/j.procbio.2006.01.021; MORE MI, 1994, APPL ENVIRON MICROB, V60, P1572; Stams AJM, 2009, NAT REV MICROBIOL, V7, P568, DOI 10.1038/nrmicro2166; Tsygankov AA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P968, DOI 10.1134/S0006297907090076; Voronin OG, 2012, INT J HYDROGEN ENERG, V37, P10585, DOI 10.1016/j.ijhydene.2012.04.044; Voronin OG, 2007, ELECTROANAL, V19, P2264, DOI 10.1002/elan.200703967; Young JM, 2012, ENVIRON MICROBIOL, V14, P594, DOI 10.1111/j.1462-2920.2011.02596.x; ZORIN N A, 1982, Biokhimiya, V47, P827	19	3	3	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e83004	10.1371/journal.pone.0083004	http://dx.doi.org/10.1371/journal.pone.0083004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24312437	Green Published, gold, Green Submitted			2022-12-25	WOS:000327657900074
J	Wampfler, R; Mwingira, F; Javati, S; Robinson, L; Betuela, I; Siba, P; Beck, HP; Mueller, I; Felger, I				Wampfler, Rahel; Mwingira, Felistas; Javati, Sarah; Robinson, Leanne; Betuela, Inoni; Siba, Peter; Beck, Hans-Peter; Mueller, Ivo; Felger, Ingrid			Strategies for Detection of Plasmodium species Gametocytes	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; POLYMERASE-CHAIN-REACTION; SEQUENCE-BASED AMPLIFICATION; EAST SEPIK PROVINCE; FALCIPARUM GAMETOCYTES; FILTER-PAPER; CLINICAL-SAMPLES; VACCINE TRIALS; BURKINA-FASO; WOSERA AREA	Carriage and density of gametocytes, the transmission stages of malaria parasites, are determined for predicting the infectiousness of humans to mosquitoes. This measure is used for evaluating interventions that aim at reducing malaria transmission. Gametocytes need to be detected by amplification of stage-specific transcripts, which requires RNA-preserving blood sampling. For simultaneous, highly sensitive quantification of both, blood stages and gametocytes, we have compared and optimized different strategies for field and laboratory procedures in a cross sectional survey in 315 5-9 yr old children from Papua New Guinea. qRT-PCR was performed for gametocyte markers pfs25 and pvs25, Plasmodium species prevalence was determined by targeting both, 18S rRNA genes and transcripts. RNA-based parasite detection resulted in a P. falciparum positivity of 24.1%; of these 40.8% carried gametocytes. P. vivax positivity was 38.4%, with 38.0% of these carrying gametocytes. Sensitivity of DNA-based parasite detection was substantially lower with 14.1% for P. falciparum and 19.6% for P. vivax. Using the lower DNA-based prevalence of asexual stages as a denominator increased the percentage of gametocyte-positive infections to 59.1% for P. falciparum and 52.4% for P. vivax. For studies requiring highly sensitive and simultaneous quantification of sexual and asexual parasite stages, 18S rRNA transcript-based detection saves efforts and costs. RNA-based positivity is considerably higher than other methods. On the other hand, DNA-based parasite quantification is robust and permits comparison with other globally generated molecular prevalence data. Molecular monitoring of low density asexual and sexual parasitaemia will support the evaluation of effects of up-scaled antimalarial intervention programs and can also inform about small scale spatial variability in transmission intensity.	[Wampfler, Rahel; Mwingira, Felistas; Javati, Sarah; Beck, Hans-Peter; Felger, Ingrid] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Wampfler, Rahel; Mwingira, Felistas; Javati, Sarah; Beck, Hans-Peter; Felger, Ingrid] Univ Basel, Basel, Switzerland; [Javati, Sarah; Robinson, Leanne; Betuela, Inoni; Siba, Peter; Mueller, Ivo] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea; [Mueller, Ivo] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Parkville, Vic 3050, Australia	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; PNG Institute Of Medical Research; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Felger, I (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	ingrid.felger@unibas.ch		Felger, Ingrid/0000-0003-1255-2606; Beck, Hans-Peter/0000-0001-8326-4834	Swiss National Science Foundation [310030_134889]; International Centers of Excellence in Malaria Research [U19 AI089686-03]; Brazilian Swiss Joint Research Programme [BJRP 0112-07]; Australian National Health and Medical Research Council [1016443]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089686] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); International Centers of Excellence in Malaria Research; Brazilian Swiss Joint Research Programme; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swiss National Science Foundation (grant no. 310030_134889), the International Centers of Excellence in Malaria Research (grant no. U19 AI089686-03) and the Brazilian Swiss Joint Research Programme (grant no. BJRP 0112-07). L. Robinson was supported by an Australian National Health and Medical Research Council Early Career Fellowship #1016443. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiker HA, 1999, MOL BIOCHEM PARASIT, V99, P143, DOI 10.1016/S0166-6851(98)00175-3; BAIRD JK, 1993, AM J TROP MED HYG, V49, P707, DOI 10.4269/ajtmh.1993.49.707; Beurskens M, 2009, AM J TROP MED HYG, V81, P366, DOI 10.4269/ajtmh.2009.81.366; Carter R, 2000, NAT MED, V6, P241, DOI 10.1038/73062; CATTANI JA, 1986, PAPUA NEW GUINEA MED, V29, P11; Churcher TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00626; Fivelman QL, 2007, MOL BIOCHEM PARASIT, V154, P119, DOI 10.1016/j.molbiopara.2007.04.008; GENTON B, 1995, ANN TROP MED PARASIT, V89, P377, DOI 10.1080/00034983.1995.11812966; GENTON B, 1995, ANN TROP MED PARASIT, V89, P359, DOI 10.1080/00034983.1995.11812965; Hii JLK, 1997, J MED ENTOMOL, V34, P193, DOI 10.1093/jmedent/34.2.193; Jones S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-266; Kariuki MM, 1998, AM J TROP MED HYG, V59, P505, DOI 10.4269/ajtmh.1998.59.505; Kuamsab N, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-190; Li J, 1997, J MOL BIOL, V269, P203, DOI 10.1006/jmbi.1997.1038; Lima NF, 2012, EXP PARASITOL, V132, P348, DOI 10.1016/j.exppara.2012.08.010; Maeno Y, 2008, ACTA TROP, V107, P121, DOI 10.1016/j.actatropica.2008.05.001; Mlambo G, 2008, AM J TROP MED HYG, V78, P114, DOI 10.4269/ajtmh.2008.78.114; Muller I, 2003, TRENDS PARASITOL, V19, P253, DOI 10.1016/S1471-4922(03)00091-6; Murphy SC, 2012, AM J TROP MED HYG, V86, P383, DOI 10.4269/ajtmh.2012.10-0658; Nishimoto Y, 2008, MOL PHYLOGENET EVOL, V47, P45, DOI 10.1016/j.ympev.2008.01.031; Ouedraogo AL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-281; Ouedraogo AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008410; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P812, DOI 10.1016/0035-9203(82)90116-X; Prajapati SK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-111; Pritsch M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-138; R Development Core Team, 2011, R LANG ENV STAT COMP; Rosanas-Urgell A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-361; Schneider P, 2004, MOL BIOCHEM PARASIT, V137, P35, DOI 10.1016/j.molbiopara.2004.03.018; Schneider P, 2006, INT J PARASITOL, V36, P403, DOI 10.1016/j.ijpara.2006.01.002; Sinden RE, 2012, TRENDS PARASITOL, V28, P457, DOI 10.1016/j.pt.2012.07.005; Tiono AB, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-79	31	144	144	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76316	10.1371/journal.pone.0076316	http://dx.doi.org/10.1371/journal.pone.0076316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24312682	Green Published, Green Accepted, gold			2022-12-25	WOS:000325223900097
J	Bazinet, AL; Cummings, MP; Mitter, KT; Mitter, CW				Bazinet, Adam L.; Cummings, Michael P.; Mitter, Kim T.; Mitter, Charles W.			Can RNA-Seq Resolve the Rapid Radiation of Advanced Moths and Butterflies (Hexapoda: Lepidoptera: Apoditrysia)? An Exploratory Study	PLOS ONE			English	Article							CODON-SUBSTITUTION MODELS; GELECHIOIDEA LEPIDOPTERA; AMINO-ACID; PHYLOGENY; GENE; SEQUENCES; EVOLUTION; TREE; MITOCHONDRIAL; ADAPTATIONS	Recent molecular phylogenetic studies of the insect order Lepidoptera have robustly resolved family-level divergences within most superfamilies, and most divergences among the relatively species-poor early-arising superfamilies. In sharp contrast, relationships among the superfamilies of more advanced moths and butterflies that comprise the mega-diverse clade Apoditrysia (ca. 145,000 spp.) remain mostly poorly supported. This uncertainty, in turn, limits our ability to discern the origins, ages and evolutionary consequences of traits hypothesized to promote the spectacular diversification of Apoditrysia. Low support along the apoditrysian "backbone" probably reflects rapid diversification. If so, it may be feasible to strengthen resolution by radically increasing the gene sample, but case studies have been few. We explored the potential of next-generation sequencing to conclusively resolve apoditrysian relationships. We used transcriptome RNA-Seq to generate 1579 putatively orthologous gene sequences across a broad sample of 40 apoditrysians plus four outgroups, to which we added two taxa from previously published data. Phylogenetic analysis of a 46-taxon, 741-gene matrix, resulting from a strict filter that eliminated ortholog groups containing any apparent paralogs, yielded dramatic overall increase in bootstrap support for deeper nodes within Apoditrysia as compared to results from previous and concurrent 19-gene analyses. High support was restricted mainly to the huge subclade Obtectomera broadly defined, in which 11 of 12 nodes subtending multiple superfamilies had bootstrap support of 100%. The strongly supported nodes showed little conflict with groupings from previous studies, and were little affected by changes in taxon sampling, suggesting that they reflect true signal rather than artifacts of massive gene sampling. In contrast, strong support was seen at only 2 of 11 deeper nodes among the "lower", non-obtectomeran apoditrysians. These represent a much harder phylogenetic problem, for which one path to resolution might include further increase in gene sampling, together with improved orthology assignments.	[Bazinet, Adam L.; Cummings, Michael P.] Univ Maryland, Ctr Bioinformat & Computat Biol, Lab Mol Evolut, College Pk, MD 20742 USA; [Mitter, Kim T.; Mitter, Charles W.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Mitter, CW (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	cmitter@umd.edu	Bazinet, Adam/H-3182-2019		U.S. National Science Foundation [0531626, 0531769, DEB 0515699, DBI-0755048]; Hatch funds of the Maryland Agricultural Experiment Station	U.S. National Science Foundation(National Science Foundation (NSF)); Hatch funds of the Maryland Agricultural Experiment Station	Financial support was provided by the U.S. National Science Foundation's Assembling the Tree of Life program, award numbers 0531626 and 0531769; U.S. National Science Foundation grant DEB 0515699 to D. H. Janzen; U.S. National Science Foundation award DBI-0755048; and the Hatch funds of the Maryland Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberer AJ, 2011, IEEE INT C BIOINFORM, P118, DOI 10.1109/BIBM.2011.70; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson DP, 2004, FIFTH IEEE/ACM INTERNATIONAL WORKSHOP ON GRID COMPUTING, PROCEEDINGS, P4, DOI 10.1109/GRID.2004.14; Bazinet A, 2008, DISTRIBUTED GRID COM, P2; Bazinet A. L., 2011, 2011 IEEE International Symposium on Parallel & Distributed Processing, Workshops and Phd Forum, P1896, DOI 10.1109/IPDPS.2011.344; Bazinet AL, 2007, FUTURE GENER COMP SY, V23, P517, DOI 10.1016/j.future.2006.07.009; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Cho S, 2011, SYST BIOL, V60, P782, DOI 10.1093/sysbio/syr079; CORNISHBOWDEN A, 1985, NUCLEIC ACIDS RES, V13, P3021, DOI 10.1093/nar/13.9.3021; Cummings M. P, 2005, EDUCAUSE REV, V40, P116; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; DAVIS DR, 1986, SMITH CONTR ZOOL, V434; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Heikkila M, 2012, P ROY SOC B-BIOL SCI, V279, P1093, DOI 10.1098/rspb.2011.1430; Hittinger CT, 2010, P NATL ACAD SCI USA, V107, P1476, DOI 10.1073/pnas.0910449107; Kaila L, 2004, CLADISTICS, V20, P303, DOI 10.1111/j.1096-0031.2004.00027.x; Kaila L, 2011, MOL PHYLOGENET EVOL, V61, P801, DOI 10.1016/j.ympev.2011.08.016; Katoh K, 2012, BIOINFORMATICS, V28, P3144, DOI 10.1093/bioinformatics/bts578; Kawahara AY, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-182; Kim MJ, 2011, MOL PHYLOGENET EVOL, V61, P436, DOI 10.1016/j.ympev.2011.07.013; Kocot KM, 2013, MOL PHYLOGENET EVOL, V69, P764, DOI 10.1016/j.ympev.2013.07.001; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; KOCOT KM, 2013, PHYLOTREEPRUNER PHYL; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; KRISTENSEN N P, 1984, Steenstrupia, V10, P141; Kristensen N.P., 1998, HDB ZOOLOGY, V4, P7, DOI 10.1515/9783110804744.7; KRISTENSEN NP, 1983, Z ZOOL SYST EVOL, V21, P101; KRISTENSEN NP, 2003, HDB ZOOLOGY, V2; Kristensen NP, 1998, HDB ZOOLOGY, V4; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042558, 10.1371/journal.pone.0043023]; Lu HD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0069950, 10.1371/journal.pone.0072410]; Miller NJ, 2012, ENVIRON ENTOMOL, V41, P997, DOI 10.1603/EN11216; MINET J, 1991, ENTOMOL SCAND, V22, P69; MINET J, 1986, Alexanor, V14, P291; Mitchell A, 2006, SYST ENTOMOL, V31, P21, DOI 10.1111/j.1365-3113.2005.00306.x; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Pick KS, 2010, MOL BIOL EVOL, V27, P1983, DOI 10.1093/molbev/msq089; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Regier JC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072678, 10.1371/journal.pone.0058568]; Regier JC, 2012, SYST ENTOMOL, V37, P635, DOI 10.1111/j.1365-3113.2012.00641.x; Regier JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035574; Regier JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023408; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Roe AD, 2009, GENETICS MOL BIOL LE, P1, DOI [10.1201/9781420060201-c1, DOI 10.1201/9781420060201-C1]; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; Seo TK, 2009, SYST BIOL, V58, P199, DOI 10.1093/sysbio/syp015; Sihvonen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020356; Sohn JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055066; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Wagner David L., 2001, P249; Whitfield JB, 2007, TRENDS ECOL EVOL, V22, P258, DOI 10.1016/j.tree.2007.01.012; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Wiens JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042925; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240; Yamamoto S, 2007, MOL PHYLOGENET EVOL, V44, P711, DOI 10.1016/j.ympev.2006.12.027; Yang ZH, 2000, GENETICS, V155, P431; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Young CJ, 2006, ZOOTAXA, P1; Zahiri R, 2011, ZOOL SCR, V40, P158, DOI 10.1111/j.1463-6409.2010.00459.x; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zwick A, 2008, SYST ENTOMOL, V33, P190, DOI 10.1111/j.1365-3113.2007.00410.x; Zwick A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047450; Zwickl D., 2006, GARLI GENETIC ALGORI	78	79	82	4	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82615	10.1371/journal.pone.0082615	http://dx.doi.org/10.1371/journal.pone.0082615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324810	Green Published, gold			2022-12-25	WOS:000327949300161
J	Nangia, V; Jonas, JB; Nair, D; Saini, N; Nangia, P; Panda-Jonas, S				Nangia, Vinay; Jonas, Jost B.; Nair, Deepa; Saini, Nandita; Nangia, Prabhat; Panda-Jonas, Songhomitra			Prevalence and Associated Factors for Pterygium in Rural Agrarian Central India. The Central India Eye and Medical Study	PLOS ONE			English	Article							ADULT CHINESE POPULATION; RISK-FACTORS; PINGUECULA; EPIDEMIOLOGY; SINGAPORE; HEALTH	Purpose: To evaluate the prevalence of pterygia and associated factors in a rural population in a mostly undeveloped agrarian region. Methods: The Central India Eye and Medical Study is a population-based study performed in a rural region of Central India. The study comprised 4711 subjects (aged 30+ years). A detailed ophthalmic and medical examination was performed. A pterygium was diagnosed during the slit lamp examination and confirmed on corneal photographs. It was defined as a fleshy fibrovascular growth, crossing the limbus and typically seen on the nasal, and sometimes temporal, conjunctiva. Results: A pterygium was detected in 798 eyes (prevalence rate: 8.47 +/- 0.29%) of 608 (12.91 +/- 0.49%) subjects. Bilateral pterygia were present in 190 subjects (4.0% of study population). Pterygia prevalence increased from 6.7 +/- 0.8% in the age group 30-39 years, to 13.5 +/- 1.2% in the age group 50-59 years, to 25.3 +/- 2.1% in the age group 70-79 years. Prevalence of pterygia was associated with older age (P<0.001; regression coefficient B: 0.02; odds ratio (OR): 1.02; 95%CI: 1.01, 1.03), male gender (P<0.001; B:-0.73; OR: .48; 95%CI:0.39,0.61), lower level of education (P<0.001; B:-0.30; OR:0.74; 95%CI:0.69,0.80), lower body height (P=0.001; B:-0.02; OR:0.98; 95%CI:0.97,0.99), and higher cylindrical refractive error (P<0.001; B:0.23;OR:1.26; 95% CI:1.18,1.34). If the education level was dropped, the number of hours spent with vigorous activity outdoors (P=0.001; B:0.001; OR:1.001; 95% CI:1.000,1.0001) was significantly associated with the prevalence of pterygia, in addition to older age (P<0.001; B:0.03;OR:1.03; 95% CI:1.03,1.04), male gender (P<0.001; B:-0.49; OR:0.62; 95% CI:0.49,0.77), lower body height (P=0.005; B:-0.02; OR:0.98; 95% CI:0.97,0.99), and higher cylindrical refractive error (P<0.001;B: 0.23;OR:1.25; 95% CI:1.18,1.34). Conclusions: Pterygium prevalence in rural Central India is about 13% among adult Indians aged 30+ years. Older age, male gender, lower educational level, lower body height and more time spent outdoors with vigorous work were associated factors. Since the living conditions in the study location were mostly untouched by modern developments, the results may show the prevalence and associations of pterygia without major medical or technologic influences.	[Nangia, Vinay; Jonas, Jost B.; Nair, Deepa; Saini, Nandita; Nangia, Prabhat] Suraj Eye Inst, Nagpur, Maharashtra, India; [Jonas, Jost B.; Panda-Jonas, Songhomitra] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Suraj Eye Institute; Ruprecht Karls University Heidelberg	Nangia, V (corresponding author), Suraj Eye Inst, Nagpur, Maharashtra, India.	nagpursuraj@gmail.com; jost.jonas@medma.uni-heidelberg.de			Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; Carl Zeiss Meditec Co., Jena, Germany	Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; Carl Zeiss Meditec Co., Jena, Germany	Supported by an unrestricted grant from Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; and Carl Zeiss Meditec Co., Jena, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding of this study did not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Al-Bdour MD, 2004, ACTA OPHTHALMOL SCAN, V82, P64, DOI 10.1046/j.1600-0420.2003.0213.x; Ang M, 2012, OPHTHALMOLOGY, V119, P1509, DOI 10.1016/j.ophtha.2012.02.009; Asokan R, 2012, OPHTHAL PHYSL OPT, V32, P39, DOI 10.1111/j.1475-1313.2011.00882.x; Bradley JC, 2010, BRIT J OPHTHALMOL, V94, P815, DOI 10.1136/bjo.2008.151852; Cajucom-Uy H, 2010, BRIT J OPHTHALMOL, V94, P977, DOI 10.1136/bjo.2008.150847; Fotouhi A, 2009, EYE, V23, P1125, DOI 10.1038/eye.2008.200; Gazzard G, 2002, BRIT J OPHTHALMOL, V86, P1341, DOI 10.1136/bjo.86.12.1341; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Jonas JB, 2010, AM J HYPERTENS, V23, P347, DOI 10.1038/ajh.2009.276; Landers J, 2011, CLIN EXP OPHTHALMOL, V39, P604, DOI 10.1111/j.1442-9071.2011.02532.x; Li ZJ, 2013, CORNEA, V32, P806, DOI 10.1097/ICO.0b013e31826dff30; Liang QF, 2010, CHINESE MED J-PEKING, V123, P1699, DOI 10.3760/cma.j.issn.0366-6999.2010.13.016; Lu J, 2009, EYE, V23, P421, DOI 10.1038/sj.eye.6703005; Lu P, 2007, CLIN EXP OPHTHALMOL, V35, P828, DOI 10.1111/j.1442-9071.2007.01630.x; Luthra R, 2001, ARCH OPHTHALMOL-CHIC, V119, P1827, DOI 10.1001/archopht.119.12.1827; Ma K, 2007, CORNEA, V26, P1184, DOI 10.1097/ICO.0b013e318151f9c6; MARMAMULA S, 2013, INVEST OPHTH VIS SCI, DOI DOI 10.1167/I0VS.13-12529; McCarty CA, 2000, BRIT J OPHTHALMOL, V84, P289, DOI 10.1136/bjo.84.3.289; MORAN DJ, 1984, BRIT J OPHTHALMOL, V68, P343, DOI 10.1136/bjo.68.5.343; Nangia V, 2010, OPHTHALMOLOGY, V117, P1360, DOI 10.1016/j.ophtha.2009.11.040; Nemesure B, 2008, OPHTHALMOLOGY, V115, P2153, DOI 10.1016/j.ophtha.2008.08.003; Nolan TM, 2003, AM J PATHOL, V162, P567, DOI 10.1016/S0002-9440(10)63850-3; NORN MS, 1979, ACTA OPHTHALMOL, V57, P96; Panchapakesan J, 1998, AUST NZ J OPHTHALMOL, V26, pS2, DOI 10.1111/j.1442-9071.1998.tb01362.x; Rezvan Farhad, 2012, Acta Med Iran, V50, P689; Rim THT, 2013, CORNEA, V32, P962, DOI 10.1097/ICO.0b013e3182801668; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Saw S M, 1999, Ophthalmic Epidemiol, V6, P219, DOI 10.1076/opep.6.3.219.1504; Sherwin JC, 2013, ACTA OPHTHALMOL, V91, P363, DOI 10.1111/j.1755-3768.2011.02314.x; Shiroma H, 2009, AM J OPHTHALMOL, V148, P766, DOI 10.1016/j.ajo.2009.06.006; Sun LP, 2013, OPHTHAL EPIDEMIOL, V20, P148, DOI 10.3109/09286586.2013.763991; Tano T, 2013, ACTA OPHTHALMOL, V91, pE232, DOI 10.1111/aos.12044; TAYLOR HR, 1992, ARCH OPHTHALMOL-CHIC, V110, P99, DOI 10.1001/archopht.1992.01080130101035; Viso E, 2011, EYE, V25, P350, DOI 10.1038/eye.2010.204; West S, 2009, BRIT J OPHTHALMOL, V93, P1287, DOI 10.1136/bjo.2008.152694; Wong TY, 2001, AM J OPHTHALMOL, V131, P176, DOI 10.1016/S0002-9394(00)00703-0; Wu Kaili, 2002, Yan Ke Xue Bao, V18, P181; Zhao L, 2013, INVEST OPHTH VIS SCI, V54, P1509, DOI 10.1167/iovs.12-11183; Zhong H, 2012, INVEST OPHTH VIS SCI, V53, P6617, DOI 10.1167/iovs.11-8947	39	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82439	10.1371/journal.pone.0082439	http://dx.doi.org/10.1371/journal.pone.0082439			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324789	Green Submitted, Green Published, gold			2022-12-25	WOS:000327949300147
J	Recoquillay, J; Leterrier, C; Calandreau, L; Bertin, A; Pitel, F; Gourichon, D; Vignal, A; Beaumont, C; Le Bihan-Duval, E; Arnould, C				Recoquillay, Julien; Leterrier, Christine; Calandreau, Ludovic; Bertin, Aline; Pitel, Frederique; Gourichon, David; Vignal, Alain; Beaumont, Catherine; Le Bihan-Duval, Elisabeth; Arnould, Cecile			Evidence of Phenotypic and Genetic Relationships between Sociality, Emotional Reactivity and Production Traits in Japanese Quail	PLOS ONE			English	Article							COTURNIX-COTURNIX-JAPONICA; JUNGLEFOWL GALLUS-GALLUS; FEAR-RELATED BEHAVIOR; OPEN-FIELD BEHAVIOR; RED JUNGLEFOWL; DIVERGENT SELECTION; TONIC IMMOBILITY; REINSTATEMENT BEHAVIOR; FEATHER-PECKING; BODY-WEIGHT	The social behavior of animals, which is partially controlled by genetics, is one of the factors involved in their adaptation to large breeding groups. To understand better the relationships between different social behaviors, fear behaviors and production traits, we analyzed the phenotypic and genetic correlations of these traits in Japanese quail by a second generation crossing of two lines divergently selected for their social reinstatement behavior. Analyses of results for 900 individuals showed that the phenotypic correlations between behavioral traits were low with the exception of significant correlations between sexual behavior and aggressive pecks both at phenotypic (0.51) and genetic (0.90) levels. Significant positive genetic correlations were observed between emotional reactivity toward a novel object and sexual (0.89) or aggressive (0.63) behaviors. The other genetic correlations were observed mainly between behavioral and production traits. Thus, the level of emotional reactivity, estimated by the duration of tonic immobility, was positively correlated with weight at 17 and 65 days of age (0.76 and 0.79, respectively) and with delayed egg laying onset (0.74). In contrast, a higher level of social reinstatement behavior was associated with an earlier egg laying onset (-0.71). In addition, a strong sexual motivation was correlated with an earlier laying onset (-0.68) and a higher number of eggs laid (0.82). A low level of emotional reactivity toward a novel object and also a higher aggressive behavior were genetically correlated with a higher number of eggs laid (0.61 and 0.58, respectively). These results bring new insights into the complex determinism of social and emotional reactivity behaviors in birds and their relationships with production traits. Furthermore, they highlight the need to combine animal welfare and production traits in selection programs by taking into account traits of sociability and emotional reactivity.	[Recoquillay, Julien; Beaumont, Catherine; Le Bihan-Duval, Elisabeth] INRA, Rech Avicoles UR83, F-37380 Nouzilly, France; [Leterrier, Christine; Calandreau, Ludovic; Bertin, Aline; Arnould, Cecile] INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France; [Leterrier, Christine; Calandreau, Ludovic; Bertin, Aline; Arnould, Cecile] CNRS, UMR7247, Nouzilly, France; [Leterrier, Christine; Calandreau, Ludovic; Bertin, Aline; Arnould, Cecile] Univ Tours, Tours, France; [Leterrier, Christine; Calandreau, Ludovic; Bertin, Aline; Arnould, Cecile] IFCE, Nouzilly, France; [Pitel, Frederique; Vignal, Alain] INRA ENVT, Genet Cellulaire UMR444, Castanet Tolosan, France; [Gourichon, David] UE1295 Pole Experimentat Avicole Tours, Nouzilly, France	INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Arnould, C (corresponding author), INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France.	Cecile.Arnould@tours.inra.fr	Pitel, Frédérique/C-2847-2009; Vignal, Alain/AAJ-5697-2021; Vignal, Alain/I-6253-2017; Leterrier, Christine/AAY-7201-2020	Pitel, Frédérique/0000-0002-1477-7633; Vignal, Alain/0000-0002-6797-2125; Vignal, Alain/0000-0002-6797-2125; 	French National Research Agency [ANR-09-GENM-008]	French National Research Agency(French National Research Agency (ANR))	The study was supported by the French National Research Agency (grant ANR-09-GENM-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnvall B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035162; Beaumont C, 2005, ANIM GENET, V36, P401, DOI 10.1111/j.1365-2052.2005.01336.x; BLOHOWIAK CC, 1985, J COMP PSYCHOL, V99, P30, DOI 10.1037/0735-7036.99.1.30; Buitenhuis AJ, 2004, BEHAV GENET, V34, P325, DOI 10.1023/B:BEGE.0000017876.82142.73; Burns M, 1998, PSYCHOBIOLOGY, V26, P249; Collias NE, 1996, ANIM BEHAV, V51, P1337, DOI 10.1006/anbe.1996.0137; Desire L, 2002, BEHAV PROCESS, V60, P165, DOI 10.1016/S0376-6357(02)00081-5; FAURE JM, 1982, ANN GENET SEL ANIM, V14, P187, DOI 10.1186/1297-9686-14-2-187; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Formanek L, 2008, APPL ANIM BEHAV SCI, V112, P174, DOI 10.1016/j.applanim.2007.07.004; FUMIHITO A, 1994, P NATL ACAD SCI USA, V91, P12505, DOI 10.1073/pnas.91.26.12505; GERKEN M, 1992, POULTRY SCI, V71, P779, DOI 10.3382/ps.0710779; Hirschenhauser K, 2008, PHYSIOL BEHAV, V95, P457, DOI 10.1016/j.physbeh.2008.07.013; Jones RB, 1997, APPL ANIM BEHAV SCI, V52, P87, DOI 10.1016/S0168-1591(96)01146-X; JONES RB, 1991, J COMP PSYCHOL, V105, P15, DOI 10.1037/0735-7036.105.1.15; Jones RB, 1999, POULT AVIAN BIOL REV, V10, P213; Karlsson AC, 2010, BRIT POULTRY SCI, V51, P170, DOI 10.1080/00071661003745802; Keeling L, 2004, NATURE, V431, P645, DOI 10.1038/431645a; Kjaer JB, 2001, APPL ANIM BEHAV SCI, V71, P229, DOI 10.1016/S0168-1591(00)00184-2; Legarra A., 2011, TM THRESHOLD MODEL; Lynn SE, 2008, GEN COMP ENDOCR, V157, P233, DOI 10.1016/j.ygcen.2008.05.009; Marin RH, 2002, POULTRY SCI, V81, P981, DOI 10.1093/ps/81.7.981; Marks HL, 1996, POULTRY SCI, V75, P1198, DOI 10.3382/ps.0751198; Mench Joy, 2001, P177, DOI 10.1079/9780851993973.0177; Mignon-Grasteau S, 2003, POULTRY SCI, V82, P1839, DOI 10.1093/ps/82.12.1839; Mignon-Grasteau S, 2002, PROD ANIM, V15, P357; MILLS AD, 1991, J COMP PSYCHOL, V105, P25, DOI 10.1037/0735-7036.105.1.25; MILLS AD, 1993, PHYSIOL BEHAV, V53, P183, DOI 10.1016/0031-9384(93)90029-F; Minvielle F, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-87; Minvielle F, 2002, POULTRY SCI, V81, P321, DOI 10.1093/ps/81.3.321; Nestor KE, 1996, POULTRY SCI, V75, P303, DOI 10.3382/ps.0750303; Nol E, 1996, ANIM BEHAV, V52, P813, DOI 10.1006/anbe.1996.0226; Price EO, 1998, GENETICS AND THE BEHAVIOR OF DOMESTIC ANIMALS, P31; PRICE EO, 1984, Q REV BIOL, V59, P1, DOI 10.1086/413673; Richard S, 2008, PROD ANIM, V21, P71; Rodenburg TB, 2003, POULTRY SCI, V82, P861, DOI 10.1093/ps/82.6.861; Saint-Dizier H, 2008, APPL ANIM BEHAV SCI, V112, P297, DOI 10.1016/j.applanim.2007.09.005; Schutz K, 2002, BEHAV GENET, V32, P423, DOI 10.1023/A:1020880211144; Schutz KE, 2004, BEHAV GENET, V34, P121, DOI 10.1023/B:BEGE.0000009481.98336.fc; Schweitzer C, 2010, ANIM BEHAV, V79, P571, DOI 10.1016/j.anbehav.2009.11.023; Schweitzer C, 2009, DEV PSYCHOBIOL, V51, P311, DOI 10.1002/dev.20370; Schweitzer C, 2011, ANIM BEHAV, V81, P535, DOI 10.1016/j.anbehav.2010.11.017; Schweitzer C, 2010, APPL ANIM BEHAV SCI, V125, P143, DOI 10.1016/j.applanim.2010.04.005; SEFTON AE, 1975, POULTRY SCI, V54, P788, DOI 10.3382/ps.0540788; SIEGEL PB, 1972, ANIM BEHAV, V20, P564, DOI 10.1016/S0003-3472(72)80021-6; Silva LP, 2013, LIVEST SCI, V153, P27, DOI 10.1016/j.livsci.2013.01.014; Sorensen DA., 2002, STAT BIOL HEALTH; Vaisanen J, 2005, BRIT POULTRY SCI, V46, P156, DOI 10.1080/00071660500062638; Veissier I, 2007, PROD ANIM, V20, P3; Wiren A, 2009, POULTRY SCI, V88, P1162, DOI 10.3382/ps.2008-00492; Wiren A, 2011, BEHAV GENET, V41, P303, DOI 10.1007/s10519-010-9377-6; Wright D, 2010, MOL ECOL, V19, P5140, DOI 10.1111/j.1365-294X.2010.04882.x	52	14	14	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82157	10.1371/journal.pone.0082157	http://dx.doi.org/10.1371/journal.pone.0082157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324761	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300136
J	Severin, I; Ostman, O; Lindstrom, ES				Severin, Ina; Ostman, Orjan; Lindstrom, Eva S.			Variable Effects of Dispersal on Productivity of Bacterial Communities Due to Changes in Functional Trait Composition	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; PHYLOGENETIC DIVERSITY	Previous studies have shown variable relationships between dispersal rate and ecosystem functioning, but the reasons for and mechanisms behind variable dispersal rate - functioning patterns are currently unknown. In this study we used six bacterial lake water communities in a laboratory experiment in order to investigate how dispersal among communities influences community productivity by evaluating three different mechanisms: 1) changes in taxonomic diversity, 2) changes in phylogenetic diversity or 3) changes in the composition of functional traits. The experiment was conducted in two phases; (A) a dialysis bag experiment where the dispersal rate among six communities was manipulated and the subsequent change in bacterial diversity and growth rate was recorded, and (B) a regrowth experiment where we manipulated available resources to study how well a taxon grows on certain organic carbon resources, i.e. their functional traits. From experiment (B) we could thus estimate changes in functional traits in communities in experiment (A). Bacterial production was affected by dispersal, but not consistently among lakes. Neither change in taxonomic or phylogenetic diversity with dispersal could explain the observed dispersal - productivity relationships. Instead, changes in trait composition with dispersal, especially the communities' ability to use p-coumaric acid, an aromatic compound, could explain the observed dispersal - productivity relationships. Changes in this trait caused by dispersal seemed especially important for bacterial productivity in waters with a high aromaticity of the organic matter pool. We conclude that the effect of dispersal on bacterial communities can affect ecosystem functioning in different ways, through changes in functional key-traits which are important for the local environment.	[Severin, Ina; Lindstrom, Eva S.] Uppsala Univ, Dept Ecol & Genet Limnol, Uppsala, Sweden; [Ostman, Orjan] Uppsala Univ, Dept Ecol & Genet Anim Ecol, Uppsala, Sweden	Uppsala University; Uppsala University	Severin, I (corresponding author), Univ Copenhagen, Marine Biol Sect, Dept Biol, Helsingor, Denmark.	ina.severin@bio.ku.dk	LindstrÃm, Eva/H-5930-2016; Östman, Örjan/ABF-8714-2020	LindstrÃm, Eva/0000-0001-8920-3071; Östman, Örjan/0000-0002-1930-0148	Carl Trygger foundation; Swedish Research Council [2009-5172, 2007-5932]	Carl Trygger foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by a grant from the Carl Trygger foundation to ESL and OO and by separate grants from the Swedish Research Council to ESL (project number 2009-5172) and OO (2007-5932). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, ECOLOGY HUMIC SUBSTA; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Becker J, 2012, ECOL LETT, V15, P468, DOI 10.1111/j.1461-0248.2012.01759.x; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; delGiorgio P, 1996, LIMNOL OCEANOGR, V41, P783, DOI 10.4319/lo.1996.41.4.0783; Gomez-Consarnau L, 2012, ENVIRON MICROBIOL, V14, P2361, DOI 10.1111/j.1462-2920.2012.02804.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Helmus MR, 2012, ECOLOGY, V93, pS31, DOI 10.1890/11-0435.1; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Jaffe R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000683; Jousset A, 2011, ECOL LETT, V14, P537, DOI 10.1111/j.1461-0248.2011.01613.x; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Lindstrom ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025883; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lundin D, 2012, ENV MICROBIOL REP, V4, P367, DOI 10.1111/j.1758-2229.2012.00345.x; Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160; Matthiessen B, 2006, ECOL LETT, V9, P652, DOI 10.1111/j.1461-0248.2006.00916.x; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R-project, 2011, R LANG ENV STAT COMP; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Salcher MM, 2013, ISME J, V7, P896, DOI 10.1038/ismej.2012.162; Seitzinger SP, 2005, LIMNOL OCEANOGR, V50, P1; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Srivastava DS, 2012, ECOL LETT, V15, P637, DOI 10.1111/j.1461-0248.2012.01795.x; Stedmon CA, 2005, LIMNOL OCEANOGR, V50, P1415, DOI 10.4319/lo.2005.50.5.1415; Tan JQ, 2012, ECOLOGY, V93, P1164, DOI 10.1890/11-1557.1; Thurnman EM, 1985, ORGANIC GEOCHEMISTRY; Venail PA, 2008, NATURE, V452, P210, DOI 10.1038/nature06554; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x	33	19	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80825	10.1371/journal.pone.0080825	http://dx.doi.org/10.1371/journal.pone.0080825			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324633	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300047
J	Zhu, MC; Wang, WZ; Liu, BH; Huang, JS				Zhu, Minchen; Wang, Weizhi; Liu, Binghan; Huang, Jingshan			Efficient Video Panoramic Image Stitching Based on an Improved Selection of Harris Corners and a Multiple-Constraint Corner Matching	PLOS ONE			English	Article							REGISTRATION	Video panoramic image stitching is extremely time-consuming among other challenges. We present a new algorithm: (i) Improved, self-adaptive selection of Harris corners. The successful stitching relies heavily on the accuracy of corner selection. We fragment each image into numerous regions and select corners within each region according to the normalized variance of region grayscales. Such a selection is self-adaptive and guarantees that corners are distributed proportional to region texture information. The possible clustering of corners is also avoided. (ii) Multiple-constraint corner matching. The traditional Random Sample Consensus (RANSAC) algorithm is inefficient, especially when handling a large number of images with similar features. We filter out many inappropriate corners according to their position information, and then generate candidate matching pairs based on grayscales of adjacent regions around corners. Finally we apply multiple constraints on every two pairs to remove incorrectly matched pairs. By a significantly reduced number of iterations needed in RANSAC, the stitching can be performed in a much more efficient manner. Experiments demonstrate that (i) our corner matching is four times faster than normalized cross-correlation function (NCC) rough match in RANSAC and (ii) generated panoramas feature a smooth transition in overlapping image areas and satisfy real-time human visual requirements.	[Zhu, Minchen; Liu, Binghan] Fuzhou Univ, Coll Math & Comp Sci, Fuzhou 350002, Fujian, Peoples R China; [Wang, Weizhi] Fuzhou Univ, Coll Civil Engn, Fuzhou 350002, Fujian, Peoples R China; [Huang, Jingshan] Univ S Alabama, Sch Comp, Mobile, AL 36688 USA	Fuzhou University; Fuzhou University; University of South Alabama	Liu, BH (corresponding author), Fuzhou Univ, Coll Math & Comp Sci, Fuzhou 350002, Fujian, Peoples R China.	lbh@fzu.edu.cn			Natural Science Foundation of the Fujian Province, China [2012J01263]; Fujian Province, China [2009J1007]	Natural Science Foundation of the Fujian Province, China; Fujian Province, China	This research was supported by Natural Science Foundation of the Fujian Province, China (under Grant Numbers 2012J01263 and the Fujian Province, China (under Grant Number 2009J1007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[曹世翔 Cao Shixiang], 2011, [计算机研究与发展, Journal of Computer Research and Development], V48, P1788; Chalechale A, 2005, IEEE T SYST MAN CY A, V35, P28, DOI 10.1109/TSMCA.2004.838464; Gupta R, 1997, IEEE T PATTERN ANAL, V19, P963, DOI 10.1109/34.615446; Harris C., 1988, P ALV VIS C MANCH UK, VVolume 15, P147, DOI [10.5244/C.2.23, DOI 10.5244/C.2.23]; Lacey AJ, 2000, P BRIT MACH VIS C, P646; Mikolajczyk K, 2005, IEEE T PATTERN ANAL, V27, P1615, DOI 10.1109/TPAMI.2005.188; Nister D, 2006, J FIELD ROBOT, V23, P3, DOI 10.1002/rob.20103; Reddy BS, 1996, IEEE T IMAGE PROCESS, V5, P1266, DOI 10.1109/83.506761; Sivic J, 2003, P 9 IEEE INT C COMP, V2, P27; [余宏生 YU Hong-sheng], 2009, [红外技术, Infrared Technology], V31, P348; [张媛 ZHANG Yuan], 2009, [中国图象图形学报, Journal of Image and Graphics], V14, P1188; Zhao Wan-jin, 2008, Computer Engineering, V34, P212; Zhu Q, 2006, IEEE GEOSCI REMOTE S, V3, P207, DOI 10.1109/LGRS.2005.861735; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	14	3	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81182	10.1371/journal.pone.0081182	http://dx.doi.org/10.1371/journal.pone.0081182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324675	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300078
J	Fisher, BS; Estrano, CE; Cole, JA				Fisher, Bridget S.; Estrano, Carlos E.; Cole, Judith A.			Modeling Long-Term Host Cell-Giardia lamblia Interactions in an In Vitro Co-Culture System	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; EPITHELIAL BARRIER FUNCTION; NF-KAPPA-B; GENE-EXPRESSION; INTESTINAL MACROPHAGES; INNATE IMMUNITY; OSMOTIC-STRESS; APOPTOSIS; MOUSE; MICE	Globally, there are greater than 700,000 deaths per year associated with diarrheal disease. The flagellated intestinal parasite, Giardia lamblia, is one of the most common intestinal pathogens in both humans and animals throughout the world. While attached to the gastrointestinal epithelium, Giardia induces epithelial cell apoptosis, disrupts tight junctions, and increases intestinal permeability. The underlying cellular and molecular mechanisms of giardiasis, including the role lamina propria immune cells, such as macrophages, play in parasite control or clearance are poorly understood. Thus far, one of the major obstacles in ascertaining the mechanisms of Giardia pathology is the lack of a functionally relevant model for the long-term study of the parasite in vitro. Here we report on the development of an in vitro co-culture model which maintains the basolateral-apical architecture of the small intestine and allows for long-term survival of the parasite. Using transwell inserts, Caco-2 intestinal epithelial cells and IC-21 macrophages are co-cultured in the presence of Giardia trophozoites. Using the developed model, we show that Giardia trophozoites survive over 21 days and proliferate in a combination media of Caco-2 cell and Giardia medium. Giardia induces apoptosis of epithelial cells through caspase-3 activation and macrophages do not abrogate this response. Additionally, macrophages induce Caco-2 cells to secrete the pro-inflammatory cytokines, GRO and IL-8, a response abolished by Giardia indicating parasite induced suppression of the host immune response. The co-culture model provides additional complexity and information when compared to a single-cell model. This model will be a valuable tool for answering long-standing questions on host-parasite biology that may lead to discovery of new therapeutic interventions.	[Fisher, Bridget S.; Estrano, Carlos E.; Cole, Judith A.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA	University of Memphis	Fisher, BS (corresponding author), Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA.	bsutton2@memphis.edu	Estrano, Carlos E./B-3576-2009		University of Memphis Intramural Research Grant	University of Memphis Intramural Research Grant	The work was supported by the University of Memphis Intramural Research Grant. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Ashbolt NJ, 2004, TOXICOLOGY, V198, P229, DOI 10.1016/j.tox.2004.01.030; Auyeung KKW, 2010, INVEST NEW DRUG, V28, P1, DOI 10.1007/s10637-008-9207-3; Bai F, 2013, J NAT MED, P1; Basset C, 2003, VACCINE, V21, pS12, DOI 10.1016/S0264-410X(03)00195-6; Bayraktar MR, 2005, ACTA TROP, V95, P116, DOI 10.1016/j.actatropica.2005.05.006; BELOSEVIC M, 1986, CLIN EXP IMMUNOL, V65, P622; BELOSEVIC M, 1992, CLIN EXP IMMUNOL, V87, P304, DOI 10.1111/j.1365-2249.1992.tb02992.x; Bienz M, 2003, INFECT IMMUN, V71, P1569, DOI 10.1128/IAI.71.3.1569-1573.2003; Buret AG, 2002, PARASITOLOGY, V125, P11, DOI 10.1017/S0031182002001853; Cakarova L, 2009, AM J RESP CRIT CARE, V180, P521, DOI 10.1164/rccm.200812-1837OC; Chen J, 2011, HORM METAB RES, V43, P681, DOI 10.1055/s-0031-1286306; Chin AC, 2002, INFECT IMMUN, V70, P3673, DOI 10.1128/IAI.70.7.3673-3680.2002; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; Davids BJ, 2011, GIARDIA: A MODEL ORGANISM, P381; Duell BL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/852419; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Escobedo Angel A., 2010, Infectious Disorders - Drug Targets, V10, P329; Felice DL, 2009, J FUNCT FOODS, V1, P109, DOI 10.1016/j.jff.2008.09.014; Fleet JC, 2003, PHYSIOL GENOMICS, V13, P57, DOI 10.1152/physiolgenomics.00152.2002; Fritz JM, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-76; Fujita Jun, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P243; GILLIN FD, 1981, EXP PARASITOL, V52, P9, DOI 10.1016/0014-4894(81)90055-2; GOTTSTEIN B, 1990, PARASITE IMMUNOL, V12, P659, DOI 10.1111/j.1365-3024.1990.tb00995.x; Haller D, 2000, GUT, V47, P79, DOI 10.1136/gut.47.1.79; Hanevik K, 2007, J INFECTION, V55, P524, DOI 10.1016/j.jinf.2007.09.004; Hansen WR, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000169; Haque R, 2009, CLIN INFECT DIS, V48, P1191, DOI 10.1086/597580; HEYWORTH MF, 1985, GASTROENTEROLOGY, V89, P1360, DOI 10.1016/0016-5085(85)90656-0; HILL DR, 1987, INFECT IMMUN, V55, P3155, DOI 10.1128/IAI.55.12.3155-3161.1987; Hubert A, 2004, BIOCHIMIE, V86, P533, DOI 10.1016/j.biochi.2004.07.009; Kamda JD, 2009, INFECT IMMUN, V77, P685, DOI 10.1128/IAI.00718-08; KANE AV, 1991, J PARASITOL, V77, P974, DOI 10.2307/3282752; KANWAR SS, 1987, MED MICROBIOL IMMUN, V176, P83, DOI 10.1007/BF00200679; Kanzato H, 2001, BIOSCI BIOTECH BIOCH, V65, P449, DOI 10.1271/bbb.65.449; Kasper LH, 2001, INFECT IMMUN, V69, P1, DOI 10.1128/IAI.69.1.1-8.2001; Kayali AG, 2000, DIABETES, V49, P1783, DOI 10.2337/diabetes.49.11.1783; KEYSTONE JS, 1978, CAN MED ASSOC J, V119, P241; Lauwaet T, 2010, J ANTIMICROB CHEMOTH, V65, P531, DOI 10.1093/jac/dkp501; Le Ferrec E, 2001, ATLA-ALTERN LAB ANIM, V29, P649, DOI 10.1177/026119290102900604; Lee HY, 2012, PARASITE IMMUNOL, V34, P183, DOI 10.1111/j.1365-3024.2012.01354.x; Lenaerts K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-91; Leonard F, 2010, MOL PHARMACEUT, V7, P2103, DOI 10.1021/mp1000795; Lichtenberger C, 1999, J IMMUNOL METHODS, V227, P75, DOI 10.1016/S0022-1759(99)00076-9; Lo YL, 2013, CHEM-BIOL INTERACT, V205, P188, DOI 10.1016/j.cbi.2013.07.003; Lujan HD, 1996, P NATL ACAD SCI USA, V93, P7628, DOI 10.1073/pnas.93.15.7628; Ma'ayeh SY, 2012, INT J PARASITOL, V42, P501, DOI 10.1016/j.ijpara.2012.04.004; MAUEL J, 1971, J EXP MED, V134, P335, DOI 10.1084/jem.134.2.335; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Minoz-Cruz S, 2010, EXP PARASITOL, V126, P298, DOI 10.1016/j.exppara.2010.06.013; Muller N, 2005, INT J PARASITOL, V35, P1339, DOI 10.1016/j.ijpara.2005.07.008; NASH TE, 1987, J INFECT DIS, V156, P974, DOI 10.1093/infdis/156.6.974; OBERHUBER G, 1990, J CLIN PATHOL, V43, P641, DOI 10.1136/jcp.43.8.641; OWEN RL, 1981, INFECT IMMUN, V33, P591, DOI 10.1128/IAI.33.2.591-601.1981; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Panaro MA, 2007, FEMS IMMUNOL MED MIC, V51, P302, DOI 10.1111/j.1574-695X.2007.00304.x; PETERSON MD, 1992, J CELL SCI, V102, P581; Petri WA, 2003, TRENDS PARASITOL, V19, P523, DOI 10.1016/j.pt.2003.09.003; Read C, 2002, INT J PARASITOL, V32, P229, DOI 10.1016/S0020-7519(01)00340-X; RENDTORFF ROBERT C., 1954, AMER JOUR HYG, V59, P209; Ringqvist E, 2011, INT J PARASITOL, V41, P277, DOI 10.1016/j.ijpara.2010.09.011; ROBERTSTHOMSON IC, 1978, GASTROENTEROLOGY, V75, P42; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Roxstrom-Lindquist K, 2005, INFECT IMMUN, V73, P8204, DOI 10.1128/IAI.73.12.8204-8208.2005; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; Samak G, 2010, AM J PHYSIOL-GASTR L, V299, pG572, DOI 10.1152/ajpgi.00265.2010; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Scott KGE, 2002, GASTROENTEROLOGY, V123, P1179, DOI 10.1053/gast.2002.36002; Singer SM, 2000, J INFECT DIS, V181, P1510, DOI 10.1086/315409; Smith PD, 2011, MUCOSAL IMMUNOL, V4, P31, DOI 10.1038/mi.2010.66; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Stadelmann B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045325; Stark D, 2009, CLIN MICROBIOL REV, V22, P634, DOI 10.1128/CMR.00017-09; Teoh DA, 2000, J PARASITOL, V86, P800; Tremblay E, 2006, J CELL BIOCHEM, V99, P1175, DOI 10.1002/jcb.21015; Troeger H, 2007, GUT, V56, P328, DOI 10.1136/gut.2006.100198; Turner HL, 2010, GUT MICROBES, V1, P22, DOI 10.4161/gmic.1.1.11427; Ulukan H, 2001, INT J CANCER, V94, P200, DOI 10.1002/ijc.1463; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Venkatesan P, 1997, PARASITE IMMUNOL, V19, P137, DOI 10.1046/j.1365-3024.1997.d01-189.x; Versteeg HH, 2000, BIOCHEM J, V350, P717, DOI 10.1042/0264-6021:3500717; WALKER WS, 1976, J IMMUNOL, V116, P911; Wang Y, 2012, MOLECULES, V17, P10052, DOI 10.3390/molecules170910052; Ward HD, 2009, CLIN INFECT DIS, V48, P1198, DOI 10.1086/597581	84	22	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81104	10.1371/journal.pone.0081104	http://dx.doi.org/10.1371/journal.pone.0081104			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312526	Green Submitted, gold, Green Published			2022-12-25	WOS:000327947800034
J	Guo, CY; Yan, Y; Cui, HC; Huang, XH; Qin, QW				Guo, Chuanyu; Yan, Yang; Cui, Huachun; Huang, Xiaohong; Qin, Qiwei			miR-homoHSV of Singapore Grouper Iridovirus (SGIV) Inhibits Expression of the SGIV Pro-apoptotic Factor LITAF and Attenuates Cell Death	PLOS ONE			English	Article							VIRUS-ENCODED MICRORNAS; GENE-EXPRESSION; VIRAL REPLICATION; IMMUNE-SYSTEM; BIOGENESIS; CANCER; IDENTIFICATION; TRANSLATION; REGULATORS; SENESCENCE	Growing evidence demonstrates that various large DNA viruses could encode microRNAs (miRNAs) that regulate host and viral genes to achieve immune evasion. In this study, we report that miR-homoHSV, an miRNA encoded by Singapore grouper iridovirus (SGIV), can attenuate SGIV-induced cell death. Mechanistically, SGIV miR-homoHSV targets SGIV ORF136R, a viral gene that encodes the pro-apoptotic lipopolysaccharide-induced TNF-alpha (LITAF)-like factor. miR-homoHSV suppressed exogenous and endogenous SGIV LITAF expression, and thus inhibited SGIV LITAF-induced apoptosis. Meanwhile, miR-homoHSV expression was able to attenuate cell death induced by viral infection, presumably facilitating viral replication through the down-regulation of the pro-apoptotic gene SGIV LITAF. Together, our data suggest miR-homoHSV may serve as a feedback regulator of cell death during viral infection. The findings of this study provide a better understanding of SGIV replication and pathogenesis.	[Guo, Chuanyu; Yan, Yang; Huang, Xiaohong; Qin, Qiwei] Chinese Acad Sci, Key Lab Trop Marine Bioresources & Ecol, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China; [Guo, Chuanyu] Univ Chinese Acad Sci, Beijing, Peoples R China; [Cui, Huachun] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Alabama System; University of Alabama Birmingham	Qin, QW (corresponding author), Chinese Acad Sci, Key Lab Trop Marine Bioresources & Ecol, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China.	qinqw@scsio.ac.cn	Guo, Chuanyu/AAB-8369-2020		National Basic Research Program of China (973) [2012CB114402]; National Natural Science Foundation of China [41206137]; Knowledge Innovative Program of the Chinese Academy of Sciences [SQ201116, KZCX2-EW-Q213]	National Basic Research Program of China (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovative Program of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported by grants from the National Basic Research Program of China (973) (2012CB114402), the National Natural Science Foundation of China (41206137), the Knowledge Innovative Program of the Chinese Academy of Sciences (SQ201116, KZCX2-EW-Q213). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Bauman Y, 2011, CELL HOST MICROBE, V9, P93, DOI 10.1016/j.chom.2011.01.008; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Cai XZ, 2006, PLOS PATHOG, V2, P236, DOI 10.1371/journal.ppat.0020023; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fang J, 2012, APOPTOSIS, V17, P410, DOI 10.1007/s10495-011-0683-0; Garofalo M, 2010, CELL DEATH DIFFER, V17, P200, DOI 10.1038/cdd.2009.105; Glorian V, 2011, CELL DEATH DIFFER, V18, P1692, DOI 10.1038/cdd.2011.35; GRAVELL M, 1965, ANN NY ACAD SCI, V126, P555, DOI 10.1111/j.1749-6632.1965.tb14302.x; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Guo CJ, 2009, APOPTOSIS, V14, P1331, DOI 10.1007/s10495-009-0401-3; He JF, 2011, J BIOCHEM MOL TOXIC, V25, P404, DOI 10.1002/jbt.20396; Herranz C, 2011, VIROLOGY, V410, P56, DOI 10.1016/j.virol.2010.10.035; Huang XH, 2008, BIOCHEM BIOPH RES CO, V373, P140, DOI 10.1016/j.bbrc.2008.06.003; Huang XH, 2011, APOPTOSIS, V16, P831, DOI 10.1007/s10495-011-0616-y; Huang XH, 2009, AQUACULTURE, V292, P172, DOI 10.1016/j.aquaculture.2009.04.019; Huang YH, 2007, APOPTOSIS, V12, P1569, DOI 10.1007/s10495-007-0089-1; Hussain M, 2008, J VIROL, V82, P9164, DOI 10.1128/JVI.01109-08; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Loparev VN, 1998, P NATL ACAD SCI USA, V95, P3786, DOI 10.1073/pnas.95.7.3786; Nair V, 2006, TRENDS MICROBIOL, V14, P169, DOI 10.1016/j.tim.2006.02.007; O'Brien V, 1998, J GEN VIROL, V79, P1833, DOI 10.1099/0022-1317-79-8-1833; Parry CM, 2000, J EXP MED, V191, P573, DOI 10.1084/jem.191.3.573; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Qin QW, 2003, DIS AQUAT ORGAN, V53, P1, DOI 10.3354/dao053001; Qin QW, 2001, J VIROL METHODS, V98, P17, DOI 10.1016/S0166-0934(01)00350-0; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Salim H, 2012, BRIT J CANCER, V107, P1361, DOI 10.1038/bjc.2012.382; Seo GJ, 2008, J VIROL, V82, P9823, DOI 10.1128/JVI.01144-08; Song WJ, 2004, J VIROL, V78, P12576, DOI 10.1128/JVI.78.22.12576-12590.2004; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Tang S, 2008, P NATL ACAD SCI USA, V105, P10931, DOI 10.1073/pnas.0801845105; Teodoro JG, 1997, J VIROL, V71, P1739, DOI 10.1128/JVI.71.3.1739-1746.1997; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Tsang WP, 2008, APOPTOSIS, V13, P1215, DOI 10.1007/s10495-008-0256-z; Umbach JL, 2010, J VIROL, V84, P1189, DOI 10.1128/JVI.01712-09; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Verduci L, 2010, J BIOL CHEM, V285, P39551, DOI 10.1074/jbc.M110.114736; Waidner LA, 2011, VIROLOGY, V411, P25, DOI 10.1016/j.virol.2010.12.023; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu HF, 2012, MOL CELL BIOCHEM, V362, P141, DOI 10.1007/s11010-011-1136-3; Yan B, 2012, APOPTOSIS, V17, P717, DOI 10.1007/s10495-012-0710-9; Yan Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019148; Zhang J, 2010, BIOCHEM BIOPH RES CO, V399, P1, DOI 10.1016/j.bbrc.2010.07.013; Zheng SR, 2012, ONCOL REP, V27, P1149, DOI 10.3892/or.2012.1634	55	9	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e83027	10.1371/journal.pone.0083027	http://dx.doi.org/10.1371/journal.pone.0083027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312676	Green Submitted, Green Published, gold			2022-12-25	WOS:000327947800105
J	Wang, Q; Cao, ZJ; Qu, YL; Peng, XW; Guo, S; Chen, L				Wang, Qiang; Cao, Zhaojin; Qu, Yingli; Peng, Xiaowu; Guo, Shu; Chen, Li			Residential Exposure to 50 Hz Magnetic Fields and the Association with Miscarriage Risk: A 2-Year Prospective Cohort Study	PLOS ONE			English	Article							SPONTANEOUS-ABORTION; ELECTRIC BLANKETS; POWER-LINES; POPULATION	Objective: The hypothesis of whether exposure to extremely low-frequency magnetic fields (ELF-MF) may increase miscarriage risk is controversial. A 2-year prospective cohort study was designed to study the association between exposure to 50 Hz magnetic fields (MF) and the miscarriage risk for women residing in the area of the Pearl-River Delta of China. Method: Two towns with densely distributed power supply constructions were selected as the study sites. From 2010 to 2012, 552 women in the region who were at approximately 8 weeks of gestation or who planned to have a baby within 1 year were selected as candidate subjects. Exposure to MF was estimated by measurements at their front doors and in the alley in front of the subjects' houses. The average exposure level was used as a cutoff point to define the exposed group. Clinical miscarriage was diagnosed by local obstetricians. Staffs from the local population and family planning service stations were responsible for the follow-up interviews every 2 months. Results: Four hundred and thirteen pregnant women were selected for the cohort study. The average residential exposure to MF was 0.099 mu T. No significantly increased risk of miscarriage was found to be associated with the average front-door exposure (p>0.05). However, miscarriage risk was found to be significantly associated with maximum alley exposure (p=0.001). The relative risk (RR) of miscarriage from maximum alley exposure was 2.35 (95% C.I.: 1.18-4.71). In addition, Cox regression analysis showed that the adjusted hazard ratio of maximum alley exposure for miscarriage was 1.72 (95% C.I.: 1.10-2.69). Conclusion: Although the miscarriage incidence was shown to be positively associated with the maximum alley MF exposure, the association between miscarriage risk and the exposure to MF was not confirmed in the study. The results of this study are of interest concerning MF exposure assessment and pregnancy outcomes.	[Wang, Qiang; Cao, Zhaojin; Qu, Yingli] Chinese Ctr Dis Control & Prevent, Inst Environm Hlth & Related Prod Safety, Dept Environm Epidemiol, Beijing, Peoples R China; [Peng, Xiaowu; Guo, Shu] Minist Environm Protect, South China Inst Environm Sci, Ctr Res Environm & Hlth, Guangzhou, Guangdong, Peoples R China; [Chen, Li] Chinese Med Assoc, Chinese Journal Prevent Med, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute of Environmental Health, Chinese Center for Disease Control & Prevention	Cao, ZJ (corresponding author), Chinese Ctr Dis Control & Prevent, Inst Environm Hlth & Related Prod Safety, Dept Environm Epidemiol, Beijing, Peoples R China.	zhaojincao@gmail.com			Commonweal and Environmental Protection Project of the Ministry of Environmental Protection of the People's Republic of China (MEP) [200909107]	Commonweal and Environmental Protection Project of the Ministry of Environmental Protection of the People's Republic of China (MEP)	This study was funded by the Commonweal and Environmental Protection Project of the Ministry of Environmental Protection of the People's Republic of China (MEP) (No. 200909107). URL: http://kjs.mep.gov.cn/gyxhykyzx/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belanger K, 1998, EPIDEMIOLOGY, V9, P36, DOI 10.1097/00001648-199801000-00009; BREYSSE P, 1994, AM J IND MED, V25, P177, DOI 10.1002/ajim.4700250204; Feizi AAHP, 2007, ASIAN PAC J CANCER P, V8, P69; Griebel CP, 2005, AM FAM PHYSICIAN, V72, P1243; Huss A, 2009, AM J EPIDEMIOL, V169, P167, DOI 10.1093/aje/kwn297; Lee GM, 2000, EPIDEMIOLOGY, V11, P406, DOI 10.1097/00001648-200007000-00008; Lee GM, 2002, EPIDEMIOLOGY, V13, P21, DOI 10.1097/00001648-200201000-00005; Li DK, 2002, EPIDEMIOLOGY, V13, P9, DOI 10.1097/00001648-200201000-00004; LINDBOHM ML, 1992, AM J EPIDEMIOL, V136, P1041, DOI 10.1093/oxfordjournals.aje.a116569; Mezei G, 2006, J EXPO SCI ENV EPID, V16, P477, DOI 10.1038/sj.jea.7500457; WERTHEIMER N, 1979, AM J EPIDEMIOL, V109, P273, DOI 10.1093/oxfordjournals.aje.a112681; WERTHEIMER N, 1986, BIOELECTROMAGNETICS, V7, P13, DOI 10.1002/bem.2250070103; World Health Organization, 2007, 2007 WHO RES AG EXTR; World Health Organization, 2007, ENV HLTH CRIT, V238	14	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82113	10.1371/journal.pone.0082113	http://dx.doi.org/10.1371/journal.pone.0082113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312633	Green Submitted, gold, Green Published			2022-12-25	WOS:000327947800085
J	Guttman, C; Davidov, G; Yahalom, A; Shaked, H; Kolusheva, S; Bitton, R; Barber-Zucker, S; Chill, JH; Zarivach, R				Guttman, Chen; Davidov, Geula; Yahalom, Adi; Shaked, Hadassa; Kolusheva, Sofiya; Bitton, Ronit; Barber-Zucker, Shiran; Chill, Jordan H.; Zarivach, Raz			BtcA, A Class IA Type III Chaperone, Interacts with the BteA N- Terminal Domain through a Globular/Non-Globular Mechanism	PLOS ONE			English	Article							TRIPLE-RESONANCE EXPERIMENTS; MULTIPLE SEQUENCE ALIGNMENT; SECONDARY STRUCTURE; SECRETION EFFECTOR; VIRULENCE FACTORS; CRYSTAL-STRUCTURE; BACTERIAL; COMPLEXES; BINDING; SERVER	Bordetella pertussis, the etiological agent of "whooping cough'' disease, utilizes the type III secretion system (T3SS) to deliver a 69 kDa cytotoxic effector protein, BteA, directly into the host cells. As with other T3SS effectors, prior to its secretion BteA binds BtcA, a 13.9 kDa protein predicted to act as a T3SS class IA chaperone. While this interaction had been characterized for such effector-chaperone pairs in other pathogens, it has yet to be fully investigated in Bordetella. Here we provide the first biochemical proof that BtcA is indeed a class IA chaperone, responsible for the binding of BteA's N-terminal domain. We bring forth extensive evidence that BtcA binds its substrate effector through a dual-interface binding mechanism comprising of non-globular and bi-globular interactions at a moderate micromolar level binding affinity. We demonstrate that the non-globular interactions involve the first 31 N-terminal residues of BteA287 and their removal leads to destabilization of the effector-chaperone complex and lower binding affinities to BtcA. These findings represent an important first step towards a molecular understanding of BteA secretion and cell entry.	[Guttman, Chen; Davidov, Geula; Barber-Zucker, Shiran; Zarivach, Raz] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Guttman, Chen; Davidov, Geula; Barber-Zucker, Shiran; Zarivach, Raz] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Kolusheva, Sofiya; Bitton, Ronit] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, IL-84105 Beer Sheva, Israel; [Bitton, Ronit] Ben Gurion Univ Negev, Dept Chem Engn, IL-84105 Beer Sheva, Israel; [Yahalom, Adi; Shaked, Hadassa; Chill, Jordan H.] Bar Ilan Univ, Dept Chem, Ramat Gan, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Bar Ilan University	Chill, JH (corresponding author), Bar Ilan Univ, Dept Chem, Ramat Gan, Israel.	Jordan.Chill@biu.ac.il; zarivach@bgu.ac.il	ZARIVACH, RAZ/F-1671-2012; Chill, Jordan/W-5048-2018	ZARIVACH, RAZ/0000-0001-6543-0296; Chill, Jordan/0000-0002-9518-824X; Bitton, Ronit/0000-0001-9601-9926; Davidov, Geula/0000-0001-5153-4940; Barber-Zucker, Shiran/0000-0003-1835-730X; Kolusheva, Sofiya/0000-0002-4406-2241	EU [239182, 227764]	EU(European Commission)	The research leading to these results has received funding from the EU Seventh Framework Programme (FP7/2007-2013 under grant agreement 239182 and 227764 (P-CUBE)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Birtalan S, 2001, NAT STRUCT BIOL, V8, P974, DOI 10.1038/nsb1101-974; Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Carn F, 2012, BIOMACROMOLECULES, V13, P751, DOI 10.1021/bm201674n; Chen HL, 2005, NUCLEIC ACIDS RES, V33, P3193, DOI 10.1093/nar/gki633; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Cristobal S, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-5; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; French CT, 2009, CELL MICROBIOL, V11, P1735, DOI 10.1111/j.1462-5822.2009.01361.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gendrin C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002637; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Guinier A., 1955, SMALL ANGLE SCATTERI; Guttman C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055650; Halavaty AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049388; Janjusevic R, 2013, J BACTERIOL, V195, P658, DOI 10.1128/JB.01621-12; Kleckner IR, 2010, BIOCHIM BIOPHYS ACTA, V1814, P942; Letzelter M, 2006, EMBO J, V25, P3223, DOI 10.1038/sj.emboj.7601202; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Locher M, 2005, J BIOL CHEM, V280, P31149, DOI 10.1074/jbc.M500603200; McGuffin LJ, 2013, NUCLEIC ACIDS RES, V41, pW368, DOI 10.1093/nar/gkt294; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Shrivastava R, 2009, CURR OPIN MICROBIOL, V12, P88, DOI 10.1016/j.mib.2009.01.001; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Vogelaar NJ, 2010, BIOCHEMISTRY-US, V49, P5870, DOI 10.1021/bi100432e; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vujanac M, 2013, ACTA CRYSTALLOGR D, V69, P546, DOI 10.1107/S0907444912051086; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	41	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81557	10.1371/journal.pone.0081557	http://dx.doi.org/10.1371/journal.pone.0081557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312558	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500076
J	Hagiwara, D; Takahashi-Nakaguchi, A; Toyotome, T; Yoshimi, A; Abe, K; Kamei, K; Gonoi, T; Kawamoto, S				Hagiwara, Daisuke; Takahashi-Nakaguchi, Azusa; Toyotome, Takahito; Yoshimi, Akira; Abe, Keietsu; Kamei, Katsuhiko; Gonoi, Tohru; Kawamoto, Susumu			NikA/TcsC Histidine Kinase Is Involved in Conidiation, Hyphal Morphology, and Responses to Osmotic Stress and Antifungal Chemicals in Aspergillus fumigatus	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION; 2-COMPONENT SYSTEM; VIRULENCE FACTOR; MULTISTEP PHOSPHORELAY; FUNGICIDE-SENSITIVITY; ASEXUAL DEVELOPMENT; GENE; RESISTANCE; REGULATORS	The fungal high osmolarity glycerol (HOG) pathway is composed of a two-component system (TCS) and Hog1-type mitogen-activated protein kinase (MAPK) cascade. A group III (Nik1-type) histidine kinase plays a major role in the HOG pathway of several filamentous fungi. In this study, we characterized a group III histidine kinase, NikA/TcsC, in the life-threatening pathogenic fungus, Aspergillus fumigatus. A deletion mutant of nikA showed low conidia production, abnormal hyphae, marked sensitivity to high osmolarity stresses, and resistance to cell wall perturbing reagents such as congo red and calcofluor white, as well as to fungicides such as fludioxonil, iprodione, and pyrrolnitrin. None of these phenotypes were observed in mutants of the SskA response regulator and SakA MAPK, which were thought to be downstream components of NikA. In contrast, in response to fludioxonil treatment, NikA was implicated in the phosphorylation of SakA MAPK and the transcriptional upregulation of catA, dprA, and dprB, which are regulated under the control of SakA. We then tested the idea that not only NikA, but also the other 13 histidine kinases play certain roles in the regulation of the HOG pathway. Interestingly, the expression of fos1, phkA, phkB, fhk5, and fhk6 increased by osmotic shock or fludioxonil treatment in a SakA-dependent manner. However, deletion mutants of the histidine kinases showed no significant defects in growth under the tested conditions. Collectively, although the signal transduction network related to NikA seems complicated, NikA plays a crucial role in several aspects of A. fumigatus physiology and, to a certain extent, modulates the HOG pathway.	[Hagiwara, Daisuke; Takahashi-Nakaguchi, Azusa; Toyotome, Takahito; Kamei, Katsuhiko; Gonoi, Tohru; Kawamoto, Susumu] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan; [Yoshimi, Akira; Abe, Keietsu] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 980, Japan	Chiba University; Tohoku University	Hagiwara, D (corresponding author), Chiba Univ, Med Mycol Res Ctr, Chiba, Japan.	dhagi@chiba-u.jp	Hagiwara, Daisuke/A-3488-2016; gonoi, tohru/AAC-5181-2021; , gonoi/GRS-0648-2022	Hagiwara, Daisuke/0000-0003-1382-3914; gonoi, tohru/0000-0003-3655-7911; , gonoi/0000-0003-3655-7911; Toyotome, Takahito/0000-0003-2822-2767; YOSHIMI, Akira/0000-0003-4331-2744	Ministry of Education, Science, Sports and Culture; NEKKEN; Medical Mycology Research Center, Chiba University [12-2]; MEXT; Grants-in-Aid for Scientific Research [25305012] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NEKKEN; Medical Mycology Research Center, Chiba University; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research (to D. H.) from the Ministry of Education, Science, Sports and Culture, and partly by a Cooperative Research Grant of NEKKEN (2010-2012), a Cooperative Research Program of Medical Mycology Research Center, Chiba University (12-2), and MEXT Special Budget for Research Projects: The Project on Controlling Aspergillosis and the Related Emerging Mycoses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby JL, 1996, CELL, V86, P845, DOI 10.1016/S0092-8674(00)80158-0; Avenot H, 2005, CURR GENET, V47, P234, DOI 10.1007/s00294-005-0568-2; Bahn YS, 2006, MOL BIOL CELL, V17, P3122, DOI 10.1091/mbc.E06-02-0113; Bahn YS, 2008, EUKARYOT CELL, V7, P2017, DOI 10.1128/EC.00323-08; Banno S, 2007, CURR GENET, V51, P197, DOI 10.1007/s00294-006-0116-8; BEEVER RE, 1986, J BACTERIOL, V168, P1358, DOI 10.1128/jb.168.3.1358-1365.1986; Boyce KJ, 2011, MOL MICROBIOL, V82, P1164, DOI 10.1111/j.1365-2958.2011.07878.x; Buschart A, 2012, J BIOTECHNOL, V157, P268, DOI 10.1016/j.jbiotec.2011.09.017; CARROLL AM, 1994, FUNGAL GENET NEWSLET, V41, P22, DOI DOI 10.4148/1941-4765.1367; Catlett NL, 2003, EUKARYOT CELL, V2, P1151, DOI 10.1128/EC.2.6.1151-1161.2003; Chauhan N, 2008, INFECT IMMUN, V76, P4795, DOI 10.1128/IAI.00834-08; Clemons KV, 2002, MED MYCOL, V40, P259, DOI 10.1080/mmy.40.3.259.262; Cui W, 2002, FUNGAL GENET BIOL, V36, P187, DOI 10.1016/S1087-1845(02)00009-9; Dongo A, 2009, APPL ENVIRON MICROB, V75, P127, DOI 10.1128/AEM.00993-08; Du C, 2006, MED MYCOL, V44, P211, DOI 10.1080/13693780500338886; Furukawa K, 2005, MOL MICROBIOL, V56, P1246, DOI 10.1111/j.1365-2958.2005.04605.x; Furukawa K, 2002, APPL ENVIRON MICROB, V68, P5304, DOI 10.1128/AEM.68.11.5304-5310.2002; Hagiwara D, 2007, BIOSCI BIOTECH BIOCH, V71, P1003, DOI 10.1271/bbb.60665; Hagiwara D, 2007, BIOSCI BIOTECH BIOCH, V71, P844, DOI 10.1271/bbb.70051; Hoch JA, 1995, 2 COMPONENT SIGNAL T, P1; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Hoi JWS, 2011, MOL BIOL CELL, V22, P1896, DOI 10.1091/mbc.E10-11-0914; Islas-Flores I., 2011, Asian Journal of Biochemistry, V6, P1; Izumitsu K, 2007, EUKARYOT CELL, V6, P171, DOI 10.1128/EC.00326-06; Ji YJ, 2012, MYCOPATHOLOGIA, V174, P273, DOI 10.1007/s11046-012-9557-4; Jones CA, 2007, MOL BIOL CELL, V18, P2123, DOI 10.1091/mbc.E06-03-0226; Krappmann S, 2006, EUKARYOT CELL, V5, P212, DOI 10.1128/EC.5.1.212-215.2006; Lamarre C, 2007, FUNGAL GENET BIOL, V44, P682, DOI 10.1016/j.fgb.2007.01.009; Latge JP, 2005, MED MYCOL, V43, pS15, DOI 10.1080/13693780400029155; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lee JW, 2011, EUKARYOT CELL, V10, P998, DOI 10.1128/EC.05124-11; Leroux P, 2002, PEST MANAG SCI, V58, P876, DOI 10.1002/ps.566; Li DM, 2010, CURR OPIN MICROBIOL, V13, P424, DOI 10.1016/j.mib.2010.04.007; Lin CH, 2010, FUNGAL GENET BIOL, V47, P818, DOI 10.1016/j.fgb.2010.06.009; Luo YY, 2012, CURR MICROBIOL, V64, P449, DOI 10.1007/s00284-012-0093-8; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Mah JH, 2006, EUKARYOT CELL, V5, P1585, DOI 10.1128/EC.00192-06; McCormick A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038262; Meena N, 2010, J BIOL CHEM, V285, P12121, DOI 10.1074/jbc.M109.075721; Mizuno T, 1998, J BIOCHEM, V123, P555; Motoyama T, 2005, CURR GENET, V47, P298, DOI 10.1007/s00294-005-0572-6; Motoyama T, 2005, FUNGAL GENET BIOL, V42, P200, DOI 10.1016/j.fgb.2004.11.002; Nemecek JC, 2006, SCIENCE, V312, P583, DOI 10.1126/science.1124105; Ochiai N, 2002, BIOSCI BIOTECH BIOCH, V66, P2209, DOI 10.1271/bbb.66.2209; Ochiai N, 2001, PEST MANAG SCI, V57, P437, DOI 10.1002/ps.302; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Pott GB, 2000, FUNGAL GENET BIOL, V31, P55, DOI 10.1006/fgbi.2000.1225; Rispail N, 2010, MOL PLANT PATHOL, V11, P395, DOI [10.1111/J.1364-3703.2010.00612.X, 10.1111/j.1364-3703.2010.00612.x]; Schumacher MM, 1997, CURR MICROBIOL, V34, P340, DOI 10.1007/s002849900193; THAU N, 1994, INFECT IMMUN, V62, P4380, DOI 10.1128/IAI.62.10.4380-4388.1994; Vargas-Perez I, 2007, EUKARYOT CELL, V6, P1570, DOI 10.1128/EC.00085-07; Viaud M, 2006, MOL PLANT MICROBE IN, V19, P1042, DOI 10.1094/MPMI-19-1042; Yoshimi A, 2005, EUKARYOT CELL, V4, P1820, DOI 10.1128/EC.4.11.1820-1828.2005; Yoshimi A, 2004, MOL GENET GENOMICS, V271, P228, DOI 10.1007/s00438-003-0974-4; Yoshimi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054893; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	56	54	55	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80881	10.1371/journal.pone.0080881	http://dx.doi.org/10.1371/journal.pone.0080881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312504	Green Published, gold, Green Submitted			2022-12-25	WOS:000327944500043
J	Sagong, W; Jeon, WP; Choi, H				Sagong, Woong; Jeon, Woo-Pyung; Choi, Haecheon			Hydrodynamic Characteristics of the Sailfish (Istiophorus platypterus) and Swordfish (Xiphias gladius) in Gliding Postures at Their Cruise Speeds	PLOS ONE			English	Article							AQUATIC ANIMAL PROPULSION; TURBULENT BOUNDARY-LAYER; INERTIAL FLOW REGIMES; SWIMMING FISH; DRAG REDUCTION; BLUE MARLIN; BODY FORM; WAKE; PERFORMANCE; LOCOMOTION	The sailfish and swordfish are known as the fastest sea animals, reaching their maximum speeds of around 100 km/h. In the present study, we investigate the hydrodynamic characteristics of these fishes in their cruise speeds of about 1 body length per second. We install a taxidermy specimen of each fish in a wind tunnel, and measure the drag on its body and boundary-layer velocity above its body surface at the Reynolds number corresponding to its cruising condition. The drag coefficients of the sailfish and swordfish based on the free-stream velocity and their wetted areas are measured to be 0.0075 and 0.0091, respectively, at their cruising conditions. These drag coefficients are very low and comparable to those of tuna and pike and smaller than those of dogfish and small-size trout. On the other hand, the long bill is one of the most distinguished features of these fishes from other fishes, and we study its role on the ability of drag modification. The drag on the fish without the bill or with an artificially-made shorter one is slightly smaller than that with the original bill, indicating that the bill itself does not contribute to any drag reduction at its cruise speed. From the velocity measurement near the body surface, we find that at the cruise speed flow separation does not occur over the whole body even without the bill, and the boundary layer flow is affected only at the anterior part of the body by the bill.	[Sagong, Woong; Jeon, Woo-Pyung; Choi, Haecheon] Seoul Natl Univ, Dept Mech & Aerosp Engn, Seoul, South Korea	Seoul National University (SNU)	Choi, H (corresponding author), Seoul Natl Univ, Dept Mech & Aerosp Engn, Seoul, South Korea.	choi@snu.ac.kr	Choi, Haecheon/D-1016-2011	Choi, Haecheon/0000-0003-0696-847X	NRF of the Korean Ministry of Science, ICT & Future Planning [20120008740, 2012K001368, 2012M2A8A4055647]	NRF of the Korean Ministry of Science, ICT & Future Planning	This work is supported by the NRF Programs (20120008740, 2012K001368 and 2012M2A8A4055647) of the Korean Ministry of Science, ICT & Future Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleyev Y.G, 1977, NEKTON; Allan WH, 1961, US NAV ORD TEST STN, V2759, P1; Anderson EJ, 2001, J EXP BIOL, V204, P81; BAKER AN, 1966, COPEIA, P818, DOI 10.2307/1441409; Barlow J.B., 1999, LOW SPEED WIND TUNNE; Barrett DS, 1999, J FLUID MECH, V392, P183, DOI 10.1017/S0022112099005455; Bartol IK, 2003, J EXP BIOL, V206, P725, DOI 10.1242/jeb.00137; Bartol IK, 2005, J EXP BIOL, V208, P327, DOI 10.1242/jeb.01356; Bechert DW, 1997, J FLUID MECH, V338, P59, DOI 10.1017/S0022112096004673; Bernal Diego, 2010, P436, DOI 10.1201/b10190-15; BLOCK BA, 1992, J EXP BIOL, V166, P267; Borazjani I, 2008, J EXP BIOL, V211, P1541, DOI 10.1242/jeb.015644; Borazjani I, 2009, J EXP BIOL, V212, P576, DOI 10.1242/jeb.025007; BUSHNELL DM, 1991, ANNU REV FLUID MECH, V23, P65, DOI 10.1146/annurev.fluid.23.1.65; CHOI H, 1993, J FLUID MECH, V255, P503, DOI 10.1017/S0022112093002575; Dabiri JO, 2010, J EXP BIOL, V213, P1217, DOI 10.1242/jeb.034660; DeGraaff DB, 2000, J FLUID MECH, V422, P319, DOI 10.1017/S0022112000001713; Drucker EG, 1999, J EXP BIOL, V202, P2393; Drucker EG, 2002, INTEGR COMP BIOL, V42, P243, DOI 10.1093/icb/42.2.243; Fierstine HL, 1997, B MAR SCI, V61, P495; Fish FE, 2006, ANNU REV FLUID MECH, V38, P193, DOI 10.1146/annurev.fluid.38.050304.092201; Gazzola M, 2012, J FLUID MECH, V698, P5, DOI 10.1017/jfm.2011.558; Govoni JJ, 2004, COPEIA, P391; Han M, 1996, KR Patent, Patent No. [10-0107068-0000, 1001070680000]; Harris JE, 1936, J EXP BIOL, V13, P476; Helfman G, 2009, DIVERSITY FISHES BIO; Hoolihan JP, 2005, MAR BIOL, V146, P1015, DOI 10.1007/s00227-004-1488-2; Kempf G, 1932, J COMP PHYSL, V17, P353; Kozlov LF, 1973, BIOPHYSICS-USSR, V18, P606; Lane FW, 1941, COUNTRY LIFE, V90, P534; LIGHTHILL MJ, 1970, J FLUID MECH, V44, P265, DOI 10.1017/S0022112070001830; LIGHTHILL MJ, 1971, PROC R SOC SER B-BIO, V179, P125, DOI 10.1098/rspb.1971.0085; LIGHTHILL MJ, 1960, J FLUID MECH, V9, P305, DOI 10.1017/S0022112060001110; LIGHTHILL MJ, 1969, ANNU REV FLUID MECH, V1, P413, DOI 10.1146/annurev.fl.01.010169.002213; Liu H, 1996, J EXP BIOL, V199, P1245; Magnuson J.J., 1979, FISH PHYSIOL, V7, P239, DOI DOI 10.1016/S1546-5098(08)60166-1; MAGNUSON JJ, 1973, FISH B-NOAA, V71, P337; Muller UK, 1997, J EXP BIOL, V200, P2893; MUSICK JA, 1990, COPEIA, P1130, DOI 10.2307/1446498; Nakamura I, 1985, FAO FISH SYNOP, V5, P1; Ovchinnikov V. V, 1971, SWORDFISHES BILLFISH; OVCHINNKOV V. V., 1966, BIOFIZIKA, V11, P186; Park H, 2010, EXP MECH, V50, P1313, DOI 10.1007/s11340-009-9330-x; Park H, 2010, J EXP BIOL, V213, P3269, DOI 10.1242/jeb.046052; Roberson J.A., 1972, J HYDR ENG DIV-ASCE, V98, P1187, DOI [10.1061/JYCEAJ.0003350, DOI 10.1061/JYCEAJ.0003350]; Rohr J, 1998, J EXP BIOL, V201, P1447; Sagong W, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.3005861; Schlichting H., 2017, BOUNDARY LAYER THEOR; SPALART PR, 1988, J FLUID MECH, V187, P61, DOI 10.1017/S0022112088000345; Sundnes G, 1963, ICNAF ENV S SPEC PUB, V6, P743; Talbot F. H., 1962, Copeia, V1962, P468, DOI 10.2307/1440943; Tokic G, 2012, P ROY SOC B-BIOL SCI, V279, P3065, DOI 10.1098/rspb.2012.0057; Tytell ED, 2007, EXP FLUIDS, V43, P701, DOI 10.1007/s00348-007-0343-x; van Rees WM, 2013, J FLUID MECH, V722, DOI 10.1017/jfm.2013.157; VIDELER JJ, 1995, BIOL FLUID DYNAMICS, P1; Vogel S, 1994, LIFE MOVING FLUIDS; Walford L.A., 1937, MARINE GAME FISHES P; Walsh MJ, 1982, AIAA19820169; WALTERS V, 1962, AM ZOOL, V2, P143; WARDLE CS, 1988, J FISH BIOL, V32, P471, DOI 10.1111/j.1095-8649.1988.tb05382.x; Webb P.W., 1975, B FISH RES BOARD CAN, V190, P1, DOI DOI 10.1002/RRA.1371; WEBB PW, 1978, J EXP BIOL, V74, P211; White FM, 2017, FLUID MECH-SOV RES; Wolfgang MJ, 1999, J EXP BIOL, V202, P2303	64	19	19	3	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81323	10.1371/journal.pone.0081323	http://dx.doi.org/10.1371/journal.pone.0081323			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312547	Green Published, gold, Green Submitted			2022-12-25	WOS:000327944500067
J	Wang, XW; Zhao, XF; Wang, JX				Wang, Xian-Wei; Zhao, Xiao-Fan; Wang, Jin-Xing			C-type Lectin Binds to beta-Integrin to Promote Hemocytic Phagocytosis in an Invertebrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Integrin; Invertebrates; Phagocytosis; Protein-Protein Interactions; RNA Interference (RNAi); C-type Lectin; Opsonin	PATTERN-RECOGNITION RECEPTOR; PROTEIN; LIGAND; DOMAIN; CELLS; SHRIMP; IDENTIFICATION; COLLECTINS; PATHOGENS; DEFENSE	Phagocytosis is a conserved cellular response among metazoans. Opsonins are some molecules that label targets to increase their susceptibility to phagocytosis. Opsonins are usually captured by receptors on the surface of phagocytes. Our previous study found the C-type lectin FcLec4 from Chinese white shrimp Fenneropenaeus chinensis might function as an opsonin to facilitate bacterial clearance. In the present study we purified the native FcLec4 protein and confirmed its opsonic activity in the near relation, kuruma shrimp Marsupenaeus japonicus. The possible receptor of FcLec4 was identified as -integrin by panning a T7 phage display library of shrimp hemocytes and then confirmed by co-immunoprecipitation assay. We further proved that the interaction between FcLec4 and -integrin did not rely on the carbohydrate recognition domain but on the N terminus of FcLec4. In addition, inhibition of FcLec4 expression using RNAi delayed bacterial clearance, and -integrin knockdown suppressed the opsonic activity of FcLec4. This study is the first to show the direct interaction between an opsonin and its receptor in crustaceans. Our study provides new insights into invertebrate phagocytosis and the functions of C-type lectins.	[Wang, Xian-Wei; Zhao, Xiao-Fan; Wang, Jin-Xing] Shandong Univ, Shandong Prov Key Lab Anim Cells & Dev Biol, Key Lab Plant Cell Engn & Germplasm Innovat, Sch Life Sci,Minist Educ, Jinan 250100, Shandong, Peoples R China	Shandong University	Wang, JX (corresponding author), Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	jxwang@sdu.edu.cn	Wang, Jin-Xing/AAU-1514-2021; Zhao, Xiao-Fan/AGW-9886-2022	Zhao, Xiao-Fan/0000-0003-1809-4730; Wang, Jin-Xing/0000-0003-0283-3930	National Natural Science Foundation of China [31130056, 31302217]; National Basic Research Program of China (973 Program) [2012CB114405]; Ph.D. Programs Foundation of the Ministry of Education of China [20110131130003]; Provincial Natural Science Foundation of Shandong, China [ZR2011CM014]; China Postdoctoral Science Foundation [2013M540553]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China); Provincial Natural Science Foundation of Shandong, China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported financially by National Natural Science Foundation of China Grants 31130056 and 31302217 (to J.-X. W. and X.-W. W.), National Basic Research Program of China (973 Program, 2012CB114405 (to J.-X. W.), the Ph.D. Programs Foundation of the Ministry of Education of China (Grant 20110131130003 to J.-X. W.), the Provincial Natural Science Foundation of Shandong, China (Grant ZR2011CM014 to J.-X. W.), and the China Postdoctoral Science Foundation (Grant 2013M540553 to X.-W. W.).	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Arlinghaus FT, 2013, J BIOL CHEM, V288, P947, DOI 10.1074/jbc.M112.399618; Arlinghaus FT, 2012, TOXICON, V60, P512, DOI 10.1016/j.toxicon.2012.03.001; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bottazzi B, 2009, IMMUNOL REV, V227, P9, DOI 10.1111/j.1600-065X.2008.00719.x; Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200; Chiba H, 2001, INFECT IMMUN, V69, P1587, DOI 10.1128/IAI.69.3.1587-1592.2001; Cohen ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020597; Duperthuy M, 2011, P NATL ACAD SCI USA, V108, P2993, DOI 10.1073/pnas.1015326108; Fairn GD, 2012, TRENDS IMMUNOL, V33, P397, DOI 10.1016/j.it.2012.03.003; Ghiran I, 2000, J EXP MED, V192, P1797, DOI 10.1084/jem.192.12.1797; Goh YS, 2011, IMMUNOLOGY, V133, P74, DOI 10.1111/j.1365-2567.2011.03411.x; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; Jia W, 2005, BLOOD, V106, P3854, DOI 10.1182/blood-2005-04-1658; Kamiguti AS, 2003, FEBS LETT, V549, P129, DOI 10.1016/S0014-5793(03)00799-3; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Koizumi N, 1999, J INSECT PHYSIOL, V45, P853, DOI 10.1016/S0022-1910(99)00069-4; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; Lee SY, 2001, J IMMUNOL, V166, P7319, DOI 10.4049/jimmunol.166.12.7319; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Li DF, 2007, VIROLOGY, V368, P122, DOI 10.1016/j.virol.2007.06.027; Litvack ML, 2010, INNATE IMMUN-LONDON, V16, P191, DOI 10.1177/1753425910369271; Liu WF, 2009, J PROTEOME RES, V8, P1198, DOI 10.1021/pr800840x; Ma THT, 2008, J INVERTEBR PATHOL, V99, P332, DOI 10.1016/j.jip.2008.08.003; MALHOTRA R, 1990, J EXP MED, V172, P955, DOI 10.1084/jem.172.3.955; Mamali I, 2009, DEV COMP IMMUNOL, V33, P858, DOI 10.1016/j.dci.2009.02.004; May RC, 2001, J CELL SCI, V114, P1061; Nagaosa K, 2011, J BIOL CHEM, V286, P25770, DOI 10.1074/jbc.M110.204503; PASQUALINI R, 1995, J CELL BIOL, V130, P1189, DOI 10.1083/jcb.130.5.1189; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0; Shiratsuchi A, 2012, J BIOL CHEM, V287, P21663, DOI 10.1074/jbc.M111.333807; Takagi J, 2004, BIOCHEM SOC T, V32, P403, DOI 10.1042/BST0320403; Takagi J, 2002, BIOCHEMISTRY-US, V41, P4339, DOI 10.1021/bi016047u; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; THORNQVIST PO, 1994, DEV COMP IMMUNOL, V18, P3, DOI 10.1016/0145-305X(94)90247-X; Tian YY, 2009, DEV COMP IMMUNOL, V33, P772, DOI 10.1016/j.dci.2009.01.002; Tozer EC, 1996, J BIOL CHEM, V271, P21978, DOI 10.1074/jbc.271.36.21978; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; van de Wetering JK, 2004, EUR J BIOCHEM, V271, P1229, DOI 10.1111/j.1432-1033.2004.04040.x; Wang SA, 2009, J IMMUNOL, V182, P5250, DOI 10.4049/jimmunol.0802970; Wang XW, 2011, FISH SHELLFISH IMMUN, V30, P241, DOI 10.1016/j.fsi.2010.10.012; Wang XW, 2009, DEV COMP IMMUNOL, V33, P1039, DOI 10.1016/j.dci.2009.05.004; Watthanasurorot A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002062; Wu CL, 2011, PROTEOMICS, V11, P2249, DOI 10.1002/pmic.201000728; Wu WL, 2008, J PROTEOME RES, V7, P424, DOI 10.1021/pr700639t; Ye T, 2012, J PROTEOME RES, V11, P4834, DOI 10.1021/pr300274k; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	49	98	104	2	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2405	2414		10.1074/jbc.M113.528885	http://dx.doi.org/10.1074/jbc.M113.528885			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24324258	hybrid, Green Published			2022-12-25	WOS:000331130200044
J	Biswas, S; DiSilvestre, DA; Dong, PH; Tomaselli, GF				Biswas, Subrata; DiSilvestre, Deborah A.; Dong, Peihong; Tomaselli, Gordon F.			Mechanisms of a Human Skeletal Myotonia Produced by Mutation in the C-Terminus of Na(V)1.4: Is Ca2+ Regulation Defective?	PLOS ONE			English	Article							GATED SODIUM-CHANNELS; COLD-AGGRAVATED MYOTONIA; EF-HAND DOMAIN; PARAMYOTONIA-CONGENITA; INTRACELLULAR CALCIUM; CARDIAC EXCITABILITY; FAST INACTIVATION; NA+ CHANNELS; CALMODULIN; MUSCLE	Mutations in the cytoplasmic tail (CT) of voltage gated sodium channels cause a spectrum of inherited diseases of cellular excitability, yet to date only one mutation in the CT of the human skeletal muscle voltage gated sodium channel (hNa(V)1.4(F1705I)) has been linked to cold aggravated myotonia. The functional effects of altered regulation of hNa(V)1.4(F1705I) are incompletely understood. The location of the hNa(V)1.4(F1705I) in the CT prompted us to examine the role of Ca2+ and calmodulin (CaM) regulation in the manifestations of myotonia. To study Na channel related mechanisms of myotonia we exploited the differences in rat and human Na(V)1.4 channel regulation by Ca2+ and CaM. hNa(V)1.4(F1705I) inactivation gating is Ca2+-sensitive compared to wild type hNa(V)1.4 which is Ca2+ insensitive and the mutant channel exhibits a depolarizing shift of the V-1/2 of inactivation with CaM over expression. In contrast the same mutation in the rNa(V)1.4 channel background (rNa(V)1.4(F1698I)) eliminates Ca2+ sensitivity of gating without affecting the CaM over expression induced hyperpolarizing shift in steady-state inactivation. The differences in the Ca2+ sensitivity of gating between wild type and mutant human and rat Na(V)1.4 channels are in part mediated by a divergence in the amino acid sequence in the EF hand like (EFL) region of the CT. Thus the composition of the EFL region contributes to the species differences in Ca2+/CaM regulation of the mutant channels that produce myotonia. The myotonia mutation F1705I slows I-Na decay in a Ca2+-sensitive fashion. The combination of the altered voltage dependence and kinetics of I-Na decay contribute to the myotonic phenotype and may involve the Ca2+-sensing apparatus in the CT of Na(V)1.4.	[Biswas, Subrata; DiSilvestre, Deborah A.; Dong, Peihong; Tomaselli, Gordon F.] Johns Hopkins Univ, Dept Med, Div Cardiol, Baltimore, MD USA	Johns Hopkins University	Tomaselli, GF (corresponding author), Johns Hopkins Univ, Dept Med, Div Cardiol, Baltimore, MD USA.	gtomasel@jhmi.edu			National Institutes of Health [RO1HL50411]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health (RO1HL50411 to Dr. Gordon F. Tomaselli). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABITCH J, 1990, NATURE, V346, P321, DOI 10.1038/346321b0; BERS DM, 1994, METHOD CELL BIOL, V40, P3; Bissay V, 2011, NEUROMUSCULAR DISORD, V21, P590, DOI 10.1016/j.nmd.2011.05.006; Biswas S, 2008, J GEN PHYSIOL, V131, P197, DOI 10.1085/jgp.200709863; Biswas S, 2009, CIRC RES, V104, P870, DOI 10.1161/CIRCRESAHA.108.193565; Bruton JD, 2010, J PHYSIOL-LONDON, V588, P4275, DOI 10.1113/jphysiol.2010.198598; Casini S, 2009, CARDIOVASC RES, V81, P72, DOI 10.1093/cvr/cvn274; Chagot B, 2009, J BIOL CHEM, V284, P6436, DOI 10.1074/jbc.M807747200; Cormier JW, 2002, J BIOL CHEM, V277, P9233, DOI 10.1074/jbc.M110204200; Deschenes I, 2002, CIRC RES, V90, pE49, DOI 10.1161/01.RES.0000012502.92751.E6; Dice MS, 2004, MUSCLE NERVE, V30, P277, DOI 10.1002/mus.20080; Eisenberg B, 2013, BIOPHYS J, V104, P1849, DOI 10.1016/j.bpj.2013.03.049; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Featherstone DE, 1998, J PHYSIOL-LONDON, V506, P627, DOI 10.1111/j.1469-7793.1998.627bv.x; Gaudioso C, 2011, BIOCHEM BIOPH RES CO, V411, P329, DOI 10.1016/j.bbrc.2011.06.142; Glaaser IW, 2006, J BIOL CHEM, V281, P24015, DOI 10.1074/jbc.M605473200; Glaaser IW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1717; Green DS, 1998, J PHYSIOL-LONDON, V510, P685, DOI 10.1111/j.1469-7793.1998.685bj.x; Groome JR, 2008, CHANNELS, V2, P39, DOI 10.4161/chan.2.1.6051; HEINE R, 1993, HUM MOL GENET, V2, P1349, DOI 10.1093/hmg/2.9.1349; Jurkat-Rott K, 2010, PFLUG ARCH EUR J PHY, V460, P239, DOI 10.1007/s00424-010-0814-4; Kim J, 2004, J BIOL CHEM, V279, P45004, DOI 10.1074/jbc.M407286200; Kubota T, 2009, MUSCLE NERVE, V39, P666, DOI 10.1002/mus.21155; Mantegazza M, 2001, P NATL ACAD SCI USA, V98, P15348, DOI 10.1073/pnas.211563298; Miller TM, 2004, NEUROLOGY, V63, P1647, DOI 10.1212/01.WNL.0000143383.91137.00; Miloushev VZ, 2009, J BIOL CHEM, V284, P6446, DOI 10.1074/jbc.M807401200; Mitrovic N, 1999, BRAIN, V122, P1085, DOI 10.1093/brain/122.6.1085; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; Plassart-Schiess E, 1998, J PHYSIOL-LONDON, V507, P721, DOI 10.1111/j.1469-7793.1998.721bs.x; Potet F, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M806871200; Rayan DLR, 2010, CURR OPIN NEUROL, V23, P466, DOI 10.1097/WCO.0b013e32833cc97e; Richmond JE, 1997, J PHYSIOL-LONDON, V499, P589, DOI 10.1113/jphysiol.1997.sp021952; Rossignol E, 2007, NEUROLOGY, V69, P1937, DOI 10.1212/01.wnl.0000290831.08585.2c; Ruff RL, 1999, AM J PHYSIOL-CELL PH, V277, pC937, DOI 10.1152/ajpcell.1999.277.5.C937; Sarhan MF, 2012, P NATL ACAD SCI USA, V109, P3558, DOI 10.1073/pnas.1114748109; Sarhan MF, 2009, J BIOL CHEM, V284, P33265, DOI 10.1074/jbc.M109.052910; Schoser BGH, 2007, MUSCLE NERVE, V35, P599, DOI 10.1002/mus.20733; Shah VN, 2006, P NATL ACAD SCI USA, V103, P3592, DOI 10.1073/pnas.0507397103; Tan HL, 2002, NATURE, V415, P442, DOI 10.1038/415442a; Van Petegem F, 2012, BIOPHYS J, V103, P2243, DOI 10.1016/j.bpj.2012.10.020; Wang CJ, 2012, STRUCTURE, V20, P1167, DOI 10.1016/j.str.2012.05.001; Wingo TL, 2004, NAT STRUCT MOL BIOL, V11, P219, DOI 10.1038/nsmb737; Wu FF, 2005, J PHYSIOL-LONDON, V565, P371, DOI 10.1113/jphysiol.2005.082909; Young KA, 2005, J PHYSIOL-LONDON, V565, P349, DOI 10.1113/jphysiol.2004.081422	45	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81063	10.1371/journal.pone.0081063	http://dx.doi.org/10.1371/journal.pone.0081063			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324661	gold, Green Published, Green Submitted			2022-12-25	WOS:000328566700028
J	Grote, S; Condit, R; Hubbell, S; Wirth, C; Ruger, N				Grote, Steffi; Condit, Richard; Hubbell, Stephen; Wirth, Christian; Rueger, Nadja			Response of Demographic Rates of Tropical Trees to Light Availability: Can Position-Based Competition Indices Replace Information from Canopy Census Data?	PLOS ONE			English	Article							RAIN-FOREST; DENSITY-DEPENDENCE; INTERSPECIFIC VARIATION; NEIGHBORHOOD ANALYSIS; NEOTROPICAL FOREST; GROWTH-RESPONSES; RECRUITMENT; MORTALITY; BIOMASS; HETEROGENEITY	For trees in tropical forests, competition for light is thought to be a central process that offers opportunities for niche differentiation through light gradient partitioning. In previous studies, a canopy index based on three-dimensional canopy census data has been shown to be a good predictor of species-specific demographic rates across the entire tree community on Barro Colorado Island, Panama, and has allowed quantifying between-species variation in light response. However, almost all other forest census plots lack data on the canopy structure. Hence, this study aims at assessing whether position-based neighborhood competition indices can replace information from canopy census data and produce similar estimates of the interspecific variation of light responses. We used inventory data from the census plot at Barro Colorado Island and calculated neighborhood competition indices with varying relative effects of the size and distance of neighboring trees. Among these indices, we selected the one that was most strongly correlated with the canopy index. We then compared outcomes of hierarchical Bayesian models for species-specific recruitment and growth rates including either the canopy index or the selected neighborhood competition index as predictor. Mean posterior estimates of light response parameters were highly correlated between models (r>0.85) and indicated that most species regenerate and grow better in higher light. Both light estimation approaches consistently found that the interspecific variation of light response was larger for recruitment than for growth rates. However, the classification of species into different groups of light response, e. g. weaker than linear (decelerating) vs. stronger than linear (accelerating) differed between approaches. These results imply that while the classification into light response groups might be biased when using neighborhood competition indices, they may be useful for determining species rankings and between-species variation of light response and therefore enable large comparative studies between different forest census plots.	[Grote, Steffi; Wirth, Christian] Univ Leipzig, D-04109 Leipzig, Germany; [Condit, Richard; Hubbell, Stephen; Rueger, Nadja] Smithsonian Trop Res Inst, Ctr Trop Forest Sci, Washington, DC USA; [Hubbell, Stephen] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Wirth, Christian; Rueger, Nadja] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Leipzig University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of California System; University of California Los Angeles	Grote, S (corresponding author), Univ Leipzig, D-04109 Leipzig, Germany.	grote.steffi@gmail.com	Rüger, Nadja/J-6393-2015; Wirth, Christian/A-4446-2016; Rüger, Nadja/Q-6418-2019	Rüger, Nadja/0000-0003-2371-4172; Rüger, Nadja/0000-0003-2371-4172	Deutsche Forschungsgemeinschaft DFG [RU 1536/3-1]; National Science Foundation [DEB-0640386, DEB-0425651, DEB-0346488, DEB-0129874, DEB-00753102, DEB-9909347, DEB-9615226, DEB-9405933, DEB-9221033, DEB-9100058, DEB-8906869, DEB-8605042, DEB-8206992, DEB-7922197]; Center for Tropical Forest Science,; Smithsonian Tropical Research Institute; John D. and Catherine T. MacArthur Foundation; Mellon Foundation; Small World Institute Fund	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); Center for Tropical Forest Science,(Smithsonian InstitutionSmithsonian Tropical Research Institute); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); John D. and Catherine T. MacArthur Foundation; Mellon Foundation; Small World Institute Fund	NR was funded by a research grant from Deutsche Forschungsgemeinschaft DFG (RU 1536/3-1). The BCI forest dynamics research project was made possible by National Science Foundation grants to Stephen P. Hubbell: DEB-0640386, DEB-0425651, DEB-0346488, DEB-0129874, DEB-00753102, DEB-9909347, DEB-9615226, DEB-9615226, DEB-9405933, DEB-9221033, DEB-9100058, DEB-8906869, DEB-8605042, DEB-8206992, DEB-7922197, support from the Center for Tropical Forest Science, the Smithsonian Tropical Research Institute, the John D. and Catherine T. MacArthur Foundation, the Mellon Foundation, the Small World Institute Fund, and numerous private individuals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyeman VK, 1999, J ECOL, V87, P815, DOI 10.1046/j.1365-2745.1999.00400.x; Bohlman S, 2006, J TROP ECOL, V22, P123, DOI 10.1017/S0266467405003019; Bolker B, 2008, ECOLOGICAL MODELS DA; BROWN S, 1989, FOREST SCI, V35, P881; CANHAM CD, 1994, CAN J FOREST RES, V24, P337, DOI 10.1139/x94-046; Canham CD, 2004, CAN J FOREST RES, V34, P778, DOI [10.1139/x03-232, 10.1139/X03-232]; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; CHESSON PL, 1985, THEOR POPUL BIOL, V28, P263, DOI 10.1016/0040-5809(85)90030-9; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Condit R, 1996, J VEG SCI, V7, P405, DOI 10.2307/3236284; Condit R, 1996, J TROP ECOL, V12, P231, DOI 10.1017/S0266467400009433; Condit R, 1998, METHODS RESULTS BARR; Condit R, 2006, SCIENCE, V313, P98, DOI 10.1126/science.1124712; Das A, 2012, CAN J FOREST RES, V42, P1983, DOI 10.1139/x2012-142; DENSLOW JS, 1990, ECOLOGY, V71, P165, DOI 10.2307/1940257; Gelman A., 2004, BAYESIAN DATA ANAL; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Gilbert B, 2006, ECOLOGY, V87, P1281, DOI 10.1890/0012-9658(2006)87[1281:LHTITT]2.0.CO;2; Gourlet-Fleury S, 2000, FOREST ECOL MANAG, V131, P269, DOI 10.1016/S0378-1127(99)00212-1; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; HARTSHORN GS, 1980, BIOTROPICA, V12, P23, DOI 10.2307/2388152; Hegyi F, 1974, ROYAL COLL FORESTRY, V30, P74, DOI DOI 10.1111/1365-2435.12428; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; King DA, 2005, FUNCT ECOL, V19, P445, DOI 10.1111/j.1365-2435.2005.00982.x; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; Kobe RK, 1999, ECOLOGY, V80, P187, DOI 10.1890/0012-9658(1999)080[0187:LGPATT]2.0.CO;2; Leigh E. G., 1996, ECOLOGY TROPICAL FOR; LEIGH EG, 1999, TROPICAL FOREST ECOL; Lev-Yadun S, 2005, BIOL J LINN SOC, V84, P313, DOI 10.1111/j.1095-8312.2005.00434.x; MARTIN GL, 1984, FOREST SCI, V30, P731; Muller-Landau HC, 2008, J ECOL, V96, P653, DOI 10.1111/j.1365-2745.2008.01399.x; Peacock J, 2007, J VEG SCI, V18, P535, DOI 10.1111/j.1654-1103.2007.tb02568.x; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Poorter L, 1999, FUNCT ECOL, V13, P396, DOI 10.1046/j.1365-2435.1999.00332.x; R Core Team, 2012, R LANG ENV STAT COMP; RICKLEFS RE, 1977, AM NAT, V111, P376, DOI 10.1086/283169; Ruger N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025330; Ruger N, 2011, OIKOS, V120, P1047, DOI 10.1111/j.1600-0706.2010.19021.x; Ruger N, 2009, J ECOL, V97, P1360, DOI 10.1111/j.1365-2745.2009.01552.x; Sack L, 2001, FUNCT ECOL, V15, P145, DOI 10.1046/j.1365-2435.2001.00507.x; Stoll P, 2005, ECOLOGY, V86, P3048, DOI 10.1890/04-1540; TOME M, 1989, FOREST SCI, V35, P816; Uriarte M, 2005, J ECOL, V93, P291, DOI 10.1111/j.0022-0477.2005.00984.x; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; WELDEN CW, 1991, ECOLOGY, V72, P35, DOI 10.2307/1938900; Windsor DM, 1990, SMITHSONIAN CONTRIBU, V29; Wirth R, 2001, ACTA OECOL, V22, P235, DOI 10.1016/S1146-609X(01)01123-7; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; Wykoff W., 1982, USERS GUIDE STAND PR	51	7	7	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81787	10.1371/journal.pone.0081787	http://dx.doi.org/10.1371/journal.pone.0081787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324723	Green Published, gold, Green Submitted			2022-12-25	WOS:000328566700051
J	Papoiu, ADP; Nattkemper, LA; Sanders, KM; Kraft, RA; Chan, YH; Coghill, RC; Yosipovitch, G				Papoiu, Alexandru D. P.; Nattkemper, Leigh A.; Sanders, Kristen M.; Kraft, Robert A.; Chan, Yiong-Huak; Coghill, Robert C.; Yosipovitch, Gil			Brain's Reward Circuits Mediate Itch Relief. A Functional MRI Study of Active Scratching	PLOS ONE			English	Article							PAIN; PATHWAYS	Previous brain imaging studies investigating the brain processing of scratching used an exogenous intervention mimicking scratching, performed not by the subjects themselves, but delivered by an investigator. In real life, scratching is a conscious, voluntary, controlled motor response to itching, which is directed to the perceived site of distress. In this study we aimed to visualize in real-time by brain imaging the core mechanisms of the itch-scratch cycle when scratching was performed by subjects themselves. Secondly, we aimed to assess the correlations between brain patterns of activation and psychophysical ratings of itch relief or pleasurability of scratching. We also compared the patterns of brain activity evoked by self-scratching vs. passive scratching. We used a robust tridimensional Arterial Spin Labeling fMRI technique that is less sensitive to motion artifacts: 3D gradient echo and spin echo (GRASE) - Propeller. Active scratching was accompanied by a higher pleasurability and induced a more pronounced deactivation of the anterior cingulate cortex and insula, in comparison with passive scratching. A significant involvement of the reward system including the ventral tegmentum of the midbrain, coupled with a mechanism deactivating the periaqueductal gray matter (PAG), suggests that itch modulation operates in reverse to the mechanism known to suppress pain. Our findings not only confirm a role for the central networks processing reward in the pleasurable aspects of scratching, but also suggest they play a role in mediating itch relief.	[Papoiu, Alexandru D. P.; Yosipovitch, Gil] Wake Forest Sch Med, Dept Dermatol, Winston Salem, NC USA; [Coghill, Robert C.; Yosipovitch, Gil] Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC USA; [Yosipovitch, Gil] Wake Forest Sch Med, Dept Regenerat Med, Winston Salem, NC USA; [Kraft, Robert A.] Wake Forest Univ, Dept Biomed Engn, Winston Salem, NC 27109 USA; [Kraft, Robert A.] Virginia Tech, Winston Salem, NC USA; [Nattkemper, Leigh A.; Sanders, Kristen M.] Wake Forest Univ, Grad Sch Biomed Sci, PhD Program Neurosci, Winston Salem, NC 27109 USA; [Chan, Yiong-Huak] Natl Univ Singapore, Yong Loo Lin Sch Med, Biostat Unit, Singapore 117548, Singapore	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Virginia Polytechnic Institute & State University; Wake Forest University; National University of Singapore	Yosipovitch, G (corresponding author), Temple Univ, Sch Med, Dept Dermatol, Philadelphia, PA 19122 USA.	gil.yosipovitch@tuhs.temple.edu	Yosipovitch, Gil/K-3517-2019	Sanders, Kristen/0000-0002-9326-427X	National Institute of Health [ARO1-55902]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Health grant ARO1-55902. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; Davidson S, 2010, TRENDS NEUROSCI, V33, P550, DOI 10.1016/j.tins.2010.09.002; Davidson S, 2009, NAT NEUROSCI, V12, P544, DOI 10.1038/nn.2292; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Leknes S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017870; McGinty VB, 2011, BEHAV BRAIN RES, V225, P348, DOI 10.1016/j.bbr.2011.07.036; Napadow V, 2012, CEREB CORTEX; O'Neill JL, 2011, ACTA DERM-VENEREOL, V91, P537, DOI 10.2340/00015555-1126; Papoiu ADP, 2012, NEUROIMAGE, V59, P3611, DOI 10.1016/j.neuroimage.2011.10.099; Papoiu ADP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017786; Saif Bin GA, 2012, BRIT J DERMATOL, V166, P981, DOI [10.1111/j.1365-2133.2012.10826.x, DOI 10.1111/J.1365-2133.2012.10826.X.PUBMED:22242789]; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Tan H, 2011, MAGN RESON MED, V66, P168, DOI 10.1002/mrm.22768; Tzschentke TM, 2000, AMINO ACIDS, V19, P211, DOI 10.1007/s007260070051; Vierow V, 2009, J NEUROPHYSIOL, V102, P3216, DOI 10.1152/jn.00207.2009; Yosipovitch G, 2008, J INVEST DERMATOL, V128, P1806, DOI 10.1038/jid.2008.3	18	77	79	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82389	10.1371/journal.pone.0082389	http://dx.doi.org/10.1371/journal.pone.0082389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324781	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700075
J	Mudiam, MKR; Ch, R; Saxena, PN				Mudiam, Mohana Krishna Reddy; Ch, Ratnasekhar; Saxena, Prem Narain			Gas Chromatography-Mass Spectrometry Based Metabolomic Approach for Optimization and Toxicity Evaluation of Earthworm Sub-Lethal Responses to Carbofuran	PLOS ONE			English	Article							ENVIRONMENTAL METABOLOMICS; SAMPLE PREPARATION; CAENORHABDITIS-ELEGANS; METAPHIRE-POSTHUMA; EXTRACTION; TISSUE; H-1-NMR; METABOANALYST; OPPORTUNITIES; PERFORMANCE	Despite recent advances in understanding mechanism of toxicity, the development of biomarkers (biochemicals that vary significantly with exposure to chemicals) for pesticides and environmental contaminants exposure is still a challenging task. Carbofuran is one of the most commonly used pesticides in agriculture and said to be most toxic carbamate pesticide. It is necessary to identify the biochemicals that can vary significantly after carbofuran exposure on earthworms which will help to assess the soil ecotoxicity. Initially, we have optimized the extraction conditions which are suitable for high-throughput gas chromatography mass spectrometry (GC-MS) based metabolomics for the tissue of earthworm, Metaphire posthuma. Upon evaluation of five different extraction solvent systems, 80% methanol was found to have good extraction efficiency based on the yields of metabolites, multivariate analysis, total number of peaks and reproducibility of metabolites. Later the toxicity evaluation was performed to characterize the tissue specific metabolomic perturbation of earthworm, Metaphire posthuma after exposure to carbofuran at three different concentration levels (0.15, 0.3 and 0.6 mg/kg of soil). Seventeen metabolites, contributing to the best classification performance of highest dose dependent carbofuran exposed earthworms from healthy controls were identified. This study suggests that GC-MS based metabolomic approach was precise and sensitive to measure the earthworm responses to carbofuran exposure in soil, and can be used as a promising tool for environmental eco-toxicological studies.	[Mudiam, Mohana Krishna Reddy; Ch, Ratnasekhar] CSIR Indian Inst Toxicol Res, Analyt Chem Sect, Lucknow, Uttar Pradesh, India; [Mudiam, Mohana Krishna Reddy; Ch, Ratnasekhar] CSIR Indian Inst Toxicol Res, Acad Sci & Innovat Res, Lucknow, Uttar Pradesh, India; [Saxena, Prem Narain] CSIR Indian Inst Toxicol Res, SEM Facil, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Mudiam, MKR (corresponding author), CSIR Indian Inst Toxicol Res, Analyt Chem Sect, Lucknow, Uttar Pradesh, India.	mohanitrc@gmail.com	Mudiam, Mohana Krishna Reddy/O-6824-2014	Mudiam, Mohana Krishna Reddy/0000-0002-0771-8053	CSIR, New Delhi [OLP-0004]	CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The authors greatly acknowledge CSIR, New Delhi for their financial support through INDEPTH and EMPOWER scheme (OLP-0004) to carry out this research work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A J, 2005, ANAL CHEM, V77, P8086, DOI 10.1021/ac051211v; Aliferis KA, 2011, METABOLOMICS, V7, P35, DOI 10.1007/s11306-010-0231-x; Alvarez MD, 2010, METABOLOMICS, V6, P541, DOI 10.1007/s11306-010-0222-y; Aslund MLW, 2012, ENVIRON SCI TECHNOL, V46, P1111, DOI 10.1021/es202327k; Begum G, 2004, AQUAT TOXICOL, V66, P83, DOI 10.1016/j.aquatox.2003.08.002; Broadhurst D., 2007, P MET SOC 3 ANN INT; Brown PJ, 2004, CHEMOSPHERE, V57, P1675, DOI 10.1016/j.chemosphere.2004.05.041; Brown SAE, 2008, ENVIRON TOXICOL CHEM, V27, P828, DOI 10.1897/07-412.1; Bruce SJ, 2009, ANAL CHEM, V81, P3285, DOI 10.1021/ac8024569; Bundy JG, 2009, METABOLOMICS, V5, P3, DOI 10.1007/s11306-008-0152-0; Campbell S, 2004, CHEMOSPHERE, V54, P1155, DOI 10.1016/j.chemosphere.2003.09.018; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; European Commision health and consumer protection Deirectorate general, 2012, UN E 3 CHEM CONT PES; Ewald JC, 2009, ANAL CHEM, V81, P3623, DOI 10.1021/ac900002u; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Filzmoser P., 2009, MULTIVARIATE STAT AN, V66, P112; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gao XF, 2010, ANAL CHEM, V82, P6447, DOI 10.1021/ac1006552; Geier FM, 2011, ANAL CHEM, V83, P3730, DOI 10.1021/ac2001109; Gibb JOT, 1997, BIOMARKERS, V2, P295, DOI 10.1080/135475097231526; Gibney MJ, 2005, AM J CLIN NUTR, V82, P497, DOI 10.1093/ajcn/82.3.497; GILMAN AP, 1974, J AGR FOOD CHEM, V22, P625, DOI 10.1021/jf60194a018; GUPTA RC, 1994, J TOXICOL ENV HEALTH, V43, P383, DOI 10.1080/15287399409531931; Hernandez M H, 2011, ECOTOX ENVIRON SAFE, V74, P1905, DOI DOI 10.1016/J.EC0ENV.2011.07.016; Horton H. Robert, 2006, PRINCIPLES BIOCH; Hu ZP, 2012, J PROTEOME RES, V11, P5903, DOI 10.1021/pr300666p; Hughes SL, 2009, J PROTEOME RES, V8, P3512, DOI 10.1021/pr9001806; Johnson CH, 2012, ANNU REV PHARMACOL, V52, P37, DOI 10.1146/annurev-pharmtox-010611-134748; Jones OAH, 2008, CHEMOSPHERE, V71, P601, DOI 10.1016/j.chemosphere.2007.08.056; Jones OAH, 2012, J PROTEOME RES, V11, P1446, DOI 10.1021/pr201142c; Koek MM, 2011, METABOLOMICS, V7, P307, DOI 10.1007/s11306-010-0254-3; Koek MM, 2006, ANAL CHEM, V78, P1272, DOI 10.1021/ac051683+; Krishnan P, 2005, J EXP BOT, V56, P255, DOI 10.1093/jxb/eri010; Lankadurai BP, 2013, METABOLOMICS, V9, P44, DOI 10.1007/s11306-012-0427-3; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Li X, 2009, ANAL CHIM ACTA, V633, P257, DOI 10.1016/j.aca.2008.11.058; Liang SH, 2009, J HAZARD MATER, V172, P1212, DOI 10.1016/j.jhazmat.2009.07.126; Liang SH, 2009, COMP BIOCHEM PHYS C, V149, P349, DOI 10.1016/j.cbpc.2008.09.004; Liebeke M, 2012, METABOLOMICS, V8, P819, DOI 10.1007/s11306-011-0377-1; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; Lundstedt T, 1998, CHEMOMETR INTELL LAB, V42, P3, DOI 10.1016/S0169-7439(98)00065-3; McKelvie JR, 2009, METABOLOMICS, V5, P84, DOI 10.1007/s11306-008-0122-6; Meng JR, 2012, ANAL CHIM ACTA, V710, P125, DOI 10.1016/j.aca.2011.09.033; Michaud MR, 2007, J COMP PHYSIOL B, V177, P753, DOI 10.1007/s00360-007-0172-5; Milatovic D, 2005, TOXICOLOGY, V208, P13, DOI 10.1016/j.tox.2004.11.004; Miller MG, 2007, J PROTEOME RES, V6, P540, DOI 10.1021/pr060623x; Monselise EB, 2003, BIOCHEM BIOPH RES CO, V302, P427, DOI 10.1016/S0006-291X(03)00194-3; Organisation for Economic Cooperation and Development (OECD), 1984, GUID TEST CHEM 207 E; Parab GS, 2009, ANAL CHEM, V81, P1315, DOI 10.1021/ac801645t; Peijnenburg W J G M, 2009, ECOTOXICOLOGY MODELI, P177, DOI DOI 10.1007/978-1-4419-0197-27.; Podrabsky JE, 2007, J EXP BIOL, V210, P2253, DOI 10.1242/jeb.005116; Poynton HC, 2011, ENVIRON SCI TECHNOL, V45, P3710, DOI 10.1021/es1037222; Ralston-Hooper K, 2008, AQUAT TOXICOL, V88, P48, DOI 10.1016/j.aquatox.2008.03.002; Rocha SM, 2012, J CHROMATOGR A, V1252, P155, DOI 10.1016/j.chroma.2012.06.067; Rubin AL, 2006, RISK CHARACTERIZATIO; Rubingh CM, 2006, METABOLOMICS, V2, P53, DOI 10.1007/s11306-006-0022-6; Sanchez-Hernandez JC, 2006, REV ENVIRON CONTAM T, V188, P85, DOI 10.1007/978-0-387-32964-2_3; Sellick CA, 2010, METABOLOMICS, V6, P427, DOI 10.1007/s11306-010-0216-9; Shin MH, 2010, ANAL CHEM, V82, P6660, DOI 10.1021/ac1012656; Simpson MJ, 2009, ANAL BIOANAL CHEM, V394, P137, DOI 10.1007/s00216-009-2612-4; Singh R, 2012, J HAZARD MATER, V237, P355, DOI 10.1016/j.jhazmat.2012.08.064; Southam AD, 2011, ENVIRON SCI TECHNOL, V45, P3759, DOI 10.1021/es103814d; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; STENERSEN J, 1973, J AGR FOOD CHEM, V21, P166, DOI 10.1021/jf60186a013; SUNDARAMAN V, 1992, TISSUE CELL, V24, P745, DOI 10.1016/0040-8166(92)90046-A; Tripathi G, 2005, J ENVIRON BIOL, V26, P61; Viant MR, 2008, MOL BIOSYST, V4, P980, DOI 10.1039/b805354e; Viant MR, 2009, METABOLOMICS, V5, P1, DOI 10.1007/s11306-009-0157-3; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Winder CL, 2008, ANAL CHEM, V80, P2939, DOI 10.1021/ac7023409; Wishart DS, 2008, J CHROMATOGR B, V871, P164, DOI 10.1016/j.jchromb.2008.05.001; Wu HF, 2008, ANAL BIOCHEM, V372, P204, DOI 10.1016/j.ab.2007.10.002; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xuan JK, 2011, J PROTEOME RES, V10, P5433, DOI 10.1021/pr2006796	76	24	26	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81077	10.1371/journal.pone.0081077	http://dx.doi.org/10.1371/journal.pone.0081077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324663	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300070
J	Panteris, E; Adamakis, IDS; Daras, G; Hatzopoulos, P; Rigas, S				Panteris, Emmanuel; Adamakis, Ioannis-Dimosthenis S.; Daras, Gerasimos; Hatzopoulos, Polydefkis; Rigas, Stamatis			Differential Responsiveness of Cortical Microtubule Orientation to Suppression of Cell Expansion among the Developmental Zones of Arabidopsis thaliana Root Apex	PLOS ONE			English	Article							CELLULOSE MICROFIBRIL ALIGNMENT; ORDINARY EPIDERMAL-CELLS; FUNCTIONAL ASSOCIATION; EARLY RESPONSE; WALL; SYNTHASE; ORGANIZATION; ELONGATION; GROWTH; MORPHOGENESIS	The bidirectional relationship between cortical microtubule orientation and cell wall structure has been extensively studied in elongating cells. Nevertheless, the possible interplay between microtubules and cell wall elements in meristematic cells still remains elusive. Herein, the impact of cellulose synthesis inhibition and suppressed cell elongation on cortical microtubule orientation was assessed throughout the developmental zones of Arabidopsis thaliana root apex by whole-mount tubulin immunolabeling and confocal microscopy. Apart from the wild-type, thanatos and pom2-4 mutants of Cellulose SynthaseA3 and Cellulose Synthase Interacting1, respectively, were studied. Pharmacological and mechanical approaches inhibiting cell expansion were also applied. Cortical microtubules of untreated wild-type roots were predominantly transverse in the meristematic, transition and elongation root zones. Cellulose-deficient mutants, chemical inhibition of cell expansion, or growth in soil resulted in microtubule reorientation in the elongation zone, wherein cell length was significantly decreased. Combinatorial genetic and chemical suppression of cell expansion extended microtubule reorientation to the transition zone. According to the results, transverse cortical microtubule orientation is established in the meristematic root zone, persisting upon inhibition of cell expansion. Microtubule reorientation in the elongation zone could be attributed to conditional suppression of cell elongation. The differential responsiveness of microtubule orientation to genetic and environmental cues is most likely associated with distinct biophysical traits of the cells among each developmental root zone.	[Panteris, Emmanuel; Adamakis, Ioannis-Dimosthenis S.] Aristotle Univ Thessaloniki, Sch Biol, Dept Bot, GR-54006 Thessaloniki, Macedonia, Greece; [Daras, Gerasimos; Hatzopoulos, Polydefkis; Rigas, Stamatis] Agr Univ Athens, Dept Biotechnol, GR-11855 Athens, Greece	Aristotle University of Thessaloniki; Agricultural University of Athens	Panteris, E (corresponding author), Aristotle Univ Thessaloniki, Sch Biol, Dept Bot, GR-54006 Thessaloniki, Macedonia, Greece.	epanter@bio.auth.gr; srigas@aua.gr	Panteris, Emmanuel/K-3723-2012	Panteris, Emmanuel/0000-0002-2360-6078; Daras, Gerasimos/0000-0003-4570-766X	Research Committee of Aristotle University of Thessaloniki [89348]; GSRT; IKY	Research Committee of Aristotle University of Thessaloniki; GSRT(Greek Ministry of Development-GSRT); IKY	EP was supported by the Research Committee of Aristotle University of Thessaloniki (grant no. 89348). PH and SR were supported by the GSRT Excellence 2012-2015 grant. GD acknowledges support from IKY fellowships of excellence for postgraduate studies in Greece-Siemens program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027423; Ambrose C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1444; Baluska F, 2001, DEV BIOL, V231, P113, DOI 10.1006/dbio.2000.0115; Baskin TI, 2004, PLANT PHYSIOL, V135, P2279, DOI 10.1104/pp.104.040493; Baskin TI, 1997, PLANT PHYSIOL, V113, P493, DOI 10.1104/pp.113.2.493; BASKIN TI, 1995, PLANT PHYSIOL, V107, P233, DOI 10.1104/pp.107.1.233; Baskin TI, 1996, J MICROSC-OXFORD, V182, P149, DOI 10.1046/j.1365-2818.1996.135417.x; BASKIN TI, 1995, PLANTA, V197, P514, DOI 10.1007/BF00196673; Baskin TI, 2010, TRENDS PLANT SCI, V15, P593, DOI 10.1016/j.tplants.2010.08.006; Bengough AG, 2011, J EXP BOT, V62, P59, DOI 10.1093/jxb/erq350; Bichet A, 2001, PLANT J, V25, P137, DOI 10.1046/j.1365-313x.2001.00946.x; Blancaflor EB, 2000, J PLANT GROWTH REGUL, V19, P406, DOI 10.1007/s003440000044; Bringmann M, 2012, TRENDS PLANT SCI, V17, P666, DOI 10.1016/j.tplants.2012.06.003; Bringmann M, 2012, PLANT CELL, V24, P163, DOI 10.1105/tpc.111.093575; Chan J, 2011, J CELL SCI, V124, P1088, DOI 10.1242/jcs.086702; Chan J, 2010, J CELL SCI, V123, P3490, DOI 10.1242/jcs.074641; Chu ZQ, 2007, PLANT PHYSIOL, V143, P213, DOI 10.1104/pp.106.088393; Collings DA, 2005, CAN J BOT, V83, P579, DOI [10.1139/B05-032, 10.1139/b05-032]; Daras G, 2009, NEW PHYTOL, V184, P114, DOI 10.1111/j.1469-8137.2009.02960.x; DeBolt S, 2007, P NATL ACAD SCI USA, V104, P5854, DOI 10.1073/pnas.0700789104; Fisher DD, 1998, PLANT PHYSIOL, V116, P1043, DOI 10.1104/pp.116.3.1043; Fujita M, 2012, PROTOPLASMA, V249, pS59, DOI 10.1007/s00709-011-0332-z; Fujita M, 2011, PLANT J, V66, P915, DOI 10.1111/j.1365-313X.2011.04552.x; Gardiner J, 2013, PROTOPLASMA, V250, P391, DOI 10.1007/s00709-012-0377-7; Gu Y, 2010, P NATL ACAD SCI USA, V107, P12866, DOI 10.1073/pnas.1007092107; HAMANT O, 2013, CURR OPIN P IN PRESS; HEATH IB, 1974, J THEOR BIOL, V48, P445, DOI 10.1016/S0022-5193(74)80011-1; HEIM DR, 1990, PLANT PHYSIOL, V93, P695, DOI 10.1104/pp.93.2.695; Hejnowicz Z, 2000, J PLANT GROWTH REGUL, V19, P31, DOI 10.1007/s003440000005; Himmelspach R, 2003, PLANT J, V36, P565, DOI 10.1046/j.1365-313X.2003.01906.x; Le J, 2004, PHYSIOL PLANTARUM, V121, P513, DOI 10.1111/j.1399-3054.2004.00342.x; Le J, 2001, PLANT PHYSIOL, V125, P519, DOI 10.1104/pp.125.2.519; LEDBETTER MC, 1963, J CELL BIOL, V19, P239, DOI 10.1083/jcb.19.1.239; Li SD, 2012, P NATL ACAD SCI USA, V109, P185, DOI 10.1073/pnas.1118560109; Lloyd C, 2011, INT REV CEL MOL BIO, V287, P287, DOI 10.1016/B978-0-12-386043-9.00007-4; Mei Y, 2012, PLANT CELL, V24, P1066, DOI 10.1105/tpc.111.095059; NICK P, 1990, PLANTA, V181, P162, DOI 10.1007/BF02411533; NODET P, 1990, J GEN MICROBIOL, V136, P303, DOI 10.1099/00221287-136-2-303; Panteris E, 2005, NEW PHYTOL, V167, P721, DOI 10.1111/j.1469-8137.2005.01464.x; PANTERIS E, 1993, NEW PHYTOL, V125, P509, DOI 10.1111/j.1469-8137.1993.tb03899.x; PANTERIS E, 1993, PROTOPLASMA, V174, P91, DOI 10.1007/BF01379041; PANTERIS E, 1994, NEW PHYTOL, V127, P771, DOI 10.1111/j.1469-8137.1994.tb02981.x; Panteris E, 2011, CYTOSKELETON, V68, P401, DOI 10.1002/cm.20522; Paradez A, 2006, CURR OPIN PLANT BIOL, V9, P571, DOI 10.1016/j.pbi.2006.09.005; Paredez AR, 2008, PLANT PHYSIOL, V147, P1723, DOI 10.1104/pp.108.120196; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Peng L, 2013, PLANT BIOLOGY, V15, P405, DOI 10.1111/j.1438-8677.2012.00630.x; Refregier G, 2004, PLANT PHYSIOL, V135, P959, DOI 10.1104/pp.104.038711; Sampathkumar A, 2013, PLANT PHYSIOL, V162, P675, DOI 10.1104/pp.113.215277; Smith LG, 2005, ANNU REV CELL DEV BI, V21, P271, DOI 10.1146/annurev.cellbio.21.122303.114901; Sugimoto K, 2000, PLANT PHYSIOL, V124, P1493, DOI 10.1104/pp.124.4.1493; Szymanski DB, 2009, CURR BIOL, V19, pR800, DOI 10.1016/j.cub.2009.07.056; Takesue K, 1999, PROTOPLASMA, V206, P27, DOI 10.1007/BF01279250; Tsang DL, 2011, PLANT PHYSIOL, V156, P596, DOI 10.1104/pp.111.175372; Verbelen JP, 2006, PLANT SIGNAL BEHAV, V1, P296, DOI 10.4161/psb.1.6.3511; Wasteneys GO, 2006, J PLANT RES, V119, P5, DOI 10.1007/s10265-005-0233-3; Wasteneys GO, 2004, CURR OPIN PLANT BIOL, V7, P651, DOI 10.1016/j.pbi.2004.09.008; Wightman R, 2007, PLANT J, V52, P742, DOI 10.1111/j.1365-313X.2007.03271.x; Zhang CH, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-27	59	24	24	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82442	10.1371/journal.pone.0082442	http://dx.doi.org/10.1371/journal.pone.0082442			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324790	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300148
J	Stewart, PA; Luks, J; Roycik, MD; Sang, QXA; Zhang, JF				Stewart, Paul A.; Luks, Jennifer; Roycik, Mark D.; Sang, Qing-Xiang Amy; Zhang, Jinfeng			Differentially Expressed Transcripts and Dysregulated Signaling Pathways and Networks in African American Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; AURORA-B; TUMOR MICROENVIRONMENT; PROSTATE-CANCER; POOR-PROGNOSIS; WHITE WOMEN; BLACK-WOMEN; RNA-SEQ; IN-VIVO; SURVIVAL	African Americans (AAs) have higher mortality rate from breast cancer than that of Caucasian Americans (CAs) even when socioeconomic factors are accounted for. To better understand the driving biological factors of this health disparity, we performed a comprehensive differential gene expression analysis, including subtype- and stage-specific analysis, using the breast cancer data in the Cancer Genome Atlas (TCGA). In total, 674 unique genes and other transcripts were found differentially expressed between these two populations. The numbers of differentially expressed genes between AA and CA patients increased in each stage of tumor progression: there were 26 in stage I, 161 in stage II, and 223 in stage III. Resistin, a gene that is linked to obesity, insulin resistance, and breast cancer, was expressed more than four times higher in AA tumors. An uncharacterized, long, non-coding RNA, LOC90784, was down-regulated in AA tumors, and its expression was inversely related to cancer stage and was the lowest in triple negative AA breast tumors. Network analysis showed increased expression of a majority of components in p53 and BRCA1 subnetworks in AA breast tumor samples, and members of the aurora B and polo-like kinase signaling pathways were also highly expressed. Higher gene expression diversity was observed in more advanced stage breast tumors suggesting increased genomic instability during tumor progression. Amplified resistin expression may indicate insulin-resistant type II diabetes and obesity are associated with AA breast cancer. Expression of LOC90784 may have a protective effect on breast cancer patients, and its loss, particularly in triple negative breast cancer, could be having detrimental effects. This work helps elucidate molecular mechanisms of breast cancer health disparity and identifies putative biomarkers and therapeutic targets such as resistin, and the aurora B and polo-like kinase signaling pathways for treating AA breast cancer patients.	[Stewart, Paul A.; Luks, Jennifer; Roycik, Mark D.; Sang, Qing-Xiang Amy] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Sang, Qing-Xiang Amy] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Zhang, Jinfeng] Florida State Univ, Dept Stat, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Sang, QXA (corresponding author), Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA.	qxsang@chem.fsu.edu; jinfeng@stat.fsu.edu			Florida State University; Elsa U. Pardee; Elsa U. Pardee Foundation	Florida State University; Elsa U. Pardee; Elsa U. Pardee Foundation	Salaries of QXS and JZ are paid by Florida State University. MDR's salary was paid by Elsa U. Pardee grant to Dr. Sang. PAS was supported by a graduate assistantship from Florida State University. JL is compensated hourly for teaching labs at Florida State University. This work was in part supported by Elsa U. Pardee Foundation (http://www.pardeefoundation.org/) to Dr. Sang and the Florida State University ( http://www.fsu.edu/) to Dr. Sang and Dr. Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albain KS, 2009, JNCI-J NATL CANCER I, V101, P984, DOI 10.1093/jnci/djp175; Amend K, 2006, CANCER RES, V66, P8327, DOI 10.1158/0008-5472.CAN-06-1927; American Cancer Society, 2013, CANC FACTS FIG 2013; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Badve S, 2007, CLIN CANCER RES, V13, P4415, DOI 10.1158/1078-0432.CCR-07-0122; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berois N, 2006, J HISTOCHEM CYTOCHEM, V54, P317, DOI 10.1369/jhc.5A6783.2005; Bertucci F, 2002, HUM MOL GENET, V11, P863, DOI 10.1093/hmg/11.8.863; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Calderon-Margalit R, 2004, INT J CANCER, V112, P357, DOI 10.1002/ijc.20429; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Carey LA, 2011, ONCOLOGIST, V16, P71, DOI 10.1634/theoncologist.2011-S1-71; DAVION S, 2012, J CANC THERAPY, V3, P649, DOI DOI 10.4236/JCT.2012.325084; Davoli A, 2010, CANCER CHEMOTH PHARM, V65, P611, DOI 10.1007/s00280-009-1208-1; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Dookeran KA, 2010, ANN SURG ONCOL, V17, P1398, DOI 10.1245/s10434-009-0889-3; ELLEDGE RM, 1994, J NATL CANCER I, V86, P705, DOI 10.1093/jnci/86.9.705; Field LA, 2012, CANCER-AM CANCER SOC, V118, P1334, DOI 10.1002/cncr.26405; Fiscella K, 1997, BRIT MED J, V314, P1724, DOI 10.1136/bmj.314.7096.1724; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gapstur SM, 1996, CANCER, V77, P1465, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1465::AID-CNCR7>3.0.CO;2-B; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Grunda Jessica M, 2012, BMC Res Notes, V5, P248, DOI 10.1186/1756-0500-5-248; Gully CP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-42; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Harris LN, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1622; Hemmi H, 2012, J IMMUNOL, V188, P1147, DOI 10.4049/jimmunol.1102541; Jatoi I, 2003, CANCER-AM CANCER SOC, V98, P894, DOI 10.1002/cncr.11604; Jovov B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030168; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Kitamura N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016060; Kool M, 1999, CANCER RES, V59, P175; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krig SR, 2011, MOL CANCER RES, V9, P1406, DOI 10.1158/1541-7786.MCR-11-0227; Lee YC, 2012, GYNECOL ONCOL, V125, P742, DOI 10.1016/j.ygyno.2012.02.032; Maire V, 2013, CANCER RES, V73, P813, DOI 10.1158/0008-5472.CAN-12-2633; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Morris GJ, 2007, CANCER-AM CANCER SOC, V110, P876, DOI 10.1002/cncr.22836; Mulligan AM, 2013, CLIN CANCER RES, V19, P336, DOI 10.1158/1078-0432.CCR-11-3314; Nacu S, 2007, BIOINFORMATICS, V23, P850, DOI 10.1093/bioinformatics/btm019; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Newman LA, 2006, J CLIN ONCOL, V24, P1342, DOI 10.1200/JCO.2005.03.3472; Newman LA, 2002, CANCER-AM CANCER SOC, V94, P2844, DOI 10.1002/cncr.10575; Pal T, 2008, GENET TEST, V12, P401, DOI 10.1089/gte.2007.0108; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Piotrowski A, 2006, GENE CHROMOSOME CANC, V45, P656, DOI 10.1002/gcc.20331; Pitteri SJ, 2011, CANCER RES, V71, P5090, DOI 10.1158/0008-5472.CAN-11-0568; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Rodenhiser DI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2121; Ryser S, 2009, CANCER RES, V69, P1125, DOI 10.1158/0008-5472.CAN-08-2134; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stead LA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2242; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Sun CA, 2010, BREAST CANCER RES TR, V123, P869, DOI 10.1007/s10549-010-0792-4; Takagi K, 2013, HORM CANCER-US, V4, P92, DOI 10.1007/s12672-012-0130-x; Takeshita M, 2013, LUNG CANCER, V80, P85, DOI 10.1016/j.lungcan.2012.12.018; Tatsuka M, 1998, CANCER RES, V58, P4811; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; WAGSTAFF L, 2010, BREAST CANCER RES, V15, P15, DOI DOI 10.1186/BCR2482; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang X, 2011, J PROTEOME RES, V10, P3920, DOI 10.1021/pr2000144; Wang Y, 2013, BRIT J CANCER, V108, P1765, DOI 10.1038/bjc.2013.138; Wojcik BE, 1998, CANCER, V82, P1310, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1310::AID-CNCR14>3.0.CO;2-9; Wolfgang CD, 2000, P NATL ACAD SCI USA, V97, P9437, DOI 10.1073/pnas.160270597; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Yang S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-211; Zaika AI, 1999, CANCER RES, V59, P3257; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714; Zhang M, 2007, J STEROID BIOCHEM, V105, P91, DOI 10.1016/j.jsbmb.2007.01.002; Zong XY, 2011, BMB REP, V44, P595, DOI 10.5483/BMBRep.2011.44.9.595	86	57	57	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82460	10.1371/journal.pone.0082460	http://dx.doi.org/10.1371/journal.pone.0082460			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324792	Green Submitted, Green Published, gold			2022-12-25	WOS:000327949300150
J	Umar, M; Upadhyay, R; Kumar, S; Ghoshal, UC; Mittal, B				Umar, Meenakshi; Upadhyay, Rohit; Kumar, Shaleen; Ghoshal, Uday Chand; Mittal, Balraj			Association of Common Polymorphisms in TNFA, NFkB1 and NFKBIA with Risk and Prognosis of Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; FUNCTIONAL INSERTION/DELETION POLYMORPHISM; GENE INCREASES SUSCEPTIBILITY; PROMOTER POLYMORPHISM; NO ASSOCIATION; CANCER-RISK; REGION; SURVIVAL; INFLAMMATION	Background: Tumour necrosis factor-alpha (TNF-alpha) and nuclear factor of kappa light chain gene enhancer in activated B cells (NF-kappa B) play critical role in carcinogenesis processes like tumour initiation, proliferation, migration and invasion. Single nucleotide polymorphisms in TNF-alpha, NF-kappa B and its inhibitor I kappa B genes were shown to be associated with susceptibility and prognosis of several cancers; however, their role in esophageal squamous cell carcinoma (ESCC) is not well recognised. Therefore, in present study, we aimed to investigate association of common polymorphisms in TNFA, NFkB1 and NFKBIA with risk and prognosis of ESCC in northern Indian population. Methods: We genotyped 290 ESCC patients (including 162 followed up cases) and 311 mean age, gender and ethnicity matched controls for TNFA -308G>A, NFkB1 -94ATTG ins/del and NFKBIA (-826C>T and 3'UTRA>G) polymorphisms using PCR alone or followed by RFLP and TaqMan assay. Results: TNFA -308GA genotype was associated with increased risk of ESCC specifically in females and in patients with regional lymph node involvement, while, NFKBIA -826CT+TT genotype conferred decreased risk of ESCC in females. Haplotypes of NFKBIA -826C>T and 3'UTRA>G polymorphisms, C-826G3'UTR and T-826A3'UTR, were associated with reduced risk of ESCC. No independent role of NFkB1 -94ATTG ins/del polymorphism in susceptibility of ESCC was found. Multi-dimensionality reduction analysis showed three factor model TNFA-308, NFKBIA-826, NFKBIA 3'UTR as better predictor for risk of ESCC. Furthermore, combined risk genotype analysis of all studied polymorphisms showed increased risk of ESCC in patients with 1-3 risk genotype compared to '0' risk genotype. Survival analysis did not show any significant prognostic effect of studied polymorphisms. However, in stepwise multivariate analysis, metastasis was found to be independent prognostic predictor of ESCC patients. Conclusion: TNFA-308 and NFKBIA (-826C>T and 3'UTRA>G) polymorphisms may play role in susceptibility but not in prognosis of ESCC patients in northern Indian population.	[Umar, Meenakshi; Upadhyay, Rohit; Mittal, Balraj] Sanjay Gandhi Post Grad Inst Med Sci, Dept Genet, Lucknow, Uttar Pradesh, India; [Kumar, Shaleen] Sanjay Gandhi Post Grad Inst Med Sci, Dept Radiotherapy, Lucknow, Uttar Pradesh, India; [Ghoshal, Uday Chand] Sanjay Gandhi Post Grad Inst Med Sci, Dept Gastroenterol, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Mittal, B (corresponding author), Sanjay Gandhi Post Grad Inst Med Sci, Dept Genet, Lucknow, Uttar Pradesh, India.	bml_pgi@yahoo.com	Upadhyay, Rohit/A-5854-2015; Umar, Meenakshi/AAY-7759-2021; Umar, Meenakshi/AFV-9658-2022	Upadhyay, Rohit/0000-0003-1859-7784; 	Indian Council of Medical Research, New Delhi	Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	The authors acknowledge the fellowship grant from Indian Council of Medical Research, New Delhi. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM LJ, 1993, CLIN EXP IMMUNOL, V92, P14; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barbisan G, 2012, TUMOR BIOL, V33, P1549, DOI 10.1007/s13277-012-0408-1; Correa GTB, 2011, ORAL ONCOL, V47, P888, DOI 10.1016/j.oraloncology.2011.07.001; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Bu H, 2007, J CANCER RES CLIN, V133, P859, DOI 10.1007/s00432-007-0228-7; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cheng CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056130; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Deans C, 2007, ANN SURG ONCOL, V14, P329, DOI 10.1245/s10434-006-9122-9; Dupont WD, 1997, CONTROL CLIN TRIALS, V18, P274, DOI 10.1016/S0197-2456(97)00074-3; Gao JF, 2007, SCAND J GASTROENTERO, V42, P345, DOI 10.1080/00365520600880856; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Guo W, 2005, CHINESE MED J-PEKING, V118, P1870; He YC, 2009, CARCINOGENESIS, V30, P1916, DOI 10.1093/carcin/bgp226; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Jain M, 2007, CANCER INVEST, V25, P340, DOI 10.1080/07357900701358074; Jain SK, 2004, CYTOKINE, V26, P102, DOI 10.1016/j.cyto.2004.01.002; Kang MR, 2009, PATHOLOGY, V41, P622, DOI 10.3109/00313020903257756; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim JG, 2009, JPN J CLIN ONCOL, V39, P497, DOI 10.1093/jjco/hyp056; KIM WW, 2005, J KOREAN SURG SOC, V68, P288; Lehnerdt GF, 2008, INT J IMMUNOPATH PH, V21, P827, DOI 10.1177/039463200802100407; Li MQ, 2011, GENET TEST MOL BIOMA, V15, P743, DOI 10.1089/gtmb.2011.0068; Lin CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035078; Liu CJ, 2005, J ORAL PATHOL MED, V34, P608, DOI 10.1111/j.1600-0714.2005.00359.x; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Louis E, 1998, CLIN EXP IMMUNOL, V113, P401; Mestiri S, 2001, CANCER, V91, P672, DOI 10.1002/1097-0142(20010215)91:4<672::AID-CNCR1050>3.0.CO;2-J; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Riemann K, 2007, INT J CLIN PHARM TH, V45, P423; Riemann K, 2006, PHARMACOGENET GENOM, V16, P783, DOI 10.1097/01.fpc.0000230414.74726.f6; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Singh H, 2009, INT J GYNECOL CANCER, V19, P1190, DOI 10.1111/IGC.0b013e3181a3a3af; Song SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021726; Szlosarek P, 2006, EUR J CANCER, V42, P745, DOI 10.1016/j.ejca.2006.01.012; Tang TL, 2010, DNA CELL BIOL, V29, P9, DOI 10.1089/dna.2009.0937; Tao YP, 2012, J CANCER RES CLIN, V138, P1891, DOI 10.1007/s00432-012-1269-0; Tian F, 2006, ACTA BIOCH BIOPH SIN, V38, P318, DOI 10.1111/j.1745-7270.2006.00166.x; Tselepis C, 2002, ONCOGENE, V21, P6071, DOI 10.1038/sj.onc.1205731; Umar M, 2011, J SURG ONCOL, V103, P716, DOI 10.1002/jso.21881; Upadhyay R, 2008, CLIN IMMUNOL, V128, P199, DOI 10.1016/j.clim.2008.03.519; Upadhyay R, 2011, ANN SURG ONCOL, V18, P880, DOI 10.1245/s10434-010-1371-y; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; WILSON AG, 1993, J EXP MED, V177, P557, DOI 10.1084/jem.177.2.557; Wu HC, 2004, UROL INT, V73, P41, DOI 10.1159/000078803; Yasui K, 2001, GENE CHROMOSOME CANC, V32, P112, DOI 10.1002/gcc.1172; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Yoo JH, 2005, NUCLEIC ACIDS RES, V33, pW483, DOI 10.1093/nar/gki428; Zhang P, 2009, CANCER GENET CYTOGEN, V191, P73, DOI 10.1016/j.cancergencyto.2009.01.017; Zhou B, 2010, ANN ONCOL, V21, P506, DOI 10.1093/annonc/mdp507; Zhou B, 2009, CANCER LETT, V275, P72, DOI 10.1016/j.canlet.2008.10.002; Zou YF, 2011, CANCER INVEST, V29, P78, DOI 10.3109/07357907.2010.535054	56	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81999	10.1371/journal.pone.0081999	http://dx.doi.org/10.1371/journal.pone.0081999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324738	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300119
J	Yi, X; Zeng, C; Liu, HL; Chen, XL; Zhang, P; Yun, BS; Jin, G; Zhou, AM				Yi, Xin; Zeng, Chun; Liu, Hongli; Chen, Xiaoli; Zhang, Ping; Yun, Boo Seok; Jin, Ge; Zhou, Aimin			Lack of RNase L Attenuates Macrophage Functions	PLOS ONE			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; MIGRATION-INHIBITORY FACTOR; MANNOSE-RECEPTOR; INTERFERON ACTION; PROSTATE-CANCER; ACTIVATION; EXPRESSION; MICE; ENDOCYTOSIS; MECHANISMS	Background: Macrophages are one of the major cell types in innate immunity against microbial infection. It is believed that the expression of proinflammatory genes such as tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1 beta, IL-6, and cyclooxygenase-2 (Cox-2) by macrophages is also crucial for activation of both innate and adaptive immunities. RNase L is an interferon (IFN) inducible enzyme which is highly expressed in macrophages. It has been demonstrated that RNase L regulates the expression of certain inflammatory genes. However, its role in macrophage function is largely unknown. Methodology: Bone marrow-derived macrophages (BMMs) were generated from RNase L+/+ and (-/-) mice. The migration of BMMs was analyzed by using Transwell migration assays. Endocytosis and phagocytosis of macrophages were assessed by using fluorescein isothiocyanate (FITC)-Dextran 40,000 and FITC-E. coli bacteria, respectively. The expression of inflammatory genes was determined by Western Blot and ELISA. The promoter activity of Cox-2 was measured by luciferase reporter assays. Conclusions/Findings: Lack of RNase L significantly decreased the migration of BMMs induced by M-CSF, but at a less extent by GM-CSF and chemokine C-C motif ligand-2 (CCL2). Interestingly, RNase L deficient BMMs showed a significant reduction of endocytic activity to FITC-Dextran 40,000, but no any obvious effect on their phagocytic activity to FITC-bacteria under the same condition. RNase L impacts the expression of certain genes related to cell migration and inflammation such as transforming growth factor (TGF)-beta, IL-1 beta, IL-10, CCL2 and Cox-2. Furthermore, the functional analysis of the Cox-2 promoter revealed that RNase L regulated the expression of Cox-2 in macrophages at its transcriptional level. Taken together, our findings provide direct evidence showing that RNase L contributes to innate immunity through regulating macrophage functions.	[Yi, Xin; Zeng, Chun; Yun, Boo Seok; Zhou, Aimin] Cleveland State Univ, Dept Chem, Clin Chem Program, Cleveland, OH 44115 USA; [Zhou, Aimin] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA; [Zhou, Aimin] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA; [Jin, Ge] Case Western Reserve Univ, Sch Dent Med, Dept Biol Sci, Cleveland, OH 44106 USA; [Liu, Hongli] Eighth Hosp Xian, Cent Lab, Xian, Peoples R China; [Chen, Xiaoli] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Pathol, Xian 710049, Peoples R China; [Zhang, Ping] China Acad Chinese Med Sci, Wanjing Hosp, Dept Pathol, Beijing, Peoples R China	Cleveland State University; Cleveland State University; Cleveland Clinic Foundation; Case Western Reserve University; Xi'an Jiaotong University; China Academy of Chinese Medical Sciences	Zhou, AM (corresponding author), Cleveland State Univ, Dept Chem, Clin Chem Program, Cleveland, OH 44115 USA.	a.zhou@csuohio.edu			National Institutes of Health [R15DK084460-01A2]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK084460] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Institutes of Health (R15DK084460-01A2) to AZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Adler AF, 2010, NANO TODAY, V5, P553, DOI 10.1016/j.nantod.2010.10.007; Adnan M, 2012, J BIOL CHEM, V287, P43651, DOI 10.1074/jbc.M112.399964; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Choi WT, 2011, EXP BIOL MED, V236, P637, DOI 10.1258/ebm.2011.010389; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; EZEKOWITZ RAB, 1991, NATURE, V351, P155, DOI 10.1038/351155a0; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; Falcone DJ, 2001, BLOOD, V97, P777, DOI 10.1182/blood.V97.3.777; Fiala M, 2002, EUR J CLIN INVEST, V32, P360, DOI 10.1046/j.1365-2362.2002.00994.x; Gomes RN, 2006, SHOCK, V26, P457, DOI 10.1097/01.shk.0000228801.56223.92; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; Kim JS, 2006, BLOOD, V108, P1821, DOI 10.1182/blood-2005-10-009191; KRUSKAL BA, 1994, PEDIATR RES, V35, pA184; Leitner WW, 2003, NAT MED, V9, P33, DOI 10.1038/nm813; Li XL, 2008, P NATL ACAD SCI USA, V105, P20816, DOI 10.1073/pnas.0807265105; Li XL, 2000, J BIOL CHEM, V275, P8880, DOI 10.1074/jbc.275.12.8880; Li XL, 1998, J VIROL, V72, P2752, DOI 10.1128/JVI.72.4.2752-2759.1998; Liang SL, 2006, IUBMB LIFE, V58, P508, DOI 10.1080/15216540600838232; Loberg RD, 2007, NEOPLASIA, V9, P556, DOI 10.1593/neo.07307; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Mittal R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001203; Montaner LJ, 1999, J IMMUNOL, V162, P4606; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Opalek Judy M, 2007, J Inflamm (Lond), V4, P19, DOI 10.1186/1476-9255-4-19; Paulnock DM, 2000, BOOK MACROPHAGE PRAC, P81; Peiser L, 2000, INFECT IMMUN, V68, P1953, DOI 10.1128/IAI.68.4.1953-1963.2000; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Raveh D, 1998, J LEUKOCYTE BIOL, V64, P108, DOI 10.1002/jlb.64.1.108; Sampaio NG, 2011, J CELL SCI, V124, P2021, DOI 10.1242/jcs.075309; Shanmugam N, 2004, DIABETES, V53, P795, DOI 10.2337/diabetes.53.3.795; Silverman RH, 2002, VIRAL IMMUNOL, V15, P77, DOI 10.1089/088282402317340242; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Tajima T, 2008, J PHARMACOL EXP THER, V326, P493, DOI 10.1124/jpet.108.137992; TANNER AR, 1984, GUT, V25, P760, DOI 10.1136/gut.25.7.760; Tnani M, 1998, J INTERF CYTOK RES, V18, P361, DOI 10.1089/jir.1998.18.361; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Upham JP, 2010, J VIROL, V84, P3730, DOI 10.1128/JVI.02148-09; WU JY, 1993, J IMMUNOL, V151, P4325; Xiang Y, 2003, CANCER RES, V63, P6795; Zhou AM, 2005, J INTERF CYTOK RES, V25, P595, DOI 10.1089/jir.2005.25.595; Zhou AM, 1998, J INTERF CYTOK RES, V18, P953, DOI 10.1089/jir.1998.18.953; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355	45	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81269	10.1371/journal.pone.0081269	http://dx.doi.org/10.1371/journal.pone.0081269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324683	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300085
J	Doyle, EL; Hummel, AW; Demorest, ZL; Starker, CG; Voytas, DF; Bradley, P; Bogdanove, AJ				Doyle, Erin L.; Hummel, Aaron W.; Demorest, Zachary L.; Starker, Colby G.; Voytas, Daniel F.; Bradley, Philip; Bogdanove, Adam J.			TAL Effector Specificity for base 0 of the DNA Target Is Altered in a Complex, Effector- and Assay-Dependent Manner by Substitutions for the Tryptophan in Cryptic Repeat-1	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; EFFICIENT CONSTRUCTION; BINDING SPECIFICITY; CRYSTAL-STRUCTURE; BACTERIAL-BLIGHT; GENES; RECOGNITION; MECHANISMS; SEQUENCE; NUCLEASE	TAL effectors are re-targetable transcription factors used for tailored gene regulation and, as TAL effector-nuclease fusions (TALENs), for genome engineering. Their hallmark feature is a customizable central string of polymorphic amino acid repeats that interact one-to-one with individual DNA bases to specify the target. Sequences targeted by TAL effector repeats in nature are nearly all directly preceded by a thymine (T) that is required for maximal activity, and target sites for custom TAL effector constructs have typically been selected with this constraint. Multiple crystal structures suggest that this requirement for T at base 0 is encoded by a tryptophan residue (W232) in a cryptic repeat N-terminal to the central repeats that exhibits energetically favorable van der Waals contacts with the T. We generated variants based on TAL effector PthXo1 with all single amino acid substitutions for W232. In a transcriptional activation assay, many substitutions altered or relaxed the specificity for T and a few were as active as wild type. Some showed higher activity. However, when replicated in a different TAL effector, the effects of the substitutions differed. Further, the effects differed when tested in the context of a TALEN in a DNA cleavage assay, and in a TAL effector-DNA binding assay. Substitution of the N-terminal region of the PthXo1 construct with that of one of the TAL effector-like proteins of Ralstonia solanacearum, which have arginine in place of the tryptophan, resulted in specificity for guanine as the 5' base but low activity, and several substitutions for the arginine, including tryptophan, destroyed activity altogether. Thus, the effects on specificity and activity generated by substitutions at the W232 (or equivalent) position are complex and context dependent. Generating TAL effector scaffolds with high activity that robustly accommodate sites without a T at position 0 may require larger scale re-engineering.	[Doyle, Erin L.; Hummel, Aaron W.; Bogdanove, Adam J.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA 50011 USA; [Demorest, Zachary L.; Starker, Colby G.; Voytas, Daniel F.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Demorest, Zachary L.; Starker, Colby G.; Voytas, Daniel F.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN USA; [Demorest, Zachary L.] Cellectis Plant Sci, New Brighton, MN USA; [Bradley, Philip] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Bogdanove, Adam J.] Cornell Univ, Ithaca, NY USA	Iowa State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Fred Hutchinson Cancer Center; Cornell University	Bogdanove, AJ (corresponding author), Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA 50011 USA.	ajb7@cornell.edu	Bogdanove, Adam/ABE-6252-2020	Doyle, Erin/0000-0001-9880-7440; Starker, Colby/0000-0002-6774-7227; Voytas, Daniel/0000-0002-4944-1224	National Institutes of Health [R01 GM098861, R01 GM088277]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098861, R01GM088277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from the National Institutes of Health (R01 GM098861 to AJB and DFV and R01 GM088277 to PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blount BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033279; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; de Lange O, 2013, NEW PHYTOL, V199, P773, DOI 10.1111/nph.12324; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; DOYLE EL, 2013, TRENDS CELL BIOL, P14242, DOI DOI 10.1016/J.TCB.2013.1004.1003; Gao HS, 2012, CELL RES, V22, P1716, DOI 10.1038/cr.2012.156; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Genin S, 2012, ANNU REV PHYTOPATHOL, V50, P67, DOI 10.1146/annurev-phyto-081211-173000; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; LAMB BM, 2013, NUCLEIC ACIDS RES, P14242, DOI DOI 10.1093/NAR/GKT1754; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Mahfouz MM, 2012, PLANT MOL BIOL, V78, P311, DOI 10.1007/s11103-011-9866-x; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mak ANS, 2013, CURR OPIN STRUC BIOL, V23, P93, DOI 10.1016/j.sbi.2012.11.001; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Meckler JF, 2013, NUCLEIC ACIDS RES, V41, P4118, DOI 10.1093/nar/gkt085; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morbitzer R, 2010, P NATL ACAD SCI USA, V107, P21617, DOI 10.1073/pnas.1013133107; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2012, CURR OPIN BIOTECH, V23, P644, DOI 10.1016/j.copbio.2012.01.013; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; Romer P, 2010, NEW PHYTOL, V187, P1048, DOI 10.1111/j.1469-8137.2010.03217.x; Romer P, 2009, PLANT PHYSIOL, V150, P1697, DOI 10.1104/pp.109.139931; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Sun N, 2012, MOL BIOSYST, V8, P1255, DOI 10.1039/c2mb05461b; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Verdier V, 2012, NEW PHYTOL, V196, P1197, DOI 10.1111/j.1469-8137.2012.04367.x; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; Yu YH, 2011, MOL PLANT MICROBE IN, V24, P1102, DOI 10.1094/MPMI-11-10-0254; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179	43	35	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82120	10.1371/journal.pone.0082120	http://dx.doi.org/10.1371/journal.pone.0082120			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312634	Green Published, Green Submitted, gold			2022-12-25	WOS:000327947800086
J	Martins, RC; Catry, T; Santos, CD; Palmeirim, JM; Granadeiro, JP				Martins, Ricardo C.; Catry, Teresa; Santos, Carlos D.; Palmeirim, Jorge M.; Granadeiro, Jose P.			Seasonal Variations in the Diet and Foraging Behaviour of Dunlins Calidris alpina in a South European Estuary: Improved Feeding Conditions for Northward Migrants	PLOS ONE			English	Article							DUTCH WADDEN SEA; BURYING DEPTH; NEREIS-DIVERSICOLOR; SCROBICULARIA-PLANA; MACOMA-BALTHICA; STOPOVER SITES; BODY-WEIGHT; TIDAL FLATS; SIPHON SIZE; RED KNOTS	During the annual cycle, migratory waders may face strikingly different feeding conditions as they move between breeding areas and wintering grounds. Thus, it is of crucial importance that they rapidly adjust their behaviour and diet to benefit from peaks of prey abundance, in particular during migration, when they need to accumulate energy at a fast pace. In this study, we compared foraging behaviour and diet of wintering and northward migrating dunlins in the Tagus estuary, Portugal, by video-recording foraging birds and analysing their droppings. We also estimated energy intake rates and analysed variations in prey availability, including those that were active at the sediment surface. Wintering and northward migrating dunlins showed clearly different foraging behaviour and diet. In winter, birds predominantly adopted a tactile foraging technique (probing), mainly used to search for small buried bivalves, with some visual surface pecking to collect gastropods and crop bivalve siphons. Contrastingly, in spring dunlins generally used a visual foraging strategy, mostly to consume worms, but also bivalve siphons and shrimps. From winter to spring, we found a marked increase both in the biomass of invertebrate prey in the sediment and in the surface activity of worms and siphons. The combination of these two factors, together with the availability of shrimps in spring, most likely explains the changes in the diet and foraging behaviour of dunlins. Northward migrating birds took advantage from the improved feeding conditions in spring, achieving 65% higher energy intake rates as compared with wintering birds. Building on these results and on known daily activity budgets for this species, our results suggest that Tagus estuary provides high-quality feeding conditions for birds during their stopovers, enabling high fattening rates. These findings show that this large wetland plays a key role as a stopover site for migratory waders within the East Atlantic Flyway.	[Martins, Ricardo C.] Univ Lisbon, Museu Nacl Hist Nat & Ciencia, Ctr Biol Ambiental, P-1699 Lisbon, Portugal; [Catry, Teresa; Santos, Carlos D.] Univ Lisbon, Ctr Estudos Ambiente & Mar, Museu Nacl Hist Nat & Ciencia, P-1699 Lisbon, Portugal; [Santos, Carlos D.] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Palmeirim, Jorge M.] Univ Lisbon, Fac Ciencias, Dept Biol Anim, Ctr Biol Ambiental, Lisbon, Portugal; [Granadeiro, Jose P.] Univ Aveiro, Dept Biol, Ctr Estudos Ambiente & Mar, P-3800 Aveiro, Portugal	Universidade de Lisboa; Universidade de Lisboa; Max Planck Society; Universidade de Lisboa; Universidade de Aveiro	Martins, RC (corresponding author), Univ Lisbon, Museu Nacl Hist Nat & Ciencia, Ctr Biol Ambiental, P-1699 Lisbon, Portugal.	ricjmartins@hotmail.com	Martins, Ricardo C./AAB-7012-2019; Santos, Carlos/E-5881-2013; Palmeirim, Jorge M/A-1323-2014; Catry, Teresa/A-8082-2012; Granadeiro, José Pedro/E-8060-2011	Martins, Ricardo C./0000-0003-2540-8574; Santos, Carlos/0000-0001-5693-9795; Palmeirim, Jorge M/0000-0003-4734-8162; Catry, Teresa/0000-0003-4047-9995; Granadeiro, José Pedro/0000-0002-7207-3474	Fundacao para a Ciencia e a Tecnologia [PTDC/MAR/119920/2010, SFRH/BD/44871/2008, SFRH/BPD/46967/2008, SFRH/BPD/64786/2009]; project "Sustainable Use of Marine Resources - MARES'' [CENTRO-07-ST24-FEDER-002033]; "Mais Centro'' Regional Operational Programme (Centro Region); European Regional Development Fund (ERDF); Fundação para a Ciência e a Tecnologia [PTDC/MAR/119920/2010] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); project "Sustainable Use of Marine Resources - MARES''; "Mais Centro'' Regional Operational Programme (Centro Region); European Regional Development Fund (ERDF)(European Commission); Fundação para a Ciência e a Tecnologia	This study was supported by Fundacao para a Ciencia e a Tecnologia (http://alfa.fct.mctes.pt/) through Project PTDC/MAR/119920/2010 and grants to RCM (SFRH/BD/44871/2008), TC (SFRH/BPD/46967/2008) and CDS (SFRH/BPD/64786/2009). JPG was under a research contract within project "Sustainable Use of Marine Resources - MARES'' (CENTRO-07-ST24-FEDER-002033), co-financed by "Mais Centro'' Regional Operational Programme (Centro Region) and European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AJ, 2004, P ROY SOC B-BIOL SCI, V271, P875, DOI 10.1098/rspb.2003.2663; Beninger PG, 2011, MAR ECOL PROG SER, V428, P259, DOI 10.3354/meps09050; BWPi, 2006, BIREDS W PAL INT BIR; Cabral M.J., 2005, LIVRO VERMELHO VERTE; Catry T, 2012, J AVIAN BIOL, V43, P79, DOI 10.1111/j.1600-048X.2011.05497.x; Catry T, 2011, BIRD CONSERV INT, V21, P438, DOI 10.1017/S0959270910000626; Clark NA, 1983, ECOLOGY DUNLIN CALID; DAVIDSON PE, 1971, BIRD STUDY, V18, P177, DOI 10.1080/00063657109476312; Delany S., 2009, ATLAS WADER POPULATI; Dias MP, 2006, BIOL CONSERV, V131, P446, DOI 10.1016/j.biocon.2006.02.020; Dierschke V, 1999, J SEA RES, V42, P49, DOI 10.1016/S1385-1101(99)00013-1; DURELL SEALD, 1990, BIRD STUDY, V37, P44; ESSELINK P, 1989, MAR ECOL PROG SER, V56, P243, DOI 10.3354/meps056243; FERNS PN, 1984, IBIS, V126, P457; GOEDE AA, 1990, ARDEA, V78, P135; GOSSCUSTARD JD, 1977, J APPL ECOL, V14, P681, DOI 10.2307/2402803; Granadeiro JP, 2007, HYDROBIOLOGIA, V587, P291, DOI 10.1007/s10750-007-0692-8; Granadeiro JP, 2006, ACTA OECOL, V29, P293, DOI 10.1016/j.actao.2005.11.008; Guerreiro J, 1991, THESIS U LISBON; International Wader Study Group, 2003, WADER STUDY GROUP C, P202; IUCN, 2022, IUCN RED LIST THREAT; KERSTEN M, 1987, ARDEA, V75, P175; Kuwae T, 2012, ECOL LETT, V15, P347, DOI 10.1111/j.1461-0248.2012.01744.x; Kuwae T, 2010, MAR ECOL PROG SER, V406, P281, DOI 10.3354/meps08519; Lopes R.J., 1998, Airo, V9, P27; Lopes RJ, 2006, J ORNITHOL, V147, P385, DOI 10.1007/s10336-005-0048-y; Lourenco PM, 2008, ACTA OECOL, V34, P122, DOI 10.1016/j.actao.2008.04.005; Lourenco PM, 2005, J APPL ECOL, V42, P477, DOI 10.1111/j.1365-2664.2005.01045.x; Luis A, 2002, HYDROBIOLOGIA, V475, P335, DOI 10.1023/A:1020339409151; MacDonald EC, 2012, CONDOR, V114, P135, DOI 10.1525/cond.2012.100246; Masero JA, 1999, ACTA OECOL, V20, P429, DOI 10.1016/S1146-609X(99)00125-3; MOREIRA FM, 1995, THESIS U LISBON; MOURITSEN KN, 1993, BIRD STUDY, V40, P212, DOI 10.1080/00063659309477185; MOURITSEN KN, 1992, MAR ECOL PROG SER, V85, P1, DOI 10.3354/meps085001; MOURITSEN KN, 1994, J AVIAN BIOL, V25, P55, DOI 10.2307/3677294; Nebel S, 2005, ANIM BIOL, V55, P235, DOI 10.1163/1570756054472818; NEHLS G, 1993, NETH J SEA RES, V31, P375, DOI 10.1016/0077-7579(93)90054-V; PIENKOWSKI MW, 1979, BIRD STUDY, V26, P134, DOI 10.1080/00063657909476632; PIERSMA T, 1993, NETH J SEA RES, V31, P503, DOI 10.1016/0077-7579(93)90062-W; Piersma Theunis, 2005, P262; RANDS MRW, 1981, ORNIS SCAND, V12, P28, DOI 10.2307/3675901; Rodrigues AM, 2006, HYDROBIOLOGIA, V555, P99, DOI 10.1007/s10750-005-1109-1; Rosa S, 2006, IBIS, V148, P88, DOI 10.1111/j.1474-919X.2006.00497.x; Santos CD, 2010, ACTA OECOL, V36, P166, DOI 10.1016/j.actao.2009.11.008; Santos CD, 2010, J AVIAN BIOL, V41, P18, DOI 10.1111/j.1600-048X.2009.04860.x; Santos CD, 2009, J EXP MAR BIOL ECOL, V372, P43, DOI 10.1016/j.jembe.2009.02.005; Santos CD, 2005, ARDEOLA, V52, P235; Scheiffarth G, 1997, HELGOLANDER MEERESUN, V51, P373, DOI 10.1007/BF02908721; Smith RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045121; STEVENTON D J, 1977, Ringing and Migration, V1, P141; van de Kam J, 2004, SHOREBIRDS ILLUSTRAT; van Gils JA, 2005, P ROY SOC B-BIOL SCI, V272, P2609, DOI 10.1098/rspb.2005.3245; Verkuil YI, 2012, BIOL CONSERV, V149, P51, DOI 10.1016/j.biocon.2012.01.059; Viegas I, 2007, SCI MAR, V71, P451, DOI 10.3989/scimar.2007.71n3451; Warnock N, 2010, J AVIAN BIOL, V41, P621, DOI 10.1111/j.1600-048X.2010.05155.x; WOLFF WJ, 1990, ARDEA, V78, P17; WORRALL DH, 1984, BIRD STUDY, V31, P203, DOI 10.1080/00063658409476842; ZWARTS L, 1990, ARDEA, V78, P339; ZWARTS L, 1989, MAR ECOL PROG SER, V56, P255, DOI 10.3354/meps056255; ZWARTS L, 1993, NETH J SEA RES, V31, P441, DOI 10.1016/0077-7579(93)90059-2; ZWARTS L, 1992, MAR ECOL PROG SER, V83, P129, DOI 10.3354/meps083129; ZWARTS L, 1989, MAR BIOL, V100, P227, DOI 10.1007/BF00391963; ZWARTS L, 1994, J EXP MAR BIOL ECOL, V183, P193, DOI 10.1016/0022-0981(94)90087-6; ZWARTS L, 1991, NETH J SEA RES, V28, P231, DOI 10.1016/0077-7579(91)90021-R	64	24	27	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81174	10.1371/journal.pone.0081174	http://dx.doi.org/10.1371/journal.pone.0081174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312532	Green Published, gold, Green Submitted			2022-12-25	WOS:000327947800039
J	Wang, X; Du, YZ; Fan, L; Ye, P; Yuan, Y; Lu, XC; Wang, F; Zeng, Q				Wang, Xi; Du, YingZhen; Fan, Li; Ye, Ping; Yuan, Ying; Lu, XueChun; Wang, Fan; Zeng, Qiang			Relationships between HDL-C, hs-CRP, with Central Arterial Stiffness in Apparently Healthy People Undergoing a General Health Examination	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ASSOCIATION; CHOLESTEROL; LIPOPROTEINS; INDEX; WOMEN; OLDER; MEN	Background: Some cardiovascular risk factors have been confirmed to be positively correlated with arterial stiffness. However, it is unclear whether HDL-C, a well-established anti-risk factor, has an independent association with arterial stiffness. The aim of this study was to evaluate the relationship between HDL-C levels and arterial stiffness and the possible role of high-sensitivity C-reactive protein (hs-CRP) in this potential correlation in apparently healthy adults undergoing a general health examination in China. Materials and Methods: This was a cross-sectional survey. In total, 15,302 participants (age range, 18-82 years; mean, 43.88 +/- 8.44 years) were recruited during routine health status examinations. A questionnaire was used and we measured the body mass index, systolic and diastolic blood pressure, and fasting glucose, and serum lipid, uric acid, hs-CRP, and serum creatinine levels of each participant. Central arterial stiffness was assessed by carotid-femoral pulse wave velocity (cf-PWV). Results: HDL-C levels decreased as cf-PWV increased. Pearson's correlation analysis revealed that HDL-C levels were associated with cf-PWV (r=-0.18, P<0.001). hs-CRP levels were positively associated with cf-PWV (r=0.13). After adjustment for all confounders, HDL-C was inversely independently associated with all quartiles of cf-PWV. Furthermore, HDL-C was associated with cf-PWV in different quartiles of hs-CRP, and the correlation coefficients (r) gradually decreased with increasing hs-CRP levels (quartiles 1-4). Conclusions: HDL-C is inversely independently associated with central arterial stiffness. The anti-inflammatory activity of HDL-C may mediate its relationship with cf-PWV. Further, long-term follow-up studies are needed to evaluate whether high HDL-C levels are protective against central artery stiffening through the anti-inflammatory activity of HDL-C.	[Wang, Xi; Fan, Li; Ye, Ping; Lu, XueChun; Wang, Fan] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China; [Du, YingZhen] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Resp, Beijing, Peoples R China; [Yuan, Ying] Inst Aviat Med, Affiliated Hosp, Dept Internal Med 2, Beijing, Peoples R China; [Zeng, Qiang] Chinese Peoples Liberat Army Gen Hosp, Int Med Ctr, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Fan, L (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China.	fanli301@sina.com			State Science and Technology Support Program of China [2009BAI86B04, 2012BAI37B04]; Military Eleventh Year Health Promotion Programe [10BJZ18]	State Science and Technology Support Program of China; Military Eleventh Year Health Promotion Programe	This study was supported by a grant from the State Science and Technology Support Program of China (2009BAI86B04, 2012BAI37B04) and Military Eleventh Year Health Promotion Programe (10BJZ18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagona C, 2003, EUR J CLIN INVEST, V33, P457, DOI 10.1046/j.1365-2362.2003.01165.x; Besler C, 2012, EMBO MOL MED, V4, P251, DOI 10.1002/emmm.201200224; Campbell S, 2013, EXPERT REV CARDIOVAS, V11, P343, DOI [10.1586/ERC.13.17, 10.1586/erc.13.17]; Cecelja M, 2009, HYPERTENSION, V54, P1328, DOI 10.1161/HYPERTENSIONAHA.109.137653; Dart AM, 2004, ARTERIOSCL THROM VAS, V24, P962, DOI 10.1161/01.ATV.0000126371.14332.ab; Heinecke JW, 2010, J CLIN LIPIDOL, V4, P371, DOI 10.1016/j.jacl.2010.08.005; Ishisone T, 2013, INT HEART J, V54, P160, DOI 10.1536/ihj.54.160; Jae SY, 2012, J ATHEROSCLER THROMB, V19, P1035, DOI 10.5551/jat.13516; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Masugata H, 2013, J INT MED RES, V41, P325, DOI 10.1177/0300060513476590; Matsui Y, 2004, HYPERTENS RES, V27, P851, DOI 10.1291/hypres.27.851; Pal S, 2013, J CLIN HYPERTENS, V15, P118, DOI 10.1111/jch.12038; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sattler K, 2009, CARDIOVASC RES, V82, P201, DOI 10.1093/cvr/cvp070; Shankar A, 2008, NEPHROL DIAL TRANSPL, V23, P1910, DOI 10.1093/ndt/gfm878; Stancu CS, 2012, CELL TISSUE RES, V349, P433, DOI 10.1007/s00441-012-1437-1; Takahashi R, 2010, J ATHEROSCLER THROMB, V17, P1282, DOI 10.5551/jat.5272; Tran-Dinh A, 2013, BRIT J PHARMACOL, V169, P493, DOI 10.1111/bph.12174; van den Bogaard B, 2012, ATHEROSCLEROSIS, V225, P481, DOI 10.1016/j.atherosclerosis.2012.09.022; Wang F, 2011, EUR J CLIN INVEST, V41, P929, DOI 10.1111/j.1365-2362.2011.02481.x; Weng CY, 2012, INT J MED SCI, V9, P730, DOI 10.7150/ijms.4752; Yasmin, 2005, ARTERIOSCL THROM VAS, V25, P372, DOI 10.1161/01.ATV.0000151373.33830.41; Zhang LX, 2007, NEPHROL DIAL TRANSPL, V22, P1093, DOI 10.1093/ndt/gfl763; ZHAO WW, 2012, NUTR METAB CARDIOVAS, V22, P14242	25	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81778	10.1371/journal.pone.0081778	http://dx.doi.org/10.1371/journal.pone.0081778			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312587	Green Submitted, Green Published, gold			2022-12-25	WOS:000327947800057
J	Habersack, M; Luschin, G				Habersack, Marion; Luschin, Gero			Insecurities of Women Regarding Breast Cancer Research: A Qualitative Study	PLOS ONE			English	Article							CLINICAL-TRIALS; DECISION-MAKING; PARTICIPATION; BARRIERS; CHEMOPREVENTION; IDENTIFICATION; RECRUITMENT; PREVENTION	Objectives: Only 1.2%-11% of all potential study participants participate in cancer studies. Low participation rates can result in bias or in a failure to obtain data saturation. Subject-scientific psychology assumes that reasons for acting are based on individual premises. The objective of this study was to render reproducible individual reasons of female breast cancer patients to participate or not participate in breast cancer studies using a qualitative approach. Methods: Problem-based interviews were conducted with female breast cancer patients. The selection of interview partners continued until theoretical data saturation was achieved. Results: As main arguments against participation emotional overload and too many medication side-effects were stated. Improvement of health-related values, long-term protection and comprehensive follow-up exams were stated as arguments for participation. Trust in the attending physician was mentioned as influencing both participation and non-participation. Conclusions: A significant influential factor determining willingness to participate in studies was one's contentment with patient-physician communication. In order to guarantee an adequate patient decision-making process, keeping existing standards for patient briefings is absolutely mandatory.	[Habersack, Marion] Med Univ Graz, Off Vice Rector Teaching & Studies, Graz, Austria; [Luschin, Gero] Womens Hlth Assoc Graz, Graz, Austria	Medical University of Graz	Habersack, M (corresponding author), Med Univ Graz, Off Vice Rector Teaching & Studies, Graz, Austria.	marion.habersack@medunigraz.at						Altschuler A, 2005, WOMEN HEALTH, V41, P81, DOI 10.1300/J013v41n02_06; Brown R, 2011, PSYCHO-ONCOLOGY, V20, P361, DOI 10.1002/pon.1748; Brown RF, 2011, SUPPORT CARE CANCER, V19, P1227, DOI 10.1007/s00520-010-0942-6; Carlin JB, 2002, J PAEDIATR CHILD H, V38, P300, DOI 10.1046/j.1440-1754.2002.00855.x; Cox AC, 2006, SUPPORT CARE CANCER, V14, P303, DOI 10.1007/s00520-005-0916-2; Ellis PM, 2002, ANN ONCOL, V13, P1414, DOI 10.1093/annonc/mdf255; Flick U., 2011, QUALITATIVE SOZIALFO, V12; Gehrke B, 2008, OLDER PEOPLE NEW MED; Holzkamp K, 1993, SUBJEKTWISSENSCHAFTL; Holzkamp K, 1994, LECT CONT POTSD C LE; Houlihan RH, 2010, CANCER-AM CANCER SOC, V116, P3569, DOI 10.1002/cncr.25230; Kim SYH, 2004, J MED ETHICS, V30, P73, DOI 10.1136/jme.2002.001461; Kromrey H., 2009, EMPIRISCHE SOZIALFOR; Lamnek S., 2010, QUALITATIVE SOZIALFO; Lara PN, 2001, J CLIN ONCOL, V19, P1728, DOI 10.1200/JCO.2001.19.6.1728; Lemieux J, 2008, J CLIN ONCOL, V26, P4458, DOI 10.1200/JCO.2007.15.3726; Lichtmann M, 2011, UNDERSTANDING EVALUA; Loehberg CR, 2010, BREAST CANCER RES TR, V121, P101, DOI 10.1007/s10549-010-0845-8; Luschin G, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-25; Mancini J, 2007, CONTEMP CLIN TRIALS, V28, P684, DOI 10.1016/j.cct.2007.03.001; Mandelblatt J, 2005, PREV MED, V40, P611, DOI 10.1016/j.ypmed.2004.09.004; Mayring P., 2016, MIXED METHODOLOGY PS, V6th edition; Mayring P, 1994, QUALITATIVE CONTENT; Mills EJ, 2006, LANCET ONCOL, V7, P141, DOI 10.1016/S1470-2045(06)70576-9; Murthy VH, 2004, JAMA-J AM MED ASSOC, V291, P2720, DOI 10.1001/jama.291.22.2720; Peppercorn JM, 2004, LANCET, V363, P263, DOI 10.1016/S0140-6736(03)15383-4; Rondanina G, 2008, J CLIN ONCOL, V26, P1537, DOI 10.1200/JCO.2007.13.6739; Townsley CA, 2005, J CLIN ONCOL, V23, P3112, DOI 10.1200/JCO.2005.00.141; Witzel A., 1985, QUALITATIVE FORSCHUN, P227; Witzel Andreas, 2000, PROBLEM CTR INTERVIE	30	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81770	10.1371/journal.pone.0081770	http://dx.doi.org/10.1371/journal.pone.0081770			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312584	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500096
J	Novaes, RML; Ribeiro, RA; Lemos, JP; Lovato, MB				Lage Novaes, Renan Milagres; Ribeiro, Renata Acacio; Lemos-Filho, Jose Pires; Lovato, Maria Bernadete			Concordance between Phylogeographical and Biogeographical Patterns in the Brazilian Cerrado: Diversification of the Endemic Tree Dalbergia miscolobium (Fabaceae)	PLOS ONE			English	Article							STATISTICAL-METHOD; POPULATION-GROWTH; SOUTH; CONSERVATION; VEGETATION; DIVERSITY; EVOLUTION; CHLOROPLAST; SOFTWARE; PLANT	Few studies have addressed the phylogeography of species of the Cerrado, the largest savanna biome of South America. Here we aimed to investigate the phylogeographical structure of Dalbergia miscolobium, a widespread tree from the Cerrado, and to verify its concordance with plant phylogeographical and biogeographical patterns so far described. A total of 287 individuals from 32 populations were analyzed by sequencing the trnL intron of the chloroplast DNA and the internal transcribed spacer of the nuclear ribosomal DNA. Analysis of population structure and tests of population expansion were performed and the time of divergence of haplotypes was estimated. Twelve and 27 haplotypes were identified in the cpDNA and nrDNA data, respectively. The star-like network configuration and the mismatch distributions indicated a recent spatial and demographic expansion of the species. Consistent with previous tree phylogeographical studies of Cerrado trees, the cpDNA also suggested a recent expansion towards the southern Cerrado. The diversity of D. miscolobium was widespread but high levels of genetic diversity were found in the Central Eastern and in the southern portion of Central Western Cerrado. The combined analysis of cpDNA and nrDNA supported a phylogeographic structure into seven groups. The phylogeographical pattern showed many concordances with biogeographical and phylogeographical studies in the Cerrado, mainly with the Cerrado phytogeographic provinces superimposed to our sampling area. The data reinforced the uniqueness of Northeastern and Southeastern Cerrados and the differentiation between Eastern and Western Central Cerrados. The recent diversification of the species (estimated between the Pliocene and the Pleistocene) and the 'genealogical concordances' suggest that a shared and persistent pattern of species diversification might have been present in the Cerrado over time. This is the first time that an extensive 'genealogical concordance' between phylogeographic and phytogeographic patterns is shown for the Cerrado biome.	[Lage Novaes, Renan Milagres] Empresa Brasileira Pesquisa Agropecuaria, Londrina, Brazil; [Ribeiro, Renata Acacio] Univ Fed Vales Jequitinhonha & Mucuri, Dept Ciencias Biol, Diamantina, Brazil; [Lemos-Filho, Jose Pires] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bot, Belo Horizonte, MG, Brazil; [Lovato, Maria Bernadete] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Lovato, MB (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil.	lovatomb@icb.ufmg.br		Milagres L. Novaes, Renan/0000-0002-8113-9578	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CNPq	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The Pro-Reitoria de Pesquisa of the Universidade Federal de Minas Gerais provided resources for editing the language of the manuscript. R. A. R., M. B. L., and J.P.L-F. received research fellowships from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab'Saber A.N., 1983, REV SERVICO PUBLICO, V111, P41; Albaladejo RG, 2005, TAXON, V54, P987, DOI 10.2307/25065483; Avise J.C, 2000, PHYLOGEOGRAPHY HIST, DOI DOI 10.2307/J.CTV1NZFGJ7; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beheregaray LB, 2008, MOL ECOL, V17, P3754, DOI 10.1111/j.1365-294X.2008.03857.x; Behling H, 1997, QUATERNARY RES, V48, P348, DOI 10.1006/qres.1997.1932; Behling H, 2002, PALAEOGEOGR PALAEOCL, V177, P19, DOI 10.1016/S0031-0182(01)00349-2; Bitocchi E, 2012, P NATL ACAD SCI USA, V109, pE788, DOI 10.1073/pnas.1108973109; Brante A, 2012, J HERED, V103, P630, DOI 10.1093/jhered/ess030; Bridgewater S, 2004, BIODIVERS CONSERV, V13, P2295, DOI 10.1023/B:BIOC.0000047903.37608.4c; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Carvalho Ad, 1989, SYSTEMATIC STUDIES G; Castro A. A.J. F., 1999, PESQUISA FOCO, V7, P147; Castro AAJF, 1994, THESIS U ESTADUAL CA; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collevatti RG, 2003, MOL ECOL, V12, P105, DOI 10.1046/j.1365-294X.2003.01701.x; Collevatti RG, 2009, ANN BOT-LONDON, V104, P655, DOI 10.1093/aob/mcp157; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Da Silva JMC, 2002, BIOSCIENCE, V52, P225, DOI 10.1641/0006-3568(2002)052[0225:BPACIT]2.0.CO;2; Delgado-Salinas A, 1999, SYST BOT, V24, P438, DOI 10.2307/2419699; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Durigan G., 2003, Edinburgh Journal of Botany, V60, P217, DOI 10.1017/S0960428603000155; Durigan G, 2006, SYST ASSOC SPEC VOL, P67; EITEN G, 1972, BOT REV, V38, P201, DOI 10.1007/BF02859158; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Fang JY, 2013, PLOS ONE, V8, P1; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Fiaschi P, 2009, J SYST EVOL, V47, P477, DOI 10.1111/j.1759-6831.2009.00046.x; Fu YX, 1997, GENETICS, V147, P915; Garrick RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-118; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Jones FA, 2013, J BIOGEOGR, V40, P720, DOI 10.1111/jbi.12037; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Kropf M, 2012, J BIOGEOGR, V39, P799, DOI 10.1111/j.1365-2699.2011.02668.x; Novaes RML, 2010, MOL ECOL, V19, P985, DOI 10.1111/j.1365-294X.2010.04530.x; Ledru Marie-Pierre., 2002, CERRADOS BRAZIL ECOL, P33; Ledru MP, 1996, PALAEOGEOGR PALAEOCL, V123, P239, DOI 10.1016/0031-0182(96)00105-8; Li JC, 2013, MOL ECOL, V22, P1933, DOI 10.1111/mec.12220; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Machado Moara, 2011, Investig Genet, V2, P3, DOI 10.1186/2041-2223-2-3; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Mayle FE, 2004, J QUATERNARY SCI, V19, P713, DOI 10.1002/jqs.887; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NEI M, 1974, GENETICS, V76, P379; Nogueira C, 2011, J BIOGEOGR, V38, P1907, DOI 10.1111/j.1365-2699.2011.02538.x; Oliveira-Filho A., 2002, CERRADOS BRAZIL, P91, DOI [10.1590/1519-6984.02016, DOI 10.7312/OLIV12042-007]; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pennington RT, 2006, SYST ASSOC SPEC VOL, P1; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; PRADO DE, 1993, ANN MO BOT GARD, V80, P902, DOI 10.2307/2399937; Queiroz CD, 2011, MOL PHYLOGENET EVOL, V59, P293, DOI 10.1016/j.ympev.2011.01.013; Ramos ACS, 2007, ANN BOT-LONDON, V100, P1219, DOI 10.1093/aob/mcm221; Ratter J. A., 1992, Edinburgh Journal of Botany, V49, P235; Ratter J. A., 2003, Edinburgh Journal of Botany, V60, P57, DOI 10.1017/S0960428603000064; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rull V, 2011, TRENDS ECOL EVOL, V26, P508, DOI 10.1016/j.tree.2011.05.011; Scariot A, 2005, CERRADO ECOLOGIA BIO; Silva Junior MC, 2005, 100 ARVORES CERRADO; Simon MF, 2009, P NATL ACAD SCI USA, V106, P20359, DOI 10.1073/pnas.0903410106; Simon MF, 2000, BIOL CONSERV, V96, P279, DOI 10.1016/S0006-3207(00)00085-9; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TEMPLETON AR, 1992, GENETICS, V132, P619; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; Vieira LT, 2012, PADROES DIVERSIDADE; Weiss S, 2007, PHYLOGEOGRAPHY SO EU; Werneck FP, 2012, J BIOGEOGR, V39, P1695, DOI 10.1111/j.1365-2699.2012.02715.x; Werneck FP, 2011, QUATERNARY SCI REV, V30, P1630, DOI 10.1016/j.quascirev.2011.03.009	84	29	29	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82198	10.1371/journal.pone.0082198	http://dx.doi.org/10.1371/journal.pone.0082198			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312640	gold, Green Submitted, Green Published			2022-12-25	WOS:000327944500123
J	Pan, JB; Hu, SC; Shi, D; Cai, MC; Li, YB; Zou, Q; Ji, ZL				Pan, Jian-Bo; Hu, Shi-Chang; Shi, Dan; Cai, Mei-Chun; Li, Yin-Bo; Zou, Quan; Ji, Zhi-Liang			PaGenBase: A Pattern Gene Database for the Global and Dynamic Understanding of Gene Function	PLOS ONE			English	Article							WEB-BASED TOOL; HOUSEKEEPING GENES; TISSUE; EXPRESSION; IDENTIFICATION; ATLAS; MOUSE	Pattern genes are a group of genes that have a modularized expression behavior under serial physiological conditions. The identification of pattern genes will provide a path toward a global and dynamic understanding of gene functions and their roles in particular biological processes or events, such as development and pathogenesis. In this study, we present PaGenBase, a novel repository for the collection of tissue-and time-specific pattern genes, including specific genes, selective genes, housekeeping genes and repressed genes. The PaGenBase database is now freely accessible at http://bioinf.xmu.edu.cn/PaGenBase/. In the current version (PaGenBase 1.0), the database contains 906,599 pattern genes derived from the literature or from data mining of more than 1,145,277 gene expression profiles in 1,062 distinct samples collected from 11 model organisms. Four statistical parameters were used to quantitatively evaluate the pattern genes. Moreover, three methods (quick search, advanced search and browse) were designed for rapid and customized data retrieval. The potential applications of PaGenBase are also briefly described. In summary, PaGenBase will serve as a resource for the global and dynamic understanding of gene function and will facilitate high-level investigations in a variety of fields, including the study of development, pathogenesis and novel drug discovery.	[Shi, Dan; Cai, Mei-Chun; Li, Yin-Bo; Ji, Zhi-Liang] Xiamen Univ, Sch Life Sci, State Key Lab Stress Cell Biol, Xiamen, Fujian, Peoples R China; [Pan, Jian-Bo; Ji, Zhi-Liang] Xiamen Univ, Coll Chem & Chem Engn, Dept Biol Chem, Key Lab Chem Biol Fujian Prov, Xiamen, Fujian, Peoples R China; [Hu, Shi-Chang; Zou, Quan] Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Ji, ZL (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Stress Cell Biol, Xiamen, Fujian, Peoples R China.	appo@xmu.edu.cn	Pan, Jianbo/M-6708-2018; Zou, Quan/A-7801-2015	Pan, Jianbo/0000-0001-6014-8160; 	Fundamental Research Funds for the Central Universities [2010121084]; Natural Science Foundation of China (NSFC) [31271405]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for the Central Universities (#2010121084) and the Natural Science Foundation of China (NSFC#31271405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bedell VM, 2012, DEVELOPMENT, V139, P793, DOI 10.1242/dev.071720; Bjorling E, 2008, MOL CELL PROTEOMICS, V7, P825, DOI 10.1074/mcp.M700411-MCP200; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Cheguru P, 2012, PFLUG ARCH EUR J PHY, V463, P429, DOI 10.1007/s00424-011-1066-7; Cho C, 2001, NAT GENET, V28, P82, DOI 10.1038/ng0501-82; De Ferrari L, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-277; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dezso Z, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-49; Dong B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021012; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Guibinga GH, 2010, MOL THER, V18, P54, DOI 10.1038/mt.2009.178; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kogenaru S, 2010, THEOR CHEM ACC, V125, P651, DOI 10.1007/s00214-009-0670-5; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Krupp M, 2012, BIOINFORMATICS, V28, P1184, DOI 10.1093/bioinformatics/bts084; KUMAR RS, 2004, SEMIN ANESTH PERIO M, V23, P12, DOI DOI 10.1053/j.sane.2003.12.010; Kumar S, 2011, BIOINFORMATICS, V27, P3319, DOI 10.1093/bioinformatics/btr567; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; Lee S, 2007, J BIOCHEM MOL BIOL, V40, P226; Liang S, 2006, PHYSIOL GENOMICS, V26, P158, DOI 10.1152/physiolgenomics.00313.2005; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Makawita S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008599; Pan JB, 2012, BIOINFORMATICS, V28, P1544, DOI 10.1093/bioinformatics/bts169; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Richards CL, 2012, PLOS GENET, V8, P482, DOI 10.1371/journal.pgen.1002662; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Steger K, 2011, INT J ANDROL, V34, P513, DOI 10.1111/j.1365-2605.2010.01129.x; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tarraga J, 2008, NUCLEIC ACIDS RES, V36, pW308, DOI 10.1093/nar/gkn303; Thorrez L, 2011, GENOME RES, V21, P95, DOI 10.1101/gr.109173.110; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; VIGUIE F, 1990, HUM GENET, V85, P171; Wang YP, 2006, NUCLEIC ACIDS RES, V34, pW492, DOI 10.1093/nar/gkl067; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xiao SJ, 2010, BIOINFORMATICS, V26, P1273, DOI 10.1093/bioinformatics/btq109; Zhang YE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001179	40	84	86	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80747	10.1371/journal.pone.0080747	http://dx.doi.org/10.1371/journal.pone.0080747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312499	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500041
J	Tak, H; Haque, MM; Kim, MJ; Lee, JH; Baik, JH; Kim, Y; Kim, DJ; Grailhe, R; Kim, YK				Tak, HyeJin; Haque, Md Mamunul; Kim, Min Jung; Lee, Joo Hyun; Baik, Ja-Hyun; Kim, YoungSoo; Kim, Dong Jin; Grailhe, Regis; Kim, Yun Kyung			Bimolecular Fluorescence Complementation; Lighting-Up Tau-Tau Interaction in Living Cells	PLOS ONE			English	Article							NEURITE OUTGROWTH; PROTEIN-KINASE; PHOSPHORYLATION; MICROTUBULES; AGGREGATION; ACTIVATION; BINDING; ASSAY; NEURODEGENERATION; FORSKOLIN	Abnormal tau aggregation is a pathological hallmark of many neurodegenerative disorders and it is becoming apparent that soluble tau aggregates play a key role in neurodegeneration and memory impairment. Despite this pathological importance, there is currently no single method that allows monitoring soluble tau species in living cells. In this regard, we developed a cell-based sensor that visualizes tau self-assembly. By introducing bimolecular fluorescence complementation (BiFC) technique to tau, we were able to achieve spatial and temporal resolution of tau-tau interactions in a range of states, from soluble dimers to large aggregates. Under basal conditions, tau-BiFC cells exhibited little fluorescence intensity, implying that the majority of tau molecules exist as monomers. Upon chemically induced tau hyperphosphorylation, BiFC fluorescence greatly increased, indicating an increased level of tau-tau interactions. As an indicator of tau assembly, our BiFC sensor would be a useful tool for investigating tau pathology.	[Tak, HyeJin; Haque, Md Mamunul; Kim, Min Jung; Kim, YoungSoo; Kim, Dong Jin; Kim, Yun Kyung] Korea Inst Sci & Technol, Brain Sci Inst, Ctr Neuromed, Seoul, South Korea; [Tak, HyeJin; Baik, Ja-Hyun] Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea; [Haque, Md Mamunul] UST, Daejon, South Korea; [Lee, Joo Hyun; Grailhe, Regis] Inst Pasteur Korea, Sungnam, South Korea	Korea Institute of Science & Technology (KIST); Korea University; University of Science & Technology (UST); Institut Pasteur Korea	Kim, YK (corresponding author), Korea Inst Sci & Technol, Brain Sci Inst, Ctr Neuromed, Seoul, South Korea.	yunkyungkim@kist.re.kr	Haque, Md Mamunul/AAE-6270-2020; Kim, YoungSoo/AAO-1970-2020	Haque, Md Mamunul/0000-0002-3494-4953; Kim, YoungSoo/0000-0001-5029-7082	Korea Institute of Science and Technology [2E23870, 2E24138]; Korea government (MSIP) [2007-00559]; National Research Foundation of Korea [NRF-2012R1A1A2004980]	Korea Institute of Science and Technology(Korea Institute of Science & Technology (KIST)); Korea government (MSIP); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by an intramural funding from Korea Institute of Science and Technology (2E23870 and 2E24138, the Korea government (MSIP, number 2007-00559), and the National Research Foundation of Korea individual scientist supporting program (NRF-2012R1A1A2004980). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIAS C, 1993, J NEUROCHEM, V61, P673; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Brandt R, 2005, BBA-MOL BASIS DIS, V1739, P331, DOI 10.1016/j.bbadis.2004.06.018; Brunden KR, 2008, J ALZHEIMERS DIS, V14, P393; Cheng HC, 2002, J BIOL CHEM, V277, P33930, DOI 10.1074/jbc.M201206200; Chun WJ, 2007, J NEUROCHEM, V103, P2529, DOI 10.1111/j.1471-4159.2007.04941.x; Chun W, 2007, J BIOL CHEM, V282, P23410, DOI 10.1074/jbc.M703706200; Chun W, 2011, METHODS MOL BIOL, V670, P109, DOI 10.1007/978-1-60761-744-0_9; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; Gendron TF, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-13; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hansen TV, 2003, NEUROSCI LETT, V347, P57, DOI 10.1016/S0304-3940(03)00581-0; Jenkins SM, 1999, J NEUROCHEM, V73, P1843; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Liu SJ, 2004, J BIOL CHEM, V279, P50078, DOI 10.1074/jbc.M406109200; MARANTZ R, 1969, SCIENCE, V165, P498, DOI 10.1126/science.165.3892.498; Minoura I, 2006, BIOPHYS J, V90, P3739, DOI 10.1529/biophysj.105.071324; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; RICHTERLANDSBERG C, 1986, J CELL BIOL, V102, P821, DOI 10.1083/jcb.102.3.821; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Tian Q, 2009, J ALZHEIMERS DIS, V17, P631, DOI 10.3233/JAD-2009-1088; Zhang Z, 2010, BRAIN RES, V1345, P176, DOI 10.1016/j.brainres.2010.04.074	24	43	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81682	10.1371/journal.pone.0081682	http://dx.doi.org/10.1371/journal.pone.0081682			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312574	Green Published, gold, Green Submitted			2022-12-25	WOS:000327944500087
J	Wang, JL; Park, JW; Drissi, H; Wang, XF; Xu, RH				Wang, Jianle; Park, Jung W.; Drissi, Hicham; Wang, Xiaofang; Xu, Ren-He			Epigenetic Regulation of miR-302 by JMJD1C Inhibits Neural Differentiation of Human Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Embryonic Stem Cell; Epigenetics; Histone Methylation; MicroRNA; Neurodifferentiation	HISTONE METHYLATION; ES CELLS; PLURIPOTENCY; TARGETS; GROWTH; IDENTIFICATION; EXPRESSION; MOUSE	It has been recently reported that the regulatory circuitry formed by OCT4, miR-302, and NR2F2 controls both pluripotency and neural differentiation of human embryonic stem cells (hESCs). We show here that JMJD1C, a histone 3 lysine 9 (H3K9) demethylase expressed in hESCs, directly interacts with this circuitry. hESCs with stable knockdown of JMJD1C remain pluripotent while having reduced miR-302 expression, decreased BMP signaling, and enhanced TGF signaling. JMJD1C binds to the miR-302 promoter and reduces H3K9 methylation. Withdrawal of basic fibroblast growth factor (bFGF) from the culture induces neural differentiation of the knockdown, but not the control, cells within 3 days, accompanied by elevated NR2F2 expression. This can be attenuated with miR-302 mimics or an H3K9 methytransferase inhibitor. Together, our findings suggest that JMJD1C represses neural differentiation of hESCs at least partially by epigenetically sustaining miR-302 expression and that JMJD1C knockdown is sufficient to trigger neural differentiation upon withdrawal of exogenous bFGF.	[Wang, Jianle; Park, Jung W.; Wang, Xiaofang; Xu, Ren-He] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Drissi, Hicham] Univ Connecticut, Ctr Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut	Wang, XF (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA.	xiaofangwang@uchc.edu; renhexu@uchc.edu	Xu, Ren-He/M-3125-2016; wang, xiaofang/A-9967-2015; Xu, Ren-He/AAK-7392-2021; Park, Jung Woo/R-6263-2019	wang, xiaofang/0000-0002-2911-0161; Park, Jung Woo/0000-0003-0657-7401; drissi, hicham/0000-0002-3322-281X	Connecticut Stem Cell Research Grants [06SCB14, 09SCD01, 10SCA21, 11SCB08]	Connecticut Stem Cell Research Grants	This work was supported by Connecticut Stem Cell Research Grants 06SCB14 and 09SCD01 (to R. X.), 10SCA21 (to X. W.), and 11SCB08 (to H. D.).	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Barroso-delJesus A, 2011, FASEB J, V25, P1497, DOI 10.1096/fj.10-172221; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Castermans D, 2007, EUR J HUM GENET, V15, P422, DOI 10.1038/sj.ejhg.5201785; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Coskun V, 2012, CURR OPIN NEUROBIOL, V22, P762, DOI 10.1016/j.conb.2012.07.001; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Katoh M, 2006, INT J MOL MED, V17, P795; Katoh M, 2007, INT J ONCOL, V31, P219; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Kim SM, 2010, NUCLEIC ACIDS RES, V38, P6389, DOI 10.1093/nar/gkq491; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090; Lin G, 2010, METHODS MOL BIOL, V636, P1, DOI 10.1007/978-1-60761-691-7_1; Lipchina I, 2012, CELL CYCLE, V11, P1517, DOI 10.4161/cc.19846; Lipchina I, 2011, GENE DEV, V25, P2173, DOI 10.1101/gad.17221311; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Miyazono K, 2000, J CELL SCI, V113, P1101; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Rosa A, 2011, EMBO J, V30, P237, DOI 10.1038/emboj.2010.319; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang JL, 2010, BIOL REPROD, V82, P105, DOI 10.1095/biolreprod.109.078055; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wang XF, 2009, J BIOL CHEM, V284, P34054, DOI 10.1074/jbc.M109.052290; Wen S, 2009, PROG NEUROBIOL, V87, P98, DOI 10.1016/j.pneurobio.2008.10.002; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	38	34	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2384	2395		10.1074/jbc.M113.535799	http://dx.doi.org/10.1074/jbc.M113.535799			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24318875	Green Published, hybrid			2022-12-25	WOS:000331130200042
J	Rauch, JN; Gestwicki, JE				Rauch, Jennifer N.; Gestwicki, Jason E.			Binding of Human Nucleotide Exchange Factors to Heat Shock Protein 70 (Hsp70) Generates Functionally Distinct Complexes in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Isothermal Titration Calorimetry; Molecular Chaperone; Protein Complexes; Protein Folding; Protein Misfolding; Protein-Protein Interactions; Hsp40; Cochaperones	HEAT-SHOCK-PROTEIN; HIGH-THROUGHPUT SCREEN; MOLECULAR CHAPERONES; STRUCTURAL BASIS; NEGATIVE REGULATOR; HSP110 CHAPERONES; HSC70 CHAPERONE; QUALITY-CONTROL; ATP HYDROLYSIS; J-DOMAIN	Background: There has been an expansion of the number of Hsp70 cochaperones in mammals, providing the opportunity for combinatorial assembly of permutations with specialized functions. Results: We studied the chaperone activity of Hsp70 combined with four different NEFs and four J proteins. Conclusion: Some combinations were active, whereas others were inactive. Significance: Cochaperones appear to expand the functional diversity of Hsp70. Proteins with Bcl2-associated anthanogene (BAG) domains act as nucleotide exchange factors (NEFs) for the molecular chaperone heat shock protein 70 (Hsp70). There are six BAG family NEFs in humans, and each is thought to link Hsp70 to a distinct cellular pathway. However, little is known about how the NEFs compete for binding to Hsp70 or how they might differentially shape its biochemical activities. Toward these questions, we measured the binding of human Hsp72 (HSPA1A) to BAG1, BAG2, BAG3, and the unrelated NEF Hsp105. These studies revealed a clear hierarchy of affinities: BAG3 > BAG1 > Hsp105 >> BAG2. All of the NEFs competed for binding to Hsp70, and their relative affinity values predicted their potency in nucleotide and peptide release assays. Finally, we combined the Hsp70-NEF pairs with cochaperones of the J protein family (DnaJA1, DnaJA2, DnaJB1, and DnaJB4) to generate 16 permutations. The activity of the combinations in ATPase and luciferase refolding assays were dependent on the identity and stoichiometry of both the J protein and NEF so that some combinations were potent chaperones, whereas others were inactive. Given the number and diversity of cochaperones in mammals, it is likely that combinatorial assembly could generate a large number of distinct permutations.	[Rauch, Jennifer N.; Gestwicki, Jason E.] Univ Michigan, Dept Biochem, Ann Arbor, MI 48109 USA; [Rauch, Jennifer N.; Gestwicki, Jason E.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Rauch, Jennifer N.; Gestwicki, Jason E.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Gestwicki, Jason E.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Gestwicki, Jason E.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94158 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gestwicki, JE (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, Inst Neurodegenerat Dis, 675 Nelson Rising Ln, San Francisco, CA 94158 USA.	jason.gestwicki@ucsf.edu	Rauch, Jennifer/AGI-2683-2022	Rauch, Jennifer/0000-0001-6853-5915	National Institutes of Health [NS059690]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS059690.	Ahmad A, 2011, P NATL ACAD SCI USA, V108, P18966, DOI 10.1073/pnas.1111220108; Alberti S, 2003, CELL STRESS CHAPERON, V8, P225, DOI 10.1379/1466-1268(2003)008<0225:BNEFOH>2.0.CO;2; Assimon VA, 2013, CURR PHARM DESIGN, V19, P404; Bhangoo MK, 2007, MOL BIOL CELL, V18, P3414, DOI 10.1091/mbc.E07-01-0088; Bimston D, 1998, EMBO J, V17, P6871, DOI 10.1093/emboj/17.23.6871; Blazer Levi L, 2010, Curr Protoc Cytom, VChapter 13, DOI 10.1002/0471142956.cy1311s51; Brehmer D, 2004, J BIOL CHEM, V279, P27957, DOI 10.1074/jbc.M403558200; Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588; Briknarova K, 2001, NAT STRUCT BIOL, V8, P349, DOI 10.1038/86236; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Brive L, 2001, BIOCHEM BIOPH RES CO, V289, P1099, DOI 10.1006/bbrc.2001.6087; Brodsky JL, 2006, CURR TOP MED CHEM, V6, P1215, DOI 10.2174/156802606777811997; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Carrettiero DC, 2009, J NEUROSCI, V29, P2151, DOI 10.1523/JNEUROSCI.4660-08.2009; Cesa LC, 2013, ACS CHEM BIOL, V8, P1988, DOI 10.1021/cb400356m; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Chang L, 2011, CHEM BIOL, V18, P210, DOI 10.1016/j.chembiol.2010.12.010; Chang L, 2010, J BIOL CHEM, V285, P21282, DOI 10.1074/jbc.M110.124149; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Doong H, 2000, ONCOGENE, V19, P4385, DOI 10.1038/sj.onc.1203797; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; Erbse A, 2004, BIOCHEM SOC T, V32, P617, DOI 10.1042/BST0320617; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Finka A, 2013, CELL STRESS CHAPERON, V18, P591, DOI 10.1007/s12192-013-0413-3; Franceschelli S, 2008, J CELL PHYSIOL, V215, P575, DOI 10.1002/jcp.21397; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Gassler CS, 2001, J BIOL CHEM, V276, P32538, DOI 10.1074/jbc.M105328200; Gillies AT, 2012, MOL BIOSYST, V8, P2901, DOI 10.1039/c2mb25248a; Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Li Z, 2013, NAT STRUCT MOL BIOL, V20, P929, DOI 10.1038/nsmb.2608; Liu Y., 2010, PLOS COMPUT BIOL, V6; Luders J, 2000, J BIOL CHEM, V275, P14817, DOI 10.1074/jbc.275.20.14817; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Mattoo RUH, 2013, J BIOL CHEM, V288, P21399, DOI 10.1074/jbc.M113.479253; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Miyata Y, 2010, J BIOMOL SCREEN, V15, P1211, DOI 10.1177/1087057110380571; Nollen EAA, 2000, MOL CELL BIOL, V20, P1083, DOI 10.1128/MCB.20.3.1083-1088.2000; Oh HJ, 1999, J BIOL CHEM, V274, P15712, DOI 10.1074/jbc.274.22.15712; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Rerole AL, 2011, METHODS MOL BIOL, V787, P205, DOI 10.1007/978-1-61779-295-3_16; Ricci Laura, 2008, Curr Chem Genomics, V2, P90, DOI 10.2174/1875397300802010090; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; Saxena A, 2012, J BIOL CHEM, V287, P19158, DOI 10.1074/jbc.M111.297580; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shaner L, 2006, BIOCHEMISTRY-US, V45, P15075, DOI 10.1021/bi061279k; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Smith MC, 2013, BIOCHEMISTRY-US, V52, P5354, DOI 10.1021/bi4009209; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Song JW, 2001, NAT CELL BIOL, V3, P276, DOI 10.1038/35060068; Srinivasan SR, 2012, MOL BIOSYST, V8, P2323, DOI 10.1039/c2mb25145k; Stuart JK, 1998, J BIOL CHEM, V273, P22506, DOI 10.1074/jbc.273.35.22506; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Thompson AD, 2012, ACS CHEM BIOL, V7, P1677, DOI 10.1021/cb3002599; Tsukahara F, 2010, BLOOD, V116, P3582, DOI 10.1182/blood-2009-10-249623; Tzankov S, 2008, J BIOL CHEM, V283, P27100, DOI 10.1074/jbc.M803923200; Vembar SS, 2010, J BIOL CHEM, V285, P22484, DOI 10.1074/jbc.M110.102186; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Williamson DS, 2009, J MED CHEM, V52, P1510, DOI 10.1021/jm801627a; Wisen S, 2008, ANAL BIOCHEM, V374, P371, DOI 10.1016/j.ab.2007.12.009; Wittung-Stafshede P, 2003, BIOCHEMISTRY-US, V42, P4937, DOI 10.1021/bi027333o; Xu XP, 2012, J BIOL CHEM, V287, P5661, DOI 10.1074/jbc.M111.275057; Xu Z, 2013, J CELL SCI, V126, P4173, DOI 10.1242/jcs.126102; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P1309, DOI 10.1038/nsmb.1518; Yamagishi N, 2000, BIOCHEM BIOPH RES CO, V272, P850, DOI 10.1006/bbrc.2000.2864; ZEINER M, 1995, P NATL ACAD SCI USA, V92, P11465, DOI 10.1073/pnas.92.25.11465; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	86	107	117	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1402	1414		10.1074/jbc.M113.521997	http://dx.doi.org/10.1074/jbc.M113.521997			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24318877	hybrid, Green Published			2022-12-25	WOS:000332401700018
J	Rani, N; Bharti, S; Manchanda, M; Nag, TC; Ray, R; Chauhan, SS; Kumari, S; Arya, DS				Rani, Neha; Bharti, Saurabh; Manchanda, Mansi; Nag, T. C.; Ray, Ruma; Chauhan, S. S.; Kumari, Santosh; Arya, Dharamvir Singh			Regulation of Heat Shock Proteins 27 and 70, p-Akt/p-eNOS and MAPKs by Naringin Dampens Myocardial Injury and Dysfunction In Vivo after Ischemia/Reperfusion	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; OXYGEN SPECIES GENERATION; LIPID PEROXIDES; RAT-HEART; OVEREXPRESSION; GLUTATHIONE; INHIBITION; ACTIVATION; MECHANISMS; RESISTANCE	Naringin has antioxidant properties that could improve redox-sensitive myocardial ischemia reperfusion (IR) injury. This study was designed to investigate whether naringin restores the myocardial damage and dysfunction in vivo after IR and the mechanisms underlying its cardioprotective effects. Naringin (20-80 mg/kg/day, p.o.) or saline were administered to rats for 14 days and the myocardial IR injury was induced on 15(th) day by occluding the left anterior descending coronary artery for 45 min and subsequent reperfusion for 60 min. Post-IR rats exhibited pronounced cardiac dysfunction as evidenced by significantly decreased mean arterial pressure, heart rate, +LVdP/dt(max) (inotropic state), -LVdP/dt(max) (lusitropic state) and increased left ventricular end diastolic pressure as compared to sham group, which was improved by naringin. Further, on histopathological and ultrastructural assessments myocardium and myocytes appeared more normal in structure and the infarct size was reduced significantly in naringin 40 and 80 mg/kg/day group. This amelioration of post-IR-associated cardiac injury by naringin was accompanied by increased nitric oxide (NO) bioavailability, decreased NO inactivation to nitrotyrosine, amplified protein expressions of Hsp27, Hsp70, beta-catenin and increased p-eNOS/eNOS, p-Akt/Akt, and p-ERK/ERK ratio. In addition, IR-induced TNF-alpha/IKK-beta/ NF-B-K upregulation and JNK phosphorylation were significantly attenuated by naringin. Moreover, western blotting and immunohistochemistry analysis of apoptotic signaling pathway further established naringin cardioprotective potential as it upregulated Bcl-2 expression and downregulated Bax and Caspase-3 expression with reduced TUNEL positivity. Naringin also normalized the cardiac injury markers (lactate dehydrogenase and creatine kinase-MB), endogenous antioxidant activities (superoxide dismutase, reduced glutathione and glutathione peroxidase) and lipid peroxidation levels. Thus, naringin restored IR injury by preserving myocardial structural integrity and regulating Hsp27, Hsp70, p-eNOS/p-Akt/p-ERK signaling and inflammatory response.	[Rani, Neha; Bharti, Saurabh; Arya, Dharamvir Singh] All India Inst Med Sci, Dept Pharmacol, New Delhi, India; [Manchanda, Mansi; Chauhan, S. S.] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Nag, T. C.] All India Inst Med Sci, Dept Anat, New Delhi 110029, India; [Ray, Ruma] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India; [Kumari, Santosh] Indian Agr Res Inst, Dept Plant Physiol, New Delhi 110012, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Arya, DS (corresponding author), All India Inst Med Sci, Dept Pharmacol, New Delhi, India.	dsarya16@hotmail.com	NAG, TAPAS CHANDRA/R-6285-2019; Rani, Dr. Neha/ABD-8800-2021; manchanda, mansi/AAK-2359-2020; Kumari, Santosh/I-3683-2019	NAG, TAPAS CHANDRA/0000-0002-6962-0844; Rani, Dr. Neha/0000-0001-9767-7525; Kumari, Santosh/0000-0001-8430-3268; Manchanda, Mansi/0000-0003-0857-5557	Department of Science and Technology, Govt. of India under the INSPIRE-DST-Fellowship programme [IF120584, IF10332]	Department of Science and Technology, Govt. of India under the INSPIRE-DST-Fellowship programme	The authors gratefully acknowledge Mr. B.M. Sharma for his technical assistance during the course of the surgery and in the preparation of histopathological slides and the Department of Science and Technology, Govt. of India for providing fellowship to Neha Rani (IF120584) and Saurabh Bharti (IF10332) under the INSPIRE-DST-Fellowship programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajay M, 2003, LIFE SCI, V74, P603, DOI 10.1016/j.lfs.2003.06.039; Alam MA, 2013, NUTRIENTS, V5, P637, DOI 10.3390/nu5030637; Armstrong SC, 2004, CARDIOVASC RES, V61, P427, DOI 10.1016/j.cardiores.2003.09.031; Bharti S, 2012, EUR J NUTR, V51, P719, DOI 10.1007/s00394-011-0251-y; Bharti S, 2012, FEBS LETT, V586, P180, DOI 10.1016/j.febslet.2011.12.015; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Catalucci D, 2009, J CELL BIOL, V184, P923, DOI 10.1083/jcb.200805063; Christians ES, 2012, INT J BIOCHEM CELL B, V44, P1632, DOI 10.1016/j.biocel.2012.06.006; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Engelbrecht AM, 2006, J NUTR BIOCHEM, V17, P265, DOI 10.1016/j.jnutbio.2005.05.001; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Huang H, 2013, INT J MOL MED; Konstantinidis K, 2012, ARTERIOSCL THROM VAS, V32, P1552, DOI 10.1161/ATVBAHA.111.224915; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Leger JP, 2000, CIRCULATION, V102, P1703, DOI 10.1161/01.CIR.102.14.1703; Liu L, 2007, CHINESE MED J-PEKING, V120, P2271, DOI 10.1097/00029330-200712020-00023; Lu XY, 2008, CARDIOVASC RES, V79, P500, DOI 10.1093/cvr/cvn091; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; MARKLUND S, 1974, European Journal of Biochemistry, V47, P469, DOI 10.1111/j.1432-1033.1974.tb03714.x; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; Moss NC, 2007, AM J PHYSIOL-HEART C, V293, pH2248, DOI 10.1152/ajpheart.00776.2007; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Okubo S, 2001, CIRCULATION, V103, P877, DOI 10.1161/01.CIR.103.6.877; Portbury AL, 2012, J MOL CELL CARDIOL, V52, P526, DOI 10.1016/j.yjmcc.2011.10.023; Raedschelders K, 2012, PHARMACOL THERAPEUT, V133, P230, DOI 10.1016/j.pharmthera.2011.11.004; Rajadurai M, 2006, TOXICOLOGY, V228, P259, DOI 10.1016/j.tox.2006.09.005; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Schulz R, 2004, CARDIOVASC RES, V61, P402, DOI 10.1016/j.cardiores.2003.09.019; Sharma AK, 2011, BRIT J NUTR, V106, P1713, DOI 10.1017/S000711451100225X; Sun HY, 2006, APOPTOSIS, V11, P1583, DOI 10.1007/s10495-006-9037-8; Turer AT, 2010, AM J CARDIOL, V106, P360, DOI 10.1016/j.amjcard.2010.03.032; Yow TT, 2011, BRIT J PHARMACOL, V163, P1017, DOI 10.1111/j.1476-5381.2011.01315.x	33	46	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82577	10.1371/journal.pone.0082577	http://dx.doi.org/10.1371/journal.pone.0082577			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324809	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700090
J	Dinh, H; Rajasekaran, S				Hieu Dinh; Rajasekaran, Sanguthevar			PMS: A Panoptic Motif Search Tool	PLOS ONE			English	Article							LINEAR MOTIFS; DISCOVERY; ALGORITHMS; PROTEINS	Background: Identification of DNA/Protein motifs is a crucial problem for biologists. Computational techniques could be of great help in this identification. In this direction, many computational models for motifs have been proposed in the literature. Methods: One such important model is the (l, d) motif model. In this paper we describe a motif search web tool that predominantly employs this motif model. This web tool exploits the state-of-the art algorithms for solving the (l, d) motif search problem. Results: The online tool has been helping scientists identify many unknown motifs. Many of our predictions have been successfully verified as well. We hope that this paper will expose this crucial tool to many more scientists. Availability and requirements: Project name: PMS - Panoptic Motif Search Tool. Project home page: http://pms.engr.uconn.edu or http://motifsearch.com. Licence: PMS tools will be readily available to any scientist wishing to use it for non-commercial purposes, without restrictions. The online tool is freely available without login.	[Hieu Dinh; Rajasekaran, Sanguthevar] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06260 USA	University of Connecticut	Rajasekaran, S (corresponding author), Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06260 USA.	rajasek@engr.uconn.edu			NSF [0829916]; NIH [R01-LM010101]; NATIONAL LIBRARY OF MEDICINE [R01LM010101] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work has been supported in part by the following grants: NSF 0829916 and NIH R01-LM010101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Davey NE, 2006, NUCLEIC ACIDS RES, V34, P3546, DOI 10.1093/nar/gkl486; Davila J, 2007, IEEE ACM T COMPUT BI, V4, P544, DOI 10.1109/TCBB.2007.70241; Dinh H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041425; Dinh H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-410; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; Eskin E, 2002, BIOINFORMATICS, V18, pS354, DOI DOI 10.1093/BIOINFORMATICS/18.SUPPL_1.S354.; JONASSEN I, 1995, PROTEIN SCI, V4, P1587, DOI 10.1002/pro.5560040817; Lieber DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014444; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; Pisanti N, 2006, LECT NOTES COMPUT SC, V3887, P757, DOI 10.1007/11682462_69; Rajasekaran S, 2005, J COMPUT BIOL, V12, P1117, DOI 10.1089/cmb.2005.12.1117; Rajasekaran S, 2009, FRONT BIOSCI-LANDMRK, V14, P5052, DOI 10.2741/3586; Sharma D, 2011, CORR; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053	15	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80660	10.1371/journal.pone.0080660	http://dx.doi.org/10.1371/journal.pone.0080660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324619	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300037
J	Lee, SM; Park, JW; Kim, BJ; Park, CW; Park, JS; Jun, JK; Yoon, BH				Lee, Seung Mi; Park, Jeong Woo; Kim, Byoung Jae; Park, Chan-Wook; Park, Joong Shin; Jun, Jong Kwan; Yoon, Bo Hyun			Acute Histologic Chorioamnionitis Is a Risk Factor for Adverse Neonatal Outcome in Late Preterm Birth after Preterm Premature Rupture of Membranes	PLOS ONE			English	Article							NEAR-TERM INFANTS; ANTENATAL CORTICOSTEROIDS; GESTATIONAL-AGE; INTRAAMNIOTIC INFLAMMATION; RESPIRATORY DISORDERS; MORBIDITY; SINGLETON; MORTALITY; CARE; INTERLEUKIN-6	Background: The objective of this study was to determine whether acute histologic chorioamnionitis is associated with adverse neonatal outcomes in late preterm infants who were born after preterm PROM. Methodology/Principal Findings: The relationship between the presence of acute histologic chorioamnionitis and adverse neonatal outcome was examined in patients with preterm PROM who delivered singleton preterm newborns between 34 weeks and 36 6/7 weeks of gestation. Nonparametric statistics were used for data analysis. The frequency of acute histologic chorioamnionitis was 24% in patients with preterm PROM who delivered preterm newborns between 34 weeks and 36 6/7 weeks of gestation. Newborns born to mothers with histologic chorioamnionitis had significantly higher rates of adverse neonatal outcome (74% vs 51%; p<0.005) than those without histologic chorioamnionitis. This relationship remained significant after adjustment for gestational age at preterm PROM, gestational age at delivery, and exposure to antenatal corticosteroids. Conclusions/Significance: The presence of acute histologic chorioamnionitis is associated with adverse neonatal outcome in late preterm infants born to mothers with preterm PROM.	[Lee, Seung Mi; Park, Jeong Woo; Kim, Byoung Jae; Park, Chan-Wook; Park, Joong Shin; Jun, Jong Kwan; Yoon, Bo Hyun] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Lee, Seung Mi; Kim, Byoung Jae] Seoul Metropolitan Govt Seoul Natl Univ, Boramae Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Park, Jeong Woo] Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Obstet & Gynecol, Gyeongnam, Gyeonggi, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Inje University	Yoon, BH (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	yoonbh@snu.ac.kr	Yoon, Bo Hyun/H-6344-2011; PARK, Chan-Wook/G-3663-2013; Park, Joong Shin/D-5741-2012	PARK, Chan-Wook/0000-0002-1290-6438; Park, Joong Shin/0000-0002-5246-0477; Park, Jeong Woo/0000-0001-6499-0814	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C0768]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This work was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (No. HI12C0768). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists Committee on Obstetric Practice, 2008, Obstet Gynecol, V111, P805, DOI 10.1097/AOG.0b013e318169f722; Arnon S, 2001, PAEDIATR PERINAT EP, V15, P252, DOI 10.1046/j.1365-3016.2001.00357.x; Bastek JA, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.065; Bastek JA, 2010, AM J PERINAT, V27, P163, DOI 10.1055/s-0029-1234036; Bastek JA, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.08.002; Berard A, 2012, ARCH DIS CHILD-FETAL, V97, pF329, DOI 10.1136/fetalneonatal-2011-300969; Celik IH, 2013, J MATERN-FETAL NEO M, V26, P459, DOI 10.3109/14767058.2012.735994; Choi SJ, 2009, AUST NZ J OBSTET GYN, V49, P173, DOI 10.1111/j.1479-828X.2009.00970.x; Colin AA, 2010, PEDIATRICS, V126, P115, DOI 10.1542/peds.2009-1381; Davidoff MJ, 2006, SEMIN PERINATOL, V30, P8, DOI 10.1053/j.semperi.2006.01.009; Porto AMF, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1696; Fernandez-Carrocera Luis Alberto, 2004, Gac Med Mex, V140, P367; Gilbert WM, 2003, OBSTET GYNECOL, V102, P488, DOI 10.1016/S0029-7844(03)00617-3; Gray RF, 2004, PEDIATRICS, V114, P736, DOI 10.1542/peds.2003-1150-L; Gyamfi-Bannerman C, 2012, OBSTET GYNECOL, V119, P555, DOI 10.1097/AOG.0b013e31824758f6; Harijan P, 2012, SEMIN FETAL NEONAT M, V17, P159, DOI 10.1016/j.siny.2012.02.002; Huddy CLJ, 2001, ARCH DIS CHILD-FETAL, V85, pF23, DOI 10.1136/fn.85.1.F23; Khan RL, 2008, J CHILD NEUROL, V23, P144, DOI 10.1177/0883073807308711; Khashu M, 2009, PEDIATRICS, V123, P109, DOI 10.1542/peds.2007-3743; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; Laughon SK, 2010, OBSTET GYNECOL, V116, P1047, DOI 10.1097/AOG.0b013e3181f73f97; Lee J, 2009, J PERINAT MED, V37, P53, DOI 10.1515/JPM.2009.036; Lee SM, 2011, J MATERN-FETAL NEO M, V24, P37, DOI 10.3109/14767058.2010.482622; Lipkind HS, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.007; Mac Bird T, 2010, PEDIATRICS, V126, pE311, DOI 10.1542/peds.2009-2869; Mally PV, 2013, AM J PERINAT, V30, P425, DOI 10.1055/s-0032-1326989; Martin Joyce A, 2006, Natl Vital Stat Rep, V55, P1; Martin Joyce A, 2011, Natl Vital Stat Rep, V60, P1; McIntire DD, 2008, OBSTET GYNECOL, V111, P35, DOI 10.1097/01.AOG.0000297311.33046.73; Nomura Y, 2008, J CHILD PSYCHOL PSYC, V49, P1108, DOI 10.1111/j.1469-7610.2008.01939.x; Pillekamp F, 2007, NEONATOLOGY, V91, P155, DOI 10.1159/000097446; Polam S, 2005, ARCH PEDIAT ADOL MED, V159, P1032, DOI 10.1001/archpedi.159.11.1032; Raju TNK, 2006, PEDIATRICS, V118, P1207, DOI 10.1542/peds.2006-0018; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Rovira N, 2011, EARLY HUM DEV, V87, P253, DOI 10.1016/j.earlhumdev.2011.01.024; Sarici SU, 2004, PEDIATRICS, V113, P775, DOI 10.1542/peds.113.4.775; Seubert DE, 1999, AM J OBSTET GYNECOL, V181, P1087, DOI 10.1016/S0002-9378(99)70086-4; Shapiro SM, 2003, PEDIATR NEUROL, V29, P410, DOI 10.1016/j.pediatrneurol.2003.09.011; Shapiro-Mendoza CK, 2008, PEDIATRICS, V121, pE223, DOI 10.1542/peds.2006-3629; Shim SS, 2004, AM J OBSTET GYNECOL, V191, P1339, DOI 10.1016/j.ajog.2004.06.085; Talge NM, 2010, PEDIATRICS, V126, P1124, DOI 10.1542/peds.2010-1536; Tomashek KM, 2007, J PEDIATR-US, V151, P450, DOI 10.1016/j.jpeds.2007.05.002; Ventolini G, 2008, AM J PERINAT, V25, P79, DOI 10.1055/s-2007-1022470; Wang ML, 2004, PEDIATRICS, V114, P372, DOI 10.1542/peds.114.2.372; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4; Yoon BH, 2000, AM J OBSTET GYNECOL, V182, P675, DOI 10.1067/mob.2000.104207; Yoon BH, 2000, AM J OBSTET GYNECOL, V183, P1124, DOI 10.1067/mob.2000.109035; Zanardo V, 2008, PEDIATR DEVEL PATHOL, V11, P350, DOI 10.2350/07-08-0324.1	48	35	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e79941	10.1371/journal.pone.0079941	http://dx.doi.org/10.1371/journal.pone.0079941			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324586	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300013
J	Pondeville, E; David, JP; Guittard, E; Maria, A; Jacques, JC; Ranson, H; Bourgouin, C; Dauphin-Villemant, C				Pondeville, Emilie; David, Jean-Philippe; Guittard, Emilie; Maria, Annick; Jacques, Jean-Claude; Ranson, Hilary; Bourgouin, Catherine; Dauphin-Villemant, Chantal			Microarray and RNAi Analysis of P450s in Anopheles gambiae Male and Female Steroidogenic Tissues: CYP307A1 Is Required for Ecdysteroid Synthesis	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; CYTOCHROME-P450 ENZYME; PROTHORACIC GLANDS; ECDYSONE SYNTHESIS; BOMBYX-MORI; C-ELEGANS; EXPRESSION; BIOSYNTHESIS; GENES; EVOLUTION	In insects, the steroid hormone 20-hydroxyecdysone (20E) coordinates major developmental transitions. While the first and the final steps of 20E biosynthesis are characterized, the pathway from 7-dehydrocholesterol to 5 beta-ketodiol, commonly referred as the "black box", remains hypothetical and whether there are still unidentified enzymes is unknown. The black box would include some oxidative steps, which are believed to be mediated by P450 enzymes. To identify new enzyme(s) involved in steroid synthesis, we analyzed by small-scale microarray the expression of all the genes encoding P450 enzymes of the malaria mosquito Anopheles gambiae in active steroidogenic organs of adults, ovaries from blood-fed females and male reproductive tracts, compared to inactive steroidogenic organs, ovaries from non-blood-fed females. Some genes encoding P450 enzymes were specifically overexpressed in female ovaries after a blood-meal or in male reproductive tracts but only three genes were found to be overexpressed in active steroidogenic organs of both females and males: cyp307a1, cyp4g16 and cyp6n1. Among these genes, only cyp307a1 has an expression pattern similar to other mosquito steroidogenic genes. Moreover, loss-of-function by transient RNAi targeting cyp307a1 disrupted ecdysteroid production demonstrating that this gene is required for ecdysteroid biosynthesis in Anopheles gambiae.	[Pondeville, Emilie; Guittard, Emilie; Maria, Annick; Dauphin-Villemant, Chantal] UPMC, CNRS, FRE2852, Paris, France; [Pondeville, Emilie; Bourgouin, Catherine] Inst Pasteur, Unit Insect Vector Genet & Genom, Dept Parasitol & Mycol, CNRS Unit Hosts Vectors & Infect Agents URA3012, Paris, France; [David, Jean-Philippe; Ranson, Hilary] Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England; [David, Jean-Philippe] Univ Grenoble, CNRS, UMR 5553, Lab Ecol Alpine, Grenoble, France; [Jacques, Jean-Claude; Bourgouin, Catherine] Inst Pasteur, Ctr Prod & Infect Anopheles, Paris, France; [Dauphin-Villemant, Chantal] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Liverpool School of Tropical Medicine; University of Liverpool; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Lausanne	Pondeville, E (corresponding author), UPMC, CNRS, FRE2852, Paris, France.	emilie.pondeville@pasteur.fr	DAVID, jean-philippe/F-3077-2012; Bourgouin, Catherine/F-1253-2014	DAVID, jean-philippe/0000-0002-3950-5909; Bourgouin, Catherine/0000-0002-9209-845X; Crilat, Emilie/0000-0001-8796-5582; Ranson, Hilary/0000-0003-2332-8247; Pondeville, Emilie/0000-0001-8545-8472	Universite Pierre et Marie Curie; Ministere de la Recherche Scientifique; Fondation pour la Recherche Medicale; Fondation des Treilles award; Institut Pasteur; Wellcome Trust [072833/Z/03/Z]	Universite Pierre et Marie Curie; Ministere de la Recherche Scientifique; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation des Treilles award; Institut Pasteur(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Universite Pierre et Marie Curie and the Ministere de la Recherche Scientifique (EP, EG, AM, and CDV), by the Fondation pour la Recherche Medicale and a Fondation des Treilles award (to EP), by the Institut Pasteur (to EP, JCJ and CB), and by the Wellcome Trust (Grant number 072833/Z/03/Z, to JPD and HR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, BIOL MOSQUITOES DEV; Aragon S, 2002, INSECT BIOCHEM MOLEC, V32, P153, DOI 10.1016/S0965-1748(01)00095-9; Boisson B, 2006, FEBS LETT, V580, P1988, DOI 10.1016/j.febslet.2006.02.069; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R., 2005, P1; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; Gilbert LI, 2005, VITAM HORM, V73, P31, DOI 10.1016/S0083-6729(05)73002-8; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Hentze JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055131; Iga M, 2010, PEPTIDES, V31, P456, DOI 10.1016/j.peptides.2009.08.002; Lafont R., 2012, INSECT ENDOCRINOLOGY, P106, DOI DOI 10.1016/13978-0-12-384749-2.10004.4; Lang M, 2012, SCIENCE, V337, P1658, DOI 10.1126/science.1224829; Maibeche-Coisne M, 2000, BIOCHEM BIOPH RES CO, V273, P1132, DOI 10.1006/bbrc.2000.3058; Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; Mykles DL, 2011, J STEROID BIOCHEM, V127, P196, DOI 10.1016/j.jsbmb.2010.09.001; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Niwa R, 2011, APPL ENTOMOL ZOOL, V46, P533, DOI 10.1007/s13355-011-0074-6; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Ono H, 2012, BIOCHEM BIOPH RES CO, V421, P561, DOI 10.1016/j.bbrc.2012.04.045; Ou QX, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001160; Parvy JP, 2005, DEV BIOL, V282, P84, DOI 10.1016/j.ydbio.2005.02.028; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Pondeville E, 2008, P NATL ACAD SCI USA, V105, P19631, DOI 10.1073/pnas.0809264105; Raikhel A.S., 2005, P433; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Rewitz KF, 2006, INSECT BIOCHEM MOLEC, V36, P188, DOI 10.1016/j.ibmb.2005.12.002; Rewitz KF, 2007, INSECT BIOCHEM MOLEC, V37, P741, DOI 10.1016/j.ibmb.2007.02.012; Rewitz Kim F, 2011, Front Endocrinol (Lausanne), V2, P108, DOI 10.3389/fendo.2011.00108; Rewitz KF, 2009, INSECT BIOCHEM MOLEC, V39, P475, DOI 10.1016/j.ibmb.2009.04.005; Rottiers V, 2006, DEV CELL, V10, P473, DOI 10.1016/j.devcel.2006.02.008; Sieglaff DH, 2005, INSECT BIOCHEM MOLEC, V35, P471, DOI 10.1016/j.ibmb.2005.01.011; Spindler KD, 2009, CELL MOL LIFE SCI, V66, P3837, DOI 10.1007/s00018-009-0112-5; Swevers L., 2005, P87; Sztal T, 2007, INSECT BIOCHEM MOLEC, V37, P1044, DOI 10.1016/j.ibmb.2007.05.017; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; Warren JT, 2009, INSECT BIOCHEM MOLEC, V39, P677, DOI 10.1016/j.ibmb.2009.08.004; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; Yang P, 2008, J INSECT PHYSIOL, V54, P636, DOI 10.1016/j.jinsphys.2008.01.001; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428; Yoshiyama-Yanagawa T, 2011, J BIOL CHEM, V286, P25756, DOI 10.1074/jbc.M111.244384	51	27	30	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e79861	10.1371/journal.pone.0079861	http://dx.doi.org/10.1371/journal.pone.0079861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324583	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000327949300010
J	Wang, J; Azziz, A; Fan, B; Malkov, S; Klifa, C; Newitt, D; Yitta, S; Hylton, N; Kerlikowske, K; Shepherd, JA				Wang, Jeff; Azziz, Ania; Fan, Bo; Malkov, Serghei; Klifa, Catherine; Newitt, David; Yitta, Silaja; Hylton, Nola; Kerlikowske, Karla; Shepherd, John A.			Agreement of Mammographic Measures of Volumetric Breast Density to MRI	PLOS ONE			English	Article							CANCER RISK; SCREENING MAMMOGRAPHY; TISSUE COMPOSITION; BODY-COMPOSITION; TAMOXIFEN; WOMEN; MODEL; REDUCTION; PATTERNS; INDEX	Background: Clinical scores of mammographic breast density are highly subjective. Automated technologies for mammography exist to quantify breast density objectively, but the technique that most accurately measures the quantity of breast fibroglandular tissue is not known. Purpose: To compare the agreement of three automated mammographic techniques for measuring volumetric breast density with a quantitative volumetric MRI-based technique in a screening population. Materials and Methods: Women were selected from the UCSF Medical Center screening population that had received both a screening MRI and digital mammogram within one year of each other, had Breast Imaging Reporting and Data System (BI-RADS) assessments of normal or benign finding, and no history of breast cancer or surgery. Agreement was assessed of three mammographic techniques (Single-energy X-ray Absorptiometry [SXA], Quantra, and Volpara) with MRI for percent fibroglandular tissue volume, absolute fibroglandular tissue volume, and total breast volume. Results: Among 99 women, the automated mammographic density techniques were correlated with MRI measures with R-2 values ranging from 0.40 (log fibroglandular volume) to 0.91 (total breast volume). Substantial agreement measured by kappa statistic was found between all percent fibroglandular tissue measures (0.72 to 0.63), but only moderate agreement for log fibroglandular volumes. The kappa statistics for all percent density measures were highest in the comparisons of the SXA and MRI results. The largest error source between MRI and the mammography techniques was found to be differences in measures of total breast volume. Conclusion: Automated volumetric fibroglandular tissue measures from screening digital mammograms were in substantial agreement with MRI and if associated with breast cancer could be used in clinical practice to enhance risk assessment and prevention.	[Wang, Jeff; Azziz, Ania; Fan, Bo; Malkov, Serghei; Newitt, David; Yitta, Silaja; Hylton, Nola; Shepherd, John A.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Klifa, Catherine] Synarc Inc, Newark, CA USA; [Kerlikowske, Karla] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Kerlikowske, Karla] Univ Calif San Francisco, Dept Epidemiol Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Synarc; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shepherd, JA (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	john.shepherd@ucsf.edu	Hylton, Nola/AAF-7861-2019; Shepherd, John/S-3146-2018	Shepherd, John/0000-0003-2280-2541; Malkov, Serghei/0000-0003-0548-6022	NIH [21CA157254, 1R01CA166945, P01CA154292]; California Breast Cancer Research Program (CBCRP) [18IB-0042]; NATIONAL CANCER INSTITUTE [P01CA154292, R01CA166945, R21CA157254] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Breast Cancer Research Program (CBCRP); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding sources include the NIH and the California Breast Cancer Research Program (CBCRP). NIH Funding sources: 1) R21CA157254 (http://projectreporter.nih.gov/project_info_details.cfm?aid = 8436160&icde = 16530215&ddparam = &ddvalue = &ddsub = &cr = 1&csb = default&cs = ASC). 2) 1R01CA166945 (http://projectreporter.nih.gov/project_info_details.cfm? aid = 8439678&icde = 16530236&ddparam = &ddvalue = &ddsub = &cr = 1&csb = default&cs = ASC). 3) P01CA154292 (http://projectreporter.nih.gov/project_info_details.cfm?aid = 8555529&icde = 16530253&ddparam = &ddvalue = &ddsub = &cr = 1&csb = default&cs = ASC). CBCRP Funding sources: 18IB-0042 (http://cbcrp.org.127.seekdotnet.com/research/PageGrant.asp? grant_id = 18020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken Z, 2010, CANCER EPIDEM BIOMAR, V19, P418, DOI 10.1158/1055-9965.EPI-09-1059; American College of Radiology (ACR), 2003, ILL BREAST IM REP DA; Barlow WE, 2006, JNCI-J NATL CANCER I, V98, P1204, DOI 10.1093/jnci/djj331; Boyd N, 2009, LANCET ONCOL, V10, P569, DOI 10.1016/S1470-2045(09)70078-6; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Chen JH, 2011, MAGN RESON IMAGING, V29, P91, DOI 10.1016/j.mri.2010.07.009; Chlebowski RT, 2003, JNCI-J NATL CANCER I, V95, P4, DOI 10.1093/jnci/95.1.4; Chow CK, 2000, CANCER EPIDEM BIOMAR, V9, P917; Cummings SR, 2009, JNCI-J NATL CANCER I, V101, P384, DOI 10.1093/jnci/djp018; Cuzick J, 2004, JNCI-J NATL CANCER I, V96, P621, DOI 10.1093/jnci/djh106; Cuzick J, 2011, J NATL CANCER I, V103, P744, DOI 10.1093/jnci/djr079; Hartman K, 2008, LECT NOTES COMPUT SC, V5116, P33, DOI 10.1007/978-3-540-70538-3_5; Heine JJ, 2011, ACAD RADIOL, V18, P547, DOI 10.1016/j.acra.2010.12.007; Highnam R, 2010, LECT NOTES COMPUT SC, V6136, P342, DOI 10.1007/978-3-642-13666-5_46; Kallenberg MGJ, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/16/5155; Kelly TL, 1998, APPL RADIAT ISOTOPES, V49, P511, DOI 10.1016/S0969-8043(97)00226-1; Kerlikowske K, 2007, J NATL CANCER I, V99, P386, DOI 10.1093/jnci/djk066; Kerlikowske K, 2011, ANN INTERN MED, V155, P493, DOI 10.7326/0003-4819-155-8-201110180-00005; Khazen M, 2008, CANCER EPIDEM BIOMAR, V17, P2268, DOI 10.1158/1055-9965.EPI-07-2547; Klifa C, 2004, P ANN INT IEEE EMBS, V26, P1667; Klifa C, 2010, MAGN RESON IMAGING, V28, P8, DOI 10.1016/j.mri.2009.05.040; Kontos D, 2010, P SPIE MED IMAGING 2; Kopans DB, 2008, RADIOLOGY, V246, P348, DOI 10.1148/radiol.2461070309; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leung J, 2006, SINGLE XRAY ABSORPTI; Malkov S, 2009, MED PHYS, V36, P5525, DOI 10.1118/1.3253972; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; Pawluczyk O, 2003, MED PHYS, V30, P352, DOI 10.1118/1.1539038; Pietrobelli A, 1996, AM J PHYSIOL-ENDOC M, V271, pE941, DOI 10.1152/ajpendo.1996.271.6.E941; Shepherd JA, 2006, MED PHYS, V33, P1490, DOI 10.1118/1.2193691; Shepherd JA, 2011, CANCER EPIDEM BIOMAR, V20, P1473, DOI 10.1158/1055-9965.EPI-10-1150; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Ursin G, 1996, JNCI-J NATL CANCER I, V88, P129; van Engeland S, 2006, IEEE T MED IMAGING, V25, P273, DOI 10.1109/TMI.2005.862741; WOLFE JN, 1976, CANCER, V37, P2486, DOI 10.1002/1097-0142(197605)37:5<2486::AID-CNCR2820370542>3.0.CO;2-8; WOLFE JN, 1976, AM J ROENTGENOL, V126, P1130, DOI 10.2214/ajr.126.6.1130; Wu S., 2012, FULLY AUTOMATED FIBR, V7361, P244	37	23	24	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81653	10.1371/journal.pone.0081653	http://dx.doi.org/10.1371/journal.pone.0081653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324712	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300101
J	Xu, TS; Liu, WA; Luo, JX; Li, CF; Ba, XQ; Ampah, KK; Wang, XG; Jiang, Y; Zeng, XL				Xu, Tingshuang; Liu, Wenai; Luo, Jixian; Li, Chunfeng; Ba, Xueqing; Ampah, Khamal Kwesi; Wang, Xiaoguang; Jiang, Yong; Zeng, Xianlu			Lipid Raft Is Required for PSGL-1 Ligation Induced HL-60 Cell Adhesion on ICAM-1	PLOS ONE			English	Article							E-SELECTIN; P-SELECTIN; TYROSINE-PHOSPHORYLATION; LEUKOCYTE ADHESION; INTEGRIN ACTIVATION; ACTIN CYTOSKELETON; LATERAL MOBILITY; ENGAGEMENT; CHOLESTEROL; NEUTROPHILS	P-selectin glycoprotein ligand-1 (PSGL-1) and integrins are adhesion molecules that play critical roles in host defense and innate immunity. PSGL-1 mediates leukocyte rolling and primes leukocytes for integrin-mediated adhesion. However, the mechanism that PSGL-1 as a rolling receptor in regulating integrin activation has not been well characterized. Here, we investigate the function of lipid raft in regulating PSGL-1 induced beta 2 integrin-mediated HL-60 cells adhesion. PSGL-1 ligation with antibody enhances the beta 2 integrin activation and beta 2 integrin-dependent adhesion to ICAM-1. Importantly, with the treatment of methyl-beta-cyclodextrin (M beta CD), we confirm the role of lipid raft in regulating the activation of beta 2 integrin. Furthermore, we find that the protein level of PSGL-1 decreased in raft fractions in M beta CD treated cells. PSGL-1 ligation induces the recruitment of spleen tyrosine kinase (Syk), a tyrosine kinase and Vav1 (the pivotal downstream effector of Syk signaling pathway involved in cytoskeleton regulation) to lipid raft. Inhibition of Syk activity with pharmacologic inhibitor strongly reduces HL-60 cells adhesion, implicating Syk is crucial for PSGL-1 mediated beta 2 integrin activation. Taken together, we report that ligation of PSGL-1 on HL-60 cells activates beta 2 integrin, for which lipid raft integrity and Syk activation are responsible. These findings have shed new light on the mechanisms that connect leukocyte initial rolling with subsequent adhesion.	[Xu, Tingshuang; Liu, Wenai; Li, Chunfeng; Ba, Xueqing; Ampah, Khamal Kwesi; Zeng, Xianlu] NE Normal Univ, Inst Cytol & Genet, Changchun, Jilin Province, Peoples R China; [Luo, Jixian] Shanxi Univ, Dept Biosci, Taiyuan, Peoples R China; [Wang, Xiaoguang] Changchun Teachers Coll, Dept Biosci, Changchun, Peoples R China; [Jiang, Yong] Southern Med Univ, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China	Northeast Normal University - China; Shanxi University; Southern Medical University - China	Wang, XG (corresponding author), Changchun Teachers Coll, Dept Biosci, Changchun, Peoples R China.	wangxiaoguang58@sina.com; zengx779@nenu.edu.cn		Ba, Xueqing/0000-0002-1075-5496	National Natural Science Foundation of China [30971498, 81071726, 31271509]; National Basic Research Program of China [2010CB529704]; Natural Science Foundation of Jilin Province [201115165]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Jilin Province	This work was supported, in whole or in part, by the National Natural Science Foundation of China (30971498, 81071726, and 31271509), the National Basic Research Program of China (2010CB529704), and the Natural Science Foundation of Jilin Province (201115165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbal C, 2006, BLOOD, V108, P3352, DOI 10.1182/blood-2006-04-013912; Atarashi K, 2005, J IMMUNOL, V174, P1424, DOI 10.4049/jimmunol.174.3.1424; Ba XQ, 2005, CELL IMMUNOL, V237, P1, DOI 10.1016/j.cellimm.2005.09.004; Ba XQ, 2005, J CELL BIOCHEM, V94, P365, DOI 10.1002/jcb.20213; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Dixit N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00188; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Evangelista V, 1999, BLOOD, V93, P876, DOI 10.1182/blood.V93.3.876.403k25_876_885; Handa K, 2001, BIOCHEM BIOPH RES CO, V285, P788, DOI 10.1006/bbrc.2001.5225; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Hidari KIPJ, 1997, J BIOL CHEM, V272, P28750, DOI 10.1074/jbc.272.45.28750; Hogg N, 2002, IMMUNOL REV, V186, P164, DOI 10.1034/j.1600-065X.2002.18614.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Itoh S, 2007, J LEUKOCYTE BIOL, V81, P1414, DOI 10.1189/jlb.0606398; Bakker GJ, 2012, P NATL ACAD SCI USA, V109, P4869, DOI 10.1073/pnas.1116425109; Kiely JM, 2003, J IMMUNOL, V171, P3216, DOI 10.4049/jimmunol.171.6.3216; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Leitinger B, 2002, J CELL SCI, V115, P963; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Luo JX, 2010, J CELL BIOCHEM, V110, P910, DOI 10.1002/jcb.22603; Martins PAD, 2006, J LEUKOCYTE BIOL, V79, P499, DOI 10.1189/jlb.0605318; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Mitchell JS, 2009, IMMUNOL CELL BIOL, V87, P324, DOI 10.1038/icb.2008.103; Mueller H, 2010, BLOOD, V115, P3118, DOI 10.1182/blood-2009-11-254185; Nguyen DH, 2005, EXP CELL RES, V304, P559, DOI 10.1016/j.yexcr.2004.11.022; Rajendran L, 2003, P NATL ACAD SCI USA, V100, P8241, DOI 10.1073/pnas.1331629100; Rinko LJ, 2004, BIOPHYS J, V86, P544, DOI 10.1016/S0006-3495(04)74133-8; Riteau B, 2003, J EXP MED, V198, P469, DOI 10.1084/jem.20021995; Rossy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005403; SAKO D, 1995, CELL, V83, P323, DOI 10.1016/0092-8674(95)90173-6; Schmidt C, 2009, EMBO J, V28, P711, DOI 10.1038/emboj.2009.20; Setiadi H, 2008, BLOOD, V111, P1989, DOI 10.1182/blood-2007-09-113423; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Shulman Z, 2006, BLOOD, V108, P2150, DOI 10.1182/blood-2006-04-017608; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Snapp KR, 2002, BLOOD, V99, P4494, DOI 10.1182/blood.V99.12.4494; Stadtmann A, 2011, EUR J IMMUNOL, V41, P2074, DOI 10.1002/eji.201041196; Urzainqui A, 2002, IMMUNITY, V17, P401, DOI 10.1016/S1074-7613(02)00420-X; Xue ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056911; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; Zarbock A, 2008, J EXP MED, V205, P2339, DOI 10.1084/jem.20072660; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	46	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81807	10.1371/journal.pone.0081807	http://dx.doi.org/10.1371/journal.pone.0081807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312591	gold, Green Published, Green Submitted			2022-12-25	WOS:000327947800059
J	Jeanplong, F; Falconer, SJ; Oldham, JM; Thomas, M; Gray, TS; Hennebry, A; Matthews, KG; Kemp, FC; Patel, K; Berry, C; Nicholas, G; McMahon, CD				Jeanplong, Ferenc; Falconer, Shelley J.; Oldham, Jenny M.; Thomas, Mark; Gray, Tarra S.; Hennebry, Alex; Matthews, Kenneth G.; Kemp, Frederick C.; Patel, Ketan; Berry, Carole; Nicholas, Gina; McMahon, Christopher D.			Discovery of a Mammalian Splice Variant of Myostatin That Stimulates Myogenesis	PLOS ONE			English	Article							BETA SUPERFAMILY MEMBER; SKELETAL-MUSCLE; MYOBLAST PROLIFERATION; GENOMIC ORGANIZATION; EXPRESSION; GENE; GROWTH; BINDING; DIFFERENTIATION; PROTEIN	Myostatin plays a fundamental role in regulating the size of skeletal muscles. To date, only a single myostatin gene and no splice variants have been identified in mammals. Here we describe the splicing of a cryptic intron that removes the coding sequence for the receptor binding moiety of sheep myostatin. The deduced polypeptide sequence of the myostatin splice variant (MSV) contains a 256 amino acid N-terminal domain, which is common to myostatin, and a unique C-terminus of 65 amino acids. Western immunoblotting demonstrated that MSV mRNA is translated into protein, which is present in skeletal muscles. To determine the biological role of MSV, we developed an MSV over-expressing C2C12 myoblast line and showed that it proliferated faster than that of the control line in association with an increased abundance of the CDK2/Cyclin E complex in the nucleus. Recombinant protein made for the novel C-terminus of MSV also stimulated myoblast proliferation and bound to myostatin with high affinity as determined by surface plasmon resonance assay. Therefore, we postulated that MSV functions as a binding protein and antagonist of myostatin. Consistent with our postulate, myostatin protein was co-immunoprecipitated from skeletal muscle extracts with an MSV-specific antibody. MSV over-expression in C2C12 myoblasts blocked myostatin-induced Smad2/3-dependent signaling, thereby confirming that MSV antagonizes the canonical myostatin pathway. Furthermore, MSV over-expression increased the abundance of MyoD, Myogenin and MRF4 proteins (P < 0.05), which indicates that MSV stimulates myogenesis through the induction of myogenic regulatory factors. To help elucidate a possible role in vivo, we observed that MSV protein was more abundant during early post-natal muscle development, while myostatin remained unchanged, which suggests that MSV may promote the growth of skeletal muscles. We conclude that MSV represents a unique example of intra-genic regulation in which a splice variant directly antagonizes the biological activity of the canonical gene product.	[Jeanplong, Ferenc; Falconer, Shelley J.; Oldham, Jenny M.; Thomas, Mark; Gray, Tarra S.; Hennebry, Alex; Matthews, Kenneth G.; Berry, Carole; Nicholas, Gina; McMahon, Christopher D.] AgResearch Ltd, Hamilton, New Zealand; [Kemp, Frederick C.; Patel, Ketan] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Kemp, Frederick C.; Patel, Ketan] Univ Reading, Inst Cardiovasc & Metab Res, Reading, Berks, England	AgResearch - New Zealand; University of Reading; University of Reading	Jeanplong, F (corresponding author), AgResearch Ltd, Hamilton, New Zealand.	frank.jeanplong@gmail.com	Jeanplong, Ferenc/M-4920-2013	Falconer, Shelley/0000-0003-2860-3842	Foundation of Research Science and Technology New Zealand [C10X0703]	Foundation of Research Science and Technology New Zealand(New Zealand Foundation for Research, Science and Technology)	This study was supported by a research grant (C10X0703) of the Foundation of Research Science and Technology New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Castelhano-Barbosa EC, 2005, GROWTH DEVELOP AGING, V69, P3; Covi JA, 2008, COMP BIOCHEM PHYS A, V150, P423, DOI 10.1016/j.cbpa.2008.04.608; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Garikipati DK, 2007, ENDOCRINOLOGY, V148, P2106, DOI 10.1210/en.2006-1299; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Huang KL, 2011, COMP BIOCHEM PHYS D, V6, P238, DOI 10.1016/j.cbd.2011.04.002; Jeanplong F, 2003, J ENDOCRINOL, V176, P425, DOI 10.1677/joe.0.1760425; Jeanplong F, 2001, MOL CELL BIOCHEM, V220, P31, DOI 10.1023/A:1010801511963; Joulia D, 2003, EXP CELL RES, V286, P263, DOI 10.1016/S0014-4827(03)00074-0; Kondas K, 2008, J BIOL CHEM, V283, P23677, DOI 10.1074/jbc.M803025200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lobel L, 2002, PROTEIN EXPRES PURIF, V25, P124, DOI 10.1006/prep.2002.1618; Maccatrozzo L, 2001, FEBS LETT, V509, P36, DOI 10.1016/S0014-5793(01)03124-6; Marshall P, 2001, J BIOL CHEM, V276, P20719, DOI 10.1074/jbc.M102100200; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McMahon CD, 2003, AM J PHYSIOL-ENDOC M, V284, pE377, DOI 10.1152/ajpendo.00282.2002; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; MONTGOMERY GW, 1993, NAT GENET, V4, P410, DOI 10.1038/ng0893-410; Oldham JM, 2009, J PHYSIOL-LONDON, V587, P669, DOI 10.1113/jphysiol.2008.161521; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Sharma M, 1999, J CELL PHYSIOL, V180, P1; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Takehara-Kasamatsu Yuka, 2007, J Med Invest, V54, P276, DOI 10.2152/jmi.54.276; Thies RS, 2001, GROWTH FACTORS, V18, P251; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Xing F, 2007, DEV GENES EVOL, V217, P549, DOI 10.1007/s00427-007-0162-3; Yang JZ, 2001, MOL REPROD DEV, V60, P351, DOI 10.1002/mrd.1097	34	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81713	10.1371/journal.pone.0081713	http://dx.doi.org/10.1371/journal.pone.0081713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312578	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000327944500091
J	Majumder, K; Chakrabarti, S; Morton, JS; Panahi, S; Kaufman, S; Davidge, ST; Wu, JP				Majumder, Kaustav; Chakrabarti, Subhadeep; Morton, Jude S.; Panahi, Sareh; Kaufman, Susan; Davidge, Sandra T.; Wu, Jianping			Egg-Derived Tri-Peptide IRW Exerts Antihypertensive Effects in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							BLOOD-PRESSURE; OXIDATIVE STRESS; BIOACTIVE PEPTIDES; FOOD PROTEINS; MILK; DAMAGE; SUPEROXIDE; RELEASE; RHYTHM	Background: There is a growing interest in using functional food components as therapy for cardiovascular diseases such as hypertension. We have previously characterized a tri-peptide IRW (Ile-Arg-Trp) from egg white protein ovotransferrin; this peptide showed anti-inflammatory, anti-oxidant and angiotensin converting enzyme (ACE) inhibitor properties in vitro. Given the pathogenic roles played by angiotensin, oxidative stress and inflammation in the spontaneously hypertensive rat (SHR), we tested the therapeutic potential of IRW in this well-established model of hypertension. Methods and Results: 16-17 week old male SHRs were orally administered IRW at either a low dose (3 mg/Kg BW) or a high dose (15 mg/Kg BW) daily for 18 days. Blood pressure (BP) and heart rate were measured by telemetry. Animals were sacrificed at the end of the treatment for vascular function studies and measuring markers of inflammation. IRW treatment attenuated mean BP by similar to 10 mmHg and similar to 40 mmHg at the low-and high-dose groups respectively compared to untreated SHRs. Heart rate was not affected. Reduction in BP was accompanied by the restoration of diurnal variations in BP, preservation of nitric oxide dependent vasorelaxation, as well as reduction of plasma angiotensin II, other inflammatory markers and tissue fibrosis. Conclusion: Our results demonstrate anti-hypertensive effects of IRW in vivo likely mediated through ACE inhibition, endothelial nitric oxide synthase and anti-inflammatory properties.	[Majumder, Kaustav; Panahi, Sareh; Wu, Jianping] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Chakrabarti, Subhadeep; Morton, Jude S.; Davidge, Sandra T.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Kaufman, Susan; Davidge, Sandra T.] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Chakrabarti, Subhadeep; Morton, Jude S.; Kaufman, Susan; Davidge, Sandra T.; Wu, Jianping] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Chakrabarti, Subhadeep; Morton, Jude S.; Davidge, Sandra T.] Univ Alberta, Cardiovasc Res Ctr, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Wu, JP (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	jwu3@ualberta.ca	Chakrabarti, Subhadeep/AAD-1078-2022; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Davidge, Sandra/0000-0002-5559-4905; Wu, Jian/0000-0002-3394-1507; Majumder, Kaustav/0000-0003-2094-7835	Natural Sciences and Engineering Research Council (NSERC) of Canada; Alberta Livestock and Meat Agency (ALMA); Canadian Institute for Health Research (CIHR); Alberta Innovates-Health Solutions (AIHS); Tier I Canada Research Chair in Women's Cardiovascular Health	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Livestock and Meat Agency (ALMA); Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions (AIHS); Tier I Canada Research Chair in Women's Cardiovascular Health	This work is supported by grants from Natural Sciences and Engineering Research Council (NSERC) of Canada and Alberta Livestock and Meat Agency (ALMA) to J. Wu. S. Chakrabarti is supported by a fellowship from Canadian Institute for Health Research (CIHR). S. T. Davidge is an Alberta Innovates-Health Solutions (AIHS) supported AHFMR Scientist and a Tier I Canada Research Chair in Women's Cardiovascular Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcendor DJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-95; Aleixandre A, 2008, NUTR HOSP, V23, P313; Arenas IA, 2004, AM J PHYSIOL-CELL PH, V286, pC779, DOI 10.1152/ajpcell.00398.2003; ATKINSON AB, 1979, LANCET, V2, P836; Bagnost T, 2010, CARDIOVASC RES, V87, P569, DOI 10.1093/cvr/cvq081; Bejjani S, 2013, J AGR FOOD CHEM, V61, P1487, DOI 10.1021/jf302904t; Brown MJ, 2006, BMJ-BRIT MED J, V332, P833, DOI 10.1136/bmj.332.7545.833; Cabassi A, 2001, J HYPERTENS, V19, P1233, DOI 10.1097/00004872-200107000-00008; Chakrabarti S, 2009, J STEROID BIOCHEM, V117, P99, DOI 10.1016/j.jsbmb.2009.07.007; Cheung IWY, 2009, J AGR FOOD CHEM, V57, P9234, DOI 10.1021/jf9018245; Chockalingam A, 2008, CAN J CARDIOL, V24, P441, DOI 10.1016/S0828-282X(08)70617-2; COCA A, 1994, J HYPERTENS, V12, pS13; Cuzzocrea S, 2004, FASEB J, V18, P94, DOI 10.1096/fj.03-0428com; Davalos A, 2004, J FOOD PROTECT, V67, P1939, DOI 10.4315/0362-028X-67.9.1939; de las Heras N, 2006, J RENIN-ANGIO-ALDO S, V7, P192, DOI 10.3317/jraas.2006.037; Dornas WC, 2011, J BIOSCIENCES, V36, P731, DOI 10.1007/s12038-011-9097-y; Feihl F, 2008, CARDIOVASC RES, V78, P274, DOI 10.1093/cvr/cvn022; Franco MD, 2003, CARDIOVASC RES, V60, P228, DOI 10.1016/S0008-6363(03)00541-8; Fujita H, 1999, IMMUNOPHARMACOLOGY, V44, P123, DOI 10.1016/S0162-3109(99)00118-6; Gielis JF, 2011, FREE RADICAL BIO MED, V50, P765, DOI 10.1016/j.freeradbiomed.2010.12.018; Hasler CM, 2000, J AM COLL NUTR, V19, p499S, DOI 10.1080/07315724.2000.10718972; HENRY R, 1990, HYPERTENSION, V16, P422, DOI 10.1161/01.HYP.16.4.422; Hong HJ, 2001, HYPERTENSION, V38, P1044, DOI 10.1161/hy1101.095331; Huang WY, 2010, FOOD CHEM, V123, P635, DOI 10.1016/j.foodchem.2010.04.083; Huang WY, 2010, J AGR FOOD CHEM, V58, P10840, DOI 10.1021/jf102120c; Hultstrom M, 2012, J HYPERTENS, V30, P1087, DOI 10.1097/HJH.0b013e328352b89a; Iroyukifujita H, 2000, CLASSIFICATION ANTIH, P65; Khanna A, 2008, CURR OPIN NEPHROL HY, V17, P477, DOI 10.1097/MNH.0b013e3283069d72; Kietadisorn R, 2012, AM J PHYSIOL-ENDOC M, V302, pE481, DOI 10.1152/ajpendo.00540.2011; Koh KK, 2009, CARDIOVASC RES, V81, P649, DOI 10.1093/cvr/cvn354; Korhonen H, 2003, CURR PHARM DESIGN, V9, P1297, DOI 10.2174/1381612033454892; LEMMER B, 1993, HYPERTENSION, V22, P97, DOI 10.1161/01.HYP.22.1.97; Liu KL, 2009, CLIN EXP PHARMACOL P, V36, P455, DOI 10.1111/j.1440-1681.2009.05153.x; Majumder K, 2013, J AGR FOOD CHEM; Majumder K, 2010, FOOD RES INT, V43, P1371, DOI 10.1016/j.foodres.2010.04.027; Martinez-Maqueda D, 2012, FOOD FUNCT, V3, P350, DOI 10.1039/c2fo10192k; Masuda O, 1996, J NUTR, V126, P3063, DOI 10.1093/jn/126.12.3063; Meisel H, 2004, BIOFACTORS, V21, P55, DOI 10.1002/biof.552210111; Merchant SJ, 2004, HYPERTENS PREGNANCY, V23, P47, DOI 10.1081/PRG-120028281; Miguel M, 2006, J NUTR, V136, P1457, DOI 10.1093/jn/136.6.1457; Morton JS, 2010, AM J PHYSIOL-REG I, V298, pR930, DOI 10.1152/ajpregu.00641.2009; Moser Marvin, 2007, J Clin Hypertens (Greenwich), V9, P316, DOI 10.1111/j.1524-6175.2007.07152.x; Paravicini TM, 2006, CARDIOVASC RES, V71, P247, DOI 10.1016/j.cardiores.2006.05.001; Portaluppi F, 2012, SLEEP MED REV, V16, P151, DOI 10.1016/j.smrv.2011.04.003; Reaves PY, 2003, EXP PHYSIOL, V88, P467, DOI 10.1113/eph8802579; Salvemini Daniela, 2003, Methods Mol Biol, V225, P291; Schwartz GJ, 1999, AM J PHYSIOL-REG I, V276, pR1623, DOI 10.1152/ajpregu.1999.276.6.R1623; Shimamura T, 1999, J HYPERTENS, V17, P211, DOI 10.1097/00004872-199917020-00005; Sipola M, 2001, J PHYSIOL PHARMACOL, V52, P745; Sriramula S, 2011, CARDIOVASC RES, V92, P401, DOI 10.1093/cvr/cvr242; Theuwissen E, 2007, J NUTR, V137, P583, DOI 10.1093/jn/137.3.583; Torruco-Uco JG, 2008, CIENC TEC ALIMENTAR, V6, P158, DOI 10.1080/11358120809487641; TRIPPODO NC, 1981, CIRC RES, V48, P309, DOI 10.1161/01.RES.48.3.309; WHO, 2013, GLOB ATL CARD DIS PR; Wu LY, 2002, HYPERTENSION, V39, P809, DOI 10.1161/hy0302.105207; Yoshikawa M, 2000, BIOFACTORS, V12, P143, DOI 10.1002/biof.5520120122; Zicha J, 1999, PHYSIOL REV, V79, P1227, DOI 10.1152/physrev.1999.79.4.1227	57	95	97	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82829	10.1371/journal.pone.0082829	http://dx.doi.org/10.1371/journal.pone.0082829			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312436	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300087
J	Floriano, VH; Torres, US; Spotti, AR; Ferraz, JRL; Tognola, WA				Floriano, Valdeci Helio; Torres, Ulysses S.; Spotti, Antonio Ronaldo; Lopes Ferraz-Filho, Jose Roberto; Tognola, Waldir Antonio			The Role of Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging in Differentiating between Infectious and Neoplastic Focal Brain Lesions: Results from a Cohort of 100 Consecutive Patients	PLOS ONE			English	Article							MAGNETIC-RESONANCE PERFUSION; CEREBRAL BLOOD-VOLUME; MASS LESIONS; DIAGNOSIS; TUMORS; GRADE; DIFFUSION; ABSCESSES; GLIOMAS	Background and Purpose: Differentiating between infectious and neoplastic focal brain lesions that are detected by conventional structural magnetic resonance imaging (MRI) may be a challenge in routine practice. Brain perfusion-weighted MRI (PWI) may be employed as a complementary non-invasive tool, providing relevant data on hemodynamic parameters, such as the degree of angiogenesis of lesions. We aimed to employ dynamic susceptibility contrast-enhanced perfusion MR imaging (DSC-MRI) to differentiate between infectious and neoplastic brain lesions by investigating brain microcirculation changes. Materials and Methods: DSC-MRI perfusion studies of one hundred consecutive patients with non-cortical neoplastic (n = 54) and infectious (n = 46) lesions were retrospectively assessed. MRI examinations were performed using a 1.5-T scanner. A preload of paramagnetic contrast agent (gadolinium) was administered 30 seconds before acquisition of dynamic images, followed by a standard dose 10 seconds after starting imaging acquisitions. The relative cerebral blood volume (rCBV) values were determined by calculating the regional cerebral blood volume in the solid areas of lesions, normalized to that of the contralateral normal-appearing white matter. Discriminant analyses were performed to determine the cutoff point of rCBV values that would allow the differentiation of neoplastic from infectious lesions and to assess the corresponding diagnostic performance of rCBV when using this cutoff value. Results: Neoplastic lesions had higher rCBV values (4.28 +/- 2.11) than infectious lesions (0.63 +/- 0.49) (p<0.001). When using an rCBV value <1.3 as the parameter to define infectious lesions, the sensitivity of the method was 97.8% and the specificity was 92.6%, with a positive predictive value of 91.8%, a negative predictive value of 98.0%, and an accuracy of 95.0%. Conclusion: PWI is a useful complementary tool in distinguishing between infectious and neoplastic brain lesions; an elevated discriminatory value for diagnosis of infectious brain lesions was observed in this sample of patients when the rCBV cutoff value was set to 1.3.	[Floriano, Valdeci Helio; Torres, Ulysses S.; Lopes Ferraz-Filho, Jose Roberto] Sao Jose do Rio Preto Med Sch FAMERP, Dept Radiol, Hosp Base, Sao Paulo, Brazil; [Spotti, Antonio Ronaldo; Tognola, Waldir Antonio] Sao Jose do Rio Preto Med Sch FAMERP, Dept Neurol Sci, Hosp Base, Sao Paulo, Brazil		Floriano, VH (corresponding author), Sao Jose do Rio Preto Med Sch FAMERP, Dept Radiol, Hosp Base, Sao Paulo, Brazil.	hellio.com@gmail.com	Torres, Ulysses S./E-6034-2011	Torres, Ulysses S./0000-0002-1911-9090				Aiken AH, 2010, NEUROIMAG CLIN N AM, V20, P557, DOI 10.1016/j.nic.2010.07.011; Al-Okaili RN, 2006, RADIOGRAPHICS, V26, pS173, DOI 10.1148/rg.26si065513; Aronen HJ, 2002, NEUROIMAG CLIN N AM, V12, P501, DOI 10.1016/S1052-5149(02)00026-6; Batra A, 2003, J COMPUT ASSIST TOMO, V27, P882, DOI 10.1097/00004728-200311000-00009; Bladowska J, 2013, EUR J RADIOL, V82, P1292, DOI 10.1016/j.ejrad.2013.01.033; Calamante F, 2003, MED RAD DIA IMG, P53; Cha S, 2002, RADIOLOGY, V223, P11, DOI 10.1148/radiol.2231010594; Covarrubias DJ, 2004, ONCOLOGIST, V9, P528, DOI 10.1634/theoncologist.9-5-528; Erdogan C, 2005, J COMPUT ASSIST TOMO, V29, P663, DOI 10.1097/01.rct.0000168868.50256.55; Ernst TM, 1998, RADIOLOGY, V208, P663, DOI 10.1148/radiology.208.3.9722843; Hakyemez B, 2006, J MAGN RESON IMAGING, V24, P817, DOI 10.1002/jmri.20707; Hall WA, 1998, CANCER, V82, P1749, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1756::AID-CNCR23>3.0.CO;2-2; Haris M, 2008, NEURORADIOLOGY, V50, P531, DOI 10.1007/s00234-008-0378-6; Holmes TM, 2004, AM J ROENTGENOL, V183, P1247, DOI 10.2214/ajr.183.5.1831247; Hourani R, 2008, AM J NEURORADIOL, V29, P366, DOI 10.3174/ajnr.A0810; Karampekios S, 2005, EUR RADIOL, V15, P485, DOI 10.1007/s00330-004-2556-1; Keston P, 2003, CLIN RADIOL, V58, P505, DOI 10.1016/S0009-9260(03)00130-2; Lacerda S, 2009, NEUROIMAG CLIN N AM, V19, P527, DOI 10.1016/j.nic.2009.08.007; Law M, 2002, RADIOLOGY, V222, P715, DOI 10.1148/radiol.2223010558; Lee IH, 2010, EUR J RADIOL, V76, P48, DOI 10.1016/j.ejrad.2009.05.013; Lee SK, 2012, NEUROIMAG CLIN N AM, V22, P123, DOI 10.1016/j.nic.2012.02.001; Muccio CF, 2008, RADIOL MED, V113, P747, DOI 10.1007/s11547-008-0254-9; Omuro AMP, 2006, LANCET NEUROL, V5, P937, DOI 10.1016/S1474-4422(06)70597-X; Paldino MJ, 2009, MAGN RESON IMAGING C, V17, P277, DOI 10.1016/j.mric.2009.01.007; Paulson ES, 2008, RADIOLOGY, V249, P601, DOI 10.1148/radiol.2492071659; Rollin N, 2006, NEURORADIOLOGY, V48, P150, DOI 10.1007/s00234-005-0030-7; Rumboldt Z, 2007, SEMIN ROENTGENOL, V42, P62, DOI 10.1053/j.ro.2006.08.012; Shin JH, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790783; Singh A, 2007, J MAGN RESON IMAGING, V26, P871, DOI 10.1002/jmri.21080; Sugahara T, 1998, AM J ROENTGENOL, V171, P1479, DOI 10.2214/ajr.171.6.9843274; The WHO, 2020, CLASSIFICATION TUMOU; Toh CH, 2013, AM J NEURORADIOL, V34, P1145, DOI 10.3174/ajnr.A3383; Vossough Arastoo, 2011, FUNCTIONAL NEURORADI, P197; Wong JC, 2000, AM J ROENTGENOL, V174, P1147, DOI 10.2214/ajr.174.4.1741147	34	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81509	10.1371/journal.pone.0081509	http://dx.doi.org/10.1371/journal.pone.0081509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324699	Green Published, gold, Green Submitted			2022-12-25	WOS:000328566700042
J	Kmieciak, M; Payne, KK; Wang, XY; Manjili, MH				Kmieciak, Maciej; Payne, Kyle K.; Wang, Xiang-Yang; Manjili, Masoud H.			IFN-Y R alpha Is a Key Determinant of CD8+T Cell-Mediated Tumor Elimination or Tumor Escape and Relapse in FVB Mouse	PLOS ONE			English	Article							HER-2/NEU ANTIGEN LOSS; BREAST-CANCER; INTERFERON-GAMMA; DOWN-REGULATION; EXPRESSION; CARCINOMA; EQUILIBRIUM; DORMANCY	During the past decade, the dual function of the immune system in tumor inhibition and tumor progression has become appreciated. We have previously reported that neu-specific T cells can induce rejection of neu positive mouse mammary carcinoma (MMC) and also facilitate tumor relapse by inducing neu antigen loss and epithelial to mesenchymal transition (EMT). Here, we sought to determine the mechanism by which CD8+ T cells either eliminate the tumor, or maintain tumor cells in a dormant state and eventually facilitate tumor relapse. We show that tumor cells that express high levels of IFN-Y R alpha are eliminated by CD8+ T cells. In contrast, tumor cells that express low levels of IFN-Y R alpha do not die but remain dormant and quiescent in the presence of IFN-Y producing CD8+ T cells until they hide themselves from the adaptive immune system by losing the tumor antigen, neu. Relapsed tumor cells show CD44+CD24- phenotype with higher rates of tumorigenesis, in vivo. Acquisition of CD44+CD24- phenotype in relapsed tumors was not solely due to Darwinian selection. Our data suggest that tumor cells control the outcome of tumor immune surveillance through modulation of the expression of IFN-Y R alpha.	[Kmieciak, Maciej; Payne, Kyle K.; Manjili, Masoud H.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Massey Canc Ctr, Richmond, VA 23298 USA; [Wang, Xiang-Yang] Virginia Commonwealth Univ, Dept Human & Mol Genet, Massey Canc Ctr, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University	Kmieciak, M (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Massey Canc Ctr, Richmond, VA 23298 USA.	mkmieciak@vcu.edu; mmanjili@vcu.edu	Payne, Kyle/AAL-6614-2020	Payne, Kyle/0000-0002-6531-9835	VCU Presidential Research Quest Fund; National Institutes of Health [P30CA16059]; NATIONAL CANCER INSTITUTE [R01CA154708, P30CA016059] Funding Source: NIH RePORTER	VCU Presidential Research Quest Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the VCU Presidential Research Quest Fund (M. H. Manjili) and flow cytometry shared resources facility supported in part by the National Institutes of Health grant P30CA16059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bots M, 2006, IMMUNOL CELL BIOL, V84, P79, DOI 10.1111/j.1440-1711.2005.01417.x; Bui JD, 2006, J IMMUNOL, V176, P905, DOI 10.4049/jimmunol.176.2.905; Czerniecki BJ, 2007, CANCER RES, V67, P1842, DOI 10.1158/0008-5472.CAN-06-4038; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Farrar JD, 1999, J IMMUNOL, V162, P2842; Grange C, 2008, NEOPLASIA, V10, P1433, DOI 10.1593/neo.08902; Idowu MO, 2012, HUM PATHOL, V43, P364, DOI 10.1016/j.humpath.2011.05.005; Kmieciak M, 2011, J TRANSL MED, V9; Kmieciak M, 2007, EUR J IMMUNOL, V37, P675, DOI 10.1002/eji.200636639; Kmieciak M, 2011, BREAST CANCER RES TR, V126, P385, DOI 10.1007/s10549-010-0942-8; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kominsky SL, 2000, CANCER RES, V60, P3904; Lin Y, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-59; Lucci A, 2012, LANCET ONCOL, V13, P688, DOI 10.1016/S1470-2045(12)70209-7; Manjili MH, 2008, INT J CANCER, V123, P1476, DOI 10.1002/ijc.23663; Medema JP, 2001, P NATL ACAD SCI USA, V98, P11515, DOI 10.1073/pnas.201398198; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; O'Sullivan T, 2012, J EXP MED, V209, P1869, DOI 10.1084/jem.20112738; Payne KK, 2012, ARCH IMMUNOL THER EX, V60, P345, DOI 10.1007/s00005-012-0185-y; Reim F, 2009, CANCER RES, V69, P8058, DOI 10.1158/0008-5472.CAN-09-0834; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Schwinn N, 2009, INT J CANCER, V124, P1594, DOI 10.1002/ijc.24098; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sharma A, 2012, CANCER-AM CANCER SOC, V118, P4354, DOI 10.1002/cncr.26734; Sun HM, 2013, CLIN TRANSL ONCOL, V15, P46, DOI 10.1007/s12094-012-0891-2; Teng MWL, 2008, J LEUKOCYTE BIOL, V84, P988, DOI 10.1189/jlb.1107774	27	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82544	10.1371/journal.pone.0082544	http://dx.doi.org/10.1371/journal.pone.0082544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324806	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700087
J	Kobashi, H; Kamiya, K; Yanome, K; Igarashi, A; Shimizu, K				Kobashi, Hidenaga; Kamiya, Kazutaka; Yanome, Kyohei; Igarashi, Akihito; Shimizu, Kimiya			Longitudinal Assessment of Optical Quality and Intraocular Scattering Using the Double-Pass Instrument in Normal Eyes and Eyes with Short Tear Breakup Time	PLOS ONE			English	Article							HIGHER-ORDER ABERRATIONS; SERIAL MEASUREMENTS; POSTBLINK CHANGES; DRY EYE; UP TIME; FILM; BLINKING; REPEATABILITY; EYEDROPS; VISION	Purpose: To assess the longitudinal changes in optical quality including intraocular scattering in normal eyes and eyes with short tear breakup time (TBUT). Methods: We prospectively examined twenty eyes of 20 healthy subjects, and age-matched twenty eyes of 20 short TBUT subjects. The modulation transfer function (MTF) cutoff frequency, the Strehl ratio, and the objective scattering index (OSI) were quantitatively assessed using an Optical Quality Analysis System. We investigated the changes in these variables measured consecutively at the initial examination, 5, and 10 seconds without blinking. We also compared these variables in eyes with short TBUT with those in normal eyes. Results: No significant differences in the MTF cutoff frequency, Strehl ratio, or OSI were detected over a 10-second period in normal eyes. These variables also became significantly degraded even over a 5-second period in eyes with short TBUT (p<0.01). We found significant differences in these variables at 5 and 10 seconds (p<0.05), but none immediately after the blink between normal and short TBUT eyes. Conclusions: Optical quality including intraocular scattering deteriorated significantly with time in eyes with short TBUT, whereas we found significant differences over a 10-second period in normal eyes. Eyes with short TBUT showed greater deterioration in optical quality after the blink than normal eyes. The longitudinal assessment of optical quality may be effective in distinguishing eyes with short TBUT from normal eyes.	[Kobashi, Hidenaga; Kamiya, Kazutaka; Yanome, Kyohei; Igarashi, Akihito; Shimizu, Kimiya] Kitasato Univ, Sch Med, Dept Ophthalmol, Sangamihara, Kanagawa, Japan	Kitasato University	Kamiya, K (corresponding author), Kitasato Univ, Sch Med, Dept Ophthalmol, Sangamihara, Kanagawa, Japan.	kamiyak-tky@umin.ac.jp						Artal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016823; Benito A, 2011, J CATARACT REFR SURG, V37, P1481, DOI 10.1016/j.jcrs.2011.03.036; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bron AJ, 2007, OCUL SURF, V5, P108; Diaz-Valle D, 2012, J CATARACT REFR SURG, V38, P1192, DOI 10.1016/j.jcrs.2012.02.040; Kaido M, 2008, OPTOMETRY VISION SCI, V85, P758, DOI 10.1097/OPX.0b013e3181819f0a; Koh S, 2002, AM J OPHTHALMOL, V134, P115, DOI 10.1016/S0002-9394(02)01430-7; Koh S, 2008, CORNEA, V27, P275, DOI 10.1097/ICO.0b013e31815be9c8; Koh S, 2008, INVEST OPHTH VIS SCI, V49, P133, DOI 10.1167/iovs.07-0762; Koh S, 2006, INVEST OPHTH VIS SCI, V47, P3318, DOI 10.1167/iovs.06-0018; Lemp Michael A., 1995, CLAO Journal, V21, P221; Lemp MA, 2007, OCUL SURF, V5, P75; Montes-Mico R, 2005, INVEST OPHTH VIS SCI, V46, P4468, DOI 10.1167/iovs.05-0609; Montes-Mico R, 2005, INVEST OPHTH VIS SCI, V46, P1615, DOI 10.1167/iovs.05-0017; Montes-Mico R, 2004, INVEST OPHTH VIS SCI, V45, P1752, DOI 10.1167/iovs.03-0839; Montes-Mico R, 2004, J REFRACT SURG, V20, P243, DOI 10.3928/1081-597X-20040501-08; Montes-Mico R, 2004, OPHTHALMOLOGY, V111, P758, DOI 10.1016/j.ophtha.2003.06.027; Saad A, 2010, J CATARACT REFR SURG, V36, P28, DOI 10.1016/j.jcrs.2009.07.033; SHIMMURA S, 1995, BRIT J OPHTHALMOL, V79, P1007, DOI 10.1136/bjo.79.11.1007; Thibos LN, 1999, OPTOMETRY VISION SCI, V76, P817, DOI 10.1097/00006324-199912000-00016; TODA I, 1995, OPHTHALMOLOGY, V102, P302; TODA I, 1993, ACTA OPHTHALMOL, V71, P347, DOI 10.1111/j.1755-3768.1993.tb07146.x; Vilaseca M, 2010, OPTOMETRY VISION SCI, V87, P675, DOI 10.1097/OPX.0b013e3181ea1ad3	23	21	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82427	10.1371/journal.pone.0082427	http://dx.doi.org/10.1371/journal.pone.0082427			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324787	Green Submitted, Green Published, gold			2022-12-25	WOS:000328566700080
J	Meyer-Losic, F; Newman, SP; Day, JM; Reed, MJ; Kasprzyk, PG; Purohit, A; Foster, PA				Meyer-Losic, Florence; Newman, Simon P.; Day, Joanna M.; Reed, Michael J.; Kasprzyk, Philip G.; Purohit, Atul; Foster, Paul A.			STX140, but Not Paclitaxel, Inhibits Mammary Tumour Initiation and Progression in C3(1)/SV40T/t-Antigen Transgenic Mice	PLOS ONE			English	Article							BREAST-CANCER CELLS; INDUCED PERIPHERAL NEUROPATHY; IN-VITRO; MOUSE MODEL; OVARIAN-CANCER; VIVO; PROSTATE; CARCINOMA; GROWTH; AGENTS	Despite paclitxael's clinical success, treating hormone-refractory breast cancer remains challenging. Paclitaxel has a poor pharmacological profile, characterized by a low therapeutic index (TIX) caused by severe dose limiting toxicities, such as neutropenia and peripheral neuropathy. Consequently, new drugs are urgently required. STX140, a compound previously shown to have excellent efficacy against many tumors, is here compared to paclitaxel in three translational in vivo breast cancer models, a rat model of peripheral neuropathy, and through pharmacological testing. Three different in vivo mouse models of breast cancer were used; the metastatic 4T1 orthotopic model, the C3(1)/SV40 T-Ag model, and the MDA-MB-231 xenograft model. To determine TIX and pharmacological profile of STX140, a comprehensive dosing regime was performed in mice bearing MDA-MD-231 xenografts. Finally, peripheral neuropathy was examined using a rat plantar thermal hyperalgesia model. In the 4T1 metastatic model, STX140 and paclitaxel significantly inhibited primary tumor growth and lung metastases. All C3(1)/SV40 T-Ag mice in the control and paclitaxel treated groups developed palpable mammary cancer. STX140 blocked 47% of tumors developing and significantly inhibited growth of tumors that did develop. STX140 treatment caused a significant (P<0.001) survival advantage for animals in early and late intervention groups. Conversely, in C3(1)/SV40 T-Ag mice, paclitaxel failed to inhibit tumor growth and did not increase survival time. Furthermore, paclitaxel, but not STX140, induced significant peripheral neuropathy and neutropenia. These results show that STX140 has a greater anti-cancer efficacy, TIX, and reduced neurotoxicity compared to paclitaxel in C3(1)/SV40 T-Ag mice and therefore may be of significant benefit to patients with breast cancer.	[Meyer-Losic, Florence] IPSEN, IPSEN Innovat, Paris, France; [Newman, Simon P.; Day, Joanna M.; Reed, Michael J.; Purohit, Atul] Univ London Imperial Coll Sci Technol & Med, Oncol Drug Discovery & Womens Hlth Grp, London, England; [Kasprzyk, Philip G.] IPSEN, Ipsen Biomeasure, Milford, MA USA; [Foster, Paul A.] Univ Birmingham, Ctr Endocrinol Diabet & Metab, Sch Clin & Expt Med, Birmingham, W Midlands, England	Ipsen; Imperial College London; Ipsen; University of Birmingham	Foster, PA (corresponding author), Univ Birmingham, Ctr Endocrinol Diabet & Metab, Sch Clin & Expt Med, Birmingham, W Midlands, England.	p.a.foster@bham.ac.uk	Foster, Paul/D-1615-2011	Foster, Paul/0000-0001-7190-1592	Sterix Ltd.	Sterix Ltd.	This research was supported by Sterix Ltd., a member of the Ipsen Group and the Corrigan-Walla Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becher OJ, 2006, CANCER RES, V66, P3355, DOI 10.1158/0008-5472.CAN-05-3827; Calvo A, 2002, INT J CANCER, V101, P224, DOI 10.1002/ijc.10589; Chander SK, 2007, BRIT J CANCER, V96, P1368, DOI 10.1038/sj.bjc.6603727; Day JM, 2003, J STEROID BIOCHEM, V84, P317, DOI 10.1016/S0960-0760(03)00045-1; Foster PA, 2008, BREAST CANCER RES TR, V111, P251, DOI 10.1007/s10549-007-9791-5; Foster PA, 2008, ANTICANCER RES, V28, P1483; Foster PA, 2008, ANTICANCER RES, V28, P577; Green JE, 2000, ONCOGENE, V19, P1020, DOI 10.1038/sj.onc.1203280; Green JE, 2001, CANCER RES, V61, P7449; Hardman WE, 2011, NUTR CANCER, V63, P960, DOI 10.1080/01635581.2011.589959; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hensley H, 2007, CANCER BIOL THER, V6, P1717, DOI 10.4161/cbt.6.11.4830; Huh JI, 2006, CANCER RES, V66, P3495, DOI 10.1158/0008-5472.CAN-04-2372; Huh JI, 2005, ONCOGENE, V24, P790, DOI 10.1038/sj.onc.1208221; Ireson CR, 2004, BRIT J CANCER, V90, P932, DOI 10.1038/sj.bjc.6601591; Jared JA, 2012, DRUG DIS DEV THER, V6, P371; Leese MP, 2006, J MED CHEM, V49, P7683, DOI 10.1021/jm060705x; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; MacCarthy-Morrogh L, 2000, CANCER RES, V60, P5441; Newman SP, 2007, BRIT J CANCER, V97, P1673, DOI 10.1038/sj.bjc.6604100; Newman SP, 2008, CLIN CANCER RES, V14, P597, DOI 10.1158/1078-0432.CCR-07-1717; Newman SP, 2006, CANCER RES, V66, P324, DOI 10.1158/0008-5472.CAN-05-2391; Newman SP, 2004, INT J CANCER, V109, P533, DOI 10.1002/ijc.20045; Pachman DR, 2011, CLIN PHARMACOL THER, V90, P377, DOI 10.1038/clpt.2011.115; Purohit A, 2000, INT J CANCER, V85, P584, DOI 10.1002/(SICI)1097-0215(20000215)85:4<584::AID-IJC22>3.3.CO;2-H; Radiloff Daniel R, 2008, Drug Discov Today Dis Models, V4, P83; Raobaikady B, 2005, INT J CANCER, V117, P150, DOI 10.1002/ijc.21066; Russnes HG, 2011, J CLIN INVEST, V121, P3810, DOI 10.1172/JCI57088; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Smith SB, 2004, LIFE SCI, V74, P2593, DOI 10.1016/j.lfs.2004.01.002; Stengel C, 2010, BRIT J CANCER, V102, P316, DOI 10.1038/sj.bjc.6605489; Suarez F, 2007, INVEST OPHTH VIS SCI, V48, P3437, DOI 10.1167/iovs.06-0796; Tagg SLC, 2008, BRIT J CANCER, V99, P1842, DOI 10.1038/sj.bjc.6604752; Van S, 2010, INT J NANOMED, V5, P825, DOI 10.2147/IJN.S13482; Wolf S, 2008, EUR J CANCER, V44, P1507, DOI 10.1016/j.ejca.2008.04.018; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642	36	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e80305	10.1371/journal.pone.0080305	http://dx.doi.org/10.1371/journal.pone.0080305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324595	gold, Green Published, Green Submitted			2022-12-25	WOS:000328566700006
J	Zimmerman, DL; Boddy, CS; Schoenherr, CS				Zimmerman, David L.; Boddy, Craig S.; Schoenherr, Christopher S.			Oct4/Sox2 Binding Sites Contribute to Maintaining Hypomethylation of the Maternal Igf2/H19 Imprinting Control Region	PLOS ONE			English	Article							ENHANCER-BLOCKING ACTIVITY; EMBRYONIC STEM-CELLS; DNA METHYLATION; H19/IGF2 LOCUS; CTCF BINDING; H19; EXPRESSION; TRANSCRIPTION; CHROMATIN; MUTATION	A central question in genomic imprinting is how parental-specific DNA methylation of imprinting control regions (ICR) is established during gametogenesis and maintained after fertilization. At the imprinted Igf2/H19 locus, CTCF binding maintains the unmethylated state of the maternal ICR after the blastocyst stage. In addition, evidence from Beckwith-Wiedemann patients and cultured mouse cells suggests that two Sox-Oct binding motifs within the Igf2/H19 ICR also participate in maintaining hypomethylation of the maternal allele. We found that the Sox and octamer elements from both Sox-Oct motifs were required to drive hypomethylation of integrated transgenes in mouse embryonic carcinoma cells. Oct4 and Sox2 showed cooperative binding to the Sox-Oct motifs, and both were present at the endogenous ICR. Using a mouse with mutations in the Oct4 binding sites, we found that maternally transmitted mutant ICRs acquired partial methylation in somatic tissues, but there was little effect on imprinted expression of H19 and Igf2. A subset of mature oocytes also showed partial methylation of the mutant ICR, which suggested that the Sox-Oct motifs provide some protection from methylation during oogenesis. The Sox-Oct motifs, however, were not required for erasure of paternal methylation in primordial germ cells, which indicated that the oocyte methylation was acquired post-natally. Maternally inherited mutant ICRs were unmethylated in blastocysts, which suggested that at least a portion of the methylation in somatic tissues occurred after implantation. These findings provide evidence that Sox-Oct motifs contribute to ICR hypomethylation in post-implantation embryos and maturing oocytes and link imprinted DNA methylation with key stem cell/germline transcription factors.	[Zimmerman, David L.; Boddy, Craig S.; Schoenherr, Christopher S.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Zimmerman, David L.] Coll Ozarks, Dept Biol, Point Lookout, MO USA; [Boddy, Craig S.] Washington Univ, Sch Med, Div Med Educ, St Louis, MO USA	University of Illinois System; University of Illinois Urbana-Champaign; Washington University (WUSTL)	Zimmerman, DL (corresponding author), Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA.	dzimmerman@cofo.edu			National Institutes of Health [RO1-CA105017]; NATIONAL CANCER INSTITUTE [R01CA105017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health [RO1-CA105017 to C. J. S]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Chen YM, 2009, NUCLEIC ACIDS RES, V37, P793, DOI 10.1093/nar/gkn985; Demars J, 2010, HUM MOL GENET, V19, P803, DOI 10.1093/hmg/ddp549; Engel N, 2004, NAT GENET, V36, P883, DOI 10.1038/ng1399; Engel N, 2008, HUM MOL GENET, V17, P3021, DOI 10.1093/hmg/ddn200; Engel N, 2006, HUM MOL GENET, V15, P2945, DOI 10.1093/hmg/ddl237; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hori N, 2002, J BIOL CHEM, V277, P27960, DOI 10.1074/jbc.M202280200; Hori N, 2012, J BIOL CHEM, V287, P44006, DOI 10.1074/jbc.M112.424580; Hudson QJ, 2010, HEREDITY, V105, P45, DOI 10.1038/hdy.2010.23; Ideraabdullah FY, 2011, DEV BIOL, V355, P349, DOI 10.1016/j.ydbio.2011.04.036; Jones BK, 2002, HUM MOL GENET, V11, P411, DOI 10.1093/hmg/11.4.411; Kaufman Y, 2009, P NATL ACAD SCI USA, V106, P10242, DOI 10.1073/pnas.0902087106; Kitchen NS, 2010, J CELL BIOCHEM, V111, P665, DOI 10.1002/jcb.22751; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Matsuo K, 1998, EMBO J, V17, P1446, DOI 10.1093/emboj/17.5.1446; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Murrell A, 2011, BIOCHEM CELL BIOL, V89, P469, DOI [10.1139/o11-043, 10.1139/O11-043]; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Pant V, 2004, MOL CELL BIOL, V24, P3497, DOI 10.1128/MCB.24.8.3497-3504.2004; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Poole RL, 2012, EUR J HUM GENET, V20, P240, DOI 10.1038/ejhg.2011.166; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Smallwood SA, 2012, TRENDS GENET, V28, P33, DOI 10.1016/j.tig.2011.09.004; Srivastava M, 2000, GENE DEV, V14, P1186; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; Szabo PE, 2004, MOL CELL BIOL, V24, P4791, DOI 10.1128/MCB.24.11.4791-4800.2004; SZABO PE, 1995, GENE DEV, V9, P1857, DOI 10.1101/gad.9.15.1857; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; Weksberg R, 2010, EUR J HUM GENET, V18, P8, DOI 10.1038/ejhg.2009.106	38	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81962	10.1371/journal.pone.0081962	http://dx.doi.org/10.1371/journal.pone.0081962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324735	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700056
J	Arnspang, EC; Schwartzentruber, J; Clausen, MP; Wiseman, PW; Lagerholm, BC				Arnspang, Eva C.; Schwartzentruber, Jeremy; Clausen, Mathias P.; Wiseman, Paul W.; Lagerholm, B. Christoffer			Bridging the Gap between Single Molecule and Ensemble Methods for Measuring Lateral Dynamics in the Plasma Membrane	PLOS ONE			English	Article							IMAGE CORRELATION SPECTROSCOPY; UNDERGO HOP DIFFUSION; TRANSPORT MEASUREMENTS; TRACKING; PROTEINS; CHOLESTEROL; BLINKING; CELLS	The lateral dynamics of proteins and lipids in the mammalian plasma membrane are heterogeneous likely reflecting both a complex molecular organization and interactions with other macromolecules that reside outside the plane of the membrane. Several methods are commonly used for characterizing the lateral dynamics of lipids and proteins. These experimental and data analysis methods differ in equipment requirements, labeling complexities, and further oftentimes give different results. It would therefore be very convenient to have a single method that is flexible in the choice of fluorescent label and labeling densities from single molecules to ensemble measurements, that can be performed on a conventional wide-field microscope, and that is suitable for fast and accurate analysis. In this work we show that k-space image correlation spectroscopy (kICS) analysis, a technique which was originally developed for analyzing lateral dynamics in samples that are labeled at high densities, can also be used for fast and accurate analysis of single molecule density data of lipids and proteins labeled with quantum dots (QDs). We have further used kICS to investigate the effect of the label size and by comparing the results for a biotinylated lipid labeled at high densities with Atto647N-strepatvidin (sAv) or sparse densities with sAv-QDs. In this latter case, we see that the recovered diffusion rate is two-fold greater for the same lipid and in the same cell-type when labeled with Atto647N-sAv as compared to sAv-QDs. This data demonstrates that kICS can be used for analysis of single molecule data and furthermore can bridge between samples with a labeling densities ranging from single molecule to ensemble level measurements.	[Arnspang, Eva C.; Clausen, Mathias P.; Lagerholm, B. Christoffer] Univ Southern Denmark, Dept Phys Chem & Pharm, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark; [Arnspang, Eva C.; Clausen, Mathias P.; Lagerholm, B. Christoffer] Univ Southern Denmark, DaMBIC Danish Mol Biomed Imaging Ctr, Odense, Denmark; [Schwartzentruber, Jeremy; Wiseman, Paul W.] McGill Univ, Dept Phys, Montreal, PQ, Canada; [Schwartzentruber, Jeremy; Wiseman, Paul W.] McGill Univ, Dept Chem, Montreal, PQ, Canada	University of Southern Denmark; University of Southern Denmark; McGill University; McGill University	Lagerholm, BC (corresponding author), Univ Southern Denmark, Dept Phys Chem & Pharm, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark.	christoffer.lagerholm@imm.ox.ac.uk	Clausen, Mathias P./AAE-6487-2020; Arnspang, Eva C/Y-1132-2018	Clausen, Mathias P./0000-0003-1196-6241; Arnspang, Eva C/0000-0002-3095-4070; Schwartzentruber, Jeremy/0000-0002-6183-2092; Lagerholm, Christoffer/0000-0003-4678-5168	VillumKann Rasmussen Foundation; Leo Pharma Forskningsfond; Lundbeck Foundation; Novo Nordisk Foundation; Danish Natural Research Foundation; Danish Ministry of Science; Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC	VillumKann Rasmussen Foundation; Leo Pharma Forskningsfond(LEO Pharma); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Natural Research Foundation(Danish Natural Science Research Council); Danish Ministry of Science; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the VillumKann Rasmussen Foundation (to BioNET), Leo Pharma Forskningsfond, the Lundbeck Foundation, the Novo Nordisk Foundation, the Danish Natural Research Foundation (to MEMPHYS-Center for Biomembrane Physics), and the Danish Ministry of Science (to DaMBIC - Danish Molecular Biomedical Imaging Center). PWW acknowledges grant support from the Natural Sciences and Engineering Research Council of Canada (NSERC). JS acknowledges fellowship support from NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2010, NAT METHODS, V7, P170, DOI 10.1038/nmeth0310-170; Arnspang Christensen E, 2012, PLOS ONE, V7; Arnspang EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048521; Bannai H, 2006, NAT PROTOC, V1, P2628, DOI 10.1038/nprot.2006.429; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Chakraborty SK, 2007, NANO LETT, V7, P2618, DOI 10.1021/nl0709930; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Chen Y, 2006, J CELL BIOL, V175, P169, DOI 10.1083/jcb.200512116; Clausen MP, 2013, NANO LETT, V13, P2332, DOI 10.1021/nl303151f; Clausen MP, 2011, CURR PROTEIN PEPT SC, V12, P699; Digman MA, 2005, BIOPHYS J, V88, pL33, DOI 10.1529/biophysj.105.061788; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Durisic N, 2007, BIOPHYS J, V93, P1338, DOI 10.1529/biophysj.107.106864; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Haustein E, 2007, ANNU REV BIOPH BIOM, V36, P151, DOI 10.1146/annurev.biophys.36.040306.132612; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; Hohng S, 2004, J AM CHEM SOC, V126, P1324, DOI 10.1021/ja039686w; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; Inui K, 1997, CELL BIOL INT, V21, P419, DOI 10.1006/cbir.1997.0165; Kenworthy Anne K., 2007, V398, P179, DOI 10.1007/978-1-59745-513-8_13; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kolin DL, 2006, BIOPHYS J, V91, P3061, DOI 10.1529/biophysj.106.082768; Orr G, 2005, BIOPHYS J, V89, P1362, DOI 10.1529/biophysj.104.056192; Owen DM, 2009, TRAFFIC, V10, P962, DOI 10.1111/j.1600-0854.2009.00908.x; Ramadurai S, 2009, J AM CHEM SOC, V131, P12650, DOI 10.1021/ja902853g; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Semrau S, 2007, BIOPHYS J, V92, P613, DOI 10.1529/biophysj.106.092577; Semrau S, 2011, BIOPHYS J, V100, P1810, DOI 10.1016/j.bpj.2010.12.3746; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Umemura YM, 2008, BIOPHYS J, V95, P435, DOI 10.1529/biophysj.107.123018; Wieser S, 2008, METHODS, V46, P131, DOI 10.1016/j.ymeth.2008.06.010; Wieser S, 2008, BIOPHYS J, V95, P5988, DOI 10.1529/biophysj.108.141655; Wiseman PW, 2000, J MICROSC-OXFORD, V200, P14, DOI 10.1046/j.1365-2818.2000.00736.x; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034	36	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e78096	10.1371/journal.pone.0078096	http://dx.doi.org/10.1371/journal.pone.0078096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324577	Green Submitted, Green Published, gold			2022-12-25	WOS:000327949300005
J	Du, LY; Kou, ZH; Ma, CQ; Tao, XR; Wang, LL; Zhao, GY; Chen, YQ; Yu, F; Tseng, CTK; Zhou, YS; Jiang, SB				Du, Lanying; Kou, Zhihua; Ma, Cuiqing; Tao, Xinrong; Wang, Lili; Zhao, Guangyu; Chen, Yaoqing; Yu, Fei; Tseng, Chien-Te K.; Zhou, Yusen; Jiang, Shibo			A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; S PROTEIN; FUNCTIONAL RECEPTOR; SARS-COV; PNEUMONIA; TARGET; ENTRY; HIV-1; EMC	An emerging respiratory infectious disease with high mortality, Middle East respiratory syndrome (MERS), is caused by a novel coronavirus (MERS-CoV). It was first reported in 2012 in Saudi Arabia and has now spread to eight countries. Development of effective therapeutics and vaccines is crucial to save lives and halt the spread of MERS-CoV. Here, we show that a recombinant protein containing a 212-amino acid fragment (residues 377-588) in the truncated receptor-binding domain (RBD: residues 367-606) of MERS-CoV spike (S) protein fused with human IgG Fc fragment (S377-588-Fc) is highly expressed in the culture supernatant of transfected 293T cells. The purified S377-588-Fc protein efficiently binds to dipeptidyl peptidase 4 (DPP4), the receptor of MERS-CoV, and potently inhibited MERS-CoV infection, suggesting its potential to be further developed as a therapeutic modality for treating MERS-CoV infection and saving the patients' lives. The recombinant S377-588-Fc is able to induce in the vaccinated mice strong MERS-CoV S-specific antibodies, which blocks the binding of RBD to DPP4 receptor and effectively neutralizes MERS-CoV infection. These findings indicate that this truncated RBD protein shows promise for further development as an effective and safe vaccine for the prevention of MERS-CoV infection.	[Du, Lanying; Ma, Cuiqing; Wang, Lili; Yu, Fei; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [Kou, Zhihua; Zhao, Guangyu; Zhou, Yusen] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Tao, Xinrong; Tseng, Chien-Te K.] Univ Texas Med Branch, Dept Microbiol, Galveston, TX 77555 USA; [Tao, Xinrong; Tseng, Chien-Te K.] Univ Texas Med Branch, Dept Immunol, Galveston, TX 77555 USA; [Chen, Yaoqing] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Jiang, Shibo] Fudan Univ, Key Lab Med Mol Virol, Minist Educ, Shanghai 200433, Peoples R China; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Minist Hlth, Shanghai 200433, Peoples R China; [Jiang, Shibo] Fudan Univ, Inst Med Microbi, Shanghai 200433, Peoples R China	New York Blood Center; Beijing Institute of Microbiology & Epidemiology; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Minnesota System; University of Minnesota Twin Cities; Fudan University; Fudan University; Fudan University	Zhou, YS (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	yszhou@bmi.ac.cn; sjiang@nybloodcenter.org	Yu, Fei/K-4953-2019; chen, yaoqing/S-2623-2016; Jiang, Shibo/L-4500-2014	Yu, Fei/0000-0001-6332-4326; chen, yaoqing/0000-0002-1278-3327; Jiang, Shibo/0000-0001-8283-7135	New York Blood Center [NYB000068]; National 973 Program of China [2011CB504706, 2012CB519001]	New York Blood Center; National 973 Program of China(National Basic Research Program of China)	This research was supported by grants from the New York Blood Center (NYB000068) and the National 973 Program of China (2011CB504706, 2012CB519001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assiri A, 2013, NEW ENGL J MED, V369, P886, DOI 10.1056/NEJMx130039; Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0; Cauchemez S, 2013, EURO SURVEILL, V18; Chan JFW, 2012, J INFECTION, V65, P477, DOI 10.1016/j.jinf.2012.10.002; Chan JFW, 2013, J INFECT DIS, V207, P1743, DOI 10.1093/infdis/jit123; Chen YQ, 2013, J VIROL, V87, P10777, DOI 10.1128/JVI.01756-13; de WE, 2013, PLOS ONE, V8; Devitt E, 2013, NAT MED, V19, P952, DOI 10.1038/nm0813-952; Du LY, 2013, J VIROL, V87, P9939, DOI 10.1128/JVI.01048-13; Du LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053568; Du LY, 2009, VIROLOGY, V393, P144, DOI 10.1016/j.virol.2009.07.018; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Gierer S, 2013, J VIROL, V87, P5502, DOI 10.1128/JVI.00128-13; Hall RD, 2013, CANCER CONTROL, V20, P22, DOI 10.1177/107327481302000105; He YX, 2006, J IMMUNOL, V176, P6085, DOI 10.4049/jimmunol.176.10.6085; He YX, 2004, BIOCHEM BIOPH RES CO, V324, P773, DOI 10.1016/j.bbrc.2004.09.106; Huang CJ, 2010, APPL MICROBIOL BIOT, V87, P401, DOI 10.1007/s00253-010-2590-7; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Jiang SB, 2013, J INFECTION, V66, P464, DOI 10.1016/j.jinf.2012.12.003; Lau SKP, 2013, J VIROL, V87, P8638, DOI 10.1128/JVI.01055-13; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li ZL, 2011, P NATL ACAD SCI USA, V108, P4388, DOI 10.1073/pnas.1012861108; Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328; Lu L, 2013, MICROBES INFECT, V15, P625, DOI 10.1016/j.micinf.2013.06.003; Mailles A, 2013, Euro Surveill, V18; Memish ZA, 2013, NEW ENGL J MED, V369, P587, DOI 10.1056/NEJMx130036; Mou H, 2013, J VIROL, V87, P9379, DOI 10.1128/JVI.01277-13; Munster VJ, 2013, NEW ENGL J MED, V368, P1560, DOI 10.1056/NEJMc1215691; Pranchevicius MCS, 2013, BIOENGINEERED, V4, P305, DOI 10.4161/bioe.24666; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Tao XR, 2013, J VIROL, V87, P9953, DOI 10.1128/JVI.01562-13; The Health Protection Agency (HPA) UK Novel Coronavirus Investigation team, 2013, EURO SURVEILL, V18; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; Wang NS, 2013, CELL RES, V23, P986, DOI 10.1038/cr.2013.92; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Wong SK, 2004, J BIOL CHEM, V279, P3197, DOI 10.1074/jbc.C300520200; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang MY, 2009, VACCINE, V27, P857, DOI 10.1016/j.vaccine.2008.11.083	41	122	140	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81587	10.1371/journal.pone.0081587	http://dx.doi.org/10.1371/journal.pone.0081587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324708	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300098
J	Fraysse, M; Pinazo, C; Faure, VM; Fuchs, R; Lazzari, P; Raimbault, P; Pairaud, I				Fraysse, Marion; Pinazo, Christel; Faure, Vincent Martin; Fuchs, Rosalie; Lazzari, Paolo; Raimbault, Patrick; Pairaud, Ivane			Development of a 3D Coupled Physical-Biogeochemical Model for the Marseille Coastal Area (NW Mediterranean Sea): What Complexity Is Required in the Coastal Zone?	PLOS ONE			English	Article							HYDRODYNAMIC-ECOSYSTEM MODEL; RHONE RIVER PLUME; CHLOROPHYLL-A; TEMPORAL VARIABILITY; ORGANIC-MATTER; PLANKTONIC ECOSYSTEM; SKILL ASSESSMENT; FRESH-WATER; SW LAGOON; IN-SITU	Terrestrial inputs (natural and anthropogenic) from rivers, the atmosphere and physical processes strongly impact the functioning of coastal pelagic ecosystems. The objective of this study was to develop a tool for the examination of these impacts on the Marseille coastal area, which experiences inputs from the Rhone River and high rates of atmospheric deposition. Therefore, a new 3D coupled physical/biogeochemical model was developed. Two versions of the biogeochemical model were tested, one model considering only the carbon (C) and nitrogen (N) cycles and a second model that also considers the phosphorus (P) cycle. Realistic simulations were performed for a period of 5 years (2007-2011). The model accuracy assessment showed that both versions of the model were able of capturing the seasonal changes and spatial characteristics of the ecosystem. The model also reproduced upwelling events and the intrusion of Rhone River water into the Bay of Marseille well. Those processes appeared to greatly impact this coastal oligotrophic area because they induced strong increases in chlorophyll-a concentrations in the surface layer. The model with the C, N and P cycles better reproduced the chlorophyll-a concentrations at the surface than did the model without the P cycle, especially for the Rhone River water. Nevertheless, the chlorophyll-a concentrations at depth were better represented by the model without the P cycle. Therefore, the complexity of the biogeochemical model introduced errors into the model results, but it also improved model results during specific events. Finally, this study suggested that in coastal oligotrophic areas, improvements in the description and quantification of the hydrodynamics and the terrestrial inputs should be preferred over increasing the complexity of the biogeochemical model.	[Fraysse, Marion; Pairaud, Ivane] IFREMER, Lab Environm Ressources Provence Azur Corse, La Seyne Sur Mer, France; [Fraysse, Marion; Pinazo, Christel; Faure, Vincent Martin; Fuchs, Rosalie; Raimbault, Patrick] Aix Marseille Univ, CNRS INSU, IRD, MIO,UM 110, Marseille, France; [Fraysse, Marion; Pinazo, Christel; Faure, Vincent Martin; Fuchs, Rosalie; Raimbault, Patrick] Univ Toulon & Var, CNRS INSU, IRD, MIO,UM 110, La Grade, France; [Lazzari, Paolo] Ist Nazl Oceanog & Geofis Sperimentale OGS, Dept Oceanog, Trieste, Italy	Ifremer; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); Universite de Toulon; Istituto Nazionale di Oceanografia e di Geofisica Sperimentale	Fraysse, M (corresponding author), IFREMER, Lab Environm Ressources Provence Azur Corse, La Seyne Sur Mer, France.	marion.fraysse@univ-amu.fr	PINAZO, Christel/AID-3407-2022; Pinazo, Christel/G-2746-2010; PINAZO, Christel/ABF-8800-2020	PINAZO, Christel/0000-0002-1707-2858; Faure, Vincent/0000-0001-8732-4865; Lazzari, Paolo/0000-0001-6819-4612	PACA region; IFREMER grant; GIRAC; PNEC-EC2CO MASSILIA; water agency (AERMC); PERSEUS European FP7 project	PACA region(Region Provence-Alpes-Cote d'Azur); IFREMER grant; GIRAC; PNEC-EC2CO MASSILIA; water agency (AERMC); PERSEUS European FP7 project	This work was supported by the PACA region (http://www.regionpaca.fr/), IFREMER grant (www.ifremer.fr/), GIRAC (http://www.polemerpaca.com/Environnement-et-amenagement-du-littoral/Gestion-de-l-eau-en-zone-cotiere/GIRAC) and PNEC-EC2CO MASSILIA (http://www.insu.cnrs.fr/actions-sur-projets/ec2co) projects, sustained by the water agency (AERMC, www.eaurmc.fr/) and the PERSEUS European FP7 project (http://www.perseus-fp7.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JI, 2007, J MARINE SYST, V64, P3, DOI 10.1016/j.jmarsys.2006.02.010; Allen JI, 2007, J MARINE SYST, V68, P381, DOI 10.1016/j.jmarsys.2007.01.005; Allou A, 2010, CONT SHELF RES, V30, P724, DOI 10.1016/j.csr.2010.01.006; Aminot A., 2004, HYDROLOGIE ECOSYSTEM; Arhonditsis GB, 2004, MAR ECOL PROG SER, V271, P13, DOI 10.3354/meps271013; Arnoux-Chiavassa S, 2003, OCEANOL ACTA, V26, P299, DOI 10.1016/S0399-1784(03)00058-6; Auger PA, 2011, BIOGEOSCIENCES, V8, P3231, DOI 10.5194/bg-8-3231-2011; Baklouti M, 2006, PROG OCEANOGR, V71, P1, DOI 10.1016/j.pocean.2006.05.002; Baklouti M, 2006, PROG OCEANOGR, V71, P34, DOI 10.1016/j.pocean.2006.05.003; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Beker Beatriz, 1999, Oceanis, V25, P395; Bougaran G, 2010, J THEOR BIOL, V265, P443, DOI 10.1016/j.jtbi.2010.04.018; Broche P, 1998, OCEANOL ACTA, V21, P725, DOI 10.1016/S0399-1784(99)80002-4; Campbell R, 2013, PROG OCEANOGR, V109, P47, DOI 10.1016/j.pocean.2012.09.005; COSTE B, 1974, Tethys, V6, P727; Crout NMJ, 2009, ENVIRON MODELL SOFTW, V24, P1, DOI 10.1016/j.envsoft.2008.06.004; Deliat G, 2001, MATIERE ORGANIQUE DI; DROOP MR, 1968, J MAR BIOL ASSOC UK, V48, P689, DOI 10.1017/S0025315400019238; Edwards KP, 2012, OCEAN SCI, V8, P983, DOI 10.5194/os-8-983-2012; ELSAYED MA, 1994, CONT SHELF RES, V14, P507, DOI 10.1016/0278-4343(94)90101-5; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Estournel C, 2001, ESTUAR COAST SHELF S, V53, P25, DOI 10.1006/ecss.2000.0685; Faure V, 2006, CR BIOL, V329, P813, DOI 10.1016/j.crvi.2006.07.006; Faure V, 2010, MAR POLLUT BULL, V61, P465, DOI 10.1016/j.marpolbul.2010.06.041; Faure V, 2010, MAR POLLUT BULL, V61, P480, DOI 10.1016/j.marpolbul.2010.06.040; Flynn KJ, 2008, J PLANKTON RES, V30, P423, DOI 10.1093/plankt/fbn007; Fontana C, 2009, CONT SHELF RES, V29, P1397, DOI 10.1016/j.csr.2009.03.005; Franks PJS, 2009, J PLANKTON RES, V31, P1299, DOI 10.1093/plankt/fbp069; Fuchs R, 2012, MAR POLLUT BULL, V64, P1596, DOI 10.1016/j.marpolbul.2012.05.016; Fulton EA, 2010, J MARINE SYST, V81, P171, DOI 10.1016/j.jmarsys.2009.12.012; Gatti J, 2008, INTRUSIONS COURANT M; Gatti J, 2006, CONT SHELF RES, V26, P1794, DOI 10.1016/j.csr.2006.05.012; Geider RJ, 1998, LIMNOL OCEANOGR, V43, P679, DOI 10.4319/lo.1998.43.4.0679; Goberville E, 2010, MAR ECOL PROG SER, V408, P129, DOI 10.3354/meps08564; Gohin F, 2005, REMOTE SENS ENVIRON, V95, P29, DOI 10.1016/j.rse.2004.11.007; Gohin F, 2011, OCEAN SCI, V7, P705, DOI 10.5194/os-7-705-2011; Gohin F, 2002, INT J REMOTE SENS, V23, P1639, DOI 10.1080/01431160110071879; Gouze E, 2008, BILAN MATIERE ETANG; Gutierrez-Rodriguez A, 2011, ESTUAR COAST SHELF S, V95, P77, DOI 10.1016/j.ecss.2011.08.008; Halsband-Lenk C, 2002, J EXP MAR BIOL ECOL, V271, P121, DOI 10.1016/S0022-0981(02)00025-4; Harmelin-Vivien M, 2008, CONT SHELF RES, V28, P1911, DOI 10.1016/j.csr.2008.03.002; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Ibanez C, 1997, LIMNOL OCEANOGR, V42, P89; INSEE, 2009, RES REC POP; Jany C, 2012, RSTODELERPAC1219; Jolliff JK, 2009, J MARINE SYST, V76, P64, DOI 10.1016/j.jmarsys.2008.05.014; Klausmeier CA, 2007, J THEOR BIOL, V246, P278, DOI 10.1016/j.jtbi.2006.12.032; Kriest I, 2010, PROG OCEANOGR, V86, P337, DOI 10.1016/j.pocean.2010.05.002; Lacroix G, 2007, J MARINE SYST, V64, P66, DOI 10.1016/j.jmarsys.2006.01.010; Lazzari P, 2012, BIOGEOSCIENCES, V9, P217, DOI 10.5194/bg-9-217-2012; Le Tissier M.D.A., 2006, ROLE COASTAL OCEAN D; Leonardos N, 2005, J PHYCOL, V41, P567, DOI 10.1111/j.1529-8817.2005.00082.x; Libralato S, 2009, ECOL MODEL, V220, P2960, DOI 10.1016/j.ecolmodel.2009.08.017; Lonborg C, 2009, MAR CHEM, V113, P219, DOI 10.1016/j.marchem.2009.02.003; Los FJ, 2008, J MARINE SYST, V74, P259, DOI 10.1016/j.jmarsys.2008.01.002; Ludwig W, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003594; Ludwig W, 2009, PROG OCEANOGR, V80, P199, DOI 10.1016/j.pocean.2009.02.001; Markaki Z, 2010, MAR CHEM, V120, P187, DOI 10.1016/j.marchem.2008.10.005; MILLOT C, 1990, CONT SHELF RES, V10, P885, DOI 10.1016/0278-4343(90)90065-T; MILLOT C, 1980, OCEANOL ACTA, V3, P399; Minas H.J., 1968, CAH OCEANOGR, V20, P647; Morel A., 1990, WATER POLLUTION RES, V20, P45; Moutin T, 1998, HYDROBIOLOGIA, V374, P237; Nicolle A, 2009, OCEAN DYNAM, V59, P953, DOI 10.1007/s10236-009-0221-6; OSPAR Commission, 1998, ASMO MOD WORKSH EUTR; Ourmieres Y, 2009, J MARINE SYST, V75, P100, DOI 10.1016/j.jmarsys.2008.08.003; Pairaud IL, 2011, J MARINE SYST, V88, P20, DOI 10.1016/j.jmarsys.2011.02.010; Para J, 2010, BIOGEOSCIENCES, V7, P4083, DOI 10.5194/bg-7-4083-2010; Petrenko A, 2008, J MARINE SYST, V74, P406, DOI 10.1016/j.jmarsys.2008.03.004; Petrenko AA, 2003, OCEANOL ACTA, V26, P323, DOI 10.1016/S0399-1784(03)00038-0; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pinazo C, 1996, J MARINE SYST, V7, P161, DOI 10.1016/0924-7963(95)00028-3; Pinazo C, 2012, 50 ECSA C VEN IT; Poggiale JC, 2010, PHILOS T R SOC B, V365, P3495, DOI 10.1098/rstb.2010.0165; Pont D, 2002, ESTUAR COAST SHELF S, V54, P1, DOI 10.1006/ecss.2001.0829; Radach G, 2006, OCEANOGR MAR BIOL, V44, P1; Raimbault P, 2008, BIOGEOSCIENCES, V5, P281, DOI 10.5194/bg-5-281-2008; Raimbault P., 2004, OCEANIS, V30, P189; Reffray G, 2004, OCEAN DYNAM, V54, P179, DOI 10.1007/s10236-003-0079-y; RHEE GY, 1978, LIMNOL OCEANOGR, V23, P10, DOI 10.4319/lo.1978.23.1.0010; Rose JM, 2007, LIMNOL OCEANOGR, V52, P886, DOI 10.4319/lo.2007.52.2.0886; Rose KA, 2009, J MARINE SYST, V76, P34, DOI 10.1016/j.jmarsys.2008.05.013; Saito MA, 2008, LIMNOL OCEANOGR, V53, P276, DOI 10.4319/lo.2008.53.1.0276; Sempere R, 2000, GLOBAL BIOGEOCHEM CY, V14, P669, DOI 10.1029/1999GB900069; Shutler JD, 2011, J MARINE SYST, V88, P169, DOI 10.1016/j.jmarsys.2011.03.013; Skogen MD, 2005, J MARINE SYST, V57, P289, DOI 10.1016/j.jmarsys.2005.06.002; Smith CL, 2000, J MARINE SYST, V26, P1, DOI 10.1016/S0924-7963(00)00010-5; Stow CA, 2009, J MARINE SYST, V76, P4, DOI 10.1016/j.jmarsys.2008.03.011; Tett P, 2003, CONT SHELF RES, V23, P1635, DOI 10.1016/j.csr.2003.06.013; Thingstad TF, 1998, LIMNOL OCEANOGR, V43, P88, DOI 10.4319/lo.1998.43.1.0088; Travers M, 2009, ECOL MODEL, V220, P3089, DOI 10.1016/j.ecolmodel.2009.08.016; Tusseau-Vuillemin MH, 1998, J GEOPHYS RES-OCEANS, V103, P7693, DOI 10.1029/97JC03709; Van Wambeke F, 2002, MICROB ECOL, V43, P119, DOI 10.1007/s00248-001-0038-4; Wan Z, 2012, OCEAN SCI, V8, P683, DOI 10.5194/os-8-683-2012; Younes WAN, 2003, OCEANOL ACTA, V26, P311, DOI 10.1016/S0399-1784(03)00037-9	95	19	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80012	10.1371/journal.pone.0080012	http://dx.doi.org/10.1371/journal.pone.0080012			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324589	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300016
J	Gruttner, S; Hopf, C; Kumar, A; Kempken, F				Gruettner, Stefanie; Hopf, Christina; Kumar, Abhishek; Kempken, Frank			Deletions in cox2 mRNA Result in Loss of Splicing and RNA Editing and Gain of Novel RNA Editing Sites	PLOS ONE			English	Article							PLANT-MITOCHONDRIA; PROTEINS; GENE; ELECTROPORATION; RECOGNITION	As previously demonstrated, the maize cox2 RNA is fully edited in cauliflower mitochondria. Use of constructs with a deleted cox2 intron, however, led to a loss of RNA editing at almost all editing sites, with only a few sites still partially edited. Likewise, one deletion in exon 1 and three in exon 2 abolish RNA editing at all cox2 sites analyzed. Furthermore, intron splicing is abolished using these deletions. Mutation of a cytosine residue, which is normally edited and localized directly adjacent to the intron, to thymidine did not result in restoration of splicing, indicating that the loss of splicing was not due to loss of RNA editing. One deletion in exon 2 did not lead to loss of splicing. Instead, most editing sites were found to be edited, only three were not edited. Unexpectedly, we observed additional RNA editing events at new sites. Thus it appears that deletions in the cox2 RNA sequence can have a strong effect on RNA processing, leading to loss of splicing, loss of editing at all sites, or even to a gain of new editing sites. As these effects are not limited to the vicinity of the respective deletions, but appear to be widespread or even affect all editing sites, they may not be explained by the loss of PPR binding sites. Instead, it appears that several parts of the cox2 transcript are required for proper RNA processing. This indicates the roles of the RNA sequence and structural elements in the recognition of the editing sites.	[Kempken, Frank] Univ Kiel, Inst Bot, Abt Bot Genet & Mol Biol, Kiel, Germany; Univ Kiel, Bot Garten, Kiel, Germany	University of Kiel; University of Kiel	Kempken, F (corresponding author), Univ Kiel, Inst Bot, Abt Bot Genet & Mol Biol, Olshausenstr 40, Kiel, Germany.	fkempken@bot.uni-kiel.de	Kumar, Abhishek/A-8727-2012	Kumar, Abhishek/0000-0003-4172-4059; Kempken, Frank/0000-0002-7853-8009; Gruttner, Stefanie/0000-0002-2117-7839	German Research Association (DFG) [Ke409/15-3]	German Research Association (DFG)(German Research Foundation (DFG))	The work was funded by the German Research Association (DFG) with a grant to Frank Kempken Grant Number Ke409/15-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2013, FEBS LETT, V587, P887, DOI 10.1016/j.febslet.2013.02.009; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; BINDER S, 1992, J BIOL CHEM, V267, P7615; Bolle N, 2007, RNA, V13, P2061, DOI 10.1261/rna.758307; Bolle N, 2006, FEBS LETT, V580, P4443, DOI 10.1016/j.febslet.2006.07.011; Bonen L, 2011, PLANT MITOCHONDRIA; Bonen L, 2008, MITOCHONDRION, V8, P26, DOI 10.1016/j.mito.2007.09.005; BORNER GV, 1995, MOL GEN GENET, V246, P739, DOI 10.1007/BF00290721; Bruhs A, 2011, ADVAN PL BIO, V1, P157; Castandet B, 2010, NUCLEIC ACIDS RES, V38, P7112, DOI 10.1093/nar/gkq591; Choury D, 2004, NUCLEIC ACIDS RES, V32, P6397, DOI 10.1093/nar/gkh969; COVELLO PS, 1989, NATURE, V341, P662, DOI 10.1038/341662a0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dawson TR, 2004, J BIOL CHEM, V279, P4941, DOI 10.1074/jbc.M310068200; del Campo EM, 2000, NUCLEIC ACIDS RES, V28, P1092, DOI 10.1093/nar/28.5.1092; Farre JC, 2001, NUCLEIC ACIDS RES, V29, P2484, DOI 10.1093/nar/29.12.2484; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; GUALBERTO JM, 1989, NATURE, V341, P660, DOI 10.1038/341660a0; HIESEL R, 1989, SCIENCE, V246, P1632, DOI 10.1126/science.2480644; Hinrichsen I, 2009, PLANT MOL BIOL, V70, P663, DOI 10.1007/s11103-009-9498-6; Howad W, 1997, P NATL ACAD SCI USA, V94, P11090, DOI 10.1073/pnas.94.20.11090; Kempken F, 2009, ENDOCYT CELL RES, V19, P1; Kempken Frank, 2007, Methods Mol Biol, V372, P177, DOI 10.1007/978-1-59745-365-3_13; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Neuwirt J, 2005, RNA, V11, P1563, DOI 10.1261/rna.2740905; Pring DR, 2001, CURR GENET, V39, P371, DOI 10.1007/s002940100211; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Staudinger M, 2005, MOL GENET GENOMICS, V273, P130, DOI 10.1007/s00438-005-1117-x; Staudinger M, 2003, MOL GENET GENOMICS, V269, P553, DOI 10.1007/s00438-003-0863-x; Takenaka M, 2004, NUCLEIC ACIDS RES, V32, P4137, DOI 10.1093/nar/gkh763; Takenaka M, 2008, MITOCHONDRION, V8, P35, DOI 10.1016/j.mito.2007.09.004; Takenaka M, 2007, METHOD ENZYMOL, V424, P439, DOI 10.1016/S0076-6879(07)24020-0; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Tang JW, 2010, PLANT J, V61, P456, DOI 10.1111/j.1365-313X.2009.04082.x; Verbitskiy D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.397992; Verbitskiy D, 2010, PLANT SIGNAL BEHAV, V5, P558, DOI 10.4161/psb.11095; Verbitskiy D, 2010, PLANT J, V61, P446, DOI 10.1111/j.1365-313X.2009.04076.x; Zehrmann A, 2011, RNA BIOL, V8, P67, DOI 10.4161/rna.8.1.14298; Zehrmann A, 2010, FEBS LETT, V584, P4181, DOI 10.1016/j.febslet.2010.08.049; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zuker M, 1989, MATH METHODS DNA SEQ, P159	43	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82067	10.1371/journal.pone.0082067	http://dx.doi.org/10.1371/journal.pone.0082067			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324745	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300125
J	Nakamura, Y; Shi, XY; Numata, T; Mori, Y; Inoue, R; Lossin, C; Baram, TZ; Hirose, S				Nakamura, Yuki; Shi, Xiuyu; Numata, Tomohiro; Mori, Yasuo; Inoue, Ryuji; Lossin, Christoph; Baram, Tallie Z.; Hirose, Shinichi			Novel HCN2 Mutation Contributes to Febrile Seizures by Shifting the Channel's Kinetics in a Temperature-Dependent Manner	PLOS ONE			English	Article							HYPERPOLARIZATION-ACTIVATED CURRENTS; NUCLEOTIDE-GATED CHANNELS; N-LINKED GLYCOSYLATION; TEMPORAL-LOBE EPILEPSY; PACEMAKER CHANNEL; H-CHANNELS; CATION CHANNELS; I-H; INTEGRATIVE PROPERTIES; HIPPOCAMPAL-NEURONS	Hyperpolarization-activated cyclic nucleotide-gated (HCN) channel-mediated currents, known as I-h, are involved in the control of rhythmic activity in neuronal circuits and in determining neuronal properties including the resting membrane potential. Recent studies have shown that HCN channels play a role in seizure susceptibility and in absence and limbic epilepsy including temporal lobe epilepsy following long febrile seizures (FS). This study focused on the potential contributions of abnormalities in the HCN2 isoform and their role in FS. A novel heterozygous missense mutation in HCN2 exon 1 leading to p. S126L was identified in two unrelated patients with FS. The mutation was inherited from the mother who had suffered from FS in a pedigree. To determine the effect of this substitution we conducted whole-cell patch clamp electrophysiology. We found that mutant channels had elevated sensitivity to temperature. More specifically, they displayed faster kinetics at higher temperature. Kinetic shift by change of temperature sensitivity rather than the shift of voltage dependence led to increased availability of I-h in conditions promoting FS. Responses to cyclic AMP did not differ between wildtype and mutant channels. Thus, mutant HCN2 channels cause significant cAMP-independent enhanced availability of Ih during high temperatures, which may contribute to hyperthermia-induced neuronal hyperexcitability in some individuals with FS.	[Nakamura, Yuki; Hirose, Shinichi] Fukuoka Univ, Fac Med, Dept Pediat, Fukuoka 81401, Japan; [Nakamura, Yuki; Shi, Xiuyu; Hirose, Shinichi] Fukuoka Univ, Res Inst Mol Pathomech Epilepsy, Fukuoka 81401, Japan; [Shi, Xiuyu] Chinese Peoples Liberat Army Gen Hosp, Dept Pediat, Beijing, Peoples R China; [Numata, Tomohiro; Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto, Japan; [Inoue, Ryuji] Fukuoka Univ, Fac Med, Dept Physiol, Fukuoka 81401, Japan; [Lossin, Christoph] Univ Calif Davis, Sch Med, Dept Neurol, Sacramento, CA 95817 USA; [Baram, Tallie Z.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Baram, Tallie Z.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; [Baram, Tallie Z.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA	Fukuoka University; Fukuoka University; Chinese People's Liberation Army General Hospital; Kyoto University; Fukuoka University; University of California System; University of California Davis; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Hirose, S (corresponding author), Fukuoka Univ, Fac Med, Dept Pediat, Fukuoka 81401, Japan.	hirose@fukuoka-u.ac.jp	Baram, Tallie Z/J-6447-2014; Numata, Tomohiro/AAC-2330-2021; Numata, Tomohiro/AAW-2453-2020; Lossin, Christoph/A-6128-2012	Numata, Tomohiro/0000-0002-5719-4884; Numata, Tomohiro/0000-0002-5719-4884; Lossin, Christoph/0000-0001-8101-2924; HIROSE, Shinichi/0000-0001-6796-3790	Japan Society for the Promotion of Science (JSPS) [21791048, 24791096, 24249060, 25670481]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [221S0002, 25129708]; MEXT; Ministry of Health, Labor and Welfare, Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [H23-Nanji-Ippan-78, 24-7]; Joint Usage/Research Program of Medical Research Institute; Tokyo Medical and Dental University; Mitsubishi Foundation; Takeda Scientific Foundation; Research grants for Central Research Institute for the Molecular Pathomechanisms of Epilepsy of Fukuoka University; Recommended Projects of Fukuoka University [117016]; NIH [NS35439, NS078279]; Grants-in-Aid for Scientific Research [22136008] Funding Source: KAKEN; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS035439, R01NS078279, R01NS035439] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP; Joint Usage/Research Program of Medical Research Institute; Tokyo Medical and Dental University; Mitsubishi Foundation; Takeda Scientific Foundation(Takeda Science Foundation (TSF)); Research grants for Central Research Institute for the Molecular Pathomechanisms of Epilepsy of Fukuoka University; Recommended Projects of Fukuoka University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Grant-in-Aid for Young Scientists (B) (21791048 and 24791096 to Y.N.), Grant-in-Aid for Scientific Research (A) (24249060 to S. H.), Grant-in-Aid for Challenging Exploratory research (25670481 to S. H.), Bilateral Joint Research Projects (S. H.) from Japan Society for the Promotion of Science (JSPS), Grants for Scientific Research on Innovative Areas (221S0002 and 25129708 to S. H.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), MEXT-supported Program for the Strategic Research Foundation at Private Universities 2013-2017 (S. H.), a Grant-in-aid for the Research on Measures for Intractable Diseases (No. H23-Nanji-Ippan-78 to S. H.) from the Ministry of Health, Labor and Welfare, Intramural Research Grant (24-7) for Neurological and Psychiatric Disorders of NCNP (S. H.), the Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University (S. H.), grants from The Mitsubishi Foundation (S. H.) and Takeda Scientific Foundation (S. H.), 2013-2017 "Research grants for Central Research Institute for the Molecular Pathomechanisms of Epilepsy of Fukuoka University" (S. H.), Recommended Projects of Fukuoka University (117016 to S. H.), and NIH grants NS35439 and NS078279 (T.Z.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili EA, 2002, NEWS PHYSIOL SCI, V17, P32, DOI 10.1152/physiologyonline.2002.17.1.32; Aponte Y, 2006, J PHYSIOL-LONDON, V574, P229, DOI 10.1113/jphysiol.2005.104042; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Brewster AL, 2005, NEUROBIOL DIS, V19, P200, DOI 10.1016/j.nbd.2004.12.015; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Coulon P, 2009, CELL CALCIUM, V46, P333, DOI 10.1016/j.ceca.2009.09.005; Dibbens LM, 2010, ANN NEUROL, V67, P542, DOI 10.1002/ana.21909; DiFrancesco JC, 2011, J NEUROSCI, V31, P17327, DOI 10.1523/JNEUROSCI.3727-11.2011; Dyhrfjeld-Johnsen J, 2008, FRONT CELL NEUROSCI, V2, DOI 10.3389/neuro.03.002.2008; Escayg A, 2010, EPILEPSIA, V51, P1650, DOI 10.1111/j.1528-1167.2010.02640.x; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Gravante B, 2004, J BIOL CHEM, V279, P43847, DOI 10.1074/jbc.M401598200; Hawkins NA, 2011, NEUROBIOL DIS, V41, P655, DOI 10.1016/j.nbd.2010.11.016; HILLE B, 2001, ION CHANNELS EXCITAB, V18; Hodgson ES, 2008, PEDIATRICS, V121, P1281, DOI 10.1542/peds.2008-0939; Jung S, 2007, J NEUROSCI, V27, P13012, DOI 10.1523/JNEUROSCI.3605-07.2007; Kanyshkova T, 2011, NEUROBIOL DIS; Kuisle M, 2006, J PHYSIOL-LONDON, V575, P83, DOI 10.1113/jphysiol.2006.110486; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lewis AS, 2011, MOL CELL NEUROSCI, V46, P357, DOI 10.1016/j.mcn.2010.11.007; Lewis AS, 2010, CHANNELS, V4, P215, DOI 10.4161/chan.4.3.11630; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Lupica CR, 2001, J NEUROPHYSIOL, V86, P261, DOI 10.1152/jn.2001.86.1.261; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; Magee JC, 1998, J NEUROSCI, V18, P7613; McClelland S, 2011, ANN NEUROL, V70, P454, DOI 10.1002/ana.22479; McClelland S, 2011, NEUROSCI LETT, V497, P155, DOI 10.1016/j.neulet.2011.02.032; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Noam Y, 2011, CURR OPIN NEUROBIOL; Nolan MF, 2007, J NEUROSCI, V27, P12440, DOI 10.1523/JNEUROSCI.2358-07.2007; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Poolos NP, 2006, J NEUROSCI, V26, P7995, DOI 10.1523/JNEUROSCI.2069-06.2006; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Proenza C, 2002, J BIOL CHEM, V277, P29634, DOI 10.1074/jbc.M200504200; Qu LT, 2007, NEUROBIOL DIS, V27, P320, DOI 10.1016/j.nbd.2007.06.003; Rodrigues ARA, 2006, J NEUROPHYSIOL, V95, P76, DOI 10.1152/jn.00624.2005; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 2003, TRENDS NEUROSCI, V26, P550, DOI 10.1016/j.tins.2003.08.003; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Santoro B, 2010, EPILEPSIA, V51, P1624, DOI 10.1111/j.1528-1167.2010.02554.x; Shin M, 2008, NEUROBIOL DIS, V32, P26, DOI 10.1016/j.nbd.2008.06.013; SOLOMON JS, 1993, J PHYSIOL-LONDON, V462, P393, DOI 10.1113/jphysiol.1993.sp019561; Surges R, 2006, EUR J NEUROSCI, V24, P94, DOI 10.1111/j.1460-9568.2006.04880.x; Ulens C, 2001, J BIOL CHEM, V276, P6069, DOI 10.1074/jbc.C000738200; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wallace RH, 2003, NEUROLOGY, V61, P765, DOI 10.1212/01.WNL.0000086379.71183.78; Wimmer VC, 2010, J CLIN INVEST, V120, P2661, DOI 10.1172/JCI42219; Zha QQ, 2008, J NEUROCHEM, V105, P68, DOI 10.1111/j.1471-4159.2007.05110.x; Zong XG, 2005, J BIOL CHEM, V280, P34224, DOI 10.1074/jbc.M506544200	54	37	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80376	10.1371/journal.pone.0080376	http://dx.doi.org/10.1371/journal.pone.0080376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324597	Green Published, gold			2022-12-25	WOS:000327949300020
J	Pepin, J; Abou Chakra, CN; Pepin, E; Nault, V				Pepin, Jacques; Abou Chakra, Claire Nour; Pepin, Eric; Nault, Vincent			Evolution of the Global Use of Unsafe Medical Injections, 2000-2010	PLOS ONE			English	Article								Objective: Since 1999, substantial efforts have been made by the international community to reduce the risks associated with unsafe injections, through ministries of health, international donors, the World Health Organization and the Safe Injection Global Network. The present study attempted to measure the progress, or lack thereof, made over the 2000-2010 decade in reducing unsafe injections in ten regions of the world corresponding to developing and transitional economies. Methods: Data about the number of injections per person per year and the proportion of re-use of syringes and needles were obtained for 2010, mainly from population surveys, and compared with previous estimates for 2000 which had used various sources of information including injection safety assessments, population surveys and published studies on injection practices. Results: From 2000 to 2010, in developing countries and transitional economies, the average number of injections per person per year decreased from 3.40 to 2.88, while the proportion of re-use of injection devices dropped from 39.8% to 5.5%. Combining both factors the number of unsafe injections per person per year decreased from 1.35 to 0.16. Even if substantial progress has been made, the Eastern Mediterranean region remains problematic, with 0.57 unsafe injections per person per year. In sub-Saharan Africa and Latin America, people now receive on average only 0.04-0.05 unsafe injections per year. Conclusion: Substantial progress has been made in reducing the number of unsafe injections in developing countries and transitional economies, essentially through a reduction in the re-use of injection devices. In some regions, elimination of unsafe injections might become a reasonable goal.	[Pepin, Jacques; Abou Chakra, Claire Nour; Pepin, Eric; Nault, Vincent] Univ Sherbrooke, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Pepin, J (corresponding author), Univ Sherbrooke, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1K 2R1, Canada.	jacques.pepin@usherbrooke.ca			Safe Injection Global Network	Safe Injection Global Network	This work was supported by the Safe Injection Global Network which however had no role in data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this article are those of the authors only.	Altaf Arshad, 2006, J Coll Physicians Surg Pak, V16, P622; [Anonymous], INJ PRACT RAP ASS RE; Bhunia R, 2010, INDIAN PEDIATR, V47, P409, DOI 10.1007/s13312-010-0076-4; Fan CX, 2012, INT HEALTH, V4, P295, DOI 10.1016/j.inhe.2012.08.002; Hauri AM, 2004, INT J STD AIDS, V15, P7, DOI 10.1258/095646204322637182; Hauri AM., 2004, COMP QUANTIFICATION; Hutin YJF, 2003, BMJ-BRIT MED J, V327, P1075, DOI 10.1136/bmj.327.7423.1075; Logez S, 2004, AM J INFECT CONTROL, V32, P31, DOI 10.1016/j.ajic.2003.06.006; Measure DHS, 2013, DEMOGRAPHIC HLTH SUR; Measure DHS website, 2013, EG DEM HLTH SURV 200; Reeler AV, 2000, B WORLD HEALTH ORGAN, V78, P135; Talaat M, 2003, TROP MED INT HEALTH, V8, P234, DOI 10.1046/j.1365-3156.2003.01015.x; The SIGN Alliance website, 2013, SAF INJ GLOB NETW AD; The SIGN Alliance website, 2013, SUMM COUNTR INJ SAF; UNAIDS, 2010, UNAIDS REP GLOB AIDS; United Nations Department of Economic and Social Affairs website, 2013, WORLD POP PROSP 2010; World Health Organization, 2000, TOOL C ASS IN PRESS; Yan Y. W., 2007, SMJ Singapore Medical Journal, V48, P769	18	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80948	10.1371/journal.pone.0080948	http://dx.doi.org/10.1371/journal.pone.0080948			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324650	gold, Green Published			2022-12-25	WOS:000327949300062
J	Yu, XF; Li, Y; Wang, XY				Yu, Xuefei; Li, Ye; Wang, Xiaoyuan			Molecular Evolution of Threonine Dehydratase in Bacteria	PLOS ONE			English	Article							L-ISOLEUCINE PRODUCTION; ACT DOMAIN; PROTEIN; DEAMINASE; ENZYMES; EXPRESSION; STABILITY; HOMOLOGY; SERINE	Threonine dehydratase converts L-threonine to 2-ketobutyrate. Several threonine dehydratases exist in bacteria, but their origins and evolutionary pathway are unknown. Here we analyzed all the available threonine dehydratases in bacteria and proposed an evolutionary pathway leading to the genes encoding three different threonine dehydratases CTD, BTD1 and BTD2. The ancestral threonine dehydratase might contain only a catalytic domain, but one or two ACT-like subdomains were fused during the evolution, resulting BTD1 and BTD2, respectively. Horizontal gene transfer, gene fusion, gene duplication, and gene deletion may occur during the evolution of this enzyme. The results are important for understanding the functions of various threonine dehydratases found in bacteria.	[Yu, Xuefei; Wang, Xiaoyuan] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Yu, Xuefei; Li, Ye] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Peoples R China; [Wang, Xiaoyuan] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Wang, XY (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.	xiaoyuanwang@hotmail.com			National Key Basic Research Program of China [2012CB725202]; National Natural Science Foundation of China [31370131]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by grants from National Key Basic Research Program of China (2012CB725202) and National Natural Science Foundation of China (31370131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Alves R, 2002, J MOL BIOL, V320, P751, DOI 10.1016/S0022-2836(02)00546-6; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bershtein S, 2008, MOL BIOL EVOL, V25, P2311, DOI 10.1093/molbev/msn174; Bhaskara RM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00040; Chatterjee R, 2006, TRENDS BIOTECHNOL, V24, P28, DOI 10.1016/j.tibtech.2005.11.002; Chen L, 2013, APPL MICROBIOL BIOT, V97, P2939, DOI 10.1007/s00253-012-4176-z; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Christen P, 2001, CHEM REC, V1, P436, DOI 10.1002/tcr.10005; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daniel RM, 2003, ANNU REV BIOPH BIOM, V32, P69, DOI 10.1146/annurev.biophys.32.110601.142445; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Fani R, 2009, PHYS LIFE REV, V6, P23, DOI 10.1016/j.plrev.2008.12.003; Fields PA, 2001, COMP BIOCHEM PHYS A, V129, P417, DOI 10.1016/S1095-6433(00)00359-7; Fondi M, 2009, RES MICROBIOL, V160, P502, DOI 10.1016/j.resmic.2009.05.001; Gallagher DT, 1998, STRUCTURE, V6, P465, DOI 10.1016/S0969-2126(98)00048-3; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; GOSS TJ, 1985, MOL GEN GENET, V201, P308, DOI 10.1007/BF00425676; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Guillouet S, 2001, APPL MICROBIOL BIOT, V57, P667, DOI 10.1007/s00253-001-0829-z; Guillouet S, 1999, APPL ENVIRON MICROB, V65, P3100; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Hashiguchi K, 1997, BIOSCI BIOTECH BIOCH, V61, P105, DOI 10.1271/bbb.61.105; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; KAGAN Z S, 1969, Biokhimiya, V34, P564; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; MADAN VK, 1983, BIOCHEM PHYSIOL PFL, V178, P43, DOI 10.1016/S0015-3796(83)80068-7; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; MOCKEL B, 1992, J BACTERIOL, V174, P8065; Opiyo SO, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-362; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; PETERSEN JGL, 1988, GENETICS, V119, P527; Rison SCG, 2002, CURR OPIN STRUC BIOL, V12, P374, DOI 10.1016/S0959-440X(02)00331-7; Shulman A, 2008, BIOCHEMISTRY-US, V47, P11783, DOI 10.1021/bi800901n; Simanshu DK, 2007, J BIOSCIENCES, V32, P1195, DOI 10.1007/s12038-007-0121-1; Simanshu DK, 2006, J BIOL CHEM, V281, P39630, DOI 10.1074/jbc.M605721200; SZAMOSI I, 1993, PLANT PHYSIOL, V101, P999, DOI 10.1104/pp.101.3.999; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; TOMOVA V S, 1969, Biokhimiya, V34, P266; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430; Yin LH, 2012, METAB ENG, V14, P542, DOI 10.1016/j.ymben.2012.06.002	45	7	8	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80750	10.1371/journal.pone.0080750	http://dx.doi.org/10.1371/journal.pone.0080750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324624	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300041
J	Bire, S; Ley, D; Casteret, S; Mermod, N; Bigot, Y; Rouleux-Bonnin, F				Bire, Solenne; Ley, Deborah; Casteret, Sophie; Mermod, Nicolas; Bigot, Yves; Rouleux-Bonnin, Florence			Optimization of the piggyBac Transposon Using mRNA and Insulators: Toward a More Reliable Gene Delivery System	PLOS ONE			English	Article							SLEEPING-BEAUTY; TOL2; EXPRESSION; EFFICIENT; MUTAGENESIS; CELLS	Integrating and expressing stably a transgene into the cellular genome remain major challenges for gene-based therapies and for bioproduction purposes. While transposon vectors mediate efficient transgene integration, expression may be limited by epigenetic silencing, and persistent transposase expression may mediate multiple transposition cycles. Here, we evaluated the delivery of the piggyBac transposase messenger RNA combined with genetically insulated transposons to isolate the transgene from neighboring regulatory elements and stabilize expression. A comparison of piggyBac transposase expression from messenger RNA and DNA vectors was carried out in terms of expression levels, transposition efficiency, transgene expression and genotoxic effects, in order to calibrate and secure the transposition-based delivery system. Messenger RNA reduced the persistence of the transposase to a narrow window, thus decreasing side effects such as superfluous genomic DNA cleavage. Both the CTF/NF1 and the D4Z4 insulators were found to mediate more efficient expression from a few transposition events. We conclude that the use of engineered piggyBac transposase mRNA and insulated transposons offer promising ways of improving the quality of the integration process and sustaining the expression of transposon vectors.	[Bire, Solenne; Rouleux-Bonnin, Florence] Univ Tours, GICC, UMR CNRS 7292, Tours, France; [Bire, Solenne; Ley, Deborah; Mermod, Nicolas] Univ Lausanne, Inst Biotechnol, Lausanne, Switzerland; [Bire, Solenne; Ley, Deborah; Mermod, Nicolas] Univ Lausanne, Ctr Biotechnol UNIL EPFL, Lausanne, Switzerland; [Bire, Solenne; Casteret, Sophie; Bigot, Yves] Ctr INRA Val de Loire, PRC, UMR INRA CNRS 7247, Nouzilly, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; University of Lausanne; University of Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE	Bire, S (corresponding author), Univ Lausanne, Inst Biotechnol, Lausanne, Switzerland.	solenne.bire@unil.ch; florence.bonnin@univ-tours.fr	Rouleux, Florence/AFT-8675-2022		Francois Rabelais University of Tours; European Commission [SyntheGeneDelivery 018716]; CNRS; French MENRT; AFM [14020, 14509, 15519]; GR CNRS [2157]; La Ligue Nationale contre le cancer	Francois Rabelais University of Tours; European Commission(European CommissionEuropean Commission Joint Research Centre); CNRS(Centre National de la Recherche Scientifique (CNRS)); French MENRT; AFM(Association Francaise contre les Myopathies); GR CNRS; La Ligue Nationale contre le cancer(Ligue nationale contre le cancer)	This work was supported by the Francois Rabelais University of Tours and funded by grants from the European Commission (SyntheGeneDelivery 018716), the CNRS, the French MENRT, the AFM (Grants 14020, 14509 and 15519), the GR CNRS 2157 and La Ligue Nationale contre le cancer. Solenne Bire held a doctoral fellowship from the French MENRT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bire S, 2013, TOPICS CURRENT GENET, V23, P3; Bire S, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-75; Bire Solenne, 2012, Methods Mol Biol, V859, P1, DOI 10.1007/978-1-61779-603-6_1; Buzdin A, 2003, NUCLEIC ACIDS RES, V31, P4385, DOI 10.1093/nar/gkg496; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Dalsgaard T, 2009, MOL THER, V17, P121, DOI 10.1038/mt.2008.224; Di Matteo Mario, 2012, Methods Mol Biol, V859, P241, DOI 10.1007/978-1-61779-603-6_14; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Esnault G, 2009, MOL CELL BIOL, V29, P2409, DOI 10.1128/MCB.00779-08; Furushima K, 2012, GENETICS, V192, P1235, DOI 10.1534/genetics.112.140855; Garrison BS, 2007, MOL CELL BIOL, V27, P8824, DOI 10.1128/MCB.00498-07; Gaussin A, 2012, GENE THER, V19, P15, DOI 10.1038/gt.2011.70; Geurts AM, 2006, PLOS GENET, V2, P1413, DOI 10.1371/journal.pgen.0020156; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Horie K, 2001, P NATL ACAD SCI USA, V98, P9191, DOI 10.1073/pnas.161071798; Huang X, 2010, MOL THER, V18, P1803, DOI 10.1038/mt.2010.141; Huls M, 2013, BLOOD J VIS EXP, V72; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-25; Kumar M, 2001, HUM GENE THER, V12, P1893, DOI 10.1089/104303401753153947; Lacoste A, 2009, CELL STEM CELL, V5, P332, DOI 10.1016/j.stem.2009.07.011; Le Fourn V, 2013, METAB ENG; Ley D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062784; Liu J, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-31; Meir YJJ, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-28; Mousnier A, 2007, P NATL ACAD SCI USA, V104, P13615, DOI 10.1073/pnas.0705162104; Nakanishi H, 2010, MOL THER, V18, P707, DOI 10.1038/mt.2009.302; Ottaviani A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000394; Palazzoli F, 2011, NAT BIOTECHNOL, V29, P593, DOI 10.1038/nbt.1907; Palazzoli F, 2010, GENETICA, V138, P285, DOI 10.1007/s10709-009-9426-3; Recillas-Targa F, 2004, BIOESSAYS, V26, P796, DOI 10.1002/bies.20059; Steiniger M, 2006, NUCLEIC ACIDS RES, V34, P2820, DOI 10.1093/nar/gkl179; Suganuma R, 2005, BIOL REPROD, V73, P1157, DOI 10.1095/biolreprod.105.044669; Sumiyama K, 2010, GENOMICS, V95, P306, DOI 10.1016/j.ygeno.2010.02.006; Urschitz J, 2010, P NATL ACAD SCI USA, V107, P8117, DOI 10.1073/pnas.1003674107; Van Tendeloo VF, 2007, CURR OPIN MOL THER, V9, P423; WANG G, 1995, MOL CELL BIOL, V15, P1759; Wilber A, 2006, MOL THER, V13, P625, DOI 10.1016/j.ymthe.2005.10.014; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108	42	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82559	10.1371/journal.pone.0082559	http://dx.doi.org/10.1371/journal.pone.0082559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312663	gold, Green Published, Green Submitted			2022-12-25	WOS:000327947800101
J	Clarke, WE; Parkin, IA; Gajardo, HA; Gerhardt, DJ; Higgins, E; Sidebottom, C; Sharpe, AG; Snowdon, RJ; Federico, ML; Iniguez-Luy, FL				Clarke, Wayne E.; Parkin, Isobel A.; Gajardo, Humberto A.; Gerhardt, Daniel J.; Higgins, Erin; Sidebottom, Christine; Sharpe, Andrew G.; Snowdon, Rod J.; Federico, Maria L.; Iniguez-Luy, Federico L.			Genomic DNA Enrichment Using Sequence Capture Microarrays: a Novel Approach to Discover Sequence Nucleotide Polymorphisms (SNP) in Brassica napus L	PLOS ONE			English	Article							QUANTITATIVE TRAIT ANALYSIS; OILSEED RAPE; SEED YIELD; COMPLEX TRAITS; IDENTIFICATION; ARABIDOPSIS; DIVERSITY; HETEROSIS; SELECTION; MARKERS	Targeted genomic selection methodologies, or sequence capture, allow for DNA enrichment and large-scale resequencing and characterization of natural genetic variation in species with complex genomes, such as rapeseed canola (Brassica napus L., AACC, 2n=38). The main goal of this project was to combine sequence capture with next generation sequencing (NGS) to discover single nucleotide polymorphisms (SNPs) in specific areas of the B. napus genome historically associated (via quantitative trait loci -QTL- analysis) to traits of agronomical and nutritional importance. A 2.1 million feature sequence capture platform was designed to interrogate DNA sequence variation across 47 specific genomic regions, representing 51.2 Mb of the Brassica A and C genomes, in ten diverse rapeseed genotypes. All ten genotypes were sequenced using the 454 Life Sciences chemistry and to assess the effect of increased sequence depth, two genotypes were also sequenced using Illumina HiSeq chemistry. As a result, 589,367 potentially useful SNPs were identified. Analysis of sequence coverage indicated a four-fold increased representation of target regions, with 57% of the filtered SNPs falling within these regions. Sixty percent of discovered SNPs corresponded to transitions while 40% were transversions. Interestingly, fifty eight percent of the SNPs were found in genic regions while 42% were found in intergenic regions. Further, a high percentage of genic SNPs was found in exons (65% and 64% for the A and C genomes, respectively). Two different genotyping assays were used to validate the discovered SNPs. Validation rates ranged from 61.5% to 84% of tested SNPs, underpinning the effectiveness of this SNP discovery approach. Most importantly, the discovered SNPs were associated with agronomically important regions of the B. napus genome generating a novel data resource for research and breeding this crop species.	[Clarke, Wayne E.; Parkin, Isobel A.; Higgins, Erin] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada; [Gajardo, Humberto A.; Federico, Maria L.; Iniguez-Luy, Federico L.] Agriaquaculture Nutr Genom Ctr CGNA, Genom & Bioinformat Unit, Temuco, LA USA; [Gerhardt, Daniel J.] Roche NimbleGen Inc, Madison, WI USA; [Sidebottom, Christine; Sharpe, Andrew G.] Natl Res Council Canada, Inst Plant Biotechnol, Saskatoon, SK S7N 0W9, Canada; [Snowdon, Rod J.] Univ Giessen, Dept Plant Breeding, D-35390 Giessen, Germany	Agriculture & Agri Food Canada; Roche Holding; National Research Council Canada; Justus Liebig University Giessen	Iniguez-Luy, FL (corresponding author), Agriaquaculture Nutr Genom Ctr CGNA, Genom & Bioinformat Unit, Temuco, LA USA.	federico.iniguez@cgna.cl	Gajardo, Humberto A./GQO-7623-2022; Parkin, Isobel/AAD-6625-2020	Gajardo, Humberto A./0000-0002-5754-9796; Parkin, Isobel/0000-0002-5807-9466	Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT); FONDECYT [Regular 1100732]; CONICYT REGIONAL/GORE LA [ARAUCANIA/CGNA/R10C1001]	Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT REGIONAL/GORE LA	This research was funded by Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT), FONDECYT/Regular 1100732 and CONICYT REGIONAL/GORE LA ARAUCANIA/CGNA/R10C1001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Bancroft I, 2011, NAT BIOTECHNOL, V29, P762, DOI 10.1038/nbt.1926; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Basunanda P, 2007, PLANT BREEDING, V126, P581, DOI 10.1111/j.1439-0523.2007.01404.x; Basunanda P, 2010, THEOR APPL GENET, V120, P271, DOI 10.1007/s00122-009-1133-z; Bus A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-281; Bus A, 2011, THEOR APPL GENET, V123, P1413, DOI 10.1007/s00122-011-1676-7; Cho K, 2010, PLANT J, V61, P591, DOI 10.1111/j.1365-313X.2009.04084.x; COLLINS DW, 1994, GENOMICS, V20, P386, DOI 10.1006/geno.1994.1192; Cowling W. A., 2011, Genetics, genomics and breeding of oilseed brassicas, P219; Deschamps S, 2010, MOL BREEDING, V25, P553, DOI 10.1007/s11032-009-9357-9; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Edwards D., 2012, GENETICS GENOMICS BR, P152; Edwards D, 2012, CEREAL GENOMICS, P57; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fu Y, 2010, PLANT J, V62, P898, DOI 10.1111/j.1365-313X.2010.04196.x; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Gali K. K., 2011, Genetics, genomics and breeding of oilseed brassicas, P85; Ganal MW, 2009, CURR OPIN PLANT BIOL, V12, P211, DOI 10.1016/j.pbi.2008.12.009; Gehringer A, 2007, BREEDING SCI, V57, P315, DOI 10.1270/jsbbs.57.315; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Grover CE, 2012, AM J BOT, V99, P312, DOI 10.3732/ajb.1100323; Hayward Alice, 2012, Journal of Plant Biotechnology, V39, P49, DOI 10.5010/JPB.2012.39.1.049; Hayward A, 2012, PLANT BIOTECHNOL J, V10, P750, DOI 10.1111/j.1467-7652.2012.00719.x; Henry RJ, 2012, J BIOSCIENCES, V37, P829, DOI 10.1007/s12038-012-9253-z; Hickling D., 2001, CANOLA MEAL FEED IND, V3rd; Hu ZY, 2012, PLANT BREEDING, V131, P293, DOI 10.1111/j.1439-0523.2011.01947.x; Iniguez-Luy FL, 2011, PLANT GENET GENOMICS, V9, P291, DOI 10.1007/978-1-4419-7118-0_10; Kaur S, 2012, PLANT BIOTECHNOL J, V10, P125, DOI 10.1111/j.1467-7652.2011.00644.x; Kidwell Kimberlee K., 1992, P1; Korber N, 2012, THEOR APPL GENET, V125, P1275, DOI 10.1007/s00122-012-1912-9; Kramer CC, 2009, MOL BREEDING, V24, P419, DOI 10.1007/s11032-009-9303-x; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LaFramboise T, 2009, NUCLEIC ACIDS RES, V37, P4181, DOI 10.1093/nar/gkp552; Li XR, 2012, GENOME RES, V22, P2436, DOI 10.1101/gr.140277.112; Iniguez-Luy FL, 2009, THEOR APPL GENET, V120, P31, DOI 10.1007/s00122-009-1157-4; Mammadov Jafar, 2012, Int J Plant Genomics, V2012, P728398, DOI 10.1155/2012/728398; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mayerhofer R, 2005, GENETICS, V171, P1977, DOI 10.1534/genetics.105.049098; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Nagaharu U., 1935, JPN J BOT, V7, P389; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Olson M, 2007, NAT METHODS, V4, P891, DOI 10.1038/nmeth1107-891; Osborn TC, 2003, BIOTECHNOL AGRIC FOR, V52, P69; Park S, 2010, MOL GENET GENOMICS, V283, P135, DOI 10.1007/s00438-009-0504-0; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Parkin IAP, 2010, GENOME, V53, P929, DOI 10.1139/G10-053; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Quijada PA, 2006, THEOR APPL GENET, V113, P549, DOI 10.1007/s00122-006-0323-1; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Radoev M, 2008, GENETICS, V179, P1547, DOI 10.1534/genetics.108.089680; Raman R., 2011, P 11, P36; Riaz A, 2001, PLANT BREEDING, V120, P411, DOI 10.1046/j.1439-0523.2001.00636.x; Salmon A, 2012, G3-GENES GENOM GENET, V2, P921, DOI 10.1534/g3.112.003392; Sambrook J, 2001, MOL CLONING LAB MANU; SHAHIDI F, 1990, CANOLA RAPESEED PROD, P3; Snowdon R., 2007, Oilseeds, P55; Snowdon RJ, 2012, PLANT BREEDING, V131, P351, DOI 10.1111/j.1439-0523.2012.01976.x; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Takeda S, 2008, NAT REV GENET, V9, P444, DOI 10.1038/nrg2342; Trick M, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-50; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Udall JA, 2005, GENETICS, V169, P967, DOI 10.1534/genetics.104.033209; Udall JA, 2006, THEOR APPL GENET, V113, P597, DOI 10.1007/s00122-006-0324-0; Wang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-101; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; [No title captured]	70	30	31	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81992	10.1371/journal.pone.0081992	http://dx.doi.org/10.1371/journal.pone.0081992			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312619	Green Published, gold			2022-12-25	WOS:000327947800079
J	Fendri, I; Ben Hassena, A; Grosset, N; Barkallah, M; Khannous, L; Chuat, V; Gautier, M; Gdoura, R				Fendri, Imen; Ben Hassena, Amal; Grosset, Noel; Barkallah, Mohamed; Khannous, Lamia; Chuat, Victoria; Gautier, Michel; Gdoura, Radhouane			Genetic Diversity of Food-Isolated Salmonella Strains through Pulsed Field Gel Electrophoresis (PFGE) and Enterobacterial Repetitive Intergenic Consensus (ERIC-PCR)	PLOS ONE			English	Article							ENTERICA SEROVAR ENTERITIDIS; ESCHERICHIA-COLI; FERMENTED MILK; TYPHIMURIUM; PREVALENCE; RESISTANCE; PRODUCTS; SEAFOOD; SEROTYPES; CHICKEN	All over the world, the incidence of Salmonella spp contamination on different food sources like broilers, clams and cow milk has increased rapidly in recent years. The multifaceted properties of Salomnella serovars allow the microorganism to grow and multiply in various food matrices, even under adverse conditions. Therefore, methods are needed to detect and trace this pathogen along the entire food supply network. In the present work, PFGE and ERIC-PCR were used to subtype 45 Salmonella isolates belonging to different serovars and derived from different food origins. Among these isolates, S. Enteritidis and S. Kentucky were found to be the most predominant serovars. The Discrimination Index obtained by ERIC-PCR (0.85) was slightly below the acceptable confidence value. The best discriminatory ability was observed when PFGE typing method was used alone (DI = 0.94) or combined with ERIC-PCR (DI = 0.93). A wide variety of profiles was observed between the different serovars using PFGE or/and ERIC-PCR. This diversity is particularly important when the sample origins are varied and even within the same sampling origin.	[Fendri, Imen; Ben Hassena, Amal; Barkallah, Mohamed; Khannous, Lamia; Gdoura, Radhouane] Univ Sfax, Fac Sci Sfax, Unite Rech Toxicol Microbiol Environm & Sante, Sfax, Tunisia; [Fendri, Imen; Grosset, Noel; Gautier, Michel] Dept Agroalimentaire Agrocampus Ouest, Microbiol Lab, Rennes, France; [Chuat, Victoria] INRA, CIRMBIA, UMR Sci & Technol Lait & Loeuf STLO 1253, F-35042 Rennes, France	Universite de Sfax; Faculty of Sciences Sfax; Institut Agro; Agrocampus Ouest; INRAE	Fendri, I (corresponding author), Univ Sfax, Fac Sci Sfax, Unite Rech Toxicol Microbiol Environm & Sante, Sfax, Tunisia.	imen.fendri@yahoo.fr	martel, celine/O-6651-2016; Gdoura, Radhouane/I-6865-2018; Gdoura, Radhouane/AAD-6486-2022; ben hassena, amal/GNP-4643-2022	martel, celine/0000-0002-1800-4558; Gdoura, Radhouane/0000-0003-1140-3780; ben hassena, amal/0000-0001-7046-487X; FENDRI, Imen/0000-0002-4071-5444	Ministere de l'enseignement superieur et de la recherche scientifique	Ministere de l'enseignement superieur et de la recherche scientifique	This work received financial support from "Ministere de l'enseignement superieur et de la recherche scientifique'' granted to the "Unite de Recherche de Toxicologie, Microbiologie Environnementale et Sante". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi-Ghozzi I, 2011, PATHOL BIOL, V59, P207, DOI 10.1016/j.patbio.2010.06.001; Adzitey F, 2013, FOOD CONTROL, V32, P607, DOI 10.1016/j.foodcont.2012.12.016; Akoachere JFTK, 2009, J HEALTH POPUL NUTR, V27, P612; Alali WQ, 2013, POULTRY SCI, V92, P836, DOI 10.3382/ps.2012-02783; Arguello H, 2013, INT J FOOD MICROBIOL, V161, P44, DOI 10.1016/j.ijfoodmicro.2012.11.013; Barkallah M, 2013, VET MICROBIOL, V164, P101, DOI 10.1016/j.vetmic.2013.01.036; Barua H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057811; Ben Aissa R, 2007, J INFECTION, V55, P324, DOI 10.1016/j.jinf.2007.06.007; Bhowmick PP, 2012, INDIAN J MED RES, V135, P371; Chen MH, 2011, FOOD MICROBIOL, V28, P399, DOI 10.1016/j.fm.2010.10.002; FERESU S, 1990, J APPL BACTERIOL, V69, P814, DOI 10.1111/j.1365-2672.1990.tb01578.x; Gorman R, 2004, J CLIN MICROBIOL, V42, P2314, DOI 10.1128/JCM.42.5.2314-2316.2004; Grimont PAD., 2007, ANTIGENIC FORMULAE S, V9th ed, P166; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Julian E., 2010, Morbidity and Mortality Weekly Report, V59, P1647; Kumar R, 2008, MOL BIOTECHNOL, V40, P95, DOI 10.1007/s12033-008-9067-2; Kumar R, 2012, J AOAC INT, V95, P1652, DOI 10.5740/jaoacint.11-341; Kwon YK, 2010, POULTRY SCI, V89, P236, DOI 10.3382/ps.2009-00420; Lim H, 2005, INT J FOOD MICROBIOL, V105, P411, DOI 10.1016/j.ijfoodmicro.2005.03.019; Morshed R, 2010, NEW MICROBIOL, V33, P47; Munch S, 2013, BERL MUNCH TIERARZTL, V126, P16, DOI 10.2376/0005-9366-126-16; Mufandaedza J, 2006, INT J FOOD MICROBIOL, V108, P147, DOI 10.1016/j.ijfoodmicro.2005.11.005; Nath G, 2010, INFECT GENET EVOL, V10, P530, DOI 10.1016/j.meegid.2010.02.004; Pallavi Singh, 2013, Molecular and Cellular Probes, V27, P80; Rantsiou K, 2012, INT J FOOD MICROBIOL, V154, P37, DOI 10.1016/j.ijfoodmicro.2011.12.010; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Sangdee A, 2013, J MICROBIOL, V51, P31, DOI 10.1007/s12275-013-2244-4; Shah DH, 2012, INFECT IMMUN, V80, P4203, DOI 10.1128/IAI.00790-12; Shariat N, 2013, FOOD MICROBIOL, V34, P164, DOI 10.1016/j.fm.2012.11.012; Stevens A, 2008, INT J FOOD MICROBIOL, V123, P191, DOI 10.1016/j.ijfoodmicro.2008.01.007; Struelens M. J., 1996, Clin Microbiol Infect, V2, P2, DOI 10.1111/j.1469-0691.1996.tb00193.x; Sukhnanand S, 2005, J CLIN MICROBIOL, V43, P3688, DOI 10.1128/JCM.43.8.3688-3698.2005; Torpdahl M, 2005, J MICROBIOL METH, V63, P173, DOI 10.1016/j.mimet.2005.03.006; Turki Y, 2014, WORLD J MICROB BIOT, V30, P87, DOI 10.1007/s11274-013-1414-1; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Yuan W, 2010, SCI TOTAL ENVIRON, V408, P1446, DOI 10.1016/j.scitotenv.2009.12.019; Zou W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059224	37	27	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81315	10.1371/journal.pone.0081315	http://dx.doi.org/10.1371/journal.pone.0081315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312546	Green Published, gold			2022-12-25	WOS:000327947800043
J	Wu, CA; Streisfeld, MA; Nutter, LI; Cross, KA				Wu, Carrie A.; Streisfeld, Matthew A.; Nutter, Laura I.; Cross, Kaitlyn A.			The Genetic Basis of a Rare Flower Color Polymorphism in Mimulus lewisii Provides Insight into the Repeatability of Evolution	PLOS ONE			English	Article							IPOMOEA-PURPUREA; FLORAL PIGMENTATION; POPULATION-GENETICS; ADAPTIVE EVOLUTION; MORNING GLORY; WHITE FLOWERS; BIOSYNTHESIS; ADAPTATION; FLAVONOIDS; MUTATIONS	A long-standing question in evolutionary biology asks whether the genetic changes contributing to phenotypic evolution are predictable. Here, we identify a genetic change associated with segregating variation in flower color within a population of Mimulus lewisii. To determine whether these types of changes are predictable, we combined this information with data from other species to investigate whether the spectrum of mutations affecting flower color transitions differs based on the evolutionary time-scale since divergence. We used classic genetic techniques, along with gene expression and population genetic approaches, to identify the putative, loss-of-function mutation that generates rare, white flowers instead of the common, pink color in M. lewisii. We found that a frameshift mutation in an anthocyanin pathway gene is responsible for the white-flowered polymorphism found in this population of M. lewisii. Comparison of our results with data from other species reveals a broader spectrum of flower color mutations segregating within populations relative to those that fix between populations. These results suggest that the genetic basis of fixed differences in flower color may be predictable, but that for segregating variation is not.	[Wu, Carrie A.; Nutter, Laura I.; Cross, Kaitlyn A.] Univ Richmond, Dept Biol, Richmond, VA 23173 USA; [Streisfeld, Matthew A.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA	University of Richmond; University of Oregon	Wu, CA (corresponding author), Univ Richmond, Dept Biol, Richmond, VA 23173 USA.	cwu@richmond.edu	Wu, Carrie/AAE-8433-2022		University of Richmond; University of Oregon; NSF grant [DEB-1258199]; NSF [EF-0723814]	University of Richmond; University of Oregon; NSF grant(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	CAW and KAC were funded through the University of Richmond. MAS was funded through the University of Oregon and NSF grant DEB-1258199. LIN was funded through NSF grant EF-0723814. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beardsley PM, 2003, EVOLUTION, V57, P1397, DOI 10.1111/j.0014-3820.2003.tb00347.x; Broun P, 2005, CURR OPIN PLANT BIOL, V8, P272, DOI 10.1016/j.pbi.2005.03.006; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Chang SM, 2005, GENETICS, V170, P1967, DOI 10.1534/genetics.104.034975; Coberly LC, 2008, EVOLUTION, V62, P1076, DOI 10.1111/j.1558-5646.2008.00355.x; Coberly LC, 2003, MOL ECOL, V12, P1113, DOI 10.1046/j.1365-294X.2003.01786.x; Conte GL, 2012, P ROY SOC B-BIOL SCI, V279, P5039, DOI 10.1098/rspb.2012.2146; Dick CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018230; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fehr C, 2004, MOL ECOL, V13, P1839, DOI 10.1111/j.1365-294X.2004.02182.x; Gompel N, 2009, DEV BIOL, V332, P36, DOI 10.1016/j.ydbio.2009.04.040; Habu Y, 1998, PLANT J, V16, P371, DOI 10.1046/j.1365-313x.1998.00308.x; Harborne J.B., 1984, PHYTOCHEMICAL METHOD, Vsecond; Hickman J. C., 1993, JEPSON MANUAL HIGHER; Hiesey W., 1971, EXPT STUDIES NATURE; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Hopkins R, 2011, NATURE, V469, P411, DOI 10.1038/nature09641; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; KOES RE, 1994, BIOESSAYS, V16, P123, DOI 10.1002/bies.950160209; Martin C, 2010, PLANT PHYSIOL, V154, P506, DOI 10.1104/pp.110.161331; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; Morita Y, 2006, PLANT CELL PHYSIOL, V47, P457, DOI 10.1093/pcp/pcj012; Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011; Orr HA, 2000, EVOLUTION, V54, P13, DOI 10.1111/j.0014-3820.2000.tb00002.x; Otto SP, 2004, P ROY SOC B-BIOL SCI, V271, P705, DOI 10.1098/rspb.2003.2635; Quattrocchio F., 2006, SCI FLAVONOIDS, P97, DOI [DOI 10.1007/978-0-387-28822-2_4, 10.1007/978-0-387-28822-2_4]; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Rausher MD, 2008, INT J PLANT SCI, V169, P7, DOI 10.1086/523358; RAUSHER MD, 1993, GENETICS, V134, P1237; Rebeiz M, 2009, SCIENCE, V326, P1663, DOI 10.1126/science.1178357; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Streisfeld MA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003385; Streisfeld MA, 2011, EVOLUTION, V65, P629, DOI 10.1111/j.1558-5646.2010.01165.x; Streisfeld MA, 2009, MOL BIOL EVOL, V26, P433, DOI 10.1093/molbev/msn268; Warren J, 2001, NEW PHYTOL, V151, P237, DOI 10.1046/j.1469-8137.2001.00159.x; Wilbert SM, 1997, BIOCHEM SYST ECOL, V25, P437, DOI 10.1016/S0305-1978(97)00027-6; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Wittkopp PJ, 2009, SCIENCE, V326, P540, DOI 10.1126/science.1176980; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	47	25	25	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81173	10.1371/journal.pone.0081173	http://dx.doi.org/10.1371/journal.pone.0081173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312531	Green Published, gold			2022-12-25	WOS:000327947800038
J	Bel, Y; Jakubowska, AK; Costa, J; Herrero, S; Escriche, B				Bel, Yolanda; Jakubowska, Agata K.; Costa, Juliana; Herrero, Salvador; Escriche, Baltasar			Comprehensive Analysis of Gene Expression Profiles of the Beet Armyworm Spodoptera exigua Larvae Challenged with Bacillus thuringiensis Vip3Aa Toxin	PLOS ONE			English	Article							VEGETATIVE INSECTICIDAL PROTEIN; HELICOVERPA-ARMIGERA; BACULOVIRUS INFECTION; MICROARRAY ANALYSIS; SEQUENCE TAGS; MANDUCA-SEXTA; HOST-DEFENSE; LEPIDOPTERA; BINDING; TRANSCRIPTOME	Host-pathogen interactions result in complex relationship, many aspects of which are not completely understood. Vip proteins, which are Bacillus thuringensis (Bt) insecticidal toxins produced during the vegetative stage, are selectively effective against specific insect pests. This new group of Bt proteins represents an interesting alternative to the classical Bt Cry toxins because current data suggests that they do not share the same mode of action. We have designed and developed a genome-wide microarray for the beet armyworm Spodoptera exigua, a serious lepidopteran pest of many agricultural crops, and used it to better understand how lepidopteran larvae respond to the treatment with the insecticidal protein Vip3Aa. With this approach, the goal of our study was to evaluate the changes in gene expression levels caused by treatment with sublethal doses of Vip3Aa (causing 99% growth inhibition) at 8 and 24 h after feeding. Results indicated that the toxin provoked a wide transcriptional response, with 19% of the microarray unigenes responding significantly to treatment. The number of up-and down-regulated unigenes was very similar. The number of genes whose expression was regulated at 8 h was similar to the number of genes whose expression was regulated after 24 h of treatment. The up-regulated sequences were enriched for genes involved in innate immune response and in pathogen response such as antimicrobial peptides (AMPs) and repat genes. The down-regulated sequences were mainly unigenes with homology to genes involved in metabolism. Genes related to the mode of action of Bt Cry proteins were found, in general, to be slightly overexpressed. The present study is the first genome-wide analysis of the response of lepidopteran insects to Vip3Aa intoxication. An insight into the molecular mechanisms and components related to Vip intoxication will allow designing of more effective management strategies for pest control.	[Bel, Yolanda; Jakubowska, Agata K.; Herrero, Salvador; Escriche, Baltasar] Univ Valencia, Dept Genet, Valencia, Spain; [Costa, Juliana] UNESP, Dept Appl Biol, Jaboticabal, SP, Brazil	University of Valencia; Universidade Estadual Paulista	Escriche, B (corresponding author), Univ Valencia, Dept Genet, Valencia, Spain.	baltasar.escriche@uv.es	Bel, Yolanda/I-2700-2015; Escriche, Baltasar/N-5136-2014; Herrero, Salva/ABE-5123-2020; Herrero, Salvador/J-5767-2013	Bel, Yolanda/0000-0002-6367-9220; Escriche, Baltasar/0000-0003-4889-793X; Herrero, Salva/0000-0001-5690-2108; Herrero, Salvador/0000-0001-5690-2108	Spanish Ministerio de Ciencia e Innovacion [PBH2008-0113-PC, AGL2009-13340-C02-01, AGL2012-39946-C02-01]; European FEDER funds; Generalitat Valenciana [GVPrometeo2011-044]; CAPES Foundation of the Brazilian Ministry of Education [194/09]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European FEDER funds(European Commission); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); CAPES Foundation of the Brazilian Ministry of Education(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by the Spanish Ministerio de Ciencia e Innovacion (PBH2008-0113-PC, AGL2009-13340-C02-01 and AGL2012-39946-C02-01), European FEDER funds, and the Generalitat Valenciana (GVPrometeo2011-044). J. Costa was funded by CAPES Foundation of the Brazilian Ministry of Education (194/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkefi-Mesrati L, 2011, J INVERTEBR PATHOL, V106, P250, DOI 10.1016/j.jip.2010.10.002; Ahn SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001088; Atsumi S, 2012, P NATL ACAD SCI USA, V109, pE1591, DOI 10.1073/pnas.1120698109; Bang K, 2012, MOL BIOL REP, V39, P5151, DOI 10.1007/s11033-011-1311-3; Beckage NE, 2008, INSECT IMMUNOLOGY, P1; BELL RA, 1976, ANN ENTOMOL SOC AM, V69, P365, DOI 10.1093/aesa/69.2.365; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bravo A, 2008, TRENDS BIOTECHNOL, V26, P573, DOI 10.1016/j.tibtech.2008.06.005; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Burkness Eric C, 2010, GM Crops, V1, P337, DOI 10.4161/gmcr.1.5.14765; Cancino-Rodezno A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037034; Cancino-Rodezno A, 2010, BIOTECHNOL GENET ENG, V26, P65; Cancino-Rodezno A, 2010, INSECT BIOCHEM MOLEC, V40, P58, DOI 10.1016/j.ibmb.2009.12.010; Chakroun M, 2012, J INVERTEBR PATHOL, V110, P334, DOI 10.1016/j.jip.2012.03.021; Cluzeau CVM, 2012, HUM MOL GENET, V21, P3632, DOI 10.1093/hmg/dds193; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Contreras E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055330; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duvic B, 2012, J INSECT PHYSIOL, V58, P881, DOI 10.1016/j.jinsphys.2012.04.001; Estruch J.J., 2001, US patent, Patent No. [6 , 291 , 156 B1, 6291156, US6291156 B1]; Estruch JJ, 1996, P NATL ACAD SCI USA, V93, P5389, DOI 10.1073/pnas.93.11.5389; Eum JH, 2007, DEV COMP IMMUNOL, V31, P1107, DOI 10.1016/j.dci.2007.02.002; Freitak D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-56; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Guo ZB, 2012, PEST MANAG SCI, V68, P718, DOI 10.1002/ps.2318; Hakim RS, 2010, ANNU REV ENTOMOL, V55, P593, DOI 10.1146/annurev-ento-112408-085450; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hernandez-Martinez P, 2013, J INVERTEBR PATHOL, V113, P78, DOI 10.1016/j.jip.2013.02.001; Hernandez-Martinez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012795; Herrero S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-96; Herrero S, 2002, APPL ENVIRON MICROB, V68, P4090, DOI 10.1128/AEM.68.8.4090-4094.2002; Herrero S, 2007, INSECT BIOCHEM MOLEC, V37, P1109, DOI 10.1016/j.ibmb.2007.06.007; Huang LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008098; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Hwang J, 2011, J INVERTEBR PATHOL, V108, P194, DOI 10.1016/j.jip.2011.09.003; Ibrahim Mohamed A, 2010, Bioeng Bugs, V1, P31, DOI 10.4161/bbug.1.1.10519; Insecticide Resistance Action Committee, STRAT SUST CONTR BEE; Jakubowska AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003379; Jakubowska AK, 2010, J VIROL, V84, P2547, DOI 10.1128/JVI.01860-09; Ji DJ, 2004, J INSECT PHYSIOL, V50, P489, DOI 10.1016/j.jinsphys.2004.03.005; Jiang H, 2010, ADV EXP MED BIOL, V708, P181; Kanost MR, 2004, IMMUNOL REV, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Kao CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001314; Khajuria C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-286; Kurtz RW, 2010, SOUTHWEST ENTOMOL, V35, P391, DOI 10.3958/059.035.0321; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee MK, 2003, APPL ENVIRON MICROB, V69, P4648, DOI 10.1128/AEM.69.8.4648-4657.2003; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Liu JG, 2011, J INVERTEBR PATHOL, V108, P92, DOI 10.1016/j.jip.2011.07.007; Ma G, 2005, INSECT BIOCHEM MOLEC, V35, P729, DOI 10.1016/j.ibmb.2005.02.011; Ma G, 2012, DEV COMP IMMUNOL, V37, P184, DOI 10.1016/j.dci.2011.08.017; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Navarro-Cerrillo G, 2013, COMP BIOCHEM PHYS B, V164, P10, DOI 10.1016/j.cbpb.2012.09.004; Navarro-Cerrillo G, 2012, INSECT MOL BIOL, V21, P335, DOI 10.1111/j.1365-2583.2012.01139.x; Oppert B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034624; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Paris M, 2012, J INVERTEBR PATHOL, V109, P201, DOI 10.1016/j.jip.2011.11.004; Pascual L, 2012, INSECT BIOCHEM MOLEC, V42, P557, DOI 10.1016/j.ibmb.2012.04.003; Provost B, 2011, INSECT BIOCHEM MOLEC, V41, P582, DOI 10.1016/j.ibmb.2011.03.010; Rahman MM, 2004, P NATL ACAD SCI USA, V101, P2696, DOI 10.1073/pnas.0306669101; Rodriguez-Cabrera L, 2008, TOXICON, V51, P681, DOI 10.1016/j.toxicon.2007.12.002; Salem TZ, 2011, VIROLOGY, V412, P167, DOI 10.1016/j.virol.2011.01.006; Shao QM, 2012, J BIOL CHEM, V287, P14270, DOI 10.1074/jbc.M112.354548; Shi LM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S10; Shin SW, 1998, INSECT BIOCHEM MOLEC, V28, P827, DOI 10.1016/S0965-1748(98)00077-0; Singh G, 2010, APPL ENVIRON MICROB, V76, P7202, DOI 10.1128/AEM.01552-10; Tamez-Guerra P, 2008, J INVERTEBR PATHOL, V98, P218, DOI 10.1016/j.jip.2008.02.008; Tetreau G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-248; Vachon V, 2012, J INVERTEBR PATHOL, V111, P1, DOI 10.1016/j.jip.2012.05.001; van Frankenhuyzen K, 2011, BACILLUS THURINGIENS; van Munster M, 2007, INSECT MOL BIOL, V16, P25, DOI 10.1111/j.1365-2583.2006.00692.x; Vogel H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-308; Wang Q, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-9; Welchman David P, 2009, Cell Host Microbe, V6, P107, DOI 10.1016/j.chom.2009.07.008; Wen ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018278; Wu P, 2011, MOL BIOL REP, V38, P333, DOI 10.1007/s11033-010-0112-4; Wu S, 2010, DEV COMP IMMUNOL, V34, P1191, DOI 10.1016/j.dci.2010.06.013; Yao JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044090; Yu XQ, 2002, INSECT BIOCHEM MOLEC, V32, P1287, DOI 10.1016/S0965-1748(02)00091-7	79	45	46	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81927	10.1371/journal.pone.0081927	http://dx.doi.org/10.1371/journal.pone.0081927			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312604	gold, Green Published, Green Submitted			2022-12-25	WOS:000327944500105
J	Kamp, A; Stief, P; Knappe, J; de Beer, D				Kamp, Anja; Stief, Peter; Knappe, Jan; de Beer, Dirk			Response of the Ubiquitous Pelagic Diatom Thalassiosira weissflogii to Darkness and Anoxia	PLOS ONE			English	Article							MARINE PLANKTONIC DIATOMS; AMMONIA FERMENTATION; NITRATE-ASSIMILATION; NITROGEN-METABOLISM; UREA CYCLE; DENITRIFICATION; NITRITE; EVOLUTIONARY; PATHWAYS; ECOLOGY	Thalassiosira weissflogii, an abundant, nitrate-storing, bloom-forming diatom in the world's oceans, can use its intracellular nitrate pool for dissimilatory nitrate reduction to ammonium (DNRA) after sudden shifts to darkness and anoxia, most likely as a survival mechanism. T. weissflogii cells that stored 4 mM N-15-nitrate consumed 1.15 (+/- 0.25) fmol NO3- cell(-1) h(-1) and simultaneously produced 1.57 (+/- 0.21) fmol (NH4+)-N-15 cell(-1) h(-1) during the first 2 hours of dark/anoxic conditions. Ammonium produced from intracellular nitrate was excreted by the cells, indicating a dissimilatory rather than assimilatory pathway. Nitrite and the greenhouse gas nitrous oxide were produced at rates 2-3 orders of magnitude lower than the ammonium production rate. While DNRA activity was restricted to the first few hours of darkness and anoxia, the subsequent degradation of photopigments took weeks to months, supporting the earlier finding that diatoms resume photosynthesis even after extended exposure to darkness and anoxia. Considering the high global abundance of T. weissflogii, its production of ammonium and nitrous oxide might be of ecological importance for oceanic oxygen minimum zones and the atmosphere, respectively.	[Kamp, Anja; Knappe, Jan; de Beer, Dirk] Max Planck Inst Marine Microbiol, Microsensor Grp, Bremen, Germany; [Kamp, Anja] Jacobs Univ Bremen, Mol Life Sci Res Ctr, D-28759 Bremen, Germany; [Stief, Peter] Univ Southern Denmark, NordCEE, Dept Biol, Odense, Denmark	Max Planck Society; Jacobs University; University of Southern Denmark	Kamp, A (corresponding author), Max Planck Inst Marine Microbiol, Microsensor Grp, Bremen, Germany.	a.kamp@jacobs-university.de	Knappe, Jan/T-9288-2019; Stief, Peter/C-1090-2017; de Beer, Dirk/L-4840-2013; Knappe, Jan/AAR-4457-2020	Stief, Peter/0000-0002-6355-150X; de Beer, Dirk/0000-0001-5274-1781; Kamp, Anja/0000-0002-5987-7611; Knappe, Jan/0000-0001-8568-0479	Max Planck Society (Germany); German Research Foundation [KA 3187/2-1]	Max Planck Society (Germany)(Max Planck Society); German Research Foundation(German Research Foundation (DFG))	Financial support was provided by the Max Planck Society (Germany), and by a grant from the German Research Foundation awarded to A. K. (KA 3187/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2006, CURR OPIN PLANT BIOL, V9, P264, DOI 10.1016/j.pbi.2006.03.013; Allen AE, 2011, NATURE, V473, P203, DOI 10.1038/nature10074; Amin SA, 2012, MICROBIOL MOL BIOL R, V76, P667, DOI 10.1128/MMBR.00007-12; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Ashworth J, 2013, P NATL ACAD SCI USA, V110, P7518, DOI 10.1073/pnas.1300962110; Assmy P, 2011, EUKARYOTIC MICROBES, P435; Bender SJ, 2012, PROTIST, V163, P232, DOI 10.1016/j.protis.2011.07.008; Bernhard JM, 2012, ISME J, V6, P951, DOI 10.1038/ismej.2011.171; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bowler C, 2010, ANNU REV MAR SCI, V2, P333, DOI 10.1146/annurev-marine-120308-081051; BRAMAN RS, 1989, ANAL CHEM, V61, P2715, DOI 10.1021/ac00199a007; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; Catalanotti C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00150; Clark DR, 2002, NEW PHYTOL, V155, P101, DOI 10.1046/j.1469-8137.2002.00435.x; Collos Y, 1998, MAR ECOL PROG SER, V171, P293, DOI 10.3354/meps171293; Dalber A, 2005, J INORG BIOCHEM, V99, P185, DOI 10.1016/j.jinorgbio.2004.09.018; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; DORTCH O, 1991, MAR BIOL, V110, P183; DORTCH Q, 1990, MAR ECOL PROG SER, V61, P183, DOI 10.3354/meps061183; EPPLEY R W, 1970, Journal of Phycology, V6, P344, DOI 10.1111/j.1529-8817.1970.tb02405.x; Fernie AR, 2012, TRENDS PLANT SCI, V17, P395, DOI 10.1016/j.tplants.2012.02.005; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Ginger ML, 2010, PROTIST, V161, P642, DOI 10.1016/j.protis.2010.09.001; Glock N, 2013, BIOGEOSCIENCES, V10, P4767, DOI 10.5194/bg-10-4767-2013; Glud RN, 2008, MAR BIOL RES, V4, P243, DOI 10.1080/17451000801888726; Glud RN, 2009, LIMNOL OCEANOGR, V54, P723, DOI 10.4319/lo.2009.54.3.0723; Guieysse B, 2013, BIOGEOSCI DISCUSS, V10, P9739, DOI DOI 10.5194/BGD-10-9739-2013; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Harnstrom K, 2011, P NATL ACAD SCI USA, V108, P4252, DOI 10.1073/pnas.1013528108; Hogslund S, 2008, J EXP MAR BIOL ECOL, V359, P85, DOI 10.1016/j.jembe.2008.02.015; Jewson DH, 2006, EUR J PHYCOL, V41, P131, DOI 10.1080/09670260600652903; Jorgensen B.B., 1996, EUTROPHICATION COAST, V52, P115, DOI DOI 10.1029/CE052P0115; Kamp A, 2011, P NATL ACAD SCI USA, V108, P5649, DOI 10.1073/pnas.1015744108; KEMPERS AJ, 1989, ANAL CHIM ACTA, V221, P147, DOI 10.1016/S0003-2670(00)81948-0; KESTER DR, 1967, LIMNOL OCEANOGR, V12, P176, DOI 10.4319/lo.1967.12.1.0176; Kim SW, 2009, APPL ENVIRON MICROB, V75, P2652, DOI 10.1128/AEM.02536-08; Kobayashi M, 1996, J BIOL CHEM, V271, P16263, DOI 10.1074/jbc.271.27.16263; Kraft B, 2011, J BIOTECHNOL, V155, P104, DOI 10.1016/j.jbiotec.2010.12.025; Lam P, 2011, ANNU REV MAR SCI, V3, P317, DOI 10.1146/annurev-marine-120709-142814; LASHOF DA, 1990, NATURE, V344, P529, DOI 10.1038/344529a0; Lewis J, 1999, J PLANKTON RES, V21, P343, DOI 10.1093/plankt/21.2.343; Lin JT, 1998, ADV MICROB PHYSIOL, V39, P1; Llewellyn CA, 2011, PHYTOPLANKTON PIGMEN, P609; LOMSTEIN E, 1990, MAR ECOL PROG SER, V61, P97, DOI 10.3354/meps061097; Mackey KRM, 2011, PROG OCEANOGR, V91, P545, DOI 10.1016/j.pocean.2011.09.001; MacMinn A, 2013, P ROY SOC LOND B BIO, V280; MANN KH, 1993, ICES J MAR SCI, V50, P105, DOI 10.1006/jmsc.1993.1013; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Otte S, 1999, APPL ENVIRON MICROB, V65, P3148; Pina-Ochoa E, 2010, P NATL ACAD SCI USA, V107, P1148, DOI 10.1073/pnas.0908440107; Ploug H, 2001, LIMNOL OCEANOGR, V46, P1624, DOI 10.4319/lo.2001.46.7.1624; Preisler A, 2007, ISME J, V1, P341, DOI 10.1038/ismej.2007.50; Prihoda J, 2012, J EXP BOT, V63, P1543, DOI 10.1093/jxb/err441; RIGUALHERNANDEZ AS, J PLANKTON RES; Risgaard-Petersen N, 2006, NATURE, V443, P93, DOI 10.1038/nature05070; RISGAARDPETERSEN N, 1995, SOIL SCI SOC AM J, V59, P1077, DOI 10.2136/sssaj1995.03615995005900040018x; Sanford RA, 2012, P NATL ACAD SCI USA, V109, P19709, DOI [10.1073/pnas.1211238109, 10.1073/pnas.]; Sayama M, 2005, APPL ENVIRON MICROB, V71, P7575, DOI 10.1128/AEM.71.11.7575-7577.2005; Smart DR, 2001, P NATL ACAD SCI USA, V98, P7875, DOI 10.1073/pnas.131572798; SMETACEK VS, 1985, MAR BIOL, V84, P239, DOI 10.1007/BF00392493; Stief P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073257; Szymczak-Zyla M, 2008, LIMNOL OCEANOGR, V53, P851, DOI 10.4319/lo.2008.53.2.0851; Takasaki K, 2004, J BIOL CHEM, V279, P12414, DOI 10.1074/jbc.M313761200; Thamdrup B, 2012, ANNU REV ECOL EVOL S, V43, P407, DOI 10.1146/annurev-ecolsys-102710-145048; Warembourg F. R, 1993, NITROGEN ISOTOPE TEC, P157; WASMUND N, 1989, ESTUAR COAST SHELF S, V28, P651, DOI 10.1016/0272-7714(89)90052-8; Wright JJ, 2012, NAT REV MICROBIOL, V10, P381, DOI 10.1038/nrmicro2778; Zhou ZM, 2002, J BIOL CHEM, V277, P1892, DOI 10.1074/jbc.M109096200; Zopfi J, 2001, APPL ENVIRON MICROB, V67, P5530, DOI 10.1128/AEM.67.12.5530-5537.2001	71	21	21	7	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82605	10.1371/journal.pone.0082605	http://dx.doi.org/10.1371/journal.pone.0082605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312664	Green Published, gold, Green Submitted			2022-12-25	WOS:000327944500139
J	May, WA; Grigoryan, RS; Keshelava, N; Cabral, DJ; Christensen, LL; Jenabi, J; Ji, LY; Triche, TJ; Lawlor, ER; Reynolds, CP				May, William A.; Grigoryan, Rita S.; Keshelava, Nino; Cabral, Daniel J.; Christensen, Laura L.; Jenabi, Jasmine; Ji, Lingyun; Triche, Timothy J.; Lawlor, Elizabeth R.; Reynolds, C. Patrick			Characterization and Drug Resistance Patterns of Ewing's Sarcoma Family Tumor Cell Lines	PLOS ONE			English	Article							PRIMITIVE NEUROECTODERMAL TUMOR; CHILDRENS-ONCOLOGY-GROUP; SOLID TUMORS; CHIMERIC TRANSCRIPTS; CONTINUOUS-INFUSION; CYTOTOXICITY ASSAY; PROGNOSTIC IMPACT; GENE FUSIONS; REAL-TIME; PHARMACOKINETICS	Despite intensive treatment with chemotherapy, radiotherapy and surgery, over 70% of patients with metastatic Ewing's Sarcoma Family of Tumors (EFT) will die of their disease. We hypothesize that properly characterized laboratory models reflecting the drug resistance of clinical tumors will facilitate the application of new therapeutic agents to EFT. To determine resistance patterns, we studied newly established EFT cell lines derived from different points in therapy: two established at diagnosis (CHLA-9, CHLA-32), two after chemotherapy and progressive disease (CHLA-10, CHLA-25), and two at relapse after myeloablative therapy and autologous bone marrow transplantation (post-ABMT) (CHLA-258, COG-E-352). The new lines were compared to widely studied EFT lines TC-71, TC-32, SK-N-MC, and A-673. These lines were extensively characterized with regard to identity (short tandem repeat (STR) analysis), p53, p16/14 status, and EWS/ETS breakpoint and target gene expression profile. The DIMSCAN cytotoxicity assay was used to assess in vitro drug sensitivity to standard chemotherapy agents. No association was found between drug resistance and the expression of EWS/ETS regulated genes in the EFT cell lines. No consistent association was observed between drug sensitivity and p53 functionality or between drug sensitivity and p16/14 functionality across the cell lines. Exposure to chemotherapy prior to cell line initiation correlated with drug resistance of EFT cell lines in 5/8 tested agents at clinically achievable concentrations (CAC) or the lower tested concentration (LTC): (cyclophosphamide (as 4-HC) and doxorubicin at CAC, etoposide, irinotecan (as SN-38) and melphalan at LTC; P<0.1 for one agent, and P<0.05 for four agents. This panel of well-characterized drug-sensitive and drug-resistant cell lines will facilitate in vitro preclinical testing of new agents for EFT.	[May, William A.; Grigoryan, Rita S.; Keshelava, Nino; Christensen, Laura L.; Jenabi, Jasmine; Ji, Lingyun] Childrens Hosp Los Angeles, Childrens Ctr Canc & Blood Dis, Los Angeles, CA 90027 USA; [May, William A.; Keshelava, Nino; Triche, Timothy J.] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [May, William A.; Grigoryan, Rita S.; Keshelava, Nino; Christensen, Laura L.] Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90033 USA; [Triche, Timothy J.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Lawlor, Elizabeth R.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI USA; [Lawlor, Elizabeth R.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Cabral, Daniel J.; Reynolds, C. Patrick] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Ctr Canc, Lubbock, TX 79430 USA; [Cabral, Daniel J.; Reynolds, C. Patrick] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA; [Cabral, Daniel J.; Reynolds, C. Patrick] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Pediat, Lubbock, TX 79430 USA; [Cabral, Daniel J.; Reynolds, C. Patrick] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Internal Med, Lubbock, TX 79430 USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California; University of Southern California; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Reynolds, CP (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Med, Ctr Canc, Lubbock, TX 79430 USA.	patrick.reynolds@ttuhsc.edu		Reynolds, C. Patrick/0000-0002-2827-8536	Rett's Initiative via the National Childhood Cancer Foundation; Department of Defense [USAMRC 06213001]; NIH [CA90666]; Cancer Prevention & Research Institute of Texas [RP RP110763]; NATIONAL CANCER INSTITUTE [R01CA090666, R01CA134604] Funding Source: NIH RePORTER	Rett's Initiative via the National Childhood Cancer Foundation; Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention & Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Rett's Initiative (www.EFTlab.org) via the National Childhood Cancer Foundation and in part by USAMRC 06213001 from the Department of Defense. WAM was also supported by NIH Grant CA90666 and CPR by Cancer Prevention & Research Institute of Texas Grant RP RP110763. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abudu A, 1999, BRIT J CANCER, V79, P1185, DOI 10.1038/sj.bjc.6690190; Al-Faris N, 2007, PEDIATR BLOOD CANCER, V49, P190, DOI 10.1002/pbc.21140; Amir G, 2002, HUM PATHOL, V33, P170, DOI 10.1053/hupa.2002.31475; Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; Aryee DNT, 2000, LAB INVEST, V80, P1833, DOI 10.1038/labinvest.3780194; Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Batra S, 2004, CANCER RES, V64, P5415, DOI 10.1158/0008-5472.CAN-04-0377; BENNETT CL, 1987, CANCER RES, V47, P1952; Bhatia S, 2007, BLOOD, V109, P46, DOI 10.1182/blood-2006-01-023101; BIEDLER JL, 1973, CANCER RES, V33, P2643; BOAS J, 1995, J CLIN ONCOL, V13, P2954; Burchill SA, 2003, J CLIN PATHOL, V56, P96, DOI 10.1136/jcp.56.2.96; Burdach S, 2000, ANN ONCOL, V11, P1451, DOI 10.1023/A:1026539908115; Burke MJ, 2007, PEDIATR BLOOD CANCER, V49, P196, DOI 10.1002/pbc.21182; de Alava E, 2000, AM J PATHOL, V156, P849, DOI 10.1016/S0002-9440(10)64953-X; de Alava E, 1998, J CLIN ONCOL, V16, P1248, DOI 10.1200/JCO.1998.16.4.1248; de Alava E, 2000, CANCER-AM CANCER SOC, V89, P783, DOI 10.1002/1097-0142(20000815)89:4<783::AID-CNCR10>3.0.CO;2-Q; DINCALCI M, 1982, CANCER CHEMOTH PHARM, V7, P141; ETTINGER LJ, 1994, CANCER, V73, P1297, DOI 10.1002/1097-0142(19940215)73:4<1297::AID-CNCR2820730427>3.0.CO;2-#; Folpe AL, 2000, AM J SURG PATHOL, V24, P1657, DOI 10.1097/00000478-200012000-00010; Frgala T, 2007, MOL CANCER THER, V6, P886, DOI 10.1158/1535-7163.MCT-04-0331; Furman WL, 1996, J CLIN ONCOL, V14, P1504, DOI 10.1200/JCO.1996.14.5.1504; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Ginsberg JP, 1999, J CLIN ONCOL, V17, P1809, DOI 10.1200/JCO.1999.17.6.1809; Guilhaumou R, 2011, CANCER CHEMOTH PHARM, V68, P1191, DOI 10.1007/s00280-010-1541-4; Honoki K, 2007, CANCER-AM CANCER SOC, V110, P1351, DOI 10.1002/cncr.22908; Houghton PJ, 2007, PEDIATR BLOOD CANCER, V49, P928, DOI 10.1002/pbc.21078; Huang HY, 2005, J CLIN ONCOL, V23, P548, DOI 10.1200/JCO.2005.02.081; Janknecht R, 2005, GENE, V363, P1, DOI 10.1016/j.gene.2005.08.007; Juergens C, 2006, PEDIATR BLOOD CANCER, V47, P22, DOI 10.1002/pbc.20820; Kang MH, 2011, PEDIATR BLOOD CANCER, V56, P239, DOI 10.1002/pbc.22801; Keshelava N, 2005, METH MOLEC MED, V110, P139; Keshelava N, 1998, CANCER RES, V58, P5396; Keshelava N, 2000, CANCER CHEMOTH PHARM, V45, P1, DOI 10.1007/PL00006736; Kovar H, 1997, ONCOGENE, V15, P2225, DOI 10.1038/sj.onc.1201397; Labuhn M, 2001, ONCOGENE, V20, P1103, DOI 10.1038/sj.onc.1204197; Lin PP, 1999, CANCER RES, V59, P1428; Ma MK, 2000, CLIN CANCER RES, V6, P813; Martinez-Ramirez A, 2003, CANCER GENET CYTOGEN, V141, P138, DOI 10.1016/S0165-4608(02)00670-2; Martini J, 2007, J STRUCT BIOL, V158, P401, DOI 10.1016/j.jsb.2006.12.012; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; McCune JS, 2009, J CLIN PHARMACOL, V49, P88, DOI 10.1177/0091270008325928; Meier VS, 1998, DIAGN MOL PATHOL, V7, P29, DOI 10.1097/00019606-199802000-00006; Melcher R, 2005, CANCER GENET CYTOGEN, V158, P84, DOI 10.1016/j.cancergencyto.2004.08.023; Mintz MB, 2005, CANCER RES, V65, P1748, DOI 10.1158/0008-5472.CAN-04-2463; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Oberlin O, 2006, J CLIN ONCOL, V24, P3997, DOI 10.1200/JCO.2006.05.7059; Projic P, 2007, CROAT MED J, V48, P473; Rodriguez-Galindo C, 2003, MED PEDIATR ONCOL, V40, P276, DOI 10.1002/mpo.10240; Sabbagh R., 1993, Proceedings of the American Association for Cancer Research Annual Meeting, V34, P198; SETHI VS, 1981, CANCER RES, V41, P3551; Snyder KM, 2007, PEDIATR BLOOD CANCER, V49, P115, DOI 10.1002/pbc.21238; STRUCK RF, 1987, CANCER RES, V47, P2723; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; Tsuchiya T, 2000, CANCER GENET CYTOGEN, V120, P91, DOI 10.1016/S0165-4608(99)00255-1; Tubergen DG, 1996, J PEDIAT HEMATOL ONC, V18, P352, DOI 10.1097/00043426-199611000-00004; van Doorninck JA, 2010, J CLIN ONCOL, V28, P1989, DOI 10.1200/JCO.2009.24.5845; Wei G, 2000, CANCER-AM CANCER SOC, V89, P793, DOI 10.1002/1097-0142(20000815)89:4<793::AID-CNCR11>3.0.CO;2-M; WHANGPENG J, 1986, CANCER GENET CYTOGEN, V21, P185, DOI 10.1016/0165-4608(86)90001-4; WHANGPENG J, 1984, NEW ENGL J MED, V311, P584, DOI 10.1056/NEJM198408303110907; Whelan JS, 2004, PEDIATR BLOOD CANCER, V43, P237, DOI 10.1002/pbc.20107; Zoubek A, 1996, J CLIN ONCOL, V14, P1245, DOI 10.1200/JCO.1996.14.4.1245; Zwerner JP, 2008, ONCOGENE, V27, P3282, DOI 10.1038/sj.onc.1210991	63	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80060	10.1371/journal.pone.0080060	http://dx.doi.org/10.1371/journal.pone.0080060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312454	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500009
J	Gough, DJ; Koetz, L; Levy, DE				Gough, Daniel J.; Koetz, Lisa; Levy, David E.			The MEK-ERK Pathway Is Necessary for Serine Phosphorylation of Mitochondrial STAT3 and Ras-Mediated Transformation	PLOS ONE			English	Article							ELECTRON-TRANSPORT CHAIN; INDEPENDENT PATHWAYS; SIGNAL TRANSDUCER; ACTIVATION; CANCER; KINASE; MOUSE; SURVIVAL; IL-6	Activating mutations in the RasGTPases are the most common oncogenic lesions in human cancer. Similarly, elevated STAT3 expression and/or phosphorylation are observed in the majority of human cancers. We recently found that activated Ras requires a mitochondrial rather than a nuclear activity of STAT3 to support cellular transformation. This mitochondrial activity of STAT3 was supported by phosphorylation on serine 727 (S727) in the carboxyl-terminus of STAT3. In this study we show that the H-Ras oncoprotein engages the MEK-ERK pathway to drive phosphorylation of STAT3 on S727, while phosphoinositide 3-kinase (PI3K) and mTOR activity were superfluous. Moreover, pharmacological inhibition of MEK reduced transformation by H-, K- or N-Ras. However, cells expressing a mitochondrially restricted STAT3 with a phospho-mimetic mutation at S727 were partially resistant to inhibition of the ERK pathway, exhibiting a partial rescue of anchorage-independent cell growth in the presence of MEK inhibitor. This study shows that the MEK-ERK pathway is required for activated Ras-induced phosphorylation of STAT3 on S727, that inhibition of STAT3 S727 phosphorylation contributes to the anti-oncogenic potential of MEK inhibitors, and that mitochondrial STAT3 is one of the critical substrates of the Ras-MEK-ERK- axis during cellular transformation.	[Gough, Daniel J.; Koetz, Lisa; Levy, David E.] NYU, Langone Sch Med, New York, NY 10016 USA	New York University; NYU Langone Medical Center	Levy, DE (corresponding author), NYU, Langone Sch Med, New York, NY 10016 USA.	david.levy@nyumc.org	Levy, David/GPS-4945-2022; Levy, David/AAG-6202-2019	Levy, David/0000-0002-7320-7788; Gough, Daniel/0000-0001-6479-1735; Gough, Daniel/0000-0001-5725-8668	National Institutes of Health [AI28900]; Leukemia and Lymphoma Society [3401-11]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by grant AI28900 from the National Institutes of Health and 3401-11 from the Leukemia and Lymphoma Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Chin L, 2003, NAT REV CANCER, V3, P559, DOI 10.1038/nrc1145; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Frank DA, 1997, J CLIN INVEST, V100, P3140, DOI 10.1172/JCI119869; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Gough DJ, 2012, JAK-STAT SIGNALING: FROM BASICS TO DISEASE, P91, DOI 10.1007/978-3-7091-0891-8_6; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Jain N, 1998, ONCOGENE, V17, P3157, DOI 10.1038/sj.onc.1202238; JANSSEN JWG, 1987, ONCOGENE, V1, P175; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Neel Nicole F, 2011, Genes Cancer, V2, P275, DOI 10.1177/1947601911407329; Redell MS, 2013, BLOOD, V121, P1083, DOI 10.1182/blood-2012-04-421925; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Spiekermann K, 2001, EUR J HAEMATOL, V67, P63, DOI 10.1034/j.1600-0609.2001.t01-1-00385.x; Szczepanek K, 2012, MITOCHONDRION, V12, P180, DOI 10.1016/j.mito.2011.08.011; Szczepanek K, 2011, J BIOL CHEM, V286, P29610, DOI 10.1074/jbc.M111.226209; Thompson N, 2005, CURR OPIN PHARMACOL, V5, P350, DOI 10.1016/j.coph.2005.04.007; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7	36	96	101	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e83395	10.1371/journal.pone.0083395	http://dx.doi.org/10.1371/journal.pone.0083395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24312439	Green Published, gold, Green Submitted			2022-12-25	WOS:000327670300089
J	Deng, XT; Sabino, EC; Cunha-Neto, E; Ribeiro, AL; Ianni, B; Mady, C; Busch, MP; Seislstead, M				Deng, Xutao; Sabino, Ester C.; Cunha-Neto, Edecio; Ribeiro, Antonio L.; Ianni, Barbara; Mady, Charles; Busch, Michael P.; Seislstead, Mark		REDS II Chagas Study Grp	Genome Wide Association Study (GWAS) of Chagas Cardiomyopathy in Trypanosoma cruzi Seropositive Subjects	PLOS ONE			English	Article							SLCO1B1 GENE; DISEASE; PATHOGENESIS; EXPRESSION; PROTEIN; POLYMORPHISMS; VARIANTS; ANCESTRY; RISK	Background: Familial aggregation of Chagas cardiac disease in T. cruzi-infected persons suggests that human genetic variation may be an important determinant of disease progression. Objective: To perform a GWAS using a well-characterized cohort to detect single nucleotide polymorphisms (SNPs) and genes associated with cardiac outcomes. Methods: A retrospective cohort study was developed by the NHLBI REDS-II program in Brazil. Samples were collected from 499 T. cruzi seropositive blood donors who had donated between 1996 and 2002, and 101 patients with clinically diagnosed Chagas cardiomyopathy. In 2008-2010, all subjects underwent a complete medical examination. After genotype calling, quality control filtering with exclusion of 20 cases, and imputation of 1,000 genomes variants; association analysis was performed for 7 cardiac and parasite related traits, adjusting for population stratification. Results: The cohort showed a wide range of African, European, and modest Native American admixture proportions, consistent with the recent history of Brazil. No SNPs were found to be highly (P<10(-8)) associated with cardiomyopathy. The two mostly highly associated SNPs for cardiomyopathy (rs4149018 and rs12582717; P-values <10(-6)) are located on Chromosome 12p12.2 in the SLCO1B1 gene, a solute carrier family member. We identified 44 additional genic SNPs associated with six traits at P-value <10(-6) : Ejection Fraction, PR, QRS, QT intervals, antibody levels by EIA, and parasitemia by PCR. Conclusion: This GWAS identified suggestive SNPs that may impact the risk of progression to cardiomyopathy. Although this Chagas cohort is the largest examined by GWAS to date, (580 subjects), moderate sample size may explain in part the limited number of significant SNP variants. Enlarging the current sample through expanded cohorts and meta-analyses, and targeted studies of candidate genes, will be required to confirm and extend the results reported here. Future studies should also include exposed seronegative controls to investigate genetic associations with susceptibility or resitance to T. cruzi infection and non-Chagas cardiomathy.	[Deng, Xutao; Busch, Michael P.; Seislstead, Mark] Blood Syst Res Inst, San Francisco, CA USA; [Sabino, Ester C.] Univ Sao Paulo, Dept Infect Dis, Inst Trop Med, Sao Paulo, Brazil; [Cunha-Neto, Edecio] Univ Sao Paulo, Immunol Lab, Heart Inst InCor, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Cunha-Neto, Edecio] Inst Nacl Ciencia & Tecnol, Inst Invest Immunol, Sao Paulo, Brazil; [Ribeiro, Antonio L.] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil; [Ribeiro, Antonio L.] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil; [Ianni, Barbara; Mady, Charles] Univ Sao Paulo, Sch Med, Cardiomyopathy Unit, Heart Inst InCor, Sao Paulo, Brazil; [Busch, Michael P.; Seislstead, Mark] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Seislstead, Mark] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	Vitalant; Vitalant Research Institute; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade de Sao Paulo; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Seislstead, M (corresponding author), Blood Syst Res Inst, San Francisco, CA USA.	Mark.Seielstad@ucsf.edu	Nastari, Luciano/C-8528-2012; Mady, Charles/C-8870-2012; Ribeiro, Ana Cristina/HHN-7466-2022; Sabino, Ester C/F-7750-2010; Ribeiro, Antonio L/C-2707-2009; Cunha-Neto, Edecio/B-4157-2009; Seielstad, Mark/T-7841-2019; Balarin, Marly/D-9913-2014; Ianni, Barbara Maria/C-7689-2012; Salemi, Vera MC/C-9104-2013	Nastari, Luciano/0000-0002-7959-3827; Mady, Charles/0000-0002-8838-199X; Ribeiro, Ana Cristina/0000-0002-0493-8376; Sabino, Ester C/0000-0003-2623-5126; Ribeiro, Antonio L/0000-0002-2740-0042; Cunha-Neto, Edecio/0000-0002-3699-3345; Ianni, Barbara Maria/0000-0002-1588-5492; Salemi, Vera MC/0000-0002-7152-1810; Keating, Sheila/0000-0002-8324-3694; Seielstad, Mark/0000-0001-5783-1401	National Heart, Lung, and Blood Institute [HHSN268200417175C]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is supported by National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study-II (REDS-II), International Component Contract (HHSN268200417175C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharinejad S, 2005, AM J TRANSPLANT, V5, P2185, DOI 10.1111/j.1600-6143.2005.01006.x; Ansorge HL, 2009, J BIOL CHEM, V284, P8427, DOI 10.1074/jbc.M805582200; Basquiera AL, 2003, HEART, V89, P1186, DOI 10.1136/heart.89.10.1186; Cunha-Neto E, 2005, AM J PATHOL, V167, P305, DOI 10.1016/S0002-9440(10)62976-8; Cunha-Neto E, 2001, AUTOIMMUNITY, V34, P187, DOI 10.3109/08916930109007383; Cunha-Neto E, 2011, ADV PARASIT, V76, P129, DOI 10.1016/B978-0-12-385895-5.00006-2; Cunha-Neto E, 2009, MEM I OSWALDO CRUZ, V104, P252, DOI 10.1590/S0074-02762009000900032; Depre C, 2002, CIRC RES, V91, P1007, DOI 10.1161/01.RES.0000044380.54893.4B; Drigo SA, 2006, MICROBES INFECT, V8, P598, DOI 10.1016/j.micinf.2005.08.009; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fossa A, 2000, BRIT J CANCER, V83, P743, DOI 10.1054/bjoc.2000.1365; Furihata T, 2009, PHARMACOGENOMICS J, V9, P185, DOI 10.1038/tpj.2009.3; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ishikawa T, 2012, PHARMACOGENOMICS, V13, P993, DOI [10.2217/PGS.12.74, 10.2217/pgs.12.74]; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Lins TC, 2011, J EPIDEMIOL, V21, P240, DOI 10.2188/jea.JE20100164; Lopes HF, 2001, HYPERTENSION, V38, P616, DOI 10.1161/hy09t1.094504; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Nogueira LG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001867; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Nunes MDP, 2010, REV ESP CARDIOL, V63, P788, DOI 10.1016/S0300-8932(10)70181-0; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramasawmy R, 2006, J INFECT DIS, V193, P1394, DOI 10.1086/503368; Ramasawmy R, 2009, J INFECT DIS, V199, P1838, DOI 10.1086/599212; Reue K, 2009, CURR OPIN LIPIDOL, V20, P165, DOI 10.1097/MOL.0b013e32832adee5; Ribeiro AL, 2013, PLOS NEGLEC IN PRESS; Ribeiro AL, 2012, NAT REV CARDIOL, V9, P576, DOI 10.1038/nrcardio.2012.109; Sabino EC, 2013, TRANSFUSION, V53, P1257, DOI 10.1111/j.1537-2995.2012.03902.x; Sabino EC, 2013, CIRCULATION, V127, P1105, DOI 10.1161/CIRCULATIONAHA.112.123612; Sanbe A, 2013, J BIOL CHEM, V288, P8910, DOI 10.1074/jbc.M112.368324; Schofield CJ, 2006, TRENDS PARASITOL, V22, P583, DOI 10.1016/j.pt.2006.09.011; Silva-Grecco RL, 2010, AM J TROP MED HYG, V82, P45, DOI 10.4269/ajtmh.2010.08-0626; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Teixeira PC, 2012, WORLD J CLIN INFECT, V2, P39, DOI DOI 10.5495/WJCID.V2.I3.39; Williams-Blangero S, 2011, ADV PARASIT, V75, P147, DOI 10.1016/B978-0-12-385863-4.00007-1; Yang M, 2012, LEUKEMIA LYMPHOMA, V53, P1211, DOI 10.3109/10428194.2011.637214	39	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79629	10.1371/journal.pone.0079629	http://dx.doi.org/10.1371/journal.pone.0079629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24324551	Green Published, gold, Green Submitted			2022-12-25	WOS:000327313100033
J	Fang, MY; Jin, LH; Zhang, C; Tan, YY; Jiang, PX; Ge, N; Li, HP; Xing, XH				Fang, Mingyue; Jin, Lihua; Zhang, Chong; Tan, Yinyee; Jiang, Peixia; Ge, Nan; Li, Heping; Xing, Xinhui			Rapid Mutation of Spirulina platensis by a New Mutagenesis System of Atmospheric and Room Temperature Plasmas (ARTP) and Generation of a Mutant Library with Diverse Phenotypes	PLOS ONE			English	Article							ARTHROSPIRA-PLATENSIS; PRESSURE; RADIOFREQUENCY; MICROALGAE; TRANSFORMATION; CYANOPHYTA; RESISTANT; RADIATION; BIOMASS; UV	In this paper, we aimed to improve the carbohydrate productivity of Spirulina platensis by generating mutants with increased carbohydrate content and growth rate. ARTP was used as a new mutagenesis tool to generate a mutant library of S. platensis with diverse phenotypes. Protocol for rapid mutation of S. platensis by 60 s treatment with helium driven ARTP and high throughput screening method of the mutants using the 96-well microplate and microplate reader was established. A mutant library of 62 mutants was then constructed and ideal mutants were selected out. The characteristics of the mutants after the mutagenesis inclined to be stable after around 9th subculture, where the total mutation frequency and positive mutation frequency in terms of specific growth rate reached 45% and 25%, respectively. The mutants in mutant library showed diverse phenotypes in terms of cell growth rate, carbohydrate content and flocculation intensity. The positive mutation frequency in terms of cellular carbohydrate content with the increase by more than 20% percent than the wild strain was 32.3%. Compared with the wild strain, the representative mutants 3-A10 and 3-B2 showed 40.3% and 78.0% increase in carbohydrate content, respectively, while the mutant 4-B3 showed 10.5% increase in specific growth rate. The carbohydrate contents of the representative mutants were stable during different subcultures, indicating high genetic stability. ARTP was demonstrated to be an effective and non-GMO mutagenesis tool to generate the mutant library for multicellular microalgae.	[Fang, Mingyue; Jin, Lihua; Zhang, Chong; Tan, Yinyee; Jiang, Peixia; Xing, Xinhui] Tsinghua Univ, Dept Chem Engn, Minist Educ, Key Lab Ind Biocatalysis, Beijing 100084, Peoples R China; [Ge, Nan; Li, Heping] Tsinghua Univ, Dept Engn Phys, Beijing 100084, Peoples R China; [Jin, Lihua] Beijing Polytech, Colloge Bioengn, Beijing, Peoples R China	Tsinghua University; Tsinghua University; Beijing Polytechnic	Li, HP (corresponding author), Tsinghua Univ, Dept Engn Phys, Beijing 100084, Peoples R China.	liheping@tsinghua.edu.cn; xhxing@tsinghua.edu.cn	Li, He-Ping/C-1109-2017	Li, He-Ping/0000-0002-3149-757X	JSTCREAST of Japan; Tsinghua University Initiative Scientific Research Program [2011Z01019]; China postdoctoral science foundation [20100480280]	JSTCREAST of Japan; Tsinghua University Initiative Scientific Research Program; China postdoctoral science foundation(China Postdoctoral Science Foundation)	This work was supported by JSTCREAST of Japan, Tsinghua University Initiative Scientific Research Program (2011Z01019) and China postdoctoral science foundation (No.20100480280). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa S, 2012, BIORESOURCE TECHNOL, V108, P211, DOI 10.1016/j.biortech.2012.01.004; Amaro HM, 2011, APPL ENERG, V88, P3402, DOI 10.1016/j.apenergy.2010.12.014; Bezerra RP, 2011, BIORESOURCE TECHNOL, V102, P3215, DOI 10.1016/j.biortech.2010.11.009; Borowitzka M. A., 1988, MICROALGAL BIOTECHNO; Brennan L, 2010, RENEW SUST ENERG REV, V14, P557, DOI 10.1016/j.rser.2009.10.009; Chen HB, 2010, BIOCHEM ENG J, V53, P52, DOI 10.1016/j.bej.2010.09.004; Chinnasamy S, 2010, BIORESOURCE TECHNOL, V101, P3097, DOI 10.1016/j.biortech.2009.12.026; Christenson L, 2011, BIOTECHNOL ADV, V29, P686, DOI 10.1016/j.biotechadv.2011.05.015; CIFERRI O, 1983, MICROBIOL REV, V47, P551, DOI 10.1128/MMBR.47.4.551-578.1983; Gao KS, 2008, ENVIRON EXP BOT, V63, P123, DOI 10.1016/j.envexpbot.2007.10.031; Harun R, 2010, RENEW SUST ENERG REV, V14, P1037, DOI 10.1016/j.rser.2009.11.004; Harun R, 2010, J CHEM TECHNOL BIOT, V85, P199, DOI 10.1002/jctb.2287; Hirayama S, 1998, STUD SURF SCI CATAL, V114, P657; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Hua XF, 2010, BIOCHEM ENG J, V49, P201, DOI 10.1016/j.bej.2009.12.014; Jin Lihua, 2011, Sheng Wu Gong Cheng Xue Bao, V27, P461; KAWAMURA M, 1986, NUCLEIC ACIDS RES, V14, P1985, DOI 10.1093/nar/14.5.1985; Kawata Y, 2004, MAR BIOTECHNOL, V6, P355, DOI 10.1007/s10126-003-0037-1; LANFALONI L, 1991, FEMS MICROBIOL LETT, V83, P85; Lee Y, 2004, HDB MICROALGAL CULTU; Li G, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2938692; Li HP, 2008, AIP CONF PROC, V982, P584; Li HP, 2007, PLASMA CHEM PLASMA P, V27, P529, DOI 10.1007/s11090-007-9079-x; Li HP, 2012, IEEE T PLASMA SCI, V40, P2853, DOI 10.1109/TPS.2012.2213274; Li HP, 2011, PLASMA PROCESS POLYM, V8, P224, DOI 10.1002/ppap.201000035; Lu Y, 2011, BIOCHEM ENG J, V55, P17, DOI 10.1016/j.bej.2011.02.020; Markou G, 2011, APPL ENERG, V88, P3389, DOI 10.1016/j.apenergy.2010.12.042; Martins J, 2011, MICROB ECOL, V62, P241, DOI 10.1007/s00248-011-9806-y; Matsumoto M, 2003, APPL BIOCHEM BIOTECH, V105, P247, DOI 10.1385/ABAB:105:1-3:247; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; ORTEGA-CALVO JJ, 1993, J APPL PHYCOL, V5, P425, DOI 10.1007/BF02182735; Pangestuti R, 2011, J FUNCT FOODS, V3, P255, DOI 10.1016/j.jff.2011.07.001; Pittman JK, 2011, BIORESOURCE TECHNOL, V102, P17, DOI 10.1016/j.biortech.2010.06.035; Rawat I, 2011, APPL ENERG, V88, P3411, DOI 10.1016/j.apenergy.2010.11.025; RICCARDI G, 1988, FEMS MICROBIOL LETT, V49, P19; RICCARDI G, 1981, J BACTERIOL, V147, P1002, DOI 10.1128/JB.147.3.1002-1007.1981; Singh DP, 1997, WORLD J MICROB BIOT, V13, P179, DOI 10.1023/A:1018537730287; Singh RK, 2011, J ANTIBIOT, V64, P401, DOI 10.1038/ja.2011.21; Spolaore P, 2006, J BIOSCI BIOENG, V101, P87, DOI 10.1263/jbb.101.87; Toyomizu M, 2001, J APPL PHYCOL, V13, P209, DOI 10.1023/A:1011182613761; Vonshak A, 1997, SPIRULINA PLATENSIS; Wang LY, 2010, J APPL MICROBIOL, V108, P851, DOI 10.1111/j.1365-2672.2009.04483.x; Wang ZP, 2005, J PHYCOL, V41, P622, DOI 10.1111/j.1529-8817.2005.00087.x; Wu HY, 2005, FISHERIES SCI, V71, P454, DOI 10.1111/j.1444-2906.2005.00984.x; Xu LX, 2011, BIORESOURCE TECHNOL, V102, P5113, DOI 10.1016/j.biortech.2011.01.066	45	75	91	9	196	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77046	10.1371/journal.pone.0077046	http://dx.doi.org/10.1371/journal.pone.0077046			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24319517	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400097
J	Tomasello, MF; Guarino, F; Reina, S; Messina, A; De Pinto, V				Tomasello, Marianna F.; Guarino, Francesca; Reina, Simona; Messina, Angela; De Pinto, Vito			The Voltage-Dependent Anion Selective Channel 1 (VDAC1) Topography in the Mitochondrial Outer Membrane as Detected in Intact Cell	PLOS ONE			English	Article							PEPTIDE-SPECIFIC ANTIBODIES; N-TERMINUS; PROTEIN; APOPTOSIS; TOPOLOGY; PORIN; TRANSPORT; PROBES; OXYGEN	Voltage-Dependent Anion selective Channel maintains the permeability of the outer mitochondrial membrane and is relevant in bioenergetic metabolism and apoptosis. The structure of the protein was shown to be a beta-barrel formed by 19 strands. The topology or sideness of the pore has been predicted with various approaches but a general consensus was never reached. This is an important issue since VDAC is considered receptor of Hexokinase and Bcl-2. We fused at VDAC1 C-terminus two tags separated by a caspase cleavage site. Activation in cellulo of caspases was used to eventually separate the two reporters. This experiment did not require the isolation of mitochondria and limited the possibility of outer membrane rupture due to similar procedures. Our results show that the C-terminus end of VDAC faces the mitochondrial inter-membrane space.	[De Pinto, Vito] Univ Catania, Dept Biol Geol & Environm Sci, Mol Biol Sect, Catania, Italy; Natl Inst Biomembranes & Biosyst, Sect Catania, Catania, Italy	University of Catania	De Pinto, V (corresponding author), Univ Catania, Dept Biol Geol & Environm Sci, Mol Biol Sect, Catania, Italy.	vdpbiofa@unict.it	Flora, Tomasello Marianna/E-9527-2018; Messina, Angela/ABC-9518-2020; De Pinto, Vito/AAC-2634-2019	Flora, Tomasello Marianna/0000-0001-6745-2181; GUARINO, Francesca Maria/0000-0002-0704-7333; De Pinto, Vito/0000-0001-5513-2906; MESSINA, Angela Anna/0000-0002-5745-9846	FIRB-MERIT [RBNE08HWLZ]; PRIN [2010CSJX4F]	FIRB-MERIT(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	The financial support of FIRB-MERIT RBNE08HWLZ and PRIN 2010CSJX4F is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbel N, 2010, J BIOL CHEM, V285, P6053, DOI 10.1074/jbc.M109.082990; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; BABEL D, 1991, BIOL CHEM H-S, V372, P1027, DOI 10.1515/bchm3.1991.372.2.1027; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Borgese N, 2001, MOL BIOL CELL, V12, P2482, DOI 10.1091/mbc.12.8.2482; Colombini M, 2009, TRENDS BIOCHEM SCI, V34, P382, DOI 10.1016/j.tibs.2009.05.001; De Pinto V, 2008, J BIOENERG BIOMEMBR, V40, P139, DOI 10.1007/s10863-008-9140-3; De Stefani D, 2012, CELL DEATH DIFFER, V19, P267, DOI 10.1038/cdd.2011.92; DEPINTO V, 1991, BIOCHEMISTRY-US, V30, P10191, DOI 10.1021/bi00106a017; Geula S, 2012, BIOCHEM J, V444, P475, DOI 10.1042/BJ20112079; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005; HUIZING M, 1994, LANCET, V344, P762, DOI 10.1016/S0140-6736(94)92257-8; KONSTANTINOVA SA, 1995, J BIOENERG BIOMEMBR, V27, P93, DOI 10.1007/BF02110336; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Liscum L, 1999, BBA-MOL CELL BIOL L, V1438, P19, DOI 10.1016/S1388-1981(99)00043-8; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Mannella CA, 1998, J STRUCT BIOL, V121, P207, DOI 10.1006/jsbi.1997.3954; McDonald BM, 2009, FEBS LETT, V583, P739, DOI 10.1016/j.febslet.2009.01.039; Messina A, 2012, BBA-BIOMEMBRANES, V1818, P1466, DOI 10.1016/j.bbamem.2011.10.005; Pastorino JG, 2008, J BIOENERG BIOMEMBR, V40, P171, DOI 10.1007/s10863-008-9148-8; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; PLUTNER H, 1992, J CELL BIOL, V119, P1097, DOI 10.1083/jcb.119.5.1097; Reina S, 2013, BBA-BIOENERGETICS, V1827, P793, DOI 10.1016/j.bbabio.2013.03.007; Reina S, 2010, FEBS LETT, V584, P2837, DOI 10.1016/j.febslet.2010.04.066; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Rosano C, 2011, MITOCHONDRION, V11, P513, DOI 10.1016/j.mito.2011.01.012; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Schembri L, 2007, NAT METHODS, V4, P107, DOI 10.1038/nmeth0207-107; Schembri L, 2009, ANAL CHEM, V81, P9590, DOI 10.1021/ac9015227; Shimizu S, 2001, J CELL BIOL, V152, P237, DOI 10.1083/jcb.152.2.237; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Shoshan-Barmatzt V, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00164; STANLEY S, 1995, J BIOL CHEM, V270, P16694, DOI 10.1074/jbc.270.28.16694; Sun Y, 2012, J BIOL CHEM, V287, P40652, DOI 10.1074/jbc.M112.419721; Tomasello F, 2009, CELL RES, V19, P1363, DOI 10.1038/cr.2009.98; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Zeth K, 2010, BBA-BIOENERGETICS, V1797, P1292, DOI 10.1016/j.bbabio.2010.04.019	38	57	60	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81522	10.1371/journal.pone.0081522	http://dx.doi.org/10.1371/journal.pone.0081522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324700	Green Submitted, Green Published, gold			2022-12-25	WOS:000328566700043
J	Erkut, C; Vasilj, A; Boland, S; Habermann, B; Shevchenko, A; Kurzchalia, TV				Erkut, Cihan; Vasilj, Andrej; Boland, Sebastian; Habermann, Bianca; Shevchenko, Andrej; Kurzchalia, Teymuras V.			Molecular Strategies of the Caenorhabditis elegans Dauer Larva to Survive Extreme Desiccation	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; C-ELEGANS; TOLERANCE MECHANISMS; BETA REGRESSION; LIFE-SPAN; GENE; EXPRESSION; STRESS; ANHYDROBIOSIS; TREHALOSE	Massive water loss is a serious challenge for terrestrial animals, which usually has fatal consequences. However, some organisms have developed means to survive this stress by entering an ametabolic state called anhydrobiosis. The molecular and cellular mechanisms underlying this phenomenon are poorly understood. We recently showed that Caenorhabditis elegans dauer larva, an arrested stage specialized for survival in adverse conditions, is resistant to severe desiccation. However, this requires a preconditioning step at a mild desiccative environment to prepare the organism for harsher desiccation conditions. A systems approach was used to identify factors that are activated during this preconditioning. Using microarray analysis, proteomics, and bioinformatics, genes, proteins, and biochemical pathways that are upregulated during this process were identified. These pathways were validated via reverse genetics by testing the desiccation tolerances of mutants. These data show that the desiccation response is activated by hygrosensation (sensing the desiccative environment) via head neurons. This leads to elimination of reactive oxygen species and xenobiotics, expression of heat shock and intrinsically disordered proteins, polyamine utilization, and induction of fatty acid desaturation pathway. Remarkably, this response is specific and involves a small number of functional pathways, which represent the generic toolkit for anhydrobiosis in plants and animals.	[Erkut, Cihan; Vasilj, Andrej; Boland, Sebastian; Shevchenko, Andrej; Kurzchalia, Teymuras V.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Habermann, Bianca] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society; Max Planck Society	Kurzchalia, TV (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	kurzchalia@mpi-cbg.de	Erkut, Cihan/D-9163-2011; Habermann, Bianca/N-4886-2016; Boland, Sebastian/AAJ-3560-2020; Boland, Sebastian/AAL-4065-2020	Erkut, Cihan/0000-0003-4378-9075; Habermann, Bianca/0000-0002-2457-7504; Boland, Sebastian/0000-0002-6694-2039; 	MPI-CBG	MPI-CBG	This study was funded by MPI-CBG internal grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT PS, 1981, J COMP NEUROL, V198, P435, DOI 10.1002/cne.901980305; Alcazar R, 2011, PLANT SIGNAL BEHAV, V6, P243, DOI 10.4161/psb.6.2.14317; Back P, 2010, EXP GERONTOL, V45, P603, DOI 10.1016/j.exger.2010.01.014; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Battista JR, 2001, CRYOBIOLOGY, V43, P133, DOI 10.1006/cryo.2001.2357; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bock KW, 2012, BIOCHEM PHARMACOL, V84, P1000, DOI 10.1016/j.bcp.2012.07.009; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; BRENNER S, 1974, GENETICS, V77, P71; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a; Burnell AM, 2005, EXP GERONTOL, V40, P850, DOI 10.1016/j.exger.2005.09.006; Calahan D, 2011, GENETICS, V189, P507, DOI 10.1534/genetics.111.130369; CANO RJ, 1995, SCIENCE, V268, P1060, DOI 10.1126/science.7538699; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Cavalcanti ARO, 2003, J MOL EVOL, V56, P28, DOI 10.1007/s00239-002-2377-2; Chakrabortee S, 2012, MOL BIOSYST, V8, P210, DOI 10.1039/c1mb05263b; Chakrabortee S, 2010, P NATL ACAD SCI USA, V107, P16084, DOI 10.1073/pnas.1006276107; COCA MA, 1994, PLANT MOL BIOL, V25, P479, DOI 10.1007/BF00043876; Colbert HA, 1997, J NEUROSCI, V17, P8259; Cornette R, 2011, IUBMB LIFE, V63, P419, DOI 10.1002/iub.463; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; CULOTTI JG, 1978, GENETICS, V90, P243; Dong J, 2005, BBA-GENE STRUCT EXPR, V1727, P16, DOI 10.1016/j.bbaexp.2004.11.007; DRENNAN PM, 1993, J PLANT PHYSIOL, V142, P493, DOI 10.1016/S0176-1617(11)81257-5; Dufe VT, 2005, FEBS LETT, V579, P6037, DOI 10.1016/j.febslet.2005.09.050; Eisenhaber F, 2003, NUCLEIC ACIDS RES, V31, P3631, DOI 10.1093/nar/gkg537; Erkut Cihan, 2012, Worm, V1, P61, DOI 10.4161/worm.19040; Erkut C, 2011, CURR BIOL, V21, P1331, DOI 10.1016/j.cub.2011.06.064; Farrant JM, 2011, CURR OPIN PLANT BIOL, V14, P340, DOI 10.1016/j.pbi.2011.03.018; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Franca MB, 2007, COMP BIOCHEM PHYS A, V146, P621, DOI 10.1016/j.cbpa.2006.02.030; FRENKEN LGJ, 1993, MOL MICROBIOL, V9, P591, DOI 10.1111/j.1365-2958.1993.tb01719.x; GADD GM, 1987, FEMS MICROBIOL LETT, V48, P249, DOI 10.1016/0378-1097(87)90171-6; Gal TZ, 2004, FEBS LETT, V577, P21, DOI 10.1016/j.febslet.2004.09.049; Gechev TS, 2012, CELL MOL LIFE SCI, V69, P3175, DOI 10.1007/s00018-012-1088-0; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gombos Z, 2001, J BIOL CHEM, V276, P22529, DOI 10.1074/jbc.M010508200; Gusev O, 2011, CELL STRESS CHAPERON, V16, P81, DOI 10.1007/s12192-010-0223-9; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Hart AC, 1999, J NEUROSCI, V19, P1952; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Garcia AH, 2011, J BIOSCIENCES, V36, P939, DOI 10.1007/s12038-011-9107-0; Houthoofd K, 2002, EXP GERONTOL, V37, P1015, DOI 10.1016/S0531-5565(02)00063-3; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hussain SS, 2011, BIOTECHNOL ADV, V29, P300, DOI 10.1016/j.biotechadv.2011.01.003; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jonsson I., 2014, OPEN ZOOL J, V3, P1, DOI [10.2174/1874336601003010001, DOI 10.2174/1874336601003010001]; Kahn-Kirby AH, 2004, CELL, V119, P889, DOI 10.1016/j.cell.2004.11.005; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kniazeva M, 2003, GENETICS, V163, P159; Kormish JD, 2005, DEV BIOL, V287, P35, DOI 10.1016/j.ydbio.2005.08.027; Kulas J, 2008, ARCH BIOCHEM BIOPHYS, V472, P65, DOI 10.1016/j.abb.2008.02.002; Lee JY, 2013, GENE, V524, P373, DOI 10.1016/j.gene.2013.04.032; Lee JY, 2012, HUM MOL GENET, V21, P3215, DOI 10.1093/hmg/dds155; Li DX, 2009, BIOMACROMOLECULES, V10, P1469, DOI 10.1021/bm9002688; Liao VHC, 2002, J BIOL CHEM, V277, P42049, DOI 10.1074/jbc.M206740200; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; Liu Y, 2011, FEBS LETT, V585, P630, DOI 10.1016/j.febslet.2011.01.020; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; MACRAE M, 1995, GENETICS, V140, P517; Mannervik Bengt, 2008, Drug Metabolism and Drug Interactions, V23, P13; Manning Gerard, 2005, WormBook, P1; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martinelli T, 2008, J PLANT PHYSIOL, V165, P580, DOI 10.1016/j.jplph.2007.01.019; Matyash V, 2004, PLOS BIOL, V2, P1561, DOI 10.1371/journal.pbio.0020280; McElwee JJ, 2006, MECH AGEING DEV, V127, P458, DOI 10.1016/j.mad.2006.01.006; Merivee E, 2010, J INSECT PHYSIOL, V56, P1671, DOI 10.1016/j.jinsphys.2010.06.017; Minois N, 2011, AGING-US, V3, P716, DOI 10.18632/aging.100361; Morcos M, 2008, AGING CELL, V7, P260, DOI 10.1111/j.1474-9726.2008.00371.x; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nelson TJ, 1996, P NATL ACAD SCI USA, V93, P13808, DOI 10.1073/pnas.93.24.13808; Pellerone FI, 2003, INT J PARASITOL, V33, P1195, DOI 10.1016/S0020-7519(03)00173-5; Pereira ED, 2003, CELL STRESS CHAPERON, V8, P120; Perens EA, 2005, DEV CELL, V8, P893, DOI 10.1016/j.devcel.2005.03.009; Rascio N, 2005, CRIT REV PLANT SCI, V24, P209, DOI 10.1080/07352680591008583; Reardon W, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-6; Rizzo AM, 2010, COMP BIOCHEM PHYS B, V156, P115, DOI 10.1016/j.cbpb.2010.02.009; Roach T, 2008, PHYSIOL PLANTARUM, V133, P131, DOI 10.1111/j.1399-3054.2007.00986.x; Roach T, 2010, PLANT CELL ENVIRON, V33, P59, DOI 10.1111/j.1365-3040.2009.02053.x; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Schokraie E, 2011, J ZOOL SYST EVOL RES, V49, P111, DOI 10.1111/j.1439-0469.2010.00608.x; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shannon AJ, 2005, J EXP BIOL, V208, P2433, DOI 10.1242/jeb.01629; SHENMILLER J, 1995, AM J BOT, V82, P1367, DOI 10.2307/2445863; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Singh K, 2011, CURR BIOL, V21, P825, DOI 10.1016/j.cub.2011.04.010; Smith JR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002375; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Solomon A, 2004, GENETICS, V167, P161, DOI 10.1534/genetics.167.1.161; Sullivan ER, 1999, GENE, V230, P277, DOI 10.1016/S0378-1119(99)00026-8; SULSTON JE, 1974, GENETICS, V77, P95; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Tukey J.W., 1977, EXPLORATORY DATA ANA, P1; Tunnacliffe A, 2005, HYDROBIOLOGIA, V546, P315, DOI 10.1007/s10750-005-4239-6; Tyson T, 2007, INT J PARASITOL, V37, P763, DOI 10.1016/j.ijpara.2006.12.015; Tyson Trevor, 2012, BMC Research Notes, V5, P68, DOI 10.1186/1756-0500-5-68; Vasilj A, 2012, J PROTEOME RES, V11, P3680, DOI 10.1021/pr300147z; Watanabe M, 2006, APPL ENTOMOL ZOOL, V41, P15, DOI 10.1303/aez.2006.15; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Welch AZ, 2013, MOL BIOL CELL, V24, P115, DOI 10.1091/mbc.E12-07-0524; Wharton DA, 2008, J EXP BIOL, V211, P2901, DOI 10.1242/jeb.020743; Wheeler JM, 2006, GENETICS, V174, P1327, DOI 10.1534/genetics.106.059089; [No title captured]	115	65	73	3	261	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82473	10.1371/journal.pone.0082473	http://dx.doi.org/10.1371/journal.pone.0082473			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324795	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300151
J	Ho, HT; Singh, H; Heng, S; Nero, TL; Paule, S; Parker, MW; Johnson, AT; Jiao, GS; Nie, GY				Ho, Huiting; Singh, Harmeet; Heng, Sophea; Nero, Tracy L.; Paule, Sarah; Parker, Michael W.; Johnson, Alan T.; Jiao, Guan-Sheng; Nie, Guiying			Small Molecule Proprotein Convertase Inhibitors for Inhibition of Embryo Implantation	PLOS ONE			English	Article							ENDOMETRIAL STROMAL CELLS; PRO-PROTEIN CONVERTASES; IN-VITRO; GP160; PC6; DECIDUALIZATION; RECEPTIVITY; WOMEN; BIOLOGY; FURIN	Uterine proprotein convertase (PC) 6 plays a critical role in embryo implantation and is pivotal for pregnancy establishment. Inhibition of PC6 may provide a novel approach for the development of non-hormonal and female-controlled contraceptives. We investigated a class of five synthetic non-peptidic small molecule compounds that were previously reported as potent inhibitors of furin, another PC member. We examined (i) the potency of these compounds in inhibiting PC6 activity in vitro; (ii) their binding modes in the PC6 active site in silico; (iii) their efficacy in inhibiting PC6-dependent cellular processes essential for embryo implantation using human cell-based models. All five compounds showed potent inhibition of PC6 activity in vitro, and in silico docking demonstrated that these inhibitors could adopt a similar binding mode in the PC6 active site. However, when these compounds were tested for their inhibition of decidualization of primary human endometrial stromal cells, a PC6-dependent cellular process critical for embryo implantation, only one (compound 1o) showed potent inhibition. The lack of activity in the cell-based assay may reflect the inability of the compounds to penetrate the cell membrane. Because compound's lipophilicity is linked to cell penetration, a measurement of lipophilicity (logP) was calculated for each compound. Compound 1o is unique as it appears the most lipophilic among the five compounds. Compound 1o also inhibited another crucial PC6-dependent process, the attachment of human trophoblast spheroids to endometrial epithelial cells (a model for human embryo attachment). We thus identified compound 1o as a potent small molecule PC6 inhibitor with pharmaceutical potential to inhibit embryo implantation. Our findings also highlight that human cell-based functional models are vital to complement the biochemical and in silico analyses in the selection of promising drug candidates. Further investigations for compound 1o are warranted in animal models to test its utility as an implantation-inhibiting contraceptive drug.	[Ho, Huiting; Singh, Harmeet; Heng, Sophea; Paule, Sarah; Nie, Guiying] Prince Henrys Inst Med Res, Clayton, Vic, Australia; [Ho, Huiting; Heng, Sophea; Nie, Guiying] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Nero, Tracy L.; Parker, Michael W.] St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia; [Nero, Tracy L.; Parker, Michael W.] St Vincents Inst Med Res, ACRF Rat Drug Discovery Ctr, Fitzroy, Vic 3065, Australia; [Parker, Michael W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Johnson, Alan T.; Jiao, Guan-Sheng] PanThera Biopharma LLC, Dept Chem, Aiea, HI USA	Prince Henry's Institute of Medical Research; Monash University; St. Vincent's Institute of Medical Research; St. Vincent's Institute of Medical Research; University of Melbourne	Jiao, GS (corresponding author), PanThera Biopharma LLC, Dept Chem, Aiea, HI USA.	gjiao@pantherabio.com; guiying.nie@princehenrys.org	Parker, Michael W/F-9069-2013	Parker, Michael W/0000-0002-3101-1138; Nero, Tracy/0000-0002-3393-1843; Nie, Guiying/0000-0001-9641-087X	National Health and Medical Research Council of Australia [611831, 1041835, 1021645, 1044182]; Victorian Government's Operational Infrastructure Support Program; United States Department of Defense U.S. Army Medical Research and Material Command [V549P-6073]; Pacific Telehealth and Technology (Hui, Honolulu, HI, USA)	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; United States Department of Defense U.S. Army Medical Research and Material Command; Pacific Telehealth and Technology (Hui, Honolulu, HI, USA)	This work was supported by the National Health and Medical Research Council of Australia Postgraduate scholarship number 611831 (to H. H), Senior Research Fellowship number 1041835 (to G.N), Senior Principal Research Fellow number 1021645 (to M. W. P), and Project grant number 1044182 (to G.N.), the Victorian Government's Operational Infrastructure Support Program, the United States Department of Defense U.S. Army Medical Research and Material Command [contract V549P-6073] (to A.T.J. and G.-S.J.). Prince Henry's Institute data audit number is 13-07. The authors thank Pacific Telehealth and Technology (Hui, Honolulu, HI, USA) for funding administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljofan M, 2012, CONTRACEPTION, V85, P602, DOI 10.1016/j.contraception.2011.10.004; Couture Frederic, 2011, Biomol Concepts, V2, P421; Decroly E, 1996, J BIOL CHEM, V271, P30442, DOI 10.1074/jbc.271.48.30442; Dimitriadis E, 2002, MOL HUM REPROD, V8, P636, DOI 10.1093/molehr/8.7.636; Freyer C, 2007, REPRODUCTION, V133, P1189, DOI 10.1530/REP-06-0285; Fugere M, 2005, TRENDS PHARMACOL SCI, V26, P294, DOI 10.1016/j.tips.2005.04.006; Fugere M, 2007, MOL PHARMACOL, V71, P323, DOI 10.1124/mol.106.027946; Heng S, 2011, ENDOCRINOLOGY, V152, P5041, DOI 10.1210/en.2011-1273; Heng S, 2011, HUM REPROD, V26, P840, DOI 10.1093/humrep/der002; Heng S, 2010, ENDOCRINOLOGY, V151, P3909, DOI 10.1210/en.2010-0326; Ho H, 2012, PEPTIDES; Ho HT, 2012, PEPTIDES, V38, P266, DOI 10.1016/j.peptides.2012.09.014; Ho HT, 2012, FERTIL STERIL, V97, P974, DOI 10.1016/j.fertnstert.2012.01.116; Jiao GS, 2006, P NATL ACAD SCI USA, V103, P19707, DOI 10.1073/pnas.0606555104; Kenakin TP, 2012, PHARMACOLOGY IN DRUG DISCOVERY: UNDERSTANDING DRUG RESPONSE, P1; Kibler KV, 2004, J BIOL CHEM, V279, P49055, DOI 10.1074/jbc.M403394200; Miranda L, 1996, P NATL ACAD SCI USA, V93, P7695, DOI 10.1073/pnas.93.15.7695; Nie GY, 2005, BIOL REPROD, V72, P1029, DOI 10.1095/biolreprod.104.036889; Nishida Masato, 2002, Hum Cell, V15, P104, DOI 10.1111/j.1749-0774.2002.tb00105.x; Okada H, 2005, J CLIN ENDOCR METAB, V90, P1028, DOI 10.1210/jc.2004-0904; Paule S, 2012, HUM REPROD, V27, P2766, DOI 10.1093/humrep/des203; Salamonsen LA, 2009, REPROD FERT DEVELOP, V21, P923, DOI 10.1071/RD09145; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; Singh H, 2011, HUM REPROD, V26, P748, DOI 10.1093/humrep/der019; Vollenweider F, 1996, BIOCHEM J, V314, P521, DOI 10.1042/bj3140521	26	2	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81380	10.1371/journal.pone.0081380	http://dx.doi.org/10.1371/journal.pone.0081380			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324690	Green Published, gold			2022-12-25	WOS:000327949300090
J	Hu, ZQ; Yang, RC				Hu, Zhiqiu; Yang, Rong-Cai			A New Distribution-Free Approach to Constructing the Confidence Region for Multiple Parameters	PLOS ONE			English	Article							DEPTH	Construction of confidence intervals or regions is an important part of statistical inference. The usual approach to constructing a confidence interval for a single parameter or confidence region for two or more parameters requires that the distribution of estimated parameters is known or can be assumed. In reality, the sampling distributions of parameters of biological importance are often unknown or difficult to be characterized. Distribution-free nonparametric resampling methods such as bootstrapping and permutation have been widely used to construct the confidence interval for a single parameter. There are also several parametric (ellipse) and nonparametric (convex hull peeling, bagplot and HPDregionplot) methods available for constructing confidence regions for two or more parameters. However, these methods have some key deficiencies including biased estimation of the true coverage rate, failure to account for the shape of the distribution inherent in the data and difficulty to implement. The purpose of this paper is to develop a new distribution-free method for constructing the confidence region that is based only on a few basic geometrical principles and accounts for the actual shape of the distribution inherent in the real data. The new method is implemented in an R package, distfree cr/R. The statistical properties of the new method are evaluated and compared with those of the other methods through Monte Carlo simulation. Our new method outperforms the other methods regardless of whether the samples are taken from normal or non-normal bivariate distributions. In addition, the superiority of our method is consistent across different sample sizes and different levels of correlation between the two variables. We also analyze three biological data sets to illustrate the use of our new method for genomics and other biological researches.	[Hu, Zhiqiu; Yang, Rong-Cai] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; Res & Innovat Div, Edmonton, AB, Canada	University of Alberta	Yang, RC (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	rong-cai.yang@ales.ualberta.ca		Hu, Zhiqiu/0000-0001-5600-4236	Natural Sciences and Engineering Research Council of Canada [183983]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research is supported by the Natural Sciences and Engineering Research Council of Canada discovery grant (Award # 183983) to R-C Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bolker B, 2012, EMDBOOK ECOLOGICAL M; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Davidson R., 2004, ECONOMETRIC THEORY M; de Peretti C, 2010, COMPUT STAT DATA AN, V54, P262, DOI 10.1016/j.csda.2009.09.012; Denis JB, 1996, J R STAT SOC C-APPL, V45, P479; DONOHO DL, 1992, ANN STAT, V20, P1803, DOI 10.1214/aos/1176348890; Draper N.R., 1998, WILEY SERIES PROBABI, V326; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Green PJ, 1981, INTERPRETING MULTIVA; Hu Z, 2013, CROP SCI, DOI [10.2135/cropsci2013.2104.0218, DOI 10.2135/CR0PSCI2013.2104.0218]; Hyndman RJ, 1996, AM STAT, V50, P361, DOI 10.2307/2684934; Korn G.A., 1968, MATH HDB SCI ENG DEF; Liu RY, 1999, ANN STAT, V27, P783; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Petitjean M., 1992, APPL STOCH MODEL BUS, V8, P91; PORZIO G., 2000, QUANDERNI STAT, V2, P85; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2012, R LANG ENV STAT COMP; Rawlings JO, 1998, APPL REGRESSION ANAL, DOI 10.1007/b98890; Rousseeuw PJ, 1999, AM STAT, V53, P382, DOI 10.2307/2686061; Schoonjans F, 2011, EPIDEMIOLOGY, V22, P750, DOI 10.1097/EDE.0b013e318225c1de; Seldin MF, 2011, NAT REV GENET, V12, P523, DOI 10.1038/nrg3002; Shriver Mark D., 2005, Human Genomics, V2, P81; SONG WMT, 1993, 1993 WINTER SIMULATION CONFERENCE PROCEEDINGS, P374; VanDerWal J, 2012, SDMT TOOLS SPECIES D; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Wolf P, 2012, APLPACK ANOTHER PLOT; Yan WK, 2007, CROP SCI, V47, P643, DOI 10.2135/cropsci2006.06.0374; Yang RC, 2009, CROP SCI, V49, P1564, DOI 10.2135/cropsci2008.11.0665; Yeh AB, 1997, J ROY STAT SOC B MET, V59, P639, DOI 10.1111/1467-9868.00088	33	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81179	10.1371/journal.pone.0081179	http://dx.doi.org/10.1371/journal.pone.0081179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324674	Green Submitted, Green Published, gold			2022-12-25	WOS:000327949300077
J	Kluth, S; Distl, O				Kluth, Susanne; Distl, Ottmar			Congenital Sensorineural Deafness in Dalmatian Dogs Associated with Quantitative Trait Loci	PLOS ONE			English	Article							NONSYNDROMIC HEARING IMPAIRMENT; AUDITORY-EVOKED RESPONSE; HEREDITARY DEAFNESS; INNER-EAR; WAARDENBURG-SYNDROME; STICKLER-SYNDROME; GENETIC APPROACH; CHINESE FAMILY; PIGMENT-CELLS; MOUSE MODELS	A genome-wide association study (GWAS) was performed for 235 Dalmatian dogs using the canine Illumina high density bead chip to identify quantitative trait loci (QTL) associated with canine congenital sensorineural deafness (CCSD). Data analysis was performed for all Dalmatian dogs and in addition, separately for brown-eyed and blue-eyed dogs because of the significant influence of eye colour on CCSD in Dalmatian dogs. Mixed linear model analysis (MLM) revealed seven QTL with experiment-wide significant associations (-log(10)P>5.0) for CCSD in all Dalmatian dogs. Six QTL with experiment-wide significant associations for CCSD were found in brown-eyed Dalmatian dogs and in blue-eyed Dalmatian dogs, four experiment-wide significant QTL were detected. The experiment-wide CCSD-associated SNPs explained 82% of the phenotypic variance of CCSD. Five CCSD-loci on dog chromosomes (CFA) 6, 14, 27, 29 and 31 were in close vicinity of genes shown as causative for hearing loss in human and/or mouse.	[Kluth, Susanne; Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Distl, O (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany.	ottmar.distl@tiho-hannover.de			Gesellschaft zur Forderung kynologischer Forschung (gkf) e.V., Bonn; Club fur Dalmatiner-Freunde e.V. [CDF-DI/2010-1]	Gesellschaft zur Forderung kynologischer Forschung (gkf) e.V., Bonn; Club fur Dalmatiner-Freunde e.V.	The study was supported by a grant of the Gesellschaft zur Forderung kynologischer Forschung (gkf) e.V., Bonn, and by the Club fur Dalmatiner-Freunde e.V. (CDF-DI/2010-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Annunen S, 1999, AM J HUM GENET, V65, P974, DOI 10.1086/302585; Aspengren S, 2009, INT REV CEL MOL BIO, V272, P245, DOI 10.1016/S1937-6448(08)01606-7; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Ben-Yosef T, 2003, HUM MOL GENET, V12, P2049, DOI 10.1093/hmg/ddg210; Bischoff AMLC, 2004, AUDIOL NEURO-OTOL, V9, P34, DOI 10.1159/000074185; Bosley TM, 2007, NEUROLOGY, V69, P1245, DOI 10.1212/01.wnl.0000276947.59704.cf; Bosley TM, 2008, AM J MED GENET A, V146A, P1235, DOI 10.1002/ajmg.a.32262; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Busch-Nentwich E, 2004, DEVELOPMENT, V131, P943, DOI 10.1242/dev.00961; CABLE J, 1994, PIGM CELL RES, V7, P17, DOI 10.1111/j.1600-0749.1994.tb00015.x; Cargill EJ, 2004, GENETICS, V166, P1385, DOI 10.1534/genetics.166.3.1385; Cassereau J, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-87; Charizopoulou N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1200; Cheng J, 2007, CLIN GENET, V72, P471, DOI 10.1111/j.1399-0004.2007.00889.x; Chiu HS, 2012, GENESIS, V50, P711, DOI 10.1002/dvg.22032; Clark LA, 2006, P NATL ACAD SCI USA, V103, P1376, DOI 10.1073/pnas.0506940103; Crimella C, 2010, J MED GENET, V47, P712, DOI 10.1136/jmg.2010.077909; GREIBROKK T, 1994, J AM ANIM HOSP ASSOC, V30, P170; Ho H, 2011, PIGM CELL MELANOMA R, V24, P595, DOI 10.1111/j.1755-148X.2011.00889.x; HOLLIDAY TA, 1992, J VET INTERN MED, V6, P166, DOI 10.1111/j.1939-1676.1992.tb00332.x; Hou JH, 2012, ANN NY ACAD SCI, V1258, P185, DOI 10.1111/j.1749-6632.2012.06529.x; Joberty G, 1999, MOL CELL BIOL, V19, P6585; Juraschko K, 2003, VET J, V166, P164, DOI 10.1016/S1090-0233(02)00256-3; Juraschko K, 2003, MAMM GENOME, V14, P547, DOI 10.1007/s00335-002-3033-2; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Katoh M, 2002, INT J MOL MED, V9, P585; Kim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025174; Kirikoshi H, 2002, INT J ONCOL, V20, P1183; Konrad M, 2006, AM J HUM GENET, V79, P949, DOI 10.1086/508617; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Leibovici M, 2008, CURR TOP DEV BIOL, V84, P385, DOI 10.1016/S0070-2153(08)00608-X; Lovicu FJ, 2000, MECH DEVELOP, V94, P261, DOI 10.1016/S0925-4773(00)00292-6; LURIE MH, 1948, LARYNGOSCOPE, V58, P279, DOI 10.1288/00005537-194804000-00001; Martin S, 1999, EUR J HUM GENET, V7, P807, DOI 10.1038/sj.ejhg.5200377; McGuirt WT, 1999, NAT GENET, V23, P413, DOI 10.1038/70516; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Muhle AC, 2002, VET J, V163, P311, DOI 10.1053/tvjl.2001.0661; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Ohbayashi N, 2012, J BIOCHEM, V151, P343, DOI 10.1093/jb/mvs009; Pausch H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036346; Peng AW, 2009, J NEUROSCI, V29, P15083, DOI 10.1523/JNEUROSCI.2782-09.2009; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Petit C, 2006, TRENDS MOL MED, V12, P57, DOI 10.1016/j.molmed.2005.12.006; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Rak SG, 2005, VET J, V169, P188, DOI 10.1016/j.tvjl.2004.01.015; Richards AJ, 1996, HUM MOL GENET, V5, P1339, DOI 10.1093/hmg/5.9.1339; Richardson GP, 2011, ANNU REV PHYSIOL, V73, P311, DOI 10.1146/annurev-physiol-012110-142228; Sampaio ALL, 2010, INT J PEDIATR OTORHI, V74, P934, DOI 10.1016/j.ijporl.2010.05.020; Scheifele PM, 2012, VET CLIN N AM-SMALL, V42, P1241, DOI 10.1016/j.cvsm.2012.08.012; Schiaffino MV, 2010, INT J BIOCHEM CELL B, V42, P1094, DOI 10.1016/j.biocel.2010.03.023; Scott G, 2002, PIGM CELL RES, V15, P322, DOI 10.1034/j.1600-0749.2002.02056.x; Sitaram A, 2012, PHYSIOLOGY, V27, P85, DOI 10.1152/physiol.00043.2011; SLEPECKY NB, 1992, MATRIX, V12, P80, DOI 10.1016/S0934-8832(11)80108-3; STEEL KP, 1989, DEVELOPMENT, V107, P453; Steel KP, 2001, NAT GENET, V27, P143, DOI 10.1038/84758; Strain GM, 2012, VET CLIN N AM-SMALL, V42, P1209, DOI 10.1016/j.cvsm.2012.08.010; Strain GM, 2004, VET J, V167, P23, DOI 10.1016/S1090-0233(03)00104-7; STRAIN GM, 1993, AM J VET RES, V54, P1817; STRAIN GM, 1992, J VET INTERN MED, V6, P175, DOI 10.1111/j.1939-1676.1992.tb00333.x; Stritzel S, 2009, J ANIM BREED GENET, V126, P59, DOI 10.1111/j.1439-0388.2008.00761.x; Stritzel S, 2007, ANIM GENET, V38, P662, DOI 10.1111/j.1365-2052.2007.01660.x; Tachibana M, 2003, PIGM CELL RES, V16, P448, DOI 10.1034/j.1600-0749.2003.00066.x; THALMANN I, 1993, CONNECT TISSUE RES, V29, P191, DOI 10.3109/03008209309016826; Van Laer L, 1998, NAT GENET, V20, P194; Vartiainen M, 2000, MOL CELL BIOL, V20, P1772, DOI 10.1128/MCB.20.5.1772-1783.2000; Wangemann P, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-30; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8; Wilson WJ, 2005, AM J VET RES, V66, P2177, DOI 10.2460/ajvr.2005.66.2177; Yan D, 2008, FRONT BIOSCI-LANDMRK, V13, P4972, DOI 10.2741/3056; Yu CA, 2003, GENOMICS, V82, P575, DOI 10.1016/S0888-7543(03)00175-7; Zhang Z, 2002, INT J BIOCHEM CELL B, V34, P325, DOI 10.1016/S1357-2725(01)00134-0	73	11	11	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80642	10.1371/journal.pone.0080642	http://dx.doi.org/10.1371/journal.pone.0080642			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324618	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300036
J	Thomassin, JL; Lee, MJ; Brannon, JR; Sheppard, DC; Gruenheid, S; Le Moual, H				Thomassin, Jenny-Lee; Lee, Mark J.; Brannon, John R.; Sheppard, Donald C.; Gruenheid, Samantha; Le Moual, Herve			Both Group 4 Capsule and Lipopolysaccharide O-Antigen Contribute to Enteropathogenic Escherichia coli Resistance to Human alpha-Defensin 5	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; PANETH CELLS; POLYSACCHARIDE; EXPRESSION; IDENTIFICATION; BIOSYNTHESIS; ORGANIZATION; SECRETION; IMMUNITY; DIARRHEA	Enteropathogenic and enterohemorrhagic Escherichia coli (EPEC and EHEC) are food-borne pathogens that colonize the small intestine and colon, respectively. To cause disease, these pathogens must overcome the action of different host antimicrobial peptides (AMPs) secreted into these distinct niches. We have shown previously that EHEC expresses high levels of the OmpT protease to inactivate the human cathelicidin LL-37, an AMP present in the colon. In this study, we investigate the mechanisms used by EPEC to resist human alpha-defensin 5 (HD-5), the most abundant AMP in the small intestine. Quantitative PCR was used to measure transcript levels of various EPEC surface structures. High transcript levels of gfcA, a gene required for group 4 capsule (G4C) production, were observed in EPEC, but not in EHEC. The unencapsulated EPEC Delta gfcA and EHEC wild-type strains were more susceptible to HD-5 than EPEC wild-type. Since the G4C is composed of the same sugar repeats as the lipopolysaccharide O-antigen, an -antigen ligase (waaL) deletion mutant was generated in EPEC to assess its role in HD-5 resistance. The Delta waaL EPEC strain was more susceptible to HD-5 than both the wild-type and Delta gfcA strains. The Delta gfcA Delta waaL EPEC strain was not significantly more susceptible to HD-5 than the Delta waaL strain, suggesting that the absence of -antigen influences G4C formation. To determine whether the G4C and -antigen interact with HD-5, total polysaccharide was purified from wild-type EPEC and added to the Delta gfcA Delta waaL strain in the presence of HD-5. The addition of exogenous polysaccharide protected the susceptible strain against HD-5 killing in a dose-dependent manner, suggesting that HD-5 binds to the polysaccharides present on the surface of EPEC. Altogether, these findings indicate that EPEC relies on both the G4C and the -antigen to resist the bactericidal activity of HD-5.	[Thomassin, Jenny-Lee; Lee, Mark J.; Brannon, John R.; Sheppard, Donald C.; Gruenheid, Samantha; Le Moual, Herve] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Sheppard, Donald C.; Gruenheid, Samantha; Le Moual, Herve] McGill Univ, Microbiome & Dis Tolerance Ctr, Montreal, PQ, Canada; [Le Moual, Herve] McGill Univ, Fac Dent, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Le Moual, H (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.	herve.le-moual@mcgill.ca	Sheppard, Donald/B-4637-2008; Thomassin, Jenny-Lee/M-6705-2019	Sheppard, Donald/0000-0001-8877-880X; Thomassin, Jenny-Lee/0000-0003-4226-420X; Gruenheid, Samantha/0000-0002-0908-6715	Canadian Institutes of Health Research (CIHR) [MOP-15551]; Natural Sciences and Engineering Research Council (NSERC) [RGPIN-217482]; Canada Research Chair; Faculty of Medicine, McGill University	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Faculty of Medicine, McGill University	Funding for this work was provided by the Canadian Institutes of Health Research (CIHR, MOP-15551) and the Natural Sciences and Engineering Research Council (NSERC, RGPIN-217482). S.G. is supported by a Canada Research Chair. J-L.T. was awarded a Hugh Burke fellowship from the Faculty of Medicine, McGill University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Banemann A, 1998, INFECT IMMUN, V66, P5607, DOI 10.1128/IAI.66.12.5607-5612.1998; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Campos MA, 2004, INFECT IMMUN, V72, P7107, DOI 10.1128/IAI.72.12.7107-7114.2004; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; Clarke SC, 2002, BRIT J BIOMED SCI, V59, P123, DOI 10.1080/09674845.2002.11783647; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Donnenberg MS, 2013, TRENDS MICROBIOL, V21, P317, DOI 10.1016/j.tim.2013.05.003; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Ferrieres L, 2007, MICROBIOL-SGM, V153, P1070, DOI 10.1099/mic.0.2006/002907-0; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; GOLDMAN RC, 1982, J BACTERIOL, V151, P1210, DOI 10.1128/JB.151.3.1210-1221.1982; Gruenheid S, 2012, FEMS MICROBIOL LETT, V330, P81, DOI 10.1111/j.1574-6968.2012.02528.x; HAKANSSON S, 1987, J CLIN MICROBIOL, V25, P714; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hase K, 2002, INFECT IMMUN, V70, P953, DOI 10.1128/IAI.70.2.953-963.2002; JOHNSON AR, 1971, ANAL BIOCHEM, V44, P628, DOI 10.1016/0003-2697(71)90252-1; Law RJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009977; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; LEVINE MM, 1978, LANCET, V1, P1119; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llobet E, 2008, MICROBIOL-SGM, V154, P3877, DOI 10.1099/mic.0.2008/022301-0; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Mount KLB, 2007, ANTIMICROB AGENTS CH, V51, P3391, DOI 10.1128/AAC.00473-07; Nagy G, 2006, INFECT IMMUN, V74, P5914, DOI 10.1128/IAI.00619-06; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Patrick S, 2009, MICROBIOL-SGM, V155, P1039, DOI 10.1099/mic.0.025361-0; Peleg A, 2005, J BACTERIOL, V187, P5259, DOI 10.1128/JB.187.15.5259-5266.2005; PERRY MB, 1986, BIOCHEM CELL BIOL, V64, P21, DOI 10.1139/o86-004; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sathiyamoorthy K, 2011, BIOCHEMISTRY-US, V50, P5465, DOI 10.1021/bi101869h; Shifrin Y, 2008, J BACTERIOL, V190, P5063, DOI 10.1128/JB.00440-08; Shirin T, 2011, MICROBES INFECT, V13, P1111, DOI 10.1016/j.micinf.2011.06.014; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Thomassin JL, 2012, GUT MICROBES, V3, P556, DOI 10.4161/gmic.21656; Thomassin JL, 2012, INFECT IMMUN, V80, P483, DOI 10.1128/IAI.05674-11; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Wang L, 1998, INFECT IMMUN, V66, P3545, DOI 10.1128/IAI.66.8.3545-3551.1998; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; WIDMALM G, 1993, CARBOHYD RES, V247, P255, DOI 10.1016/0008-6215(93)84258-8; Wu MF, 2009, INFECT IMMUN, V77, P615, DOI 10.1128/IAI.00931-08; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zilbauer M, 2011, INFLAMM BOWEL DIS, V17, P2076, DOI 10.1002/ibd.21577	55	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82475	10.1371/journal.pone.0082475	http://dx.doi.org/10.1371/journal.pone.0082475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324796	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300152
J	Alexander, J; Mendy, J; Vang, L; Avanzini, JB; Garduno, F; Manayani, DJ; Ishioka, G; Farness, P; Ping, LH; Swanstrom, R; Parks, R; Liao, HX; Haynes, BF; Montefiori, DC; LaBranche, C; Smith, J; Gurwith, M; Mayall, T				Alexander, Jeff; Mendy, Jason; Vang, Lo; Avanzini, Jenny B.; Garduno, Fermin; Manayani, Darly J.; Ishioka, Glenn; Farness, Peggy; Ping, Li-Hua; Swanstrom, Ronald; Parks, Robert; Liao, Hua-Xin; Haynes, Barton F.; Montefiori, David C.; LaBranche, Celia; Smith, Jonathan; Gurwith, Marc; Mayall, Tim			Pre-Clinical Development of a Recombinant, Replication-Competent Adenovirus Serotype 4 Vector Vaccine Expressing HIV-1 Envelope 1086 Clade C	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEUTRALIZING ANTIBODY-RESPONSE; V1/V2 DOMAIN; DOUBLE-BLIND; MONOCLONAL-ANTIBODIES; CELL RESPONSES; EFFICACY TRIAL; INFECTION; GP120; EPITOPES	Background: There is a well-acknowledged need for an effective AIDS vaccine that protects against HIV-1 infection or limits in vivo viral replication. The objective of these studies is to develop a replication-competent, vaccine vector based on the adenovirus serotype 4 (Ad4) virus expressing HIV-1 envelope (Env) 1086 clade C glycoprotein. Ad4 recombinant vectors expressing Env gp160 (Ad4Env160), Env gp140 (Ad4Env140), and Env gp120 (Ad4Env120) were evaluated. Methods: The recombinant Ad4 vectors were generated with a full deletion of the E3 region of Ad4 to accommodate the env gene sequences. The vaccine candidates were assessed in vitro following infection of A549 cells for Env-specific protein expression and for posttranslational transport to the cell surface as monitored by the binding of broadly neutralizing antibodies (bNAbs). The capacity of the Ad4Env vaccines to induce humoral immunity was evaluated in rabbits for Env gp140 and V1V2-specific binding antibodies, and HIV-1 pseudovirus neutralization. Mice immunized with the Ad4Env160 vaccine were assessed for IFN gamma T cell responses specific for overlapping Env peptide sets. Results: Robust Env protein expression was confirmed by western blot analysis and recognition of cell surface Env gp160 by multiple bNAbs. Ad4Env vaccines induced humoral immune responses in rabbits that recognized Env 1086 gp140 and V1V2 polypeptide sequences derived from 1086 clade C, A244 clade AE, and gp70 V1V2 CASE A2 clade B fusion protein. The immune sera efficiently neutralized tier 1 clade C pseudovirus MW965.26 and neutralized the homologous and heterologous tier 2 pseudoviruses to a lesser extent. Env-specific T cell responses were also induced in mice following Ad4Env160 vector immunization. Conclusions: The Ad4Env vaccine vectors express high levels of Env glycoprotein and induce both Env-specific humoral and cellular immunity thus supporting further development of this new Ad4 HIV-1 Env vaccine platform in Phase 1 clinical trials.	[Alexander, Jeff; Mendy, Jason; Vang, Lo; Avanzini, Jenny B.; Garduno, Fermin; Manayani, Darly J.; Ishioka, Glenn; Farness, Peggy; Smith, Jonathan; Gurwith, Marc; Mayall, Tim] PaxVax Inc, San Diego, CA USA; [Ping, Li-Hua; Swanstrom, Ronald] Univ N Carolina, UNC Ctr AIDS Res, Chapel Hill, NC USA; [Parks, Robert; Liao, Hua-Xin; Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC USA; [Montefiori, David C.; LaBranche, Celia] Duke Univ, Sch Med, Dept Surg, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University	Alexander, J (corresponding author), PaxVax Inc, San Diego, CA USA.	jalexander@paxvax.com			National Institute of Allergy and Infectious Diseases, National Institutes of Health [1R43AI091546-01]; Primate Central Immunology Contract [HHSN27201100016C]; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant from the NIAID, Division of AIDS [AI 100645]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI091546, R44AI091546, UM1AI100645] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Primate Central Immunology Contract; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant from the NIAID, Division of AIDS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases, National Institutes of Health (grant 1R43AI091546-01), Primate Central Immunology Contract # HHSN27201100016C (to DCM), and The Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant from the NIAID, Division of AIDS, AI 100645. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Alam SM, 2013, J VIROL, V87, P1554, DOI 10.1128/JVI.00718-12; Alexander J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031177; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Beddows S, 2007, VIROLOGY, V360, P329, DOI 10.1016/j.virol.2006.10.032; Berkhout B, 2012, EXPERT OPIN BIOL TH, V12, P1315, DOI 10.1517/14712598.2012.707177; Bonsignori M, 2012, TRENDS MICROBIOL, V20, P532, DOI 10.1016/j.tim.2012.08.011; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; COHEN J, 2013, MORE WOES STRUGGLING, P14242; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; de Souza MS, 2012, J IMMUNOL, V188, P5166, DOI 10.4049/jimmunol.1102756; Dolin R, 2009, NEW ENGL J MED, V361, P2279, DOI 10.1056/NEJMe0909972; Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342; *FDA CTR BIOL EV R, 2012, VACC REL BIOL PROD A, P14242; Feng Y, 2012, J BIOL CHEM, V287, P5673, DOI 10.1074/jbc.M111.317776; Ferrantelli F, 2004, J INFECT DIS, V189, P2167, DOI 10.1086/420833; FISHER AG, 1986, SCIENCE, V233, P655, DOI 10.1126/science.3014663; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gao F, 2009, VIROLOGY, V394, P91, DOI 10.1016/j.virol.2009.07.041; Gilbert PB, 2005, J INFECT DIS, V192, P974, DOI 10.1086/432734; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Gilbert P, 2010, J INFECT DIS, V202, P595, DOI 10.1086/654816; Gorny MK, 2012, VIROLOGY, V427, P198, DOI 10.1016/j.virol.2012.02.003; Guenaga J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016074; Gurwith M, 2013, LANCET INFECT DIS, V13, P238, DOI 10.1016/S1473-3099(12)70345-6; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hoxie JA, 2010, ANNU REV MED, V61, P135, DOI 10.1146/annurev.med.60.042507.164323; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; LEE SJ, 1989, AIDS RES HUM RETROV, V5, P441, DOI 10.1089/aid.1989.5.441; LIAO HX, 2013, J VIROL, P14242; Liao L, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S2-O31; Ludwig SL, 1998, J INFECT DIS, V178, P1776, DOI 10.1086/314498; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; Moir S, 2011, NAT STRUCT MOL BIOL, V18, P1317, DOI 10.1038/nsmb.2194; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; *NAT I ALL, 2013, QUESTIONS ANSWERS HV, P14242; Nawaz F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001301; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Ping LH, 2013, J VIROL, V87, P7218, DOI 10.1128/JVI.03577-12; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Pinter A, 1998, VACCINE, V16, P1803, DOI 10.1016/S0264-410X(98)00182-0; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Postler TS, 2013, J VIROL, V87, P2, DOI 10.1128/JVI.02053-12; Rerks-Ngarm S, 2013, J INFECT DIS, V207, P1195, DOI 10.1093/infdis/jis478; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shabram PW, 1997, HUM GENE THER, V8, P453, DOI 10.1089/hum.1997.8.4-453; Takahashi MN, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-39; Tong T, 2012, J VIROL, V86, P3574, DOI 10.1128/JVI.06938-11; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wang LS, 2009, J VIROL, V83, P7166, DOI 10.1128/JVI.00374-09; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Zolla-Pazner S, 2011, J VIROL, V85, P9887, DOI 10.1128/JVI.05086-11	67	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82380	10.1371/journal.pone.0082380	http://dx.doi.org/10.1371/journal.pone.0082380			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312658	Green Published, Green Submitted, gold			2022-12-25	WOS:000327947800096
J	Edwards, MW; Aultman, JA; Harber, G; Bhatt, JM; Sztul, E; Xu, QG; Zhang, P; Michalek, SM; Katz, J				Edwards, Michael W.; Aultman, James A.; Harber, Gregory; Bhatt, Jay M.; Sztul, Elizabeth; Xu, Qingan; Zhang, Ping; Michalek, Suzanne M.; Katz, Jannet			Role of mTOR Downstream Effector Signaling Molecules in Francisella Tularensis Internalization by Murine Macrophages	PLOS ONE			English	Article							P70 S6 KINASE; COLI K1 INVASION; MAMMALIAN TARGET; ACTIN CYTOSKELETON; REGULATED KINASE; PHOSPHOINOSITIDE 3-KINASE; PHOSPHOLIPASE-C; BINDING PARTNER; RAPAMYCIN TOR; ACTIVATION	Francisella tularensis is an infectious, gram-negative, intracellular microorganism, and the cause of tularemia. Invasion of host cells by intracellular pathogens like Francisella is initiated by their interaction with different host cell membrane receptors and the rapid phosphorylation of different downstream signaling molecules. PI3K and Syk have been shown to be involved in F. tularensis host cell entry, and both of these signaling molecules are associated with the master regulator serine/threonine kinase mTOR; yet the involvement of mTOR in F. tularensis invasion of host cells has not been assessed. Here, we report that infection of macrophages with F. tularensis triggers the phosphorylation of mTOR downstream effector molecules, and that signaling via TLR2 is necessary for these events. Inhibition of mTOR or of PI3K, ERK, or p38, but not Akt signaling, downregulates the levels of phosphorylation of mTOR downstream targets, and significantly reduces the number of F. tularensis cells invading macrophages. Moreover, while phosphorylation of mTOR downstream effectors occurs via the PI3K pathway, it also involves PLCy1 and Ca2+ signaling. Furthermore, abrogation of PLC or Ca2+ signaling revealed their important role in the ability of F. tularensis to invade host cells. Together, these findings suggest that F. tularensis invasion of primary macrophages utilize a myriad of host signaling pathways to ensure effective cell entry.	[Aultman, James A.; Zhang, Ping; Katz, Jannet] Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL 35294 USA; [Edwards, Michael W.; Harber, Gregory; Xu, Qingan; Michalek, Suzanne M.; Katz, Jannet] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Bhatt, Jay M.; Sztul, Elizabeth] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Katz, J (corresponding author), Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL 35294 USA.	meow@uab.edu		Zhang, Ping/0000-0002-4585-9893	United States Public Health Service [AL-56460]; National Institutes of Health [T32 AI-007051(MWE)]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was mainly supported by the United States Public Health Service grant AL-56460 (to SMM) and by National Institutes of Health T32 AI-007051(MWE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvisais EW, 2006, J BIOL CHEM, V281, P26904, DOI 10.1074/jbc.M605371200; Berven LA, 2004, EXP CELL RES, V296, P183, DOI 10.1016/j.yexer.2003.12.032; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Bulavin DV, 2002, CURR OPIN GENET DEV, V12, P92, DOI 10.1016/S0959-437X(01)00270-2; Casanovas O, 2000, J BIOL CHEM, V275, P35091, DOI 10.1074/jbc.M006324200; Casas-Terradellas E, 2008, BBA-MOL CELL RES, V1783, P2241, DOI 10.1016/j.bbamcr.2008.08.011; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Chen XG, 2010, MOL CARCINOGEN, V49, P603, DOI 10.1002/mc.20628; Clemens DL, 2007, ANN NY ACAD SCI, V1105, P160, DOI 10.1196/annals.1409.001; Coombes BK, 2002, CELL MICROBIOL, V4, P447, DOI 10.1046/j.1462-5822.2002.00203.x; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Cowley SC, 2010, J IMMUNOL, V184, P5791, DOI 10.4049/jimmunol.1000362; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; Eguchi S, 1999, J BIOL CHEM, V274, P36843, DOI 10.1074/jbc.274.52.36843; ELKINS KL, 1992, MICROB PATHOGENESIS, V13, P417, DOI 10.1016/0882-4010(92)90085-3; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; Ganesan LP, 2004, J BIOL CHEM, V279, P54416, DOI 10.1074/jbc.M408188200; Genolet R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-33; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Guay J, 1997, J CELL SCI, V110, P357; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hazlett KRO, 2008, INFECT IMMUN, V76, P4479, DOI 10.1128/IAI.00610-08; Hu ZH, 2006, J BIOL CHEM, V281, P24247, DOI 10.1074/jbc.M602898200; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Ip CKM, 2011, ONCOGENE, V30, P2420, DOI 10.1038/onc.2010.615; Ip Carman K M, 2012, Spermatogenesis, V2, P44; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Kierbel A, 2005, MOL BIOL CELL, V16, P2577, DOI 10.1091/mbc.E04-08-0717; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim MJ, 2000, EXP MOL MED, V32, P101, DOI 10.1038/emm.2000.18; Ko Y, 2011, MICROB PATHOGENESIS, V50, P326, DOI 10.1016/j.micpath.2011.02.007; Kwok T, 2002, INFECT IMMUN, V70, P2108, DOI 10.1128/IAI.70.4.2108-2120.2002; Leinweber BD, 1999, BIOCHEM J, V344, P117, DOI 10.1042/0264-6021:3440117; Lennartz MR, 1999, INT J BIOCHEM CELL B, V31, P415, DOI 10.1016/S1357-2725(98)00108-3; Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294; Li QA, 2010, MED MICROBIOL IMMUN, V199, P333, DOI 10.1007/s00430-010-0168-8; Liu L, 2008, ONCOGENE, V27, P4998, DOI 10.1038/onc.2008.137; Loegering DJ, 2006, MICROB PATHOGENESIS, V41, P218, DOI 10.1016/j.micpath.2006.07.007; LONG GW, 1993, J CLIN MICROBIOL, V31, P152, DOI 10.1128/JCM.31.1.152-154.1993; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Markova B, 2010, ONCOGENE, V29, P739, DOI 10.1038/onc.2009.374; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; May RC, 2001, J CELL SCI, V114, P1061; Menges CW, 2008, ONCOGENE, V27, P2934, DOI 10.1038/sj.onc.1210957; Neal MD, 2006, J IMMUNOL, V176, P3070, DOI 10.4049/jimmunol.176.5.3070; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Ohira T, 2010, J BIOL CHEM, V285, P3451, DOI 10.1074/jbc.M109.044131; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Parsa KVL, 2008, MOL IMMUNOL, V45, P3012, DOI 10.1016/j.molimm.2008.01.011; Pyronnet S, 2000, BIOCHEM PHARMACOL, V60, P1237, DOI 10.1016/S0006-2952(00)00429-9; Rameh LE, 1998, J BIOL CHEM, V273, P23750, DOI 10.1074/jbc.273.37.23750; Rane MJ, 2001, J BIOL CHEM, V276, P3517, DOI 10.1074/jbc.M005953200; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Reddy MA, 2000, J BIOL CHEM, V275, P36769, DOI 10.1074/jbc.M007382200; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Rydkina E, 2008, J MED MICROBIOL, V57, P1172, DOI 10.1099/jmm.0.47806-0; Santic M, 2010, CELL MICROBIOL, V12, P129, DOI 10.1111/j.1462-5822.2009.01400.x; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schmitz F, 2008, EUR J IMMUNOL, V38, P2981, DOI 10.1002/eji.200838761; Shi YY, 2002, J BIOL CHEM, V277, P15712, DOI 10.1074/jbc.M200043200; Sukumaran SK, 2003, J BIOL CHEM, V278, P45753, DOI 10.1074/jbc.M307374200; Sukumaran SK, 2002, J BIOL CHEM, V277, P12253, DOI 10.1074/jbc.M110740200; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Tokuda H, 2003, AM J PHYSIOL-ENDOC M, V284, pE1202, DOI 10.1152/ajpendo.00300.2002; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; WENG QP, 1995, MOL CELL BIOL, V15, P2333; Wlodarski P, 2005, CANCER RES, V65, P7800, DOI 10.1158/0008-5472.CAN-04-4180; Wong R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-15; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang P, 2005, INFECT IMMUN, V73, P3990, DOI 10.1128/IAI.73.7.3990-3998.2005; Zhang P, 2009, MOL IMMUNOL, V46, P677, DOI 10.1016/j.molimm.2008.08.281; Zhang YG, 2001, J BIOL CHEM, V276, P20913, DOI 10.1074/jbc.M009047200	88	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e83226	10.1371/journal.pone.0083226	http://dx.doi.org/10.1371/journal.pone.0083226			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312679	Green Published, Green Submitted, gold			2022-12-25	WOS:000327947800106
J	Kalmar-Nagy, K; Degrell, P; Szabo, A; Sumegi, K; Wittmann, I; Gallyas, F; Sumegi, B				Kalmar-Nagy, Karoly; Degrell, Peter; Szabo, Aliz; Sumegi, Katalin; Wittmann, Istvan; Gallyas, Ferenc, Jr.; Sumegi, Balazs			PARP Inhibition Attenuates Acute Kidney Allograft Rejection by Suppressing Cell Death Pathways and Activating PI-3K-Akt Cascade	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; APOPTOSIS-INDUCING FACTOR; INDUCED OXIDATIVE STRESS; N-TERMINAL KINASE; P38 MAP KINASES; POLY(ADP-RIBOSE) POLYMERASE; RENAL-TRANSPLANTATION; ISCHEMIA-REPERFUSION; ENDOTHELIAL DYSFUNCTION; CARDIAC-FUNCTION	Background: Novel immunosuppressive therapy facilitates long term allograft survival, but acute tubular necrosis and ischemia-reperfusion during transplantation can compromise allograft function. These processes are related to oxidative stress which activates poly- (ADP-ribose) polymerase (PARP) contributing to the activation of cell death pathways. Here we raised the possibility that PARP inhibition curbs cell death pathways and shifts kinase signaling to improved graft survival. Methods Findings: In an acute rat kidney rejection model, we provided evidence that the PARP inhibitor 4-hydroxyquinazoline (4OHQ) attenuates rejection processes initiated oxidative/nitrosative stress, nuclear poly-ADP-ribosylation and the disintegration of the tubulo-interstitial structures. The PARP inhibitor attenuated rejection processes induced proapoptotic pathways by increasing Bcl-2/Bax ratio and suppressing pro-apoptotic t-Bid levels. In transplanted kidneys, the cell death inducing JNK1/2 is normally activated, but PARP inhibition suppressed this activation with having only modest effects on ERK1/2 and p38 MAP kinases. In untreated transplanted kidneys, no significant alterations were detected in the cytoprotective PI-3K-Akt pathway, but the PARP inhibitor significantly activated Akt (by S473 phosphorylation) and suppressed GSK-3 beta, as well as activated acute NF-kappaB activation contributing to graft protection. Conclusion: These data show the protective role of PARP inhibition on graft survival by attenuating poly-ADP-ribosylation, oxidative stress, suppressing pro-apoptotic and increasing anti-apoptotic protein level, and by shifting MAP kinases and PI3-K-Akt pathways to cytoprotective direction. Thus, addition of PARP inhibitors to standard immunosuppressive therapies during kidney transplantation may provide increased protection to prolong graft survival.	[Kalmar-Nagy, Karoly] Univ Pecs, Sch Med, Dept Surg, Pecs, Hungary; [Degrell, Peter; Wittmann, Istvan] Univ Pecs, Sch Med, Dept Internal Med 2, Pecs, Hungary; [Degrell, Peter; Wittmann, Istvan] Univ Pecs, Sch Med, Nephrol Ctr, Pecs, Hungary; [Szabo, Aliz; Sumegi, Katalin; Gallyas, Ferenc, Jr.; Sumegi, Balazs] Univ Pecs, Sch Med, Dept Biochem & Med Chem, Pecs, Hungary; [Gallyas, Ferenc, Jr.; Sumegi, Balazs] Univ Pecs, Szentagothai Res Ctr, Pecs, Hungary	University of Pecs; University of Pecs; University of Pecs; University of Pecs; University of Pecs	Gallyas, F (corresponding author), Univ Pecs, Sch Med, Dept Biochem & Med Chem, Pecs, Hungary.	ferenc.gallyas@aok.pte.hu	Gallyas, Ferenc/AAY-5343-2020; Gallyas, Ferenc/C-2272-2012	Gallyas, Ferenc/0000-0002-1906-4333	Social Renewal Operational Programme [4.2.2/B-10/1-2010-0029, 4.2.1.B-10/2/KONV-2010-0002]; MTA-PTE Nuclear-Mitochondrial Interactions Research Group;  [OTKA K-73738];  [OTKA K-104220]	Social Renewal Operational Programme; MTA-PTE Nuclear-Mitochondrial Interactions Research Group; ; 	OTKA K-73738, OTKA K-104220, Social Renewal Operational Programme-4.2.2/B-10/1-2010-0029, Social Renewal Operational Programme-4.2.1.B-10/2/KONV-2010-0002, MTA-PTE Nuclear-Mitochondrial Interactions Research Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Elmageed ZY, 2012, CELL SIGNAL, V24, P1, DOI 10.1016/j.cellsig.2011.07.019; Bartha E, 2009, CARDIOVASC RES, V83, P501, DOI 10.1093/cvr/cvp144; Bedke J, 2010, MOL IMMUNOL, V47, P1047, DOI 10.1016/j.molimm.2009.11.012; Cassis P, 2011, TRANSPLANTATION, V92, P271, DOI 10.1097/TP.0b013e3182241106; D'Amico F, 2013, LIVER TRANSPLANT, V19, P135, DOI 10.1002/lt.23527; Danilovic A, 2011, TRANSPL P, V43, P1443, DOI 10.1016/j.transproceed.2011.02.020; Ekblad T, 2013, FEBS J, V280, P3563, DOI 10.1111/febs.12298; Erne BV, 2013, ANN THORAC SURG, V95, P1021, DOI 10.1016/j.athoracsur.2012.11.008; Farivar AS, 2005, ANN THORAC SURG, V80, P950, DOI 10.1016/j.athoracsur.2005.02.035; Ferencz A, 2009, TRANSPL P, V41, P60, DOI 10.1016/j.transproceed.2008.08.149; Fu HL, 2012, MOL MED, V18, P1128, DOI 10.2119/molmed.2012.00088; Garber K, 2013, NAT REV DRUG DISCOV, V12, P725, DOI 10.1038/nrd4147; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Halmosi R, 2001, MOL PHARMACOL, V59, P1497, DOI 10.1124/mol.59.6.1497; Hseu YC, 2012, FOOD CHEM TOXICOL, V50, P1245, DOI 10.1016/j.fct.2012.02.020; Hsing CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017598; Joo DJ, 2010, TRANSPL P, V42, P729, DOI 10.1016/j.transproceed.2010.02.033; Kanai M, 2007, NAT CELL BIOL, V9, P1175, DOI 10.1038/ncb1638; Kedzierska K, 2011, TRANSPL P, V43, P3577, DOI 10.1016/j.transproceed.2011.08.091; Kellum JA, 2008, CRIT CARE MED, V36, pS141, DOI 10.1097/CCM.0b013e318168c4a4; Kidokoro K, 2012, KIDNEY BLOOD PRESS R, V35, P549, DOI 10.1159/000339494; Komjati K, 2005, CNS NEUROL DISORD-DR, V4, P179, DOI 10.2174/1568007053544138; Kovacs K, 2006, BIOCHEM PHARMACOL, V71, P441, DOI 10.1016/j.bcp.2005.05.036; Lakatos P, 2013, BBA-MOL CELL RES, V1833, P743, DOI 10.1016/j.bbamcr.2012.12.003; Latchoumycandane C, 2006, TOXICOL APPL PHARM, V217, P125, DOI 10.1016/j.taap.2006.08.001; LEE S, 1967, SURGERY, V61, P771; Lee YR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056284, 10.1371/journal.pone.0063255]; Li X, 2007, NEUROSCIENCE, V144, P56, DOI 10.1016/j.neuroscience.2006.08.065; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; Mester L, 2009, NEUROTOX RES, V16, P68, DOI 10.1007/s12640-009-9049-6; Neves PDMD, 2013, ANN DIAGN PATHOL, V17, P75, DOI 10.1016/j.anndiagpath.2012.08.002; Nasrabady SE, 2012, NEUROPHARMACOLOGY, V63, P415, DOI 10.1016/j.neuropharm.2012.04.014; Nguyen KC, 2013, TOXICOLOGY, V306, P114, DOI 10.1016/j.tox.2013.02.010; O'Connell S, 2012, TOXICOL SCI, V126, P101, DOI 10.1093/toxsci/kfr330; Ojo AO, 1997, TRANSPLANTATION, V63, P968, DOI 10.1097/00007890-199704150-00011; Pacher P, 2005, ANTIOXID REDOX SIGN, V7, P1568, DOI 10.1089/ars.2005.7.1568; Pacher P, 2008, AM J PATHOL, V173, P2, DOI 10.2353/ajpath.2008.080019; Racz B, 2010, FREE RADICAL BIO MED, V49, P1978, DOI 10.1016/j.freeradbiomed.2010.09.026; Rajesh M, 2006, BIOCHEM BIOPH RES CO, V350, P1056, DOI 10.1016/j.bbrc.2006.09.160; Rao P, 2005, DIABETES, V54, P1664, DOI 10.2337/diabetes.54.6.1664; Rattanavich R, 2013, EXP MOL PATHOL, V94, P445, DOI 10.1016/j.yexmp.2013.03.001; Roesner JP, 2010, SHOCK, V33, P507, DOI 10.1097/SHK.0b013e3181c4fb08; Rogers NM, 2012, BRIT J PHARMACOL, V166, P194, DOI 10.1111/j.1476-5381.2011.01590.x; Fuentes MCR, 2008, TRANSPL P, V40, P2897, DOI 10.1016/j.transproceed.2008.08.109; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Sacks S, 2013, ADV EXP MED BIOL, V735, P247, DOI 10.1007/978-1-4614-4118-2_17; Sarszegi Z, 2012, MOL CELL BIOCHEM, V365, P129, DOI 10.1007/s11010-012-1252-8; Schwabe RF, 2004, FASEB J, V18, P720, DOI 10.1096/fj.03-0771fje; Szabo C, 2002, CIRCULATION, V106, P2680, DOI 10.1161/01.CIR.0000038365.78031.9C; Szabo G, 2006, J HEART LUNG TRANSPL, V25, P794, DOI 10.1016/j.healun.2006.03.017; Szabo G, 2006, TRANSPL INT, V19, P506, DOI 10.1111/j.1432-2277.2005.00262.x; Tapodi A, 2005, J BIOL CHEM, V280, P35767, DOI 10.1074/jbc.M507075200; Theruvath TP, 2008, TRANSPLANTATION, V85, P1500, DOI 10.1097/TP.0b013e31816fefb5; Varona-Santos JL, 2008, DIABETOLOGIA, V51, P2271, DOI 10.1007/s00125-008-1169-7; Veres B, 2003, BIOCHEM PHARMACOL, V65, P1373, DOI 10.1016/S0006-2952(03)00077-7; Veres B, 2004, J PHARMACOL EXP THER, V310, P247, DOI 10.1124/jpet.104.065151; Veto S, 2010, BRAIN, V133, P822, DOI 10.1093/brain/awp337; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Wyrsch P, 2012, MOL CELL; Xu BY, 2008, DIABETES-METAB RES, V24, P404, DOI 10.1002/dmrr.842; Xu Y, 2006, J BIOL CHEM, V281, P8788, DOI 10.1074/jbc.M508135200; Ying WH, 2005, J NEUROSCI RES, V79, P216, DOI 10.1002/jnr.20289; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang FX, 2013, J BIOL CHEM, V288, P11348, DOI 10.1074/jbc.M112.429134	64	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81928	10.1371/journal.pone.0081928	http://dx.doi.org/10.1371/journal.pone.0081928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312605	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000327947800067
J	Romero-Garcia, J; Francisco, C; Biarnes, X; Planas, A				Romero-Garcia, Javier; Francisco, Carles; Biarnes, Xevi; Planas, Antoni			Structure-Function Features of a Mycoplasma Glycolipid Synthase Derived from Structural Data Integration, Molecular Simulations, and Mutational Analysis	PLOS ONE			English	Article							ACHOLEPLASMA-LAIDLAWII; GLUCOSYL-3-PHOSPHOGLYCERATE SYNTHASE; CRYSTAL-STRUCTURE; MEMBRANE-LIPIDS; GLYCOSYLTRANSFERASE; GENITALIUM; RESIDUES; BILAYER; ENZYME; CLASSIFICATION	Glycoglycerolipids are structural components of mycoplasma membranes with a fundamental role in membrane properties and stability. Their biosynthesis is mediated by glycosyltransferases (GT) that catalyze the transfer of glycosyl units from a sugar nucleotide donor to diacylglycerol. The essential function of glycolipid synthases in mycoplasma viability, and the absence of glycoglycerolipids in animal host cells make these GT enzymes a target for drug discovery by designing specific inhibitors. However, rational drug design has been hampered by the lack of structural information for any mycoplasma GT. Most of the annotated GTs in pathogenic mycoplasmas belong to family GT2. We had previously shown that MG517 in Mycoplasma genitalium is a GT-A family GT2 membrane-associated glycolipid synthase. We present here a series of structural models of MG517 obtained by homology modeling following a multiple-template approach. The models have been validated by mutational analysis and refined by long scale molecular dynamics simulations. Based on the models, key structure-function relationships have been identified: The N-terminal GT domain has a GT-A topology that includes a non-conserved variable region involved in acceptor substrate binding. Glu193 is proposed as the catalytic base in the GT mechanism, and Asp40, Tyr126, Tyr169, Ile170 and Tyr218 define the substrates binding site. Mutation Y169F increases the enzyme activity and significantly alters the processivity (or sequential transferase activity) of the enzyme. This is the first structural model of a GT-A glycoglycerolipid synthase and provides preliminary insights into structure and function relationships in this family of enzymes.	[Romero-Garcia, Javier; Francisco, Carles; Biarnes, Xevi; Planas, Antoni] Univ Ramon Llull, Biochem Lab, Inst Quim Sarria, Barcelona, Spain	Universitat Ramon Llull; Institut Quimic de Sarria	Planas, A (corresponding author), Univ Ramon Llull, Biochem Lab, Inst Quim Sarria, Barcelona, Spain.	antoni.planas@iqs.edu	PLANAS, ANTONI/I-4803-2015; Biarnés, Xevi/AAA-3107-2019	PLANAS, ANTONI/0000-0001-7073-3320; Biarnés, Xevi/0000-0003-4121-9474	Ministry of Economy and Competitivity, Spain [BFU2010-22209-C02-02]	Ministry of Economy and Competitivity, Spain	The work was supported by grant BFU2010-22209-C02-02, Ministry of Economy and Competitivity, Spain (http://www.mineco.gob.es/portal/site/mineco/idi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres E, 2012, BIOCATAL BIOTRANSFOR, V30, P274, DOI 10.3109/10242422.2012.674733; Andres E, 2011, J BIOL CHEM, V286, P35367, DOI 10.1074/jbc.M110.214148; Pereira PJB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003748; Berendsen H. J. C., 1991, COMP PHYS COMMUN, V91, P43; Botte C, 2005, J BIOL CHEM, V280, P34691, DOI 10.1074/jbc.M505622200; Breton C, 2012, CURR OPIN STRUC BIOL, V22, P540, DOI 10.1016/j.sbi.2012.06.007; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cunha BA, 2006, CLIN MICROBIOL INFEC, V12, P12, DOI 10.1111/j.1469-0691.2006.01393.x; DAHLQVIST A, 1995, BIOCHEMISTRY-US, V34, P13381, DOI 10.1021/bi00041a015; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Edman M, 2003, J BIOL CHEM, V278, P8420, DOI 10.1074/jbc.M211492200; Falk L, 2005, SEX TRANSM INFECT, V81, P73, DOI 10.1136/sti.2004.010439; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fritz TA, 2004, P NATL ACAD SCI USA, V101, P15307, DOI 10.1073/pnas.0405657101; Fulton Z, 2008, J BIOL CHEM, V283, P27881, DOI 10.1074/jbc.M801853200; Garinot-Schneider C, 2000, J BIOL CHEM, V275, P31407, DOI 10.1074/jbc.M004524200; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; HORNER PJ, 1993, LANCET, V342, P582, DOI 10.1016/0140-6736(93)91411-E; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Keenleyside WJ, 2001, J BACTERIOL, V183, P77, DOI 10.1128/JB.183.1.77-85.2001; Klement MLR, 2007, MOL MICROBIOL, V65, P1444, DOI 10.1111/j.1365-2958.2007.05865.x; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LINDBLOM G, 1986, BIOCHEMISTRY-US, V25, P7502, DOI 10.1021/bi00371a037; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Marrie TJ, 2012, SEMIN RESP CRIT CARE, V33, P244, DOI 10.1055/s-0032-1315636; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nielsen MM, 2011, J BIOL CHEM, V286, P15155, DOI 10.1074/jbc.M110.199844; Patenaude SI, 2002, NAT STRUCT BIOL, V9, P685, DOI 10.1038/nsb832; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Petrova P, 1999, J AM CHEM SOC, V121, P5535, DOI 10.1021/ja983854g; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Razin S, 2010, BIOLOGICALS, V38, P183, DOI 10.1016/j.biologicals.2009.11.008; Retief J D, 2000, Methods Mol Biol, V132, P243; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Tarbouriech N, 2001, J MOL BIOL, V314, P655, DOI 10.1006/jmbi.2001.5159; Urresti S, 2012, J BIOL CHEM, V287, P24649, DOI 10.1074/jbc.M112.368191; Vikstrom S, 1999, BIOCHEMISTRY-US, V38, P5511, DOI 10.1021/bi982532m; Ye YZ, 2005, BIOINFORMATICS, V21, P2362, DOI 10.1093/bioinformatics/bti353; Zhang YN, 2003, BIOCHEMISTRY-US, V42, P13512, DOI 10.1021/bi035430r	47	8	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81990	10.1371/journal.pone.0081990	http://dx.doi.org/10.1371/journal.pone.0081990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312618	Green Submitted, Green Published, gold			2022-12-25	WOS:000327947800078
J	Campeau, JL; Wu, GS; Bell, JR; Rasmussen, J; Sim, VL				Campeau, Jody L.; Wu, Gengshu; Bell, John R.; Rasmussen, Jay; Sim, Valerie L.			Early Increase and Late Decrease of Purkinje Cell Dendritic Spine Density in Prion-Infected Organotypic Mouse Cerebellar Cultures	PLOS ONE			English	Article							IN-VITRO; SCRAPIE; MICE; DISEASE; HIPPOCAMPUS; PROTEIN; BRAIN; ASSAY; PRP	Prion diseases are infectious neurodegenerative diseases associated with the accumulation of protease-resistant prion protein, neuronal loss, spongiform change and astrogliosis. In the mouse model, the loss of dendritic spines is one of the earliest pathological changes observed in vivo, occurring 4-5 weeks after the first detection of protease-resistant prion protein in the brain. While there are cell culture models of prion infection, most do not recapitulate the neuropathology seen in vivo. Only the recently developed prion organotypic slice culture assay has been reported to undergo neuronal loss and the development of some aspects of prion pathology, namely small vacuolar degeneration and tubulovesicular bodies. Given the rapid replication of prions in this system, with protease-resistant prion protein detectable by 21 days, we investigated whether the dendritic spine loss and altered dendritic morphology seen in prion disease might also develop within the lifetime of this culture system. Indeed, six weeks after first detection of protease-resistant prion protein in tga20 mouse cerebellar slice cultures infected with RML prion strain, we found a statistically significant loss of Purkinje cell dendritic spines and altered dendritic morphology in infected cultures, analogous to that seen in vivo. In addition, we found a transient but statistically significant increase in Purkinje cell dendritic spine density during infection, at the time when protease-resistant prion protein was first detectable in culture. Our findings support the use of this slice culture system as one which recapitulates prion disease pathology and one which may facilitate study of the earliest stages of prion disease pathogenesis.	[Campeau, Jody L.; Wu, Gengshu; Bell, John R.; Rasmussen, Jay; Sim, Valerie L.] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Sim, Valerie L.] Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada; [Sim, Valerie L.] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Sim, VL (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada.	valerie.sim@ualberta.ca	Sim, Valerie/C-4137-2013; Rasmussen, Jay/P-8200-2018	Sim, Valerie/0000-0002-0088-8666; Rasmussen, Jay/0000-0001-6905-745X	PrioNet Canada [G119990412]; Alberta Prion Research Institute [G224200029]	PrioNet Canada; Alberta Prion Research Institute	Funding was provided by PrioNet Canada (Project number G119990412; http://www.nce-rce.gc.ca/NetworksCentres-CentresReseaux/PreviouslyFunded-FinancesAnterieurement_eng.asp) and the Alberta Prion Research Institute (Project number G224200029; www.prioninstitute.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrow PA, 1999, NEUROBIOL DIS, V6, P406, DOI 10.1006/nbdi.1999.0255; Belichenko PV, 2000, NEUROPATH APPL NEURO, V26, P143, DOI 10.1046/j.1365-2990.2000.026002143.x; Brown D, 2001, NEUROREPORT, V12, P179, DOI 10.1097/00001756-200101220-00043; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Chiti Z, 2006, NEUROBIOL DIS, V22, P363, DOI 10.1016/j.nbd.2005.12.002; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Falsig J, 2008, NAT PROTOC, V3, P555, DOI 10.1038/nprot.2008.13; Falsig J, 2008, NAT NEUROSCI, V11, P109, DOI 10.1038/nn2028; Falsig J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002985; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Fuhrmann M, 2007, J NEUROSCI, V27, P6224, DOI 10.1523/JNEUROSCI.5062-06.2007; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; GAHWILER BH, 1988, TRENDS NEUROSCI, V11, P484, DOI 10.1016/0166-2236(88)90007-0; Jeffrey M, 2009, BRAIN PATHOL, V19, P1, DOI 10.1111/j.1750-3639.2008.00150.x; Johnston AR, 1998, NEUROBIOL DIS, V5, P188, DOI 10.1006/nbdi.1998.0194; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kovacs GG, 2005, AM J PATHOL, V166, P287, DOI 10.1016/S0002-9440(10)62252-3; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Shott R, 2012, PRION, V6, P60; Siskova Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055004; White JJ, 2013, WIRES DEV BIOL, V2, P149, DOI 10.1002/wdev.65	21	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81776	10.1371/journal.pone.0081776	http://dx.doi.org/10.1371/journal.pone.0081776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312586	gold, Green Submitted, Green Published			2022-12-25	WOS:000327944500097
J	Dias, JM; Valentim, JM; Sousa, MC				Dias, Joao Miguel; Valentim, Juliana Marques; Sousa, Magda Catarina			A Numerical Study of Local Variations in Tidal Regime of Tagus Estuary, Portugal	PLOS ONE			English	Article							HEAT-TRANSPORT MODELS; AVEIRO LAGOON; ENVIRONMENTAL VARIABLES; RIA; SALT; HYDRODYNAMICS; CALIBRATION; BAY; PROPAGATION; VALIDATION	Tidal dynamics of shallow estuaries and lagoons is a complex matter that has attracted the attention of a large number of researchers over the last few decades. The main purpose of the present work is to study the intricate tidal dynamics of the Tagus estuary, which states as the largest estuary of the Iberian Peninsula and one of the most important wetlands in Portugal and Europe. Tagus has large areas of low depth and a remarkable geomorphology, both determining the complex propagation of tidal waves along the estuary of unknown manner. A non-linear two-dimensional vertically integrated hydrodynamic model was considered to be adequate to simulate its hydrodynamics and an application developed from the SIMSYS2D model was applied to study the tidal propagation along the estuary. The implementation and calibration of this model revealed its accuracy to predict tidal properties along the entire system. Several model runs enabled the analysis of the local variations in tidal dynamics, through the interpretation of amplitude and phase patterns of the main tidal constituents, tidal asymmetry, tidal ellipses, form factor and tidal dissipation. Results show that Tagus estuary tidal dynamics is extremely dependent on an estuarine resonance mode for the semi-diurnal constituents that induce important tidal characteristics. Besides, the estuarine coastline features and topography determines the changes in tidal propagation along the estuary, which therefore result essentially from a balance between convergence/divergence and friction and advection effects, besides the resonance effects.	[Dias, Joao Miguel; Valentim, Juliana Marques; Sousa, Magda Catarina] Univ Aveiro, Dept Fis, CESAM, P-3800 Aveiro, Portugal	Universidade de Aveiro	Dias, JM (corresponding author), Univ Aveiro, Dept Fis, CESAM, Campus Santiago, P-3800 Aveiro, Portugal.	joao.dias@ua.pt	Dias, João Miguel/F-3292-2010; Sousa, Magda C/L-7665-2014	Dias, João Miguel/0000-0002-7613-6241; Sousa, Magda C/0000-0003-2575-3263	FCT [PTDC/AACCLI/104085/2008, PTDC/MAR/107939/2008]; COMPETE/QREN/UE; Portuguese Science Foundation [SFRH/BD/60209/2009]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); COMPETE/QREN/UE; Portuguese Science Foundation(Portuguese Foundation for Science and Technology)	This work was been partially supported by FCT in the framework of the research projects PTDC/AACCLI/104085/2008 - ECOSAM: Effects of Carbon Dioxide increase on Salt Marshes and PTDC/MAR/107939/2008 - DyEPlume: Estuarine Dynamics and Plume Propagation in the Portuguese coast - Impacts of Climate Change, co-funded by COMPETE/QREN/UE. The third author of this work has been supported by the Portuguese Science Foundation through a doctoral grant (SFRH/BD/60209/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JN, 1997, ESTUAR COAST SHELF S, V44, P39, DOI 10.1006/ecss.1996.0113; Alvera-Azcarate A, 2003, ESTUAR COAST SHELF S, V57, P715, DOI 10.1016/S0272-7714(02)00413-4; AUBREY DG, 1985, ESTUAR COAST SHELF S, V21, P185, DOI 10.1016/0272-7714(85)90096-4; Brogueira MJ, 2007, MAR ENVIRON RES, V64, P616, DOI 10.1016/j.marenvres.2007.06.007; Burling MC, 2003, ESTUAR COAST SHELF S, V57, P725, DOI 10.1016/S0272-7714(02)00343-8; Canario J, 2005, MAR POLLUT BULL, V50, P1142, DOI 10.1016/j.marpolbul.2005.06.052; Canhanga S, 2005, J MARINE SYST, V58, P83, DOI 10.1016/j.jmarsys.2005.08.001; CASTAING P, 1981, MAR GEOL, V40, P101, DOI 10.1016/0025-3227(81)90045-1; Cheng R. T., 1991, TIDAL HYDRODYNAMICS, P201; Dias JM, 2011, J COASTAL RES, P1495; Dias JM, 2011, J COASTAL RES, P1008; Dias JM, 2006, J COASTAL RES, P1680; Dias JM, 2009, J COASTAL RES, P1345; Dias JM, 2009, ENVIRON MODELL SOFTW, V24, P711, DOI 10.1016/j.envsoft.2008.10.017; Dias JM, 2006, ENVIRON MODELL SOFTW, V21, P1, DOI 10.1016/j.envsoft.2004.09.002; Dias JM, 2000, PHYS CHEM EARTH PT B, V25, P369, DOI 10.1016/S1464-1909(00)00028-9; Dias JM, 2003, OCEAN DYNAM, V53, P220, DOI 10.1007/s10236-003-0048-5; e Silva J.D, 2007, THESIS U WALES BANGO; Fernandes A, 2013, J COASTAL RES, P1128, DOI 10.2112/SI65-191.1; Fernandes EH, 2001, J COASTAL RES, P470; Fortunato AB, 1997, CONT SHELF RES, V17, P1689, DOI 10.1016/S0278-4343(97)00047-2; Fortunato AB, 2000, COMPUTATIONAL METHODS IN WATER RESOURCES, VOLS 1 AND 2, P889; Fortunato AB, 1999, OCEANOL ACTA, V22, P31, DOI 10.1016/S0399-1784(99)80030-9; Freire P, 2013, J COASTAL RES, P482, DOI 10.2112/SI65-082.1; Gameiro C, 2007, ESTUAR COAST SHELF S, V75, P21, DOI 10.1016/j.ecss.2007.05.014; Hsu MH, 1999, J HYDRAUL ENG-ASCE, V125, P166, DOI 10.1061/(ASCE)0733-9429(1999)125:2(166); Leendertse JJ, 1971, R708NYC RAND CORP; LEENDERTSE JJ, 1987, R3572USGS RAND CORP; Li M, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002585; Martins IM, 2007, J MARINE SYST, V68, P537, DOI 10.1016/j.jmarsys.2007.02.004; Mellor G.L, 1996, INTRO PHYS OCEANOGRA; Neves FJ, 2010, THESIS U LISBOA LISB; Oliveira A, 2006, ESTUAR COAST SHELF S, V70, P76, DOI 10.1016/j.ecss.2006.05.033; Oliveira I.B.M., 1993, P COAST ENG C ASCE, P2745; Parker B.B., 1991, TIDAL HYDRODYNAMICS, P237; Pawlowicz R, 2002, COMPUT GEOSCI-UK, V28, P929, DOI 10.1016/S0098-3004(02)00013-4; PRANDLE D, 1982, CONT SHELF RES, V1, P191, DOI 10.1016/0278-4343(82)90004-8; Pugh D., 1987, TIDES SURGES MEAN SE; Pugh D. T., 2004, CHANGING SEA LEVELS; Rilo A, 2013, J COASTAL RES, P820, DOI 10.2112/SI65-139.1; Silva H, 2009, HYDROBIOLOGIA, V621, P33, DOI 10.1007/s10750-008-9630-7; Silva TA, 2013, J COASTAL RES, P582, DOI 10.2112/SI65-099.1; Sivakholundu KM, 2006, EVALUATION RIVER REG; Sousa MC, 2007, J COASTAL RES, P1075; Sousa-Dias A, 2008, ESTUAR COAST SHELF S, V76, P21, DOI 10.1016/j.ecss.2007.05.039; Vale LM, 2011, J COASTAL RES, P1604; Vale LM, 2011, J COASTAL RES, P1609; Valente AS, 2009, J MARINE SYST, V75, P131, DOI 10.1016/j.jmarsys.2008.08.008; Valentim JM, 2013, ESTUAR COAST SHELF S, V130, P138, DOI 10.1016/j.ecss.2013.04.005; Valentim JM, 2012, THESIS U AVEIRO PORT; Vaz N, 2009, J COASTAL RES, P1090; Vaz N, 2007, COMPUT GEOSCI-UK, V33, P1204, DOI 10.1016/j.cageo.2007.02.001; Warner JC, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002691; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]; Zacharias I, 2008, ENVIRON MODELL SOFTW, V23, P751, DOI 10.1016/j.envsoft.2007.09.007	55	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80450	10.1371/journal.pone.0080450	http://dx.doi.org/10.1371/journal.pone.0080450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312474	gold, Green Published, Green Submitted			2022-12-25	WOS:000327944500025
J	Nowicka, A; Marini, FC; Solley, TN; Elizondo, PB; Zhang, Y; Sharp, HJ; Broaddus, R; Kolonin, M; Mok, SC; Thompson, MS; Woodward, WA; Lu, KR; Salimian, B; Nagrath, D; Klopp, AH				Nowicka, Aleksandra; Marini, Frank C.; Solley, Travis N.; Elizondo, Paula B.; Zhang, Yan; Sharp, Hadley J.; Broaddus, Russell; Kolonin, Mikhail; Mok, Samuel C.; Thompson, Melissa S.; Woodward, Wendy A.; Lu, Karen; Salimian, Bahar; Nagrath, Deepak; Klopp, Ann H.			Human Omental-Derived Adipose Stem Cells Increase Ovarian Cancer Proliferation, Migration, and Chemoresistance	PLOS ONE			English	Article							METASTASIS; GROWTH; MODEL	Objectives: Adipose tissue contains a population of multipotent adipose stem cells (ASCs) that form tumor stroma and can promote tumor progression. Given the high rate of ovarian cancer metastasis to the omental adipose, we hypothesized that omental-derived ASC may contribute to ovarian cancer growth and dissemination. Materials and Methods: We isolated ASCs from the omentum of three patients with ovarian cancer, with (O-ASC4, O-ASC5) and without (O-ASC1) omental metastasis. BM-MSCs, SQ-ASCs, O-ASCs were characterized with gene expression arrays and metabolic analysis. Stromal cells effects on ovarian cancer cells proliferation, chemoresistance and radiation resistance was evaluated using co-culture assays with luciferase-labeled human ovarian cancer cell lines. Transwell migration assays were performed with conditioned media from O-ASCs and control cell lines. SKOV3 cells were intraperitionally injected with or without O-ASC1 to track in-vivo engraftment. Results: O-ASCs significantly promoted in vitro proliferation, migration chemotherapy and radiation response of ovarian cancer cell lines. O-ASC4 had more marked effects on migration and chemotherapy response on OVCA 429 and OVCA 433 cells than O-ASC1. Analysis of microarray data revealed that O-ASC4 and O-ASC5 have similar gene expression profiles, in contrast to O-ASC1, which was more similar to BM-MSCs and subcutaneous ASCs in hierarchical clustering. Human O-ASCs were detected in the stroma of human ovarian cancer murine xenografts but not uninvolved ovaries. Conclusions: ASCs derived from the human omentum can promote ovarian cancer proliferation, migration, chemoresistance and radiation resistance in-vitro. Furthermore, clinical O-ASCs isolates demonstrate heterogenous effects on ovarian cancer in-vitro.	[Nowicka, Aleksandra; Solley, Travis N.; Zhang, Yan; Sharp, Hadley J.; Woodward, Wendy A.; Klopp, Ann H.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Marini, Frank C.] Wake Forest Baptist Med Ctr, Dept Canc Biol, Winston Salem, NC USA; [Elizondo, Paula B.] Asuragen Inc, Austin, TX USA; [Broaddus, Russell] Univ Texas MD Anderson Canc Ctr, Dept Pathol Adm, Houston, TX 77030 USA; [Kolonin, Mikhail] Univ Texas Hlth Sci Ctr Houston, Ctr Stem Cell & Regenerat Med, Houston, TX 77030 USA; [Mok, Samuel C.; Lu, Karen] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA; [Thompson, Melissa S.] Gulf Coast Consortia, Houston, TX USA; [Salimian, Bahar; Nagrath, Deepak] Rice Univ, Chem & Biomol Engn Dept, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; Wake Forest University; Wake Forest Baptist Medical Center; Asuragen; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; Rice University	Klopp, AH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.	aklopp@mdanderson.org	Marini, Frank C/L-8018-2016; Woodward, Wendy/AAX-6593-2020	Woodward, Wendy/0000-0002-7935-739X; Nagrath, Deepak/0000-0002-8999-2282; Kolonin, Mikhail/0000-0002-3743-7869	University of Texas MD Anderson Cancer Centre NCI Specialized Programs of Research Excellence (SPORE) in Ovarian Cancer Developmental Research Award (DRP) [CA83639]; National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA133057, P50CA083639, P30CA016672] Funding Source: NIH RePORTER	University of Texas MD Anderson Cancer Centre NCI Specialized Programs of Research Excellence (SPORE) in Ovarian Cancer Developmental Research Award (DRP); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by research grants from The University of Texas MD Anderson Cancer Centre NCI Specialized Programs of Research Excellence (SPORE) in Ovarian Cancer Developmental Research Award (DRP) (Grant No. CA83639) [http://www.mdanderson.org/Departments/ovarianspore/] and the grants R01CA133057 from the National Institutes of Health [www.nih.gov]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2008, AACR M, P966; Baer PC, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/812693; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Caneba CA, 2012, AM J PHYSIOL-ENDOC M, V303, pE1036, DOI 10.1152/ajpendo.00151.2012; Coffelt SB, 2009, P NATL ACAD SCI USA, V106, P3806, DOI 10.1073/pnas.0900244106; Harichandan A, 2011, BEST PRACT RES CL HA, V24, P25, DOI 10.1016/j.beha.2011.01.001; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kidd S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030563; Klopp AH, 2012, CLIN CANCER RES, V18, P771, DOI 10.1158/1078-0432.CCR-11-1916; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Le T, 2007, ANN SURG ONCOL, V14, P2649, DOI 10.1245/s10434-007-9460-2; Lis R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038340; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Orbay H, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/461718; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Rada T, 2011, STEM CELL REV REP, V7, P64, DOI 10.1007/s12015-010-9147-0; Sarrazin S, 2006, BBA-REV CANCER, V1765, P25, DOI 10.1016/j.bbcan.2005.08.004; Sleeman JP, 2009, INT J CANCER, V125, P2747, DOI 10.1002/ijc.24702; Sonntag WE, 2006, AM J PHYSIOL-ENDOC M, V291, pE604, DOI 10.1152/ajpendo.00012.2006; Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132; Wegrowski Y, 2004, CRIT REV ONCOL HEMAT, V49, P259, DOI 10.1016/j.critrevonc.2003.10.005; Zoidis E, 2011, MOL CELL BIOCHEM, V348, P33, DOI 10.1007/s11010-010-0634-z	24	70	72	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81859	10.1371/journal.pone.0081859	http://dx.doi.org/10.1371/journal.pone.0081859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312594	Green Published, gold			2022-12-25	WOS:000327944500100
J	Rohn, TT; Day, RJ; Catlin, LW; Brown, RJ; Rajic, AJ; Poon, WW				Rohn, Troy T.; Day, Ryan J.; Catlin, Lindsey W.; Brown, Raquel J.; Rajic, Alexander J.; Poon, Wayne W.			Immunolocalization of an Amino-Terminal Fragment of Apolipoprotein E in the Pick's Disease Brain	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; POLYMORPHISM; EPSILON-4; CLEAVAGE; ALLELE; TAU	Although the risk factor for apolipoprotein E (apoE) polymorphism in Alzheimer's disease (AD) has been well described, the role that apoE plays in other neurodegenerative diseases, including Pick's disease, is not well established. To examine a possible role of apoE in Pick's disease, an immunohistochemical analysis was performed utilizing a novel site-directed antibody that is specific for an amino-terminal fragment of apoE. Application of this antibody, termed the amino-terminal apoE cleavage fragment (nApoECF) antibody, consistently labeled Pick bodies within area CA1 of the hippocampus in 4 of the 5 cases examined. Co-localization of the nApoECF antibody with PHF-1, a general marker for Pick bodies, as well as with an antibody to caspase-cleaved tau (TauC3) was evident within the hippocampus. While staining of the nApoECF antibody was robust in area CA1, little co-localization with PHF-1 in Pick bodies within the dentate gyrus was observed. A quantitative analysis indicated that approximately 86% of the Pick bodies identified in area CA1 labeled with the nApoECF antibody. The presence of truncated apoE within Pick bodies suggests a broader role of apoE beyond AD and raises the question as to whether this protein contributes to pathogenesis associated with Pick's disease.	[Rohn, Troy T.; Day, Ryan J.; Catlin, Lindsey W.; Brown, Raquel J.] Boise State Univ, Dept Biol Sci, Boise, ID 83725 USA; [Rajic, Alexander J.; Poon, Wayne W.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA USA	Idaho; Boise State University; University of California System; University of California Irvine	Rohn, TT (corresponding author), Boise State Univ, Dept Biol Sci, Boise, ID 83725 USA.	trohn@boisestate.edu		Poon, Wayne/0000-0003-0625-3968	National Institutes of Health [1R15AG042781-01A1]; NATIONAL INSTITUTE ON AGING [P50AG016573, R15AG042781] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant 1R15AG042781-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eisenstein M, 2011, NATURE, V475, pS20, DOI 10.1038/475S20a; FARRER LA, 1995, EXP NEUROL, V136, P162, DOI 10.1006/exnr.1995.1093; Feher A, 2009, ALZ DIS ASSOC DIS, V23, P224, DOI 10.1097/WAD.0b013e318199dd7d; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Hasegawa M, 2006, NEUROPATHOLOGY, V26, P484, DOI 10.1111/j.1440-1789.2006.00666.x; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Kalman J, 2000, NEUROBIOL AGING, V21, P555, DOI 10.1016/S0197-4580(00)00150-0; Rohn T.T., 2009, INT J PHYSL PATH PHA, V1, P24; Rohn TT, 2013, INT J MOL SCI, V14, P14908, DOI 10.3390/ijms140714908; Rohn TT, 2012, BRAIN RES, V1475, P106, DOI 10.1016/j.brainres.2012.08.003; Rohn TT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020495; Schneider A, 2008, NEUROTHERAPEUTICS, V5, P443, DOI 10.1016/j.nurt.2008.05.006; Takeda N, 2012, ADV EXP MED BIOL, V724, P300, DOI 10.1007/978-1-4614-0653-2_23; Uchihara T, 2003, NEUROPATHOLOGY, V23, P318, DOI 10.1046/j.1440-1789.2003.00523.x; Wakabayashi K, 1998, ACTA NEUROPATHOL, V95, P450, DOI 10.1007/s004010050824; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240	18	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80180	10.1371/journal.pone.0080180	http://dx.doi.org/10.1371/journal.pone.0080180			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312462	Green Published, gold			2022-12-25	WOS:000327944500016
J	Rohr, CO; Levin, LN; Mentaberry, AN; Wirth, SA				Rohr, Cristian O.; Levin, Laura N.; Mentaberry, Alejandro N.; Wirth, Sonia A.			A First Insight into Pycnoporus sanguineus BAFC 2126 Transcriptome	PLOS ONE			English	Article							WHITE-ROT FUNGI; ARYL-ALCOHOL OXIDASE; PHANEROCHAETE-CHRYSOSPORIUM; SECRETOME ANALYSIS; GENOME SEQUENCE; CELLOBIOSE DEHYDROGENASE; LANOSTANE TRITERPENOIDS; MANGANESE PEROXIDASE; LIGNIN DEGRADATION; CRYSTAL-STRUCTURE	Fungi of the genus Pycnoporus are white-rot basidiomycetes widely studied because of their ability to synthesize high added-value compounds and enzymes of industrial interest. Here we report the sequencing, assembly and analysis of the transcriptome of Pycnoporus sanguineus BAFC 2126 grown at stationary phase, in media supplemented with copper sulfate. Using the 454 pyrosequencing platform we obtained a total of 226,336 reads (88,779,843 bases) that were filtered and de novo assembled to generate a reference transcriptome of 7,303 transcripts. Putative functions were assigned for 4,732 transcripts by searching similarities of six-frame translated sequences against a customized protein database and by the presence of conserved protein domains. Through the analysis of translated sequences we identified transcripts encoding 178 putative carbohydrate active enzymes, including representatives of 15 families with roles in lignocellulose degradation. Furthermore, we found many transcripts encoding enzymes related to lignin hydrolysis and modification, including laccases and peroxidases, as well as GMC oxidoreductases, copper radical oxidases and other enzymes involved in the generation of extracellular hydrogen peroxide and iron homeostasis. Finally, we identified the transcripts encoding all of the enzymes involved in terpenoid backbone biosynthesis pathway, various terpene synthases related to the biosynthesis of sesquiterpenoids and triterpenoids precursors, and also cytochrome P450 monooxygenases, glutathione S-transferases and epoxide hydrolases with potential functions in the biodegradation of xenobiotics and the enantioselective biosynthesis of biologically active drugs. To our knowledge this is the first report of a transcriptome of genus Pycnoporus and a resource for future molecular studies in P. sanguineus.	[Rohr, Cristian O.] Inst Ecol Genet & Evoluc, Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Levin, Laura N.] Univ Buenos Aires, Dept Biodiversidad & Biol Expt, Lab Micol Expt, Buenos Aires, DF, Argentina; [Mentaberry, Alejandro N.; Wirth, Sonia A.] Univ Buenos Aires, Lab Agrobiotecnol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Wirth, SA (corresponding author), Univ Buenos Aires, Lab Agrobiotecnol, Buenos Aires, DF, Argentina.	sawirth@fbmc.fcen.uba.ar		Wirth, Sonia/0000-0003-2930-9979	Agencia Nacional para la Promocion de la Ciencia y la Tecnologia, ANPCyT [BID PICT2010-00394]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET [PIP2011-2013 N 0092]	Agencia Nacional para la Promocion de la Ciencia y la Tecnologia, ANPCyT(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Grant BID PICT2010-00394 from the Agencia Nacional para la Promocion de la Ciencia y la Tecnologia, ANPCyT (http://www.agencia.mincyt.gob.ar/) and Grant PIP2011-2013 N 0092 from the Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET (http://www.conicet.gov.ar/). CR is a PhD Fellow of CONICET, LL, AM and SW are Research Scientists of CONICET, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger S, 2009, MOL MICROBIOL, V72, P1181, DOI 10.1111/j.1365-2958.2009.06717.x; Akihisa T, 2007, J NAT PROD, V70, P948, DOI 10.1021/np0780001; Akileswaran L, 1999, APPL ENVIRON MICROB, V65, P415; Alvarado IE, 2003, WORLD J MICROB BIOT, V19, P157, DOI 10.1023/A:1023264200256; Archelas A, 1998, J MOL CATAL B-ENZYM, V5, P79, DOI 10.1016/S1381-1177(98)00011-3; Aro N, 2005, FEMS MICROBIOL REV, V29, P719, DOI 10.1016/j.femsre.2004.11.006; Asther M, 1998, MICOL NEOTROP APL, V11, P69; Bhat MK, 2000, BIOTECHNOL ADV, V18, P355, DOI 10.1016/S0734-9750(00)00041-0; Carabajal M, 2013, J BIOTECHNO IN PRESS; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Cheng CR, 2010, PHYTOCHEMISTRY, V71, P1579, DOI 10.1016/j.phytochem.2010.06.005; Collins PJ, 1997, APPL ENVIRON MICROB, V63, P3444, DOI 10.1128/AEM.63.9.3444-3450.1997; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dantan-Gonzalez E, 2008, INT MICROBIOL, V11, P163, DOI 10.2436/20.1501.01.56; Dudhgaonkar S, 2009, INT IMMUNOPHARMACOL, V9, P1272, DOI 10.1016/j.intimp.2009.07.011; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; Eggert C, 1996, APPL ENVIRON MICROB, V62, P1151, DOI 10.1128/AEM.62.4.1151-1158.1996; ESPOSITO E, 1993, J BIOTECHNOL, V29, P219, DOI 10.1016/0168-1656(93)90054-Q; FAISON BD, 1983, APPL ENVIRON MICROB, V46, P1140, DOI 10.1128/AEM.46.5.1140-1145.1983; FALCONNIER B, 1994, J BIOTECHNOL, V37, P123, DOI 10.1016/0168-1656(94)90003-5; Fernandez IS, 2009, ACTA CRYSTALLOGR D, V65, P1196, DOI 10.1107/S0907444909035860; Fernandez-Fueyo E, 2012, P NATL ACAD SCI USA, V109, P5458, DOI 10.1073/pnas.1119912109; Ferraz A, 1998, WORLD J MICROB BIOT, V14, P487, DOI 10.1023/A:1008875730177; Ferraz A, 2008, ENZYME MICROB TECH, V43, P178, DOI 10.1016/j.enzmictec.2007.10.002; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Glass NL, 2013, ANN REV MIC IN PRESS; Gomez-Toribio V, 2009, APPL ENVIRON MICROB, V75, P3944, DOI 10.1128/AEM.02137-08; Guillen F, 1997, ARCH BIOCHEM BIOPHYS, V339, P190, DOI 10.1006/abbi.1996.9834; GUTIERREZ A, 1994, APPL ENVIRON MICROB, V60, P1783; Hallberg BM, 2004, J MOL BIOL, V341, P781, DOI 10.1016/j.jmb.2004.06.033; Hernandez-Ortega A, 2011, J BIOL CHEM, V286, P41105, DOI 10.1074/jbc.M111.282467; Huang HC, 2012, PHYTOCHEMISTRY, V84, P177, DOI 10.1016/j.phytochem.2012.08.011; Janusz G, 2013, ENZYME MICROB TECH, V52, P1, DOI 10.1016/j.enzmictec.2012.10.003; JEFFRIES TW, 1981, APPL ENVIRON MICROB, V42, P290, DOI 10.1128/AEM.42.2.290-296.1981; Jensen KA, 2002, APPL ENVIRON MICROB, V68, P2699, DOI 10.1128/AEM.68.6.2699-2703.2002; Ji XL, 2012, INT BIODETER BIODEGR, V75, P55, DOI 10.1016/j.ibiod.2012.09.001; Kamo T, 2003, J NAT PROD, V66, P1104, DOI 10.1021/np0300479; Kapich A, 1999, BIOCHEM BIOPH RES CO, V259, P212, DOI 10.1006/bbrc.1999.0742; KERSTEN PJ, 1995, J BACTERIOL, V177, P6106, DOI 10.1128/jb.177.21.6106-6110.1995; Kimura Y, 2002, ANTICANCER RES, V22, P3309; KIRK TK, 1978, ARCH MICROBIOL, V117, P277, DOI 10.1007/BF00738547; Klonowska A, 2003, RES MICROBIOL, V154, P25, DOI 10.1016/S0923-2508(02)00005-0; Kumar SVS, 2003, BIOTECHNOL BIOENG, V83, P386, DOI 10.1002/bit.10681; Lenin L, 2002, MYCOLOGIA, V94, P377, DOI 10.2307/3761771; Lesage-Meessen L, 2011, FEMS MICROBIOL LETT, V325, P37, DOI 10.1111/j.1574-6968.2011.02412.x; Levin L, 2007, PROCESS BIOCHEM, V42, P995, DOI 10.1016/j.procbio.2007.03.008; Litthauer D, 2007, ENZYME MICROB TECH, V40, P563, DOI 10.1016/j.enzmictec.2006.05.011; Liu DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036146; Lomascolo A, 2003, J APPL MICROBIOL, V94, P618, DOI 10.1046/j.1365-2672.2003.01879.x; Lomascolo A, 2002, MYCOL RES, V106, P1193, DOI 10.1017/S0953756202006494; Lomascolo A, 2011, APPL MICROBIOL BIOT, V92, P1129, DOI 10.1007/s00253-011-3596-5; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; MacDonald J, 2011, APPL ENVIRON MICROB, V77, P3211, DOI 10.1128/AEM.02490-10; Mahajan S, 2010, APPL MICROBIOL BIOT, V86, P1903, DOI 10.1007/s00253-010-2516-4; Makela MR, 2013, FUNGAL BIOL-UK, V117, P62, DOI 10.1016/j.funbio.2012.11.006; Martinez AT, 2002, ENZYME MICROB TECH, V30, P425, DOI 10.1016/S0141-0229(01)00521-X; Martinez AT, 2005, INT MICROBIOL, V8, P195; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Alvarez JM, 2009, FUNGAL GENET BIOL, V46, P104, DOI 10.1016/j.fgb.2008.10.002; Minto RE, 2009, APPL ENVIRON MICROB, V75, P1156, DOI 10.1128/AEM.02049-08; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Moukha SM, 1999, GENE, V234, P23, DOI 10.1016/S0378-1119(99)00189-4; Mtui G. Y. S., 2012, Scientific Research and Essays, V7, P1544; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Nomura M, 2008, ANTICANCER RES, V28, P2691; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Olson A, 2012, NEW PHYTOL, V194, P1001, DOI 10.1111/j.1469-8137.2012.04128.x; Palmieri G, 2000, APPL ENVIRON MICROB, V66, P920, DOI 10.1128/AEM.66.3.920-924.2000; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Pedersen H, 2006, MYCOREMEDIATION FUNG; Pitsawong W, 2010, J BIOL CHEM, V285, P9697, DOI 10.1074/jbc.M109.073247; Pointing SB, 2001, APPL MICROBIOL BIOT, V57, P20; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; QUIROGA EN, 1995, BBA-PROTEIN STRUCT M, V1251, P75, DOI 10.1016/0167-4838(95)00070-B; Ravalason H, 2008, APPL MICROBIOL BIOT, V80, P719, DOI 10.1007/s00253-008-1596-x; REISER J, 1994, J BIOL CHEM, V269, P28152; Ruiz-Duenas FJ, 2009, J EXP BOT, V60, P441, DOI 10.1093/jxb/ern261; Ryvarden L, 1991, GENERA POLYPORES NOM, V5; Saparrat M, 2010, FUNGAL BIOL-UK, V114, P999, DOI 10.1016/j.funbio.2010.09.010; Sato S, 2007, MICROBIOL-SGM, V153, P3023, DOI 10.1099/mic.0.2006/000513-0; Shim SH, 2004, J NAT PROD, V67, P1110, DOI 10.1021/np030383p; Sigoillot C, 2002, ENZYME MICROB TECH, V31, P876, DOI 10.1016/S0141-0229(02)00208-9; Siqueira EMD, 1997, MYCOL RES, V101, P188; SMANIA A, 1995, J ETHNOPHARMACOL, V45, P177, DOI 10.1016/0378-8741(94)01212-I; Smania A, 2003, PHYTOTHER RES, V17, P1069, DOI 10.1002/ptr.1304; Stapleton PC, 2003, FEMS MICROBIOL LETT, V221, P167, DOI 10.1016/S0378-1097(03)00212-X; Suzuki H, 2008, APPL MICROBIOL BIOT, V80, P99, DOI 10.1007/s00253-008-1539-6; Suzuki H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-444; Tang JD, 2012, APPL ENVIRON MICROB, V78, P2272, DOI 10.1128/AEM.06745-11; Uzan E, 2010, J APPL MICROBIOL, V108, P2199, DOI 10.1111/j.1365-2672.2009.04623.x; Uzan E, 2011, APPL MICROBIOL BIOT, V90, P97, DOI 10.1007/s00253-010-3075-4; Vanden Wymelenberg A, 2006, APPL ENVIRON MICROB, V72, P4871, DOI 10.1128/AEM.00375-06; Vanden Wymelenberg A, 2006, FUNGAL GENET BIOL, V43, P343, DOI 10.1016/j.fgb.2006.01.003; Vanden Wymelenberg A, 2009, APPL ENVIRON MICROB, V75, P4058, DOI 10.1128/AEM.00314-09; Watanabe T, 2010, APPL MICROBIOL BIOT, V87, P215, DOI 10.1007/s00253-010-2438-1; Welti S, 2012, FUNGAL DIVERS, V55, P47, DOI 10.1007/s13225-011-0149-2; Wesenberg D, 2003, BIOTECHNOL ADV, V22, P161, DOI 10.1016/j.biotechadv.2003.08.011; Wongnate T, 2013, FEBS J, V280, P3009, DOI 10.1111/febs.12280; Wymelenberg AV, 2011, APPL ENVIRON MICROB, V77, P4499, DOI 10.1128/AEM.00508-11; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoshikawa K, 2005, J NAT PROD, V68, P911, DOI 10.1021/np058024c; Yoshikawa K, 2005, J NAT PROD, V68, P69, DOI 10.1021/np040130b; Yu GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044031; Zjawiony JK, 2004, J NAT PROD, V67, P300, DOI 10.1021/np030372w	105	16	17	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81033	10.1371/journal.pone.0081033	http://dx.doi.org/10.1371/journal.pone.0081033			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312521	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500053
J	Stanford, NJ; Lubitz, T; Smallbone, K; Klipp, E; Mendes, P; Liebermeister, W				Stanford, Natalie J.; Lubitz, Timo; Smallbone, Kieran; Klipp, Edda; Mendes, Pedro; Liebermeister, Wolfram			Systematic Construction of Kinetic Models from Genome-Scale Metabolic Networks	PLOS ONE			English	Article							GLYCOLYTIC-FLUX; RECONSTRUCTION; UNCERTAINTY; INTEGRATION; LANGUAGE; GLUCOSE	The quantitative effects of environmental and genetic perturbations on metabolism can be studied in silico using kinetic models. We present a strategy for large-scale model construction based on a logical layering of data such as reaction fluxes, metabolite concentrations, and kinetic constants. The resulting models contain realistic standard rate laws and plausible parameters, adhere to the laws of thermodynamics, and reproduce a predefined steady state. These features have not been simultaneously achieved by previous workflows. We demonstrate the advantages and limitations of the workflow by translating the yeast consensus metabolic network into a kinetic model. Despite crudely selected data, the model shows realistic control behaviour, a stable dynamic, and realistic response to perturbations in extracellular glucose concentrations. The paper concludes by outlining how new data can continuously be fed into the workflow and how iterative model building can assist in directing experiments.	[Stanford, Natalie J.; Smallbone, Kieran; Mendes, Pedro] Univ Manchester, Sch Comp Sci, Manchester Ctr Integrat Syst Biol, Manchester, Lancs, England; [Lubitz, Timo; Klipp, Edda] Humboldt Univ, Inst Biol Theoret Biophys, D-10099 Berlin, Germany; [Mendes, Pedro] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA; [Liebermeister, Wolfram] Charite, Inst Biochem, D-13353 Berlin, Germany	University of Manchester; Humboldt University of Berlin; Virginia Polytechnic Institute & State University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Stanford, NJ (corresponding author), Univ Manchester, Sch Comp Sci, Manchester Ctr Integrat Syst Biol, Manchester, Lancs, England.	natalie.stanford@manchester.ac.uk	Liebermeister, Wolfram/AAC-7326-2020	Liebermeister, Wolfram/0000-0002-2568-2381; Mendes, Pedro/0000-0001-6507-9168; Stanford, Natalie J/0000-0003-4958-0184	EPSRC through the Manchester Doctoral Training Centre ISBML [EP/F500009/1]; BBSRC through the Manchester Doctoral Training Centre ISBML [EP/F500009/1]; Manchester Centre for Integrative Systems Biology [BB/C0082191]; EU [289434]; German Research Foundation; OncoPath project; USA's NIGMS [GM080219]; BBSRC [BB/J019259/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J019259/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080219] Funding Source: NIH RePORTER	EPSRC through the Manchester Doctoral Training Centre ISBML(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC through the Manchester Doctoral Training Centre ISBML(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Manchester Centre for Integrative Systems Biology; EU(European Commission); German Research Foundation(German Research Foundation (DFG)); OncoPath project; USA's NIGMS; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the EPSRC and BBSRC for financial support of this work through the Manchester Doctoral Training Centre ISBML (grant EP/F500009/1 supported NJS) and the Manchester Centre for Integrative Systems Biology (grant BB/C0082191 supported KS and PM), the EU FP7 programme: UniCellSys (supported PM, TL, EK, and WL), BaSysBio (supported TL, EK, and WL), BioPreDyn (grant 289434, supported PM and KS), the German Research Foundation (supported WL), the OncoPath project (supported TL and EK), and the USA's NIGMS (grant GM080219) supported PM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker BM, 2000, MOL BIOCHEM PARASIT, V106, P1, DOI 10.1016/S0166-6851(99)00197-8; Conant GC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100170; Dobson PD, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-145; Ederer M, 2007, BIOPHYS J, V92, P1846, DOI 10.1529/biophysj.106.094094; Grimbs S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100186; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Haldane JBS, 1930, ENZYMES; Heijnen JJ, 2005, BIOTECHNOL BIOENG, V91, P534, DOI 10.1002/bit.20558; Heinemann M, 2010, CURR OPIN MICROBIOL, V13, P337, DOI 10.1016/j.mib.2010.02.005; Heinrich R., 1996, REGULATION CELLULAR, V416; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Hynne R, 2001, BIOPHYS CHEM, V94, P121; Kholodenko B, 2000, BIOTECHNOL BIOENG, V59, P239; Korzeniewski B, 1998, BIOCHEM J, V330, P1189, DOI 10.1042/bj3301189; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; Li P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-582; Liebermeister W, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-41; Liebermeister W, 2010, BIOINFORMATICS, V26, P1528, DOI 10.1093/bioinformatics/btq141; Lubitz T, 2010, J PHYS CHEM B, V114, P16298, DOI 10.1021/jp108764b; Mendes P, 2011, P 9 INT C COMP METH, P5; Miskovic L, 2010, TRENDS BIOTECHNOL, V28, P391, DOI 10.1016/j.tibtech.2010.05.003; OEHLEN LJWM, 1994, MICROBIOL-SGM, V140, P1891, DOI 10.1099/13500872-140-8-1891; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pritchard L, 2002, EUR J BIOCHEM, V269, P3894, DOI 10.1046/j.1432-1033.2002.03055.x; Reijenga KA, 2001, BIOPHYS J, V80, P626, DOI 10.1016/S0006-3495(01)76043-2; Rojas I, 2007, BMC SYST BIOL, DOI [DOI 10.1186/1752-0509-1-51-56, 10.1186/1752-0509-1-S1-S6, DOI 10.1186/1752-0509-1-S1-S6]; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Schuster S, 1999, TRENDS BIOTECHNOL, V17, P53, DOI 10.1016/S0167-7799(98)01290-6; Smallbone K, 2007, FEBS J, V274, P5576, DOI 10.1111/j.1742-4658.2007.06076.x; Smallbone Kieran, 2013, Methods Mol Biol, V985, P113, DOI 10.1007/978-1-62703-299-5_7; Smallbone K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-6; Smallbone K, 2009, J THEOR BIOL, V258, P311, DOI 10.1016/j.jtbi.2009.01.027; Soh K, 2012, FEMS YEAST RES; Somsen OJG, 2000, BIOCHEM J, V352, P593, DOI 10.1042/0264-6021:3520593; Steuer R, 2006, P NATL ACAD SCI USA, V103, P11868, DOI 10.1073/pnas.0600013103; Swainston N, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-186; Teusink B, 2000, EUR J BIOCHEM, V267, P5313, DOI 10.1046/j.1432-1327.2000.01527.x; Teusink B, 1998, TRENDS BIOCHEM SCI, V23, P162, DOI 10.1016/S0968-0004(98)01205-5; Thomas S, 1998, EUR J BIOCHEM, V258, P956, DOI 10.1046/j.1432-1327.1998.2580956.x; Vargas FA, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-75; Wang LQ, 2006, METAB ENG, V8, P133, DOI 10.1016/j.ymben.2005.11.003; Wang LQ, 2004, BIOPHYS J, V87, P3750, DOI 10.1529/biophysj.104.048090; Wegscheider R., 1902, Z PHYS CHEM, V39U, P257, DOI [10.1515/zpch-1902-3919, DOI 10.1038/NATURE13900]	47	67	67	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79195	10.1371/journal.pone.0079195	http://dx.doi.org/10.1371/journal.pone.0079195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24324546	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000327143800040
J	Popescu, VD; Rozylowicz, L; Cogalniceanu, D; Niculae, IM; Cucu, AL				Popescu, Viorel D.; Rozylowicz, Laurentiu; Cogalniceanu, Dan; Niculae, Iulian Mihaita; Cucu, Adina Livia			Moving into Protected Areas? Setting Conservation Priorities for Romanian Reptiles and Amphibians at Risk from Climate Change	PLOS ONE			English	Article							LAND-USE CHANGE; SPECIES DISTRIBUTIONS; LOCAL ADAPTATION; BIODIVERSITY; NETWORK; MODELS; ECTOTHERMS; DIVERSITY; IRREPLACEABILITY; UNCERTAINTY	Rapid climate change represents one of the top threats to biodiversity, causing declines and extinctions of many species. Range shifts are a key response, but in many cases are incompatible with the current extent of protected areas. In this study we used ensemble species distribution models to identify range changes for 21 reptile and 16 amphibian species in Romania for the 2020s and 2050s time horizons under three emission scenarios (A1B = integrated world, rapid economic growth, A2A = divided world, rapid economic growth [realistic scenario], B2A = regional development, environmentally-friendly scenario) and no-and limited-dispersal assumptions. We then used irreplaceability analysis to test the efficacy of the Natura 2000 network to meet conservation targets. Under all scenarios and time horizons, 90% of the species suffered range contractions (greatest loses under scenarios B2A for 2020s, and A1B for 2050s), and four reptile species expanded their ranges. Two reptile and two amphibian species are predicted to completely lose climate space by 2050s. Currently, 35 species do not meet conservation targets (>40% representation in protected areas), but the target is predicted to be met for 4 - 14 species under future climate conditions, with higher representation under the limited-dispersal scenario. The Alpine and Steppic-Black Sea biogeographic regions have the highest irreplaceability value, and act as climate refugia for many reptiles and amphibians. The Natura 2000 network performs better for achieving herpetofauna conservation goals in the future, owing to the interaction between drastic range contractions, and range shifts towards existing protected areas. Thus, conservation actions for herpetofauna in Romania need to focus on: (1) building institutional capacity of protected areas in the Alpine and Steppic-Black Sea biogeographic regions, and (2) facilitating natural range shifts by improving the conservation status of herpetofauna outside protected areas, specifically in traditionally-managed landscapes and abandoned cropland.	[Popescu, Viorel D.] Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada; [Popescu, Viorel D.; Rozylowicz, Laurentiu; Niculae, Iulian Mihaita; Cucu, Adina Livia] Univ Bucharest, Ctr Environm Res CCMESI, Bucharest, Romania; [Cogalniceanu, Dan] Univ Ovidius Constanta, Fac Nat & Agr Sci, Constanta, Romania	Simon Fraser University; University of Bucharest; Ovidius University	Popescu, VD (corresponding author), Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada.	vioreldpopescu@gmail.com	Popescu, Viorel/AAP-4699-2021; Niculae, Mihaita Iulian/I-6591-2016; Cogalniceanu, Dan/B-7065-2011; Rozylowicz, Laurentiu/B-4540-2009; Popescu, Viorel/O-3792-2014	Cogalniceanu, Dan/0000-0003-2959-014X; Rozylowicz, Laurentiu/0000-0001-7174-032X; Niculae, Mihaita Iulian/0000-0001-7340-6835	Romanian National Authority for Scientific Research, CNCS - UEFISCDI [PN-II-RU-TE-2011-3-0183]; David H. Smith Conservation Research Fellowship from the Society for Conservation Biology	Romanian National Authority for Scientific Research, CNCS - UEFISCDI; David H. Smith Conservation Research Fellowship from the Society for Conservation Biology	This work was supported by a grant of the Romanian National Authority for Scientific Research, CNCS - UEFISCDI (http://uefiscdi.gov.ro), project number PN-II-RU-TE-2011-3-0183. VDP was partly supported by a David H. Smith Conservation Research Fellowship from the Society for Conservation Biology (www.smithfellows.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon P, 2010, ANIM CONSERV, V13, P363, DOI 10.1111/j.1469-1795.2009.00343.x; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2007, CONSERV BIOL, V21, P1423, DOI 10.1111/j.1523-1739.2007.00827.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Atkins KE, 2010, J THEOR BIOL, V266, P449, DOI 10.1016/j.jtbi.2010.07.014; Balteanu D., 2010, J GEOGR, V54, P95; Beale CM, 2012, PHILOS T R SOC B, V367, P247, DOI 10.1098/rstb.2011.0178; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cahill AE, 2013, P R SOC LOND B, V280; Coetzee BWT, 2009, GLOBAL ECOL BIOGEOGR, V18, P701, DOI 10.1111/j.1466-8238.2009.00485.x; Cogalniceanu D, 2013, IVERS DISTR IN PRESS; COGALNICEANU D, 1993, AMPHIBIA-REPTILIA, V14, P90, DOI DOI 10.1163/156853893X00237; Cogalniceanu D, 2013, ZOOKEYS, P35, DOI 10.3897/zookeys.296.4872; Cox NA, 2009, EUROPEAN RED LIST RE; D'Amen M, 2011, BIOL CONSERV, V144, P989, DOI 10.1016/j.biocon.2010.11.004; D'Amen M, 2009, BIOL CONSERV, V142, P3060, DOI 10.1016/j.biocon.2009.08.004; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Evans D, 2012, NAT CONSERV-BULGARIA, P11, DOI 10.3897/natureconservation.1.1808; Ferrier S, 2000, BIOL CONSERV, V93, P303, DOI 10.1016/S0006-3207(99)00149-4; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fischer J, 2012, CONSERV LETT, V5, P167, DOI 10.1111/j.1755-263X.2012.00227.x; Groves CR, 2012, BIODIVERS CONSERV, V21, P1651, DOI 10.1007/s10531-012-0269-3; Gruber B, 2012, NAT CONSERV-BULGARIA, P45, DOI 10.3897/natureconservation.3.3732; Hamann A, 2013, DIVERS DISTRIB, V19, P268, DOI 10.1111/j.1472-4642.2012.00945.x; Hartel T, 2010, BIOL CONSERV, V143, P1118, DOI 10.1016/j.biocon.2010.02.006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hochkirch A, 2013, CONSERV LETT, V6, P462, DOI 10.1111/conl.12006; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Ioja CI, 2010, BIOL CONSERV, V143, P2468, DOI 10.1016/j.biocon.2010.06.013; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Kareiva P, 2007, SCI AM, V297, P50, DOI 10.1038/scientificamerican1007-50; Knorn J, 2012, BIOL CONSERV, V146, P204, DOI 10.1016/j.biocon.2011.12.020; Kuemmerle T, 2009, REG ENVIRON CHANGE, V9, P1, DOI 10.1007/s10113-008-0050-z; Kujala H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053315; Lawler JJ, 2010, CONSERV BIOL, V24, P38, DOI 10.1111/j.1523-1739.2009.01403.x; Lindsey HA, 2013, NATURE, V494, P463, DOI 10.1038/nature11879; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Mitchell TD, 2004, 55 TYND CTR CLIM CHA; Mueller D, 2009, J LAND USE SCI, V4, P109, DOI 10.1080/17474230802645881; Opermanis O, 2012, BIOL CONSERV, V153, P227, DOI 10.1016/j.biocon.2012.04.031; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Patru-Stupariu I, 2013, BIODIVERS CONSERV, V22, P2023, DOI 10.1007/s10531-013-0523-3; Popescu VD, 2011, ECOL APPL, V21, P1283, DOI 10.1890/10-0658.1; Pressey RL, 2004, CONSERV BIOL, V18, P1677, DOI 10.1111/j.1523-1739.2004.00434.x; PRESSEY RL, 1994, BIODIVERS CONSERV, V3, P242, DOI 10.1007/BF00055941; Pressey RL, 2008, SPATIAL CONSERVATION; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; R Development Core Team, 2012, R LANG ENV STAT COMP; Rasanen K, 2003, EVOLUTION, V57, P352, DOI 10.1554/0014-3820(2003)057[0352:GVIAST]2.0.CO;2; Rozylowicz L, 2013, EUR J WILDLIFE RES, V59, P47, DOI 10.1007/s10344-012-0646-y; Rozylowicz L, 2011, BIODIVERS CONSERV, V20, P561, DOI 10.1007/s10531-010-9967-x; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Skelly DK, 2004, EVOLUTION, V58, P160; Soutullo A, 2010, CONSERV BIOL, V24, P362, DOI 10.1111/j.1523-1739.2010.01465.x; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Temple HJ, 2009, EUROPEAN RED LIST AM; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Tingley R, 2009, J BIOGEOGR, V36, P1656, DOI 10.1111/j.1365-2699.2009.02117.x; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Zajitschek SRK, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-13; Zar JH., 2010, BIOSTAT ANAL	68	34	40	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79330	10.1371/journal.pone.0079330	http://dx.doi.org/10.1371/journal.pone.0079330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24324547	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400106
J	Zhang, C; Zhang, S; Zhang, Z; He, J; Xu, Y; Liu, S				Zhang, C.; Zhang, S.; Zhang, Z.; He, J.; Xu, Y.; Liu, S.			ROCK has a crucial role in regulating prostate tumor growth through interaction with c-Myc	ONCOGENE			English	Article						ROCK; c-Myc; prostate cancer cells; proliferation; protein stability	B-CELL LYMPHOMAS; PROTEIN STABILITY; GENE-EXPRESSION; BREAST-CANCER; KINASE; PHOSPHORYLATION; TRANSFORMATION; DEGRADATION; CYCLE; FBW7	Rho-associated kinase (ROCK) has an essential role in governing cell morphology and motility, and increased ROCK activity contributes to cancer cell invasion and metastasis. Burgeoning data suggest that ROCK is also involved in the growth regulation of tumor cells. However, thus far, the molecular mechanisms responsible for ROCK-governed tumor cell growth have not been clearly elucidated. Here we showed that inhibition of ROCK kinase activity, either by a selective ROCK inhibitor Y27632 or by specific ROCK small interfering RNA (siRNA) molecules, attenuated not only motility but also the proliferation of PC3 prostate cancer cells in vitro and in vivo. Importantly, mechanistic investigation revealed that ROCK endowed cancer cells with tumorigenic capability, mainly by targeting c-Myc. ROCK could increase the transcriptional activity of c-Myc by promoting c-Myc protein stability, and ROCK inhibition reduced c-Myc-mediated expression of mRNA targets (such as HSPC111) and microRNA targets (such as miR-17-92 cluster). We provided evidence demonstrating that ROCK1 directly interacted with and phosphorylated c-Myc, resulting in stabilization of the protein and activation of its transcriptional activity. Suppression of ROCK-c-Myc downstream molecules, such as c-Myc-regulated miR-17, also impaired tumor cell growth in vitro and in vivo. In addition, c-Myc was shown to exert a positive feedback regulation on ROCK by increasing RhoA mRNA expression. Therefore, inhibition of ROCK and its stimulated signaling might prove to be a promising strategy for restraining tumor progression in prostate cancer.	[Zhang, C.; Zhang, S.; Liu, S.] Chinese Acad Sci, State Key Lab Environm Chem & Ecotoxicol, Res Ctr Ecoenvironm Sci, Beijing 100085, Peoples R China; [Zhang, C.; Zhang, Z.; Xu, Y.] Tianjin Med Univ, Tianjin Inst Urol, Hosp 2, Dept Urol, Tianjin, Peoples R China; [He, J.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Tianjin Medical University; Tufts University	Liu, S (corresponding author), Chinese Acad Sci, State Key Lab Environm Chem & Ecotoxicol, Res Ctr Ecoenvironm Sci, Beijing 100085, Peoples R China.	xuyong8816@sina.com; sjliu@rcees.ac.cn			National Natural Science Foundation of China [21377159, 81172451]; national '973' program [2014CB932000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); national '973' program(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (grant numbers: 21377159, 81172451) and from the national '973' program (grant number: 2014CB932000). We thank lab members for their invaluable assistance with experiments and reagents, and Michael Rosenblatt, MD, of Merck & Co. Inc. for his review of the manuscript and helpful suggestions.	Alarcon-Vargas D, 2004, J BIOL CHEM, V279, P5008, DOI 10.1074/jbc.M312054200; Alarcon-Vargas D, 2002, ONCOGENE, V21, P4384, DOI 10.1038/sj.onc.1205543; ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; Boku S, 2013, BRAIN RES, V1492, P7, DOI 10.1016/j.brainres.2012.11.034; Bu Qiang, 2011, Zhonghua Zhong Liu Za Zhi, V33, P202; Butt AJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1985; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Gualco G, 2009, AM J SURG PATHOL, V33, P1815, DOI 10.1097/PAS.0b013e3181bb9a18; Hahmann C, 2010, CELL MOL LIFE SCI, V67, P171, DOI 10.1007/s00018-009-0189-x; Hann SR, 2006, SEMIN CANCER BIOL, V16, P288, DOI 10.1016/j.semcancer.2006.08.004; Hesan Luo JZ, 2012, BIOCHEM J, V442, P311; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; James K, 2007, J CARDIOVASC PHARM, V50, P17; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lane J, 2008, INT J ONCOL, V33, P585, DOI 10.3892/ijo_00000044; Lin SL, 2007, CARCINOGENESIS, V28, P310, DOI 10.1093/carcin/bgl134; Liu SJ, 2007, J CLIN INVEST, V117, P3296, DOI 10.1172/JCI32084; Liu SJ, 2011, MOL BIOL REP, V38, P1363, DOI 10.1007/s11033-010-0238-4; Liu SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011272; Liu SJ, 2009, CANCER RES, V69, P8742, DOI 10.1158/0008-5472.CAN-09-1541; Lochhead PA, 2010, ONCOGENE, V29, P2591, DOI 10.1038/onc.2010.3; LUSCHER B, 1992, J CELL BIOL, V118, P775, DOI 10.1083/jcb.118.4.775; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Noguchi K, 2001, BIOCHEM BIOPH RES CO, V281, P1313, DOI 10.1006/bbrc.2001.4498; Popov N, 2007, CELL CYCLE, V6, P2327, DOI 10.4161/cc.6.19.4804; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Routhier A, 2010, ONCOL REP, V23, P861, DOI 10.3892/or_00000708; Ruzinova MB, 2010, AM J SURG PATHOL, V34, P882, DOI 10.1097/PAS.0b013e3181db83af; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; SETH A, 1991, J BIOL CHEM, V266, P23521; SETH A, 1993, MOL CELL BIOL, V13, P4125, DOI 10.1128/MCB.13.7.4125; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Wang CG, 2011, CELL CYCLE, V10, P57, DOI 10.4161/cc.10.1.14449; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhang Y, 2009, J CELL SCI, V122, P2197, DOI 10.1242/jcs.040659	43	58	60	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 4	2014	33	49					5582	5591		10.1038/onc.2013.505	http://dx.doi.org/10.1038/onc.2013.505			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AW1ZW	24317511				2022-12-25	WOS:000346088700002
J	Nooh, MM; Chumpia, MM; Hamilton, TB; Bahouth, SW				Nooh, Mohammed M.; Chumpia, Maryanne M.; Hamilton, Thomas B.; Bahouth, Suleiman W.			Sorting of beta(1)-Adrenergic Receptors Is Mediated by Pathways That Are Either Dependent on or Independent of Type I PDZ, Protein Kinase A (PKA), and SAP97	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adrenergic Receptor; Confocal Microscopy; G Protein-coupled Receptor (GPCR); Protein Kinase A (PKA); Trafficking	ENDOCYTIC RECYCLING SIGNAL; COUPLED RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; MEMBRANE TRAFFICKING; BETA-ARRESTIN; PHOSPHORYLATION SITES; ANCHORING PROTEINS; CRYSTAL-STRUCTURE; AMPA RECEPTORS; BINDING	The (1)-adrenergic receptor ((1)-AR) is a target for treatment of major cardiovascular diseases, such as heart failure and hypertension. Recycling of agonist-internalized (1)-AR is dependent on type I PSD-95/DLG/ZO1 (PDZ) in the C-tail of the (1)-AR and on protein kinase A (PKA) activity (Gardner, L. A., Naren, A. P., and Bahouth, S. W. (2007) J. Biol. Chem. 282, 5085-5099). We explored the effects of point mutations in the PDZ and in the activity of PKA on recycling of the (1)-AR and its binding to the PDZ-binding protein SAP97. These studies indicated that (1)-AR recycling was inhibited by PKA inhibitors and by mutations in the PDZ that interfered with SAP97 binding. The trafficking effects of short sequences differing in PDZ and SAP97 binding were examined using chimeric mutant (1)-AR. (1)-AR chimera containing the type I PDZ of the (2)-adrenergic receptor that does not bind to SAP97 failed to recycle except when serine 312 was mutated to aspartic acid. (1)-AR chimera with type I PDZ sequences from the C-tails of aquaporin-2 or GluR1 recycled in a SAP97- and PKA-dependent manner. Non-PDZ (1)-AR chimera derived from -opioid, dopamine 1, or GluR2 receptors promoted rapid recycling of chimeric (1)-AR in a SAP97- and PKA-independent manner. Moreover, the nature of the residue at position -3 in the PDZ regulated whether the (1)-AR was internalized alone or in complex with SAP97. These results indicate that divergent pathways were involved in trafficking the (1)-AR and provide a roadmap for its trafficking via type I PDZs versus non-PDZs.	[Nooh, Mohammed M.; Chumpia, Maryanne M.; Hamilton, Thomas B.; Bahouth, Suleiman W.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; [Nooh, Mohammed M.] Cairo Univ, Dept Biochem, Fac Pharm, Cairo 11562, Egypt	University of Tennessee System; University of Tennessee Health Science Center; Egyptian Knowledge Bank (EKB); Cairo University	Bahouth, SW (corresponding author), Univ Tennessee HSC, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	sbahouth@uthsc.edu		Nooh, Mohammed/0000-0001-9794-4099	confocal microscopy unit at the NEI Vision Core (NEI, National Institutes of Health) [5P30EY13080-10]; NATIONAL EYE INSTITUTE [P30EY013080] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085848] Funding Source: NIH RePORTER	confocal microscopy unit at the NEI Vision Core (NEI, National Institutes of Health); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the confocal microscopy unit at the NEI Vision Core (NEI, National Institutes of Health, Grant 5P30EY13080-10, D. Johnson, principal investigator), the Molecular Resources Center for DNA sequencing, and Daniel Morse for figure preparation.	Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chu P, 1997, J BIOL CHEM, V272, P27124, DOI 10.1074/jbc.272.43.27124; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dunn HA, 2013, J BIOL CHEM, V288, P15023, DOI 10.1074/jbc.M113.473660; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Fredericks ZL, 1996, J BIOL CHEM, V271, P13796, DOI 10.1074/jbc.271.23.13796; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Gardner LA, 2004, J BIOL CHEM, V279, P21135, DOI 10.1074/jbc.M313652200; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; Gardner LA, 2006, J BIOL CHEM, V281, P33537, DOI 10.1074/jbc.M601809200; Gardner LA, 2011, CELL SIGNAL, V23, P46, DOI 10.1016/j.cellsig.2010.07.020; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; Heydorn A, 2004, J BIOL CHEM, V279, P54291, DOI 10.1074/jbc.M406169200; Hu LA, 2002, J BIOL CHEM, V277, P1607, DOI 10.1074/jbc.M107297200; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Katsura T, 1997, AM J PHYSIOL-RENAL, V272, pF816; Klussmann E, 1999, J BIOL CHEM, V274, P4934, DOI 10.1074/jbc.274.8.4934; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Li X, 2013, J BIOL CHEM, V288, P33797, DOI 10.1074/jbc.M113.470559; Liu Y, 2007, BIOCHEMISTRY-US, V46, P10864, DOI 10.1021/bi700879k; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Magalhaes AC, 2010, NAT NEUROSCI, V13, P622, DOI 10.1038/nn.2529; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; MARSH EW, 1995, J CELL BIOL, V129, P1509, DOI 10.1083/jcb.129.6.1509; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Naim E, 2005, KIDNEY INT, V68, P955, DOI 10.1111/j.1523-1755.2005.00489.x; Nisar SP, 2012, J BIOL CHEM, V287, P24505, DOI 10.1074/jbc.M112.347104; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Nooh MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063379; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Penn RB, 1999, J PHARMACOL EXP THER, V288, P428; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Seibold A, 2000, MOL PHARMACOL, V58, P1162, DOI 10.1124/mol.58.5.1162; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Signoret N, 2000, J CELL BIOL, V151, P1281, DOI 10.1083/jcb.151.6.1281; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Tanowitz M, 2003, J BIOL CHEM, V278, P45978, DOI 10.1074/jbc.M304504200; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Tran TM, 2007, BIOCHEMISTRY-US, V46, P14438, DOI 10.1021/bi700922h; Valentine CD, 2011, MOL BIOL CELL, V22, P2970, DOI 10.1091/mbc.E11-01-0034; Vargas GA, 2004, J BIOL CHEM, V279, P37461, DOI 10.1074/jbc.M401034200; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; von Ossowski I, 2006, FEBS J, V273, P5219, DOI 10.1111/j.1742-4658.2006.05521.x; Zhou WG, 2008, J NEUROSCI, V28, P10220, DOI 10.1523/JNEUROSCI.3434-08.2008	52	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2277	2294		10.1074/jbc.M113.513481	http://dx.doi.org/10.1074/jbc.M113.513481			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24324269	hybrid, Green Published			2022-12-25	WOS:000331130200033
J	Boltz, A; Told, R; Napora, KJ; Palkovits, S; Werkmeister, RM; Schmidl, D; Popa-Cherecheanu, A; Garhofer, G; Schmetterer, L				Boltz, Agnes; Told, Reinhard; Napora, Katarzyna J.; Palkovits, Stefan; Werkmeister, Rene M.; Schmidl, Doreen; Popa-Cherecheanu, Alina; Garhoefer, Gerhard; Schmetterer, Leopold			Optic Nerve Head Blood Flow Autoregulation during Changes in Arterial Blood Pressure in Healthy Young Subjects	PLOS ONE			English	Article							OCULAR PERFUSION-PRESSURE; LASER-DOPPLER FLOWMETRY; OPEN-ANGLE GLAUCOMA; ISOMETRIC-EXERCISE; NITRIC-OXIDE; INTRAOCULAR-PRESSURE; HUMANS; REPRODUCIBILITY; CIRCULATION; PARAMETERS	Aim: In the present study the response of optic nerve head blood flow to an increase in ocular perfusion pressure during isometric exercise was studied. Based on our previous studies we hypothesized that subjects with an abnormal blood flow response, defined as a decrease in blood flow of more than 10% during or after isometric exercise, could be identified. Methods: A total of 40 healthy subjects were included in this study. Three periods of isometric exercise were scheduled, each consisting of 2 minutes of handgripping. Optic nerve head blood flow was measured continuously before, during and after handgripping using laser Doppler flowmetry. Blood pressure was measured non-invasively in one-minute intervals. Intraocular pressure was measured at the beginning and the end of the measurements and ocular perfusion pressure was calculated as 2/3* mean arterial pressure -intraocular pressure. Results: Isometric exercise was associated with an increase in ocular perfusion pressure during all handgripping periods (p < 0.001). By contrast no change in optic nerve head blood flow was seen. However, in a subgroup of three subjects blood flow showed a consistent decrease of more than 10% during isometric exercise although their blood pressure values increased. In addition, three other subjects showed a consistent decline of blood flow of more than 10% during the recovery periods. Conclusion: Our data confirm previous results indicating that optic nerve head blood flow is autoregulated during an increase in perfusion pressure. In addition, we observed a subgroup of 6 subjects (15%) that showed an abnormal response, which is in keeping with our previous data. The mechanisms underlying this abnormal response remain to be shown.	[Boltz, Agnes; Told, Reinhard; Napora, Katarzyna J.; Palkovits, Stefan; Schmidl, Doreen; Garhoefer, Gerhard; Schmetterer, Leopold] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria; [Boltz, Agnes; Told, Reinhard; Napora, Katarzyna J.; Werkmeister, Rene M.; Schmidl, Doreen; Schmetterer, Leopold] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Popa-Cherecheanu, Alina] Emergency Univ Hosp, Dept Ophthalmol, Bucharest, Romania	Medical University of Vienna; Medical University of Vienna	Schmetterer, L (corresponding author), Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria.	leopold.schmetterer@meduniwien.ac.at		Schmetterer, Leopold/0000-0002-7189-1707; Schmidl, Doreen/0000-0001-5664-7768; Told, Reinhard/0000-0003-2046-7081; Popa-Cherecheanu, Alina/0000-0003-4189-6571	Austrian Science Fund (FWF) [P21406]; Austrian Science Fund (FWF) [P 21406] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The present study was supported by the Austrian Science Fund (FWF, project number P21406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTKO JJ, 1976, J NERV MENT DIS, V163, P307, DOI 10.1097/00005053-197611000-00003; Boltz A, 2013, AM J PHYSIOL-HEART C, V304, pH170, DOI 10.1152/ajpheart.00408.2012; Cherecheanu AP, 2013, CURR OPIN PHARMACOL, V13, P36, DOI 10.1016/j.coph.2012.09.003; Ciulla TA, 2002, ACTA OPHTHALMOL SCAN, V80, P468, DOI 10.1034/j.1600-0420.2002.800503.x; Claassen JAHR, 2011, J CEREBR BLOOD F MET, V31, P1572, DOI 10.1038/jcbfm.2011.69; Costa VP, 2009, BRIT J OPHTHALMOL, V93, P1276, DOI 10.1136/bjo.2008.149047; Feigl B, 2009, PROG RETIN EYE RES, V28, P63, DOI 10.1016/j.preteyeres.2008.11.004; Flammer J, 2008, CAN J OPHTHALMOL, V43, P317, DOI 10.3129/i08-056; Fuchsjager-Mayrl G, 2003, INVEST OPHTH VIS SCI, V44, P728, DOI 10.1167/iovs.02-0372; He Z, 2011, CLIN EXP OPTOM, V94, P133, DOI 10.1111/j.1444-0938.2010.00564.x; Iester M, 2007, OPHTHALMOLOGICA, V221, P180, DOI 10.1159/000099298; Kur J, 2012, PROG RETIN EYE RES, V31, P377, DOI 10.1016/j.preteyeres.2012.04.004; Leske MC, 2009, CURR OPIN OPHTHALMOL, V20, P73, DOI 10.1097/ICU.0b013e32831eef82; Liang Y, 2010, EXP EYE RES, V90, P203, DOI 10.1016/j.exer.2009.10.009; Luksch A, 2003, INVEST OPHTH VIS SCI, V44, P734, DOI 10.1167/iovs.02-0177; Luksch A, 2009, ACTA OPHTHALMOL, V87, P875, DOI 10.1111/j.1755-3768.2008.01388.x; Mackenzie PJ, 2008, CAN J OPHTHALMOL, V43, P308, DOI 10.3129/i08-042; Moore D, 2008, CLIN OPHTHALMOL, V2, P849; Movaffaghy A, 1998, EXP EYE RES, V67, P561, DOI 10.1006/exer.1998.0556; Okuno T, 2002, INVEST OPHTH VIS SCI, V43, P784; Pemp B, 2008, CAN J OPHTHALMOL, V43, P295, DOI 10.3129/i08-049; Pillunat LE, 1997, EXP EYE RES, V64, P737, DOI 10.1006/exer.1996.0263; Piper C, 2013, INVEST OPHTH VIS SCI, V54, P714, DOI 10.1167/iovs.12-9773; Polak K, 2007, ARCH OPHTHALMOL-CHIC, V125, P494, DOI 10.1001/archopht.125.4.494; Polska E, 2004, BRIT J OPHTHALMOL, V88, P533, DOI 10.1136/bjo.2003.028480; Polska E, 2007, INVEST OPHTH VIS SCI, V48, P3768, DOI 10.1167/iovs.07-0307; Portmann N, 2011, INVEST OPHTH VIS SCI, V52, P7068, DOI 10.1167/iovs.11-7758; Riva CE, 1997, GRAEF ARCH CLIN EXP, V235, P618, DOI 10.1007/BF00946937; RIVA CE, 1992, EXP EYE RES, V55, P499, DOI 10.1016/0014-4835(92)90123-A; Riva CE, 2010, ACTA OPHTHALMOL, V88, P622, DOI 10.1111/j.1755-3768.2009.01621.x; ROBINSON F, 1986, INVEST OPHTH VIS SCI, V27, P722; Schmetterer L, 1998, INVEST OPHTH VIS SCI, V39, P1210; Schmidl D, 2013, INVEST OPHTH VIS SCI, V54, P1964, DOI 10.1167/iovs.12-11406; Schmidl D, 2012, INVEST OPHTH VIS SCI, V53, P4337, DOI 10.1167/iovs.11-9055; Schmidl D, 2011, EXP EYE RES, V93, P141, DOI 10.1016/j.exer.2010.09.002; Shibata M, 2012, INVEST OPHTH VIS SCI, V53, P3726, DOI 10.1167/iovs.11-9316; Shiga Y, 2013, CURR EYE RES, V38, P691, DOI 10.3109/02713683.2012.758292; Takayama H, 2003, CIRC J, V67, P1046, DOI 10.1253/circj.67.1046; Toda N, 2007, PROG RETIN EYE RES, V26, P205, DOI 10.1016/j.preteyeres.2007.01.004; Tzeng YC, 2013, EUR J APPL PHYSL; Weigert G, 2005, OPHTHALMOLOGY, V112, P1337, DOI 10.1016/j.ophtha.2005.03.016; WOLZT M, 1995, BRIT J CLIN PHARMACO, V39, P347, DOI 10.1111/j.1365-2125.1995.tb04462.x	42	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82351	10.1371/journal.pone.0082351	http://dx.doi.org/10.1371/journal.pone.0082351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324774	gold, Green Published, Green Submitted			2022-12-25	WOS:000328566700071
J	Chiara, M; Horner, DS; Spada, A				Chiara, Matteo; Horner, David S.; Spada, Alberto			De Novo Assembly of the Transcriptome of the Non-Model Plant Streptocarpus rexii Employing a Novel Heuristic to Recover Locus-Specific Transcript Clusters	PLOS ONE			English	Article							MORPHOLOGICAL NOVELTY; GROWTH-PATTERNS; LARGE SETS; EVOLUTION; OPTIMIZATION	De novo transcriptome characterization from Next Generation Sequencing data has become an important approach in the study of non-model plants. Despite notable advances in the assembly of short reads, the clustering of transcripts into unigene-like (locus-specific) clusters remains a somewhat neglected subject. Indeed, closely related paralogous transcripts are often merged into single clusters by current approaches. Here, a novel heuristic method for locus-specific clustering is compared to that implemented in the de novo assembler Oases, using the same initial transcript collections, derived from Arabidopsis thaliana and the developmental model Streptocarpus rexii. We show that the proposed approach improves cluster specificity in the A. thaliana dataset for which the reference genome is available. Furthermore, for the S. rexii data our filtered transcript collection matches a larger number of distinct annotated loci in reference genomes than the Oases set, while containing a reduced overall number of loci. A detailed discussion of advantages and limitations of our approach in processing de novo transcriptome reconstructions is presented. The proposed method should be widely applicable to other organisms, irrespective of the transcript assembly method employed. The S. rexii transcriptome is available as a sophisticated and augmented publicly available online database.	[Chiara, Matteo; Horner, David S.] Univ Milan, Dipartimento Biosci, Milan, Italy; [Spada, Alberto] Univ Milan, Dipartimento Sci Agr & Ambientali Prod, Milan, Italy	University of Milan; University of Milan	Horner, DS (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	David.Horner@unimi.it	Horner, David/AAC-2274-2022; spada, alberto/I-9005-2017	spada, alberto/0000-0001-7665-0446; CHIARA, MATTEO/0000-0003-3983-4961				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bombarely A, 2011, NUCLEIC ACIDS RES, V39, pD1149, DOI 10.1093/nar/gkq866; Clarke K, 2013, SCI CHINA LIFE SCI, V56, P156, DOI 10.1007/s11427-013-4444-x; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haznedaroglu BZ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-170; JONG K, 1975, NEW PHYTOL, V75, P297, DOI 10.1111/j.1469-8137.1975.tb01400.x; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Moller M, 2001, EVOLUTION, V55, P918, DOI 10.1554/0014-3820(2001)055[0918:EOMNAP]2.0.CO;2; Nishii K, 2007, PLANT SYST EVOL, V265, P135, DOI 10.1007/s00606-007-0515-4; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; Qu WB, 2012, NUCLEIC ACIDS RES, V40, pW205, DOI 10.1093/nar/gks552; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Rozen S, 2000, Methods Mol Biol, V132, P365; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Syed NH, 2012, TRENDS PLANT SCI, V17, P616, DOI 10.1016/j.tplants.2012.06.001; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang JS, 2010, J SYST EVOL, V48, P94, DOI 10.1111/j.1759-6831.2010.00066.x; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	23	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e80961	10.1371/journal.pone.0080961	http://dx.doi.org/10.1371/journal.pone.0080961			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324652	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700024
J	Kotyuk, E; Keszler, G; Nemeth, N; Ronai, Z; Sasvari-Szekely, M; Szekely, A				Kotyuk, Eszter; Keszler, Gergely; Nemeth, Nora; Ronai, Zsolt; Sasvari-Szekely, Maria; Szekely, Anna			Glial Cell Line-Derived Neurotrophic Factor (GDNF) as a Novel Candidate Gene of Anxiety	PLOS ONE			English	Article							GENDER-DIFFERENCES; DEPRESSION SCALE; HOSPITAL ANXIETY; HAPLOTYPE RECONSTRUCTION; GLN460ARG POLYMORPHISM; ASSOCIATION ANALYSIS; BIPOLAR DISORDER; RECEPTOR GENE; VARIANTS; SCHIZOPHRENIA	Glial cell line-derived neurotrophic factor (GDNF) is a neurotrophic factor for dopaminergic neurons with promising therapeutic potential in Parkinson's disease. A few association analyses between GDNF gene polymorphisms and psychiatric disorders such as schizophrenia, attention deficit hyperactivity disorder and drug abuse have also been published but little is known about any effects of these polymorphisms on mood characteristics such as anxiety and depression. Here we present an association study between eight (rs1981844, rs3812047, rs3096140, rs2973041, rs2910702, rs1549250, rs2973050 and rs11111) GDNF single nucleotide polymorphisms (SNPs) and anxiety and depression scores measured by the Hospital Anxiety and Depression Scale (HADS) on 708 Caucasian young adults with no psychiatric history. Results of the allele-wise single marker association analyses provided significant effects of two single nucleotide polymorphisms on anxiety scores following the Bonferroni correction for multiple testing (p = 0.00070 and p = 0.00138 for rs3812047 and rs3096140, respectively), while no such result was obtained on depression scores. Haplotype analysis confirmed the role of these SNPs; mean anxiety scores raised according to the number of risk alleles present in the haplotypes (p = 0.00029). A significant sexgene interaction was also observed since the effect of the rs3812047 A allele as a risk factor of anxiety was more pronounced in males. In conclusion, this is the first demonstration of a significant association between the GDNF gene and mood characteristics demonstrated by the association of two SNPs of the GDNF gene (rs3812047 and rs3096140) and individual variability of anxiety using self-report data from a non-clinical sample.	[Kotyuk, Eszter] Eotvos Lorand Univ, Doctoral Sch Psychol, Budapest, Hungary; [Kotyuk, Eszter; Szekely, Anna] Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary; [Keszler, Gergely; Nemeth, Nora; Ronai, Zsolt; Sasvari-Szekely, Maria] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand University; Semmelweis University	Szekely, A (corresponding author), Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary.	szekely.anna@ppk.elte.hu	Kotyuk, Eszter/K-3116-2018; Ronai, Zsolt/A-2473-2008	Kotyuk, Eszter/0000-0002-6630-087X; Ronai, Zsolt/0000-0002-0909-7932	Hungarian Scientific Research Funds [OTKA K81466, K100845]; Active Psychology Foundation	Hungarian Scientific Research Funds(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Active Psychology Foundation	The Hungarian Scientific Research Funds (OTKA K81466 and K100845) and the Active Psychology Foundation has provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadiantehrani S, 2013, J NEUROCHEM; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Alonso P, 2013, J ANXIETY DISORD, V27, P321, DOI 10.1016/j.janxdis.2013.02.012; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Boor K, 2002, CURR MED CHEM, V9, P793, DOI 10.2174/0929867024606821; BRESLAU N, 1995, EPIDEMIOL REV, V17, P96, DOI 10.1093/oxfordjournals.epirev.a036191; Cardoner N, 2013, DEPRESS ANXIETY, V30, P225, DOI 10.1002/da.22025; Cass WA, 2006, ANN NY ACAD SCI, V1074, P272, DOI 10.1196/annals.1369.024; Conway KP, 2006, J CLIN PSYCHIAT, V67, P247, DOI 10.4088/JCP.v67n0211; Diniz BS, 2012, J PSYCHIATR RES, V46, P135, DOI 10.1016/j.jpsychires.2011.09.007; Everitt B. S., 2002, CAMBRIDGE DICT STAT; Faludi Gabor, 2012, Neuropsychopharmacol Hung, V14, P221; Farrell M, 2001, BRIT J PSYCHIAT, V179, P432, DOI 10.1192/bjp.179.5.432; FEINGOLD A, 1994, PSYCHOL BULL, V116, P429, DOI 10.1037/0033-2909.116.3.429; Furukawa TA, 2010, J PSYCHOSOM RES, V68, P581, DOI 10.1016/j.jpsychores.2009.05.003; Golan M, 2011, INT J NEUROPSYCHOPH, V14, P1289, DOI 10.1017/S1461145710001550; Granholm AC, 2000, J NEUROSCI, V20, P3182, DOI 10.1523/JNEUROSCI.20-09-03182.2000; Greenwood TA, 2001, AM J MED GENET, V105, P145, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1161>3.0.CO;2-8; Grimm L, 1998, HUM MOL GENET, V7, P1873, DOI 10.1093/hmg/7.12.1873; Halbreich U, 1997, PSYCHOPHARMACOL BULL, V33, P281; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; Hejjas K, 2009, AM J MED GENET B, V150B, P295, DOI 10.1002/ajmg.b.30799; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; HUDSON J, 1995, BRAIN RES BULL, V36, P425, DOI 10.1016/0361-9230(94)00224-O; Kralovicova J, 2006, DIABETES, V55, P260, DOI 10.2337/diabetes.55.01.06.db05-0773; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; Lasky-Su J, 2008, AM J MED GENET B, V147B, P1345, DOI 10.1002/ajmg.b.30867; Lee KB, 2001, PSYCHIAT RES, V104, P11, DOI 10.1016/S0165-1781(01)00294-3; Lewinsohn PM, 1998, J ABNORM PSYCHOL, V107, P109, DOI 10.1037/0021-843X.107.1.109; Liu Q, 2012, J AFFECT DISORDERS, V141, P367, DOI 10.1016/j.jad.2012.03.018; Lonka-Nevalaita L, 2010, J NEUROSCI, V30, P11403, DOI 10.1523/JNEUROSCI.5888-09.2010; Lopez-Urrutia E, 2012, VIRUS RES, V166, P43, DOI 10.1016/j.virusres.2012.02.026; McGuffin P, 1996, ARCH GEN PSYCHIAT, V53, P129; Michel TM, 2008, EUR PSYCHIAT, V23, P413, DOI 10.1016/j.eurpsy.2008.06.001; Michelato A, 2004, NEUROSCI LETT, V357, P235, DOI 10.1016/j.neulet.2003.12.089; Moyer RA, 2011, NEUROPSYCHOPHARMACOL, V36, P753, DOI 10.1038/npp.2010.208; Muinos-Gimeno M, 2009, HUM MUTAT, V30, P1062, DOI 10.1002/humu.21005; Muszbek K, 2006, QUAL LIFE RES, V15, P761, DOI 10.1007/s11136-005-3627-8; Nagy G, 2008, PROG NEURO-PSYCHOPH, V32, P1884, DOI 10.1016/j.pnpbp.2008.08.021; Nitta A, 2004, J NEUROSCI RES, V78, P250, DOI 10.1002/jnr.20258; Pandaranayaka PJE, 2010, MOL VIS, V16, P2891; Pigott TA, 1999, J CLIN PSYCHIAT, V60, P4; Rosa AR, 2006, NEUROSCI LETT, V407, P146, DOI 10.1016/j.neulet.2006.08.026; Serretti A, 2001, AM J MED GENET, V105, P283, DOI 10.1002/ajmg.1321; Serretti A, 1999, AM J MED GENET, V88, P294, DOI 10.1002/(SICI)1096-8628(19990820)88:4<294::AID-AJMG2>3.0.CO;2-H; Shalev I, 2009, PSYCHONEUROENDOCRINO, V34, P382, DOI 10.1016/j.psyneuen.2008.09.017; Smarr KL, 2011, ARTHRIT CARE RES, V63, pS454, DOI 10.1002/acr.20556; Stein MB, 1999, AM J PSYCHIAT, V156, P246; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stephens M., 2003, DOCUMENTATION PHASE; Suarez BK, 2006, AM J HUM GENET, V78, P315, DOI 10.1086/500272; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Syed Z, 2007, AM J MED GENET B, V144B, P375, DOI 10.1002/ajmg.b.30459; Tseng PT, 2013, PROG NEURO-PSYCHOPH, V40, P334, DOI 10.1016/j.pnpbp.2012.09.009; Uchida S, 2011, NEURON, V69, P359, DOI 10.1016/j.neuron.2010.12.023; Wang XQ, 2011, J AFFECT DISORDERS, V132, P418, DOI 10.1016/j.jad.2011.03.043; Williams HJ, 2007, SCHIZOPHR RES, V97, P271, DOI 10.1016/j.schres.2007.09.004; Yoshimura T, 2011, PROG NEURO-PSYCHOPH, V35, P1268, DOI 10.1016/j.pnpbp.2011.04.003; Zhang XB, 2010, J AFFECT DISORDERS, V126, P326, DOI 10.1016/j.jad.2010.03.003; Zigmond AS, 1983, PSYCHIAT SCAND, V76, P361, DOI [DOI 10.1111/J.1600-0447.1983.TB09716.X, DOI 10.1111/J.1600-0447.1983.TB09716.X.PUBMED:6880820]	62	25	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e80613	10.1371/journal.pone.0080613	http://dx.doi.org/10.1371/journal.pone.0080613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324616	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700012
J	Minharro, S; Mol, JPS; Dorneles, EMS; Pauletti, RB; Neubauer, H; Melzer, F; Poester, FP; Dasso, MG; Pinheiro, ES; Soares, PM; Santos, RL; Heinemann, MB; Lage, AP				Minharro, Silvia; Silva Mol, Juliana P.; Dorneles, Elaine M. S.; Pauletti, Rebeca B.; Neubauer, Heinrich; Melzer, Falk; Poester, Fernando P.; Dasso, Mauricio G.; Pinheiro, Elaine S.; Soares Filho, Paulo M.; Santos, Renato L.; Heinemann, Marcos B.; Lage, Andrey P.			Biotyping and Genotyping (MLVA16) of Brucella abortus Isolated from Cattle in Brazil, 1977 to 2008	PLOS ONE			English	Article							MELITENSIS; IDENTIFICATION; STRAINS; PCR	Brucellosis is a worldwide distributed zoonosis that causes important economic losses to animal production. In Brazil, information on the distribution of biovars and genotypes of Brucella spp. is scarce or unavailable. This study aimed (i) to biotype and genotype 137 Brazilian cattle isolates (from 1977 to 2008) of B. abortus and (ii) to analyze their distribution. B. abortus biovars 1, 2 and 3 (subgroup 3b) were confirmed and biovars 4 and 6 were first described in Brazil. Genotyping by the panel 1 revealed two groups, one clustering around genotype 40 and another around genotype 28. Panels 2A and 2B disclosed a high diversity among Brazilian B. abortus strains. Eighty-nine genotypes were found by MLVA16. MLVA16 panel 1 and 2 showed geographic clustering of some genotypes. Biotyping and MLVA16 genotyping of Brazilian B. abortus isolates were useful to better understand the epidemiology of bovine brucellosis in the region.	[Minharro, Silvia; Silva Mol, Juliana P.; Dorneles, Elaine M. S.; Pauletti, Rebeca B.; Poester, Fernando P.; Heinemann, Marcos B.; Lage, Andrey P.] Univ Fed Minas Gerais, Dept Vet Prevent Med, Escola Vet, Belo Horizonte, MG, Brazil; [Minharro, Silvia] Univ Fed Tocantins, Escola Med Vet & Zootecnia, Araguaina, Tocantins, Brazil; [Neubauer, Heinrich; Melzer, Falk] Inst Bakterielle Infektionen & Zoonosen, Friedrich Loeffler Inst, Bundesforschungsinst Tiergesundheit, Jena, Germany; [Dasso, Mauricio G.] Fundacao Estadual Pesquisa Agr, Inst Pesquisas Vet Desiderio Finamor, Eldorado Do Sul, RS, Brazil; [Pinheiro, Elaine S.] Ctr Pesquisa & Desenvolvimento Sanidade Anim, Inst Biol, Sao Paulo, Brazil; [Soares Filho, Paulo M.] Minist Agr Pecuaria & Abastecimento, Lab Nacl Agr, Pedro Leopoldo, MG, Brazil; [Santos, Renato L.] Univ Fed Minas Gerais, Dept Clin & Cirurgia Vet, Escola Vet, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal do Tocantins (UFT); Friedrich Loeffler Institute; Universidade de Sao Paulo; Universidade Federal de Minas Gerais	Lage, AP (corresponding author), Univ Fed Minas Gerais, Dept Vet Prevent Med, Escola Vet, Belo Horizonte, MG, Brazil.	alage@vet.ufmg.br	Heinemann, Marcos B/G-2780-2015; Dorneles, Elaine/J-1115-2016; Heinemann, Marcos Bryan/AAI-9390-2020; de Lima Santos, Renato/A-1134-2008; Dorneles, Elaine/V-2816-2019; Pinheiro, Eliana ESP Scarcelli/K-1005-2013; Minharro, Silvia SM/K-9933-2015; Pinheiro, Eliana/AIC-8924-2022	Heinemann, Marcos B/0000-0001-6444-9788; Heinemann, Marcos Bryan/0000-0001-6444-9788; de Lima Santos, Renato/0000-0002-4830-0470; Dorneles, Elaine/0000-0002-2753-1296; Pinheiro, Eliana ESP Scarcelli/0000-0003-4142-6983; Pinheiro, Eliana/0000-0003-4142-6983; Mol, Juliana/0000-0002-6946-8213; Minharro, Silvia/0000-0001-5844-5326	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais Fapemig; Fundacao de Estudo e Pesquisa em Medicina Veterinaria e Zootecnia FEP-MVZ; CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais Fapemig(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Estudo e Pesquisa em Medicina Veterinaria e Zootecnia FEP-MVZ; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais Fapemig and Fundacao de Estudo e Pesquisa em Medicina Veterinaria e Zootecnia FEP-MVZ. Silvia Minharro, Juliana P. S. Mol, Elaine M. S. Dorneles, Rebeca B. Pauletti, Marcos B. Heinemann, Renato L. Santos and Andrey P. Lage had fellowships from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2007, J MICROBIOL METH, V69, P137, DOI 10.1016/j.mimet.2006.12.015; Alvarez J, 2011, RES VET SCI, V90, P208, DOI 10.1016/j.rvsc.2010.05.028; BAILY GG, 1992, J TROP MED HYG, V95, P271; BANAI M, 1990, J CLIN MICROBIOL, V28, P1057, DOI 10.1128/JCM.28.5.1057-1059.1990; BRICKER BJ, 1994, J CLIN MICROBIOL, V32, P2660, DOI 10.1128/JCM.32.11.2660-2666.1994; Bricker BJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-37; Bricker BJ, 2002, VET MICROBIOL, V90, P433, DOI 10.1016/S0378-1135(02)00227-4; Cespedes S, 2011, J CLIN MICROBIOL, V49, P2461, DOI 10.1128/JCM.01176-10; CLOECKAERT A, 1995, MICROBIOL-UK, V141, P2111, DOI 10.1099/13500872-141-9-2111; Cloeckaert A, 2003, MICROBES INFECT, V5, P593, DOI 10.1016/S1286-4579(03)00091-1; Corbel M.J., 2006, BRUCELLOSIS HUMANS A; CORBEL MJ, 1991, J CLIN MICROBIOL, V29, P1066, DOI 10.1128/JCM.29.5.1066-1068.1991; Ferreira AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042514; GARCIA MM, 1988, CAN J VET RES, V52, P338; Garcia-Carillo D, 1972, REV LAT AM MICROBIOL, V14, P117; Garcia-Yoldi D, 2007, VACCINE, V25, P2858, DOI 10.1016/j.vaccine.2006.09.063; Garin-Baastuji B., 1993, Point Veterinaire, V25, P107; GIORGI W, 1972, Revista de Microbiologia, V3, P39; Her M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-230; Hirsh DC, 2003, MICROBIOLOGIA VET, P191; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Langoni H., 2000, Brazilian Journal of Veterinary Research and Animal Science, V37, P444; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Lucero NE, 2008, EPIDEMIOL INFECT, V136, P496, DOI 10.1017/S0950268807008795; Luna-Martinez JE, 2002, VET MICROBIOL, V90, P19, DOI 10.1016/S0378-1135(02)00241-9; Mac Faddin JF, 1980, PRUEBAS BIOQUIMICAS; Marianelli C, 2008, J HOSP INFECT, V68, P274, DOI 10.1016/j.jhin.2008.01.003; Megid J, 2005, VET REC, V156, P147, DOI 10.1136/vr.156.5.147; Ocampo-Sosa AA, 2005, VET MICROBIOL, V110, P41, DOI 10.1016/j.vetmic.2005.06.007; Poester FP, 2002, VET MICROBIOL, V90, P55, DOI 10.1016/S0378-1135(02)00245-6; Ragan VE, 2002, VET MICROBIOL, V90, P11, DOI 10.1016/S0378-1135(02)00240-7; rasil Secretaria de Defesa Agropecuaria Ministerio da Agricultura Pecuaria e Abastecimento, 2004, INSTR NORM 6 8 JAN 2, P6; Renukaradhya GJ, 2002, VET MICROBIOL, V90, P183, DOI 10.1016/S0378-1135(02)00253-5; Valdezate S, 2010, J CLIN MICROBIOL, V48, P2734, DOI 10.1128/JCM.00533-10; Vercesi Filho A. E., 2002, Archivos Latinoamericanos de Produccion Animal, V10, P86; VERGER JM, 1985, INT J SYST BACTERIOL, V35, P292, DOI 10.1099/00207713-35-3-292; Verger JM, 1988, TECHNIQUES BRUCELLOS; Whatmore AM, 2006, J CLIN MICROBIOL, V44, P1982, DOI 10.1128/JCM.02039-05; Whatmore AM, 2009, INFECT GENET EVOL, V9, P1168, DOI 10.1016/j.meegid.2009.07.001	39	22	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81152	10.1371/journal.pone.0081152	http://dx.doi.org/10.1371/journal.pone.0081152			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324670	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700032
J	Svedenkrans, J; Henckel, E; Kowalski, J; Norman, M; Bohlin, K				Svedenkrans, Jenny; Henckel, Ewa; Kowalski, Jan; Norman, Mikael; Bohlin, Kajsa			Long-Term Impact of Preterm Birth on Exercise Capacity in Healthy Young Men: A National Population-Based Cohort Study	PLOS ONE			English	Article							HIGHER BLOOD-PRESSURE; PHYSICAL-ACTIVITY; PULMONARY-FUNCTION; AEROBIC CAPACITY; CHILDREN BORN; WEIGHT; MORTALITY; FITNESS; AGE; PERFORMANCE	Background: Increasing numbers of survivors of preterm birth are growing into adulthood today. Long-term health-effects of prematurity are still poorly understood, but include increased risk for diabetes, obesity and cardiovascular diseases in adult life. To test if reduced physical fitness may be a link in the causal chain of preterm birth and diseases in later life, the association of preterm birth and adult exercise capacity was investigated. The hypothesis was that preterm birth contributes independently of other risk factors to lower physical fitness in adulthood. Methods and Findings: Population-based national cohort study of all males conscripting for military service in 1993-2001 and born in Sweden 1973-1983, n = 218,820. Data were retrieved from the Swedish Conscript Register, the Medical Birth Register and the Population and Housing Census 1990. Primary outcome was the results from maximal exercise test (W-max in Watt) performed at conscription. Association to perinatal and socioeconomic risk factors, other co-variates and confounders were analysed. General linear modelling showed that preterm birth predicted low W-max in a dose-response related pattern, with 25 Watt reduction in W-max for the lowest gestational ages, those born <= 27 weeks. Low birth weight for gestational age also independently predicted low W-max compared to normal and high birth weight (32 Watt reduction for those with a birth weight Standard Deviation Score <2). Low parental education was significantly associated with reduced W-max (range 17 Watt), as well as both low and high current BMI, with severe obesity resulting in a 16 Watt deficit compared to W-max top performance. Conclusion: Being born preterm as well as being born small for gestational age predicts low exercise capacity in otherwise healthy young men. The effect size of being born preterm equal or exceed that of other known risk factors for unfitness in adults, such as low parental education and overweight.	[Svedenkrans, Jenny; Henckel, Ewa; Kowalski, Jan; Norman, Mikael; Bohlin, Kajsa] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Svedenkrans, Jenny; Henckel, Ewa; Norman, Mikael; Bohlin, Kajsa] Karolinska Univ Hosp Huddinge, Dept Neonatol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Bohlin, K (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	kajsa.bohlin@ki.se	Kowalski, Jan/HDM-3504-2022; Henckel, Ewa/AAD-3185-2019; Svedenkrans, Jenny/AAF-4982-2021	Henckel, Ewa/0000-0003-0775-1563; Norman, Mikael/0000-0003-4191-3781; Svedenkrans, Jenny/0000-0002-6194-5118	Swedish Heart Lung Foundation; Stockholm County Council; Karolinska Institutet; Stiftelsen Samariten	Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Stiftelsen Samariten	Funding to the authors during preparation of this work was received from Swedish Heart Lung Foundation, Stockholm County Council, Karolinska Institutet and Stiftelsen Samariten. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; [Anonymous], 2003, SWED MED BIRTH REG S; [Anonymous], 1992, POP HOUS CENS 1990 7; BARALDI E, 1991, EUR J PEDIATR, V150, P713, DOI 10.1007/BF01958761; Bassuk SS, 2005, J APPL PHYSIOL, V99, P1193, DOI 10.1152/japplphysiol.00160.2005; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Blennow M, 2009, JAMA-J AM MED ASSOC, V301, P2225, DOI 10.1001/jama.2009.771; Bonamy AKE, 2007, J INTERN MED, V262, P635, DOI 10.1111/j.1365-2796.2007.01868.x; Bonamy AKE, 2005, PEDIATR RES, V58, P845, DOI 10.1203/01.PDR.0000181373.29290.80; Clemm H, 2012, PEDIATRICS, V129, pE97, DOI 10.1542/peds.2011-0326; Crump C, 2011, JAMA-J AM MED ASSOC, V306, P1233, DOI 10.1001/jama.2011.1331; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; Finnstrom O, 1997, ACTA PAEDIATR, V86, P503, DOI 10.1111/j.1651-2227.1997.tb08921.x; Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960; Gross SJ, 1998, J PEDIATR-US, V133, P188, DOI 10.1016/S0022-3476(98)70219-7; Haapanen-Niemi N, 2000, INT J OBESITY, V24, P1465, DOI 10.1038/sj.ijo.0801426; Hack M, 2007, J PEDIATR-US, V151, P635, DOI 10.1016/j.jpeds.2007.04.063; Hackam DG, 2010, CAN J CARDIOL, V26, P249, DOI 10.1016/S0828-282X(10)70379-2; Hiscock R, 2012, J PUBLIC HEALTH-UK, V34, P390, DOI 10.1093/pubmed/fds012; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Hult M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013582; Johansson S, 2005, CIRCULATION, V112, P3430, DOI 10.1161/CIRCULATIONAHA.105.540906; Kaijser M, 2009, DIABETES, V58, P523, DOI 10.2337/db08-0558; Kajantie E, 2010, J PEDIATR-US, V157, P610, DOI 10.1016/j.jpeds.2010.04.002; Kilbride HW, 2003, J PEDIATR-US, V143, P488, DOI 10.1067/S0022-3476(03)00413-X; Kriemler S, 2005, CLIN J SPORT MED, V15, P349, DOI 10.1097/01.jsm.0000180023.44889.dd; LaMonte MJ, 2005, J APPL PHYSIOL, V99, P1205, DOI 10.1152/japplphysiol.00193.2005; Lewandowski AJ, 2013, CIRCULATION, V127, P197, DOI 10.1161/CIRCULATIONAHA.112.126920; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Moss TJM, 2006, CLIN EXP PHARMACOL P, V33, P280, DOI 10.1111/j.1440-1681.2006.04359.x; Nosarti C, 2012, ARCH GEN PSYCHIAT, V69, P610, DOI 10.1001/archgenpsychiatry.2011.1374; Parizkova J, 2008, BRIT J NUTR, V99, pS26, DOI 10.1017/S0007114508892483; Peacock JL, 2012, PEDIATR RES, V71, P305, DOI 10.1038/pr.2011.50; Rogers M, 2005, PEDIATRICS, V116, pE58, DOI 10.1542/peds.2004-1603; Ruiz JR, 2006, AM J CLIN NUTR, V84, P299; Saigal S, 2007, PEDIATRICS, V119, pE562, DOI 10.1542/peds.2006-2328; Schubert U, 2011, J DEV ORIG HLTH DIS, V2, P218, DOI 10.1017/S2040174411000274; Smith LJ, 2008, PEDIATRICS, V122, pE287, DOI 10.1542/peds.2007-3657; Sweden SC, 1982, 19824 MIS, P20; Thijssen DHJ, 2010, EUR J APPL PHYSIOL, V108, P845, DOI 10.1007/s00421-009-1260-x; Vrijlandt EJLE, 2006, AM J RESP CRIT CARE, V173, P890, DOI 10.1164/rccm.200507-1140OC; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Welsh L, 2010, THORAX, V65, P165, DOI 10.1136/thx.2008.107474	44	47	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e80869	10.1371/journal.pone.0080869	http://dx.doi.org/10.1371/journal.pone.0080869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324639	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700020
J	Bunse, CE; Borchers, S; Varanasi, PR; Tischer, S; Figueiredo, C; Immenschuh, S; Kalinke, U; Kohl, U; Goudeva, L; Maecker-Kolhoff, B; Ganser, A; Blasczyk, R; Weissinger, EM; Eiz-Vesper, B				Bunse, Carola E.; Borchers, Sylvia; Varanasi, Pavankumar R.; Tischer, Sabine; Figueiredo, Constanca; Immenschuh, Stephan; Kalinke, Ulrich; Koehl, Ulrike; Goudeva, Lilia; Maecker-Kolhoff, Britta; Ganser, Arnold; Blasczyk, Rainer; Weissinger, Eva M.; Eiz-Vesper, Britta			Impaired Functionality of Antiviral T Cells in G-CSF Mobilized Stem Cell Donors: Implications for the Selection of CTL Donor	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; VERSUS-HOST-DISEASE; EPSTEIN-BARR-VIRUS; BLOOD MONONUCLEAR-CELLS; BONE-MARROW; ADOPTIVE TRANSFER; CYTOMEGALOVIRUS-INFECTION; TRANSPLANTATION; THERAPY; RECONSTITUTION	Adoptive transfer of antiviral T cells enhances immune reconstitution and decreases infectious complications after stem cell transplantation. Information on number and function of antiviral T cells in stem cell grafts is scarce. We investigated (1) immunomodulatory effects of G-CSF on antiviral T cells, (2) the influence of apheresis, and (3) the optimal time point to collect antiviral cells. CMV-, EBV- and ADV-specific T cells were enumerated in 170 G-CSF-mobilized stem cell and 24 non-mobilized platelet donors using 14 HLA-matched multimers. T-cell function was evaluated by IFN-gamma ELISpot and granzyme B secretion. Immunophenotyping was performed by multicolor flow cytometry. G-CSF treatment did not significantly influence frequency of antiviral T cells nor their in vitro expansion rate upon antigen restimulation. However, T-cell function was significantly impaired, as expressed by a mean reduction in secretion of IFN-gamma (75% in vivo, 40% in vitro) and granzyme B (32% target-independent, 76% target-dependent) as well as CD107a expression (27%). Clinical follow up data indicate that the first CMV-reactivation in patients and with it the need for T-cell transfer occurs while the donor is still under the influence of G-CSF. To overcome these limitations, T-cell banking before mobilization or recruitment of third party donors might be an option to optimize T-cell production.	[Bunse, Carola E.; Tischer, Sabine; Figueiredo, Constanca; Immenschuh, Stephan; Goudeva, Lilia; Blasczyk, Rainer; Eiz-Vesper, Britta] Hannover Med Sch, Inst Transfus Med, Hannover, Germany; [Borchers, Sylvia; Varanasi, Pavankumar R.; Ganser, Arnold; Weissinger, Eva M.] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Kalinke, Ulrich] Ctr Expt & Clin Infect Res, TWINCORE, Inst Expt Infect Res, Hannover, Germany; [Koehl, Ulrike] Hannover Med Sch, Inst Cellular Therapeut, Hannover, Germany; [Maecker-Kolhoff, Britta] Hannover Med Sch, Dept Pediat Hematol & Oncol, Hannover, Germany; [Bunse, Carola E.; Borchers, Sylvia; Varanasi, Pavankumar R.; Tischer, Sabine; Koehl, Ulrike; Maecker-Kolhoff, Britta; Ganser, Arnold; Blasczyk, Rainer; Weissinger, Eva M.; Eiz-Vesper, Britta] Hannover Med Sch, IFB Tx, Integrated Res & Treatment Ctr Transplantat, Hannover, Germany	Hannover Medical School; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Hannover Medical School; Hannover Medical School	Eiz-Vesper, B (corresponding author), Hannover Med Sch, Inst Transfus Med, Hannover, Germany.	eiz-vesper.britta@mh-hannover.de	Varanasi, Pavankumar/AGP-6339-2022; Immenschuh, Stephan/AAM-9181-2020; Maecker-Kolhoff, Britta/AFV-1492-2022	Varanasi, Pavankumar/0000-0003-4658-0453; Immenschuh, Stephan/0000-0003-3722-5791; Kalinke, Ulrich/0000-0003-0503-9564; Koehl, Ulrike/0000-0002-8159-9160; Blasczyk, Rainer/0000-0003-3875-3190	Integrated Research and Treatment Center Transplantation (IFB-Tx); German Federal Ministry of Education and Research [01EO0802]; Hannover Biomedical Research School (HBRS); PhD program "Molecular Medicine"; Ministry of Education and Research (DZIF); German Children's Cancer Research Fund (Deutsche Kinderkrebshilfe); Immunotherapy Foundation (Stiftung Immuntherapie)	Integrated Research and Treatment Center Transplantation (IFB-Tx); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Hannover Biomedical Research School (HBRS); PhD program "Molecular Medicine"; Ministry of Education and Research (DZIF); German Children's Cancer Research Fund (Deutsche Kinderkrebshilfe); Immunotherapy Foundation (Stiftung Immuntherapie)	This work is supported in part by funding from the Integrated Research and Treatment Center Transplantation (IFB-Tx) funded by the German Federal Ministry of Education and Research (reference number: 01EO0802), the Hannover Biomedical Research School (HBRS) and the PhD program "Molecular Medicine", the Ministry of Education and Research (DZIF), the German Children's Cancer Research Fund (Deutsche Kinderkrebshilfe), and the Immunotherapy Foundation (Stiftung Immuntherapie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Alanio C, 2010, BLOOD, V115, P3718, DOI 10.1182/blood-2009-10-251124; Amrein K, 2012, BLOOD REV, V26, P33, DOI 10.1016/j.blre.2011.09.003; Anasetti C, 2012, NEW ENGL J MED, V367, P1487, DOI 10.1056/NEJMoa1203517; Arpinati M, 2000, BLOOD, V95, P2484, DOI 10.1182/blood.V95.8.2484; Baldomero H, 2011, BONE MARROW TRANSPL, V46, P485, DOI 10.1038/bmt.2011.11; Bensinger WI, 2001, NEW ENGL J MED, V344, P175, DOI 10.1056/NEJM200101183440303; Bensinger WI, 2012, CURR OPIN ONCOL, V24, P191, DOI 10.1097/CCO.0b013e32834f5c27; Biron KK, 2006, ANTIVIR RES, V71, P154, DOI 10.1016/j.antiviral.2006.05.002; Boeckh M, 1999, Transpl Infect Dis, V1, P165, DOI 10.1034/j.1399-3062.1999.010305.x; Bollard CM, 2003, ACTA HAEMATOL-BASEL, V110, P139, DOI 10.1159/000072463; Borchers S, 2011, TRANSPL INFECT DIS, V13, P222, DOI 10.1111/j.1399-3062.2011.00626.x; Borchers S, 2011, HUM GENE THER; Borchers S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050248; Burkett MW, 2005, J IMMUNOTHER, V28, P396, DOI 10.1097/01.cji.0000165357.11548.6d; Cobbold M, 2005, J EXP MED, V202, P379, DOI 10.1084/jem.20040613; Comoli P, 2008, BLOOD CELL MOL DIS, V40, P68, DOI 10.1016/j.bcmd.2007.06.020; Einsele H, 2008, BLOOD CELL MOL DIS, V40, P71, DOI 10.1016/j.bcmd.2007.07.002; Feuchtinger T, 2006, BRIT J HAEMATOL, V134, P64, DOI 10.1111/j.1365-2141.2006.06108.x; Flowers MED, 2002, BLOOD, V100, P415, DOI 10.1182/blood-2002-01-0011; Franzke A, 2003, BLOOD, V102, P734, DOI 10.1182/blood-2002-04-1200; Franzke A, 2006, CYTOKINE GROWTH F R, V17, P235, DOI 10.1016/j.cytogfr.2006.05.002; Gratama JW, 2010, BLOOD, V116, P1655, DOI 10.1182/blood-2010-03-273508; Hernandez JM, 2005, LEUKEMIA, V19, P1088, DOI 10.1038/sj.leu.2403753; Icheva V, 2013, J CLIN ONCOL, V31, P39, DOI 10.1200/JCO.2011.39.8495; Koehl U, 2008, KLIN PADIATR, V220, P348, DOI 10.1055/s-0028-1086029; Korbling M, 2011, BLOOD, V117, P6411, DOI 10.1182/blood-2010-12-322214; Ljungman P, 2009, BONE MARROW TRANSPL, V44, P521, DOI 10.1038/bmt.2009.263; Luo XH, 2010, BIOL BLOOD MARROW TR, V16, P994, DOI 10.1016/j.bbmt.2010.02.007; Mielcarek M, 2012, BLOOD, V119, P2675, DOI 10.1182/blood-2011-12-396275; O'Reilly RJ, 2011, BEST PRACT RES CL HA, V24, P381, DOI 10.1016/j.beha.2011.06.001; Pan LP, 1999, BLOOD, V93, P4071, DOI 10.1182/blood.V93.12.4071.412k41_4071_4078; Peggs KS, 2011, CLIN INFECT DIS, V52, P49, DOI 10.1093/cid/ciq042; Powles R, 2010, LANCET ONCOL, V11, P305, DOI 10.1016/S1470-2045(10)70001-2; Reddy V, 2000, TRANSPLANTATION, V69, P691, DOI 10.1097/00007890-200002270-00041; REUSSER P, 1991, BLOOD, V78, P1373; RIDDELL SR, 1991, REV INFECT DIS, V13, pS966; Rutella S, 2005, J IMMUNOL, V175, P7085, DOI 10.4049/jimmunol.175.11.7085; Rutella S, 2002, BLOOD, V100, P2562, DOI 10.1182/blood-2001-12-0291; Samuel ER, 2012, BR J HAEMATOL; Schlahsa L, 2011, TRANSFUSION, V51, P293, DOI 10.1111/j.1537-2995.2010.02820.x; Schmitz N, 2006, BLOOD, V108, P4288, DOI 10.1182/blood-2006-05-024042; Shafer-Weaver Kimberly, 2003, J Transl Med, V1, P14, DOI 10.1186/1479-5876-1-14; Sloand EM, 2005, BLOOD, V105, P1847, DOI 10.1182/blood-2004-12-4766; Smith MS, 2010, CELL HOST MICROBE, V8, P284, DOI 10.1016/j.chom.2010.08.001; Sukdolak C, 2013, BIOL BLOOD IN PRESS; Tayebi H, 2001, BONE MARROW TRANSPL, V27, P167, DOI 10.1038/sj.bmt.1702753; Toh HC, 2009, CLIN IMMUNOL, V132, P83, DOI 10.1016/j.clim.2009.03.509; Ukena SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051644; Wilkie GM, 2004, J IMMUNOTHER, V27, P309, DOI 10.1097/00002371-200407000-00007; Yao JX, 2008, CLIN INFECT DIS, V46, pE96, DOI 10.1086/587749; Zaia J, 2009, BONE MARROW TRANSPL, V44, P471, DOI 10.1038/bmt.2009.258; Zaritskaya L, 2009, J IMMUNOTHER, V32, P186, DOI 10.1097/CJI.0b013e318197b1b2; Zeng DF, 1997, BLOOD, V90, P453	54	21	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e77925	10.1371/journal.pone.0077925	http://dx.doi.org/10.1371/journal.pone.0077925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324576	Green Submitted, gold, Green Published			2022-12-25	WOS:000327949300004
J	Li, XY; Jiang, J; Zhao, XY; Wang, JF; Han, HH; Zhao, Y; Peng, B; Zhong, RG; Ying, WT; Qian, XH				Li, Xianyu; Jiang, Jing; Zhao, Xinyuan; Wang, Jifeng; Han, Huanhuan; Zhao, Yan; Peng, Bo; Zhong, Rugang; Ying, Wantao; Qian, Xiaohong			N-glycoproteome Analysis of the Secretome of Human Metastatic Hepatocellular Carcinoma Cell Lines Combining Hydrazide Chemistry, HILIC Enrichment and Mass Spectrometry	PLOS ONE			English	Article							GLYCOSYLATION SITES; PROTEINS; MIGRATION; PROTEOME; REVEALS; QUANTIFICATION; IDENTIFICATION; EXTRACTION; EXPRESSION; BIOMARKER	Cancer cell metastasis is a major cause of cancer death. Unfortunately, the underlying molecular mechanisms remain unknown, which results in the lack of efficient diagnosis, therapy and prevention approaches. Nevertheless, the dysregulation of the cancer cell secretome is known to play key roles in tumor transformation and progression. The majority of proteins in the secretome are secretory proteins and membrane-released proteins, and, mostly, the glycosylated proteins. Until recently, few studies have explored protein N-glycosylation changes in the secretome, although protein glycosylation has received increasing attention in the study of tumor development processes. Here, the N-glycoproteins in the secretome of two human hepatocellular carcinoma (HCC) cell lines with low (MHCC97L) or high (HCCLM3) metastatic potential were investigated with a in-depth characterization of the N-glycosites by combining two general glycopeptide enrichment approaches, hydrazide chemistry and zwitterionic hydrophilic interaction chromatography (zic-HILIC), with mass spectrometry analysis. A total of 1,213 unique N-glycosites from 611 N-glycoproteins were confidently identified. These N-glycoproteins were primarily localized to the extracellular space and plasma membrane, supporting the important role of N-glycosylation in the secretory pathway. Coupling label-free quantification with a hierarchical clustering strategy, we determined the differential regulation of several N-glycoproteins that are related to metastasis, among which AFP, DKK1, FN1, CD151 and TGF beta 2 were up-regulated in HCCLM3 cells. The inclusion of the well-known metastasis-related proteins AFP and DKK1 in this list provides solid supports for our study. Further western blotting experiments detecting FN1 and FAT1 confirmed our discovery. The glycoproteome strategy in this study provides an effective means to explore potential cancer biomarkers.	[Li, Xianyu; Zhao, Xinyuan; Wang, Jifeng; Zhong, Rugang; Qian, Xiaohong] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing, Peoples R China; [Li, Xianyu; Jiang, Jing; Zhao, Xinyuan; Wang, Jifeng; Han, Huanhuan; Zhao, Yan; Peng, Bo; Ying, Wantao; Qian, Xiaohong] Beijing Inst Radiat Med, State Key Lab Prote, Beijing Proteome Res Ctr, Beijing, Peoples R China	Beijing University of Technology; Academy of Military Medical Sciences - China	Ying, WT (corresponding author), Beijing Inst Radiat Med, State Key Lab Prote, Beijing Proteome Res Ctr, Beijing, Peoples R China.	proteomics@126.com; qianxh1@163.com			National Key Program for Basic Research of China [2011CB910603, 2013CB911204]; National High Technology Research and Development Program of China [2012AA020203]; International Scientific Cooperation Project of China [2011DFB30370]; National Natural Science Foundation of China [21275005, 31100591, 21235001]; Beijing Nova Program [Z121107002512014]	National Key Program for Basic Research of China; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); International Scientific Cooperation Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	The authors are grateful for financial support from the National Key Program for Basic Research of China [2011CB910603, 2013CB911204]; National High Technology Research and Development Program of China [2012AA020203]; International Scientific Cooperation Project of China [2011DFB30370], National Natural Science Foundation of China [21275005, 31100591, 21235001], Beijing Nova Program ( Z121107002512014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Apte SS, 2004, INT J BIOCHEM CELL B, V36, P981, DOI 10.1016/j.biocel.2004.01.014; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Boersema PJ, 2013, MOL CELL PROTEOMICS, V12, P158, DOI 10.1074/mcp.M112.023614; Brown KJ, 2012, EXPERT REV PROTEOMIC, V9, P337, DOI [10.1586/epr.12.21, 10.1586/EPR.12.21]; Calvano CD, 2008, J PROTEOMICS, V71, P304, DOI 10.1016/j.jprot.2008.06.013; Cao J, 2011, SCI CHINA LIFE SCI, V54, P34, DOI 10.1007/s11427-010-4122-1; Cao J, 2009, J PROTEOME RES, V8, P662, DOI 10.1021/pr800826u; Chang YH, 2012, MOL CELL PROTEOMICS, V11, P1320, DOI 10.1074/mcp.M112.017384; Chen TY, 2011, ANN SURG ONCOL, V18, P2348, DOI 10.1245/s10434-011-1574-x; Chevallet M, 2007, PROTEOMICS, V7, P1757, DOI 10.1002/pmic.200601024; DIEZITZA I, 1993, EUR J CANCER, V29A, P1256, DOI 10.1016/0959-8049(93)90068-Q; Drake PM, 2011, ANAL BIOCHEM, V408, P71, DOI 10.1016/j.ab.2010.08.010; Drake PM, 2010, CLIN CHEM, V56, P223, DOI 10.1373/clinchem.2009.136333; Eichelbaum K, 2012, NAT BIOTECHNOL, V30, P984, DOI 10.1038/nbt.2356; Hassan MI, 2008, J MOL BIOL, V384, P663, DOI 10.1016/j.jmb.2008.09.072; HILL KE, 1993, P NATL ACAD SCI USA, V90, P537, DOI 10.1073/pnas.90.2.537; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ji XN, 2003, J CANCER RES CLIN, V129, P556, DOI 10.1007/s00432-003-0475-1; Kikkawa Y, 2002, J BIOL CHEM, V277, P44864, DOI 10.1074/jbc.M208731200; KOLI K, 1995, CANCER RES, V55, P1540; Koli K, 2001, MICROSC RES TECHNIQ, V52, P354, DOI 10.1002/1097-0029(20010215)52:4<354::AID-JEMT1020>3.0.CO;2-G; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Li Y, 2004, J CANCER RES CLIN, V130, P460, DOI 10.1007/s00432-004-0564-9; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; Pan S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003251; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SAUERMANN U, 1992, J NEUROSCI RES, V33, P142, DOI 10.1002/jnr.490330118; Shen CP, 2012, PROTEOMICS, V12, P1917, DOI 10.1002/pmic.201200027; Shen QJ, 2012, LANCET ONCOL, V13, P817, DOI 10.1016/S1470-2045(12)70233-4; Shimizu K, 2001, J BIOL CHEM, V276, P25753, DOI 10.1074/jbc.M103473200; Sudhir PR, 2012, MOL CELL PROTEOMICS, V11, P901, DOI 10.1074/mcp.M112.020875; Swiercz JM, 2008, J BIOL CHEM, V283, P1893, DOI 10.1074/jbc.M706822200; Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1; Tang ZY, 2001, WORLD J GASTROENTERO, V7, P597; Tian J, 1999, BRIT J CANCER, V81, P814, DOI 10.1038/sj.bjc.6690769; Tian YA, 2007, NAT PROTOC, V2, P334, DOI 10.1038/nprot.2007.42; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Wang L, 2012, J PROTEOME RES, V11, P143, DOI 10.1021/pr200916k; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yang GL, 2013, PROTEOMICS, V13, P1481, DOI 10.1002/pmic.201200259; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Yeh CB, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/595292; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027553; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827; Zhang XA, 2002, MOL BIOL CELL, V13, P1, DOI 10.1091/mbc.01-10-0481; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zhu WH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840518; Zielinska DF, 2012, MOL CELL, V46, P542, DOI 10.1016/j.molcel.2012.04.031; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	54	22	22	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81921	10.1371/journal.pone.0081921	http://dx.doi.org/10.1371/journal.pone.0081921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324730	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300114
J	Raza, A; Ghanchi, NK; Zubairi, AB; Raheem, A; Nizami, S; Beg, MA				Raza, Afsheen; Ghanchi, Najia K.; Zubairi, Ali bin Sarwar; Raheem, Ahmed; Nizami, Sobia; Beg, Mohammad Asim			Tumor Necrosis Factor -alpha, Interleukin-10, Intercellular and Vascular Adhesion Molecules Are Possible Biomarkers of Disease Severity in Complicated Plasmodium vivax Isolates from Pakistan	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; SEVERE MALARIA; INFECTED ERYTHROCYTE; CYTOKINE PROFILES; SERUM-LEVELS; LUNG INJURY; FALCIPARUM; ACTIVATION; THROMBOMODULIN; CYTOADHERENCE	Background: Cytokine-mediated endothelial activation pathway is a known mechanism of pathogenesis employed by Plasmodium falciparum to induce severe disease symptoms in human host. Though considered benign, complicated cases of Plasmodium vivax are being reported worldwide and from Pakistan. It has been hypothesized that P. vivax utilizes similar mechanism of pathogenesis, as that of P. falciparum for manifestations of severe malaria. Therefore, the main objective of this study was to characterize the role of cytokines and endothelial activation markers in complicated Plasmodium vivax isolates from Pakistan. Methods and Principle Findings: A case control study using plasma samples from well-characterized groups suffering from P. vivax infection including uncomplicated cases (n=100), complicated cases (n=82) and healthy controls (n=100) were investigated. Base line levels of Tumor necrosis factor-alpha (TNF-alpha), Interleukin-6 (IL-6), Interleukin-10 (IL-10), Intercellular adhesion molecule-1 (ICAM-1), Vascular adhesion molecule-1(VCAM-1) and E-selectin were measured by ELISA. Correlation of cytokines and endothelial activation markers was done using Spearman's correlation analysis. Furthermore, significance of these biomarkers as indicators of disease severity was also analyzed. The results showed that TNF-alpha, IL-10, ICAM-1 and VCAM-1 were 3-fold, 3.7 fold and 2 fold increased between uncomplicated and complicated cases. Comparison of healthy controls with uncomplicated cases showed no significant difference in TNF-alpha concentrations while IL-6, IL-10, ICAM-1, VCAM-1 and E-selectin were found to be elevated respectively. In addition, significant positive correlation was observed between TNF-alpha and IL-10/ICAM-1, IL-6 and IL-10, ICAM-1 and VCAM-1. A Receiver operating curve (ROC) was generated which showed that TNF-alpha, IL-10, ICAM-1 and VCAM-1 were the best individual predictors of complicated P. vivax malaria. Conclusion: The results suggest that though endothelial adhesion molecules are inducible by pro-inflammatory cytokine TNF-alpha, however, cytokine-mediated endothelial activation pathway is not clearly demonstrated as a mechanism of pathogenesis in complicated P. vivax malaria cases from Pakistan.	[Raza, Afsheen; Ghanchi, Najia K.; Raheem, Ahmed; Beg, Mohammad Asim] Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Sindh, Pakistan; [Zubairi, Ali bin Sarwar] Aga Khan Hosp, Dept Med, Karachi, Sindh, Pakistan; [Nizami, Sobia] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Sindh, Pakistan	Aga Khan University; Aga Khan University	Beg, MA (corresponding author), Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Sindh, Pakistan.	masim.beg@aku.edu	Raza, Afsheen/AAI-8839-2020	Raza, Afsheen/0000-0002-0264-3304	Aga Khan University Research Council [339 102017PM]	Aga Khan University Research Council	This work was supported by Aga Khan University Research Council grant [grant ID: 339 102017P&M]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre MA, 2010, EMERG INFECT DIS, V16, P1611, DOI 10.3201/eid1610.100685; Andrade BB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000650; Andrade BB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-13; Andrade BB, 2011, MEM I OSWALDO CRUZ, V106, P70, DOI 10.1590/S0074-02762011000900009; [Anonymous], [No title captured]; Anstey NM, 2007, J INFECT DIS, V195, P589, DOI 10.1086/510756; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Beg MA, 2002, AM J TROP MED HYG, V67, P230, DOI 10.4269/ajtmh.2002.67.230; BOEHME MWJ, 1994, CLIN INVESTIGATOR, V72, P598, DOI 10.1007/BF00227452; Bridges DJ, 2010, BLOOD, V115, P1472, DOI 10.1182/blood-2009-07-235150; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; Chotivanich KT, 1998, AM J TROP MED HYG, V59, P73, DOI 10.4269/ajtmh.1998.59.73; Conroy AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015291; Costa FTM, 2011, MEM I OSWALDO CRUZ, V106, P79, DOI 10.1590/S0074-02762011000900010; Craig A, 2001, MOL BIOCHEM PARASIT, V115, P129, DOI 10.1016/S0166-6851(01)00275-4; Cserti-Gazdewich CM, 2012, BRIT J HAEMATOL, V159, P223, DOI 10.1111/bjh.12014; de Mast Q, 2009, AM J TROP MED HYG, V80, P492, DOI 10.4269/ajtmh.2009.80.492; Faille D, 2009, THROMB HAEMOSTASIS, V102, P1093, DOI 10.1160/TH09-05-0337; Francischetti IMB, 2008, MICROCIRCULATION, V15, P81, DOI 10.1080/10739680701451516; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Goncalves RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044394; Gopisetty S, 2007, GUT, V56, P447, DOI 10.1136/gut.2006.114454; Hemmer CJ, 2006, TROP MED INT HEALTH, V11, P817, DOI 10.1111/j.1365-3156.2006.01635.x; Hugosson E, 2004, PARASITE IMMUNOL, V26, P111, DOI 10.1111/j.0141-9838.2004.00678.x; Hussain R, 2002, J IMMUNOL METHODS, V264, P95, DOI 10.1016/S0022-1759(02)00092-3; JAKOBSEN PH, 1994, IMMUNOLOGY, V83, P665; Jenkins N, 2007, J INFECT DIS, V196, P321, DOI 10.1086/518795; Kochar DK, 2009, AM J TROP MED HYG, V80, P194, DOI 10.4269/ajtmh.2009.80.194; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; Lacerda MVG, 2012, CLIN INFECT DIS, V55, pE67, DOI 10.1093/cid/cis615; Lopez JA, 2010, BLOOD, V115, P1317, DOI 10.1182/blood-2009-12-254060; Mantik M, 2008, PEDIATRICS, V121, pS129, DOI 10.1542/peds.2007-2022PPPP; Mehmood A, 2012, J INFECT DEV COUNTR, V6, P664, DOI 10.3855/jidc.2107; Metanat M, 2010, IRAN J PARASITOL, V5, P69; Ohnishi K, 1999, AM J TROP MED HYG, V60, P248, DOI 10.4269/ajtmh.1999.60.248; Pleass RJ, 2009, TRENDS PARASITOL, V25, P296, DOI 10.1016/j.pt.2009.04.002; POBER JS, 1988, AM J PATHOL, V133, P426; Sarkar S, 2010, LUNG INDIA, V27, P154, DOI 10.4103/0970-2113.68323; Seoh JY, 2003, AM J TROP MED HYG, V68, P102, DOI 10.4269/ajtmh.2003.68.102; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Tan LKK, 2008, LANCET INFECT DIS, V8, P449, DOI 10.1016/S1473-3099(08)70153-1; Taylor Walter R J, 2006, Treat Respir Med, V5, P419, DOI 10.2165/00151829-200605060-00007; Tchinda VHM, 2007, ACTA TROP, V102, P20, DOI 10.1016/j.actatropica.2007.02.011; Tesfamariam B, 2007, VASC PHARMACOL, V46, P229, DOI 10.1016/j.vph.2006.11.005; Turner GDH, 1998, AM J PATHOL, V152, P1477; Warhurst DC, 1996, J CLIN PATHOL, V49, P533, DOI 10.1136/jcp.49.7.533; Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955; Yeo TW, 2010, J INFECT DIS, V202, P109, DOI 10.1086/653211	49	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81363	10.1371/journal.pone.0081363	http://dx.doi.org/10.1371/journal.pone.0081363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324686	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300087
J	Smith, SMC; Friedle, SA; Watters, JJ				Smith, Stephanie M. C.; Friedle, Scott A.; Watters, Jyoti J.			Chronic Intermittent Hypoxia Exerts CNS Region-Specific Effects on Rat Microglial Inflammatory and TLR4 Gene Expression	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; NITRIC-OXIDE SYNTHASE; SPATIAL-LEARNING DEFICITS; RECEPTOR 4; BRAIN-INJURY; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; NEURONAL DEATH; MOUSE MODEL; ACTIVATION	Intermittent hypoxia (IH) during sleep is a hallmark of sleep apnea, causing significant neuronal apoptosis, and cognitive and behavioral deficits in CNS regions underlying memory processing and executive functions. IH-induced neuroinflammation is thought to contribute to cognitive deficits after IH. In the present studies, we tested the hypothesis that IH would differentially induce inflammatory factor gene expression in microglia in a CNS region-dependent manner, and that the effects of IH would differ temporally. To test this hypothesis, adult rats were exposed to intermittent hypoxia (2 min intervals of 10.5% O-2) for 8 hours/day during their respective sleep cycles for 1, 3 or 14 days. Cortex, medulla and spinal cord tissues were dissected, microglia were immunomagnetically isolated and mRNA levels of the inflammatory genes iNOS, COX-2, TNF alpha, IL-1 beta and IL-6 and the innate immune receptor TLR4 were compared to levels in normoxia. Inflammatory gene expression was also assessed in tissue homogenates (containing all CNS cells). We found that microglia from different CNS regions responded to IH differently. Cortical microglia had longer lasting inflammatory gene expression whereas spinal microglial gene expression was rapid and transient. We also observed that inflammatory gene expression in microglia frequently differed from that in tissue homogenates from the same region, indicating that cells other than microglia also contribute to IH-induced neuroinflammation. Lastly, microglial TLR4 mRNA levels were strongly upregulated by IH in a region-and time-dependent manner, and the increase in TLR4 expression appeared to coincide with timing of peak inflammatory gene expression, suggesting that TLR4 may play a role in IH-induced neuroinflammation. Together, these data indicate that microglial-specific neuroinflammation may play distinct roles in the effects of intermittent hypoxia in different CNS regions.	[Smith, Stephanie M. C.; Friedle, Scott A.; Watters, Jyoti J.] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Watters, JJ (corresponding author), Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr W, Madison, WI 53706 USA.	jjwatters@wisc.edu		Smith, Stephanie/0000-0002-2063-0515	NIH [NS049033, HL111598]; University of Wisconsin Graduate School; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049033] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin Graduate School; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH NS049033, NIH HL111598, University of Wisconsin Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acarin L, 2002, J NEUROSCI RES, V68, P745, DOI 10.1002/jnr.10261; Akinnusi M, 2012, SLEEP BREATH, P1; Ali Latisha K, 2008, Rev Neurol Dis, V5, P191; Atalaia A, 2007, AMYOTROPH LATERAL SC, V8, P101, DOI 10.1080/17482960601029883; Balistreri CR, 2008, CURR PHARM DESIGN, V14, P2672, DOI 10.2174/138161208786264089; Bombois S, 2010, J NUTR HEALTH AGING, V14, P212, DOI 10.1007/s12603-010-0052-7; Crain JM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-24; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Fellner L, 2013, GLIA, V61, P349, DOI 10.1002/glia.22437; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Gozal D, 2001, J NEUROSCI, V21, P2442, DOI 10.1523/JNEUROSCI.21-07-02442.2001; Gozal E, 2002, J NEUROCHEM, V83, P331, DOI 10.1046/j.1471-4159.2002.01134.x; Hines DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060388; HOCH CC, 1986, J CLIN PSYCHIAT, V47, P499; Huxtable AG, 2013, J APPL PHYSIOL, V114, P879, DOI 10.1152/japplphysiol.01347.2012; Iadecola C, 1997, J NEUROSCI, V17, P9157; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; Kim J, 2010, EUR RESPIR J, V35, P843, DOI 10.1183/09031936.00075409; Kim SY, 2010, IMMUNOLOGY, V129, P516, DOI 10.1111/j.1365-2567.2009.03203.x; Klein JB, 2003, RESP PHYSIOL NEUROBI, V136, P91, DOI 10.1016/S1569-9048(03)00074-0; Kraft AD, 2009, NEUROTOXICOLOGY, V30, P785, DOI 10.1016/j.neuro.2009.07.001; Lecanu L, 1998, BRIT J PHARMACOL, V125, P584, DOI 10.1038/sj.bjp.0702119; Lee H-K, 2013, BRAIN RES; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li RC, 2004, NEUROBIOL DIS, V17, P44, DOI 10.1016/j.nbd.2004.05.006; Li RC, 2003, AM J RESP CRIT CARE, V168, P469, DOI 10.1164/rccm.200211-1264OC; Ling LM, 2001, J NEUROSCI, V21, P5381, DOI 10.1523/JNEUROSCI.21-14-05381.2001; MANONESPAILLAT R, 1989, NEUROREHAB NEURAL RE, V3, P133; MARCUS CL, 1991, PEDIATRICS, V88, P132; Marta M, 2009, ANN NY ACAD SCI, V1173, P458, DOI 10.1111/j.1749-6632.2009.04849.x; Morrell MJ, 2010, THORAX, V65, P908, DOI 10.1136/thx.2009.126730; Morrell MJ, 2006, ADV EXP MED BIOL, V588, P75; Morrell MJ, 2003, SLEEP MED, V4, P451, DOI 10.1016/S1389-9457(03)00159-X; Nagata N, 2000, BRAIN DEV-JPN, V22, P315, DOI 10.1016/S0387-7604(00)00123-6; Nair D, 2011, AM J RESP CRIT CARE, V184, P1305, DOI 10.1164/rccm.201107-1173OC; Nair D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019847; Nikodemova M, 2011, NEUROSCIENCE, V190, P67, DOI 10.1016/j.neuroscience.2011.06.006; Nikodemova M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-147; Ock J, 2007, J NEUROSCI RES, V85, P1989, DOI 10.1002/jnr.21322; Pae EK, 2005, NEUROSCI LETT, V375, P123, DOI 10.1016/j.neulet.2004.10.091; Parmentier-Batteur S, 2001, J CEREBR BLOOD F MET, V21, P15, DOI 10.1097/00004647-200101000-00003; Peppard PE, 2013, AM J EPIDEM IN PRESS; Prout AP, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.020; Ramanathan L, 2005, J NEUROCHEM, V93, P47, DOI 10.1111/j.1471-4159.2004.02988.x; Reeves SR, 2006, NEUROSCI LETT, V402, P233, DOI 10.1016/j.neulet.2006.04.013; Row BW, 2003, AM J RESP CRIT CARE, V167, P1548, DOI 10.1164/rccm.200209-1050OC; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Sansing LH, 2011, ANN NEUROL, V70, P646, DOI 10.1002/ana.22528; Shan XY, 2007, NEUROBIOL DIS, V28, P206, DOI 10.1016/j.nbd.2007.07.013; Simakajornboon N, 2001, BRAIN RES, V895, P111, DOI 10.1016/S0006-8993(01)02054-6; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Spooren A, 2011, BRAIN RES REV, V67, P157, DOI 10.1016/j.brainresrev.2011.01.002; Tran K, 2010, RESPIROLOGY, V15, P272, DOI 10.1111/j.1440-1843.2009.01669.x; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang Y, 2010, RESP PHYSIOL NEUROBI, V174, P307, DOI 10.1016/j.resp.2010.09.001; Aviles-Reyes RX, 2010, J NEUROCHEM, V112, P854, DOI 10.1111/j.1471-4159.2009.06535.x; Xu W, 2004, NEUROSCIENCE, V126, P313, DOI 10.1016/j.neuroscience.2004.03.055; Yao LL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-23; Zhang SXL, 2012, COMPR PHYSIOL, V2, P1767, DOI 10.1002/cphy.c100060; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919	62	17	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81584	10.1371/journal.pone.0081584	http://dx.doi.org/10.1371/journal.pone.0081584			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324707	gold, Green Submitted, Green Published			2022-12-25	WOS:000327949300097
J	Wen, DH; Huang, XZ; Zhang, M; Zhang, LY; Chen, J; Gu, Y; Hao, CM				Wen, Donghai; Huang, Xinzhong; Zhang, Min; Zhang, Liying; Chen, Jing; Gu, Yong; Hao, Chuan-Ming			Resveratrol Attenuates Diabetic Nephropathy via Modulating Angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; AMELIORATES RENAL ALTERATIONS; VEGF EXPRESSION; UP-REGULATION; EARLY-STAGE; SIRT1; HYPOXIA; INHIBITOR; RECEPTOR; PROTECTS	Angiogenesis plays an important role in the pathogenesis of diabetic nephropathy (DN). In the present study, we investigated the therapeutic potential of resveratrol, a polyphenol with antiangiogenic activity in DN. In a type 1 diabetic rat model, resveratrol treatment blunted the increases of urine albumin excretion, kidney weight and creatinine clearance rate. The increases of glomerular diameter, mesangium accumulation, glomerular basement membrane thickness and renal fibrosis in diabetic rats were also reduced by resveratrol treatment. In the diabetic kidney, increased expression of vascular endothelial growth factor (VEGF), Flk-1 and angiopoietin 2, and reduced expression of Tie-2 were observed. These changes in angiogenic hormones and associated receptors were attenuated by resveratrol treatment. No changes in angiopoietin 1 expression were detected among each group of rats. Resveratrol also significantly downregulated high glucose-induced VEGF and Flk-1 expressions in cultured mouse glomerular podocytes and endothelial cells, respectively. These effects were attenuated by knocking-down silent information regulator 1 (Sirt1) expression. In contrast, upregulation of Sirt1 in cultured endothelial cells reduced Flk-1 expression. Increased permeability and cellular junction disruption of cultured endothelial cells caused by VEGF were also inhibited by resveratrol pretreatment. Taken together, the present study demonstrated that resveratrol may attenuate DN via modulating angiogenesis.	[Wen, Donghai; Huang, Xinzhong; Zhang, Min; Zhang, Liying; Chen, Jing; Gu, Yong; Hao, Chuan-Ming] Fudan Univ, Huashan Hosp, Dept Internal Med, Shanghai 200433, Peoples R China	Fudan University	Hao, CM (corresponding author), Fudan Univ, Huashan Hosp, Dept Internal Med, Shanghai 200433, Peoples R China.	chuanminghao@fudan.edu.cn	Chen, Jing/AAM-2184-2021		National Natural Science Foundation of China [30570861]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China (30570861, to CMH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akis N, 2004, KIDNEY INT, V65, P2223, DOI 10.1111/j.1523-1755.2004.00634.x; Alex D, 2010, J CELL BIOCHEM, V109, P339, DOI 10.1002/jcb.22405; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Burns J, 2002, J AGR FOOD CHEM, V50, P3337, DOI 10.1021/jf0112973; Chen J, 2006, J AM SOC NEPHROL, V17, P1283, DOI 10.1681/ASN.2005101032; Cooper ME, 1999, DIABETES, V48, P2229, DOI 10.2337/diabetes.48.11.2229; De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Feige JN, 2008, CURR OPIN CELL BIOL, V20, P303, DOI 10.1016/j.ceb.2008.03.012; Ferrara N, 2000, RECENT PROG HORM RES, V55, P15; Flyvbjerg A, 2002, DIABETES, V51, P3090, DOI 10.2337/diabetes.51.10.3090; Garvin S, 2006, CANCER LETT, V231, P113, DOI 10.1016/j.canlet.2005.01.031; Hasegawa K, 2010, J BIOL CHEM, V285, P13045, DOI 10.1074/jbc.M109.067728; He WJ, 2010, J CLIN INVEST, V120, P1056, DOI 10.1172/JCI41563; Ichinose K, 2006, DIABETES, V55, P1232, DOI 10.2337/db05-1367; Ichinose K, 2005, DIABETES, V54, P2891, DOI 10.2337/diabetes.54.10.2891; Joussen AM, 2002, AM J PATHOL, V160, P1683, DOI 10.1016/S0002-9440(10)61115-7; Kalluri R, 2000, CURR OPIN NEPHROL HY, V9, P413, DOI 10.1097/00041552-200007000-00013; Kanesaki Y, 2005, AM J KIDNEY DIS, V45, P288, DOI 10.1053/j.ajkd.2004.09.020; Kang DH, 2003, CURR OPIN NEPHROL HY, V12, P43, DOI 10.1097/00041552-200301000-00008; Kim MY, 2013, DIABETOLOGIA, V56, P204, DOI 10.1007/s00125-012-2747-2; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Lin MT, 2003, MOL PHARMACOL, V64, P1029, DOI 10.1124/mol.64.5.1029; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Nakagawa T, 2009, DIABETES, V58, P1471, DOI 10.2337/db09-0119; Nasu T, 2009, DIABETES, V58, P2365, DOI 10.2337/db08-1790; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Osterby R, 1999, NEPHROL DIAL TRANSPL, V14, P348, DOI 10.1093/ndt/14.2.348; Park SY, 2007, CANCER LETT, V258, P63, DOI 10.1016/j.canlet.2007.08.011; Parving HH, 2008, NEW ENGL J MED, V358, P2433, DOI 10.1056/NEJMoa0708379; Patel KR, 2010, CANCER RES, V70, P7392, DOI 10.1158/0008-5472.CAN-10-2027; Pichler RH, 2010, CURR DIABETES REP, V10, P297, DOI 10.1007/s11892-010-0126-2; Saito D, 2011, AM J PHYSIOL-RENAL, V300, pF873, DOI 10.1152/ajprenal.00503.2010; Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]; Sung SH, 2006, J AM SOC NEPHROL, V17, P3093, DOI 10.1681/ASN.2006010064; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tang ZH, 2007, J HUAZHONG U SCI-MED, V27, P508, DOI 10.1007/s11596-007-0508-0; Thirunavukkarasu M, 2007, FREE RADICAL BIO MED, V43, P720, DOI 10.1016/j.freeradbiomed.2007.05.004; Tong QS, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-101; US Renal Data System, 2010, USRDS 2010 ANN DAT R; Valmadrid CT, 2000, ARCH INTERN MED, V160, P1093, DOI 10.1001/archinte.160.8.1093; Visconti RP, 2002, P NATL ACAD SCI USA, V99, P8219, DOI 10.1073/pnas.122109599; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wen DH, 2012, AM J PHYSIOL-RENAL, V303, pF1534, DOI 10.1152/ajprenal.00083.2012; Wen DH, 2011, AM J NEPHROL, V34, P423, DOI 10.1159/000331701; Woolf AS, 2001, PEDIATR NEPHROL, V16, P177, DOI 10.1007/s004670000509; Yamamoto Y, 2004, DIABETES, V53, P1831, DOI 10.2337/diabetes.53.7.1831; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yu H, 2007, CHINESE MED J-PEKING, V120, P1672, DOI 10.1097/00029330-200710010-00006; Zhang QZ, 2005, MOL CANCER THER, V4, P1465, DOI 10.1158/1535-7163.MCT-05-0198; Zhang SX, 2006, J AM SOC NEPHROL, V17, P475, DOI 10.1681/ASN.2005020217	54	72	78	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82336	10.1371/journal.pone.0082336	http://dx.doi.org/10.1371/journal.pone.0082336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312656	Green Published, Green Submitted, gold			2022-12-25	WOS:000327947800093
J	Cai, AP; Qiu, RF; Li, LW; Zheng, DD; Dong, YG; Yu, DQ; Huang, YL; Rao, SQ; Zhou, YL; Mai, WY				Cai, Anping; Qiu, Ruofeng; Li, Liwen; Zheng, Dongdan; Dong, Yugang; Yu, Danqing; Huang, Yuli; Rao, Shaoqi; Zhou, Yingling; Mai, Weiyi			Atorvastatin Treatment of Rats with Ischemia-Reperfusion Injury Improves Adipose-Derived Mesenchymal Stem Cell Migration and Survival via the SDF-1 alpha/CXCR-4 Axis	PLOS ONE			English	Article							BONE-MARROW; MYOCARDIAL-INFARCTION; CARDIAC-FUNCTION; HEART-DISEASE; UP-REGULATION; THERAPY; REPAIR	Background: Adipose-derived mesenchymal stem cells (ASCs) transplantation is a promising approach for myocardium repair. Promotion of ASCs migration and survival is the key for improving ASCs efficiency. SDF-1 alpha is a critical factor responsible for ASCs migration and survival. Atorvastatin (Ator) is capable of up-regulating SDF-1 alpha. Therefore, we're going to investigate whether ASCs migration and survival could be improved with atorvastatin. Methods: In vitro study, cardiomyocytes were subjected to anoxia-reoxygenation injury and subsequently divided into different groups: group blank control, Ator, Ator plus L-NAME (A+L-NAME) and Ator plus AMD3100 (A+AMD3100). When migration analysis completed, cardiomyocytes were used for subsequent analyses. In vivo study, rats underwent ischemia-reperfusion injury were assigned into different groups corresponding to in vitro protocols. ASCs were transplanted on the seventh day of atorvastatin therapy. Seven days later, the rates of migration, differentiation and apoptosis were evaluated. Results: Compared with other groups, ASCs migration in vitro was significantly improved in group Ator, which was dependent on SDF-1 alpha/CXCR-4 coupling. Results of in vivo study were consistent with that of in vitro study, further supporting the notion that the efficacy of atorvastatin on ASCs migration improvement was related to SDF-1 alpha/CXCR-4 axis. Higher vessel density in group Ator might be another mechanism responsible for migration improvement. Concomitantly, apoptosis was significantly reduced in group Ator, whereas no significant difference of differentiation was found. Conclusion: Migration and survival of ASCs could be improved by atorvastatin under ischemia-reperfusion injury, which were ascribed to SDF-1 alpha/CXCR-4 axis.	[Cai, Anping; Qiu, Ruofeng; Zheng, Dongdan; Dong, Yugang; Huang, Yuli; Mai, Weiyi] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Anping; Li, Liwen; Yu, Danqing; Zhou, Yingling] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Cardiovasc Inst, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Rao, Shaoqi] Sun Yat Sen Univ, Dept Epidemiol & Hlth Stat, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Sun Yat Sen University	Zhou, YL (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Cardiovasc Inst, Dept Cardiol, Guangzhou, Guangdong, Peoples R China.	drcacocolacai@gmail.com; wymai@hotmail.com	Qiu, Ruofeng/R-5465-2016; Huang, Yuli/AAB-1006-2022	Qiu, Ruofeng/0000-0002-4687-7970; Cai, Anping/0000-0003-3953-5881; Rao, Shaoqi/0000-0001-7809-3700	Technology Project Foundation of Guangdong Province, China [2009A030301004, 2011B031800021, 2011B031800263]; cardiovascular medication of Guangdong Province [2011X25]; Health Ministry of Guangdong province, China [B2011310, A2012663]	Technology Project Foundation of Guangdong Province, China; cardiovascular medication of Guangdong Province; Health Ministry of Guangdong province, China	This work was supported by the grants from the Technology Project Foundation of Guangdong Province, China (2009A030301004, 2011B031800021, and2011B031800263). The research grant of cardiovascular medication of Guangdong Province (2011X25. Medical Scientific Research Grant of the Health Ministry of Guangdong province, China (B2011310, A2012663). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Almsherqi ZA, 2006, CELL RES, V16, P297, DOI 10.1038/sj.cr.7310037; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Bobis-Wozowicz S, 2011, EXP HEMATOL, V39, P686, DOI 10.1016/j.exphem.2011.03.004; Cai AP, 2011, ACTA BIOCH BIOPH SIN, V43, P857, DOI 10.1093/abbs/gmr087; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Fonarow GC, 2008, AM HEART J, V155, P200, DOI 10.1016/j.ahj.2006.10.043; Frangogiannis NG, 2011, J AM COLL CARDIOL, V58, P2424, DOI 10.1016/j.jacc.2011.08.031; Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742; Harjola VP, 2010, EUR J HEART FAIL, V12, P239, DOI 10.1093/eurjhf/hfq002; Huang CY, 2011, AM J PHYSIOL-HEART C, V301, pH1496, DOI 10.1152/ajpheart.00365.2011; Li MC, 2010, EXP MOL PATHOL, V88, P250, DOI 10.1016/j.yexmp.2009.12.001; Li N, 2009, STEM CELLS, V27, P961, DOI 10.1002/stem.6; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Madonna R, 2009, ARTERIOSCL THROM VAS, V29, P1723, DOI 10.1161/ATVBAHA.109.187179; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Qiu RF, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-99; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Saini V, 2011, J BIOL CHEM, V286, P33466, DOI 10.1074/jbc.M111.233742; Schober A, 2006, TRENDS CARDIOVAS MED, V16, P103, DOI 10.1016/j.tcm.2006.01.006; Sheng T, 2005, CIRCULATION, V111, P2438, DOI 10.1161/01.CIR.0000167553.49133.81; Tongers J, 2011, EUR HEART J, V32, P1197, DOI 10.1093/eurheartj/ehr018	22	24	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e79100	10.1371/journal.pone.0079100	http://dx.doi.org/10.1371/journal.pone.0079100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312447	Green Published, gold, Green Submitted			2022-12-25	WOS:000327944500005
J	Chang, CM; Yin, WY; Wei, CK; Lin, CH; Huang, KY; Lin, SP; Lee, CH; Chou, P; Lee, CC				Chang, Chun-Ming; Yin, Wen-Yao; Wei, Chang-Kuo; Lin, Chun-Hung; Huang, Kuang-Yung; Lin, Shih-Pin; Lee, Cheng-Hung; Chou, Pesus; Lee, Ching-Chih			The Association of Socioeconomic Status and Access to Low-Volume Service Providers in Breast Cancer	PLOS ONE			English	Article							HOSPITAL VOLUME; 5-YEAR SURVIVAL; MORTALITY; SURGERY; IMPACT; WOMEN	Background: No large-scale study has explored the combined effect of patients' individual and neighborhood socioeconomic status (SES) on their access to a low-volume provider for breast cancer surgery. The purpose of this study was to explore under a nationwide universal health insurance system whether breast cancer patients from a lower individual and neighborhood SES are disproportionately receiving breast cancer surgery from low-volume providers. Methods: 5,750 patients who underwent breast cancer surgery in 2006 were identified from the Taiwan National Health Insurance Research Database. The Cox proportional hazards model was used to compare the access to a low-volume provider between the different individual and neighborhood SES groups after adjusting for possible confounding and risk factors. Hosmer-Lemeshow goodness-of-fit statistic was used to determine how well the model fit the data. Results: Univariate analysis data shows that patients in disadvantaged neighborhood were more likely to receive breast cancer surgery at low-volume hospitals; and lower-SES patients were more likely to receive surgery from low-volume surgeons. In multivariate analysis, after adjusting for patient characteristics, the odds ratios of moderate-and low-SES patients in disadvantaged neighborhood receiving surgery at low-volume hospitals was 1.47 (95% confidence interval=1.19-1.81) and 1.31 (95% confidence interval=1.05-1.64) respectively compared with high-SES patients in advantaged neighborhood. Moderate-and low-SES patients from either advantaged or disadvantaged neighborhood had an odds ratios ranging from 1.51 to 1.80 (p<0.001) to receiving surgery from low-volume surgeons. In Hosmer-Lemeshow goodness-of-fit test, p>0.05 that shows the model has a good fit. Conclusions: In this population-based cross-sectional study, even under a nationwide universal health insurance system, disparities in access to healthcare existed. Breast cancer patients from a lower individual and neighborhood SES are more likely to receive breast cancer surgery from low-volume providers. The authorities and public health policies should keep focusing on these vulnerable groups.	[Chang, Chun-Ming; Yin, Wen-Yao; Wei, Chang-Kuo; Lin, Chun-Hung; Lin, Shih-Pin; Lee, Cheng-Hung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Surg, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Clin Epidemiol & Biostat, Chiayi, Taiwan; [Huang, Kuang-Yung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Rheumatol, Chiayi, Taiwan; [Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Chang, Chun-Ming; Yin, Wen-Yao; Wei, Chang-Kuo; Lin, Chun-Hung; Huang, Kuang-Yung; Lin, Shih-Pin; Lee, Cheng-Hung; Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Tzu Chi University	Lee, CC (corresponding author), Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan.	hematcd2@hotamil.com						Al-Refaie WB, 2012, J AM COLL SURGEONS, V214, P81, DOI 10.1016/j.jamcollsurg.2011.10.003; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Braaten T, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-178; Chang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044325; Chang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040590; Chen CS, 2008, BREAST CANCER RES TR, V110, P349, DOI 10.1007/s10549-007-9715-4; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Gentil J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-351; Gooiker G A, 2010, Eur J Surg Oncol, V36 Suppl 1, pS27, DOI 10.1016/j.ejso.2010.06.024; Gruen RL, 2009, CA-CANCER J CLIN, V59, P192, DOI 10.3322/caac.20018; Kong AL, 2011, ANN SURG ONCOL, V18, P3220, DOI 10.1245/s10434-011-2001-z; Kwok J, 2010, CANCER-AM CANCER SOC, V116, P476, DOI 10.1002/cncr.24774; Lin HC, 2008, STROKE, V39, P2744, DOI 10.1161/STROKEAHA.108.519090; Roohan PJ, 1998, AM J PUBLIC HEALTH, V88, P454, DOI 10.2105/AJPH.88.3.454; Vrijens F, 2012, BREAST, V21, P261, DOI 10.1016/j.breast.2011.12.002; Wang JJ, 2001, INT J NURS STUD, V38, P339, DOI 10.1016/S0020-7489(00)00072-9	16	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81801	10.1371/journal.pone.0081801	http://dx.doi.org/10.1371/journal.pone.0081801			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	265IN	24312589	Green Published, gold, Green Submitted			2022-12-25	WOS:000327944500099
J	Chattha, KS; Kandasamy, S; Vlasova, AN; Saif, LJ				Chattha, Kuldeep S.; Kandasamy, Sukumar; Vlasova, Anastasia N.; Saif, Linda J.			Vitamin A Deficiency Impairs Adaptive B and T Cell Responses to a Prototype Monovalent Attenuated Human Rotavirus Vaccine and Virulent Human Rotavirus Challenge in a Gnotobiotic Piglet Model	PLOS ONE			English	Article							IMMUNE-RESPONSES; RETINOIC-ACID; VIRUS-INFECTION; ANTIBODY-RESPONSE; DIARRHEA; SUPPLEMENTATION; INTERFERON; INFANTS; IMPACT; TRANSLOCATION	Rotaviruses (RV) are a major cause of gastroenteritis in children. Widespread vitamin A deficiency is associated with reduced efficacy of vaccines and higher incidence of diarrheal infections in children in developing countries. We established a vitamin A deficient (VAD) gnotobiotic piglet model that mimics subclinical vitamin A deficiency in children to study its effects on an oral human rotavirus (HRV) vaccine and virulent HRV challenge. Piglets derived from VAD and vitamin A sufficient (VAS) sows were orally vaccinated with attenuated HRV or mock, with/without supplemental vitamin A and challenged with virulent HRV. Unvaccinated VAD control piglets had significantly lower hepatic vitamin A, higher severity and duration of diarrhea and HRV fecal shedding post-challenge as compared to VAS control pigs. Reduced protection coincided with significantly higher innate (IFN alpha) cytokine and CD8 T cell frequencies in the blood and intestinal tissues, higher pro-inflammatory (IL12) and 2-3 fold lower anti-inflammatory (IL10) cytokines, in VAD compared to VAS control pigs. Vaccinated VAD pigs had higher diarrhea severity scores compared to vaccinated VAS pigs, which coincided with lower serum IgA HRV antibody titers and significantly lower intestinal IgA antibody secreting cells post-challenge in the former groups suggesting lower anamnestic responses. A trend for higher serum HRV IgG antibodies was observed in VAD vs VAS vaccinated groups post-challenge. The vaccinated VAD (non-vitamin A supplemented) pigs had significantly higher serum IL12 (PID2) and IFN gamma (PID6) compared to vaccinated VAS groups suggesting higher Th1 responses in VAD conditions. Furthermore, regulatory T-cell responses were compromised in VAD pigs. Supplemental vitamin A in VAD pigs did not fully restore the dysregulated immune responses to AttHRV vaccine or moderate virulent HRV diarrhea. Our findings suggest that that VAD in children in developing countries may partially contribute to more severe rotavirus infection and lower HRV vaccine efficacy.	[Chattha, Kuldeep S.; Kandasamy, Sukumar; Vlasova, Anastasia N.; Saif, Linda J.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Dept Vet Prevent Med, Wooster, OH 44691 USA	University System of Ohio; Ohio State University	Chattha, KS (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Dept Vet Prevent Med, Wooster, OH 44691 USA.	chattha.2@osu.edu; saif.2@osu.edu	Vlasova, Anastasia N/C-2062-2016; Saif, Linda/E-4005-2011	Vlasova, Anastasia N/0000-0002-1447-6283; 	National Institutes of Health [R21AI083546]; Ohio Agricultural Research and Development Center (OARDC) of The Ohio State University, Wooster, Ohio; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Agricultural Research and Development Center (OARDC) of The Ohio State University, Wooster, Ohio; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health (R21AI083546 to LJS) and federal funds appropriated to the Ohio Agricultural Research and Development Center (OARDC) of The Ohio State University, Wooster, Ohio (to LJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED F, 1991, BRIT J NUTR, V65, P475, DOI 10.1079/BJN19910106; AHMED F, 1990, BRIT J NUTR, V63, P363, DOI 10.1079/BJN19900122; Angel J, 1999, J INTERF CYTOK RES, V19, P655, DOI 10.1089/107999099313802; Bahl R, 1999, J NUTR, V129, P1569, DOI 10.1093/jn/129.8.1569; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bhaskaram P., 1997, Indian Journal of Pediatrics, V64, P503, DOI 10.1007/BF02737757; Bjersing JL, 2002, CLIN EXP IMMUNOL, V130, P404, DOI 10.1046/j.1365-2249.2002.02009.x; CANTORNA MT, 1994, J IMMUNOL, V152, P1515; Chattha KS, 2013, J IMMUNOL IN PRESS; Chattha KS, 2013, VACCINE, V31, P1916, DOI 10.1016/j.vaccine.2013.02.020; Cui DM, 2000, J NUTR, V130, P1132, DOI 10.1093/jn/130.5.1132; DEBOISSIEU D, 1993, J PEDIATR GASTR NUTR, V16, P29; Desselberger U, 2011, J INFECT DIS, V203, P188, DOI 10.1093/infdis/jiq031; Diness BR, 2010, J INFECT DIS, V202, pS243, DOI 10.1086/653569; Duriancik DM, 2010, CELL IMMUNOL, V265, P156, DOI 10.1016/j.cellimm.2010.08.006; Feng N, 2008, J VIROL, V82, P7578, DOI 10.1128/JVI.00391-08; Gray J, 2011, J INTERN MED, V270, P206, DOI 10.1111/j.1365-2796.2011.02409.x; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; Humphrey JH, 1996, J PEDIATR-US, V128, P489, DOI 10.1016/S0022-3476(96)70359-1; Imdad Aamer, 2011, BMC Public Health, V11 Suppl 3, pS20, DOI 10.1186/1471-2458-11-S3-S20; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jiang V, 2010, HUM VACCINES, V6, P532, DOI 10.4161/hv.6.7.11278; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kaufman DR, 2011, J IMMUNOL, V187, P1877, DOI 10.4049/jimmunol.1101248; Kozakova H, 2003, MICROBES INFECT, V5, P405, DOI 10.1016/S1286-4579(03)00045-5; Leal Jorymar Y, 2004, Invest. clín, V45, P243; LECCE J G, 1990, Molecular Biotherapy, V2, P211; Long KZ, 2007, J INFECT DIS, V196, P978, DOI 10.1086/521195; Long KZ, 2006, J INFECT DIS, V194, P1217, DOI 10.1086/508292; Ma YF, 2005, J IMMUNOL, V174, P7961, DOI 10.4049/jimmunol.174.12.7961; Molenaar R, 2011, J IMMUNOL, V186, P1934, DOI 10.4049/jimmunol.1001672; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Osanai M, 2007, MOL PHARMACOL, V71, P250, DOI 10.1124/mol.106.029579; Parreno V, 1999, J GEN VIROL, V80, P1417, DOI 10.1099/0022-1317-80-6-1417; Patel MM, 2009, J INFECT DIS, V200, pS291, DOI 10.1086/605059; Rahman MM, 1999, J NUTR, V129, P2192, DOI 10.1093/jn/129.12.2192; Reifen R, 2004, INT J VITAM NUTR RES, V74, P355, DOI 10.1024/0300-9831.74.5.355; ROMBOUT JHWM, 1992, BRIT J NUTR, V68, P753, DOI 10.1079/BJN19920131; Rudraraju R, 2012, CLIN VACCINE IMMUNOL, V19, P757, DOI 10.1128/CVI.05576-11; Saif LJ, 1996, ARCH VIROL, P153; SCHWERS A, 1985, ANN RECH VET, V16, P213; SEMBA RD, 1995, LANCET, V345, P1330; Stephensen CB, 1996, J NUTR, V126, P94, DOI 10.1093/jn/126.1.94; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Surman SL, 2012, VIRAL IMMUNOL, V25, P341, DOI 10.1089/vim.2012.0023; Tate JE, 2012, VACCINE, V30, pA179, DOI 10.1016/j.vaccine.2011.08.110; Thurnham DI, 2000, J INFECT DIS, V182, pS23, DOI 10.1086/315912; Van YH, 2009, DIABETES, V58, P146, DOI 10.2337/db08-1154; Villamor E, 2005, CLIN MICROBIOL REV, V18, P446, DOI 10.1128/CMR.18.3.446-464.2005; Vlasova AN, 2013, J IMMUNOL, V190, P4742, DOI 10.4049/jimmunol.1203575; Ward LA, 1996, J GEN VIROL, V77, P1431, DOI 10.1099/0022-1317-77-7-1431; WHO, 2009, GLOB PREV VIT A DEF, P55; WIEDERMANN U, 1993, INFECT IMMUN, V61, P3952, DOI 10.1128/IAI.61.9.3952-3957.1993; WIEDERMANN U, 1995, INFECT IMMUN, V63, P3062, DOI 10.1128/IAI.63.8.3062-3068.1995; Wieringa FT, 2004, EUR J CLIN NUTR, V58, P1498, DOI 10.1038/sj.ejcn.1601998; Yuan LJ, 1996, J VIROL, V70, P3075, DOI 10.1128/JVI.70.5.3075-3083.1996; Yuan LJ, 2002, VET IMMUNOL IMMUNOP, V87, P147, DOI 10.1016/S0165-2427(02)00046-6; Zhang W, 2008, VET IMMUNOL IMMUNOP, V122, P175, DOI 10.1016/j.vetimm.2007.10.003	59	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82966	10.1371/journal.pone.0082966	http://dx.doi.org/10.1371/journal.pone.0082966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312675	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500148
J	Drewnowska, JM; Swiecicka, I				Drewnowska, Justyna M.; Swiecicka, Izabela			Eco-Genetic Structure of Bacillus cereus sensu lato Populations from Different Environments in Northeastern Poland	PLOS ONE			English	Article							GROUP STRAINS; THURINGIENSIS; DIVERSITY; WEIHENSTEPHANENSIS; EVOLUTION; PCR; PATHOGENICITY; SYSTEMATICS; SPECIATION; INFERENCE	The Bacillus cereus group, which includes entomopathogens and etiologic agents of foodborne illness or anthrax, persists in various environments. The basis of their ecological diversification remains largely undescribed. Here we present the genetic structure and phylogeny of 273 soil B. cereus s.l. isolates from diverse habitats in northeastern Poland, with samplings acquired from the last European natural forest (Bialowieza National Park), the largest marshes in Europe (Biebrza National Park), and a farm. Inmulti-locus sequence typing (MLST), despite negative selection in seven housekeeping loci, the isolates exhibited high genetic diversity (325 alleles), mostly resulting from mutation events, and represented 148 sequencing types (131 STs new and 17 STs already described) grouped into 19 complexes corresponding with bacterial clones, and 80 singletons. Phylogenetic analyses showed that 74% of the isolates clustered with B. cereus s.l. environmental references (clade III), while only 11 and 15%, respectively, grouped with isolates of clinical origin (clade I), and B. cereus ATCC 14579 and reference B. thuringiensis (clade II). Predominantly within clade III, we found lineages adapted to low temperature (thermal ecotypes), while putative toxigenic isolates (cytK-positive) were scattered in all clades of the marsh and farm samplings. The occurrence of 92% of STs in bacilli originating from one habitat, and the description of new STs for 78% of the isolates, strongly indicate the existence of specific genotypes within the natural B. cereus s.l. populations. In contrast to the human-associated B. cereus s.l. that exhibit a significant level of similarity, the environmental isolates appear more complex. Thus we propose dividing B. cereus s.l. into two groups, the first including environmental isolates, and the second covering those that are of clinical relevance.	[Drewnowska, Justyna M.; Swiecicka, Izabela] Univ Bialystok, Dept Microbiol, Bialystok, Poland	University of Bialystok	Swiecicka, I (corresponding author), Univ Bialystok, Dept Microbiol, Bialystok, Poland.	izabelas@uwb.edu.pl	Drewnowska, Justyna M/K-2076-2016	Drewnowska, Justyna M/0000-0002-2004-8824; Swiecicka, Izabela/0000-0002-2750-9451	Ministry of Science and Higher Education in Poland [N N304 281 140]; fund "Specific scientific equipment"	Ministry of Science and Higher Education in Poland(Ministry of Science and Higher Education, Poland); fund "Specific scientific equipment"	This work has been founded by the Ministry of Science and Higher Education in Poland grant # N N304 281 140 and partly by the fund "Specific scientific equipment - 2012". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartoszewicz M, 2009, J APPL MICROBIOL, V106, P1967, DOI 10.1111/j.1365-2672.2009.04166.x; Ben-Dov E, 1999, APPL ENVIRON MICROB, V65, P3714; BenDov E, 1997, APPL ENVIRON MICROB, V63, P4883, DOI 10.1128/AEM.63.12.4883-4890.1997; Broughton LC, 2000, OECOLOGIA, V125, P420, DOI 10.1007/s004420000456; Bullied WJ, 2002, CAN J PLANT SCI, V82, P291; Ceuppens S, 2013, FEMS MICROBIOL ECOL, V84, P433, DOI 10.1111/1574-6941.12110; Cohan FM, 2007, CURR BIOL, V17, pR373, DOI 10.1016/j.cub.2007.03.032; Cohan FM, 2006, PHILOS T R SOC B, V361, P1985, DOI 10.1098/rstb.2006.1918; Connor N, 2010, APPL ENVIRON MICROB, V76, P1349, DOI 10.1128/AEM.01988-09; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Didelot X, 2009, SYST APPL MICROBIOL, V32, P81, DOI 10.1016/j.syapm.2009.01.001; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Guinebretiere MH, 2008, ENVIRON MICROBIOL, V10, P851, DOI 10.1111/j.1462-2920.2007.01495.x; Guinebretiere MH, 2013, INT J SYST EVOL MICR, V63, P31, DOI 10.1099/ijs.0.030627-0; Guinebretiere MH, 2010, J CLIN MICROBIOL, V48, P3388, DOI 10.1128/JCM.00921-10; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Horner-Devine MC, 2004, P ROY SOC B-BIOL SCI, V271, P113, DOI 10.1098/rspb.2003.2549; Hoton FM, 2009, ENV MICROBIOL REP, V1, P177, DOI 10.1111/j.1758-2229.2009.00028.x; Hu XM, 2009, FEMS MICROBIOL ECOL, V70, P344, DOI 10.1111/j.1574-6941.2009.00771.x; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Koeppel AF, 2013, ISME J, V7, P1080, DOI 10.1038/ismej.2013.3; Lechner S, 1998, INT J SYST BACTERIOL, V48, P1373, DOI 10.1099/00207713-48-4-1373; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Logan NA, 2012, J APPL MICROBIOL, V112, P417, DOI 10.1111/j.1365-2672.2011.05204.x; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Materna AC, 2012, ISME J, V6, P2168, DOI 10.1038/ismej.2012.65; McArthur JV, 2006, MICROBIAL ECOLOGY EV, P253; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Murawska E, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00108-13; Nakamura LK, 1998, INT J SYST BACTERIOL, V48, P1031, DOI 10.1099/00207713-48-3-1031; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004; Radnedge L, 2003, APPL ENVIRON MICROB, V69, P2755, DOI 10.1128/AEM.69.5.2755-2764.2003; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Raymond B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000905; Reiter L, 2011, J MICROBIOL METH, V86, P210, DOI 10.1016/j.mimet.2011.05.006; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Sorokin A, 2006, APPL ENVIRON MICROB, V72, P1569, DOI 10.1128/AEM.72.2.1569-1578.2006; Soufiane B, 2010, CURR MICROBIOL, V60, P343, DOI 10.1007/s00284-009-9547-z; Swiecicka I, 2006, FEMS MICROBIOL ECOL, V56, P132, DOI 10.1111/j.1574-6941.2006.00063.x; Swiecicka I, 2008, BIOCONTROL SCI TECHN, V18, P221, DOI 10.1080/09583150801942334; Swiecicka I, 2013, FEMS MICROBIOL ECOL, V85, P262, DOI 10.1111/1574-6941.12116; Synge H., 2004, EUROPEAN MODELS GOOD; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thorsen L, 2006, APPL ENVIRON MICROB, V72, P5118, DOI 10.1128/AEM.00170-06; Turner JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055726; van Frankenhuyzen K, 2009, J INVERTEBR PATHOL, V101, P1, DOI 10.1016/j.jip.2009.02.009; von Stetten F, 1999, ENVIRON MICROBIOL, V1, P503, DOI 10.1046/j.1462-2920.1999.00070.x; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Ward DM, 2006, PHILOS T R SOC B, V361, P1997, DOI 10.1098/rstb.2006.1919; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; Zwick ME, 2012, GENOME RES, V22, P1512, DOI 10.1101/gr.134437.111	57	25	26	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80175	10.1371/journal.pone.0080175	http://dx.doi.org/10.1371/journal.pone.0080175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312460	gold, Green Published, Green Submitted			2022-12-25	WOS:000327944500015
J	Kim, K; Park, SJ; Na, S; Kim, JS; Choi, H; Kim, YK; Paek, E; Lee, C				Kim, Kyutae; Park, Seong-Jun; Na, Seungjin; Kim, Jun Seok; Choi, Hyungwon; Kim, Yoon Ki; Paek, Eunok; Lee, Cheolju			Reinvestigation of Aminoacyl-TRNA Synthetase Core Complex by Affinity Purification-Mass Spectrometry Reveals TARSL2 as a Potential Member of the Complex	PLOS ONE			English	Article							PROTEIN INTERACTIONS; BREAST-CANCER; C-MYC; TRANSLATION; ASSIGNMENT; INTERACTS; TARGET; SIGNAL; FANCD2; AIMP2	Twenty different aminoacyl-tRNA synthetases (ARSs) link each amino acid to their cognate tRNAs. Individual ARSs are also associated with various non-canonical activities involved in neuronal diseases, cancer and autoimmune diseases. Among them, eight ARSs (D, EP, I, K, L, M, Q and RARS), together with three ARS-interacting multifunctional proteins (AIMPs), are currently known to assemble the multi-synthetase complex (MSC). However, the cellular function and global topology of MSC remain unclear. In order to understand the complex interaction within MSC, we conducted affinity purification-mass spectrometry (AP-MS) using each of AIMP1, AIMP2 and KARS as a bait protein. Mass spectrometric data were funneled into SAINT software to distinguish true interactions from background contaminants. A total of 40, 134, 101 proteins in each bait scored over 0.9 of SAINT probability in HEK 293T cells. Complex-forming ARSs, such as DARS, EPRS, IARS, Kars, LARS, MARS, QARS and RARS, were constantly found to interact with each bait. Variants such as, AIMP2-DX2 and AIMP1 isoform 2 were found with specific peptides in KARS precipitates. Relative enrichment analysis of the mass spectrometric data demonstrated that TARSL2 (threonyl-tRNA synthetase like-2) was highly enriched with the ARS-core complex. The interaction was further confirmed by coimmunoprecipitation of TARSL2 with other ARS core-complex components. We suggest TARSL2 as a new component of ARS core-complex.	[Kim, Kyutae; Park, Seong-Jun; Kim, Jun Seok; Lee, Cheolju] Korea Inst Sci & Technol, Biomed Res Inst, Seoul, South Korea; [Kim, Kyutae; Kim, Yoon Ki] Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea; [Na, Seungjin; Paek, Eunok] Hanyang Univ, Div Comp Sci & Engn, Seoul 133791, South Korea; [Choi, Hyungwon] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Lee, Cheolju] Univ Sci & Technol, Dept Biol Chem, Taejon, South Korea	Korea Institute of Science & Technology (KIST); Korea University; Hanyang University; National University of Singapore	Lee, C (corresponding author), Korea Inst Sci & Technol, Biomed Res Inst, Seoul, South Korea.	clee270@kist.re.kr	Choi, Hyungwon/S-8824-2019	Choi, Hyungwon/0000-0002-6687-3088; Kim, Yoon Ki/0000-0003-1303-072X; Na, Seungjin/0000-0002-5159-2048	Biomedical Convergence Global Frontier program; Proteogenomics Research program; MEST; KIST intramural program	Biomedical Convergence Global Frontier program; Proteogenomics Research program; MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); KIST intramural program	This study was supported by grants from the Biomedical Convergence Global Frontier program and the Proteogenomics Research program funded by MEST, and a KIST intramural program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazykin GA, 2011, NUCLEIC ACIDS RES, V39, P567, DOI 10.1093/nar/gkq806; Bhatia VN, 2009, ANAL CHEM, V81, P9819, DOI 10.1021/ac901335x; Camilleri-Broet S, 2007, ONCOGENE, V26, P142, DOI 10.1038/sj.onc.1209762; Chen F W, 1999, Int Rev Immunol, V18, P429, DOI 10.3109/08830189909088492; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Choi JW, 2012, J MOL CELL BIOL, V4, P164, DOI 10.1093/jmcb/mjs018; Choi JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001351; Choi JW, 2009, J CELL SCI, V122, P2710, DOI 10.1242/jcs.049767; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fermin D, 2011, PROTEOMICS, V11, P1340, DOI 10.1002/pmic.201000650; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Halwani R, 2004, J VIROL, V78, P7553, DOI 10.1128/JVI.78.14.7553-7564.2004; Han JM, 2008, P NATL ACAD SCI USA, V105, P11206, DOI 10.1073/pnas.0800297105; Hong EA, 2012, BIOCHEM SOC T, V40, P826, DOI 10.1042/BST20120030; Jung SY, 2008, ANAL CHEM, V80, P1721, DOI 10.1021/ac7021025; Kean MJ, 2012, METHODS, V57, P400, DOI 10.1016/j.ymeth.2012.06.002; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Kim E, 2008, J IMMUNOL, V180, P2894, DOI 10.4049/jimmunol.180.5.2894; Kim JH, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-50; Kim MJ, 2003, NAT GENET, V34, P330, DOI 10.1038/ng1182; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; Mahadev K, 2002, EXP CELL RES, V279, P40, DOI 10.1006/excr.2002.5583; Meerschaert K, 2008, J PROTEOME RES, V7, P4962, DOI 10.1021/pr800325u; Meriin AB, 2012, J CELL SCI, V125, P2665, DOI 10.1242/jcs.098954; Na S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010199; Nathanson L, 2000, J BIOL CHEM, V275, P31559, DOI 10.1074/jbc.C000385200; Oeffinger M, 2012, PROTEOMICS, V12, P1591, DOI 10.1002/pmic.201100509; Pardo M, 2012, J PROTEOME RES, V11, P1462, DOI 10.1021/pr2011632; Park SG, 2010, IUBMB LIFE, V62, P296, DOI 10.1002/iub.324; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Park SG, 2005, AM J PATHOL, V166, P387, DOI 10.1016/S0002-9440(10)62262-6; Park SG, 2002, J BIOL CHEM, V277, P45243, DOI 10.1074/jbc.M207934200; Sardiu ME, 2008, P NATL ACAD SCI USA, V105, P1454, DOI 10.1073/pnas.0706983105; Sareen A, 2012, NUCLEIC ACIDS RES, V40, P8425, DOI 10.1093/nar/gks638; Schmitt MJ, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-41; Skarra DV, 2011, PROTEOMICS, V11, P1508, DOI 10.1002/pmic.201000770; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Wang GH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-225; Wang GH, 2012, BIOCHEM J, V446, P415, DOI 10.1042/BJ20112050; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Yuan FH, 2009, J BIOL CHEM, V284, P24443, DOI 10.1074/jbc.M109.016006; Zaidi N, 2012, CANCER RES, V72, P3709, DOI 10.1158/0008-5472.CAN-11-4112; Zhang J, 2012, CANCER LETT, V318, P34, DOI 10.1016/j.canlet.2011.11.033; Zhao J, 2011, J PROTEOMICS, V75, P588, DOI 10.1016/j.jprot.2011.08.021	50	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81734	10.1371/journal.pone.0081734	http://dx.doi.org/10.1371/journal.pone.0081734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312579	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500092
J	Kirsten, TB; Lippi, LL; Bevilacqua, E; Bernardi, MM				Kirsten, Thiago B.; Lippi, Luciana L.; Bevilacqua, Estela; Bernardi, Maria M.			LPS Exposure Increases Maternal Corticosterone Levels, Causes Placental Injury and Increases IL-1B Levels in Adult Rat Offspring: Relevance to Autism	PLOS ONE			English	Article							PRENATAL IMMUNE ACTIVATION; INFLAMMATORY RESPONSE; EXPERIMENTAL-MODEL; SOCIAL-BEHAVIOR; AMNIOTIC-FLUID; BRAIN; INFECTION; CYTOKINES; EXPRESSION; CHALLENGE	Maternal immune activation can induce neuropsychiatric disorders, such as autism and schizophrenia. Previous investigations by our group have shown that prenatal treatment of rats on gestation day 9.5 with lipopolysaccharide (LPS; 100 mu g/kg, intraperitoneally), which mimics infections by gram-negative bacteria, induced autism-like behavior in male rats, including impaired communication and socialization and induced repetitive/restricted behavior. However, the behavior of female rats was unchanged. Little is known about how LPS-induced changes in the pregnant dam subsequently affect the developing fetus and the fetal immune system. The present study evaluated the hypothalamic-pituitary-adrenal (HPA) axis activity, the placental tissue and the reproductive performance of pregnant Wistar rats exposed to LPS. In the adult offspring, we evaluated the HPA axis and pro-inflammatory cytokine levels with or without a LPS challenge. LPS exposure increased maternal serum corticosterone levels, injured placental tissue and led to higher post-implantation loss, resulting in fewer live fetuses. The HPA axis was not affected in adult offspring. However, prenatal LPS exposure increased IL-1 beta serum levels, revealing that prenatal LPS exposure modified the immune response to a LPS challenge in adulthood. Increased IL-1 beta levels have been reported in several autistic patients. Together with our previous studies, our model induced autistic-like behavioral and immune disturbances in childhood and adulthood, indicating that it is a robust rat model of autism.	[Kirsten, Thiago B.; Lippi, Luciana L.] Univ Sao Paulo, Sch Vet Med, Dept Pathol, Sao Paulo, Brazil; [Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil; [Bernardi, Maria M.] Univ Paulista, Grad Program Environm & Expt Pathol, Sao Paulo, Brazil; [Bernardi, Maria M.] Univ Paulista, Grad Program Dent, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Paulista; Universidade Paulista	Kirsten, TB (corresponding author), Univ Sao Paulo, Sch Vet Med, Dept Pathol, Sao Paulo, Brazil.	thik@hotmail.com	Bernardi, M. M./H-8418-2012; Bevilacqua, Estela/H-3354-2011; Bernardi, Maria/T-6813-2019; Kirsten, Thiago Berti/AAS-2166-2021	Bernardi, M. M./0000-0002-6860-9416; Bevilacqua, Estela/0000-0003-4178-4625; Kirsten, Thiago Berti/0000-0002-4032-4355	Sao Paulo Research Foundation (FAPESP) [2008/53861-5, 2012/07007-8, 2009/51886-3]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by the Sao Paulo Research Foundation (FAPESP grant 2008/53861-5, 2012/07007-8 and thematic grant 2009/51886-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashdown H, 2006, MOL PSYCHIATR, V11, P47, DOI 10.1038/sj.mp.4001748; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Bayer TA, 1999, J PSYCHIATR RES, V33, P543, DOI 10.1016/S0022-3956(99)00039-4; Bell MJ, 2004, PEDIATR RES, V56, P541, DOI 10.1203/01.PDR.0000139407.89883.6B; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Burton GJ, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P189; Cai ZW, 2000, PEDIATR RES, V47, P64, DOI 10.1203/00006450-200001000-00013; CASEY ML, 1989, J CLIN INVEST, V83, P430, DOI 10.1172/JCI113901; Coyle P, 2009, BEHAV BRAIN RES, V197, P210, DOI 10.1016/j.bbr.2008.08.022; Croonenberghs J, 2002, NEUROPSYCHOBIOLOGY, V45, P1, DOI 10.1159/000048665; de Lima CB, 2010, INT IMMUNOPHARMACOL, V10, P1335, DOI 10.1016/j.intimp.2010.08.015; Dey SK, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P147; Dunn AJ, 2006, CLIN NEUROSCI RES, V6, P52, DOI 10.1016/j.cnr.2006.04.002; Gayle DA, 2004, AM J PHYSIOL-REG I, V286, pR1024, DOI 10.1152/ajpregu.00664.2003; Giovanoli S, 2013, SCIENCE, V339, P1095, DOI 10.1126/science.1228261; Golan HM, 2005, NEUROPHARMACOLOGY, V48, P903, DOI 10.1016/j.neuropharm.2004.12.023; HALL GA, 1974, AM J PATHOL, V77, P299; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Jyonouchi H, 2001, J NEUROIMMUNOL, V120, P170, DOI 10.1016/S0165-5728(01)00421-0; KENT S, 1992, TRENDS PHARMACOL SCI, V13, P24, DOI 10.1016/0165-6147(92)90012-U; Kirsten TB, 2012, J NEUROSCI RES, V90, P1903, DOI 10.1002/jnr.23089; Kirsten TB, 2010, NEUROIMMUNOMODULAT, V17, P240, DOI 10.1159/000290040; Kirsten TB, 2011, PHYSIOL BEHAV, V104, P417, DOI 10.1016/j.physbeh.2011.04.049; Kirsten TB, 2011, LIFE SCI, V89, P15, DOI 10.1016/j.lfs.2011.04.023; Kirsten TB, 2010, BEHAV BRAIN RES, V211, P77, DOI 10.1016/j.bbr.2010.03.009; Kwon O, 2002, BIOL PHARM BULL, V25, P1165, DOI 10.1248/bpb.25.1165; Lenczowski MJP, 1997, AM J PHYSIOL-REG I, V273, pR1870, DOI 10.1152/ajpregu.1997.273.6.R1870; Levario-Carrillo M, 2004, EXP TOXICOL PATHOL, V55, P489, DOI 10.1078/0940-2993-00346; Li XH, 2009, J NEUROIMMUNOL, V207, P111, DOI 10.1016/j.jneuroim.2008.12.002; MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005; Maynard TM, 2001, SCHIZOPHRENIA BULL, V27, P457, DOI 10.1093/oxfordjournals.schbul.a006887; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; Meyer U, 2011, PEDIATR RES, V69, p26R, DOI 10.1203/PDR.0b013e318212c196; Meyer U, 2009, NEUROSCI BIOBEHAV R, V33, P1061, DOI 10.1016/j.neubiorev.2009.05.001; Mor Gil, 2003, Reprod Biol Endocrinol, V1, P119, DOI 10.1186/1477-7827-1-119; REUL JMHM, 1994, J CLIN INVEST, V93, P2600, DOI 10.1172/JCI117272; RICHARDS IS, 2008, PRINCIPLES PRACTICE, P139; Romero E, 2010, MOL PSYCHIATR, V15, P372, DOI 10.1038/mp.2008.44; SILEN ML, 1989, AM J PATHOL, V135, P239; SUTANTO W, 1987, ENDOCRINOLOGY, V121, P1405, DOI 10.1210/endo-121-4-1405; Urakubo A, 2001, SCHIZOPHR RES, V47, P27, DOI 10.1016/S0920-9964(00)00032-3; Vismari L, 2012, IMMUNOPHARM IMMUNOT, V34, P578, DOI 10.3109/08923973.2011.638305; Wang XY, 2006, SEMIN FETAL NEONAT M, V11, P343, DOI 10.1016/j.siny.2006.04.002; Xu DX, 2006, TOXICOL LETT, V163, P20, DOI 10.1016/j.toxlet.2005.09.009; Zhao L, 2008, TOXICOL SCI, V103, P149, DOI 10.1093/toxsci/kfn027	45	64	67	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82244	10.1371/journal.pone.0082244	http://dx.doi.org/10.1371/journal.pone.0082244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312647	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500130
J	Lo, R; Chandar, NB; Kesharwani, MK; Jain, A; Ganguly, B				Lo, Rabindranath; Chandar, Nellore Bhanu; Kesharwani, Manoj K.; Jain, Aastha; Ganguly, Bishwajit			In Silico Studies in Probing the Role of Kinetic and Structural Effects of Different Drugs for the Reactivation of Tabun-Inhibited AChE	PLOS ONE			English	Article							ORGANOPHOSPHORUS NERVE AGENTS; POLARIZABLE CONTINUUM MODEL; HUMAN ACETYLCHOLINESTERASE; CHOLINESTERASE CATALYSIS; UNCHARGED REACTIVATORS; ALPHA-NUCLEOPHILES; CRYSTAL-STRUCTURES; TRANSITION-STATES; OXIMES; SARIN	We have examined the reactivation mechanism of the tabun-conjugated AChE with various drugs using density functional theory (DFT) and post-Hartree-Fock methods. The electronic environments and structural features of neutral oximes (deazapralidoxime and 3-hydroxy-2-pyridinealdoxime) and charged monopyridinium oxime (2-PAM) and bispyridinium oxime (Ortho-7) are different, hence their efficacy varies towards the reactivation process of tabun-conjugated AChE. The calculated potential energy surfaces suggest that a monopyridinium reactivator is less favorable for the reactivation of tabun-inhibited AChE compared to a bis-quaternary reactivator, which substantiates the experimental study. The rate determining barrier with neutral oximes was found to be similar to 2.5 kcal/mol, which was similar to 5.0 kcal/mol lower than charged oxime drugs such as Ortho-7. The structural analysis of the calculated geometries suggest that the charged oximes form strong O center dot center dot center dot H and N center dot center dot center dot H hydrogen bonding and C-H center dot center dot center dot pi non-bonding interaction with the tabun-inhibited enzyme to stabilize the reactant complex compared to separated reactants, which influences the activation barrier. The ability of neutral drugs to cross the blood-brain barrier was also found to be superior to charged antidotes, which corroborates the available experimental observations. The calculated activation barriers support the superiority of neutral oximes for the activation of tabun-inhibited AChE compared to charged oximes. However, they lack effective interactions with their peripheral sites. Docking studies revealed that the poor binding affinity of simple neutral oxime drugs such as 3-hydroxy-2-pyridinealdoxime inside the active-site gorge of AChE was significantly augmented with the addition of neutral peripheral units compared to conventional charged peripheral sites. The newly designed oxime drug 2 appears to be an attractive candidate as efficient antidote to kinetically and structurally reactivate the tabun-inhibited enzyme.	[Lo, Rabindranath; Chandar, Nellore Bhanu; Kesharwani, Manoj K.; Jain, Aastha; Ganguly, Bishwajit] CSIR Cent Salt & Marine Chem Res Inst, Analyt Discipline, Computat & Simulat Unit, Bhavnagar, Gujarat, India; [Lo, Rabindranath; Chandar, Nellore Bhanu; Kesharwani, Manoj K.; Jain, Aastha; Ganguly, Bishwajit] CSIR Cent Salt & Marine Chem Res Inst, Centralized Instrument Facil, Computat & Simulat Unit, Bhavnagar, Gujarat, India; [Chandar, Nellore Bhanu; Ganguly, Bishwajit] CSIR CSMCRI, Acad Sci & Innovat Res, Bhavnagar, Gujarat, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI)	Ganguly, B (corresponding author), CSIR Cent Salt & Marine Chem Res Inst, Analyt Discipline, Computat & Simulat Unit, Bhavnagar, Gujarat, India.	ganguly@csmcri.org	Kesharwani, Manoj/H-2815-2012; Lo, Rabindranath/AAC-7685-2021; Lo, Rabindranath/D-6991-2016	Kesharwani, Manoj/0000-0002-8247-5119; Lo, Rabindranath/0000-0002-4436-3618; Lo, Rabindranath/0000-0002-4436-3618	MSM; SIP; CSIR, New Delhi; DST, New Delhi	MSM(Ministry of Education, Youth & Sports - Czech Republic); SIP; CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); DST, New Delhi(Department of Science & Technology (India))	MSM, SIP, CSIR, New Delhi and DST, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisaraie L, 2006, J CHEM INF MODEL, V46, P1174, DOI 10.1021/ci050343m; [Anonymous], PALL 3413 SOFTW; [Anonymous], 2007, AUT VERS 4 2; Barone V, 1998, J COMPUT CHEM, V19, P404, DOI 10.1002/(SICI)1096-987X(199803)19:4<404::AID-JCC3>3.0.CO;2-W; Barone V, 1997, J CHEM PHYS, V107, P3210, DOI 10.1063/1.474671; BERENDS F, 1959, BIOCHIM BIOPHYS ACTA, V34, P576, DOI 10.1016/0006-3002(59)90321-X; Cances E, 1997, J CHEM PHYS, V107, P3032, DOI 10.1063/1.474659; Deb PK, 2012, MOL DIVERS, V16, P803, DOI 10.1007/s11030-012-9394-x; Delfino RT, 2009, J PHYS CHEM B, V113, P8402, DOI 10.1021/jp810686k; Eddleston M, 2002, QJM-INT J MED, V95, P275, DOI 10.1093/qjmed/95.5.275; Ekstrom FJ, 2007, CLIN PHARMACOL THER, V82, P282, DOI 10.1038/sj.clpt.6100151; Ekstrom F, 2006, BIOCHEM PHARMACOL, V72, P597, DOI 10.1016/j.bcp.2006.05.027; Frisch M.J., 2009, GAUSSIAN 09 REVIS D0; Geerlings P, 2003, CHEM REV, V103, P1793, DOI 10.1021/cr990029p; Goncalves AD, 2006, J BRAZIL CHEM SOC, V17, P968, DOI 10.1590/S0103-50532006000500022; GONZALEZ C, 1991, J CHEM PHYS, V95, P5853, DOI 10.1063/1.461606; GONZALEZ C, 1990, J PHYS CHEM-US, V94, P5523, DOI 10.1021/j100377a021; HANSCH C, 1964, J AM CHEM SOC, V86, P1616, DOI 10.1021/ja01062a035; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; Hehre W.J., 1988, AB INITIO MOL ORBITA; Hornberg A, 2010, BIOCHEM PHARMACOL, V79, P507, DOI 10.1016/j.bcp.2009.08.027; Houk KN, 1997, J AM CHEM SOC, V119, P10147, DOI 10.1021/ja963847x; JARV J, 1984, BIOORG CHEM, V12, P259, DOI 10.1016/0045-2068(84)90010-5; Kalisiak J, 2012, J MED CHEM, V55, P465, DOI 10.1021/jm201364d; Kalisiak J, 2011, J MED CHEM, V54, P3319, DOI 10.1021/jm200054r; Khan MAS, 2011, J MOL GRAPH MODEL, V29, P1039, DOI 10.1016/j.jmgm.2011.04.009; Koelle G B, 1981, FUNDAM APPL TOXICOL, V1, P129; Kovarik Zrinka, 2007, Arhiv za Higijenu Rada i Toksikologiju, V58, P201, DOI 10.2478/v10004-007-0013-7; Lorke DE, 2009, J APPL TOXICOL, V29, P459, DOI 10.1002/jat.1457; MARRS TC, 1993, PHARMACOL THERAPEUT, V58, P51, DOI 10.1016/0163-7258(93)90066-M; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Mennucci B, 1997, J CHEM PHYS, V106, P5151, DOI 10.1063/1.473558; Mercey G, 2012, J MED CHEM, V55, P10791, DOI 10.1021/jm3015519; Mercey G, 2012, ACCOUNTS CHEM RES, V45, P756, DOI 10.1021/ar2002864; Mercey G, 2011, CHEM COMMUN, V47, P5295, DOI 10.1039/c1cc10787a; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Moller C, 1934, PHYS REV, V46, P0618, DOI 10.1103/PhysRev.46.618; Nurulain SM, 2011, TROP J PHARM RES, V10, P341, DOI 10.4314/tjpr.v10i3.10; QUINN DM, 1987, CHEM REV, V87, P955, DOI 10.1021/cr00081a005; Renou J, 2013, CHEM-BIOL INTERACT, V203, P81, DOI 10.1016/j.cbi.2012.09.023; Saint-Andre G, 2011, TETRAHEDRON, V67, P6352, DOI 10.1016/j.tet.2011.05.130; Sakurada K, 2003, NEUROCHEM RES, V28, P1401, DOI 10.1023/A:1024960819430; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TAFURI J, 1987, ANN EMERG MED, V16, P193, DOI 10.1016/S0196-0644(87)80015-X; Taylor P, 1995, TOXICOL LETT, V82-3, P453, DOI 10.1016/0378-4274(95)03575-3; TAYLOR P, 1975, BIOCHEMISTRY-US, V14, P1989, DOI 10.1021/bi00680a029; Tomasi J, 1999, J MOL STRUC-THEOCHEM, V464, P211, DOI 10.1016/S0166-1280(98)00553-3; Vyas S, 2008, CHEM-BIOL INTERACT, V175, P187, DOI 10.1016/j.cbi.2008.05.006; Wang J, 2006, J PHYS CHEM B, V110, P7567, DOI 10.1021/jp060370v; Wang J, 2005, J PHYS CHEM B, V109, P1006, DOI 10.1021/jp040574g; Wang J, 2007, J PHYS CHEM B, V111, P2404, DOI 10.1021/jp067741s; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Wong L, 2000, BIOCHEMISTRY-US, V39, P5750, DOI 10.1021/bi992906r; Worek F, 2004, BIOCHEM PHARMACOL, V68, P2237, DOI 10.1016/j.bcp.2004.07.038; Worek F, 2007, BIOCHEM PHARMACOL, V73, P1807, DOI 10.1016/j.bcp.2007.02.008; Zhao Y, 2008, ACCOUNTS CHEM RES, V41, P157, DOI 10.1021/ar700111a	56	9	10	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e79591	10.1371/journal.pone.0079591	http://dx.doi.org/10.1371/journal.pone.0079591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312449	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500006
J	Wood, TE; Detto, M; Silver, WL				Wood, Tana E.; Detto, Matteo; Silver, Whendee L.			Sensitivity of Soil Respiration to Variability in Soil Moisture and Temperature in a Humid Tropical Forest	PLOS ONE			English	Article							CARBON-DIOXIDE LOSSES; AMAZONIAN RAIN-FOREST; CO2 EFFLUX; EXPERIMENTAL DROUGHT; TEMPORAL VARIATION; IRON REDUCTION; WATER CONTENT; CLIMATE; PHOTOSYNTHESIS; DECOMPOSITION	Precipitation and temperature are important drivers of soil respiration. The role of moisture and temperature are generally explored at seasonal or inter-annual timescales; however, significant variability also occurs on hourly to daily time-scales. We used small (1.54 m(2)), throughfall exclusion shelters to evaluate the role soil moisture and temperature as temporal controls on soil CO2 efflux from a humid tropical forest in Puerto Rico. We measured hourly soil CO2 efflux, temperature and moisture in control and exclusion plots (n = 6) for 6-months. The variance of each time series was analyzed using orthonormal wavelet transformation and Haar-wavelet coherence. We found strong negative coherence between soil moisture and soil respiration in control plots corresponding to a two-day periodicity. Across all plots, there was a significant parabolic relationship between soil moisture and soil CO2 efflux with peak soil respiration occurring at volumetric soil moisture of approximately 0.375 m(3)/m(3). We additionally found a weak positive coherence between CO2 and temperature at longer time-scales and a significant positive relationship between soil temperature and CO2 efflux when the analysis was limited to the control plots. The coherence between CO2 and both temperature and soil moisture were reduced in exclusion plots. The reduced CO2 response to temperature in exclusion plots suggests that the positive effect of temperature on CO2 is constrained by soil moisture availability.	[Wood, Tana E.] USDA, Int Inst Trop Forestry, Forest Serv, Rio Piedras, PR USA; [Wood, Tana E.] Fdn Puertorriquena Conservac, San Juan, PR USA; [Detto, Matteo] Smithsonian Trop Res Inst, Apartado Balboa, Panama; Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	United States Department of Agriculture (USDA); United States Forest Service; Smithsonian Institution; Smithsonian Tropical Research Institute; University of California System; University of California Berkeley	Wood, TE (corresponding author), USDA, Int Inst Trop Forestry, Forest Serv, Rio Piedras, PR USA.	wood.tana@gmail.com	Silver, Whendee L./H-1118-2012	Silver, Whendee L./0000-0003-0372-8745; Wood, Tana/0000-0001-6322-6224	National Oceanic and Atmospheric Administration (NOAA); National Science Foundation (NSF) [DEB-0620910]; United States Department of Agriculture (USDA) Forest Service International Institute of Tropical Forestry; Division Of Earth Sciences [1331841] Funding Source: National Science Foundation	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); United States Department of Agriculture (USDA) Forest Service International Institute of Tropical Forestry; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Research support was provided by the National Oceanic and Atmospheric Administration (NOAA) Climate and Global Change Postdoctoral Fellowship, DEB-0620910 from the National Science Foundation (NSF) to the Institute of Tropical Ecosystem Studies (IEET), University of Puerto Rico, and the United States Department of Agriculture (USDA) Forest Service International Institute of Tropical Forestry as part of the Long Term Ecological Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2005, ECOL LETT, V8, P626, DOI 10.1111/j.1461-0248.2005.00756.x; Amthor JS, 2010, AGR FOREST METEOROL, V150, P497, DOI 10.1016/j.agrformet.2009.11.020; Balser TC, 2009, GLOBAL CHANGE BIOL, V15, P2935, DOI 10.1111/j.1365-2486.2009.01946.x; Cattanio JH, 2002, BIOL FERT SOILS, V36, P102, DOI 10.1007/s00374-002-0517-x; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Chacon N, 2006, BIOGEOCHEMISTRY, V78, P67, DOI 10.1007/s10533-005-2343-3; Chambers JQ, 2004, ECOL APPL, V14, pS72; Cleveland CC, 2006, P NATL ACAD SCI USA, V103, P10316, DOI 10.1073/pnas.0600989103; Cleveland CC, 2011, ECOL LETT, V14, P939, DOI 10.1111/j.1461-0248.2011.01658.x; Cleveland CC, 2010, ECOLOGY, V91, P2313, DOI 10.1890/09-1582.1; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; Corlett RT, 2011, TRENDS ECOL EVOL, V26, P606, DOI 10.1016/j.tree.2011.06.015; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2004, GLOBAL CHANGE BIOL, V10, P718, DOI 10.1111/j.1365-2486.2004.00762.x; Davidson EA, 2000, BIOGEOCHEMISTRY, V48, P53, DOI 10.1023/A:1006204113917; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; DeAngelis KM, 2010, ENVIRON MICROBIOL, V12, P3137, DOI 10.1111/j.1462-2920.2010.02286.x; Detto M, AM NATURALI IN PRESS; Dubinsky EA, 2010, ECOLOGY, V91, P2604, DOI 10.1890/09-1365.1; EDWARDS NT, 1975, SOIL SCI SOC AM J, V39, P361, DOI 10.2136/sssaj1975.03615995003900020034x; Hall SJ, 2013, ECOSYSTEMS, V16, P576, DOI 10.1007/s10021-012-9631-2; Heartsill-Scalley T, 2007, J HYDROL, V333, P472, DOI 10.1016/j.jhydrol.2006.09.019; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Holdridge LR, 1967, LIFE ZONE ECOLOGY; Holland EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1137, DOI 10.1029/2000GB001264; INO Y, 1969, JPN J BOT, V20, P153; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Kumar P., 1995, WAVELETS GEOPHYS, P151; KURSAR TA, 1989, PLANT SOIL, V113, P21, DOI 10.1007/BF02181917; Kuzyakov Y, 2010, GLOBAL CHANGE BIOL, V16, P3386, DOI 10.1111/j.1365-2486.2010.02179.x; Liptzin D, 2011, ECOSYSTEMS, V14, P171, DOI 10.1007/s10021-010-9402-x; Liptzin D, 2009, SOIL BIOL BIOCHEM, V41, P1696, DOI 10.1016/j.soilbio.2009.05.013; Londo AJ, 1999, SOIL SCI SOC AM J, V63, P637, DOI 10.2136/sssaj1999.03615995006300030029x; Medina E., 1972, "Tropical Ecology", Proceedings of the New Delhi Symposium, January, 1971., P245; Metcalfe DB, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000443; Mondal D, 2010, ANN I STAT MATH, V62, P943, DOI 10.1007/s10463-008-0195-z; Norman AG, 1966, ADV AGRON, V18, P57, DOI DOI 10.1016/S0065-2113(08)60648-3; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rowlings DW, 2012, GLOBAL CHANGE BIOL, V18, P726, DOI 10.1111/j.1365-2486.2011.02563.x; Schwendenmann L, 2003, BIOGEOCHEMISTRY, V64, P111, DOI 10.1023/A:1024941614919; Schwendenmann L, 2006, GLOBAL CHANGE BIOL, V12, P1878, DOI 10.1111/j.1365-2486.2006.01235.x; Silver WL, 1999, BIOGEOCHEMISTRY, V44, P301, DOI 10.1007/BF00996995; SINGH JS, 1977, BOT REV, V43, P499, DOI 10.1007/BF02860844; Sotta ED, 2006, FOREST ECOL MANAG, V237, P57, DOI 10.1016/j.foreco.2006.09.027; Sotta ED, 2004, GLOBAL CHANGE BIOL, V10, P601, DOI 10.1111/j.1529-8817.2003.00761.x; Sotta ED, 2007, GLOBAL CHANGE BIOL, V13, P2218, DOI 10.1111/j.1365-2486.2007.01416.x; STARK JM, 1995, APPL ENVIRON MICROB, V61, P218, DOI 10.1128/AEM.61.1.218-221.1995; Subke JA, 2006, GLOBAL CHANGE BIOL, V12, P921, DOI 10.1111/j.1365-2486.2006.01117.x; Tang JW, 2005, GLOBAL CHANGE BIOL, V11, P1298, DOI 10.1111/j.1365-2486.2005.00978.x; Vandecar KL, 2009, ECOLOGY, V90, P2547, DOI 10.1890/08-1516.1; Vargas R, 2008, NEW PHYTOL, V179, P460, DOI 10.1111/j.1469-8137.2008.02481.x; Vargas R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000620; VITOUSEK PM, 1984, ECOLOGY, V65, P285, DOI 10.2307/1939481; WOFSY SC, 1988, J GEOPHYS RES-ATMOS, V93, P1377, DOI 10.1029/JD093iD02p01377; Wood TE, 2012, BIOL REV, V87, P912, DOI 10.1111/j.1469-185X.2012.00232.x; Wood TE, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB004014	57	67	73	3	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80965	10.1371/journal.pone.0080965	http://dx.doi.org/10.1371/journal.pone.0080965			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312508	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500045
J	Zheng, J; Chan, PL; Liu, YP; Qin, G; Xiang, Z; Lam, KT; Lewis, DB; Lau, YL; Tu, WW				Zheng, Jian; Chan, Ping-Lung; Liu, Yinping; Qin, Gang; Xiang, Zheng; Lam, Kwok-Tai; Lewis, David B.; Lau, Yu-Lung; Tu, Wenwei			ICOS Regulates the Generation and Function of Human CD4(+) Treg in a CTLA-4 Dependent Manner	PLOS ONE			English	Article							T-CELL FUNCTION; INDUCIBLE COSTIMULATOR ICOS; CD40-ACTIVATED B-CELLS; NAIVE PRECURSORS; DENDRITIC CELLS; ANTIGEN 4; NOD MICE; EXPRESSION; LIGAND; CD28	Inducible co-stimulator (ICOS) is a member of CD28/Cytotoxic T-lymphocyte Antigen-4 (CTLA-4) family and broadly expressed in activated CD4(+) T cells and induced regulatory CD4(+) T cells (CD4(+) iTreg). ICOS-related signal pathway could be activated by the interaction between ICOS and its ligand (ICOSL). In our previous work, we established a cost-effective system to generate a novel human allo-antigen specific CD4(hi) Treg by co-culturing their naive precursors with allogeneic CD40-activated B cells in vitro. Here we investigate the role of ICOS in the generation and function of CD4(hi) Treg by interrupting ICOS-ICOSL interaction with ICOS-Ig. It is found that blockade of ICOS-ICOSL interaction impairs the induction and expansion of CD4(hi) Treg induced by allogeneic CD40-activated B cells. More importantly, CD4(hi) Treg induced with the addition of ICOS-Ig exhibits decreased suppressive capacity on alloantigen-specific responses. Dysfunction of CD4(hi) Treg induced with ICOS-Ig is accompanied with its decreased exocytosis and surface CTLA-4 expression. Through inhibiting endocytosis with E64 and pepstatin A, surface CTLA-4 expression and suppressive functions of induced CD4(hi) Treg could be partly reversed. Conclusively, our results demonstrate the beneficial role of ICOS-ICOSL signal pathway in the generation and function of CD4(hi) Treg and uncover a novel relationship between ICOS and CTLA-4.	[Zheng, Jian; Chan, Ping-Lung; Liu, Yinping; Qin, Gang; Xiang, Zheng; Lam, Kwok-Tai; Lau, Yu-Lung; Tu, Wenwei] Univ Hong Kong, LKS Fac Med, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Lewis, David B.] Stanford Univ, Sch Med, Dept Pediat, Div Immunol & Allergy, Stanford, CA 94305 USA	University of Hong Kong; Stanford University	Tu, WW (corresponding author), Univ Hong Kong, LKS Fac Med, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.	wwtu@hkucc.hku.hk	; Lau, Yu Lung/C-4322-2009	Chan, Ping Lung/0000-0002-5639-2117; Lau, Yu Lung/0000-0002-4780-0289	NSFC/RGC Joint Research Scheme [N_HKU 747/11]; University Grants Committee of the Hong Kong Special Administrative Region, China [AoE/M-12/06]	NSFC/RGC Joint Research Scheme(National Natural Science Foundation of China (NSFC)); University Grants Committee of the Hong Kong Special Administrative Region, China	This work was supported in part by NSFC/RGC Joint Research Scheme (N_HKU 747/11), http://www.ugc.edu.hk/eng/rgc/fund/nsfc_rgc_jrs.htm; the Area of Excellence program supported by the University Grants Committee of the Hong Kong Special Administrative Region, China (AoE/M-12/06), http://www.ugc.edu.hk/eng/ugc/activity/aoes/aoes.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Beier KC, 2000, EUR J IMMUNOL, V30, P3707, DOI 10.1002/1521-4141(200012)30:12<3707::AID-IMMU3707>3.0.CO;2-Q; Bertram EM, 2002, EUR J IMMUNOL, V32, P3376, DOI 10.1002/1521-4141(200212)32:12<3376::AID-IMMU3376>3.0.CO;2-Y; Burmeister Y, 2008, J IMMUNOL, V180, P774, DOI 10.4049/jimmunol.180.2.774; Chen H, 2009, P NATL ACAD SCI USA, V106, P2729, DOI 10.1073/pnas.0813175106; Chen Y, 2012, J IMMUNOL, V188, P1698, DOI 10.4049/jimmunol.1102448; Chuang E, 1997, J IMMUNOL, V159, P144; Clay BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007525; Conrad C, 2012, CANCER RES, V72, P5240, DOI 10.1158/0008-5472.CAN-12-2271; Currie AJ, 2009, J IMMUNOL, V183, P7898, DOI 10.4049/jimmunol.0901060; de Aguero MG, 2012, J CLIN INVEST, V122, P1700, DOI 10.1172/JCI59725; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; Galicia G, 2009, J CLIN IMMUNOL, V29, P426, DOI 10.1007/s10875-009-9287-7; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Grinberg-Bleyer Y, 2010, J EXP MED, V207, P1871, DOI 10.1084/jem.20100209; Harada H, 2003, J CLIN INVEST, V112, P234, DOI 10.1172/JCI200317008; Hodgson R, 2011, TRANSPLANTATION, V91, P1090, DOI 10.1097/TP.0b013e31821774e0; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Koguchi Y, 2007, BLOOD, V110, P2520, DOI 10.1182/blood-2007-03-081299; Kornete M, 2012, J IMMUNOL, V188, P1064, DOI 10.4049/jimmunol.1101303; Liakou CI, 2008, P NATL ACAD SCI USA, V105, P14987, DOI 10.1073/pnas.0806075105; Linterman MA, 2009, IMMUNITY, V30, P228, DOI 10.1016/j.immuni.2008.12.015; Lischke T, 2012, J IMMUNOL, V189, P234, DOI 10.4049/jimmunol.1102034; Maeda S, 2011, AM J PATHOL, V179, P2360, DOI 10.1016/j.ajpath.2011.07.048; Martin-Orozco N, 2010, CANCER RES, V70, P9581, DOI 10.1158/0008-5472.CAN-10-1379; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; Mead KI, 2005, J IMMUNOL, V174, P4803, DOI 10.4049/jimmunol.174.8.4803; Moore TV, 2011, AM J RESP CELL MOL, V45, P843, DOI 10.1165/rcmb.2010-0466OC; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Prevot N, 2010, EUR J IMMUNOL, V40, P2267, DOI 10.1002/eji.201040416; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Smith KM, 2003, J IMMUNOL, V170, P2310, DOI 10.4049/jimmunol.170.5.2310; Strauss L, 2008, J IMMUNOL, V180, P2967, DOI 10.4049/jimmunol.180.5.2967; Takahashi N, 2009, J IMMUNOL, V182, P5515, DOI 10.4049/jimmunol.0803256; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Taylor PA, 2005, BLOOD, V105, P3372, DOI 10.1182/blood-2004-10-3869; Tu WW, 2008, BLOOD, V112, P2554, DOI 10.1182/blood-2008-04-152041; Tuettenberg A, 2009, J IMMUNOL, V182, P3349, DOI 10.4049/jimmunol.0802733; Uchida K, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/795026; Watanabe M, 2005, INT IMMUNOL, V17, P269, DOI 10.1093/intimm/dxh206; Whitehead GS, 2012, J ALLERGY CLIN IMMUN, V129, P207, DOI 10.1016/j.jaci.2011.08.009; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wu J, 2009, CLIN CHIM ACTA, V403, P229, DOI 10.1016/j.cca.2009.03.037; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yong PFK, 2009, IMMUNOL REV, V229, P101, DOI 10.1111/j.1600-065X.2009.00764.x; Zheng J, 2009, J IMMUNOL, V183, P3742, DOI 10.4049/jimmunol.0901329; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	50	41	45	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82203	10.1371/journal.pone.0082203	http://dx.doi.org/10.1371/journal.pone.0082203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312642	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500124
J	Walling, BE; Kuang, ZZ; Hao, YH; Estrada, D; Wood, JD; Lian, FF; Miller, LA; Shah, AB; Jeffries, JL; Haasch, RT; Lyding, JW; Pop, E; Lau, GW				Walling, Brent E.; Kuang, Zhizhou; Hao, Yonghua; Estrada, David; Wood, Joshua D.; Lian, Feifei; Miller, Lou Ann; Shah, Amish B.; Jeffries, Jayme L.; Haasch, Richard T.; Lyding, Joseph W.; Pop, Eric; Lau, Gee W.			Helical Carbon Nanotubes Enhance the Early Immune Response and Inhibit Macrophage-Mediated Phagocytosis of Pseudomonas aeruginosa	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; PULMONARY; EXPOSURE; LUNG; INFLAMMATION; CLEARANCE; CYTOTOXICITY; MICE; ASPIRATION; INHALATION	Aerosolized or aspirated manufactured carbon nanotubes have been shown to be cytotoxic, cause pulmonary lesions, and demonstrate immunomodulatory properties. CD-1 mice were used to assess pulmonary toxicity of helical carbon nanotubes (HCNTs) and alterations of the immune response to subsequent infection by Pseudomonas aeruginosa in mice. HCNTs provoked a mild inflammatory response following either a single exposure or 2X/week for three weeks (multiple exposures) but were not significantly toxic. Administering HCNTs 2X/week for three weeks resulted in pulmonary lesions including granulomas and goblet cell hyperplasia. Mice exposed to HCNTs and subsequently infected by P. aeruginosa demonstrated an enhanced inflammatory response to P. aeruginosa and phagocytosis by alveolar macrophages was inhibited. However, clearance of P. aeruginosa was not affected. HCNT exposed mice depleted of neutrophils were more effective in clearing P. aeruginosa compared to neutrophil-depleted control mice, accompanied by an influx of macrophages. Depletion of systemic macrophages resulted in slightly inhibited bacterial clearance by HCNT treated mice. Our data indicate that pulmonary exposure to HCNTs results in lesions similar to those caused by other nanotubes and pre-exposure to HCNTs inhibit alveolar macrophage phagocytosis of P. aeruginosa. However, clearance was not affected as exposure to HCNTs primed the immune system for an enhanced inflammatory response to pulmonary infection consisting of an influx of neutrophils and macrophages.	[Walling, Brent E.; Kuang, Zhizhou; Hao, Yonghua; Jeffries, Jayme L.; Lau, Gee W.] Univ Illinois, Dept Pathobiol, Urbana, IL USA; [Estrada, David; Wood, Joshua D.; Lian, Feifei; Lyding, Joseph W.; Pop, Eric] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL USA; [Estrada, David; Wood, Joshua D.; Lian, Feifei; Lyding, Joseph W.; Pop, Eric] Univ Illinois, Micro & Nanotechnol Lab, Urbana, IL USA; [Wood, Joshua D.; Lyding, Joseph W.; Pop, Eric] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [Miller, Lou Ann; Shah, Amish B.; Haasch, Richard T.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Lau, GW (corresponding author), Univ Illinois, Dept Pathobiol, Urbana, IL USA.	geelau@illinois.edu	Pop, Eric/A-9475-2009; Lau, Gee W/H-4073-2018	Pop, Eric/0000-0003-0436-8534; Haasch, Richard/0000-0001-9479-2595; Estrada, David/0000-0001-5894-0773	American Lung Association DeSouza Research Award [DS-192835-N]; NIH [HL090699]; Abbott Laboratories; T32 Infection Biology training Grant; Army Research Office (ARO); National Science Foundation (NSF); Beckman Foundation; NSF Graduate Research Fellowship Program (GRFP); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI078876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES022905] Funding Source: NIH RePORTER	American Lung Association DeSouza Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott Laboratories(Abbott Laboratories); T32 Infection Biology training Grant; Army Research Office (ARO); National Science Foundation (NSF)(National Science Foundation (NSF)); Beckman Foundation; NSF Graduate Research Fellowship Program (GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the American Lung Association DeSouza Research Award (DS-192835-N) and the NIH (HL090699) grant to G.W.L., and a fellowship from the Abbott Laboratories and a T32 Infection Biology training Grant to B.E.W. Additional support comes from the Army Research Office (ARO) (F.L., E.P., and J.D.W.), the National Science Foundation (NSF) (F.L. and E.P.), the Beckman Foundation (J.D.W) and the NSF Graduate Research Fellowship Program (GRFP) (D.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGI K, 1995, PHYS REV LETT, V74, P2307, DOI 10.1103/PhysRevLett.74.2307; Antonini JM, 2000, LUNG, V178, P341, DOI 10.1007/s004080000038; Chen XQ, 2003, NANO LETT, V3, P1299, DOI 10.1021/nl034367o; Chou CC, 2008, NANO LETT, V8, P437, DOI 10.1021/nl0723634; Diekema DJ, 1999, CLIN INFECT DIS, V29, P595, DOI 10.1086/598640; Elgrabli D, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-20; Ellinger-Ziegelbauer H, 2009, TOXICOLOGY, V266, P16, DOI 10.1016/j.tox.2009.10.007; Erdely A, 2009, NANO LETT, V9, P36, DOI 10.1021/nl801828z; GALER DM, 1992, REGUL TOXICOL PHARM, V15, P291, DOI 10.1016/0273-2300(92)90040-G; Han JH, 2008, INHAL TOXICOL, V20, P741, DOI [10.1080/08958370801942238, 10.1080/08958370801942238 ]; Hao YH, 2012, CELL MICROBIOL, V14, P401, DOI 10.1111/j.1462-5822.2011.01727.x; Hashimoto S, 1996, AM J PHYSIOL-LUNG C, V270, pL819, DOI 10.1152/ajplung.1996.270.5.L819; Herzog E, 2009, TOXICOL APPL PHARM, V234, P378, DOI 10.1016/j.taap.2008.10.015; Hu XK, 2010, SCI TOTAL ENVIRON, V408, P1812, DOI 10.1016/j.scitotenv.2010.01.035; Huizar I, 2011, AM J RESP CELL MOL, V45, P858, DOI 10.1165/rcmb.2010-0401OC; Inoue K, 2010, FREE RADICAL BIO MED, V48, P924, DOI 10.1016/j.freeradbiomed.2010.01.013; Inoue K, 2009, TOXICOL APPL PHARM, V237, P306, DOI 10.1016/j.taap.2009.04.003; Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l; Kim JE, 2010, J TOXICOL ENV HEAL A, V73, P1530, DOI 10.1080/15287394.2010.511578; Koh AY, 2009, INFECT IMMUN, V77, P5300, DOI 10.1128/IAI.00501-09; Kooguchi K, 1998, INFECT IMMUN, V66, P3164, DOI 10.1128/IAI.66.7.3164-3169.1998; Kuang ZZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027091; Kuempel ED, 2011, J OCCUP ENVIRON MED, V53, pS91, DOI 10.1097/JOM.0b013e31821b1f3f; Lam CW, 2006, CRIT REV TOXICOL, V36, P189, DOI 10.1080/10408440600570233; Lau KT, 2006, COMPOS PART B-ENG, V37, P437, DOI 10.1016/j.compositesb.2006.02.008; Li JG, 2007, ENVIRON TOXICOL, V22, P415, DOI 10.1002/tox.20270; Matthews IP, 2013, ENVIRON TOXICOL PHAR, V35, P461, DOI 10.1016/j.etap.2013.02.002; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mercer RR, 2008, AM J PHYSIOL-LUNG C, V294, pL87, DOI 10.1152/ajplung.00186.2007; Mercer RR, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-21; Mitchell LA, 2009, NAT NANOTECHNOL, V4, P451, DOI [10.1038/nnano.2009.151, 10.1038/NNANO.2009.151]; Mitchell LA, 2007, TOXICOL SCI, V100, P203, DOI 10.1093/toxsci/kfm196; Nygaard UC, 2009, TOXICOL SCI, V109, P113, DOI 10.1093/toxsci/kfp057; Oyabu T, 2011, INHAL TOXICOL, V23, P784, DOI 10.3109/08958378.2011.608096; Pacurari M, 2011, TOXICOL APPL PHARM, V255, P18, DOI 10.1016/j.taap.2011.05.012; Pauluhn J, 2010, REGUL TOXICOL PHARM, V57, P78, DOI 10.1016/j.yrtph.2009.12.012; Peigney A, 2001, CARBON, V39, P507, DOI 10.1016/S0008-6223(00)00155-X; Porter DW, 2010, TOXICOLOGY, V269, P136, DOI 10.1016/j.tox.2009.10.017; Roberts JR, 2011, J TOXICOL ENV HEAL A, V74, P790, DOI 10.1080/15287394.2011.567954; Ronzani C, 2012, ARCH TOXICOL, V86, P137, DOI 10.1007/s00204-011-0741-y; Ryman-Rasmussen JP, 2009, AM J RESP CELL MOL, V40, P349, DOI 10.1165/rcmb.2008-0276OC; Saito R., 1998, PHYS PROPERTIES CARB, P1; Scarff JM, 2008, CLIN VACCINE IMMUNOL, V15, P367, DOI 10.1128/CVI.00419-07; Shen H, 1998, CURR OPIN IMMUNOL, V10, P450, DOI 10.1016/S0952-7915(98)80120-9; Shvedova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL552, DOI 10.1152/ajplung.90287.2008; Shvedova AA, 2009, PHARMACOL THERAPEUT, V121, P192, DOI 10.1016/j.pharmthera.2008.10.009; Shvedova AA, 2008, AM J RESP CELL MOL, V38, P579, DOI 10.1165/rcmb.2007-0255OC; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; STONE KC, 1992, AM J RESP CELL MOL, V6, P235, DOI 10.1165/ajrcmb/6.2.235; Swedin L, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-16; Tkach AV, 2011, ACS NANO, V5, P5755, DOI 10.1021/nn2014479; Volodin A, 2004, NANO LETT, V4, P1775, DOI 10.1021/nl0491576; WANG P, 2013, SMALL, P50105, DOI DOI 10.1002/SMLL.201300607.[; Wang X, 2009, J NANOSCI NANOTECHNO, V9, P3025, DOI 10.1166/jnn.2009.025; Zhang SP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000564	55	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80283	10.1371/journal.pone.0080283	http://dx.doi.org/10.1371/journal.pone.0080283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24324555	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500124
J	Carneiro, AB; Iaciura, BMF; Nohara, LL; Lopes, CD; Veas, EMC; Mariano, VS; Bozza, PT; Lopes, UG; Atella, GC; Almeida, IC; Silva-Neto, MAC				Carneiro, Alan Brito; Ferreira Iaciura, Bruna Maria; Nohara, Lilian Lie; Lopes, Carla Duque; Cordero Veas, Esteban Mauricio; Mariano, Vania Sammartino; Bozza, Patricia Torres; Lopes, Ulisses Gazos; Atella, Georgia Correa; Almeida, Igor Correia; Cardoso Silva-Neto, Mario Alberto			Lysophosphatidylcholine Triggers TLR2-and TLR4-Mediated Signaling Pathways but Counteracts LPS-Induced NO Synthesis in Peritoneal Macrophages by Inhibiting NF-kappa B Translocation and MAPK/ERK Phosphorylation	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CUTTING EDGE; NITRIC-OXIDE; ACTIVATION; EXPRESSION; ATHEROSCLEROSIS; MECHANISMS; LDL; INFLAMMATION; DYSFUNCTION	Background: Lysophosphatidylcholine (LPC) is the main phospholipid component of oxidized low-density lipoprotein (oxLDL) and is usually noted as a marker of several human diseases, such as atherosclerosis, cancer and diabetes. Some studies suggest that oxLDL modulates Toll-like receptor (TLR) signaling. However, effector molecules that are present in oxLDL particles and can trigger TLR signaling are not yet clear. LPC was previously described as an attenuator of sepsis and as an immune suppressor. In the present study, we have evaluated the role of LPC as a dual modulator of the TLR-mediated signaling pathway. Methodology/Principal Findings: HEK 293A cells were transfected with TLR expression constructs and stimulated with LPC molecules with different fatty acid chain lengths and saturation levels. All LPC molecules activated both TLR4 and TLR2-1 signaling, as evaluated by NF-kappa B activation and IL-8 production. These data were confirmed by Western blot analysis of NF-kappa B translocation in isolated nuclei of peritoneal murine macrophages. However, LPC counteracted the TLR4 signaling induced by LPS. In this case, NF-kappa B translocation, nitric oxide (NO) synthesis and the expression of inducible nitric oxide synthase (iNOS) were blocked. Moreover, LPC activated the MAP Kinases p38 and JNK, but not ERK, in murine macrophages. Interestingly, LPC blocked LPS-induced ERK activation in peritoneal macrophages but not in TLR-transfected cells. Conclusions/Significance: The above results indicate that LPC is a dual-activity ligand molecule. It is able to trigger a classical proinflammatory phenotype by activating TLR4- and TLR2-1-mediated signaling. However, in the presence of classical TLR ligands, LPC counteracts some of the TLR-mediated intracellular responses, ultimately inducing an anti-inflammatory phenotype; LPC may thus play a role in the regulation of cell immune responses and disease progression.	[Carneiro, Alan Brito; Ferreira Iaciura, Bruna Maria; Atella, Georgia Correa; Cardoso Silva-Neto, Mario Alberto] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Mol & Biotecnol, CCS, Rio De Janeiro, Brazil; [Carneiro, Alan Brito; Ferreira Iaciura, Bruna Maria; Atella, Georgia Correa; Cardoso Silva-Neto, Mario Alberto] Univ Fed Rio de Janeiro, INCT EM, Rio De Janeiro, Brazil; [Nohara, Lilian Lie; Lopes, Carla Duque; Cordero Veas, Esteban Mauricio; Mariano, Vania Sammartino] Univ Texas El Paso, Dept Biol Sci, Border Biomed Res Ctr, El Paso, TX 79968 USA; [Lopes, Carla Duque; Mariano, Vania Sammartino] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol Patogen, Sao Paulo, Brazil; [Bozza, Patricia Torres; Almeida, Igor Correia] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Imunofarmacol, Rio De Janeiro, Brazil; [Lopes, Ulisses Gazos] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Parasitol Mol, CCS, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; University of Texas System; University of Texas El Paso; Universidade de Sao Paulo; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Almeida, IC (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Imunofarmacol, Rio De Janeiro, Brazil.		Cordero, Esteban M/F-2511-2012; Bozza, Patricia T./AAE-2933-2021; Lopes, Carla/D-5058-2012; Mariano, Vânia Sammartino/AAV-1851-2020; Bozza, Patricia T./AAM-4537-2021; Cordero, Esteban M./Q-6513-2019; Lopes, Ulisses Gazos/T-6634-2019; Atella, Georgia/AAK-7897-2020; Almeida, Igor C./AAF-9409-2019; Lopes, Ulisses/N-4416-2013; Mariano, Vania/L-1953-2014	Cordero, Esteban M/0000-0002-6099-5113; Lopes, Carla/0000-0003-0702-5043; Mariano, Vânia Sammartino/0000-0002-5399-5676; Bozza, Patricia T./0000-0001-8349-9529; Cordero, Esteban M./0000-0002-6099-5113; Almeida, Igor C./0000-0002-2443-8213; 	FAPERJ; CNPq; CAPES; National Institutes of Health (NIH) [8G12MD007592, 2G12RR008124-16A1, 2G12RR008124-16A1S1]; Research Centers in Minority Institutions (RCMI) program [8G12MD007592, 2G12RR008124-16A1, 2G12RR008124-16A1S1]; National Institutes on Minority Health and Health Disparities (NIMHD), a component of the NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Centers in Minority Institutions (RCMI) program; National Institutes on Minority Health and Health Disparities (NIMHD), a component of the NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants from FAPERJ, CNPq, CAPES, and the National Institutes of Health (NIH) (8G12MD007592, 2G12RR008124-16A1, and 2G12RR008124-16A1S1). The authors are grateful to the Biomolecule Analysis Core Facility (BACF) at the University of Texas at El Paso (UTEP) for the access to the instrumentation supported by the Research Centers in Minority Institutions (RCMI) program, grants 8G12MD007592, 2G12RR008124-16A1, and 2G12RR008124-16A1S1, to the Border Biomedical Research Center (BBRC) at UTEP, from the National Institutes on Minority Health and Health Disparities (NIMHD), a component of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar N, 2007, MOL CELL BIOCHEM, V295, P113, DOI 10.1007/s11010-006-9280-x; Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; Aktan F, 2003, NITRIC OXIDE-BIOL CH, V8, P235, DOI 10.1016/S1089-8603(03)00032-6; BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; Bzowska M, 2012, INFLAMMATION, V35, P1567, DOI 10.1007/s10753-012-9472-3; Chisolm GM, 2000, FREE RADICAL BIO MED, V28, P1815, DOI 10.1016/S0891-5849(00)00344-0; Cho WH, 2012, EUR J CLIN MICROBIOL, V31, P1805, DOI 10.1007/s10096-011-1505-6; Cole JE, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/393946; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Erridge C, 2009, J INNATE IMMUN, V1, P340, DOI 10.1159/000191413; George J, 1999, LUPUS, V8, P220, DOI 10.1191/096120399678847597; Golodne DM, 2003, J BIOL CHEM, V278, P27766, DOI 10.1074/jbc.M212421200; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Harnett W, 2010, NAT REV IMMUNOL, V10, P278, DOI 10.1038/nri2730; Huang AN, 1999, FREE RADICAL BIO MED, V26, P526, DOI 10.1016/S0891-5849(98)00236-6; Jackson SK, 2008, J LEUKOCYTE BIOL, V84, P86, DOI 10.1189/jlb.0907601; Jonassen JA, 2005, UROL RES, V33, P329, DOI 10.1007/s00240-005-0485-3; Kabarowski JH, 2009, PROSTAG OTH LIPID M, V89, P73, DOI 10.1016/j.prostaglandins.2009.04.007; Kannan Y, 2012, J BIOL CHEM, V287, P23479, DOI 10.1074/jbc.M111.320960; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kouglas P, 2006, MED SCI MONITOR, V12, pRA5; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Magalhaes KG, 2010, J INFECT DIS, V202, P1369, DOI 10.1086/656477; Mankan AK, 2009, J CELL MOL MED, V13, P631, DOI 10.1111/j.1582-4934.2009.00632.x; McDonald D, 2006, J CELL BIOL, V172, P541, DOI 10.1083/jcb.200507101; MEHTA D, 1990, AM REV RESPIR DIS, V142, P157, DOI 10.1164/ajrccm/142.1.157; Mesquita RD, 2008, INFECT IMMUN, V76, P5543, DOI 10.1128/IAI.00683-08; Miller I, 2006, ELECTROPHORESIS, V27, P1626, DOI 10.1002/elps.200500744; Miller YI, 2005, FUTUR CARDIOL, V1, P785, DOI 10.2217/14796678.1.6.785; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Murch O, 2006, BRIT J PHARMACOL, V148, P769, DOI 10.1038/sj.bjp.0706788; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; Qian F, 2012, AM J PHYSIOL-LUNG C, V302, pL866, DOI 10.1152/ajplung.00277.2011; RYBORG AK, 1995, BRIT J DERMATOL, V133, P398, DOI 10.1111/j.1365-2133.1995.tb02667.x; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; Schmid W, 2008, LIFE SCI, V83, P50, DOI 10.1016/j.lfs.2008.05.002; Seimon TA, 2010, CELL METAB, V12, P467, DOI 10.1016/j.cmet.2010.09.010; Shamshiev AT, 2007, J EXP MED, V204, P441, DOI 10.1084/jem.20061737; Silva-Neto Mario A C, 2012, J Parasitol Res, V2012, P625838, DOI 10.1155/2012/625838; STEINBRECHER UP, 1990, FREE RADICAL BIO MED, V9, P155, DOI 10.1016/0891-5849(90)90119-4; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; STREMLER KE, 1989, J BIOL CHEM, V264, P5331; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Sweetser MT, 1998, J BIOL CHEM, V273, P34775, DOI 10.1074/jbc.273.52.34775; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Wang M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000697; Xu Y, 2002, BBA-MOL CELL BIOL L, V1582, P81, DOI 10.1016/S1388-1981(02)00140-3; Yan JJ, 2004, NAT MED, V10, P161, DOI 10.1038/nm989	52	76	77	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76233	10.1371/journal.pone.0076233	http://dx.doi.org/10.1371/journal.pone.0076233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24312681	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500154
J	Tanno, H; Shigematsu, T; Nishikawa, S; Hayakawa, A; Denda, K; Tanaka, T; Komada, M				Tanno, Hidetaka; Shigematsu, Takeshi; Nishikawa, Shuhei; Hayakawa, Akira; Denda, Kimitoshi; Tanaka, Toshiaki; Komada, Masayuki			Ubiquitin-interacting Motifs Confer Full Catalytic Activity, but Not Ubiquitin Chain Substrate Specificity, to Deubiquitinating Enzyme USP37	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Deubiquitination; Protease; Protein Degradation; Ubiquitin; Ubiquitination	POLYUBIQUITIN; PROTEIN; RECOGNITION; FAMILY	Ubiquitin-specific proteases (USPs) consist of a family of deubiquitinating enzymes with more than 50 members in humans. Three of them, including USP37, contain ubiquitin-interacting motifs (UIMs), an approximate to 20-amino acid -helical stretch that binds to ubiquitin. However, the roles of the UIMs in these USP enzymes remain unknown. USP37 has three UIMs, designated here as UIMs 1, 2, and 3 from the N-terminal side, between the Cys and His boxes comprising the catalytic core. Here, we examined the role of the UIMs in USP37 using its mutants that harbor mutations in the UIMs. The nuclear localization of USP37 was not affected by the UIM mutations. However, mutations in UIM2 or UIM3, but not UIM1, resulted in a significant decrease in USP37 binding to ubiquitinated proteins in the cell. In vitro, a region of USP37 harboring the three UIMs also bound to both Lys(48)-linked and Lys(63)-linked ubiquitin chains in a UIM2- and UIM3-dependent manner. The level of USP37 ubiquitination was also reduced by mutations in UIM2 or UIM3, suggesting their role in ubiquitination of USP37 itself. Finally, mutants lacking functional UIM2 or UIM3 exhibited a reduced isopeptidase activity toward ubiquitinated proteins in the cell and both Lys(48)-linked and Lys(63)-linked ubiquitin chains. These results suggested that the UIMs in USP37 contribute to the full enzymatic activity, but not ubiquitin chain substrate specificity, of USP37 possibly by holding the ubiquitin chain substrate in the proximity of the catalytic core.	[Tanno, Hidetaka; Shigematsu, Takeshi; Nishikawa, Shuhei; Hayakawa, Akira; Denda, Kimitoshi; Tanaka, Toshiaki; Komada, Masayuki] Tokyo Inst Technol, Dept Biol Sci, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Komada, M (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Midori Ku, 4259-B16 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	makomada@bio.titech.ac.jp	Tanaka, Toshiaki/C-5567-2013	Tanaka, Toshiaki/0000-0002-9448-1452; Tanno, Hidetaka/0000-0001-6749-0938	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22370068, 24112003]; Grants-in-Aid for Scientific Research [26440048] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 22370068 and 24112003 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. K.).	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Burrows AC, 2012, J BIOL CHEM, V287, P39021, DOI 10.1074/jbc.M112.390328; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Das CM, 2013, ONCOGENE, V32, P1691, DOI 10.1038/onc.2012.182; Denuc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005571; Eletr ZM, 2014, BBA-MOL CELL RES, V1843, P114, DOI 10.1016/j.bbamcr.2013.06.027; Fujimuro M, 2005, METHOD ENZYMOL, V399, P75, DOI 10.1016/S0076-6879(05)99006-X; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Reyes-Turcu FE, 2008, J BIOL CHEM, V283, P19581, DOI 10.1074/jbc.M800947200; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Song AX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013202; Tanno H, 2012, MOL BIOL CELL, V23, P1343, DOI 10.1091/mbc.E11-09-0817; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Yang WC, 2013, ONCOGENE, V32, P5167, DOI 10.1038/onc.2012.537	28	21	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2415	2423		10.1074/jbc.M113.528372	http://dx.doi.org/10.1074/jbc.M113.528372			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24324262	Green Published, hybrid			2022-12-25	WOS:000331130200045
J	Kostler, WJ; Zeisel, A; Korner, C; Tsai, JM; Jacob-Hirsch, J; Ben-Chetrit, N; Sharma, K; Cohen-Dvashi, H; Yitzhaky, A; Lader, E; Tschulena, U; Rechavi, G; Domany, E; Wiemann, S; Yarden, Y				Koestler, Wolfgang J.; Zeisel, Amit; Koerner, Cindy; Tsai, Jonathan M.; Jacob-Hirsch, Jasmine; Ben-Chetrit, Nir; Sharma, Kirti; Cohen-Dvashi, Hadas; Yitzhaky, Assif; Lader, Eric; Tschulena, Ulrich; Rechavi, Gideon; Domany, Eytan; Wiemann, Stefan; Yarden, Yosef			Epidermal Growth-Factor - Induced Transcript Isoform Variation Drives Mammary Cell Migration	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; GENOME-WIDE ANALYSIS; PRE-MESSENGER-RNA; SPLICING REGULATION; LAMA3 GENE; EXPRESSION; BINDING; TARGET; SWITCH; MICROARRAYS	Signal-induced transcript isoform variation (TIV) includes alternative promoter usage as well as alternative splicing and alternative polyadenylation of mRNA. To assess the phenotypic relevance of signal-induced TIV, we employed exon arrays and breast epithelial cells, which migrate in response to the epidermal growth factor (EGF). We show that EGF rapidly - within one hour - induces widespread TIV in a significant fraction of the transcriptome. Importantly, TIV characterizes many genes that display no differential expression upon stimulus. In addition, similar EGF-dependent changes are shared by a panel of mammary cell lines. A functional screen, which utilized isoform-specific siRNA oligonucleotides, indicated that several isoforms play essential, non-redundant roles in EGF-induced mammary cell migration. Taken together, our findings highlight the importance of TIV in the rapid evolvement of a phenotypic response to extracellular signals.	[Koestler, Wolfgang J.; Tsai, Jonathan M.; Ben-Chetrit, Nir; Cohen-Dvashi, Hadas; Yarden, Yosef] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Zeisel, Amit; Yitzhaky, Assif; Domany, Eytan] Weizmann Inst Sci, IL-76100 Rehovot, Israel; [Koerner, Cindy; Sharma, Kirti; Tschulena, Ulrich; Wiemann, Stefan] German Canc Res Ctr, Div Mol Genome Anal, Heidelberg, Germany; [Jacob-Hirsch, Jasmine; Rechavi, Gideon] Tel Aviv Univ, Sheba Canc Res Ctr, Chaim Sheba Med Ctr, IL-69978 Tel Aviv, Israel; [Jacob-Hirsch, Jasmine; Rechavi, Gideon] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Lader, Eric] Qiagen, Frederick, MD USA	Weizmann Institute of Science; Weizmann Institute of Science; Helmholtz Association; German Cancer Research Center (DKFZ); Chaim Sheba Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Domany, E (corresponding author), Weizmann Inst Sci, IL-76100 Rehovot, Israel.	eytan.domany@weizmann.ac.il; yosef.yarden@weizmann.ac.il	YARDEN, YOSEF/K-1467-2012; DOMANY, EYTAN/K-1560-2012; Wiemann, Stefan/E-4424-2013	Wiemann, Stefan/0000-0003-4683-3174; Koerner, Cindy/0000-0003-1150-9462; Tsai, Jonathan/0000-0001-5868-2305; Shukla, Kirti/0000-0001-5083-3981	German-Israeli Project Cooperation (DIP); National Cancer Institute (Bethesda, MD); European Research Council; Seventh Framework Program of the European Commission; Israel Cancer Research Fund; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Israel Science Foundation (ISF); Leir Charitable Foundation; Ph.D. Track fellowship	German-Israeli Project Cooperation (DIP); National Cancer Institute (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Research Council(European Research Council (ERC)European Commission); Seventh Framework Program of the European Commission; Israel Cancer Research Fund; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Israel Science Foundation (ISF)(Israel Science Foundation); Leir Charitable Foundation; Ph.D. Track fellowship	The authors' research is supported by the German-Israeli Project Cooperation (DIP), the National Cancer Institute (Bethesda, MD), the European Research Council, the Seventh Framework Program of the European Commission, the Israel Cancer Research Fund and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, the Israel Science Foundation (ISF) and the Leir Charitable Foundation. WJK is supported by a Ph.D. Track fellowship for specialist medical doctors donated by the Linda and Michael Jacobs Charitable Trust. YY is the incumbent of the Harold and Zelda Goldenberg Professorial Chair and ED is the incumbent of the Henry J. Leir Professorial Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Amin EM, 2011, CANCER CELL, V20, P768, DOI 10.1016/j.ccr.2011.10.016; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Bar-Joseph Z, 2012, NAT REV GENET, V13, P552, DOI 10.1038/nrg3244; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Bouizar Z, 1999, J BONE MINER RES, V14, P406, DOI 10.1359/jbmr.1999.14.3.406; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Celotto AM, 2002, RNA, V8, P718, DOI 10.1017/S1355838202021064; Dietze EC, 2005, J CELL SCI, V118, P5005, DOI 10.1242/jcs.02616; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Goldberg MS, 2012, J EXP MED, V209, P217, DOI 10.1084/jem.20111487; Goncalves V, 2008, RNA, V14, P2538, DOI 10.1261/rna.1253408; Grigoryev YA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007906; Hamill KJ, 2010, DERMATOL CLIN, V28, P79, DOI 10.1016/j.det.2009.10.009; Hamill KJ, 2009, J BIOL CHEM, V284, P35588, DOI 10.1074/jbc.M109.052811; Hang XY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-126; Hartmann B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r11; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Huser CA, 2010, CELL DEATH DIFFER, V17, P304, DOI 10.1038/cdd.2009.126; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Kwan T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000608; Li CX, 2006, CANCER RES, V66, P1990, DOI 10.1158/0008-5472.CAN-05-2593; Li JR, 2011, J CLIN INVEST, V121, P4655, DOI 10.1172/JCI46134; Lin KT, 2012, CANC RES; Liu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049453; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Mckee AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r159; Meng Q, 2007, P NATL ACAD SCI USA, V104, P5866, DOI 10.1073/pnas.0701065104; Miller KA, 2000, J BIOL CHEM, V275, P8176, DOI 10.1074/jbc.275.11.8176; Moller-Levet CS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000571; Nowak DG, 2008, J CELL SCI, V121, P3487, DOI 10.1242/jcs.016410; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Prinos P, 2011, NAT STRUCT MOL BIOL, V18, P673, DOI 10.1038/nsmb.2040; Rajan P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029088; RYAN MC, 1994, J BIOL CHEM, V269, P22779; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Singer GAC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-349; Southby J, 1996, ENDOCRINOLOGY, V137, P1349, DOI 10.1210/en.137.4.1349; Tarcic G, 2012, FASEB J, V26, P1582, DOI 10.1096/fj.11-194654; Virolle T, 2000, EMBO REP, V1, P328, DOI 10.1093/embo-reports/kvd066; Virolle T, 2002, NUCLEIC ACIDS RES, V30, P1789, DOI 10.1093/nar/30.8.1789; Vitorino P, 2008, GENE DEV, V22, P3268, DOI 10.1101/gad.1725808; Vorlova S, 2011, MOL CELL, V43, P927, DOI 10.1016/j.molcel.2011.08.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Wu G, 1998, UROLOGY, V51, P110, DOI 10.1016/S0090-4295(98)00077-6; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yata K, 2012, MOL CELL, V45, P371, DOI 10.1016/j.molcel.2011.12.028; Yoon OK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002882; Zeisel A, 2012, J BIOMOLECULAR SCREE; Zeisel A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.62; Zeisel A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-400; Zhang LQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031229; Zhou Z, 2012, MOL CELL	58	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e80566	10.1371/journal.pone.0080566	http://dx.doi.org/10.1371/journal.pone.0080566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324612	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700011
J	Li, L; Li, DL; Liu, SZ; Ma, XL; Dietrich, CR; Hu, HC; Zhang, GS; Liu, ZY; Zheng, J; Wang, GY; Schnable, PS				Li, Li; Li, Delin; Liu, Sanzhen; Ma, Xiaoli; Dietrich, Charles R.; Hu, Heng-Cheng; Zhang, Gaisheng; Liu, Zhiyong; Zheng, Jun; Wang, Guoying; Schnable, Patrick S.			The Maize glossy13 Gene, Cloned via BSR-Seq and Seq-Walking Encodes a Putative ABC Transporter Required for the Normal Accumulation of Epicuticular Waxes	PLOS ONE			English	Article							MESSENGER-RNA DECAY; PCR METHOD; MUTATIONS; ELEMENT; LOCUS; WATER; BIOSYNTHESIS; TRANSPOSITION; COMPLEXITY; DISCOVERY	Aerial plant surfaces are covered by epicuticular waxes that among other purposes serve to control water loss. Maize glossy mutants originally identified by their "glossy" phenotypes exhibit alterations in the accumulation of epicuticular waxes. By combining data from a BSR-Seq experiment and the newly developed Seq-Walking technology, GRMZM2G118243 was identified as a strong candidate for being the glossy13 gene. The finding that multiple EMS-induced alleles contain premature stop codons in GRMZM2G118243, and the one knockout allele of gl13, validates the hypothesis that gene GRMZM2G118243 is gl13. Consistent with this, GRMZM2G118243 is an ortholog of AtABCG32 (Arabidopsis thaliana), HvABCG31 (barley) and OsABCG31 (rice), which encode ABCG subfamily transporters involved in the trans-membrane transport of various secondary metabolites. We therefore hypothesize that gl13 is involved in the transport of epicuticular waxes onto the surfaces of seedling leaves.	[Li, Li; Zhang, Gaisheng] Northwest Agr & Forestry Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Li, Li; Liu, Sanzhen; Dietrich, Charles R.; Hu, Heng-Cheng; Schnable, Patrick S.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Li, Delin; Ma, Xiaoli; Liu, Zhiyong; Schnable, Patrick S.] China Agr Univ, Dept Plant Genet & Breeding, Beijing 100094, Hebei, Peoples R China; [Zheng, Jun; Wang, Guoying] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Hebei, Peoples R China; [Schnable, Patrick S.] Iowa State Univ, Ctr Plant Genom, Ames, IA USA	Northwest A&F University - China; Iowa State University; China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Iowa State University	Schnable, PS (corresponding author), Iowa State Univ, Dept Agron, Ames, IA 50011 USA.	Schnable@iastate.edu	Li, Delin/AAO-2275-2021	Li, Delin/0000-0002-3689-3790; Schnable, Patrick/0000-0001-9169-5204; Liu liu, Zhiyong zhi yong/0000-0002-6958-5233	National Science Foundation [DBI-0344852, IOS-1027527]	National Science Foundation(National Science Foundation (NSF))	This material is based in part upon work supported by the National Science Foundation under Grant numbers DBI-0344852 and IOS-1027527. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEMAN M, 1986, GENETICS, V112, P107; AMANO E, 1965, MUTAT RES, V2, P344, DOI 10.1016/0027-5107(65)90070-9; Balciunas D, 2005, ZEBRAFISH, V1, P335, DOI 10.1089/zeb.2005.1.335; BALLINGER DG, 1989, P NATL ACAD SCI USA, V86, P9402, DOI 10.1073/pnas.86.23.9402; Banasiak J, 2013, J EXP BOT, V64, P1005, DOI 10.1093/jxb/ers380; Benito MI, 1997, MOL CELL BIOL, V17, P5165, DOI 10.1128/MCB.17.9.5165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bessire M, 2011, PLANT CELL, V23, P1958, DOI 10.1105/tpc.111.083121; Bolduc C, 2004, OBES RES, V12, P750, DOI 10.1038/oby.2004.90; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Chen GX, 2011, PLANT SIGNAL BEHAV, V6, P1297, DOI 10.4161/psb.6.9.17507; Chen GX, 2011, P NATL ACAD SCI USA, V108, P12354, DOI 10.1073/pnas.1108444108; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Davidson RM, 2011, PLANT GENOME-US, V4, P191, DOI 10.3835/plantgenome2011.05.0015; Dietrich CR, 2002, GENETICS, V160, P697; Edwards D, 2002, BIOTECHNIQUES, V32, P1090, DOI 10.2144/02325rr04; Fadool JM, 1998, P NATL ACAD SCI USA, V95, P5182, DOI 10.1073/pnas.95.9.5182; FEDOROFF NV, 1984, P NATL ACAD SCI-BIOL, V81, P3825, DOI 10.1073/pnas.81.12.3825; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Greene EA, 2003, GENETICS, V164, P731; Hansen JD, 1997, PLANT PHYSIOL, V113, P1091, DOI 10.1104/pp.113.4.1091; Imam JS, 2010, NUCLEIC ACIDS RES, V38, P1559, DOI 10.1093/nar/gkp1115; Jenks Matthew A, 2002, Arabidopsis Book, V1, pe0016, DOI 10.1199/tab.0016; Kerstiens G, 1996, J EXP BOT, V47, P1813, DOI 10.1093/jxb/47.12.1813; Kilstrup M, 2000, Nucleic Acids Res, V28, pE55, DOI 10.1093/nar/28.11.e55; KOLATTUKUDY PE, 1996, PLANT CUTICLES INTEG, P83, DOI DOI 10.1016/J.MICRON.2007.11.010; Kunst L, 2003, PROG LIPID RES, V42, P51, DOI 10.1016/S0163-7827(02)00045-0; Lee SB, 2013, MOL PLANT, V6, P246, DOI 10.1093/mp/sss159; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Li L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003202; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Li XR, 2012, GENOME RES, V22, P2436, DOI 10.1101/gr.140277.112; Lisch D, 2002, TRENDS PLANT SCI, V7, P498, DOI 10.1016/S1360-1385(02)02347-6; Liu SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036406; Liu SZ, 2009, GENETICS, V183, P1215, DOI 10.1534/genetics.109.108936; Liu SZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000733; Lundqvist U., 1985, Barley Genetics Newsletter, V15, P89; LUNDQVIST U, 1988, HEREDITAS, V108, P1, DOI 10.1111/j.1601-5223.1988.tb00676.x; Mariani C, 2000, Plant Cell, V12, P1795; MARTIN C, 1988, GENETICS, V119, P171; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; MOOSE SP, 1994, PLANT CELL, V6, P1343, DOI 10.1105/tpc.6.10.1343; Muller C, 2005, J CHEM ECOL, V31, P2621, DOI 10.1007/s10886-005-7617-7; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; O'Malley RC, 2007, NAT PROTOC, V2, P2910, DOI 10.1038/nprot.2007.425; Paschold A, 2012, GENOME RES, V22, P2445, DOI 10.1101/gr.138461.112; PostBeittenmiller D, 1996, ANNU REV PLANT PHYS, V47, P405, DOI 10.1146/annurev.arplant.47.1.405; Rayson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031917; Riederer M, 2001, J EXP BOT, V52, P2023, DOI 10.1093/jexbot/52.363.2023; ROBERTSON DS, 1978, MUTAT RES, V51, P21, DOI 10.1016/0027-5107(78)90004-0; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; SCHNABLE PS, 1994, MAYDICA, V39, P279; SHYAMALA V, 1989, GENE, V84, P1, DOI 10.1016/0378-1119(89)90132-7; Sturaro M, 2005, PLANT PHYSIOL, V138, P478, DOI 10.1104/pp.104.058164; Tacke E, 1995, PLANT J, V8, P907, DOI 10.1046/j.1365-313X.1995.8060907.x; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; Vandenbussche M, 2008, PLANT J, V54, P1105, DOI 10.1111/j.1365-313X.2008.03482.x; Wang XF, 2009, PLANT CELL, V21, P1053, DOI 10.1105/tpc.109.065714; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xu XJ, 1997, PLANT PHYSIOL, V115, P501, DOI 10.1104/pp.115.2.501	66	60	66	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82333	10.1371/journal.pone.0082333	http://dx.doi.org/10.1371/journal.pone.0082333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324772	Green Submitted, gold, Green Published			2022-12-25	WOS:000328566700069
J	MacLean, SA; Bonter, DN				MacLean, Sarah A.; Bonter, David N.			The Sound of Danger: Threat Sensitivity to Predator Vocalizations, Alarm Calls, and Novelty in Gulls	PLOS ONE			English	Article							RESPONSES; AVOIDANCE; RECOGNITION; RISK; DISCRIMINATE; RELIABILITY; BEHAVIOR; SIGNALS; BIRDS; PREY	The threat sensitivity hypothesis predicts that organisms will evaluate the relative danger of and respond differentially to varying degrees of predation threat. Doing so allows potential prey to balance the costs and benefits of anti-predator behaviors. Threat sensitivity has undergone limited testing in the auditory modality, and the relative threat level of auditory cues from different sources is difficult to infer across populations when variables such as background risk and experience are not properly controlled. We experimentally exposed a single population of two sympatric gull species to auditory stimuli representing a range of potential threats in order to compare the relative threat of heterospecific alarm calls, conspecific alarms calls, predator vocalizations, and novel auditory cues. Gulls were able to discriminate among a diverse set of threat indicators and respond in a graded manner commensurate with the level of threat. Vocalizations of two potential predators, the human voice and bald eagle call, differed in their threat level compared to each other and to alarm calls. Conspecific alarm calls were more threatening than heterospecfic alarm calls to the larger great black-backed gull, but the smaller herring gull weighed both equally. A novel cue elicited a response intermediate between known threats and a known non-threat in herring gulls, but not great black-backed gulls. Our results show that the relative threat level of auditory cues from different sources is highly species-dependent, and that caution should be exercised when comparing graded and threshold threat sensitive responses.	[MacLean, Sarah A.] Cornell Univ, Dept Nat Resources, Ithaca, NY 14853 USA; [Bonter, David N.] Cornell Lab Ornithol, Ithaca, NY USA	Cornell University; Cornell University	MacLean, SA (corresponding author), Cornell Univ, Dept Nat Resources, Fernow Hall, Ithaca, NY 14853 USA.	maclean@berkeley.edu	Bonter, David/H-1313-2013	Bonter, David/0000-0003-1768-1941; MacLean, Sarah/0000-0001-8240-2529	Hunter R. Rawlings III Cornell Presidential research Scholarship	Hunter R. Rawlings III Cornell Presidential research Scholarship	This work was supported by the Hunter R. Rawlings III Cornell Presidential research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amo L, 2008, FUNCT ECOL, V22, P289, DOI 10.1111/j.1365-2435.2007.01361.x; Amo L, 2011, ARDEA, V99, P177, DOI 10.5253/078.099.0207; Barrera JP, 2011, ANIM BEHAV, V81, P779, DOI 10.1016/j.anbehav.2011.01.010; Biedenweg TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014549; Blumstein DT, 2008, BEHAV ECOL SOCIOBIOL, V62, P457, DOI 10.1007/s00265-007-0473-4; Blumstein DT, 2004, ANIM BEHAV, V68, P1257, DOI 10.1016/j.anbehav.2003.12.024; Blumstein DT, 2004, P ROY SOC B-BIOL SCI, V271, P1851, DOI 10.1098/rspb.2004.2808; Bonadonna F, 2009, ANN NY ACAD SCI, V1170, P428, DOI 10.1111/j.1749-6632.2009.03890.x; Brown GE, 2006, CAN J ZOOL, V84, P1, DOI 10.1139/Z05-166; Brown GE, 2006, BEHAV ECOL SOCIOBIOL, V61, P9, DOI 10.1007/s00265-006-0232-y; Brown GE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2712; Brown GE, 2009, BEHAV ECOL SOCIOBIOL, V63, P699, DOI 10.1007/s00265-008-0703-4; CHENEY DL, 1988, ANIM BEHAV, V36, P477, DOI 10.1016/S0003-3472(88)80018-6; Christensen JW, 2005, APPL ANIM BEHAV SCI, V93, P53, DOI 10.1016/j.applanim.2005.06.017; Crawford BA, 2012, ETHOLOGY, V118, P41, DOI 10.1111/j.1439-0310.2011.01983.x; DRURY WH, 1973, BIRD BANDING, V44, P267, DOI 10.2307/4511982; Edelaar P, 2006, IBIS, V148, P664, DOI 10.1111/j.1474-919X.2006.00567.x; Ellis JC, 2006, CONDOR, V108, P211, DOI 10.1650/0010-5422(2006)108[0211:NAAABS]2.0.CO;2; Fallow PM, 2011, BEHAV ECOL, V22, P401, DOI 10.1093/beheco/arq221; Ferrari MCO, 2009, ANIM BEHAV, V78, P11, DOI 10.1016/j.anbehav.2009.03.016; Goodale E, 2008, BEHAV ECOL, V19, P887, DOI 10.1093/beheco/arn045; Griffin AS, 2004, LEARN BEHAV, V32, P131; Helfman GS, 1997, ETHOLOGY, V103, P369; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; Hollen LI, 2009, ANIM BEHAV, V78, P791, DOI 10.1016/j.anbehav.2009.07.021; HUTSON GD, 1993, APPL ANIM BEHAV SCI, V35, P255, DOI 10.1016/0168-1591(93)90141-B; Johnson FR, 2003, AUST J ZOOL, V51, P577, DOI 10.1071/ZO03031; Leavesley AJ, 2005, ANIM BEHAV, V70, P365, DOI 10.1016/j.anbehav.2004.10.017; Leclaire S, 2009, IBIS, V151, P584, DOI 10.1111/j.1474-919X.2009.00935.x; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Magrath RD, 2007, BEHAV ECOL, V18, P944, DOI 10.1093/beheco/arm063; Magrath RD, 2012, P ROY SOC B-BIOL SCI, V279, P902, DOI 10.1098/rspb.2011.1362; Magrath RD, 2009, BEHAV ECOL, V20, P745, DOI 10.1093/beheco/arp055; Marler P, 1957, BEHAVIOUR, V11, DOI [DOI 10.1163/156853956X00066, 10.1163/156853956X00066]; Mathis A, 1996, ANIM BEHAV, V51, P185, DOI 10.1006/anbe.1996.0016; Mirza RS, 2006, BEHAVIOUR, V143, P877, DOI 10.1163/156853906778017926; Rainey HJ, 2004, BEHAVIOUR, V141, P1263, DOI 10.1163/1568539042729658; Randler C, 2006, ETHOLOGY, V112, P411, DOI 10.1111/j.1439-0310.2006.01191.x; Roth TC, 2008, ANIM BEHAV, V76, P2021, DOI 10.1016/j.anbehav.2008.08.022; Savoca MS, 2011, CONDOR, V113, P565, DOI 10.1525/cond.2011.100192; SEYFARTH RM, 1980, SCIENCE, V210, P801, DOI 10.1126/science.7433999; Stephan C, 2008, BIOL LETTERS, V4, P641, DOI 10.1098/rsbl.2008.0488; Talling JC, 1998, APPL ANIM BEHAV SCI, V58, P255, DOI 10.1016/S0168-1591(97)00142-1; TINBERGEN N., 1959, BEHAVIOUR, V15, P1; TODD CS, 1982, J WILDLIFE MANAGE, V46, P636, DOI 10.2307/3808554; VERHEYDEN C, 1994, AUK, V111, P285, DOI 10.2307/4088593; Welbergen JA, 2008, ANIM BEHAV, V76, P811, DOI 10.1016/j.anbehav.2008.03.020; Wisenden BD, 2006, ENVIRON BIOL FISH, V81, P141; Yorzinski JL, 2007, ETHOLOGY, V113, P1219, DOI 10.1111/j.1439-0310.2007.01435.x; Zuberbuhler K, 2001, BEHAV ECOL SOCIOBIOL, V50, P414, DOI 10.1007/s002650100383; [No title captured]; [No title captured]	52	21	21	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82384	10.1371/journal.pone.0082384	http://dx.doi.org/10.1371/journal.pone.0082384			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324780	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700074
J	Zhao, FQ; Yang, J; He, HS; Dai, LM				Zhao, Fuqiang; Yang, Jian; He, Hong S.; Dai, Limin			Effects of Natural and Human-Assisted Regeneration on Landscape Dynamics in a Korean Pine Forest in Northeast China	PLOS ONE			English	Article							SEED DISPERSAL; CHANGBAI MOUNTAIN; RECRUITMENT; SIMULATION; DIVERSITY; FRAGMENTATION; CONSEQUENCES; RESTORATION; SUCCESSION; COMMUNITY	Improper forest harvesting can potentially degrade forest ecosystem functions and services. Human-assisted regeneration (e.g., planting) is often used to increase the rate of forest recovery and thereby reduce regeneration failure. Seed dispersal is a fundamental ecological process that can also influence spatio-temporal patterns of forest regeneration. In this study, we investigated the relative contribution of planting and seed dispersal on forest regeneration at landscape scales. Because such influences can be further complicated by timber harvest intensity and seed availability within and around harvested area, we also evaluated the effects of those factors on forest landscape dynamics. We used the forest landscape model LANDIS to simulate the dynamics of Korean pinebroadleaf mixed forests in Northeast China. We considered three factors: timber harvest intensity (3 levels), seed dispersal and whether or not planting was used. The results showed that planting was more important in maintaining the abundance of Korean pine (Pinus koraiensis), a climax keystone species in this region, under the high-intensity harvesting option during early succession. In contrast, seed dispersal was more important during late succession. Korean pine can be successfully regenerated through seed dispersal under low and medium harvest intensities. Our results also indicated that effective natural regeneration will require protecting seed-production trees (seed rain). This study results provide a basis for more effectively managing Chinese temperate forests and possibly other similar ecosystems.	[Zhao, Fuqiang; Yang, Jian; He, Hong S.; Dai, Limin] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [He, Hong S.] Univ Missouri, Sch Nat Resources, Columbia, MO USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University of Missouri System; University of Missouri Columbia	Yang, J (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	yangjian@iae.ac.cn	Yang, Jian/L-3415-2016; Yang, Jian/H-3169-2011	Yang, Jian/0000-0002-2170-589X; He, Hong S./0000-0002-3983-2512	973 project [2011CB403206]; NSFC [41071121]; Hundred Talents Program of Chinese Academy of Science	973 project(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Hundred Talents Program of Chinese Academy of Science	This research is funded by the 973 project "2011CB403206", the NSFC grant 41071121, and the Hundred Talents Program of Chinese Academy of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez R, 2005, INT J WILDLAND FIRE, V14, P277, DOI 10.1071/WF04066; Bacles CFE, 2006, SCIENCE, V311, P628, DOI 10.1126/science.1121543; BORMANN FH, 1968, SCIENCE, V159, P882, DOI 10.1126/science.159.3817.882; Boucher Y, 2009, LANDSCAPE ECOL, V24, P171, DOI 10.1007/s10980-008-9294-8; Burns R. M., 1990, AGR HDB, V2, P877, DOI DOI 10.1093/JHERED/ESP102; Cramer JM, 2007, BIOL CONSERV, V137, P415, DOI 10.1016/j.biocon.2007.02.019; Cusack D, 2004, FOREST ECOL MANAG, V188, P1, DOI 10.1016/S0378-1127(03)00302-5; FAO, 2006, 147 FAO; HALPERN CB, 1995, ECOL APPL, V5, P913, DOI 10.2307/2269343; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; He HS, 1999, ECOL MODEL, V114, P213, DOI 10.1016/S0304-3800(98)00147-1; He HS, 2005, J BIOGEOGR, V32, P2043, DOI 10.1111/j.1365-2699.2005.01353.x; He HS, 2002, ECOL MODEL, V156, P153, DOI 10.1016/S0304-3800(02)00104-7; He HS, 1999, ECOSYSTEMS, V2, P308, DOI 10.1007/s100219900082; Hewitt N, 2002, J BIOGEOGR, V29, P351, DOI 10.1046/j.1365-2699.2002.00679.x; Hutchins HE, 1996, OECOLOGIA, V107, P120, DOI 10.1007/BF00582242; Keenan Rodney J., 1993, Environmental Reviews, V1, P121, DOI 10.1139/a93-010; Kimmins JP, 2007, FISHES FORESTRY WORL; Lafleur B, 2010, CAN J FOREST RES, V40, P1843, DOI 10.1139/X10-128; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Landres PB, 1999, ECOL APPL, V9, P1179, DOI 10.2307/2641389; Levine JM, 2003, ANNU REV ECOL EVOL S, V34, P549, DOI 10.1146/annurev.ecolsys.34.011802.132400; Li WH, 2004, FOREST ECOL MANAG, V201, P33, DOI 10.1016/j.foreco.2004.06.010; Liu Z. G., 2004, CHIN J APPL ECOL, V15, P958; Lu Chang-Hu, 2002, Acta Zoologica Sinica, V48, P317; [鲁长虎 Lu Changhu], 2003, [生态学杂志, Chinese Journal of Ecology], V22, P49; Herrera JM, 2010, CONSERV BIOL, V24, P1089, DOI 10.1111/j.1523-1739.2010.01459.x; Matthiessen B, 2006, ECOL LETT, V9, P652, DOI 10.1111/j.1461-0248.2006.00916.x; McEuen AB, 2004, ECOLOGY, V85, P507, DOI 10.1890/03-4006; [孟涛 MENG Tao], 2008, [世界地质, World Geology], V27, P338; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Nathan R, 2004, PLANT ECOL, V171, P123, DOI 10.1023/B:VEGE.0000029379.32705.0f; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Paquette A, 2010, FRONT ECOL ENVIRON, V8, P27, DOI 10.1890/080116; PETRANKA JW, 1994, FOREST ECOL MANAG, V67, P135, DOI 10.1016/0378-1127(94)90012-4; Piao ZJ, 2011, ANN FOREST SCI, V68, P911, DOI 10.1007/s13595-011-0097-8; Shao G, 2001, ACTA ECOLOGIA SINICA, V21, P1564; Shao GF, 1996, CAN J FOREST RES, V26, P206, DOI 10.1139/x26-024; Summerville KS, 2002, ECOL APPL, V12, P820, DOI 10.2307/3060992; Swamy V, 2011, ECOL LETT, V14, P195, DOI 10.1111/j.1461-0248.2010.01571.x; SWANSON FJ, 1975, GEOLOGY, V3, P393, DOI 10.1130/0091-7613(1975)3<393:IOCARC>2.0.CO;2; SWINDEL BF, 1983, SCIENCE, V219, P1421, DOI 10.1126/science.219.4591.1421; Wang BC, 2002, TRENDS ECOL EVOL, V17, P379, DOI 10.1016/S0169-5347(02)02541-7; Wang Z., 1980, RES FOREST ECOSYSTEM, V1, P25; Xu CG, 2004, ECOL MODEL, V180, P57, DOI 10.1016/j.ecolmodel.2004.01.018; Xu Z, 1992, FOREST ECOSYSTEM RES, V6, P1; Yang YQ, 2011, POL J ECOL, V59, P413; YOUNG KR, 1987, VEGETATIO, V71, P157; Yu DP, 2011, ENVIRON MANAGE, V48, P1122, DOI 10.1007/s00267-011-9633-4; Zhao FQ, 2011, ENVIRON MANAGE, V48, P1136, DOI 10.1007/s00267-011-9669-5; Zhao G, 2002, J FOREST, V100, P34; Zhao G, 2005, J LIAONING FORESTRY, P7	52	4	4	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82414	10.1371/journal.pone.0082414	http://dx.doi.org/10.1371/journal.pone.0082414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324785	gold, Green Published, Green Submitted			2022-12-25	WOS:000328566700079
J	Ai, BJ; Li, J; Feng, DM; Li, F; Guo, SY				Ai, Bingjie; Li, Jie; Feng, Dongmei; Li, Feng; Guo, Shuyuan			The Elimination of DNA from the Cry Toxin-DNA Complex Is a Necessary Step in the Mode of Action of the Cry8 Toxin	PLOS ONE			English	Article							BORDER MEMBRANE-VESICLES; BACILLUS-THURINGIENSIS; CRYSTAL PROTEIN; DELTA-ENDOTOXIN; LARVAL MIDGUT; BINDING; TOXICITY; GENE; ACTIVATION	Several crystal (Cry) proteins are known to occur as DNA-protein complexes. However, the role of the DNA associated with the activated toxin in the mechanism of action of the Cry toxin has long been ignored. Here, we focused on the DNA-activated Cry toxin complex. Both forms of the Cry8Ca2 and Cry8Ea1 toxins, i.e., with or without bound DNA, were separately obtained. Size-exclusion chromatography analysis indicated that the Cry8Ca2 toxin-DNA complex has a tight or compact structure. The Cry8Ca2 toxin-DNA complex is more likely to move toward the air/water interface and is more hydrophobic than the toxin without DNA. Competitive binding assays indicated that the Cry8Ca2 and Cry8Ea1 toxins without DNA specifically bind to the midgut of Anomala corpulenta and Holotrichia parallela larvae, respectively. In contrast, the association of DNA with each toxin might result in the nonspecific recognition of the Cry toxin and its target receptor in the insect midgut. The association of the DNA fragment with the Cry8 toxin was shown to protect the Cry protein from digestion by proteases. Based on our results, we propose an additional step in the mechanism of action of the Cry8 toxin and elucidate the function of the associated DNA as well as the importance of the removal of this DNA for the insecticidal activity of the toxin.	[Ai, Bingjie; Li, Jie; Feng, Dongmei; Li, Feng; Guo, Shuyuan] Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China	Beijing Institute of Technology	Guo, SY (corresponding author), Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China.	guosy@bit.edu.cn			Natural Science Foundation of China [31171911]; Major State Basic Research Development Program of China (973 Program) [2009CB118902]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the Natural Science Foundation of China (grant no. 31171911) and the Major State Basic Research Development Program of China (973 Program; grant no. 2009CB118902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIETLOT HP, 1993, J BIOL CHEM, V268, P8240; CHOMA CT, 1990, EUR J BIOCHEM, V189, P523, DOI 10.1111/j.1432-1033.1990.tb15518.x; Clairmont FR, 1998, J BIOL CHEM, V273, P9292, DOI 10.1074/jbc.273.15.9292; Demel R A, 1974, Methods Enzymol, V32, P539; Estela A, 2004, APPL ENVIRON MICROB, V70, P1378, DOI 10.1128/AEM.70.3.1378-1384.2004; Finney D.J., 1971, PROBIT ANAL; GARCZYNSKI SF, 1995, INSECT BIOCHEM MOLEC, V25, P409, DOI 10.1016/0965-1748(94)00072-7; Guo SY, 2011, FEMS MICROBIOL LETT, V317, P203, DOI 10.1111/j.1574-6968.2011.02230.x; Guo SY, 2009, J STRUCT BIOL, V168, P259, DOI 10.1016/j.jsb.2009.07.004; Higuchi M, 2007, COMP BIOCHEM PHYS B, V147, P716, DOI 10.1016/j.cbpb.2007.04.013; Hossain DM, 2004, APPL ENVIRON MICROB, V70, P4604, DOI 10.1128/AEM.70.8.4604-4612.2004; Hua G, 2001, APPL ENVIRON MICROB, V67, P872, DOI 10.1128/AEM.67.2.872-879.2001; Huang DF, 2007, J INVERTEBR PATHOL, V95, P175, DOI 10.1016/j.jip.2007.02.016; Li HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053079; Luo K, 1999, APPL ENVIRON MICROB, V65, P457; OGIWARA K, 1995, CURR MICROBIOL, V30, P227, DOI 10.1007/BF00293638; Padilla C, 2006, APPL ENVIRON MICROB, V72, P901, DOI 10.1128/AEM.72.1.901-907.2006; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rausell C, 2004, BBA-BIOMEMBRANES, V1660, P99, DOI 10.1016/j.bbamem.2003.11.004; Rodriguez-Almazan C, 2011, BIOCHEMISTRY-US, V50, P388, DOI 10.1021/bi101239r; Hernandez-Rodriguez CS, 2008, APPL ENVIRON MICROB, V74, P7654, DOI 10.1128/AEM.01373-08; SATO R, 1994, CURR MICROBIOL, V28, P15, DOI 10.1007/BF01575980; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Shu C, 2007, CURR MICROBIOL, V55, P492, DOI 10.1007/s00284-007-9018-3; Shu CL, 2009, APPL MICROBIOL BIOT, V84, P701, DOI 10.1007/s00253-009-1971-2; Shu CL, 2009, CURR MICROBIOL, V58, P389, DOI 10.1007/s00284-008-9338-y; Soberon M, 2009, CELL MOL LIFE SCI, V66, P1337, DOI 10.1007/s00018-008-8330-9; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Xia XF, 2000, BIOCHEM J, V349, P835, DOI 10.1042/bj3490835; Yu H, 2006, CURR MICROBIOL, V53, P13, DOI 10.1007/s00284-005-0097-8; Zuniga-Navarrete F, 2013, PEPTIDES, V41, P81, DOI 10.1016/j.peptides.2012.05.019	32	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81335	10.1371/journal.pone.0081335	http://dx.doi.org/10.1371/journal.pone.0081335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324685	Green Published, Green Submitted, gold			2022-12-25	WOS:000327949300086
J	Kim, KJ; Godarova, A; Seedle, K; Kim, MH; Ince, TA; Wells, SI; Driscoll, JJ; Godar, S				Kim, Kui-Jin; Godarova, Alzbeta; Seedle, Kari; Kim, Min-Ho; Ince, Tan A.; Wells, Susanne I.; Driscoll, James J.; Godar, Samuel			Rb Suppresses Collective Invasion, Circulation and Metastasis of Breast Cancer Cells in CD44-Dependent Manner	PLOS ONE			English	Article							E-CADHERIN; TUMOR; PROTEINS; IDENTIFICATION; INACTIVATION; DETERMINANT; INDUCTION; PHENOTYPE; MIGRATION; LEADS	Basal-like breast carcinomas (BLCs) present with extratumoral lymphovascular invasion, are highly metastatic, presumably through a hematogenous route, have augmented expression of CD44 oncoprotein and relatively low levels of retinoblastoma (Rb) tumor suppressor. However, the causal relation among these features is not clear. Here, we show that Rb acts as a key suppressor of multiple stages of metastatic progression. Firstly, Rb suppresses collective cell migration (CCM) and CD44-dependent formation of F-actin positive protrusions in vitro and cell-cluster based lymphovascular invasion in vivo. Secondly, Rb inhibits the release of single cancer cells and cell clusters into the hematogenous circulation and subsequent metastatic growth in lungs. Finally, CD44 expression is required for collective motility and all subsequent stages of metastatic progression initiated by loss of Rb function. Altogether, our results suggest that Rb/CD44 pathway is a crucial regulator of CCM and metastatic progression of BLCs and a promising target for anti-BLCs therapy.	[Kim, Kui-Jin; Godarova, Alzbeta; Seedle, Kari; Driscoll, James J.; Godar, Samuel] Univ Cincinnati, Coll Med, Vontz Ctr Mol Studies, Dept Canc Biol, Cincinnati, OH 45221 USA; [Kim, Min-Ho] Ulsan Univ Hosp, Biomed Res Ctr, Ulsan, South Korea; [Ince, Tan A.] Univ Miami, Miller Sch Med, Dept Pathol, Braman Family Breast Canc Inst, Miami, FL 33136 USA; [Ince, Tan A.] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA; [Wells, Susanne I.] Cincinnati Childrens Hosp Med Ctr, Div Oncol, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA; [Driscoll, James J.] Univ Cincinnati, Coll Med, Div Hematol & Oncol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University of Ulsan; Ulsan University Hospital; University of Miami; University of Miami; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Godar, S (corresponding author), Univ Cincinnati, Coll Med, Vontz Ctr Mol Studies, Dept Canc Biol, Cincinnati, OH 45221 USA.	samuel.godar@gmail.com		Driscoll, James/0000-0001-8364-0617; Kim, Min-ho/0000-0003-4909-2308; Ince, Tan/0000-0003-0315-6425	Department of Cancer Biology, College of Medicine, University of Cincinnati	Department of Cancer Biology, College of Medicine, University of Cincinnati	This work was supported by Department of Cancer Biology, College of Medicine, University of Cincinnati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLF GR, 1997, Patent No. 5916561; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Arima Y, 2008, CANCER RES, V68, P5104, DOI 10.1158/0008-5472.CAN-07-5680; Arima Y, 2012, J BIOL CHEM, V287, P7896, DOI 10.1074/jbc.M111.313759; Bellacchio E, 2013, J CELL PHYSIOL, V228, P285, DOI 10.1002/jcp.24137; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Futterman MA, 2011, DEV DYNAM, V240, P1502, DOI 10.1002/dvdy.22607; Gauthier ML, 2007, CANCER CELL, V12, P479, DOI 10.1016/j.ccr.2007.10.017; Giesing M, 2010, BJU INT, V105, P1000, DOI 10.1111/j.1464-410X.2009.08920.x; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Jiang Z, 2002, J CELL BIOL, V156, P185, DOI 10.1083/jcb.200106084; Jiang Z, 2010, J CLIN INVEST, V120, P3296, DOI 10.1172/JCI41490; KASID A, 1985, SCIENCE, V228, P725, DOI 10.1126/science.4039465; Kats-Ugurlu G, 2009, J PATHOL, V219, P287, DOI 10.1002/path.2613; LIOTTA LA, 1976, CANCER RES, V36, P889; Matise LA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3217; Mehes G, 2001, AM J PATHOL, V159, P17, DOI 10.1016/S0002-9440(10)61667-7; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Robinson GW, 2001, ONCOGENE, V20, P7115, DOI 10.1038/sj.onc.1204888; Sabatier R, 2011, EUR J CANCER, V47, P1537, DOI 10.1016/j.ejca.2011.02.002; Shibue T, 2012, CANCER DISCOV, V2, P706, DOI 10.1158/2159-8290.CD-11-0239; Simin K, 2004, PLOS BIOL, V2, P194, DOI 10.1371/journal.pbio.0020022; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Subhawong AP, 2009, AM J SURG PATHOL, V33, P163, DOI 10.1097/PAS.0b013e31817f9790; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Theodoropoulos PA, 2010, CANCER LETT, V288, P99, DOI 10.1016/j.canlet.2009.06.027; Vooijs M, 1999, ONCOGENE, V18, P5293, DOI 10.1038/sj.onc.1202999; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; YOUNG DSF, 2009, Patent No. 7507537	41	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80590	10.1371/journal.pone.0080590	http://dx.doi.org/10.1371/journal.pone.0080590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324613	Green Submitted, Green Published, gold			2022-12-25	WOS:000327949300032
J	Sagaram, US; El-Mounadi, K; Buchko, GW; Berg, HR; Kaur, J; Pandurangi, RS; Smith, TJ; Shah, DM				Sagaram, Uma Shankar; El-Mounadi, Kaoutar; Buchko, Garry W.; Berg, Howard R.; Kaur, Jagdeep; Pandurangi, Raghu S.; Smith, Thomas J.; Shah, Dilip M.			Structural and Functional Studies of a Phosphatidic Acid-Binding Antifungal Plant Defensin MtDef4: Identification of an RGFRRR Motif Governing Fungal Cell Entry	PLOS ONE			English	Article							3-DIMENSIONAL SOLUTION STRUCTURE; PISUM-SATIVUM DEFENSIN-1; EFFECTOR PROTEINS; ANTIMICROBIAL PEPTIDES; FUSARIUM-OXYSPORUM; CHEMICAL-SHIFT; OOMYCETE; STRESS; NAD1; TRANSLOCATION	MtDef4 is a 47-amino acid cysteine-rich evolutionary conserved defensin from a model legume Medicago truncatula. It is an apoplast-localized plant defense protein that inhibits the growth of the ascomycetous fungal pathogen Fusarium graminearum in vitro at micromolar concentrations. Little is known about the mechanisms by which MtDef4 mediates its antifungal activity. In this study, we show that MtDef4 rapidly permeabilizes fungal plasma membrane and is internalized by the fungal cells where it accumulates in the cytoplasm. Furthermore, analysis of the structure of MtDef4 reveals the presence of a positively charged Upsilon-core motif composed of beta(2) and beta(3) strands connected by a positively charged RGFRRR loop. Replacement of the RGFRRR sequence with AAAARR or RGFRAA abolishes the ability of MtDef4 to enter fungal cells, suggesting that the RGFRRR loop is a translocation signal required for the internalization of the protein. MtDef4 binds to phosphatidic acid (PA), a precursor for the biosynthesis of membrane phospholipids and a signaling lipid known to recruit cytosolic proteins to membranes. Amino acid substitutions in the RGFRRR sequence which abolish the ability of MtDef4 to enter fungal cells also impair its ability to bind PA. These findings suggest that MtDef4 is a novel antifungal plant defensin capable of entering into fungal cells and affecting intracellular targets and that these processes are mediated by the highly conserved cationic RGFRRR loop via its interaction with PA.	[Sagaram, Uma Shankar; El-Mounadi, Kaoutar; Berg, Howard R.; Kaur, Jagdeep; Pandurangi, Raghu S.; Smith, Thomas J.; Shah, Dilip M.] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Buchko, Garry W.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA	Donald Danforth Plant Science Center; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Shah, DM (corresponding author), Donald Danforth Plant Sci Ctr, St Louis, MO USA.	dshah@danforthcenter.org	Mounadi, Kaoutar el/R-3064-2019; Berg, R. Howard/M-2839-2013; Kaur, Jagdeep/C-4155-2015; Shah, Dilip/M-2850-2013; Buchko, Garry/G-6173-2015	Berg, R. Howard/0000-0001-5081-2769; Kaur, Jagdeep/0000-0002-3238-4825; Buchko, Garry/0000-0002-3639-1061; Sagaram, Uma Shankar/0000-0003-4353-1090	NSF [MCB-0924124]; Div Of Molecular and Cellular Bioscience [0924124] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research has been supported by the NSF grant MCB-0924124. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts AM, 2008, CELL MOL LIFE SCI, V65, P2069, DOI 10.1007/s00018-008-8035-0; Almeida MS, 2000, ARCH BIOCHEM BIOPHYS, V378, P278, DOI 10.1006/abbi.2000.1824; Almeida MS, 2002, J MOL BIOL, V315, P749, DOI 10.1006/jmbi.2001.5252; Alves ID, 2010, BBA-BIOMEMBRANES, V1798, P2231, DOI 10.1016/j.bbamem.2010.02.009; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Athenstaedt K, 1999, EUR J BIOCHEM, V266, P1, DOI 10.1046/j.1432-1327.1999.00822.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bloch C, 1998, PROTEINS, V32, P334, DOI 10.1002/(SICI)1097-0134(19980815)32:3<334::AID-PROT9>3.0.CO;2-H; BROEKAERT WF, 1990, FEMS MICROBIOL LETT, V69, P55, DOI [10.1111/j.1574-6968.1990.tb04174.x, 10.1016/S0378-1097(98)00477-7]; BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI [10.1104/pp.108.4.1353, 10.1016/j.chiabu.2021.105188]; Broekaert WF, 1997, CRIT REV PLANT SCI, V16, P297, DOI 10.1080/713608148; CAPPELLINI RA, 1965, MYCOLOGIA, V57, P962, DOI 10.2307/3756895; Carvalho AD, 2009, PEPTIDES, V30, P1007, DOI 10.1016/j.peptides.2009.01.018; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; CORRELL JC, 1987, PHYTOPATHOLOGY, V77, P1640, DOI 10.1094/Phyto-77-1640; DeSamblanx GW, 1997, J BIOL CHEM, V272, P1171, DOI 10.1074/jbc.272.2.1171; Dracatos PM, 2014, MOL PLANT PATHOL, V15, P67, DOI 10.1111/mpp.12066; Drin G, 2001, BIOCHEMISTRY-US, V40, P1824, DOI 10.1021/bi002019k; Ellis JG, 2011, P NATL ACAD SCI USA, V108, P14381, DOI 10.1073/pnas.1111668108; Fant F, 1998, J MOL BIOL, V279, P257, DOI 10.1006/jmbi.1998.1767; Fant F, 1999, PROTEINS, V37, P388, DOI 10.1002/(SICI)1097-0134(19991115)37:3<388::AID-PROT7>3.0.CO;2-F; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Goddard T. D., 2008, SPARKY 3; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Guo L, 2011, J BIOL CHEM, V286, P13336, DOI 10.1074/jbc.M110.190892; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Janssen BJC, 2003, BIOCHEMISTRY-US, V42, P8214, DOI 10.1021/bi034379o; Kale SD, 2011, CELL MICROBIOL, V13, P1839, DOI 10.1111/j.1462-5822.2011.01659.x; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Kaur J, 2012, MOL PLANT PATHOL, V13, P1032, DOI 10.1111/j.1364-3703.2012.00813.x; Kaur Jagdeep, 2011, Fungal Biology Reviews, V25, P128, DOI 10.1016/j.fbr.2011.07.004; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Lay FT, 2003, J MOL BIOL, V325, P175, DOI 10.1016/S0022-2836(02)01103-8; Lay FT, 2012, J BIOL CHEM, V287, P19961, DOI 10.1074/jbc.M111.331009; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Lobo DS, 2007, BIOCHEMISTRY-US, V46, P987, DOI 10.1021/bi061441j; Munoz A, 2012, MOL MICROBIOL, V85, P89, DOI 10.1111/j.1365-2958.2012.08091.x; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramamoorthy V, 2007, MOL MICROBIOL, V66, P771, DOI 10.1111/j.1365-2958.2007.05955.x; Ramamoorthy V, 2007, CELL MICROBIOL, V9, P1491, DOI 10.1111/j.1462-5822.2006.00887.x; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Rodriguez E, 2001, J BIOCHEM-TOKYO, V130, P19, DOI 10.1093/oxfordjournals.jbchem.a002957; Saff EB, 1997, MATH INTELL, V19, P5, DOI 10.1007/BF03024331; Sagaram US, 2012, ACS SYM SER, V1095, P317; Sagaram US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018550; Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046; Spelbrink RG, 2004, PLANT PHYSIOL, V135, P2055, DOI 10.1104/pp.104.040873; Stotz HU, 2009, PLANT SIGNAL BEHAV, V4, P1010, DOI 10.4161/psb.4.11.9755; Sun FR, 2013, MOL PLANT MICROBE IN, V26, P330, DOI 10.1094/MPMI-07-12-0184-R; TERRAS FRG, 1992, J BIOL CHEM, V267, P15301; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Thevissen K, 2000, MOL PLANT MICROBE IN, V13, P54, DOI 10.1094/MPMI.2000.13.1.54; Thevissen K, 2000, P NATL ACAD SCI USA, V97, P9531, DOI 10.1073/pnas.160077797; Thevissen K, 2005, CURR DRUG TARGETS, V6, P923, DOI 10.2174/138945005774912771; Thevissen K, 2003, PEPTIDES, V24, P1705, DOI 10.1016/j.peptides.2003.09.014; Thevissen K, 2012, MOL MICROBIOL, V84, P166, DOI 10.1111/j.1365-2958.2012.08017.x; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Tyler BM, 2009, CELL MICROBIOL, V11, P13, DOI 10.1111/j.1462-5822.2008.01240.x; van der Weerden NL, 2008, J BIOL CHEM, V283, P14445, DOI 10.1074/jbc.M709867200; van der Weerden NL, 2010, J BIOL CHEM, V285, P37513, DOI 10.1074/jbc.M110.134882; Wang XM, 2005, PLANT PHYSIOL, V139, P566, DOI 10.1104/pp.105.068809; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Yaeno T, 2011, P NATL ACAD SCI USA, V108, P14682, DOI 10.1073/pnas.1106002108; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101	70	88	90	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82485	10.1371/journal.pone.0082485	http://dx.doi.org/10.1371/journal.pone.0082485			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324798	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300154
J	Malisova, L; Kovacova, Z; Koc, M; Kracmerova, J; Stich, V; Rossmeislova, L				Malisova, Lucia; Kovacova, Zuzana; Koc, Michal; Kracmerova, Jana; Stich, Vladimir; Rossmeislova, Lenka			Ursodeoxycholic Acid but Not Tauroursodeoxycholic Acid Inhibits Proliferation and Differentiation of Human Subcutaneous Adipocytes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; ADIPOSE-TISSUE; BILE-ACIDS; INSULIN SENSITIVITY; EPITHELIAL-CELLS; CHEMICAL CHAPERONES; METABOLIC DISEASE; DEOXYCHOLIC-ACID	Stress of endoplasmic reticulum (ERS) is one of the molecular triggers of adipocyte dysfunction and chronic low inflammation accompanying obesity. ERS can be alleviated by chemical chaperones from the family of bile acids (BAs). Thus, two BAs currently used to treat cholestasis, ursodeoxycholic and tauroursodeoxycholic acid (UDCA and TUDCA), could potentially lessen adverse metabolic effects of obesity. Nevertheless, BAs effects on human adipose cells are mostly unknown. They could regulate gene expression through pathways different from their chaperone function, namely through activation of farnesoid X receptor (FXR) and TGR5, G-coupled receptor. Therefore, this study aimed to analyze effects of UDCA and TUDCA on human preadipocytes and differentiated adipocytes derived from paired samples of two distinct subcutaneous adipose tissue depots, abdominal and gluteal. While TUDCA did not alter proliferation of cells from either depot, UDCA exerted strong anti-proliferative effect. In differentiated adipocytes, acute exposition to neither TUDCA nor UDCA was able to reduce effect of ERS stressor tunicamycin. However, exposure of cells to UDCA during whole differentiation process decreased expression of ERS markers. At the same time however, UDCA profoundly inhibited adipogenic conversion of cells. UDCA abolished expression of PPAR. and lipogenic enzymes already in the early phases of adipogenesis. This anti-adipogenic effect of UDCA was not dependent on FXR or TGR5 activation, but could be related to ability of UDCA to sustain the activation of ERK1/2 previously linked with PPAR. inactivation. Finally, neither BAs did lower expression of chemokines inducible by TLR4 pathway, when UDCA enhanced their expression in gluteal adipocytes. Therefore while TUDCA has neutral effect on human preadipocytes and adipocytes, the therapeutic use of UDCA different from treating cholestatic diseases should be considered with caution because UDCA alters functions of human adipose cells.	[Malisova, Lucia; Kovacova, Zuzana; Koc, Michal; Kracmerova, Jana; Stich, Vladimir; Rossmeislova, Lenka] Charles Univ Prague, Fac Med 3, Dept Sport Med, Prague, Czech Republic; [Malisova, Lucia; Kovacova, Zuzana; Koc, Michal; Kracmerova, Jana; Stich, Vladimir; Rossmeislova, Lenka] Fac Med 3, Franco Czech Lab Clin Res Obes, Prague, Czech Republic; [Malisova, Lucia; Kovacova, Zuzana; Koc, Michal; Kracmerova, Jana; Stich, Vladimir; Rossmeislova, Lenka] Fac Med Toulouse, INSERM, F-31073 Toulouse, France	Charles University Prague; Charles University Prague; Institut National de la Sante et de la Recherche Medicale (Inserm)	Rossmeislova, L (corresponding author), Charles Univ Prague, Fac Med 3, Dept Sport Med, Prague, Czech Republic.	Lenka.Rossmeislova@lf3.cuni.cz	Rossmeislová, Lenka/D-1931-2013; Koc, Michal/D-1234-2014	Rossmeislová, Lenka/0000-0002-7611-7585; Koc, Michal/0000-0003-0928-4196; Neubert, Jana/0000-0002-2159-7139	Ministry of Health [IGA NT 11450-3-2010]; Grant Agency of the Czech Republic [GACR 301/11/0748]; Charles University [HEALTH-F2-2008-2011 00, UNCE 204015]	Ministry of Health; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Charles University	The study was supported by IGA NT 11450-3-2010 of Ministry of Health, grant GACR 301/11/0748 of the Grant Agency of the Czech Republic, Collaborative Project ADAPT (www.adapt-eu.net), Contract No. HEALTH-F2-2008-2011 00), and UNCE 204015 of Charles University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkarim M, 2010, J BIOL CHEM, V285, P36759, DOI 10.1074/jbc.M110.166231; Akare S, 2006, INT J CANCER, V119, P2958, DOI 10.1002/ijc.22231; Amaral JD, 2007, J BIOL CHEM, V282, P34250, DOI 10.1074/jbc.M704075200; Bergamini A, 1997, HEPATOLOGY, V25, P927, DOI 10.1002/hep.510250423; Berger E, 2011, BIOCHEM BIOPH RES CO, V409, P610, DOI 10.1016/j.bbrc.2011.05.043; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; BOUSCAREL B, 1995, AM J PHYSIOL-GASTR L, V268, pG908, DOI 10.1152/ajpgi.1995.268.6.G908; Byrne AM, 2010, CARCINOGENESIS, V31, P737, DOI 10.1093/carcin/bgq011; Camp HS, 1997, J BIOL CHEM, V272, P10811; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Ceylan-Isik AF, 2011, J MOL CELL CARDIOL, V50, P107, DOI 10.1016/j.yjmcc.2010.10.023; Elliott CL, 2001, MOL HUM REPROD, V7, P787, DOI 10.1093/molehr/7.8.787; Engin F, 2010, DIABETES OBES METAB, V12, P108, DOI 10.1111/j.1463-1326.2010.01282.x; Evans J, 2011, CLIN ENDOCRINOL, V74, P51, DOI 10.1111/j.1365-2265.2010.03883.x; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Iguchi Y, 2011, BIOL PHARM BULL, V34, P1, DOI 10.1248/bpb.34.1; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799; Kim JM, 2005, CLIN EXP IMMUNOL, V140, P450, DOI 10.1111/j.1365-2249.2005.02804.x; Krishna-Subramanian S, 2012, INT J CANCER, V130, P2771, DOI 10.1002/ijc.26336; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Laurencikiene J, 2012, INT J OBESITY, V36, P1494, DOI 10.1038/ijo.2012.21; Lew JL, 2004, J BIOL CHEM, V279, P8856, DOI 10.1074/jbc.M306422200; Li N, 2002, J PHARMACOL EXP THER, V301, P551, DOI 10.1124/jpet.301.2.551; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; Mlinar B, 2011, CLIN CHEM LAB MED, V49, P1925, DOI 10.1515/CCLM.2011.697; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Peiro-Jordan R, 2012, EUR J CANCER PREV, V21, P413, DOI 10.1097/CEJ.0b013e32834ef16f; Pols TWH, 2011, J HEPATOL, V54, P1263, DOI 10.1016/j.jhep.2010.12.004; Rizzo G, 2006, MOL PHARMACOL, V70, P1164, DOI 10.1124/mol.106.023820; Shah SA, 2006, INT J CANCER, V118, P532, DOI 10.1002/ijc.21365; Sharma NK, 2008, J CLIN ENDOCR METAB, V93, P4532, DOI 10.1210/jc.2008-1001; Shiraki K, 2005, INT J MOL MED, V16, P729; Svensson PA, 2013, BIOCHEM BIOPH RES CO, V433, P563, DOI 10.1016/j.bbrc.2013.03.031; Tan GD, 2004, OBES RES, V12, P114, DOI 10.1038/oby.2004.15; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; Tiwari A, 2009, DRUG DISCOV TODAY, V14, P523, DOI 10.1016/j.drudis.2009.02.005; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhou L, 2010, DIABETES	50	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82086	10.1371/journal.pone.0082086	http://dx.doi.org/10.1371/journal.pone.0082086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312631	Green Published, gold, Green Submitted			2022-12-25	WOS:000327947800083
J	Pritchard, TJ; Kawase, Y; Haghighi, K; Anjak, A; Cai, W; Jiang, M; Nicolaou, P; Pylar, G; Karakikes, I; Rapti, K; Rubinstein, J; Hajjar, RJ; Kranias, EG				Pritchard, Tracy J.; Kawase, Yoshiaki; Haghighi, Kobra; Anjak, Ahmad; Cai, Wenfeng; Jiang, Min; Nicolaou, Persoulla; Pylar, George; Karakikes, Ioannis; Rapti, Kleopatra; Rubinstein, Jack; Hajjar, Roger J.; Kranias, Evangelia G.			Active Inhibitor-1 Maintains Protein Hyper-Phosphorylation in Aging Hearts and Halts Remodeling in Failing Hearts	PLOS ONE			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; RABBIT SKELETAL-MUSCLE; INBRED MOUSE STRAINS; PHOSPHATASE INHIBITOR-1; DILATED CARDIOMYOPATHY; NEGATIVE REGULATOR; HUMAN MYOCARDIUM; FAILURE; PHOSPHOLAMBAN; CONTRACTILITY	Impaired sarcoplasmic reticulum calcium cycling and depressed contractility are key characteristics in heart failure. Defects in sarcoplasmic reticulum function are characterized by decreased SERCA2a Ca-transport that is partially attributable to dephosphorylation of its regulator phospholamban by increased protein phosphatase 1 activity. Inhibition of protein phosphatase 1 through activation of its endogenous inhibitor-1 has been shown to enhance cardiac Ca-handling and contractility as well as protect from pathological stress remodeling in young mice. In this study, we assessed the long-term effects of inducible expression of constitutively active inhibitor-1 in the adult heart and followed function and remodeling through the aging process, up to 20 months. Mice with inhibitor-1 had normal survival and similar function to WTs. There was no overt remodeling as evidenced by measures of left ventricular end-systolic and diastolic diameters and posterior wall dimensions, heart weight to tibia length ratio, and histology. Higher phosphorylation of phospholamban at both Ser16 and Thr17 was maintained in aged hearts with active inhibitor-1, potentially offsetting the effects of elevated Ser2815-phosphorylation in ryanodine receptor, as there were no increases in arrhythmias under stress conditions in 20-month old mice. Furthermore, long-term expression of active inhibitor-1 via recombinant adeno-associated virus type 9 gene transfer in rats with pressure-overload induced heart failure improved function and prevented remodeling, associated with increased phosphorylation of phospholamban at Ser16 and Thr17. Thus, chronic inhibition of protein phosphatase 1, through increases in active inhibitor-1, does not accelerate age-related cardiomyopathy and gene transfer of this molecule in vivo improves function and halts remodeling in the long term.	[Pritchard, Tracy J.; Haghighi, Kobra; Cai, Wenfeng; Nicolaou, Persoulla; Pylar, George; Kranias, Evangelia G.] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA; [Anjak, Ahmad; Jiang, Min; Rubinstein, Jack] Univ Cincinnati, Dept Internal Med, Div Cardiovasc Dis, Cincinnati, OH 45267 USA; [Kawase, Yoshiaki; Karakikes, Ioannis; Rapti, Kleopatra; Hajjar, Roger J.] Ichan Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Icahn School of Medicine at Mount Sinai	Kranias, EG (corresponding author), Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA.	litsa.kranias@uc.edu		Rubinstein, Jack/0000-0002-8811-1551; Karakikes, Ioannis/0000-0002-4348-600X	National Institutes of Health [HL26057, HL64018, HL093183, HL100396]; NHLBI [HHSN268201000045C, HL007382 TG]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093183, R01HL026057, R01HL064018, P20HL100396, R37HL026057, T32HL007382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by National Institutes of Health grants HL26057 and HL64018 (to E. G. K.); HL093183, HL100396, and NHLBI Program of Excellence in Nanotechnology (PEN) Award Contract HHSN268201000045C (to R. J. H.); and HL007382 TG (to T. J. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN A, 1982, EUR J BIOCHEM, V126, P235, DOI 10.1111/j.1432-1033.1982.tb06771.x; Barnabei MS, 2010, PHYSIOL GENOMICS, V42A, P103, DOI 10.1152/physiolgenomics.00071.2010; Barrick CJ, 2007, AM J PHYSIOL-HEART C, V292, pH2119, DOI 10.1152/ajpheart.00816.2006; Beeri R, 2002, CIRCULATION, V106, P1756, DOI 10.1161/01.CIR.0000035240.92015.E4; Berthonneche C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006610; Carr AN, 2002, MOL CELL BIOL, V22, P4124, DOI 10.1128/MCB.22.12.4124-4135.2002; Chen GL, 2010, BASIC RES CARDIOL, V105, P573, DOI 10.1007/s00395-010-0106-3; Chu G, 2002, BASIC RES CARDIOL S1, V97, P143; Dash R, 2001, J MOL CELL CARDIOL, V33, P1345, DOI 10.1006/jmcc.2001.1394; del Monte F, 2001, CIRCULATION, V104, P1424, DOI 10.1161/hc3601.095574; El-Armouche A, 2004, CARDIOVASC RES, V61, P87, DOI 10.1016/j.cardiores.2003.11.005; El-Armouche A, 2003, FASEB J, V17, P437, DOI 10.1096/fj.02-0057fje; Endo S, 1996, BIOCHEMISTRY-US, V35, P5220, DOI 10.1021/bi952940f; Fish KM, 2013, CIRC-HEART FAIL, V6, P310, DOI 10.1161/CIRCHEARTFAILURE.112.971325; Gupta RC, 2003, AM J PHYSIOL-HEART C, V285, pH2373, DOI 10.1152/ajpheart.00442.2003; HUANG FL, 1976, EUR J BIOCHEM, V70, P419, DOI 10.1111/j.1432-1033.1976.tb11032.x; Hulot JS, 2011, CIRCULATION, V124, P796, DOI 10.1161/CIRCULATIONAHA.111.031229; Kho C, 2011, NATURE, V477, P601, DOI 10.1038/nature10407; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Kratlian Razmig Garo, 2012, Curr Heart Fail Rep, V9, P33, DOI 10.1007/s11897-011-0077-1; LIMAS CJ, 1987, CARDIOVASC RES, V21, P601, DOI 10.1093/cvr/21.8.601; Lou Q, 2012, ADV EXP MED BIOL, V740, P1145, DOI 10.1007/978-94-007-2888-2_52; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; National Research Council, 1996, GUIDE CARE USE LAB A, V7th ed., P140, DOI [10.17226/5140, DOI 10.17226/5140]; National Research Council (US), 2011, GUIDE CARE USE LAB A; Neumann J, 1997, J MOL CELL CARDIOL, V29, P265, DOI 10.1006/jmcc.1996.0271; Nicolaou P, 2009, J MOL CELL CARDIOL, V47, P365, DOI 10.1016/j.yjmcc.2009.05.010; Nicolaou P, 2009, CIRC RES, V104, P1012, DOI 10.1161/CIRCRESAHA.108.189811; Pathak A, 2005, CIRC RES, V96, P756, DOI 10.1161/01.RES.0000161256.85833.fa; Rodriguez P, 2007, AM J PHYSIOL-HEART C, V293, pH762, DOI 10.1152/ajpheart.00104.2007; Rodriguez P, 2006, J BIOL CHEM, V281, P38599, DOI 10.1074/jbc.M604139200; Schwinger RHG, 1999, J MOL CELL CARDIOL, V31, P479, DOI 10.1006/jmcc.1998.0897; SCHWINGER RHG, 1995, CIRCULATION, V92, P3220, DOI 10.1161/01.CIR.92.11.3220; Shah AP, 2010, CARDIOVASC RES, V87, P683, DOI 10.1093/cvr/cvq111; SHENOLIKAR S, 1995, SEMIN CANCER BIOL, V6, P219, DOI 10.1006/scbi.1995.0029; STEENAART NAE, 1992, ARCH BIOCHEM BIOPHYS, V293, P17, DOI 10.1016/0003-9861(92)90359-5; Suckau L, 2009, CIRCULATION, V119, P1241, DOI 10.1161/CIRCULATIONAHA.108.783852; UNVERFERTH DV, 1988, AM HEART J, V115, P139, DOI 10.1016/0002-8703(88)90529-7; Wittopper K, 2010, J CLIN INVEST, V120, P617, DOI 10.1172/JCI40545; Yuan QQ, 2007, CIRCULATION, V115, P300, DOI 10.1161/CIRCULATIONAHA.106.654699	40	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80717	10.1371/journal.pone.0080717	http://dx.doi.org/10.1371/journal.pone.0080717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312496	Green Submitted, gold, Green Published			2022-12-25	WOS:000327944500040
J	Reiter, ME; Andersen, DE				Reiter, Matthew E.; Andersen, David E.			Evidence of Territoriality and Species Interactions from Spatial Point-Pattern Analyses of Subarctic-Nesting Geese	PLOS ONE			English	Article							LESSER SNOW GOOSE; ASSOCIATIONS; PREDATION; RANGE	Quantifying spatial patterns of bird nests and nest fate provides insights into processes influencing a species' distribution. At Cape Churchill, Manitoba, Canada, recent declines in breeding Eastern Prairie Population Canada geese (Branta canadensis interior) has coincided with increasing populations of nesting lesser snow geese (Chen caerulescens caerulescens) and Ross's geese (Chen rossii). We conducted a spatial analysis of point patterns using Canada goose nest locations and nest fate, and lesser snow goose nest locations at two study areas in northern Manitoba with different densities and temporal durations of sympatric nesting Canada and lesser snow geese. Specifically, we assessed (1) whether Canada geese exhibited territoriality and at what scale and nest density; and (2) whether spatial patterns of Canada goose nest fate were associated with the density of nesting lesser snow geese as predicted by the protective-association hypothesis. Between 2001 and 2007, our data suggest that Canada geese were territorial at the scale of nearest neighbors, but were aggregated when considering overall density of conspecifics at slightly broader spatial scales. The spatial distribution of nest fates indicated that lesser snow goose nest proximity and density likely influence Canada goose nest fate. Our analyses of spatial point patterns suggested that continued changes in the distribution and abundance of breeding lesser snow geese on the Hudson Bay Lowlands may have impacts on the reproductive performance of Canada geese, and subsequently the spatial distribution of Canada goose nests.	[Reiter, Matthew E.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, Minnesota Cooperat Fish & Wildlife Res Unit, St Paul, MN 55108 USA; [Andersen, David E.] US Geol Survey, Minnesota Cooperat Fish & Wildlife Res Unit, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; United States Department of the Interior; United States Geological Survey	Reiter, ME (corresponding author), Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, Minnesota Cooperat Fish & Wildlife Res Unit, St Paul, MN 55108 USA.	mreiter@pointblue.org			Eastern Prairie Population Canada Goose Committee (EPPCGC) of the Mississippi Flyway Council; U.S. Geological Survey (Cooperative Research Units); Minnesota Department of Natural Resources (DNR); Iowa Department of Natural Resources, Manitoba Conservation; Missouri Department of Conservation (DOC); Arkansas Game and Fish Commission (GFC); U.S. Fish and Wildlife Service (FWS); Wildlife Management Institute; U.S. Geological Survey [64]	Eastern Prairie Population Canada Goose Committee (EPPCGC) of the Mississippi Flyway Council; U.S. Geological Survey (Cooperative Research Units)(United States Geological Survey); Minnesota Department of Natural Resources (DNR); Iowa Department of Natural Resources, Manitoba Conservation; Missouri Department of Conservation (DOC); Arkansas Game and Fish Commission (GFC); U.S. Fish and Wildlife Service (FWS)(US Fish & Wildlife Service); Wildlife Management Institute; U.S. Geological Survey(United States Geological Survey)	This project was funded through the Eastern Prairie Population Canada Goose Committee (EPPCGC) of the Mississippi Flyway Council and the U.S. Geological Survey (Cooperative Research Units). Individual members of the EPPCGC that contributed funds included the Minnesota Department of Natural Resources (DNR), the Iowa Department of Natural Resources, Manitoba Conservation, the Missouri Department of Conservation (DOC), the Arkansas Game and Fish Commission (GFC), and the U.S. Fish and Wildlife Service (FWS). EPPCGC funds were passed through the Wildlife Management Institute to the University of Minnesota, and U.S. Geological Survey funds supported Research Work Order No. 64 at the Minnesota Cooperative Fish and Wildlife Research Unit. Agency personnel (MN DNR, IA DNR, MB Conservation, MO DOC, AR GFC, and FWS) assisted in data collection as part of annual monitoring of Eastern Prairie Population Canada Geese. Project proposals were reviewed by the Research Committee of the MFC Technical Section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN M, 1992, OECOLOGIA, V91, P134, DOI 10.1007/BF00317252; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baldwin FB, 2011, AUK, V128, P404, DOI 10.1525/auk.2011.10266; Bayard TS, 2010, AUK, V127, P485, DOI 10.1525/auk.2010.09089; Brown C. R., 1996, COLONIALITY CLIFF SW; BURGER J, 1984, AM NAT, V123, P327, DOI 10.1086/284207; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Clark RG, 1999, ECOLOGY, V80, P272, DOI 10.1890/0012-9658(1999)080[0272:AHSPFP]2.0.CO;2; Cooke F., 1995, SNOW GEESE LA PEROUS; Didiuk AB, 2001, STATUS ROSSS GEESE, P19; Diggle P., 2003, STAT ANAL SPATIAL PO; FINDLAY CS, 1982, EVOLUTION, V36, P786, DOI 10.1111/j.1558-5646.1982.tb05445.x; GADALLAH FL, 1995, J APPL ECOL, V32, P276, DOI 10.2307/2405095; HAASE P, 1995, J VEG SCI, V6, P575, DOI 10.2307/3236356; Humburg Dale D., 2000, Canadian Wildlife Service Occasional Paper, V103, P123; Jefferies RL, 2006, J ECOL, V94, P234, DOI 10.1111/j.1365-2745.2005.01086.x; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Lack D., 1968, pvii; Lepage D, 1996, CAN J ZOOL, V74, P1866, DOI 10.1139/z96-210; Liu C, 2001, J VEG SCI, V12, P411, DOI 10.2307/3236855; MALECKI RA, 1980, J WILDLIFE MANAGE, V44, P229, DOI 10.2307/3808375; MARTIN TE, 1993, BIOSCIENCE, V43, P523, DOI 10.2307/1311947; Mowbray T.B., 2000, BIRDS N AM, V.; Mowbray TB, 2002, BIRDS N AM; RAVELING DG, 1989, J WILDLIFE MANAGE, V53, P87, DOI 10.2307/3801311; Reiter ME, 2013, WATERBIRDS, V36, P20, DOI 10.1675/063.036.0105; Reiter ME, 2008, J FIELD ORNITHOL, V79, P429, DOI 10.1111/j.1557-9263.2008.00181.x; Richardson DS, 1999, BEHAV ECOL SOCIOBIOL, V46, P373, DOI 10.1007/s002650050632; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; Samelius G, 2007, J ANIM ECOL, V76, P873, DOI 10.1111/j.1365-2656.2007.01278.x; Tilman David, 1997, Monographs in Population Biology, V30, P233; Walter SE, 1997, J WILDLIFE MANAGE, V61, P768, DOI 10.2307/3802183; WELLER MILTON W., 1956, JOUR WILDLIFE MANAGEMENT, V20, P111, DOI 10.2307/3797414; WESTERSKOV K, 1950, J WILDLIFE MANAGE, V14, P56, DOI 10.2307/3795978; Wiens J.A., 1989, ECOLOGY BIRD COMMUNI, V1; [No title captured]; [No title captured]; [No title captured]; [No title captured]	39	4	4	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81029	10.1371/journal.pone.0081029	http://dx.doi.org/10.1371/journal.pone.0081029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312520	Green Published, gold			2022-12-25	WOS:000327944500052
J	Sasaki, M; Matsubara, T; Nitta, T; Sato, Y; Nakanuma, Y				Sasaki, Motoko; Matsubara, Takashi; Nitta, Takeo; Sato, Yasunori; Nakanuma, Yasuni			GNAS and KRAS Mutations are Common in Intraductal Papillary Neoplasms of the Bile Duct	PLOS ONE			English	Article							FREQUENT GNAS; EXPRESSION; MUCIN; TUMORS; LIVER; OVEREXPRESSION; COUNTERPARTS; SIMILARITIES; ADENOMA	Intraductal papillary neoplasms of the bile duct (IPNB) shows favorable prognosis and is regarded as a biliary counterpart of intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Although activating point mutations of GNAS at codon 201 have been detected in approximately two thirds of IPMNs of the pancreas, there have been few studies on GNAS mutations in IPNBs. This study investigates the status of GNAS and KRAS mutations and their association with clinicopathological factors in IPNBs. We examined the status of GNAS mutation at codon 201 and KRAS mutation at codon 12&13, degree of mucin production and immunohistochemical expressions of MUC mucin core proteins in 29 patients (M/ F = 15/14) with IPNB in intrahepatic and perihilar bile ducts (perihilar IPNB) and 6 patients (M/F = 5/1) with IPNB in distal bile ducts (distal IPNB). GNAS mutations and KRAS mutations were detected in 50% and 46.2% of IPNBs, respectively. There was no significant correlation between the status of GNAS mutation and clinicopathological factors in IPNBs, whereas, the status of KRAS mutation was significantly inversely correlated with the degree of MUC2 expression in IPNBs (p < 0.05). All IPNBs with GNAS mutation only showed high-mucin production. Degree of mucin production was significantly higher in perihilar IPNBs than distal IPNBs (p < 0.05). MUC2 and MUC5AC expression was significantly higher in IPNBs with high-mucin production than those with low-mucin production (p < 0.01 and p < 0.05, respectively). In conclusions, this study firstly disclosed frequent GNAS mutations in IPNBs, similarly to IPMNs. This may suggest a common histopathogenesis of IPNBs and IPMNs. The status of KRAS mutations was inversely correlated to MUC2 expression and this may suggest heterogeneous properties of IPNBs. IPNBs with high-mucin production are characterized by perihilar location and high expression of MUC2 and MUC5AC, irrespective of the status of GNAS and KRAS mutations.	[Sasaki, Motoko; Matsubara, Takashi; Nitta, Takeo; Sato, Yasunori; Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa, Japan	Kanazawa University	Nakanuma, Y (corresponding author), Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa, Japan.	nakanuma@staff.kanazawa-u.ac.jp	Sasaki, Motoko/K-5913-2015	Sasaki, Motoko/0000-0003-2514-760X	Ministry of Education, Culture, Sports and Science and Technology of Japan [22390067]	Ministry of Education, Culture, Sports and Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by a Grant-in Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports and Science and Technology of Japan (22390067). There is nothing to disclose regarding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SC, 2003, HUM PATHOL, V34, P902, DOI 10.1016/S0046-8177(03)00337-X; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; [Anonymous], 2009, TNM CLASSIFICATION M; Freda PU, 2007, PITUITARY, V10, P275, DOI 10.1007/s11102-007-0058-2; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Hsu M, 2013, CANCER-AM CANCER SOC, V119, P1669, DOI 10.1002/cncr.27955; Ishikawa A, 2004, LAB INVEST, V84, P629, DOI 10.1038/labinvest.3700087; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Kim HJ, 2000, ENDOSCOPY, V32, P389, DOI 10.1055/s-2000-8996; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Matsubara A, 2013, J PATHOL, V229, P579, DOI 10.1002/path.4153; Matthaei H, 2012, HPB, V14, P677, DOI 10.1111/j.1477-2574.2012.00504.x; NAKANUMA Y, 1989, HEPATOLOGY, V10, P174, DOI 10.1002/hep.1840100209; Nakanuma Y., 2010, WHO CLASSIFICATION T, P217; Nakanuma Y, 2010, PATHOL INT, V60, P419, DOI 10.1111/j.1440-1827.2010.02543.x; Nault JC, 2012, J HEPATOL, V56, P184, DOI 10.1016/j.jhep.2011.07.018; Nishikawa G, 2013, BRIT J CANCER, V108, P951, DOI 10.1038/bjc.2013.47; Ohtsuka M, 2011, AM J SURG PATHOL, V35, P512, DOI 10.1097/PAS.0b013e3182103f36; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Rocha FG, 2012, HEPATOLOGY, V56, P1352, DOI 10.1002/hep.25786; Round AN, 2007, GLYCOBIOLOGY, V17, P578, DOI 10.1093/glycob/cwm027; Round AN, 2012, BIOMACROMOLECULES, V13, P3253, DOI 10.1021/bm301024x; Sasaki M, 2008, J PATHOL, V215, P175, DOI 10.1002/path.2345; Sasaki M, 1996, HEPATOLOGY, V24, P1074; Sasaki M, 2007, PROG HISTOCHEM CYTO, V42, P61, DOI 10.1016/j.proghi.2007.02.001; Sasaki M, 2013, HISTOPATHOLOGY, V62, P446, DOI 10.1111/his.12016; Shibahara H, 2004, AM J SURG PATHOL, V28, P327, DOI 10.1097/00000478-200403000-00005; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Yamada M, 2012, J PATHOL, V228, P113, DOI 10.1002/path.4012	29	43	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81706	10.1371/journal.pone.0081706	http://dx.doi.org/10.1371/journal.pone.0081706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312577	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500090
J	Siddani, BR; Pochineni, LP; Palanisamy, M				Siddani, Bhaskara Rao; Pochineni, Lakshmi Priyanka; Palanisamy, Manimaran			Candidate Gene Identification for Systemic Lupus Erythematosus Using Network Centrality Measures and Gene Ontology	PLOS ONE			English	Article							DISEASE GENES; TOOL; PRIORITIZATION; INFORMATION; PREDICTION; DISCOVERY; BIOLOGY	Systemic lupus erythematosus (SLE) commonly accredited as "the great imitator'' is a highly complex disease involving multiple gene susceptibility with non-specific symptoms. Many experimental and computational approaches have been used to investigate the disease related candidate genes. But the limited knowledge of gene function and disease correlation and also lack of complete functional details about the majority of genes in susceptible locus, encumbrances the identification of SLE related candidate genes. In this paper, we have studied the human immunome network (undirected) using various graph theoretical centrality measures integrated with the gene ontology terms to predict the new candidate genes. As a result, we have identified 8 candidate genes, which may act as potential targets for SLE disease. We have also carried out the same analysis by replacing the human immunome network with human immunome signaling network (directed) and as an outcome we have obtained 5 candidate genes as potential targets for SLE disease. From the comparison study, we have found these two approaches are complementary in nature.	[Siddani, Bhaskara Rao; Pochineni, Lakshmi Priyanka; Palanisamy, Manimaran] CR Rao Adv Inst Math Stat & Comp Sci, Hyderabad, Andhra Pradesh, India; [Pochineni, Lakshmi Priyanka] Univ Hyderabad, Dept Biotechnol & Bioinformat, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Palanisamy, M (corresponding author), CR Rao Adv Inst Math Stat & Comp Sci, Hyderabad, Andhra Pradesh, India.	pa.manimaran@gmail.com			Department of Science and Technology, Government of India (DST-CMS GoI) [SR/S4/MS:516/07]	Department of Science and Technology, Government of India (DST-CMS GoI)	Financial support from the Department of Science and Technology, Government of India (DST-CMS GoI Project No. SR/S4/MS:516/07 Dated 21.04.2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie EA, 2006, BIOINFORMATICS, V22, P773, DOI 10.1093/bioinformatics/btk031; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barrenas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008090; Castiblanco J, 2008, INFECT GENET EVOL, V8, P541, DOI 10.1016/j.meegid.2008.03.001; Castro J, 2008, AUTOIMMUN REV, V7, P345, DOI 10.1016/j.autrev.2008.01.001; Chautard E, 2009, PATHOL BIOL, V57, P324, DOI 10.1016/j.patbio.2008.10.004; Chen J, 2006, NUCLEIC ACIDS RES, V37, pW305; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Cheng D, 2008, NUCLEIC ACIDS RES, V36, pW399, DOI 10.1093/nar/gkn296; Chinese Scientist, 2005, CHINESE J RHEUMATOLO, V10, P582; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Florez AF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-484; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hegde SR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000237; Hristovski D, 2005, INT J MED INFORM, V74, P289, DOI 10.1016/j.ijmedinf.2004.04.024; Huang QY, 2008, J HUM GENET, V53, P644, DOI 10.1007/s10038-008-0295-x; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Jacob CO, 2012, P NATL ACAD SCI USA, V109, pE59, DOI 10.1073/pnas.1113251108; Jeffries MA, 2011, EPIGENETICS-US, V6, P593, DOI 10.4161/epi.6.5.15374; Junker BH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-219; Kanemitsu T, 2011, US patent, Patent No. [US2011/0053887, 20110053887]; Karopka T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-325; Kranthi T, 2013, MOL BIOSYST, V9, P2163, DOI 10.1039/c3mb25589a; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Manimaran P, 2009, MOL BIOSYST, V5, P1936, DOI [10.1039/b905264j, 10.1039/B905264j]; Migliorini P, 2010, EUR CYTOKINE NETW, V21, P264, DOI 10.1684/ecn.2010.0210; Ortutay C, 2006, CELL IMMUNOL, V244, P87, DOI 10.1016/j.cellimm.2007.01.012; Ortutay C, 2009, NUCLEIC ACIDS RES, V37, P622, DOI 10.1093/nar/gkn982; Ortutay Csaba, 2008, Immunome Res, V4, P4, DOI 10.1186/1745-7580-4-4; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Pflegerl P, 2009, P NATL ACAD SCI USA, V106, P20423, DOI 10.1073/pnas.0910371106; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Radivojac P, 2008, PROTEINS, V72, P1030, DOI 10.1002/prot.21989; Romzova M, 2006, HUM IMMUNOL, V67, P706, DOI 10.1016/j.humimm.2006.05.006; Sha Y, 2010, BALK J MED GENET, V13, P35, DOI 10.2478/v10034-010-0024-6; Tiffin N, 2006, NUCLEIC ACIDS RES, V34, P3067, DOI 10.1093/nar/gkl381; Tranchevent LC, 2011, BRIEF BIOINFORM, V12, P22, DOI 10.1093/bib/bbq007; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Wang E, 2013, SEMIN CANCER BIOL, V23, P286, DOI 10.1016/j.semcancer.2013.06.001; Yoshida Y, 2009, NUCLEIC ACIDS RES, V37, pW147, DOI 10.1093/nar/gkp384; Zhang A., 2009, PROT INT NETW COMP; Zhu MJ, 2007, INT J BIOL SCI, V3, P420	45	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81766	10.1371/journal.pone.0081766	http://dx.doi.org/10.1371/journal.pone.0081766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312583	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500095
J	Wei, E; Jia, YL; Tan, O; Potsaid, B; Liu, JJ; Choi, W; Fujimoto, JG; Huang, D				Wei, Eric; Jia, Yali; Tan, Ou; Potsaid, Benjamin; Liu, Jonathan J.; Choi, WooJhon; Fujimoto, James G.; Huang, David			Parafoveal Retinal Vascular Response to Pattern Visual Stimulation Assessed with OCT Angiography	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; SCANNING LASER OPHTHALMOSCOPE; AMPLITUDE-DECORRELATION ANGIOGRAPHY; FLICKER-INDUCED CHANGES; HEAD BLOOD-FLOW; VESSEL DIAMETER; NERVE; LIGHT; LUMINANCE; VELOCITY	We used optical coherence tomography (OCT) angiography with a high-speed swept-source OCT system to investigate retinal blood flow changes induced by visual stimulation with a reversing checkerboard pattern. The split-spectrum amplitude-decorrelation angiography (SSADA) algorithm was used to quantify blood flow as measured with parafoveal flow index (PFI), which is proportional to the density of blood vessels and the velocity of blood flow in the parafoveal region of the macula. PFI measurements were taken in 15 second intervals during a 4 minute period consisting of 1 minute of baseline, 2 minutes with an 8 Hz reversing checkerboard pattern stimulation, and 1 minute without stimulation. PFI measurements increased 6.1+/-4.7% (p=.001) during the first minute of stimulation, with the most significant increase in PFI occurring 30 seconds into stimulation (p<0.001). These results suggest that pattern stimulation induces a change to retinal blood flow that can be reliably measured with OCT angiography.	[Wei, Eric; Jia, Yali; Tan, Ou; Huang, David] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Potsaid, Benjamin; Liu, Jonathan J.; Choi, WooJhon; Fujimoto, James G.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Potsaid, Benjamin; Liu, Jonathan J.; Choi, WooJhon; Fujimoto, James G.] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Potsaid, Benjamin] Thorlabs Inc, Adv Imaging Grp, Newton, NJ USA	Oregon Health & Science University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Jia, YL (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA.	jiaya@ohsu.edu		Jia, Yali/0000-0002-2784-1905	NIH [R01 EY013516, P30EY010572]; Research to Prevent Blindness [R01-Ey11289-26]; AFOSR [FA9550-10-1-0551]; NATIONAL EYE INSTITUTE [P30EY010572, R01EY013516, R01EY011289] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH Grants R01 EY013516, Rosenbaum's P30EY010572, an unrestricted grant from Research to Prevent Blindness, R01-Ey11289-26 and AFOSR FA9550-10-1-0551. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, Z136 ANSI; BAKER HD, 1949, J OPT SOC AM, V39, P172, DOI 10.1364/JOSA.39.000172; Barton JK, 2005, OPT EXPRESS, V13, P5234, DOI 10.1364/OPEX.13.005234; Bedggood Phillip, 2012, Biomed Opt Express, V3, P3264, DOI 10.1364/BOE.3.003264; Chui TYP, 2012, BIOMED OPT EXPRESS, V3, P2537, DOI 10.1364/BOE.3.002537; COGAN DG, 1961, ARCH OPHTHALMOL-CHIC, V66, P366, DOI 10.1001/archopht.1961.00960010368014; Falsini B, 2002, INVEST OPHTH VIS SCI, V43, P2309; Flammer J, 1994, Surv Ophthalmol, V38 Suppl, pS3, DOI 10.1016/0039-6257(94)90041-8; Formaz F, 1997, CURR EYE RES, V16, P1252, DOI 10.1076/ceyr.16.12.1252.5021; Garhofer G, 2011, MICROVASC RES, V82, P351, DOI 10.1016/j.mvr.2011.07.001; Garhofer G, 2004, J GLAUCOMA, V13, P340, DOI 10.1097/00061198-200408000-00013; Garhofer G, 2004, VISION RES, V44, P833, DOI 10.1016/j.visres.2003.11.013; Gugleta K, 2012, GRAEF ARCH CLIN EXP, V250, P589, DOI 10.1007/s00417-011-1842-2; Holder GE, 2001, PROG RETIN EYE RES, V20, P531, DOI 10.1016/S1350-9462(00)00030-6; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Kimura I, 2003, BRIT J OPHTHALMOL, V87, P1469, DOI 10.1136/bjo.87.12.1469; KIRYU J, 1995, INVEST OPHTH VIS SCI, V36, P1240; Kotliar KE, 2011, MICROVASC RES, V81, P123, DOI 10.1016/j.mvr.2010.11.007; Liu GJ, 2012, BIOMED OPT EXPRESS, V3, P2669, DOI 10.1364/BOE.3.002669; Mandecka A, 2007, DIABETES CARE, V30, P3048, DOI 10.2337/dc07-0927; Michelson G, 2002, RETINA-J RET VIT DIS, V22, P336, DOI 10.1097/00006982-200206000-00013; Nelson DA, 2005, OPHTHAL SURG LAS IM, V36, P57; PATTANAIK SN, 2000, TIME DEPENDENT VISUA, P47; Pinhas A, 2013, BIOMED OPT EXPRESS, V4, P1305, DOI 10.1364/BOE.4.001305; Polak K, 2002, INVEST OPHTH VIS SCI, V43, P2721; Potsaid B, 2010, OPT EXPRESS, V18, P20029, DOI 10.1364/OE.18.020029; PULIAFITO CA, 1995, OPHTHALMOLOGY, V102, P217; Ritt M, 2012, HYPERTENSION, V60, P871, DOI 10.1161/HYPERTENSIONAHA.112.192666; RIVA CE, 1991, NEUROSCI LETT, V128, P291, DOI 10.1016/0304-3940(91)90282-X; Riva CE, 2005, PROG RETIN EYE RES, V24, P183, DOI 10.1016/j.preteyeres.2004.07.002; RIVA CE, 1985, INVEST OPHTH VIS SCI, V26, P1124; Riva CE, 2001, INVEST OPHTH VIS SCI, V42, P756; Roy C S, 1890, J Physiol, V11, P85; Sato Y, 1997, IEEE T BIO-MED ENG, V44, P225, DOI 10.1109/10.563292; SCHEINER AJ, 1994, INVEST OPHTH VIS SCI, V35, P3436; SCHUMAN JS, 1995, ARCH OPHTHALMOL-CHIC, V113, P586, DOI 10.1001/archopht.1995.01100050054031; Strenn K, 1997, BRIT J OPHTHALMOL, V81, P360, DOI 10.1136/bjo.81.5.360; Tam J, 2011, BIOMED OPT EXPRESS, V2, P781, DOI 10.1364/BOE.2.000781; Tokayer J, 2013, BIOMED OPT EXPRESS, V4, P1909, DOI 10.1364/BOE.4.001909; VILLRINGER A, 1995, CEREBROVAS BRAIN MET, V7, P240; Wang YM, 2011, BIOMED OPT EXPRESS, V2, P1852, DOI 10.1364/BOE.001852; Wang YM, 2011, INVEST OPHTH VIS SCI, V52, P840, DOI 10.1167/iovs.10-5985; Zawadzki RJ, 2011, BIOMED OPT EXPRESS, V2, P1674, DOI 10.1364/BOE.2.001674; Zhong ZY, 2008, OPT EXPRESS, V16, P12746, DOI 10.1364/OE.16.012746; Zou WY, 2011, BIOMED OPT EXPRESS, V2, P3309, DOI 10.1364/BOE.2.003309	46	42	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81343	10.1371/journal.pone.0081343	http://dx.doi.org/10.1371/journal.pone.0081343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312549	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500068
J	Zygmunt, PM; Ermund, A; Movahed, P; Andersson, DA; Simonsen, C; Jonsson, BAG; Blomgren, A; Birnir, B; Bevan, S; Eschalier, A; Mallet, C; Gomis, A; Hogestatt, ED				Zygmunt, Peter M.; Ermund, Anna; Movahed, Pouya; Andersson, David A.; Simonsen, Charlotte; Jonsson, Bo A. G.; Blomgren, Anders; Birnir, Bryndis; Bevan, Stuart; Eschalier, Alain; Mallet, Christophe; Gomis, Ana; Hogestatt, Edward D.			Monoacylglycerols Activate TRPV1-A Link between Phospholipase C and TRPV1	PLOS ONE			English	Article							VANILLOID RECEPTOR TRPV1; CAPSAICIN RECEPTOR; SENSORY NERVES; 2-ARACHIDONOYLGLYCEROL; LIPASE; 2-ARACHIDONYLGLYCEROL; CHANNELS; PAIN; DIACYLGLYCEROL; ANANDAMIDE	Phospholipase C-mediated hydrolysis of phosphatidylinositol 4,5-bisphosphate generates diacylglycerol, inositol 1,4,5-trisphosphate and protons, all of which can regulate TRPV1 activity via different mechanisms. Here we explored the possibility that the diacylglycerol metabolites 2-arachidonoylglycerol and 1-arachidonoylglycerol, and not metabolites of these monoacylglycerols, activate TRPV1 and contribute to this signaling cascade. 2-Arachidonoylglycerol and 1-arachidonoylglycerol activated native TRPV1 on vascular sensory nerve fibers and heterologously expressed TRPV1 in whole cells and inside-out membrane patches. The monoacylglycerol lipase inhibitors methylarachidonoyl-fluorophosphonate and JZL184 prevented the metabolism of deuterium-labeled 2-arachidonoylglycerol and deuterium-labeled 1-arachidonoylglycerol in arterial homogenates, and enhanced TRPV1-mediated vasodilator responses to both monoacylglycerols. In mesenteric arteries from TRPV1 knock-out mice, vasodilator responses to 2-arachidonoylglycerol were minor. Bradykinin and adenosine triphosphate, ligands of phospholipase C-coupled membrane receptors, increased the content of 2-arachidonoylglycerol in dorsal root ganglia. In HEK293 cells expressing the phospholipase C-coupled histamine H-1 receptor, exposure to histamine stimulated the formation of 2-AG, and this effect was augmented in the presence of JZL184. These effects were prevented by the diacylglycerol lipase inhibitor tetrahydrolipstatin. Histamine induced large whole cell currents in HEK293 cells co-expressing TRPV1 and the histamine H-1 receptor, and the TRPV1 antagonist capsazepine abolished these currents. JZL184 increased the histamine-induced currents and tetrahydrolipstatin prevented this effect. The calcineurin inhibitor ciclosporin and the endogenous "entourage'' compound palmitoylethanolamide potentiated the vasodilator response to 2-arachidonoylglycerol, disclosing TRPV1 activation of this monoacylglycerol at nanomolar concentrations. Furthermore, intracerebroventricular injection of JZL184 produced TRPV1-dependent antinociception in the mouse formalin test. Our results show that intact 2-arachidonoylglycerol and 1-arachidonoylglycerol are endogenous TRPV1 activators, contributing to phospholipase C-dependent TRPV1 channel activation and TRPV1-mediated antinociceptive signaling in the brain.	[Zygmunt, Peter M.; Ermund, Anna; Movahed, Pouya; Simonsen, Charlotte; Jonsson, Bo A. G.; Blomgren, Anders; Hogestatt, Edward D.] Lund Univ, Dept Lab Med, Lund, Sweden; [Andersson, David A.; Bevan, Stuart] Kings Coll London, Wolfson Ctr Age Related Dis, London, England; [Birnir, Bryndis] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Eschalier, Alain; Mallet, Christophe] Clermont Univ, Univ Auvergne, Pharmacol Lab, Fac Med Pharm, Clermont Ferrand, France; [Eschalier, Alain; Mallet, Christophe] INSERM, Neuro Dol U1107, Clermont Ferrand, France; [Eschalier, Alain] CHU Clermont Ferrand, Serv Pharmacol, Hop G Montpied, Clermont Ferrand, France; [Gomis, Ana] Univ Miguel Hernandez, CSIC, Inst Neurociencias, Sant Joan dAlacant, Spain; [Zygmunt, Peter M.; Hogestatt, Edward D.] Lund Univ, Lund Univ Pain Res Ctr, Lund, Sweden	Lund University; University of London; King's College London; Uppsala University; Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Clermont Ferrand; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Lund University	Zygmunt, PM (corresponding author), Lund Univ, Dept Lab Med, Lund, Sweden.	peter.zygmunt@med.lu.se; edward.hogestatt@med.lu.se	Ermund, Anna/AAG-3160-2020; Andersson, David A/C-3435-2008; Bevan, Stuart/A-8821-2008; ESCHALIER, Alain/L-9957-2015; Gomis, Ana/S-1854-2017; Mallet, Christophe/K-2918-2015	Andersson, David A/0000-0001-7451-8548; Gomis, Ana/0000-0003-4651-7673; Jonsson, Bo/0000-0002-8767-0589; Mallet, Christophe/0000-0002-0873-6763; Birnir, Bryndis/0000-0002-1763-0266; Ermund, Anna/0000-0002-3233-043X; Bevan, Stuart John/0000-0002-8977-1797; Zygmunt, Peter/0000-0002-5102-8199; Movahed, Pouya/0000-0003-2041-3550	Swedish Research Council, the School of Pharmaceutical Sciences (FLAK), Lund University; UK Medical Research Council; Spanish government [BFU2009-07835]; CONSOLIDER-INGENIO [CSD2007-0023]	Swedish Research Council, the School of Pharmaceutical Sciences (FLAK), Lund University; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Spanish government(Spanish GovernmentEuropean Commission); CONSOLIDER-INGENIO(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Swedish Research Council, the School of Pharmaceutical Sciences (FLAK), Lund University, the UK Medical Research Council and by grants from the Spanish government (BFU2009-07835 and CONSOLIDER-INGENIO 2010 CSD2007-0023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenmyr L, 2013, BASIC CLIN PHARM TOX; ALLEN AC, 1992, J NEUROCHEM, V58, P1130, DOI 10.1111/j.1471-4159.1992.tb09372.x; Andersson DA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1559; Awumey EM, 2008, AM J PHYSIOL-HEART C, V294, pH2363, DOI 10.1152/ajpheart.01042.2007; Barriere DA, 2013, PLOSONE; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Blankman JL, 2013, PHARMACOL REV, V65, P849, DOI 10.1124/pr.112.006387; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Chang JW, 2012, CHEM BIOL, V19, P579, DOI 10.1016/j.chembiol.2012.03.009; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Clapham DE, 2005, PHARMACOL REV, V57, P427, DOI 10.1124/pr.57.4.6; De Petrocellis L, 2001, FEBS LETT, V506, P253, DOI 10.1016/S0014-5793(01)02934-9; Di Marzo V, 2012, PHILOS T R SOC B, V367, P3216, DOI 10.1098/rstb.2011.0382; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; Doly S, 2004, NEUROSCI LETT, V357, P123, DOI 10.1016/j.neulet.2003.12.051; Elphick MR, 2012, PHILOS T R SOC B, V367, P3201, DOI 10.1098/rstb.2011.0394; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; Golech SA, 2004, MOL BRAIN RES, V132, P87, DOI 10.1016/j.molbrainres.2004.08.025; Guindon J, 2011, BRIT J PHARMACOL, V163, P1464, DOI 10.1111/j.1476-5381.2010.01192.x; Hanus L, 2001, P NATL ACAD SCI USA, V98, P3662, DOI 10.1073/pnas.061029898; Hardie RC, 2007, J PHYSIOL-LONDON, V578, P9, DOI 10.1113/jphysiol.2006.118372; Hardie RC, 2011, PFLUG ARCH EUR J PHY, V461, P493, DOI 10.1007/s00424-011-0922-9; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hogestatt ED, 2005, J BIOL CHEM, V280, P31405, DOI 10.1074/jbc.M501489200; Huang JH, 2006, CURR NEUROPHARMACOL, V4, P197, DOI 10.2174/157015906778019554; Huang JH, 2010, CURR BIOL, V20, P189, DOI 10.1016/j.cub.2009.12.019; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Iwasaki Y, 2008, LIPIDS, V43, P471, DOI 10.1007/s11745-008-3182-5; KAWASAKI H, 1988, NATURE, V335, P164, DOI 10.1038/335164a0; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Laine K, 2002, INVEST OPHTH VIS SCI, V43, P3216; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; Leung HT, 2008, NEURON, V58, P884, DOI 10.1016/j.neuron.2008.05.001; Lev S, 2012, J BIOL CHEM, V287, P1436, DOI 10.1074/jbc.M111.266585; Liao HT, 2011, BRIT J PHARMACOL, V163, P330, DOI 10.1111/j.1476-5381.2011.01214.x; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Maione S, 2006, J PHARMACOL EXP THER, V316, P969, DOI 10.1124/jpet.105.093286; Mallet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012748; McVey DC, 2005, GASTROENTEROLOGY, V128, P1306, DOI 10.1053/j.gastro.2005.03.017; Mcvey DC, 2003, J PHARMACOL EXP THER, V304, P713, DOI 10.1124/jpet.102.043893; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Minke B, 2010, J NEUROGENET, V24, P216, DOI 10.3109/01677063.2010.514369; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Montell C, 2008, NEURON, V58, P825, DOI 10.1016/j.neuron.2008.06.006; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Montell C, 2011, PFLUG ARCH EUR J PHY, V461, P499, DOI 10.1007/s00424-010-0920-3; Moody JS, 2001, BIOCHEMISTRY-US, V40, P861, DOI 10.1021/bi002303b; Movahed P, 2005, J BIOL CHEM, V280, P38496, DOI 10.1074/jbc.M507429200; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Ortar G, 2008, J MED CHEM, V51, P6970, DOI 10.1021/jm800978m; Pearce LV, 2008, N-S ARCH PHARMACOL, V377, P149, DOI 10.1007/s00210-007-0258-3; Potenzieri C, 2009, BRAIN RES, V1268, P38, DOI 10.1016/j.brainres.2009.02.061; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Reisenberg M, 2012, PHILOS T R SOC B, V367, P3264, DOI 10.1098/rstb.2011.0387; Rouzer CA, 2002, CHEM PHYS LIPIDS, V119, P69, DOI 10.1016/S0009-3084(02)00068-3; Saario SM, 2004, BIOCHEM PHARMACOL, V67, P1381, DOI 10.1016/j.bcp.2003.12.003; Savinainen JR, 2012, ACTA PHYSIOL, V204, P267, DOI 10.1111/j.1748-1716.2011.02280.x; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Sigel E, 2011, P NATL ACAD SCI USA, V108, P18150, DOI 10.1073/pnas.1113444108; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Sugiura T, 1999, J BIOL CHEM, V274, P2794, DOI 10.1074/jbc.274.5.2794; Sugiura T, 2006, PROG LIPID RES, V45, P405, DOI 10.1016/j.plipres.2006.03.003; Szallasi A, 1999, PHARMACOL REV, V51, P159; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Walter L, 2004, J NEUROSCI, V24, P8068, DOI 10.1523/JNEUROSCI.2419-04.2004; Wang XB, 2005, J PHYSIOL-LONDON, V564, P541, DOI 10.1113/jphysiol.2004.081844; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zygmunt PM, 2000, EUR J PHARMACOL, V396, P39, DOI 10.1016/S0014-2999(00)00207-7; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761; Zygmunt PM, 2002, J NEUROSCI, V22, P4720, DOI 10.1523/JNEUROSCI.22-11-04720.2002; ZYGMUNT PM, 1994, ACTA PHYSIOL SCAND, V152, P375, DOI 10.1111/j.1748-1716.1994.tb09819.x	83	110	111	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81618	10.1371/journal.pone.0081618	http://dx.doi.org/10.1371/journal.pone.0081618			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312564	gold, Green Published, Green Submitted			2022-12-25	WOS:000327944500079
J	Roy, B; Brennecke, AM; Agarwal, S; Krey, M; Duber, S; Weiss, S				Roy, Bishnudeo; Brennecke, Anne-Margarete; Agarwal, Shiwani; Krey, Martina; Dueber, Sandra; Weiss, Siegfried			An Intrinsic Propensity of Murine Peritoneal B1b Cells to Switch to IgA in Presence of TGF-beta and Retinoic Acid	PLOS ONE			English	Article							MARGINAL ZONE; B-CELLS; SOMATIC HYPERMUTATION; GUT; IMMUNITY; TGF-BETA-1; INDUCTION; SECRETION	Aims: In the present study we have investigated the comparative switching propensity of murine peritoneal and splenic B cell subpopulations to IgA in presence of retinoic acid (RA) and TGF-beta. Methods and Results: To study the influence of RA and TGF-b on switching of B cell subpopulations to IgA, peritoneal (B1a, B1b and B2 cells) and splenic (B1a, marginal zone, and B2) B cells from normal BALB/c mice were FACS purified, cultured for 4 days in presence of RA and TGF-beta and the number of IgA producing cells was determined by ELISPOT assay or FACS analysis. In presence of TGF-beta, peritoneal B1b cells switched to IgA more potently than other peritoneal B cell subpopulations. When TGF-beta was combined with retinoic acid (RA), switching to IgA was even more pronounced. Under these conditions, "innate'' B cells like peritoneal and splenic B1 cells and MZ B cells produced IgA more readily than B2 cells. Additionally, high frequency of nucleotide exchanges indicating somatic hypermutation in VH regions was observed. Besides IgA induction, RA treatment of sorted PEC and splenic B cells led to expression of gut homing molecules -alpha(4)beta(7) and CCR9. Intraperitoneal transfer of RA-treated B1 cells into Rag1(-/-) recipients resulted in IgA in serum and gut lavage, most efficiently amongst B1b cell recipients. Conclusion: Present study demonstrates the differential and synergistic effect of RA and TGF-b on switching of different B cell subpopulations to IgA and establishes the prominence of peritoneal B1b cells in switching to IgA under the influence of these two factors. Our study extends our knowledge about the existing differences among B cell subpopulations with regards to IgA production and indicates towards their differential contribution to gut associated humoral immunity.	[Roy, Bishnudeo; Brennecke, Anne-Margarete; Agarwal, Shiwani; Krey, Martina; Dueber, Sandra; Weiss, Siegfried] Helmholtz Ctr Infect Res, Braunschweig, Lower Saxony, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Roy, B (corresponding author), Helmholtz Ctr Infect Res, Braunschweig, Lower Saxony, Germany.	Bishnudeo.Roy@helmholtz-hzi.de	Roy, Bishnudeo/Q-2629-2018	Roy, Bishnudeo/0000-0002-7339-9556	German Research Council (DFG); Ministry for Education and Research (BMBF); Helmholtz Association via the HZI Graduate School	German Research Council (DFG)(German Research Foundation (DFG)); Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Helmholtz Association via the HZI Graduate School	This work was supported in part by the German Research Council (DFG), the Ministry for Education and Research (BMBF) and the Helmholtz Association via the HZI Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; Bergthorsdottir S, 2001, J IMMUNOL, V166, P2228, DOI 10.4049/jimmunol.166.4.2228; Bowman EP, 2002, J EXP MED, V195, P269, DOI 10.1084/jem.20010670; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Chen ML, 2008, J IMMUNOL, V180, P7327, DOI 10.4049/jimmunol.180.11.7327; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de Waard R, 1998, Dev Immunol, V6, P81, DOI 10.1155/1998/37576; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Fagarasan S, 2008, CURR OPIN IMMUNOL, V20, P170, DOI 10.1016/j.coi.2008.04.002; Farstad IN, 1995, SCAND J IMMUNOL, V42, P662, DOI 10.1111/j.1365-3083.1995.tb03709.x; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Honorine R, 2011, NUCLEIC ACIDS RES, V39, P2809, DOI 10.1093/nar/gkq1192; HORNQUIST CE, 1995, J IMMUNOL, V155, P2877; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Kaminski DA, 2006, J IMMUNOL, V177, P6025, DOI 10.4049/jimmunol.177.9.6025; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; Macpherson AJ, 2012, TRENDS IMMUNOL, V33, P160, DOI 10.1016/j.it.2012.02.002; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1034/j.1600-065X.2000.017515.x; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Oliver AM, 1999, J IMMUNOL, V162, P7198; Rosado MM, 2009, MUCOSAL IMMUNOL, V2, P351, DOI 10.1038/mi.2009.15; Roy B, 2013, EUR J IMMUNOL, V43, P2023, DOI 10.1002/eji.201243070; Roy B, 2009, MOL IMMUNOL, V46, P1613, DOI 10.1016/j.molimm.2009.02.026; Seo GY, 2013, J LEUKOCYTE BIOL, V94, P325, DOI 10.1189/jlb.0313128; SNAPPER CM, 1993, J IMMUNOL, V150, P2737; SNAPPER CM, 1993, J IMMUNOL, V151, P4625; SONODA E, 1989, J EXP MED, V170, P1415, DOI 10.1084/jem.170.4.1415; STALL AM, 1992, ANN NY ACAD SCI, V651, P33; Stavnezer J, 2009, J IMMUNOL, V182, P5, DOI 10.4049/jimmunol.182.1.5; Tumang JR, 2005, J IMMUNOL, V174, P3173, DOI 10.4049/jimmunol.174.6.3173; van Ginkel FW, 1999, J IMMUNOL, V163, P1951; Watanabe K, 2010, J IMMUNOL, V184, P2785, DOI 10.4049/jimmunol.0901823; Woof JM, 2004, IMMUNOLOGY, V113, P175, DOI 10.1111/j.1365-2567.2004.01958.x; Zan H, 1998, J IMMUNOL, V161, P5217	41	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82121	10.1371/journal.pone.0082121	http://dx.doi.org/10.1371/journal.pone.0082121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324757	gold, Green Published, Green Submitted			2022-12-25	WOS:000328566700062
J	Servas, C; Romisch, K				Servas, Christina; Roemisch, Karin			The Sec63p J-Domain Is Required for ERAD of Soluble Proteins in Yeast	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; SACCHAROMYCES-CEREVISIAE; TRANSMEMBRANE PROTEIN; MOLECULAR CHAPERONES; SECRETORY PROTEIN; QUALITY-CONTROL; GENE-PRODUCT; DEGRADATION; TRANSLOCATION; COMPLEX	How misfolded proteins are exported from the ER to the cytosol for degradation (ER-associated Degradation, ERAD) and which proteins are participating in this process is not understood. Several studies using a single, leaky mutant indicated that Sec63p might be involved in ERAD. More recently, Sec63p was also found strongly associated with proteasomes attached to the protein-conducting channel in the ER membrane which presumably form part of the export machinery. These observations prompted us to reinvestigate the role of Sec63p in ERAD by generating new mutants which were selected in a screen monitoring the intracellular accumulation of the ERAD substrate CPY*. We show that a mutation in the DnaJ-domain of Sec63p causes a defect in ERAD, whereas mutations in the Brl, acidic, and transmembrane domains only affect protein import into the ER. Unexpectedly, mutations in the acidic domain which mediates interaction of Sec63p with Sec62p also caused defects in cotranslational import. In contrast to mammalian cells where SEC63 expression levels affect steady-state levels of multi-spanning transmembrane proteins, the sec63 J-domain mutant was only defective in ERAD of soluble substrates.	[Servas, Christina; Roemisch, Karin] Univ Saarland, Fac Nat Sci & Technol 8, Dept Microbiol, D-66123 Saarbrucken, Germany	Saarland University	Romisch, K (corresponding author), Univ Saarland, Fac Nat Sci & Technol 8, Dept Microbiol, D-66123 Saarbrucken, Germany.	k.roemisch@mx.uni-saarland.de	Römisch, Karin/AAO-1210-2021	Römisch, Karin/0000-0003-0415-6558	Saarland University; BMBF	Saarland University; BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by a core research grant of the Saarland University to KR, and by part of a BMBF grant to the Saarland University (Female Professor's Programme I, 2008-13) to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Davila S, 2004, NAT GENET, V36, P575, DOI 10.1038/ng1357; DESHAIES RJ, 1990, MOL CELL BIOL, V10, P6024, DOI 10.1128/MCB.10.11.6024; FELDHEIM D, 1992, MOL CELL BIOL, V12, P3288, DOI 10.1128/MCB.12.7.3288; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; GEORGOPOULOS CP, 1980, MOL GEN GENET, V178, P583, DOI 10.1007/BF00337864; Harada Y, 2011, J BIOL CHEM, V286, P2956, DOI 10.1074/jbc.M110.159517; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jermy AJ, 2006, J BIOL CHEM, V281, P7899, DOI 10.1074/jbc.M511402200; Jung GM, 1999, J BIOCHEM-TOKYO, V126, P1; Kabani M, 2003, MOL BIOL CELL, V14, P3437, DOI 10.1091/mbc.E02-12-0847; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Landry SJ, 2003, BIOCHEMISTRY-US, V42, P4926, DOI 10.1021/bi027070y; Lipson C, 2008, J BIOL CHEM, V283, P7166, DOI 10.1074/jbc.M705893200; LYMAN SK, 1995, J CELL BIOL, V131, P1163, DOI 10.1083/jcb.131.5.1163; Mades A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049243; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Meyer HA, 2000, J BIOL CHEM, V275, P14550, DOI 10.1074/jbc.275.19.14550; Misselwitz E, 1999, J BIOL CHEM, V274, P20110, DOI 10.1074/jbc.274.29.20110; Monk KR, 2013, DIS MODEL MECH, V6, P135, DOI 10.1242/dmm.009217; Ng DTW, 1996, J CELL BIOL, V132, P499, DOI 10.1083/jcb.132.4.499; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Ng WY, 2007, J CELL SCI, V120, P682, DOI 10.1242/jcs.03351; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Pilon M, 1998, MOL BIOL CELL, V9, P3455, DOI 10.1091/mbc.9.12.3455; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Qian YQ, 1996, J MOL BIOL, V260, P224, DOI 10.1006/jmbi.1996.0394; Reithinger JH, 2013, J BIOL CHEM, V288, P18058, DOI 10.1074/jbc.M113.473009; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; ROTHBLATT JA, 1989, J CELL BIOL, V109, P2641, DOI 10.1083/jcb.109.6.2641; Rubenstein EM, 2012, J CELL BIOL, V197, P761, DOI 10.1083/jcb.201203061; Scheper W, 2003, J BIOL CHEM, V278, P37998, DOI 10.1074/jbc.M300176200; Scott DC, 2008, J CELL BIOL, V181, P1095, DOI 10.1083/jcb.200804053; Tran JR, 2011, J BIOL CHEM, V286, P5744, DOI 10.1074/jbc.M110.179259; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tyedmers J, 2000, P NATL ACAD SCI USA, V97, P7214, DOI 10.1073/pnas.97.13.7214; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2010, J BIOL CHEM, V285, P22484, DOI 10.1074/jbc.M110.102186; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Wang X, 2005, J CELL SCI, V118, P723, DOI 10.1242/jcs.01671; Willer M, 2003, BIOCHEMISTRY-US, V42, P7171, DOI 10.1021/bi034395l; Willer M, 2003, YEAST, V20, P133, DOI 10.1002/yea.954; Wittke S, 2000, MOL BIOL CELL, V11, P3859, DOI 10.1091/mbc.11.11.3859; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262; Zimmermann R, 2006, TRENDS MOL MED, V12, P567, DOI 10.1016/j.molmed.2006.10.004	56	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82058	10.1371/journal.pone.0082058	http://dx.doi.org/10.1371/journal.pone.0082058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324744	gold, Green Submitted, Green Published			2022-12-25	WOS:000327949300124
J	Chandrasekhar, A; Kalmykov, EA; Polusani, SR; Mathis, SA; Zucker, SN; Nicholson, BJ				Chandrasekhar, Anjana; Kalmykov, Edward A.; Polusani, Srikanth R.; Mathis, Sandra A.; Zucker, Shoshanna N.; Nicholson, Bruce J.			Intercellular Redistribution of cAMP Underlies Selective Suppression of Cancer Cell Growth by Connexin26	PLOS ONE			English	Article							GAP-JUNCTIONAL COMMUNICATION; MITOSIS-SPECIFIC PHOSPHORYLATION; DEPENDENT PROTEIN-KINASE; PHASE-PROMOTING FACTOR; NEGATIVE REGULATION; CYCLE ARREST; TUMOR-CELLS; HELA-CELLS; GENES; PERMEABILITY	Connexins (Cx), which constitute gap junction intercellular channels in vertebrates, have been shown to suppress transformed cell growth and tumorigenesis, but the mechanism(s) still remain largely speculative. Here, we define the molecular basis by which Cx26, but less frequently Cx43 or Cx32, selectively confer growth suppression on cancer cells. Functional intercellular coupling is shown to be required, producing partial blocks of the cell cycle due to prolonged activation of several mitogenic kinases. PKA is both necessary and sufficient for the Cx26 induced growth inhibition in low serum and the absence of anchorage. Activation of PKA was not associated with elevated cAMP levels, but appeared to result from a redistribution of cAMP throughout the cell population, eliminating the cell cycle oscillations in cAMP required for efficient cell cycle progression. Cx43 and Cx32 fail to mediate this redistribution as, unlike Cx26, these channels are closed during the G2/M phase of the cell cycle when cAMP levels peak. Comparisons of tumor cell lines indicate that this is a general pattern, with growth suppression by connexins occurring whenever cAMP oscillates with the cell cycle, and the gap junction remain open throughout the cell cycle. Thus, gap junctional coupling, in the absence of any external signals, provides a general means to limit the mitotic rate of cell populations.	[Chandrasekhar, Anjana; Kalmykov, Edward A.; Polusani, Srikanth R.; Mathis, Sandra A.; Nicholson, Bruce J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Zucker, Shoshanna N.] DYouville Coll, Sch Pharm, Dept Pharmaceut Social & Adm Sci, Buffalo, NY USA	University of Texas System; University of Texas Health San Antonio; D'Youville College	Nicholson, BJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	NicholsonB@uthscsa.edu	Polusani, Srikanth R/H-7318-2015	Nicholson, Bruce/0000-0003-1649-7173; polusani, Srikanth/0000-0002-7186-0345	NIH [R01 CA048049, P30 CA54174, P01 AG19316, P30 AG013319]; NATIONAL CANCER INSTITUTE [P30CA054174, R01CA048049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013319, P01AG019316] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported by the following: NIH - R01 CA048049, P30 CA54174, P01 AG19316, and P30 AG013319. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON MM, 1981, J CELL BIOL, V91, P573, DOI 10.1083/jcb.91.2.573; Beahm DL, 2006, J BIOL CHEM, V281, P7994, DOI 10.1074/jbc.M506533200; Bedner P, 2006, J BIOL CHEM, V281, P6673, DOI 10.1074/jbc.M511235200; Boassa D, 2010, TRAFFIC, V11, P1471, DOI 10.1111/j.1600-0854.2010.01109.x; Chen CH, 2000, J IMMUNOL, V165, P5597, DOI 10.4049/jimmunol.165.10.5597; D'Angiolella V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000247; Dangi S, 2006, CELL PROLIFERAT, V39, P261, DOI 10.1111/j.1365-2184.2006.00388.x; Deng YQ, 2006, HEARING RES, V220, P87, DOI 10.1016/j.heares.2006.07.004; DuflotDancer A, 1997, ONCOGENE, V15, P2151, DOI 10.1038/sj.onc.1201393; EGHBALI B, 1991, P NATL ACAD SCI USA, V88, P10701, DOI 10.1073/pnas.88.23.10701; Ellinger-Ziegelbauer H, 1999, MOL CELL BIOL, V19, P3857; Gellhaus A, 2004, J BIOL CHEM, V279, P36931, DOI 10.1074/jbc.M404073200; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; Goldberg GS, 1999, NAT CELL BIOL, V1, P457, DOI 10.1038/15693; GOLDBERG GS, 1995, BIOTECHNIQUES, V18, P490; Goldberg GS, 2002, J BIOL CHEM, V277, P36725, DOI 10.1074/jbc.M109797200; GRIECO D, 1994, P NATL ACAD SCI USA, V91, P9896, DOI 10.1073/pnas.91.21.9896; Grieco D, 1996, SCIENCE, V271, P1718, DOI 10.1126/science.271.5256.1718; Gupta N, 2001, J CLIN PATHOL-MOL PA, V54, P293, DOI 10.1136/mp.54.5.293; Habermann H, 2002, J UROLOGY, V167, P655, DOI 10.1016/S0022-5347(01)69118-3; Hernandez VH, 2007, NAT METHODS, V4, P353, DOI 10.1038/NMETH1031; Hossain MZ, 1998, J CELL PHYSIOL, V176, P332, DOI 10.1002/(SICI)1097-4652(199808)176:2<332::AID-JCP11>3.3.CO;2-O; Huang RP, 2001, INT J CANCER, V92, P130, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1165>3.3.CO;2-7; Johnstone SR, 2010, J CELL BIOCHEM, V110, P772, DOI 10.1002/jcb.22590; Kalra J, 2006, CARCINOGENESIS, V27, P2528, DOI 10.1093/carcin/bgl110; Kanemitsu MY, 1998, CELL GROWTH DIFFER, V9, P13; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; Keryer G, 1998, J BIOL CHEM, V273, P34594, DOI 10.1074/jbc.273.51.34594; King TJ, 2005, BBA-BIOMEMBRANES, V1719, P24, DOI 10.1016/j.bbamem.2005.07.010; King TJ, 2005, CELL COMMUN ADHES, V12, P293, DOI 10.1080/15419060500514168; Kotani S, 1998, MOL CELL, V1, P371, DOI 10.1016/S1097-2765(00)80037-4; Krysko DV, 2005, APOPTOSIS, V10, P459, DOI 10.1007/s10495-005-1875-2; Lampe PD, 1998, J CELL SCI, V111, P833; LAU AF, 1992, MOL BIOL CELL, V3, P865, DOI 10.1091/mbc.3.8.865; LEE SW, 1991, P NATL ACAD SCI USA, V88, P2825, DOI 10.1073/pnas.88.7.2825; LOEWENSTEIN WR, 1966, NATURE, V209, P1248, DOI 10.1038/2091248a0; Lutz W, 2001, J BIOL CHEM, V276, P20774, DOI 10.1074/jbc.M101324200; McLachlan E, 2006, CANCER RES, V66, P9886, DOI 10.1158/0008-5472.CAN-05-4302; Mehta P, 1999, DEV GENET, V24, P91, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<91::AID-DVG10>3.0.CO;2-#; Mesnil M, 2005, BBA-BIOMEMBRANES, V1719, P125, DOI 10.1016/j.bbamem.2005.11.004; MESNIL M, 1995, CANCER RES, V55, P629; MEYER DJ, 1981, J CELL BIOL, V91, P505, DOI 10.1083/jcb.91.2.505; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; Nam HJ, 2008, CELL SIGNAL, V20, P1349, DOI 10.1016/j.cellsig.2008.03.008; NAUS CCG, 1992, CANCER RES, V52, P4208; Nicholson BJ, 2003, J CELL SCI, V116, P4479, DOI 10.1242/jcs.00821; NIGG EA, 1985, CELL, V41, P1039, DOI 10.1016/S0092-8674(85)80084-2; Omori Y, 1999, CARCINOGENESIS, V20, P1913, DOI 10.1093/carcin/20.10.1913; Orellana JA, 2010, GLIA, V58, P329, DOI 10.1002/glia.20926; Plotkin LI, 2002, J BIOL CHEM, V277, P8648, DOI 10.1074/jbc.M108625200; Qin H, 2002, J BIOL CHEM, V277, P29132, DOI 10.1074/jbc.M200797200; Rahmouni S, 2006, NAT CELL BIOL, V8, P524, DOI 10.1038/ncb1398; RYAN WL, 1968, SCIENCE, V162, P1484, DOI 10.1126/science.162.3861.1484; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sanchez-Alvarez R, 2006, GLIA, V54, P125, DOI 10.1002/glia.20363; SCHWARTZ MA, 1989, P NATL ACAD SCI USA, V86, P4525, DOI 10.1073/pnas.86.12.4525; Sohl G, 2003, CELL COMMUN ADHES, V10, P173, DOI 10.1080/15419060390262877; Solan JL, 2003, J CELL SCI, V116, P2203, DOI 10.1242/jcs.00428; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Su YA, 2000, MOL CARCINOGEN, V28, P119, DOI 10.1002/1098-2744(200006)28:2<119::AID-MC8>3.0.CO;2-N; Thomas T, 2003, CELL COMMUN ADHES, V10, P353, DOI 10.1080/714040452; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Xie HQ, 1997, J CELL BIOL, V137, P203, DOI 10.1083/jcb.137.1.203; Yamashita YM, 1996, NATURE, V384, P276, DOI 10.1038/384276a0; Zambon AC, 2005, P NATL ACAD SCI USA, V102, P8561, DOI 10.1073/pnas.0503363102; ZEILIG CE, 1976, J CELL BIOL, V71, P515, DOI 10.1083/jcb.71.2.515; Zhang YW, 2003, CANCER RES, V63, P1623	69	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82335	10.1371/journal.pone.0082335	http://dx.doi.org/10.1371/journal.pone.0082335			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312655	Green Published, gold, Green Submitted			2022-12-25	WOS:000327947800092
J	Lin, T; Diao, YF; Kang, JW; Lee, JE; Kim, DK; Jin, DI				Lin, Tao; Diao, Yun Fei; Kang, Jung Won; Lee, Jae Eun; Kim, Dong Kyo; Jin, Dong Il			Chromosomes in the Porcine First Polar Body Possess Competence of Second Meiotic Division within Enucleated MII Stage Oocytes	PLOS ONE			English	Article							GERMINAL VESICLE STAGE; IN-VITRO; EMBRYOS; BLASTOCYSTS; REMOVAL; DEFECTS; IVF	To determine whether chromosomes in the porcine first polar body (PB1) can complete the second meiotic division and subsequently undergo normal pre-implantation embryonic development, we examined the developmental competence of PB1 chromosomes injected into enucleated MII stage oocytes by nuclear transfer method (chromosome replacement group, CR group). After parthenogenetic activation (PA) or in vitro fertilization (IVF), the cleavage rate of reconstructed oocytes in the IVF group (CR-IVF group, 36.4 +/- 3.2%) and PA group (CR-PA group, 50.8 +/- 4.2%) were significantly lower than that of control groups in which normal MII oocytes were subjected to IVF (MII- IVF group, 75.8 +/- 1.5%) and PA (MII- PA group, 86.9 +/- 3.7%). Unfertilized rates was significantly higher in the CR-IVF group (48.6 +/- 3.3%) than in the MII-IVF group (13.1 +/- 3.4%). The blastocyst formation rate was 8.3 +/- 1.9% in the CR-PA group, whereas no blastocyst formation was observed in the CR-IVF group. To produce tetraploid parthenogenetic embryos, intact MII stage oocytes injected with PB1chromosomes were electrically stimulated, treated with 7.5 mu g/mL cytochalasin B for 3 h (MII oocyte + PB1 + CB group), and then cultured without cytochalasin B. The average cleavage rate of reconstructed oocytes was 72.5% (48 of 66), and the blastocyst formation rate was 18.7% (9 of 48). Chromosome analysis showed similar proportions of haploid and diploid cells in the control (normal MII oocytes) and CR groups after PA; overall, 23.6% of blastocysts were tetraploid in the MII oocyte + PB1 + CB group. These results demonstrate that chromosomes in PB1 can participate in normal preimplantation embryonic development when injected into enucleated MII stage oocytes, and that tetraploid PA blastocysts are produced (although at a low proportion) when PB1 chromosomes are injected into intact MII stage oocytes.	[Lin, Tao; Diao, Yun Fei; Kang, Jung Won; Lee, Jae Eun; Kim, Dong Kyo; Jin, Dong Il] Chungnam Natl Univ, Dept Anim Sci & Biotechnol, Taejon, South Korea; [Kim, Dong Kyo] Rural Dev Adm, Dept Anim Biotechnol & Environm, Natl Inst Anim Sci, Suwon, South Korea	Chungnam National University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Jin, DI (corresponding author), Chungnam Natl Univ, Dept Anim Sci & Biotechnol, Taejon, South Korea.	dijin@cnu.ac.kr		Lin, Tao/0000-0001-9100-6042	BioGreen 21 Program of the Rural Development Administration [PJ009060]; Bio-industry Technology Development Program [IPET312060-5]; Ministry for Food and Agriculture, Republic of Korea	BioGreen 21 Program of the Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Bio-industry Technology Development Program; Ministry for Food and Agriculture, Republic of Korea	This work was supported by the BioGreen 21 Program of the Rural Development Administration (grant no. PJ009060) and the Bio-industry Technology Development Program (grant no. IPET312060-5) of the Ministry for Food and Agriculture, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catala MG, 2012, FERTIL STERIL, V97, P1004, DOI 10.1016/j.fertnstert.2011.12.043; Curnow EC, 2000, MOL REPROD DEV, V56, P372, DOI 10.1002/1098-2795(200007)56:3&lt;372::AID-MRD7&gt;3.0.CO;2-W; Ebner T, 1999, FERTIL STERIL, V72, P599, DOI 10.1016/S0015-0282(99)00315-5; FENG YL, 1997, FERTILITY STERILITY; Galeati G, 2011, ANIM REPROD SCI, V127, P43, DOI 10.1016/j.anireprosci.2011.07.010; Hao YH, 2004, BIOL REPROD, V70, P1644, DOI 10.1095/biolreprod.103.026005; Hara K, 2005, CRYOBIOLOGY, V50, P216, DOI 10.1016/j.cryobiol.2005.01.003; He ZY, 2003, FERTIL STERIL, V79, P347, DOI 10.1016/S0015-0282(02)04674-5; Iwasaki S, 2000, BIOL REPROD, V62, P470, DOI 10.1095/biolreprod62.2.470; Krivokharchenko A, 2002, MOL REPROD DEV, V61, P460, DOI 10.1002/mrd.90001; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lee K, 2013, MOL REPROD DEV, V80, P145, DOI 10.1002/mrd.22143; Li JS, 2005, CURR BIOL, V15, pR756, DOI 10.1016/j.cub.2005.09.010; Lin JW, 2011, CELL STEM CELL, V8, P371, DOI 10.1016/j.stem.2011.02.007; Okada Y, 2007, NAT BIOTECHNOL, V25, P233, DOI 10.1038/nbt1280; Park KE, 2005, J REPROD DEVELOP, V51, P151, DOI 10.1262/jrd.51.151; Prochazka R, 2004, THERIOGENOLOGY, V62, P155, DOI 10.1016/j.theriogenology.2003.08.017; Santos MA, 2010, REPRODUCTION, V139, P23, DOI 10.1530/REP-09-0187; Sembon S, 2011, THERIOGENOLOGY, V76, P598, DOI 10.1016/j.theriogenology.2011.03.010; SNOW MHL, 1973, NATURE, V244, P513, DOI 10.1038/244513a0; Verlinsky Y, 1998, J ASSIST REPROD GEN, V15, P285, DOI 10.1023/A:1022592427128; Wakayama S, 2007, STEM CELLS, V25, P986, DOI 10.1634/stemcells.2006-0615; Wakayama T, 1997, J REPROD FERTIL, V110, P263, DOI 10.1530/jrf.0.1100263; Wakayama T, 1998, BIOL REPROD, V59, P100, DOI 10.1095/biolreprod59.1.100; Wang GJ, 2011, THERIOGENOLOGY, V75, P826, DOI 10.1016/j.theriogenology.2010.10.023; Yang CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014242	26	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82766	10.1371/journal.pone.0082766	http://dx.doi.org/10.1371/journal.pone.0082766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312673	Green Submitted, Green Published, gold			2022-12-25	WOS:000327947800103
J	Zou, QF; Hou, Y; Shen, F; Wang, YZ				Zou, Qifei; Hou, Ying; Shen, Feng; Wang, Yizheng			Polarized Regulation of Glycogen Synthase Kinase-3 beta Is Important for Glioma Cell Invasion	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; TUMOR PROGRESSION; MIGRATION; MACROPHAGES; PLASTICITY; GSK-3-BETA; MOVEMENT; SYMMETRY; MOTILITY; LITHIUM	Glioma malignancy greatly depends on its aggressive invasion. The establishment of cell polarity is an important initial step for cell migration, which is essential for cell-directional translocation. However, our understanding of the molecular mechanisms underlying cell polarity formation in glioma cell invasion remains limited. Glycogen synthase kinase-3 (GSK-3) has a critical role in the formation of cell polarity. We therefore investigated whether localized GSK-3 beta, a subtype of GSK-3, is important for glioma cell invasion. We reported here that the localized phosphorylation of GSK-3 beta at the Ser9 (pSer9-GSK-3 beta) was critical for glioma cell invasion. Scratching glioma cell monolayer up-regulated pSer9-GSK-3 beta specifically at the wound edge. Inhibition of GSK-3 impaired the cell polarity and reduced the directional persistence of cell migration. Consistently, down-regulation of GSK-3 alpha and 3 beta by specific small interfering RNAs inhibited glioma cell invasion. Over-expressing wild-type or constitutively active forms of GSK-3 beta also inhibited the cell invasion. These results indicated the polarized localization of GSK-3 regulation in cell migration might be also important for glioma cell migration. Further, EGF regulated both GSK-3 alpha and 3 beta, but only pSer9-GSK-3 beta was enriched at the leading edge of scratched glioma cells. Up-or down-regulation of GSK-3 beta inhibited EGF-stimulated cell invasion. Moreover, EGF specifically regulated GSK-3 beta, but not GSK-3 alpha, through atypical PKC pathways. Our results indicated that GSK-3 was important for glioma cell invasion and localized inhibition of GSK-3 beta was critical for cell polarity formation.	[Zou, Qifei; Hou, Ying; Shen, Feng] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China; [Wang, Yizheng] Chinese Acad Sci, Inst Neurosci, Lab Neural Signal Transduct, Shanghai, Peoples R China	Naval Medical University; Chinese Academy of Sciences	Shen, F (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China.	shenfengdfgd@yahoo.com.cn; yzwang@ion.ac.cn	Shen, Feng/GSD-2508-2022		973 Program [2006CB806600]; Shanghai Science and Technology Committee [09411962700];  [KSCX2-YW-R-099]	973 Program(National Basic Research Program of China); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); 	This work was supported by grants from 973 Program (2006CB806600) and KSCX2-YW-R-099 and Shanghai Science and Technology Committee Funding (09411962700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto K, 1996, EMBO J, V15, P788, DOI 10.1002/j.1460-2075.1996.tb00414.x; Baudoin JP, 2008, DEV NEUROSCI-BASEL, V30, P132, DOI 10.1159/000109858; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Ehrengruber MU, 1996, J EXP BIOL, V199, P741; ELDARFINKELMAN H, 1995, J BIOL CHEM, V270, P987, DOI 10.1074/jbc.270.3.987; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Hedgepeth CM, 1999, MOL CELL BIOL, V19, P7147; Hegerfeldt Y, 2002, CANCER RES, V62, P2125; HSU HH, 2007, J BIOMED ENG, V27, P15; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jiang W, 2008, J BIOL CHEM, V283, P20978, DOI 10.1074/jbc.M802588200; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; KLEIHUES P, 1995, GLIA, V15, P211, DOI 10.1002/glia.440150303; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Kobayashi T, 2006, MOL CELL BIOL, V26, P898, DOI 10.1128/MCB.26.3.898-911.2006; Kuo JC, 2006, J CELL BIOL, V172, P619, DOI 10.1083/jcb.200505138; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Li B, 2003, CANCER RES, V63, P7443; Lu BW, 2000, ANNU REV NEUROSCI, V23, P531, DOI 10.1146/annurev.neuro.23.1.531; LUNDJOHANSEN M, 1990, CANCER RES, V50, P6039; Mueller MM, 2003, ACTA NEUROCHIR, V145, P999, DOI 10.1007/s00701-003-0132-0; Nierenberg AA, 2008, J CLIN PSYCHIAT, V69, P4; Nowicki MO, 2008, NEURO-ONCOLOGY, V10, P690, DOI 10.1215/15228517-2008-041; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Sundberg AL, 2003, EUR J NUCL MED MOL I, V30, P1348, DOI 10.1007/s00259-003-1308-9; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Yam PT, 2007, J CELL BIOL, V178, P1207, DOI 10.1083/jcb.200706012; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200	34	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81814	10.1371/journal.pone.0081814	http://dx.doi.org/10.1371/journal.pone.0081814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312592	gold, Green Published, Green Submitted			2022-12-25	WOS:000327947800060
J	Alipour, M; Lou, YF; Zimmerman, D; Bording-Jorgensen, MW; Sergi, C; Liu, JJ; Wine, E				Alipour, Misagh; Lou, Yuefei; Zimmerman, Daniel; Bording-Jorgensen, Michael W.; Sergi, Consolato; Liu, Julia J.; Wine, Eytan			A Balanced IL-1 beta Activity Is Required for Host Response to Citrobacter rodentium Infection	PLOS ONE			English	Article							INFLAMMASOME ACTIVATION; BACTERIAL CLEARANCE; DEFENSE; MUCOSAL; INNATE; CELLS; MACROPHAGES; RECRUITMENT; RESISTANCE; CASPASE-1	Microbial sensing plays essential roles in the innate immune response to pathogens. In particular, NLRP3 forms a multiprotein inflammasome complex responsible for the maturation of interleukin (IL)-1 beta. Our aim was to delineate the role of the NLRP3 inflammasome in macrophages, and the contribution of IL-1 beta to the host defense against Citrobacter rodentium acute infection in mice. Nlrp3(-/-) and background C57BL/6 (WT) mice were infected by orogastric gavage, received IL-1 beta (0.5 mu g/mouse; ip) on 0, 2, and 4 days post-infection (DPI), and assessed on 6 and 10 DPI. Infected Nlrp3(-/-) mice developed severe colitis; IL-1 beta treatments reduced colonization, abrogated dissemination of bacteria to mesenteric lymph nodes, and protected epithelial integrity of infected Nlrp3(-/-) mice. In contrast, IL-1 beta treatments of WT mice had an opposite effect with increased penetration of bacteria and barrier disruption. Microscopy showed reduced damage in Nlrp3(-/-) mice, and increased severity of disease in WT mice with IL-1 beta treatments, in particular on 10 DPI. Secretion of some pro-inflammatory plasma cytokines was dissipated in Nlrp3(-/-) compared to WT mice. IL-1 beta treatments elevated macrophage infiltration into infected crypts in Nlrp3(-/-) mice, suggesting that IL-1 beta may improve macrophage function, as exogenous administration of IL-1 beta increased phagocytosis of C. rodentium by peritoneal Nlrp3(-/-) macrophages in vitro. As well, the exogenous administration of IL-1 beta to WT peritoneal macrophages damaged the epithelial barrier of C. rodentium-infected polarized CMT-93 cells. Treatment of Nlrp3(-/-) mice with IL-1 beta seems to confer protection against C. rodentium infection by reducing colonization, protecting epithelial integrity, and improving macrophage activity, while extraneous IL-1 beta appeared to be detrimental to WT mice. Together, these findings highlight the importance of balanced cytokine responses as IL-1 beta improved bacterial clearance in Nlrp3(-/-) mice but increased tissue damage when given to WT mice.	[Alipour, Misagh; Lou, Yuefei; Zimmerman, Daniel; Bording-Jorgensen, Michael W.; Wine, Eytan] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Alipour, Misagh; Lou, Yuefei; Zimmerman, Daniel; Bording-Jorgensen, Michael W.; Liu, Julia J.; Wine, Eytan] Univ Alberta, Ctr Excellence Gastrointestinal Inflammat & Immun, Edmonton, AB, Canada; [Sergi, Consolato] Univ Alberta, Dept Pathol, Edmonton, AB T6G 2E1, Canada; [Liu, Julia J.] Univ Alberta, Dept Med, Edmonton, AB T6G 2E1, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Wine, E (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB, Canada.	wine@ualberta.ca	Sergi, Consolato/A-1126-2009	Bording-Jorgensen, Michael/0000-0002-3714-2470; Sergi, Consolato/0000-0002-2779-7879	Alberta Innovates-Health Solutions (AIHS); Women and Children's Health Research Institute (WCHRI); Canadian Institutes of Health Research (CIHR); Canadian Association of Gastroenterology (CAG); Centre for Excellence for Gastrointestinal Inflammation and Immunity Research (CEGIIR) at the University of Alberta; Alberta Inflammatory Bowel Disease Consortium; CIHR/CAG	Alberta Innovates-Health Solutions (AIHS); Women and Children's Health Research Institute (WCHRI); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Association of Gastroenterology (CAG); Centre for Excellence for Gastrointestinal Inflammation and Immunity Research (CEGIIR) at the University of Alberta; Alberta Inflammatory Bowel Disease Consortium; CIHR/CAG	This work was funded through grants awarded by Alberta Innovates-Health Solutions (AIHS) and the Women and Children's Health Research Institute (WCHRI) to EW, and Canadian Institutes of Health Research (CIHR) and the Canadian Association of Gastroenterology (CAG) to JJL. Infrastructure in EW's laboratory is funded by the Centre for Excellence for Gastrointestinal Inflammation and Immunity Research (CEGIIR) at the University of Alberta and The Alberta Inflammatory Bowel Disease Consortium, which is supported by an AIHS Interdisciplinary Team Grant. MA is a recipient of AIHS and CIHR/CAG postdoctoral fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bergstrom KS, 2012, CELL MICROBIOL, V14, P475, DOI 10.1111/j.1462-5822.2012.01750.x; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Borenshtein D, 2008, CURR OPIN GASTROEN, V24, P32, DOI 10.1097/MOG.0b013e3282f2b0fb; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Ceballos-Olvera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002452; Dann SM, 2008, J IMMUNOL, V180, P6816, DOI 10.4049/jimmunol.180.10.6816; de Veerdonk FLV, 2011, TRENDS IMMUNOL, V32, P110, DOI 10.1016/j.it.2011.01.003; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Geddes K, 2011, NAT MED, V17, P837, DOI 10.1038/nm.2391; Gibson DL, 2008, CELL MICROBIOL, V10, P388, DOI 10.1111/j.1462-5822.2007.01052.x; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Guttman JA, 2006, CELL MICROBIOL, V8, P634, DOI 10.1111/j.1462-5822.2005.00656.x; Hall LJ, 2013, INFECT IMMUN, V81, P460, DOI 10.1128/IAI.00953-12; Hirata Y, 2010, CELL HOST MICROBE, V7, P151, DOI 10.1016/j.chom.2010.01.006; Hirota SA, 2011, INFLAMM BOWEL DIS, V17, P1359, DOI 10.1002/ibd.21478; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Khan MA, 2006, INFECT IMMUN, V74, P2522, DOI 10.1128/IAI.74.5.2522-2536.2006; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; LaRock CN, 2012, CELL HOST MICROBE, V12, P799, DOI 10.1016/j.chom.2012.10.020; Lebeis SL, 2007, J IMMUNOL, V179, P566, DOI 10.4049/jimmunol.179.1.566; Lebeis SL, 2009, INFECT IMMUN, V77, P604, DOI 10.1128/IAI.00907-08; Liu ZP, 2012, J BIOL CHEM, V287, P16955, DOI 10.1074/jbc.M112.358705; Maaser C, 2004, INFECT IMMUN, V72, P3315, DOI 10.1128/IAI.72.6.3315-3324.2004; MacDonald TT, 2003, INT J MED MICROBIOL, V293, P87, DOI 10.1078/1438-4221-00247; Manta C, 2013, MUCOSAL IMMUNOL, V6, P177, DOI 10.1038/mi.2012.61; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Ota N, 2011, NAT IMMUNOL, V12, P941, DOI 10.1038/ni.2089; Palmer CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007787; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Simmons CP, 2003, INFECT IMMUN, V71, P5077, DOI 10.1128/IAI.71.9.5077-5086.2003; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Smith PD, 2011, MUCOSAL IMMUNOL, V4, P31, DOI 10.1038/mi.2010.66; Spehlmann ME, 2009, J IMMUNOL, V183, P3332, DOI 10.4049/jimmunol.0900600; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Verma D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034977; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Wang Y, 2006, BRIT J PHARMACOL, V148, P814, DOI 10.1038/sj.bjp.0706784; Wendelsdorf K, 2010, J THEOR BIOL, V264, P1225, DOI 10.1016/j.jtbi.2010.03.027; Wiles S, 2005, CELL MICROBIOL, V7, P1163, DOI 10.1111/j.1462-5822.2005.00544.x; Wiles S, 2004, CELL MICROBIOL, V6, P963, DOI 10.1111/j.1462-5822.2004.00414.x; Wiles S, 2006, INFECT IMMUN, V74, P5391, DOI 10.1128/IAI.00848-06; Wine E, 2010, AM J PATHOL, V177, P1320, DOI 10.2353/ajpath.2010.091068; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	59	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80656	10.1371/journal.pone.0080656	http://dx.doi.org/10.1371/journal.pone.0080656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312491	gold, Green Published, Green Submitted			2022-12-25	WOS:000327944500035
J	Guo, HY; King, MC				Guo, Haiyan; King, Megan C.			A Quality Control Mechanism Linking Meiotic Success to Release of Ascospores	PLOS ONE			English	Article							ASCUS-WALL ENDOLYSIS; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; NUCLEAR-ENVELOPE; DROSOPHILA OOGENESIS; S-PHASE; CHECKPOINT; RECOMBINATION; MEIOSIS; CHROMOSOMES	Eukaryotic organisms employ a variety of mechanisms during meiosis to assess and ensure the quality of their gametes. Defects or delays in successful meiotic recombination activate conserved mechanisms to delay the meiotic divisions, but many multicellular eukaryotes also induce cell death programs to eliminate gametes deemed to have failed during meiosis. It is generally thought that yeasts lack such mechanisms. Here, we show that in the fission yeast Schizosaccharomyces pombe, defects in meiotic recombination lead to the activation of a checkpoint that is linked to ascus wall endolysis - the process by which spores are released in response to nutritional cues for subsequent germination. Defects in meiotic recombination are sensed as unrepaired DNA damage through the canonical ATM and ATR DNA damage response kinases, and this information is communicated to the machinery that stimulates ascus wall breakdown. Viability of spores that undergo endolysis spontaneously is significantly higher than that seen upon chemical endolysis, demonstrating that this checkpoint contributes to a selective mechanism for the germination of high quality progeny. These results provide the first evidence for the existence of a checkpoint linking germination to meiosis and suggest that analysis solely based on artificial, enzymatic endolysis bypasses an important quality control mechanism in this organism and potentially other ascomycota, which are models widely used to study meiosis.	[Guo, Haiyan; King, Megan C.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Yale University	King, MC (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	megan.king@yale.edu			G. Harold and Leila Y. Mathers Charitable Foundation; Searle Scholars Program; National Institutes of Health [DP2OD008429]; Yale College Dean's Research Fellowship; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008429] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Charitable Foundation; Searle Scholars Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale College Dean's Research Fellowship; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	M.C.K. was supported by the G. Harold and Leila Y. Mathers Charitable Foundation, the Searle Scholars Program and the New Innovator Award from the National Institutes of Health (DP2OD008429). H. G. was supported by a Yale College Dean's Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdu U, 2002, CURR BIOL, V12, P1645, DOI 10.1016/S0960-9822(02)01165-X; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Boddy MN, 2000, MOL CELL BIOL, V20, P8758, DOI 10.1128/MCB.20.23.8758-8766.2000; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Catlett MG, 2003, MOL BIOL CELL, V14, P4707, DOI 10.1091/mbc.E03-05-0288; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Dekker N, 2007, YEAST, V24, P279, DOI 10.1002/yea.1464; del Dedo JE, 2009, EUKARYOT CELL, V8, P1278, DOI 10.1128/EC.00148-09; Ding DQ, 2012, SCIENCE, V336, P732, DOI 10.1126/science.1219518; Ding DQ, 2004, DEV CELL, V6, P329, DOI 10.1016/S1534-5807(04)00059-0; Ding DQ, 1998, J CELL SCI, V111, P701; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Forsburg SL, 2000, NAT GENET, V25, P263, DOI 10.1038/77015; Ghabrial A, 1999, NAT CELL BIOL, V1, P354, DOI 10.1038/14046; Hartl L, 2011, FUNGAL GENET BIOL, V48, P185, DOI 10.1016/j.fgb.2010.06.011; Hiraoka Y, 2009, DEV CELL, V17, P598, DOI 10.1016/j.devcel.2009.10.014; Hochwagen A, 2006, CURR BIOL, V16, pR217, DOI 10.1016/j.cub.2006.03.009; Horn HF, 2013, J CELL BIOL, V202, P1023, DOI 10.1083/jcb.201304004; LIN YK, 1994, GENETICS, V136, P769; Longhese MP, 2009, DNA REPAIR, V8, P1127, DOI 10.1016/j.dnarep.2009.04.005; Lu BC, 2003, FUNGAL GENET BIOL, V39, P82, DOI 10.1016/S1087-1845(03)00024-0; MacQueen AJ, 2011, TRENDS CELL BIOL, V21, P393, DOI 10.1016/j.tcb.2011.03.004; Malkova A, 1996, GENETICS, V143, P741; MANNERS DJ, 1977, CARBOHYD RES, V57, P189, DOI 10.1016/S0008-6215(00)81930-8; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Niwa O, 2000, EMBO J, V19, P3831, DOI 10.1093/emboj/19.14.3831; Pankratz DG, 2005, MOL BIOL CELL, V16, P1651, DOI 10.1091/mbc.E04-10-0934; Penkner A, 2007, DEV CELL, V12, P873, DOI 10.1016/j.devcel.2007.05.004; Phadnis N, 2011, TRENDS GENET, V27, P411, DOI 10.1016/j.tig.2011.06.007; Sato A, 2009, CELL, V139, P907, DOI 10.1016/j.cell.2009.10.039; Shimada M, 2002, EMBO J, V21, P2807, DOI 10.1093/emboj/21.11.2807; Shimanuki M, 1997, MOL GEN GENET, V254, P238, DOI 10.1007/s004380050412; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; TANAKA K, 1982, J CELL SCI, V56, P263; Vachova L, 2011, J CELL BIOL, V194, P679, DOI 10.1083/jcb.201103129	37	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82758	10.1371/journal.pone.0082758	http://dx.doi.org/10.1371/journal.pone.0082758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312672	gold, Green Submitted, Green Published			2022-12-25	WOS:000327944500146
J	Lindenburg, LH; Vinkenborg, JL; Oortwijn, J; Aper, SJA; Merkx, M				Lindenburg, Laurens H.; Vinkenborg, Jan L.; Oortwijn, Jorn; Aper, Stijn J. A.; Merkx, Maarten			MagFRET: The First Genetically Encoded Fluorescent Mg2+ Sensor	PLOS ONE			English	Article							MAGNESIUM-DEFICIENCY; INTRACELLULAR MAGNESIUM; IN-VIVO; CA2+; CALCIUM; PROTEIN; INDICATORS; MECHANISM; BINDING; ERYTHROCYTES	Magnesium has important structural, catalytic and signaling roles in cells, yet few tools exist to image this metal ion in real time and at subcellular resolution. Here we report the first genetically encoded sensor for Mg2+, MagFRET-1. This sensor is based on the high-affinity Mg2+ binding domain of human centrin 3 (HsCen3), which undergoes a transition from a molten-globular apo form to a compactly-folded Mg2+-bound state. Fusion of Cerulean and Citrine fluorescent domains to the ends of HsCen3, yielded MagFRET-1, which combines a physiologically relevant Mg2+ affinity (K-d = 148 mu M) with a 50% increase in emission ratio upon Mg2+ binding due to a change in FRET efficiency between Cerulean and Citrine. Mutations in the metal binding sites yielded MagFRET variants whose Mg2+ affinities were attenuated 2- to 100-fold relative to MagFRET-1, thus covering a broad range of Mg2+ concentrations. In situ experiments in HEK293 cells showed that MagFRET-1 can be targeted to the cytosol and the nucleus. Clear responses to changes in extracellular Mg2+ concentration were observed for MagFRET-1-expressing HEK293 cells when they were permeabilized with digitonin, whereas similar changes were not observed for intact cells. Although MagFRET-1 is also sensitive to Ca2+, this affinity is sufficiently attenuated (K-d of 10 mu M) to make the sensor insensitive to known Ca2+ stimuli in HEK293 cells. While the potential and limitations of the MagFRET sensors for intracellular Mg2+ imaging need to be further established, we expect that these genetically encoded and ratiometric fluorescent Mg2+ sensors could prove very useful in understanding intracellular Mg2+ homeostasis and signaling.	[Lindenburg, Laurens H.; Vinkenborg, Jan L.; Oortwijn, Jorn; Aper, Stijn J. A.; Merkx, Maarten] Eindhoven Univ Technol, Dept Biomed Engn, Biol Chem Lab, NL-5600 MB Eindhoven, Netherlands	Eindhoven University of Technology	Merkx, M (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Biol Chem Lab, POB 513, NL-5600 MB Eindhoven, Netherlands.	m.merkx@tue.nl	Merkx, Maarten/E-7009-2011; Lindenburg, Laurens/J-5433-2014	Lindenburg, Laurens/0000-0001-6775-8041	Netherlands Organization of Scientific Research NWO (VIDI grant) [700.56.428]; ERC [280255]	Netherlands Organization of Scientific Research NWO (VIDI grant)(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission)	This work was supported by the Netherlands Organization of Scientific Research NWO (VIDI grant 700.56.428) and by an ERC starting grant(280255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bo S, 2008, CURR OPIN LIPIDOL, V19, P50, DOI 10.1097/MOL.0b013e3282f33ccc; Bootman MD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011171; Chaudhary DP, 2010, BIOL TRACE ELEM RES, V134, P119, DOI 10.1007/s12011-009-8465-z; COHEN SM, 1977, P NATL ACAD SCI USA, V74, P4271, DOI 10.1073/pnas.74.10.4271; CORKEY BE, 1986, J BIOL CHEM, V261, P2567; Cox JA, 2005, BIOCHEMISTRY-US, V44, P840, DOI 10.1021/bi048294e; Dittmer PJ, 2009, J BIOL CHEM, V284, P16289, DOI 10.1074/jbc.M900501200; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; FISCHERFANTUZZI L, 1988, MOL CELL BIOL, V8, P5495, DOI 10.1128/MCB.8.12.5495; Fonseca Carla P., 2000, Metal-Based Drugs, V7, P357, DOI 10.1155/MBD.2000.357; Golynskiy MV, 2010, CHEMBIOCHEM, V11, P2264, DOI 10.1002/cbic.201000143; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; Gunther T, 2006, MAGNESIUM RES, V19, P225; Gunther T, 2007, MAGNESIUM RES, V20, P161; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; HUI KY, 1992, BIOCHEM BIOPH RES CO, V184, P790, DOI 10.1016/0006-291X(92)90659-9; HURLEY TW, 1992, AM J PHYSIOL, V263, pC300, DOI 10.1152/ajpcell.1992.263.2.C300; Isshiki M, 1998, P NATL ACAD SCI USA, V95, P5009, DOI 10.1073/pnas.95.9.5009; Jiang TR, 1998, J MOL CELL CARDIOL, V30, P2193, DOI 10.1006/jmcc.1998.0779; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Killilea DW, 2008, P NATL ACAD SCI USA, V105, P5768, DOI 10.1073/pnas.0712401105; Kim HM, 2007, ANGEW CHEM INT EDIT, V46, P3460, DOI 10.1002/anie.200700169; Kim HM, 2007, J ORG CHEM, V72, P2088, DOI 10.1021/jo062341m; Koay MS, 2013, DALTON T, V42, P3230, DOI 10.1039/c2dt32082g; Kohn JE, 2005, P NATL ACAD SCI USA, V102, P10841, DOI 10.1073/pnas.0503055102; Komatsu H, 2005, J AM CHEM SOC, V127, P10798, DOI 10.1021/ja0528228; Komatsu H, 2004, J AM CHEM SOC, V126, P16353, DOI 10.1021/ja049624l; Konrad M, 2003, J AM SOC NEPHROL, V14, P249, DOI 10.1097/01.ASN.0000049161.60740.CE; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Lindenburg L, 2012, CHEMBIOCHEM, V13, P349, DOI 10.1002/cbic.201100739; Maguire ME, 2006, CURR OPIN STRUC BIOL, V16, P432, DOI 10.1016/j.sbi.2006.06.006; Miranda JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049371; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Okumoto S, 2005, P NATL ACAD SCI USA, V102, P8740, DOI 10.1073/pnas.0503274102; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Palmer AE, 2011, TRENDS BIOTECHNOL, V29, P144, DOI 10.1016/j.tibtech.2010.12.004; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; Qi Z, 2000, BRIT J PHARMACOL, V131, P370, DOI 10.1038/sj.bjp.0703563; Qiao W, 2006, P NATL ACAD SCI USA, V103, P8674, DOI 10.1073/pnas.0600928103; RAJU B, 1989, AM J PHYSIOL, V256, pC540, DOI 10.1152/ajpcell.1989.256.3.C540; RESNICK LM, 1984, P NATL ACAD SCI-BIOL, V81, P6511, DOI 10.1073/pnas.81.20.6511; Romani AMP, 2007, FRONT BIOSCI-LANDMRK, V12, P308, DOI 10.2741/2066; Rude RK, 2004, J NUTR BIOCHEM, V15, P710, DOI 10.1016/j.jnutbio.2004.08.001; RUTTER GA, 1990, BIOCHEM J, V271, P627, DOI 10.1042/bj2710627; Schlingmann KP, 2007, BBA-MOL BASIS DIS, V1772, P813, DOI 10.1016/j.bbadis.2007.03.009; Schweigel M, 2006, AM J PHYSIOL-GASTR L, V290, pG56, DOI 10.1152/ajpgi.00014.2005; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Shindo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023684; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Trapani V, 2012, METHOD ENZYMOL, V505, P421, DOI 10.1016/B978-0-12-388448-0.00030-9; Trapani V, 2010, ANALYST, V135, P1855, DOI 10.1039/c0an00087f; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/NMETH.1368, 10.1038/nmeth.1368]; Wang W, 2013, NAT MED, V19, P305, DOI 10.1038/nm.3079; Wegner SV, 2010, J AM CHEM SOC, V132, P2567, DOI 10.1021/ja9097324; Xie J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00146; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106	60	43	43	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82009	10.1371/journal.pone.0082009	http://dx.doi.org/10.1371/journal.pone.0082009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312622	Green Published, gold, Green Submitted			2022-12-25	WOS:000327944500112
J	Lou, JQ; Cao, YQ; Sun, PD; Zheng, P				Lou, Juqing; Cao, Yongqing; Sun, Peide; Zheng, Ping			The Effects of Operational Conditions on the Respiration Rate of Tubificidae	PLOS ONE			English	Article							WASTE-WATER TREATMENT; BRANCHIURA-SOWERBYI OLIGOCHAETA; SLUDGE REDUCTION; ACTIVATED-SLUDGE; TUBIFEX-TUBIFEX; ENVIRONMENTAL-FACTORS; WORM REACTOR; GROWTH; TEMPERATURE; TOXICITY	Tubificidae is often used in the wastewater treatment systems to minimize the sludge production because it can be fed on the activated sludge. The process conditions have effect on the growth, reproduction, and sludge reduction efficiency of Tubificidae. The effects of the water quality, density of worms, pH, temperature and dissolved oxygen (DO) concentration on the respiration rate of Tubificidae were investigated to determine the optimal conditions for the growth and metabolism of the worms and reveal the mechanisms involving the efficient sludge reduction in terms of these conditions. It was observed that the respiration rate was highest in the water discharged from an ecosystem that included symbiotic Tubificidae and microbes and was lowest in distilled water. Considering density of the worms, the highest rate was 81.72+/-5.12 mg O-2/g(dry weight).h.L with 0.25 g (wet weight) of worms in 1 L test flask. The maximum Tubificidae respiration rate was observed at a pH of 8.0+/-0.05, a rate that was more than twice as high as those observed at other pH values. The respiration rate increased in the temperature range of similar to 8 degrees C-22 degrees C, whereas the rate declined in the temperature range of similar to 22 degrees C-30 degrees C. The respiration rate of Tubificidae was very high for DO range of similar to 3.5-4.5 mg/L, and the rates were relatively low for out of this DO range. The results of this study revealed the process conditions which influenced the growth, and reproduction of Tubificidae and sludge reduction at a microscopic level, which could be a theoretical basis for the cultivation and application of Tubificidae in wastewater treatment plants.	[Lou, Juqing; Zheng, Ping] Zhejiang Univ, Dept Environm Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Lou, Juqing; Cao, Yongqing; Sun, Peide] Zhejiang Gongshang Univ, Sch Environm Sci & Engn, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Gongshang University	Zheng, P (corresponding author), Zhejiang Univ, Dept Environm Engn, Hangzhou 310003, Zhejiang, Peoples R China.	pzheng@zju.edu.cn	郑, 平/B-1890-2014		Innovative Research Team in High Educational Institutions of Zhejiang Province, China [T200912]; Natural Science Foundation of Zhejiang Province, China [Y12E080076]; Scientific Research Project of Department of Education of Zhejiang province, China [Y201017078]	Innovative Research Team in High Educational Institutions of Zhejiang Province, China; Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Scientific Research Project of Department of Education of Zhejiang province, China	This study was financed by Innovative Research Team in High Educational Institutions of Zhejiang Province, China (No. T200912), Natural Science Foundation of Zhejiang Province, China (No. Y12E080076), and Scientific Research Project of Department of Education of Zhejiang province, China (No. Y201017078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsterberg G, 1924, SINNESPHYSIOLOGIE TU; ANTONIOU P, 1990, WATER RES, V24, P97, DOI 10.1016/0043-1354(90)90070-M; APHA, 2005, STANDARD METHODS EXA, V21st; ASTON RJ, 1981, AQUACULTURE, V26, P155, DOI 10.1016/0044-8486(81)90118-6; ASTON RJ, 1982, AQUACULTURE, V29, P137, DOI 10.1016/0044-8486(82)90040-0; BRKOVICPOPOVIC I, 1977, ENVIRON POLLUT, V13, P93, DOI 10.1016/0013-9327(77)90093-3; Chapman KK, 1999, ENVIRON TOXICOL, V14, P271, DOI 10.1002/(SICI)1522-7278(199905)14:2<271::AID-TOX8>3.0.CO;2-F; CHAPMAN PM, 1982, WATER RES, V16, P1405, DOI 10.1016/0043-1354(82)90225-1; COLLIER JG, 1947, BIOL BULL, V92, P167, DOI 10.2307/1538303; Densem JW, 1982, THESIS U WALES CARDI; Drewes CD, 1997, AM ZOOL, V37, P346; Egeler P, 1997, CHEMOSPHERE, V35, P835, DOI 10.1016/S0045-6535(97)00128-8; Elissen HJH, 2006, WATER RES, V40, P3713, DOI 10.1016/j.watres.2006.08.029; Elissen HJH, 2007, THESIS WAGENINGEN U; FOWLER DJ, 1965, AM MIDL NAT, V74, P418, DOI 10.2307/2423271; FOX HM, 1945, J EXP BIOL, V21, P161; [郭茂新 Guo Maoxin], 2011, [环境科学学报, Acta Scientiae Circumstantiae], V31, P2657; Guo XS, 2007, J ENVIRON SCI-CHINA, V19, P257, DOI 10.1016/S1001-0742(07)60042-4; HANER A, 1994, WATER RES, V28, P863, DOI 10.1016/0043-1354(94)90092-2; Hawkins S, 2010, BIORESOURCE TECHNOL, V101, P4513, DOI 10.1016/j.biortech.2010.01.090; Hendrickx TLG, 2009, WATER RES, V43, P943, DOI 10.1016/j.watres.2008.11.034; Hendrickx TLG, 2011, WATER RES, V45, P4923, DOI 10.1016/j.watres.2011.06.031; Heugens EHW, 2003, ENVIRON SCI TECHNOL, V37, P2145, DOI 10.1021/es0264347; LAFONT M, 1987, HYDROBIOLOGIA, V155, P179, DOI 10.1007/BF00025647; Lee NM, 1996, WATER RES, V30, P1781, DOI 10.1016/0043-1354(96)00059-0; Liu YC, 2010, BIORESOURCE TECHNOL, V101, P901, DOI 10.1016/j.biortech.2009.09.015; LOCHHEAD G, 1983, HYDROBIOLOGIA, V98, P107, DOI 10.1007/BF02185627; Lou JQ, 2011, INT C NANJ, P4442; Low EW, 2000, WATER RES, V34, P3204, DOI 10.1016/S0043-1354(99)00364-4; Lucan-Bouche ML, 1999, AQUAT TOXICOL, V45, P9, DOI 10.1016/S0166-445X(98)00091-5; Ma Wang-gang, 2011, Huanjing Kexue, V32, P2340; Mayhew M, 1997, ENVIRON TECHNOL, V18, P883, DOI 10.1080/09593331808616607; Mosleh YY, 2006, CHEMOSPHERE, V64, P121, DOI 10.1016/j.chemosphere.2005.10.045; Ratsak CH, 2006, HYDROBIOLOGIA, V564, P197, DOI 10.1007/s10750-005-1719-7; Rensink JH, 1997, WATER SCI TECHNOL, V36, P171, DOI 10.1016/S0273-1223(97)00679-3; Reynoldson TB, 1996, HYDROBIOLOGIA, V334, P199, DOI 10.1007/BF00017370; REYNOLDSON TB, 1987, HOLARCTIC ECOL, V10, P241; SALVADO H, 1995, WATER RES, V29, P1041, DOI 10.1016/0043-1354(94)00258-9; Schenkova J, 2006, BIOLOGIA, V61, P517, DOI 10.2478/s11756-006-0085-x; Sturdivant SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034539; Tamis J, 2011, WATER RES, V45, P5916, DOI 10.1016/j.watres.2011.08.046; Tian Y, 2010, BIORESOURCE TECHNOL, V101, P6069, DOI 10.1016/j.biortech.2010.03.011; TIMMERMANS P, 1983, WATER RES, V17, P1249, DOI 10.1016/0043-1354(83)90249-X; Villasenor J, 2011, BIORESOURCE TECHNOL, V102, P6562, DOI 10.1016/j.biortech.2011.03.080; WALKER JG, 1970, BIOL BULL, V138, P235, DOI 10.2307/1540205; Wei YS, 2003, WATER RES, V37, P4453, DOI 10.1016/S0043-1354(03)00441-X; Wei YS, 2003, ENVIRON SCI TECHNOL, V37, P3171, DOI 10.1021/es026176d; Wei Yuan-song, 2005, Huanjing Kexue, V26, P76; Wei YS, 2006, HYDROBIOLOGIA, V564, P213, DOI 10.1007/s10750-005-1720-1; Wei YS, 2009, J HAZARD MATER, V163, P87, DOI 10.1016/j.jhazmat.2008.06.065; WHITLEY L S, 1970, Journal Water Pollution Control Federation, V42, pR57; WIEDERHOLM T, 1987, WATER AIR SOIL POLL, V36, P131, DOI 10.1007/BF00450625; Zhao LM, 2012, ADV MATER RES-SWITZ, V446-449, P2824, DOI 10.4028/www.scientific.net/AMR.446-449.2824; Zhong X, 2009, AIP C P, P133	54	3	3	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81219	10.1371/journal.pone.0081219	http://dx.doi.org/10.1371/journal.pone.0081219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312538	gold, Green Published, Green Submitted			2022-12-25	WOS:000327944500061
J	Gozdziewicz, TK; Lugowski, C; Lukasiewicz, J				Gozdziewicz, Tomasz K.; Lugowski, Czeslaw; Lukasiewicz, Jolanta			First Evidence for a Covalent Linkage between Enterobacterial Common Antigen and Lipopolysaccharide in Shigella sonnei Phase II ECALPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Endotoxin; Lipopolysaccharide (LPS); Mass Spectrometry (MS); NMR; ECA; Shigella; Enterobacterial Common Antigen	TETANUS TOXOID CONJUGATE; O-SPECIFIC POLYSACCHARIDE; ESCHERICHIA-COLI; CHEMICAL CHARACTERIZATION; SERRATIA-MARCESCENS; R-MUTANTS; IMMUNOGENICITY; BIOSYNTHESIS; IDENTIFICATION; ANTIBODIES	Background: Enterobacterial common antigen (ECA) is a surface antigen of all enteric bacteria. Results: ECA polysaccharide substitutes the outer core region of Shigella sonnei lipopolysaccharide (LPS). Conclusion: First structural evidence for the existence of ECA covalently associated with LPS (ECA(LPS)). Significance: ECA(LPS) is the only immunogenic form of ECA and could be a target for therapeutic strategies against nosocomial infections. Enterobacterial common antigen (ECA) is expressed by Gram-negative bacteria belonging to Enterobacteriaceae, including emerging drug-resistant pathogens such as Escherichia coli, Klebsiella pneumoniae, and Proteus spp. Recent studies have indicated the importance of ECA for cell envelope integrity, flagellum expression, and resistance of enteric bacteria to acetic acid and bile salts. ECA, a heteropolysaccharide built from the trisaccharide repeating unit, 3)--d-Fucp4NAc-(14)--d-ManpNAcA-(14)--d-GlcpNAc-(1, occurs as a cyclic form (ECA(CYC)), a phosphatidylglycerol (PG)-linked form (ECA(PG)), and an endotoxin/lipopolysaccharide (LPS)-associated form (ECA(LPS)). Since the discovery of ECA in 1962, the structures of ECA(PG) and ECA(CYC) have been completely elucidated. However, no direct evidence has been presented to support a covalent linkage between ECA and LPS; only serological indications of co-association have been reported. This is paradoxical, given that ECA was first identified based on the capacity of immunogenic ECA(LPS) to elicit antibodies cross-reactive with enterobacteria. Using a simple isolation protocol supported by serological tracking of ECA epitopes and NMR spectroscopy and mass spectrometry, we have succeeded in the first detection, isolation, and complete structural analysis of poly- and oligosaccharides of Shigella sonnei phase II ECA(LPS). ECA(LPS) consists of the core oligosaccharide substituted with one to four repeating units of ECA at the position occupied by the O-antigen in the case of smooth S. sonnei phase I. These data represent the first structural evidence for the existence of ECA(LPS) in the half-century since it was first discovered and provide insights that could prove helpful in further structural analyses and screening of ECA(LPS) among Enterobacteriaceae species.	[Gozdziewicz, Tomasz K.; Lugowski, Czeslaw; Lukasiewicz, Jolanta] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Immunochem, PL-53114 Wroclaw, Poland; [Lugowski, Czeslaw] Univ Opole, Dept Biotechnol & Mol Biol, PL-45035 Opole, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; University of Opole	Lukasiewicz, J (corresponding author), Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Immunochem, R Weigla 12, PL-53114 Wroclaw, Poland.	czaja@iitd.pan.wroc.pl		Lukasiewicz, Jolanta/0000-0001-8081-7261; Lugowski, Czeslaw/0000-0002-2336-0530	Wroclaw Research Centre EIT+ within the project "Biotechnologies and Advanced Medical Technologies"-BioMed [POIG.01.01.02-02-003/08]; European Regional Development Fund (Operational Programme Innovative Economy) [1.1.2]	Wroclaw Research Centre EIT+ within the project "Biotechnologies and Advanced Medical Technologies"-BioMed; European Regional Development Fund (Operational Programme Innovative Economy)(European Commission)	This work was supported by Wroclaw Research Centre EIT+ within the project "Biotechnologies and Advanced Medical Technologies"-BioMed (POIG.01.01.02-02-003/08) co-financed by the European Regional Development Fund (Operational Programme Innovative Economy, 1.1.2).	Barua S, 2002, MOL MICROBIOL, V43, P629, DOI 10.1046/j.1365-2958.2002.02768.x; BASU S, 1987, EUR J BIOCHEM, V162, P75, DOI 10.1111/j.1432-1033.1987.tb10544.x; Castelli ME, 2008, J BACTERIOL, V190, P213, DOI 10.1128/JB.01348-07; Castelli ME, 2011, J BACTERIOL, V193, P63, DOI 10.1128/JB.00839-10; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; DELL A, 1984, CARBOHYD RES, V133, P95, DOI 10.1016/0008-6215(84)85186-1; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Duda KA, 2009, ARCH IMMUNOL THER EX, V57, P147, DOI 10.1007/s00005-009-0018-9; Erbel PJA, 2003, J BACTERIOL, V185, P1995, DOI 10.1128/JB.185.6.1995-2004.2003; Fregolino E, 2012, CARBOHYD RES, V363, P29, DOI 10.1016/j.carres.2012.09.017; GAMIAN A, 1982, EUR J BIOCHEM, V129, P105, DOI 10.1111/j.1432-1033.1982.tb07027.x; Goddard T., 2001, SPARKY; Kajimura J, 2005, J BACTERIOL, V187, P6917, DOI 10.1128/JB.187.20.6917-6927.2005; KISS P, 1978, EUR J BIOCHEM, V88, P211, DOI 10.1111/j.1432-1033.1978.tb12440.x; KUHN HM, 1988, FEMS MICROBIOL LETT, V54, P195, DOI 10.1111/j.1574-6968.1988.tb02743.x; KUHN HM, 1983, INFECT IMMUN, V40, P696, DOI 10.1128/IAI.40.2.696-700.1983; KUNIN CM, 1963, J EXP MED, V118, P565, DOI 10.1084/jem.118.4.565; KUNIN CM, 1962, P SOC EXP BIOL MED, V111, P160, DOI 10.3181/00379727-111-27734; KUNIN CM, 1963, J BACTERIOL, V85, P541, DOI 10.1128/JB.85.3.541-548.1963; Lehrer J, 2007, J BACTERIOL, V189, P2618, DOI 10.1128/JB.01905-06; LUGOWSKI C, 1983, INFECT IMMUN, V42, P1086, DOI 10.1128/IAI.42.3.1086-1091.1983; Lugowski C, 1996, FEMS IMMUNOL MED MIC, V16, P21, DOI 10.1016/S0928-8244(96)00065-X; LUGOWSKI C, 1983, CARBOHYD RES, V118, P173, DOI 10.1016/0008-6215(83)88045-8; LUGOWSKI C, 1987, Postepy Higieny i Medycyny Doswiadczalnej, V41, P384; LUGOWSKI C, 1978, EUR J BIOCHEM, V91, P89, DOI 10.1111/j.1432-1033.1978.tb20941.x; LUGOWSKI C, 1991, FEMS MICROBIOL LETT, V77, P315, DOI 10.1016/0378-1097(91)90572-R; MAKELA PH, 1976, BACTERIOL REV, V40, P591; MANNEL D, 1978, EUR J BIOCHEM, V86, P361, DOI 10.1111/j.1432-1033.1978.tb12318.x; MAYER H, 1972, INFECT IMMUN, V6, P540, DOI 10.1128/IAI.6.4.540-544.1972; MEIERDIETER U, 1990, J BIOL CHEM, V265, P13490; Muller-Loennies S, 2007, INT J MED MICROBIOL, V297, P321, DOI 10.1016/j.ijmm.2007.04.002; Muszynski A, 2013, MICROBIOL-SGM, V159, P1782, DOI 10.1099/mic.0.066662-0; Rabsztyn K, 2011, BIOCHEMISTRY-MOSCOW+, V76, P832, DOI 10.1134/S0006297911070145; Radziejewska-Lebrecht J, 2003, ADV EXP MED BIOL, V529, P215; Radziejewska-Lebrecht J, 1998, ACTA BIOCHIM POL, V45, P1011, DOI 10.18388/abp.1998_4358; Ramos-Morales F, 2003, J BACTERIOL, V185, P5328, DOI 10.1128/JB.185.17.5328-5332.2003; Richmond P, 1999, VACCINE, V18, P641, DOI 10.1016/S0264-410X(99)00276-5; Richmond P, 2001, J INFECT DIS, V183, P160, DOI 10.1086/317646; Richmond P, 2001, INFECT IMMUN, V69, P2378, DOI 10.1128/IAI.69.4.2378-2382.2001; Rick PD, 1998, GLYCOBIOLOGY, V8, P557, DOI 10.1093/glycob/8.6.557; RICK PD, 1985, J BACTERIOL, V162, P494, DOI 10.1128/JB.162.2.494-503.1985; Snape MD, 2005, LANCET INFECT DIS, V5, P21, DOI 10.1016/S1473-3099(04)01251-4; Vinogradov EV, 1999, EUR J BIOCHEM, V261, P629, DOI 10.1046/j.1432-1327.1999.00280.x; VINOGRADOV EV, 1994, CARBOHYD RES, V258, P223, DOI 10.1016/0008-6215(94)84088-1; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83	46	19	20	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2745	2754		10.1074/jbc.M113.512749	http://dx.doi.org/10.1074/jbc.M113.512749			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24324266	Green Published, hybrid			2022-12-25	WOS:000333403000024
J	Li, J; Yu, H; Zhang, FZ; Lin, CY; Gao, JH; Fang, J; Ding, XH; Shen, ZC; Xu, XL				Li, Jing; Yu, Hui; Zhang, Fengzhen; Lin, Chaoyang; Gao, Jianhua; Fang, Jun; Ding, Xiahui; Shen, Zhicheng; Xu, Xiaoli			A Built-In Strategy to Mitigate Transgene Spreading from Genetically Modified Corn	PLOS ONE			English	Article							CONTAINMENT STRATEGIES; MAIZE; PLANTS; TRANSFORMATION; HERBICIDE; BIOSAFETY; HYBRIDS; CROP	Transgene spreading is a major concern in cultivating genetically modified (GM) corn. Cross-pollination may cause the spread of transgenes from GM cornfields to conventional fields. Occasionally, seed lot contamination, volunteers, mixing during sowing, harvest, and trade can also lead to transgene escape. Obviously, new biological confinement technologies are highly desired to mitigate transgene spreading in addition to physical separation and isolation methods. In this study, we report the development of a built-in containment method to mitigate transgene spreading in corn. In this method, an RNAi cassette for suppressing the expression of the nicosulfuron detoxifying enzyme CYP81A9 and an expression cassette for the glyphosate tolerant 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) gene G10 were constructed and transformed into corn via Agrobacterium-mediated transformation. The GM corn plants that were generated were found to be sensitive to nicosulfuron but resistant to glyphosate, which is exactly the opposite of conventional corn. Field tests demonstrated that GM corn plants with silenced CYP81A9 could be killed by applying nicosulfuron at 40 g/ha, which is the recommended dose for weed control in cornfields. This study suggests that this built-in containment method for controlling the spread of corn transgenes is effective and easy to implement.	[Li, Jing; Yu, Hui; Zhang, Fengzhen; Lin, Chaoyang; Gao, Jianhua; Fang, Jun; Ding, Xiahui; Shen, Zhicheng; Xu, Xiaoli] Zhejiang Univ, State Key Lab Rice Biol, Inst Insect Sci, Sch Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Xu, XL (corresponding author), Zhejiang Univ, State Key Lab Rice Biol, Inst Insect Sci, Sch Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	xuxiaoli@zju.edu.cn		Li, Jing/0000-0001-9714-5924	National Natural Science Foundation of China [31000855]; Department of Agriculture of China [2011ZX08010-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Agriculture of China	This work was supported by the National Natural Science Foundation of China (31000855), and Grants from the Department of Agriculture of China (2011ZX08010-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breyer D, 2012, MOLECULAR FARMING IN PLANTS: RECENT ADVANCES AND FUTURE PROSPECTS, P259, DOI 10.1007/978-94-007-2217-0_12; Breyer D, 2009, J MED PLANTS RES, V3, P825; Brown H., 1994, HERBICIDES INHIBITIN, P47; BROWN HM, 1990, PESTIC SCI, V29, P263, DOI 10.1002/ps.2780290304; Dalton R, 2009, NATURE, V462, P404, DOI 10.1038/462404a; Dam T, 2010, US Patent, Patent No. [7,705,200, 7705200]; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Fox JL, 2003, NAT BIOTECHNOL, V21, P3, DOI 10.1038/nbt0103-3b; GREEN JM, 1993, WEED SCI, V41, P508, DOI 10.1017/S0043174500052267; Hills MJ, 2007, TRENDS PLANT SCI, V12, P177, DOI 10.1016/j.tplants.2007.02.002; Huesken Alexandra, 2010, Environmental Biosafety Research, V9, P67, DOI 10.1051/ebr/2010009; Ishida Y, 1996, NAT BIOTECHNOL, V14, P745, DOI 10.1038/nbt0696-745; KANG MS, 1993, J HERED, V84, P216, DOI 10.1093/oxfordjournals.jhered.a111321; Kreuz K, 1996, PLANT PHYSIOL, V111, P349, DOI 10.1104/pp.111.2.349; Lee D, 2006, TRENDS BIOTECHNOL, V24, P109, DOI 10.1016/j.tibtech.2006.01.006; Lee SM, 2006, MOL CELLS, V21, P401; Lin CY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001818; Lin CY, 2010, PROTEIN EXPRES PURIF, V74, P60, DOI 10.1016/j.pep.2010.04.015; Liu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031625; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu BR., 2008, COLLECT BIOSAF REV, V4, P66; Maliga P, 2012, ADV PHOTOSYNTHESIS R, V35, P393; Messeguer J, 2006, PLANT BIOTECHNOL J, V4, P633, DOI 10.1111/j.1467-7652.2006.00207.x; Mezzalama M, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue2-fulltext-5; Michael Bannert, 2006, SIMULATION TRANSGENI; Munsch MA, 2010, CROP SCI, V50, P909, DOI 10.2135/cropsci2009.03.0117; Palaudelmas M, 2009, TRANSGENIC RES, V18, P583, DOI 10.1007/s11248-009-9250-7; Ramessar K, 2008, PLANT SCI, V174, P409, DOI 10.1016/j.plantsci.2008.02.002; Rigano MM, 2012, BIOENGINEERED, V3, P329, DOI 10.4161/bioe.21452; Shen Z, 2006, CN Patent, Patent No. [WO/2012/068966 A1, 2012068966]; Shiferaw B, 2011, FOOD SECUR, V3, P475, DOI 10.1007/s12571-011-0153-0; Stewart CN, 2000, BIOTECHNIQUES, V29, P832, DOI 10.2144/00294bi01; VALVERDE BE, 2005, P 20 AS PAC WEED SCI, P63; Weider C, 2009, CROP SCI, V49, P77, DOI 10.2135/cropsci2007.12.0694	34	13	13	4	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81645	10.1371/journal.pone.0081645	http://dx.doi.org/10.1371/journal.pone.0081645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324711	Green Published, Green Submitted, gold			2022-12-25	WOS:000328566700047
J	Hof, MHP; Vrijkotte, TGM; de Hoog, MLA; van Eijsden, M; Zwinderman, AH				Hof, Michel H. P.; Vrijkotte, Tanja G. M.; de Hoog, Marieke L. A.; van Eijsden, Manon; Zwinderman, Aeilko H.			Association between Infancy BMI Peak and Body Composition and Blood Pressure at Age 5-6 Years	PLOS ONE			English	Article							BIRTH-WEIGHT; MASS INDEX; CHILDHOOD OBESITY; POSTNATAL-GROWTH; METABOLIC RISK; CHILDREN; ADIPOSITY; OVERWEIGHT; HYPERTENSION; ADULTHOOD	Introduction: The development of overweight is often measured with the body mass index (BMI). During childhood the BMI curve has two characteristic points: the adiposity rebound at 6 years and the BMI peak at 9 months of age. In this study, the associations between the BMI peak and body composition measures and blood pressure at age 5-6 years were investigated. Methods: Measurements from the Amsterdam Born Children and their Development (ABCD) study were available for this study. Blood pressure (systolic and diastolic) and body composition measures (BMI, waist-to-height ratio, fat percentage) were gathered during a health check at about 6 years of age (n = 2822). All children had multiple BMI measurements between the 0-4 years of age. For boys and girls separately, child-specific BMI peaks were extracted from mixed effect models. Associations between the estimated BMI peak and the health check measurements were analysed with linear models. In addition, we investigated the potential use of the BMI at 9 months as a surrogate measure for the magnitude of the BMI peak. Results: After correction for the confounding effect of fetal growth, both timing and magnitude of the BMI peak were significantly and positively associated (p<0.001) with all body composition measures at the age of 5-6 years. The BMI peak showed no direct association with blood pressure at the age 5-6 year, but was mediated by the current BMI. The correlation between the magnitude of the BMI peak and BMI at 9 months was approximately 0.93 and similar associations with the measures at 5-6 years were found. Conclusion: The magnitude of the BMI peak was associated with body composition measures at 5-6 years of age. Moreover, the BMI at 9 months could be used as surrogate measure for the magnitude of the BMI peak.	[Hof, Michel H. P.; Zwinderman, Aeilko H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Bioinformat & Biostat, NL-1105 AZ Amsterdam, Netherlands; [Hof, Michel H. P.; Vrijkotte, Tanja G. M.; de Hoog, Marieke L. A.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [de Hoog, Marieke L. A.; van Eijsden, Manon] Publ Hlth Serv Amsterdam GGD, Dept Epidemiol Documentat & Hlth Promot, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam	Hof, MHP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Bioinformat & Biostat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.h.hof@amc.uva.nl		Vrijkotte, Tanja/0000-0003-3641-4048				Ay L, 2009, J CLIN ENDOCR METAB, V94, P2023, DOI 10.1210/jc.2008-2045; Barlow SE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.3.e29; Belfort MB, 2007, J PEDIATR-US, V151, P670, DOI 10.1016/j.jpeds.2007.05.010; Brion MA, 2007, J HUM HYPERTENS, V21, P283, DOI 10.1038/sj.jhh.1002152; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cederholm J, 2011, EUROPEAN J CARDIOVAS, V3, P21; Chen B, 2011, ASIA PAC J CLIN NUTR, V20, P557; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Cole T J, 2004, BMC Pediatr, V4, P6; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-24; Ekelund U, 2007, J CLIN ENDOCR METAB, V92, P98, DOI 10.1210/jc.2006-1071; Flynn JT, 2008, AM J HYPERTENS, V21, P605, DOI 10.1038/ajh.2008.159; Gundogdu Z, 2008, PUBLIC HEALTH NUTR, V11, P1085, DOI 10.1017/S1368980008002280; Guo SS, 2002, AM J CLIN NUTR, V76, P653, DOI 10.1093/ajcn/76.3.653; He Q, 2000, HYPERTENSION, V36, P165, DOI 10.1161/01.HYP.36.2.165; Hemachandra AH, 2007, PEDIATRICS, V119, pE1264, DOI 10.1542/peds.2005-2486; Hindmarsh PC, 2010, PEDIATRICS, V126, pE1507, DOI 10.1542/peds.2010-0358; Hof MHP, 2011, ANN HUM BIOL, V38, P544, DOI 10.3109/03014460.2011.576701; Lagstrom H, 2008, PEDIATRICS, V122, pE876, DOI 10.1542/peds.2007-2354; Lammi N, 2009, DIABETOLOGIA, V52, P408, DOI 10.1007/s00125-008-1244-0; Lloyd LJ, 2010, INT J OBESITY, V34, P18, DOI 10.1038/ijo.2009.61; Min JW, 2007, J HUM HYPERTENS, V21, P868, DOI 10.1038/sj.jhh.1002215; Mokha JS, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-73; Mook-Kanamori DO, 2011, EUR J ENDOCRINOL, V165, P623, DOI 10.1530/EJE-11-0067; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ong KK, 2009, J CLIN ENDOCR METAB, V94, P1527, DOI 10.1210/jc.2008-2489; Rolland-Cachera MF, 2006, INT J OBESITY, V30, pS11, DOI 10.1038/sj.ijo.0803514; ROLLANDCACHERA MF, 1984, AM J CLIN NUTR, V39, P129, DOI 10.1093/ajcn/39.1.129; Rosner B, 2008, AM J EPIDEMIOL, V167, P653, DOI 10.1093/aje/kwm348; Rotteveel J, 2008, PEDIATRICS, V122, P313, DOI 10.1542/peds.2007-2012; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Silverwood RJ, 2009, INT J OBESITY, V33, P929, DOI 10.1038/ijo.2009.108; Simonetti GD, 2011, CIRCULATION, V123, P292, DOI 10.1161/CIRCULATIONAHA.110.958769; Sinaiko AR, 1996, NEW ENGL J MED, V335, P1968, DOI 10.1056/NEJM199612263352607; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Singhal A, 2003, AM J CLIN NUTR, V77, P726, DOI 10.1093/ajcn/77.3.726; Sorof J, 2002, HYPERTENSION, V40, P441, DOI 10.1161/01.HYP.0000032940.33466.12; Stamatakis E, 2010, INT J OBESITY, V34, P41, DOI 10.1038/ijo.2009.217; Stettler N, 2010, CURR OPIN CLIN NUTR, V13, P294, DOI 10.1097/MCO.0b013e328337d7b9; Taylor RW, 2005, CURR OPIN CLIN NUTR, V8, P607, DOI 10.1097/01.mco.0000168391.60884.93; Toschke AM, 2010, ACTA PAEDIATR, V99, P24, DOI 10.1111/j.1651-2227.2009.01544.x; Tu YK, 2005, AM J EPIDEMIOL, V161, P27, DOI 10.1093/aje/kwi002; van Dijk AE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-251; van Eijsden M, 2011, INT J EPIDEMIOL, V40, P1176, DOI 10.1093/ije/dyq128; Wen XZ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-38; Whitaker RC, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e5; Williams SM, 2009, OBESITY, V17, P335, DOI 10.1038/oby.2008.547; Willig AL, 2010, AM J HYPERTENS, V23, P904, DOI 10.1038/ajh.2010.82; Zhao MF, 2002, INT J EPIDEMIOL, V31, P1043, DOI 10.1093/ije/31.5.1043	51	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80517	10.1371/journal.pone.0080517	http://dx.doi.org/10.1371/journal.pone.0080517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324605	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300025
J	Wu, LH; Cai, QQ; Dong, YW; Wang, R; He, BM; Qi, B; Xu, CJ; Wu, XZ				Wu, Li Hui; Cai, Qian Qian; Dong, Yi Wei; Wang, Rong; He, Bao Mei; Qi, Bing; Xu, Chang Jun; Wu, Xing Zhong			Decoy Oligonucleotide Rescues IGF1R Expression from MicroRNA-223 Suppression	PLOS ONE			English	Article							MESSENGER-RNA; CELLS; INHIBITION; TARGETS; GROWTH	A mature miRNA generally suppresses hundreds of mRNA targets. To evaluate the selective effect of synthetic oligonucleotide decoys on hsa-miR-223 activity, reporters containing 3' untranslated regions (UTR) of IGF1R, FOXO1, POLR3G, FOXO3, CDC27, FBXW7 and PAXIP1 mRNAs were constructed for the luciferase assay. The oligonucleotide decoys were designed and synthesized according to mature miR-223 sequence and its target mRNA sequence. Quantitative RT-PCR & western analysis were used to measure miR-223-targeted mRNA expression, Interestingly, apart from the antisense oligonucleotide, decoy nucleotides which were complementary to the 5', central or 3' region of mature miR-223 suppressed miR-223 targeting the 3' UTR of IGF1R, FOXO1, FOXO3, CDC27, POLR3G, and FBXW7 mRNAs and rescued the expression of these genes to varying degrees from miR-223 suppression at both mRNA and protein levels. All decoys had no effect on PAXIP1 which was not targeted by miR-223. The decoy 1 that was based on the sequence of IGF1R 3' UTR rescued the expression of IGF1R more significantly than other decoy nucleotides except the antisense decoy 4. Decoy 1 also rescued the expression of FOXO3 and POLR3G of which their 3' UTRs have similar binding sites for miR-223 with IGF1R 3' UTR. However decoy 1 failed to recover Sp1, CDC27 and FBXW7 expression. These data support that the sequence-specific decoy oligonucleotides might represent exogenous competing RNA which selectively inhibits microRNA targeting.	[Wu, Li Hui; Cai, Qian Qian; He, Bao Mei] Wenzhou Med Coll, Yu Ying Childrens Hosp, Dept Childrens Hlth Care, Wenzhou, Peoples R China; [Dong, Yi Wei; Wang, Rong; Qi, Bing; Wu, Xing Zhong] Fudan Univ, Dept Biochem & Mol Biol, Shanghai Med Coll, Key Lab Glycoconjugate Res,Minist Publ Hlth, Shanghai, Peoples R China; [Xu, Chang Jun] Guiyang Coll Tradit Chinese Med, Dept Biochem & Mol Biol, Guiyang, Guizhou Provinc, Peoples R China	Wenzhou Medical University; Fudan University; Guizhou University of Traditional Chinese Medicine	Wu, LH (corresponding author), Wenzhou Med Coll, Affiliated Hosp 1, Wenzhou, Peoples R China.	lhwu@wzmc.net; xz_wu@shmu.edu.cn		Wu, Xing Zhong/0000-0003-3506-5544	National Key Basic Research Program of China [2012CB822104]; Natural Science Foundation of China [81271505, 30970641, 31170767]; Shanghai Leading Academic Discipline Project [B110]	National Key Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by grants from National Key Basic Research Program of China (2012CB822104), the Natural Science Foundation of China (81271505, 30970641, 31170767), and the Shanghai Leading Academic Discipline Project (B110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brown JR, 2005, DRUG DISCOV TODAY, V10, P595, DOI 10.1016/S1359-6446(05)03399-4; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Enright AJ, 2004, GENOME BIOL, V5; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Grentzmann G, 1998, RNA, V4, P479; Hammond SM, 2006, TRENDS MOL MED, V12, P99, DOI 10.1016/j.molmed.2006.01.004; Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp040; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Jeyapalan Z, 2011, NUCLEIC ACIDS RES, V39, P3026, DOI 10.1093/nar/gkq1003; Jia CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027008; Kim VN, 2005, MOL CELLS, V19, P1; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Robertson Barbara, 2010, Silence, V1, P10, DOI 10.1186/1758-907X-1-10; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Vermeulen A, 2007, RNA, V13, P723, DOI 10.1261/rna.448107; Wu LH, 2012, FEBS LETT, V586, P1038, DOI 10.1016/j.febslet.2012.02.050; Wu XZ, 2006, CELL BIOL INT, V30, P672, DOI 10.1016/j.cellbi.2006.04.009; Xu YF, 2010, J BIOL CHEM, V285, P34439, DOI 10.1074/jbc.M110.152306; Yang TT, 1996, ANAL BIOCHEM, V241, P103, DOI 10.1006/abio.1996.0383; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	25	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82167	10.1371/journal.pone.0082167	http://dx.doi.org/10.1371/journal.pone.0082167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324762	Green Published, gold, Green Submitted			2022-12-25	WOS:000327949300137
J	Zhao, MY; Lee, WP; Garrison, EP; Marth, GT				Zhao, Mengyao; Lee, Wan-Ping; Garrison, Erik P.; Marth, Gabor T.			SSW Library: An SIMD Smith-Waterman C/C plus plus Library for Use in Genomic Applications	PLOS ONE			English	Article							DATABASE SEARCHES; READ ALIGNMENT; INSTRUCTIONS; SCALE; MAP	Background: The Smith-Waterman algorithm, which produces the optimal pairwise alignment between two sequences, is frequently used as a key component of fast heuristic read mapping and variation detection tools for next-generation sequencing data. Though various fast Smith-Waterman implementations are developed, they are either designed as monolithic protein database searching tools, which do not return detailed alignment, or are embedded into other tools. These issues make reusing these efficient Smith-Waterman implementations impractical. Results: To facilitate easy integration of the fast Single-Instruction-Multiple-Data Smith-Waterman algorithm into third-party software, we wrote a C/C++ library, which extends Farrar's Striped Smith-Waterman (SSW) to return alignment information in addition to the optimal Smith-Waterman score. In this library we developed a new method to generate the full optimal alignment results and a suboptimal score in linear space at little cost of efficiency. This improvement makes the fast Single-Instruction-Multiple-Data Smith-Waterman become really useful in genomic applications. SSW is available both as a C/C++ software library, as well as a stand-alone alignment tool at: https://github.com/mengyao/Complete-Striped-Smith-Waterman-Library. Conclusions: The SSW library has been used in the primary read mapping tool MOSAIK, the split-read mapping program SCISSORS, the MEI detector TANGRAM, and the read-overlap graph generation program RZMBLR. The speeds of the mentioned software are improved significantly by replacing their ordinary Smith-Waterman or banded Smith-Waterman module with the SSW Library.	[Zhao, Mengyao; Lee, Wan-Ping; Garrison, Erik P.; Marth, Gabor T.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA	Boston College	Zhao, MY (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	marth@bc.edu; zhaomengyao@gmail.com	Lee, Wan-Ping/ABD-4571-2021	Lee, Wan-Ping/0000-0002-5305-1181	National Human Genome Research Institute [R01 HG4719]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006513, R01HG004719] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work has been funded by grant R01 HG4719 from the National Human Genome Research Institute to GTM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL F, 1990, J MOL BIOL, V215, P403; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Farrar M, 2007, BIOINFORMATICS, V23, P156, DOI 10.1093/bioinformatics/btl582; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Korpar M, 2013, BIOINFORMATICS, V29, P2494, DOI 10.1093/bioinformatics/btt410; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee W-P, 2013, ARXIV13091149; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu YC, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-117; Liu Yongchao, 2010, BMC Res Notes, V3, P93, DOI 10.1186/1756-0500-3-93; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Rognes T, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-221; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Szalkowski Adam, 2008, BMC Res Notes, V1, P107, DOI 10.1186/1756-0500-1-107; Wozniak A, 1997, COMPUT APPL BIOSCI, V13, P145	16	86	87	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82138	10.1371/journal.pone.0082138	http://dx.doi.org/10.1371/journal.pone.0082138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324759	gold, Green Published, Green Submitted			2022-12-25	WOS:000327949300134
J	Lv, JJ; Liu, P; Wang, Y; Gao, BQ; Chen, P; Li, J				Lv, Jianjian; Liu, Ping; Wang, Yu; Gao, Baoquan; Chen, Ping; Li, Jian			Transcriptome Analysis of Portunus trituberculatus in Response to Salinity Stress Provides Insights into the Molecular Basis of Osmoregulation	PLOS ONE			English	Article							EPITHELIAL POTENTIAL DIFFERENCE; FREE AMINO-ACIDS; SWIMMING CRAB; CARCINUS-MAENAS; NA+/K+-ATPASE; RNA-SEQ; WATER TRANSPORT; PLASMA-MEMBRANE; EURYHALINE CRAB; SMALL GTPASES	Background: The swimming crab, Portunus trituberculatus, which is naturally distributed in the coastal waters of Asia-Pacific countries, is an important farmed species in China. Salinity is one of the most important abiotic factors that influence not only the distribution and abundance of crustaceans, it is also an important factor for artificial propagation of the crab. To better understand the interaction between salinity stress and osmoregulation, we performed a transcriptome analysis in the gills of Portunus trituberculatus challenged with salinity stress, using the Illumina Deep Sequencing technology. Results: We obtained 27,696,835, 28,268,353 and 33,901,271 qualified Illumina read pairs from low salinity challenged (LC), non-challenged (NC), and high salinity challenged (HC) Portunus trituberculatus cDNA libraries, respectively. The overall de novo assembly of cDNA sequence data generated 94,511 unigenes, with an average length of 644 bp. Comparative genomic analysis revealed that 1,705 genes differentially expressed in salinity stress compared to the controls, including 615 and 1,516 unigenes in NC vs LC and NC vs HC respectively. GO functional enrichment analysis results showed some differentially expressed genes were involved in crucial processes related to osmoregulation, such as ion transport processes, amino acid metabolism and synthesis processes, proteolysis process and chitin metabolic process. Conclusion: This work represents the first report of the utilization of the next generation sequencing techniques for transcriptome analysis in Portunus trituberculatus and provides valuable information on salinity adaptation mechanism. Results reveal a substantial number of genes modified by salinity stress and a few important salinity acclimation pathways, which will serve as an invaluable resource for revealing the molecular basis of osmoregulation in Portunus trituberculatus. In addition, the most comprehensive sequences of transcripts reported in this study provide a rich source for identification of novel genes in the crab.	[Lv, Jianjian; Liu, Ping; Wang, Yu; Gao, Baoquan; Chen, Ping; Li, Jian] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Minist Agr, Key Lab Sustainable Utilizat Marine Fisheries Res, Qingdao, Peoples R China; [Wang, Yu] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Shanghai Ocean University	Li, J (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Minist Agr, Key Lab Sustainable Utilizat Marine Fisheries Res, Qingdao, Peoples R China.	jianjian997@163.com			National High Technology Research and Development Program of China [2012AA10A409]; Projects of independent innovation in Shandong Province [2013CXC80202]; Agricultural science and Technology Achievements Transformation Fund Project of the Ministry of science and technology [2013GB23260589]; Project development of science and technology in Shandong Province [2011GHY11526]; National Science Foundation for Post-doctoral Scientists of China [2013M531657]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Projects of independent innovation in Shandong Province; Agricultural science and Technology Achievements Transformation Fund Project of the Ministry of science and technology; Project development of science and technology in Shandong Province; National Science Foundation for Post-doctoral Scientists of China(China Postdoctoral Science FoundationNational Natural Science Foundation of China (NSFC))	Financial support for this study was provided by the National High Technology Research and Development Program of China (Project 2012AA10A409), Projects of independent innovation in Shandong Province (Project 2013CXC80202), Agricultural science and Technology Achievements Transformation Fund Project of the Ministry of science and technology (Project 2013GB23260589), Project development of science and technology in Shandong Province (Project 2011GHY11526) and the National Science Foundation for Post-doctoral Scientists of China (Project 2013M531657). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Azad AK, 2008, PLANT CELL PHYSIOL, V49, P1196, DOI 10.1093/pcp/pcn095; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Cerda J, 2010, J EXP ZOOL PART A, V313A, P623, DOI 10.1002/jez.634; Charmantier G., 2008, OSMOTIC IONIC REGULA; Dai A.Y., 1986, MARINE CRABS CHINA S; DALLA VIA GJ, 1986, AQUACULTURE, V55, P297, DOI 10.1016/0044-8486(86)90170-5; DALLA VIA J, 1986, AQUACULTURE, V55, P307, DOI 10.1016/0044-8486(86)90171-7; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dooley PC, 2000, COMP BIOCHEM PHYS A, V127, P155, DOI 10.1016/S1095-6433(00)00247-6; DREWS G, 1987, J COMP PHYSIOL B, V157, P345, DOI 10.1007/BF00693361; Freire CA, 2008, COMP BIOCHEM PHYS A, V151, P272, DOI 10.1016/j.cbpa.2007.05.008; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053915; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; Henry RP, 2002, J EXP ZOOL, V292, P595, DOI 10.1002/jez.10075; Huang QS, 2010, FISH SHELLFISH IMMUN, V29, P75, DOI 10.1016/j.fsi.2010.02.014; Huong DTT, 2001, COMP BIOCHEM PHYS A, V128, P317, DOI 10.1016/S1095-6433(00)00310-X; Jayasundara N, 2007, J EXP BIOL, V210, P2070, DOI 10.1242/jeb.004309; Jiang Shan, 2011, Journal of Fisheries of China, V35, P1475; Johnston M, 2011, SILENCE, V2, P1, DOI [10.1186/1758-907X-2-1, DOI 10.1186/1758-907X-2-1.PUBMED:21247442]; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; KRIPPEITDREWS P, 1989, J COMP PHYSIOL B, V159, P43, DOI 10.1007/BF00692682; Kwong RWM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070764; LANG MA, 1987, AM J PHYSIOL, V252, pR768, DOI 10.1152/ajpregu.1987.252.4.R768; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058627, 10.1371/journal.pone.0076131]; Liu L, 2012, AQUACULTURE, V344, P66, DOI 10.1016/j.aquaculture.2012.01.034; Liu Y, 2011, FISH SHELLFISH IMMUN, V31, P29, DOI 10.1016/j.fsi.2011.02.016; Lu Y L, 2012, J FISH SCI CHIN, V19, P237; Lu YunLiang, 2012, Journal of Fisheries of China, V36, P1392; Luquet CM, 2005, J EXP BIOL, V208, P3627, DOI 10.1242/jeb.01820; [吕富 Lv Fu], 2010, [海洋湖沼通报, Transactions of Oceanology and Limnology], P137; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Maresova L, 2012, FEMS YEAST RES, V12, P332, DOI 10.1111/j.1567-1364.2011.00780.x; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; McNamara JC, 2012, J COMP PHYSIOL B, V182, P997, DOI 10.1007/s00360-012-0665-8; Meng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058563; Mirzaei M, 2012, PROTEOMICS, V12, P864, DOI 10.1002/pmic.201100389; MORRIS RJ, 1982, COMP BIOCHEM PHYS A, V72, P497, DOI 10.1016/0300-9629(82)90114-1; Nie QH, 2012, PLOS ONE, P7; ONKEN H, 1995, J EXP BIOL, V198, P767; PEQUEUX A, 1995, J CRUSTACEAN BIOL, V15, P1, DOI 10.2307/1549010; Proespraiwong P, 2010, COMP BIOCHEM PHYS B, V156, P86, DOI 10.1016/j.cbpb.2010.02.007; Rainbow PS, 2001, J EXP MAR BIOL ECOL, V264, P1, DOI 10.1016/S0022-0981(01)00289-1; Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547; Romano N, 2012, AQUACULTURE, V334, P12, DOI 10.1016/j.aquaculture.2011.12.035; Salma U, 2012, COMP BIOCHEM PHYS B, V161, P197, DOI 10.1016/j.cbpb.2011.11.005; Sanchez CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-626; Santoni V, 2003, BIOCHEM J, V373, P289, DOI 10.1042/BJ20030159; Shikata Y, 2005, EXP CELL RES, V304, P40, DOI 10.1016/j.yexcr.2004.11.001; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; [隋延鸣 Sui Yanming], 2012, [大连海洋大学学报, Journal of Dalian Ocean University], V27, P398; TAN CH, 1981, COMP BIOCHEM PHYS A, V70, P485, DOI 10.1016/0300-9629(81)92559-7; Tan SH, 2000, MAR BIOTECHNOL, V2, P126; Tipsmark CK, 2010, J EXP BIOL, V213, P368, DOI 10.1242/jeb.034785; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; Towle DW, 2011, COMP BIOCHEM PHYS D, V6, P115, DOI 10.1016/j.cbd.2010.11.001; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Tsai JR, 2007, J EXP BIOL, V210, P620, DOI 10.1242/jeb.02684; Wang SY, 2012, FISH SHELLFISH IMMUN, V32, P544, DOI 10.1016/j.fsi.2012.01.002; Wang SY, 2012, FISH SHELLFISH IMMUN, V32, P331, DOI 10.1016/j.fsi.2011.11.025; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weihrauch D, 2002, J EXP BIOL, V205, P2765; Xu QH, 2011, MAR BIOL, V158, P2161, DOI 10.1007/s00227-011-1721-8; Xu QH, 2010, J EXP MAR BIOL ECOL, V394, P105, DOI 10.1016/j.jembe.2010.08.002; Young M. D., 2010, METHOD GENE ONTOLOGY; Yu CG, 2003, J ZHEJIANG OCEAN U, V22, P108; Zeng DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057515; Zheng Ping-ping, 2010, Fisheries Science (Liaoning), V29, P634	71	97	103	5	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82155	10.1371/journal.pone.0082155	http://dx.doi.org/10.1371/journal.pone.0082155			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312639	gold, Green Published, Green Submitted			2022-12-25	WOS:000327947800087
J	Wei, WJ; Xiong, JY; Zhang, YP				Wei, Wenjuan; Xiong, Jianyin; Zhang, Yinping			Influence of Precision of Emission Characteristic Parameters on Model Prediction Error of VOCs/Formaldehyde from Dry Building Material	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; INITIAL EMITTABLE CONCENTRATION; PARTITION-COEFFICIENTS; DIFFUSION-COEFFICIENTS; VOC EMISSIONS; FORMALDEHYDE; TEMPERATURE	Mass transfer models are useful in predicting the emissions of volatile organic compounds (VOCs)and formaldehyde from building materials in indoor environments. They are also useful for human exposure evaluation and in sustainable building design. The measurement errors in the emission characteristic parameters in these mass transfer models, i.e., the initial emittable concentration (C-0), the diffusion coefficient (D), and the partition coefficient (K), can result in errors in predicting indoor VOC and formaldehyde concentrations. These errors have not yet been quantitatively well analyzed in the literature. This paper addresses this by using modelling to assess these errors for some typical building conditions. The error in C-0, as measured in environmental chambers and applied to a reference living room in Beijing, has the largest influence on the model prediction error in indoor VOC and formaldehyde concentration, while the error in K has the least effect. A correlation between the errors in D, K, and C-0 and the error in the indoor VOC and formaldehyde concentration prediction is then derived for engineering applications. In addition, the influence of temperature on the model prediction of emissions is investigated. It shows the impact of temperature fluctuations on the prediction errors in indoor VOC and formaldehyde concentrations to be less than 7% at 23 +/- 0.5 degrees C and less than 30% at 23 +/- 2 degrees C.	[Wei, Wenjuan; Zhang, Yinping] Tsinghua Univ, Dept Bldg Sci, Beijing 100084, Peoples R China; [Xiong, Jianyin] Beijing Inst Technol, Sch Mech Engn, Beijing 100081, Peoples R China	Tsinghua University; Beijing Institute of Technology	Zhang, YP (corresponding author), Tsinghua Univ, Dept Bldg Sci, Beijing 100084, Peoples R China.	zhangyp@tsinghua.edu.cn	Wei, Wenjuan/AAE-2569-2022; Zhang, Yinping/B-5187-2012	Wei, Wenjuan/0000-0002-8232-8186; Zhang, Yinping/0000-0001-9175-7890	National Natural Science Foundation of China [50725620, 51106011]; Ministry of Science and Technology of China [2012BAJ02B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This research was supported by the National Natural Science Foundation of China (No. 50725620 and No. 51106011) and by the 12th 5-year key project, Ministry of Science and Technology of China (No. 2012BAJ02B01). (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, 18584 GB; [Anonymous], 2007, D6670 ASTM; Choi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013423; Cox SS, 2010, INDOOR AIR, V20, P424, DOI 10.1111/j.1600-0668.2010.00666.x; Cox SS, 2001, J AIR WASTE MANAGE, V51, P1195, DOI 10.1080/10473289.2001.10464349; Cox SS, 2001, ATMOS ENVIRON, V35, P3823, DOI 10.1016/S1352-2310(01)00175-3; de Bortoli M, 1999, INDOOR AIR, V9, P103; Deng BQ, 2004, ATMOS ENVIRON, V38, P1173, DOI 10.1016/j.atmosenv.2003.11.009; Deng QQ, 2009, ATMOS ENVIRON, V43, P2080, DOI 10.1016/j.atmosenv.2008.12.052; Haghighat F, 2002, INDOOR AIR, V12, P81, DOI 10.1034/j.1600-0668.2002.1e008.x; He ZK, 2010, INDOOR BUILT ENVIRON, V19, P465, DOI 10.1177/1420326X10373332; Howard-Reed C, 2011, BUILD ENVIRON, V46, P1504, DOI 10.1016/j.buildenv.2011.01.024; Li F, 2005, BUILD ENVIRON, V40, P1366, DOI 10.1016/j.buildenv.2004.10.016; Liu Z, 2013, BUILD ENVIRON, V64, P7, DOI 10.1016/j.buildenv.2013.02.012; Mlynar MF, 1998, TAPPI J, V81, P185; Oppl R, 2008, GEFAHRST REINHALT L, V68, P83; Rappengluck B, 2006, ATMOS ENVIRON, V40, P7508, DOI 10.1016/j.atmosenv.2006.07.016; Wang XK, 2011, CHINESE SCI BULL, V56, P222, DOI 10.1007/s11434-010-4254-5; Wang XK, 2009, J AIR WASTE MANAGE, V59, P819, DOI 10.3155/1047-3289.59.7.819; Wei WJ, 2013, ENVIRON SCI TECHNOL, V47, P7848, DOI 10.1021/es400721j; Wei WJ, 2012, BUILD ENVIRON, V57, P282, DOI 10.1016/j.buildenv.2012.05.008; WHO, 2000, GUID AIR QUAL; Xiong JY, 2008, ATMOS ENVIRON, V42, P5278, DOI 10.1016/j.atmosenv.2008.02.062; Xiong JY, 2013, ENVIRON SCI TECHNOL, V47, P8540, DOI 10.1021/es401173d; Xiong JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049342; Xiong JY, 2011, ENVIRON SCI TECHNOL, V45, P10111, DOI 10.1021/es202117w; Xiong JY, 2011, ENVIRON SCI TECHNOL, V45, P3584, DOI 10.1021/es200277p; Xu Y, 2003, ATMOS ENVIRON, V37, P2497, DOI 10.1016/S1352-2310(03)00160-2; Yao Y, 2011, THESIS TSINGHUA U; Yao Y, 2011, ATMOS ENVIRON, V45, P5602, DOI 10.1016/j.atmosenv.2011.04.033; Yu CWF, 2013, INDOOR BUILT ENVIRON, V22, P21, DOI 10.1177/1420326X12474966; Zhang YP, 2007, ATMOS ENVIRON, V41, P3203, DOI 10.1016/j.atmosenv.2006.10.081	32	7	8	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e80736	10.1371/journal.pone.0080736	http://dx.doi.org/10.1371/journal.pone.0080736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312497	gold, Green Submitted, Green Published			2022-12-25	WOS:000327947800019
J	Davis, J; Kwong, JQ; Kitsis, RN; Molkentin, JD				Davis, Jennifer; Kwong, Jennifer Q.; Kitsis, Richard N.; Molkentin, Jeffery D.			Apoptosis Repressor with a CARD Domain (ARC) Restrains Bax-Mediated Pathogenesis in Dystrophic Skeletal Muscle	PLOS ONE			English	Article							CASPASE RECRUITMENT DOMAIN; MITOCHONDRIAL PERMEABILITY TRANSITION; CONGENITAL MUSCULAR-DYSTROPHY; CELL-DEATH; MDX MICE; REPERFUSION INJURY; DEFICIENT MUSCLE; CALCIUM INFLUX; PROTEIN ARC; NECROSIS	Myofiber wasting in muscular dystrophy has largely been ascribed to necrotic cell death, despite reports identifying apoptotic markers in dystrophic muscle. Here we set out to identify the contribution of canonical apoptotic pathways to skeletal muscle degeneration in muscular dystrophy by genetically deleting a known inhibitor of apoptosis, apoptosis repressor with a card domain (Arc), in dystrophic mouse models. Nol3 (Arc protein) genetic deletion in the dystrophic Sgcd or Lama2 null backgrounds showed exacerbated skeletal muscle pathology with decreased muscle performance compared with single null dystrophic littermate controls. The enhanced severity of the dystrophic phenotype associated with Nol3 deletion was caspase independent but dependent on the mitochondria permeability transition pore (MPTP), as the inhibitor Debio-025 partially rescued skeletal muscle pathology in Nol3(-/-)Sgcd(-/-) double targeted mice. Mechanistically, Nol3(-/-)Sgcd(-/-) mice showed elevated total and mitochondrial Bax protein levels, as well as greater mitochondrial swelling, suggesting that Arc normally restrains the cell death effects of Bax in skeletal muscle. Indeed, knockdown of Arc in mouse embryonic fibroblasts caused an increased sensitivity to cell death that was fully blocked in Bax Bak1 (genes encoding Bax and Bak) double null fibroblasts. Thus Arc deficiency in dystrophic muscle exacerbates disease pathogenesis due to a Bax-mediated sensitization of mitochondria-dependent death mechanisms.	[Davis, Jennifer; Kwong, Jennifer Q.; Molkentin, Jeffery D.] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45221 USA; [Kitsis, Richard N.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Kitsis, Richard N.] Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Bronx, NY USA; [Molkentin, Jeffery D.] Howard Hughes Med Inst, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute	Molkentin, JD (corresponding author), Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45221 USA.	Jeff.Molkentin@cchmc.org	Kwong, Jennifer/L-4348-2019	DAVIS, JENNIFER/0000-0003-2380-1321; Molkentin, Jeffery/0000-0002-3558-6529	National Institutes of Health; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL119353] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS072027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Grants from the National Institutes of Health (JDM and RK) and the Howard Hughes Medical Institute (JDM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abmayr S, 2004, HUM MOL GENET, V13, P213, DOI 10.1093/hmg/ddh018; Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Anversa P, 1998, BASIC RES CARDIOL, V93, P8; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; BRAY GM, 1970, ACTA NEUROPATHOL, V15, P34, DOI 10.1007/BF00690687; CAULFIELD JB, 1966, ANN NY ACAD SCI, V138, P151; CharriautMarlangue C, 1995, NEUROREPORT, V7, P61, DOI 10.1097/00001756-199512290-00014; Chatterjee S, 2003, J THORAC CARDIOV SUR, V125, P1461, DOI 10.1016/S0022-5223(02)73229-7; Donath S, 2006, CIRCULATION, V113, P1203, DOI 10.1161/CIRCULATIONAHA.105.576785; Ekhterae D, 1999, CIRC RES, V85, pE70; Foo RSY, 2007, J BIOL CHEM, V282, P5529, DOI 10.1074/jbc.M609046200; Girgenrath M, 2004, J CLIN INVEST, V114, P1635, DOI 10.1172/JCI200422928; Goldstein JA, 2010, J GEN PHYSIOL, V136, P29, DOI 10.1085/jgp.201010436; Goonasekera SA, 2011, J CLIN INVEST, V121, P1044, DOI 10.1172/JCI43844; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; Gustafsson AB, 2004, J BIOL CHEM, V279, P21233, DOI 10.1074/jbc.M400695200; Hack AA, 2000, J CELL SCI, V113, P2535; Hack AA, 1998, J CELL BIOL, V142, P1279, DOI 10.1083/jcb.142.5.1279; Hochhauser E, 2003, AM J PHYSIOL-HEART C, V284, pH2351, DOI 10.1152/ajpheart.00783.2002; Honda A, 2007, J MUSCLE RES CELL M, V28, P243, DOI 10.1007/s10974-007-9122-9; Kajstura J, 1996, LAB INVEST, V74, P86; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Karch J, 2013, ELIFE, V2, DOI 10.7554/eLife.00772; Koseki T, 1998, P NATL ACAD SCI USA, V95, P5156, DOI 10.1073/pnas.95.9.5156; Kuang W, 1998, EXP CELL RES, V241, P117, DOI 10.1006/excr.1998.4025; MATSUDA R, 1995, J BIOCHEM-TOKYO, V118, P959, DOI 10.1093/jb/118.5.959; Medina-Ramirez CM, 2011, CANCER RES, V71, P7705, DOI 10.1158/0008-5472.CAN-11-2192; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; Millay DP, 2009, P NATL ACAD SCI USA, V106, P19023, DOI 10.1073/pnas.0906591106; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nam YJ, 2004, MOL CELL, V15, P901, DOI 10.1016/j.molcel.2004.08.020; Nam YJ, 2007, J BIOL CHEM, V282, P5522, DOI 10.1074/jbc.M609186200; Neuss M, 2001, J BIOL CHEM, V276, P33915, DOI 10.1074/jbc.M104080200; Sandri M, 2001, J NEUROPATH EXP NEUR, V60, P302, DOI 10.1093/jnen/60.3.302; SMITH J, 1995, CELL DEATH DIFFER, V2, P243; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; TIDBALL JG, 1995, J CELL SCI, V108, P2197; TURNER PR, 1991, J CELL BIOL, V115, P1701, DOI 10.1083/jcb.115.6.1701; Watchko JF, 2002, J APPL PHYSIOL, V93, P407, DOI 10.1152/japplphysiol.01242.2001; Whelan RS, 2012, P NATL ACAD SCI USA, V109, P6566, DOI 10.1073/pnas.1201608109; Wissing ER, 2010, NEUROMUSCULAR DISORD, V20, P753, DOI 10.1016/j.nmd.2010.06.016; WOO M, 1987, J NEUROL SCI, V82, P111, DOI 10.1016/0022-510X(87)90011-6; Yasuda S, 2005, NATURE, V436, P1025, DOI 10.1038/nature03844; Zaiman AL, 2011, CIRCULATION, V124, P2533, DOI 10.1161/CIRCULATIONAHA.111.034512	44	6	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82053	10.1371/journal.pone.0082053	http://dx.doi.org/10.1371/journal.pone.0082053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312627	Green Published, gold, Green Submitted			2022-12-25	WOS:000327944500117
J	Eakin, K; Li, YZ; Chiang, YH; Hoffer, BJ; Rosenheim, H; Greig, NH; Miller, JP				Eakin, Katharine; Li, Yazhou; Chiang, Yung-Hsiao; Hoffer, Barry J.; Rosenheim, Hilary; Greig, Nigel H.; Miller, Jonathan P.			Exendin-4 Ameliorates Traumatic Brain Injury-Induced Cognitive Impairment in Rats	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; CONTROLLED CORTICAL IMPACT; TYPE-2 DIABETES-MELLITUS; MORRIS WATER MAZE; ALZHEIMERS-DISEASE; SIGNALING PATHWAY; GENE-EXPRESSION; BINDING-SITES; UNITED-STATES; AMYLOID-BETA	Traumatic brain injury represents a major public health issue that affects 1.7 million Americans each year and is a primary contributing factor (30.5%) of all injury-related deaths in the United States. The occurrence of traumatic brain injury is likely underestimated and thus has been termed "a silent epidemic". Exendin-4 is a long-acting glucagon-like peptide-1 receptor agonist approved for the treatment of type 2 diabetes mellitus that not only effectively induces glucose-dependent insulin secretion to regulate blood glucose levels but also reduces apoptotic cell death of pancreatic beta-cells. Accumulating evidence also supports a neurotrophic and neuroprotective role of glucagon-like peptide-1 in an array of cellular and animal neurodegeneration models. In this study, we evaluated the neuroprotective effects of Exendin-4 using a glutamate toxicity model in vitro and fluid percussion injury in vivo. We found neuroprotective effects of Exendin-4 both in vitro, using markers of cell death, and in vivo, using markers of cognitive function, as assessed by Morris Water Maze. In combination with the reported benefits of ex-4 in other TBI models, these data support repositioning of Exendin-4 as a potential treatment for traumatic brain injury.	[Eakin, Katharine; Hoffer, Barry J.; Rosenheim, Hilary; Miller, Jonathan P.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH 44106 USA; [Li, Yazhou; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Lab Translat Gerontol, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Chiang, Yung-Hsiao] Taipei Med Univ, Grad Inst Neural Regenerat Med, PhD Program Neural Regenerat Med, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan	Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Miller, JP (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH 44106 USA.	jonathan.p.miller@case.edu		Miller, Jonathan/0000-0001-5441-1751	Intramural Research Program of the National Institute on Aging, National Institutes of Health; Lincoln Master Clinician in Neurosurgery Award, USPHS [NS070825]; National Science Council of Taiwan [NSC98-2321-B-038-002-MY3]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000333] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Lincoln Master Clinician in Neurosurgery Award, USPHS; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health; the Lincoln Master Clinician in Neurosurgery Award to Jonathan Miller, USPHS # NS070825; and the National Science Council of Taiwan to Yung-Hsiao Chiang, #NSC98-2321-B-038-002-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bak AM, 2011, EXPERT OPIN THER TAR, V15, P1153, DOI 10.1517/14728222.2011.600691; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; CDC, 2010, INJURY PREVENTION CO; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Faul MD, 2010, TRAUMATIC BRAIN INJU, P2002; Finset A, 1999, PSYCHOSOM MED, V61, P576, DOI 10.1097/00006842-199907000-00024; Gallwitz B, 2011, DRUGS, V71, P1675, DOI 10.2165/11592810-000000000-00000; Gilman CP, 2003, J NEUROCHEM, V87, P1137, DOI 10.1046/j.1471-4159.2003.02073.x; GOKE R, 1995, NEUROENDOCRINOLOGY, V62, P130, DOI 10.1159/000126997; GOKE R, 1995, EUR J NEUROSCI, V7, P2294, DOI 10.1111/j.1460-9568.1995.tb00650.x; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Heile AMB, 2009, NEUROSCI LETT, V463, P176, DOI 10.1016/j.neulet.2009.07.071; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Holscher C, 2010, VITAM HORM, V84, P331, DOI [10.1016/B978-0-12-381517-0.00013-8, 10.1016/S0083-6729(10)84005-1]; Holst JJ, 2011, CURR MED RES OPIN, V27, P547, DOI 10.1185/03007995.2010.549466; Kastin AJ, 2003, INT J OBESITY, V27, P313, DOI 10.1038/sj.ijo.0802206; Leker RR, 2002, ACTA NEUROCHIR SUPPL, V83, P49; Lenzlinger PM, 2001, J NEUROTRAUM, V18, P479, DOI 10.1089/089771501300227288; Li H, 2010, NEUROSCI LETT, V486, P38, DOI 10.1016/j.neulet.2010.09.040; Li YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032008; Li YZ, 2010, J NEUROCHEM, V113, P1621, DOI 10.1111/j.1471-4159.2010.06731.x; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Luciani P, 2010, CELL MOL LIFE SCI, V67, P3711, DOI 10.1007/s00018-010-0398-3; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Perry T, 2003, TRENDS PHARMACOL SCI, V24, P377, DOI 10.1016/S0165-6147(03)00160-3; Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481; Perry T, 2007, EXP NEUROL, V203, P293, DOI 10.1016/j.expneurol.2006.09.028; Rachmany L, 2012, AGE DORDR; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Salcedo I, 2012, BRIT J PHARMACOL, V166, P1586, DOI 10.1111/j.1476-5381.2012.01971.x; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	58	50	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82016	10.1371/journal.pone.0082016	http://dx.doi.org/10.1371/journal.pone.0082016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312624	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500114
J	Godin-Heymann, N; Wang, YH; Slee, E; Lu, X				Godin-Heymann, Nadia; Wang, Yihua; Slee, Elizabeth; Lu, Xin			Phosphorylation of ASPP2 by RAS/MAPK Pathway Is Critical for Its Full Pro-Apoptotic Function	PLOS ONE			English	Article							STIMULATING PROTEIN; ONCOGENIC RAS; TUMOR-GROWTH; CANCER; P53; EXPRESSION; KINASE; ACTIVATION; CARCINOMA; REGION	We reported recently that apoptosis-stimulating protein of p53 (ASPP) 2, an activator of p53, co-operates with oncogenic RAS to enhance the transcription and apoptotic function of p53. However, the detailed mechanism remains unknown. Here we show that ASPP2 is a novel substrate of mitogen-activated protein kinase (MAPK). Phosphorylation of ASPP2 by MAPK is required for RAS-induced increased binding to p53 and increased transactivation of pro-apoptotic genes. In contrast, an ASPP2 phosphorylation mutant exhibits reduced p53 binding and fails to enhance transactivation and apoptosis. Thus phosphorylation of ASPP2 by RAS/MAPK pathway provides a novel link between RAS and p53 in regulating apoptosis.	[Godin-Heymann, Nadia; Wang, Yihua; Slee, Elizabeth; Lu, Xin] Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res Ltd, Oxford, England	Ludwig Institute for Cancer Research; University of Oxford	Lu, X (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res Ltd, Oxford, England.	xin.lu@ludwig.ox.ac.uk		Wang, Yihua/0000-0001-5561-0648; Lu, Xin/0000-0002-6587-1152	Ludwig Institute for Cancer Research Ltd.	Ludwig Institute for Cancer Research Ltd.	This work is supported by the Ludwig Institute for Cancer Research Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cong WL, 2010, CURR BIOL, V20, P1408, DOI 10.1016/j.cub.2010.06.024; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Kampa KM, 2009, P NATL ACAD SCI USA, V106, P4390, DOI 10.1073/pnas.0809080106; Liu ZJ, 2005, FEBS LETT, V579, P1587, DOI 10.1016/j.febslet.2005.01.069; Lossos IS, 2002, LEUKEMIA LYMPHOMA, V43, P2309, DOI 10.1080/1042819021000040017; Russo A, 2005, ANN ONCOL, V16, P44, DOI 10.1093/annonc/mdi907; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Sapkota GP, 2002, BIOCHEM J, V362, P481, DOI 10.1042/0264-6021:3620481; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Sgroi DC, 1999, CANCER RES, V59, P5656; Sottocornola R, 2010, DEV CELL, V19, P126, DOI 10.1016/j.devcel.2010.06.003; Sridhar SS, 2005, MOL CANCER THER, V4, P677, DOI 10.1158/1535-7163.MCT-04-0297; Trigiante G, 2006, NAT REV CANCER, V6, P217, DOI 10.1038/nrc1818; Vives V, 2006, GENE DEV, V20, P1262, DOI 10.1101/gad.374006; Wang Y, 2013, CELL DEATH DIFFER, V20, P525, DOI 10.1038/cdd.2013.3; Wang Y, 2010, ONCOGENE, V29, P4658, DOI 10.1038/onc.2010.218; Wang YH, 2012, P NATL ACAD SCI USA, V109, P13325, DOI 10.1073/pnas.1120193109; Wang ZP, 2013, P NATL ACAD SCI USA, V110, P312, DOI 10.1073/pnas.1201514110; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhao J, 2010, HEPATOLOGY, V51, P142, DOI 10.1002/hep.23247	21	11	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82022	10.1371/journal.pone.0082022	http://dx.doi.org/10.1371/journal.pone.0082022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312625	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000327944500115
J	Gustafsdottir, SM; Ljosa, V; Sokolnicki, KL; Wilson, JA; Walpita, D; Kemp, MM; Seiler, KP; Carrel, HA; Golub, TR; Schreiber, SL; Clemons, PA; Carpenter, AE; Shamji, AF				Gustafsdottir, Sigrun M.; Ljosa, Vebjorn; Sokolnicki, Katherine L.; Wilson, J. Anthony; Walpita, Deepika; Kemp, Melissa M.; Seiler, Kathleen Petri; Carrel, Hyman A.; Golub, Todd R.; Schreiber, Stuart L.; Clemons, Paul A.; Carpenter, Anne E.; Shamji, Alykhan F.			Multiplex Cytological Profiling Assay to Measure Diverse Cellular States	PLOS ONE			English	Article							RESPONSES; DATABASE; LIGAND; CELLS	Computational methods for image-based profiling are under active development, but their success hinges on assays that can capture a wide range of phenotypes. We have developed a multiplex cytological profiling assay that "paints the cell" with as many fluorescent markers as possible without compromising our ability to extract rich, quantitative profiles in high throughput. The assay detects seven major cellular components. In a pilot screen of bioactive compounds, the assay detected a range of cellular phenotypes and it clustered compounds with similar annotated protein targets or chemical structure based on cytological profiles. The results demonstrate that the assay captures subtle patterns in the combination of morphological labels, thereby detecting the effects of chemical compounds even though their targets are not stained directly. This image-based assay provides an unbiased approach to characterize compound-and disease-associated cell states to support future probe discovery.	[Clemons, Paul A.] Broad Inst Harvard, Cambridge, MA USA; MIT, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Clemons, PA (corresponding author), Broad Inst Harvard, Cambridge, MA USA.	pclemons@broadinstitute.org; anne@broadinstitute.org; ashamji@broadinstitute.org	Carpenter, Anne/C-4982-2008	Carpenter, Anne/0000-0003-1555-8261	National Science Foundation [DBI 1148823]; National Institutes of Health [U54 HG005032]; US National Institutes of Health [RL1HG004671];  [RL1CA133834];  [RL1GM084437];  [UL1RR024924]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024924] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG005032, RL1HG004671] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Science Foundation CAREER award DBI 1148823 (AEC), and National Institutes of Health grant U54 HG005032 (SLS). KPS and PAC were supported in part by US National Institutes of Health Genomics Based Drug Discovery-Target ID Project grant RL1HG004671, which is administratively linked to the US National Institutes of Health grants RL1CA133834, RL1GM084437, and UL1RR024924. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CL, 2006, METHOD ENZYMOL, V414, P440, DOI 10.1016/S0076-6879(06)14024-0; Badr CE, 2011, NEURO-ONCOLOGY, V13, P1213, DOI 10.1093/neuonc/nor067; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Feng Y, 2009, NAT REV DRUG DISCOV, V8, P567, DOI 10.1038/nrd2876; Futamura Y, 2012, CHEM BIOL, V19, P1620, DOI 10.1016/j.chembiol.2012.10.014; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li FH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003043; Ljosa V, 2013, J BIOMOL SCREEN, V18, P1321, DOI 10.1177/1087057113503553; Ljosa V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000603; Loo LH, 2007, NAT METHODS, V4, P445, DOI 10.1038/NMETH1032; Marceau F, 2012, TOXICOL APPL PHARM, V259, P1, DOI 10.1016/j.taap.2011.12.004; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Petrone FM, 2012, ACS CHEM BIOL, V7, P1399, DOI 10.1021/cb3001028; Riganti C, 2011, CURR MED CHEM, V18, P872, DOI 10.2174/092986711794927685; ROBERTS JR, 1990, CANCER RES, V50, P710; Seiler KP, 2008, NUCLEIC ACIDS RES, V36, pD351, DOI 10.1093/nar/gkm843; Stegmaier K, 2007, PLOS MED, V4, P702, DOI 10.1371/journal.pmed.0040122; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanaka M, 2005, PLOS BIOL, V3, P764, DOI 10.1371/journal.pbio.0030128; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947	24	122	121	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e80999	10.1371/journal.pone.0080999	http://dx.doi.org/10.1371/journal.pone.0080999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312513	Green Submitted, Green Published, gold			2022-12-25	WOS:000327944500049
J	Ha, JG; Min, HJ; Ahn, SH; Kim, CH; Yoon, JH; Lee, JG; Cho, HJ				Ha, Jong Gyun; Min, Hyun Jin; Ahn, Sang Hyeon; Kim, Chang-Hoon; Yoon, Joo-Heon; Lee, Jeung-Gweon; Cho, Hyung-Ju			The Dimension of Hyoid Bone Is Independently Associated with the Severity of Obstructive Sleep Apnea	PLOS ONE			English	Article							UPPER AIRWAY; MULTILEVEL SURGERY; CEPHALOMETRY; SUSPENSION; EXPANSION; PHARYNGOPLASTY; HYPERTENSION; MORPHOLOGY; ENDOSCOPY	Introduction: We hypothesized that the size of the hyoid bone itself may affect the severity of sleep apnea. The aim of this study was to identify the relationship between hyoid bone dimensions and the severity of sleep apnea using computerized tomography (CT) axial images. Methods: We retrospectively measured the hyoid bone in axial images of neck CTs and correlated these measurements with results of polysomnography in a total of 106 male patients. The new hyoid bone parameters studied in this study were as follows: distance between bilateral lesser horns (LH-d), distance between bilateral greater horns (GH-d), distance from the most anterior end of the hyoid arch to GH-d (AP), distance from the greater to the lesser horn on right and left sides (GH-LH), and the anterior angle between bilateral extensive lines from the greater to the lesser horn (H-angle). Data was analyzed using univariate and multivariate logistic regression, and Pearson correlation tests. Results: We found a significant inverse correlation between the apnea-hypopnea index (AHI) and GH-d or AP. Neither the LH-d, GH-LH, nor H-angle were associated with the AHI. The patient group that met the criteria of both GH-d < 45.4 and AP < 33.4 demonstrated the most severe AHI. Conclusion: The lateral width or antero-posterior length of hyoid bone was associated with AHI and predicted the severity of sleep apnea in male patients. This finding supports the role of expansion hyoidplasty for treatment of sleep apnea. Preoperative consideration of these parameters may improve surgical outcomes in male patients with sleep apnea.	[Ha, Jong Gyun; Min, Hyun Jin; Ahn, Sang Hyeon; Kim, Chang-Hoon; Yoon, Joo-Heon; Lee, Jeung-Gweon; Cho, Hyung-Ju] Yonsei Univ, Coll Med, Severance Hosp, Dept Otorhinolaryngol, Seoul, South Korea; [Kim, Chang-Hoon; Yoon, Joo-Heon; Cho, Hyung-Ju] Yonsei Univ, Coll Med, Airway Mucus Ist, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Cho, HJ (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Otorhinolaryngol, Seoul, South Korea.	hyungjucho@yuhs.ac	Kim, Chang-Hoon/D-7205-2016; Yoon, Joo-Heon/E-5781-2016; Chung-ang, HyunJin/AAO-9395-2020	Kim, Chang-Hoon/0000-0003-1238-6396; Ahn, Sang Hyeon/0000-0002-2389-0005; Cho, Hyung-Ju/0000-0002-2851-3225; Ha, Jong-Gyun/0000-0002-2712-1297; Yoon, Joo-Heon/0000-0003-2404-7156	Basic Science Research Program through the National Research Foundation of Korea (NRF) [NRF-2013R1A1A1010151]; Ministry of Education, Science and Technology	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by grants NRF-2013R1A1A1010151 to H.J. Cho from the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MM, 2006, CURR OPIN PULM MED, V12, P397, DOI 10.1097/01.mcp.0000245706.77064.51; Baisch A, 2006, OTOLARYNG HEAD NECK, V134, P856, DOI 10.1016/j.otohns.2006.01.015; Bowden MT, 2005, ARCH OTOLARYNGOL, V131, P440, DOI 10.1001/archotol.131.5.440; Bucchieri A, 2004, Minerva Stomatol, V53, P33; Cahali MB, 2004, SLEEP, V27, P942, DOI 10.1093/sleep/27.5.942; George JR, 2012, LARYNGOSCOPE, V122, P2600, DOI 10.1002/lary.23561; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Hamans E, 2013, SLEEP BREATH, V17, P195, DOI 10.1007/s11325-012-0673-7; Heo JY, 2011, ACTA OTO-LARYNGOL, V131, P84, DOI 10.3109/00016489.2010.514007; Julia-Serda G, 2006, SLEEP BREATH, V10, P181, DOI 10.1007/s11325-006-0073-y; Kezirian EJ, 2011, EUR ARCH OTO-RHINO-L, V268, P1233, DOI 10.1007/s00405-011-1633-8; Kim SJ, 2012, J ORAL MAXIL SURG, V70, P1404, DOI 10.1016/j.joms.2011.03.016; LOWE AA, 1986, AM J ORTHOD DENTOFAC, V90, P484, DOI 10.1016/0889-5406(86)90108-3; Mohsenin V, 2001, CHEST, V120, P1442, DOI 10.1378/chest.120.5.1442; Mukhopadhyay PP, 2010, J FORENSIC LEG MED, V17, P321, DOI 10.1016/j.jflm.2010.04.014; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Pang KP, 2007, OTOLARYNG HEAD NECK, V137, P110, DOI 10.1016/j.otohns.2007.03.014; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; RILEY RW, 1994, OTOLARYNG HEAD NECK, V111, P717, DOI 10.1016/S0194-5998(94)70557-7; Schwab RJ, 1996, AM J RESP CRIT CARE, V154, P1106, DOI 10.1164/ajrccm.154.4.8887615; Stuck BA, 2005, OTOLARYNG HEAD NECK, V133, P397, DOI 10.1016/j.otohns.2005.06.002; THAWLEY SE, 1983, LARYNGOSCOPE, V93, P1387; Toh ST, 2013, JAMA OTOLARYNGOL, V139, P817, DOI 10.1001/jamaoto.2013.3906; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	24	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81590	10.1371/journal.pone.0081590	http://dx.doi.org/10.1371/journal.pone.0081590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312562	Green Published, Green Submitted, gold			2022-12-25	WOS:000327944500077
J	Ringshausen, FC; Nienhaus, A; Schablon, A; Costa, JT; Knoop, H; Hoffmeyer, F; Bunger, J; Merget, R; Harth, V; Schultze-Werninghaus, G; Rohde, G				Ringshausen, Felix C.; Nienhaus, Albert; Schablon, Anja; Costa, Jose Torres; Knoop, Heiko; Hoffmeyer, Frank; Buenger, Juergen; Merget, Rolf; Harth, Volker; Schultze-Werninghaus, Gerhard; Rohde, Gernot			Frequent Detection of Latent Tuberculosis Infection among Aged Underground Hard Coal Miners in the Absence of Recent Tuberculosis Exposure	PLOS ONE			English	Article							HEALTH-CARE WORKERS; GAMMA RELEASE ASSAY; OBSTRUCTIVE PULMONARY-DISEASE; AFRICAN GOLD MINERS; T-CELL RESPONSES; SKIN-TEST; ACTIVE TUBERCULOSIS; ELDERLY PERSONS; UNITED-STATES; RISK-FACTORS	Background: Miners are at particular risk for tuberculosis (TB) infection due to exposure to silica dust and silicosis. The objectives of the present observational cohort study were to determine the prevalence of latent TB infection (LTBI) among aged German underground hard coal miners with silicosis or chronic obstructive pulmonary disease (COPD) using two commercial interferon-gamma release assays (IGRAs) and to compare their performance with respect to predictors of test positivity. Methods: Between October 2008 and June 2010, miners were consecutively recruited when routinely attending pneumoconiosis clinics for an expert opinion. Both IGRAs, the QuantiFERON (R)-TB Gold In-Tube (QFT) and the T-SPOT (R). TB (T-SPOT), were performed at baseline. A standardized clinical interview was conducted at baseline and at follow-up. The cohort was prospectively followed regarding the development of active TB for at least two years after inclusion of the last study subject. Independent predictors of IGRA positivity were calculated using logistic regression. Results: Among 118 subjects (mean age 75 years), none reported recent exposure to TB. Overall, the QFT and the T-SPOT yielded similarly high rates of positive results (QFT: 46.6%; 95% confidence interval 37.6-55.6%; T-SPOT: 61.0%; 95% confidence interval 52.2-69.8%). Positive results were independently predicted by age >= 80 years and foreign country of birth for both IGRAs. In addition, radiological evidence of prior healed TB increased the chance of a positive QFT result fivefold. While 28 subjects were lost to follow-up, no cases of active TB occurred among 90 subjects during an average follow-up of >2 years. Conclusions: Considering the high prevalence of LTBI, the absence of recent TB exposure, and the currently low TB incidence in Germany, our study provides evidence for the persistence of specific interferon-gamma responses even decades after putative exposure. However, the clinical value of current IGRAs among our study population, although probably limited, remains uncertain.	[Ringshausen, Felix C.] Hannover Med Sch, Dept Resp Med, Hannover, Germany; [Nienhaus, Albert; Schablon, Anja] Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Hamburg, Germany; [Costa, Jose Torres] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Knoop, Heiko; Schultze-Werninghaus, Gerhard] Ruhr Univ Bochum, Univ Hosp Bergmannsheil, Dept Pneumol Allergol & Sleep Med, Bochum, Germany; [Hoffmeyer, Frank; Buenger, Juergen; Merget, Rolf] Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, Bochum, Germany; [Harth, Volker] Univ Med Ctr Hamburg Eppendorf, Inst Occupat & Maritime Med ZfAM, Hamburg, Germany; [Rohde, Gernot] Maastricht Univ Med Ctr, Dept Resp Med, Maastricht, Netherlands	Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; Universidade do Porto; Ruhr University Bochum; Ruhr University Bochum; University of Hamburg; University Medical Center Hamburg-Eppendorf; Maastricht University; Maastricht University Medical Centre (MUMC)	Ringshausen, FC (corresponding author), Hannover Med Sch, Dept Resp Med, Hannover, Germany.	Ringshausen.Felix@mh-hannover.de	Ringshausen, Felix C./AAA-9154-2021; Rohde, Gernot GU/F-3060-2013; Harth, Volker/AGG-1586-2022; Bünger, Jürgen/AAJ-1113-2020; Torres da Costa, Jose/N-8280-2013	Ringshausen, Felix C./0000-0001-9084-4968; Rohde, Gernot GU/0000-0002-5193-7755; Harth, Volker/0000-0003-4308-223X; Hoffmeyer, Frank/0000-0002-0870-4171; Torres da Costa, Jose/0000-0003-3947-8688; Bunger, Jurgen/0000-0001-6831-7854	Institution for Statutory Accident Insurance and Prevention in Health and Welfare Services, Hamburg, Germany; Institution for Statutory Accident Insurance and Prevention in Resources and Chemical Industry, Sector Mining, Bochum, Germany	Institution for Statutory Accident Insurance and Prevention in Health and Welfare Services, Hamburg, Germany; Institution for Statutory Accident Insurance and Prevention in Resources and Chemical Industry, Sector Mining, Bochum, Germany	This work was supported by unrestricted research grants from the Institution for Statutory Accident Insurance and Prevention in Health and Welfare Services, Hamburg, Germany and the Institution for Statutory Accident Insurance and Prevention in Resources and Chemical Industry, Sector Mining, Bochum, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichelburg MC, 2009, CLIN INFECT DIS, V48, P954, DOI 10.1086/597351; *AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_; Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; [Anonymous], 2013, WHO GLOBAL HLTH OBSE; Arend SM, 2002, J INFECT DIS, V186, P1797, DOI 10.1086/345760; Baur X, 2008, Pneumologie, V62, P659, DOI 10.1055/s-2008-1038281; Bentley Tanya G K, 2012, BMC Res Notes, V5, P563, DOI 10.1186/1756-0500-5-563; Brodhun B, 2013, REPORT EPIDEMIOLOGY; Chang KC, 2001, INT J TUBERC LUNG D, V5, P177; Chen WH, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001206; Corbett EL, 1999, AM J RESP CRIT CARE, V159, P94, DOI 10.1164/ajrccm.159.1.9803048; Creswell J, 2011, EUR RESPIR J, V37, P1269, DOI 10.1183/09031936.00084310; Diel R, 2011, Pneumologie, V65, P359, DOI 10.1055/s-0030-1256439; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Diel R, 2012, CHEST, V142, P63, DOI 10.1378/chest.11-3157; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; GIRLING DJ, 1992, AM REV RESPIR DIS, V145, P36; Goletti D, 2010, EUR RESPIR J, V36, P135, DOI 10.1183/09031936.00140009; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hauer B, 2011, EUR RESPIR J, V38, P467, DOI 10.1183/09031936.00199910; Hochberg NS, 2013, CLIN INFECT DIS, V56, P1240, DOI 10.1093/cid/cit027; Horsburgh CR, 2010, AM J RESP CRIT CARE, V182, P420, DOI 10.1164/rccm.200909-1355OC; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Inghammar M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010138; International Labor Office (ILO), 2002, INT LAB OFF OCC SAF, V22; Jeong YJ, 2012, J KOREAN MED SCI, V27, P761, DOI 10.3346/jkms.2012.27.7.761; Leung CC, 2008, EUR RESPIR J, V31, P266, DOI 10.1183/09031936.00054707; Leung CC, 2010, AM J RESP CRIT CARE, V182, P834, DOI 10.1164/rccm.200912-1875OC; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Mori T, 2007, INT J TUBERC LUNG D, V11, P1021; Nienhaus A, 2007, Pneumologie, V61, P613, DOI 10.1055/s-2007-980104; OXMAN AD, 1993, AM REV RESPIR DIS, V148, P38, DOI 10.1164/ajrccm/148.1.38; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2010, NAT REV MICROBIOL, V8, P242, DOI 10.1038/nrmicro2236-c1; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rees D, 2007, INT J TUBERC LUNG D, V11, P474; Ringshausen FC, 2011, CLIN VACCINE IMMUNOL, V18, P1176, DOI 10.1128/CVI.05058-11; Ringshausen FC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-220; Ringshausen Felix C, 2009, J Occup Med Toxicol, V4, P11, DOI 10.1186/1745-6673-4-11; Sester U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017813; STEAD WW, 1987, ANN INTERN MED, V107, P837, DOI 10.7326/0003-4819-107-6-837; STEAD WW, 1987, ANN INTERN MED, V107, P843, DOI 10.7326/0003-4819-107-6-843; teWaterNaude JM, 2006, OCCUP ENVIRON MED, V63, P187, DOI 10.1136/oem.2004.018614; Winston CA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-206	44	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82005	10.1371/journal.pone.0082005	http://dx.doi.org/10.1371/journal.pone.0082005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312620	Green Submitted, gold, Green Published			2022-12-25	WOS:000327944500110
J	Song, CF; Papachristos, K; Rawson, S; Huss, M; Wieczorek, H; Paci, E; Trinick, J; Harrison, MA; Muench, SP				Song, Chun Feng; Papachristos, Kostas; Rawson, Shaun; Huss, Markus; Wieczorek, Helmut; Paci, Emanuele; Trinick, John; Harrison, Michael A.; Muench, Stephen P.			Flexibility within the Rotor and Stators of the Vacuolar H+-ATPase	PLOS ONE			English	Article							V-ATPASE; 3-DIMENSIONAL STRUCTURE; ELECTRON-MICROSCOPY; CENTRAL STALK; V-0 DOMAINS; NA+-ATPASE; SYNTHASE; ROTATION; SUBUNIT; RING	The V-ATPase is a membrane-bound protein complex which pumps protons across the membrane to generate a large proton motive force through the coupling of an ATP-driven 3-stroke rotary motor (V-1) to a multistroke proton pump (V-o). This is done with near 100% efficiency, which is achieved in part by flexibility within the central rotor axle and stator connections, allowing the system to flex to minimise the free energy loss of conformational changes during catalysis. We have used electron microscopy to reveal distinctive bending along the V-ATPase complex, leading to angular displacement of the V-1 domain relative to the V-o domain to a maximum of similar to 30 degrees. This has been complemented by elastic network normal mode analysis that shows both flexing and twisting with the compliance being located in the rotor axle, stator filaments, or both. This study provides direct evidence of flexibility within the V-ATPase and by implication in related rotary ATPases, a feature predicted to be important for regulation and their high energetic efficiencies.	[Song, Chun Feng] Hebei Med Univ, Elect Microscopy Ctr, Shijiazhuang, Peoples R China; [Papachristos, Kostas; Paci, Emanuele; Trinick, John] Univ Leeds, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Rawson, Shaun; Harrison, Michael A.; Muench, Stephen P.] Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England; [Huss, Markus; Wieczorek, Helmut] Univ Osnabruck, Abt Tierphysiol, Fachbere Biol Chem, Osnabruck, Germany	Hebei Medical University; University of Leeds; University of Leeds; University Osnabruck	Muench, SP (corresponding author), Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England.	s.p.muench@leeds.ac.uk	Muench, Stephen/AAI-9529-2020; Paci, Emanuele/B-1893-2010	Muench, Stephen/0000-0001-6869-4414; Paci, Emanuele/0000-0002-4891-2768; Rawson, Shaun/0000-0002-2973-2630	MRC [G1000567]; BBSRC [BB/D016142/1]; Deutsche Forschungsgemeinschaft [SFB 431, SFB 944]; Wellcome Trust [099752/Z/12/Z]; Biotechnology and Biological Sciences Research Council [BB/D016142/1] Funding Source: researchfish; Medical Research Council [G1000567] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the MRC (G1000567) (http://www.mrc.ac.uk/index.htm) to SPM and BBSRC (BB/D016142/1) (www.bbsrc.ac.uk/) to MAH and JT, and from the Deutsche Forschungsgemeinschaft (SFB 431 to HW and MH, SFB 944 to HW)(http://www.dfg.de/en/). SR was supported by a studentship from the Wellcome Trust (099752/Z/12/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; Benlekbir S, 2012, NAT STRUCT MOL BIOL, V19, P1356, DOI 10.1038/nsmb.2422; Bernal RA, 2004, STRUCTURE, V12, P1789, DOI 10.1016/j.str.2004.07.017; Birmanns S, 2011, J STRUCT BIOL, V173, P428, DOI 10.1016/j.jsb.2010.11.002; Bond S, 2008, J BIOL CHEM, V283, P36513, DOI 10.1074/jbc.M805232200; Bottcher B, 2000, J MOL BIOL, V296, P449, DOI 10.1006/jmbi.1999.3435; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Brink J, 2004, STRUCTURE, V12, P185, DOI 10.1016/j.str.2004.01.015; Burgess SA, 2004, J STRUCT BIOL, V147, P247, DOI 10.1016/j.jsb.2004.04.004; Chacon P, 2003, J MOL BIOL, V326, P485, DOI 10.1016/S0022-2836(02)01426-2; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Diepholz M, 2008, BIOCHEM SOC T, V36, P1027, DOI 10.1042/BST0361027; Diepholz M, 2008, STRUCTURE, V16, P1789, DOI 10.1016/j.str.2008.09.010; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Giraud MF, 2012, J STRUCT BIOL, V177, P490, DOI 10.1016/j.jsb.2011.10.015; Grabe M, 2000, BIOPHYS J, V78, P2798, DOI 10.1016/S0006-3495(00)76823-8; Harrison M, 2000, BIOCHEMISTRY-US, V39, P7531, DOI 10.1021/bi000159o; Hong-Hermesdorf A, 2006, FEBS LETT, V580, P932, DOI 10.1016/j.febslet.2006.01.018; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Huss M, 2007, FEBS LETT, V581, P5566, DOI 10.1016/j.febslet.2007.11.004; Hutcheon ML, 2001, P NATL ACAD SCI USA, V98, P8519, DOI 10.1073/pnas.151236798; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Imamura H, 2005, P NATL ACAD SCI USA, V102, P17929, DOI 10.1073/pnas.0507764102; Kinosita K, 2000, PHILOS T R SOC B, V355, P473, DOI 10.1098/rstb.2000.0589; Lau WCY, 2010, P NATL ACAD SCI USA, V107, P1367, DOI 10.1073/pnas.0911085107; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Matthies D, 2011, J MOL BIOL, V413, P593, DOI 10.1016/j.jmb.2011.08.055; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; MUENCH SP, 2013, J MOL BIOL; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Muench SP, 2009, J MOL BIOL, V386, P989, DOI 10.1016/j.jmb.2009.01.014; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Norgett EE, 2007, J BIOL CHEM, V282, P14421, DOI 10.1074/jbc.M701226200; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Pogoryelov D, 2007, J BACTERIOL, V189, P5895, DOI 10.1128/JB.00581-07; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; SCHWEIKL H, 1989, J BIOL CHEM, V264, P11136; Sielaff H, 2008, P NATL ACAD SCI USA, V105, P17760, DOI 10.1073/pnas.0807683105; Stember JN, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3167410; Stewart AG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1693; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Sugawa M, 2011, BIOPHYS J, V101, P2201, DOI 10.1016/j.bpj.2011.09.016; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Tama F, 2002, J MOL BIOL, V321, P297, DOI 10.1016/S0022-2836(02)00627-7; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tani K, 2013, MICROSCOPY-JPN, V62, P467, DOI 10.1093/jmicro/dft020; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vollmar M, 2009, J BIOL CHEM, V284, P18228, DOI 10.1074/jbc.M109.006916; Vonck J, 2009, J BIOL CHEM, V284, P10110, DOI 10.1074/jbc.M808498200; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wachter A, 2011, P NATL ACAD SCI USA, V108, P3924, DOI 10.1073/pnas.1011581108; WALKER M, 1985, J MOL BIOL, V184, P535, DOI 10.1016/0022-2836(85)90300-6; Wriggers W, 1998, J MOL BIOL, V284, P1247, DOI 10.1006/jmbi.1998.2232; Yokoyama K, 2003, J BIOL CHEM, V278, P24255, DOI 10.1074/jbc.M303104200; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	68	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82207	10.1371/journal.pone.0082207	http://dx.doi.org/10.1371/journal.pone.0082207			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24312643	gold, Green Published, Green Accepted			2022-12-25	WOS:000327944500125
J	Lukman, S; Lane, DP; Verma, CS				Lukman, Suryani; Lane, David P.; Verma, Chandra S.			Mapping the Structural and Dynamical Features of Multiple p53 DNA Binding Domains: Insights into Loop 1 Intrinsic Dynamics	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; FREQUENCY NORMAL-MODES; FULL-LENGTH P53; CORE DOMAIN; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; INDUCED FIT; WILD-TYPE; IN-VITRO; MUTATIONS	The transcription factor p53 regulates cellular integrity in response to stress. p53 is mutated in more than half of cancerous cells, with a majority of the mutations localized to the DNA binding domain (DBD). In order to map the structural and dynamical features of the DBD, we carried out multiple copy molecular dynamics simulations (totaling 0.8 mu s). Simulations show the loop 1 to be the most dynamic element among the DNA-contacting loops (loops 1-3). Loop 1 occupies two major conformational states: extended and recessed; the former but not the latter displays correlations in atomic fluctuations with those of loop 2 (similar to 24 angstrom apart). Since loop 1 binds to the major groove whereas loop 2 binds to the minor groove of DNA, our results begin to provide some insight into the possible mechanism underpinning the cooperative nature of DBD binding to DNA. We propose (1) a novel mechanism underlying the dynamics of loop 1 and the possible tread-milling of p53 on DNA and (2) possible mutations on loop 1 residues to restore the transcriptional activity of an oncogenic mutation at a distant site.	[Lukman, Suryani; Verma, Chandra S.] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore; [Lane, David P.] Agcy Sci Technol & Res, Lab p53, Singapore, Singapore; [Verma, Chandra S.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Verma, Chandra S.] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Agency for Science Technology & Research (A*STAR); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Lukman, S (corresponding author), Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore.	luks@bii.a-star.edu.sg; chandra@bii.a-star.edu.sg		Lukman, Suryani/0000-0002-8913-1343; Lane, David/0000-0003-0551-3545	Agency for Science, Technology and Research, Singapore	Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR))	The authors thank Agency for Science, Technology and Research, Singapore for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Arbely E, 2011, P NATL ACAD SCI USA, V108, P8251, DOI 10.1073/pnas.1105028108; Barakat K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027651; BARGONETTI J, 1992, GENE DEV, V6, P1886, DOI 10.1101/gad.6.10.1886; Benson NC, 2012, J PHYS CHEM B, V116, P8722, DOI 10.1021/jp302103t; Berlow RB, 2012, J MOL BIOL, V419, P171, DOI 10.1016/j.jmb.2012.03.013; Bista M, 2012, P NATL ACAD SCI USA, V109, P15752, DOI 10.1073/pnas.1214176109; Bowman GR, 2012, P NATL ACAD SCI USA, V109, P11681, DOI 10.1073/pnas.1209309109; Brachmann RK, 1998, EMBO J, V17, P1847, DOI 10.1093/emboj/17.7.1847; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Butler JS, 2003, BIOCHEMISTRY-US, V42, P2396, DOI 10.1021/bi026635n; Calhoun S, 2011, BIOCHEMISTRY-US, V50, P5345, DOI 10.1021/bi200192j; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; Case D.A., 2022, AMBER 2020; Chen JM, 2001, J PROTEIN CHEM, V20, P101, DOI 10.1023/A:1011065022283; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dhulesia A, 2008, J AM CHEM SOC, V130, P8931, DOI 10.1021/ja0752080; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Duan JX, 2006, BIOCHEMISTRY-US, V45, P7483, DOI 10.1021/bi0603165; ElSawy KM, 2012, J CHEM INF MODEL, V52, P770, DOI 10.1021/ci200467s; Emamzadah S, 2011, MOL CANCER RES, V9, P1493, DOI 10.1158/1541-7786.MCR-11-0351; Fen CX, 2007, J MOL BIOL, V371, P1238, DOI 10.1016/j.jmb.2007.05.099; Fraser JS, 2011, P NATL ACAD SCI USA, V108, P16247, DOI 10.1073/pnas.1111325108; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gorfe AA, 2008, STRUCTURE, V16, P885, DOI 10.1016/j.str.2008.03.009; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Grant BJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001207; Grant BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025711; HAINAUT P, 1993, CANCER RES, V53, P1739; HAINAUT P, 1993, CANCER RES, V53, P4469; Ho WC, 2006, J BIOL CHEM, V281, P20494, DOI 10.1074/jbc.M603634200; Holloway DE, 2011, FEBS J, V278, P4136, DOI 10.1111/j.1742-4658.2011.08320.x; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hubbard ST, 1993, NACCESS; Huyen Y, 2004, STRUCTURE, V12, P1237, DOI 10.1016/j.str.2004.05.007; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Inga A, 2001, ONCOGENE, V20, P3409, DOI 10.1038/sj.onc.1204457; Joerger AC, 2005, J BIOL CHEM, V280, P16030, DOI 10.1074/jbc.M500179200; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; Jordan JJ, 2012, P NATL ACAD SCI USA, V109, P14387, DOI 10.1073/pnas.1205971109; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kamerzell TJ, 2008, J PHARM SCI-US, V97, P3494, DOI 10.1002/jps.21269; Kawaguchi T, 2005, ONCOGENE, V24, P6976, DOI 10.1038/sj.onc.1208839; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kosztin D, 1997, BIOPHYS J, V73, P557, DOI 10.1016/S0006-3495(97)78093-7; Kwon E, 2008, PROTEINS, V70, P280, DOI 10.1002/prot.21608; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Lickwar CR, 2012, NATURE, V484, P251, DOI 10.1038/nature10985; Lilyestrom W, 2006, GENE DEV, V20, P2373, DOI 10.1101/gad.1456306; Liu J, 2006, STRUCTURE, V14, P1811, DOI 10.1016/j.str.2006.10.009; Loh SN, 2010, METALLOMICS, V2, P442, DOI 10.1039/c003915b; Lubin DJ, 2010, J MOL BIOL, V395, P705, DOI 10.1016/j.jmb.2009.11.013; Lukman S, 2012, PROTEINS, V80, P1066, DOI 10.1002/prot.24008; Lukman S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000922; Lukman S, 2010, FEBS LETT, V584, P1235, DOI 10.1016/j.febslet.2010.02.035; McLure KG, 1998, EMBO J, V17, P3342, DOI 10.1093/emboj/17.12.3342; Merabet A, 2010, BIOCHEM J, V427, P225, DOI 10.1042/BJ20091888; MILLER SD, 1995, MOL CELL BIOL, V15, P6554; Natan E, 2009, P NATL ACAD SCI USA, V106, P14327, DOI 10.1073/pnas.0907840106; Noskov SY, 2002, J PHYS CHEM B, V106, P13047, DOI 10.1021/jp022140w; Okorokov AL, 2009, CURR OPIN STRUC BIOL, V19, P197, DOI 10.1016/j.sbi.2009.02.003; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Osborne MJ, 2001, BIOCHEMISTRY-US, V40, P9846, DOI 10.1021/bi010621k; Pan YP, 2007, J BIOL CHEM, V282, P691, DOI 10.1074/jbc.M605908200; Pan YP, 2005, BIOCHEMISTRY-US, V44, P1423, DOI 10.1021/bi047845y; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Petty TJ, 2011, EMBO J, V30, P2167, DOI 10.1038/emboj.2011.127; Puca R, 2011, CELL CYCLE, V10, P1679, DOI 10.4161/cc.10.10.15642; Reuveni S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.208101; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; Saller E, 1999, EMBO J, V18, P4424, DOI 10.1093/emboj/18.16.4424; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Smirnova IN, 2003, BIOCHEMISTRY-US, V42, P3025, DOI 10.1021/bi027329c; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tafvizi A, 2011, P NATL ACAD SCI USA, V108, P563, DOI 10.1073/pnas.1016020107; Tama F, 2000, PROTEINS, V41, P1; Tan YH, 2009, BIOPHYS CHEM, V145, P37, DOI 10.1016/j.bpc.2009.08.008; Tidow H, 2006, J BIOL CHEM, V281, P32526, DOI 10.1074/jbc.M604725200; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tu C, 2008, ACTA CRYSTALLOGR D, V64, P471, DOI 10.1107/S0907444908003338; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; VANGUNSTEREN WF, 1977, MOL PHYS, V34, P1311, DOI 10.1080/00268977700102571; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WANG Y, 1995, MOL CELL BIOL, V15, P2157; Wang Y, 2007, ACTA CRYSTALLOGR D, V63, P276, DOI 10.1107/S0907444906048499; Wassman CD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2361; WEBER G, 1972, BIOCHEMISTRY-US, V11, P864, DOI 10.1021/bi00755a028; Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071; Xu X, 2012, J STRUCT BIOL, V177, P358, DOI 10.1016/j.jsb.2011.12.008; Yang L, 2008, STRUCTURE, V16, P321, DOI 10.1016/j.str.2007.12.011; Zheng WJ, 2006, P NATL ACAD SCI USA, V103, P7664, DOI 10.1073/pnas.0510426103; Zupnick A, 2006, J BIOL CHEM, V281, P20464, DOI 10.1074/jbc.M603387200	103	41	41	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80221	10.1371/journal.pone.0080221	http://dx.doi.org/10.1371/journal.pone.0080221			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24324553	Green Published, gold			2022-12-25	WOS:000327252100135
J	Wang, JH; Cui, SZ; Zhang, XL; Wu, YB; Tang, HS				Wang, Jiahong; Cui, Shuzhong; Zhang, Xiangliang; Wu, Yinbing; Tang, Hongsheng			High Expression of Heat Shock Protein 90 Is Associated with Tumor Aggressiveness and Poor Prognosis in Patients with Advanced Gastric Cancer	PLOS ONE			English	Article							HSP90; CHEMOTHERAPY; SURGERY; CELLS	The heat shock protein 90 (HSP90) is overexpressed and highly associated with poor prognosis in many malignancies. However, the role of HSP90 in gastric cancer has not been thoroughly elucidated. The aim of this study is to investigate the relationship of HSP90 expression with clinicopathological parameters and prognosis in advanced gastric cancer, and estimate the alteration of HSP90 expression after neoadjuvant chemotherapy. HSP90 and matrix metallopeptidase 9 (MMP-9) antigen expression was evaluated by immunohistochemistry in 322 advanced gastric carcinoma samples. The relationships between HSP90 and clinicopathological parameters and prognosis were analyzed. The response of HSP90 level was assessed in chemotherapeutic effect in 54 patients received 1-2 cycles of neoadjuvant chemotherapy. The positive expression of HSP90 was found to be 69.6% in 322 advanced gastric carcinoma samples. HSP90 protein expression was significantly associated with depth invasion (P < 0.001), lymph node metastasis (P < 0.001) and stage of disease (P < 0.001). The positive rates of HSP90 expression were higher in both prominent serosal invasion group (P < 0.001) and lymph node metastasis group (P < 0.001). Moreover, HSP90 was significantly correlated with MMP-9 among 322 gastric cancer tissues (P < 0.001). In univariate and multivariate analyses, HSP90 was an independent prognostic factor for both recurrence-free survival (RFS) and overall survival (OS). These results suggested that HSP90 may play an important role on tumor invasion, metastasis and prognosis, and might act as a promising target for prognostic prediction.	[Wang, Jiahong; Cui, Shuzhong; Zhang, Xiangliang; Wu, Yinbing; Tang, Hongsheng] Guangzhou Med Univ, Affiliated Oncol Hosp, Dept Abdominal Surg, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Wang, JH (corresponding author), Guangzhou Med Univ, Affiliated Oncol Hosp, Dept Abdominal Surg, Guangzhou, Guangdong, Peoples R China.	cuishuzhong@126.com		Xu, Lin/0000-0002-2710-3507; Wang, Jing/0000-0002-3075-2874; chai, anping/0000-0003-4651-7307; Wang, Liping/0000-0001-6893-3809				Aghdassi A, 2007, CANCER RES, V67, P616, DOI 10.1158/0008-5472.CAN-06-1567; Al-Batran SE, 2008, J CLIN ONCOL, V26, P1435, DOI 10.1200/JCO.2007.13.9378; Bagatell R, 2004, MOL CANCER THER, V3, P1021; Bang YJ, 2010, LANCET, V376, P1302; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Chu DK, 2011, INT J CANCER, V129, P887, DOI 10.1002/ijc.25734; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Dikken JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-329; Dudeja V, 2009, GUT, V58, P1000, DOI 10.1136/gut.2007.140194; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Hong J, 2012, J CLIN INVEST, V122, P2165, DOI 10.1172/JCI61380; Jego G, 2010, CANC LETT; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kang GH, 2010, HISTOPATHOLOGY, V56, P694, DOI 10.1111/j.1365-2559.2010.03550.x; Lagarrigue F, 2010, CANCER RES, V70, P6978, DOI 10.1158/0008-5472.CAN-10-0861; Lang SA, 2007, MOL CANCER THER, V6, P1123, DOI 10.1158/1535-7163.MCT-06-0628; Lee KH, 2011, CANCER SCI, V102, P1388, DOI 10.1111/j.1349-7006.2011.01944.x; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Pick E, 2007, CANCER RES, V67, P2932, DOI 10.1158/0008-5472.CAN-06-4511; Ruiz MIG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001722; Solit DB, 2003, SEMIN ONCOL, V30, P709, DOI 10.1016/S0093-7754(03)00346-4; Tweedle EM, 2010, GUT, V59, P1501, DOI 10.1136/gut.2009.196626; Wang RE, 2011, CURR MED CHEM, V18, P4250; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716	25	189	198	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62876	10.1371/journal.pone.0062876	http://dx.doi.org/10.1371/journal.pone.0062876			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23638161	Green Published, gold, Green Submitted			2022-12-25	WOS:000318343700078
J	Shen, ZY; Chen, L; Xu, L				Shen, Zhenyao; Chen, Lei; Xu, Liang			A Topography Analysis Incorporated Optimization Method for the Selection and Placement of Best Management Practices	PLOS ONE			English	Article							NONPOINT-SOURCE POLLUTION; PARAMETER UNCERTAINTY ANALYSIS; GORGES RESERVOIR REGION; WATER ASSESSMENT-TOOL; SWAT MODEL; DIFFUSE POLLUTION; QUALITY; STORMWATER; AREA; SOIL	Best Management Practices (BMPs) are one of the most effective methods to control nonpoint source (NPS) pollution at a watershed scale. In this paper, the use of a topography analysis incorporated optimization method (TAIOM) was proposed, which integrates topography analysis with cost-effective optimization. The surface status, slope and the type of land use were evaluated as inputs for the optimization engine. A genetic algorithm program was coded to obtain the final optimization. The TAIOM was validated in conjunction with the Soil and Water Assessment Tool (SWAT) in the Yulin watershed in Southwestern China. The results showed that the TAIOM was more cost-effective than traditional optimization methods. The distribution of selected BMPs throughout landscapes comprising relatively flat plains and gentle slopes, suggests the need for a more operationally effective scheme, such as the TAIOM, to determine the practicability of BMPs before widespread adoption. The TAIOM developed in this study can easily be extended to other watersheds to help decision makers control NPS pollution.	[Shen, Zhenyao; Chen, Lei; Xu, Liang] Beijing Normal Univ, State Key Lab Water Environm Simulat, Sch Environm, Beijing 100875, Peoples R China	Beijing Normal University	Shen, ZY (corresponding author), Beijing Normal Univ, State Key Lab Water Environm Simulat, Sch Environm, Beijing 100875, Peoples R China.	zyshen@bnu.edu.cn	Xu, Lu/X-4357-2019; Chen, Lei/AAD-3766-2019	Chen, Lei/0000-0001-8415-3896; Shen, Zhenyao/0000-0002-6620-1943	National Science Foundation for Distinguished Young Scholars [51025933]; National Science Foundation for Innovative Research Group [51121003]; National Basic Research Program of China (973 Project) [2010CB429003]	National Science Foundation for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Science Foundation for Innovative Research Group; National Basic Research Program of China (973 Project)(National Basic Research Program of China)	This study was supported through funding from the National Science Foundation for Distinguished Young Scholars (No. 51025933), the National Science Foundation for Innovative Research Group (No. 51121003) and the National Basic Research Program of China (973 Project, 2010CB429003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaspour KC, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007615; Arabi M, 2006, WATER RESOUR RES, V42, DOI 10.1029/2006WR004931; Arnold JG, 1998, J AM WATER RESOUR AS, V34, P73, DOI 10.1111/j.1752-1688.1998.tb05961.x; Barragan F, 2011, PLOS ONE, V6; Bekele EG, 2005, WATER RESOUR RES, V41, DOI 10.1029/2005WR004090; Brezonik PL, 1999, WATER SCI TECHNOL, V39, P323, DOI 10.1016/S0273-1223(99)00350-9; Cha SM, 2012, DESALIN WATER TREAT, V38, P389, DOI 10.5004/dwt.2012.3594; Chen Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016909; Cisneros JM, 2011, AGR WATER MANAGE, V98, P1545, DOI 10.1016/j.agwat.2011.05.009; Cools J, 2011, ENVIRON MODELL SOFTW, V26, P44, DOI 10.1016/j.envsoft.2010.04.017; Douglas-Mankin KR, 2010, T ASABE, V53, P1423; Eckley CS, 2011, SCI TOTAL ENVIRON, V409, P514, DOI 10.1016/j.scitotenv.2010.10.024; Gassman PW, 2007, T ASABE, V50, P1211, DOI 10.13031/2013.23637; Giri S, 2012, J ENVIRON MANAGE, V103, P24, DOI 10.1016/j.jenvman.2012.02.033; Gitau MW, 2008, T ASABE, V51, P1925, DOI 10.13031/2013.25398; Gitau MW, 2004, T ASAE, V47, P1923, DOI 10.13031/2013.17805; Holland J.H., 1992, ADAPTATION NATURAL A; Hsieh C-D, 2007, J ENVIRON MANAGE, V85, P10; Islam N, 2011, ENVIRON REV, V19, P68, DOI [10.1139/A11-001, 10.1139/a11-001]; Jenkins JG, 2012, J SOIL WATER CONSERV, V67, P134, DOI [10.2489/jswc.67.2.134, 10.2489/jSWC.67.2.134]; Kaini P, 2012, WATER RESOUR MANAG, V26, P1827, DOI 10.1007/s11269-012-9989-0; Keatley BE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015913; Kim HC, 2010, WATER SCI TECHNOL, V62, P1003, DOI 10.2166/wst.2010.333; Kollat JB, 2007, ENVIRON MODELL SOFTW, V22, P1691, DOI 10.1016/j.envsoft.2007.02.001; Lam QD, 2011, ENVIRON MONIT ASSESS, V183, P351, DOI 10.1007/s10661-011-1926-9; Lee JG, 2012, ENVIRON MODELL SOFTW, V37, P6, DOI 10.1016/j.envsoft.2012.04.011; Leh MD, 2008, HYDROL PROCESS, V22, P4190, DOI 10.1002/hyp.7021; Liu X., 2001, B SOIL WATER CONSERV, V21, P4, DOI DOI 10.3969/J.ISSN.1000-288X.2001.01.015; Maringanti C, 2011, ENVIRON MANAGE, V48, P448, DOI 10.1007/s00267-011-9696-2; Maringanti C, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007094; McCarron CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025635; Meals DW, 2010, J ENVIRON QUAL, V39, P85, DOI 10.2134/jeq2009.0108; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Nash J.E., 1970, J HYDROL, V10, P282, DOI [DOI 10.1016/0022-1694(70)90255-6, 10.1016/0022-1694(70)90255-6]; Nelson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038558; Nikolaidis NP, 2009, ECOL MODEL, V220, P383, DOI 10.1016/j.ecolmodel.2008.10.003; Orgiazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034847; Panagopoulos Y, 2012, ENVIRON MODELL SOFTW, V30, P57, DOI 10.1016/j.envsoft.2011.11.006; Qi HH, 2008, J AM WATER RESOUR AS, V44, P866, DOI 10.1111/j.1752-1688.2008.00209.x; Qi HH, 2011, WATER RESOUR MANAG, V25, P565, DOI 10.1007/s11269-010-9714-9; Rabotyagov S, 2010, ECOL APPL, V20, P1542, DOI 10.1890/08-0680.1; RITZEL BJ, 1994, WATER RESOUR RES, V30, P1589, DOI 10.1029/93WR03511; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Shen ZY, 2012, HYDROL EARTH SYST SC, V16, P121, DOI 10.5194/hess-16-121-2012; Shen ZY, 2010, SCI TOTAL ENVIRON, V408, P1971, DOI 10.1016/j.scitotenv.2009.12.007; Shen ZY, 2008, SCI TOTAL ENVIRON, V405, P195, DOI 10.1016/j.scitotenv.2008.06.009; Short JS, 2012, ENVIRON SCI TECHNOL, V46, P1316, DOI 10.1021/es2020499; Sivertun A, 2003, ENVIRON MODELL SOFTW, V18, P887, DOI 10.1016/S1364-8152(03)00107-5; Srinivasan MS, 2009, J HYDROL, V379, P54, DOI 10.1016/j.jhydrol.2009.09.044; Srivastava P, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000365; Srivastava P, 2007, T ASABE, V50, P1683, DOI 10.13031/2013.23961; Studds CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035969; Tomer MD, 2003, J SOIL WATER CONSERV, V58, P198; Turpin N, 2005, ENVIRON MODELL SOFTW, V20, P187, DOI 10.1016/j.envsoft.2003.09.004; Woznicki SA, 2011, T ASABE, V54, P171; Wu J, 2006, J AM WATER RESOUR AS, V42, P1193, DOI 10.1111/j.1752-1688.2006.tb05606.x; Xu ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039762; Young KD, 2011, J WATER RES PL-ASCE, V137, P268, DOI 10.1061/(ASCE)WR.1943-5452.0000110; Zhang T, 2010, ENVIRON MODEL ASSESS, V15, P569, DOI 10.1007/s10666-010-9225-3; Zhang XD, 2009, AGR WATER MANAGE, V96, P1723, DOI 10.1016/j.agwat.2009.07.011; Zhen J, 2006, J ENVIRON SCI HEAL A, V41, P1391, DOI 10.1080/10934520600657172	61	64	75	6	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54520	10.1371/journal.pone.0054520	http://dx.doi.org/10.1371/journal.pone.0054520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349917	Green Published, Green Submitted, gold			2022-12-25	WOS:000313943000044
J	Xu, L; Wu, M; Han, ZJ				Xu, Lu; Wu, Min; Han, Zhaojun			Overexpression of Multiple Detoxification Genes in Deltamethrin Resistant Laodelphax striatellus (Hemiptera: Delphacidae) in China	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; SMALL BROWN PLANTHOPPER; TIME QUANTITATIVE PCR; IN-FIELD POPULATIONS; INSECTICIDE RESISTANCE; PYRETHROID RESISTANCE; CYTOCHROME-P450 GENES; KNOCKDOWN RESISTANCE; BLATTELLA-GERMANICA; FIPRONIL RESISTANCE	Background: The small brown planthopper (SBPH), Laodelphax striatellus (Fallen), is one of the major rice pests in Asia and has developed resistance to multiple classes of insecticides. Understanding resistance mechanisms is essential to the management of this pest. Biochemical and molecular assays were performed in this study to systematically characterize deltamethrin resistance mechanisms with laboratory-selected resistant and susceptible strains of SBPH. Methodology/Principal Findings: Deltamethrin resistant strains of SBPH (JH-del) were derived from a field population by continuously selections (up to 30 generations) in the laboratory, while a susceptible strain (JHS) was obtained from the same population by removing insecticide pressure for 30 generations. The role of detoxification enzymes in the resistance was investigated using synergism and enzyme activity assays with strains of different resistant levels. Furthermore, 71 cytochrome P450, 93 esterases and 12 glutathione-S-transferases cDNAs were cloned based on transcriptome data of a field collected population. Semi-quantitative RT-PCR screening analysis of 176 identified detoxification genes demonstrated that multiple P450 and esterase genes were overexpressed (>2-fold) in JH-del strains (G4 and G30) when compared to that in JHS, and the results of quantitative PCR coincided with the semi-quantitative RT-PCR results. Target mutation at IIS3-IIS6 regions encoded by the voltage-gated sodium channel gene was ruled out for conferring the observed resistance. Conclusion/Significance: As the first attempt to discover genes potentially involved in SBPH pyrethroid resistance, this study putatively identified several candidate genes of detoxification enzymes that were significantly overexpressed in the resistant strain, which matched the synergism and enzyme activity testing. The biochemical and molecular evidences suggest that the high level pyrethroid resistance in L. striatellus could be due to enhanced detoxification rather than target insensitivity. The findings lay a solid ground for further resistance mechanism elucidation studies.	[Xu, Lu; Wu, Min; Han, Zhaojun] Nanjing Agr Univ, Coll Plant Protect, Educ Minist, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Han, ZJ (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Educ Minist, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China.	zjhan@njau.edu.cn	Xu, Lu/X-4357-2019; Chen, Lei/AAD-3766-2019	Chen, Lei/0000-0001-8415-3896; Shen, Zhenyao/0000-0002-6620-1943	Projects of Development Plan of the State Key Fundamental Research (973 Projects) [2010CB126204]; National Natural Science Foundation of China (NSFC) [31130045]	Projects of Development Plan of the State Key Fundamental Research (973 Projects)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by the Projects of Development Plan of the State Key Fundamental Research (973 Projects, Grant No. 2010CB126204) and National Natural Science Foundation of China (NSFC, Grant No. 31130045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026228; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brogdon WG, 1998, EMERG INFECT DIS, V4, P605, DOI 10.3201/eid0404.980410; Brun-Barale A, 2010, PEST MANAG SCI, V66, P900, DOI 10.1002/ps.1960; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Denholm I, 2002, SCIENCE, V297, P2222, DOI 10.1126/science.1077266; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Enayati AA, 2010, PESTIC BIOCHEM PHYS, V97, P243, DOI 10.1016/j.pestbp.2010.03.003; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Gao BL, 2008, INT J PEST MANAGE, V54, P13, DOI 10.1080/09670870701553303; Gong MQ, 2005, ACTA BIOCH BIOPH SIN, V37, P317, DOI 10.1111/j.1745-7270.2005.00042.x; Haddi K, 2012, INSECT BIOCHEM MOLEC, V42, P506, DOI 10.1016/j.ibmb.2012.03.008; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hemingway J, 2000, INSECT BIOCHEM MOLEC, V30, P1009, DOI 10.1016/S0965-1748(00)00079-5; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hougard JM, 2002, J MED ENTOMOL, V39, P526, DOI 10.1603/0022-2585-39.3.526; Huang SJ, 2007, PESTIC BIOCHEM PHYS, V87, P14, DOI 10.1016/j.pestbp.2006.05.002; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; Karunker I, 2009, INSECT BIOCHEM MOLEC, V39, P697, DOI 10.1016/j.ibmb.2009.08.006; Kasai S, 2000, INSECT BIOCHEM MOLEC, V30, P163, DOI 10.1016/S0965-1748(99)00114-9; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024323; KISIMOTO R, 1989, APPL ENTOMOL ZOOL, V24, P157, DOI 10.1303/aez.24.157; Komagata O, 2010, INSECT BIOCHEM MOLEC, V40, P146, DOI 10.1016/j.ibmb.2010.01.006; Kranthi KR, 2001, J ECON ENTOMOL, V94, P253, DOI 10.1603/0022-0493-94.1.253; Le Goff G, 2003, INSECT BIOCHEM MOLEC, V33, P701, DOI 10.1016/S0965-1748(03)00064-X; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liu N., 2011, PLOS ONE, V6; Liu ZW, 2003, PEST MANAG SCI, V59, P1355, DOI 10.1002/ps.768; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miller RJ, 1999, J MED ENTOMOL, V36, P533, DOI 10.1093/jmedent/36.5.533; Miyazaki M, 1996, MOL GEN GENET, V252, P61, DOI 10.1007/BF02173205; Moores GD, 1998, PESTIC BIOCHEM PHYS, V62, P164, DOI 10.1006/pest.1998.2373; Morin S, 2002, INSECT BIOCHEM MOLEC, V32, P1781, DOI 10.1016/S0965-1748(02)00137-6; Nakao T, 2011, J ECON ENTOMOL, V104, P646, DOI 10.1603/EC10391; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; OPPENOORTH FJ, 1979, PESTIC BIOCHEM PHYS, V11, P176, DOI 10.1016/0048-3575(79)90057-9; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Shen B, 2003, PESTIC BIOCHEM PHYS, V75, P19, DOI 10.1016/S0048-3575(03)00014-2; Silva AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036366; Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Tan J, 2002, INSECT BIOCHEM MOLEC, V32, P445, DOI 10.1016/S0965-1748(01)00122-9; Tang J, 2010, PEST MANAG SCI, V66, P121, DOI 10.1002/ps.1836; Vontas J, 2007, INSECT MOL BIOL, V16, P315, DOI 10.1111/j.1365-2583.2007.00728.x; Vontas J, 2005, INSECT MOL BIOL, V14, P509, DOI 10.1111/j.1365-2583.2005.00582.x; Wang Li-Hua, 2008, Acta Entomologica Sinica, V51, P930; Wang LH, 2010, PEST MANAG SCI, V66, P1096, DOI 10.1002/ps.1984; WHEELOCK GD, 1992, PESTIC BIOCHEM PHYS, V43, P67, DOI 10.1016/0048-3575(92)90020-Z; Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108; Yang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029418; Yang YH, 2008, PESTIC BIOCHEM PHYS, V92, P101, DOI 10.1016/j.pestbp.2008.07.001; Yang YH, 2006, J ECON ENTOMOL, V99, P1784, DOI 10.1603/0022-0493-99.5.1784; Zeng JW, 2012, SCI HORTIC-AMSTERDAM, V134, P32, DOI 10.1016/j.scienta.2011.10.018; Zhai, 2006, B ENTOMOL, P141; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhang YL, 2012, PESTIC BIOCHEM PHYS, V104, P277, DOI 10.1016/j.pestbp.2012.10.002; Zhu F, 2008, INSECT MOL BIOL, V17, P27, DOI 10.1111/j.1365-2583.2008.00777.x; Zhu YC, 2003, INSECT MOL BIOL, V12, P39, DOI 10.1046/j.1365-2583.2003.00385.x; Zhu Yu Cheng, 2012, PLoS One, V7, pe37586, DOI 10.1371/journal.pone.0037586; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031; Zimmer CT, 2011, PESTIC BIOCHEM PHYS, V100, P264, DOI 10.1016/j.pestbp.2011.04.011	65	64	75	6	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79443	10.1371/journal.pone.0079443	http://dx.doi.org/10.1371/journal.pone.0079443			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	23349917	gold, Green Submitted, Green Published			2022-12-25	WOS:000326503400115
J	Grange, LJ; Smith, CR				Grange, Laura J.; Smith, Craig R.			Megafaunal Communities in Rapidly Warming Fjords along the West Antarctic Peninsula: Hotspots of Abundance and Beta Diversity	PLOS ONE			English	Article							DEPTH-RELATED CHANGES; CLIMATE-CHANGE; SUBMARINE CANYONS; MARINE ECOSYSTEM; SEDIMENTATION; BIOMASS; VARIABILITY; SEA; MACROBENTHOS; PYCNOGONIDA	Glacio-marine fjords occur widely at high latitudes and have been extensively studied in the Arctic, where heavy meltwater inputs and sedimentation yield low benthic faunal abundance and biodiversity in inner-middle fjords. Fjord benthic ecosystems remain poorly studied in the subpolar Antarctic, including those in extensive fjords along the West Antarctic Peninsula (WAP). Here we test ecosystem predictions from Arctic fjords on three subpolar, glacio-marine fjords along the WAP. With seafloor photographic surveys we evaluate benthic megafaunal abundance, community structure, and species diversity, as well as the abundance of demersal nekton and macroalgal detritus, in soft-sediment basins of Andvord, Flandres and Barilari Bays at depths of 436-725 m. We then contrast these fjord sites with three open shelf stations of similar depths. Contrary to Arctic predictions, WAP fjord basins exhibited 3 to 38-fold greater benthic megafaunal abundance than the open shelf, and local species diversity and trophic complexity remained high from outer to inner fjord basins. Furthermore, WAP fjords contained distinct species composition, substantially contributing to beta and gamma diversity at 400-700 m depths along the WAP. The abundance of demersal nekton and macroalgal detritus was also substantially higher in WAP fjords compared to the open shelf. We conclude that WAP fjords are important hotspots of benthic abundance and biodiversity as a consequence of weak meltwater influences, low sedimentation disturbance, and high, varied food inputs. We postulate that WAP fjords differ markedly from their Arctic counterparts because they are in earlier stages of climate warming, and that rapid warming along the WAP will increase meltwater and sediment inputs, deleteriously impacting these biodiversity hotspots. Because WAP fjords also provide important habitat and foraging areas for Antarctic krill and baleen whales, there is an urgent need to develop better understanding of the structure, dynamics and climate-sensitivity of WAP subpolar fjord ecosystems.	[Grange, Laura J.; Smith, Craig R.] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Grange, LJ (corresponding author), Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England.	J.Grange@noc.soton.ac.uk	Grange, Laura/E-8495-2014	Grange, Laura/0000-0001-9222-6848	Office of Polar Programs (OPP), United States National Science Foundation [OPP-0636806, OPP-0732711]; Biological Oceanography Program (BIO OCE), United States National Science Foundation [BIO OCE-1155703]	Office of Polar Programs (OPP), United States National Science Foundation; Biological Oceanography Program (BIO OCE), United States National Science Foundation	This material is based upon work supported by the Office of Polar Programs (OPP), United States National Science Foundation under the LARISSA and FOODBANCS2 Projects Grant Nos. OPP-0636806 and OPP-0732711 respectively to C. R. S. Writing and publication costs were supported in part by the Biological Oceanography Program (BIO OCE), United States National Science Foundation under the BOWLs Project Grant No. BIO OCE-1155703 to C. R. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WB, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P82; [Anonymous], 1995, GLACIAL ENV; Arango CP, 2011, DEEP-SEA RES PT II, V58, P212, DOI 10.1016/j.dsr2.2010.05.019; ARNAUD F, 1987, ADV MAR BIOL, V24, P1; Ashley GM, 2000, GEOL SOC AM BULL, V112, P657, DOI 10.1130/0016-7606(2000)112<0657:MSAACG>2.3.CO;2; Barnes DKA, 2007, PHILOS T R SOC B, V362, P11, DOI 10.1098/rstb.2006.1951; Barry James P., 2003, Antarctic Research Series, V78, P327; Clarke A, 2007, PHILOS T R SOC B, V362, P149, DOI 10.1098/rstb.2006.1958; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; De Leo FC, 2010, P ROY SOC B-BIOL SCI, V277, P2783, DOI 10.1098/rspb.2010.0462; Domack E.W., 1996, ANTARCT RES SER, V70, P135, DOI [10.1029/AR070p0135, DOI 10.1029/AR070P0135]; DOMACK EW, 1993, ANTAR RES S, V60, P265; DOMACK EW, 1993, GEOL SOC AM BULL, V105, P1175, DOI 10.1130/0016-7606(1993)105<1175:OAPCOM>2.3.CO;2; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Fetzer I, 2002, POLAR BIOL, V25, P303, DOI 10.1007/s00300-001-0345-8; Glud RN, 2002, MAR ECOL PROG SER, V238, P15, DOI 10.3354/meps238015; GRIFFITH TW, 1989, MAR GEOL, V85, P181, DOI 10.1016/0025-3227(89)90153-9; Holte B, 1998, POLAR BIOL, V19, P375, DOI 10.1007/s003000050262; Hop H, 2002, POLAR RES, V21, P167, DOI 10.1111/j.1751-8369.2002.tb00073.x; Howe JA, 2010, SPECIAL PUBLICATION, V344; Jones DOB, 2007, POLAR BIOL, V30, P1579, DOI 10.1007/s00300-007-0319-6; Jones DOB, 2007, MAR BIOL RES, V3, P191, DOI 10.1080/17451000701455287; Kedra M, 2010, POLAR BIOL, V33, P1, DOI 10.1007/s00300-009-0679-1; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Mahon AR, 2008, MAR BIOL, V155, P315, DOI 10.1007/s00227-008-1029-5; McLeod RJ, 2010, LIMNOL OCEANOGR, V55, P2097, DOI 10.4319/lo.2010.55.5.2097; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Nowacek DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019173; Pabis K, 2011, POLAR BIOL, V34, P489, DOI 10.1007/s00300-010-0903-z; Pabis K, 2010, POLAR BIOL, V33, P141, DOI 10.1007/s00300-009-0692-4; Piepenburg D, 2002, POLAR BIOL, V25, P146, DOI 10.1007/s003000100322; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Renaud PE, 2007, POLAR BIOL, V30, P295, DOI 10.1007/s00300-006-0183-9; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Roman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013255; Runge JP, 2006, AM NAT, V167, P925, DOI 10.1086/503531; Schmidt K, 2011, LIMNOL OCEANOGR, V56, P1411, DOI 10.4319/lo.2011.56.4.1411; Sicinski J, 2011, DEEP-SEA RES PT II, V58, P30, DOI 10.1016/j.dsr2.2010.09.005; Simard Y, 1999, CAN J FISH AQUAT SCI, V56, P1182, DOI 10.1139/cjfas-56-7-1182; Skold M, 2003, MAR ECOL PROG SER, V250, P163, DOI 10.3354/meps250163; Smith CR, 2012, OCEANOGRAPHY, V25, P188, DOI 10.5670/oceanog.2012.94; Starmans A, 1999, MAR BIOL, V135, P269, DOI 10.1007/s002270050624; Steig EJ, 2009, NATURE, V457, P459, DOI 10.1038/nature07669; Sumida PYG, 2008, DEEP-SEA RES PT II, V55, P2465, DOI 10.1016/j.dsr2.2008.06.006; Syvitski J.P.M., 1987, FJORDS PROCESSES PRO; SYVITSKI JPM, 1989, ARCTIC, V42, P232; Thiele D, 2004, DEEP-SEA RES PT II, V51, P2311, DOI 10.1016/j.dsr2.2004.07.007; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Ugland KI, 2003, J ANIM ECOL, V72, P888, DOI 10.1046/j.1365-2656.2003.00748.x; Vetter EW, 2010, MAR ECOL-EVOL PERSP, V31, P183, DOI 10.1111/j.1439-0485.2009.00351.x; Ware C, 2011, MAR MAMMAL SCI, V27, P587, DOI 10.1111/j.1748-7692.2010.00427.x; Weslawski Jan Marcin, 2011, Marine Biodiversity, V41, P71, DOI 10.1007/s12526-010-0073-9; Wlodarska-Kowalczuk M, 1998, POLAR BIOL, V20, P66, DOI 10.1007/s003000050277; Wlodarska-Kowalczuk M, 2005, MAR ECOL PROG SER, V303, P31, DOI 10.3354/meps303031; Wlodarska-Kowalczuk M, 2004, POLAR BIOL, V27, P155, DOI 10.1007/s00300-003-0568-y; Wlodarska-Kowalczuk M, 2007, ESTUAR COAST SHELF S, V74, P274, DOI 10.1016/j.ecss.2007.04.017; Wlodarska-Kowalczuk M, 2012, MAR ECOL PROG SER, V463, P73, DOI 10.3354/meps09858	61	140	140	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e77917	10.1371/journal.pone.0077917	http://dx.doi.org/10.1371/journal.pone.0077917			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312442	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000327947800002
J	Williams, O; Gbadero, D; Edowhorhu, G; Brearley, A; Slusher, T; Lund, TC				Williams, Olatundun; Gbadero, Daniel; Edowhorhu, Grace; Brearley, Ann; Slusher, Tina; Lund, Troy C.			Glucose-6-Phosphate Dehydrogenase Deficiency in Nigerian Children	PLOS ONE			English	Article							ANEMIA	Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzymopathy and in Sub-Saharan Africa, is a significant cause of infection-and drug-induced hemolysis and neonatal jaundice. Our goals were to determine the prevalence of G6PD deficiency among Nigerian children of different ethnic backgrounds and to identify predictors of G6PD deficiency by analyzing vital signs and hematocrit and by asking screening questions about symptoms of hemolysis. We studied 1,122 children (561 males and 561 females) aged 1 month to 15 years. The mean age was 7.4 +/- 3.2 years. Children of Yoruba ethnicity made up the largest group (77.5%) followed by those Igbo descent (10.6%) and those of Igede (10.2%) and Tiv (1.8%) ethnicity. G6PD status was determined using the fluorescent spot method. We found that the overall prevalence of G6PD deficiency was 15.3% (24.1% in males, 6.6% in females). Yoruba children had a higher prevalence (16.9%) than Igede (10.5%), Igbo (10.1%) and Tiv (5.0%) children. The odds of G6PD deficiency were 0.38 times as high in Igbo children compared to Yoruba children (p = 0.0500). The odds for Igede and Tiv children were not significantly different from Yoruba children (p = 0.7528 and 0.9789 respectively). Mean oxygen saturation, heart rate and hematocrit were not significantly different in G6PD deficient and G6PD sufficient children. The odds of being G6PD deficient were 2.1 times higher in children with scleral icterus than those without (p = 0.0351). In conclusion, we determined the prevalence of G6PD deficiency in Nigerian sub-populations. The odds of G6PD deficiency were decreased in Igbo children compared to Yoruba children. There was no association between vital parameters or hematocrit and G6PD deficiency. We found that a history of scleral icterus may increase the odds of G6PD deficiency, but we did not exclude other common causes of icterus such as sickle cell disease or malarial infection.	[Williams, Olatundun; Slusher, Tina; Lund, Troy C.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Williams, Olatundun; Slusher, Tina; Lund, Troy C.] Univ Minnesota, Div Global Hlth, Minneapolis, MN USA; [Gbadero, Daniel] Bowen Univ, Teaching Hosp, Dept Pediat, Ogbomosho, Nigeria; [Edowhorhu, Grace] Bowen Univ, Teaching Hosp, Dept Lab Med, Ogbomosho, Nigeria; [Brearley, Ann] Univ Minnesota, Biostat Design & Anal Ctr, Clin & Translat Sci Inst, Minneapolis, MN USA; [Lund, Troy C.] Univ Minnesota, Div Blood & Marrow Transplant, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lund, TC (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.	lundx072@umn.edu			National Center for Research Resources [UL1TR000114]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Biostatistics was made available through grant UL1TR000114 from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, B WORLD HEALTH ORGAN, V67, P601; BEUTLER E, 1968, BLOOD, V32, P816, DOI 10.1182/blood.V32.5.816.816; BIENZLE U, 1975, BLOOD, V46, P591, DOI 10.1182/blood.V46.4.591.591; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8; Kaplan M, 2011, SEMIN PERINATOL, V35, P155, DOI 10.1053/j.semperi.2011.02.010; May J, 2000, TROP MED INT HEALTH, V5, P119, DOI 10.1046/j.1365-3156.2000.00529.x; Orimadegun AE, 2011, J INFECT DEV COUNTR, V5, P792, DOI 10.3855/jidc.1837; Peters AL, 2009, J HISTOCHEM CYTOCHEM, V57, P1003, DOI 10.1369/jhc.2009.953828; STEINBERG MH, 1988, BLOOD, V71, P748	10	39	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68800	10.1371/journal.pone.0068800	http://dx.doi.org/10.1371/journal.pone.0068800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	24349006	Green Submitted, Green Published, gold			2022-12-25	WOS:000321718700041
J	Wang, CJ; Song, XD; Li, YJ; Han, F; Gao, SY; Wang, XZ; Xie, SY; Lv, CJ				Wang, Congjie; Song, Xiaodong; Li, Youjie; Han, Fang; Gao, Shuyan; Wang, Xiaozhi; Xie, Shuyang; Lv, Changjun			Low-Dose Paclitaxel Ameliorates Pulmonary Fibrosis by Suppressing TGF-beta 1/Smad3 Pathway via miR-140 Upregulation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; MONOCLONAL-ANTIBODY; CELLS; SMAD3; INHIBITION; MODEL; FIBROBLASTS; TISSUE	Abnormal TGF-beta 1/Smad3 activation plays an important role in the pathogenesis of pulmonary fibrosis, which can be prevented by paclitaxel (PTX). This study aimed to investigate an antifibrotic effect of the low-dose PTX (10 to 50 nM in vitro, and 0.6 mg/kg in vivo). PTX treatment resulted in phenotype reversion of epithelial-mesenchymal transition (EMT) in alveolar epithelial cells (AECs) with increase of miR-140. PTX resulted in an amelioration of bleomycin (BLM)-induced pulmonary fibrosis in rats with reduction of the wet lung weight to body weight ratios and the collagen deposition. Our results further demonstrated that PTX inhibited the effect of TGF-beta 1 on regulating the expression of Smad3 and phosphorylated Smad3 (p-Smad3), and restored the levels of E-cadherin, vimentin and alpha-SMA. Moreover, lower miR-140 levels were found in idiopathic pulmonary fibrosis (IPF) patients, TGF-beta 1-treated AECs and BLM-instilled rat lungs. Through decreasing Smad3/p-Smad3 expression and upregulating miR-140, PTX treatment could significantly reverse the EMT of AECs and prevent pulmonary fibrosis of rats. The action of PTX to ameliorate TGF-beta 1-induced EMT was promoted by miR-140, which increased E-cadherin levels and reduced the expression of vimentin, Smad3 and p-Smad3. Collectively, our results demonstrate that low-dose PTX prevents pulmonary fibrosis by suppressing the TGF-beta 1/Smad3 pathway via upregulating miR-140.	[Wang, Congjie; Han, Fang; Gao, Shuyan; Lv, Changjun] Binzhou Med Univ, Dept Clin Med, Yantai, Peoples R China; [Song, Xiaodong] Binzhou Med Univ, Med Res Ctr, Yantai, Peoples R China; [Li, Youjie; Gao, Shuyan; Xie, Shuyang] Binzhou Med Univ, Key Lab Tumor Mol Biol, Dept Biochem & Mol Biol, Yantai, Peoples R China; [Wang, Xiaozhi] Binzhou Med Univ, Affiliated Hosp, Dept Resp Med, Binzhou, Peoples R China	Binzhou Medical University; Binzhou Medical University; Binzhou Medical University; Binzhou Medical University	Lv, CJ (corresponding author), Binzhou Med Univ, Dept Clin Med, Yantai, Peoples R China.	shuyangxie@yahoo.com.cn	Wang, Che/A-2784-2015; Li, Song/C-6701-2014; Zheng, Po Xing/M-3244-2014	Li, Song/0000-0003-2713-9136; Chiang-Ni, Chuan/0000-0002-0753-035X; Zheng, Po Xing/0000-0001-5827-5865; Jiang, Xun/0000-0002-3344-4797	National Natural Science Foundation of China [81273957]; Taishan Scholar Project; Important Project of Science and Technology of Shandong Province [2010GWZ20254, 2011GHY11501];  [NCET-10-0919]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Project; Important Project of Science and Technology of Shandong Province; 	This work was supported by the National Natural Science Foundation of China (Grant No. 81273957), NCET-10-0919, "Taishan Scholar Project" and Important Project of Science and Technology of Shandong Province (Grant No. 2010GWZ20254, 2011GHY11501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON IYR, 1974, AM J PATHOL, V77, P185; ALLEN EM, 1977, J IMMUNOL, V119, P343; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Bocchino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014003; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; BRAHN E, 1994, ARTHRITIS RHEUM, V37, P839, DOI 10.1002/art.1780370611; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Choi HS, 2007, J SURG RES, V141, P183, DOI 10.1016/j.jss.2006.12.558; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Dutsch-Wicherek M, 2010, AM J REPROD IMMUNOL, V63, P181, DOI 10.1111/j.1600-0897.2009.00803.x; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Hay ED, 1995, ACTA ANAT, V154, P8; HAY J, 1991, ARCH TOXICOL, V65, P81, DOI 10.1007/BF02034932; JULESELYSEE K, 1990, CLIN CHEST MED, V11, P1; Kage H, 2012, CURR OPIN PULM MED, V18, P517, DOI 10.1097/MCP.0b013e3283566721; Khalil N, 1996, AM J RESP CELL MOL, V14, P131, DOI 10.1165/ajrcmb.14.2.8630262; KHALIL N, 1989, J EXP MED, V170, P727, DOI 10.1084/jem.170.3.727; Kim JH, 2007, J KOREAN MED SCI, V22, P898, DOI 10.3346/jkms.2007.22.5.898; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; KUHN C, 1989, AM REV RESPIR DIS, V140, P1693, DOI 10.1164/ajrccm/140.6.1693; Liu SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047482; Liu XL, 2005, PLOS MED, V2, P1334, DOI 10.1371/journal.pmed.0020354; MCDONALD JA, 1986, J CLIN INVEST, V78, P1237, DOI 10.1172/JCI112707; Mitsuhashi H, 1996, AM J RESP CRIT CARE, V153, P369, DOI 10.1164/ajrccm.153.1.8542145; Murakami Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016081; Nicolas FE, 2008, RNA, V14, P2513, DOI 10.1261/rna.1221108; Pais H, 2010, RNA, V16, P489, DOI 10.1261/rna.1701210; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Robinson CM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-74; Sato N, 2000, AM J RESP CRIT CARE, V161, P1681, DOI 10.1164/ajrccm.161.5.9907104; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Sharma SK, 1996, AM J RESP CRIT CARE, V154, P193, DOI 10.1164/ajrccm.154.1.8680680; Silva CIS, 2007, J THORAC IMAG, V22, P221, DOI 10.1097/01.rti.0000213588.52343.13; Sun L, 2011, J PATHOL, V225, P364, DOI 10.1002/path.2961; SZAPIEL SV, 1979, AM REV RESPIR DIS, V120, P893; Tanaka KI, 2010, AM J PHYSIOL-LUNG C, V298, pL348, DOI 10.1152/ajplung.00289.2009; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Tardif G, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-148; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; THRALL RS, 1979, AM J PATHOL, V95, P117; Tran PL, 1997, J CLIN INVEST, V99, P608, DOI 10.1172/JCI119203; Uhal Bruce D., 1998, American Journal of Physiology, V275, pL1192; Vanderburg CR, 1996, ACTA ANAT, V157, P87; Venkatesan N, 2004, AM J PHYSIOL-LUNG C, V287, pL1342, DOI 10.1152/ajplung.00035.2004; Wang HD, 2002, AM J RESP CRIT CARE, V165, P406, DOI 10.1164/ajrccm.165.3.2003149; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Zhang DS, 2010, LAB INVEST, V90, P436, DOI 10.1038/labinvest.2009.149; Zhao JS, 2002, AM J PHYSIOL-LUNG C, V282, pL585, DOI 10.1152/ajplung.00151.2001; Zhao LJ, 2011, J SURG RES, V171, P819, DOI 10.1016/j.jss.2010.04.059; Zhou J, 2010, WORLD J GASTROENTERO, V16, P3330, DOI 10.3748/wjg.v16.i26.3330; Zhou YC, 2011, INT J RADIAT ONCOL, V81, P1530, DOI 10.1016/j.ijrobp.2011.06.1956; Zhu SK, 2004, CIRC RES, V94, P617, DOI 10.1161/01.RES.0000118599.25944.D5	68	107	118	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70725	10.1371/journal.pone.0070725	http://dx.doi.org/10.1371/journal.pone.0070725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967091	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000012
J	Wang, C; Tian, LL; Li, S; Li, HB; Zhou, Y; Wang, H; Yang, QZ; Ma, LJ; Shang, DJ				Wang, Che; Tian, Li-Li; Li, Song; Li, Hui-Bing; Zhou, Yang; Wang, He; Yang, Qing-Zhu; Ma, Li-Jie; Shang, De-Jing			Rapid Cytotoxicity of Antimicrobial Peptide Tempoprin-1CEa in Breast Cancer Cells through Membrane Destruction and Intracellular Calcium Mechanism	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; CHINESE BROWN FROG; SYSTEMIC INOCULATION; RANA-CHENSINENSIS; TUMOR-GROWTH; APOPTOSIS; DEATH; LINES; PHOSPHATIDYLSERINE; MITOCHONDRIA	Temporin-1CEa is an antimicrobial peptide isolated from the skin secretions of the Chinese brown frog (Rana chensinensis). We have previously reported the rapid and broad-spectrum anticancer activity of temporin-1CEa in vitro. However, the detailed mechanisms for temporin-1CEa-induced cancer cell death are still weakly understood. In the present study, the mechanisms of temporin-1CEa-induced rapid cytotoxicity on two human breast cancer cell lines, MDA-MB-231 and MCF-7, were investigated. The MTT assay and the LDH leakage assay indicated that one-hour of incubation with temporin-1CEa led to cytotoxicity in a dose-dependent manner. The morphological observation using electronic microscopes suggested that one-hour exposure of temporin-1CEa resulted in profound morphological changes in both MDA-MB-231 and MCF-7 cells. The membrane-disrupting property of temporin-1CEa was further characterized by induction of cell-surface exposure of phosphatidylserine, elevation of plasma membrane permeability and rapid depolarization of transmembrane potential. Moreover, temporin-1CEa evoked intracellular calcium ion and reactive oxygen species (ROS) elevations as well as collapse of mitochondrial membrane potential (Delta phi m). In summary, the present study indicates that temporin-1CEa triggers rapid cell death in breast cancer cells. This rapid cytotoxic activity might be mediated by both membrane destruction and intracellular calcium mechanism.	[Wang, Che; Tian, Li-Li; Wang, He; Yang, Qing-Zhu; Shang, De-Jing] Liaoning Normal Univ, Liaoning Prov Key Lab Biotechnol & Drug Discovery, Dalian, Peoples R China; [Wang, Che; Li, Hui-Bing; Zhou, Yang; Ma, Li-Jie] Liaoning Normal Univ, Dept Pharm, Sch Chem & Chem Engn, Dalian, Peoples R China; [Li, Song] Dalian Univ Technol, Lab Biophys & Pharmacol, Sch Phys & Optoelect Engn, Dalian, Peoples R China; [Shang, De-Jing] Liaoning Normal Univ, Fac Life Sci, Dalian, Peoples R China	Liaoning Normal University; Liaoning Normal University; Dalian University of Technology; Liaoning Normal University	Shang, DJ (corresponding author), Liaoning Normal Univ, Liaoning Prov Key Lab Biotechnol & Drug Discovery, Dalian, Peoples R China.	dejingshang@yahoo.com	Wang, Che/A-2784-2015; Li, Song/C-6701-2014; Zheng, Po Xing/M-3244-2014	Li, Song/0000-0003-2713-9136; Chiang-Ni, Chuan/0000-0002-0753-035X; Zheng, Po Xing/0000-0001-5827-5865; Jiang, Xun/0000-0002-3344-4797	National Natural Science Foundation of China [30970352, 81202448, 31272314]; Scientific Research Fund of Liaoning Provincial Education Department [L2012382]; Program for Liaoning Innovative Research Team in University [LT2012019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Liaoning Provincial Education Department; Program for Liaoning Innovative Research Team in University	This work was supported by the National Natural Science Foundation of China (30970352, 81202448 and 31272314), the Scientific Research Fund of Liaoning Provincial Education Department (L2012382), and the Program for Liaoning Innovative Research Team in University (LT2012019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Benna S, 2011, INT J MOL SCI, V12, P8027, DOI 10.3390/ijms12118027; Ausbacher D, 2012, BBA-BIOMEMBRANES, V1818, P2917, DOI 10.1016/j.bbamem.2012.07.005; Burdick MD, 1997, J BIOL CHEM, V272, P24198, DOI 10.1074/jbc.272.39.24198; Chan SC, 1998, ANTICANCER RES, V18, P4467; CRUCIANI RA, 1991, P NATL ACAD SCI USA, V88, P3792, DOI 10.1073/pnas.88.9.3792; Dennis J W, 1991, Semin Cancer Biol, V2, P411; Dobrzynska I, 2005, MOL CELL BIOCHEM, V276, P113, DOI 10.1007/s11010-005-3557-3; Eliassen LT, 2006, INT J CANCER, V119, P493, DOI 10.1002/ijc.21886; Franco R, 2006, J MEMBRANE BIOL, V209, P43, DOI 10.1007/s00232-005-0837-5; Helmerhorst EJ, 1999, J BIOL CHEM, V274, P7286, DOI 10.1074/jbc.274.11.7286; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Kulkarni MM, 2009, J BIOL CHEM, V284, P15496, DOI 10.1074/jbc.M809079200; Li J, 2000, NAT MED, V6, P49, DOI 10.1038/71527; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Lin VCL, 2003, AM J PATHOL, V162, P1781, DOI 10.1016/S0002-9440(10)64313-1; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Mader JS, 2007, EXP CELL RES, V313, P2634, DOI 10.1016/j.yexcr.2007.05.015; Mader JS, 2006, EXPERT OPIN INV DRUG, V15, P933, DOI 10.1517/13543784.15.8.933; Mader JS, 2005, MOL CANCER THER, V4, P612, DOI 10.1158/1535-7163.MCT-04-0077; Makovitzki A, 2009, CANCER RES, V69, P3458, DOI 10.1158/0008-5472.CAN-08-3021; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Papo N, 2006, CANCER RES, V66, P5371, DOI 10.1158/0008-5472.CAN-05-4569; Paredes-Gamero EJ, 2012, BBA-GEN SUBJECTS, V1820, P1062, DOI 10.1016/j.bbagen.2012.02.015; Perez-Tomas R, 2006, CURR MED CHEM, V13, P1859, DOI 10.2174/092986706777585077; Schweizer F, 2009, EUR J PHARMACOL, V625, P190, DOI 10.1016/j.ejphar.2009.08.043; Segura C, 2007, BIOCHEM BIOPH RES CO, V353, P908, DOI 10.1016/j.bbrc.2006.12.113; Shang DJ, 2009, ZOOL SCI, V26, P220, DOI 10.2108/zsj.26.220; Steinstraesser L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018321; Sureda FX, 1997, CYTOMETRY, V28, P74, DOI 10.1002/(SICI)1097-0320(19970501)28:1<74::AID-CYTO9>3.0.CO;2-H; Tan JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022836; Tu YF, 2011, BBA-BIOENERGETICS, V1807, P1125, DOI 10.1016/j.bbabio.2011.04.015; UTSUGI T, 1991, CANCER RES, V51, P3062; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang C, 2012, BIOCHIMIE, V94, P434, DOI 10.1016/j.biochi.2011.08.011; Yoon WH, 1996, BIOCHEM BIOPH RES CO, V222, P694, DOI 10.1006/bbrc.1996.0806	36	107	118	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60462	10.1371/journal.pone.0060462	http://dx.doi.org/10.1371/journal.pone.0060462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23967091	gold, Green Published			2022-12-25	WOS:000319109800052
J	Zhu, X; Silva, LCR; Doane, TA; Horwath, WR				Zhu, Xia; Silva, Lucas C. R.; Doane, Timothy A.; Horwath, William R.			Iron: The Forgotten Driver of Nitrous Oxide Production in Agricultural Soil	PLOS ONE			English	Article							SPECTROPHOTOMETRIC DETERMINATION; WETLAND SOILS; NO EMISSIONS; FERROUS IRON; OXIDATION; REDUCTION; N2O; NITRATE; MICROORGANISMS; HYDROXYLAMINE	In response to rising interest over the years, many experiments and several models have been devised to understand emission of nitrous oxide (N2O) from agricultural soils. Notably absent from almost all of this discussion is iron, even though its role in both chemical and biochemical reactions that generate N2O was recognized well before research on N2O emission began to accelerate. We revisited iron by exploring its importance alongside other soil properties commonly believed to control N2O production in agricultural systems. A set of soils from California's main agricultural regions was used to observe N2O emission under conditions representative of typical field scenarios. Results of multivariate analysis showed that in five of the twelve different conditions studied, iron ranked higher than any other intrinsic soil property in explaining observed emissions across soils. Upcoming studies stand to gain valuable information by considering iron among the drivers of N2O emission, expanding the current framework to include coupling between biotic and abiotic reactions.	[Zhu, Xia] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Zhu, Xia] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhu, Xia; Silva, Lucas C. R.; Doane, Timothy A.; Horwath, William R.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Davis	Doane, TA (corresponding author), Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA.	tadoane@ucdavis.edu	Zhu-Barker, Xia/F-1520-2015; Silva, Lucas C R/E-1202-2016; Silva, Lucas/GQH-8201-2022; Silva, Lucas/AAA-2476-2022; Feng, Yingang/B-6304-2008	Zhu-Barker, Xia/0000-0001-9050-3696; Silva, Lucas C R/0000-0002-4838-327X; Silva, Lucas/0000-0002-4838-327X; zhu, xinshu/0000-0002-2238-539X; He, Zhili/0000-0001-8225-7333; Feng, Yingang/0000-0002-0879-1316	California Department of Resources Recycling and Recovery [IWM09027]; J. G. Boswell Endowed Chair in Soil Science; University of California Agricultural Experiment Station	California Department of Resources Recycling and Recovery; J. G. Boswell Endowed Chair in Soil Science; University of California Agricultural Experiment Station(University of California System)	Support was provided by the California Department of Resources Recycling and Recovery (www.calrecycle.ca.gov), Agreement IWM09027; the J. G. Boswell Endowed Chair in Soil Science; and the University of California Agricultural Experiment Station (http://caes.ucdavis.edu/research/agexpstn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengtsson G, 2002, J CHEM SOC DALTON, P2548, DOI 10.1039/b201602h; BOUWMAN AF, 1993, GLOBAL BIOGEOCHEM CY, V7, P557, DOI 10.1029/93GB01186; Bouwman AF, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI [10.1029/2001GB001811, 10.1029/2001GB001812]; BREMNER JM, 1946, NATURE, V158, P790, DOI 10.1038/158790b0; Bremner JM, 1997, NUTR CYCL AGROECOSYS, V49, P7, DOI 10.1023/A:1009798022569; BREMNER JM, 1980, SOIL BIOL BIOCHEM, V12, P263, DOI 10.1016/0038-0717(80)90072-3; BURESH RJ, 1976, J ENVIRON QUAL, V5, P320, DOI 10.2134/jeq1976.00472425000500030021x; Burger M, 2011, ACS SYM SER, V1072, P179; Burt R, 1992, 42 USDA; CASSEL DK, 1986, AGRONOMY, V9, P901; Chalamet A, 1976, SOIL BIOL BIOCHEM, V9, P281; CHAO TT, 1966, SOIL SCI SOC AM PRO, V30, P193, DOI 10.2136/sssaj1966.03615995003000020016x; Clement JC, 2005, SOIL BIOL BIOCHEM, V37, P2323, DOI 10.1016/j.soilbio.2005.03.027; Davidson EA, 2000, BIOSCIENCE, V50, P667, DOI 10.1641/0006-3568(2000)050[0667:TACMOS]2.0.CO;2; Doane TA, 2003, ANAL LETT, V36, P2713, DOI 10.1081/AL-120024647; Dobbie KE, 1999, J GEOPHYS RES-ATMOS, V104, P26891, DOI 10.1029/1999JD900378; Dominik P, 2000, TALANTA, V51, P701, DOI 10.1016/S0039-9140(99)00324-0; EICHNER MJ, 1990, J ENVIRON QUAL, V19, P272, DOI 10.2134/jeq1990.00472425001900020013x; Finzi AC, 2011, FRONT ECOL ENVIRON, V9, P74, DOI 10.1890/100137; Freibauer A, 2003, BIOGEOCHEMISTRY, V63, P93, DOI 10.1023/A:1023398108860; Freney JR, 1997, NUTR CYCL AGROECOSYS, V49, P1, DOI 10.1023/A:1009702832489; Glass JB, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00061; Goetz O., 2010, HDB PARTIAL LEAST SQ, P411, DOI [10.1007/978-3-540-32827-8_33, DOI 10.1007/978-3-540-32827-8]; HANSEN HCB, 1994, GEOCHIM COSMOCHIM AC, V58, P2599, DOI 10.1016/0016-7037(94)90131-7; HENDRICKSON AH, 1945, PLANT PHYSIOL, V20, P517, DOI 10.1104/pp.20.4.517; Li CS, 2000, J GEOPHYS RES-ATMOS, V105, P4369, DOI 10.1029/1999JD900949; LOVELAND PJ, 1984, J SOIL SCI, V35, P243, DOI 10.1111/j.1365-2389.1984.tb00280.x; LOVLEY DR, 1987, APPL ENVIRON MICROB, V53, P1536, DOI 10.1128/AEM.53.7.1536-1540.1987; Marcoulides GA, 2009, MIS QUART, V33, P171; MEIKLEJOHN J, 1953, J GEN MICROBIOL, V8, P58, DOI 10.1099/00221287-8-1-58; Reay DS, 2012, NAT CLIM CHANGE, V2, P410, DOI 10.1038/NCLIMATE1458; ROBERTSON K, 1994, J ENVIRON QUAL, V23, P805, DOI 10.2134/jeq1994.00472425002300040027x; Sahrawat K. L., 1986, Advances in Soil Science, USA, V4, P103; SCHUPPLI PA, 1983, SOIL SCI SOC AM J, V47, P1026, DOI 10.2136/sssaj1983.03615995004700050037x; Shrestha J, 2009, SOIL SCI, V174, P156, DOI 10.1097/SS.0b013e3181988fbf; Silver WL, 2011, IRON REDOX ENGINE DR; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Skiba U., 2000, CHEMOSPHERE GLOBAL C, V2, P379, DOI DOI 10.1016/S1465-9972(00)00016-7; Stehfest E, 2006, NUTR CYCL AGROECOSYS, V74, P207, DOI 10.1007/s10705-006-9000-7; Straub KL, 1996, APPL ENVIRON MICROB, V62, P1458, DOI 10.1128/AEM.62.4.1458-1460.1996; Tenenhaus M, 2005, COMPUT STAT DATA AN, V48, P159, DOI 10.1016/j.csda.2004.03.005; Thomson AJ, 2012, PHILOS T R SOC B, V367, P1157, DOI 10.1098/rstb.2011.0415; Veihmeyer FJ, 1931, SOIL SCI, V32, P181, DOI 10.1097/00010694-193109000-00003; VERDOUW H, 1978, WATER RES, V12, P399, DOI 10.1016/0043-1354(78)90107-0; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490; Williams EJ, 1992, GLOBAL BIOGEOCHEM CY, V6, P351, DOI 10.1029/92GB02124	46	194	208	28	177	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60146	10.1371/journal.pone.0060146	http://dx.doi.org/10.1371/journal.pone.0060146			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555906	Green Published, gold, Green Submitted			2022-12-25	WOS:000317263900060
J	Zhu, XY; Li, P; Yang, YB; Liu, ML				Zhu, Xin-Yuan; Li, Pei; Yang, Ya-Bing; Liu, Mei-Lin			Xuezhikang, Extract of Red Yeast Rice, Improved Abnormal Hemorheology, Suppressed Caveolin-1 and Increased eNOS Expression in Atherosclerotic Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; BLOOD-CELLS; HEART-DISEASE; ERYTHROCYTES; VISCOSITY; AORTA; DEFORMABILITY; PATHOGENESIS; ACTIVATION; PATHWAY	Background: Xuezhikang is the extract of red yeast rice, which has been widely used for the management of atherosclerotic disease, but the molecular basis of its antiatherosclerotic effects has not yet been fully identified. Here we investigated the changes of eNOS in vascular endothelia and RBCs, eNOS regulatory factor Caveolin-1 in endothelia, and hemorheological parameters in atherosclerotic rats to explore the protective effects of Xuezhikang. Methodology/Principal Findings: Wistar rats were divided into 4 groups (n = 12/group) group C, controls; group M, high-cholesterol diet (HCD) induced atherosclerotic models; group X, HCD+Xuezhikang; and group L, HCD+Lovastatin. In group X, Xuezhikang inhibited oxidative stress, down-regulated caveolin-1 in aorta wall (P<0.05), up-regulated eNOS expression in vascular endothelia and erythrocytes (P<0.05), increased NOx (nitrite and nitrate) in plasma and cGMP in erythrocyte plasma and aorta wall (P<0.05), increased erythrocyte deformation index (EDI), and decreased whole blood viscosity and plasma viscosity (P<0.05), with the improvement of arterial pathology. Conclusions/Significance: Xuezhikang up-regulated eNOS expression in vascular endothelia and RBCs, increased plasma NOx and improved abnormal hemorheology in high cholesterol diet induced atherosclerotic rats. The elevated eNOS/NO and improved hemorheology may be beneficial to atherosclerotic disease.	[Zhu, Xin-Yuan; Li, Pei; Yang, Ya-Bing; Liu, Mei-Lin] Peking Univ, Dept Geriatr, Hosp 1, Beijing 100871, Peoples R China	Peking University	Liu, ML (corresponding author), Peking Univ, Dept Geriatr, Hosp 1, Beijing 100871, Peoples R China.	meilinliu@yahoo.com	Zhu-Barker, Xia/F-1520-2015; Silva, Lucas C R/E-1202-2016; Silva, Lucas/GQH-8201-2022; Silva, Lucas/AAA-2476-2022; Feng, Yingang/B-6304-2008	Zhu-Barker, Xia/0000-0001-9050-3696; Silva, Lucas C R/0000-0002-4838-327X; Silva, Lucas/0000-0002-4838-327X; zhu, xinshu/0000-0002-2238-539X; He, Zhili/0000-0001-8225-7333; Feng, Yingang/0000-0002-0879-1316	China Health & Medical Development Foundation	China Health & Medical Development Foundation	This work was supported by China Health & Medical Development Foundation (http://www.chmdf.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almofti MR, 2006, CLIN EXP PHARMACOL P, V33, P305, DOI 10.1111/j.1440-1681.2006.04366.x; Bor-Kucukatay M, 2003, AM J PHYSIOL-HEART C, V284, pH1577, DOI 10.1152/ajpheart.00665.2002; Chen LY, 1998, J CARDIOVASC PHARM, V32, P57, DOI 10.1097/00005344-199807000-00009; Cokic VP, 2008, BLOOD, V111, P1117, DOI 10.1182/blood-2007-05-088732; Cortese-Krott MM, 2012, BLOOD, V120, P4229, DOI 10.1182/blood-2012-07-442277; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Engel D, 2011, FASEB J, V25, P3838, DOI 10.1096/fj.11-183350; Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125; Gladwin MT, 2003, NAT MED, V9, P496, DOI 10.1038/nm0503-496; Gori T, 2011, CLIN HEMORHEOL MICRO, V49, P37, DOI 10.3233/CH-2011-1455; HAHN R, 1989, ANGIOLOGY, V40, P914, DOI 10.1177/000331978904001010; Herold S, 2004, INORG CHEM, V43, P3783, DOI 10.1021/ic035340a; Heyman SN, 1999, MICROCIRCULATION, V6, P199; Horn P, 2011, FREE RADICAL RES, V45, P653, DOI 10.3109/10715762.2011.574288; Huang ZY, 2004, LIFE SCI, V75, P3103, DOI 10.1016/j.lfs.2004.04.054; JORIS I, 1983, AM J PATHOL, V113, P341; Jubelin BC, 1996, AM J HYPERTENS, V9, P1214, DOI 10.1016/S0895-7061(96)00257-9; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; Koenig W, 1998, ARTERIOSCL THROM VAS, V18, P768, DOI 10.1161/01.ATV.18.5.768; Korbut RA, 2002, J PHYSIOL PHARMACOL, V53, P655; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; Kuwai T, 2006, J ATHEROSCLER THROMB, V13, P286, DOI 10.5551/jat.13.286; Lam TY, 2006, EUR J PHARMACOL, V546, P134, DOI 10.1016/j.ejphar.2006.07.003; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Lee AJ, 1998, CIRCULATION, V97, P1467; Lee BK, 2008, CLIN HEMORHEOL MICRO, V39, P43, DOI 10.3233/CH-2008-1066; Li HG, 2000, J PATHOL, V190, P244, DOI 10.1002/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8; Li JJ, 2005, CLIN CHIM ACTA, V352, P217, DOI 10.1016/j.cccn.2004.09.026; Lu ZL, 2008, AM J CARDIOL, V101, P1689, DOI 10.1016/j.amjcard.2008.02.056; Ma JY, 2000, J AGR FOOD CHEM, V48, P5220, DOI 10.1021/jf000338c; MONCADA S, 1991, PHARMACOL REV, V43, P109; Ozuyaman B, 2008, TRENDS MOL MED, V14, P314, DOI 10.1016/j.molmed.2008.05.002; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Rassaf T, 2003, NAT MED, V9, P481, DOI 10.1038/nm0503-481; Recchia FA, 2000, AM J PHYSIOL-HEART C, V279, pH852, DOI 10.1152/ajpheart.2000.279.2.H852; Toda N, 2011, INT J ANGIOL, V20, P121, DOI 10.1055/s-0031-1283220; Tsuda K, 2000, BIOCHEM BIOPH RES CO, V275, P946, DOI 10.1006/bbrc.2000.3408; Xue ZH, 2007, CLIN EXP PHARMACOL P, V34, P27, DOI 10.1111/j.1440-1681.2007.04547.x; Zorio E, 2008, CLIN HEMORHEOL MICRO, V39, P33, DOI 10.3233/CH-2008-1065	40	194	208	28	177	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62731	10.1371/journal.pone.0062731	http://dx.doi.org/10.1371/journal.pone.0062731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23555906	Green Submitted, gold, Green Published			2022-12-25	WOS:000318852400008
